Citrus Sinensis ID: 007167

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-----
Protein Sequence
MNFLPIFSAIFFLVGTIFLPIKADPVEDKQALLDFIHNIHNSRSLNWNESSSLCKSWTGVTCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLSSENARPPALPVQPPVAEPSRKKSTKLSEPALLGIALGGVALAFVICALLMICRYNKQDNDRIPVKSQKKEMSLKEGVSGSHDKNSKLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTENRSEISSSAATPKATETASSSTAHLDSFLS
Secondary Structure (PSIPRED)
cccHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHHcccccccccccccccccccEEEEEccccccEEEEEEcccccEEEccHHHHcccccccEEEcccccccccccccccccccccEEEcccccccccccccccccccccEEEccccccccccccccccccccccEEccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccEEEEccccccccHHHHHHHHccccccccccEEEEEEEccccEEEEEEcccccccHHHHHHHHHHHccccccccccccEEEEcccEEEEEEcccccccHHHHHccccccccccccHHHHHHHHHHHHHHHHHHHccccccccccccccccEEEcccccEEEccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHcccccccccccccccHHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHcccccccccccHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHHHccccccHHHHHHHHHHHHccccccccccccccccccEEEEEEcccccEEEEEEccccccccccccccccccccccEEEcccccccccccccccccccccEEEcccccccEEccccccccccccEEEcccccccEEccccccccccccEEEcccccccccccHHHcccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccEEEEEcccccccHHHHHHHHHHHcccccccEEEEEEcccccEEEEEEcccccccHHHHHHHHHHHHHHHHHccHEEEEEEcccccEEEEEEccccccHHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHHHccccEEEccccHHHEEcccccccEEccHcHHHHcccccccHccccccccHHHHcccccccccHHHHHHHHHHHHHccccccccccccccccHHHHHHHHHHHHHHHHHccHHHHccccHHHHHHHHHHHHHHHHHccccccccHHHHHHHHHHHcccccccccccccccccccccccccccccccccHHHHHHHcc
Coil and Loop (DISEMBL)
MNFLPIFSAIFFLVGtiflpikadpvedKQALLDFIHNIhnsrslnwnessslckswtgvtcsadhSRVVALrlpgmalrgeippntiGRLSALQNLSlrsnslsglfpsdfsklenlTSLHlqfnsfsgplpldfsvwnnltvidlsnnffnasipasISKLTHLSALNLannsltgtlprslqrfpswafagnnlssenarppalpvqppvaepsrkkstklsepalLGIALGGVALAFVICALLMICRYnkqdndripvksqkkemslkegvsgshdknsklvffegcnlvFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYyskdeklmvydyfepgsvsamlhgrrgegqssldwdTRVRIAIGAARGIAhihtenggklvhggikasNIFLNSQGHVCVSDIGLaalmspmpppamraagyrapevtdtrkatqasdvFSFGVLLLELLtgkspihatggdeVVHLVRWVNSVVREEWTAEVFDvellrypnIEEEMVEMLQVGMACVvrmpeerpkmADVLKMVEDIRRvkaenppstenrseisssaatpkatetassstahldsfls
Flexible Loop (DISEMBL)
MNFLPIFSAIFFLVGTIFLPIKADPVEDKQALLDFIHNIHNSRSLNWNESSSLCKSWTGVTCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLSSENARPPALPVQPPVAEPSRKKSTKLSEPALLGIALGGVALAFVICALLMICRYNkqdndripvksqkkemslkegvsgshdknsKLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRlkevnvgkrefeqqmeivggirhenvVALRAYYYSKDEKLMVYDYFEPGSVSAMLHgrrgegqssldwdTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVreewtaevfdvELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRrvkaenppstenrseisssaatpkatetassstahldsfls
Low Complexity Region (SEG)
MNFLPIFSAIFFLVGTIFLPIKADPVEDKQALLDFIHNIHNSRSLNWNESSSLCKSWTGVTCSADHSRVVALRLPGMALRGEIPPNTIGrlsalqnlslrsnslsGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKlthlsalnlannsltgtlPRSLQRFPSWAFAGNNLSSENARPPALPVQPPVAEPSRKKSTKLSEPallgialggvalaFVICALLMICRYNKQDNDRIPVKSQKKEMSLKEGVSGSHDKNSKLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVriaigaargiahihTENGGKLVHGGIKASNIFLNSQGHVCVSDIglaalmspmpppamraagyrapEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTENRSEISSSAATPKATETASSSTAHLDSFLS
Disordered region (IsUnstruct)
**FLPIFSAIFFLVGTIFLPIKADPVEDKQALLDFIHNIHNSRSLNWNESSSLCKSWTGVTCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFA**********************************ALLGIALGGVALAFVICALLMICRYNK*****************************KLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHG******SSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALM**************************ASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRM***********************************************************
Disordered Region (DISOPRED)
*NFLPIFSAIFFLVGTIFLPIKADPVEDKQALLDFIHNIHNSRSLNWNESSSLCKSWTGVTCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLSSE*****************************LGIALGGVALAFVICALLMICRYN********************************VFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVG*REFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIH*****EVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMV*********************************************
Disordered Region (DISEMBL)
MNFLPIFSAIFFLVGTIFLPIKADPVEDKQALLDFIHNIHNSRSLNWNESSSLCKSWTGVTCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLSSEN***********************SEPALLGIALGGVALAFVICALLMICRYNKQDNDRIPVK***************HDKNSKLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLH*********LDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAE************************************
Disordered Region (DISPRO)
MNFLPIFSAIFFLVGTIFLPIKADPVEDKQALLDFIHNIHNSRSLNWNESSSLCKSWTGVTCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLSSENARPPALPV**************LSEPALLGIALGGVALAFVICALLMICRYNKQ**************************NSKLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR****************************************
Transmembrane Helix (TMHMM)
oooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MNFLPIFSAIFFLVGTIFLPIKADPVEDKQALLDFIHNIHNSRSLNWNESSSLCKSWTGVTCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLSSENARPPALPVQPPVAEPSRKKSTKLSEPALLGIALGGVALAFVICALLMICRYNKQDNDRIPVKSQKKEMSLKEGVSGSHDKNSKLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTENRSEISSSAATPKATETASSSTAHLDSFLS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	615	2.2.26 [Sep-21-2011]
Q9SUQ3	638	Probable inactive recepto	yes	no	0.934	0.901	0.578	0.0
Q9FK10	601	Probable inactive recepto	no	no	0.905	0.926	0.528	1e-167
Q9SH71	587	Putative inactive recepto	no	no	0.891	0.933	0.511	1e-158
Q9LVM0	654	Probable inactive recepto	no	no	0.947	0.891	0.483	1e-156
Q9FL63	614	Inactive leucine-rich rep	no	no	0.905	0.907	0.465	1e-153
Q9C9Y8	640	Probable inactive recepto	no	no	0.944	0.907	0.479	1e-152
Q9FHK7	640	Probable leucine-rich rep	no	no	0.941	0.904	0.450	1e-141
Q9LP77	655	Probable inactive recepto	no	no	0.882	0.829	0.426	1e-126
Q9LVI6	647	Probable inactive recepto	no	no	0.897	0.853	0.415	1e-122
Q9M8T0	627	Probable inactive recepto	no	no	0.907	0.889	0.397	1e-113

>sp|Q9SUQ3|Y4374_ARATH Probable inactive receptor kinase At4g23740 OS=Arabidopsis thaliana GN=At4g23740 PE=1 SV=1

 Score =  692 bits (1787), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 354/612 (57%), Positives = 450/612 (73%), Gaps = 37/612 (6%)

Query: 23  ADPVEDKQALLDFIHNIHNSRSLNWNESSSLCKSWTGVTCSADHSRVVALRLPGMALRGE 82
           +DP+EDK+ALL+F+  +  +RSLNWNE+S +C  WTGVTC+ D SR++A+RLPG+ L G+
Sbjct: 24  SDPLEDKRALLEFLTIMQPTRSLNWNETSQVCNIWTGVTCNQDGSRIIAVRLPGVGLNGQ 83

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNL 142
           IPPNTI RLSAL+ LSLRSN +SG FP DF +L++L  L+LQ N+ SGPLPLDFSVW NL
Sbjct: 84  IPPNTISRLSALRVLSLRSNLISGEFPKDFVELKDLAFLYLQDNNLSGPLPLDFSVWKNL 143

Query: 143 TVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLP-----RSLQRF---------- 187
           T ++LSNN FN +IP+S+S+L  + +LNLANN+L+G +P      SLQ            
Sbjct: 144 TSVNLSNNGFNGTIPSSLSRLKRIQSLNLANNTLSGDIPDLSVLSSLQHIDLSNNYDLAG 203

Query: 188 --PSW--AFAGNNLSSENARPPA----LPVQPPVAEPSRKKSTK-----LSEPALL---- 230
             P W   F  ++ +  +  PP     L   PP +E + +K +K     LSE   L    
Sbjct: 204 PIPDWLRRFPFSSYTGIDIIPPGGNYTLVTPPPPSEQTHQKPSKARFLGLSETVFLLIVI 263

Query: 231 -GIALGGVALAFVICALLMICRYNKQDNDRIPVKSQKKE-MSLKEGVSGSHDKNSKLVFF 288
               +   ALAFV+    +  +  + D      K QKK  MS ++ VS   D N++L FF
Sbjct: 264 AVSIVVITALAFVLTVCYVRRKLRRGDGVISDNKLQKKGGMSPEKFVSRMEDVNNRLSFF 323

Query: 289 EGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEI 348
           EGCN  FDLEDLLRASAEVLGKGTFGT YKA LEDA++V VKRLK+V  GKR+FEQQMEI
Sbjct: 324 EGCNYSFDLEDLLRASAEVLGKGTFGTTYKAVLEDATSVAVKRLKDVAAGKRDFEQQMEI 383

Query: 349 VGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIG 408
           +GGI+HENVV L+AYYYSKDEKLMVYDYF  GSV+++LHG RGE +  LDW+TR++IAIG
Sbjct: 384 IGGIKHENVVELKAYYYSKDEKLMVYDYFSRGSVASLLHGNRGENRIPLDWETRMKIAIG 443

Query: 409 AARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRA 468
           AA+GIA IH EN GKLVHG IK+SNIFLNS+ + CVSD+GL A+MSP+ PP  R AGYRA
Sbjct: 444 AAKGIARIHKENNGKLVHGNIKSSNIFLNSESNGCVSDLGLTAVMSPLAPPISRQAGYRA 503

Query: 469 PEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVF 528
           PEVTDTRK++Q SDV+SFGV+LLELLTGKSPIH T GDE++HLVRWV+SVVREEWTAEVF
Sbjct: 504 PEVTDTRKSSQLSDVYSFGVVLLELLTGKSPIHTTAGDEIIHLVRWVHSVVREEWTAEVF 563

Query: 529 DVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI--RRVKAENPPSTEN 586
           D+ELLRY NIEEEMVEMLQ+ M+CVV+  ++RPKM+D+++++E++  RR   E  P  + 
Sbjct: 564 DIELLRYTNIEEEMVEMLQIAMSCVVKAADQRPKMSDLVRLIENVGNRRTSIEPEPELKP 623

Query: 587 RSEI-SSSAATP 597
           +SE  +S  +TP
Sbjct: 624 KSENGASETSTP 635

Arabidopsis thaliana (taxid: 3702)

>sp|Q9FK10|Y5332_ARATH Probable inactive receptor kinase At5g53320 OS=Arabidopsis thaliana GN=At5g53320 PE=1 SV=1

 Score =  589 bits (1518), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 325/615 (52%), Positives = 413/615 (67%), Gaps = 58/615 (9%)

Query: 9   AIFFLVGTIF-LPIKADPV-EDKQALLDFIHNIHNSRSLNWNESSSLCKSWTGVTCSADH 66
            +  L+  IF + I+A+ + EDK  LL F++NI++S SLNW+ S S+C  WTGVTC++DH
Sbjct: 5   VVLILIVVIFNVCIEAETIKEDKHTLLQFVNNINHSHSLNWSPSLSICTKWTGVTCNSDH 64

Query: 67  SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFN 126
           S V AL L    LRG+I  + I RLS L+ L L SN++SG FP+    L+NLT L L FN
Sbjct: 65  SSVDALHLAATGLRGDIELSIIARLSNLRFLILSSNNISGTFPTTLQALKNLTELKLDFN 124

Query: 127 SFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSA------------------ 168
            FSGPLP D S W  L V+DLSNN FN SIP+SI KLT L +                  
Sbjct: 125 EFSGPLPSDLSSWERLQVLDLSNNRFNGSIPSSIGKLTLLHSLNLAYNKFSGEIPDLHIP 184

Query: 169 ----LNLANNSLTGTLPRSLQRFPSWAFAGNNLSSENARPPALPVQPPVAEPSRKKSTKL 224
               LNLA+N+LTGT+P+SLQRFP  AF GN             V  PV   S +K TK 
Sbjct: 185 GLKLLNLAHNNLTGTVPQSLQRFPLSAFVGNK------------VLAPV-HSSLRKHTKH 231

Query: 225 SEPALLGIALGGVALAFVICALLMICRYNKQDNDRIPVKSQKKEMSLKEGVSGSH--DKN 282
               +LGIAL   ++ F I ALL I       N     +S K + S +   S  +  + +
Sbjct: 232 HNHVVLGIAL---SVCFAILALLAILLVIIIHNREEQRRSSKDKPSKRRKDSDPNVGEGD 288

Query: 283 SKLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREF 342
           +K+VFFEG NLVFDLEDLLRASAEVLGKG FGT YK  LED++T+VVKR+KEV+V +REF
Sbjct: 289 NKIVFFEGKNLVFDLEDLLRASAEVLGKGPFGTTYKVDLEDSATIVVKRIKEVSVPQREF 348

Query: 343 EQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRG-EGQSSLDWDT 401
           EQQ+E +G I+HENV  LR Y+YSKDEKL+VYDY+E GS+S +LHG++G   +  L+W+T
Sbjct: 349 EQQIENIGSIKHENVATLRGYFYSKDEKLVVYDYYEHGSLSTLLHGQKGLRDRKRLEWET 408

Query: 402 RVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAM 461
           R+ +  G ARG+AHIH+++GGKLVHG IK+SNIFLN +G+ C+S  G+A LM  +P    
Sbjct: 409 RLNMVYGTARGVAHIHSQSGGKLVHGNIKSSNIFLNGKGYGCISGTGMATLMHSLP---R 465

Query: 462 RAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVRE 521
            A GYRAPE+TDTRK TQ SDV+SFG+L+ E+LTGKS        EV +LVRWVNSVVRE
Sbjct: 466 HAVGYRAPEITDTRKGTQPSDVYSFGILIFEVLTGKS--------EVANLVRWVNSVVRE 517

Query: 522 EWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENP 581
           EWT EVFD ELLR   +EEEMVEMLQVGM C  R+PE+RP M +V++MVE+IR  K    
Sbjct: 518 EWTGEVFDEELLRCTQVEEEMVEMLQVGMVCTARLPEKRPNMIEVVRMVEEIRPEKL--- 574

Query: 582 PSTENRSEISSSAAT 596
            ++  RSE+S+ A T
Sbjct: 575 -ASGYRSEVSTGATT 588

Arabidopsis thaliana (taxid: 3702)

>sp|Q9SH71|Y1421_ARATH Putative inactive receptor-like protein kinase At1g64210 OS=Arabidopsis thaliana GN=At1g64210 PE=3 SV=1

 Score =  560 bits (1442), Expect = e-158,   Method: Compositional matrix adjust.
 Identities = 309/604 (51%), Positives = 392/604 (64%), Gaps = 56/604 (9%)

Query: 10  IFFLVGTIFLPIKADPVED-KQALLDFIHNIHNSRSLNWNESSSLCKSWTGVTCSADHSR 68
            FF +   F+ I +  +ED K+ALL F+ + ++SR L+WN+SS +C SWTGVTC+ +  R
Sbjct: 6   FFFSLILCFVLISSQTLEDDKKALLHFLSSFNSSR-LHWNQSSDVCHSWTGVTCNENGDR 64

Query: 69  VVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSF 128
           +V++RLP +   G IPP TI RLS+L+ LSLR N  +G FPSDF+ L++LT L+LQ N  
Sbjct: 65  IVSVRLPAVGFNGLIPPFTISRLSSLKFLSLRKNHFTGDFPSDFTNLKSLTHLYLQHNHL 124

Query: 129 SGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNS------------- 175
           SGPL   FS   NL V+DLSNN FN SIP S+S LT L  LNLANNS             
Sbjct: 125 SGPLLAIFSELKNLKVLDLSNNGFNGSIPTSLSGLTSLQVLNLANNSFSGEIPNLHLPKL 184

Query: 176 ---------LTGTLPRSLQRFPSWAFAGNNLSSENARPPALPVQPPVAEPSRKKSTKLSE 226
                    L GT+P+SLQRF S AF+GNNL+    +              RK    LS+
Sbjct: 185 SQINLSNNKLIGTIPKSLQRFQSSAFSGNNLTERKKQ--------------RKTPFGLSQ 230

Query: 227 PALLGIALGGVALAFVICALLMICRYNKQDNDRIPVKSQKKEMSLKEGVSGSHDKNS--- 283
            A L I      L     + +MI  + K    RI  K +K++ S   G   S D N+   
Sbjct: 231 LAFLLILSAACVLCVSGLSFIMITCFGKT---RISGKLRKRDSSSPPGNWTSRDDNTEEG 287

Query: 284 -KLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREF 342
            K++FF G N +FDL+DLL +SAEVLGKG FGT YK  +ED STVVVKRLKEV VG+REF
Sbjct: 288 GKIIFFGGRNHLFDLDDLLSSSAEVLGKGAFGTTYKVTMEDMSTVVVKRLKEVVVGRREF 347

Query: 343 EQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGE-GQSSLDWDT 401
           EQQMEI+G IRHENV  L+AYYYSKD+KL VY Y+  GS+  +LHG RG   +  LDWD 
Sbjct: 348 EQQMEIIGMIRHENVAELKAYYYSKDDKLAVYSYYNHGSLFEILHGNRGRYHRVPLDWDA 407

Query: 402 RVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAM 461
           R+RIA GAARG+A IH    GK +HG IK+SNIFL+SQ + C+ D+GL  +M  +P    
Sbjct: 408 RLRIATGAARGLAKIHE---GKFIHGNIKSSNIFLDSQCYGCIGDVGLTTIMRSLPQTTC 464

Query: 462 RAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHA-----TGGDEVVHLVRWVN 516
             +GY APE+TDTR++TQ SDV+SFGV+LLELLTGKSP+       TGG E + L  W+ 
Sbjct: 465 LTSGYHAPEITDTRRSTQFSDVYSFGVVLLELLTGKSPVSQAELVPTGG-ENMDLASWIR 523

Query: 517 SVVREEWTAEVFDVELL-RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
           SVV +EWT EVFD+E+L +    EEEMVEMLQ+G+ACV    +ERP +A VLK++EDIR 
Sbjct: 524 SVVAKEWTGEVFDMEILSQSGGFEEEMVEMLQIGLACVALKQQERPHIAQVLKLIEDIRS 583

Query: 576 VKAE 579
           V AE
Sbjct: 584 VDAE 587

Arabidopsis thaliana (taxid: 3702)

>sp|Q9LVM0|Y5830_ARATH Probable inactive receptor kinase At5g58300 OS=Arabidopsis thaliana GN=At5g58300 PE=1 SV=1

 Score =  551 bits (1419), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 304/629 (48%), Positives = 409/629 (65%), Gaps = 46/629 (7%)

Query: 3   FLPIFSAIFFLVGTIFLPIK-ADPVEDKQALLDFIHNIHNSRSLNWNESSSLCKSWTGVT 61
           FL      F  V T F     AD   D+QALL F  ++ + R LNWN ++ +CKSW GVT
Sbjct: 22  FLSTCLVSFLFVTTTFCSYAIADLNSDRQALLAFAASVPHLRRLNWNSTNHICKSWVGVT 81

Query: 62  CSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSL 121
           C++D + V ALRLPG+ L G IPPNT+G+L +L+ LSLRSN LSG  P D   L +L  +
Sbjct: 82  CTSDGTSVHALRLPGIGLLGPIPPNTLGKLESLRILSLRSNLLSGNLPPDIHSLPSLDYI 141

Query: 122 HLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSAL------------ 169
           +LQ N+FSG +P  F V   L ++DLS N F   IPA+   L  L+ L            
Sbjct: 142 YLQHNNFSGEVP-SF-VSRQLNILDLSFNSFTGKIPATFQNLKQLTGLSLQNNKLSGPVP 199

Query: 170 ----------NLANNSLTGTLPRSLQRFPSWAFAGNNL--------SSENARPPAL---- 207
                     NL+NN L G++P +L  FPS +F+GN L         + ++ PP+L    
Sbjct: 200 NLDTVSLRRLNLSNNHLNGSIPSALGGFPSSSFSGNTLLCGLPLQPCATSSPPPSLTPHI 259

Query: 208 --PVQPPVAEPSRKKSTKLSEPALLGIALGGVALAFVICALLMIC---RYNKQDNDRIPV 262
             P  PP       K  KL    ++ IA GG AL  +I  +++ C   + +K+++  + V
Sbjct: 260 STPPLPPFPHKEGSKR-KLHVSTIIPIAAGGAALLLLITVIILCCCIKKKDKREDSIVKV 318

Query: 263 KSQKKEMSLKEGVSGSHDKNSKLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALE 322
           K+  ++   + G      + +KLVFF GC+  FDLEDLLRASAEVLGKG++GTAYKA LE
Sbjct: 319 KTLTEKAKQEFGSGVQEPEKNKLVFFNGCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLE 378

Query: 323 DASTVVVKRLKEVNVGKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFEPGS 381
           +++TVVVKRLKEV  GKREFEQQMEI+  +  H +VV LRAYYYSKDEKLMV DY+  G+
Sbjct: 379 ESTTVVVKRLKEVAAGKREFEQQMEIISRVGNHPSVVPLRAYYYSKDEKLMVCDYYPAGN 438

Query: 382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGH 441
           +S++LHG RG  ++ LDWD+RV+I + AA+GIAH+H   G K  HG IK+SN+ +  +  
Sbjct: 439 LSSLLHGNRGSEKTPLDWDSRVKITLSAAKGIAHLHAAGGPKFSHGNIKSSNVIMKQESD 498

Query: 442 VCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIH 501
            C+SD GL  LM+ +P   MR AGYRAPEV +TRK T  SDV+SFGVL+LE+LTGKSP+ 
Sbjct: 499 ACISDFGLTPLMA-VPIAPMRGAGYRAPEVMETRKHTHKSDVYSFGVLILEMLTGKSPVQ 557

Query: 502 ATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERP 561
           +   D++V L RWV SVVREEWT+EVFD+EL+R+ NIEEEMV+MLQ+ MACV ++PE RP
Sbjct: 558 SPSRDDMVDLPRWVQSVVREEWTSEVFDIELMRFQNIEEEMVQMLQIAMACVAQVPEVRP 617

Query: 562 KMADVLKMVEDIRRVKAENP-PSTENRSE 589
            M DV++M+E+IR   +E   PS+++ S+
Sbjct: 618 TMDDVVRMIEEIRVSDSETTRPSSDDNSK 646

Arabidopsis thaliana (taxid: 3702)

>sp|Q9FL63|Y5410_ARATH Inactive leucine-rich repeat receptor-like serine/threonine-protein kinase At5g24100 OS=Arabidopsis thaliana GN=At5g24100 PE=2 SV=1

 Score =  541 bits (1393), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 283/608 (46%), Positives = 392/608 (64%), Gaps = 51/608 (8%)

Query: 10  IFFLVGTIFLPIKADPVEDKQALLDFIHNIHNSRSLNWNESSSLCKSWTGVTCSADHSRV 69
           +FF    ++  +  D   D+QALLDF++NI + RSL WN SS +C +W GVTC  D +RV
Sbjct: 15  LFFGSSALYSQVTGDLAGDRQALLDFLNNIIHPRSLAWNTSSPVCTTWPGVTCDIDGTRV 74

Query: 70  VALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFS 129
            AL LPG +L G IPP TI RLS LQ LSLRSN L G FP DF +L+ L ++ L  N FS
Sbjct: 75  TALHLPGASLLGVIPPGTISRLSELQILSLRSNGLRGPFPIDFLQLKKLKAISLGNNRFS 134

Query: 130 GPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLA----------------- 172
           GPLP D++ W NLTV+DL +N FN SIPA  + LT L +LNLA                 
Sbjct: 135 GPLPSDYATWTNLTVLDLYSNRFNGSIPAGFANLTGLVSLNLAKNSFSGEIPDLNLPGLR 194

Query: 173 -----NNSLTGTLPRSLQRFPSWAFAGNNLSSENARPPALPVQPPVAEPSRKKSTKLSEP 227
                NN+LTG++P SL+RF + AF+GNNL  ENA PPA+       +  +K    +SEP
Sbjct: 195 RLNFSNNNLTGSIPNSLKRFGNSAFSGNNLVFENAPPPAV----VSFKEQKKNGIYISEP 250

Query: 228 ALLGIALG-GVALAFVICALLMICRYNKQDND-------------RIPVKSQKKEMSLKE 273
           A+LGIA+     + FVI  ++++C   +Q                ++P + +  ++  ++
Sbjct: 251 AILGIAISVCFVIFFVIAVVIIVCYVKRQRKSETEPKPDKLKLAKKMPSEKEVSKLGKEK 310

Query: 274 GVSGSHDKN--SKLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKR 331
            +    DK+  +K++FFEG NL F+LEDLL ASAE LGKG FG  YKA LED+  + VKR
Sbjct: 311 NIEDMEDKSEINKVMFFEGSNLAFNLEDLLIASAEFLGKGVFGMTYKAVLEDSKVIAVKR 370

Query: 332 LKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRG 391
           LK++ V +++F+ QMEIVG I+HENV  LRAY  SK+EKLMVYDY   GS+S  LHG+  
Sbjct: 371 LKDIVVSRKDFKHQMEIVGNIKHENVAPLRAYVCSKEEKLMVYDYDSNGSLSLRLHGKNA 430

Query: 392 -EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLA 450
            EG   L+W+TR+R  IG A+G+ HIHT+N   L HG IK+SN+F+NS+G+ C+S+ GL 
Sbjct: 431 DEGHVPLNWETRLRFMIGVAKGLGHIHTQN---LAHGNIKSSNVFMNSEGYGCISEAGLP 487

Query: 451 ALMSPM---PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDE 507
            L +P+      A     YRAPEVTDTR++T  SD++SFG+L+LE LTG+S +      E
Sbjct: 488 LLTNPVVRADSSARSVLRYRAPEVTDTRRSTPESDIYSFGILMLETLTGRSIMDDR--KE 545

Query: 508 VVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVL 567
            + LV WVN V+ ++WT EVFD+EL++ PN+E ++++MLQ+G +C   +P +RP M  V+
Sbjct: 546 GIDLVVWVNDVISKQWTGEVFDLELVKTPNVEAKLLQMLQLGTSCTAMVPAKRPDMVKVV 605

Query: 568 KMVEDIRR 575
           + +E+I R
Sbjct: 606 ETLEEIER 613

Arabidopsis thaliana (taxid: 3702)

>sp|Q9C9Y8|Y3868_ARATH Probable inactive receptor kinase At3g08680 OS=Arabidopsis thaliana GN=At3g08680 PE=1 SV=1

 Score =  540 bits (1390), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 303/632 (47%), Positives = 403/632 (63%), Gaps = 51/632 (8%)

Query: 3   FLPIFSAIFFLVGTIFLP--IKADPVEDKQALLDFIHNIHNSRSLNWNESSSLCKSWTGV 60
            + I +A  FL+ T F+   + AD   DKQALL+F   + +SR LNWN +  +C SWTG+
Sbjct: 1   MMKIIAAFLFLLVTTFVSRCLSADIESDKQALLEFASLVPHSRKLNWNSTIPICASWTGI 60

Query: 61  TCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTS 120
           TCS +++RV ALRLPG  L G +P  T  +L AL+ +SLRSN L G  PS    L  + S
Sbjct: 61  TCSKNNARVTALRLPGSGLYGPLPEKTFEKLDALRIISLRSNHLQGNIPSVILSLPFIRS 120

Query: 121 LHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTG-- 178
           L+   N+FSG +P   S  + L  +DLS N  + +IP S+  LT L+ L+L NNSL+G  
Sbjct: 121 LYFHENNFSGTIPPVLS--HRLVNLDLSANSLSGNIPTSLQNLTQLTDLSLQNNSLSGPI 178

Query: 179 -------------------TLPRSLQRFPSWAFAGNNLSSENARPPALPVQPPVAEPS-- 217
                              ++P S++ FP+ +F GN+L       P  P       PS  
Sbjct: 179 PNLPPRLKYLNLSFNNLNGSVPSSVKSFPASSFQGNSLLCGAPLTPC-PENTTAPSPSPT 237

Query: 218 ------------RKKSTK-LSEPALLGIALGGVALAFVICALLMIC----RYNKQDNDRI 260
                       R  + K LS  A++GIA+GG  L F+I A++ +C    R   QD+  +
Sbjct: 238 TPTEGPGTTNIGRGTAKKVLSTGAIVGIAVGGSVLLFIILAIITLCCAKKRDGGQDSTAV 297

Query: 261 P-VKSQKKEMSLKEGVSGSHD-KNSKLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYK 318
           P  K  + +   +E  SG  + + +KLVFFEG +  FDLEDLLRASAEVLGKG++GT YK
Sbjct: 298 PKAKPGRSDNKAEEFGSGVQEAEKNKLVFFEGSSYNFDLEDLLRASAEVLGKGSYGTTYK 357

Query: 319 AALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIR-HENVVALRAYYYSKDEKLMVYDYF 377
           A LE+ +TVVVKRLKEV  GKREFEQQME VG I  H NV  LRAYY+SKDEKL+VYDY+
Sbjct: 358 AILEEGTTVVVKRLKEVAAGKREFEQQMEAVGRISPHVNVAPLRAYYFSKDEKLLVYDYY 417

Query: 378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLN 437
           + G+ S +LHG    G+++LDW+TR+RI + AARGI+HIH+ +G KL+HG IK+ N+ L 
Sbjct: 418 QGGNFSMLLHGNNEGGRAALDWETRLRICLEAARGISHIHSASGAKLLHGNIKSPNVLLT 477

Query: 438 SQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGK 497
            + HVCVSD G+A LMS       R+ GYRAPE  +TRK TQ SDV+SFGVLLLE+LTGK
Sbjct: 478 QELHVCVSDFGIAPLMSHHTLIPSRSLGYRAPEAIETRKHTQKSDVYSFGVLLLEMLTGK 537

Query: 498 SPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP-NIEEEMVEMLQVGMACVVRM 556
           +    TG +EVV L +WV SVVREEWT EVFDVEL++   N+EEEMV+MLQ+ MACV + 
Sbjct: 538 AAGKTTGHEEVVDLPKWVQSVVREEWTGEVFDVELIKQQHNVEEEMVQMLQIAMACVSKH 597

Query: 557 PEERPKMADVLKMVEDIRRVKAENPPSTENRS 588
           P+ RP M +V+ M+E+IR   + + P + NR+
Sbjct: 598 PDSRPSMEEVVNMMEEIR--PSGSGPGSGNRA 627

Arabidopsis thaliana (taxid: 3702)

>sp|Q9FHK7|Y5516_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g05160 OS=Arabidopsis thaliana GN=At5g05160 PE=1 SV=1

 Score =  502 bits (1293), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 290/644 (45%), Positives = 401/644 (62%), Gaps = 65/644 (10%)

Query: 8   SAIFFLVGTIFLPIKADPVEDKQALLDFIHNIHNSRSLNWNESSSLCKSWTGVTCSADH- 66
           S  F L+    + + AD   D+QALL+F  ++ +   LNWN++ SLC SW G+TC   + 
Sbjct: 12  SFFFLLLAATAVLVSADLASDEQALLNFAASVPHPPKLNWNKNLSLCSSWIGITCDESNP 71

Query: 67  -SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQF 125
            SRVVA+RLPG+ L G IPP T+G+L AL+ LSLRSNSL G  PSD   L +L  L+LQ 
Sbjct: 72  TSRVVAVRLPGVGLYGSIPPATLGKLDALKVLSLRSNSLFGTLPSDILSLPSLEYLYLQH 131

Query: 126 NSFSGPLPLDF--SVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNS-------- 175
           N+FSG L  +   S+   L V+DLS N  + +IP+ +  L+ ++ L L NNS        
Sbjct: 132 NNFSGELTTNSLPSISKQLVVLDLSYNSLSGNIPSGLRNLSQITVLYLQNNSFDGPIDSL 191

Query: 176 --------------LTGTLPRSLQRFPSWAFAGNNL--------SSENARPPALPVQPPV 213
                         L+G +P  L++ P ++F GN+L         S  A  P+  +  P+
Sbjct: 192 DLPSVKVVNLSYNNLSGPIPEHLKKSPEYSFIGNSLLCGPPLNACSGGAISPSSNLPRPL 251

Query: 214 AE---PSRKKSTKLSEPALL---GIALGGVALAFVICALLMICRYNKQDNDRIPVKSQ-- 265
            E   P R++ +K    A++    +A+  + + F++C   ++ +  K++     V++Q  
Sbjct: 252 TENLHPVRRRQSKAYIIAIVVGCSVAVLFLGIVFLVC---LVKKTKKEEGGGEGVRTQMG 308

Query: 266 ----KKEMSLKEGVSGSHDKNSKLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAAL 321
               KK      GV    +KN KL FFE CN  FDLEDLL+ASAEVLGKG+FGTAYKA L
Sbjct: 309 GVNSKKPQDFGSGVQDP-EKN-KLFFFERCNHNFDLEDLLKASAEVLGKGSFGTAYKAVL 366

Query: 322 EDASTVVVKRLKEVNVGKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFEPG 380
           ED + VVVKRL+EV   K+EFEQQMEIVG I +H N V L AYYYSKDEKL+VY Y   G
Sbjct: 367 EDTTAVVVKRLREVVASKKEFEQQMEIVGKINQHSNFVPLLAYYYSKDEKLLVYKYMTKG 426

Query: 381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG 440
           S+  ++HG RG+    +DW+TR++IA G ++ I+++H+    K VHG IK+SNI L    
Sbjct: 427 SLFGIMHGNRGD--RGVDWETRMKIATGTSKAISYLHSL---KFVHGDIKSSNILLTEDL 481

Query: 441 HVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPI 500
             C+SD  L  L + +P    R  GY APEV +TR+ +Q SDV+SFGV++LE+LTGK+P+
Sbjct: 482 EPCLSDTSLVTLFN-LPTHTPRTIGYNAPEVIETRRVSQRSDVYSFGVVILEMLTGKTPL 540

Query: 501 HATGGDE---VVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMP 557
              G ++   V+ L RWV SVVREEWTAEVFDVELL++ NIEEEMV+MLQ+ +ACV R P
Sbjct: 541 TQPGLEDERVVIDLPRWVRSVVREEWTAEVFDVELLKFQNIEEEMVQMLQLALACVARNP 600

Query: 558 EERPKMADVLKMVEDIRRVKAENPPSTENRSEISSSAATPKATE 601
           E RPKM +V +M+ED+RR+  ++    +NR   +SS AT   +E
Sbjct: 601 ESRPKMEEVARMIEDVRRLD-QSQQLQQNR---TSSEATSNVSE 640

Probable leucine-rich repeat receptor-like protein kinase.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LP77|Y1848_ARATH Probable inactive receptor kinase At1g48480 OS=Arabidopsis thaliana GN=RKL1 PE=1 SV=1

 Score =  451 bits (1161), Expect = e-126,   Method: Compositional matrix adjust.
 Identities = 261/612 (42%), Positives = 359/612 (58%), Gaps = 69/612 (11%)

Query: 28  DKQALLDFIHNIHNSRSLNWNESSSLCKSWTGVTCSADHSRVVALRLPGMALRGEIPPNT 87
           D+ ALL  + +    R+  WN   +   +W GV C ++  RV ALRLPG+AL G+IP   
Sbjct: 36  DRTALLS-LRSAVGGRTFRWNIKQTSPCNWAGVKCESN--RVTALRLPGVALSGDIPEGI 92

Query: 88  IGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL 147
            G L+ L+ LSLR N+LSG  P D S   NL  L+LQ N FSG +P      ++L  ++L
Sbjct: 93  FGNLTQLRTLSLRLNALSGSLPKDLSTSSNLRHLYLQGNRFSGEIPEVLFSLSHLVRLNL 152

Query: 148 SNNFFNASIPASISKLTHLSAL---------------------NLANNSLTGTLPRSLQR 186
           ++N F   I +  + LT L  L                     N++NNSL G++P++LQR
Sbjct: 153 ASNSFTGEISSGFTNLTKLKTLFLENNQLSGSIPDLDLPLVQFNVSNNSLNGSIPKNLQR 212

Query: 187 FPSWAFAGNNLSS-------ENARPPALPVQ-----PPVAEPS--RKKSTKLSEPALLGI 232
           F S +F   +L         +    P+ P       PP  E S  +KK  KLS  A+ GI
Sbjct: 213 FESDSFLQTSLCGKPLKLCPDEETVPSQPTSGGNRTPPSVEGSEEKKKKNKLSGGAIAGI 272

Query: 233 ALGGV-ALAFVICALLMICRYNKQDNDRI----PVKSQKKEM-SLKEGVS---------- 276
            +G V   A ++  L+++CR       R      +K Q+ E+   KE V           
Sbjct: 273 VIGCVVGFALIVLILMVLCRKKSNKRSRAVDISTIKQQEPEIPGDKEAVDNGNVYSVSAA 332

Query: 277 -------------GSHDKNSKLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALED 323
                        G+     KLVFF     VFDLEDLLRASAEVLGKGTFGTAYKA L+ 
Sbjct: 333 AAAAMTGNGKASEGNGPATKKLVFFGNATKVFDLEDLLRASAEVLGKGTFGTAYKAVLDA 392

Query: 324 ASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVS 383
            + V VKRLK+V +  +EF++++E+VG + HEN+V LRAYY+S+DEKL+VYD+   GS+S
Sbjct: 393 VTVVAVKRLKDVMMADKEFKEKIELVGAMDHENLVPLRAYYFSRDEKLLVYDFMPMGSLS 452

Query: 384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVC 443
           A+LHG RG G+S L+WD R RIAIGAARG+ ++H++ G    HG IK+SNI L       
Sbjct: 453 ALLHGNRGAGRSPLNWDVRSRIAIGAARGLDYLHSQ-GTSTSHGNIKSSNILLTKSHDAK 511

Query: 444 VSDIGLAALMSPMPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHAT 503
           VSD GLA L+        RA GYRAPEVTD ++ +Q  DV+SFGV+LLEL+TGK+P ++ 
Sbjct: 512 VSDFGLAQLVGSSATNPNRATGYRAPEVTDPKRVSQKGDVYSFGVVLLELITGKAPSNSV 571

Query: 504 GGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMV-EMLQVGMACVVRMPEERPK 562
             +E V L RWV SV R+EW  EVFD ELL     EEEM+ EM+Q+G+ C  + P++RP+
Sbjct: 572 MNEEGVDLPRWVKSVARDEWRREVFDSELLSLATDEEEMMAEMVQLGLECTSQHPDQRPE 631

Query: 563 MADVLKMVEDIR 574
           M++V++ +E++R
Sbjct: 632 MSEVVRKMENLR 643

Arabidopsis thaliana (taxid: 3702)

>sp|Q9LVI6|RLK90_ARATH Probable inactive receptor kinase RLK902 OS=Arabidopsis thaliana GN=RLK902 PE=1 SV=1

 Score =  439 bits (1130), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 258/621 (41%), Positives = 359/621 (57%), Gaps = 69/621 (11%)

Query: 23  ADPVEDKQALLDFIHNIHNSRSLNWNESSSLCKSWTGVTCSADHSRVVALRLPGMALRGE 82
            D   DK ALL F   +   R+L W+   +   +WTGV C  D  RV ALRLPG  L G 
Sbjct: 29  GDLAADKSALLSFRSAV-GGRTLLWDVKQTSPCNWTGVLC--DGGRVTALRLPGETLSGH 85

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNL 142
           IP    G L+ L+ LSLR N L+G  P D     +L  L+LQ N FSG +P      +NL
Sbjct: 86  IPEGIFGNLTQLRTLSLRLNGLTGSLPLDLGSCSDLRRLYLQGNRFSGEIPEVLFSLSNL 145

Query: 143 TVIDLSNNFFNASIPASISKLTHLSAL---------------------NLANNSLTGTLP 181
             ++L+ N F+  I +    LT L  L                     N++NN L G++P
Sbjct: 146 VRLNLAENEFSGEISSGFKNLTRLKTLYLENNKLSGSLLDLDLSLDQFNVSNNLLNGSIP 205

Query: 182 RSLQRFPSWAFAGNNLS-------SENARPPALPVQ----PPVAEPS--RKKSTKLSEPA 228
           +SLQ+F S +F G +L        S     P+ P+     P   E S  +KK  KLS  A
Sbjct: 206 KSLQKFDSDSFVGTSLCGKPLVVCSNEGTVPSQPISVGNIPGTVEGSEEKKKRKKLSGGA 265

Query: 229 LLGIALGGVALAFVICALLMICRYNKQDNDR-------------IPVKSQKKEMSLKEGV 275
           + GI +G V    +I  +LM+  + K+ N+R             + +  +K  +   E  
Sbjct: 266 IAGIVIGCVVGLSLIVMILMVL-FRKKGNERTRAIDLATIKHHEVEIPGEKAAVEAPENR 324

Query: 276 SGSHDKN--------------SKLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAAL 321
           S  ++ +               KLVFF     VFDLEDLLRASAEVLGKGTFGTAYKA L
Sbjct: 325 SYVNEYSPSAVKAVEVNSSGMKKLVFFGNATKVFDLEDLLRASAEVLGKGTFGTAYKAVL 384

Query: 322 EDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS 381
           +  + V VKRLK+V +  REF++++E+VG + HEN+V LRAYYYS DEKL+VYD+   GS
Sbjct: 385 DAVTLVAVKRLKDVTMADREFKEKIEVVGAMDHENLVPLRAYYYSGDEKLLVYDFMPMGS 444

Query: 382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGH 441
           +SA+LHG +G G+  L+W+ R  IA+GAARG+ ++H+++     HG +K+SNI L +   
Sbjct: 445 LSALLHGNKGAGRPPLNWEVRSGIALGAARGLDYLHSQDPLS-SHGNVKSSNILLTNSHD 503

Query: 442 VCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIH 501
             VSD GLA L+S       RA GYRAPEVTD R+ +Q +DV+SFGV+LLELLTGK+P +
Sbjct: 504 ARVSDFGLAQLVSASSTTPNRATGYRAPEVTDPRRVSQKADVYSFGVVLLELLTGKAPSN 563

Query: 502 ATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP---NIEEEMVEMLQVGMACVVRMPE 558
           +   +E + L RWV+SV REEW  EVFD EL+      ++EEEM EMLQ+G+ C  + P+
Sbjct: 564 SVMNEEGMDLARWVHSVAREEWRNEVFDSELMSIETVVSVEEEMAEMLQLGIDCTEQHPD 623

Query: 559 ERPKMADVLKMVEDIRRVKAE 579
           +RP M +V++ ++++R+  A+
Sbjct: 624 KRPVMVEVVRRIQELRQSGAD 644

Arabidopsis thaliana (taxid: 3702)

>sp|Q9M8T0|Y3288_ARATH Probable inactive receptor kinase At3g02880 OS=Arabidopsis thaliana GN=At3g02880 PE=1 SV=1

 Score =  410 bits (1053), Expect = e-113,   Method: Compositional matrix adjust.
 Identities = 244/614 (39%), Positives = 352/614 (57%), Gaps = 56/614 (9%)

Query: 6   IFSAIFFLVGTIFLPIKADPVEDKQALLDFIHNIHNSRSLNWNESSSLCKSWTGVTCSAD 65
           +F  +F+L       + +D   D++ALL  + N    R L WN S+S   +W GV C  D
Sbjct: 12  VFLFVFYLAA-----VTSDLESDRRALLA-VRNSVRGRPLLWNMSASSPCNWHGVHC--D 63

Query: 66  HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQF 125
             RV ALRLPG  L G +P   IG L+ L+ LSLR NSLSG  PSDFS L  L  L+LQ 
Sbjct: 64  AGRVTALRLPGSGLFGSLPIGGIGNLTQLKTLSLRFNSLSGPIPSDFSNLVLLRYLYLQG 123

Query: 126 NSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSAL---------------- 169
           N+FSG +P       ++  I+L  N F+  IP +++  T L  L                
Sbjct: 124 NAFSGEIPSLLFTLPSIIRINLGENKFSGRIPDNVNSATRLVTLYLERNQLSGPIPEITL 183

Query: 170 -----NLANNSLTGTLPRSLQRFPSWAFAGNNL------SSENARPPALPVQPPVAEPSR 218
                N+++N L G++P SL  +P  AF GN L      + E   P       P   P +
Sbjct: 184 PLQQFNVSSNQLNGSIPSSLSSWPRTAFEGNTLCGKPLDTCEAESPNGGDAGGPNTPPEK 243

Query: 219 KKSTKLSEPALLGIALGGVALAFVICALLMICRYNKQDNDRIPVKSQKKEMSL------- 271
           K S KLS  A++GI +G V    ++  +L      ++  + +P ++ +  ++        
Sbjct: 244 KDSDKLSAGAIVGIVIGCVVGLLLLLLILFCLCRKRKKEENVPSRNVEAPVAAATSSAAI 303

Query: 272 -KEGV----------SGSHDKNSKLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAA 320
            KE V          S S   N  L FF      FDL+ LL+ASAEVLGKGT G++YKA+
Sbjct: 304 PKETVVVVPPAKATGSESGAVNKDLTFFVKSFGEFDLDGLLKASAEVLGKGTVGSSYKAS 363

Query: 321 LEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG 380
            E    V VKRL++V V ++EF +++ ++G + H N+V L AYY+S+DEKL+V++Y   G
Sbjct: 364 FEHGLVVAVKRLRDVVVPEKEFRERLHVLGSMSHANLVTLIAYYFSRDEKLLVFEYMSKG 423

Query: 381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG 440
           S+SA+LHG +G G++ L+W+TR  IA+GAAR I+++H+ + G   HG IK+SNI L+   
Sbjct: 424 SLSAILHGNKGNGRTPLNWETRAGIALGAARAISYLHSRD-GTTSHGNIKSSNILLSDSY 482

Query: 441 HVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPI 500
              VSD GLA ++S    P  R  GYRAPE+TD RK +Q +DV+SFGVL+LELLTGKSP 
Sbjct: 483 EAKVSDYGLAPIISSTSAPN-RIDGYRAPEITDARKISQKADVYSFGVLILELLTGKSPT 541

Query: 501 HATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY-PNIEEEMVEMLQVGMACVVRMPEE 559
           H    +E V L RWV SV  ++  ++V D EL RY P   E ++ +L++GM+C  + P+ 
Sbjct: 542 HQQLNEEGVDLPRWVQSVTEQQTPSDVLDPELTRYQPEGNENIIRLLKIGMSCTAQFPDS 601

Query: 560 RPKMADVLKMVEDI 573
           RP MA+V +++E++
Sbjct: 602 RPSMAEVTRLIEEV 615

Arabidopsis thaliana (taxid: 3702)

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	615
302143694	660	unnamed protein product [Vitis vinifera]	0.982	0.915	0.696	0.0
359490541	656	PREDICTED: probable inactive receptor ki	0.972	0.911	0.694	0.0
255545080	621	ATP binding protein, putative [Ricinus c	0.967	0.958	0.695	0.0
224116930	634	predicted protein [Populus trichocarpa]	0.969	0.940	0.690	0.0
224118140	633	predicted protein [Populus trichocarpa]	0.982	0.954	0.679	0.0
356507598	633	PREDICTED: probable inactive receptor ki	0.982	0.954	0.660	0.0
356516005	633	PREDICTED: probable inactive receptor ki	0.982	0.954	0.657	0.0
356551470	691	PREDICTED: probable inactive receptor ki	0.965	0.859	0.64	0.0
449463460	630	PREDICTED: probable inactive receptor ki	0.951	0.928	0.635	0.0
359473900	716	PREDICTED: probable inactive receptor ki	0.978	0.840	0.625	0.0

>gi|302143694|emb|CBI22555.3| unnamed protein product [Vitis vinifera]

 Score =  886 bits (2289), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 440/632 (69%), Positives = 521/632 (82%), Gaps = 28/632 (4%)

Query: 1   MNFLPIFSAIFFLVGTIFLPIKADPVEDKQALLDFIHNIHNSRSLNWNESSSLCKSWTGV 60
           M    IFS I FL+GTI     A+PVEDKQALLDF++NI++SR+LNWNE SS+C +WTGV
Sbjct: 1   MGVKSIFS-IIFLLGTISFQGFAEPVEDKQALLDFLNNINHSRTLNWNEYSSVCNTWTGV 59

Query: 61  TCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTS 120
           TCS DHSRV+AL LPG+  RGEIPPNT+G+LSA+Q LSLRSN+++  FPSDFSKLENLT+
Sbjct: 60  TCSGDHSRVIALHLPGIGFRGEIPPNTLGQLSAVQILSLRSNAITSPFPSDFSKLENLTA 119

Query: 121 LHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTG-- 178
           L+LQ+N FSGPLP+DFSVW NLT+I+LSNN FN SIP+SISKLTHL+AL+LANNSL+G  
Sbjct: 120 LYLQYNKFSGPLPIDFSVWKNLTIINLSNNGFNGSIPSSISKLTHLAALDLANNSLSGEI 179

Query: 179 --------------------TLPRSLQRFPSWAFAGNNLSSENARPPALPVQPPVAEPSR 218
                               TLP+SL+RFP+WAF+GNN+S+ENA    +P   P   P  
Sbjct: 180 PDLNTSSLQHINLSNNLLNGTLPQSLRRFPNWAFSGNNISTENA----IPPVFPPNNPPL 235

Query: 219 KKSTKLSEPALLGIALGGVALAFVICALLMICRYNKQDNDR-IPVKSQKKEMSLKEGVSG 277
           +KS KLSEPALLGI LGG  + FV+ ALLMI  Y+K+D +    VKSQK E S+K+ VSG
Sbjct: 236 RKSKKLSEPALLGIILGGSVVGFVLFALLMIVCYSKRDRETGFIVKSQKGEGSVKKTVSG 295

Query: 278 SHDKNSKLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNV 337
           SHD +++LVFFEGC+  FDLEDLLRASAEVLGKGTFGT YKAALEDA+T+VVKRLKEV++
Sbjct: 296 SHDGSNRLVFFEGCSFAFDLEDLLRASAEVLGKGTFGTTYKAALEDATTLVVKRLKEVSL 355

Query: 338 GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSL 397
            +R+FEQQM+IVG IRHENV  LRAYYYSKDEKLMVYD++  GSVS++LHGRRG+G+ SL
Sbjct: 356 VRRDFEQQMQIVGQIRHENVAPLRAYYYSKDEKLMVYDFYGQGSVSSILHGRRGDGRVSL 415

Query: 398 DWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP 457
           DW+TR+RIA+GAARGIAHIHTENGGKLVHG IKASNIFLNS+ + CVSD+GL  LM+P P
Sbjct: 416 DWETRLRIALGAARGIAHIHTENGGKLVHGNIKASNIFLNSRRYGCVSDLGLGTLMTPTP 475

Query: 458 PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNS 517
            P  RAAGYRAPEVTDTRKA+QASDV+SFGVLLLELLTGKSPIH TGGDEV+HLVRWVNS
Sbjct: 476 MPMTRAAGYRAPEVTDTRKASQASDVYSFGVLLLELLTGKSPIHNTGGDEVIHLVRWVNS 535

Query: 518 VVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVK 577
           VVREEWTAEVFDVELLRYPNIEEEMVEMLQ+GM CVV+MPE+RPKMA+V+KM+E I++V 
Sbjct: 536 VVREEWTAEVFDVELLRYPNIEEEMVEMLQIGMNCVVKMPEQRPKMAEVVKMMESIQQVN 595

Query: 578 AENPPSTENRSEISSSAATPKATETASSSTAH 609
             N PS+E +SE+SSS  TP A     SS+A 
Sbjct: 596 TGNRPSSETKSEVSSSTPTPPAAAEMGSSSAQ 627

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359490541|ref|XP_002267446.2| PREDICTED: probable inactive receptor kinase At4g23740-like [Vitis vinifera]

 Score =  879 bits (2271), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 434/625 (69%), Positives = 514/625 (82%), Gaps = 27/625 (4%)

Query: 8   SAIFFLVGTIFLPIKADPVEDKQALLDFIHNIHNSRSLNWNESSSLCKSWTGVTCSADHS 67
           S I   V     P  A+PVEDKQALLDF++NI++SR+LNWNE SS+C +WTGVTCS DHS
Sbjct: 35  SRICTAVEVALCPGFAEPVEDKQALLDFLNNINHSRTLNWNEYSSVCNTWTGVTCSGDHS 94

Query: 68  RVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNS 127
           RV+AL LPG+  RGEIPPNT+G+LSA+Q LSLRSN+++  FPSDFSKLENLT+L+LQ+N 
Sbjct: 95  RVIALHLPGIGFRGEIPPNTLGQLSAVQILSLRSNAITSPFPSDFSKLENLTALYLQYNK 154

Query: 128 FSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTG--------- 178
           FSGPLP+DFSVW NLT+I+LSNN FN SIP+SISKLTHL+AL+LANNSL+G         
Sbjct: 155 FSGPLPIDFSVWKNLTIINLSNNGFNGSIPSSISKLTHLAALDLANNSLSGEIPDLNTSS 214

Query: 179 -------------TLPRSLQRFPSWAFAGNNLSSENARPPALPVQPPVAEPSRKKSTKLS 225
                        TLP+SL+RFP+WAF+GNN+S+ENA    +P   P   P  +KS KLS
Sbjct: 215 LQHINLSNNLLNGTLPQSLRRFPNWAFSGNNISTENA----IPPVFPPNNPPLRKSKKLS 270

Query: 226 EPALLGIALGGVALAFVICALLMICRYNKQDNDR-IPVKSQKKEMSLKEGVSGSHDKNSK 284
           EPALLGI LGG  + FV+ ALLMI  Y+K+D +    VKSQK E S+K+ VSGSHD +++
Sbjct: 271 EPALLGIILGGSVVGFVLFALLMIVCYSKRDRETGFIVKSQKGEGSVKKTVSGSHDGSNR 330

Query: 285 LVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQ 344
           LVFFEGC+  FDLEDLLRASAEVLGKGTFGT YKAALEDA+T+VVKRLKEV++ +R+FEQ
Sbjct: 331 LVFFEGCSFAFDLEDLLRASAEVLGKGTFGTTYKAALEDATTLVVKRLKEVSLVRRDFEQ 390

Query: 345 QMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVR 404
           QM+IVG IRHENV  LRAYYYSKDEKLMVYD++  GSVS++LHGRRG+G+ SLDW+TR+R
Sbjct: 391 QMQIVGQIRHENVAPLRAYYYSKDEKLMVYDFYGQGSVSSILHGRRGDGRVSLDWETRLR 450

Query: 405 IAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAA 464
           IA+GAARGIAHIHTENGGKLVHG IKASNIFLNS+ + CVSD+GL  LM+P P P  RAA
Sbjct: 451 IALGAARGIAHIHTENGGKLVHGNIKASNIFLNSRRYGCVSDLGLGTLMTPTPMPMTRAA 510

Query: 465 GYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWT 524
           GYRAPEVTDTRKA+QASDV+SFGVLLLELLTGKSPIH TGGDEV+HLVRWVNSVVREEWT
Sbjct: 511 GYRAPEVTDTRKASQASDVYSFGVLLLELLTGKSPIHNTGGDEVIHLVRWVNSVVREEWT 570

Query: 525 AEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPST 584
           AEVFDVELLRYPNIEEEMVEMLQ+GM CVV+MPE+RPKMA+V+KM+E I++V   N PS+
Sbjct: 571 AEVFDVELLRYPNIEEEMVEMLQIGMNCVVKMPEQRPKMAEVVKMMESIQQVNTGNRPSS 630

Query: 585 ENRSEISSSAATPKATETASSSTAH 609
           E +SE+SSS  TP A     SS+A 
Sbjct: 631 ETKSEVSSSTPTPPAAAEMGSSSAQ 655

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255545080|ref|XP_002513601.1| ATP binding protein, putative [Ricinus communis] gi|223547509|gb|EEF49004.1| ATP binding protein, putative [Ricinus communis]

 Score =  866 bits (2238), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 431/620 (69%), Positives = 503/620 (81%), Gaps = 25/620 (4%)

Query: 1   MNFLPIFSAIFFLVGTIFLPIKADPVEDKQALLDFIHNIHNSRSLNWNESSSLCKSWTGV 60
           MN L IFS I F  G + L   A+P+EDKQALLDF+H IH S SLNW+ SSS+C  WTGV
Sbjct: 3   MNPLFIFSIILFF-GAVSLSTIAEPIEDKQALLDFLHGIHRSHSLNWSNSSSVCNEWTGV 61

Query: 61  TCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTS 120
           TC+ DHSR++ LRLPG+ ++G+IPPNT+GRLSA+Q LSLRSN LSG FPSDF +L NLT 
Sbjct: 62  TCNRDHSRIIVLRLPGVGIQGQIPPNTLGRLSAIQILSLRSNGLSGSFPSDFVRLGNLTG 121

Query: 121 LHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLS------------- 167
           L+LQFNSFSG LP DFS+W NLTV+DLSNN FN SIP SIS LTHL+             
Sbjct: 122 LYLQFNSFSGSLPSDFSMWKNLTVLDLSNNAFNGSIPPSISNLTHLTSLNLSNNSLSGVI 181

Query: 168 ---------ALNLANNSLTGTLPRSLQRFPSWAFAGNNLSSENARPPALPVQPPVAEPSR 218
                    +LNLANN L G +P+SL RFP WAF+GNNLSSEN  PPALP++PP  +PSR
Sbjct: 182 PDISNPSLQSLNLANNDLNGRVPQSLLRFPRWAFSGNNLSSENVLPPALPLEPPSPQPSR 241

Query: 219 KKSTKLSEPALLGIALGGVALAFVICALLMICRYNKQD-NDRIPVKSQKKEMSLKEGVSG 277
           K + KLSE A+LGI LGG  L F + ALLMIC Y+K+   D +P KSQKKE +LK+  S 
Sbjct: 242 K-TKKLSESAILGIVLGGCVLGFAVIALLMICCYSKKGREDILPTKSQKKEGALKKKASE 300

Query: 278 SHDKNSKLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNV 337
             DKN++LVFFEGC+L FDLEDLLRASAEVLGKGTFGT YKAALEDA+TVVVKRLKE++V
Sbjct: 301 RQDKNNRLVFFEGCSLAFDLEDLLRASAEVLGKGTFGTTYKAALEDANTVVVKRLKEMSV 360

Query: 338 GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSL 397
            K++FEQQME++G IRH N+ ALRAYY+SKDEKL V DY+E GSVSAMLHG+RGEG+  L
Sbjct: 361 VKKDFEQQMEVIGSIRHPNISALRAYYFSKDEKLTVCDYYEQGSVSAMLHGKRGEGRIPL 420

Query: 398 DWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP 457
           DW+TR++I IGAARGIA++HT+NGGKLVHG IKASNIFLNS+G+ C+SD+GLA LMS MP
Sbjct: 421 DWETRLKIVIGAARGIAYVHTQNGGKLVHGNIKASNIFLNSEGYGCISDVGLATLMSSMP 480

Query: 458 PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNS 517
           PP MRAAGYRAPEVTDTRKAT ASDV+SFGVLLLELLTGKSP HATGGDEVVHLVRWV+S
Sbjct: 481 PPVMRAAGYRAPEVTDTRKATHASDVYSFGVLLLELLTGKSPTHATGGDEVVHLVRWVHS 540

Query: 518 VVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVK 577
           VVREEWTAEVFDVELLRYPNIEEEMVEMLQ+GM CV RMPE+RPKM DV++MVE++R+  
Sbjct: 541 VVREEWTAEVFDVELLRYPNIEEEMVEMLQIGMNCVTRMPEQRPKMLDVVRMVEEVRQGS 600

Query: 578 AENPPSTENRSEISSSAATP 597
           + NPPS+E   E + S  TP
Sbjct: 601 SGNPPSSETNLETAVSNQTP 620

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224116930|ref|XP_002331849.1| predicted protein [Populus trichocarpa] gi|222875087|gb|EEF12218.1| predicted protein [Populus trichocarpa]

 Score =  859 bits (2220), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 430/623 (69%), Positives = 508/623 (81%), Gaps = 27/623 (4%)

Query: 11  FFLVGTIFLPIKADPVEDKQALLDFIHNIHNSRSLNWNESSSLCKSWTGVTCSADHSRVV 70
           F   G +FLP  ADPVEDK+ALL F+HNIH SR +NW ES+S+C +WTGV+CS DHSRV 
Sbjct: 14  FLFFGAVFLPTTADPVEDKKALLYFLHNIHLSRPVNWKESTSVCNNWTGVSCSNDHSRVT 73

Query: 71  ALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSD-FSKLENLTSLHLQFNSFS 129
           AL LPG+  RG IPPNT+ RLSA+Q LSL SN +SG FP D  SKL+NLT L LQ N+FS
Sbjct: 74  ALVLPGVGFRGPIPPNTLRRLSAIQILSLGSNGISGSFPYDELSKLKNLTILFLQSNNFS 133

Query: 130 GPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSL------------- 176
           GPLP DFSVWNNLT+++LSNN FN S P SIS LTHL++LNLANNSL             
Sbjct: 134 GPLPSDFSVWNNLTILNLSNNGFNGSFPPSISNLTHLTSLNLANNSLSGNIPDINVSSLQ 193

Query: 177 ---------TGTLPRSLQRFPSWAFAGNNLSSENARPPALPVQPPVAEPSRKKSTKLSEP 227
                    TG++P+SLQRFPS AF+GN LSSENA PPALPV PP ++   KKS+KL EP
Sbjct: 194 QLELANNNFTGSVPKSLQRFPSSAFSGNILSSENALPPALPVHPPSSQ-PSKKSSKLREP 252

Query: 228 ALLGIALGGVALAFVICALLMI-CRYNKQDNDRIPVKSQKKEMSLKEGVSGSHDKNSKLV 286
           A+LGIALGG  L FV+ A+LM+ CR+ K  N    + ++KKE SLK+  S S ++N++L 
Sbjct: 253 AILGIALGGCVLGFVVIAVLMVLCRFKK--NREGGLATKKKESSLKKTASKSQEQNNRLF 310

Query: 287 FFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQM 346
           FFE C+L FDLEDLLRASAEVLGKGTFG AYKAALEDASTVVVKRLKEV V K+EFEQQM
Sbjct: 311 FFEHCSLAFDLEDLLRASAEVLGKGTFGIAYKAALEDASTVVVKRLKEVTVPKKEFEQQM 370

Query: 347 EIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIA 406
            + G IRH NV  LRAYYYSKDE+LMVYD++E GSVS+MLHG+RGEG + +DW+TR++IA
Sbjct: 371 IVAGSIRHANVSPLRAYYYSKDERLMVYDFYEEGSVSSMLHGKRGEGHTPIDWETRLKIA 430

Query: 407 IGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGY 466
           IGAARGIAH+HT+NGGKLVHG IK+SNIFLNSQG+ CVSDIGLA+LMSP+PPP MRAAGY
Sbjct: 431 IGAARGIAHVHTQNGGKLVHGNIKSSNIFLNSQGYGCVSDIGLASLMSPVPPPMMRAAGY 490

Query: 467 RAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAE 526
           RAPEVTD+RKA  ASDV+S+GVLLLELLTGKSP+HATGGDEVVHLVRWVNSVVREEWTAE
Sbjct: 491 RAPEVTDSRKAAHASDVYSYGVLLLELLTGKSPMHATGGDEVVHLVRWVNSVVREEWTAE 550

Query: 527 VFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTEN 586
           VFD+ELLRYPNIEEEMVEMLQ+GMACVVRMPE+RPKM DV+KMVE+IRR+  ++ PSTE+
Sbjct: 551 VFDLELLRYPNIEEEMVEMLQIGMACVVRMPEQRPKMPDVVKMVEEIRRLSTDDRPSTES 610

Query: 587 RSEISSSAATPKATETASSSTAH 609
           + EI+ +  +P+  E AS+S+A 
Sbjct: 611 KLEIAVATPSPQTAEVASTSSAQ 633

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224118140|ref|XP_002317741.1| predicted protein [Populus trichocarpa] gi|222858414|gb|EEE95961.1| predicted protein [Populus trichocarpa]

 Score =  851 bits (2199), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 428/630 (67%), Positives = 512/630 (81%), Gaps = 26/630 (4%)

Query: 3   FLPIFSAIFFLVGTIFLPIKADPVEDKQALLDFIHNIHNSRSLNWNESSSLCKSWTGVTC 62
            L IFSA  F  G + L I ADPV+DKQALLDF+HNI +S  +NW+E++S+C SWTGV+C
Sbjct: 7   LLFIFSAFLFF-GEVLLSITADPVDDKQALLDFLHNILHSHPVNWHENTSVCNSWTGVSC 65

Query: 63  SADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSD-FSKLENLTSL 121
           S D+SRV ALRLPG+  RG IPPNT+ RLSA+Q LSLRSN +SG FP D FSKL NLT L
Sbjct: 66  SNDNSRVTALRLPGVGFRGPIPPNTLSRLSAIQILSLRSNGISGSFPYDEFSKLRNLTIL 125

Query: 122 HLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSL----- 176
            LQ N+FSGPLP DFS+WN LT+++LSNN FN  IP SIS LTHL+AL+LANNSL     
Sbjct: 126 FLQSNNFSGPLPSDFSIWNYLTILNLSNNGFNGRIPPSISNLTHLTALSLANNSLSGNIP 185

Query: 177 -----------------TGTLPRSLQRFPSWAFAGNNLSSENARPPALPVQPPVAEPSRK 219
                            TG+LP+SLQRFPS AF+GNNLSSENA PPALP+ PP ++   K
Sbjct: 186 DINVPSLQHLDLTNNNFTGSLPKSLQRFPSSAFSGNNLSSENALPPALPIHPPSSQ-PSK 244

Query: 220 KSTKLSEPALLGIALGGVALAFVICALLMICRYNKQDNDRIPVKSQKKEMSLKEGVSGSH 279
           KS+KLSEPA+L IA+GG  L FV+ A +++  ++K+  +   + ++ KE+SLK+  S S 
Sbjct: 245 KSSKLSEPAILAIAIGGCVLGFVVLAFMIVVCHSKKRREG-GLATKNKEVSLKKTASKSQ 303

Query: 280 DKNSKLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGK 339
           ++N++L FFE C+L FDLEDLLRASAEVLGKGTFG AYKAALE+A+TVVVKRLKEV V K
Sbjct: 304 EQNNRLFFFEHCSLAFDLEDLLRASAEVLGKGTFGIAYKAALEEATTVVVKRLKEVAVPK 363

Query: 340 REFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDW 399
           +EFEQQM  VG IRH NV  LRAYYYSKDE+LMVYD++E GSVSAMLH +RGEG + +DW
Sbjct: 364 KEFEQQMIAVGSIRHVNVSPLRAYYYSKDERLMVYDFYEEGSVSAMLHVKRGEGHTPMDW 423

Query: 400 DTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP 459
           +TR++IAIGAARGIAHIHT+NGGKLVHG IK+SNIFLNSQGH CVSDIGLA+LMSPMPPP
Sbjct: 424 ETRLKIAIGAARGIAHIHTQNGGKLVHGNIKSSNIFLNSQGHGCVSDIGLASLMSPMPPP 483

Query: 460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVV 519
            MRAAGYRAPEVTDTRKAT ASDV+S+GV LLELLTGKSP+H TGGDEVVHLVRWVNSVV
Sbjct: 484 VMRAAGYRAPEVTDTRKATHASDVYSYGVFLLELLTGKSPMHTTGGDEVVHLVRWVNSVV 543

Query: 520 REEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAE 579
           REEWTAEVFD+ELLRYPNIEEEMVEMLQ+G++CVVRMPE+RPKM DV+KMVE+IR+V  E
Sbjct: 544 REEWTAEVFDLELLRYPNIEEEMVEMLQIGLSCVVRMPEQRPKMPDVVKMVEEIRQVSTE 603

Query: 580 NPPSTENRSEISSSAATPKATETASSSTAH 609
           NPPS++++ EIS +  +P+A E  S+S+  
Sbjct: 604 NPPSSDSKLEISVATPSPQAAEVGSTSSVQ 633

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356507598|ref|XP_003522551.1| PREDICTED: probable inactive receptor kinase At4g23740-like [Glycine max]

 Score =  845 bits (2182), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 416/630 (66%), Positives = 499/630 (79%), Gaps = 26/630 (4%)

Query: 3   FLPIFSAIFFLVGTIFLPIKADPVEDKQALLDFIHNIHNSRSLNWNESSSLCKSWTGVTC 62
            L IFSA   +   + + + A+PVEDKQALLDF+ N+ +S  +NW+E++S+C+SW GV C
Sbjct: 7   LLFIFSAALVMEAVLLVSVVAEPVEDKQALLDFLDNMSHSPHVNWDENTSVCQSWRGVIC 66

Query: 63  SADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLH 122
           ++D SRV+ LRLPG  L G I PNT+ RLSAL+ +SLRSN +SG FP  FS+L+NLTSL+
Sbjct: 67  NSDESRVIELRLPGAGLSGPISPNTLSRLSALEVVSLRSNGISGPFPDGFSELKNLTSLY 126

Query: 123 LQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSAL------------- 169
           LQ N FSG LPLDFSVWNNL+V++LSNN FN SIP SIS LTHL++L             
Sbjct: 127 LQSNKFSGSLPLDFSVWNNLSVVNLSNNSFNGSIPFSISNLTHLTSLVLANNSLSGQIPD 186

Query: 170 ---------NLANNSLTGTLPRSLQRFPSWAFAGNNLSSENARPPALPVQPPVAEPSRKK 220
                    NLANN+L+G +P SL RFPS AFAGNNL+S +A PPA P++PP A P+ KK
Sbjct: 187 LNIRSLRELNLANNNLSGVVPNSLLRFPSSAFAGNNLTSAHALPPAFPMEPPAAYPA-KK 245

Query: 221 STKLSEPALLGIALGGVALAFVICALLMI-CRYNKQDNDRIPVKSQKKEMSLKEGVSGSH 279
           S  LSEPALLGI +G   L FV+ A+ MI C Y     +   VKSQKK  +LK   SGS 
Sbjct: 246 SKGLSEPALLGIIIGACVLGFVLIAVFMIVCCYQNAGVNVQAVKSQKKHATLKTESSGSQ 305

Query: 280 DKNSKLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGK 339
           DKN+K+VFFEGCNL FDLEDLLRASAE+LGKGTFG  YKAALEDA+TVVVKRLKEV VGK
Sbjct: 306 DKNNKIVFFEGCNLAFDLEDLLRASAEILGKGTFGMTYKAALEDATTVVVKRLKEVTVGK 365

Query: 340 REFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDW 399
           R+FEQQME+VG I+HENV A+RAYYYSK+EKL+VYDY++ GSVSA+LHG+ GEG+SSLDW
Sbjct: 366 RDFEQQMEVVGKIKHENVDAVRAYYYSKEEKLIVYDYYQQGSVSALLHGKGGEGRSSLDW 425

Query: 400 DTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP 459
           D+R+RIAIGAARGIA IH ++GGKLVHG +KASNIF NSQG+ C+SDIGLA LMSP+P P
Sbjct: 426 DSRLRIAIGAARGIACIHAQHGGKLVHGNLKASNIFFNSQGYGCISDIGLATLMSPIPMP 485

Query: 460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVV 519
           AMRA GYRAPEVTDTRKAT ASDV+SFGVLLLELLTGKSPI+ T G++VVHLVRWVNSVV
Sbjct: 486 AMRATGYRAPEVTDTRKATHASDVYSFGVLLLELLTGKSPINNTEGEQVVHLVRWVNSVV 545

Query: 520 REEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAE 579
           REEWTAEVFDV+LLRYPNIEEEMV MLQ+GMAC  R+P++RPKM DV++M+E+IRRV   
Sbjct: 546 REEWTAEVFDVQLLRYPNIEEEMVGMLQIGMACAARIPDQRPKMPDVVRMIEEIRRVNTP 605

Query: 580 NPPSTENRSEISSSAATPKATETASSSTAH 609
           N PSTE+RSE  +S  TP+A +  S+S   
Sbjct: 606 NLPSTESRSE--ASTPTPRAVDIPSTSVQQ 633

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356516005|ref|XP_003526687.1| PREDICTED: probable inactive receptor kinase At4g23740-like [Glycine max]

 Score =  844 bits (2180), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 414/630 (65%), Positives = 500/630 (79%), Gaps = 26/630 (4%)

Query: 3   FLPIFSAIFFLVGTIFLPIKADPVEDKQALLDFIHNIHNSRSLNWNESSSLCKSWTGVTC 62
            L IFSA   +   + + + A+PVEDKQALLDF+ N+ +S  +NW+E+SS+C+SW GV C
Sbjct: 7   LLFIFSAALVMEAVLLVSVGAEPVEDKQALLDFLDNMSHSPHVNWDENSSVCQSWRGVIC 66

Query: 63  SADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLH 122
           ++D SRV+ LRLPG  L G IPPNT+ RLSAL+ +SLRSN +SG FP  FS+L+NLTSL 
Sbjct: 67  NSDKSRVIELRLPGAGLSGPIPPNTLSRLSALEVVSLRSNGISGPFPHGFSELKNLTSLF 126

Query: 123 LQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSAL------------- 169
           LQ N+ SG LPLDFSVWNNL+V++LSNN FN +IP SISKLTHL++L             
Sbjct: 127 LQSNNISGQLPLDFSVWNNLSVVNLSNNSFNENIPFSISKLTHLTSLVLANNSLSGQIPD 186

Query: 170 ---------NLANNSLTGTLPRSLQRFPSWAFAGNNLSSENARPPALPVQPPVAEPSRKK 220
                    NLANN+L+G +P+SL RFPS AFAGNNL+S +A PPA P++PP A P+ KK
Sbjct: 187 LDIPSLRELNLANNNLSGAVPKSLLRFPSSAFAGNNLTSADALPPAFPMEPPAAYPA-KK 245

Query: 221 STKLSEPALLGIALGGVALAFVICALLMI-CRYNKQDNDRIPVKSQKKEMSLKEGVSGSH 279
           S +L EPALLGI +G   L FV+ A  MI C Y     +   VKS+KK+ +LK   SGS 
Sbjct: 246 SKRLGEPALLGIIIGACVLGFVVIAGFMILCCYQNAGVNAQAVKSKKKQATLKTESSGSQ 305

Query: 280 DKNSKLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGK 339
           DKN+K+VFFEGCNL FDLEDLLRASAE+L KGTFG  YKAALEDA+TV VKRLKEV VGK
Sbjct: 306 DKNNKIVFFEGCNLAFDLEDLLRASAEILAKGTFGMTYKAALEDATTVAVKRLKEVTVGK 365

Query: 340 REFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDW 399
           R+FEQ ME+VG I+HENV A+RAYYYSK+EKL+VYDY++ GSV AMLHG+ GE +SSLDW
Sbjct: 366 RDFEQLMEVVGKIKHENVDAVRAYYYSKEEKLIVYDYYQQGSVCAMLHGKGGECRSSLDW 425

Query: 400 DTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP 459
           D+R+RIAIGA RGIAHIH ++GGKLVHG IKASNIFLNSQG+ C+SDIGLA LMSP+P P
Sbjct: 426 DSRLRIAIGAVRGIAHIHAQHGGKLVHGNIKASNIFLNSQGYGCISDIGLATLMSPIPMP 485

Query: 460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVV 519
           AMRA GYRAPEVTDTRKAT ASDV+SFGVLLLELLTGKSPI++T G++VVHLVRWVNSVV
Sbjct: 486 AMRATGYRAPEVTDTRKATHASDVYSFGVLLLELLTGKSPINSTEGEQVVHLVRWVNSVV 545

Query: 520 REEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAE 579
           REEWTAEVFDVELLRYPNIEEEMV MLQ+GMAC  R+P++RPKM D+++M+E+IRRV   
Sbjct: 546 REEWTAEVFDVELLRYPNIEEEMVVMLQIGMACAARIPDQRPKMPDLVRMIEEIRRVNTP 605

Query: 580 NPPSTENRSEISSSAATPKATETASSSTAH 609
           NPPSTE+RSE+S+   TP+A +  S+S   
Sbjct: 606 NPPSTESRSEVST--PTPRAVDIPSTSVQQ 633

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356551470|ref|XP_003544098.1| PREDICTED: probable inactive receptor kinase At4g23740-like [Glycine max]

 Score =  803 bits (2075), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 400/625 (64%), Positives = 483/625 (77%), Gaps = 31/625 (4%)

Query: 9   AIFFLVGTIFLPIKADPVEDKQALLDFIHNIHNSRSLNWNESSSLCKSWTGVTCSADHSR 68
            + F++G +   + A+PVEDKQALLDF+ +I++S  LNWN+S+S+CK W GV C+ D S+
Sbjct: 74  GLLFMIGAMLFGVGAEPVEDKQALLDFLQSINHSHYLNWNKSTSVCKRWIGVICNNDQSQ 133

Query: 69  VVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSF 128
           V+AL L    L G IPPNT+ RL AL+ +SL SNS++G FP+ FS+L+NLT L+LQ N+F
Sbjct: 134 VIALHLTRTGLSGPIPPNTLSRLLALETVSLASNSITGSFPTGFSQLKNLTYLYLQSNNF 193

Query: 129 SGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSAL------------------- 169
           SGPLP DFSVW NL++ +LSNN FN SIP S+S LTHL++L                   
Sbjct: 194 SGPLPSDFSVWKNLSIANLSNNSFNGSIPFSLSNLTHLTSLVLVNNSLSGEVPDLNIPTL 253

Query: 170 ---NLANNSLTGTLPRSLQRFPSWAFAGNNLSSENARPPALPVQPPVAEPSRKKSTKLSE 226
              NLA+N+L+G +P+SL+RFPS AF+GNNL S +A PP+  VQ P   P+RKKS  L E
Sbjct: 254 QELNLASNNLSGVVPKSLERFPSGAFSGNNLVSSHALPPSFAVQTPNPHPTRKKSKGLRE 313

Query: 227 PALLGIALGGVALAF-VICALLMICRYNKQDNDRIPVKSQKKEMSLKEGVSGSHDKNSKL 285
           PALLGI +GG  L   VI    ++C Y K   D   VKSQK E+S K+  S S +KN K+
Sbjct: 314 PALLGIIIGGCVLGVAVIATFAIVCCYEKGGADGQQVKSQKIEVSRKKEGSESREKN-KI 372

Query: 286 VFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQ 345
           VFFEGCNL FDLEDLLRASAEVLGKGTFGT YKAALEDA+TV VKRLK+V VGKREFEQQ
Sbjct: 373 VFFEGCNLAFDLEDLLRASAEVLGKGTFGTVYKAALEDATTVAVKRLKDVTVGKREFEQQ 432

Query: 346 MEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRI 405
           ME+VG IRH+NV +LRAYYYSK+EKLMVYDY+E GSVS+MLHG+RG G+ SLDWD+R++I
Sbjct: 433 MEMVGCIRHDNVASLRAYYYSKEEKLMVYDYYEQGSVSSMLHGKRGGGRISLDWDSRLKI 492

Query: 406 AIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG 465
            IG ARGIAHIH ++GGKLVHG IKASNIFLNSQG+ C+SDIGLA LM+    PA+RA G
Sbjct: 493 TIGVARGIAHIHAQHGGKLVHGNIKASNIFLNSQGYGCLSDIGLATLMN----PALRATG 548

Query: 466 YRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTA 525
           YRAPE TDTRK   ASDV+SFGVLLLELLTG+SP+HA GGDEVV LVRWVNSVVREEWTA
Sbjct: 549 YRAPEATDTRKTLPASDVYSFGVLLLELLTGRSPLHAKGGDEVVQLVRWVNSVVREEWTA 608

Query: 526 EVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR-VKAENPPST 584
           EVFDV+L RYPNIEEEMVEMLQ+GMACVVR P++RPK+ +V++MVE+IRR +  EN  ST
Sbjct: 609 EVFDVDLQRYPNIEEEMVEMLQIGMACVVRTPDQRPKIGEVVRMVEEIRRLINTENRSST 668

Query: 585 ENRSEISSSAATPKATETASSSTAH 609
           E+RSE   S   P A ET S+S AH
Sbjct: 669 ESRSE--GSTPIPHAIETPSTSFAH 691

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449463460|ref|XP_004149452.1| PREDICTED: probable inactive receptor kinase At4g23740-like [Cucumis sativus] gi|449515313|ref|XP_004164694.1| PREDICTED: probable inactive receptor kinase At4g23740-like [Cucumis sativus]

 Score =  796 bits (2056), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 389/612 (63%), Positives = 480/612 (78%), Gaps = 27/612 (4%)

Query: 6   IFSAIFFLVGTIFLPIKADPVEDKQALLDFIHNIHNSRSLNWNESSSLCKSWTGVTCSAD 65
           IF  I   +  I   +  +PVEDKQALLDF HNI +S SLNWN+SSS+CK+WTGV C++D
Sbjct: 7   IFVEILLFLAFISSGVLTEPVEDKQALLDFFHNIPHSPSLNWNQSSSVCKAWTGVFCNSD 66

Query: 66  HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQF 125
            S+VVALRLPG  LRG IP NT+ RLSAL+ LSLR N +SG FP DFSKL NL+SL+LQ+
Sbjct: 67  ESKVVALRLPGTGLRGPIPVNTLSRLSALEILSLRLNRISGPFPFDFSKLGNLSSLYLQY 126

Query: 126 NSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNS---------- 175
           N FSGPLP DFSVWNNL+VIDLSNN FN SIP+SISKL+HL+ LNLANNS          
Sbjct: 127 NKFSGPLPSDFSVWNNLSVIDLSNNLFNGSIPSSISKLSHLTVLNLANNSFSGEIPNLDI 186

Query: 176 ------------LTGTLPRSLQRFPSWAFAGNNLSSEN-ARPPALPVQPPVAEPSRKKST 222
                       LTG +P SLQRFPSW FAGNN++ E+ A PP+ P+QPP A+P+RK   
Sbjct: 187 PSLQRLDLSNNNLTGNVPHSLQRFPSWVFAGNNVTEEHSAIPPSFPLQPPTAQPTRKG-- 244

Query: 223 KLSEPALLGIALGGVALAFVICALLMICRYNKQ--DNDRIPVKSQKKEMSLKEGVSGSHD 280
           +LSE A+LGIA+GG  + F+  A+L+   + K+  +N    +  +KKE+S+K+    S +
Sbjct: 245 RLSESAILGIAIGGSVIVFIFLAVLLTVWWLKKGKENTSPSMDPKKKELSVKKRGFESQE 304

Query: 281 KNSKLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKR 340
           + + L FF+  NL FDLEDLLRASAEVLGKGTFG +YKAALED++TVVVKRL +V VGKR
Sbjct: 305 QKNNLNFFQDSNLAFDLEDLLRASAEVLGKGTFGVSYKAALEDSTTVVVKRLNQVTVGKR 364

Query: 341 EFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWD 400
           EFEQQME++G I+HENVV+LRAYYYSKDEKLMVYDY+  GSVSAMLHG+ G+G   LDWD
Sbjct: 365 EFEQQMELIGKIKHENVVSLRAYYYSKDEKLMVYDYYGQGSVSAMLHGKEGDGLRVLDWD 424

Query: 401 TRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPA 460
           TR++IAIGAARG+AHIHTENGGK  HG ++ASNIFLNS+G+ CVSD+GLA LM+ +P PA
Sbjct: 425 TRMKIAIGAARGLAHIHTENGGKCTHGNVRASNIFLNSKGYGCVSDVGLAGLMNSIPLPA 484

Query: 461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVR 520
            R  GYRAPE+TDTR+A++A+DV+SFGV+LLELLTGKSPIH  G +EVV+LVRWVNSVVR
Sbjct: 485 TRTPGYRAPELTDTRRASEAADVYSFGVVLLELLTGKSPIHVEGCNEVVNLVRWVNSVVR 544

Query: 521 EEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAEN 580
           EEWTAEVFDVELLRYPNIEEEMVEMLQ+G++CV +MPE+RPKM D++  +E +R+     
Sbjct: 545 EEWTAEVFDVELLRYPNIEEEMVEMLQIGLSCVAKMPEQRPKMIDLMLRIEQVRQHSTGT 604

Query: 581 PPSTENRSEISS 592
            PS+ ++S  S+
Sbjct: 605 QPSSGSKSAYST 616

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359473900|ref|XP_002271560.2| PREDICTED: probable inactive receptor kinase At4g23740-like [Vitis vinifera]

 Score =  787 bits (2032), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 394/630 (62%), Positives = 480/630 (76%), Gaps = 28/630 (4%)

Query: 1   MNFLPIFSAIFFLVGTIFLPIKADPVEDKQALLDFIHNIHNSRSLNWNESSSLCKSWTGV 60
           M  L IFS IF L+G IF    ADPV+DKQALL+F+ ++ +   +NW++ S +C +WTGV
Sbjct: 89  MKTLYIFSGIF-LLGLIFSLGNADPVDDKQALLEFVSHLPHLHPINWDKDSPVCNNWTGV 147

Query: 61  TCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTS 120
           TCS D S+V+++RLPG+  +G IPPNT+ RLSALQ LSLRSN +SG FPSDF  L+NLT 
Sbjct: 148 TCSDDKSQVISVRLPGVGFQGAIPPNTLSRLSALQILSLRSNRISGFFPSDFVNLKNLTF 207

Query: 121 LHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTG-- 178
           L+LQ+N F G LP DFSVW NLT+I+LSNN FN SIP SIS LT L ALNLA NSL+G  
Sbjct: 208 LYLQYNDFVGSLPSDFSVWKNLTIINLSNNRFNGSIPNSISNLTSLQALNLATNSLSGEI 267

Query: 179 --------------------TLPRSLQRFPSWAFAGNNLSSENA-RPPAL-PVQPPVAEP 216
                               ++P+SL RFP   F+GNN++ E +  PPAL P  PP  +P
Sbjct: 268 PDLQLSSLQQLNLSHNNLSGSMPKSLLRFPPSVFSGNNITFETSPLPPALSPSFPPYPKP 327

Query: 217 SRKKSTKLSEPALLGIALGGVALAFVICA-LLMICRYNKQDNDRIPVKSQKKEMSLKEGV 275
             + S K+ E ALLGI +   AL  V  A LL++C   ++  D    K QK  MS ++G+
Sbjct: 328 --RNSRKIGEMALLGIIVAACALGLVAFAFLLIVCCSKRKGGDGFSGKLQKGGMSPEKGI 385

Query: 276 SGSHDKNSKLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEV 335
            GS D N++L+FF+GCN VFDLEDLLRASAEVLGKGTFGT YKA LEDA+TVVVKRLKEV
Sbjct: 386 PGSQDANNRLIFFDGCNFVFDLEDLLRASAEVLGKGTFGTTYKAILEDATTVVVKRLKEV 445

Query: 336 NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQS 395
           +VGKREFEQQME+VG IRHENVV LRAYY+SKDEKLMVYDY+  GSVS +LHG+RG  + 
Sbjct: 446 SVGKREFEQQMEVVGNIRHENVVELRAYYHSKDEKLMVYDYYSLGSVSTILHGKRGGDRM 505

Query: 396 SLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP 455
            LDWDTR+RIA+GAARGIA IH ENGGK VHG IK+SNIFLN++G+ CVSD+GL  +MSP
Sbjct: 506 PLDWDTRLRIALGAARGIARIHAENGGKFVHGNIKSSNIFLNARGYGCVSDLGLTTVMSP 565

Query: 456 MPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWV 515
           + PP  RAAGYRAPEVTDTRKA+Q+SDV+SFGV+LLELLTGKSPIHATGGDEV+HLVRWV
Sbjct: 566 LAPPISRAAGYRAPEVTDTRKASQSSDVYSFGVVLLELLTGKSPIHATGGDEVIHLVRWV 625

Query: 516 NSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
           +SVVREEWTAEVFDVEL+RYPNIEEEMVEMLQ+ M CV+RMP++RPKM DV++++E++R 
Sbjct: 626 HSVVREEWTAEVFDVELMRYPNIEEEMVEMLQIAMGCVIRMPDQRPKMPDVVRLIENVRH 685

Query: 576 VKAENPPSTENRSEISSSAATPKATETASS 605
              +N  S E RSE S+   T   T ++ S
Sbjct: 686 TDTDNRSSFETRSEGSTPLPTTVGTYSSPS 715

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	615
TAIR|locus:2154227	601	AT5G53320 [Arabidopsis thalian	0.928	0.950	0.452	7.2e-123
TAIR|locus:2077898	640	AT3G08680 [Arabidopsis thalian	0.773	0.743	0.422	1.1e-116
TAIR|locus:2128414	638	AT4G23740 [Arabidopsis thalian	0.860	0.829	0.467	5.6e-116
TAIR|locus:2043858	658	AT2G26730 [Arabidopsis thalian	0.551	0.515	0.521	4.3e-113
TAIR|locus:2156784	640	RUL1 "REDUCED IN LATERAL GROWT	0.770	0.740	0.411	1.4e-112
TAIR|locus:2024517	587	AT1G64210 [Arabidopsis thalian	0.918	0.962	0.436	3.6e-112
TAIR|locus:2161308	654	AT5G58300 [Arabidopsis thalian	0.839	0.788	0.417	1.4e-96
TAIR|locus:2198090	655	RKL1 "receptor-like kinase 1"	0.482	0.453	0.474	8e-89
TAIR|locus:2088500	647	RLK902 "receptor-like kinase 9	0.479	0.455	0.468	5.6e-88
TAIR|locus:2202359	670	AT1G68400 [Arabidopsis thalian	0.521	0.479	0.495	2.1e-86

TAIR|locus:2154227 AT5G53320 [Arabidopsis thaliana (taxid:3702)]

 Score = 1208 (430.3 bits), Expect = 7.2e-123, P = 7.2e-123
 Identities = 271/599 (45%), Positives = 351/599 (58%)

Query:    10 IFFLVGTIF-LPIKADPV-EDKQALLDFIHNIHNSRSLNWNESSSLCKSWTGVTCSADHS 67
             +  L+  IF + I+A+ + EDK  LL F++NI++S SLNW+ S S+C  WTGVTC++DHS
Sbjct:     6 VLILIVVIFNVCIEAETIKEDKHTLLQFVNNINHSHSLNWSPSLSICTKWTGVTCNSDHS 65

Query:    68 RVVALRLPGMALRGEIPPNTIGXXXXXXXXXXXXXXXXGLFPSDFSKLENLTSLHLQFNS 127
              V AL L    LRG+I  + I                 G FP+    L+NLT L L FN 
Sbjct:    66 SVDALHLAATGLRGDIELSIIARLSNLRFLILSSNNISGTFPTTLQALKNLTELKLDFNE 125

Query:   128 FSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKXXXXXXXXXXXXXXXXXXPR-SLQR 186
             FSGPLP D S W  L V+DLSNN FN SIP+SI K                  P   +  
Sbjct:   126 FSGPLPSDLSSWERLQVLDLSNNRFNGSIPSSIGKLTLLHSLNLAYNKFSGEIPDLHIPG 185

Query:   187 FPSWAFAGNNLS-----SENARPPALPVQPPVAEP---SRKKSTKLSEPXXXXXXXXXXX 238
                   A NNL+     S    P +  V   V  P   S +K TK               
Sbjct:   186 LKLLNLAHNNLTGTVPQSLQRFPLSAFVGNKVLAPVHSSLRKHTKHHNHVVLGIALSVCF 245

Query:   239 XXFVICALLMICRYNKQDNDRIPVKSQKKEMSLKEGVSGSHDKNSKLVFFEGCNLVFDLE 298
                 + A+L++   + ++  R   K  K     K+      + ++K+VFFEG NLVFDLE
Sbjct:   246 AILALLAILLVIIIHNREEQRRSSKD-KPSKRRKDSDPNVGEGDNKIVFFEGKNLVFDLE 304

Query:   299 DLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVV 358
             DLLRASAEVLGKG FGT YK  LED++T+VVKR+KEV+V +REFEQQ+E +G I+HENV 
Sbjct:   305 DLLRASAEVLGKGPFGTTYKVDLEDSATIVVKRIKEVSVPQREFEQQIENIGSIKHENVA 364

Query:   359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRG-EGQSSLDWDTRVXXXXXXXXXXXXXX 417
              LR Y+YSKDEKL+VYDY+E GS+S +LHG++G   +  L+W+TR+              
Sbjct:   365 TLRGYFYSKDEKLVVYDYYEHGSLSTLLHGQKGLRDRKRLEWETRLNMVYGTARGVAHIH 424

Query:   418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXXXXXEVTDTRKA 477
             +++GGKLVHG IK+SNIFLN +G+ C+S                        E+TDTRK 
Sbjct:   425 SQSGGKLVHGNIKSSNIFLNGKGYGCISG---TGMATLMHSLPRHAVGYRAPEITDTRKG 481

Query:   478 TQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN 537
             TQ SDV+SFG+L+ E+LTGKS        EV +LVRWVNSVVREEWT EVFD ELLR   
Sbjct:   482 TQPSDVYSFGILIFEVLTGKS--------EVANLVRWVNSVVREEWTGEVFDEELLRCTQ 533

Query:   538 IEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTENRSEISSSAAT 596
             +EEEMVEMLQVGM C  R+PE+RP M +V++MVE+IR  K     ++  RSE+S+ A T
Sbjct:   534 VEEEMVEMLQVGMVCTARLPEKRPNMIEVVRMVEEIRPEKL----ASGYRSEVSTGATT 588

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

TAIR|locus:2077898 AT3G08680 [Arabidopsis thaliana (taxid:3702)]

 Score = 903 (322.9 bits), Expect = 1.1e-116, Sum P(2) = 1.1e-116
 Identities = 213/504 (42%), Positives = 284/504 (56%)

Query:   106 GLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKXXX 165
             G  P+    L  LT L LQ NS SGP+P   ++   L  ++LS N  N S+P+S+     
Sbjct:   152 GNIPTSLQNLTQLTDLSLQNNSLSGPIP---NLPPRLKYLNLSFNNLNGSVPSSVKSFPA 208

Query:   166 XXXXXXXXXXXXXXXPRSLQRFPSWAFAGNNLSSENARPPALPVQPPVAEPSRKKSTK-L 224
                            P      P       N ++ +  P      P      R  + K L
Sbjct:   209 SSFQGNSLLCGAPLTP-----CPE------NTTAPSPSPTTPTEGPGTTNIGRGTAKKVL 257

Query:   225 SEPXXXXXXXXXXXXXFVICALLMICRYNK----QDNDRIP-VKSQKKEMSLKEGVSGSH 279
             S               F+I A++ +C   K    QD+  +P  K  + +   +E  SG  
Sbjct:   258 STGAIVGIAVGGSVLLFIILAIITLCCAKKRDGGQDSTAVPKAKPGRSDNKAEEFGSGVQ 317

Query:   280 D-KNSKLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVG 338
             + + +KLVFFEG +  FDLEDLLRASAEVLGKG++GT YKA LE+ +TVVVKRLKEV  G
Sbjct:   318 EAEKNKLVFFEGSSYNFDLEDLLRASAEVLGKGSYGTTYKAILEEGTTVVVKRLKEVAAG 377

Query:   339 KREFEQQMEIVGGIR-HENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSL 397
             KREFEQQME VG I  H NV  LRAYY+SKDEKL+VYDY++ G+ S +LHG    G+++L
Sbjct:   378 KREFEQQMEAVGRISPHVNVAPLRAYYFSKDEKLLVYDYYQGGNFSMLLHGNNEGGRAAL 437

Query:   398 DWDTRVXXXXXXXXXXXXXXTENGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXX 457
             DW+TR+              + +G KL+HG IK+ N+ L  + HVCVSD           
Sbjct:   438 DWETRLRICLEAARGISHIHSASGAKLLHGNIKSPNVLLTQELHVCVSDFGIAPLMSHHT 497

Query:   458 XXXXXXXXXXXXEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNS 517
                         E  +TRK TQ SDV+SFGVLLLE+LTGK+    TG +EVV L +WV S
Sbjct:   498 LIPSRSLGYRAPEAIETRKHTQKSDVYSFGVLLLEMLTGKAAGKTTGHEEVVDLPKWVQS 557

Query:   518 VVREEWTAEVFDVELLRYP-NIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV 576
             VVREEWT EVFDVEL++   N+EEEMV+MLQ+ MACV + P+ RP M +V+ M+E+IR  
Sbjct:   558 VVREEWTGEVFDVELIKQQHNVEEEMVQMLQIAMACVSKHPDSRPSMEEVVNMMEEIR-- 615

Query:   577 KAENPPSTENRS---EISSSAATP 597
              + + P + NR+   E+  S+ +P
Sbjct:   616 PSGSGPGSGNRASSPEMIRSSDSP 639

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0009505 "plant-type cell wall" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0006084 "acetyl-CoA metabolic process" evidence=RCA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0008361 "regulation of cell size" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009926 "auxin polar transport" evidence=RCA

GO:0010015 "root morphogenesis" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0016126 "sterol biosynthetic process" evidence=RCA

GO:0016132 "brassinosteroid biosynthetic process" evidence=RCA

GO:0040007 "growth" evidence=RCA

GO:0042545 "cell wall modification" evidence=RCA

TAIR|locus:2128414 AT4G23740 [Arabidopsis thaliana (taxid:3702)]

 Score = 1143 (407.4 bits), Expect = 5.6e-116, P = 5.6e-116
 Identities = 256/548 (46%), Positives = 330/548 (60%)

Query:    67 SRVVALRLPGMA---LRGEIPPNTIGXXXXXXXXXXXXXXXXGLFPSDFSKLENLTSLHL 123
             SR+ ALR+  +    + GE P + +                 G  P DFS  +NLTS++L
Sbjct:    90 SRLSALRVLSLRSNLISGEFPKDFV-ELKDLAFLYLQDNNLSGPLPLDFSVWKNLTSVNL 148

Query:   124 QFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKXXXXXXXXXXXXXXXXXXPRS 183
               N F+G +P   S    +  ++L+NN  +  IP                       P  
Sbjct:   149 SNNGFNGTIPSSLSRLKRIQSLNLANNTLSGDIPDLSVLSSLQHIDLSNNYDLAGPIPDW 208

Query:   184 LQRFPSWAFAGNNLSSENARPPALPVQPPVAEPSRKKSTK---LSEPXXXXXXXXXXXXX 240
             L+RFP  ++ G ++         L   PP +E + +K +K   L                
Sbjct:   209 LRRFPFSSYTGIDIIPPGGNY-TLVTPPPPSEQTHQKPSKARFLGLSETVFLLIVIAVSI 267

Query:   241 FVICAL---LMIC--RYNKQDNDRI--PVKSQKKE-MSLKEGVSGSHDKNSKLVFFEGCN 292
              VI AL   L +C  R   +  D +    K QKK  MS ++ VS   D N++L FFEGCN
Sbjct:   268 VVITALAFVLTVCYVRRKLRRGDGVISDNKLQKKGGMSPEKFVSRMEDVNNRLSFFEGCN 327

Query:   293 LVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGI 352
               FDLEDLLRASAEVLGKGTFGT YKA LEDA++V VKRLK+V  GKR+FEQQMEI+GGI
Sbjct:   328 YSFDLEDLLRASAEVLGKGTFGTTYKAVLEDATSVAVKRLKDVAAGKRDFEQQMEIIGGI 387

Query:   353 RHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXX 412
             +HENVV L+AYYYSKDEKLMVYDYF  GSV+++LHG RGE +  LDW+TR+         
Sbjct:   388 KHENVVELKAYYYSKDEKLMVYDYFSRGSVASLLHGNRGENRIPLDWETRMKIAIGAAKG 447

Query:   413 XXXXXTENGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXXXXXEVT 472
                   EN GKLVHG IK+SNIFLNS+ + CVSD+                      EVT
Sbjct:   448 IARIHKENNGKLVHGNIKSSNIFLNSESNGCVSDLGLTAVMSPLAPPISRQAGYRAPEVT 507

Query:   473 DTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
             DTRK++Q SDV+SFGV+LLELLTGKSPIH T GDE++HLVRWV+SVVREEWTAEVFD+EL
Sbjct:   508 DTRKSSQLSDVYSFGVVLLELLTGKSPIHTTAGDEIIHLVRWVHSVVREEWTAEVFDIEL 567

Query:   533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI--RRVKAENPPSTENRSEI 590
             LRY NIEEEMVEMLQ+ M+CVV+  ++RPKM+D+++++E++  RR   E  P  + +SE 
Sbjct:   568 LRYTNIEEEMVEMLQIAMSCVVKAADQRPKMSDLVRLIENVGNRRTSIEPEPELKPKSEN 627

Query:   591 SSS-AATP 597
              +S  +TP
Sbjct:   628 GASETSTP 635

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

TAIR|locus:2043858 AT2G26730 [Arabidopsis thaliana (taxid:3702)]

 Score = 845 (302.5 bits), Expect = 4.3e-113, Sum P(2) = 4.3e-113
 Identities = 181/347 (52%), Positives = 228/347 (65%)

Query:   264 SQKKEMS-LKEGVSGSHDKNSKLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALE 322
             S K+E++    G+ G  ++N KLVF EG    FDLEDLLRASAEVLGKG+ GT+YKA LE
Sbjct:   313 SSKEEVTGTSSGMGGETERN-KLVFTEGGVYSFDLEDLLRASAEVLGKGSVGTSYKAVLE 371

Query:   323 DASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV 382
             + +TVVVKRLK+V   K+EFE QME+VG I+H NV+ LRAYYYSKDEKL+V+D+   GS+
Sbjct:   372 EGTTVVVKRLKDVMASKKEFETQMEVVGKIKHPNVIPLRAYYYSKDEKLLVFDFMPTGSL 431

Query:   383 SAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLVHGGIKASNIFLNSQGHV 442
             SA+LHG RG G++ LDWD R+                   KLVHG IKASNI L+     
Sbjct:   432 SALLHGSRGSGRTPLDWDNRMRIAITAARGLAHLHVS--AKLVHGNIKASNILLHPNQDT 489

Query:   443 CVSDIXXXXXXXXXXXXXXXXXXXXXXEVTDTRKATQASDVFSFGVLLLELLTGKSPIHA 502
             CVSD                       EV +TRK T  SDV+SFGVLLLELLTGKSP  A
Sbjct:   490 CVSDYGLNQLFSNSSPPNRLAGYHAP-EVLETRKVTFKSDVYSFGVLLLELLTGKSPNQA 548

Query:   503 TGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPK 562
             + G+E + L RWV SVVREEWTAEVFDVEL+RY NIEEEMV++LQ+ MACV  +P++RP 
Sbjct:   549 SLGEEGIDLPRWVLSVVREEWTAEVFDVELMRYHNIEEEMVQLLQIAMACVSTVPDQRPV 608

Query:   563 MADVLKMVEDIRRVKAENP---PSTENRSEISSSAATPKATETASSS 606
             M +VL+M+ED+ R +  +     S+++ S+ S     P  + T   S
Sbjct:   609 MQEVLRMIEDVNRSETTDDGLRQSSDDPSKGSEGQTPPGESRTPPRS 655

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0000272 "polysaccharide catabolic process" evidence=RCA

GO:0005982 "starch metabolic process" evidence=RCA

GO:0006084 "acetyl-CoA metabolic process" evidence=RCA

GO:0007020 "microtubule nucleation" evidence=RCA

GO:0007389 "pattern specification process" evidence=RCA

GO:0008361 "regulation of cell size" evidence=RCA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0009926 "auxin polar transport" evidence=RCA

GO:0010015 "root morphogenesis" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0016126 "sterol biosynthetic process" evidence=RCA

GO:0016132 "brassinosteroid biosynthetic process" evidence=RCA

GO:0040007 "growth" evidence=RCA

TAIR|locus:2156784 RUL1 "REDUCED IN LATERAL GROWTH1" [Arabidopsis thaliana (taxid:3702)]

 Score = 848 (303.6 bits), Expect = 1.4e-112, Sum P(2) = 1.4e-112
 Identities = 208/505 (41%), Positives = 284/505 (56%)

Query:   116 ENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKXXXXXXXXXXXXX 175
             + L  L L +NS SG +P      + +TV+ L NN F+  I  S+               
Sbjct:   148 KQLVVLDLSYNSLSGNIPSGLRNLSQITVLYLQNNSFDGPID-SLD-LPSVKVVNLSYNN 205

Query:   176 XXXXXPRSLQRFPSWAFAGNNL--------SSENARPPALPVQPPVAE---PSRKKSTKL 224
                  P  L++ P ++F GN+L         S  A  P+  +  P+ E   P R++ +K 
Sbjct:   206 LSGPIPEHLKKSPEYSFIGNSLLCGPPLNACSGGAISPSSNLPRPLTENLHPVRRRQSKA 265

Query:   225 SEPXXXXXXXXXXXXXFVICALLMICRYNKQDNDRIPVKSQKKEMSLKEGV---SGSHD- 280
                              ++  + ++ +  K++     V++Q   ++ K+     SG  D 
Sbjct:   266 YIIAIVVGCSVAVLFLGIVFLVCLVKKTKKEEGGGEGVRTQMGGVNSKKPQDFGSGVQDP 325

Query:   281 KNSKLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKR 340
             + +KL FFE CN  FDLEDLL+ASAEVLGKG+FGTAYKA LED + VVVKRL+EV   K+
Sbjct:   326 EKNKLFFFERCNHNFDLEDLLKASAEVLGKGSFGTAYKAVLEDTTAVVVKRLREVVASKK 385

Query:   341 EFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDW 399
             EFEQQMEIVG I +H N V L AYYYSKDEKL+VY Y   GS+  ++HG RG+    +DW
Sbjct:   386 EFEQQMEIVGKINQHSNFVPLLAYYYSKDEKLLVYKYMTKGSLFGIMHGNRGD--RGVDW 443

Query:   400 DTRVXXXXXXXXXXXXXXTENGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXX 459
             +TR+              +    K VHG IK+SNI L      C+SD             
Sbjct:   444 ETRMKIATGTSKAISYLHSL---KFVHGDIKSSNILLTEDLEPCLSD-TSLVTLFNLPTH 499

Query:   460 XXXXXXXXXXEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATG-GDE--VVHLVRWVN 516
                       EV +TR+ +Q SDV+SFGV++LE+LTGK+P+   G  DE  V+ L RWV 
Sbjct:   500 TPRTIGYNAPEVIETRRVSQRSDVYSFGVVILEMLTGKTPLTQPGLEDERVVIDLPRWVR 559

Query:   517 SVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV 576
             SVVREEWTAEVFDVELL++ NIEEEMV+MLQ+ +ACV R PE RPKM +V +M+ED+RR+
Sbjct:   560 SVVREEWTAEVFDVELLKFQNIEEEMVQMLQLALACVARNPESRPKMEEVARMIEDVRRL 619

Query:   577 KAENPPSTENRSEISSSAATPKATE 601
               ++    +NR+   SS AT   +E
Sbjct:   620 D-QSQQLQQNRT---SSEATSNVSE 640

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005618 "cell wall" evidence=IDA

GO:0005886 "plasma membrane" evidence=IDA

GO:2000605 "positive regulation of secondary growth" evidence=IMP

GO:0010089 "xylem development" evidence=RCA

GO:0044036 "cell wall macromolecule metabolic process" evidence=RCA

TAIR|locus:2024517 AT1G64210 [Arabidopsis thaliana (taxid:3702)]

 Score = 1107 (394.7 bits), Expect = 3.6e-112, P = 3.6e-112
 Identities = 261/598 (43%), Positives = 338/598 (56%)

Query:     4 LPIFSAIFFLVGTIFLPIKADPVED-KQALLDFIHNIHNSRSLNWNESSSLCKSWTGVTC 62
             + IF   F L+   F+ I +  +ED K+ALL F+ + ++SR L+WN+SS +C SWTGVTC
Sbjct:     1 MQIFLFFFSLI-LCFVLISSQTLEDDKKALLHFLSSFNSSR-LHWNQSSDVCHSWTGVTC 58

Query:    63 SADHSRVVALRLPGMALRGEIPPNTIGXXXXXXXXXXXXXXXXGLFPSDFSKLENLTSLH 122
             + +  R+V++RLP +   G IPP TI                 G FPSDF+ L++LT L+
Sbjct:    59 NENGDRIVSVRLPAVGFNGLIPPFTISRLSSLKFLSLRKNHFTGDFPSDFTNLKSLTHLY 118

Query:   123 LQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKXXXXXXXXXXXXXXXXXXPR 182
             LQ N  SGPL   FS   NL V+DLSNN FN SIP S+S                   P 
Sbjct:   119 LQHNHLSGPLLAIFSELKNLKVLDLSNNGFNGSIPTSLSGLTSLQVLNLANNSFSGEIPN 178

Query:   183 -SLQRFPSWAFAGNNLSSENARPPALP-VQPPVAEPS----RKKSTKLSEPXXXXXXXXX 236
               L +      + N L      P +L   Q      +    RKK  K             
Sbjct:   179 LHLPKLSQINLSNNKLIG--TIPKSLQRFQSSAFSGNNLTERKKQRKTPFGLSQLAFLLI 236

Query:   237 XXXXFVIC----ALLMICRYNKQDNDRIPVKSQKKEMSLKEGVSGSHDKNS----KLVFF 288
                  V+C    + +MI  + K    RI  K +K++ S   G   S D N+    K++FF
Sbjct:   237 LSAACVLCVSGLSFIMITCFGKT---RISGKLRKRDSSSPPGNWTSRDDNTEEGGKIIFF 293

Query:   289 EGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEI 348
              G N +FDL+DLL +SAEVLGKG FGT YK  +ED STVVVKRLKEV VG+REFEQQMEI
Sbjct:   294 GGRNHLFDLDDLLSSSAEVLGKGAFGTTYKVTMEDMSTVVVKRLKEVVVGRREFEQQMEI 353

Query:   349 VGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGE-GQSSLDWDTRVXXXX 407
             +G IRHENV  L+AYYYSKD+KL VY Y+  GS+  +LHG RG   +  LDWD R+    
Sbjct:   354 IGMIRHENVAELKAYYYSKDDKLAVYSYYNHGSLFEILHGNRGRYHRVPLDWDARLRIAT 413

Query:   408 XXXXXXXXXXTENGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXXX 467
                         + GK +HG IK+SNIFL+SQ + C+ D+                    
Sbjct:   414 GAARGLAKI---HEGKFIHGNIKSSNIFLDSQCYGCIGDVGLTTIMRSLPQTTCLTSGYH 470

Query:   468 XXEVTDTRKATQASDVFSFGVLLLELLTGKSPIHA-----TGGDEVVHLVRWVNSVVREE 522
               E+TDTR++TQ SDV+SFGV+LLELLTGKSP+       TGG+ +  L  W+ SVV +E
Sbjct:   471 APEITDTRRSTQFSDVYSFGVVLLELLTGKSPVSQAELVPTGGENM-DLASWIRSVVAKE 529

Query:   523 WTAEVFDVELLRYPN-IEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAE 579
             WT EVFD+E+L      EEEMVEMLQ+G+ACV    +ERP +A VLK++EDIR V AE
Sbjct:   530 WTGEVFDMEILSQSGGFEEEMVEMLQIGLACVALKQQERPHIAQVLKLIEDIRSVDAE 587

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005739 "mitochondrion" evidence=IDA

TAIR|locus:2161308 AT5G58300 [Arabidopsis thaliana (taxid:3702)]

 Score = 960 (343.0 bits), Expect = 1.4e-96, P = 1.4e-96
 Identities = 228/546 (41%), Positives = 308/546 (56%)

Query:    68 RVVALRLPGMALRGEIPPNTIGXXXXXXXXXXXXXXXXGLFPSDFSKLENLTSLHLQFNS 127
             R+++LR     L G +PP+ I                 G  PS  S+  N+  L L FNS
Sbjct:   115 RILSLR--SNLLSGNLPPD-IHSLPSLDYIYLQHNNFSGEVPSFVSRQLNI--LDLSFNS 169

Query:   128 FSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKXXXXXXXXXXXXXXXXXXPRSLQRF 187
             F+G +P  F     LT + L NN  +  +P ++                    P +L  F
Sbjct:   170 FTGKIPATFQNLKQLTGLSLQNNKLSGPVP-NLD-TVSLRRLNLSNNHLNGSIPSALGGF 227

Query:   188 PSWAFAGNNL--------SSENARPPALPVQ---PPVAE-PSRKKST-KLSEPXXXXXXX 234
             PS +F+GN L         + ++ PP+L      PP+   P ++ S  KL          
Sbjct:   228 PSSSFSGNTLLCGLPLQPCATSSPPPSLTPHISTPPLPPFPHKEGSKRKLHVSTIIPIAA 287

Query:   235 XXXXXXFVICALLMICRYNKQDN--DRI-PVKS--QKKEMSLKEGVSGSHDKNSKLVFFE 289
                    +I  +++ C   K+D   D I  VK+  +K +     GV    +KN KLVFF 
Sbjct:   288 GGAALLLLITVIILCCCIKKKDKREDSIVKVKTLTEKAKQEFGSGVQ-EPEKN-KLVFFN 345

Query:   290 GCNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIV 349
             GC+  FDLEDLLRASAEVLGKG++GTAYKA LE+++TVVVKRLKEV  GKREFEQQMEI+
Sbjct:   346 GCSYNFDLEDLLRASAEVLGKGSYGTAYKAVLEESTTVVVKRLKEVAAGKREFEQQMEII 405

Query:   350 GGI-RHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXX 408
               +  H +VV LRAYYYSKDEKLMV DY+  G++S++LHG RG  ++ LDWD+RV     
Sbjct:   406 SRVGNHPSVVPLRAYYYSKDEKLMVCDYYPAGNLSSLLHGNRGSEKTPLDWDSRVKITLS 465

Query:   409 XXXXXXXXXTENGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXXXX 468
                         G K  HG IK+SN+ +  +   C+SD                      
Sbjct:   466 AAKGIAHLHAAGGPKFSHGNIKSSNVIMKQESDACISDFGLTPLMAVPIAPMRGAGYRAP 525

Query:   469 XEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVF 528
              EV +TRK T  SDV+SFGVL+LE+LTGKSP+ +   D++V L RWV SVVREEWT+EVF
Sbjct:   526 -EVMETRKHTHKSDVYSFGVLILEMLTGKSPVQSPSRDDMVDLPRWVQSVVREEWTSEVF 584

Query:   529 DVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENP-PSTENR 587
             D+EL+R+ NIEEEMV+MLQ+ MACV ++PE RP M DV++M+E+IR   +E   PS+++ 
Sbjct:   585 DIELMRFQNIEEEMVQMLQIAMACVAQVPEVRPTMDDVVRMIEEIRVSDSETTRPSSDDN 644

Query:   588 SEISSS 593
             S+   S
Sbjct:   645 SKPKDS 650

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

TAIR|locus:2198090 RKL1 "receptor-like kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 702 (252.2 bits), Expect = 8.0e-89, Sum P(2) = 8.0e-89
 Identities = 142/299 (47%), Positives = 192/299 (64%)

Query:   277 GSHDKNSKLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVN 336
             G+     KLVFF     VFDLEDLLRASAEVLGKGTFGTAYKA L+  + V VKRLK+V 
Sbjct:   346 GNGPATKKLVFFGNATKVFDLEDLLRASAEVLGKGTFGTAYKAVLDAVTVVAVKRLKDVM 405

Query:   337 VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSS 396
             +  +EF++++E+VG + HEN+V LRAYY+S+DEKL+VYD+   GS+SA+LHG RG G+S 
Sbjct:   406 MADKEFKEKIELVGAMDHENLVPLRAYYFSRDEKLLVYDFMPMGSLSALLHGNRGAGRSP 465

Query:   397 LDWDTRVXXXXXXXXXXXXXXTENGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXX 456
             L+WD R               ++ G    HG IK+SNI L       VSD          
Sbjct:   466 LNWDVRSRIAIGAARGLDYLHSQ-GTSTSHGNIKSSNILLTKSHDAKVSDFGLAQLVGSS 524

Query:   457 XXXXXXXXXXXXXEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVN 516
                          EVTD ++ +Q  DV+SFGV+LLEL+TGK+P ++   +E V L RWV 
Sbjct:   525 ATNPNRATGYRAPEVTDPKRVSQKGDVYSFGVVLLELITGKAPSNSVMNEEGVDLPRWVK 584

Query:   517 SVVREEWTAEVFDVELLRYPNIEEEMV-EMLQVGMACVVRMPEERPKMADVLKMVEDIR 574
             SV R+EW  EVFD ELL     EEEM+ EM+Q+G+ C  + P++RP+M++V++ +E++R
Sbjct:   585 SVARDEWRREVFDSELLSLATDEEEMMAEMVQLGLECTSQHPDQRPEMSEVVRKMENLR 643

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005774 "vacuolar membrane" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

TAIR|locus:2088500 RLK902 "receptor-like kinase 902" [Arabidopsis thaliana (taxid:3702)]

 Score = 693 (249.0 bits), Expect = 5.6e-88, Sum P(2) = 5.6e-88
 Identities = 140/299 (46%), Positives = 193/299 (64%)

Query:   284 KLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFE 343
             KLVFF     VFDLEDLLRASAEVLGKGTFGTAYKA L+  + V VKRLK+V +  REF+
Sbjct:   347 KLVFFGNATKVFDLEDLLRASAEVLGKGTFGTAYKAVLDAVTLVAVKRLKDVTMADREFK 406

Query:   344 QQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRV 403
             +++E+VG + HEN+V LRAYYYS DEKL+VYD+   GS+SA+LHG +G G+  L+W+ R 
Sbjct:   407 EKIEVVGAMDHENLVPLRAYYYSGDEKLLVYDFMPMGSLSALLHGNKGAGRPPLNWEVRS 466

Query:   404 XXXXXXXXXXXXXXTENGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXX 463
                           +++     HG +K+SNI L +     VSD                 
Sbjct:   467 GIALGAARGLDYLHSQDPLSS-HGNVKSSNILLTNSHDARVSDFGLAQLVSASSTTPNRA 525

Query:   464 XXXXXXEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEW 523
                   EVTD R+ +Q +DV+SFGV+LLELLTGK+P ++   +E + L RWV+SV REEW
Sbjct:   526 TGYRAPEVTDPRRVSQKADVYSFGVVLLELLTGKAPSNSVMNEEGMDLARWVHSVAREEW 585

Query:   524 TAEVFDVELLRYP---NIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAE 579
               EVFD EL+      ++EEEM EMLQ+G+ C  + P++RP M +V++ ++++R+  A+
Sbjct:   586 RNEVFDSELMSIETVVSVEEEMAEMLQLGIDCTEQHPDKRPVMVEVVRRIQELRQSGAD 644

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0009664 "plant-type cell wall organization" evidence=RCA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0042545 "cell wall modification" evidence=RCA

TAIR|locus:2202359 AT1G68400 [Arabidopsis thaliana (taxid:3702)]

 Score = 741 (265.9 bits), Expect = 2.1e-86, Sum P(2) = 2.1e-86
 Identities = 165/333 (49%), Positives = 211/333 (63%)

Query:   280 DKNSKLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKE-VNV- 337
             DK  K+VFFEG    F+LEDLLRASAE+LGKG FGTAYKA LED + V VKRLK+ V V 
Sbjct:   342 DKG-KMVFFEGTRR-FELEDLLRASAEMLGKGGFGTAYKAVLEDGNEVAVKRLKDAVTVA 399

Query:   338 GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSL 397
             GK+EFEQQME++G +RH N+V+L+AYY++++EKL+VYDY   GS+  +LHG RG G++ L
Sbjct:   400 GKKEFEQQMEVLGRLRHTNLVSLKAYYFAREEKLLVYDYMPNGSLFWLLHGNRGPGRTPL 459

Query:   398 DWDTRVXXXXXXXXXXXXXXTE-NGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXX 456
             DW TR+                    KL HG IK++N+ L+  G+  VSD          
Sbjct:   460 DWTTRLKIAAGAARGLAFIHGSCKTLKLTHGDIKSTNVLLDRSGNARVSDFGLSIFAPSQ 519

Query:   457 XXXXXXXXXXXXXEVTDTRKATQASDVFSFGVLLLELLTGKSP-IHATG-GDEVVHLVRW 514
                          E+ D RK TQ SDV+SFGVLLLE+LTGK P +  TG     V L RW
Sbjct:   520 TVAKSNGYRAP--ELIDGRKHTQKSDVYSFGVLLLEILTGKCPNMVETGHSGGAVDLPRW 577

Query:   515 VNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIR 574
             V SVVREEWTAEVFD+EL+RY +IEEEMV +LQ+ MAC     + RPKM  V+K++EDIR
Sbjct:   578 VQSVVREEWTAEVFDLELMRYKDIEEEMVGLLQIAMACTAVAADHRPKMGHVVKLIEDIR 637

Query:   575 RVKAENPPSTENRSEISSSAATPKATETASSST 607
                +E  P  +    I+S+  +P  +E     T
Sbjct:   638 GGGSEASPCNDG---INSAVDSPCLSEDTCGGT 667

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0007169 "transmembrane receptor protein tyrosine kinase signaling pathway" evidence=ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q9SUQ3	Y4374_ARATH	No assigned EC number	0.5784	0.9349	0.9012	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	615
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	4e-43
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	9e-36
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-33
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-32
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-32
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-32
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	4e-32
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-29
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-25
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-24
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	7e-23
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-22
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-22
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-21
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	9e-20
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	9e-20
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-19
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	9e-19
PLN03150	623	PLN03150, PLN03150, hypothetical protein; Provisio	2e-18
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	3e-18
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-18
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	4e-18
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	6e-18
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-17
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	2e-17
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-17
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	4e-17
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-17
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	9e-17
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-16
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	2e-16
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	2e-16
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-16
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	4e-16
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-16
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	8e-16
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	8e-16
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-15
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	2e-15
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	3e-15
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-15
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-15
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-15
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-15
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-15
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-15
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-14
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-14
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-14
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	1e-14
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-14
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-14
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-14
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-14
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-14
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	3e-14
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	5e-14
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	6e-14
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	6e-14
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	7e-14
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-13
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-13
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-13
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-13
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	3e-13
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	4e-13
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	4e-13
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-13
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	6e-13
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	7e-13
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	8e-13
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	9e-13
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-12
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	1e-12
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-12
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-12
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-12
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-12
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	3e-12
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-12
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-12
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	4e-12
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	4e-12
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-12
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	4e-12
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-12
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	5e-12
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	6e-12
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	6e-12
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	8e-12
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-11
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-11
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	1e-11
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-11
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-11
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-11
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-11
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	2e-11
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-11
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	3e-11
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-11
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-11
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-11
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	7e-11
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	8e-11
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	8e-11
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	9e-11
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	1e-10
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-10
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-10
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-10
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-10
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-10
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	3e-10
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-10
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-10
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-10
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-10
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-10
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-10
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	5e-10
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	7e-10
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	7e-10
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	7e-10
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	9e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	9e-10
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	9e-10
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-09
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-09
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-09
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-09
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-09
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-09
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-09
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-09
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-09
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-09
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-09
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-09
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-09
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	2e-09
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-09
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-09
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	3e-09
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	3e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-09
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-09
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	4e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-09
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-09
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-09
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	5e-09
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	6e-09
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	7e-09
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	7e-09
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	7e-09
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	7e-09
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	9e-09
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	9e-09
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	9e-09
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	9e-09
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-08
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-08
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-08
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-08
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-08
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-08
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-08
pfam08263	42	pfam08263, LRRNT_2, Leucine rich repeat N-terminal	2e-08
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-08
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-08
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-08
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-08
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-08
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-08
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	5e-08
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-08
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	6e-08
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	6e-08
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	6e-08
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-07
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-07
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-07
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-07
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-07
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-07
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-07
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-07
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-07
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-07
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-07
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-07
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-07
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-07
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	3e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	4e-07
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-07
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	6e-07
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-07
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	6e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	7e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-07
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	8e-07
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	8e-07
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-06
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	1e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	1e-06
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-06
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-06
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-06
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-06
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	4e-06
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-06
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-06
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-06
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-06
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	5e-06
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-06
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-06
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	7e-06
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	7e-06
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	8e-06
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	9e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	1e-05
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-05
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-05
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-05
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	1e-05
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-05
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-05
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	2e-05
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-05
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-05
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	3e-05
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	3e-05
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	3e-05
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-05
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-05
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-05
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-05
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	4e-05
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	4e-05
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-05
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	5e-05
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-05
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	6e-05
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	7e-05
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	8e-05
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	9e-05
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-04
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-04
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-04
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-04
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	2e-04
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	2e-04
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-04
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-04
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-04
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	2e-04
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	3e-04
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-04
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	4e-04
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-04
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-04
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-04
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	4e-04
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	5e-04
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-04
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	6e-04
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	6e-04
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-04
COG4886	394	COG4886, COG4886, Leucine-rich repeat (LRR) protei	7e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	8e-04
pfam12799	43	pfam12799, LRR_4, Leucine Rich repeats (2 copies)	8e-04
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	8e-04
pfam13855	60	pfam13855, LRR_8, Leucine rich repeat	0.001
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.001
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	0.001
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	0.001
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	0.002
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	0.002
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	0.002
pfam12799	43	pfam12799, LRR_4, Leucine Rich repeats (2 copies)	0.003
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	0.003
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	0.003
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	0.003
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	0.003

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  165 bits (420), Expect = 4e-43
 Identities = 134/515 (26%), Positives = 224/515 (43%), Gaps = 71/515 (13%)

Query: 85  PNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTV 144
           P  +G LS L  L L  N LSG  P + S  + L SL L  N  SG +P  FS    L+ 
Sbjct: 492 PRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQ 551

Query: 145 IDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRS--LQRFPSWAFAGNN-LSSEN 201
           +DLS N  +  IP ++  +  L  +N+++N L G+LP +       + A AGN  L   +
Sbjct: 552 LDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGD 611

Query: 202 ARPPALPVQPPVAEPSRKKSTKLSEPALLGIALGGVALAFVICALLMICRYNKQDNDRIP 261
                 P +     PS       +  A L +AL      F+            +  + + 
Sbjct: 612 TTSGLPPCKRVRKTPSWWFYITCTLGAFLVLALVAFGFVFI------------RGRNNLE 659

Query: 262 VKSQKKEMSLKEGVSGSHDKNSKLVFFEG-CNLVFDLEDLLRASAE--VLGKGTFGTAYK 318
           +K  + E           D   +L FF+   +    + D+L +  E  V+ +G  G +YK
Sbjct: 660 LKRVENE-----------DGTWELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYK 708

Query: 319 A-ALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYF 377
             ++++    VVK + +VN         M   G ++H N+V L     S+    ++++Y 
Sbjct: 709 GKSIKNGMQFVVKEINDVNSIPSSEIADM---GKLQHPNIVKLIGLCRSEKGAYLIHEYI 765

Query: 378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLN 437
           E  ++S +L         +L W+ R +IAIG A+ +  +H      +V G +    I ++
Sbjct: 766 EGKNLSEVL--------RNLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIID 817

Query: 438 SQG--HVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT 495
            +   H+ +S  GL             ++ Y APE  +T+  T+ SD++ FG++L+ELLT
Sbjct: 818 GKDEPHLRLSLPGLLC----TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLT 873

Query: 496 GKSPIHA-TGGDEVV-----------HLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMV 543
           GKSP  A  G    +           HL  W++  +R + +              + E+V
Sbjct: 874 GKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVN------------QNEIV 921

Query: 544 EMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKA 578
           E++ + + C    P  RP   DVLK +E   R  +
Sbjct: 922 EVMNLALHCTATDPTARPCANDVLKTLESASRSSS 956

Length = 968

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  133 bits (336), Expect = 9e-36
 Identities = 57/194 (29%), Positives = 97/194 (50%), Gaps = 15/194 (7%)

Query: 308 LGKGTFGTAYKA-ALEDASTVVVKRLK--EVNVGKREFEQQMEIVGGIRHENVVALRAYY 364
           LG+G FGT Y A   +    V +K +K  + +    E  +++EI+  + H N+V L   +
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 365 YSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKL 424
             ++   +V +Y E GS+  +L    G+    L  D  +RI +    G+ ++H+     +
Sbjct: 61  EDENHLYLVMEYCEGGSLKDLLKENEGK----LSEDEILRILLQILEGLEYLHSNG---I 113

Query: 425 VHGGIKASNIFLNS-QGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEV-TDTRKATQ 479
           +H  +K  NI L+S  G V ++D GL+ L++          G   Y APEV       ++
Sbjct: 114 IHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSE 173

Query: 480 ASDVFSFGVLLLEL 493
            SD++S GV+L EL
Sbjct: 174 KSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  128 bits (323), Expect = 2e-33
 Identities = 63/202 (31%), Positives = 92/202 (45%), Gaps = 16/202 (7%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNVGKREFEQQ---MEIVGGIRHENVVALR 361
             LG G+FGT YKA        V VK LK+ +   ++ +     + I+  + H N+V L 
Sbjct: 5   RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64

Query: 362 AYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENG 421
             +  KD   +V +Y E G +   L          L  D   +IA+   RG+ ++H+   
Sbjct: 65  DAFEDKDHLYLVMEYCEGGDLFDYLSRGG-----PLSEDEAKKIALQILRGLEYLHSNG- 118

Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVT-DTRKA 477
             ++H  +K  NI L+  G V ++D GLA  +           G   Y APEV       
Sbjct: 119 --IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGY 176

Query: 478 TQASDVFSFGVLLLELLTGKSP 499
               DV+S GV+L ELLTGK P
Sbjct: 177 GPKVDVWSLGVILYELLTGKPP 198

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  125 bits (317), Expect = 2e-32
 Identities = 77/278 (27%), Positives = 120/278 (43%), Gaps = 42/278 (15%)

Query: 306 EVLGKGTFGTAYKAALEDAS-----TVVVKRLKE--VNVGKREFEQQMEIVGGIRHENVV 358
           + LG+G FG  YK  L+         V VK LKE        EF ++  I+  + H NVV
Sbjct: 5   KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64

Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT 418
            L      ++   +V +Y E G + + L   R +    L     +  A+  ARG+ ++ +
Sbjct: 65  KLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPK----LSLSDLLSFALQIARGMEYLES 120

Query: 419 ENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG----YR--APEVT 472
           +N    +H  + A N  +     V +SD GL+  +        R  G     R  APE  
Sbjct: 121 KN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD--YYRKRGGKLPIRWMAPESL 175

Query: 473 DTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE 531
              K T  SDV+SFGVLL E+ T G+ P      +EV+  ++                  
Sbjct: 176 KEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLK----------NGYR---- 221

Query: 532 LLRYPNIEEEMVE-MLQVGMACVVRMPEERPKMADVLK 568
           L + PN   E+ + MLQ    C    PE+RP  +++++
Sbjct: 222 LPQPPNCPPELYDLMLQ----CWAEDPEDRPTFSELVE 255

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  124 bits (315), Expect = 3e-32
 Identities = 74/284 (26%), Positives = 117/284 (41%), Gaps = 53/284 (18%)

Query: 306 EVLGKGTFGTAYKAALEDAS-----TVVVKRLKE--VNVGKREFEQQMEIVGGIRHENVV 358
           + LG+G FG  YK  L+         V VK LKE        EF ++  I+  + H N+V
Sbjct: 5   KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64

Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT 418
            L      ++  ++V +Y   G +   L   R +    L     +  A+  ARG+ ++ +
Sbjct: 65  KLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKE---LSLSDLLSFALQIARGMEYLES 121

Query: 419 ENGGKLVHGGIKASNIFLNSQGHVCVSDIGLA----------ALMSPMPPPAMRAAGYR- 467
           +N    +H  + A N  +     V +SD GL+               +P         R 
Sbjct: 122 KN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLP--------IRW 170

Query: 468 -APEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTA 525
            APE     K T  SDV+SFGVLL E+ T G+ P       EV+  ++            
Sbjct: 171 MAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLK----------KG 220

Query: 526 EVFDVELLRYPNIEEEMVE-MLQVGMACVVRMPEERPKMADVLK 568
                 L + PN   E+ + MLQ    C    PE+RP  +++++
Sbjct: 221 YR----LPKPPNCPPELYKLMLQ----CWAEDPEDRPTFSELVE 256

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  124 bits (314), Expect = 4e-32
 Identities = 72/282 (25%), Positives = 122/282 (43%), Gaps = 36/282 (12%)

Query: 306 EVLGKGTFGTAYKAALEDAST----VVVKRLKE--VNVGKREFEQQMEIVGGIRHENVVA 359
           + LG+G FG  YK  L+        V VK LKE      +++F ++  ++  + H NVV 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRG----EGQSSLDWDTRVRIAIGAARGIAH 415
           L      ++   +V +Y E G +   L   R       +S+L     +  AI  A+G+ +
Sbjct: 61  LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120

Query: 416 IHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR-----APE 470
           + ++     VH  + A N  +     V +SD GL+  +        +  G       APE
Sbjct: 121 LASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPE 177

Query: 471 VTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD 529
                  T  SDV+SFGVLL E+ T G +P      +EV+  +R      R         
Sbjct: 178 SLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR---KGYR--------- 225

Query: 530 VELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVE 571
             L +     +E+ E++    +C    PE+RP  +++++ +E
Sbjct: 226 --LPKPEYCPDELYELML---SCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  124 bits (314), Expect = 4e-32
 Identities = 73/272 (26%), Positives = 124/272 (45%), Gaps = 33/272 (12%)

Query: 306 EVLGKGTFGTAYKAALEDAST---VVVKRL-KEVNVGKRE-FEQQMEIVGGIRHENVVAL 360
           E LG+G+FG  Y A   D  T   V +K + K+     RE   ++++I+  ++H N+V L
Sbjct: 5   EKLGEGSFGKVYLA--RDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRL 62

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN 420
              +  +D+  +V +Y E G +  +L  R       L  D            + ++H++ 
Sbjct: 63  YDVFEDEDKLYLVMEYCEGGDLFDLLKKRG-----RLSEDEARFYLRQILSALEYLHSKG 117

Query: 421 GGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTDTRKA 477
              +VH  +K  NI L+  GHV ++D GLA  + P         G   Y APEV   +  
Sbjct: 118 ---IVHRDLKPENILLDEDGHVKLADFGLARQLDP-GEKLTTFVGTPEYMAPEVLLGKGY 173

Query: 478 TQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN 537
            +A D++S GV+L ELLTGK P    G D+++ L + +                     +
Sbjct: 174 GKAVDIWSLGVILYELLTGKPPFP--GDDQLLELFKKIGKPKPPFP---------PPEWD 222

Query: 538 IEEEMVEMLQVGMACVVRMPEERPKMADVLKM 569
           I  E  ++++     +V+ PE+R    + L+ 
Sbjct: 223 ISPEAKDLIR---KLLVKDPEKRLTAEEALQH 251

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  117 bits (296), Expect = 1e-29
 Identities = 73/285 (25%), Positives = 116/285 (40%), Gaps = 57/285 (20%)

Query: 306 EVLGKGTFGTAYKAALEDAS-----TVVVKRLKE--VNVGKREFEQQMEIVGGIRHENVV 358
           + LG+G FG  YK  L+         V VK LKE      + EF ++  I+  + H N+V
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT 418
            L       +   +V +Y   G +   L          L     +++A+  A+G+ ++ +
Sbjct: 65  RLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGE----KLTLKDLLQMALQIAKGMEYLES 120

Query: 419 ENGGKLVHGGIKASNIFLNSQGHVCVSDIGLA-----------ALMSPMPPPAMRAAGYR 467
           +N    VH  + A N  +     V +SD GL+                +P   M      
Sbjct: 121 KN---FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM------ 171

Query: 468 APEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVR----EE 522
           APE     K T  SDV+SFGVLL E+ T G+ P      +EV+ L+       R    E 
Sbjct: 172 APESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLE---DGYRLPRPEN 228

Query: 523 WTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVL 567
              E++++              MLQ    C    PE+RP  ++++
Sbjct: 229 CPDELYEL--------------MLQ----CWAYDPEDRPTFSELV 255

Length = 258

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score =  111 bits (278), Expect = 3e-25
 Identities = 74/223 (33%), Positives = 105/223 (47%), Gaps = 36/223 (16%)

Query: 6   IFSAIFFLVGTIFLPIKADPVEDKQALLDFIHNIHNSRSL--NWNESSSLCKSWTGVTCS 63
           IF   F      FL       E+ + LL F  +I++      NWN S+ +C  W G+TC+
Sbjct: 13  IFMLFFL-----FLNFSMLHAEELELLLSFKSSINDPLKYLSNWNSSADVCL-WQGITCN 66

Query: 64  ADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSK--------- 114
            + SRVV++ L G  + G+I      RL  +Q ++L +N LSG  P D            
Sbjct: 67  -NSSRVVSIDLSGKNISGKISSAIF-RLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLN 124

Query: 115 --------------LENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASI 160
                         + NL +L L  N  SG +P D   +++L V+DL  N     IP S+
Sbjct: 125 LSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSL 184

Query: 161 SKLTHLSALNLANNSLTGTLPRSLQRFPS--WAFAG-NNLSSE 200
           + LT L  L LA+N L G +PR L +  S  W + G NNLS E
Sbjct: 185 TNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGE 227

Length = 968

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  101 bits (255), Expect = 3e-24
 Identities = 57/203 (28%), Positives = 94/203 (46%), Gaps = 17/203 (8%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRLKEVNVGKREF-EQQMEIVGGIRHENVVALRAY 363
           E +GKG FG  YKA        V +K +K  +  K+E    +++I+   +H N+V     
Sbjct: 6   EKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGS 65

Query: 364 YYSKDEKLMVYDYFEPGSVSAMLHGRRG---EGQSSLDWDTRVRIAIGAARGIAHIHTEN 420
           Y  KDE  +V ++   GS+  +L        E Q +        +     +G+ ++H+  
Sbjct: 66  YLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAY-------VCKELLKGLEYLHSNG 118

Query: 421 GGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRA--AGYRAPEVTDTRKAT 478
              ++H  IKA+NI L S G V + D GL+A +S             + APEV + +   
Sbjct: 119 ---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYD 175

Query: 479 QASDVFSFGVLLLELLTGKSPIH 501
             +D++S G+  +EL  GK P  
Sbjct: 176 YKADIWSLGITAIELAEGKPPYS 198

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 98.0 bits (245), Expect = 7e-23
 Identities = 66/278 (23%), Positives = 125/278 (44%), Gaps = 42/278 (15%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKR--LKEVNVGKREF-EQQMEIVGGIRHENVVALR 361
           + +GKG+FG  Y      D    V+K   L  ++  +RE    +++I+  + H N++   
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 362 AYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLD---WDTRVRIAIGAARGIAHIHT 418
             +  K +  +V +Y + G +S  +  ++ EG+   +    D  V++ +     + ++H+
Sbjct: 66  ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLA----LKYLHS 121

Query: 419 ENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTDTR 475
               K++H  IK  NIFL S G V + D G++ ++S     A    G   Y +PE+   +
Sbjct: 122 R---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNK 178

Query: 476 KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY 535
                SD++S G +L EL T K P       E+         +++ +            Y
Sbjct: 179 PYNYKSDIWSLGCVLYELCTLKHPFEGENLLEL------ALKILKGQ------------Y 220

Query: 536 PNIEE----EMVEMLQVGMACVVRMPEERPKMADVLKM 569
           P I      E+  ++    + + + PEERP +A +L+ 
Sbjct: 221 PPIPSQYSSELRNLVS---SLLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 96.5 bits (241), Expect = 2e-22
 Identities = 53/205 (25%), Positives = 103/205 (50%), Gaps = 19/205 (9%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNVGK---REFEQQMEIVGGIRHENVVALR 361
           +++G+G FG  YK   LE    V +K++    + +   +   Q+++++  ++H N+V   
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYI 65

Query: 362 AYYYSKDEKLMVYDYFEPGSVSAML--HGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE 419
               + D   ++ +Y E GS+  ++   G   E   +  +  +V       +G+A++H +
Sbjct: 66  GSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVA-VYVYQV------LQGLAYLHEQ 118

Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTDTRK 476
               ++H  IKA+NI     G V ++D G+A  ++ +        G   + APEV +   
Sbjct: 119 ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSG 175

Query: 477 ATQASDVFSFGVLLLELLTGKSPIH 501
           A+ ASD++S G  ++ELLTG  P +
Sbjct: 176 ASTASDIWSLGCTVIELLTGNPPYY 200

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 98.3 bits (243), Expect = 4e-22
 Identities = 66/282 (23%), Positives = 117/282 (41%), Gaps = 32/282 (11%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKRE----FEQQMEIVGGIRHE-NVVAL 360
             LG+G+FG  Y A   D   V +K L +    K +    F ++++I+  + H  N+V L
Sbjct: 6   RKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN 420
             ++  +    +V +Y + GS+  +L     +G  S      + I       + ++H++ 
Sbjct: 64  YDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESE--ALFILAQILSALEYLHSKG 121

Query: 421 GGKLVHGGIKASNIFLNSQGH-VCVSDIGLAALMS---------PMPPPAMRAAGYRAPE 470
              ++H  IK  NI L+  G  V + D GLA L+           +P  ++   GY APE
Sbjct: 122 ---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178

Query: 471 V---TDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEV 527
           V        A+ +SD++S G+ L ELLTG  P                  ++ E  T  +
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSS---ATSQTLKIILELPTPSL 235

Query: 528 -FDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
              +       I +   ++L      + + P+ R   +  L 
Sbjct: 236 ASPLSPSNPELISKAASDLL---KKLLAKDPKNRLSSSSDLS 274

Length = 384

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 93.8 bits (234), Expect = 2e-21
 Identities = 71/280 (25%), Positives = 125/280 (44%), Gaps = 36/280 (12%)

Query: 298 EDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNV-GKREFEQQ----MEIVGGI 352
            DL R    VLG+G+ G  YK   +    +    LK+++V G  EF +Q    ++ +   
Sbjct: 1   SDLERVK--VLGQGSSGVVYKVRHKPTGKIYA--LKKIHVDGDEEFRKQLLRELKTLRSC 56

Query: 353 RHENVVALRAYYYSKDEKLMVYDYFEPGSVSAML--HGRRGEGQSSLDWDTRVRIAIGAA 410
               VV     +Y + E  +V +Y + GS++ +L   G+  E   +        IA    
Sbjct: 57  ESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAY-------IARQIL 109

Query: 411 RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YR 467
           +G+ ++HT+    ++H  IK SN+ +NS+G V ++D G++ ++           G   Y 
Sbjct: 110 KGLDYLHTKR--HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYM 167

Query: 468 APEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEV 527
           +PE       + A+D++S G+ LLE   GK P    G      L++ +         AE 
Sbjct: 168 SPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEE 227

Query: 528 FDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVL 567
           F            E  + +    AC+ + P++RP  A++L
Sbjct: 228 FS----------PEFRDFIS---ACLQKDPKKRPSAAELL 254

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 89.0 bits (221), Expect = 9e-20
 Identities = 70/277 (25%), Positives = 126/277 (45%), Gaps = 44/277 (15%)

Query: 307 VLGKGTFGTA--YKAALEDASTVVVKRLKEVNV------GKREFEQQMEIVGGIRHENVV 358
           VLGKG FG A  Y+   ED S VV    KEVN+       +R+   ++ I+  ++H N++
Sbjct: 7   VLGKGAFGEATLYRRT-EDDSLVV---WKEVNLTRLSEKERRDALNEIVILSLLQHPNII 62

Query: 359 ALRAYY--YSKDEKLMV-YDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAH 415
           A   YY  +  D  L++  +Y   G++   +  ++G+     + +  +         +++
Sbjct: 63  A---YYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQ---LFEEEMVLWYLFQIVSAVSY 116

Query: 416 IHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVT 472
           IH      ++H  IK  NIFL   G + + D G++ ++      A    G   Y +PE+ 
Sbjct: 117 IHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELC 173

Query: 473 DTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
              K    SD+++ G +L ELLT K    AT      + +  V  +V+  +T       +
Sbjct: 174 QGVKYNFKSDIWALGCVLYELLTLKRTFDAT------NPLNLVVKIVQGNYT-----PVV 222

Query: 533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM 569
             Y +      E++ +  + + + PE+RP   +VL  
Sbjct: 223 SVYSS------ELISLVHSLLQQDPEKRPTADEVLDQ 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 89.2 bits (222), Expect = 9e-20
 Identities = 72/280 (25%), Positives = 127/280 (45%), Gaps = 46/280 (16%)

Query: 306 EVLGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQM---EIVGGIRHENVVALR 361
           E+LG+G+FG+ Y A  +D   ++ VK ++     + E E       I+  ++H N+V   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVR-- 63

Query: 362 AYYYSK--DEKLMVY---DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRI-AIGAARGIAH 415
            YY S+  +EK  +    +Y   GS+S++L     +    L  +  +R        G+A+
Sbjct: 64  -YYGSERDEEKNTLNIFLEYVSGGSLSSLL-----KKFGKLP-EPVIRKYTRQILEGLAY 116

Query: 416 IHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRA--AG---YRAPE 470
           +H  NG  +VH  IK +NI ++S G V ++D G A  +  +          G   + APE
Sbjct: 117 LH-SNG--IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPE 173

Query: 471 VTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDV 530
           V    +  +A+D++S G  ++E+ TGK P              W          A ++ +
Sbjct: 174 VIRGEEYGRAADIWSLGCTVIEMATGKPP--------------WSEL---GNPMAALYKI 216

Query: 531 ELLRY-PNIEEEMVEMLQ-VGMACVVRMPEERPKMADVLK 568
                 P I E + E  +     C+ R P++RP   ++L+
Sbjct: 217 GSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 89.1 bits (221), Expect = 1e-19
 Identities = 66/239 (27%), Positives = 104/239 (43%), Gaps = 40/239 (16%)

Query: 306 EVLGKGTFGTAYKAAL------EDASTVVVKRLKEVNVGK--REFEQQMEIVGGIRHENV 357
           E LG+G FG  YK  L        A++V +K LKE    K  +EF Q+ E++  ++H N+
Sbjct: 11  EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNI 70

Query: 358 VALRAYYYSKDEKLMVYDYFEPGSVSAMLHGR-----------RGEGQSSLDWDTRVRIA 406
           V L      +    M+++Y   G +   L                  +SSLD    + IA
Sbjct: 71  VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130

Query: 407 IGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALM-----------SP 455
           I  A G+ ++ + +    VH  + A N  +     V +SD GL+  +           S 
Sbjct: 131 IQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSL 187

Query: 456 MPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVR 513
           +P   M       PE     K T  SD++SFGV+L E+ + G  P +     EV+ ++R
Sbjct: 188 LPVRWM------PPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 86.0 bits (213), Expect = 9e-19
 Identities = 61/209 (29%), Positives = 103/209 (49%), Gaps = 23/209 (11%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIR------HENVVA 359
             +GKG+FG  +K   +    V    +K++++ K    ++ E +   R         ++ 
Sbjct: 6   NKIGKGSFGVVFKVVRKADKRVYA--MKQIDLSKMNRREREEAIDEARVLAKLDSSYIIR 63

Query: 360 LRAYYYS--KDEKL-MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHI 416
              YY S     KL +V +Y E G +  +L  +RG     L  D   R  I    G+AH+
Sbjct: 64  ---YYESFLDKGKLNIVMEYAENGDLHKLLKMQRG---RPLPEDQVWRFFIQILLGLAHL 117

Query: 417 HTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTD 473
           H++   K++H  IK+ N+FL++  +V + D+G+A L+S     A    G   Y +PE+ +
Sbjct: 118 HSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCE 174

Query: 474 TRKATQASDVFSFGVLLLELLTGKSPIHA 502
            +   + SDV++ GV+L E  TGK P  A
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFDA 203

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional

 Score = 88.7 bits (220), Expect = 2e-18
 Identities = 64/203 (31%), Positives = 90/203 (44%), Gaps = 35/203 (17%)

Query: 57  WTGVTCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLE 116
           W+G  C  D                    +T G+   +  L L +  L G  P+D SKL 
Sbjct: 404 WSGADCQFD--------------------STKGKW-FIDGLGLDNQGLRGFIPNDISKLR 442

Query: 117 NLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSL 176
           +L S++L  NS  G +P       +L V+DLS N FN SIP S+ +LT L  LNL  NSL
Sbjct: 443 HLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSL 502

Query: 177 TGTLPRSLQRFPSWAFAGNNLSSENARPPALPVQPPVAEPSRKKSTKLSEPALLGIALGG 236
           +G +P +L        + N   ++NA    +P               LS  A +GIA G 
Sbjct: 503 SGRVPAALGGRLLHRASFN--FTDNAGLCGIPGLRACG-------PHLSVGAKIGIAFGV 553

Query: 237 VA--LAFVICALLMICRYNKQDN 257
               L  VICA   +C + ++ N
Sbjct: 554 SVAFLFLVICA---MCWWKRRQN 573

Length = 623

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 85.1 bits (211), Expect = 3e-18
 Identities = 73/298 (24%), Positives = 129/298 (43%), Gaps = 56/298 (18%)

Query: 308 LGKGTFGTAYKAALE---DAST--VVVKRLK--EVNVGKREFEQQMEIVGGIRHENVVAL 360
           LG+G FG       +   D +   V VK L        + +FE+++EI+  + HEN+V  
Sbjct: 12  LGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKY 71

Query: 361 RAYYYSKDEK--LMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT 418
           +        +   ++ +Y   GS+   L   R      ++    +  +    +G+ ++ +
Sbjct: 72  KGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLGS 127

Query: 419 ENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALM----------SPMPPPAMRAAGYRA 468
           +   + +H  + A NI + S+  V +SD GLA ++           P   P      + A
Sbjct: 128 Q---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIF----WYA 180

Query: 469 PEVTDTRKATQASDVFSFGVLLLELLT----GKSPI--------HATGGDEVVHLVRWVN 516
           PE   T K + ASDV+SFGV L EL T     +SP          A G   V  L+  + 
Sbjct: 181 PECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240

Query: 517 SVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIR 574
              R           L R P+  +E+ +++++   C    P++RP  AD++ +V+ +R
Sbjct: 241 EGER-----------LPRPPSCPDEVYDLMKL---CWEAEPQDRPSFADLILIVDRLR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 83.9 bits (208), Expect = 4e-18
 Identities = 80/276 (28%), Positives = 124/276 (44%), Gaps = 38/276 (13%)

Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG G FG  +       + V VK LK   +    F Q+ +I+  +RH+ +V L A    +
Sbjct: 14  LGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE 73

Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHG 427
           +   +V +Y   GS+   L  + GEG   L     V +A   A G+A++ + N    +H 
Sbjct: 74  EPIYIVTEYMSKGSLLDFL--KSGEG-KKLRLPQLVDMAAQIAEGMAYLESRN---YIHR 127

Query: 428 GIKASNIFLNSQGHVC-VSDIGLAALMSPMPPPAMRAAGY----RAPEVTDTRKATQASD 482
            + A NI L  +  VC ++D GLA L+      A   A +     APE  +  + T  SD
Sbjct: 128 DLAARNI-LVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSD 186

Query: 483 VFSFGVLLLELLT-GKSPIHATGGDEVVHLV----RWVNSVVREEWTAEVFDVELLRYPN 537
           V+SFG+LL E++T G+ P       EV+  V    R                  + R PN
Sbjct: 187 VWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR------------------MPRPPN 228

Query: 538 IEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
             EE+ +++   + C  + PEERP    +   +ED 
Sbjct: 229 CPEELYDLM---LQCWDKDPEERPTFEYLQSFLEDY 261

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 84.3 bits (208), Expect = 4e-18
 Identities = 69/281 (24%), Positives = 121/281 (43%), Gaps = 37/281 (13%)

Query: 306 EVLGKGTFGTAYKAALE----DASTVVVKRLKEVNVGKR--EFEQQMEIVGGIRHENVVA 359
           +V+G G FG  ++  L+        V +K LK     K+  +F  +  I+G   H N++ 
Sbjct: 11  KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIR 70

Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE 419
           L          +++ +Y E G++   L    GE  SS      +R   G A G+ ++   
Sbjct: 71  LEGVVTKFKPAMIITEYMENGALDKYLRDHDGEF-SSYQLVGMLR---GIAAGMKYLSDM 126

Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG------YRAPEVTD 473
           N    VH  + A NI +NS     VSD GL+ ++   P      +G      + APE   
Sbjct: 127 N---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIA 183

Query: 474 TRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
            RK T ASDV+SFG+++ E+++ G+ P       EV+  +                  + 
Sbjct: 184 YRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN-----------------DG 226

Query: 533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
            R P   +    + Q+ + C  +    RP+  D++ +++ +
Sbjct: 227 FRLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 84.3 bits (208), Expect = 6e-18
 Identities = 77/286 (26%), Positives = 124/286 (43%), Gaps = 45/286 (15%)

Query: 306 EVLGKGTFGTAYKAAL-----EDASTVVVKRLKEVNVGKR--EFEQQMEIVGGIRHENVV 358
           E LG+  FG  YK  L     + A  V +K LK++N  ++  EF+Q+  ++  + H N+V
Sbjct: 11  EELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIV 70

Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRR------------GEGQSSLDWDTRVRIA 406
            L      +    M+++Y   G +   L  R             G  +SSLD    + IA
Sbjct: 71  CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 407 IGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGL-----AALMSPMPPPAM 461
           I  A G+ ++ +      VH  + A NI +  Q HV +SD+GL     +A    + P ++
Sbjct: 131 IQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSL 187

Query: 462 RAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVR 520
               +  PE     K +  SD++SFGV+L E+ + G  P +     EV+ +VR       
Sbjct: 188 LPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR------- 240

Query: 521 EEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADV 566
                     +LL  P  E+    M  +   C    P  RP+  D+
Sbjct: 241 --------KRQLL--PCSEDCPPRMYSLMTECWQEGPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 69/260 (26%), Positives = 123/260 (47%), Gaps = 30/260 (11%)

Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGK-REFEQQMEIVGGIRHENVVALRAYYYS 366
           LG G FG  ++   ++   V +K LK  ++ K ++F+++++ +  +RH+++++L A    
Sbjct: 14  LGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV 73

Query: 367 KDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVH 426
            +   ++ +  E GS+ A L  R  EGQ  L   + + +A   A G+A++  +N    +H
Sbjct: 74  GEPVYIITELMEKGSLLAFL--RSPEGQV-LPVASLIDMACQVAEGMAYLEEQN---SIH 127

Query: 427 GGIKASNIFLNSQGHVC-VSDIGLAALMS-PMPPPAMRAAGYR--APEVTDTRKATQASD 482
             + A NI L  +  VC V+D GLA L+   +   + +   Y+  APE       +  SD
Sbjct: 128 RDLAARNI-LVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSD 186

Query: 483 VFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEE 541
           V+SFG+LL E+ T G+ P       EV   +                     R P   + 
Sbjct: 187 VWSFGILLYEMFTYGQVPYPGMNNHEVYDQI-----------------TAGYRMPCPAKC 229

Query: 542 MVEMLQVGMACVVRMPEERP 561
             E+ ++ + C    PE+RP
Sbjct: 230 PQEIYKIMLECWAAEPEDRP 249

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 77/271 (28%), Positives = 125/271 (46%), Gaps = 31/271 (11%)

Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG G FG  +       + V VK LK   +    F ++ +I+  +RH+ +V L A   S+
Sbjct: 14  LGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYA-VVSE 72

Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHG 427
           +   +V +Y   GS+   L  + GEG+ +L     V +A   A G+A+I   N    +H 
Sbjct: 73  EPIYIVTEYMSKGSLLDFL--KDGEGR-ALKLPNLVDMAAQVAAGMAYIERMN---YIHR 126

Query: 428 GIKASNIFLNSQGHVC-VSDIGLAALMSPMPPPAMRAAGY----RAPEVTDTRKATQASD 482
            ++++NI +   G VC ++D GLA L+      A + A +     APE     + T  SD
Sbjct: 127 DLRSANILVGD-GLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 483 VFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEE 541
           V+SFG+LL EL+T G+ P       EV+  V                     R P  ++ 
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMNNREVLEQVE-----------------RGYRMPCPQDC 228

Query: 542 MVEMLQVGMACVVRMPEERPKMADVLKMVED 572
            + + ++ + C  + PEERP    +   +ED
Sbjct: 229 PISLHELMLQCWKKDPEERPTFEYLQSFLED 259

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 81.8 bits (203), Expect = 2e-17
 Identities = 64/218 (29%), Positives = 102/218 (46%), Gaps = 26/218 (11%)

Query: 308 LGKGTFGTAYKAALEDASTV-VVKRL-KEVNVGKREFEQQME---IVGGIRHENVVALRA 362
           LGKG+FG       +D   +  +K L K+  + ++E E  +    I+  I H  +V L  
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKL-H 59

Query: 363 YYYSKDEKL-MVYDYFEPGSVSAML--HGRRGEGQSSLDWDTRVRIAIGA--ARGIAHIH 417
           Y +  +EKL +V +Y   G + + L   GR  E         R R    A     + ++H
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEE--------RARF-YAAEIVLALEYLH 110

Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTDT 474
           +     +++  +K  NI L++ GH+ ++D GLA  +S          G   Y APEV   
Sbjct: 111 SLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLG 167

Query: 475 RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLV 512
           +   +A D +S GVLL E+LTGK P +A    E+   +
Sbjct: 168 KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKI 205

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 81.3 bits (200), Expect = 4e-17
 Identities = 76/270 (28%), Positives = 115/270 (42%), Gaps = 29/270 (10%)

Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG+G FG  +       + V +K LK   +    F Q+ +++  +RHE +V L A   S+
Sbjct: 14  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 72

Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHG 427
           +   +V +Y   GS+   L   +GE    L     V +A   A G+A++   N    VH 
Sbjct: 73  EPIYIVTEYMSKGSLLDFL---KGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHR 126

Query: 428 GIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGY----RAPEVTDTRKATQASDV 483
            ++A+NI +       V+D GLA L+      A + A +     APE     + T  SDV
Sbjct: 127 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 484 FSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEM 542
           +SFG+LL EL T G+ P       EV+  V                     R P   E  
Sbjct: 187 WSFGILLTELTTKGRVPYPGMVNREVLDQVE-----------------RGYRMPCPPECP 229

Query: 543 VEMLQVGMACVVRMPEERPKMADVLKMVED 572
             +  +   C  + PEERP    +   +ED
Sbjct: 230 ESLHDLMCQCWRKEPEERPTFEYLQAFLED 259

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 84.1 bits (208), Expect = 7e-17
 Identities = 47/128 (36%), Positives = 66/128 (51%), Gaps = 10/128 (7%)

Query: 79  LRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSV 138
           L GEIP   IG L++L +L L  N+L+G  PS    L+NL  L L  N  SGP+P     
Sbjct: 224 LSGEIP-YEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFS 282

Query: 139 WNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPS------WAF 192
              L  +DLS+N  +  IP  + +L +L  L+L +N+ TG +P +L   P       W+ 
Sbjct: 283 LQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWS- 341

Query: 193 AGNNLSSE 200
             N  S E
Sbjct: 342 --NKFSGE 347

Length = 968

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 80.4 bits (199), Expect = 9e-17
 Identities = 64/283 (22%), Positives = 124/283 (43%), Gaps = 45/283 (15%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNVGK-REFEQQM-----EIVGGIRHENVV 358
           E +GKG+FGT  K     D   +V    KE++ G   E E+Q       I+  ++H N+V
Sbjct: 6   ETIGKGSFGTVRKVRRKSDGKILV---WKEIDYGNMTEKEKQQLVSEVNILRELKHPNIV 62

Query: 359 ALRAYYYSKD-----EKLMVY-DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARG 412
                YY +      + L +  +Y E G ++ ++   + E +  ++ +   RI       
Sbjct: 63  R----YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKY-IEEEFIWRILTQLLLA 117

Query: 413 IAHIH--TENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YR 467
           +   H  ++ G  ++H  +K +NIFL++  +V + D GLA ++      A    G   Y 
Sbjct: 118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYM 177

Query: 468 APEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEV 527
           +PE  +     + SD++S G L+ EL     P  A    ++   ++              
Sbjct: 178 SPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIK-------------- 223

Query: 528 FDVELLRYPNI-EEEMVEMLQVGMACVVRMPEERPKMADVLKM 569
            + +  R P     E+ E+++   + +   P++RP   ++L++
Sbjct: 224 -EGKFRRIPYRYSSELNEVIK---SMLNVDPDKRPSTEELLQL 262

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 79.9 bits (197), Expect = 1e-16
 Identities = 72/277 (25%), Positives = 122/277 (44%), Gaps = 42/277 (15%)

Query: 307 VLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQM--EIV--GGIRHENVVALRA 362
           VLGKGT+G  Y A   D ST V   +KE+      + Q +  EI     ++H N+V    
Sbjct: 15  VLGKGTYGIVYAA--RDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLG 72

Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHGRRG---EGQSSLDWDTRVRIAIGAARGIAHIHTE 419
                    +  +    GS+SA+L  + G   + + ++ + T+  +      G+ ++H +
Sbjct: 73  SDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQIL-----EGLKYLH-D 126

Query: 420 NGGKLVHGGIKASNIFLNSQGHVC-VSDIGLAALMSPMPPPAMRAAG---YRAPEVTD-- 473
           N  ++VH  IK  N+ +N+   V  +SD G +  ++ + P      G   Y APEV D  
Sbjct: 127 N--QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKG 184

Query: 474 TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELL 533
            R     +D++S G  ++E+ TGK P    G                 E  A +F V + 
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGKPPFIELG-----------------EPQAAMFKVGMF 227

Query: 534 R-YPNIEEEM-VEMLQVGMACVVRMPEERPKMADVLK 568
           + +P I E +  E     + C    P++R    D+L+
Sbjct: 228 KIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 79.7 bits (197), Expect = 2e-16
 Identities = 64/221 (28%), Positives = 101/221 (45%), Gaps = 23/221 (10%)

Query: 306 EVLGKGTFGTAYKAAL----EDASTVVVKRLKEVNVGK--REFEQQMEIVGGIRHENVVA 359
           +V+G G FG   +  L    +    V +K LK  +  K   +F  +  I+G   H N++ 
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIR 69

Query: 360 LRAYYYSKDEKLM-VYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT 418
           L     +K   +M + +Y E GS+   L  R  +G+        V +  G A G+ ++  
Sbjct: 70  LEGVV-TKSRPVMIITEYMENGSLDKFL--RENDGK--FTVGQLVGMLRGIASGMKYLSE 124

Query: 419 ENGGKLVHGGIKASNIFLNSQGHVC-VSDIGLAALMSPMPPPAMRAAG-----YRAPEVT 472
            N    VH  + A NI +NS   VC VSD GL+  +           G     + APE  
Sbjct: 125 MN---YVHRDLAARNILVNSN-LVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAI 180

Query: 473 DTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLV 512
             RK T ASDV+SFG+++ E+++ G+ P       +V+  V
Sbjct: 181 AYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAV 221

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 78.7 bits (194), Expect = 2e-16
 Identities = 66/279 (23%), Positives = 114/279 (40%), Gaps = 42/279 (15%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVG--KREFEQQMEIVGGIRHENVVALRAY 363
           E +GKG FG  YK  L+  + V VK  +       KR+F Q+ EI+    H N+V L   
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 364 YYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGK 423
              K    +V +    GS+   L  ++      L     +++++ AA G+ ++ ++N   
Sbjct: 61  CVQKQPIYIVMELVPGGSLLTFLRKKKNR----LTVKKLLQMSLDAAAGMEYLESKN--- 113

Query: 424 LVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---------YRAPEVTDT 474
            +H  + A N  +     + +SD G    MS      +             + APE  + 
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFG----MSREEEGGIYTVSDGLKQIPIKWTAPEALNY 169

Query: 475 RKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL- 532
            + T  SDV+S+G+LL E  + G +P                N   RE        +E  
Sbjct: 170 GRYTSESDVWSYGILLWETFSLGDTPYPG-----------MSNQQTRER-------IESG 211

Query: 533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVE 571
            R P  +    E+ ++ + C    PE RP  +++   ++
Sbjct: 212 YRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 61/218 (27%), Positives = 104/218 (47%), Gaps = 23/218 (10%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRLKEVNVGKREFE-QQMEIV--GGIRHENVVALR 361
           + +G+G+FG  Y A A  D+   V+K +    +  +E E  + E++    ++H N+V   
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFF 65

Query: 362 AYYYSKDEKLMVYDYFEPGSVSAMLHGRRG---EGQSSLDWDTRVRIAIGAARGIAHIHT 418
           A +       +V +Y + G +   ++ +RG        L W   V+I++G    + HIH 
Sbjct: 66  ASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW--FVQISLG----LKHIHD 119

Query: 419 ENGGKLVHGGIKASNIFLNSQGHVC-VSDIGLAALMSPMPPPAMRAAG---YRAPEVTDT 474
               K++H  IK+ NIFL+  G V  + D G+A  ++     A    G   Y +PE+   
Sbjct: 120 R---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQN 176

Query: 475 RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLV 512
           R     +D++S G +L EL T K P     G+ +  LV
Sbjct: 177 RPYNNKTDIWSLGCVLYELCTLKHPFE---GNNLHQLV 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 78.4 bits (193), Expect = 4e-16
 Identities = 69/273 (25%), Positives = 119/273 (43%), Gaps = 31/273 (11%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           + LG G FG  +       + V +K LK+ ++    F  +  ++  ++H  +V L A   
Sbjct: 12  KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV- 70

Query: 366 SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLV 425
           +++   ++ +Y E GS+   L    G     L  +  + +A   A G+A I  +N    +
Sbjct: 71  TQEPIYIITEYMENGSLVDFLKTPEG---IKLTINKLIDMAAQIAEGMAFIERKN---YI 124

Query: 426 HGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGY----RAPEVTDTRKATQAS 481
           H  ++A+NI ++      ++D GLA L+      A   A +     APE  +    T  S
Sbjct: 125 HRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 184

Query: 482 DVFSFGVLLLELLT-GKSPIHATGGDEVV-HLVRWVNSVVREEWTAEVFDVELLRYPNIE 539
           DV+SFG+LL E++T G+ P       EV+ +L R                    R P  +
Sbjct: 185 DVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLER------------------GYRMPRPD 226

Query: 540 EEMVEMLQVGMACVVRMPEERPKMADVLKMVED 572
               E+ ++   C    PEERP    +  ++ED
Sbjct: 227 NCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 81.4 bits (201), Expect = 6e-16
 Identities = 46/137 (33%), Positives = 75/137 (54%), Gaps = 4/137 (2%)

Query: 67  SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFN 126
           S +  L L G  L G+IP  ++  L++L+ L+L SN L G  P +  ++++L  ++L +N
Sbjct: 164 SSLKVLDLGGNVLVGKIPN-SLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYN 222

Query: 127 SFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRS--- 183
           + SG +P +     +L  +DL  N     IP+S+  L +L  L L  N L+G +P S   
Sbjct: 223 NLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFS 282

Query: 184 LQRFPSWAFAGNNLSSE 200
           LQ+  S   + N+LS E
Sbjct: 283 LQKLISLDLSDNSLSGE 299

Length = 968

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 77.2 bits (190), Expect = 8e-16
 Identities = 59/212 (27%), Positives = 102/212 (48%), Gaps = 33/212 (15%)

Query: 308 LGKGTFGTAYKAAL----EDASTVVVKRLKEVNVGK------REFEQQMEIVGGIRHENV 357
           +G+G+FG   KA L    ED    V+K   E+N+ K       E  +++ ++  ++H N+
Sbjct: 8   IGEGSFG---KAILVKSKEDGKQYVIK---EINISKMSPKEREESRKEVAVLSNMKHPNI 61

Query: 358 VALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRG----EGQSSLDWDTRVRIAIGAARGI 413
           V  +  +       +V DY E G +   ++ +RG    E Q  LDW  ++ +A+      
Sbjct: 62  VQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQI-LDWFVQICLAL------ 114

Query: 414 AHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPE 470
            H+H     K++H  IK+ NIFL   G + + D G+A +++     A    G   Y +PE
Sbjct: 115 KHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPE 171

Query: 471 VTDTRKATQASDVFSFGVLLLELLTGKSPIHA 502
           + + R     SD+++ G +L E+ T K    A
Sbjct: 172 ICENRPYNNKSDIWALGCVLYEMCTLKHAFEA 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 77.9 bits (192), Expect = 8e-16
 Identities = 76/301 (25%), Positives = 123/301 (40%), Gaps = 67/301 (22%)

Query: 306 EVLGKGTFGTAYKAAL------EDASTVVVKRLKEV--NVGKREFEQQMEIVGGIRHENV 357
             LG+G FG  +           D   V VK LKE   N  +++FE++ E++   +HEN+
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70

Query: 358 VALRAYYYSKDEKLMVYDYFEPGSVSAML--HGRRGEGQSSLDWDTR-------VRIAIG 408
           V         D  +MV++Y E G ++  L  HG       S D           ++IA+ 
Sbjct: 71  VKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130

Query: 409 AARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLA-------------ALMSP 455
            A G+ ++ ++     VH  +   N  +     V + D G++               M P
Sbjct: 131 IASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLP 187

Query: 456 ---MPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHL 511
              MP           PE    RK T  SDV+SFGV+L E+ T GK P +    +EV+  
Sbjct: 188 IRWMP-----------PESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC 236

Query: 512 VRWVNSVVR-EEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMV 570
           +     + R     +EV+D+              ML     C  R P++R  + D+ + +
Sbjct: 237 ITQGRLLQRPRTCPSEVYDI--------------ML----GCWKRDPQQRINIKDIHERL 278

Query: 571 E 571
           +
Sbjct: 279 Q 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 56/210 (26%), Positives = 98/210 (46%), Gaps = 11/210 (5%)

Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG G FG  ++    + + V VK LK   +  ++F  + +I+  +RH  ++ L A    +
Sbjct: 14  LGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE 73

Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHG 427
           +   +V +  + GS+   L G  G    +L     + +A   A G+A++  +N    +H 
Sbjct: 74  EPIYIVTELMKYGSLLEYLQGGAG---RALKLPQLIDMAAQVASGMAYLEAQN---YIHR 127

Query: 428 GIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGY----RAPEVTDTRKATQASDV 483
            + A N+ +       V+D GLA ++      A   A +     APE     + +  SDV
Sbjct: 128 DLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDV 187

Query: 484 FSFGVLLLELLT-GKSPIHATGGDEVVHLV 512
           +SFG+LL E++T G+ P       EV+  V
Sbjct: 188 WSFGILLTEIVTYGRMPYPGMTNAEVLQQV 217

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 66/270 (24%), Positives = 118/270 (43%), Gaps = 29/270 (10%)

Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG G FG  +     +++ V VK LK   +  + F ++  ++  ++H+ +V L A    +
Sbjct: 14  LGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE 73

Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHG 427
           +   ++ +Y   GS+   L    G     +     +  +   A G+A+I  +N    +H 
Sbjct: 74  EPIYIITEYMAKGSLLDFLKSDEG---GKVLLPKLIDFSAQIAEGMAYIERKN---YIHR 127

Query: 428 GIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGY----RAPEVTDTRKATQASDV 483
            ++A+N+ ++      ++D GLA ++      A   A +     APE  +    T  SDV
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 187

Query: 484 FSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEM 542
           +SFG+LL E++T GK P       +V+       S ++  +          R P +E   
Sbjct: 188 WSFGILLYEIVTYGKIPYPGMSNSDVM-------SALQRGY----------RMPRMENCP 230

Query: 543 VEMLQVGMACVVRMPEERPKMADVLKMVED 572
            E+  +   C     EERP   D L+ V D
Sbjct: 231 DELYDIMKTCWKEKAEERPTF-DYLQSVLD 259

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 76.0 bits (188), Expect = 3e-15
 Identities = 57/221 (25%), Positives = 93/221 (42%), Gaps = 39/221 (17%)

Query: 308 LGKGTFGTAYKA-ALEDASTVVVKRLKEVNVGKREFEQQM--EI--VGGIRHENVVALRA 362
           +G+GT+G  YKA   +    V +K+++  N  K  F      EI  +  +RH N+V L+ 
Sbjct: 7   IGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKE 65

Query: 363 YYYSKDEK--LMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAAR--------G 412
              SK +    MV++Y +        H   G     L     V+      +        G
Sbjct: 66  IVTSKGKGSIYMVFEYMD--------HDLTG-----LLDSPEVKFTESQIKCYMKQLLEG 112

Query: 413 IAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAM--RAAG--YRA 468
           + ++H+     ++H  IK SNI +N+ G + ++D GLA   +         R     YR 
Sbjct: 113 LQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRP 169

Query: 469 PEV-TDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEV 508
           PE+     +     D++S G +L EL  GK      G  E+
Sbjct: 170 PELLLGATRYGPEVDMWSVGCILAELFLGKPIFQ--GSTEL 208

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 75.6 bits (186), Expect = 4e-15
 Identities = 64/268 (23%), Positives = 119/268 (44%), Gaps = 32/268 (11%)

Query: 308 LGKGTFGTAYKAA-LEDASTVVVKRLKEVNVGKREFEQQMEIVGGIR------HENVVAL 360
           LGKG++G+ YK   L D        LKEV++G    +++ + V  IR      H N+++ 
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYA---LKEVDLGSMSQKEREDAVNEIRILASVNHPNIISY 64

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN 420
           +  +   ++  +V +Y   G +S  +  +R + +  +      RI I   RG+  +H + 
Sbjct: 65  KEAFLDGNKLCIVMEYAPFGDLSKAIS-KRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ- 122

Query: 421 GGKLVHGGIKASNIFLNSQGHVCVSDIGLAALM-SPMPPPAMRAAGYRAPEVTDTRKATQ 479
             K++H  +K++NI L +   V + D+G++ ++   M    +    Y APEV   R  + 
Sbjct: 123 --KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYSY 180

Query: 480 ASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE 539
            SD++S G LL E+ T   P  A    ++         V R ++            P I 
Sbjct: 181 KSDIWSLGCLLYEMATFAPPFEARSMQDL------RYKVQRGKYP---------PIPPIY 225

Query: 540 EEMVEMLQVGMACVVRMPEERPKMADVL 567
            +  ++     + +   P+ RP    +L
Sbjct: 226 SQ--DLQNFIRSMLQVKPKLRPNCDKIL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 75.4 bits (185), Expect = 4e-15
 Identities = 70/274 (25%), Positives = 119/274 (43%), Gaps = 37/274 (13%)

Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG G FG  + A     + V VK +K  ++    F  +  ++  ++H+ +V L A   +K
Sbjct: 14  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV-TK 72

Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQ---SSLDWDTRVRIAIGAARGIAHIHTENGGKL 424
           +   ++ ++   GS+   L    G  Q     +D+  ++      A G+A I   N    
Sbjct: 73  EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI------AEGMAFIEQRN---Y 123

Query: 425 VHGGIKASNIFLNSQGHVC-VSDIGLAALMSPMPPPAMRAAGY----RAPEVTDTRKATQ 479
           +H  ++A+NI + S   VC ++D GLA ++      A   A +     APE  +    T 
Sbjct: 124 IHRDLRAANILV-SASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 182

Query: 480 ASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI 538
            SDV+SFG+LL+E++T G+ P       EV+  +                     R P  
Sbjct: 183 KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-----------------RGYRMPRP 225

Query: 539 EEEMVEMLQVGMACVVRMPEERPKMADVLKMVED 572
           E    E+  + M C    PEERP    +  +++D
Sbjct: 226 ENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 259

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 75.6 bits (186), Expect = 4e-15
 Identities = 53/207 (25%), Positives = 90/207 (43%), Gaps = 19/207 (9%)

Query: 308 LGKGTFGTAYKAALEDASTV-VVKRLKEVNVGKREFEQ----QMEIVGGIRHENVVALRA 362
           LGKG FG      ++    +   K+L +  + KR+ EQ    + +I+  +    +V+L  
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAY 60

Query: 363 YYYSKDEKLMVYDYFEPGSVSAML--HGRRGEGQSSLDWDTRVRI-AIGAARGIAHIHTE 419
            + +KD+  +V      G +   +   G  G  ++      R    A     G+ H+H  
Sbjct: 61  AFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEA------RAIFYAAQIICGLEHLHQR 114

Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAA--GYRAPEVTDTRKA 477
               +V+  +K  N+ L+  G+V +SD+GLA  +        RA   GY APEV      
Sbjct: 115 R---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVY 171

Query: 478 TQASDVFSFGVLLLELLTGKSPIHATG 504
             + D F+ G  L E++ G+SP     
Sbjct: 172 DFSVDWFALGCTLYEMIAGRSPFRQRK 198

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 75.6 bits (186), Expect = 4e-15
 Identities = 55/233 (23%), Positives = 90/233 (38%), Gaps = 33/233 (14%)

Query: 310 KGTFGTAYKA------------ALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENV 357
           KG FG+ Y A             L+ +  +   ++  V   +     Q E         V
Sbjct: 6   KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGE------SPYV 59

Query: 358 VALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIH 417
             L   + SKD   +V +Y   G  ++++   +  G    DW  +  IA     G+  +H
Sbjct: 60  AKLYYSFQSKDYLYLVMEYLNGGDCASLI---KTLGGLPEDW-AKQYIA-EVVLGVEDLH 114

Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTRKA 477
                 ++H  IK  N+ ++  GH+ ++D GL+          +    Y APE       
Sbjct: 115 QRG---IIHRDIKPENLLIDQTGHLKLTDFGLSR-NGLENKKFVGTPDYLAPETILGVGD 170

Query: 478 TQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVRE-EWTAEVFD 529
            + SD +S G ++ E L G  P HA   D V     + N + R   W  EV +
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPPFHAETPDAV-----FDNILSRRINWPEEVKE 218

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 75.4 bits (186), Expect = 4e-15
 Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 34/223 (15%)

Query: 294 VFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIR 353
           VFD+        E LG+G++G+ YKA  ++   VV  ++  V    +E  +++ I+    
Sbjct: 4   VFDIL-------EKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCD 56

Query: 354 HENVVALRAYY--YSKDEKLM-VYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAA 410
              +V    YY  Y K+  L  V +Y   GSVS ++         +L  +    I     
Sbjct: 57  SPYIV---KYYGSYFKNTDLWIVMEYCGAGSVSDIMKIT----NKTLTEEEIAAILYQTL 109

Query: 411 RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG----- 465
           +G+ ++H+    K +H  IKA NI LN +G   ++D G++  ++      M         
Sbjct: 110 KGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLT----DTMAKRNTVIGT 162

Query: 466 --YRAPEVTDTRKATQASDVFSFGVLLLELLTGKSP---IHAT 503
             + APEV         +D++S G+  +E+  GK P   IH  
Sbjct: 163 PFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPM 205

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 74.7 bits (183), Expect = 6e-15
 Identities = 76/274 (27%), Positives = 124/274 (45%), Gaps = 37/274 (13%)

Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG+G FG  +       + V +K LK   +    F Q+ +I+  +RH+ +V L A   S+
Sbjct: 14  LGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYA-VVSE 72

Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHG 427
           +   +V ++   GS+   L  + G+G+  L     V +A   A G+A+I   N    +H 
Sbjct: 73  EPIYIVTEFMGKGSLLDFL--KEGDGK-YLKLPQLVDMAAQIADGMAYIERMN---YIHR 126

Query: 428 GIKASNIFLNSQGHVC-VSDIGLAALMSPMPPPAMRAAGY----RAPEVTDTRKATQASD 482
            ++A+NI +     VC ++D GLA L+      A + A +     APE     + T  SD
Sbjct: 127 DLRAANILV-GDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 185

Query: 483 VFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP---NI 538
           V+SFG+LL EL+T G+ P       EV+  V                     R P     
Sbjct: 186 VWSFGILLTELVTKGRVPYPGMVNREVLEQVE-----------------RGYRMPCPQGC 228

Query: 539 EEEMVEMLQVGMACVVRMPEERPKMADVLKMVED 572
            E + E++++   C  + P+ERP    +   +ED
Sbjct: 229 PESLHELMKL---CWKKDPDERPTFEYIQSFLED 259

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 77.2 bits (190), Expect = 1e-14
 Identities = 45/117 (38%), Positives = 64/117 (54%), Gaps = 1/117 (0%)

Query: 68  RVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNS 127
           ++++L L   +L GEIP   + +L  L+ L L SN+ +G  P   + L  L  L L  N 
Sbjct: 285 KLISLDLSDNSLSGEIP-ELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNK 343

Query: 128 FSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSL 184
           FSG +P +    NNLTV+DLS N     IP  +    +L  L L +NSL G +P+SL
Sbjct: 344 FSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSL 400

Length = 968

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 74.2 bits (182), Expect = 1e-14
 Identities = 78/287 (27%), Positives = 124/287 (43%), Gaps = 51/287 (17%)

Query: 307 VLGKGTFGTAYKAALEDAS----TVVVKRLKEVNVGK--REFEQQMEIVGGIRHENVVAL 360
           V+G G FG      L+        V +K LK     K  R+F  +  I+G   H N++ L
Sbjct: 11  VIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHL 70

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN 420
                     ++V +Y E GS+ A L  R+ +GQ +      V   +G  RGIA     +
Sbjct: 71  EGVVTKSKPVMIVTEYMENGSLDAFL--RKHDGQFT------VIQLVGMLRGIA-----S 117

Query: 421 GGKL------VHGGIKASNIFLNSQGHVC-VSDIGLAALMSPMPPPAMRAAG------YR 467
           G K       VH  + A NI +NS   VC VSD GL+ ++   P  A    G      + 
Sbjct: 118 GMKYLSDMGYVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWT 176

Query: 468 APEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAE 526
           APE    RK T ASDV+S+G+++ E+++ G+ P       +V+  +              
Sbjct: 177 APEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE------------- 223

Query: 527 VFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
               E  R P   +    + Q+ + C  +   ERPK   ++ +++ +
Sbjct: 224 ----EGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 74.7 bits (183), Expect = 1e-14
 Identities = 61/210 (29%), Positives = 98/210 (46%), Gaps = 19/210 (9%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNVGKREFEQQMEIVGGI-RHENVVALRAY 363
           E +GKGT+G  YK    +D S   VK L  ++    E E +  I+  +  H NVV     
Sbjct: 28  ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGM 87

Query: 364 YYSKDEKL-----MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT 418
           +Y  D+ +     +V +    GSV+ ++ G    GQ  LD      I  GA  G+ H+H 
Sbjct: 88  FYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR-LDEAMISYILYGALLGLQHLHN 146

Query: 419 ENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTDTR 475
               +++H  +K +NI L ++G V + D G++A ++        + G   + APEV    
Sbjct: 147 N---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACE 203

Query: 476 KATQAS-----DVFSFGVLLLELLTGKSPI 500
           +    S     DV+S G+  +EL  G  P+
Sbjct: 204 QQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 73.9 bits (182), Expect = 1e-14
 Identities = 59/216 (27%), Positives = 98/216 (45%), Gaps = 38/216 (17%)

Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGK------REFEQQMEIVGGIRHENVVALR 361
           +G GTFG  Y A   D   ++   +KE+ +        +E   +M+++  ++H N+V   
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMA--VKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK-- 63

Query: 362 AYYYS---KDEKLMVY-DYFEPGSVSAMLHGRRGEGQSSLDWDTRV--RIAIGAARGIAH 415
             YY      EK+ ++ +Y   G++  +L   R         D  V     +    G+A+
Sbjct: 64  --YYGVEVHREKVYIFMEYCSGGTLEELLEHGRIL-------DEHVIRVYTLQLLEGLAY 114

Query: 416 IHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP----MPPPAMRAAG---YRA 468
           +H+     +VH  IK +NIFL+  G + + D G A  +      M       AG   Y A
Sbjct: 115 LHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMA 171

Query: 469 PEVTDTRKAT---QASDVFSFGVLLLELLTGKSPIH 501
           PEV    K     +A+D++S G ++LE+ TGK P  
Sbjct: 172 PEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWS 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 74.0 bits (182), Expect = 2e-14
 Identities = 57/221 (25%), Positives = 94/221 (42%), Gaps = 25/221 (11%)

Query: 307 VLGKGTFGTAYKAA----LEDAST-VVVKRLKEVN--VGKREFEQQMEIVGGIRHENVVA 359
           VLG G FGT YK       E     V +K L+E       +E   +  ++  + H +VV 
Sbjct: 14  VLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVR 73

Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGE--GQSSLDWDTRVRIAIGAARGIAHIH 417
           L     S   +L +      G +   +   +     Q  L+W  ++      A+G++++ 
Sbjct: 74  LLGICLSSQVQL-ITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQI------AKGMSYLE 126

Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG-----YRAPEVT 472
            +   +LVH  + A N+ + +  HV ++D GLA L+           G     + A E  
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183

Query: 473 DTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLV 512
             R  T  SDV+S+GV + EL+T G  P       E+  L+
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL 224

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 60/231 (25%), Positives = 99/231 (42%), Gaps = 17/231 (7%)

Query: 307 VLGKGTFGTAYKAALEDASTV-VVKRLKEVNVGKREFE----QQMEIVGGIRHENVVALR 361
           VLGKG FG      +     +   K+L++  + KR+ E     + +I+  +    VV+L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 66

Query: 362 AYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENG 421
             Y +KD   +V      G +   ++     G    D +  V  A     G+  +H E  
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYNM---GNPGFDEERAVFYAAEITCGLEDLHRER- 122

Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAA--GYRAPEVTDTRKATQ 479
             +V+  +K  NI L+  GH+ +SD+GLA  +        R    GY APEV    + T 
Sbjct: 123 --IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTF 180

Query: 480 ASDVFSFGVLLLELLTGKSPIHA----TGGDEVVHLVRWVNSVVREEWTAE 526
           + D +  G L+ E++ GKSP          +EV   V+       E+++  
Sbjct: 181 SPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEA 231

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 55/208 (26%), Positives = 91/208 (43%), Gaps = 8/208 (3%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
             +GKG FG            V VK LK+ +   + F  +  ++  +RH N+V L     
Sbjct: 12  ATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL 70

Query: 366 SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLV 425
             +   +V +Y   GS+   L   R  G++ +    ++  A+    G+ ++  +N    V
Sbjct: 71  QGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FV 124

Query: 426 HGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTRKATQASDVFS 485
           H  + A N+ ++      VSD GLA   S           + APE    +K +  SDV+S
Sbjct: 125 HRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVKWTAPEALREKKFSTKSDVWS 184

Query: 486 FGVLLLELLT-GKSPIHATGGDEVVHLV 512
           FG+LL E+ + G+ P       +VV  V
Sbjct: 185 FGILLWEIYSFGRVPYPRIPLKDVVPHV 212

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 73.8 bits (181), Expect = 2e-14
 Identities = 70/283 (24%), Positives = 124/283 (43%), Gaps = 43/283 (15%)

Query: 306 EVLGKGTFGTAYKAALEDA----STVVVKRLKE--VNVGKREFEQQMEIVGGIRHENVVA 359
           EV+G G FG   +  L+        V +K LK       +R+F  +  I+G   H N++ 
Sbjct: 10  EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIH 69

Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAH-IHT 418
           L          +++ ++ E G++ + L  R+ +GQ +      V   +G  RGIA  +  
Sbjct: 70  LEGVVTKSRPVMIITEFMENGALDSFL--RQNDGQFT------VIQLVGMLRGIAAGMKY 121

Query: 419 ENGGKLVHGGIKASNIFLNSQGHVC-VSDIGLAALM--SPMPPPAMRAAG------YRAP 469
            +    VH  + A NI +NS   VC VSD GL+  +      P    + G      + AP
Sbjct: 122 LSEMNYVHRDLAARNILVNSN-LVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180

Query: 470 EVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVF 528
           E    RK T ASDV+S+G+++ E+++ G+ P       +V      +N++ ++       
Sbjct: 181 EAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV------INAIEQD------- 227

Query: 529 DVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVE 571
                R P   +    + Q+ + C  +    RPK   ++  ++
Sbjct: 228 ----YRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLD 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 57/221 (25%), Positives = 92/221 (41%), Gaps = 30/221 (13%)

Query: 307 VLGKGTFGTAYKAALEDASTVVVKRLKEVNVGK-------REFEQQMEIVGGIRHENVVA 359
           V+GKG FG        D   +    +K +N  K       R    +  I+  + H  +V 
Sbjct: 7   VIGKGAFGKVCIVQKRDTKKMFA--MKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVN 64

Query: 360 LRAYYYSKDEKL-MVYDYFEPGSVSAMLHG--RRGEGQSSLDWDTRVRIAIGA-ARGIAH 415
           L  Y +  +E + +V D         +L G  R    Q     + +V+  I      + +
Sbjct: 65  LW-YSFQDEENMYLVVDL--------LLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEY 115

Query: 416 IHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAA--GYRAPEVTD 473
           +H++    ++H  IK  NI L+ QGHV ++D  +A  ++P       +   GY APEV  
Sbjct: 116 LHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLC 172

Query: 474 TRKATQASDVFSFGVLLLELLTGKSPIHA---TGGDEVVHL 511
            +  + A D +S GV   E L GK P      T  D++   
Sbjct: 173 RQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAK 213

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 76.0 bits (187), Expect = 3e-14
 Identities = 42/106 (39%), Positives = 62/106 (58%), Gaps = 1/106 (0%)

Query: 79  LRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSV 138
           L G IPP+    L  L +L L  NSLSG  P    +L+NL  LHL  N+F+G +P+  + 
Sbjct: 272 LSGPIPPSIFS-LQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTS 330

Query: 139 WNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSL 184
              L V+ L +N F+  IP ++ K  +L+ L+L+ N+LTG +P  L
Sbjct: 331 LPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGL 376

Length = 968

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 72.5 bits (178), Expect = 5e-14
 Identities = 76/294 (25%), Positives = 126/294 (42%), Gaps = 48/294 (16%)

Query: 308 LGKGTFGTAYKA---ALEDAS--TVVVKRLKEVNVGK-REFEQQMEIVGGIRHENVVALR 361
           LGKG FG+        L+D +   V VK+L+       R+FE+++EI+  ++H+N+V  +
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 362 AYYYSKDEKLM--VYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE 419
              YS   + +  V +Y   GS+   L   R      LD    +  A    +G+ ++ ++
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLGSK 127

Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP------MPPPAMRAAGYRAPEVTD 473
              + VH  +   NI + S+  V + D GL  ++        +  P      + APE   
Sbjct: 128 ---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLT 184

Query: 474 TRKATQASDVFSFGVLLLELLT----GKSP----IHATGGDE-----VVHLVRWVNSVVR 520
             K + ASDV+SFGV+L EL T      SP    +   G D+     V HL+     +++
Sbjct: 185 ESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI----ELLK 240

Query: 521 EEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIR 574
                        R P       E+  +   C    P +RP  +++   VE IR
Sbjct: 241 NNG----------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 72.4 bits (177), Expect = 6e-14
 Identities = 62/231 (26%), Positives = 106/231 (45%), Gaps = 21/231 (9%)

Query: 307 VLGKGTFGTAYKAALEDASTV-VVKRLKEVNVGKREFE----QQMEIVGGIRHENVVALR 361
           VLGKG FG      +     +   K+L++  + KR+ E     + +I+  +    VV+L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLA 66

Query: 362 AYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENG 421
             Y +KD   +V      G +   ++     G++  +    V  A     G+  +H E  
Sbjct: 67  YAYETKDALCLVLTLMNGGDLKFHIYHM---GEAGFEEGRAVFYAAEICCGLEDLHQE-- 121

Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAA--GYRAPEVTDTRKATQ 479
            ++V+  +K  NI L+  GH+ +SD+GLA  +        R    GY APEV    + T 
Sbjct: 122 -RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTF 180

Query: 480 ASDVFSFGVLLLELLTGKSPIHATGG----DEVVHLVRWVNSVVREEWTAE 526
           + D ++ G LL E++ G+SP          +EV  LV+     V+EE++ +
Sbjct: 181 SPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK----EVQEEYSEK 227

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 72.1 bits (177), Expect = 6e-14
 Identities = 68/284 (23%), Positives = 131/284 (46%), Gaps = 30/284 (10%)

Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVG-KREFEQQMEIVGGIRHE----NVVALRA 362
           LG G  G+  K       TV+ K  K V++G K    +Q+     I HE     +V+   
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAK--KVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYG 70

Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGG 422
            + +++   M  ++ + GS+  +    +  G   ++     +IA+    G+ +++  +  
Sbjct: 71  AFLNENNICMCMEFMDCGSLDRIY---KKGGPIPVE--ILGKIAVAVVEGLTYLYNVH-- 123

Query: 423 KLVHGGIKASNIFLNSQGHVCVSDIGLAA-LMSPMPPPAMRAAGYRAPEVTDTRKATQAS 481
           +++H  IK SNI +NS+G + + D G++  L++ +    +  + Y +PE     K T  S
Sbjct: 124 RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVKS 183

Query: 482 DVFSFGVLLLELLTGK-----SPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP 536
           DV+S G+ ++EL  GK     S I   G D+ + ++  +  +V+E             +P
Sbjct: 184 DVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSS----DFP 239

Query: 537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAEN 580
               + V+      AC+++ P ERP    +  M   I+ ++A N
Sbjct: 240 EDLRDFVD------ACLLKDPTERPTPQQLCAMPPFIQALRASN 277

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 72.3 bits (177), Expect = 7e-14
 Identities = 65/287 (22%), Positives = 123/287 (42%), Gaps = 44/287 (15%)

Query: 308 LGKGTFGTAYKA------ALEDASTVVVKRLKEVNVGKR-EFEQQMEIVGGIRHENVVAL 360
           LG+G FG  + A        +D   V VK LK+  +  R +F+++ E++  ++HE++V  
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLH-----------GRRGEGQSSLDWDTRVRIAIGA 409
                  D  +MV++Y + G ++  L            G+  + +  L     + IA   
Sbjct: 73  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132

Query: 410 ARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP-----MPPPAMRAA 464
           A G+ ++ +++    VH  +   N  + +   V + D G++  +       +    M   
Sbjct: 133 ASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 465 GYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEW 523
            +  PE    RK T  SDV+SFGV+L E+ T GK P       EV+  +           
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT---------- 239

Query: 524 TAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMV 570
                   +L  P +  +  E+  + + C  R P++R  + ++ K++
Sbjct: 240 -----QGRVLERPRVCPK--EVYDIMLGCWQREPQQRLNIKEIYKIL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 74.1 bits (182), Expect = 1e-13
 Identities = 50/166 (30%), Positives = 76/166 (45%), Gaps = 31/166 (18%)

Query: 62  CSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLE----- 116
           CS+ +  +  L L   +L GEIP  ++G   +L+ + L+ NS SG  PS+F+KL      
Sbjct: 377 CSSGN--LFKLILFSNSLEGEIPK-SLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFL 433

Query: 117 -------------------NLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIP 157
                              +L  L L  N F G LP D      L  +DLS N F+ ++P
Sbjct: 434 DISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLP-DSFGSKRLENLDLSRNQFSGAVP 492

Query: 158 ASISKLTHLSALNLANNSLTGTLPRSL---QRFPSWAFAGNNLSSE 200
             +  L+ L  L L+ N L+G +P  L   ++  S   + N LS +
Sbjct: 493 RKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQ 538

Length = 968

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 53/211 (25%), Positives = 92/211 (43%), Gaps = 33/211 (15%)

Query: 306 EVLGKGTFGTAYKAALEDASTVV-VKRLK-EVNVGKREFEQQMEIVGGIRHENVVALRAY 363
           + +G GT+G  YKA       +V +K +K E        +Q++ ++   RH N+VA   Y
Sbjct: 9   QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA---Y 65

Query: 364 Y--YSKDEKL-MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN 420
           +  Y + +KL +V +Y   GS+  +    RG     L       +     +G+A++H   
Sbjct: 66  FGSYLRRDKLWIVMEYCGGGSLQDIYQVTRG----PLSELQIAYVCRETLKGLAYLHET- 120

Query: 421 GGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM---------PPPAMRAAGYRAPEV 471
               +H  IK +NI L   G V ++D G++A ++            P  M      APEV
Sbjct: 121 --GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWM------APEV 172

Query: 472 TDTRKA---TQASDVFSFGVLLLELLTGKSP 499
               +        D+++ G+  +EL   + P
Sbjct: 173 AAVERKGGYDGKCDIWALGITAIELAELQPP 203

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 71.5 bits (175), Expect = 1e-13
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 13/203 (6%)

Query: 307 VLGKGTFGTAYKAALEDASTV-VVKRLKEVNVGKREFE----QQMEIVGGIRHENVVALR 361
           VLGKG FG      +     +   KRL++  + KR+ E     + +I+  +  + VV L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLA 66

Query: 362 AYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENG 421
             Y +KD   +V      G +   ++     G    + +  +  A     G+  +H EN 
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNM---GNPGFEEERALFYAAEILCGLEDLHREN- 122

Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAA--GYRAPEVTDTRKATQ 479
              V+  +K  NI L+  GH+ +SD+GLA  +        R    GY APEV + ++ T 
Sbjct: 123 --TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTL 180

Query: 480 ASDVFSFGVLLLELLTGKSPIHA 502
           + D +  G L+ E++ G+SP   
Sbjct: 181 SPDYWGLGCLIYEMIEGQSPFRG 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 50/212 (23%), Positives = 100/212 (47%), Gaps = 21/212 (9%)

Query: 296 DLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQ---QMEIVGGI 352
           DLE L       LG G  G   K        ++  +   + + +   +Q   +++I+   
Sbjct: 2   DLEYL-----GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKC 56

Query: 353 RHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARG 412
               +V     +Y+  +  +  +Y + GS+  +L  +  +G+  +      +IA+   +G
Sbjct: 57  NSPYIVGFYGAFYNNGDISICMEYMDGGSLDKIL--KEVQGR--IPERILGKIAVAVLKG 112

Query: 413 IAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAA-LMSPMPPPAMRAAG---YRA 468
           + ++H ++  K++H  +K SNI +NS+G + + D G++  L++ +   A    G   Y A
Sbjct: 113 LTYLHEKH--KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL---AKTFVGTSSYMA 167

Query: 469 PEVTDTRKATQASDVFSFGVLLLELLTGKSPI 500
           PE       +  SD++S G+ L+EL TG+ P 
Sbjct: 168 PERIQGNDYSVKSDIWSLGLSLIELATGRFPY 199

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 69.6 bits (170), Expect = 3e-13
 Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 22/207 (10%)

Query: 307 VLGKGTFGTAYKAALEDASTVVVKRLKEVNVGK-----REFEQQMEIVGGIRHENVVALR 361
           V+G+G+FG A      ++       +KE+ + K      +  ++  ++  ++H N+VA +
Sbjct: 7   VVGEGSFGRALLVQHVNSDQKYA--MKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFK 64

Query: 362 AYYYSKDEKLMVYDYFEPGSVSAMLHGRRGE---GQSSLDWDTRVRIAIGAARGIAHIHT 418
             + +     +V +Y + G +   +  +RG+     + L W  ++ +      G+ HIH 
Sbjct: 65  ESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL------GVQHIHE 118

Query: 419 ENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTDTR 475
           +   +++H  IK+ NIFL   G V + D G A L++     A    G   Y  PE+ +  
Sbjct: 119 K---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENM 175

Query: 476 KATQASDVFSFGVLLLELLTGKSPIHA 502
                SD++S G +L EL T K P  A
Sbjct: 176 PYNNKSDIWSLGCILYELCTLKHPFQA 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 69.3 bits (170), Expect = 4e-13
 Identities = 72/291 (24%), Positives = 110/291 (37%), Gaps = 62/291 (21%)

Query: 306 EVLGKGTFGTA----YKAALEDASTVVVKRLKEVNVGK--REFEQQMEIVGGIRHENVVA 359
           + LG G+FG      +  +      V VK LK   +     +F ++  I+  + HEN++ 
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLI- 59

Query: 360 LRAYYYSKDEKLM-VYDYFEPGSVSAMLHGRR-GEGQSSLDWDTRVRIAIGAARGIAHIH 417
            R Y       LM V +    GS+   L     G    S   D  V+IA     G+ ++ 
Sbjct: 60  -RLYGVVLTHPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIA----NGMRYLE 114

Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG-----YR----- 467
           ++     +H  + A NI L S   V + D GL           MRA       Y      
Sbjct: 115 SKR---FIHRDLAARNILLASDDKVKIGDFGL-----------MRALPQNEDHYVMEEHL 160

Query: 468 -------APEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVV 519
                  APE   TR  + ASDV+ FGV L E+ T G+ P     G +++  +       
Sbjct: 161 KVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKI------- 213

Query: 520 REEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMV 570
                    D E  R    E    ++  V + C    P +RP  A + + +
Sbjct: 214 ---------DKEGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 69.8 bits (171), Expect = 4e-13
 Identities = 55/231 (23%), Positives = 98/231 (42%), Gaps = 42/231 (18%)

Query: 307 VLGKGTFGTAYKA-----ALEDASTVV-VKRLKEVNVGK--REFEQQMEIVGGIRHENVV 358
            LG+G FG  + A       E   T+V VK L++        EF +++++   + H+NVV
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSS----LDWDTRVRIAIGAARGIA 414
            L       +   M+ +Y + G +   L   + + +      L    +V +    A G+ 
Sbjct: 72  RLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMD 131

Query: 415 HIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAA------------LMSP---MPPP 459
           H+      + VH  + A N  ++SQ  V VS + L+              + P   + P 
Sbjct: 132 HLSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPE 188

Query: 460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVV 509
           A++   +           +  SDV+SFGVL+ E+ T G+ P +    +EV+
Sbjct: 189 AVQEDDF-----------STKSDVWSFGVLMWEVFTQGELPFYGLSDEEVL 228

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 69.2 bits (169), Expect = 4e-13
 Identities = 50/213 (23%), Positives = 96/213 (45%), Gaps = 24/213 (11%)

Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           +G G FG  +     +   V +K ++E  + + +F ++ +++  + H  +V L      +
Sbjct: 12  IGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER 71

Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHG 427
               +V+++ E G +S  L  +RG        +T + + +    G+A++ + N   ++H 
Sbjct: 72  SPICLVFEFMEHGCLSDYLRAQRG----KFSQETLLGMCLDVCEGMAYLESSN---VIHR 124

Query: 428 GIKASNIFLNSQGHVCVSDIGLAALM----------SPMPPPAMRAAGYRAPEVTDTRKA 477
            + A N  +     V VSD G+   +          +  P        + +PEV    K 
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFP------VKWSSPEVFSFSKY 178

Query: 478 TQASDVFSFGVLLLELLT-GKSPIHATGGDEVV 509
           +  SDV+SFGVL+ E+ + GK+P       EVV
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVV 211

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 69.5 bits (170), Expect = 4e-13
 Identities = 64/279 (22%), Positives = 107/279 (38%), Gaps = 38/279 (13%)

Query: 308 LGKGTFGTAYKA---ALEDASTVVVKRLKEVNVGKRE--FEQQMEIVGGIRHENVVALRA 362
           +G G FG             + VVVK L+       +  F Q+++    + H NV+    
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLG 62

Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGG 422
                   L+V ++   G +   L   RG        D   R+A   A G+  +H  +  
Sbjct: 63  QCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD-- 120

Query: 423 KLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG-------YRAPEVTDTR 475
             +H  +   N  L +   V + D GLA  +   P               + APE+ + R
Sbjct: 121 -FIHSDLALRNCQLTADLSVKIGDYGLA--LEQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 476 -------KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVF 528
                    T+ S+++S GV + EL T     +    DE V     +  VVRE+      
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQV-----LKQVVREQ------ 226

Query: 529 DVELLRYPNIEEEMVEM-LQVGMACVVRMPEERPKMADV 566
           D++L + P ++ +  +   +V   C +  PE RP   +V
Sbjct: 227 DIKLPK-PQLDLKYSDRWYEVMQFCWLD-PETRPTAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 69.8 bits (171), Expect = 6e-13
 Identities = 61/219 (27%), Positives = 99/219 (45%), Gaps = 23/219 (10%)

Query: 307 VLGKGTFGTAYKAALEDASTV-VVKRLK-EVNVGKREFEQQM---EIVG-GIRHENVVAL 360
           VLGKG+FG    A L+  +    +K LK +V +   + E  M    ++     H  +  L
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHL 61

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAAR---GIAHIH 417
              + +K+    V +Y   G +  M H      QSS  +D   R    AA    G+  +H
Sbjct: 62  FCTFQTKEHLFFVMEYLNGGDL--MFHI-----QSSGRFDEA-RARFYAAEIICGLQFLH 113

Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTDT 474
            +    +++  +K  N+ L+  GH+ ++D G+          A    G   Y APE+   
Sbjct: 114 KKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKG 170

Query: 475 RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVR 513
           +K  ++ D +SFGVLL E+L G+SP H    DE+   + 
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL 209

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 69.3 bits (169), Expect = 7e-13
 Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 23/212 (10%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNVGKREFEQQMEIVGGIR-HENVVALRAY 363
           E +GKGT+G  +K    ++ S   VK L  ++    E E +  I+  +  H NVV     
Sbjct: 24  ETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGM 83

Query: 364 YYSKDEK-----LMVYDYFEPGSVSAMLHG--RRGEGQSSLDWDTRVRIAIGAARGIAHI 416
           YY KD K      +V +    GSV+ ++ G  +RGE            I   A  G+ H+
Sbjct: 84  YYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEP---IIAYILHEALMGLQHL 140

Query: 417 HTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTD 473
           H     K +H  +K +NI L ++G V + D G++A ++        + G   + APEV  
Sbjct: 141 HVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIA 197

Query: 474 TRKATQAS-----DVFSFGVLLLELLTGKSPI 500
             +   ++     DV+S G+  +EL  G  P+
Sbjct: 198 CEQQLDSTYDARCDVWSLGITAIELGDGDPPL 229

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 68.5 bits (168), Expect = 8e-13
 Identities = 67/282 (23%), Positives = 116/282 (41%), Gaps = 44/282 (15%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKR-----EFEQQMEIVGGIRHENVVAL 360
           EV+G G     Y A     +  V   +K +++ K      E  ++++ +    H NVV  
Sbjct: 7   EVIGVGATAVVYAAICLPNNEKVA--IKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVK- 63

Query: 361 RAYYYS---KDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIH 417
             YY S    DE  +V  Y   GS+  ++  +    +  LD      +     +G+ ++H
Sbjct: 64  --YYTSFVVGDELWLVMPYLSGGSLLDIM--KSSYPRGGLDEAIIATVLKEVLKGLEYLH 119

Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR---------- 467
             NG   +H  IKA NI L   G V ++D G++A ++       R    R          
Sbjct: 120 -SNG--QIHRDIKAGNILLGEDGSVKIADFGVSASLAD---GGDRTRKVRKTFVGTPCWM 173

Query: 468 APEVTDTRKA-TQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAE 526
           APEV +        +D++SFG+  +EL TG +P       +V+ L    +    E     
Sbjct: 174 APEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLET---- 229

Query: 527 VFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
               +  +Y     +M+ +      C+ + P +RP   ++LK
Sbjct: 230 --GADYKKYSKSFRKMISL------CLQKDPSKRPTAEELLK 263

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 68.1 bits (166), Expect = 9e-13
 Identities = 67/274 (24%), Positives = 113/274 (41%), Gaps = 39/274 (14%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKE--VNVGKREFEQQMEIVGGIRHENVVALRAY 363
           E+LGKG FG  +K  L+D + V VK  KE      K +F  +  I+    H N+V L   
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGV 60

Query: 364 YYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGK 423
              +    +V +    G   + L  ++ E    L     V+ A+ AA G+A++ ++N   
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLRKKKDE----LKTKQLVKFALDAAAGMAYLESKN--- 113

Query: 424 LVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG--------YRAPEVTDTR 475
            +H  + A N  +     + +SD G    MS      + ++         + APE  +  
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFG----MSRQEDDGIYSSSGLKQIPIKWTAPEALNYG 169

Query: 476 KATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLR 534
           + +  SDV+S+G+LL E  + G  P                N   RE+           +
Sbjct: 170 RYSSESDVWSYGILLWETFSLGVCPYPGM-----------TNQQAREQVEKGYRMSCPQK 218

Query: 535 YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
            P+      ++ +V   C    PE RPK +++ K
Sbjct: 219 CPD------DVYKVMQRCWDYKPENRPKFSELQK 246

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 70.6 bits (173), Expect = 1e-12
 Identities = 44/125 (35%), Positives = 62/125 (49%), Gaps = 4/125 (3%)

Query: 79  LRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSV 138
           L G IP  ++G L  LQ L L  N LSG  P     L+ L SL L  NS SG +P     
Sbjct: 248 LTGPIPS-SLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQ 306

Query: 139 WNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQR---FPSWAFAGN 195
             NL ++ L +N F   IP +++ L  L  L L +N  +G +P++L +         + N
Sbjct: 307 LQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTN 366

Query: 196 NLSSE 200
           NL+ E
Sbjct: 367 NLTGE 371

Length = 968

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 72/277 (25%), Positives = 123/277 (44%), Gaps = 49/277 (17%)

Query: 308 LGKGTFGTAYKAALEDASTVV-VKRL----KEVNVGKREFEQQMEIVGGIRHENVVALRA 362
           +G G+FG  Y A     + VV VK++    K+ N   ++  ++++ +  ++H N +  + 
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAI---GAARGIAHIHTE 419
            Y  +    +V +Y   GS S +L   +   Q        V IA    GA +G+A++H+ 
Sbjct: 89  CYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQ-------EVEIAAITHGALQGLAYLHSH 140

Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEV---TD 473
           N   ++H  IKA NI L   G V ++D G A+  S    PA    G   + APEV    D
Sbjct: 141 N---MIHRDIKAGNILLTEPGQVKLADFGSASKSS----PANSFVGTPYWMAPEVILAMD 193

Query: 474 TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNS--VVREEWTAEVFDVE 531
             +     DV+S G+  +EL   K P+        ++ +   +S  +   EWT       
Sbjct: 194 EGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSF---- 249

Query: 532 LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
                      V+       C+ ++P+ERP  A++L+
Sbjct: 250 --------RGFVDY------CLQKIPQERPASAELLR 272

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 62/275 (22%), Positives = 127/275 (46%), Gaps = 32/275 (11%)

Query: 308 LGKGTFGTAYKAA-LEDASTVVVKRLKEVNV----GKREFEQQMEIVGGIRHENVVALRA 362
           +G+G F   Y+A  L D   V +K+++  ++     + +  ++++++  + H NV+   A
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 69

Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRV-RIAIGAARGIAHIHTENG 421
            +   +E  +V +  + G +S M+  +  + Q  L  +  V +  +     + H+H+   
Sbjct: 70  SFIEDNELNIVLELADAGDLSRMI--KHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR-- 125

Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTDTRKAT 478
            +++H  IK +N+F+ + G V + D+GL    S     A    G   Y +PE        
Sbjct: 126 -RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 184

Query: 479 QASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI 538
             SD++S G LL E+   +SP +   GD++      + S+ ++        +E   YP +
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPFY---GDKMN-----LYSLCKK--------IEQCDYPPL 228

Query: 539 EEEMV--EMLQVGMACVVRMPEERPKMADVLKMVE 571
             +    E+ Q+   C+   PE+RP +  V  + +
Sbjct: 229 PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAK 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 67.6 bits (165), Expect = 2e-12
 Identities = 63/270 (23%), Positives = 114/270 (42%), Gaps = 33/270 (12%)

Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG G FG  +         V +K + E  + + +F ++ +++  + H  +V L      +
Sbjct: 12  LGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ 71

Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHG 427
               +V ++ E G +   L  R+G+    L  D  + +      G+ ++   +    +H 
Sbjct: 72  KPLYIVTEFMENGCLLNYLRQRQGK----LSKDMLLSMCQDVCEGMEYLERNS---FIHR 124

Query: 428 GIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG------YRAPEVTDTRKATQAS 481
            + A N  ++S G V VSD G+   +  +      ++G      +  PEV +  K +  S
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTRYV--LDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKS 182

Query: 482 DVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
           DV+SFGVL+ E+ T GK P       EVV ++     + R               P +  
Sbjct: 183 DVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR---------------PKLAS 227

Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLKMV 570
             V   +V  +C    PE RP  A++L+ +
Sbjct: 228 MTV--YEVMYSCWHEKPEGRPTFAELLRAI 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 63/257 (24%), Positives = 116/257 (45%), Gaps = 32/257 (12%)

Query: 308 LGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFE-QQMEIVGGIRHENVVALRAYYY 365
           +G+G+ G    A  +     V VK++      +RE    ++ I+    HENVV +   Y 
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL 89

Query: 366 SKDEKLMVYDYFEPGSVSAML-HGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKL 424
             DE  +V ++ E G+++ ++ H R  E Q +        + +   R ++++H +    +
Sbjct: 90  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------TVCLSVLRALSYLHNQG---V 139

Query: 425 VHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTDTRKATQAS 481
           +H  IK+ +I L S G + +SD G  A +S   P      G   + APEV          
Sbjct: 140 IHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199

Query: 482 DVFSFGVLLLELLTGKSPIHATGGDEVVHLVR-----------WVNSVVREEWTAEVFDV 530
           D++S G++++E++ G+ P       + +  +R            V+SV+R        D+
Sbjct: 200 DIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLR-----GFLDL 254

Query: 531 ELLRYPNIEEEMVEMLQ 547
            L+R P+      E+LQ
Sbjct: 255 MLVREPSQRATAQELLQ 271

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 54/200 (27%), Positives = 90/200 (45%), Gaps = 13/200 (6%)

Query: 307 VLGKGTFGTAYKAALEDASTV-VVKRLKEVNVGKREFE----QQMEIVGGIRHENVVALR 361
           VLGKG FG      +     +   K+L++  + KR+ E     +  I+  +    VV+L 
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLA 66

Query: 362 AYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENG 421
             Y +KD   +V      G +   ++     G    D    +  A     G+  +  E  
Sbjct: 67  YAYETKDALCLVLTIMNGGDLKFHIYNM---GNPGFDEQRAIFYAAELCCGLEDLQRE-- 121

Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAA--GYRAPEVTDTRKATQ 479
            ++V+  +K  NI L+ +GH+ +SD+GLA  +        R    GY APEV +  K T 
Sbjct: 122 -RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTF 180

Query: 480 ASDVFSFGVLLLELLTGKSP 499
           + D +  G L+ E++ G+SP
Sbjct: 181 SPDWWGLGCLIYEMIQGQSP 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 67.8 bits (165), Expect = 2e-12
 Identities = 58/228 (25%), Positives = 101/228 (44%), Gaps = 28/228 (12%)

Query: 308 LGKGTFGTAYKAAL------EDASTVVVKRLKEV-NVGKREFEQQMEIVGGIRHENVVAL 360
           LG+G FG  + A        +D   V VK LK+  +  +++F ++ E++  ++HE++V  
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 72

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAML--HG------RRGEGQSSLDWDTRVRIAIGAARG 412
                  D  +MV++Y + G ++  L  HG        G   + L     + IA   A G
Sbjct: 73  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132

Query: 413 IAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG------- 465
           + ++ +++    VH  +   N  +     V + D G++           R  G       
Sbjct: 133 MVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMS--RDVYSTDYYRVGGHTMLPIR 187

Query: 466 YRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLV 512
           +  PE    RK T  SDV+S GV+L E+ T GK P +    +EV+  +
Sbjct: 188 WMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 235

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 20/218 (9%)

Query: 306 EVLGKGTFGTAY---KAALEDASTV-VVKRLKEVNVGKRE-FEQQME--IVGGIRHENVV 358
           +VLG+G+FG  +   K    DA  +  +K LK+  +  R+    +ME  I+  + H  +V
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIV 61

Query: 359 ALRAYYYSKDEKL-MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIH 417
            L  Y +  + KL ++ D+   G     L  R  +     + D +  +A   A  + H+H
Sbjct: 62  KLH-YAFQTEGKLYLILDFLRGGD----LFTRLSKEVMFTEEDVKFYLA-ELALALDHLH 115

Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTDT 474
           +     +++  +K  NI L+ +GH+ ++D GL+         A    G   Y APEV + 
Sbjct: 116 SLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNR 172

Query: 475 RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLV 512
           R  TQ++D +SFGVL+ E+LTG  P       E + ++
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMI 210

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 67.3 bits (165), Expect = 3e-12
 Identities = 53/215 (24%), Positives = 89/215 (41%), Gaps = 32/215 (14%)

Query: 308 LGKGTFGTAYKAA-LEDASTVVVKRL----KEVNVGK---REFEQQMEIVGGIRHENVVA 359
           +G+G  G  +KA   E   TV +K++     E  +     RE +         +H  VV 
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQAC----QHPYVVK 63

Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRR---GEGQSSLDWDTRVRIAIGAARGIAHI 416
           L   +      ++V +Y  P  +S +L        E Q                +G+A++
Sbjct: 64  LLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVK-------SYMRMLLKGVAYM 115

Query: 417 HTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAA----GYRAPEVT 472
           H      ++H  +K +N+ +++ G + ++D GLA L S   P           YRAPE+ 
Sbjct: 116 HANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL 172

Query: 473 -DTRKATQASDVFSFGVLLLELLTGKSPIHATGGD 506
              RK     D+++ G +  ELL G SP+     D
Sbjct: 173 YGARKYDPGVDLWAVGCIFAELLNG-SPLFPGEND 206

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 66.8 bits (163), Expect = 3e-12
 Identities = 55/234 (23%), Positives = 98/234 (41%), Gaps = 35/234 (14%)

Query: 306 EVLGKGTFGTAYKAAL-EDAST---VVVKRLKEVNVGKREFEQQMEIVGGIR---HENVV 358
           ++LG+G FG+  +  L +D  +   V VK +K       E E+ +     ++   H NV+
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64

Query: 359 ALRAYYYSKDEK------LMVYDYFEPGSV-SAMLHGRRGEGQSSLDWDTRVRIAIGAAR 411
            L    +           +++  + + G + S +L+ R G     L   T ++  +  A 
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124

Query: 412 GIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLA-----------ALMSPMPPPA 460
           G+ ++   N    +H  + A N  L     VCV+D GL+             ++ MP   
Sbjct: 125 GMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW 181

Query: 461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVR 513
           +      A E    R  T  SDV++FGV + E+ T G++P       E+   +R
Sbjct: 182 I------AIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLR 229

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 66.9 bits (164), Expect = 4e-12
 Identities = 75/298 (25%), Positives = 124/298 (41%), Gaps = 73/298 (24%)

Query: 306 EVLGKGTFGTAYKAALEDA-STVVVKRLKEVNVGKREFEQQMEIVGGIR----HENVVAL 360
           EV+G+GT+G  YKA  +     V +K +  +   + E +++  I   +R    H N+   
Sbjct: 12  EVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNI---LRKYSNHPNIATF 68

Query: 361 RAYYYSK------DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIA 414
              +  K      D+  +V +    GSV+ ++ G R +G+  L  +    I     RG+A
Sbjct: 69  YGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKR-LKEEWIAYILRETLRGLA 127

Query: 415 HIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR------- 467
           ++H EN  K++H  IK  NI L     V + D G++A +           G R       
Sbjct: 128 YLH-EN--KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLD-------STLGRRNTFIGTP 177

Query: 468 ---APEV-----TDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVV 519
              APEV              SDV+S G+  +EL  GK P+     D  +H +R +  + 
Sbjct: 178 YWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL----CD--MHPMRALFKIP 231

Query: 520 R---------EEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
           R         E W+ +  D        I E           C+++  E+RP M ++L+
Sbjct: 232 RNPPPTLKSPENWSKKFNDF-------ISE-----------CLIKNYEQRPFMEELLE 271

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 66.7 bits (163), Expect = 4e-12
 Identities = 70/278 (25%), Positives = 128/278 (46%), Gaps = 44/278 (15%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRLKEVNVGK------REFEQQMEIVGGIRHENVV 358
           E+LG G+FG+ Y+   L+D     VK +   + G+      ++ EQ++ ++  ++H N+V
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 359 ALRAYYYSK--DEKLMVYDYFEPGSVSAMLHGRRG---EGQSSLDWDTRVRIAIGAARGI 413
               Y  ++  ++ L ++    PG   A L  + G   E    L   TR  +      G+
Sbjct: 66  Q---YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLY--TRQILL-----GL 115

Query: 414 AHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAA-LMSPMPPPAMRAAGY-RAPEV 471
            ++H  N    VH  IK +NI +++ G V ++D G+A  ++      + + + Y  APEV
Sbjct: 116 EYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEV 172

Query: 472 TD-TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDV 530
                    A+D++S G  +LE+ TGK P     G      V  V  + R +    + D 
Sbjct: 173 IAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEG------VAAVFKIGRSKELPPIPD- 225

Query: 531 ELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
                 ++ +E  + +   + C+ R P  RP  A++L+
Sbjct: 226 ------HLSDEAKDFI---LKCLQRDPSLRPTAAELLE 254

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 66.4 bits (162), Expect = 4e-12
 Identities = 56/211 (26%), Positives = 96/211 (45%), Gaps = 12/211 (5%)

Query: 308 LGKGTFGTAYKAALEDAS-TVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYS 366
           LG G +G  Y+   +  S TV VK LKE  +   EF ++  ++  I+H N+V L      
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73

Query: 367 KDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVH 426
           +    ++ ++   G++   L   R   +  ++    + +A   +  + ++  +N    +H
Sbjct: 74  EPPFYIITEFMTYGNLLDYL---RECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIH 127

Query: 427 GGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGY----RAPEVTDTRKATQASD 482
             + A N  +     V V+D GL+ LM+     A   A +     APE     K +  SD
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 187

Query: 483 VFSFGVLLLELLT-GKSPIHATGGDEVVHLV 512
           V++FGVLL E+ T G SP       +V  L+
Sbjct: 188 VWAFGVLLWEIATYGMSPYPGIDLSQVYELL 218

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 66.6 bits (162), Expect = 4e-12
 Identities = 72/288 (25%), Positives = 120/288 (41%), Gaps = 33/288 (11%)

Query: 296 DLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHE 355
           D E+L     E +GKG+FG  +K        VV  ++ ++   + E E   + +  +   
Sbjct: 1   DPEELF-TKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59

Query: 356 NVVALRAYY--YSKDEKL-MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARG 412
           +   +  YY  Y KD KL ++ +Y   GS   +L          LD      I     +G
Sbjct: 60  DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE------PGPLDETQIATILREILKG 113

Query: 413 IAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAP 469
           + ++H+E   K +H  IKA+N+ L+  G V ++D G+A  ++          G   + AP
Sbjct: 114 LDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170

Query: 470 EVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD 529
           EV         +D++S G+  +EL  G+ P       +V+ L+   N    E        
Sbjct: 171 EVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEG------- 223

Query: 530 VELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVK 577
                Y    +E VE      AC+ + P  RP   ++LK    +R  K
Sbjct: 224 ----NYSKPLKEFVE------ACLNKEPSFRPTAKELLKHKFIVRFAK 261

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 66.7 bits (163), Expect = 4e-12
 Identities = 58/213 (27%), Positives = 106/213 (49%), Gaps = 41/213 (19%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFE-----QQMEIVGGIRHENVVAL 360
           E LG+GT+ T YK        +V   LKE+++   E       +++ ++  ++HEN+V L
Sbjct: 6   EKLGEGTYATVYKGRNRTTGEIVA--LKEIHLDAEEGTPSTAIREISLMKELKHENIVRL 63

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAM-LHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE 419
               +++++ ++V++Y +      M  HG RG    +LD +T         +GIA  H E
Sbjct: 64  HDVIHTENKLMLVFEYMDKDLKKYMDTHGVRG----ALDPNTVKSFTYQLLKGIAFCH-E 118

Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG-------------- 465
           N  +++H  +K  N+ +N +G + ++D GLA           RA G              
Sbjct: 119 N--RVLHRDLKPQNLLINKRGELKLADFGLA-----------RAFGIPVNTFSNEVVTLW 165

Query: 466 YRAPEV-TDTRKATQASDVFSFGVLLLELLTGK 497
           YRAP+V   +R  + + D++S G ++ E++TG+
Sbjct: 166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 66.2 bits (161), Expect = 5e-12
 Identities = 62/274 (22%), Positives = 126/274 (45%), Gaps = 39/274 (14%)

Query: 307 VLGKGTFG-TAYKAALEDASTVVVKRLKEVNVGKRE---FEQQMEIVGGIRHENVVALRA 362
           V+GKG++G  +      D    V+K+L   N  +RE    EQ+ +++  ++H N+VA R 
Sbjct: 7   VVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRE 66

Query: 363 YYYSKDEKL-MVYDYFEPGSVSAMLHGRRGE---GQSSLDWDTRVRIAIGAARGIAHIHT 418
            +  +D  L +V  + E G +   L  ++G+       ++W  ++ +A      + ++H 
Sbjct: 67  SWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMA------LQYLHE 120

Query: 419 ENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTDTR 475
           ++   ++H  +K  N+FL     + V D+G+A ++      A    G   Y +PE+   +
Sbjct: 121 KH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNK 177

Query: 476 KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY 535
                SDV++ G  + E+ T K   +A   + +V+                + + +L   
Sbjct: 178 PYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVY---------------RIIEGKLPPM 222

Query: 536 P-NIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
           P +   E+ E++   M    + PE+RP +  +L+
Sbjct: 223 PKDYSPELGELIAT-MLS--KRPEKRPSVKSILR 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 66.4 bits (163), Expect = 5e-12
 Identities = 50/231 (21%), Positives = 95/231 (41%), Gaps = 47/231 (20%)

Query: 306 EVLGKGTFGTAYKAALEDASTVV-VK--------RLKEVNVGKREFEQQMEIVGGIRHEN 356
           +++G+G+F T   A  ++ +    +K        + K+V   K E E    +     H  
Sbjct: 7   KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRL---NGHPG 63

Query: 357 VVALRAYYYSKDE-KL-MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIA 414
           ++ L  YY  +DE  L  V +Y   G +   +         SLD       A      + 
Sbjct: 64  IIKL--YYTFQDEENLYFVLEYAPNGELLQYIRKY-----GSLDEKCTRFYAAEILLALE 116

Query: 415 HIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP---------------MPPP 459
           ++H++    ++H  +K  NI L+   H+ ++D G A ++ P                   
Sbjct: 117 YLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173

Query: 460 AMRA--------AGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHA 502
             R         A Y +PE+ + + A ++SD+++ G ++ ++LTGK P   
Sbjct: 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRG 224

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 66.6 bits (163), Expect = 6e-12
 Identities = 65/255 (25%), Positives = 107/255 (41%), Gaps = 59/255 (23%)

Query: 288 FEGCNLVFDLEDLLRASAEVLGKGTFGTAYKA-ALEDASTVVVKRLKEVNVGKREFE--- 343
           F GC+ + D E L       LG+GTFG  YKA  ++    V +K++  ++  K  F    
Sbjct: 1   FYGCSKLRDYEIL-----GKLGEGTFGEVYKARQIKTGRVVALKKIL-MHNEKDGFPITA 54

Query: 344 -QQMEIVGGIRHENVVAL--RAYYYSKDEK------LMVYDYFEPGSVSAMLHGRRGEGQ 394
            ++++I+  ++H NVV L   A       K       MV  Y +   +S +L        
Sbjct: 55  LREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLE------- 106

Query: 395 SSLDWDTRVRIAIGAAR--------GIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSD 446
                +  V++     +        GI ++H      ++H  IKA+NI +++QG + ++D
Sbjct: 107 -----NPSVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIAD 158

Query: 447 IGLAALMSPMPPPAMRAAG--------------YRAPE-VTDTRKATQASDVFSFGVLLL 491
            GLA      PP      G              YR PE +   R+ T A D++  G +  
Sbjct: 159 FGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFA 218

Query: 492 ELLTGKSPIHATGGD 506
           E+ T + PI     D
Sbjct: 219 EMFTRR-PILQGKSD 232

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 66.6 bits (162), Expect = 6e-12
 Identities = 67/279 (24%), Positives = 127/279 (45%), Gaps = 42/279 (15%)

Query: 301 LRASAEVLGKGTFGTAYKAA-LEDASTVVVKRL----KEVNVGKREFEQQMEIVGGIRHE 355
           L +    +G G+FG  Y A  + ++  V +K++    K+ N   ++  +++  +  +RH 
Sbjct: 16  LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 75

Query: 356 NVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAH 415
           N +  R  Y  +    +V +Y   GS S +L   +   Q          +  GA +G+A+
Sbjct: 76  NTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEV----EIAAVTHGALQGLAY 130

Query: 416 IHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEV- 471
           +H+ N   ++H  +KA NI L+  G V + D G A++M+    PA    G   + APEV 
Sbjct: 131 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA----PANXFVGTPYWMAPEVI 183

Query: 472 --TDTRKATQASDVFSFGVLLLELLTGKSPI-HATGGDEVVHLVRWVNSVVREEWTAEVF 528
              D  +     DV+S G+  +EL   K P+ +      + H+ +  +  ++    +E F
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYF 243

Query: 529 DVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVL 567
                         V+      +C+ ++P++RP  ++VL
Sbjct: 244 -----------RNFVD------SCLQKIPQDRP-TSEVL 264

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 65.7 bits (160), Expect = 8e-12
 Identities = 62/280 (22%), Positives = 127/280 (45%), Gaps = 39/280 (13%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNVGKREFEQQME-------IVGGIRHENV 357
           + LG G F + Y+A  ++  + + VK++  V     E E+ +E       ++  + H ++
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 358 VALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIH 417
           + +           +  ++   GSVS +L  + G  + ++     +       RG++++H
Sbjct: 66  IRMLGATCEDSHFNLFVEWMAGGSVSHLLS-KYGAFKEAV----IINYTEQLLRGLSYLH 120

Query: 418 TENGGKLVHGGIKASNIFLNSQGH-VCVSDIGLAALMSPMPPPAMRAAG-------YRAP 469
            EN  +++H  +K +N+ ++S G  + ++D G AA ++     A    G       + AP
Sbjct: 121 -EN--QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177

Query: 470 EVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD 529
           EV    +  ++ DV+S G +++E+ T K P +A      + L+  + S            
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTA-------- 229

Query: 530 VELLRYPNIEEEMVEMLQ-VGMACVVRMPEERPKMADVLK 568
                 P+I E +   L+ V + C+   PE+RP   ++LK
Sbjct: 230 ------PSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 47/209 (22%), Positives = 89/209 (42%), Gaps = 38/209 (18%)

Query: 308 LGKGTFGTAYKA-ALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIR---------HENV 357
           +G+GT+G  YKA        V +K++K        FE +      +R         H N+
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVAIKKIK------LRFESEGIPKTALREIKLLKELNHPNI 60

Query: 358 VALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQS---SLDWDTRVRIAIGAARGIA 414
           + L   +  K +  +V+++ +      +   +RG  +S   S  +           +G+A
Sbjct: 61  IKLLDVFRHKGDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQL--------LQGLA 112

Query: 415 HIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP-----AMRAAGYRAP 469
             H+     ++H  +K  N+ +N++G + ++D GLA        P       R   YRAP
Sbjct: 113 FCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRW--YRAP 167

Query: 470 EVT-DTRKATQASDVFSFGVLLLELLTGK 497
           E+    +  +   D++S G +  ELL+ +
Sbjct: 168 ELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 65.7 bits (161), Expect = 1e-11
 Identities = 48/222 (21%), Positives = 91/222 (40%), Gaps = 61/222 (27%)

Query: 308 LGKGTFGTAYKAALEDAST---VVVKRLKEVNVGKREFEQ---------QMEIVGGIRHE 355
           LG+GT+   YKA   D  T   V +K++K   +G+R+  +         +++++  ++H 
Sbjct: 8   LGEGTYAVVYKA--RDKETGRIVAIKKIK---LGERKEAKDGINFTALREIKLLQELKHP 62

Query: 356 NVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRV-----RIAIGAA 410
           N++ L   +  K    +V+++                    ++ D         I +  A
Sbjct: 63  NIIGLLDVFGHKSNINLVFEF--------------------METDLEKVIKDKSIVLTPA 102

Query: 411 ----------RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPA 460
                     RG+ ++H+     ++H  +K +N+ + S G + ++D GLA      P   
Sbjct: 103 DIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSF-GSPNRK 158

Query: 461 MR----AAGYRAPEVT-DTRKATQASDVFSFGVLLLELLTGK 497
           M        YRAPE+    R      D++S G +  ELL   
Sbjct: 159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 64.9 bits (158), Expect = 1e-11
 Identities = 70/277 (25%), Positives = 117/277 (42%), Gaps = 45/277 (16%)

Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG G FG            V +K +KE ++ + EF ++ +++  + HE +V L      +
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ 71

Query: 368 DEKLMVYDYFEPGSVSAML--HGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLV 425
               +V +Y   G +   L  HG+R +    L+    V        G+A++ ++   + +
Sbjct: 72  RPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDV------CEGMAYLESK---QFI 122

Query: 426 HGGIKASNIFLNSQGHVCVSDIGL----------AALMSPMPPPAMRAAGYRAPEVTDTR 475
           H  + A N  ++ QG V VSD GL          +++ S  P        +  PEV    
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFP------VRWSPPEVLLYS 176

Query: 476 KATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLR 534
           K +  SDV++FGVL+ E+ + GK P             R+ NS    E   +V     L 
Sbjct: 177 KFSSKSDVWAFGVLMWEVYSLGKMPYE-----------RFNNS----ETVEKVSQGLRLY 221

Query: 535 YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVE 571
            P++  E V    +  +C     EERP    +L  +E
Sbjct: 222 RPHLASEKV--YAIMYSCWHEKAEERPTFQQLLSSIE 256

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 52/195 (26%), Positives = 96/195 (49%), Gaps = 10/195 (5%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           E++G+G FG   +        V VK +K  +V  + F ++  ++  + H+N+V L     
Sbjct: 12  EIIGEGEFGAVLQGEYT-GQKVAVKNIK-CDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69

Query: 366 SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLV 425
                + V +    G++   L   R  G++ +     ++ ++  A G+ ++ ++   KLV
Sbjct: 70  HNGLYI-VMELMSKGNLVNFL---RTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLV 122

Query: 426 HGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTRKATQASDVFS 485
           H  + A NI ++  G   VSD GLA + S     +     + APE    +K +  SDV+S
Sbjct: 123 HRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWS 182

Query: 486 FGVLLLELLT-GKSP 499
           +GVLL E+ + G++P
Sbjct: 183 YGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 65.0 bits (158), Expect = 1e-11
 Identities = 54/206 (26%), Positives = 90/206 (43%), Gaps = 10/206 (4%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           + +GKG FG          + V VK +K  +   + F  +  ++  +RH N+V L     
Sbjct: 12  QTIGKGEFGDVMLGDYR-GNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVIV 69

Query: 366 SKDEKL-MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKL 424
            +   L +V +Y   GS+   L   R  G+S L  D  ++ ++     + ++   N    
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---F 123

Query: 425 VHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTRKATQASDVF 484
           VH  + A N+ ++      VSD GL    S           + APE    +K +  SDV+
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVW 183

Query: 485 SFGVLLLELLT-GKSPIHATGGDEVV 509
           SFG+LL E+ + G+ P       +VV
Sbjct: 184 SFGILLWEIYSFGRVPYPRIPLKDVV 209

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 65.1 bits (158), Expect = 2e-11
 Identities = 74/285 (25%), Positives = 129/285 (45%), Gaps = 53/285 (18%)

Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNV-GKREFEQQMEIVGG------IRHENVVAL 360
           +G G+FG  Y A   D  T  V  +K+++  GK+  E+  +I+        I+H N +  
Sbjct: 33  IGHGSFGAVYFA--RDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAI---GAARGIAHIH 417
           +  Y  +    +V +Y   GS S +L   +   Q        V IA    GA +G+A++H
Sbjct: 91  KGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQ-------EVEIAAITHGALQGLAYLH 142

Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEV--- 471
           + N   ++H  IKA NI L   G V ++D G A++ S    PA    G   + APEV   
Sbjct: 143 SHN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS----PANSFVGTPYWMAPEVILA 195

Query: 472 TDTRKATQASDVFSFGVLLLELLTGKSPI-HATGGDEVVHLVRWVNSVVRE-EWTAEVFD 529
            D  +     DV+S G+  +EL   K P+ +      + H+ +  +  ++  EW+     
Sbjct: 196 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSD---- 251

Query: 530 VELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIR 574
                + N  +          +C+ ++P++RP   ++LK +  +R
Sbjct: 252 ----YFRNFVD----------SCLQKIPQDRPTSEELLKHMFVLR 282

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 65.2 bits (159), Expect = 2e-11
 Identities = 59/250 (23%), Positives = 94/250 (37%), Gaps = 65/250 (26%)

Query: 308 LGKGTFGTAYKAA-LEDASTVVVKRLK--EVNVGKREFEQQMEIVG-------------G 351
           LG+GT+G   KA        V +K++K  E++    +  Q + + G              
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 352 IRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAA- 410
           I+HEN++ L   Y   D   +V D      +  ++             D ++R+      
Sbjct: 77  IKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVV-------------DRKIRLTESQVK 122

Query: 411 -------RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRA 463
                   G+  +H       +H  +  +NIF+NS+G   ++D GLA       PP    
Sbjct: 123 CILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLAR--RYGYPPYSDT 177

Query: 464 AG-------------------YRAPE-VTDTRKATQASDVFSFGVLLLELLTGKSPIHAT 503
                                YRAPE +    K   A D++S G +  ELLTGK      
Sbjct: 178 LSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLF--P 235

Query: 504 GGDEVVHLVR 513
           G +E+  L R
Sbjct: 236 GENEIDQLGR 245

Length = 335

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 65/280 (23%), Positives = 132/280 (47%), Gaps = 38/280 (13%)

Query: 308 LGKGTFGTAYKAA-LEDASTVVVKRLK--EVNVGKREFE--QQMEIVGGIRHENVVALRA 362
           +GKG F   YKA  L D   V +K+++  E+   K   +  ++++++  + H NV+   A
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLA 69

Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLD---WDTRVRIAIGAARGIAHIHTE 419
            +   +E  +V +  + G +S M+   + + +   +   W   V++       + H+H++
Sbjct: 70  SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC----SALEHMHSK 125

Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTDTRK 476
              +++H  IK +N+F+ + G V + D+GL    S     A    G   Y +PE      
Sbjct: 126 ---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG 182

Query: 477 ATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWT---AEVFDVELL 533
               SD++S G LL E+   +SP +   GD+ ++L      + + ++    A+ +  EL 
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSPFY---GDK-MNLYSLCKKIEKCDYPPLPADHYSEEL- 237

Query: 534 RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
                  ++V        C+   PE+RP ++ VL++ +++
Sbjct: 238 ------RDLVSR------CINPDPEKRPDISYVLQVAKEM 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 64.2 bits (156), Expect = 3e-11
 Identities = 68/282 (24%), Positives = 114/282 (40%), Gaps = 43/282 (15%)

Query: 308 LGKGTFGTAYKAAL------EDASTVVVKRLKEVNVGKR-EFEQQMEIVGGIRHENVVAL 360
           LG+G FG  + A        +D   V VK LKE +   R +F+++ E++  ++H+++V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRF 72

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAML--HG------RRGEGQS--SLDWDTRVRIAIGAA 410
                     LMV++Y   G ++  L  HG        GE  +   L     + IA   A
Sbjct: 73  YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132

Query: 411 RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP-----MPPPAMRAAG 465
            G+ ++        VH  +   N  +     V + D G++  +       +    M    
Sbjct: 133 SGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 466 YRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWT 524
           +  PE    RK T  SD++SFGV+L E+ T GK P +     E +  +            
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGR-------- 241

Query: 525 AEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADV 566
                 EL R      E+  ++Q    C  R P++R  + D+
Sbjct: 242 ------ELERPRTCPPEVYAIMQ---GCWQREPQQRMVIKDI 274

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 64.3 bits (157), Expect = 3e-11
 Identities = 71/297 (23%), Positives = 133/297 (44%), Gaps = 55/297 (18%)

Query: 306 EVLGKGTFGTAYKAALEDASTVV-VKRL------KEVN-VGKREFEQQMEIVGGIRHENV 357
            ++G+G++G   K   ++   +V +K+       K V  +  RE    + ++  +RHEN+
Sbjct: 7   GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMRE----IRMLKQLRHENL 62

Query: 358 VALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIH 417
           V L   +  K    +V+++ +   +  +     G     LD     +      RGI   H
Sbjct: 63  VNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-----LDESRVRKYLFQILRGIEFCH 117

Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIGLA-ALMSPMPPPAMRAAG--YRAPE--VT 472
           + N   ++H  IK  NI ++  G V + D G A  L +P        A   YRAPE  V 
Sbjct: 118 SHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVG 174

Query: 473 DTRKATQASDVFSFGVLLLELLTGK------SPIHATGGDEVVHLVRWVNSVVREEWT-- 524
           DT K  +A D+++ G L+ E+LTG+      S I     D++ H+++ + +++       
Sbjct: 175 DT-KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDI-----DQLYHIIKCLGNLIPRHQEIF 228

Query: 525 -----------AEVFDVELL--RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
                       EV ++E L  R+P +   ++++ +    C+   P++RP  + +L 
Sbjct: 229 QKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAK---QCLRIDPDDRPSSSQLLH 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 64.4 bits (157), Expect = 3e-11
 Identities = 61/218 (27%), Positives = 95/218 (43%), Gaps = 30/218 (13%)

Query: 307 VLGKGTFGTAY---KAALEDASTV-VVKRLKEVNVGKRE--FEQQM---EIVGGIRHENV 357
           VLG G +G  +   K    DA  +  +K LK+  + ++    E      +++  +R    
Sbjct: 7   VLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPF 66

Query: 358 VALRAYYYSKDEKL-MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGA-ARGIAH 415
           +    Y +  D KL ++ DY   G +   L+ R    +S       VR+ I      + H
Sbjct: 67  LVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTES------EVRVYIAEIVLALDH 120

Query: 416 IHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG------YRAP 469
           +H      +++  IK  NI L+S+GHV ++D GL+     +     RA        Y AP
Sbjct: 121 LHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEF--LAEEEERAYSFCGTIEYMAP 175

Query: 470 EV--TDTRKATQASDVFSFGVLLLELLTGKSPIHATGG 505
           EV    +    +A D +S GVL  ELLTG SP    G 
Sbjct: 176 EVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGE 213

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 63.9 bits (156), Expect = 4e-11
 Identities = 71/294 (24%), Positives = 121/294 (41%), Gaps = 45/294 (15%)

Query: 306 EVLGKGTFGTAYKAALEDASTVV-VKRLKEV---NVGKREFEQQMEIVGGIRHENVVALR 361
            V+G+G +G   K   +    +V +K+ KE       K+   ++++++  +RHEN+V L+
Sbjct: 7   GVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLK 66

Query: 362 AYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENG 421
             +  K    +V++Y E      +L          L  D          + IA+ H+ N 
Sbjct: 67  EAFRRKGRLYLVFEYVE----RTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCHSHN- 120

Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP------AMRAAGYRAPE--VTD 473
             ++H  IK  NI ++  G + + D G A  +   P        A R   YRAPE  V D
Sbjct: 121 --IIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATR--WYRAPELLVGD 176

Query: 474 TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEV--VHLVRWV--------------NS 517
           T    +  DV++ G ++ ELL G+ P+   G  ++  ++L++                N 
Sbjct: 177 T-NYGKPVDVWAIGCIMAELLDGE-PLFP-GDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233

Query: 518 VVREEWTAEVFDVELL--RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM 569
                   E    E L  RYP         L    AC+   P+ER    ++L+ 
Sbjct: 234 RFAGVAFPEPSQPESLERRYPGKVSSPA--LDFLKACLRMDPKERLTCDELLQH 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 63.6 bits (155), Expect = 4e-11
 Identities = 75/290 (25%), Positives = 128/290 (44%), Gaps = 45/290 (15%)

Query: 304 SAEVLGKGTFGTAYKAALEDAST-----VVVKRLK----EVNVGKREFEQQMEIVGGIRH 354
            +++L +GTFG  +   L D        V VK +K    E+ V      Q+  ++ G+ H
Sbjct: 10  LSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTL--LLQESCLLYGLSH 67

Query: 355 ENVVALRAYYYSKDEKLMV-YDYFEPGSVSAMLH-GRRGEGQSSLDWDTR--VRIAIGAA 410
           +N++ +        E   V Y Y   G++   L   R GE  +     T+  V +AI  A
Sbjct: 68  QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127

Query: 411 RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAM-----RAAG 465
            G++++H      ++H  I A N  ++ +  V ++D  L+  + PM    +     R   
Sbjct: 128 CGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVK 184

Query: 466 YRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWT 524
           + A E    ++ + ASDV+SFGVLL EL+T G++P       E+   ++           
Sbjct: 185 WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK----------- 233

Query: 525 AEVFDVELLRYP-NIEEEMVEMLQVGMACVVR-MPEERPKMADVLKMVED 572
               D   L  P N  +E+  +    MAC     PEERP  + +++ + D
Sbjct: 234 ----DGYRLAQPINCPDELFAV----MACCWALDPEERPSFSQLVQCLTD 275

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 63.7 bits (156), Expect = 4e-11
 Identities = 53/212 (25%), Positives = 100/212 (47%), Gaps = 40/212 (18%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKRLK--------------EVNVGKREFEQQMEIVG 350
           E LG+GT+G  YKA   +    V +K+++              E+++ K           
Sbjct: 5   EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKE---------- 54

Query: 351 GIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVR-IAIGA 409
            ++H N+V L    +++ +  +V++Y +   +   L  R G    +L     ++ I    
Sbjct: 55  -LKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNL-----IKSIMYQL 107

Query: 410 ARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLA-ALMSPMPP--PAMRAAGY 466
            RG+A+ H+    +++H  +K  NI +N  G + ++D GLA A   P+      +    Y
Sbjct: 108 LRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWY 164

Query: 467 RAPEVT-DTRKATQASDVFSFGVLLLELLTGK 497
           RAPE+   ++  + A D++S G +  E++TGK
Sbjct: 165 RAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 63.4 bits (154), Expect = 6e-11
 Identities = 75/301 (24%), Positives = 125/301 (41%), Gaps = 55/301 (18%)

Query: 307 VLGKGTFGTAYKA------ALEDASTVVVKRLKE--VNVGKREFEQQMEIVGGIRHENVV 358
            LG+G FG   KA           +TV VK LKE   +   R+   +  ++  + H +V+
Sbjct: 7   TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLH----------GRRGEGQSSLDWDTRVR---- 404
            L          L++ +Y + GS+ + L           G  G   SS   +   R    
Sbjct: 67  KLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTM 126

Query: 405 -----IAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVC-VSDIGLAALMSPMPP 458
                 A   +RG+ ++      KLVH  + A N+ + ++G    +SD GL+  +     
Sbjct: 127 GDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLV-AEGRKMKISDFGLSRDVYEEDS 182

Query: 459 PAMRAAG-----YRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLV 512
              R+ G     + A E       T  SDV+SFGVLL E++T G +P      + + +L+
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLL 242

Query: 513 RWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVED 572
           +    + R E              N  EEM  ++   + C  + P++RP  AD+ K +E 
Sbjct: 243 KTGYRMERPE--------------NCSEEMYNLM---LTCWKQEPDKRPTFADISKELEK 285

Query: 573 I 573
           +
Sbjct: 286 M 286

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 62.9 bits (153), Expect = 7e-11
 Identities = 61/274 (22%), Positives = 108/274 (39%), Gaps = 41/274 (14%)

Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG G FG  +         V +K ++E  + + +F ++ +++  + H N+V L      +
Sbjct: 12  LGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ 71

Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHG 427
               +V +Y   G +   L  R+G+  +    D    +       + ++ +      +H 
Sbjct: 72  RPIFIVTEYMANGCLLNYLRERKGKLGTEWLLD----MCSDVCEAMEYLESNG---FIHR 124

Query: 428 GIKASNIFLNSQGHVCVSDIGLAALM----------SPMPPPAMRAAGYRAPEVTDTRKA 477
            + A N  +     V VSD GLA  +          +  P        +  PEV D  + 
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFP------VKWAPPEVFDYSRF 178

Query: 478 TQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP 536
           +  SDV+SFGVL+ E+ + GK P             R+ NS V E  +A        R  
Sbjct: 179 SSKSDVWSFGVLMWEVFSEGKMPYE-----------RFSNSEVVESVSAG------YRLY 221

Query: 537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKMV 570
             +    E+  +  +C    PE+RP    +L  +
Sbjct: 222 RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 64.9 bits (158), Expect = 8e-11
 Identities = 44/114 (38%), Positives = 57/114 (50%), Gaps = 1/114 (0%)

Query: 71  ALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSG 130
            L L    L GEIP N IG  S+L+ L L  N L G  P+  + L +L  L L  N   G
Sbjct: 144 TLDLSNNMLSGEIP-NDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVG 202

Query: 131 PLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSL 184
            +P +     +L  I L  N  +  IP  I  LT L+ L+L  N+LTG +P SL
Sbjct: 203 QIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSL 256

Length = 968

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 63.1 bits (153), Expect = 8e-11
 Identities = 49/198 (24%), Positives = 97/198 (48%), Gaps = 16/198 (8%)

Query: 308 LGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFE-QQMEIVGGIRHENVVALRAYYY 365
           +G+G+ G    A ++ +  +V VK++      +RE    ++ I+   +HENVV +   Y 
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87

Query: 366 SKDEKLMVYDYFEPGSVSAML-HGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKL 424
             DE  +V ++ E G+++ ++ H R  E Q +        + +   + ++ +H +    +
Sbjct: 88  VGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-------AVCLAVLKALSVLHAQG---V 137

Query: 425 VHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTDTRKATQAS 481
           +H  IK+ +I L   G V +SD G  A +S   P      G   + APE+          
Sbjct: 138 IHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEV 197

Query: 482 DVFSFGVLLLELLTGKSP 499
           D++S G++++E++ G+ P
Sbjct: 198 DIWSLGIMVIEMVDGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 62.6 bits (153), Expect = 9e-11
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 37/211 (17%)

Query: 306 EVLGKGTFGTAYKAALEDAST---VVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRA 362
           E +G+G  G  YKA   D +T   V +K+++     K     ++ I+   +H N+V    
Sbjct: 25  EKIGEGASGEVYKA--TDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYD 82

Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHG---RRGEGQSSLDWDTRVRIAIGAARGIAHIHTE 419
            Y   DE  +V +Y + GS++ ++     R  E Q +        +     +G+ ++H++
Sbjct: 83  SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIA-------YVCREVLQGLEYLHSQ 135

Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR----------AP 469
           N   ++H  IK+ NI L+  G V ++D G AA ++       +    R          AP
Sbjct: 136 N---VIHRDIKSDNILLSKDGSVKLADFGFAAQLT-------KEKSKRNSVVGTPYWMAP 185

Query: 470 EVTDTRKA-TQASDVFSFGVLLLELLTGKSP 499
           EV   RK      D++S G++ +E+  G+ P
Sbjct: 186 EVI-KRKDYGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 64.5 bits (157), Expect = 1e-10
 Identities = 42/118 (35%), Positives = 55/118 (46%), Gaps = 1/118 (0%)

Query: 66  HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQF 125
           H+ +  L L    L GEIP   +     L  L L SNSL G  P       +L  + LQ 
Sbjct: 355 HNNLTVLDLSTNNLTGEIP-EGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQD 413

Query: 126 NSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRS 183
           NSFSG LP +F+    +  +D+SNN     I +    +  L  L+LA N   G LP S
Sbjct: 414 NSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDS 471

Length = 968

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 62.7 bits (152), Expect = 1e-10
 Identities = 61/210 (29%), Positives = 95/210 (45%), Gaps = 25/210 (11%)

Query: 306 EVLGKGTFGTAYKAALE-DASTVVVKRL-KEVNVGKREFEQQME----IVGGIRHENVVA 359
           +V+GKG+FG    A  + D S   VK L K+  + K+E    M     ++  ++H  +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 360 LRAYYYSKDEKL-MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRI-AIGAARGIAHIH 417
           L  Y +   EKL  V DY   G +    H +R         + R R  A   A  I ++H
Sbjct: 61  LH-YSFQTAEKLYFVLDYVNGGEL--FFHLQRERCFL----EPRARFYAAEVASAIGYLH 113

Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAA-----GYRAPEVT 472
           + N   +++  +K  NI L+SQGHV ++D GL      + P    +       Y APEV 
Sbjct: 114 SLN---IIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGTPEYLAPEVL 168

Query: 473 DTRKATQASDVFSFGVLLLELLTGKSPIHA 502
                 +  D +  G +L E+L G  P ++
Sbjct: 169 RKEPYDRTVDWWCLGAVLYEMLYGLPPFYS 198

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 62.4 bits (151), Expect = 2e-10
 Identities = 43/197 (21%), Positives = 96/197 (48%), Gaps = 11/197 (5%)

Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYY 364
           LG G  G   K   + +  ++ ++L  + +    + +  ++++++       +V     +
Sbjct: 13  LGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 365 YSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKL 424
           YS  E  +  ++ + GS+  +L   +   +  L      +++I   RG+A++  ++  ++
Sbjct: 73  YSDGEISICMEHMDGGSLDQVLKEAKRIPEEILG-----KVSIAVLRGLAYLREKH--QI 125

Query: 425 VHGGIKASNIFLNSQGHVCVSDIGLAA-LMSPMPPPAMRAAGYRAPEVTDTRKATQASDV 483
           +H  +K SNI +NS+G + + D G++  L+  M    +    Y +PE       +  SD+
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 185

Query: 484 FSFGVLLLELLTGKSPI 500
           +S G+ L+EL  G+ PI
Sbjct: 186 WSMGLSLVELAIGRYPI 202

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 37/90 (41%), Positives = 50/90 (55%), Gaps = 5/90 (5%)

Query: 412 GIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPA-MRAAGYRAPE 470
           G+ H+H      +V+  +K +NI L+  GHV +SD+GLA   S   P A +   GY APE
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPE 165

Query: 471 VTDTRKATQAS-DVFSFGVLLLELLTGKSP 499
           V     A  +S D FS G +L +LL G SP
Sbjct: 166 VLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 62.0 bits (151), Expect = 2e-10
 Identities = 60/235 (25%), Positives = 107/235 (45%), Gaps = 43/235 (18%)

Query: 291 CNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGK----------R 340
           C  V + E L R     +G+GT+G  Y+A   D ++  +  LK+V +            R
Sbjct: 3   CRSVTEFEKLNR-----IGEGTYGIVYRA--RDTTSGEIVALKKVRMDNERDGIPISSLR 55

Query: 341 EFEQQMEIVGGIRHENVVALRAYYYSK--DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLD 398
           E    + ++  +RH N+V L+     K  D   +V +Y E   ++++L     +   +  
Sbjct: 56  E----ITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLL-----DNMPTPF 105

Query: 399 WDTRVR-IAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP 457
            +++V+ + +   RG+ ++H      ++H  +K SN+ L  +G + ++D GLA       
Sbjct: 106 SESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162

Query: 458 ---PPAMRAAGYRAPEVT-DTRKATQASDVFSFGVLLLELLT------GKSPIHA 502
               P +    YRAPE+       T A D+++ G +L ELL       GKS I  
Sbjct: 163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ 217

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 66/290 (22%), Positives = 116/290 (40%), Gaps = 49/290 (16%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNV-------GKREFEQQME--------IVG 350
           E LG G FG  YK   ++    ++  LKE+NV        KRE ++ +         I  
Sbjct: 6   EHLGSGAFGCVYKVRKKNNGQNLLA-LKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKE 64

Query: 351 GIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLD---WDTRVRIAI 407
            +RH N+V     +   D   +V D  E   +    +  + + Q   +   W+  V++ +
Sbjct: 65  QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL 124

Query: 408 GAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG-- 465
            A R   ++H E   ++VH  +  +NI L     V ++D GLA    P         G  
Sbjct: 125 -ALR---YLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQP-ESKLTSVVGTI 177

Query: 466 -YRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWT 524
            Y  PE+       + +DV++FG +L ++ T + P ++T      +++     +V     
Sbjct: 178 LYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST------NMLSLATKIVEAV-- 229

Query: 525 AEVFDVELLRYPNIEEEMVEMLQVGM--ACVVRMPEERPKMADVLKMVED 572
                     Y  + E M       +  +C+    E RP +  V  M+ D
Sbjct: 230 ----------YEPLPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD 269

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 59/209 (28%), Positives = 92/209 (44%), Gaps = 22/209 (10%)

Query: 306 EVLGKGTFGTAYKAALEDAST----VVVKRLKEVNVGKR--EFEQQMEIVGGIRHENVVA 359
            V+GKG FG  Y   L D+        VK L  +   +   +F ++  I+    H NV++
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 360 LRAYYYSKD-EKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT 418
           L       +   L+V  Y + G +    +  R E  +    D  +   +  A+G+ ++ +
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDL---RNFIRSETHNPTVKDL-IGFGLQVAKGMEYLAS 116

Query: 419 ENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALM------SPMPPPAMR-AAGYRAPEV 471
           +   K VH  + A N  L+    V V+D GLA  +      S       +    + A E 
Sbjct: 117 K---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALES 173

Query: 472 TDTRKATQASDVFSFGVLLLELLT-GKSP 499
             T+K T  SDV+SFGVLL EL+T G  P
Sbjct: 174 LQTQKFTTKSDVWSFGVLLWELMTRGAPP 202

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 59/228 (25%), Positives = 96/228 (42%), Gaps = 25/228 (10%)

Query: 308 LGKGTFGTAYKAALED-------ASTVVVKRLKE--VNVGKREFEQQMEIVGGIRHENVV 358
           LG G FG  Y+    D          V VK L++   +  K+EF ++  ++    H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGE--GQSSLDWDTRVRIAIGAARGIAHI 416
            L       + + ++ +  E G + + L   R E  G   L     + I +  A+G  ++
Sbjct: 63  KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122

Query: 417 HTENGGKLVHGGIKASNIFLNSQGHVC-----VSDIGLAALMSPMPPPAMRAAG-----Y 466
              +    +H  + A N  ++ +G+       + D GLA  +           G     +
Sbjct: 123 EQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRW 179

Query: 467 RAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVR 513
            APE     K T  SDV+SFGVL+ E+LT G+ P  A    EV+  V 
Sbjct: 180 MAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT 227

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 61.4 bits (149), Expect = 3e-10
 Identities = 75/294 (25%), Positives = 128/294 (43%), Gaps = 55/294 (18%)

Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNV-GKREFEQQMEIVGGIR------HENVVAL 360
           +G G+FG  Y A   D  T  V  +K+++  GK+  E+  +I+  +R      H N +  
Sbjct: 23  IGHGSFGAVYFA--RDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN 420
           +  Y  +    +V +Y   GS S +L   +      L       I  GA +G+A++H+  
Sbjct: 81  KGCYLREHTAWLVMEYC-LGSASDILEVHK----KPLQEVEIAAICHGALQGLAYLHSH- 134

Query: 421 GGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEV---TDT 474
             + +H  IKA NI L   G V ++D G A+L+S    PA    G   + APEV    D 
Sbjct: 135 --ERIHRDIKAGNILLTEPGTVKLADFGSASLVS----PANSFVGTPYWMAPEVILAMDE 188

Query: 475 RKATQASDVFSFGVLLLELLTGKSPIHATGG-DEVVHLVRWVN---SVVREEWTAEVFDV 530
            +     DV+S G+  +EL   K P+        + H+ +  N   ++   +W+      
Sbjct: 189 GQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--NDSPTLSSNDWS------ 240

Query: 531 ELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPST 584
                    +     +    +C+ ++P++RP   ++LK     R V  E PP+ 
Sbjct: 241 ---------DYFRNFVD---SCLQKIPQDRPSSEELLKH----RFVLRERPPTV 278

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 61.6 bits (149), Expect = 3e-10
 Identities = 54/221 (24%), Positives = 98/221 (44%), Gaps = 28/221 (12%)

Query: 306 EVLGKGTFGTAY----KAALEDASTVVVKRLKEVNVGKREFEQQM---EIVGGIRHENVV 358
           ++LGKGTFG       KA+ +  +  ++K  KEV + K E    +    ++   RH  + 
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILK--KEVIIAKDEVAHTLTESRVLKNTRHPFLT 58

Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT 418
           +L+  + +KD    V +Y   G +   L   R   +         R     A  ++ +  
Sbjct: 59  SLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSED--------RTRFYGAEIVSALDY 110

Query: 419 ENGGKLVHGGIKASNIFLNSQGHVCVSDIGL-------AALMSPMPPPAMRAAGYRAPEV 471
            + GK+V+  +K  N+ L+  GH+ ++D GL       AA M            Y APEV
Sbjct: 111 LHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTF----CGTPEYLAPEV 166

Query: 472 TDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLV 512
            +     +A D +  GV++ E++ G+ P +    +++  L+
Sbjct: 167 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 207

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 60.6 bits (147), Expect = 4e-10
 Identities = 51/209 (24%), Positives = 99/209 (47%), Gaps = 25/209 (11%)

Query: 307 VLGKGTFGTAYKAALEDASTVVVKRLKEVNV-GKREFEQQ-----MEIVGGIRHENVVAL 360
           V+G+G FG  +    +    +V+  +K++ V    + E+       +++  + H N++  
Sbjct: 7   VVGRGAFGIVHLCRRKADQKLVI--IKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIE- 63

Query: 361 RAYYYS--KDEKLM-VYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIH 417
             YY +  +D+ LM V +Y   G+++  +  R     S LD DT +   +     + H+H
Sbjct: 64  --YYENFLEDKALMIVMEYAPGGTLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVH 118

Query: 418 TENGGKLVHGGIKASNIFLNSQGHVC-VSDIGLAALMSPMPPPAMRAAG---YRAPEVTD 473
           T+    ++H  +K  NI L+    V  + D G++ ++S     A    G   Y +PE+ +
Sbjct: 119 TKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSS-KSKAYTVVGTPCYISPELCE 174

Query: 474 TRKATQASDVFSFGVLLLELLTGKSPIHA 502
            +   Q SD+++ G +L EL + K    A
Sbjct: 175 GKPYNQKSDIWALGCVLYELASLKRAFEA 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 61.2 bits (149), Expect = 4e-10
 Identities = 71/279 (25%), Positives = 114/279 (40%), Gaps = 66/279 (23%)

Query: 307 VLGKGTFGTAYKAALEDASTV-VVKRLK-EVNVGKREFEQQM------EIVGGIRHENVV 358
           VLG+G FG    A  +    +  +K LK    + + E E  M      E     RH  +V
Sbjct: 6   VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65

Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAAR---GIAH 415
            L A + ++D    V +Y   G +  M+H          D  +  R    AA    G+ +
Sbjct: 66  NLFACFQTEDHVCFVMEYAAGGDL--MMHIHT-------DVFSEPRAVFYAACVVLGLQY 116

Query: 416 IHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR-------- 467
           +H EN   +V+  +K  N+ L+++G V ++D GL               G+         
Sbjct: 117 LH-ENK--IVYRDLKLDNLLLDTEGFVKIADFGLCK----------EGMGFGDRTSTFCG 163

Query: 468 -----APEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREE 522
                APEV      T+A D +  GVL+ E+L G+SP      +EV       +S+V +E
Sbjct: 164 TPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEV------FDSIVNDE 217

Query: 523 WTAEVFDVELLRYP-NIEEEMVEMLQVGMACVVRMPEER 560
                     +RYP  +  E + +++     + R PE R
Sbjct: 218 ----------VRYPRFLSREAISIMR---RLLRRNPERR 243

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 60.5 bits (146), Expect = 4e-10
 Identities = 49/203 (24%), Positives = 98/203 (48%), Gaps = 20/203 (9%)

Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKRE----FEQQMEIVGGIRHENVVALRAY 363
           +G GT+G  YKA   + +T  +  +K + +   E     +Q++ ++   +H N+VA    
Sbjct: 17  IGSGTYGDVYKA--RNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGS 74

Query: 364 YYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGK 423
           Y  +D+  +  ++   GS+  + H      +S + + +R  +     +G+ ++H  + GK
Sbjct: 75  YLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLH--SKGK 127

Query: 424 LVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTDTRKA--- 477
           + H  IK +NI L   GHV ++D G++A ++          G   + APEV    +    
Sbjct: 128 M-HRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGY 186

Query: 478 TQASDVFSFGVLLLELLTGKSPI 500
            Q  D+++ G+  +EL   + P+
Sbjct: 187 NQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 61.1 bits (148), Expect = 4e-10
 Identities = 60/223 (26%), Positives = 95/223 (42%), Gaps = 29/223 (13%)

Query: 306 EVLGKGTFGTAYKAALEDASTV-VVKRLKE-----------VNVGKREFEQQMEIVGGIR 353
           ++LGKG+FG  + A L+  +    +K LK+             V KR      E      
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE------ 54

Query: 354 HENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGI 413
           H  +  L   + +K+    V +Y   G +  M H      QS   +D   R    AA  I
Sbjct: 55  HPFLTHLYCTFQTKENLFFVMEYLNGGDL--MFHI-----QSCHKFDLP-RATFYAAEII 106

Query: 414 AHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAA---LMSPMPPPAMRAAGYRAPE 470
             +   +   +V+  +K  NI L++ GH+ ++D G+     L             Y APE
Sbjct: 107 CGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPE 166

Query: 471 VTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVR 513
           +   +K   + D +SFGVLL E+L G+SP H    +E+   +R
Sbjct: 167 ILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR 209

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 60.9 bits (148), Expect = 4e-10
 Identities = 78/301 (25%), Positives = 132/301 (43%), Gaps = 57/301 (18%)

Query: 306 EVLGKGTFGTAYKAAL------EDASTVVVKRLKEVNVGKREFE------QQMEIVGGIR 353
           + LG+G FG   KA         + STV VK LK+ +  +++        + M+++G  +
Sbjct: 18  KPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKD-DATEKDLSDLVSEMEMMKMIG--K 74

Query: 354 HENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTR----------- 402
           H+N++ L      +    +V +Y   G++   L  RR  G+ +   D R           
Sbjct: 75  HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDL 134

Query: 403 VRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVC-VSDIGLAALMSPMPPPAM 461
           V  A   ARG+  + ++   K +H  + A N+ L ++ HV  ++D GLA  +  +     
Sbjct: 135 VSFAYQVARGMEFLASK---KCIHRDLAARNV-LVTEDHVMKIADFGLARDIHHIDYYRK 190

Query: 462 RAAG-----YRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWV 515
              G     + APE    R  T  SDV+SFGVLL E+ T G SP      +E+  L++  
Sbjct: 191 TTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK-- 248

Query: 516 NSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
               R E           +  N  +E+  ++     C   +P +RP      ++VED+ R
Sbjct: 249 -EGYRME-----------KPQNCTQELYHLM---RDCWHEVPSQRPTFK---QLVEDLDR 290

Query: 576 V 576
           +
Sbjct: 291 M 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 60.4 bits (146), Expect = 5e-10
 Identities = 37/90 (41%), Positives = 50/90 (55%), Gaps = 5/90 (5%)

Query: 412 GIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPA-MRAAGYRAPE 470
           G+ H+H      +V+  +K +NI L+  GHV +SD+GLA   S   P A +   GY APE
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPE 165

Query: 471 VTDTRKATQAS-DVFSFGVLLLELLTGKSP 499
           V     A  +S D FS G +L +LL G SP
Sbjct: 166 VLQKGTAYDSSADWFSLGCMLFKLLRGHSP 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 59.7 bits (145), Expect = 7e-10
 Identities = 63/228 (27%), Positives = 99/228 (43%), Gaps = 42/228 (18%)

Query: 308 LGKGTFGTAYKAALEDAS----TVVVKRLKE--VNVGKREFEQQMEIVGGIRHENVVALR 361
           LG G FG+  K      S     V VK LK+  +  GK+EF ++  ++  + H  +V L 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62

Query: 362 AYYYSKDEKLM-VYDYFEPGSVSAMLHGRRGEGQSSL-DWDTRVRIAIGAARGIAHIHTE 419
                K E LM V +    G +   L  RR    S L +   +V      A G+A++ ++
Sbjct: 63  GV--CKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV------AMGMAYLESK 114

Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG--YR---------- 467
           +    VH  + A N+ L ++    +SD G++         A+ A    YR          
Sbjct: 115 H---FVHRDLAARNVLLVNRHQAKISDFGMSR--------ALGAGSDYYRATTAGRWPLK 163

Query: 468 --APEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLV 512
             APE  +  K +  SDV+S+GV L E  + G  P     G EV+ ++
Sbjct: 164 WYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML 211

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 60.1 bits (145), Expect = 7e-10
 Identities = 64/223 (28%), Positives = 98/223 (43%), Gaps = 27/223 (12%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTV----VVKRLKEVNVGKR--EFEQQMEIVGGIRHENVV 358
           +VLG G FGT YK   + +  TV     +K L E    K   EF  +  I+  + H ++V
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGE--GQSSLDWDTRVRIAIGAARGIAHI 416
            L     S   +L V      G +   +H  +     Q  L+W  ++      A+G+ ++
Sbjct: 73  RLLGVCLSPTIQL-VTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQI------AKGMMYL 125

Query: 417 HTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAP------E 470
                 +LVH  + A N+ + S  HV ++D GLA L+         A G + P      E
Sbjct: 126 EER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEG-DEKEYNADGGKMPIKWMALE 181

Query: 471 VTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLV 512
               RK T  SDV+S+GV + EL+T G  P       E+  L+
Sbjct: 182 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 224

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 60.5 bits (146), Expect = 7e-10
 Identities = 53/214 (24%), Positives = 98/214 (45%), Gaps = 15/214 (7%)

Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFE--QQMEIVGGIRHENVVALRAYYY 365
           +G+GT+G  YKA  +D        LK++          +++ ++  ++H NV+AL+  + 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 366 SKDEK--LMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGK 423
           S  ++   +++DY E      +   R  +         R  +     + +  IH  +   
Sbjct: 69  SHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW 128

Query: 424 LVHGGIKASNIFLNSQG----HVCVSDIGLAALM-SPMPP-----PAMRAAGYRAPEVT- 472
           ++H  +K +NI +  +G     V ++D+G A L  SP+ P     P +    YRAPE+  
Sbjct: 129 VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL 188

Query: 473 DTRKATQASDVFSFGVLLLELLTGKSPIHATGGD 506
             R  T+A D+++ G +  ELLT +   H    D
Sbjct: 189 GARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 222

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 59.7 bits (144), Expect = 9e-10
 Identities = 54/210 (25%), Positives = 96/210 (45%), Gaps = 16/210 (7%)

Query: 296 DLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHE 355
           D E+L     E +GKG+FG  +K        VV  ++ ++   + E E   + +  +   
Sbjct: 1   DPEELF-TKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59

Query: 356 NVVALRAYY--YSKDEKL-MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARG 412
           +   +  YY  Y K  KL ++ +Y   GS   +L   R          T ++  +   +G
Sbjct: 60  DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL---RAGPFDEFQIATMLKEIL---KG 113

Query: 413 IAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAP 469
           + ++H+E   K +H  IKA+N+ L+ QG V ++D G+A  ++          G   + AP
Sbjct: 114 LDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAP 170

Query: 470 EVTDTRKATQASDVFSFGVLLLELLTGKSP 499
           EV         +D++S G+  +EL  G+ P
Sbjct: 171 EVIQQSAYDSKADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 60.0 bits (145), Expect = 9e-10
 Identities = 81/338 (23%), Positives = 135/338 (39%), Gaps = 55/338 (16%)

Query: 308 LGKGTFGTAYKAAL--------EDASTVVVKRLKEVNVGK--REFEQQMEIVGGI-RHEN 356
           LG+G FG    A              TV VK LK+    K   +   +ME++  I +H+N
Sbjct: 20  LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79

Query: 357 VVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEG-----------QSSLDWDTRVRI 405
           ++ L           ++ +Y   G++   L  RR  G           +  L +   V  
Sbjct: 80  IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139

Query: 406 AIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG 465
           A   ARG+ ++ ++   K +H  + A N+ +     + ++D GLA  +  +        G
Sbjct: 140 AYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNG 196

Query: 466 -----YRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVV 519
                + APE    R  T  SDV+SFGVLL E+ T G SP      +E+  L++      
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK------ 250

Query: 520 REEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAE 579
                      E  R         E+  +   C   +P +RP      ++VED+ RV   
Sbjct: 251 -----------EGHRMDKPANCTHELYMIMRECWHAVPSQRPTFK---QLVEDLDRVLTV 296

Query: 580 NPPSTENRSEISS--SAATPKATETASSSTAHLDSFLS 615
              ST+   ++S      +P   ++ SS ++  DS  +
Sbjct: 297 T--STDEYLDLSVPFEQYSPGCPDSPSSCSSGDDSVFA 332

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 59.8 bits (145), Expect = 9e-10
 Identities = 55/207 (26%), Positives = 100/207 (48%), Gaps = 25/207 (12%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFE-----QQMEIVGGIRHENVVAL 360
           E++G+G +G  Y+        VV   LK +N+   + +     +++ ++  +R      +
Sbjct: 7   ELIGRGAYGAVYRGKHVPTGRVVA--LKIINLDTPDDDVSDIQREVALLSQLRQSQPPNI 64

Query: 361 RAYY--YSKDEKL-MVYDYFEPGSV-SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHI 416
             YY  Y K  +L ++ +Y E GSV + M  G   E   S+     +R  + A   + +I
Sbjct: 65  TKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV----IIREVLVA---LKYI 117

Query: 417 HTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEV-T 472
           H      ++H  IKA+NI + + G+V + D G+AAL++          G   + APEV T
Sbjct: 118 HKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVIT 174

Query: 473 DTRKATQASDVFSFGVLLLELLTGKSP 499
           + +     +D++S G+ + E+ TG  P
Sbjct: 175 EGKYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 59.7 bits (145), Expect = 1e-09
 Identities = 64/291 (21%), Positives = 112/291 (38%), Gaps = 53/291 (18%)

Query: 308 LGKGTFGTAYKAALEDASTVVVKR---LKEVNVG-----KREFEQQMEIVGGIRHENVVA 359
           LG+G+FG  Y+   +       +    +K VN       + EF  +  ++      +VV 
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGE-----GQSSLDWDTRVRIAIGAARGIA 414
           L     +    L+V +    G + + L  RR E     G         +++A   A G+A
Sbjct: 74  LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMA 133

Query: 415 HIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALM-----------SPMPPPAMRA 463
           ++  +   K VH  + A N  +     V + D G+   +             +P   M  
Sbjct: 134 YLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM-- 188

Query: 464 AGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREE 522
               APE       T  SDV+SFGV+L E+ T  + P      +EV+             
Sbjct: 189 ----APESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF----------- 233

Query: 523 WTAEVFDVELLRYP-NIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVED 572
               V D   L  P N  ++++E+++    C    P+ RP   +++  ++D
Sbjct: 234 ----VIDGGHLDLPENCPDKLLELMR---MCWQYNPKMRPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 59.5 bits (145), Expect = 1e-09
 Identities = 57/225 (25%), Positives = 99/225 (44%), Gaps = 46/225 (20%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRLKE--------VNVGKREFEQQMEIVGGIRHEN 356
           + LG GTFG+ Y A   E    V +K++K+        +N+  RE +   ++     H N
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNL--REVKSLRKLN---EHPN 59

Query: 357 VVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAAR----- 411
           +V L+  +   DE   V++Y E G++  ++  R+G              +    R     
Sbjct: 60  IVKLKEVFRENDELYFVFEYME-GNLYQLMKDRKG-----------KPFSESVIRSIIYQ 107

Query: 412 ---GIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP----PAMRAA 464
              G+AHIH        H  +K  N+ ++    V ++D GLA  +   PP     + R  
Sbjct: 108 ILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-- 162

Query: 465 GYRAPEVT-DTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEV 508
            YRAPE+   +   +   D+++ G ++ EL T + P+   G  E+
Sbjct: 163 WYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR-PLFP-GSSEI 205

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 62/293 (21%), Positives = 123/293 (41%), Gaps = 61/293 (20%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQ----QMEIVGGIR-------- 353
           E++GKGT+G  Y A   + +T  +  +K+V +      +    Q ++V  +R        
Sbjct: 7   ELIGKGTYGRVYLAL--NVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64

Query: 354 --HENVVALRAYYYSKDEKLMVYDYFEPGSVSAML--HGRRGEGQ-SSLDWDTRVRIAIG 408
             H N+V    +  +++   +  +Y   GS+ + L  +GR  E                 
Sbjct: 65  LDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQV------- 117

Query: 409 AARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGL----AALMSPMPPPAMRAA 464
              G+A++H++    ++H  +KA N+ +++ G   +SD G+      +       +M+ +
Sbjct: 118 -LEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGS 173

Query: 465 GY-RAPEVTDTRKATQAS--DVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVRE 521
            +  APEV  +     ++  D++S G ++LE+  G+ P              W +    E
Sbjct: 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP--------------WSD----E 215

Query: 522 EWTAEVFDV-ELLRYPNIEEEMVEML-QVGM----ACVVRMPEERPKMADVLK 568
           E  A +F +      P I  ++   L  V +    AC    P+ RP   ++L+
Sbjct: 216 EAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 56/212 (26%), Positives = 90/212 (42%), Gaps = 26/212 (12%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRL----KEVNVGKREFEQQMEIVG---GIRHENVV 358
           EVLGKG +GT Y         + VK++      V   ++E+E+  E V     ++H N+V
Sbjct: 6   EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT 418
                    D  + ++  F PG   + +  R G     L      +       G+A++H 
Sbjct: 66  QYLGTCL-DDNTISIFMEFVPGGSISSILNRFG----PLPEPVFCKYTKQILDGVAYLHN 120

Query: 419 ENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALM---------SPMPPPAMRAAGY-RA 468
                +VH  IK +N+ L   G + + D G A  +         S M   +M    Y  A
Sbjct: 121 NC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLK-SMHGTPYWMA 176

Query: 469 PEVTDTRKATQASDVFSFGVLLLELLTGKSPI 500
           PEV +     + SD++S G  + E+ TGK P+
Sbjct: 177 PEVINESGYGRKSDIWSIGCTVFEMATGKPPL 208

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 59.7 bits (144), Expect = 1e-09
 Identities = 55/219 (25%), Positives = 102/219 (46%), Gaps = 25/219 (11%)

Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFE--QQMEIVGGIRHENVVALRAYYY 365
           +G+GT+G  YKA  +D        LK++          +++ ++  ++H NV++L+  + 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 366 SK-DEKL-MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAH-----IHT 418
           S  D K+ +++DY E      +   R  +          V++  G  + + +     IH 
Sbjct: 69  SHADRKVWLLFDYAEHDLWHIIKFHRASKANKK-----PVQLPRGMVKSLLYQILDGIHY 123

Query: 419 ENGGKLVHGGIKASNIFLNSQG----HVCVSDIGLAALM-SPMPP-----PAMRAAGYRA 468
            +   ++H  +K +NI +  +G     V ++D+G A L  SP+ P     P +    YRA
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRA 183

Query: 469 PEVT-DTRKATQASDVFSFGVLLLELLTGKSPIHATGGD 506
           PE+    R  T+A D+++ G +  ELLT +   H    D
Sbjct: 184 PELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 222

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 59.3 bits (144), Expect = 1e-09
 Identities = 69/294 (23%), Positives = 125/294 (42%), Gaps = 51/294 (17%)

Query: 296 DLEDLLRASAEVLGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQMEIVGGIRH 354
           DL+DL       +G+G FGT  K   + + T++ VKR++     K +    M++   +R 
Sbjct: 5   DLKDL-----GEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRS 59

Query: 355 ENVVALRAYY---YSKDE-----KLM--VYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVR 404
            +   +  +Y   + + +     +LM    D F        ++      +S +  +   +
Sbjct: 60  SDCPYIVKFYGALFREGDCWICMELMDISLDKF-----YKYVYEV---LKSVIPEEILGK 111

Query: 405 IAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAA-LMSPMPPPAMRA 463
           IA+   + + ++  E   K++H  +K SNI L+  G++ + D G++  L+  +     R 
Sbjct: 112 IAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIA--KTRD 167

Query: 464 AG---YRAPEVTDTRKATQ---ASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNS 517
           AG   Y APE  D          SDV+S G+ L E+ TGK P              W NS
Sbjct: 168 AGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK-----------W-NS 215

Query: 518 VVREEWTAEVFDVELLRYPNIEEEMV--EMLQVGMACVVRMPEERPKMADVLKM 569
           V   +   +V   +     N EE       +     C+++   +RPK  ++L+ 
Sbjct: 216 VF--DQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 59.3 bits (143), Expect = 1e-09
 Identities = 60/279 (21%), Positives = 128/279 (45%), Gaps = 34/279 (12%)

Query: 308 LGKGTFGTAYKAA-LEDASTVVVKRLKEVNV----GKREFEQQMEIVGGIRHENVVALRA 362
           +G+G F   Y+A  L D   V +K+++   +     +++  ++++++  + H NV+    
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLD 69

Query: 363 YYYSKDEKLMVYDYFEPGSVSAML----HGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT 418
            +   +E  +V +  + G +S M+      +R   + ++ W   V++       + H+H+
Sbjct: 70  SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTV-WKYFVQLC----SAVEHMHS 124

Query: 419 ENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTDTR 475
               +++H  IK +N+F+ + G V + D+GL    S     A    G   Y +PE     
Sbjct: 125 R---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN 181

Query: 476 KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY 535
                SD++S G LL E+   +SP +   GD+ ++L      +       E  D   L  
Sbjct: 182 GYNFKSDIWSLGCLLYEMAALQSPFY---GDK-MNLFSLCQKI-------EQCDYPPLPT 230

Query: 536 PNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIR 574
            +  E++ E++ +   C+   P++RP +  V ++ + + 
Sbjct: 231 EHYSEKLRELVSM---CIYPDPDQRPDIGYVHQIAKQMH 266

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 59.4 bits (144), Expect = 1e-09
 Identities = 53/216 (24%), Positives = 97/216 (44%), Gaps = 36/216 (16%)

Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVG-----KREFEQQMEIVGGIRHENVVALRA 362
           LG+G  G+  K  L++   +    LK +        +++  +++EI    +   +V    
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFA--LKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66

Query: 363 YYYSKDEKL--MVYDYFEPGSVSAMLH------GRRGEGQSSLDWDTRV--RIAIGAARG 412
            +  +      +  +Y E GS+ ++        GR GE         +V  +IA    +G
Sbjct: 67  AFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGE---------KVLGKIAESVLKG 117

Query: 413 IAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAA-LMSPMPPPAMRAAG---YRA 468
           ++++H+    K++H  IK SNI L  +G V + D G++  L++ +   A    G   Y A
Sbjct: 118 LSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL---AGTFTGTSFYMA 171

Query: 469 PEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATG 504
           PE    +  +  SDV+S G+ LLE+   + P    G
Sbjct: 172 PERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEG 207

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 60.6 bits (147), Expect = 2e-09
 Identities = 38/122 (31%), Positives = 60/122 (49%), Gaps = 1/122 (0%)

Query: 68  RVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNS 127
           R+  L+L      GEIP N +G+ + L  L L +N+L+G  P       NL  L L  NS
Sbjct: 333 RLQVLQLWSNKFSGEIPKN-LGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNS 391

Query: 128 FSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRF 187
             G +P       +L  + L +N F+  +P+  +KL  +  L+++NN+L G +       
Sbjct: 392 LEGEIPKSLGACRSLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDM 451

Query: 188 PS 189
           PS
Sbjct: 452 PS 453

Length = 968

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 59.2 bits (143), Expect = 2e-09
 Identities = 59/234 (25%), Positives = 102/234 (43%), Gaps = 31/234 (13%)

Query: 308 LGKGTFGTAYKAAL--------EDASTVVVKRLKEVNVGK--REFEQQMEIVGGI-RHEN 356
           LG+G FG   +A          +   TV VK LK+    K   +   +ME++  I +H+N
Sbjct: 20  LGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKN 79

Query: 357 VVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEG-----------QSSLDWDTRVRI 405
           ++ L      +    ++ +Y   G++   L  RR  G           +  L +   V  
Sbjct: 80  IINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSC 139

Query: 406 AIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG 465
           A   ARG+ ++ +    + +H  + A N+ +     + ++D GLA  +  +      + G
Sbjct: 140 AYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNG 196

Query: 466 -----YRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVR 513
                + APE    R  T  SDV+SFG+L+ E+ T G SP      +E+  L+R
Sbjct: 197 RLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLR 250

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 47/204 (23%), Positives = 89/204 (43%), Gaps = 27/204 (13%)

Query: 308 LGKGTFGTAYKA---------ALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVV 358
           +G GTFG  +           AL+  +   V RLK+      E     E+     H  ++
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEV----SHPFII 64

Query: 359 ALRAYYYSKDEKL--MVYDYFEPGSVSAMLHG-RRGEGQSSLDWDTRVRIAIGAARGIAH 415
            L  ++   D++   M+ +Y   G + + L    R    + L + + +  A+       +
Sbjct: 65  RL--FWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCAL------EY 116

Query: 416 IHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTR 475
           +H++    +V+  +K  NI L+ +GH+ ++D G A  +            Y APEV  ++
Sbjct: 117 LHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSK 173

Query: 476 KATQASDVFSFGVLLLELLTGKSP 499
              +A D ++ G+L+ E+L G  P
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 58.8 bits (143), Expect = 2e-09
 Identities = 56/212 (26%), Positives = 95/212 (44%), Gaps = 39/212 (18%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFE-----QQMEIVGGIRHENVVAL 360
           E +GKG+FG  YKA   D  T  V  +K +++ + E E     Q+++ +   R   +   
Sbjct: 7   ECIGKGSFGEVYKAI--DKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITK- 63

Query: 361 RAYY--YSKDEKL-MVYDYFEPGSVSAMLH-GRRGEGQSSLDWDTRVRIAIGAARGIAHI 416
             YY  + K  KL ++ +Y   GS   +L  G+  E   +        I      G+ ++
Sbjct: 64  --YYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAF-------ILREVLLGLEYL 114

Query: 417 HTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM---------PPPAMRAAGYR 467
           H E     +H  IKA+NI L+ +G V ++D G++  ++            P  M      
Sbjct: 115 HEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWM------ 165

Query: 468 APEVTDTRKATQASDVFSFGVLLLELLTGKSP 499
           APEV       + +D++S G+  +EL  G+ P
Sbjct: 166 APEVIKQSGYDEKADIWSLGITAIELAKGEPP 197

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 58.9 bits (142), Expect = 2e-09
 Identities = 70/297 (23%), Positives = 123/297 (41%), Gaps = 51/297 (17%)

Query: 308 LGKGTFGTAYKAAL--------EDASTVVVKRLKEVNVGK--REFEQQMEIVGGI-RHEN 356
           LG+G FG    A          ++A TV VK LK+    K   +   +ME++  I +H+N
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 82

Query: 357 VVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEG-----------QSSLDWDTRVRI 405
           ++ L           ++ +Y   G++   L  RR  G              + +   V  
Sbjct: 83  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSC 142

Query: 406 AIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG 465
               ARG+ ++ ++   K +H  + A N+ +     + ++D GLA  ++ +        G
Sbjct: 143 TYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNG 199

Query: 466 -----YRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVV 519
                + APE    R  T  SDV+SFGVL+ E+ T G SP      +E+  L++  + + 
Sbjct: 200 RLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD 259

Query: 520 REEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV 576
           +                N   E+  M++    C   +P  RP      ++VED+ R+
Sbjct: 260 KP--------------ANCTNELYMMMR---DCWHAIPSHRPTFK---QLVEDLDRI 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 67/307 (21%), Positives = 124/307 (40%), Gaps = 75/307 (24%)

Query: 308 LGKGTFGTAYKAAL------EDASTVVVKRLKEVNVG--KREFEQQMEIVGGIRHENVVA 359
           +G+G FG  ++A        E  + V VK LKE      + +F+++  ++    H N+V 
Sbjct: 13  IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72

Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDT-----------------R 402
           L           ++++Y   G ++  L  R    Q SL   T                 +
Sbjct: 73  LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132

Query: 403 VRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP------- 455
           + IA   A G+A++ +E   K VH  +   N  +     V ++D GL+  +         
Sbjct: 133 LCIAKQVAAGMAYL-SER--KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 456 ---------MPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGG 505
                    MPP ++    Y           T  SDV+++GV+L E+ + G  P +    
Sbjct: 190 ENDAIPIRWMPPESIFYNRY-----------TTESDVWAYGVVLWEIFSYGMQPYYGMAH 238

Query: 506 DEVVHLVRWVNSVVREEWTAEVFDVELLRYP-NIEEEMVEMLQVGMACVVRMPEERPKMA 564
           +EV++ VR               D  +L  P N   E+  ++++   C  ++P +RP  A
Sbjct: 239 EEVIYYVR---------------DGNVLSCPDNCPLELYNLMRL---CWSKLPSDRPSFA 280

Query: 565 DVLKMVE 571
            + ++++
Sbjct: 281 SINRILQ 287

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 51/200 (25%), Positives = 90/200 (45%), Gaps = 15/200 (7%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYY- 364
           E +GKG+FG  YK        VV  ++ ++   + E E   + +  +   +   +  YY 
Sbjct: 10  ERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYG 69

Query: 365 -YSKDEKL-MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGG 422
            Y K  KL ++ +Y   GS   +L          L+      I     +G+ ++H+E   
Sbjct: 70  SYLKGTKLWIIMEYLGGGSALDLLK------PGPLEETYIATILREILKGLDYLHSE--- 120

Query: 423 KLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTDTRKATQ 479
           + +H  IKA+N+ L+ QG V ++D G+A  ++          G   + APEV        
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF 180

Query: 480 ASDVFSFGVLLLELLTGKSP 499
            +D++S G+  +EL  G+ P
Sbjct: 181 KADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 58.3 bits (141), Expect = 2e-09
 Identities = 54/206 (26%), Positives = 92/206 (44%), Gaps = 22/206 (10%)

Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKRE--FEQ-QMEIVGGIRHENV----VAL 360
           LGKG +G+ YK       T V   +KE+ +   E  F Q  ME+   I H+ V    V  
Sbjct: 9   LGKGNYGSVYKVL--HRPTGVTMAMKEIRLELDESKFNQIIMELD--ILHKAVSPYIVDF 64

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN 420
              ++ +    M  +Y + GS+  +  G  G     +  D   RI     +G+  +  E+
Sbjct: 65  YGAFFIEGAVYMCMEYMDAGSLDKLYAG--GVATEGIPEDVLRRITYAVVKGLKFLKEEH 122

Query: 421 GGKLVHGGIKASNIFLNSQGHVCVSDIGLAA-LMSPMPPPAMRAAGYRAPEVTDTRKATQ 479
              ++H  +K +N+ +N  G V + D G++  L++ +    +    Y APE   +    Q
Sbjct: 123 --NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQ 180

Query: 480 A------SDVFSFGVLLLELLTGKSP 499
                  SDV+S G+ +LE+  G+ P
Sbjct: 181 NPTYTVQSDVWSLGLSILEMALGRYP 206

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 74/294 (25%), Positives = 122/294 (41%), Gaps = 52/294 (17%)

Query: 307 VLGKGTFGTAYKAAL--EDAS--TVVVKRLK-EVNVGK--REFEQQMEIVGGIRHENVVA 359
           +LGKG FG+  +A L  ED S   V VK LK ++       EF ++   +    H NV+ 
Sbjct: 6   MLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIK 65

Query: 360 LRAYYYSKDEK------LMVYDYFEPGSVSA-MLHGRRGEGQSSLDWDTRVRIAIGAARG 412
           L         K      +++  + + G +   +L  R GE   +L   T VR  I  A G
Sbjct: 66  LIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASG 125

Query: 413 IAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLA-----------ALMSPMPPPAM 461
           + ++ ++N    +H  + A N  LN    VCV+D GL+              S +P    
Sbjct: 126 MEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLP---- 178

Query: 462 RAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVR 520
               + A E       T  SDV++FGV + E++T G++P       E+       N +++
Sbjct: 179 --VKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI------YNYLIK 230

Query: 521 EEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIR 574
                      L + P+  E++ E++     C    P+ RP    +   +E I 
Sbjct: 231 GN--------RLKQPPDCLEDVYELMC---QCWSPEPKCRPSFQHLRDQLELIW 273

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 58.0 bits (141), Expect = 3e-09
 Identities = 50/205 (24%), Positives = 89/205 (43%), Gaps = 27/205 (13%)

Query: 308 LGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFEQQM----EIVGGIRHENVVALRA 362
           LG G FG      ++    T  +K +K+ ++ +   ++ +    EI+    H  +V L  
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60

Query: 363 YYYSKDEK--LMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN 420
            +  KD+K   M+ +Y   G +  +L  R   G    ++  R  IA        ++H   
Sbjct: 61  TF--KDKKYIYMLMEYCLGGELWTILRDR---GLFD-EYTARFYIA-CVVLAFEYLHNRG 113

Query: 421 GGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRA------AGYRAPEVTDT 474
              +++  +K  N+ L+S G+V + D G A  +        +         Y APE+   
Sbjct: 114 ---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS----GQKTWTFCGTPEYVAPEIILN 166

Query: 475 RKATQASDVFSFGVLLLELLTGKSP 499
           +    + D +S G+LL ELLTG+ P
Sbjct: 167 KGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 58.4 bits (141), Expect = 3e-09
 Identities = 65/230 (28%), Positives = 104/230 (45%), Gaps = 31/230 (13%)

Query: 306 EVLGKGTFGTAYKAALEDAST-VVVKRLK-EVNVGKREFEQQM--EIVGGIRHEN--VVA 359
           +VLGKG+FG    A L+       VK LK +V +   + E  M  + V  +  EN  +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAAR---GIAHI 416
           L   + +K+    V ++   G +  M H  + +G+  L      R    AA    G+  +
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDL--MFH-IQDKGRFDL-----YRATFYAAEIVCGLQFL 112

Query: 417 HTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTD 473
           H++    +++  +K  N+ L+  GH+ ++D G+          A    G   Y APE+  
Sbjct: 113 HSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQ 169

Query: 474 TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVV--------HLVRWV 515
             K T + D +SFGVLL E+L G+SP H    DE+         H  RW+
Sbjct: 170 GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWI 219

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 54/201 (26%), Positives = 95/201 (47%), Gaps = 16/201 (7%)

Query: 308 LGKGTFGTAYKA-ALEDASTVVVKRLK-EVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           +G GT+G  YKA  L       VK +K E        +Q++ +V   +H N+VA    Y 
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL 76

Query: 366 SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLV 425
           S+++  +  +Y   GS+  + H      +  + +  R  +     +G+A++H++  GK+ 
Sbjct: 77  SREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSK--GKM- 128

Query: 426 HGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTDTRKA---TQ 479
           H  IK +NI L   G V ++D G+AA ++          G   + APEV    K     Q
Sbjct: 129 HRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQ 188

Query: 480 ASDVFSFGVLLLELLTGKSPI 500
             D+++ G+  +EL   + P+
Sbjct: 189 LCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 58.2 bits (140), Expect = 3e-09
 Identities = 44/201 (21%), Positives = 96/201 (47%), Gaps = 18/201 (8%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQ----QMEIVGGIRHENVVALR 361
           E +G+G  GT + A   D +T     +K++N+ K+  ++    ++ ++  +++ N+V   
Sbjct: 25  EKIGQGASGTVFTAI--DVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFL 82

Query: 362 AYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENG 421
             +   DE  +V +Y   GS++ ++       ++ +D     +IA      +  +   + 
Sbjct: 83  DSFLVGDELFVVMEYLAGGSLTDVV------TETCMD---EAQIAAVCRECLQALEFLHA 133

Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTDTRKAT 478
            +++H  IK+ N+ L   G V ++D G  A ++P         G   + APEV   +   
Sbjct: 134 NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 193

Query: 479 QASDVFSFGVLLLELLTGKSP 499
              D++S G++ +E++ G+ P
Sbjct: 194 PKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 58.1 bits (140), Expect = 3e-09
 Identities = 55/220 (25%), Positives = 94/220 (42%), Gaps = 40/220 (18%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIR----HENVVALR 361
           EV+G GT+G  YK       T  +  +K ++V + E E+    +  ++    H N+    
Sbjct: 22  EVVGNGTYGQVYKG--RHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYY 79

Query: 362 AYYYSK------DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAH 415
             +  K      D+  +V ++   GSV+ ++   +G   ++L  D    I     RG+AH
Sbjct: 80  GAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG---NALKEDWIAYICREILRGLAH 136

Query: 416 IHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR-------- 467
           +H     K++H  IK  N+ L     V + D G++A +        R  G R        
Sbjct: 137 LHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD-------RTVGRRNTFIGTPY 186

Query: 468 --APEVTDTRKATQA-----SDVFSFGVLLLELLTGKSPI 500
             APEV    +   A     SD++S G+  +E+  G  P+
Sbjct: 187 WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 58.0 bits (140), Expect = 4e-09
 Identities = 48/199 (24%), Positives = 90/199 (45%), Gaps = 13/199 (6%)

Query: 308 LGKGTFGTAYKAALEDASTV-VVKRLKEVNVGKREFEQ----QMEIVGGIRHENVVALRA 362
           LGKG FG      +++   +   K+L +  + K+  E+    + EI+  +    +V L  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGG 422
            + SK    +V      G +   ++     G+  L+ +  +  +     GI H+H+    
Sbjct: 61  AFESKTHLCLVMSLMNGGDLKYHIYN---VGERGLEMERVIHYSAQITCGILHLHSM--- 114

Query: 423 KLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAA--GYRAPEVTDTRKATQA 480
            +V+  +K  N+ L+ QG+  +SD+GLA  +        RA   GY APE+      +  
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYP 174

Query: 481 SDVFSFGVLLLELLTGKSP 499
            D F+ G  + E++ G++P
Sbjct: 175 VDWFAMGCSIYEMVAGRTP 193

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 58.9 bits (142), Expect = 4e-09
 Identities = 51/205 (24%), Positives = 89/205 (43%), Gaps = 15/205 (7%)

Query: 328 VVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLH 387
           + KR+K  +    + E ++  +G + HEN++ +     S+    M+   ++    S M  
Sbjct: 196 IAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYD 255

Query: 388 GRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDI 447
                    L   TR  I       + +IH +   KL+H  IK  NIFLN  G + + D 
Sbjct: 256 EAFDWKDRPLLKQTR-AIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVLGDF 311

Query: 448 GLAALMSPMPPPAMRAAGY------RAPEVTDTRKATQASDVFSFGVLLLELLTGK-SPI 500
           G A  M           G+       +PE+       + +D++S G++LL++L+    PI
Sbjct: 312 GTA--MPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPI 369

Query: 501 HATGGDEVVHLVRWVN--SVVREEW 523
              GG     L++ ++  SV  EE+
Sbjct: 370 GDGGGKPGKQLLKIIDSLSVCDEEF 394

Length = 501

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 60/239 (25%), Positives = 102/239 (42%), Gaps = 34/239 (14%)

Query: 303 ASAEVLGKGTFGTAYKAAL-EDAST--VVVKRLKEVNVGKREFEQQMEIVGGIR---HEN 356
           A  + LG+G FG+  +  L +D S   V VK +K     + E E  +     ++   H N
Sbjct: 2   ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPN 61

Query: 357 VVALRAYYYSKDEK------LMVYDYFEPGSV-SAMLHGRRGEGQSSLDWDTRVRIAIGA 409
           V+ L        E       +++  + + G + S +L+ R G+    L     V+     
Sbjct: 62  VMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDI 121

Query: 410 ARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLA-----------ALMSPMPP 458
           A G+ ++ +++    +H  + A N  LN   +VCV+D GL+             ++ MP 
Sbjct: 122 ASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP- 177

Query: 459 PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVN 516
                  + A E    R  T  SDV+SFGV + E+ T G++P       E+   +R  N
Sbjct: 178 -----VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGN 231

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 57.9 bits (140), Expect = 4e-09
 Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 34/216 (15%)

Query: 307 VLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFE-------QQMEIVGGIRHENVVA 359
            +G+GT+G  YKA   D  T  +  LK+V +   E E       ++++I+  + H N+V 
Sbjct: 14  QIGEGTYGQVYKA--RDKDTGELVALKKVRL-DNEKEGFPITAIREIKILRQLNHRNIVN 70

Query: 360 LRAYYYSKDEKL----------MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGA 409
           L+     K + L          +V++Y +       L G    G      D         
Sbjct: 71  LKEIVTDKQDALDFKKDKGAFYLVFEYMDHD-----LMGLLESGLVHFSEDHIKSFMKQL 125

Query: 410 ARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP--MPPPAMRAAG-- 465
             G+ + H +N    +H  IK SNI LN++G + ++D GLA L +     P   +     
Sbjct: 126 LEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLW 182

Query: 466 YRAPE-VTDTRKATQASDVFSFGVLLLELLTGKSPI 500
           YR PE +    +   A DV+S G +L EL T K PI
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGELFT-KKPI 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 57.5 bits (139), Expect = 4e-09
 Identities = 54/216 (25%), Positives = 104/216 (48%), Gaps = 34/216 (15%)

Query: 307 VLGKGTFGTAYKAALEDASTVVVKRLKEVNVG---------KRE----FEQQMEIVGGIR 353
           ++G G+FG+ Y     +AS+  +  +K+V +          KR       +++ ++  ++
Sbjct: 7   LIGSGSFGSVYLGM--NASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64

Query: 354 HENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAA-RG 412
           HEN+V         D   +  +Y   GSV+A+L+   G  + +L     VR  +    +G
Sbjct: 65  HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLN-NYGAFEETL-----VRNFVRQILKG 118

Query: 413 IAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIG---------LAALMSPMPPPAMRA 463
           + ++H      ++H  IK +NI ++++G + +SD G         L+   +   P    +
Sbjct: 119 LNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175

Query: 464 AGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSP 499
             + APEV      T+ +D++S G L++E+LTGK P
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 57.7 bits (139), Expect = 5e-09
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 25/215 (11%)

Query: 306 EVLGKGTFGTAY---KAALEDASTV-VVKRLKEVNVGKREFEQQ-----MEIVGGIRHEN 356
           +VLG G +G  +   K    D   +  +K L++  + ++    +       ++  +R   
Sbjct: 6   KVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSP 65

Query: 357 VVALRAYYYSKDEKL-MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAA-RGIA 414
            +    Y +  + KL ++ DY   G +   L+ R    +        VR   G     + 
Sbjct: 66  FLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDE------VRFYSGEIILALE 119

Query: 415 HIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAA-LMSPMPPPAMRAAG---YRAPE 470
           H+H      +V+  IK  NI L+S+GHV ++D GL+   +S          G   Y APE
Sbjct: 120 HLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE 176

Query: 471 VTDTRKA-TQASDVFSFGVLLLELLTGKSPIHATG 504
           +   +    +A D +S G+L+ ELLTG SP    G
Sbjct: 177 IIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEG 211

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 57.1 bits (138), Expect = 6e-09
 Identities = 76/320 (23%), Positives = 114/320 (35%), Gaps = 99/320 (30%)

Query: 300 LLRASAEVLGKGTFGTAYKAAL----EDAS--TVVVKRLKEVNVGKREFEQQME--IVGG 351
           LLRA    LG G FG  Y+        DA    V VK L E    + E +  ME  I+  
Sbjct: 10  LLRA----LGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSK 65

Query: 352 IRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAML-HGR-RGEGQSSLDWDTRVRIAIGA 409
             H+N+V L    + +  + ++ +    G + + L   R R E  SSL     +  A   
Sbjct: 66  FNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDV 125

Query: 410 ARGIAHIHTENGGKLVHGGIKASNIFLNSQGH---VCVSDIGLA-------------ALM 453
           A+G  ++        +H  I A N  L  +G      ++D G+A               M
Sbjct: 126 AKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAM 182

Query: 454 SP---MPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVH 510
            P   MPP A     +           T  +DV+SFGVLL                    
Sbjct: 183 LPIKWMPPEAFLDGIF-----------TSKTDVWSFGVLL-------------------- 211

Query: 511 LVRWVNSVVREEWTAEVFDVELLRYPNI-EEEMVEMLQVG----------------MA-C 552
              W           E+F +  + YP    +E++E +  G                M  C
Sbjct: 212 ---W-----------EIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDC 257

Query: 553 VVRMPEERPKMADVLKMVED 572
               PE+RP  A +L+ ++ 
Sbjct: 258 WQHTPEDRPNFATILERIQY 277

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 57.7 bits (139), Expect = 7e-09
 Identities = 41/197 (20%), Positives = 96/197 (48%), Gaps = 11/197 (5%)

Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYY 364
           LG G  G  +K + + +  ++ ++L  + +    + +  ++++++       +V     +
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 72

Query: 365 YSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKL 424
           YS  E  +  ++ + GS+  +L       +  L      +++I   +G+ ++  ++  K+
Sbjct: 73  YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILG-----KVSIAVIKGLTYLREKH--KI 125

Query: 425 VHGGIKASNIFLNSQGHVCVSDIGLAA-LMSPMPPPAMRAAGYRAPEVTDTRKATQASDV 483
           +H  +K SNI +NS+G + + D G++  L+  M    +    Y +PE       +  SD+
Sbjct: 126 MHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDI 185

Query: 484 FSFGVLLLELLTGKSPI 500
           +S G+ L+E+  G+ PI
Sbjct: 186 WSMGLSLVEMAIGRYPI 202

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 57.3 bits (138), Expect = 7e-09
 Identities = 56/212 (26%), Positives = 93/212 (43%), Gaps = 30/212 (14%)

Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENV---------- 357
           +GKGTFG  Y+   +D   +   ++    + K+E   + E+   I   N+          
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKV----LSKKEIVAKKEVAHTIGERNILVRTLLDESP 56

Query: 358 --VALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGA-ARGIA 414
             V L+  + +  +  +V DY   G +   L   + EG+ S D   R +  I      + 
Sbjct: 57  FIVGLKFSFQTDSDLYLVTDYMSGGELFWHL---QKEGRFSED---RAKFYIAELVLALE 110

Query: 415 HIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEV 471
           H+H  +   +V+  +K  NI L++ GH+ + D GL+              G   Y APEV
Sbjct: 111 HLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEV 167

Query: 472 -TDTRKATQASDVFSFGVLLLELLTGKSPIHA 502
             D +  T+  D +S GVL+ E+  G SP +A
Sbjct: 168 LLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYA 199

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 57.0 bits (138), Expect = 7e-09
 Identities = 41/176 (23%), Positives = 76/176 (43%), Gaps = 29/176 (16%)

Query: 404 RIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRA 463
           +IA+   + + ++H++    ++H  +K SN+ +N  G V + D G++  +       + A
Sbjct: 107 KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA 164

Query: 464 AG--YRAPEVTDTRKATQA----SDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNS 517
               Y APE  +     +     SDV+S G+ ++EL TG+ P + +       L      
Sbjct: 165 GCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP-YDSWKTPFQQL----KQ 219

Query: 518 VVRE---EWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMV 570
           VV E   +  AE F  E   + N              C+ +  +ERP   ++L+  
Sbjct: 220 VVEEPSPQLPAEKFSPEFQDFVN-------------KCLKKNYKERPNYPELLQHP 262

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 56.8 bits (137), Expect = 7e-09
 Identities = 42/198 (21%), Positives = 94/198 (47%), Gaps = 16/198 (8%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRA 362
           E+LG G  GT YKA       ++  ++  +++    +++   ++EI+       ++    
Sbjct: 7   EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYG 66

Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGG 422
            ++ ++   +  ++ + GS+   ++ +  E           RIA+   +G+ ++      
Sbjct: 67  AFFVENRISICTEFMDGGSLD--VYRKIPE-------HVLGRIAVAVVKGLTYLW---SL 114

Query: 423 KLVHGGIKASNIFLNSQGHVCVSDIGLAA-LMSPMPPPAMRAAGYRAPEVTDTRKATQAS 481
           K++H  +K SN+ +N++G V + D G++  L++ +    +    Y APE     +    S
Sbjct: 115 KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIHS 174

Query: 482 DVFSFGVLLLELLTGKSP 499
           DV+S G+  +EL  G+ P
Sbjct: 175 DVWSLGISFMELALGRFP 192

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 56.9 bits (137), Expect = 9e-09
 Identities = 53/215 (24%), Positives = 96/215 (44%), Gaps = 23/215 (10%)

Query: 306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFEQQME-----IVGGIRHENVVA 359
           +V+GKG+FG    A  + +     VK L++  + K++ E+ +      ++  ++H  +V 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRI-AIGAARGIAHIHT 418
           L   + + D+   V DY   G +   L   R         + R R  A   A  + ++H+
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRER------CFLEPRARFYAAEIASALGYLHS 114

Query: 419 ENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAA-----GYRAPEVTD 473
            N   +V+  +K  NI L+SQGH+ ++D GL      +      +       Y APEV  
Sbjct: 115 LN---IVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNGTTSTFCGTPEYLAPEVLH 169

Query: 474 TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEV 508
            +   +  D +  G +L E+L G  P ++    E+
Sbjct: 170 KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 56.8 bits (138), Expect = 9e-09
 Identities = 59/207 (28%), Positives = 98/207 (47%), Gaps = 38/207 (18%)

Query: 311 GTFGTAYKAALEDAST---VVVKRLKEVNVGKREFEQQME-----------IVGGIRHEN 356
           GT+G  Y+A   D  T   V +K+LK         E++ E           I+  ++H N
Sbjct: 16  GTYGVVYRA--RDKKTGEIVALKKLK--------MEKEKEGFPITSLREINILLKLQHPN 65

Query: 357 VVALRAYYYSK--DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIA 414
           +V ++        D+  MV +Y E    S M   ++   QS +       + +    G+A
Sbjct: 66  IVTVKEVVVGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVK-----CLMLQLLSGVA 120

Query: 415 HIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALM-SPMPP--PAMRAAGYRAPEV 471
           H+H +N   ++H  +K SN+ LN++G + + D GLA    SP+ P    +    YRAPE+
Sbjct: 121 HLH-DN--WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPEL 177

Query: 472 T-DTRKATQASDVFSFGVLLLELLTGK 497
               ++ + A D++S G +  ELLT K
Sbjct: 178 LLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 56.7 bits (137), Expect = 9e-09
 Identities = 52/200 (26%), Positives = 97/200 (48%), Gaps = 20/200 (10%)

Query: 308 LGKGTFGTAYKAALEDAST---VVVKRLKEVNVGKREFE-QQMEIVGGIRHENVVALRAY 363
           +G+G+ G    A   D ST   V VK++      +RE    ++ I+   +H N+V + + 
Sbjct: 27  IGEGSTGIVCIA--TDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSS 84

Query: 364 YYSKDEKLMVYDYFEPGSVSAML-HGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGG 422
           Y   DE  +V ++ E G+++ ++ H R  E Q +        + +   + ++ +H +   
Sbjct: 85  YLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT-------VCLAVLKALSFLHAQ--- 134

Query: 423 KLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTDTRKATQ 479
            ++H  IK+ +I L S G V +SD G  A +S   P      G   + APEV        
Sbjct: 135 GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGT 194

Query: 480 ASDVFSFGVLLLELLTGKSP 499
             D++S G++++E++ G+ P
Sbjct: 195 EVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 56.9 bits (137), Expect = 9e-09
 Identities = 53/207 (25%), Positives = 90/207 (43%), Gaps = 19/207 (9%)

Query: 306 EVLGKGTFGTAYKAALE-DASTVVVKRL-KEVNVGKREFEQQME----IVGGIRHENVVA 359
           +V+GKG+FG    A  + D     VK L K++ + ++E +  M     ++  ++H  +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGA-ARGIAHIHT 418
           L   + + ++   V D+   G +   L   R   +       R R      A  + ++H+
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEP------RARFYAAEIASALGYLHS 114

Query: 419 ENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTDTR 475
            N   +V+  +K  NI L+SQGHV ++D GL               G   Y APEV   +
Sbjct: 115 IN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQ 171

Query: 476 KATQASDVFSFGVLLLELLTGKSPIHA 502
                 D +  G +L E+L G  P + 
Sbjct: 172 PYDNTVDWWCLGAVLYEMLYGLPPFYC 198

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 56.3 bits (136), Expect = 1e-08
 Identities = 50/207 (24%), Positives = 97/207 (46%), Gaps = 19/207 (9%)

Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKR--EFEQQMEIVGGIRHENVVALRAYYY 365
           LG G FG  YKA  ++       ++ ++   +   +F  +++I+   +H N+V L   Y+
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF 72

Query: 366 SKDEKLMVYDYFEPGSV-SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKL 424
            +++  ++ ++ + G++ S ML   RG  +  + +  R  +       +  +H+    K+
Sbjct: 73  YENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQML-----EALNFLHSH---KV 124

Query: 425 VHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEV--TDTRKAT- 478
           +H  +KA NI L   G V ++D G++A             G   + APEV   +T K   
Sbjct: 125 IHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNP 184

Query: 479 --QASDVFSFGVLLLELLTGKSPIHAT 503
               +D++S G+ L+EL   + P H  
Sbjct: 185 YDYKADIWSLGITLIELAQMEPPHHEL 211

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 56.6 bits (137), Expect = 1e-08
 Identities = 54/224 (24%), Positives = 89/224 (39%), Gaps = 33/224 (14%)

Query: 307 VLGKGTFGTAYKAALEDASTV-VVKRLKE-----------VNVGKREFEQQMEIVGGIRH 354
           VLGKG+FG    A L+    +  VK LK+               KR            +H
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG------KH 55

Query: 355 ENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIA 414
             +  L + + +KD    V +Y   G +  M H +R       D       A     G+ 
Sbjct: 56  PFLTQLHSCFQTKDRLFFVMEYVNGGDL--MFHIQR---SGRFDEPRARFYAAEIVLGLQ 110

Query: 415 HIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAA-----GYRAP 469
            +H      +++  +K  N+ L+S+GH+ ++D G+      +      +       Y AP
Sbjct: 111 FLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYIAP 165

Query: 470 EVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVR 513
           E+   +    A D ++ GVLL E+L G+SP      DE+   + 
Sbjct: 166 EILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL 209

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 56.4 bits (137), Expect = 1e-08
 Identities = 31/96 (32%), Positives = 50/96 (52%), Gaps = 12/96 (12%)

Query: 411 RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAA------ 464
           + + +IH+   G ++H  +K SNI LNS   V ++D GLA  +S +              
Sbjct: 118 KALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVA 174

Query: 465 --GYRAPEV-TDTRKATQASDVFSFGVLLLELLTGK 497
              YRAPE+   + + T+  D++S G +L E+L GK
Sbjct: 175 TRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 56.3 bits (135), Expect = 1e-08
 Identities = 44/199 (22%), Positives = 91/199 (45%), Gaps = 14/199 (7%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNVGKREFE-QQMEIVGGIRHENVVALRAY 363
           E +G+G  GT Y A  +     V ++++      K+E    ++ ++   ++ N+V     
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 364 YYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGK 423
           Y   DE  +V +Y   GS++ ++       ++ +D      +     + +  +H+    +
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLHSN---Q 136

Query: 424 LVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTDTRKATQA 480
           ++H  IK+ NI L   G V ++D G  A ++P         G   + APEV   +     
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196

Query: 481 SDVFSFGVLLLELLTGKSP 499
            D++S G++ +E++ G+ P
Sbjct: 197 VDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 56.3 bits (135), Expect = 1e-08
 Identities = 45/199 (22%), Positives = 91/199 (45%), Gaps = 14/199 (7%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNVGKREFE-QQMEIVGGIRHENVVALRAY 363
           E +G+G  GT Y A  +     V +K++      K+E    ++ ++   ++ N+V     
Sbjct: 25  EKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 84

Query: 364 YYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGK 423
           Y   DE  +V +Y   GS++ ++       ++ +D      +     + +  +H+    +
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALDFLHSN---Q 135

Query: 424 LVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTDTRKATQA 480
           ++H  IK+ NI L   G V ++D G  A ++P         G   + APEV   +     
Sbjct: 136 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 195

Query: 481 SDVFSFGVLLLELLTGKSP 499
            D++S G++ +E++ G+ P
Sbjct: 196 VDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 34/193 (17%), Positives = 82/193 (42%), Gaps = 18/193 (9%)

Query: 317 YKAALEDASTVVVKRLKEVNVGK----REFEQQMEIVGGIRHENVVALRAYYYSKDEKL- 371
           YK    +   V+++  K+ + G        E +++ +  I   N++ +  +     + L 
Sbjct: 37  YKGIFNNKE-VIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95

Query: 372 ---MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGG 428
              ++ +Y   G +  +L   +      L + T++ +AI   +G+ +++        +  
Sbjct: 96  RLSLILEYCTRGYLREVLDKEK-----DLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKN 148

Query: 429 IKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEV-TDT-RKATQASDVFSF 486
           + + +  +     + +   GL  ++S  P   +    Y + ++  D   + T   D++S 
Sbjct: 149 LTSVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSL 208

Query: 487 GVLLLELLTGKSP 499
           GV+L E+ TGK P
Sbjct: 209 GVVLWEIFTGKIP 221

Length = 283

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 56.2 bits (135), Expect = 2e-08
 Identities = 57/216 (26%), Positives = 93/216 (43%), Gaps = 26/216 (12%)

Query: 306 EVLGKGTFGTAY---KAALEDASTV-VVKRLKEVNVGKR-----EFEQQMEIVGGIRHEN 356
           +VLG G +G  +   K +  D+  +  +K LK+  + ++         + +++  IR   
Sbjct: 6   KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65

Query: 357 VVALRAYYYSKDEKL-MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGA-ARGIA 414
            +    Y +  D KL ++ DY   G +   L  R    +        V+I  G     + 
Sbjct: 66  FLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQ------EVQIYSGEIVLALE 119

Query: 415 HIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAA-LMSPMPPPAMRAAG---YRAPE 470
           H+H      +++  IK  NI L+S GHV ++D GL+          A    G   Y AP+
Sbjct: 120 HLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPD 176

Query: 471 VTDTRKA--TQASDVFSFGVLLLELLTGKSPIHATG 504
           +         +A D +S GVL+ ELLTG SP    G
Sbjct: 177 IVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDG 212

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 60/255 (23%), Positives = 105/255 (41%), Gaps = 37/255 (14%)

Query: 306 EVLGKGTFGTAYKAAL------EDASTVVVKRLKEVNVG--KREFEQQMEIVGGIRHENV 357
           E LG+  FG  YK  L      E    V +K LK+   G  + EF+ +  +   ++H N+
Sbjct: 11  EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNI 70

Query: 358 VALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQ-SSLDWDTRVRIAIGAARGIAHI 416
           V L      +    M++ Y     +   L  R       S D D  V+  +  A    HI
Sbjct: 71  VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPA-DFVHI 129

Query: 417 HTE--------NGGKLVHGGIKASNIFLNSQGHVCVSDIGL-----AALMSPMPPPAMRA 463
            T+        +   +VH  +   N+ +  + +V +SD+GL     AA    +   ++  
Sbjct: 130 VTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189

Query: 464 AGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVR--------- 513
             + +PE     K +  SD++S+GV+L E+ + G  P       +V+ ++R         
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPD 249

Query: 514 ----WVNSVVREEWT 524
               WV +++ E W 
Sbjct: 250 DCPAWVYTLMLECWN 264

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|219766 pfam08263, LRRNT_2, Leucine rich repeat N-terminal domain

 Score = 50.0 bits (120), Expect = 2e-08
 Identities = 17/40 (42%), Positives = 23/40 (57%), Gaps = 3/40 (7%)

Query: 27 EDKQALLDF---IHNIHNSRSLNWNESSSLCKSWTGVTCS 63
          +D+ ALL F   ++   +    +WN SSS   SWTGVTC 
Sbjct: 3  DDRDALLAFKSSLNGDPSGALSSWNPSSSDPCSWTGVTCD 42

Leucine Rich Repeats pfam00560 are short sequence motifs present in a number of proteins with diverse functions and cellular locations. Leucine Rich Repeats are often flanked by cysteine rich domains. This domain is often found at the N-terminus of tandem leucine rich repeats. Length = 42

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 72/299 (24%), Positives = 122/299 (40%), Gaps = 51/299 (17%)

Query: 308 LGKGTFGTAYKAAL--------EDASTVVVKRLKEVNVGK--REFEQQMEIVGGI-RHEN 356
           LG+G FG    A             + V VK LK     K   +   +ME++  I +H+N
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 357 VVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEG-----------QSSLDWDTRVRI 405
           ++ L           ++ +Y   G++   L  RR  G           +  L +   V  
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 406 AIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG 465
           A   ARG+ ++ ++   K +H  + A N+ +     + ++D GLA  +  +        G
Sbjct: 146 AYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 202

Query: 466 -----YRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVV 519
                + APE    R  T  SDV+SFGVLL E+ T G SP      +E+  L++  + + 
Sbjct: 203 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMD 262

Query: 520 REEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKA 578
           +                N   E+  M++    C   +P +RP      ++VED+ R+ A
Sbjct: 263 KPS--------------NCTNELYMMMR---DCWHAVPSQRPTFK---QLVEDLDRILA 301

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 55.1 bits (132), Expect = 2e-08
 Identities = 50/218 (22%), Positives = 93/218 (42%), Gaps = 36/218 (16%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNVGKREFEQQMEIVGGI-RHENVVALRAY 363
           E++G GT+G  YK   ++      +K +      + E +Q++ ++     H N+      
Sbjct: 12  ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGA 71

Query: 364 YYSK------DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIH 417
           +  K      D+  +V ++   GSV+ ++   +G   ++L  +    I     RG++H+H
Sbjct: 72  FIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG---NTLKEEWIAYICREILRGLSHLH 128

Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR---------- 467
                K++H  IK  N+ L     V + D G++A +        R  G R          
Sbjct: 129 QH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD-------RTVGRRNTFIGTPYWM 178

Query: 468 APEVTDTRKATQA-----SDVFSFGVLLLELLTGKSPI 500
           APEV    +   A     SD++S G+  +E+  G  P+
Sbjct: 179 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 55.4 bits (133), Expect = 3e-08
 Identities = 72/296 (24%), Positives = 114/296 (38%), Gaps = 60/296 (20%)

Query: 306 EVLGKGTFGTAYKAALEDAST-----VVVKRLKEVNVGK--REFEQQMEIVGGIRHENVV 358
           +VLG G FGT YK             V +K L+E    K  +E   +  ++  + + +V 
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72

Query: 359 ALRAYYYSKD----EKLMVY----DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAA 410
            L     +       +LM +    DY          H      Q  L+W  ++      A
Sbjct: 73  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQYLLNWCVQI------A 119

Query: 411 RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAP- 469
           +G+ ++      +LVH  + A N+ + +  HV ++D GLA L+         A G + P 
Sbjct: 120 KGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA-DEKEYHAEGGKVPI 175

Query: 470 -----EVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEW 523
                E    R  T  SDV+S+GV + EL+T G  P       E+  ++           
Sbjct: 176 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---------- 225

Query: 524 TAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPK----MADVLKMVEDIRR 575
                  E L  P I    V M+ V   C +   + RPK    + +  KM  D +R
Sbjct: 226 -----KGERLPQPPICTIDVYMIMV--KCWMIDADSRPKFRELIIEFSKMARDPQR 274

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 54.6 bits (132), Expect = 4e-08
 Identities = 60/218 (27%), Positives = 103/218 (47%), Gaps = 38/218 (17%)

Query: 308 LGKGTFGTAY---KAALEDASTVVVKRLKEVNV-GKREFEQQM---EIVGGIRHENVVAL 360
           + KG +G  +   K +  D     +K +K+ ++  K + +Q +   +I+   +   VV L
Sbjct: 1   ISKGAYGRVFLAKKKSTGD--IYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL 58

Query: 361 RAYYYS--KDEKL-MVYDYFEPGSVSAMLHGRRGEGQSSLDWD-TRVRIA-IGAARGIAH 415
              YYS    + L +V +Y   G ++++L      G  SLD D  R+ IA I  A  + +
Sbjct: 59  ---YYSFQGKKNLYLVMEYLPGGDLASLLEN---VG--SLDEDVARIYIAEIVLA--LEY 108

Query: 416 IHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAAL--------MSPMPPPAMRAAG-- 465
           +H  NG  ++H  +K  NI ++S GH+ ++D GL+ +        ++       R  G  
Sbjct: 109 LH-SNG--IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTP 165

Query: 466 -YRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHA 502
            Y APEV   +  ++  D +S G +L E L G  P H 
Sbjct: 166 DYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHG 203

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 55.2 bits (133), Expect = 4e-08
 Identities = 49/196 (25%), Positives = 89/196 (45%), Gaps = 16/196 (8%)

Query: 308 LGKGTFGTAYKAA-LEDASTVVVKRL----KEVNVGKREFEQQMEIVGGIRHENVVALRA 362
           +G G FG    A        V +K++        + KR + ++++++  +RHEN+++L  
Sbjct: 18  VGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTY-RELKLLKHLRHENIISLSD 76

Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGG 422
            + S  E +          +  +L  R  E Q    +  ++       RG+ ++H+    
Sbjct: 77  IFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQYFLYQI------LRGLKYVHSAG-- 128

Query: 423 KLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDT-RKATQAS 481
            +VH  +K SNI +N    + + D GLA +  P     +    YRAPE+  T +K     
Sbjct: 129 -VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRYYRAPEIMLTWQKYDVEV 187

Query: 482 DVFSFGVLLLELLTGK 497
           D++S G +  E+L GK
Sbjct: 188 DIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 55.0 bits (133), Expect = 4e-08
 Identities = 55/223 (24%), Positives = 99/223 (44%), Gaps = 44/223 (19%)

Query: 309 GKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFE-------QQMEIVGGIRHENVVALR 361
           G+GT+G  YKA  ++        +K+    K ++        +++ ++  ++HENVV+L 
Sbjct: 9   GRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLV 68

Query: 362 AYYYSKDEKL--MVYDYFEPGSVSAMLHGRRGEGQS-------SLDWDTRVRIAIGAARG 412
             +    +K   +++DY E      +   R+ +  S       SL W            G
Sbjct: 69  EVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQI--------LNG 120

Query: 413 IAHIHTENGGKLVHGGIKASNIFLNS----QGHVCVSDIGLAALM-SPMPPPAMRAAG-- 465
           + ++H  N   ++H  +K +NI +      +G V + D+GLA L  +P+ P A       
Sbjct: 121 VHYLH-SNW--VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA---DLDP 174

Query: 466 ------YRAPEVT-DTRKATQASDVFSFGVLLLELLTGKSPIH 501
                 YRAPE+    R  T+A D+++ G +  ELLT +    
Sbjct: 175 VVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFK 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 54.6 bits (131), Expect = 4e-08
 Identities = 61/285 (21%), Positives = 122/285 (42%), Gaps = 28/285 (9%)

Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFE-----QQMEIVGGIRHENVVALRA 362
           LG+GT+ T YK   +    +V   LKE+ +   E       +++ ++  ++H N+V L  
Sbjct: 14  LGEGTYATVYKGRSKLTDNLVA--LKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGG 422
             +++    +V++Y +       L     +  +S++            RG+ + H     
Sbjct: 72  IIHTEKSLTLVFEYLDKD-----LKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR--- 123

Query: 423 KLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMR----AAGYRAPEVT--DTRK 476
           K++H  +K  N+ +N +G + ++D GLA   S +P            YR P++    T  
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKS-IPTKTYSNEVVTLWYRPPDILLGSTDY 182

Query: 477 ATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLV-RWVNSVVREEWTAEVFDVELLRY 535
           +TQ  D++  G +  E+ TG+     +  +E +H + R + +   E W   + + E   Y
Sbjct: 183 STQI-DMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSY 241

Query: 536 PNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAEN 580
            N  +   + L        R+  +  ++   L   E  +R+ AE 
Sbjct: 242 -NYPKYRADCLHNHAP---RLDSDGAELLSKLLQFEGRKRISAEE 282

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 54.7 bits (131), Expect = 5e-08
 Identities = 40/177 (22%), Positives = 85/177 (48%), Gaps = 13/177 (7%)

Query: 327 VVVKRLKEVNVGKREFE-QQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAM 385
           V VK +      +RE    ++ I+   +H+NVV +   Y   +E  ++ ++ + G+++ +
Sbjct: 49  VAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDI 108

Query: 386 LHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVS 445
           +       Q+ L+ +    +     + + ++H++    ++H  IK+ +I L   G V +S
Sbjct: 109 V------SQTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLS 159

Query: 446 DIGLAALMSPMPPPAMRAAG---YRAPEVTDTRKATQASDVFSFGVLLLELLTGKSP 499
           D G  A +S   P      G   + APEV          D++S G++++E++ G+ P
Sbjct: 160 DFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 54.9 bits (132), Expect = 5e-08
 Identities = 44/173 (25%), Positives = 77/173 (44%), Gaps = 20/173 (11%)

Query: 352 IRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAAR 411
           + H +V+ ++    S     MV  ++     S+ L+    +    L  D  + I      
Sbjct: 114 VNHPSVIRMKDTLVSGAITCMVLPHY-----SSDLYTYLTKRSRPLPIDQALIIEKQILE 168

Query: 412 GIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRA 468
           G+ ++H     +++H  +K  NIF+N    VC+ D+G AA    + P  +  AG     A
Sbjct: 169 GLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLG-AAQFPVVAPAFLGLAGTVETNA 224

Query: 469 PEVTDTRKATQASDVFSFGVLLLELLTGKSPI---HATGGDEVV-----HLVR 513
           PEV    K    +D++S G++L E+L   S I     +  +E V     HL++
Sbjct: 225 PEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLK 277

Length = 357

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 54.8 bits (133), Expect = 5e-08
 Identities = 55/215 (25%), Positives = 94/215 (43%), Gaps = 41/215 (19%)

Query: 307 VLGKGTFGTAYKAALEDAST---VVVKRLKEVNV------GKREFEQQMEIVGGIRHENV 357
            +G G +G    A   D  T   V +K++   NV       KR   ++++++  +RHEN+
Sbjct: 7   PIGSGAYGVVCSA--VDKRTGRKVAIKKI--SNVFDDLIDAKRIL-REIKLLRHLRHENI 61

Query: 358 VALRAYYYSKD----EKL-MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVR-IAIGAAR 411
           + L              + +V +  E       LH +  +    L  D  ++       R
Sbjct: 62  IGLLDILRPPSPEDFNDVYIVTELME-----TDLH-KVIKSPQPLT-DDHIQYFLYQILR 114

Query: 412 GIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP--------AMRA 463
           G+ ++H+ N   ++H  +K SNI +NS   + + D GLA  + P              R 
Sbjct: 115 GLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRW 171

Query: 464 AGYRAPEV-TDTRKATQASDVFSFGVLLLELLTGK 497
             YRAPE+   + + T+A D++S G +  ELLT K
Sbjct: 172 --YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 54.3 bits (130), Expect = 6e-08
 Identities = 76/295 (25%), Positives = 118/295 (40%), Gaps = 60/295 (20%)

Query: 307 VLGKGTFGTAYKAA-LEDAST----VVVKRLKEVNVGK--REFEQQMEIVGGIRHENVVA 359
           VLG G FGT YK   + D       V +K L+E    K  +E   +  ++ G+    V  
Sbjct: 14  VLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCR 73

Query: 360 LRAYYYSKD----EKLMVY----DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAAR 411
           L     +       +LM Y    DY          +  R   Q  L+W  ++      A+
Sbjct: 74  LLGICLTSTVQLVTQLMPYGCLLDYVRE-------NKDRIGSQDLLNWCVQI------AK 120

Query: 412 GIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAP-- 469
           G++++      +LVH  + A N+ + S  HV ++D GLA L+  +      A G + P  
Sbjct: 121 GMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLD-IDETEYHADGGKVPIK 176

Query: 470 ----EVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWT 524
               E    R+ T  SDV+S+GV + EL+T G  P       E+  L+            
Sbjct: 177 WMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLE----------- 225

Query: 525 AEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVL----KMVEDIRR 575
                 E L  P I    V M+ V   C +   E RP+  +++    +M  D  R
Sbjct: 226 ----KGERLPQPPICTIDVYMIMV--KCWMIDSECRPRFRELVDEFSRMARDPSR 274

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 54.8 bits (132), Expect = 6e-08
 Identities = 44/169 (26%), Positives = 79/169 (46%), Gaps = 20/169 (11%)

Query: 339 KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLD 398
           +R+  +++EI+  + H NVV     +    E  ++ ++ + GS    L G     +  L 
Sbjct: 116 RRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS----LEGTHIADEQFL- 170

Query: 399 WDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP 458
                 +A     GIA++H      +VH  IK SN+ +NS  +V ++D G++ +++    
Sbjct: 171 ----ADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223

Query: 459 PAMRAAG---YRAPEVTDT-----RKATQASDVFSFGVLLLELLTGKSP 499
           P   + G   Y +PE  +T          A D++S GV +LE   G+ P
Sbjct: 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272

Length = 353

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 54.2 bits (130), Expect = 6e-08
 Identities = 53/222 (23%), Positives = 96/222 (43%), Gaps = 25/222 (11%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTV---VVKRLKEVNVGKREFEQ---QMEIVGGIRHENVV 358
           ++LG G FGT +K   + +  ++   V  +  +   G++ F++    M  +G + H  +V
Sbjct: 13  KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72

Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRG--EGQSSLDWDTRVRIAIGAARGIAHI 416
            L         +L V      GS+   +   R   + Q  L+W  ++      A+G+ ++
Sbjct: 73  RLLGICPGASLQL-VTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQI------AKGMYYL 125

Query: 417 HTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP-----MPPPAMRAAGYRAPEV 471
                 ++VH  + A NI L S   V ++D G+A L+ P               + A E 
Sbjct: 126 EEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALES 182

Query: 472 TDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLV 512
               + T  SDV+S+GV + E+++ G  P       EV  L+
Sbjct: 183 ILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL 224

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 53.8 bits (130), Expect = 1e-07
 Identities = 33/99 (33%), Positives = 53/99 (53%), Gaps = 15/99 (15%)

Query: 411 RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP--------AMR 462
           RG+ +IH+ N   ++H  +K SN+ LN+   + + D GLA +  P            A R
Sbjct: 117 RGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173

Query: 463 AAGYRAPEVTDTRKA-TQASDVFSFGVLLLELLTGKSPI 500
              YRAPE+    K  T+A D++S G +L E+L+ + P+
Sbjct: 174 --WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR-PL 209

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 50/202 (24%), Positives = 98/202 (48%), Gaps = 20/202 (9%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQ----QMEIVGGIRHENVVALR 361
           E +G+G  GT Y A   D +T     +K++N+ ++  ++    ++ ++   +H N+V   
Sbjct: 25  EKIGQGASGTVYTAI--DVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYL 82

Query: 362 AYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENG 421
             Y   DE  +V +Y   GS++ ++       ++ +D      +     + +  +H+   
Sbjct: 83  DSYLVGDELWVVMEYLAGGSLTDVV------TETCMDEGQIAAVCRECLQALEFLHSN-- 134

Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTDTRKAT 478
            +++H  IK+ NI L   G V ++D G  A ++P         G   + APEV  TRKA 
Sbjct: 135 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV-TRKAY 192

Query: 479 QAS-DVFSFGVLLLELLTGKSP 499
               D++S G++ +E++ G+ P
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 53.1 bits (127), Expect = 1e-07
 Identities = 49/210 (23%), Positives = 90/210 (42%), Gaps = 23/210 (10%)

Query: 305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKRE-------FEQQMEIVGGIRHENV 357
            ++LG+G FG  Y     D    +  +  + +    E        E +++++  ++HE +
Sbjct: 7   GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66

Query: 358 VALRAYYYSKDEKLMV--YDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAH 415
           V        + EK +    +Y   GSV   L       +S     TR  +      G+++
Sbjct: 67  VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQIL-----EGMSY 121

Query: 416 IHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP--MPPPAMRAAG----YRAP 469
           +H      +VH  IK +NI  +S G+V + D G +  +    M    +R+      + +P
Sbjct: 122 LH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP 178

Query: 470 EVTDTRKATQASDVFSFGVLLLELLTGKSP 499
           EV       + +DV+S G  ++E+LT K P
Sbjct: 179 EVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 53.6 bits (129), Expect = 1e-07
 Identities = 56/206 (27%), Positives = 90/206 (43%), Gaps = 19/206 (9%)

Query: 307 VLGKGTFGTAYKAA-LEDASTVVVKRL-KEVNVGKREFEQQME----IVGGIRHENVVAL 360
           V+GKG+FG    A    D     VK L K+  + K+E +  M     ++  ++H  +V L
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRI-AIGAARGIAHIHTE 419
              + + D+   V DY   G +   L   R   +       R R  A   A  + ++H+ 
Sbjct: 62  HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEP------RARFYAAEIASALGYLHSL 115

Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTDTRK 476
           N   +++  +K  NI L+SQGHV ++D GL               G   Y APEV   + 
Sbjct: 116 N---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQP 172

Query: 477 ATQASDVFSFGVLLLELLTGKSPIHA 502
             +  D +  G +L E+L G  P ++
Sbjct: 173 YDRTVDWWCLGAVLYEMLYGLPPFYS 198

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 38/214 (17%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKR--LKEVNVGKREFE-QQMEIVGGIRHENVVALR 361
           E +G+GT+GT +KA   E    V +KR  L + + G      +++ ++  ++H+N+V L 
Sbjct: 6   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLY 65

Query: 362 AYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENG 421
              +S  +  +V++Y +   +        G+    +D +          +G+A  H+ N 
Sbjct: 66  DVLHSDKKLTLVFEYCDQ-DLKKYFDSCNGD----IDPEIVKSFMFQLLKGLAFCHSHN- 119

Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG--------------YR 467
             ++H  +K  N+ +N  G + ++D GLA           RA G              YR
Sbjct: 120 --VLHRDLKPQNLLINKNGELKLADFGLA-----------RAFGIPVRCYSAEVVTLWYR 166

Query: 468 APEVTDTRKATQAS-DVFSFGVLLLELLTGKSPI 500
            P+V    K    S D++S G +  EL     P+
Sbjct: 167 PPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 53.4 bits (128), Expect = 1e-07
 Identities = 64/262 (24%), Positives = 114/262 (43%), Gaps = 36/262 (13%)

Query: 308 LGKGTFGTAYKAALEDASTV-VVKRLKEVN-VGKREFEQQME---IVGGIRHENVVALRA 362
           +GKG+FG   +    D   +  +K +++ + V + E    +    ++  +    +V L+ 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60

Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAAR-GIAHIHTENG 421
            + S ++  +V  +   G    + H  + EG+  L   +R R         + ++H  N 
Sbjct: 61  SFQSPEKLYLVLAFINGGE---LFHHLQREGRFDL---SRARFYTAELLCALENLHKFN- 113

Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTDTRKAT 478
             +++  +K  NI L+ QGH+ + D GL  L            G   Y APE+      T
Sbjct: 114 --VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYT 171

Query: 479 QASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI 538
           +A D ++ GVLL E+LTG  P +    DE       VN + R+         E LR+P+ 
Sbjct: 172 KAVDWWTLGVLLYEMLTGLPPFY----DEN------VNEMYRKILQ------EPLRFPDG 215

Query: 539 EEEMVEMLQVGMACVVRMPEER 560
            +   + L +G+  + R P  R
Sbjct: 216 FDRDAKDLLIGL--LSRDPTRR 235

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 53.2 bits (128), Expect = 2e-07
 Identities = 47/202 (23%), Positives = 87/202 (43%), Gaps = 32/202 (15%)

Query: 404 RIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAA-LMSPMPPPAMR 462
           +I+I   RG+ ++  ++  K++H  +K SNI +NS+G + + D G++  L+  M    + 
Sbjct: 103 KISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG 160

Query: 463 AAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHA-------------TGGDEVV 509
              Y +PE       T  SD++S G+ L+E+  G+ PI                   E  
Sbjct: 161 TRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAK 220

Query: 510 HLVRWVNSVVREEWTAEVFDVELLRY---------PN--IEEEMVEMLQVGMACVVRMPE 558
              R V+    +     +   ELL Y         P+    +E  + +     C+ + P+
Sbjct: 221 ESHRPVSGHPPDS-PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVD---KCLKKNPK 276

Query: 559 ERPKMADVLKMVEDIRRVKAEN 580
           ER  + ++ K    I+R + E 
Sbjct: 277 ERADLKELTKHPF-IKRAELEE 297

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 23/207 (11%)

Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQM---EIVGGIRHENVVALRAYY 364
           LG G FG  YKA  ++   +   ++ E    + E E  M   EI+    H  +V L   +
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYMVEIEILATCNHPYIVKLLGAF 78

Query: 365 YSKDEKLMVYDYFEPGSV--SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGG 422
           Y  D KL +   F PG    + ML   RG  +  +    R  +       + ++H+    
Sbjct: 79  YW-DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQML-----EALQYLHSM--- 129

Query: 423 KLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVT--DTRKA 477
           K++H  +KA N+ L   G + ++D G++A             G   + APEV   +T K 
Sbjct: 130 KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189

Query: 478 TQ---ASDVFSFGVLLLELLTGKSPIH 501
           T     +D++S G+ L+E+   + P H
Sbjct: 190 TPYDYKADIWSLGITLIEMAQIEPPHH 216

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 52.5 bits (126), Expect = 2e-07
 Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 41/215 (19%)

Query: 308 LGKGTFGTAYKAALEDAST---VVVKRL----------KEVNVGKREFEQQMEIVGGIRH 354
           LG+G FG  Y     D  T   + VK++          KEVN      E +++++  ++H
Sbjct: 10  LGQGAFGRVY--LCYDVDTGRELAVKQVPFDPDSPETKKEVN----ALECEIQLLKNLQH 63

Query: 355 ENVVALRAYYY---SKDEKLMVY-DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAA 410
           E +V     YY     DE L ++ +Y   GSV   L       ++     TR  +     
Sbjct: 64  ERIVQ----YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQIL----- 114

Query: 411 RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP--MPPPAMRAAG--- 465
            G+ ++H+     +VH  IK +NI  +S G+V + D G +  +         M++     
Sbjct: 115 EGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTP 171

Query: 466 -YRAPEVTDTRKATQASDVFSFGVLLLELLTGKSP 499
            + +PEV       + +DV+S G  ++E+LT K P
Sbjct: 172 YWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPP 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 57/224 (25%), Positives = 99/224 (44%), Gaps = 33/224 (14%)

Query: 306 EVLGKGTFGTAY----KAALEDASTVVVKRLKEVNVGKREFEQQM---EIVGGIRHENVV 358
           ++LGKGTFG       KA     +  ++K  KEV V K E    +    ++   RH  + 
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILK--KEVIVAKDEVAHTLTENRVLQNSRHPFLT 58

Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGA--ARGIAHI 416
           AL+  + + D    V +Y   G +    H  R    S    + R R   GA     + ++
Sbjct: 59  ALKYSFQTHDRLCFVMEYANGGEL--FFHLSRERVFS----EDRARF-YGAEIVSALDYL 111

Query: 417 HTENGGKLVHGGIKASNIFLNSQGHVCVSDIGL--------AALMSPMPPPAMRAAGYRA 468
           H+E    +V+  +K  N+ L+  GH+ ++D GL        A + +    P      Y A
Sbjct: 112 HSEK--NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPE-----YLA 164

Query: 469 PEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLV 512
           PEV +     +A D +  GV++ E++ G+ P +    +++  L+
Sbjct: 165 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 208

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 52.2 bits (125), Expect = 3e-07
 Identities = 73/300 (24%), Positives = 122/300 (40%), Gaps = 62/300 (20%)

Query: 308 LGKGTFGTAYKAAL--------EDASTVVVKRLKEVNVGKR--EFEQQMEIVGGIRHENV 357
           LG+G FG   K  L             V VK LK  + G    + ++++EI+  + HEN+
Sbjct: 12  LGEGHFG---KVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 68

Query: 358 VALRAYYYSKDEK--LMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAH 415
           V  +            ++ ++   GS+   L       ++ ++   +++ A+   +G+ +
Sbjct: 69  VKYKGICTEDGGNGIKLIMEFLPSGSLKEYL----PRNKNKINLKQQLKYAVQICKGMDY 124

Query: 416 IHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLA----------ALMSPMPPPAMRAAG 465
           + +      VH  + A N+ + S+  V + D GL            +   +  P      
Sbjct: 125 LGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVF---- 177

Query: 466 YRAPEVTDTRKATQASDVFSFGVLLLELLT----GKSP-------IHATGGD-EVVHLVR 513
           + APE     K   ASDV+SFGV L ELLT      SP       I  T G   V  LVR
Sbjct: 178 WYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR 237

Query: 514 WVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
               V+ E          L R PN  EE+ ++++    C    P +R    ++++  E I
Sbjct: 238 ----VLEEG-------KRLPRPPNCPEEVYQLMR---KCWEFQPSKRTTFQNLIEGFEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 52.9 bits (127), Expect = 3e-07
 Identities = 33/103 (32%), Positives = 55/103 (53%), Gaps = 8/103 (7%)

Query: 413 IAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMR-----AAGYR 467
           + H+H+++   ++H  IK++NI L S G V + D G + + +      +         Y 
Sbjct: 156 VHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 468 APEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVH 510
           APE+   +  ++ +D+FS GVLL ELLT K P      +EV+H
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMH 255

Length = 496

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 55/223 (24%), Positives = 100/223 (44%), Gaps = 49/223 (21%)

Query: 305 AEVLGKGTFGTAYKAALEDAST---VVVKRL----------KEVNVGKREFEQQMEIVGG 351
            ++LG+G FG  Y     DA T   + VK++          KEVN      E +++++  
Sbjct: 7   GKLLGRGAFGEVYLCY--DADTGRELAVKQVPFDPDSQETSKEVNA----LECEIQLLKN 60

Query: 352 IRHENVVALRAYYYS-----KDEKLMVYDYFEPG-SVSAMLHGRRGEGQSSLDWDTRVRI 405
           +RH+ +V     YY      +++KL ++  + PG S+   L     +   +L  +   R 
Sbjct: 61  LRHDRIVQ----YYGCLRDPEEKKLSIFVEYMPGGSIKDQL-----KAYGALTENVTRRY 111

Query: 406 AIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG 465
                +G++++H      +VH  IK +NI  +S G+V + D G +  +  +    M   G
Sbjct: 112 TRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI---CMSGTG 165

Query: 466 ---------YRAPEVTDTRKATQASDVFSFGVLLLELLTGKSP 499
                    + +PEV       + +DV+S    ++E+LT K P
Sbjct: 166 IKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 52.2 bits (125), Expect = 3e-07
 Identities = 56/205 (27%), Positives = 93/205 (45%), Gaps = 24/205 (11%)

Query: 306 EVLGKGTFGTA----YKAALEDASTVV-VKRLKEVNVGKRE--FEQQMEIVGGIRHENVV 358
            VLG+G FG      Y  A +    +V VK LK     +    +++++ I+  + HEN+V
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 359 ALRAYYYSKDEK--LMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHI 416
             +     +  K   ++ +Y   GS+   L       +  L+    +  A     G+A++
Sbjct: 70  KYKGCCSEQGGKGLQLIMEYVPLGSLRDYL------PKHKLNLAQLLLFAQQICEGMAYL 123

Query: 417 HTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLA-ALMSPMPPPAMRAAG-----YRAPE 470
           H++     +H  + A N+ L++   V + D GLA A+        +R  G     + A E
Sbjct: 124 HSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVE 180

Query: 471 VTDTRKATQASDVFSFGVLLLELLT 495
                K + ASDV+SFGV L ELLT
Sbjct: 181 CLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 24/207 (11%)

Query: 306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG--KREFEQQMEIVGGIRHENVVALRA 362
           E +G+G FG  +   L  D + V VK  +E      K +F Q+  I+    H N+V L  
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60

Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGG 422
               K    +V +  + G     L   R EG   L     +++   AA G+ ++ +++  
Sbjct: 61  VCTQKQPIYIVMELVQGGDFLTFL---RTEG-PRLKVKELIQMVENAAAGMEYLESKH-- 114

Query: 423 KLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---------YRAPEVTD 473
             +H  + A N  +  +  + +SD G    MS      + A+          + APE  +
Sbjct: 115 -CIHRDLAARNCLVTEKNVLKISDFG----MSREEEDGVYASTGGMKQIPVKWTAPEALN 169

Query: 474 TRKATQASDVFSFGVLLLELLT-GKSP 499
             + +  SDV+SFG+LL E  + G  P
Sbjct: 170 YGRYSSESDVWSFGILLWEAFSLGAVP 196

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 51.4 bits (123), Expect = 4e-07
 Identities = 39/147 (26%), Positives = 65/147 (44%), Gaps = 16/147 (10%)

Query: 356 NVVALRAYYYSKDEKLMVYDYFEPGS----VSAMLHGRRGEGQSSLDWDTRVRIAIGAAR 411
           N+V L  Y  S+D   +V  + E G     +S  L+      +    W   + +A+ A  
Sbjct: 46  NMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKR---WAAEMVVALDA-- 100

Query: 412 GIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEV 471
               +H E    +V   +  +NI L+ +GH+ ++     + +            Y APEV
Sbjct: 101 ----LHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAPEV 153

Query: 472 TDTRKATQASDVFSFGVLLLELLTGKS 498
               + T+A D +S G +L ELLTGK+
Sbjct: 154 GGISEETEACDWWSLGAILFELLTGKT 180

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 51.8 bits (124), Expect = 4e-07
 Identities = 46/205 (22%), Positives = 86/205 (41%), Gaps = 12/205 (5%)

Query: 308 LGKGTFGTAYKAALEDASTV-VVKRLKEVNVGKRE-FEQQM---EIVGGIRHENVVALRA 362
           LGKG FG      +     +   K+L +  + KR+ +E  M    I+  +    +V+L  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60

Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGG 422
            + +K +  +V      G +   ++    E                   G+ H+H     
Sbjct: 61  AFQTKTDLCLVMTIMNGGDLRYHIYNV-DEENPGFPEPRACFYTAQIISGLEHLHQR--- 116

Query: 423 KLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTDTRKATQ 479
           ++++  +K  N+ L++ G+V +SD+GLA  +          AG   + APE+    +   
Sbjct: 117 RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDF 176

Query: 480 ASDVFSFGVLLLELLTGKSPIHATG 504
           + D F+ GV L E++  + P  A G
Sbjct: 177 SVDYFALGVTLYEMIAARGPFRARG 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 51.2 bits (122), Expect = 6e-07
 Identities = 48/205 (23%), Positives = 93/205 (45%), Gaps = 19/205 (9%)

Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQM---EIVGGIRHENVVALRAYY 364
           LG G FG  YKA  ++   +   ++ +    + E E  M   +I+    H N+V L   +
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 365 YSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKL 424
           Y ++   ++ ++   G+V A++     E +  L   T  +I +   + +  ++  +  K+
Sbjct: 72  YYENNLWILIEFCAGGAVDAVML----ELERPL---TEPQIRVVCKQTLEALNYLHENKI 124

Query: 425 VHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEV-----TDTRK 476
           +H  +KA NI     G + ++D G++A  +          G   + APEV     +  R 
Sbjct: 125 IHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184

Query: 477 ATQASDVFSFGVLLLELLTGKSPIH 501
               +DV+S G+ L+E+   + P H
Sbjct: 185 YDYKADVWSLGITLIEMAQIEPPHH 209

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 51.3 bits (123), Expect = 6e-07
 Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 33/214 (15%)

Query: 307 VLGKGTFG-----TAYKAALEDAS-TVVVKRLKEVNVGKREFEQQ--------MEIVGGI 352
            LG G FG     TAY  +  DA   V VK LK         E++        M  +G  
Sbjct: 42  TLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPT---AHSSEREALMSELKIMSHLG-- 96

Query: 353 RHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARG 412
            HEN+V L          L++ +Y   G +   L  +R   +S L  +  +  +   A+G
Sbjct: 97  NHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKG 153

Query: 413 IAHIHTENGGKLVHGGIKASNIFLNSQGHVC-VSDIGLAA-LMSP----MPPPAMRAAGY 466
           +A + ++N    +H  + A N+ L + G +  + D GLA  +M+     +   A     +
Sbjct: 154 MAFLASKN---CIHRDLAARNVLL-THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKW 209

Query: 467 RAPEVTDTRKATQASDVFSFGVLLLELLT-GKSP 499
            APE       T  SDV+S+G+LL E+ + G +P
Sbjct: 210 MAPESIFNCVYTFESDVWSYGILLWEIFSLGSNP 243

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 51.2 bits (122), Expect = 6e-07
 Identities = 58/225 (25%), Positives = 100/225 (44%), Gaps = 36/225 (16%)

Query: 306 EVLGKGTFGTAYKAAL--EDASTV--VVKRL-KEVNVGKREFEQQM---EIVGGIRHENV 357
           ++LGKGTFG   K  L  E A+     +K L KEV + K E    +    ++   RH  +
Sbjct: 1   KLLGKGTFG---KVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 57

Query: 358 VALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGA--ARGIAH 415
            AL+  + + D    V +Y   G +   L   R      +  + R R   GA     + +
Sbjct: 58  TALKYAFQTHDRLCFVMEYANGGELFFHLSRER------VFTEERARF-YGAEIVSALEY 110

Query: 416 IHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGL--------AALMSPMPPPAMRAAGYR 467
           +H+ +   +V+  IK  N+ L+  GH+ ++D GL        A + +    P      Y 
Sbjct: 111 LHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPE-----YL 162

Query: 468 APEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLV 512
           APEV +     +A D +  GV++ E++ G+ P +    + +  L+
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 207

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 51.2 bits (123), Expect = 7e-07
 Identities = 60/264 (22%), Positives = 102/264 (38%), Gaps = 56/264 (21%)

Query: 327 VVVKRLKE-VNVGKR-EFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSA 384
           V VK L+   +   R +F ++++I+  +   N+  L           M+ +Y E G ++ 
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108

Query: 385 MLHGRRGE------GQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNS 438
            L     E         SL + T + +A   A G+ ++ + N    VH  +   N  +  
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGK 165

Query: 439 QGHVCVSDIGLAALMS---------------PMPPPAMRAAGYRAPEVTDTRKATQASDV 483
              + ++D G    MS               P+P   M      A E     K T  SDV
Sbjct: 166 NYTIKIADFG----MSRNLYSSDYYRVQGRAPLPIRWM------AWESVLLGKFTTKSDV 215

Query: 484 FSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD-----VELLRYPN 537
           ++FGV L E+LT  +   +    D+          V+  E     F      + L R PN
Sbjct: 216 WAFGVTLWEILTLCREQPYEHLTDQ---------QVI--ENAGHFFRDDGRQIYLPRPPN 264

Query: 538 IEEEMVEMLQVGMACVVRMPEERP 561
             +++ E++   + C  R  E+RP
Sbjct: 265 CPKDIYELM---LECWRRDEEDRP 285

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 51.3 bits (123), Expect = 7e-07
 Identities = 37/108 (34%), Positives = 53/108 (49%), Gaps = 14/108 (12%)

Query: 411 RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAM------RAA 464
           R + +IHT N   + H  +K  NI  N+   + + D GLA +     P A+         
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170

Query: 465 GYRAPEVTDT--RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVH 510
            YRAPE+  +   K T A D++S G +  E+LTGK P+    G  VVH
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK-PLFP--GKNVVH 215

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 50.6 bits (122), Expect = 8e-07
 Identities = 49/208 (23%), Positives = 91/208 (43%), Gaps = 31/208 (14%)

Query: 306 EVLGKGTFGTAYKAALEDA-STVVVKRL-KEVNVGKREFEQQM---EIVGGIRHENVVAL 360
           + LG G+FG       + +     +K L K   V  ++ E  +    I+  IRH  +V  
Sbjct: 7   KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLV-- 64

Query: 361 RAYYYSKDEK--LMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIA-IGAARGIAHIH 417
             Y   +D+    +V +Y   G + + L   R  G+       R   A +  A  + ++H
Sbjct: 65  NLYGSFQDDSNLYLVMEYVPGGELFSHL---RKSGRFPEPV-ARFYAAQVVLA--LEYLH 118

Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRA------AGYRAPEV 471
           + +   +V+  +K  N+ L+S G++ ++D G A  +        R         Y APE+
Sbjct: 119 SLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKG------RTYTLCGTPEYLAPEI 169

Query: 472 TDTRKATQASDVFSFGVLLLELLTGKSP 499
             ++   +A D ++ G+L+ E+L G  P
Sbjct: 170 ILSKGYGKAVDWWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 50.8 bits (122), Expect = 8e-07
 Identities = 48/200 (24%), Positives = 91/200 (45%), Gaps = 22/200 (11%)

Query: 308 LGKGTFGTAYKAALEDASTVV-VKRLKEVN---VGKREFEQQMEIVGGIRHENVVALRAY 363
           +G+G++G  +K    +   +V +K+  E     V K+   +++ ++  ++H N+V L   
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEV 68

Query: 364 YYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGK 423
           +  K +  +V++Y +   ++ +    RG     +      +I     + +   H  N   
Sbjct: 69  FRRKRKLHLVFEYCDHTVLNELEKNPRG-----VPEHLIKKIIWQTLQAVNFCHKHN--- 120

Query: 424 LVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP-----AMRAAGYRAPE--VTDTRK 476
            +H  +K  NI +  QG + + D G A +++          A R   YRAPE  V DT+ 
Sbjct: 121 CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATR--WYRAPELLVGDTQY 178

Query: 477 ATQASDVFSFGVLLLELLTG 496
                DV++ G +  ELLTG
Sbjct: 179 GP-PVDVWAIGCVFAELLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 50.9 bits (122), Expect = 1e-06
 Identities = 42/165 (25%), Positives = 70/165 (42%), Gaps = 27/165 (16%)

Query: 411 RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRA----AGY 466
           RG+ ++H+     ++H  IK  N+ +NS   + + D GLA +  P     M        Y
Sbjct: 114 RGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170

Query: 467 RAPEV-TDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTA 525
           RAPE+   +R  T A D++S G +  ELL  +    A    + + L+             
Sbjct: 171 RAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLI------------- 217

Query: 526 EVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMV 570
                +LL  P++ E M    +   A ++R P  +P    VL  +
Sbjct: 218 ----TDLLGTPSL-EAMRSACEGARAHILRGP-HKPPSLPVLYTL 256

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 52/230 (22%), Positives = 106/230 (46%), Gaps = 24/230 (10%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFE-----QQMEIVGGIRHENVVAL 360
           E LG+GT+ T +K   +    +V   LKE+ +   E       +++ ++  ++H N+V L
Sbjct: 12  EKLGEGTYATVFKGRSKLTENLVA--LKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTL 69

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAI-GAARGIAHIHTE 419
               ++     +V++Y +      M      +   ++     V+I +    RG+A+ H  
Sbjct: 70  HDIVHTDKSLTLVFEYLDKDLKQYM------DDCGNIMSMHNVKIFLYQILRGLAYCHRR 123

Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS-PMPPPAMRAAG--YRAPEVT--DT 474
              K++H  +K  N+ +N +G + ++D GLA   S P    +       YR P+V    +
Sbjct: 124 ---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSS 180

Query: 475 RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLV-RWVNSVVREEW 523
             +TQ  D++  G +  E+ +G+     +  ++ +HL+ R + +   E W
Sbjct: 181 EYSTQI-DMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETW 229

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 45.6 bits (109), Expect = 1e-06
 Identities = 24/83 (28%), Positives = 34/83 (40%), Gaps = 24/83 (28%)

Query: 94  LQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFN 153
           L++L L +N L+ +    F  L NL  L L                NNLT I        
Sbjct: 2   LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSG--------------NNLTSIS------- 40

Query: 154 ASIPASISKLTHLSALNLANNSL 176
              P + S L  L +L+L+ N+L
Sbjct: 41  ---PEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 50.2 bits (120), Expect = 1e-06
 Identities = 58/224 (25%), Positives = 96/224 (42%), Gaps = 34/224 (15%)

Query: 306 EVLGKGTFGTAY----KAALEDASTVVVKRLKEVNVGKREFEQQM---EIVGGIRHENVV 358
           ++LGKGTFG       KA  +  +  ++K  KEV + K E    +    ++   RH  + 
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILK--KEVIIAKDEVAHTLTESRVLQNTRHPFLT 58

Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRI---AIGAARGIAH 415
           AL+  + + D    V +Y   G +    H  R E   S D   R R     I +A G  H
Sbjct: 59  ALKYSFQTHDRLCFVMEYANGGEL--FFHLSR-ERVFSED---RARFYGAEIVSALGYLH 112

Query: 416 IHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGL-------AALMSPMPPPAMRAAGYRA 468
                   +V+  +K  N+ L+  GH+ ++D GL        A M            Y A
Sbjct: 113 -----SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTF----CGTPEYLA 163

Query: 469 PEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLV 512
           PEV +     +A D +  GV++ E++ G+ P +    +++  L+
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 207

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 72/297 (24%), Positives = 115/297 (38%), Gaps = 67/297 (22%)

Query: 308 LGKGTFGTAYKAALEDASTV---VVKRLKEVNVGKRE---FEQQMEIVGGIRHENVVALR 361
           +G G FG    + +   + V   VVK LK  N   +E   F QQ +    ++H N++   
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELK-ANASSKEQNEFLQQGDPYRILQHPNILQCL 61

Query: 362 AYYYSKDEKLMVYDYFEPGSVSAML---HGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT 418
                    L+V++Y E G + + L      R   Q  L      R+A   A G+ H+H 
Sbjct: 62  GQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLL----LQRMACEIAAGVTHMHK 117

Query: 419 ENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGY------------ 466
            N    +H  +   N FL S   V V D G+         P+     Y            
Sbjct: 118 HN---FLHSDLALRNCFLTSDLTVKVGDYGIG--------PSRYKEDYIETEDDKCVPLR 166

Query: 467 -RAPEVTDTRKA-------TQASDVFSFGVLLLELL-TGKSPIHATGGDEVVHLVRWVNS 517
             APE+             T+ S+V++ GV L EL      P       EV++       
Sbjct: 167 WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLN------H 220

Query: 518 VVREEWTAEVFDVELLRYPNIE----EEMVEMLQVGMACVVRMPEERPKMADVLKMV 570
           V++++       V+L + P +E    E   E+LQ    C +  PE+R    +V +++
Sbjct: 221 VIKDQ------QVKLFK-PQLELPYSERWYEVLQF---CWLS-PEKRATAEEVHRLL 266

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 24/219 (10%)

Query: 308 LGKGTFGTAYKAALE------DASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALR 361
           LG G FG   K   +      D +  V+K   E +V + E  ++ EI+  +  +N   +R
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSV-RDEMMREAEIMHQL--DNPYIVR 59

Query: 362 AYYYSKDEKLM-VYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN 420
                + E LM V +    G ++  L G++ E   S      V +    + G+ ++  +N
Sbjct: 60  MIGVCEAEALMLVMEMASGGPLNKFLSGKKDEITVS----NVVELMHQVSMGMKYLEGKN 115

Query: 421 GGKLVHGGIKASNIFLNSQGHVCVSDIGLA-ALMSPMPPPAMRAAG-----YRAPEVTDT 474
               VH  + A N+ L +Q +  +SD GL+ AL +       R+AG     + APE  + 
Sbjct: 116 ---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF 172

Query: 475 RKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLV 512
           RK +  SDV+S+G+ + E  + G+ P     G EV+  +
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFI 211

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 33/101 (32%), Positives = 50/101 (49%), Gaps = 11/101 (10%)

Query: 411 RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGY---- 466
           R I ++H EN  +++H  IKA NIF+N  G VC+ D G A    P+   A +  G+    
Sbjct: 193 RAIQYLH-EN--RIIHRDIKAENIFINHPGDVCLGDFGAACF--PVDINANKYYGWAGTI 247

Query: 467 --RAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGG 505
              APE+        A D++S G++L E+ T    +    G
Sbjct: 248 ATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDG 288

Length = 391

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 48.8 bits (116), Expect = 3e-06
 Identities = 56/219 (25%), Positives = 97/219 (44%), Gaps = 22/219 (10%)

Query: 307 VLGKGTFGTAYKAALEDAST----VVVKRLKEVNVGK--REFEQQMEIVGGIRHENVVAL 360
           +LG G FG   +  L+  S     V +  L+     K  R F  +   +G   H N+V L
Sbjct: 12  ILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRL 71

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN 420
                  +  ++V +Y   G++ + L  R+ EGQ  L     + +  G A G+ ++ +E 
Sbjct: 72  EGVITRGNTMMIVTEYMSNGALDSFL--RKHEGQ--LVAGQLMGMLPGLASGMKYL-SEM 126

Query: 421 GGKLVHGGIKASNIFLNSQGHVCVSDIG------LAALMSPMPPPAMRAAGYRAPEVTDT 474
           G   VH G+ A  + +NS     +S           A+ + M   +     + APE    
Sbjct: 127 G--YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSP--VLWAAPEAIQY 182

Query: 475 RKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLV 512
              + ASDV+SFG+++ E+++ G+ P     G +V+  V
Sbjct: 183 HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV 221

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 48/186 (25%), Positives = 84/186 (45%), Gaps = 25/186 (13%)

Query: 394 QSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALM 453
           +S L  +  +  +   ARG+  + +    K +H  + A NI L+    V + D GLA  +
Sbjct: 168 KSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDI 224

Query: 454 SPMPPPAMRAAG-----YRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDE 507
              P    + +      + APE    +  T  SDV+SFGVLL E+ + G SP        
Sbjct: 225 YKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASP-------- 276

Query: 508 VVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVL 567
                 +    + EE+   + D   +R P  E    E+ ++ +AC    P+ERP  + ++
Sbjct: 277 ------YPGVQINEEFCQRLKDGTRMRAP--ENATPEIYRIMLACWQGDPKERPTFSALV 328

Query: 568 KMVEDI 573
           +++ D+
Sbjct: 329 EILGDL 334

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 44.1 bits (105), Expect = 4e-06
 Identities = 17/47 (36%), Positives = 23/47 (48%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSF 128
            IP      L  L+ L L  N+L+ + P  FS L +L SL L  N+ 
Sbjct: 14  VIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60

Length = 60

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 48.9 bits (117), Expect = 4e-06
 Identities = 62/229 (27%), Positives = 97/229 (42%), Gaps = 42/229 (18%)

Query: 308 LGKGTFGT---AYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIR----------H 354
           LG+G +G    A  A   +  TV +K++  V      F +++     +R          H
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNV------FSKKILAKRALRELKLLRHFRGH 61

Query: 355 ENVVALR----AYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAA 410
           +N+  L      +  + +E   +Y Y E   + A LH     GQ   D   +  I     
Sbjct: 62  KNITCLYDMDIVFPGNFNE---LYLYEEL--MEADLHQIIRSGQPLTDAHFQSFI-YQIL 115

Query: 411 RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---PPAMR----A 463
            G+ +IH+ N   ++H  +K  N+ +N+   + + D GLA   S  P      M      
Sbjct: 116 CGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT 172

Query: 464 AGYRAPEVT-DTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHL 511
             YRAPE+    +  T+A DV+S G +L ELL  K P+   G D V  L
Sbjct: 173 RWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK-PVF-KGKDYVDQL 219

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 48.6 bits (116), Expect = 4e-06
 Identities = 35/120 (29%), Positives = 60/120 (50%), Gaps = 11/120 (9%)

Query: 411 RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVC-VSDIGLAALMSP------MPPPAMRA 463
           RG+ +IH+ N   ++H  +K +N+F+N++  V  + D GLA ++ P           +  
Sbjct: 125 RGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181

Query: 464 AGYRAPE-VTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREE 522
             YR+P  +      T+A D+++ G +  E+LTGK         E + L+     VVREE
Sbjct: 182 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREE 241

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 48.5 bits (116), Expect = 5e-06
 Identities = 29/91 (31%), Positives = 46/91 (50%), Gaps = 10/91 (10%)

Query: 424 LVHGGIKASNIFLNSQGHVCVSDIGLAA-LMSPMPPPAMRAAG---YRAPEVTDTRKATQ 479
           ++H  +K SNI L++ G+V + D G++  L+        R+AG   Y APE  D      
Sbjct: 136 VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA--KTRSAGCAAYMAPERIDPPDPNP 193

Query: 480 A----SDVFSFGVLLLELLTGKSPIHATGGD 506
                +DV+S G+ L+EL TG+ P      +
Sbjct: 194 KYDIRADVWSLGISLVELATGQFPYKNCKTE 224

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 48.5 bits (115), Expect = 5e-06
 Identities = 50/226 (22%), Positives = 103/226 (45%), Gaps = 20/226 (8%)

Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFE-----QQMEIVGGIRHENVVALRA 362
           LG+GT+ T +K   +    +V   LKE+ +   E       +++ ++  ++H N+V L  
Sbjct: 13  LGEGTYATVFKGRSKLTENLVA--LKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHD 70

Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGG 422
             +++    +V++Y +    S +       G      + ++       RG+++ H     
Sbjct: 71  IIHTERCLTLVFEYLD----SDLKQYLDNCGNLMSMHNVKI-FMFQLLRGLSYCHKR--- 122

Query: 423 KLVHGGIKASNIFLNSQGHVCVSDIGLAALMS-PMPPPAMRAAG--YRAPEV-TDTRKAT 478
           K++H  +K  N+ +N +G + ++D GLA   S P    +       YR P+V   + + +
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYS 182

Query: 479 QASDVFSFGVLLLELLTGKSPIHATGGDEVVHLV-RWVNSVVREEW 523
              D++  G +L E+ TG+     +   E +HL+ R + +   E W
Sbjct: 183 TPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETW 228

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 48.3 bits (115), Expect = 5e-06
 Identities = 43/201 (21%), Positives = 93/201 (46%), Gaps = 15/201 (7%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKRLK---EVNVGKREFEQQMEIVGGIRHENVVALR 361
           E +G+GT+G  YKA        V +K+++   E         +++ ++  + H N+V L 
Sbjct: 6   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 65

Query: 362 AYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENG 421
              +++++  +V+++        M           L      ++     +G+A  H+   
Sbjct: 66  DVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLL----QGLAFCHSH-- 119

Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIGLA-ALMSPMPPPAMRAAG--YRAPEV-TDTRKA 477
            +++H  +K  N+ +N++G + ++D GLA A   P+           YRAPE+    +  
Sbjct: 120 -RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 178

Query: 478 TQASDVFSFGVLLLELLTGKS 498
           + A D++S G +  E++T ++
Sbjct: 179 STAVDIWSLGCIFAEMVTRRA 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 48.2 bits (115), Expect = 6e-06
 Identities = 56/239 (23%), Positives = 100/239 (41%), Gaps = 42/239 (17%)

Query: 307 VLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHEN---------- 356
           VLGKG+FG   K  L +        L  + + K++   Q + V     E           
Sbjct: 7   VLGKGSFG---KVMLAERKGT--DELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPP 61

Query: 357 -VVALRAYYYSKDEKLMVYDYFEPGSVSAMLH----GRRGEGQSSLDWDTRVRIAIGAAR 411
            +  L + + + D    V +Y   G +  M H    G+  E  +       V  A   A 
Sbjct: 62  FLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGKFKEPHA-------VFYAAEIAI 112

Query: 412 GIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMR----AAGYR 467
           G+  +H++    +++  +K  N+ L+++GH+ ++D G+    +       R       Y 
Sbjct: 113 GLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCK-ENIFGGKTTRTFCGTPDYI 168

Query: 468 APEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVV-----HLVRWVNSVVRE 521
           APE+   +   ++ D ++FGVLL E+L G+ P      DE+      H V +  S+ +E
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKE 227

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 48.3 bits (115), Expect = 6e-06
 Identities = 46/203 (22%), Positives = 89/203 (43%), Gaps = 21/203 (10%)

Query: 306 EVLGKGTFGTAYKAALEDAST-VVVKRLKEVNVGK----REFEQQMEIVGGIRHENVVAL 360
           E LG G+FG    A  +       +K LK+  + K    +   Q+  I+  + H  +V +
Sbjct: 24  ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNM 83

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLD----WDTRVRIAIGAARGIAHI 416
              +  ++    + ++   G +   L   R  G+   D    +   + +A        ++
Sbjct: 84  MCSFQDENRVYFLLEFVVGGELFTHL---RKAGRFPNDVAKFYHAELVLAF------EYL 134

Query: 417 HTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTRK 476
           H+++   +++  +K  N+ L+++GHV V+D G A  +            Y APEV  ++ 
Sbjct: 135 HSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVIQSKG 191

Query: 477 ATQASDVFSFGVLLLELLTGKSP 499
             +A D ++ GVLL E + G  P
Sbjct: 192 HGKAVDWWTMGVLLYEFIAGYPP 214

Length = 329

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 48.1 bits (114), Expect = 7e-06
 Identities = 56/242 (23%), Positives = 108/242 (44%), Gaps = 29/242 (11%)

Query: 306 EVLGKGTFGTAYKAALEDASTV-VVKRLKEVNVGKRE----FEQQMEIVGGIRHENVVAL 360
           +V+G+G FG      L++A  V  +K L +  + KR     F ++ +++    ++ +  L
Sbjct: 7   KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAML---HGRRGEGQSSLDWDTRVRIAIGAARGIAHIH 417
              +  ++   +V DY+  G +  +L     R  E  +   +   + IAI +   + ++H
Sbjct: 67  HYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF-YLAEMVIAIDSVHQLHYVH 125

Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIG-LAALMSPMPPPAMRAAG---YRAPEVTD 473
            +         IK  NI ++  GH+ ++D G    LM      +  A G   Y +PE+  
Sbjct: 126 RD---------IKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQ 176

Query: 474 TRKATQAS-----DVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVF 528
             +  +       D +S GV + E+L G++P +A    E    +  +N   R ++ A+V 
Sbjct: 177 AMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI--MNHKERFQFPAQVT 234

Query: 529 DV 530
           DV
Sbjct: 235 DV 236

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 48.2 bits (115), Expect = 7e-06
 Identities = 52/236 (22%), Positives = 101/236 (42%), Gaps = 28/236 (11%)

Query: 308 LGKGTFGTAYKAALEDASTVV-VKRLKEVNVGK----REFEQQMEIVGGIRHENVVALRA 362
           +G+G +G  + A  +D   +V +KR+K+  + K    R    + +I+   + E +V L  
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKL-L 67

Query: 363 YYYSKDEKLMVYDYFEPG-------SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAH 415
           Y +  DE L +   + PG       +   +L     E  +   +   +  A+ A   + +
Sbjct: 68  YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLS----EDHARF-YMAEMFEAVDALHELGY 122

Query: 416 IHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTR 475
           IH +         +K  N  +++ GH+ ++D GL+  +       + +  Y APEV   +
Sbjct: 123 IHRD---------LKPENFLIDASGHIKLTDFGLSKGIVTYANSVVGSPDYMAPEVLRGK 173

Query: 476 KATQASDVFSFGVLLLELLTGKSPIHATGGDEV-VHLVRWVNSVVREEWTAEVFDV 530
                 D +S G +L E L G  P   +  +E   +L  W  ++ R  +    F++
Sbjct: 174 GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNL 229

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 47.8 bits (113), Expect = 8e-06
 Identities = 43/198 (21%), Positives = 89/198 (44%), Gaps = 15/198 (7%)

Query: 306 EVLGKGTFGTAYKAALEDASTVV---VKRLKEVNVGKREFEQQMEIVGGIRHENVVALRA 362
           E LG+G++ T YK   +    +V   V RL+E         ++  ++ G++H N+V L  
Sbjct: 11  EKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHD 70

Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGG 422
             ++K+   +V++Y        M      +    L  +          RG+++IH     
Sbjct: 71  IIHTKETLTLVFEYVHTDLCQYM-----DKHPGGLHPENVKLFLFQLLRGLSYIHQR--- 122

Query: 423 KLVHGGIKASNIFLNSQGHVCVSDIGLA---ALMSPMPPPAMRAAGYRAPEV-TDTRKAT 478
            ++H  +K  N+ ++  G + ++D GLA   ++ S      +    YR P+V   + + +
Sbjct: 123 YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYS 182

Query: 479 QASDVFSFGVLLLELLTG 496
              D++  G + +E++ G
Sbjct: 183 TCLDMWGVGCIFVEMIQG 200

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 47.3 bits (112), Expect = 9e-06
 Identities = 57/219 (26%), Positives = 96/219 (43%), Gaps = 24/219 (10%)

Query: 308 LGKGTFGTAYKAALE---DASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALR 361
           LG G FGT  K   +      TV VK LK  N     K E  ++  ++  + +  +V  R
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIV--R 60

Query: 362 AYYYSKDEKLM-VYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN 420
                + E  M V +  E G ++  L   +   + ++       +    + G+ ++   N
Sbjct: 61  MIGICEAESWMLVMELAELGPLNKFLQKNKHVTEKNI-----TELVHQVSMGMKYLEETN 115

Query: 421 GGKLVHGGIKASNIFLNSQGHVCVSDIGLA-ALMSPMPPPAMRAAG-----YRAPEVTDT 474
               VH  + A N+ L +Q +  +SD GL+ AL +       +  G     + APE  + 
Sbjct: 116 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNY 172

Query: 475 RKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLV 512
            K +  SDV+SFGVL+ E  + G+ P     G+EV  ++
Sbjct: 173 YKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI 211

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 47.5 bits (113), Expect = 1e-05
 Identities = 47/171 (27%), Positives = 76/171 (44%), Gaps = 27/171 (15%)

Query: 410 ARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR-- 467
           ARG+  + +    K +H  + A NI L+    V + D GLA  +    P  +R    R  
Sbjct: 183 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYK-DPDYVRKGDARLP 238

Query: 468 ----APEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREE 522
               APE    +  T  SDV+SFGVLL E+ + G SP      D              EE
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID--------------EE 284

Query: 523 WTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
           +   + +   +R P  E    E+  + + C    PE+RP  +++++++ D+
Sbjct: 285 FCRRLKEGTRMRAP--EYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDL 333

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 47.7 bits (113), Expect = 1e-05
 Identities = 53/223 (23%), Positives = 94/223 (42%), Gaps = 32/223 (14%)

Query: 301 LRASAE------VLGKGTFGTAYKAALEDASTV-VVKRLKEVNVGKRE----FEQQMEIV 349
           LR  AE      V+G+G FG       +    V  +K L +  + KR     F ++ +I+
Sbjct: 38  LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIM 97

Query: 350 GGIRHENVVALRAYYYSKDEKL--MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAI 407
                  VV L  +Y  +D++   MV +Y   G +  ++       + +  +   V +A+
Sbjct: 98  AFANSPWVVQL--FYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLAL 155

Query: 408 GAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP----MPPPAMRA 463
            A   +  IH +         +K  N+ L+  GH+ ++D G    M+         A+  
Sbjct: 156 DAIHSMGFIHRD---------VKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGT 206

Query: 464 AGYRAPEVTDTRKAT----QASDVFSFGVLLLELLTGKSPIHA 502
             Y +PEV  ++       +  D +S GV L E+L G +P +A
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 68/300 (22%), Positives = 122/300 (40%), Gaps = 62/300 (20%)

Query: 306 EVLGKGTFGTAYKAALE------DASTVVVKRLKEVNV--GKREFEQQMEIVGGI-RHEN 356
           +V+G+G FG   KA ++      DA+   +KR+KE       R+F  ++E++  +  H N
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAA---IKRMKEYASKDDHRDFAGELEVLCKLGHHPN 69

Query: 357 VVAL------RAYYYSKDEKLMVYDYFEPGSVSAMLHGRR-----------GEGQSSLDW 399
           ++ L      R Y Y      +  +Y   G++   L   R               S+L  
Sbjct: 70  IINLLGACEHRGYLY------LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS 123

Query: 400 DTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP 459
              +  A   ARG+ ++  +   + +H  + A NI +       ++D GL+         
Sbjct: 124 QQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 180

Query: 460 AMRAAGYR--APEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVN 516
            M     R  A E  +    T  SDV+S+GVLL E+++ G +P              +  
Sbjct: 181 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP--------------YCG 226

Query: 517 SVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVL----KMVED 572
               E +        L +  N ++E+ ++++    C    P ERP  A +L    +M+E+
Sbjct: 227 MTCAELYEKLPQGYRLEKPLNCDDEVYDLMR---QCWREKPYERPSFAQILVSLNRMLEE 283

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 53/221 (23%), Positives = 94/221 (42%), Gaps = 31/221 (14%)

Query: 306 EVLGKGTFGTAYKAAL----EDASTVVVKRLK-EVNVGKRE-FEQQMEIVGGIRHENVVA 359
             +G+G FG  Y+        +   V VK  K   +   RE F Q+  I+    H ++V 
Sbjct: 12  RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71

Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE 419
           L     +++   +V +    G + + L   +     SLD  + +  +   +  +A++ ++
Sbjct: 72  LIG-VITENPVWIVMELAPLGELRSYLQVNK----YSLDLASLILYSYQLSTALAYLESK 126

Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS----------PMPPPAMRAAGYRAP 469
                VH  I A N+ ++S   V + D GL+  +            +P   M      AP
Sbjct: 127 R---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWM------AP 177

Query: 470 EVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVV 509
           E  + R+ T ASDV+ FGV + E+L  G  P      ++V+
Sbjct: 178 ESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI 218

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 41/115 (35%), Positives = 57/115 (49%), Gaps = 7/115 (6%)

Query: 88  IGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL 147
           +  L  L+NL L  N LS L     S L NL +L L  N  S  LP +  + + L  +DL
Sbjct: 159 LRNLPNLKNLDLSFNDLSDLPKL-LSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDL 216

Query: 148 SNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWA---FAGNNLSS 199
           SNN     + +S+S L +LS L L+NN L   LP S+    +      + N +SS
Sbjct: 217 SNNS-IIELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQISS 269

Length = 394

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 55/234 (23%), Positives = 104/234 (44%), Gaps = 32/234 (13%)

Query: 307 VLGKGTFGTAY----KAALEDASTVVVKR---LKEVNVGKREFEQQMEIVGGIRHENVVA 359
           VLGKG+FG       K   E  +  ++K+   +++ +V     E+++  + G +   +  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSG-KPPFLTQ 65

Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLH----GRRGEGQSSLDWDTRVRIAIGAARGIAH 415
           L + + + D    V +Y   G +  M      GR  E  +       V  A   A G+  
Sbjct: 66  LHSCFQTMDRLYFVMEYVNGGDL--MYQIQQVGRFKEPHA-------VFYAAEIAIGLFF 116

Query: 416 IHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAA---LMSPMPPPAMRAAGYRAPEVT 472
           +H++    +++  +K  N+ L+S+GH+ ++D G+                   Y APE+ 
Sbjct: 117 LHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII 173

Query: 473 DTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVV-----HLVRWVNSVVRE 521
             +   ++ D ++FGVLL E+L G++P      DE+      H V +  S+ +E
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKE 227

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 64/285 (22%), Positives = 116/285 (40%), Gaps = 41/285 (14%)

Query: 308 LGKGTFGTAYKAALED------ASTVVVKRLKE-VNVGKR-EFEQQMEIVGGIRHENVVA 359
           LG+G+FG  Y+    D       + V VK + E  ++ +R EF  +  ++ G    +VV 
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVR 73

Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGE-----GQSSLDWDTRVRIAIGAARGIA 414
           L          L+V +    G + + L   R E     G+        +++A   A G+A
Sbjct: 74  LLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMA 133

Query: 415 HIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG-----YRAP 469
           ++   N  K VH  + A N  +     V + D G+   +           G     + AP
Sbjct: 134 YL---NAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 470 EVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVF 528
           E       T +SD++SFGV+L E+ +  + P      ++V+                 V 
Sbjct: 191 ESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF---------------VM 235

Query: 529 DVELLRYP-NIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVED 572
           D   L  P N  E + +++++   C    P+ RP   +++ +++D
Sbjct: 236 DGGYLDQPDNCPERVTDLMRM---CWQFNPKMRPTFLEIVNLLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 46.5 bits (110), Expect = 2e-05
 Identities = 50/199 (25%), Positives = 92/199 (46%), Gaps = 21/199 (10%)

Query: 308 LGKGTFGTAY----KAALEDASTVVVKRLKEVNVGKR------EFEQQMEIVGGIRHENV 357
           LGKG+FGT Y    K A+ +     +K LKE+ VG+       +  Q+ +++  + H  +
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEER---LKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI 64

Query: 358 VALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIH 417
           V   A +  +D   ++ +Y E   +   L   +  G+ +L  +      I    G+ ++H
Sbjct: 65  VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGK-TLSENQVCEWFIQLLLGVHYMH 123

Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTDT 474
                +++H  +KA NIFL +   + + D G++ L+      A    G   Y +PE    
Sbjct: 124 QR---RILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH 179

Query: 475 RKATQASDVFSFGVLLLEL 493
           +     SD++S G +L E+
Sbjct: 180 QGYDSKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 46.6 bits (111), Expect = 2e-05
 Identities = 55/235 (23%), Positives = 101/235 (42%), Gaps = 44/235 (18%)

Query: 295 FDLEDLLRASAEVLGKGTFGTAYKAALEDAST---VVVKRL----KEVNVGKREFEQQME 347
           FD+    +   E +G G +G    A   D  +   V +K++        + KR   ++++
Sbjct: 1   FDVGSRYKPI-ENIGSGAYGVVCSAI--DTRSGKKVAIKKIPHAFDVPTLAKRTL-RELK 56

Query: 348 IVGGIRHENVVALRAYYYSKDEKL----MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRV 403
           I+   +H+N++A+R              +V D  E    S + H    +   + +    +
Sbjct: 57  ILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME----SDLHHIIHSDQPLTEE---HI 109

Query: 404 RIAIGAA-RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP--- 459
           R  +    RG+ +IH+ N   ++H  +K SN+ +N    + + D G+A  +S  P     
Sbjct: 110 RYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKY 166

Query: 460 ------AMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLE------LLTGKSPIH 501
                 A R   YRAPE+  +  + T A D++S G +  E      L  GK+ +H
Sbjct: 167 FMTEYVATRW--YRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH 219

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 46.6 bits (110), Expect = 2e-05
 Identities = 49/210 (23%), Positives = 88/210 (41%), Gaps = 22/210 (10%)

Query: 306 EVLGKGTFGTAYKAALEDASTV-VVKRLKEVNVGKRE----FEQQMEIVGGIRHENVVAL 360
           +V+G+G FG       + +  V  +K L +  + KR     F ++ +I+       VV L
Sbjct: 49  KVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 108

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN 420
              +       MV +Y   G +  ++       + +  +   V +A+ A      IH+  
Sbjct: 109 FCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDA------IHSMG 162

Query: 421 GGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP----PPAMRAAGYRAPEVTDTRK 476
              L+H  +K  N+ L+  GH+ ++D G    M          A+    Y +PEV  ++ 
Sbjct: 163 ---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQG 219

Query: 477 AT----QASDVFSFGVLLLELLTGKSPIHA 502
                 +  D +S GV L E+L G +P +A
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVGDTPFYA 249

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 46.6 bits (110), Expect = 3e-05
 Identities = 34/112 (30%), Positives = 54/112 (48%), Gaps = 11/112 (9%)

Query: 412 GIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLA--ALMSPMPPPAMRAAGYRAP 469
           GI H+H+     ++H  +K SNI + S   + + D GLA  A  + M  P +    YRAP
Sbjct: 135 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAP 191

Query: 470 EVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVRE 521
           EV       +  D++S G ++ EL+ G      T      H+ +W N V+ +
Sbjct: 192 EVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD-----HIDQW-NKVIEQ 237

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 64/288 (22%), Positives = 117/288 (40%), Gaps = 66/288 (22%)

Query: 306 EVLGKGTFGTAYKAALEDAST---VVVKR--------------LKEVNVGKREFEQQMEI 348
           E +G+GT+G  YKA   D +T   V +K+              L+E+++ +    + + I
Sbjct: 7   EKIGEGTYGKVYKA--RDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQM-LSESIYI 63

Query: 349 VGGIRHENVVALRAYYYSKDEKLMVY---DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRI 405
           V  +  E+V         K+ K  +Y   +Y +      M    RG G+  L   T    
Sbjct: 64  VRLLDVEHVE-------EKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGR-PLPAKTIKSF 115

Query: 406 AIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVC-VSDIGLA-ALMSPMPPPAMRA 463
                +G+AH H      ++H  +K  N+ ++ Q  +  ++D+GL  A   P+       
Sbjct: 116 MYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEI 172

Query: 464 AG--YRAPEV-TDTRKATQASDVFSFGVLLLELLTGKSPIHATGGD----EVVHLVRWVN 516
               YRAPEV   +   +   D++S G +  E+   K P+    GD    +++H+ + + 
Sbjct: 173 VTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSR-KQPLFP--GDSELQQLLHIFKLLG 229

Query: 517 SVVREEWTAEVFDVELLR----------------YPNIEEEMVEMLQV 548
           +   + W      V  LR                 P++  E +++LQ 
Sbjct: 230 TPTEQVWPG----VSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQK 273

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 55/217 (25%), Positives = 98/217 (45%), Gaps = 34/217 (15%)

Query: 307 VLGKGTFGTAYKAALEDASTVV--VKRLKEVNVGKRE----FEQQMEIVGGIRHENVVAL 360
           ++G+G FG   +   E A+  +  +K +K+  +  +E    FE++ +I+       +  L
Sbjct: 8   LVGRGHFGEV-QVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQL 66

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN 420
           +  +  KD   +V +Y   G + ++L+  R E Q   D D   +  +  A  +  IH+ +
Sbjct: 67  QYAFQDKDNLYLVMEYQPGGDLLSLLN--RYEDQ--FDEDM-AQFYL--AELVLAIHSVH 119

Query: 421 GGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS---------PMPPPAMRAAGYRAPEV 471
               VH  IK  N+ ++  GH+ ++D G AA ++         P+  P      Y APEV
Sbjct: 120 QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTP-----DYIAPEV 174

Query: 472 TDTRKATQAS------DVFSFGVLLLELLTGKSPIHA 502
             T             D +S GV+  E++ G+SP H 
Sbjct: 175 LTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHE 211

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 46.1 bits (109), Expect = 3e-05
 Identities = 54/233 (23%), Positives = 104/233 (44%), Gaps = 30/233 (12%)

Query: 307 VLGKGTFGTAYKAALEDASTVVVKRL--KEVNVGKREFEQQM--EIVGGIRHEN--VVAL 360
           VLGKG+FG    A  +    +   ++  K+V +   + E  M  + V  ++ +   +  L
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLH----GRRGEGQSSLDWDTRVRIAIGAARGIAHI 416
            + + + D    V +Y   G +  M H    G+  E Q+       V  A   + G+  +
Sbjct: 67  HSCFQTVDRLYFVMEYVNGGDL--MYHIQQVGKFKEPQA-------VFYAAEISVGLFFL 117

Query: 417 HTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLA--ALMSPMPPPAM-RAAGYRAPEVTD 473
           H      +++  +K  N+ L+S+GH+ ++D G+    ++  +          Y APE+  
Sbjct: 118 HRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIA 174

Query: 474 TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVV-----HLVRWVNSVVRE 521
            +   ++ D +++GVLL E+L G+ P      DE+      H V +  S+ +E
Sbjct: 175 YQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKE 227

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 46.2 bits (109), Expect = 3e-05
 Identities = 48/216 (22%), Positives = 92/216 (42%), Gaps = 29/216 (13%)

Query: 307 VLGKGTFGTAYKAALEDASTV----VVKR--------LKEVNVGKREFEQQMEIVGGIRH 354
           V+G+G++       L+    +    VVK+        +  V   K  FEQ         H
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN------H 55

Query: 355 ENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIA 414
             +V L + + ++     V +Y   G +  M H +R   Q  L  +     +   +  + 
Sbjct: 56  PFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQR---QRKLPEEHARFYSAEISLALN 110

Query: 415 HIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAAL-MSPMPPPAMRAA--GYRAPEV 471
           ++H E G  +++  +K  N+ L+S+GH+ ++D G+    + P    +       Y APE+
Sbjct: 111 YLH-ERG--IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEI 167

Query: 472 TDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDE 507
                   + D ++ GVL+ E++ G+SP    G  +
Sbjct: 168 LRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD 203

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 46.1 bits (109), Expect = 3e-05
 Identities = 48/204 (23%), Positives = 88/204 (43%), Gaps = 27/204 (13%)

Query: 308 LGKGTFGTA-YKAALEDASTVVVKRL----KEVNVGKREFEQQMEIVGGIRHENVVALRA 362
           +G G +GT          + V +K+L    +     KR + +++ ++  ++HENV+ L  
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAY-RELRLLKHMKHENVIGL-L 80

Query: 363 YYYSKDEKL-------MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAI-GAARGIA 414
             ++ D  L       +V  +        M H +  E         R++  +    +G+ 
Sbjct: 81  DVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSE--------DRIQFLVYQMLKGLK 132

Query: 415 HIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEVT-D 473
           +IH      ++H  +K  N+ +N    + + D GLA          +    YRAPEV  +
Sbjct: 133 YIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTGYVVTRWYRAPEVILN 189

Query: 474 TRKATQASDVFSFGVLLLELLTGK 497
               TQ  D++S G ++ E+LTGK
Sbjct: 190 WMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 46.8 bits (111), Expect = 3e-05
 Identities = 45/194 (23%), Positives = 78/194 (40%), Gaps = 36/194 (18%)

Query: 327 VVVKRLKEVNV-GKRE---FEQQMEIVGGIRHENVVALRAYYYSKDEKLM-VYDYFEPGS 381
           V +K L+      + +   F ++  +   + H N+VAL     +    L  V++Y    +
Sbjct: 6   VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRT 65

Query: 382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG- 440
           +  +L         +L      R+ +     +A  H   G  +VH  +K  NI ++  G 
Sbjct: 66  LREVL-----AADGALPAGETGRLMLQVLDALACAH-NQG--IVHRDLKPQNIMVSQTGV 117

Query: 441 --HVCVSDIGLAALMSPMPPPAMRAA---------------GYRAPEVTDTRKATQASDV 483
             H  V D G+  L+     P +R A                Y APE       T  SD+
Sbjct: 118 RPHAKVLDFGIGTLL-----PGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDL 172

Query: 484 FSFGVLLLELLTGK 497
           +++G++ LE LTG+
Sbjct: 173 YAWGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 46.2 bits (109), Expect = 4e-05
 Identities = 60/219 (27%), Positives = 100/219 (45%), Gaps = 21/219 (9%)

Query: 307 VLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYS 366
           ++G G+FG  Y+A   D S  V   +K+V    +   +++ I+  + H N++ L+ YYY+
Sbjct: 73  IIGNGSFGVVYEAICIDTSEKVA--IKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYT 130

Query: 367 ----KDEK---LMVYDYFEPGSVSA-MLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT 418
               K+EK   L V   F P +V   M H  R     +L        +    R +A+IH+
Sbjct: 131 ECFKKNEKNIFLNVVMEFIPQTVHKYMKHYAR--NNHALPLFLVKLYSYQLCRALAYIHS 188

Query: 419 ENGGKLVHGGIKASNIFLNSQGHVC-VSDIGLAA--LMSPMPPPAMRAAGYRAPEVT-DT 474
           +    + H  +K  N+ ++   H   + D G A   L        + +  YRAPE+    
Sbjct: 189 KF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGA 245

Query: 475 RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVR 513
              T   D++S G ++ E++ G  PI  +G   V  LVR
Sbjct: 246 TNYTTHIDLWSLGCIIAEMILG-YPIF-SGQSSVDQLVR 282

Length = 440

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 45.4 bits (107), Expect = 4e-05
 Identities = 49/216 (22%), Positives = 95/216 (43%), Gaps = 35/216 (16%)

Query: 305 AEVLGKGTFGTAYKAALEDAST---VVVKRL----------KEVNVGKREFEQQMEIVGG 351
            ++LG+G FG  Y     DA T   + VK++          KEVN      E +++++  
Sbjct: 7   GKLLGQGAFGRVYLCY--DADTGRELAVKQVQFDPESPETSKEVNA----LECEIQLLKN 60

Query: 352 IRHENVVALRAYYYSKDEKLM--VYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGA 409
           + HE +V          E+ +    ++   GS+   L     +   +L  +   +     
Sbjct: 61  LLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL-----KSYGALTENVTRKYTRQI 115

Query: 410 ARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP--MPPPAMRAAG-- 465
             G++++H+     +VH  IK +NI  +S G+V + D G +  +    +    M++    
Sbjct: 116 LEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGT 172

Query: 466 --YRAPEVTDTRKATQASDVFSFGVLLLELLTGKSP 499
             + +PEV       + +D++S G  ++E+LT K P
Sbjct: 173 PYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 45.5 bits (108), Expect = 5e-05
 Identities = 54/214 (25%), Positives = 90/214 (42%), Gaps = 30/214 (14%)

Query: 306 EVLGKGTFGTAYKAALEDASTV-VVKRLKEVNVGKRE----FEQQMEIVGGIRHENVVAL 360
           +V+G+G FG       + +  V  +K L +  + KR     F ++ +I+     E +V L
Sbjct: 49  KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL 108

Query: 361 RAYYYSKDEK--LMVYDYFEPGS--VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHI 416
             +Y  +D+K   MV +Y  PG   V+ M             W  R   A      +  I
Sbjct: 109 --HYAFQDDKYLYMVMEYM-PGGDLVNLM-----SNYDIPEKW-ARFYTA-EVVLALDAI 158

Query: 417 HTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP----MPPPAMRAAGYRAPEVT 472
           H+      +H  +K  N+ L+  GH+ ++D G    M          A+    Y +PEV 
Sbjct: 159 HSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVL 215

Query: 473 DTRKAT----QASDVFSFGVLLLELLTGKSPIHA 502
            ++       +  D +S GV L E+L G +P +A
Sbjct: 216 KSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 249

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 45.4 bits (107), Expect = 5e-05
 Identities = 42/157 (26%), Positives = 67/157 (42%), Gaps = 22/157 (14%)

Query: 423 KLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG-----YRAPEVTDTRKA 477
           K +H  + A NI L+    V + D GLA  +   P    +        + APE    R  
Sbjct: 199 KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 258

Query: 478 TQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP 536
           T  SDV+SFGVLL E+ + G SP      D              EE+   + +   +R P
Sbjct: 259 TIQSDVWSFGVLLWEIFSLGASPYPGVKID--------------EEFCRRLKEGTRMRAP 304

Query: 537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
             +    EM Q  + C    P +RP  +++++ + ++
Sbjct: 305 --DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 339

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 45.0 bits (106), Expect = 5e-05
 Identities = 61/285 (21%), Positives = 114/285 (40%), Gaps = 41/285 (14%)

Query: 308 LGKGTFGTAYKAAL------EDASTVVVKRLKE-VNVGKR-EFEQQMEIVGGIRHENVVA 359
           LG+G+FG  Y+         E  + V +K + E  ++ +R EF  +  ++      +VV 
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVR 73

Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGE-----GQSSLDWDTRVRIAIGAARGIA 414
           L          L++ +    G + + L   R E      Q+       +++A   A G+A
Sbjct: 74  LLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMA 133

Query: 415 HIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG-----YRAP 469
           ++   N  K VH  + A N  +     V + D G+   +           G     + +P
Sbjct: 134 YL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 190

Query: 470 EVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVF 528
           E       T  SDV+SFGV+L E+ T  + P      ++V+                 V 
Sbjct: 191 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRF---------------VM 235

Query: 529 DVELLRYP-NIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVED 572
           +  LL  P N  + + E++++   C    P+ RP   +++  +++
Sbjct: 236 EGGLLDKPDNCPDMLFELMRM---CWQYNPKMRPSFLEIISSIKE 277

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 45.4 bits (107), Expect = 5e-05
 Identities = 53/219 (24%), Positives = 96/219 (43%), Gaps = 32/219 (14%)

Query: 306 EVLGKGTFGTAY-------KAALEDAST--------VVVKRLK-EVNVGKR-EFEQQMEI 348
           E LG+G FG  +          L + +         V VK L+ +V    R +F ++++I
Sbjct: 11  EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKI 70

Query: 349 VGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQ-------SSLDWDT 401
           +  +++ N++ L     S D   M+ +Y E G ++  L  R  E          S+    
Sbjct: 71  MSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130

Query: 402 RVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAA-LMSP----M 456
            + +A+  A G+ ++ + N    VH  +   N  + +   + ++D G++  L S     +
Sbjct: 131 LLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRI 187

Query: 457 PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT 495
              A+    + A E     K T ASDV++FGV L E+ T
Sbjct: 188 QGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 45.2 bits (107), Expect = 6e-05
 Identities = 54/213 (25%), Positives = 92/213 (43%), Gaps = 30/213 (14%)

Query: 307 VLGKGTFGTAYKAALEDASTV-------VVKRLKEVNVGKREFEQQME--IVGGIRHENV 357
           VLGKG +G  ++      +         V+K+   V   K     + E  I+  ++H  +
Sbjct: 3   VLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFI 62

Query: 358 VALRAYYYSKDEKL-MVYDYFEPGSVSAMLHGRRGEGQSSLD----WDTRVRIAIGAARG 412
           V L  Y +    KL ++ +Y   G +   +H  R EG    D    + + + +A+     
Sbjct: 63  VDL-IYAFQTGGKLYLILEYLSGGEL--FMHLER-EGIFMEDTACFYLSEISLALE---- 114

Query: 413 IAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAP 469
             H+H +    +++  +K  NI L++QGHV ++D GL               G   Y AP
Sbjct: 115 --HLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAP 169

Query: 470 EVTDTRKATQASDVFSFGVLLLELLTGKSPIHA 502
           E+       +A D +S G L+ ++LTG  P  A
Sbjct: 170 EILMRSGHGKAVDWWSLGALMYDMLTGAPPFTA 202

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 45.2 bits (107), Expect = 7e-05
 Identities = 63/266 (23%), Positives = 98/266 (36%), Gaps = 66/266 (24%)

Query: 308 LGKGTFGTAYKAALEDASTV-VVKRLKEVNVGKRE----FEQQMEIVGGIRHENVVALRA 362
           +G G FG        D + +  +K L++ +V  R      + + +I+    +E VV L  
Sbjct: 9   IGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKL-- 66

Query: 363 YYYS---KDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE 419
            YYS   KD    V DY   G + ++L  R G  +  L    R  IA      I  +H  
Sbjct: 67  -YYSFQDKDNLYFVMDYIPGGDMMSLLI-RLGIFEEDL---ARFYIA-ELTCAIESVHKM 120

Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSDIGL------------------------------ 449
                +H  IK  NI ++  GH+ ++D GL                              
Sbjct: 121 G---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEW 177

Query: 450 AALMSPMPPPAMRAA----------------GYRAPEVTDTRKATQASDVFSFGVLLLEL 493
           + +      P  R                   Y APEV      TQ  D +S GV+L E+
Sbjct: 178 SEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM 237

Query: 494 LTGKSPIHA-TGGDEVVHLVRWVNSV 518
           L G+ P  A T  +  + ++ W  ++
Sbjct: 238 LVGQPPFLADTPAETQLKVINWETTL 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 45.0 bits (106), Expect = 8e-05
 Identities = 63/269 (23%), Positives = 96/269 (35%), Gaps = 64/269 (23%)

Query: 306 EVLGKGTFGTAYKAALEDASTV-VVKRLKEVNVGKR----EFEQQMEIVGGIRHENVVAL 360
           + LG G FG    A   D   +  +K L++ +V  R      + + +I+    +E VV L
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN 420
              +  KD    V DY   G + ++L  R G     L      R  I  A     + + +
Sbjct: 67  YYSFQDKDNLYFVMDYIPGGDMMSLLI-RMGIFPEDL-----ARFYI--AELTCAVESVH 118

Query: 421 GGKLVHGGIKASNIFLNSQGHVCVSDIGLAALM--------------------------- 453
               +H  IK  NI ++  GH+ ++D GL                               
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWG 178

Query: 454 --------SPMPPPAMRAA---------------GYRAPEVTDTRKATQASDVFSFGVLL 490
                     + P   RAA                Y APEV      TQ  D +S GV+L
Sbjct: 179 DPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL 238

Query: 491 LELLTGKSPIHATGGDEV-VHLVRWVNSV 518
            E+L G+ P  A    E  + ++ W  S+
Sbjct: 239 YEMLVGQPPFLAQTPLETQMKVINWQTSL 267

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 44.6 bits (106), Expect = 9e-05
 Identities = 29/88 (32%), Positives = 45/88 (51%), Gaps = 4/88 (4%)

Query: 411 RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPE 470
           RG+ +IH+     ++H  +K SNI +N    + + D GLA          +    YRAPE
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 185

Query: 471 VT-DTRKATQASDVFSFGVLLLELLTGK 497
           +  +     Q  D++S G ++ ELLTGK
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 44.6 bits (105), Expect = 1e-04
 Identities = 35/112 (31%), Positives = 56/112 (50%), Gaps = 11/112 (9%)

Query: 412 GIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLA--ALMSPMPPPAMRAAGYRAP 469
           GI H+H+     ++H  +K SNI + S   + + D GLA  A  S M  P +    YRAP
Sbjct: 138 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194

Query: 470 EVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVRE 521
           EV       +  D++S G ++ E++ G   +   G D   H+ +W N V+ +
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIKGG--VLFPGTD---HIDQW-NKVIEQ 240

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 44.6 bits (105), Expect = 1e-04
 Identities = 27/89 (30%), Positives = 47/89 (52%), Gaps = 4/89 (4%)

Query: 411 RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPE 470
           RG+ +IH+ +   ++H  +K SN+ +N    + + D GLA          +    YRAPE
Sbjct: 131 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPE 187

Query: 471 VT-DTRKATQASDVFSFGVLLLELLTGKS 498
           +  +     Q  D++S G ++ ELLTG++
Sbjct: 188 IMLNWMHYNQTVDIWSVGCIMAELLTGRT 216

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 43.8 bits (104), Expect = 1e-04
 Identities = 48/229 (20%), Positives = 92/229 (40%), Gaps = 73/229 (31%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRLKEVNVGKREFEQQMEIV--GGIR--------- 353
           E +G+GT+G  YKA        V +K+++         E + E V    IR         
Sbjct: 5   EKIGEGTYGVVYKARDKLTGEIVALKKIR--------LETEDEGVPSTAIREISLLKELN 56

Query: 354 HENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAA--- 410
           H N+V L    +S+++  +V+++ +      M              D+     +      
Sbjct: 57  HPNIVRLLDVVHSENKLYLVFEFLDLDLKKYM--------------DSSPLTGLDPPLIK 102

Query: 411 -------RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRA 463
                  +GIA+ H+    +++H  +K  N+ ++ +G + ++D GLA           RA
Sbjct: 103 SYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLA-----------RA 148

Query: 464 AG--------------YRAPEV-TDTRKATQASDVFSFGVLLLELLTGK 497
            G              YRAPE+   +R+ +   D++S G +  E++  +
Sbjct: 149 FGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 43.8 bits (103), Expect = 1e-04
 Identities = 67/291 (23%), Positives = 115/291 (39%), Gaps = 60/291 (20%)

Query: 306 EVLGKGTFGTAYKAALE---DASTVVVKRLKEV--NVGKREFEQQMEIVGGI-RHENVVA 359
           +V+G+G FG   +A ++         +K LKE       R+F  ++E++  +  H N++ 
Sbjct: 8   DVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIIN 67

Query: 360 L------RAYYYSKDEK---------LMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVR 404
           L      R Y Y   E          L      E     A  HG      S+L     ++
Sbjct: 68  LLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGT----ASTLTSQQLLQ 123

Query: 405 IAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLA--------ALMSPM 456
            A   A G+ ++  +   + +H  + A N+ +       ++D GL+          M  +
Sbjct: 124 FASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRL 180

Query: 457 PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWV 515
           P   M      A E  +    T  SDV+SFGVLL E+++ G +P       E+       
Sbjct: 181 PVRWM------AIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY------ 228

Query: 516 NSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADV 566
                 E   + + +E  R  N ++E+ E+++    C    P ERP  A +
Sbjct: 229 ------EKLPQGYRMEKPR--NCDDEVYELMR---QCWRDRPYERPPFAQI 268

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 43.4 bits (102), Expect = 2e-04
 Identities = 27/110 (24%), Positives = 47/110 (42%), Gaps = 5/110 (4%)

Query: 60  VTCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLT 119
           ++  ++   +  L L     + E  P +IG LS L+ L L +N +S    S    L NL 
Sbjct: 225 LSSLSNLKNLSGLELSNN--KLEDLPESIGNLSNLETLDLSNNQIS--SISSLGSLTNLR 280

Query: 120 SLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSAL 169
            L L  NS S  LPL   +   L  + L+      ++   ++ +   + +
Sbjct: 281 ELDLSGNSLSNALPLIALLLLLL-ELLLNLLLTLKALELKLNSILLNNNI 329

Length = 394

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 43.7 bits (103), Expect = 2e-04
 Identities = 53/227 (23%), Positives = 89/227 (39%), Gaps = 47/227 (20%)

Query: 306 EVLGKGTFGTAYKAALE-----------------DASTVVVKRLKE-VNVGKR-EFEQQM 346
           E LG+G FG  +    E                     V VK L+E  N   R +F +++
Sbjct: 11  EKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEI 70

Query: 347 EIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQ------SSLDWD 400
           +I+  ++  N++ L A   + D   M+ +Y E G ++  L     +         ++ + 
Sbjct: 71  KIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYS 130

Query: 401 TRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPA 460
           T + +A   A G+ ++ + N    VH  +   N  +     + ++D G       M    
Sbjct: 131 TLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKNYTIKIADFG-------MSRNL 180

Query: 461 MRAAGYR--APEVTDTR----------KATQASDVFSFGVLLLELLT 495
                YR     V   R          K T ASDV++FGV L E+LT
Sbjct: 181 YSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 43.7 bits (103), Expect = 2e-04
 Identities = 50/215 (23%), Positives = 95/215 (44%), Gaps = 23/215 (10%)

Query: 306 EVLGKGTFGTAYKAALEDASTV-VVKRL-KEVNVGKREFEQQME----IVGGIRHENVVA 359
           +VLGKG+FG    A L+    V  +K L K+V +   + +  M     +    +H  + A
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLH-GRRGEGQSSLDWDTRVRIAIGAARGIAHIHT 418
           L   + +KD    V +Y   G +   +   R+ +   S  +   V +A+        +H 
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLAL------MFLHR 114

Query: 419 ENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAA-----GYRAPEVTD 473
            +G  +++  +K  NI L+++GH  ++D G+      +              Y APE+  
Sbjct: 115 -HG--VIYRDLKLDNILLDAEGHCKLADFGMCK--EGILNGVTTTTFCGTPDYIAPEILQ 169

Query: 474 TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEV 508
             +   + D ++ GVL+ E++ G+ P  A   D++
Sbjct: 170 ELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 43.5 bits (102), Expect = 2e-04
 Identities = 47/211 (22%), Positives = 89/211 (42%), Gaps = 21/211 (9%)

Query: 306 EVLGKGTFGTAYKAALEDASTV-VVKRLKEVNVGKRE----FEQQMEIVGGIRHENVVAL 360
           +V+G+G FG      ++    +  +K L +  + KR     F ++  ++     + +  L
Sbjct: 7   KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTL 66

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN 420
              +  ++   +V DY+  G +  +L     + +  L  D   R  I     +  IH+ +
Sbjct: 67  HYAFQDENYLYLVMDYYVGGDLLTLL----SKFEDRLPEDM-ARFYIAEM--VLAIHSIH 119

Query: 421 GGKLVHGGIKASNIFLNSQGHVCVSDIGLAALM----SPMPPPAMRAAGYRAPEVTDTR- 475
               VH  IK  N+ L+  GH+ ++D G    M    +     A+    Y +PE+     
Sbjct: 120 QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAME 179

Query: 476 ----KATQASDVFSFGVLLLELLTGKSPIHA 502
               K     D +S GV + E+L G++P +A
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGETPFYA 210

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 39/134 (29%), Positives = 63/134 (47%), Gaps = 19/134 (14%)

Query: 411 RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMR---AAGYR 467
           RG+ +IH+ N   ++H  +K SN+ LN+   + + D GLA   S              YR
Sbjct: 119 RGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYR 175

Query: 468 APEVT-DTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVV---REEW 523
           APE+  +  + T A DV+S G +  ELL  K P+    G + VH ++ +  ++    EE 
Sbjct: 176 APELLLNCSEYTTAIDVWSVGCIFAELLGRK-PLFP--GKDYVHQLKLITELLGSPSEE- 231

Query: 524 TAEVFDVELLRYPN 537
                D+  +R   
Sbjct: 232 -----DLGFIRNEK 240

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 45/207 (21%), Positives = 80/207 (38%), Gaps = 40/207 (19%)

Query: 311 GTFGTAYKAALEDASTVVVKRL-KEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDE 369
            T     K  L+  S   +K L +E+   ++           ++H N++     +    E
Sbjct: 25  NTLVAVKKINLDSCSKEDLKLLQQEIITSRQ-----------LQHPNILPYVTSFIVDSE 73

Query: 370 KLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAI---GAARGIAHIHTENGGKLVH 426
             +V      GS   +L     EG   L       IA         + +IH++     +H
Sbjct: 74  LYVVSPLMAYGSCEDLLKTHFPEGLPEL------AIAFILKDVLNALDYIHSKG---FIH 124

Query: 427 GGIKASNIFLNSQGHVCVSDIGLAALMSPM------------PPPAMRAAGYRAPEV--T 472
             +KAS+I L+  G V +S  GL   +S +            P  +++   + +PEV   
Sbjct: 125 RSVKASHILLSGDGKVVLS--GLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQ 182

Query: 473 DTRKATQASDVFSFGVLLLELLTGKSP 499
           + +   + SD++S G+   EL  G  P
Sbjct: 183 NLQGYNEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 43.4 bits (102), Expect = 2e-04
 Identities = 40/160 (25%), Positives = 70/160 (43%), Gaps = 22/160 (13%)

Query: 354 HENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGI 413
           H N+V  RA + + +E  +V  +   GS   ++     +G S L       I  G  + +
Sbjct: 58  HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSEL---AIAYILQGVLKAL 114

Query: 414 AHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM------------PPPAM 461
            +IH       VH  +KAS+I ++  G V +S  GL + +S +            P  ++
Sbjct: 115 DYIHHMG---YVHRSVKASHILISVDGKVYLS--GLRSNLSMINHGQRLRVVHDFPKYSV 169

Query: 462 RAAGYRAPEV--TDTRKATQASDVFSFGVLLLELLTGKSP 499
           +   + +PEV   + +     SD++S G+   EL  G  P
Sbjct: 170 KVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 42.8 bits (101), Expect = 3e-04
 Identities = 58/216 (26%), Positives = 91/216 (42%), Gaps = 30/216 (13%)

Query: 308 LGKGTFGTAYKAALEDAST-----------VVVKRLKEVNVGKREFEQQMEIVGGIRHEN 356
           LG+GTF   YK  L   S            VV+K L   +     F +   ++  + H++
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62

Query: 357 VVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHI 416
           +V L      +DE +MV +Y + G +   LH  R +   SL W  ++ +A   A  + H 
Sbjct: 63  LVKLYGVCV-RDENIMVEEYVKFGPLDVFLH--REKNNVSLHW--KLDVAKQLASAL-HY 116

Query: 417 HTENGGKLVHGGIKASNIFL-----NSQGHVCV--SDIGLAALMSPMPPPAMRAAGYRAP 469
             +   KLVHG +   NI +     N      +  SD G+   +        R   + AP
Sbjct: 117 LEDK--KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP-WIAP 173

Query: 470 EV--TDTRKATQASDVFSFGVLLLELLT-GKSPIHA 502
           E         T A+D +SFG  LLE+ + G+ P+  
Sbjct: 174 ECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLST 209

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 42.8 bits (100), Expect = 3e-04
 Identities = 64/287 (22%), Positives = 115/287 (40%), Gaps = 52/287 (18%)

Query: 306 EVLGKGTFGTAYKAALEDAS---TVVVKRLKEV--NVGKREFEQQMEIVGGI-RHENVVA 359
           +V+G+G FG   KA ++         +KR+KE       R+F  ++E++  +  H N++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 360 L------RAYYYSKDEKL---MVYDYFEPGSV--SAMLHGRRGEGQSSLDWDTRVRIAIG 408
           L      R Y Y   E      + D+     V  +           S+L     +  A  
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 409 AARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLA--------ALMSPMPPPA 460
            ARG+ ++  +   + +H  + A NI +       ++D GL+          M  +P   
Sbjct: 121 VARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 177

Query: 461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVV 519
           M      A E  +    T  SDV+S+GVLL E+++ G +P       E+           
Sbjct: 178 M------AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY---------- 221

Query: 520 REEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADV 566
             E   + + +E     N ++E+ ++++    C    P ERP  A +
Sbjct: 222 --EKLPQGYRLEKPL--NCDDEVYDLMR---QCWREKPYERPSFAQI 261

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 42.3 bits (99), Expect = 4e-04
 Identities = 28/89 (31%), Positives = 41/89 (46%), Gaps = 5/89 (5%)

Query: 411 RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP--PAMRAAGYRA 468
           RG+  +H      +VH  +K  NI + S G V ++D GLA + S      P +    YRA
Sbjct: 119 RGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRA 175

Query: 469 PEVTDTRKATQASDVFSFGVLLLELLTGK 497
           PEV          D++S G +  E+   K
Sbjct: 176 PEVLLQSTYATPVDMWSVGCIFAEMFRRK 204

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 42.7 bits (100), Expect = 4e-04
 Identities = 27/89 (30%), Positives = 45/89 (50%), Gaps = 4/89 (4%)

Query: 411 RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPE 470
           RG+ +IH+     ++H  +K SN+ +N    + + D GLA          +    YRAPE
Sbjct: 129 RGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRWYRAPE 185

Query: 471 VT-DTRKATQASDVFSFGVLLLELLTGKS 498
           +  +     Q  D++S G ++ ELL GK+
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKA 214

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 43.1 bits (101), Expect = 4e-04
 Identities = 27/95 (28%), Positives = 50/95 (52%), Gaps = 5/95 (5%)

Query: 423 KLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAA-----GYRAPEVTDTRKA 477
           K++H  +K++NIFL   G + + D G +   S      + ++      Y APE+ + ++ 
Sbjct: 189 KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRY 248

Query: 478 TQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLV 512
           ++ +D++S GV+L ELLT   P       E++  V
Sbjct: 249 SKKADMWSLGVILYELLTLHRPFKGPSQREIMQQV 283

Length = 478

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 42.6 bits (100), Expect = 4e-04
 Identities = 64/306 (20%), Positives = 121/306 (39%), Gaps = 63/306 (20%)

Query: 306 EVLGKGTFGTAYKAALEDAST-----------------VVVKRLK-EVNVGKR-EFEQQM 346
           E LG+G FG  +   + +                    V VK L+ + N   R +F +++
Sbjct: 11  EKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEV 70

Query: 347 EIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAML----------HGRRGEGQS- 395
           +I+  ++  N++ L      +D   M+ +Y E G ++  L          +G      + 
Sbjct: 71  KILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAH 130

Query: 396 ---SLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGL--- 449
              ++ + + + +A+  A G+ ++ + N    VH  +   N  +     + ++D G+   
Sbjct: 131 CLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLATRNCLVGENLTIKIADFGMSRN 187

Query: 450 --AALMSPMPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT--GKSPIHATGG 505
             A     +   A+    + A E     K T ASDV++FGV L E+L    + P      
Sbjct: 188 LYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTD 247

Query: 506 DEVVHLVRWVNSVVREEWTAEVF-----DVELLRYPNIEEEMVEMLQVGMACVVRMPEER 560
           ++V+            E   E F      V L R P   + + E++   + C  R   ER
Sbjct: 248 EQVI------------ENAGEFFRDQGRQVYLFRPPPCPQGLYELM---LQCWSRDCRER 292

Query: 561 PKMADV 566
           P  +D+
Sbjct: 293 PSFSDI 298

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 42.1 bits (99), Expect = 4e-04
 Identities = 47/209 (22%), Positives = 90/209 (43%), Gaps = 26/209 (12%)

Query: 306 EVLGKGTFGTAYKAALEDA--------STVVVKRLKEVNVGKRE-FEQQMEIVGGIRHEN 356
           E LG+GTF   +K    +         + V++K L + +    E F +   ++  + H++
Sbjct: 1   ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKH 60

Query: 357 VVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHI 416
           +V         DE +MV +Y + GS+   L  ++ +   ++ W   V   +  A     +
Sbjct: 61  LVLNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWA-----L 113

Query: 417 HTENGGKLVHGGIKASNIFLNSQGH--------VCVSDIGLAALMSPMPPPAMRAAGYRA 468
           H      L HG + A N+ L  +          + +SD G++  + P      R   +  
Sbjct: 114 HFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP-WVP 172

Query: 469 PE-VTDTRKATQASDVFSFGVLLLELLTG 496
           PE + + +  + A+D +SFG  L E+ +G
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 42.3 bits (99), Expect = 5e-04
 Identities = 50/203 (24%), Positives = 93/203 (45%), Gaps = 23/203 (11%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKRE---FE--QQMEIVGGIRHENVVAL 360
           E LG+G++ T YK        +V   LK +++   E   F   ++  ++ G++H N+V L
Sbjct: 11  EKLGEGSYATVYKGISRINGQLVA--LKVISMKTEEGVPFTAIREASLLKGLKHANIVLL 68

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRI-AIGAARGIAHIHTE 419
               ++K+    V++Y        M+    G    +      VR+      RG+A+IH  
Sbjct: 69  HDIIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYN------VRLFMFQLLRGLAYIH-- 120

Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAA----GYRAPEV-TDT 474
            G  ++H  +K  N+ ++  G + ++D GLA   S +P     +      YR P+V    
Sbjct: 121 -GQHILHRDLKPQNLLISYLGELKLADFGLARAKS-IPSQTYSSEVVTLWYRPPDVLLGA 178

Query: 475 RKATQASDVFSFGVLLLELLTGK 497
              + A D++  G + +E+L G+
Sbjct: 179 TDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 42.2 bits (99), Expect = 5e-04
 Identities = 55/219 (25%), Positives = 89/219 (40%), Gaps = 31/219 (14%)

Query: 306 EVLGKGTFGTAYKAAL-EDASTVVVKRLK-EVNVGKREFEQQM---EIVGGIR-HENVVA 359
            VLGKG+FG    A L E      VK LK +V +   + E  M    I+   R H  +  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE 419
           L   + + D    V ++   G +  M H      Q S  +D   R    AA   + +   
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDL--MFHI-----QKSRRFD-EARARFYAAEITSALMFL 112

Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSDIGL----------AALMSPMPPPAMRAAGYRAP 469
           +   +++  +K  N+ L+ +GH  ++D G+           +     P        Y AP
Sbjct: 113 HDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTP-------DYIAP 165

Query: 470 EVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEV 508
           E+        + D ++ GVLL E+L G +P  A   D++
Sbjct: 166 EILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 42.2 bits (99), Expect = 6e-04
 Identities = 49/205 (23%), Positives = 89/205 (43%), Gaps = 18/205 (8%)

Query: 303 ASAEVLGKGTFGTAYKAA-LEDASTVVVKRL-----KEVNVGKREFEQQMEIVGGIRHEN 356
            S + +G G +G+   A        V +K+L      E+   KR + +++ ++  ++HEN
Sbjct: 18  TSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEI-FAKRAY-RELTLLKHMQHEN 75

Query: 357 VVALRAYYYSKDEKLMVYD-YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAI-GAARGIA 414
           V+ L   + S        D Y     +   L    G   S    + +V+  +     G+ 
Sbjct: 76  VIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLS----EDKVQYLVYQMLCGLK 131

Query: 415 HIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEVT-D 473
           +IH+     ++H  +K  N+ +N    + + D GLA          +    YRAPEV  +
Sbjct: 132 YIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILN 188

Query: 474 TRKATQASDVFSFGVLLLELLTGKS 498
                Q  D++S G ++ E+LTGK+
Sbjct: 189 WMHYNQTVDIWSVGCIMAEMLTGKT 213

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 42.1 bits (99), Expect = 6e-04
 Identities = 39/189 (20%), Positives = 70/189 (37%), Gaps = 28/189 (14%)

Query: 322 EDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMV-----YDY 376
           E    V+VK       G +   ++++I+  I H  ++ L   Y  K    MV      D 
Sbjct: 117 EQRKKVIVK----AVTGGKTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDL 172

Query: 377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFL 436
           F              +    L  +  + I       +A++H   G  ++H  +K  NIFL
Sbjct: 173 FT-----------YVDRSGPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFL 218

Query: 437 NSQGHVCVSDIGLAAL--MSPMPPPAMRAAG---YRAPEVTDTRKATQASDVFSFGVLLL 491
           +   +  + D G A      P  P     +G     +PE+         +D++S G++L 
Sbjct: 219 DEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLF 278

Query: 492 ELLTGKSPI 500
           E+      +
Sbjct: 279 EMSVKNVTL 287

Length = 392

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 42.0 bits (98), Expect = 6e-04
 Identities = 29/88 (32%), Positives = 45/88 (51%), Gaps = 5/88 (5%)

Query: 412 GIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLA--ALMSPMPPPAMRAAGYRAP 469
           GI H+H+     ++H  +K SNI + S   + + D GLA  A  S M  P +    YRAP
Sbjct: 131 GIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187

Query: 470 EVTDTRKATQASDVFSFGVLLLELLTGK 497
           EV       +  D++S G ++ E++  K
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHK 215

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown]

 Score = 41.9 bits (98), Expect = 7e-04
 Identities = 31/124 (25%), Positives = 54/124 (43%), Gaps = 15/124 (12%)

Query: 85  PNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWN--NL 142
            + +  L+ L +L L +N+++ + P       NL  L L  N       L   + N  NL
Sbjct: 109 ISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKIE---SLPSPLRNLPNL 165

Query: 143 TVIDLSNNFFNASIPASISKLTHLSALNLANNSLT-----GTLPRSLQRFPSWAFAGNNL 197
             +DLS N   + +P  +S L++L+ L+L+ N ++       L  +L+         NN 
Sbjct: 166 KNLDLSFN-DLSDLPKLLSNLSNLNNLDLSGNKISDLPPEIELLSALEEL----DLSNNS 220

Query: 198 SSEN 201
             E 
Sbjct: 221 IIEL 224

Length = 394

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 41.5 bits (97), Expect = 8e-04
 Identities = 63/278 (22%), Positives = 109/278 (39%), Gaps = 36/278 (12%)

Query: 308 LGKGTFGTAYKAALE---DASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALR 361
           +G G FG      +      + VVVK L+ V+     + +F ++ +    ++H N++   
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELR-VSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61

Query: 362 AYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENG 421
                    L+V ++   G +   L   R     + D  T  R+A   A G+ H+H  N 
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120

Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP-----MPPPAMRAAGYRAPEVTDTRK 476
              +H  +   N  L +   V + D GL+           P        + APE+ D   
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178

Query: 477 A-------TQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVF 528
                   T+ S+V+S GV + EL   G  P      ++V+         VRE+      
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY------TVREQQLK--L 230

Query: 529 DVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADV 566
               L+ P + +   E++Q    C ++ PE+RP   +V
Sbjct: 231 PKPRLKLP-LSDRWYEVMQ---FCWLQ-PEQRPSAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies)

 Score = 37.1 bits (87), Expect = 8e-04
 Identities = 15/48 (31%), Positives = 22/48 (45%), Gaps = 7/48 (14%)

Query: 94  LQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
           L+ L L +N ++ L     S L NL +L L  N  +     D S  +N
Sbjct: 3   LETLDLSNNQITDL--PPLSNLPNLETLDLSGNKIT-----DLSPLSN 43

Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 41.5 bits (97), Expect = 8e-04
 Identities = 47/205 (22%), Positives = 86/205 (41%), Gaps = 22/205 (10%)

Query: 308 LGKGTFGTAYKAAL--EDASTVVVKRLKEVNVGKRE-----FEQQMEIVGGIRHENVVAL 360
           LG G+FG    A    ED   V +KR ++  + K++     F ++ +I+  I H   V L
Sbjct: 38  LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER-KILNYINHPFCVNL 96

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIG---AARGIAHIH 417
              +  +    +V ++   G     L  RR         + R    +G   AA+ +    
Sbjct: 97  YGSFKDESYLYLVLEFVIGGEFFTFL--RR---------NKRFPNDVGCFYAAQIVLIFE 145

Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTRKA 477
                 +V+  +K  N+ L+  G + ++D G A ++            Y APE+      
Sbjct: 146 YLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCGTPEYIAPEILLNVGH 205

Query: 478 TQASDVFSFGVLLLELLTGKSPIHA 502
            +A+D ++ G+ + E+L G  P +A
Sbjct: 206 GKAADWWTLGIFIYEILVGCPPFYA 230

Length = 340

>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat

 Score = 37.1 bits (87), Expect = 0.001
 Identities = 17/49 (34%), Positives = 24/49 (48%)

Query: 141 NLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPS 189
           NL  +DLSNN        +   L +L  L+L+ N+LT   P +    PS
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPS 49

Length = 60

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 41.2 bits (96), Expect = 0.001
 Identities = 62/244 (25%), Positives = 95/244 (38%), Gaps = 61/244 (25%)

Query: 304 SAEVLGKGTFGTAYKAALEDASTV-VVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRA 362
           S +V+G+G FG       +D   V  +K L++ ++ ++E       VG IR E  + + A
Sbjct: 5   SLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKE------QVGHIRAERDILVEA 58

Query: 363 -------YYYSKDEKLMVYDYFE--PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGI 413
                   +YS  +KL +Y   E  PG     L  ++    +  + +T+  IA      I
Sbjct: 59  DSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKK---DTLTEEETQFYIA-ETVLAI 114

Query: 414 AHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAA-------------LMSPMPPP- 459
             IH       +H  IK  N+ L+S+GHV +SD GL               L   +P   
Sbjct: 115 DSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171

Query: 460 ---------------------AMRAAG---YRAPEVTDTRKATQASDVFSFGVLLLELLT 495
                                A    G   Y APEV       +  D +S GV++ E+L 
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231

Query: 496 GKSP 499
           G  P
Sbjct: 232 GYPP 235

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 40.7 bits (95), Expect = 0.001
 Identities = 50/213 (23%), Positives = 90/213 (42%), Gaps = 30/213 (14%)

Query: 308 LGKG--TFGTAYKAALEDASTVVVKRLKEVNVGKRE----FEQQMEIVGGIRHENVVALR 361
           +G+G     + Y A      T+V  R+ ++     E     + ++ +    RH N++   
Sbjct: 6   IGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSW 65

Query: 362 AYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVR-IAIGAARGIAHIHTEN 420
             + +     ++  +   GS +++L     EG S    +  +  I  GA RG+ ++H +N
Sbjct: 66  TVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMS----EALIGNILFGALRGLNYLH-QN 120

Query: 421 GGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEVT-------- 472
           G   +H  IKAS+I ++  G V +S  GL+ L S +         Y  P+ +        
Sbjct: 121 G--YIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLS 176

Query: 473 ------DTRKATQASDVFSFGVLLLELLTGKSP 499
                 D       SD++S G+   EL TG+ P
Sbjct: 177 PELLRQDLYGYNVKSDIYSVGITACELATGRVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 40.7 bits (96), Expect = 0.001
 Identities = 54/225 (24%), Positives = 86/225 (38%), Gaps = 71/225 (31%)

Query: 308 LGKGTFGTAYKAA-LEDASTVVVKR--------------LKEVNVGKREFEQQMEIVGGI 352
           +G+G +GT YKA  L     V +K+              L+E+ + K+  E         
Sbjct: 7   IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQ-LESF------- 58

Query: 353 RHENVVALR--AYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAA 410
            H N+V L    +    D +L +   FE        H         +D D    ++    
Sbjct: 59  EHPNIVRLLDVCHGPRTDRELKLTLVFE--------H---------VDQDLATYLSKCPK 101

Query: 411 RGIA------------------HIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAAL 452
            G+                   H H     ++VH  +K  NI + S G V ++D GLA +
Sbjct: 102 PGLPPETIKDLMRQLLRGVDFLHSH-----RIVHRDLKPQNILVTSDGQVKIADFGLARI 156

Query: 453 MS-PMP-PPAMRAAGYRAPEVTDTRKATQAS--DVFSFGVLLLEL 493
            S  M     +    YRAPEV    +++ A+  D++S G +  EL
Sbjct: 157 YSFEMALTSVVVTLWYRAPEV--LLQSSYATPVDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 40.9 bits (96), Expect = 0.002
 Identities = 30/88 (34%), Positives = 46/88 (52%), Gaps = 5/88 (5%)

Query: 412 GIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLA--ALMSPMPPPAMRAAGYRAP 469
           GI H+H  + G ++H  +K SNI + S   + + D GLA  A  S M  P +    YRAP
Sbjct: 130 GIKHLH--SAG-IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 186

Query: 470 EVTDTRKATQASDVFSFGVLLLELLTGK 497
           EV       +  D++S G ++ E++ G 
Sbjct: 187 EVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 40.6 bits (95), Expect = 0.002
 Identities = 52/219 (23%), Positives = 97/219 (44%), Gaps = 52/219 (23%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFE-------QQMEIVGGIRHENVV 358
           E +G+GT+G  YKA   D  T     LK++ + ++E E       +++ ++  ++H N+V
Sbjct: 8   EKIGEGTYGVVYKA--RDRVTNETIALKKIRL-EQEDEGVPSTAIREISLLKEMQHGNIV 64

Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIA----IGAARGIA 414
            L+   +S+    +V++Y +      M         SS D+    R+         RGIA
Sbjct: 65  RLQDVVHSEKRLYLVFEYLDLDLKKHM--------DSSPDFAKNPRLIKTYLYQILRGIA 116

Query: 415 HIHTENGGKLVHGGIKASNIFLN-SQGHVCVSDIGLAALMSPMPPPAMRAAG-------- 465
           + H+    +++H  +K  N+ ++     + ++D GLA           RA G        
Sbjct: 117 YCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLA-----------RAFGIPVRTFTH 162

Query: 466 ------YRAPEV-TDTRKATQASDVFSFGVLLLELLTGK 497
                 YRAPE+   +R  +   D++S G +  E++  K
Sbjct: 163 EVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 40.5 bits (95), Expect = 0.002
 Identities = 50/231 (21%), Positives = 100/231 (43%), Gaps = 46/231 (19%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFE-------QQMEIVGGIRHENVV 358
           E +G+GT+G  YK   +    +V   +K++ + + E E       +++ ++  ++H N+V
Sbjct: 6   EKIGEGTYGVVYKGRNKKTGQIVA--MKKIRL-ESEEEGVPSTAIREISLLKELQHPNIV 62

Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT 418
            L+     +    +++++        +    +G+    +D +          +GI   H+
Sbjct: 63  CLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQ---YMDAELVKSYLYQILQGILFCHS 119

Query: 419 ENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG------------- 465
               +++H  +K  N+ ++++G + ++D GLA           RA G             
Sbjct: 120 R---RVLHRDLKPQNLLIDNKGVIKLADFGLA-----------RAFGIPVRVYTHEVVTL 165

Query: 466 -YRAPEVT--DTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVR 513
            YRAPEV     R +T   D++S G +  E+ T K   H  G  E+  L R
Sbjct: 166 WYRAPEVLLGSPRYSTPV-DIWSIGTIFAEMATKKPLFH--GDSEIDQLFR 213

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|205079 pfam12799, LRR_4, Leucine Rich repeats (2 copies)

 Score = 35.2 bits (82), Expect = 0.003
 Identities = 15/37 (40%), Positives = 22/37 (59%), Gaps = 2/37 (5%)

Query: 141 NLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLT 177
           NL  +DLSNN     +P  +S L +L  L+L+ N +T
Sbjct: 2   NLETLDLSNNQIT-DLPP-LSNLPNLETLDLSGNKIT 36

Leucine rich repeats are short sequence motifs present in a number of proteins with diverse functions and cellular locations. These repeats are usually involved in protein-protein interactions. Each Leucine Rich Repeat is composed of a beta-alpha unit. These units form elongated non-globular structures. Leucine Rich Repeats are often flanked by cysteine rich domains. Length = 43

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 39.5 bits (92), Expect = 0.003
 Identities = 53/218 (24%), Positives = 93/218 (42%), Gaps = 31/218 (14%)

Query: 306 EVLGKGTFGTAYKAAL------EDASTVVVKR----LKEVNVGKRE----FEQQMEIVGG 351
           E LG+GT    Y   L      ED      K     LK ++   R+    F +   ++  
Sbjct: 1   EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQ 60

Query: 352 IRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAAR 411
           + H+++V L        E +MV ++ E G +   +H  R     +  W  + ++A   A 
Sbjct: 61  VSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMH--RKSDVLTTPW--KFKVAKQLAS 116

Query: 412 GIAHIHTENGGKLVHGGIKASNIFLNSQG-------HVCVSDIGLAALMSPMPPPAMRAA 464
            ++++  +    LVHG +   NI L  +G        + +SD G+   +        R  
Sbjct: 117 ALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERIP 173

Query: 465 GYRAPE-VTDTRKATQASDVFSFGVLLLEL-LTGKSPI 500
            + APE V D++  + A+D +SFG  L E+   G+ P+
Sbjct: 174 -WIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPL 210

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 39.9 bits (93), Expect = 0.003
 Identities = 38/141 (26%), Positives = 67/141 (47%), Gaps = 17/141 (12%)

Query: 369 EKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGG 428
           E +MV ++ E G +   L  R+ +G+  + W  ++ +A   A  ++++  +N   LVHG 
Sbjct: 90  ENIMVEEFVEHGPLDVCL--RKEKGRVPVAW--KITVAQQLASALSYLEDKN---LVHGN 142

Query: 429 IKASNIFL-------NSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPE-VTDTRKATQA 480
           + A NI L        +   + +SD G++           R   + APE V      + A
Sbjct: 143 VCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVERIP-WIAPECVPGGNSLSTA 201

Query: 481 SDVFSFGVLLLEL-LTGKSPI 500
           +D +SFG  LLE+   G+ P+
Sbjct: 202 ADKWSFGTTLLEICFDGEVPL 222

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 39.6 bits (93), Expect = 0.003
 Identities = 27/102 (26%), Positives = 37/102 (36%), Gaps = 32/102 (31%)

Query: 430 KASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG------------------------ 465
           K  NI L+  GH+ +SD  L+      PPP  +A                          
Sbjct: 130 KPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRS 189

Query: 466 --------YRAPEVTDTRKATQASDVFSFGVLLLELLTGKSP 499
                   Y APEV        A D ++ G+LL E+L G +P
Sbjct: 190 NSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 39.6 bits (92), Expect = 0.003
 Identities = 44/199 (22%), Positives = 90/199 (45%), Gaps = 16/199 (8%)

Query: 307 VLGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFE---QQMEIVGGIRHENVVALRA 362
           V+G+G +G   K   ++   +V +K+ K+    +   E   ++++++  ++ EN+V L+ 
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGG 422
            +  + +  +V++Y E   +  +     G          +VR  I   + I  IH  +  
Sbjct: 68  AFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPE------KVRSYI--YQLIKAIHWCHKN 119

Query: 423 KLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP----PPAMRAAGYRAPEVTDTRKAT 478
            +VH  IK  N+ ++    + + D G A  +S          +    YR+PE+       
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYG 179

Query: 479 QASDVFSFGVLLLELLTGK 497
           +A D++S G +L EL  G+
Sbjct: 180 KAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	615
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.98
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.98
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.98
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.97
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.97
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.96
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.95
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.95
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.95
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.93
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.93
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.92
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.9
PRK09188	365	serine/threonine protein kinase; Provisional	99.88
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.88
PLN03150	623	hypothetical protein; Provisional	99.86
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.86
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.86
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.86
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.84
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.84
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.83
PRK12274	218	serine/threonine protein kinase; Provisional	99.83
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.82
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.82
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.8
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.8
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.76
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.76
PRK10345	210	hypothetical protein; Provisional	99.75
PRK14879	211	serine/threonine protein kinase; Provisional	99.72
smart00090	237	RIO RIO-like kinase.	99.72
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.71
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.7
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.69
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.69
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.66
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.62
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.61
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.61
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.61
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.57
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.52
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.5
PLN03150	623	hypothetical protein; Provisional	99.48
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.45
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.33
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.29
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.27
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.26
KOG0617	264	consensus Ras suppressor protein (contains leucine	99.23
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.23
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.21
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.16
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.15
KOG0472	565	consensus Leucine-rich repeat protein [Function un	99.14
KOG0444	1255	consensus Cytoskeletal regulator Flightless-I (con	99.13
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.11
KOG1243	690	consensus Protein kinase [General function predict	99.1
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.09
KOG4194	873	consensus Membrane glycoprotein LIG-1 [Signal tran	99.07
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.04
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	99.03
KOG4237	498	consensus Extracellular matrix protein slit, conta	98.96
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	98.92
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.92
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.9
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.9
PF13855	61	LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF	98.9
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.88
KOG3087	229	consensus Serine/threonine protein kinase [General	98.86
KOG0618	1081	consensus Serine/threonine phosphatase 2C containi	98.85
PF14580	175	LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ	98.84
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	98.83
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	98.81
PRK15370	754	E3 ubiquitin-protein ligase SlrP; Provisional	98.8
COG4248	637	Uncharacterized protein with protein kinase and he	98.78
PRK15387	788	E3 ubiquitin-protein ligase SspH2; Provisional	98.78
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.76
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.73
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	98.71
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.69
PLN03210	1153	Resistant to P. syringae 6; Provisional	98.68
KOG4237	498	consensus Extracellular matrix protein slit, conta	98.68
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	98.62
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.58
PRK09902	216	hypothetical protein; Provisional	98.53
cd00116	319	LRR_RI Leucine-rich repeats (LRRs), ribonuclease i	98.51
PLN03210	1153	Resistant to P. syringae 6; Provisional	98.5
PF08263	43	LRRNT_2: Leucine rich repeat N-terminal domain; In	98.5
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.46
KOG1859	1096	consensus Leucine-rich repeat proteins [General fu	98.45
KOG0532	722	consensus Leucine-rich repeat (LRR) protein, conta	98.44
KOG1259	490	consensus Nischarin, modulator of integrin alpha5	98.42
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.41
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.38
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.37
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	98.31
COG4886	394	Leucine-rich repeat (LRR) protein [Function unknow	98.31
KOG3207	505	consensus Beta-tubulin folding cofactor E [Posttra	98.26
KOG4579	177	consensus Leucine-rich repeat (LRR) protein associ	98.26
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.1
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.09
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.07
KOG4658	889	consensus Apoptotic ATPase [Signal transduction me	98.06
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.05
KOG0531	414	consensus Protein phosphatase 1, regulatory subuni	98.04

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=4.3e-59  Score=550.34  Aligned_cols=471  Identities=27%  Similarity=0.463  Sum_probs=301.5

Q ss_pred             cEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeec
Q 007167           68 RVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL  147 (615)
Q Consensus        68 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l  147 (615)
                      ++..|+|++|+++|.+|. .+.++++|+.|+|++|+++|.+|..+.++++|++|+|++|.++|.+|..|..+++|+.|+|
T Consensus       476 ~L~~L~ls~n~l~~~~~~-~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L  554 (968)
T PLN00113        476 RLENLDLSRNQFSGAVPR-KLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLSQLDL  554 (968)
T ss_pred             cceEEECcCCccCCccCh-hhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCCEEEC
Confidence            445555555555555554 4555555666666666666555555555666666666666666555655555666666666


Q ss_pred             CCCcCCccCCCcccCCCCCCeeeccCccccCCCccc--cccCCcccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Q 007167          148 SNNFFNASIPASISKLTHLSALNLANNSLTGTLPRS--LQRFPSWAFAGNNLSSENARPPALPVQPPVAEPSRKKSTKLS  225 (615)
Q Consensus       148 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~l~~l~~~~n~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~  225 (615)
                      ++|+++|.+|..+.++++|+.|++++|+++|.+|..  +..+....+.||+..|+......   .++..    .......
T Consensus       555 s~N~l~~~~p~~l~~l~~L~~l~ls~N~l~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~---~~~c~----~~~~~~~  627 (968)
T PLN00113        555 SQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGAFLAINASAVAGNIDLCGGDTTSG---LPPCK----RVRKTPS  627 (968)
T ss_pred             CCCcccccCChhHhcCcccCEEeccCCcceeeCCCcchhcccChhhhcCCccccCCccccC---CCCCc----cccccce
Confidence            666666555655555555666666666666555532  23333444555554443211100   00110    0101111


Q ss_pred             CcchhhhhhhhhHHHHHHHHHhhheeeccCCCCCcccccccccccccccccCCCCCCCceEEecc-cccccCHHHHHHHH
Q 007167          226 EPALLGIALGGVALAFVICALLMICRYNKQDNDRIPVKSQKKEMSLKEGVSGSHDKNSKLVFFEG-CNLVFDLEDLLRAS  304 (615)
Q Consensus       226 ~~~iigi~~~~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~  304 (615)
                      ...++++++++++++++ +++++++++++++...........              ......+.. ....++.+++....
T Consensus       628 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~  692 (968)
T PLN00113        628 WWFYITCTLGAFLVLAL-VAFGFVFIRGRNNLELKRVENEDG--------------TWELQFFDSKVSKSITINDILSSL  692 (968)
T ss_pred             eeeehhHHHHHHHHHHH-HHHHHHHHHhhhcccccccccccc--------------cccccccccccchhhhHHHHHhhC
Confidence            12223333333222222 222222222221111100000000              000011110 01123444444433


Q ss_pred             --hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          305 --AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       305 --~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                        .++||+|+||.||+|.. .++..||||+++....   ....|++.+++++|||||+++++|.+.+..++||||+++|+
T Consensus       693 ~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~---~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~  769 (968)
T PLN00113        693 KEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS---IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKN  769 (968)
T ss_pred             CcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc---ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCc
Confidence              35799999999999996 5788999999875432   22356889999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCCCC
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAM  461 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  461 (615)
                      |.++++        .++|..+.+|+.|+|+|++|||..+.++|+||||||+||+++.++.+++. ||.+..... .....
T Consensus       770 L~~~l~--------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-~~~~~  839 (968)
T PLN00113        770 LSEVLR--------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-DTKCF  839 (968)
T ss_pred             HHHHHh--------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-CCCcc
Confidence            999995        38999999999999999999997655669999999999999999988875 666544322 22335


Q ss_pred             CCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCC-CCcHH
Q 007167          462 RAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY-PNIEE  540 (615)
Q Consensus       462 ~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~~~  540 (615)
                      ++.+|+|||++.+..++.++|||||||++|||++|+.||+.... .....++|++...........+|+.+... +...+
T Consensus       840 ~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  918 (968)
T PLN00113        840 ISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQN  918 (968)
T ss_pred             ccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccccCCCCccHH
Confidence            67899999999998999999999999999999999999964332 23456677765554444445555554322 23346


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          541 EMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       541 ~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                      +..++.+++.+||+.+|++||+|+||+++|+++.+
T Consensus       919 ~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        919 EIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             HHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            67788899999999999999999999999998876

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-56  Score=456.94  Aligned_cols=282  Identities=38%  Similarity=0.644  Sum_probs=249.4

Q ss_pred             ccccCHHHHHHHH-----hhhcCcCCccEEEEEEECCCCEEEEEEeccccCC-HHHHHHHHHHHhCCCCCcccceeEEEE
Q 007167          292 NLVFDLEDLLRAS-----AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVG-KREFEQQMEIVGGIRHENVVALRAYYY  365 (615)
Q Consensus       292 ~~~~~~~~l~~~~-----~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~  365 (615)
                      ...|++.++..||     .++||+|+||.||+|.+.+|..||||++...... .++|.+|++++.+++|||+|+|+|||.
T Consensus        62 ~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~  141 (361)
T KOG1187|consen   62 LRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCL  141 (361)
T ss_pred             cceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence            4568999999999     3689999999999999999999999998876554 677999999999999999999999999


Q ss_pred             ecC-eeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEE
Q 007167          366 SKD-EKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCV  444 (615)
Q Consensus       366 ~~~-~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl  444 (615)
                      +.+ +.+||||||++|+|.++|+.....   +++|.+|++|+.++|+||+|||+...++||||||||+|||+|+++++||
T Consensus       142 e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl  218 (361)
T KOG1187|consen  142 EGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL  218 (361)
T ss_pred             cCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence            998 599999999999999999975432   7899999999999999999999999889999999999999999999999


Q ss_pred             eecccccccCC-CCCCC---CCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhh
Q 007167          445 SDIGLAALMSP-MPPPA---MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVR  520 (615)
Q Consensus       445 ~DfG~a~~~~~-~~~~~---~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  520 (615)
                      +|||+|+.... .....   .+|.||+|||++..+..++|+||||||||++|++||+.|.+.........++.|+.....
T Consensus       219 sDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~  298 (361)
T KOG1187|consen  219 SDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLE  298 (361)
T ss_pred             cCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHH
Confidence            99999976654 32222   789999999999999999999999999999999999999886554444558999988888


Q ss_pred             cccccccccccccCCCCcH-HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          521 EEWTAEVFDVELLRYPNIE-EEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       521 ~~~~~~~~d~~~~~~~~~~-~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                      +....+++|+.+....... +++..+.++|.+|++.+|.+||+|.||+++|+.+...
T Consensus       299 ~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  299 EGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             CcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            8899999999987433332 7888999999999999999999999999999766543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-47  Score=389.65  Aligned_cols=261  Identities=28%  Similarity=0.489  Sum_probs=212.0

Q ss_pred             cCHHHHHHHHhhhcCcCCccEEEEEEECCCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecC-ee
Q 007167          295 FDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKD-EK  370 (615)
Q Consensus       295 ~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~  370 (615)
                      .++.++..  .+.||+|+||+||+|.++....||||++.....+   .+.|.+|+.+|.+++|||||+++|+|.+.. ..
T Consensus        38 i~~~~l~~--~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~  115 (362)
T KOG0192|consen   38 IDPDELPI--EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSL  115 (362)
T ss_pred             cChHHhhh--hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCce
Confidence            34455433  4569999999999999986555999999865433   458999999999999999999999999887 79


Q ss_pred             eEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCC-cEEEeeccc
Q 007167          371 LMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG-HVCVSDIGL  449 (615)
Q Consensus       371 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~-~~kl~DfG~  449 (615)
                      ++|||||++|+|.++++..   ....+++..+++++.|||+||.|||++++  ||||||||+|||++.++ ++||+|||+
T Consensus       116 ~iVtEy~~~GsL~~~l~~~---~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGl  190 (362)
T KOG0192|consen  116 CIVTEYMPGGSLSVLLHKK---RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGL  190 (362)
T ss_pred             EEEEEeCCCCcHHHHHhhc---ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCcc
Confidence            9999999999999999863   24579999999999999999999999863  99999999999999998 999999999


Q ss_pred             ccccCC---CCCCCCCCCcccCccccC--CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccc
Q 007167          450 AALMSP---MPPPAMRAAGYRAPEVTD--TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWT  524 (615)
Q Consensus       450 a~~~~~---~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  524 (615)
                      ++....   ......||..|||||++.  ...|++|+|||||||++|||+||+.||...........+  +....+    
T Consensus       191 sr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v--~~~~~R----  264 (362)
T KOG0192|consen  191 SREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAV--VVGGLR----  264 (362)
T ss_pred             ceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHH--HhcCCC----
Confidence            987764   233457899999999999  568999999999999999999999999876652222111  111110    


Q ss_pred             cccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhhc
Q 007167          525 AEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKA  578 (615)
Q Consensus       525 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~  578 (615)
                           +.+  .....+.+..+++   +||..||..||++.|++..|+.+.....
T Consensus       265 -----p~~--p~~~~~~l~~l~~---~CW~~dp~~RP~f~ei~~~l~~~~~~~~  308 (362)
T KOG0192|consen  265 -----PPI--PKECPPHLSSLME---RCWLVDPSRRPSFLEIVSRLESIMSHIS  308 (362)
T ss_pred             -----CCC--CccCCHHHHHHHH---HhCCCCCCcCCCHHHHHHHHHHHHHhhc
Confidence                 111  1124455555555   8999999999999999999999987444

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-47  Score=388.33  Aligned_cols=252  Identities=29%  Similarity=0.451  Sum_probs=218.6

Q ss_pred             HHhhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          303 ASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       303 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      ...+.||+|-||+||.|.++....||+|.++......++|.+|+++|++++|+|||+++|+|..++.++||||||+.|+|
T Consensus       209 ~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL  288 (468)
T KOG0197|consen  209 KLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL  288 (468)
T ss_pred             HHHHHhcCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence            34678999999999999999888999999998878889999999999999999999999999998899999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCCCC-
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAM-  461 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~-  461 (615)
                      .++|+..   ....++..+.+.++.|||+|++||++++   +|||||.++||||+++..+||+|||+|+...+..+... 
T Consensus       289 l~yLr~~---~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~  362 (468)
T KOG0197|consen  289 LDYLRTR---EGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASE  362 (468)
T ss_pred             HHHhhhc---CCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeecC
Confidence            9999862   2457899999999999999999999998   99999999999999999999999999996554333211 


Q ss_pred             ---CCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCC
Q 007167          462 ---RAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN  537 (615)
Q Consensus       462 ---~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  537 (615)
                         -...|.|||.+....++.|||||||||+||||+| |+.||..+...+++..+.--              .+++..+.
T Consensus       363 ~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~G--------------yRlp~P~~  428 (468)
T KOG0197|consen  363 GGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERG--------------YRLPRPEG  428 (468)
T ss_pred             CCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhcc--------------CcCCCCCC
Confidence               2446999999999999999999999999999999 99999998887776655411              13445556


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhh
Q 007167          538 IEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVK  577 (615)
Q Consensus       538 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~  577 (615)
                      +++++.++++   .||+.+|++|||++.+...|+++....
T Consensus       429 CP~~vY~lM~---~CW~~~P~~RPtF~~L~~~l~~~~~~~  465 (468)
T KOG0197|consen  429 CPDEVYELMK---SCWHEDPEDRPTFETLREVLEDFFTST  465 (468)
T ss_pred             CCHHHHHHHH---HHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence            6666666555   999999999999999999999987643

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-46  Score=367.42  Aligned_cols=252  Identities=25%  Similarity=0.440  Sum_probs=207.8

Q ss_pred             cCHHHHHHHHhhhcCcCCccEEEEEEEC-CCCEEEEEEeccc--cCCHHHHHHHHHHHhCCCCCcccceeEEEEecC-ee
Q 007167          295 FDLEDLLRASAEVLGKGTFGTAYKAALE-DASTVVVKRLKEV--NVGKREFEQQMEIVGGIRHENVVALRAYYYSKD-EK  370 (615)
Q Consensus       295 ~~~~~l~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~  370 (615)
                      +...|+.+  .+.||+|..|+|||+.++ .++.+|+|.+...  ....+++.+|++++++.+|||||.++|.|+.+. ..
T Consensus        76 i~~~dle~--~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~i  153 (364)
T KOG0581|consen   76 ISLSDLER--LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEI  153 (364)
T ss_pred             cCHHHhhh--hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceE
Confidence            44556644  567999999999999976 5667899998433  223578899999999999999999999999998 59


Q ss_pred             eEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCceecCCCCCCEEeCCCCcEEEeeccc
Q 007167          371 LMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT-ENGGKLVHGGIKASNIFLNSQGHVCVSDIGL  449 (615)
Q Consensus       371 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~iiHrDik~~Nill~~~~~~kl~DfG~  449 (615)
                      .|+||||++|||++++...     ..+++....+|+.++++||.|||+ ++   ||||||||+|||++..|++||||||.
T Consensus       154 sI~mEYMDgGSLd~~~k~~-----g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGV  225 (364)
T KOG0581|consen  154 SICMEYMDGGSLDDILKRV-----GRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGV  225 (364)
T ss_pred             EeehhhcCCCCHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccc
Confidence            9999999999999999642     469999999999999999999996 54   99999999999999999999999999


Q ss_pred             ccccCCC-CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccc
Q 007167          450 AALMSPM-PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVF  528 (615)
Q Consensus       450 a~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  528 (615)
                      ++.+... ..+.+||..|||||.+.+..|+.++||||||++++|+.+|+.||..... ........+..+..+       
T Consensus       226 S~~lvnS~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~-~~~~~~~Ll~~Iv~~-------  297 (364)
T KOG0581|consen  226 SGILVNSIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNP-PYLDIFELLCAIVDE-------  297 (364)
T ss_pred             cHHhhhhhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCC-CCCCHHHHHHHHhcC-------
Confidence            9887654 3566799999999999999999999999999999999999999987521 112222222222221       


Q ss_pred             cccccCCC--CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          529 DVELLRYP--NIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       529 d~~~~~~~--~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                        ..+..|  .++++...++.   .|+++||.+||++.|+++|
T Consensus       298 --ppP~lP~~~fS~ef~~FV~---~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  298 --PPPRLPEGEFSPEFRSFVS---CCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             --CCCCCCcccCCHHHHHHHH---HHhcCCcccCCCHHHHhcC
Confidence              222222  36777888877   9999999999999999987

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-45  Score=380.35  Aligned_cols=240  Identities=23%  Similarity=0.401  Sum_probs=209.5

Q ss_pred             HhhhcCcCCccEEEEEEE-CCCCEEEEEEeccc----cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCC
Q 007167          304 SAEVLGKGTFGTAYKAAL-EDASTVVVKRLKEV----NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       304 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      .+++||+|||+.||+++. ..|..||+|++.+.    ....+.+.+|+++.+.++|||||+++++|++.+..|||.|+|.
T Consensus        22 ~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~  101 (592)
T KOG0575|consen   22 RGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCH  101 (592)
T ss_pred             eeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecC
Confidence            357899999999999997 78999999999763    3335678899999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC---
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP---  455 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~---  455 (615)
                      +++|..++..+     .++++..++.++.||+.||.|||+.+   |+|||||-.|+++++++++||+|||+|..+..   
T Consensus       102 ~~sL~el~Krr-----k~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E  173 (592)
T KOG0575|consen  102 RGSLMELLKRR-----KPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE  173 (592)
T ss_pred             CccHHHHHHhc-----CCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCccc
Confidence            99999999733     47999999999999999999999998   99999999999999999999999999999874   


Q ss_pred             CCCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCC
Q 007167          456 MPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY  535 (615)
Q Consensus       456 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  535 (615)
                      ...+.+||+.|.|||++....++..+||||+|||+|-|+.|++||....-.+....++..               +....
T Consensus       174 rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~---------------~Y~~P  238 (592)
T KOG0575|consen  174 RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN---------------EYSMP  238 (592)
T ss_pred             ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc---------------Ccccc
Confidence            345678999999999999999999999999999999999999999876544444433211               11122


Q ss_pred             CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          536 PNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       536 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ..++.+.++++.   ++++.+|.+|||+.+|+.+
T Consensus       239 ~~ls~~A~dLI~---~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  239 SHLSAEAKDLIR---KLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             cccCHHHHHHHH---HHhcCCcccCCCHHHHhcC
Confidence            356778888888   9999999999999999987

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.9e-46  Score=399.52  Aligned_cols=253  Identities=26%  Similarity=0.412  Sum_probs=215.0

Q ss_pred             hhhcCcCCccEEEEEEEC------CCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAALE------DASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      .+.||+|+||.||+|+..      +...||||.+++...  ...+|++|+++++.++|||||+++|.|.+++..+||+||
T Consensus       491 ~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEY  570 (774)
T KOG1026|consen  491 KEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEY  570 (774)
T ss_pred             hhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEe
Confidence            467999999999999843      345699999997643  367899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCC---------CCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeec
Q 007167          377 FEPGSVSAMLHGRRGEG---------QSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDI  447 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~---------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Df  447 (615)
                      |..|||.++|.......         ..+++..+.+.|+.|||.|++||-++.   +|||||..+|+||+++..+||+||
T Consensus       571 m~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~VKIsDf  647 (774)
T KOG1026|consen  571 MDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVVKISDF  647 (774)
T ss_pred             cccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEEEeccc
Confidence            99999999997543221         234899999999999999999999997   999999999999999999999999


Q ss_pred             ccccccCCCCCCCCC-----CCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhc
Q 007167          448 GLAALMSPMPPPAMR-----AAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVRE  521 (615)
Q Consensus       448 G~a~~~~~~~~~~~~-----~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  521 (615)
                      |+++.....++...+     ..+|||||.+..++|++++|||||||||||+++ |+.||.+..++|+++.++--+     
T Consensus       648 GLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~-----  722 (774)
T KOG1026|consen  648 GLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQ-----  722 (774)
T ss_pred             ccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCC-----
Confidence            999987766665554     457999999999999999999999999999999 999999999999887775111     


Q ss_pred             ccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhh
Q 007167          522 EWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVK  577 (615)
Q Consensus       522 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~  577 (615)
                               .+....+++.++   ..|+..||+..|.+||++.||-..|+......
T Consensus       723 ---------lL~~Pe~CP~~v---Y~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~s  766 (774)
T KOG1026|consen  723 ---------LLSCPENCPTEV---YSLMLECWNENPKRRPSFKEIHSRLQAWAQAS  766 (774)
T ss_pred             ---------cccCCCCCCHHH---HHHHHHHhhcCcccCCCHHHHHHHHHHHHhcC
Confidence                     122233444554   45555999999999999999999999887643

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.4e-45  Score=359.55  Aligned_cols=243  Identities=23%  Similarity=0.391  Sum_probs=200.2

Q ss_pred             hhhcCcCCccEEEEEE-ECCCCEEEEEEeccccC--------CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEee
Q 007167          305 AEVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNV--------GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYD  375 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~--------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  375 (615)
                      .+.||+|+||.|-+|. .++|+.||||.+.+...        .....++|+++|++++|||||+++++|...+..|||||
T Consensus       177 ~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE  256 (475)
T KOG0615|consen  177 SKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLE  256 (475)
T ss_pred             eeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEE
Confidence            4679999999999998 45799999999975421        12345799999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCC---CcEEEeecccccc
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQ---GHVCVSDIGLAAL  452 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~---~~~kl~DfG~a~~  452 (615)
                      |++||+|.+.+-.+     ..+.+.....++.|++.|+.|||+.|   |+||||||+|||+..+   ..+||+|||+|+.
T Consensus       257 ~v~GGeLfd~vv~n-----k~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK~  328 (475)
T KOG0615|consen  257 YVEGGELFDKVVAN-----KYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAKV  328 (475)
T ss_pred             EecCccHHHHHHhc-----cccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhhc
Confidence            99999999999753     35777888899999999999999998   9999999999999866   6799999999999


Q ss_pred             cCCC--CCCCCCCCcccCccccCCCC---CCCccchhhHHHHHHHHHhCCCCCCCCCCcc-hhhHHHHHHHhhhcccccc
Q 007167          453 MSPM--PPPAMRAAGYRAPEVTDTRK---ATQASDVFSFGVLLLELLTGKSPIHATGGDE-VVHLVRWVNSVVREEWTAE  526 (615)
Q Consensus       453 ~~~~--~~~~~~~~~y~aPE~~~~~~---~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~  526 (615)
                      ....  -.+.+||+.|.|||++.+..   +..++|+||+|||||-+++|.+||.....+. ..+++.-      .     
T Consensus       329 ~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~------G-----  397 (475)
T KOG0615|consen  329 SGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILK------G-----  397 (475)
T ss_pred             cccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhc------C-----
Confidence            8643  35678999999999996654   3458899999999999999999998766554 3333321      1     


Q ss_pred             cccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          527 VFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       527 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+...-..+..++++..+++.   +++..||++|||+.|++++
T Consensus       398 ~y~f~p~~w~~Iseea~dlI~---~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  398 RYAFGPLQWDRISEEALDLIN---WMLVVDPENRPSADEALNH  437 (475)
T ss_pred             cccccChhhhhhhHHHHHHHH---HhhEeCcccCcCHHHHhcC
Confidence            111111234456777777777   9999999999999999986

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-45  Score=380.87  Aligned_cols=274  Identities=27%  Similarity=0.440  Sum_probs=228.6

Q ss_pred             hhhcCcCCccEEEEEEECC----CCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALED----ASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      .++||.|-||+||+|.++-    ...||||.+|....  ...+|..|..||+++.||||++|.|+.......+||.|||+
T Consensus       634 e~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyME  713 (996)
T KOG0196|consen  634 EKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYME  713 (996)
T ss_pred             EEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhh
Confidence            4689999999999999753    34699999997643  35789999999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP  458 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~  458 (615)
                      ||+|+.+|+.+.    ..+++-+..-++.+||.|+.||-+.+   +|||||.++|||++.+..+||+|||+++.+.+...
T Consensus       714 NGsLDsFLR~~D----GqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~  786 (996)
T KOG0196|consen  714 NGSLDSFLRQND----GQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  786 (996)
T ss_pred             CCcHHHHHhhcC----CceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCCC
Confidence            999999998653    35999999999999999999999998   99999999999999999999999999998876553


Q ss_pred             CCCCC------CcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccccccccc
Q 007167          459 PAMRA------AGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE  531 (615)
Q Consensus       459 ~~~~~------~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  531 (615)
                      ....|      .+|.|||.+..++++.++|||||||||||+++ |..||.++.+++++..+.                 +
T Consensus       787 ~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe-----------------~  849 (996)
T KOG0196|consen  787 AAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-----------------Q  849 (996)
T ss_pred             ccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHH-----------------h
Confidence            33333      46999999999999999999999999999999 999999999988766553                 1


Q ss_pred             ccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhhcCCCCCCCcccCCCCCCCCCCCCCCCCCc
Q 007167          532 LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTENRSEISSSAATPKATETASSS  606 (615)
Q Consensus       532 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  606 (615)
                      ..+.|...++...+.+|++.||++|-.+||++.||+.+|.++.+    +|.|-........+++++....+.++.
T Consensus       850 gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIr----nP~SLk~~~~~~~r~s~~lld~~~~~~  920 (996)
T KOG0196|consen  850 GYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIR----NPNSLKTIAPESPRPSQPLLDRSGSDF  920 (996)
T ss_pred             ccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhc----CchhhcccCCCCCCCcccccCCCCCCC
Confidence            12334444566677888889999999999999999999999876    334444444445555666665554444

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-44  Score=353.15  Aligned_cols=199  Identities=24%  Similarity=0.424  Sum_probs=176.4

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      +.||+|+||+||+|+.+ ++..||||.+....-.   .+.+..|+.+|+.++|||||++++++..++..++|||||.+|+
T Consensus        16 ~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGD   95 (429)
T KOG0595|consen   16 REIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGD   95 (429)
T ss_pred             hhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCC
Confidence            34999999999999954 6789999999765322   3456789999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCC------CcEEEeecccccccCC
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQ------GHVCVSDIGLAALMSP  455 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~------~~~kl~DfG~a~~~~~  455 (615)
                      |.++++.+.     .+++.....++.|+|.||++||+++   ||||||||.|||++..      -.+||+|||+|+.+.+
T Consensus        96 Ls~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~  167 (429)
T KOG0595|consen   96 LSDYIRRRG-----RLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP  167 (429)
T ss_pred             HHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence            999998543     6999999999999999999999998   9999999999999875      4589999999999976


Q ss_pred             CC--CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 007167          456 MP--PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLV  512 (615)
Q Consensus       456 ~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~  512 (615)
                      ..  .+.+|++-|||||++..++|+.|+|+||+|+++|++++|+.||+..+..|....+
T Consensus       168 ~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~  226 (429)
T KOG0595|consen  168 GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYI  226 (429)
T ss_pred             hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH
Confidence            53  4567899999999999999999999999999999999999999987766655443

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.8e-43  Score=334.27  Aligned_cols=254  Identities=20%  Similarity=0.356  Sum_probs=199.2

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      ..++|+|+||+|||++.+ .|+.||||++.....+   ++-..+|+++|++++|+|+|.++.+|..+...++|+||++..
T Consensus         7 LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhT   86 (396)
T KOG0593|consen    7 LGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHT   86 (396)
T ss_pred             hhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchH
Confidence            356999999999999965 5788999999876543   466789999999999999999999999999999999999875


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---  457 (615)
                      -|.++-+ .    ...++.....+++.|++.|+.|+|+++   +|||||||+|||++.++.+||||||+|+.+..+.   
T Consensus        87 vL~eLe~-~----p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~Y  158 (396)
T KOG0593|consen   87 VLHELER-Y----PNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNY  158 (396)
T ss_pred             HHHHHHh-c----cCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCCcchh
Confidence            4444433 2    235888999999999999999999998   9999999999999999999999999999987432   


Q ss_pred             CCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcch-hhHHHHHHHhhhcc--------ccccc
Q 007167          458 PPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEV-VHLVRWVNSVVREE--------WTAEV  527 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~--------~~~~~  527 (615)
                      +..+.|+.|+|||.+.+ .+|...+||||+||++.||++|...|.+.++-+- ..+..-++......        ....+
T Consensus       159 TDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv  238 (396)
T KOG0593|consen  159 TDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGV  238 (396)
T ss_pred             hhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeee
Confidence            34467999999999977 7899999999999999999999999987665332 23333333222211        11111


Q ss_pred             ccccc-------cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          528 FDVEL-------LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       528 ~d~~~-------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .-++.       .++|.++....+++   ..|++.||++|++.+|++.+
T Consensus       239 ~lP~~~~~epLe~k~p~~s~~~ld~~---k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  239 RLPEPEHPEPLERKYPKISNVLLDLL---KKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             ecCCCCCccchhhhcccchHHHHHHH---HHHhcCCccccccHHHHhcC
Confidence            11111       13445555444444   49999999999999999864

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-43  Score=331.72  Aligned_cols=252  Identities=23%  Similarity=0.410  Sum_probs=198.2

Q ss_pred             HHHhhhcCcCCccEEEEEE-ECCCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeE-EEEecCe-eeEEee
Q 007167          302 RASAEVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRA-YYYSKDE-KLMVYD  375 (615)
Q Consensus       302 ~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~-~~~~~~~-~~lV~e  375 (615)
                      +...++||+|.||+|||+. ..+|..||.|.+.-...+   ..+...|+.+|++++|||||++++ .+.++.+ .+||||
T Consensus        21 y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE  100 (375)
T KOG0591|consen   21 YQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVME  100 (375)
T ss_pred             HHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHH
Confidence            3456789999999999998 678999999998754333   345678999999999999999998 4444444 899999


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCC-CCceecCCCCCCEEeCCCCcEEEeecccccccC
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENG-GKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS  454 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~-~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~  454 (615)
                      |+..|+|...++..+ +....+++...++++.|++.||+++|+.-. ..|+||||||.||+++.+|.+|++|||+++.+.
T Consensus       101 ~c~~GDLsqmIk~~K-~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~  179 (375)
T KOG0591|consen  101 LCDAGDLSQMIKHFK-KQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS  179 (375)
T ss_pred             hhcccCHHHHHHHHH-hccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence            999999999997654 345679999999999999999999998321 249999999999999999999999999999987


Q ss_pred             CCC---CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccccc
Q 007167          455 PMP---PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE  531 (615)
Q Consensus       455 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  531 (615)
                      ...   ...+||+.||+||.+.+..|+.|+||||+||++|||+.-+.||.+.+   ...+.+   .+-+.         +
T Consensus       180 s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n---~~~L~~---KI~qg---------d  244 (375)
T KOG0591|consen  180 SKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN---LLSLCK---KIEQG---------D  244 (375)
T ss_pred             chhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc---HHHHHH---HHHcC---------C
Confidence            643   35679999999999999999999999999999999999999998752   222222   22221         1


Q ss_pred             ccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          532 LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       532 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                      .+..|. +--..++.+++..|+..||+.||+...++..+
T Consensus       245 ~~~~p~-~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  245 YPPLPD-EHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             CCCCcH-HHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence            111110 11223455556699999999999864444433

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-43  Score=342.62  Aligned_cols=238  Identities=24%  Similarity=0.401  Sum_probs=199.4

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC----CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV----GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .++||+|+||.||.++.+ .++.+|+|++++...    ..+....|..++.+++||.||+++-.|++.+..|+|+||+.|
T Consensus        30 lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~G  109 (357)
T KOG0598|consen   30 LKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNG  109 (357)
T ss_pred             eeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCC
Confidence            467999999999999855 467799999987532    245678899999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccC---CC
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS---PM  456 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~---~~  456 (615)
                      |.|+.+|+..     ..+++..+.-++.+|+.||.|||+++   |||||+||+|||+|++|+++|+|||+++..-   ..
T Consensus       110 GeLf~hL~~e-----g~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~  181 (357)
T KOG0598|consen  110 GELFYHLQRE-----GRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDA  181 (357)
T ss_pred             ccHHHHHHhc-----CCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccCCCc
Confidence            9999999743     47999999999999999999999998   9999999999999999999999999998543   23


Q ss_pred             CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          457 PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       457 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                      ..+.+||+.|||||++.+..|+..+|+||+|+++|||++|..||...+..+..+.+      ..+         .+...+
T Consensus       182 t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I------~~~---------k~~~~p  246 (357)
T KOG0598|consen  182 TRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKI------LKG---------KLPLPP  246 (357)
T ss_pred             cccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHH------hcC---------cCCCCC
Confidence            44568999999999999999999999999999999999999999876544333222      211         122233


Q ss_pred             C-cHHHHHHHHHHHHHcccCCCCCCC----CHHHHHH
Q 007167          537 N-IEEEMVEMLQVGMACVVRMPEERP----KMADVLK  568 (615)
Q Consensus       537 ~-~~~~~~~l~~l~~~cl~~~P~~RP----s~~evl~  568 (615)
                      . .+.+.+++++   +.+..||++|.    ++.+|.+
T Consensus       247 ~~ls~~ardll~---~LL~rdp~~RLg~~~d~~~ik~  280 (357)
T KOG0598|consen  247 GYLSEEARDLLK---KLLKRDPRQRLGGPGDAEEIKR  280 (357)
T ss_pred             ccCCHHHHHHHH---HHhccCHHHhcCCCCChHHhhc
Confidence            3 6778888888   89999999995    4555544

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-43  Score=351.69  Aligned_cols=261  Identities=19%  Similarity=0.349  Sum_probs=209.0

Q ss_pred             HHHHhhhcCcCCccEEEEEE-ECCCCEEEEEEeccccCCHHH--HHHHHHHHhCCC-CCcccceeEEEEecC-eeeEEee
Q 007167          301 LRASAEVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNVGKRE--FEQQMEIVGGIR-HENVVALRAYYYSKD-EKLMVYD  375 (615)
Q Consensus       301 ~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~--~~~e~~~l~~l~-h~niv~l~~~~~~~~-~~~lV~e  375 (615)
                      .|.+.++||.|+||+||+|+ .+.+..||||+++.....-++  -.+|+..|++++ |||||++.+.+.+.+ ..++|||
T Consensus        11 RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE   90 (538)
T KOG0661|consen   11 RYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFE   90 (538)
T ss_pred             HHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHH
Confidence            45567789999999999998 567889999999876443333  468999999998 999999999999888 9999999


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      ||+ .+|.+++.++    ...+++.....|+.||++||+|+|++|   +.|||+||+|||+.....+||+|||+|+....
T Consensus        91 ~Md-~NLYqLmK~R----~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S  162 (538)
T KOG0661|consen   91 FMD-CNLYQLMKDR----NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS  162 (538)
T ss_pred             hhh-hhHHHHHhhc----CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc
Confidence            995 5999999865    358999999999999999999999998   99999999999999999999999999998754


Q ss_pred             --CCCCCCCCCcccCcccc-CCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC-cchhhHHHHHHHhhhccccc-----c
Q 007167          456 --MPPPAMRAAGYRAPEVT-DTRKATQASDVFSFGVLLLELLTGKSPIHATGG-DEVVHLVRWVNSVVREEWTA-----E  526 (615)
Q Consensus       456 --~~~~~~~~~~y~aPE~~-~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~-----~  526 (615)
                        +-+..+.|+.|+|||++ ..+.|+.+.|+||+|||++|+.+-+..|.+.++ +++..+...++....+.|..     .
T Consensus       163 kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~  242 (538)
T KOG0661|consen  163 KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLAS  242 (538)
T ss_pred             CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHH
Confidence              33456789999999987 456789999999999999999999999988664 34444555555544444443     1


Q ss_pred             cccccccCCC--C----cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          527 VFDVELLRYP--N----IEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       527 ~~d~~~~~~~--~----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+...++..+  .    .+....+.++++.+|++.||++|||+.|++++
T Consensus       243 ~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  243 AMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            2222222111  1    11123445555559999999999999999986

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.6e-42  Score=320.33  Aligned_cols=260  Identities=21%  Similarity=0.380  Sum_probs=204.5

Q ss_pred             HHHhhhcCcCCccEEEEEE-ECCCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecC
Q 007167          302 RASAEVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYF  377 (615)
Q Consensus       302 ~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  377 (615)
                      |...++||+|.||.||+|+ .+.|+.||||+++..+..   .....+|+..|+.++|+||+.+++.|...+...+|+|||
T Consensus         4 Y~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm   83 (318)
T KOG0659|consen    4 YEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFM   83 (318)
T ss_pred             hhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEec
Confidence            3445789999999999998 467899999999865332   456789999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC
Q 007167          378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP  457 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~  457 (615)
                      +. +|...+++.    ...++-.+...++.++.+|++|||++.   |+||||||.|+|++++|.+||+|||+|+.+....
T Consensus        84 ~t-dLe~vIkd~----~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~  155 (318)
T KOG0659|consen   84 PT-DLEVVIKDK----NIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN  155 (318)
T ss_pred             cc-cHHHHhccc----ccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence            65 899999753    457899999999999999999999998   9999999999999999999999999999987543


Q ss_pred             ---CCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCC-cchhhHHHHHHHhhhccccccc--ccc
Q 007167          458 ---PPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGG-DEVVHLVRWVNSVVREEWTAEV--FDV  530 (615)
Q Consensus       458 ---~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~--~d~  530 (615)
                         ...+.|+.|+|||.+.+ +.|+..+||||.||++.||+-|.+-|.+.++ ++...+.+.++....+.|..-.  .|.
T Consensus       156 ~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY  235 (318)
T KOG0659|consen  156 RIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY  235 (318)
T ss_pred             cccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence               23457899999999876 5699999999999999999998877766543 1222223333344445554321  111


Q ss_pred             c-ccCCC------CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          531 E-LLRYP------NIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       531 ~-~~~~~------~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      . +...|      -++.+..+.++++..++..+|.+|+++.|++++
T Consensus       236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            0 00011      122233444666669999999999999999987

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-42  Score=349.82  Aligned_cols=239  Identities=20%  Similarity=0.371  Sum_probs=203.3

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEecccc----CCHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVN----VGKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      ++.||+|+|++||+|+. ..+++||||++.+..    ...+.+.+|-++|.+| .||.||+|+-.|++...+|+|+||++
T Consensus        78 g~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~  157 (604)
T KOG0592|consen   78 GKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAP  157 (604)
T ss_pred             hheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecC
Confidence            56799999999999985 467889999986542    2234567788888888 89999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC-
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP-  457 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~-  457 (615)
                      +|+|.++|+..     ..+++...+.++.+|+.||+|||++|   ||||||||+|||+|+||++||+|||.|+.+.+.. 
T Consensus       158 nGdll~~i~K~-----Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~  229 (604)
T KOG0592|consen  158 NGDLLDLIKKY-----GSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK  229 (604)
T ss_pred             CCcHHHHHHHh-----CcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence            99999999854     47999999999999999999999998   9999999999999999999999999999885321 


Q ss_pred             ---------------CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcc
Q 007167          458 ---------------PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREE  522 (615)
Q Consensus       458 ---------------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  522 (615)
                                     ...+||..|++||++.....+..+|+|+|||++|.|+.|++||.+.++--+.+.+          
T Consensus       230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI----------  299 (604)
T KOG0592|consen  230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKI----------  299 (604)
T ss_pred             cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHH----------
Confidence                           2246788999999999999999999999999999999999999886643332222          


Q ss_pred             cccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          523 WTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       523 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                           ++-+....+++++.++++++   +.+..||.+|+|.+||.+|
T Consensus       300 -----~~l~y~fp~~fp~~a~dLv~---KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  300 -----QALDYEFPEGFPEDARDLIK---KLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             -----HHhcccCCCCCCHHHHHHHH---HHHccCccccccHHHHhhC
Confidence                 22233344567788888888   8999999999999999876

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-41  Score=339.90  Aligned_cols=254  Identities=23%  Similarity=0.371  Sum_probs=199.7

Q ss_pred             hhhcCcCCccEEEEEE-ECCCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEec--CeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSK--DEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e~~~  378 (615)
                      .++||+|+||.||||+ .++|+.||+|+++-...   ......+|+.+|++++||||++|.+...++  ..+|||+|||+
T Consensus       122 i~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd  201 (560)
T KOG0600|consen  122 IEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD  201 (560)
T ss_pred             HHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc
Confidence            3569999999999998 56789999999975532   234567999999999999999999999887  68999999998


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC-
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP-  457 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~-  457 (615)
                      + +|..++..    ..-.++..++..++.|++.||+|||.++   |+|||||.+|||||.+|.+||+|||+|+++.... 
T Consensus       202 h-DL~GLl~~----p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~  273 (560)
T KOG0600|consen  202 H-DLSGLLSS----PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS  273 (560)
T ss_pred             c-hhhhhhcC----CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence            7 78888763    2346999999999999999999999998   9999999999999999999999999999886543 


Q ss_pred             ---CCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc-hhhHHHHHHHhhhccccccc-----
Q 007167          458 ---PPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDE-VVHLVRWVNSVVREEWTAEV-----  527 (615)
Q Consensus       458 ---~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~-----  527 (615)
                         +..+.|..|+|||.+.+ ..|+.++|+||.||||.||++|+..|.+..+-+ +..+.+..+....+.|....     
T Consensus       274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~  353 (560)
T KOG0600|consen  274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHAT  353 (560)
T ss_pred             cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCccc
Confidence               33456889999999876 469999999999999999999999998866433 22333334444444454111     


Q ss_pred             -ccccccC-------CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          528 -FDVELLR-------YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       528 -~d~~~~~-------~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                       +.+....       +..+++..   ++++..++..||.+|.|+.++++.
T Consensus       354 ~~kp~~~y~r~l~E~~~~~~~~~---l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  354 IFKPQQPYKRRLRETFKDFPASA---LDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             ccCCCCcccchHHHHhccCCHHH---HHHHHHHhccCccccccHHHHhcC
Confidence             1111110       11222333   444448999999999999999874

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=2.6e-41  Score=342.87  Aligned_cols=256  Identities=17%  Similarity=0.320  Sum_probs=206.3

Q ss_pred             cCHHHHHHHHhhhcCcCCccEEEEEEECCCCEEEEEEeccccCCH----HHHHHHHHHHhCCCCCcccceeEEEEe----
Q 007167          295 FDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGK----REFEQQMEIVGGIRHENVVALRAYYYS----  366 (615)
Q Consensus       295 ~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~----~~~~~e~~~l~~l~h~niv~l~~~~~~----  366 (615)
                      ++.+++.......||+|++|.||+|.. +|+.||||+++......    +.+.+|++++++++|||||+++|++.+    
T Consensus        15 i~~~~i~~~~~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~   93 (283)
T PHA02988         15 IESDDIDKYTSVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDD   93 (283)
T ss_pred             cCHHHcCCCCCeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccC
Confidence            455666555456799999999999998 57899999997654332    567799999999999999999999977    


Q ss_pred             cCeeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc-CCCCceecCCCCCCEEeCCCCcEEEe
Q 007167          367 KDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE-NGGKLVHGGIKASNIFLNSQGHVCVS  445 (615)
Q Consensus       367 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~iiHrDik~~Nill~~~~~~kl~  445 (615)
                      ....++||||+++|+|.+++...     ..++|....+++.+++.|+.|||+. +   ++||||||+||++++++.+||+
T Consensus        94 ~~~~~lv~Ey~~~g~L~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~  165 (283)
T PHA02988         94 LPRLSLILEYCTRGYLREVLDKE-----KDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKII  165 (283)
T ss_pred             CCceEEEEEeCCCCcHHHHHhhC-----CCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEc
Confidence            34678999999999999999743     3689999999999999999999985 5   8899999999999999999999


Q ss_pred             ecccccccCCCCCCCCCCCcccCccccCC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccc
Q 007167          446 DIGLAALMSPMPPPAMRAAGYRAPEVTDT--RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEW  523 (615)
Q Consensus       446 DfG~a~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  523 (615)
                      |||+++.+........++..|+|||++.+  ..++.++|||||||++|||++|+.||......+....+      .....
T Consensus       166 dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i------~~~~~  239 (283)
T PHA02988        166 CHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLI------INKNN  239 (283)
T ss_pred             ccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHH------HhcCC
Confidence            99999877655555667889999999865  67899999999999999999999999865433322211      11110


Q ss_pred             ccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          524 TAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       524 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                             ........++++.++++   +||+.||++|||++|+++.|+.+..
T Consensus       240 -------~~~~~~~~~~~l~~li~---~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        240 -------SLKLPLDCPLEIKCIVE---ACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             -------CCCCCCcCcHHHHHHHH---HHhcCCcccCcCHHHHHHHHHHHHh
Confidence                   01111134555666555   9999999999999999999998753

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-41  Score=377.10  Aligned_cols=257  Identities=26%  Similarity=0.396  Sum_probs=213.3

Q ss_pred             hhhcCcCCccEEEEEEECC--CC----EEEEEEeccc--cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAALED--AS----TVVVKRLKEV--NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~--~~----~vavK~l~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      .+.||+|.||.||+|...+  +.    .||||.++..  .....+|.+|..+|+.++|||||+++|.|.+....++++||
T Consensus       697 ~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~ley  776 (1025)
T KOG1095|consen  697 LRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEY  776 (1025)
T ss_pred             eeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehh
Confidence            4679999999999998643  33    4899999876  33467899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCC--CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccC
Q 007167          377 FEPGSVSAMLHGRRGE--GQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS  454 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~  454 (615)
                      |++|+|..+|++.+..  ....++-.+.+.++.|||+|+.||++++   +|||||.++|+|+++...+||+|||+|+.+.
T Consensus       777 M~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy  853 (1025)
T KOG1095|consen  777 MEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLARDIY  853 (1025)
T ss_pred             cccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchhHhhh
Confidence            9999999999865422  2456889999999999999999999998   9999999999999999999999999999665


Q ss_pred             CCCCCCC-----CCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccc
Q 007167          455 PMPPPAM-----RAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVF  528 (615)
Q Consensus       455 ~~~~~~~-----~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  528 (615)
                      ..++...     -...|||||.+..+.++.|+|||||||++||++| |..||...++.++...+.      .+       
T Consensus       854 ~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~------~g-------  920 (1025)
T KOG1095|consen  854 DKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVL------EG-------  920 (1025)
T ss_pred             hchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHH------hC-------
Confidence            4433322     2457999999999999999999999999999999 999999988877655332      11       


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhhcCCC
Q 007167          529 DVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENP  581 (615)
Q Consensus       529 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~~~~  581 (615)
                       .++...+++++.+.   +++..||+.+|++||++..+++.+..+.......+
T Consensus       921 -gRL~~P~~CP~~ly---~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~~  969 (1025)
T KOG1095|consen  921 -GRLDPPSYCPEKLY---QLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGTI  969 (1025)
T ss_pred             -CccCCCCCCChHHH---HHHHHHccCChhhCccHHHHHhhhhhhhhhhccCc
Confidence             13333345555444   55559999999999999999999999887655443

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-41  Score=347.09  Aligned_cols=241  Identities=22%  Similarity=0.393  Sum_probs=206.8

Q ss_pred             hhhcCcCCccEEEEEE-ECCCCEEEEEEeccccCCH-HHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          305 AEVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNVGK-REFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~-~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      -++||+|+.|.||.|. ...++.||||++......+ +-+.+|+.+|+..+|+|||.+++.|..+++.|+|||||++|+|
T Consensus       278 ~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsL  357 (550)
T KOG0578|consen  278 FKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSL  357 (550)
T ss_pred             hhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCch
Confidence            4579999999999998 4568889999998775554 4567999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---CC
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---PP  459 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~~  459 (615)
                      .+.+...      .+++.+...|+.++++||+|||.++   |+|||||.+|||++.+|.+||+|||++..+....   .+
T Consensus       358 TDvVt~~------~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~T  428 (550)
T KOG0578|consen  358 TDVVTKT------RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRST  428 (550)
T ss_pred             hhhhhcc------cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCcccc
Confidence            9999743      5899999999999999999999998   9999999999999999999999999998886543   45


Q ss_pred             CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      .+||+.|||||+.....|.+|+||||||++++||+.|+.||-..+.-....++.            ..-.+++...+..+
T Consensus       429 mVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa------------~ng~P~lk~~~klS  496 (550)
T KOG0578|consen  429 MVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------------TNGTPKLKNPEKLS  496 (550)
T ss_pred             ccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh------------hcCCCCcCCccccC
Confidence            679999999999999999999999999999999999999997633222221111            11123444455678


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+.++|+.   +|+..||++|+++.|+++|
T Consensus       497 ~~~kdFL~---~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  497 PELKDFLD---RCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             HHHHHHHH---HHhhcchhcCCCHHHHhcC
Confidence            88888888   9999999999999999986

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-41  Score=344.30  Aligned_cols=248  Identities=27%  Similarity=0.442  Sum_probs=198.8

Q ss_pred             HhhhcCcCCccEEEEEEECCCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          304 SAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       304 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .++.||+|.||+||+|.+.+  .||||.+.-....   -+.|..|+..+++=||.||+-++|||..+.. .||+.+|+|-
T Consensus       396 l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGs  472 (678)
T KOG0193|consen  396 LGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGS  472 (678)
T ss_pred             ccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCc
Confidence            46789999999999999863  7999999765333   4679999999999999999999999998877 9999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---  457 (615)
                      +|..+||-.+    ..++..+.+.|+.|||+|+.|||.++   |||||||..||++.+++.+||+|||++..-..-.   
T Consensus       473 SLY~hlHv~e----tkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~  545 (678)
T KOG0193|consen  473 SLYTHLHVQE----TKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQ  545 (678)
T ss_pred             hhhhhccchh----hhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeecccc
Confidence            9999999643    46899999999999999999999998   9999999999999999999999999997543211   


Q ss_pred             --CCCCCCCcccCccccCC---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccc
Q 007167          458 --PPAMRAAGYRAPEVTDT---RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL  532 (615)
Q Consensus       458 --~~~~~~~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  532 (615)
                        ....+..-|||||++..   ..|++.+||||||||+|||++|..||.....+.++-.+.           .....+++
T Consensus       546 q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVG-----------rG~l~pd~  614 (678)
T KOG0193|consen  546 QLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVG-----------RGYLMPDL  614 (678)
T ss_pred             ccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEec-----------ccccCccc
Confidence              11224456999999854   458999999999999999999999998544343332221           00001111


Q ss_pred             c-CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          533 L-RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       533 ~-~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                      . ......+++++++.   .||..++++||.+.+|+..|+++..
T Consensus       615 s~~~s~~pk~mk~Ll~---~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  615 SKIRSNCPKAMKRLLS---DCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             hhhhccCHHHHHHHHH---HHHhcCcccCccHHHHHHHHHHhhh
Confidence            1 12234455555555   9999999999999999999988876

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-41  Score=333.91  Aligned_cols=250  Identities=26%  Similarity=0.420  Sum_probs=199.2

Q ss_pred             HhhhcCcCCccEEEEEEECC-CCEEEEEEeccccCC-HHHHHHHHHHHhCCCCCcccceeEEEEecC--eeeEEeecCCC
Q 007167          304 SAEVLGKGTFGTAYKAALED-ASTVVVKRLKEVNVG-KREFEQQMEIVGGIRHENVVALRAYYYSKD--EKLMVYDYFEP  379 (615)
Q Consensus       304 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lV~e~~~~  379 (615)
                      ..+.||+|+||+||++...+ |...|||........ .+.+++|+.+|++++|||||+++|.....+  .+++.|||+++
T Consensus        21 ~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~  100 (313)
T KOG0198|consen   21 KGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPG  100 (313)
T ss_pred             hhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCC
Confidence            46789999999999999654 889999988754211 456899999999999999999999865555  68999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCC-CCcEEEeecccccccCC---
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNS-QGHVCVSDIGLAALMSP---  455 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~-~~~~kl~DfG~a~~~~~---  455 (615)
                      |+|.+++....   . .+++..+.+++.|+++||+|||+++   |+||||||+|||++. ++.+||+|||+++....   
T Consensus       101 GsL~~~~~~~g---~-~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen  101 GSLSDLIKRYG---G-KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             CcHHHHHHHcC---C-CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            99999997543   2 6999999999999999999999998   999999999999999 79999999999987652   


Q ss_pred             ---CCCCCCCCCcccCccccCCCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccccc
Q 007167          456 ---MPPPAMRAAGYRAPEVTDTRK-ATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE  531 (615)
Q Consensus       456 ---~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  531 (615)
                         ......+|+.|||||++..+. ...++||||+||++.||+||+.||...     .....++-.+..+.     ..+.
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~-----~~~~~~~~~ig~~~-----~~P~  243 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEF-----FEEAEALLLIGRED-----SLPE  243 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhh-----cchHHHHHHHhccC-----CCCC
Confidence               123456899999999998533 345999999999999999999999763     11111111111111     0111


Q ss_pred             ccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          532 LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       532 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                      +  ...++++.++++.   +|+..+|++|||+.|++++--...+
T Consensus       244 i--p~~ls~~a~~Fl~---~C~~~~p~~Rpta~eLL~hpf~~~~  282 (313)
T KOG0198|consen  244 I--PDSLSDEAKDFLR---KCFKRDPEKRPTAEELLEHPFLKQN  282 (313)
T ss_pred             C--CcccCHHHHHHHH---HHhhcCcccCcCHHHHhhChhhhcc
Confidence            1  2346677888887   9999999999999999998655443

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-41  Score=339.89  Aligned_cols=237  Identities=23%  Similarity=0.412  Sum_probs=194.7

Q ss_pred             hhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChhhh
Q 007167          306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAM  385 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~  385 (615)
                      +-||.|+.|.||+|+++ +++||||+++..+      +.++.-|++++|+||+.+.|+|...--++||||||..|-|...
T Consensus       130 eWlGSGaQGAVF~Grl~-netVAVKKV~elk------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V  202 (904)
T KOG4721|consen  130 EWLGSGAQGAVFLGRLH-NETVAVKKVRELK------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV  202 (904)
T ss_pred             hhhccCcccceeeeecc-CceehhHHHhhhh------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence            45999999999999986 4889999886432      3567889999999999999999999999999999999999999


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC--CCCCC
Q 007167          386 LHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP--PAMRA  463 (615)
Q Consensus       386 l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~--~~~~~  463 (615)
                      |+..+     ++.-.....+..+||.|+.|||.+.   |||||||+-||||..+..+||+|||.++......+  ...||
T Consensus       203 Lka~~-----~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGT  274 (904)
T KOG4721|consen  203 LKAGR-----PITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGT  274 (904)
T ss_pred             HhccC-----ccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhh
Confidence            98543     6777888889999999999999987   99999999999999999999999999998876543  34588


Q ss_pred             CcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHHHHH
Q 007167          464 AGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMV  543 (615)
Q Consensus       464 ~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  543 (615)
                      ..|||||++....+++|+||||||||||||+||..||.+.+...++--+             ....-.++-...+++-.+
T Consensus       275 VaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV-------------GsNsL~LpvPstcP~Gfk  341 (904)
T KOG4721|consen  275 VAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV-------------GSNSLHLPVPSTCPDGFK  341 (904)
T ss_pred             HhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEec-------------cCCcccccCcccCchHHH
Confidence            9999999999999999999999999999999999999875432221100             000111222223444444


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 007167          544 EMLQVGMACVVRMPEERPKMADVLKMVEDI  573 (615)
Q Consensus       544 ~l~~l~~~cl~~~P~~RPs~~evl~~L~~l  573 (615)
                      -+++   +||+..|..||++++++.||+-.
T Consensus       342 lL~K---qcw~sKpRNRPSFrqil~HldIa  368 (904)
T KOG4721|consen  342 LLLK---QCWNSKPRNRPSFRQILLHLDIA  368 (904)
T ss_pred             HHHH---HHHhcCCCCCccHHHHHHHHhhc
Confidence            4555   99999999999999999998543

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-40  Score=346.27  Aligned_cols=250  Identities=27%  Similarity=0.432  Sum_probs=203.6

Q ss_pred             hhcCcCCccEEEEEEECC--C--CE-EEEEEeccc----cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeec
Q 007167          306 EVLGKGTFGTAYKAALED--A--ST-VVVKRLKEV----NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~--~--~~-vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      ++||+|+||.||+|.++.  +  .. ||||..+..    ....++|.+|.++|+.++|||||+++|++..+..+++|||+
T Consensus       163 kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl  242 (474)
T KOG0194|consen  163 KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMEL  242 (474)
T ss_pred             ceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEe
Confidence            689999999999998643  2  23 899998852    22356899999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM  456 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~  456 (615)
                      |.||+|.++|+...    ..++..++.+++.++|.||+|||+++   +|||||.++|+|++.++.+||+|||+++.-..-
T Consensus       243 ~~gGsL~~~L~k~~----~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~  315 (474)
T KOG0194|consen  243 CNGGSLDDYLKKNK----KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY  315 (474)
T ss_pred             cCCCcHHHHHHhCC----CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccCCcce
Confidence            99999999998643    26999999999999999999999998   999999999999999999999999998765311


Q ss_pred             --CC-CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccc
Q 007167          457 --PP-PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL  532 (615)
Q Consensus       457 --~~-~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  532 (615)
                        .. .......|+|||.+....|++++|||||||++||+++ |..||.+....++...+.      ...+       +.
T Consensus       316 ~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~------~~~~-------r~  382 (474)
T KOG0194|consen  316 VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIV------KNGY-------RM  382 (474)
T ss_pred             eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHH------hcCc-------cC
Confidence              11 2224568999999999999999999999999999999 899998876554332221      1111       11


Q ss_pred             cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhhc
Q 007167          533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKA  578 (615)
Q Consensus       533 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~  578 (615)
                      ......+.++..+++   +||..+|++||+|.++.+.|+.+.....
T Consensus       383 ~~~~~~p~~~~~~~~---~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  383 PIPSKTPKELAKVMK---QCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             CCCCCCHHHHHHHHH---HhccCChhhccCHHHHHHHHHHHHhccc
Confidence            112234455555555   9999999999999999999999987544

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=4.9e-40  Score=342.41  Aligned_cols=253  Identities=27%  Similarity=0.421  Sum_probs=195.1

Q ss_pred             HhhhcCcCCccEEEEEEE------CCCCEEEEEEeccccC--CHHHHHHHHHHHhCC-CCCcccceeEEEEecC-eeeEE
Q 007167          304 SAEVLGKGTFGTAYKAAL------EDASTVVVKRLKEVNV--GKREFEQQMEIVGGI-RHENVVALRAYYYSKD-EKLMV  373 (615)
Q Consensus       304 ~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~~lV  373 (615)
                      ..++||+|+||.||+|..      ..+..||||+++....  ..+.+.+|++++..+ +||||++++++|...+ ..++|
T Consensus        11 ~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv   90 (338)
T cd05102          11 LGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVI   90 (338)
T ss_pred             eeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEE
Confidence            356799999999999974      2346799999875422  235688999999999 8999999999987654 57899


Q ss_pred             eecCCCCChhhhhccCCCC---------------------------------------------------------CCCC
Q 007167          374 YDYFEPGSVSAMLHGRRGE---------------------------------------------------------GQSS  396 (615)
Q Consensus       374 ~e~~~~gsL~~~l~~~~~~---------------------------------------------------------~~~~  396 (615)
                      |||+++|+|.+++......                                                         ...+
T Consensus        91 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (338)
T cd05102          91 VEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSP  170 (338)
T ss_pred             EecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCC
Confidence            9999999999998743210                                                         0235


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC-----CCCCCCcccCccc
Q 007167          397 LDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP-----PAMRAAGYRAPEV  471 (615)
Q Consensus       397 l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~-----~~~~~~~y~aPE~  471 (615)
                      +++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......     ...++..|+|||+
T Consensus       171 l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~  247 (338)
T cd05102         171 LTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPES  247 (338)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHH
Confidence            888999999999999999999998   99999999999999999999999999986533211     1234567999999


Q ss_pred             cCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHH
Q 007167          472 TDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGM  550 (615)
Q Consensus       472 ~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~  550 (615)
                      +.+..++.++|||||||++|||++ |+.||......+..  ..   . .....       ........++.+   .+++.
T Consensus       248 ~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~--~~---~-~~~~~-------~~~~~~~~~~~l---~~li~  311 (338)
T cd05102         248 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEF--CQ---R-LKDGT-------RMRAPENATPEI---YRIML  311 (338)
T ss_pred             hhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHH--HH---H-HhcCC-------CCCCCCCCCHHH---HHHHH
Confidence            988889999999999999999997 99999764432211  11   1 11110       000112233444   44555


Q ss_pred             HcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          551 ACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       551 ~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                      +||+.||++|||+.|+++.|+++.+
T Consensus       312 ~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         312 ACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             HHccCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-40  Score=305.57  Aligned_cols=242  Identities=24%  Similarity=0.383  Sum_probs=207.6

Q ss_pred             HhhhcCcCCccEEEEEEE-CCCCEEEEEEecccc----CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCC
Q 007167          304 SAEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVN----VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       304 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      .++.||+|.||.||.|+. +.+-.||+|++.+.+    .....+.+|+++.+.++||||+++++||.+....|+++||..
T Consensus        26 igr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~  105 (281)
T KOG0580|consen   26 IGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAP  105 (281)
T ss_pred             ccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecC
Confidence            367899999999999984 467789999997653    235678999999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccC-CCC
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS-PMP  457 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~-~~~  457 (615)
                      +|++...|.+.+   ...++......++.|+|.|+.|+|.++   ||||||||+|+|++.++..||+|||-+..-. ...
T Consensus       106 ~gel~k~L~~~~---~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~kR  179 (281)
T KOG0580|consen  106 RGELYKDLQEGR---MKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSNKR  179 (281)
T ss_pred             CchHHHHHHhcc---cccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecCCCCc
Confidence            999999998654   346888889999999999999999998   9999999999999999999999999987653 334


Q ss_pred             CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCC
Q 007167          458 PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN  537 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  537 (615)
                      .+.+||..|.|||+..+..++..+|+|++|++.||++.|..||.....++....+.-+               ++.....
T Consensus       180 ~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~---------------~~~~p~~  244 (281)
T KOG0580|consen  180 KTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKV---------------DLKFPST  244 (281)
T ss_pred             eeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHc---------------cccCCcc
Confidence            5667899999999999999999999999999999999999999987766655444322               1222245


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          538 IEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       538 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ++..+.+++.   +|+..+|.+|.+..|++++
T Consensus       245 is~~a~dlI~---~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  245 ISGGAADLIS---RLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             cChhHHHHHH---HHhccCccccccHHHHhhh
Confidence            6677777766   9999999999999999887

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3e-40  Score=311.91  Aligned_cols=230  Identities=18%  Similarity=0.297  Sum_probs=196.3

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC----HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG----KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      ...||.|+||.|..++.+ .|.-+|+|++.+...-    .+...+|-.+|+.+.||+++++.+.|.+.+..+|||||.+|
T Consensus        49 ~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~G  128 (355)
T KOG0616|consen   49 LKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPG  128 (355)
T ss_pred             eeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCC
Confidence            356999999999999955 5778999999765322    24466899999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCC
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP  459 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~  459 (615)
                      |.|+++|+..     .+++...++-++.||+.|++|||+.+   |++||+||+|||+|.+|++||+|||+|+.......+
T Consensus       129 GElFS~Lrk~-----~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~rT~T  200 (355)
T KOG0616|consen  129 GELFSYLRKS-----GRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGRTWT  200 (355)
T ss_pred             ccHHHHHHhc-----CCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCcEEE
Confidence            9999999853     37999999999999999999999998   999999999999999999999999999999988888


Q ss_pred             CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      .+||+.|+|||++....+..++|.|||||++|||+.|..||.+.+...+.+-+      .         ...+...+..+
T Consensus       201 lCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI------~---------~~~v~fP~~fs  265 (355)
T KOG0616|consen  201 LCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKI------L---------EGKVKFPSYFS  265 (355)
T ss_pred             ecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHH------H---------hCcccCCcccC
Confidence            89999999999999999999999999999999999999999886653332211      1         11222334566


Q ss_pred             HHHHHHHHHHHHcccCCCCCC
Q 007167          540 EEMVEMLQVGMACVVRMPEER  560 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~R  560 (615)
                      .+++++++   ..++.|-.+|
T Consensus       266 ~~~kdLl~---~LL~vD~t~R  283 (355)
T KOG0616|consen  266 SDAKDLLK---KLLQVDLTKR  283 (355)
T ss_pred             HHHHHHHH---HHHhhhhHhh
Confidence            77777777   6777777777

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.2e-40  Score=335.98  Aligned_cols=240  Identities=24%  Similarity=0.431  Sum_probs=201.5

Q ss_pred             HHhhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCH---HHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCC
Q 007167          303 ASAEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGK---REFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       303 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      ..-+.||+|+||.||||+.+ +.+.||+|.+.+....+   +.+.+|++++++++|||||.++++|+...+.++|+||+.
T Consensus         5 hv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~   84 (808)
T KOG0597|consen    5 HVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAV   84 (808)
T ss_pred             hHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhh
Confidence            34567999999999999855 56778999998765444   447899999999999999999999999999999999997


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC-
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP-  457 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~-  457 (615)
                      + +|+.+|...     ..+.+..+..|+.+++.||.|||+.+   |+|||+||.|||++..+++|+||||+|+.+.... 
T Consensus        85 g-~L~~il~~d-----~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~  155 (808)
T KOG0597|consen   85 G-DLFTILEQD-----GKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTS  155 (808)
T ss_pred             h-hHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCce
Confidence            7 999999743     46999999999999999999999998   9999999999999999999999999999987643 


Q ss_pred             --CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCC
Q 007167          458 --PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY  535 (615)
Q Consensus       458 --~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  535 (615)
                        ....||+-|||||...++.|+..+|.||+||++||+++|++||...   .+.++++   .+..+         .....
T Consensus       156 vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~---si~~Lv~---~I~~d---------~v~~p  220 (808)
T KOG0597|consen  156 VLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR---SITQLVK---SILKD---------PVKPP  220 (808)
T ss_pred             eeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH---HHHHHHH---HHhcC---------CCCCc
Confidence              3445889999999999999999999999999999999999999753   2333332   32221         11112


Q ss_pred             CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          536 PNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       536 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ...+.+.+.+++   ..+.+||..|.+..+++.|
T Consensus       221 ~~~S~~f~nfl~---gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  221 STASSSFVNFLQ---GLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             ccccHHHHHHHH---HHhhcChhhcccHHHHhcC
Confidence            245667777777   8999999999999999875

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-39  Score=336.45  Aligned_cols=244  Identities=22%  Similarity=0.369  Sum_probs=199.4

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccc----c--CCHHHHHHHHHHHhCCC-CCcccceeEEEEecCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEV----N--VGKREFEQQMEIVGGIR-HENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~--~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      .+.||+|+||.||.|.. ..+..||+|.+...    .  ...+.+.+|+.+++.++ ||||++++.++......++||||
T Consensus        22 ~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy  101 (370)
T KOG0583|consen   22 GRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEY  101 (370)
T ss_pred             eeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEe
Confidence            45699999999999974 46799999976543    1  12445678999999999 99999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCC-CcEEEeecccccccC-
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQ-GHVCVSDIGLAALMS-  454 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~-~~~kl~DfG~a~~~~-  454 (615)
                      +.+|+|.+.+.. .    .++.+....+++.|++.|++|||+++   |+||||||+|||+|.+ +++||+|||++.... 
T Consensus       102 ~~gGdL~~~i~~-~----g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~  173 (370)
T KOG0583|consen  102 CSGGDLFDYIVN-K----GRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAISPG  173 (370)
T ss_pred             cCCccHHHHHHH-c----CCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence            999999999975 2    36888999999999999999999998   9999999999999999 999999999999872 


Q ss_pred             --CCCCCCCCCCcccCccccCCCC-C-CCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccc
Q 007167          455 --PMPPPAMRAAGYRAPEVTDTRK-A-TQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDV  530 (615)
Q Consensus       455 --~~~~~~~~~~~y~aPE~~~~~~-~-~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  530 (615)
                        ......+|++.|+|||++.+.. | ..++||||+||+||.|++|+.||++.+.......      +..         .
T Consensus       174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~k------i~~---------~  238 (370)
T KOG0583|consen  174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRK------IRK---------G  238 (370)
T ss_pred             CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHH------Hhc---------C
Confidence              3445678999999999999877 7 4799999999999999999999987332222111      111         1


Q ss_pred             cccCCCCc-HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          531 ELLRYPNI-EEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       531 ~~~~~~~~-~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                      ...-.... +.++..+++   +|+..+|.+|+++.|++++ .-++.
T Consensus       239 ~~~~p~~~~S~~~~~Li~---~mL~~~P~~R~t~~~i~~h-~w~~~  280 (370)
T KOG0583|consen  239 EFKIPSYLLSPEARSLIE---KMLVPDPSTRITLLEILEH-PWFQK  280 (370)
T ss_pred             CccCCCCcCCHHHHHHHH---HHcCCCcccCCCHHHHhhC-hhhcc
Confidence            11111223 666777776   9999999999999999944 45554

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=2e-39  Score=310.77  Aligned_cols=266  Identities=23%  Similarity=0.363  Sum_probs=202.0

Q ss_pred             ecccccccCHHHHHHHHhhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEE
Q 007167          288 FEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAY  363 (615)
Q Consensus       288 ~~~~~~~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~  363 (615)
                      ..+|..+-+++-     .+.|++|+||.||+|+++ ++..||+|+++-....   .-.-.+|+.+|.+++|||||.+..+
T Consensus        69 l~gCrsv~efe~-----lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEV  143 (419)
T KOG0663|consen   69 LGGCRSVEEFEK-----LNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEV  143 (419)
T ss_pred             ccCcccHHHHHH-----HhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEE
Confidence            445654444433     356999999999999954 5678999999754321   1234799999999999999999988


Q ss_pred             EEec--CeeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCc
Q 007167          364 YYSK--DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGH  441 (615)
Q Consensus       364 ~~~~--~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~  441 (615)
                      ....  +..|||||||+. +|.++++.-+    .++......-++.|+++|++|||.+.   |+|||||++|+|++..|.
T Consensus       144 VvG~~~d~iy~VMe~~Eh-DLksl~d~m~----q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~  215 (419)
T KOG0663|consen  144 VVGSNMDKIYIVMEYVEH-DLKSLMETMK----QPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGI  215 (419)
T ss_pred             EeccccceeeeeHHHHHh-hHHHHHHhcc----CCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCc
Confidence            8754  579999999987 8999997543    47888899999999999999999998   999999999999999999


Q ss_pred             EEEeecccccccCCC---CCCCCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchh-hHHHHHH
Q 007167          442 VCVSDIGLAALMSPM---PPPAMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATGGDEVV-HLVRWVN  516 (615)
Q Consensus       442 ~kl~DfG~a~~~~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~-~~~~~~~  516 (615)
                      +||+|||+|+.++.+   -+..+.|..|+|||.+.+. .|++..|+||+||++.||+++++.|.+...-+-. .+.+.++
T Consensus       216 lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llG  295 (419)
T KOG0663|consen  216 LKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLG  295 (419)
T ss_pred             EEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhC
Confidence            999999999999866   3455678999999998764 5899999999999999999999999876543222 2233333


Q ss_pred             Hhhhcccccccccc-----ccc---------CCCC--cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          517 SVVREEWTAEVFDV-----ELL---------RYPN--IEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       517 ~~~~~~~~~~~~d~-----~~~---------~~~~--~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ......|..-.--+     ...         +++.  .++.-.+++.   ..+..||.+|.|+.|.+++
T Consensus       296 tPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln---~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  296 TPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLN---KLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             CCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHH---HHhccCccccccHHHhhcc
Confidence            33333333211100     111         1111  1244444444   8889999999999999987

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=322.73  Aligned_cols=249  Identities=21%  Similarity=0.323  Sum_probs=198.2

Q ss_pred             HHhhhcCcCCccEEEEEEE-CCCCEEEEEEeccc--cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          303 ASAEVLGKGTFGTAYKAAL-EDASTVVVKRLKEV--NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       303 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      ...++||.|..++||+|.. ..+..||||++.-.  ...-+.+++|++.++.++||||++++..|..+...|+||.||.+
T Consensus        29 eL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~  108 (516)
T KOG0582|consen   29 ELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAG  108 (516)
T ss_pred             eEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcC
Confidence            3456799999999999984 45688999998644  33347889999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      ||+.+++...-.   ..+++..+..|++++++||.|||++|   .||||||+.||||+++|.+||+|||.+..+....  
T Consensus       109 GS~ldIik~~~~---~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R  182 (516)
T KOG0582|consen  109 GSLLDIIKTYYP---DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR  182 (516)
T ss_pred             CcHHHHHHHHcc---ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence            999999976432   35899999999999999999999998   9999999999999999999999999887664422  


Q ss_pred             -----CCCCCCCcccCccccC--CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccc---ccc
Q 007167          458 -----PPAMRAAGYRAPEVTD--TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWT---AEV  527 (615)
Q Consensus       458 -----~~~~~~~~y~aPE~~~--~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~  527 (615)
                           ...++++.|||||++.  ...|+.|+||||||++..||.+|..||......++.      ...+++...   ...
T Consensus       183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvL------l~tLqn~pp~~~t~~  256 (516)
T KOG0582|consen  183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVL------LLTLQNDPPTLLTSG  256 (516)
T ss_pred             eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHH------HHHhcCCCCCccccc
Confidence                 3346789999999953  356999999999999999999999999876654432      111222111   111


Q ss_pred             ccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007167          528 FDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK  568 (615)
Q Consensus       528 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  568 (615)
                      +|.+.  ...+..   .+.+++..|+.+||.+|||+.++++
T Consensus       257 ~~~d~--~k~~~k---sf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  257 LDKDE--DKKFSK---SFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             CChHH--hhhhcH---HHHHHHHHHhhcCcccCCCHHHHhc
Confidence            11111  111223   4455555999999999999999987

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.4e-39  Score=336.77  Aligned_cols=237  Identities=21%  Similarity=0.325  Sum_probs=193.4

Q ss_pred             hcCcCCccEEEEEEE-CCCCEEEEEEeccccC----CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          307 VLGKGTFGTAYKAAL-EDASTVVVKRLKEVNV----GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      +||+|+||.||++.. .+++.||+|+++....    ....+.+|+++++.++||||+++++++...+..++||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~   81 (323)
T cd05571           2 LLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCc
Confidence            599999999999985 4688999999875321    12456789999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC---CC
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM---PP  458 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~---~~  458 (615)
                      |.+++...     ..+++.....++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....   ..
T Consensus        82 L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  153 (323)
T cd05571          82 LFFHLSRE-----RVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMK  153 (323)
T ss_pred             HHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCccc
Confidence            99998643     36899999999999999999999998   999999999999999999999999998754221   22


Q ss_pred             CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCc
Q 007167          459 PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI  538 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  538 (615)
                      ...++..|+|||++.+..++.++||||+||++|||++|+.||...+.......+      ..+         ........
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~------~~~---------~~~~p~~~  218 (323)
T cd05571         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LME---------EIRFPRTL  218 (323)
T ss_pred             ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHH------HcC---------CCCCCCCC
Confidence            345789999999999889999999999999999999999999764432221111      111         11112234


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007167          539 EEEMVEMLQVGMACVVRMPEERP-----KMADVLKM  569 (615)
Q Consensus       539 ~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  569 (615)
                      ++++.++++   +|++.||++||     ++.|++++
T Consensus       219 ~~~~~~li~---~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         219 SPEAKSLLA---GLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CHHHHHHHH---HHccCCHHHcCCCCCCCHHHHHcC
Confidence            566666666   99999999999     89999874

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=3.7e-39  Score=327.57  Aligned_cols=240  Identities=22%  Similarity=0.368  Sum_probs=197.1

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC----HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG----KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      ..+||+|+||+||.|+.+ .|..+|+|++++...-    .+.+..|-.+|...++++||+|+-.|++.+.+||||||++|
T Consensus       146 Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPG  225 (550)
T KOG0605|consen  146 LKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPG  225 (550)
T ss_pred             heeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCC
Confidence            357999999999999965 5778999999876332    35677888999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC----
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP----  455 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~----  455 (615)
                      |++..+|...     ..|++..+..++.+++.|++.+|+.|   +|||||||+|+|||..|++||+|||++.-+..    
T Consensus       226 GD~mTLL~~~-----~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~  297 (550)
T KOG0605|consen  226 GDMMTLLMRK-----DTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRI  297 (550)
T ss_pred             ccHHHHHHhc-----CcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhhhh
Confidence            9999999743     47999999999999999999999998   99999999999999999999999999843210    


Q ss_pred             ---------------------C-----C--------------------CCCCCCCcccCccccCCCCCCCccchhhHHHH
Q 007167          456 ---------------------M-----P--------------------PPAMRAAGYRAPEVTDTRKATQASDVFSFGVL  489 (615)
Q Consensus       456 ---------------------~-----~--------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvv  489 (615)
                                           .     .                    ...+||+.|+|||++.+..|+..+|+||+|||
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~I  377 (550)
T KOG0605|consen  298 ESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCI  377 (550)
T ss_pred             hhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHH
Confidence                                 0     0                    01347888999999999999999999999999


Q ss_pred             HHHHHhCCCCCCCCCCcchhh-HHHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCC---HHH
Q 007167          490 LLELLTGKSPIHATGGDEVVH-LVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPK---MAD  565 (615)
Q Consensus       490 l~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs---~~e  565 (615)
                      +|||+.|-+||.+.+..+... ++.|-......            ....+++++++++.   +|+. ||++|.-   ++|
T Consensus       378 myEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP------------~~~~~s~eA~DLI~---rll~-d~~~RLG~~G~~E  441 (550)
T KOG0605|consen  378 MYEMLVGYPPFCSETPQETYRKIVNWRETLKFP------------EEVDLSDEAKDLIT---RLLC-DPENRLGSKGAEE  441 (550)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCC------------CcCcccHHHHHHHH---HHhc-CHHHhcCcccHHH
Confidence            999999999999887766653 44444332211            11234577777777   8888 9999985   555


Q ss_pred             HHH
Q 007167          566 VLK  568 (615)
Q Consensus       566 vl~  568 (615)
                      |-+
T Consensus       442 IK~  444 (550)
T KOG0605|consen  442 IKK  444 (550)
T ss_pred             Hhc
Confidence            544

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8e-40  Score=338.45  Aligned_cols=240  Identities=26%  Similarity=0.362  Sum_probs=203.7

Q ss_pred             hhhcCcCCccEEEEEE-ECCCCEEEEEEeccc----cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAA-LEDASTVVVKRLKEV----NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      ++.||+|+-|.|-.|+ .+.|+.+|||.+.+.    ......+++|+-+|+.+.||||++++++++++.++|+|.||+++
T Consensus        17 gkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~g   96 (786)
T KOG0588|consen   17 GKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPG   96 (786)
T ss_pred             cccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCC
Confidence            5569999999999998 567999999999765    12245688999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC--C
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM--P  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~--~  457 (615)
                      |.|++++-.+     .++.+..+.+++.||..|+.|||..+   |+|||+||+|+|+|..+++||+|||+|..-.+.  -
T Consensus        97 GELFdylv~k-----G~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklL  168 (786)
T KOG0588|consen   97 GELFDYLVRK-----GPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLL  168 (786)
T ss_pred             chhHHHHHhh-----CCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecccCCccc
Confidence            9999999743     37899999999999999999999998   999999999999999999999999999876543  2


Q ss_pred             CCCCCCCcccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          458 PPAMRAAGYRAPEVTDTRKA-TQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                      .+.+|++-|.|||++.+..| +.++||||+||+||-|++|+.||++.+-..   +...|   .++         ...-..
T Consensus       169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~---LLlKV---~~G---------~f~MPs  233 (786)
T KOG0588|consen  169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRV---LLLKV---QRG---------VFEMPS  233 (786)
T ss_pred             cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHH---HHHHH---HcC---------cccCCC
Confidence            46688999999999999998 689999999999999999999998543222   22111   111         111234


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                      +++.++.+++.   +|+..||++|.|++||++|-
T Consensus       234 ~Is~eaQdLLr---~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  234 NISSEAQDLLR---RMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             cCCHHHHHHHH---HHhccCccccccHHHHhhCc
Confidence            67788888888   99999999999999999984

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=5.8e-39  Score=332.86  Aligned_cols=239  Identities=20%  Similarity=0.303  Sum_probs=196.8

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc----CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN----VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||.||+|..+ +++.||+|.++...    ...+.+.+|++++++++||||+++++++.+++..++||||+++
T Consensus        23 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  102 (329)
T PTZ00263         23 GETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVG  102 (329)
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCC
Confidence            457999999999999965 57889999987532    1235678999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCC
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP  459 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~  459 (615)
                      |+|.+++...     ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++........
T Consensus       103 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  174 (329)
T PTZ00263        103 GELFTHLRKA-----GRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT  174 (329)
T ss_pred             ChHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCCcce
Confidence            9999999743     35788899999999999999999998   999999999999999999999999999887665555


Q ss_pred             CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      ..++..|+|||++.+..++.++|||||||++|||++|+.||......+...      .+...         .......++
T Consensus       175 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~------~i~~~---------~~~~p~~~~  239 (329)
T PTZ00263        175 LCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYE------KILAG---------RLKFPNWFD  239 (329)
T ss_pred             ecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHH------HHhcC---------CcCCCCCCC
Confidence            678899999999998889999999999999999999999997643322111      11111         111112244


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 007167          540 EEMVEMLQVGMACVVRMPEERPK-----MADVLKM  569 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~  569 (615)
                      +.+.++++   +||+.||.+||+     ++|++++
T Consensus       240 ~~~~~li~---~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        240 GRARDLVK---GLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             HHHHHHHH---HHhhcCHHHcCCCCCCCHHHHhcC
Confidence            55566665   999999999997     7888866

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.3e-40  Score=321.83  Aligned_cols=261  Identities=20%  Similarity=0.356  Sum_probs=193.4

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecC-----eeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKD-----EKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lV~e~~~  378 (615)
                      .+++|+|+||.||+|.+. .+..||||+.-...   +.-.+|+++|++++|||||++.-+|....     ...+|||||+
T Consensus        29 ~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~---r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP  105 (364)
T KOG0658|consen   29 VRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK---RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMP  105 (364)
T ss_pred             eEEEeecccceEEEEEEcCCCceeEEEEecCCC---CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhch
Confidence            357999999999999954 56889999886542   23347999999999999999998887543     3468999996


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCC-CcEEEeecccccccCCCC
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQ-GHVCVSDIGLAALMSPMP  457 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~-~~~kl~DfG~a~~~~~~~  457 (615)
                      . +|...++... ..+..++.-...-++.|+++||.|||+.+   |+||||||.|+|+|.+ |.+||||||.|+.+....
T Consensus       106 ~-tL~~~~r~~~-~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~e  180 (364)
T KOG0658|consen  106 E-TLYRVIRHYT-RANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGE  180 (364)
T ss_pred             H-HHHHHHHHHh-hcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceeeccCC
Confidence            5 8998887421 12335666677789999999999999987   9999999999999977 899999999999987654


Q ss_pred             CC--CCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCc-chhhHHHHHHHhhhccccc------cc
Q 007167          458 PP--AMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGD-EVVHLVRWVNSVVREEWTA------EV  527 (615)
Q Consensus       458 ~~--~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~------~~  527 (615)
                      ..  ..-++-|+|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+.+.. +...+++.++...+++...      +.
T Consensus       181 pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~  260 (364)
T KOG0658|consen  181 PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEF  260 (364)
T ss_pred             CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccc
Confidence            43  335788999999876 56999999999999999999999999885542 3333444333322222110      11


Q ss_pred             ccccccCC-------CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhHhh
Q 007167          528 FDVELLRY-------PNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM--VEDIRRV  576 (615)
Q Consensus       528 ~d~~~~~~-------~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~l~~~  576 (615)
                      -.+.+...       ...++   +.++++.+++..+|.+|.++.|++.+  .+++++.
T Consensus       261 ~~p~ik~~~~~~~~~~~~~~---d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  261 KFPQIKAHPWHKVFFKRLPP---DALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             cCcccccccceeecccCCCH---HHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence            11111111       12233   44555559999999999999999864  4555554

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=5.8e-39  Score=329.23  Aligned_cols=255  Identities=22%  Similarity=0.374  Sum_probs=194.8

Q ss_pred             hhhcCcCCccEEEEEEECC-----------------CCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEE
Q 007167          305 AEVLGKGTFGTAYKAALED-----------------ASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYY  365 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~  365 (615)
                      .++||+|+||.||++.+++                 +..||+|.+.....  ...++.+|++++.+++||||+++++++.
T Consensus        10 ~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   89 (304)
T cd05096          10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCV   89 (304)
T ss_pred             eeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEe
Confidence            4579999999999997543                 23699998875422  2457889999999999999999999999


Q ss_pred             ecCeeeEEeecCCCCChhhhhccCCC--------------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCC
Q 007167          366 SKDEKLMVYDYFEPGSVSAMLHGRRG--------------EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKA  431 (615)
Q Consensus       366 ~~~~~~lV~e~~~~gsL~~~l~~~~~--------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~  431 (615)
                      +.+..++||||+++|+|.+++.....              .....++|....+++.|++.||+|||+.+   |+||||||
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH~dlkp  166 (304)
T cd05096          90 DEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVHRDLAT  166 (304)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccccCcch
Confidence            99999999999999999998864321              11235789999999999999999999998   99999999


Q ss_pred             CCEEeCCCCcEEEeecccccccCCCCC-----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh--CCCCCCCCC
Q 007167          432 SNIFLNSQGHVCVSDIGLAALMSPMPP-----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT--GKSPIHATG  504 (615)
Q Consensus       432 ~Nill~~~~~~kl~DfG~a~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt--g~~p~~~~~  504 (615)
                      +|||++.++.+||+|||+++.+.....     ...++..|+|||++....++.++|||||||++|||++  +..||....
T Consensus       167 ~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  246 (304)
T cd05096         167 RNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELT  246 (304)
T ss_pred             hheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCC
Confidence            999999999999999999986643221     2234667999999988889999999999999999987  567887654


Q ss_pred             CcchhhHHHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 007167          505 GDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVED  572 (615)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  572 (615)
                      ..+..   ..+......... ..   .....+..++.+   .+++.+||..+|++|||+.||.+.|++
T Consensus       247 ~~~~~---~~~~~~~~~~~~-~~---~~~~~~~~~~~~---~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         247 DEQVI---ENAGEFFRDQGR-QV---YLFRPPPCPQGL---YELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             HHHHH---HHHHHHhhhccc-cc---cccCCCCCCHHH---HHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            43322   222221111100 00   011122333444   455559999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=5.2e-39  Score=321.91  Aligned_cols=246  Identities=24%  Similarity=0.419  Sum_probs=200.4

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChhh
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSA  384 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  384 (615)
                      .++||+|+||+||+|..+++..||+|.++......+.+.+|+++++.++|+||+++++++...+..++||||+++|+|.+
T Consensus        11 ~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   90 (261)
T cd05072          11 VKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLD   90 (261)
T ss_pred             eeecCCcCCceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHH
Confidence            46799999999999998888899999987655556788999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC----CC
Q 007167          385 MLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP----PA  460 (615)
Q Consensus       385 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~----~~  460 (615)
                      +++...   ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++........    ..
T Consensus        91 ~l~~~~---~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  164 (261)
T cd05072          91 FLKSDE---GGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGA  164 (261)
T ss_pred             HHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCceeccCCC
Confidence            997532   236889999999999999999999987   99999999999999999999999999987653221    12


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      .++..|+|||+.....++.++|||||||++|||++ |+.||......+...   .+..    .+       ........+
T Consensus       165 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~---~~~~----~~-------~~~~~~~~~  230 (261)
T cd05072         165 KFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMS---ALQR----GY-------RMPRMENCP  230 (261)
T ss_pred             ccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHH---HHHc----CC-------CCCCCCCCC
Confidence            23567999999988889999999999999999998 999997644332221   1111    10       011112233


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI  573 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l  573 (615)
                      .++   .+++.+|+..+|++||+++++++.|+++
T Consensus       231 ~~~---~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         231 DEL---YDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             HHH---HHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            444   4555599999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=318.48  Aligned_cols=256  Identities=25%  Similarity=0.406  Sum_probs=192.1

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHh--CCCCCcccceeEEEEecC----eeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVG--GIRHENVVALRAYYYSKD----EKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~--~l~h~niv~l~~~~~~~~----~~~lV~e~~~  378 (615)
                      .++||+|+||.||||++.+ +.||||++....  +..|+.|-++.+  .++|+||++++++-....    +++||+||.+
T Consensus       215 ~eli~~Grfg~V~KaqL~~-~~VAVKifp~~~--kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~  291 (534)
T KOG3653|consen  215 LELIGRGRFGCVWKAQLDN-RLVAVKIFPEQE--KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHP  291 (534)
T ss_pred             HHHhhcCccceeehhhccC-ceeEEEecCHHH--HHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeecc
Confidence            3579999999999999865 899999997543  456666666554  568999999999976655    8999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccC------CCCceecCCCCCCEEeCCCCcEEEeecccccc
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN------GGKLVHGGIKASNIFLNSQGHVCVSDIGLAAL  452 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~------~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~  452 (615)
                      +|+|.++|..+      .++|....+|+..+++||+|||+..      +|+|+|||||++||||..|+++.|+|||+|..
T Consensus       292 kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~  365 (534)
T KOG3653|consen  292 KGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALR  365 (534)
T ss_pred             CCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEE
Confidence            99999999753      6999999999999999999999865      57899999999999999999999999999988


Q ss_pred             cCCCC-----CCCCCCCcccCccccCCCC-CC-----CccchhhHHHHHHHHHhCCCCCCC--------CCCcch-----
Q 007167          453 MSPMP-----PPAMRAAGYRAPEVTDTRK-AT-----QASDVFSFGVLLLELLTGKSPIHA--------TGGDEV-----  508 (615)
Q Consensus       453 ~~~~~-----~~~~~~~~y~aPE~~~~~~-~~-----~~~DvwS~Gvvl~elltg~~p~~~--------~~~~~~-----  508 (615)
                      +.+..     ...+||.+|||||++.+.- +.     .+.||||+|.|||||++...-+..        ..+.++     
T Consensus       366 ~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt  445 (534)
T KOG3653|consen  366 LEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPT  445 (534)
T ss_pred             ecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCC
Confidence            86432     2367899999999996532 22     478999999999999996543321        111111     


Q ss_pred             hhHHH--HHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhhc
Q 007167          509 VHLVR--WVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKA  578 (615)
Q Consensus       509 ~~~~~--~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~  578 (615)
                      .+.++  .++...+..+.....     .    ...+..+-+.+..||..||+.|.|+.=|.+.+.++.....
T Consensus       446 ~e~mq~~VV~kK~RP~~p~~W~-----~----h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~  508 (534)
T KOG3653|consen  446 LEEMQELVVRKKQRPKIPDAWR-----K----HAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWE  508 (534)
T ss_pred             HHHHHHHHHhhccCCCChhhhh-----c----CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCC
Confidence            11110  111111111111110     0    1223344455569999999999999999999999887654

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=7.8e-39  Score=319.73  Aligned_cols=242  Identities=26%  Similarity=0.412  Sum_probs=197.1

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChhh
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSA  384 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  384 (615)
                      .+.||+|+||.||++.++++..+|+|.++......+.+.+|++++++++||||+++++++..++..++||||+++|+|.+
T Consensus         9 ~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~   88 (256)
T cd05114           9 MKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLN   88 (256)
T ss_pred             eeEecCCcCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHH
Confidence            35699999999999999888899999987666667789999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC----CC
Q 007167          385 MLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP----PA  460 (615)
Q Consensus       385 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~----~~  460 (615)
                      +++...    ..+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||.++.......    ..
T Consensus        89 ~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~  161 (256)
T cd05114          89 YLRQRQ----GKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGA  161 (256)
T ss_pred             HHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCC
Confidence            987432    25899999999999999999999998   99999999999999999999999999876543221    11


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      .++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....   +   .....        .......+
T Consensus       162 ~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~---i---~~~~~--------~~~~~~~~  227 (256)
T cd05114         162 KFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEM---I---SRGFR--------LYRPKLAS  227 (256)
T ss_pred             CCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---H---HCCCC--------CCCCCCCC
Confidence            23457999999988889999999999999999999 9999976543322221   1   11110        00111122


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                      .   .+.+++.+||+.+|++||++.|+++.|
T Consensus       228 ~---~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         228 M---TVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             H---HHHHHHHHHccCCcccCcCHHHHHHhh
Confidence            3   345556699999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=5.7e-39  Score=326.15  Aligned_cols=244  Identities=24%  Similarity=0.355  Sum_probs=195.1

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEecccc----CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEVN----VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      +.||+|+||+||++.. .+++.||+|.+....    .....+.+|+++++.++|+||+++++++.+++..++||||+++|
T Consensus         6 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g   85 (285)
T cd05631           6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGG   85 (285)
T ss_pred             EEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCC
Confidence            5699999999999985 578899999886432    12345778999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--C
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--P  458 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--~  458 (615)
                      +|.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||++.......  .
T Consensus        86 ~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  159 (285)
T cd05631          86 DLKFHIYNMG---NPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVR  159 (285)
T ss_pred             cHHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeec
Confidence            9998886422   236899999999999999999999998   9999999999999999999999999998764322  2


Q ss_pred             CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCc
Q 007167          459 PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI  538 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  538 (615)
                      ...++..|+|||++.+..++.++|||||||++|||++|+.||...........+.   ....        .........+
T Consensus       160 ~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~---~~~~--------~~~~~~~~~~  228 (285)
T cd05631         160 GRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVD---RRVK--------EDQEEYSEKF  228 (285)
T ss_pred             CCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHH---HHhh--------cccccCCccC
Confidence            3457889999999999899999999999999999999999998754432211111   0000        0011112234


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 007167          539 EEEMVEMLQVGMACVVRMPEERPK-----MADVLKM  569 (615)
Q Consensus       539 ~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~  569 (615)
                      ++++.++++   +||+.||++||+     ++|++++
T Consensus       229 s~~~~~li~---~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         229 SEDAKSICR---MLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             CHHHHHHHH---HHhhcCHHHhcCCCCCCHHHHhcC
Confidence            555555555   999999999997     7888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-39  Score=330.32  Aligned_cols=239  Identities=18%  Similarity=0.270  Sum_probs=196.7

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc----CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN----VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||.||+|..+ +++.||+|++....    ...+.+.+|+++++.++||||+++++++.+.+..++||||+++
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   85 (291)
T cd05612           6 IKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPG   85 (291)
T ss_pred             eeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCC
Confidence            356999999999999965 67889999986432    1235678899999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCC
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP  459 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~  459 (615)
                      |+|.+++...     ..+++.....++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++........
T Consensus        86 ~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  157 (291)
T cd05612          86 GELFSYLRNS-----GRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT  157 (291)
T ss_pred             CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCCccc
Confidence            9999999643     35889999999999999999999998   999999999999999999999999999877655455


Q ss_pred             CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      ..++..|+|||++.+..++.++|||||||++|||++|+.||......+....+      ...         ........+
T Consensus       158 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i------~~~---------~~~~~~~~~  222 (291)
T cd05612         158 LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKI------LAG---------KLEFPRHLD  222 (291)
T ss_pred             ccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhC---------CcCCCccCC
Confidence            56889999999998888999999999999999999999999765433222111      111         011112334


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 007167          540 EEMVEMLQVGMACVVRMPEERPK-----MADVLKM  569 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~  569 (615)
                      ..+.++++   +|++.||.+||+     ++|++++
T Consensus       223 ~~~~~li~---~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         223 LYAKDLIK---KLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             HHHHHHHH---HHcCCCHHHccCCccCCHHHHhcC
Confidence            55666666   999999999995     8888876

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-38  Score=318.57  Aligned_cols=246  Identities=25%  Similarity=0.425  Sum_probs=200.7

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChhh
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSA  384 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  384 (615)
                      .+.||+|+||.||+|..++++.||+|.++......+++.+|++++++++|+||+++++++...+..++||||+++++|.+
T Consensus        11 ~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   90 (261)
T cd05068          11 LRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLE   90 (261)
T ss_pred             EEEecccCCccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHH
Confidence            45799999999999998888899999998766567789999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCC-CCC-
Q 007167          385 MLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP-AMR-  462 (615)
Q Consensus       385 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~-  462 (615)
                      ++....   ...+++..+..++.|++.|+.|||+.+   |+||||||+||++++++.+||+|||+++........ ..+ 
T Consensus        91 ~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  164 (261)
T cd05068          91 YLQGGA---GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGA  164 (261)
T ss_pred             HHhccC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCC
Confidence            997532   346899999999999999999999998   999999999999999999999999999876532211 112 


Q ss_pred             --CCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          463 --AAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       463 --~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                        +..|+|||+..+..++.++||||||+++|||++ |+.||......+....+.       ...       ........+
T Consensus       165 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-------~~~-------~~~~~~~~~  230 (261)
T cd05068         165 KFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD-------QGY-------RMPCPPGCP  230 (261)
T ss_pred             cCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-------cCC-------CCCCCCcCC
Confidence              346999999988889999999999999999999 999997654332222111       000       001111223


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI  573 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l  573 (615)
                      +   .+.+++.+|++.+|++||++.++++.|+++
T Consensus       231 ~---~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         231 K---ELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             H---HHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence            3   445555699999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=7.2e-39  Score=322.02  Aligned_cols=245  Identities=21%  Similarity=0.385  Sum_probs=194.4

Q ss_pred             hhhcCcCCccEEEEEEEC----CCCEEEEEEeccccCC--HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALE----DASTVVVKRLKEVNVG--KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      .+.||+|+||.||+|.++    .+..||+|.++.....  ...+.+|+++++.++||||+++++++..++..++||||++
T Consensus        10 ~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~   89 (266)
T cd05064          10 ERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMS   89 (266)
T ss_pred             eeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCC
Confidence            467999999999999753    3567999998764322  3568899999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC-
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP-  457 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~-  457 (615)
                      +|+|.+++...    ...+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.++++|||.+....... 
T Consensus        90 ~~~L~~~l~~~----~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~  162 (266)
T cd05064          90 NGALDSFLRKH----EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI  162 (266)
T ss_pred             CCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccccch
Confidence            99999999743    236899999999999999999999998   9999999999999999999999999876543211 


Q ss_pred             ---CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccccccccccc
Q 007167          458 ---PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELL  533 (615)
Q Consensus       458 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  533 (615)
                         ....++..|+|||.+.+..++.++|||||||++||+++ |+.||......+....   +.    +..       ...
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~---~~----~~~-------~~~  228 (266)
T cd05064         163 YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKA---VE----DGF-------RLP  228 (266)
T ss_pred             hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH---HH----CCC-------CCC
Confidence               11223467999999988899999999999999999876 9999976544332211   11    100       011


Q ss_pred             CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 007167          534 RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI  573 (615)
Q Consensus       534 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l  573 (615)
                      ..+.++..+.+   ++.+||+.+|++||+++|+.+.|.++
T Consensus       229 ~~~~~~~~~~~---li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         229 APRNCPNLLHQ---LMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             CCCCCCHHHHH---HHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            12233344444   45599999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.4e-39  Score=334.74  Aligned_cols=239  Identities=18%  Similarity=0.259  Sum_probs=196.6

Q ss_pred             hhhcCcCCccEEEEEEECC--CCEEEEEEecccc----CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALED--ASTVVVKRLKEVN----VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~--~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      .+.||+|+||.||+|..++  +..||+|++....    ...+.+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus        35 ~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~  114 (340)
T PTZ00426         35 IRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVI  114 (340)
T ss_pred             EEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCC
Confidence            4579999999999998543  3579999986432    223567889999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP  458 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~  458 (615)
                      +|+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++++||+|||+++.......
T Consensus       115 ~g~L~~~i~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~~  186 (340)
T PTZ00426        115 GGEFFTFLRRN-----KRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY  186 (340)
T ss_pred             CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCCcc
Confidence            99999999743     36889999999999999999999998   99999999999999999999999999988765555


Q ss_pred             CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCc
Q 007167          459 PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI  538 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  538 (615)
                      ...+|..|+|||++.+..++.++|||||||++|||++|+.||...+.......      +...         .....+..
T Consensus       187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~------i~~~---------~~~~p~~~  251 (340)
T PTZ00426        187 TLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQK------ILEG---------IIYFPKFL  251 (340)
T ss_pred             eecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHH------HhcC---------CCCCCCCC
Confidence            56788999999999888899999999999999999999999976443222111      1111         11112234


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007167          539 EEEMVEMLQVGMACVVRMPEERP-----KMADVLKM  569 (615)
Q Consensus       539 ~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  569 (615)
                      ++.+.++++   +|++.+|++|+     +++|++++
T Consensus       252 ~~~~~~li~---~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        252 DNNCKHLMK---KLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             CHHHHHHHH---HHcccCHHHcCCCCCCCHHHHHcC
Confidence            556666666   99999999995     89998876

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-39  Score=331.02  Aligned_cols=254  Identities=23%  Similarity=0.352  Sum_probs=208.8

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      .++||+|-||.|..+..+.+..||||.++....  ...+|.+|+++|.+++|||||.++|+|..++.+++|+|||++|+|
T Consensus       543 ~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDL  622 (807)
T KOG1094|consen  543 KEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDL  622 (807)
T ss_pred             hhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcH
Confidence            688999999999999999899999999987633  357899999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCCCC-
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAM-  461 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~-  461 (615)
                      .+++.+...   +.+.-....+|+.|||.|++||.+.+   +||||+.++|+|+|.++++||+|||.++.+...++... 
T Consensus       623 nqFl~ahea---pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vq  696 (807)
T KOG1094|consen  623 NQFLSAHEL---PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQ  696 (807)
T ss_pred             HHHHHhccC---cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCceeee
Confidence            999976432   12455667789999999999999998   99999999999999999999999999997765544333 


Q ss_pred             ----CCCcccCccccCCCCCCCccchhhHHHHHHHHHh--CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCC
Q 007167          462 ----RAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT--GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY  535 (615)
Q Consensus       462 ----~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  535 (615)
                          -..+|||||.+.-+++++++|||+||+++||+++  ...||....++++++-.   ..+.+.+-...+    +...
T Consensus       697 gr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~---~~~~~~~~~~~~----l~~P  769 (807)
T KOG1094|consen  697 GRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENA---GEFFRDQGRQVV----LSRP  769 (807)
T ss_pred             cceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhh---hhhcCCCCccee----ccCC
Confidence                2568999999999999999999999999999886  88999887766554322   222222211111    1122


Q ss_pred             CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhH
Q 007167          536 PNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIR  574 (615)
Q Consensus       536 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~  574 (615)
                      +-   ....+.+++++||+.+-++||+++++..+|++..
T Consensus       770 ~~---cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~  805 (807)
T KOG1094|consen  770 PA---CPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA  805 (807)
T ss_pred             Cc---CcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence            22   3345667788999999999999999999998754

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.4e-38  Score=329.67  Aligned_cols=237  Identities=20%  Similarity=0.333  Sum_probs=193.5

Q ss_pred             hcCcCCccEEEEEEEC-CCCEEEEEEecccc----CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          307 VLGKGTFGTAYKAALE-DASTVVVKRLKEVN----VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      +||+|+||.||++... +++.||+|.++...    .....+.+|+++++.++||||+++++++..++..++||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~   81 (328)
T cd05593           2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE   81 (328)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence            5999999999999854 68899999997532    123467789999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC---CC
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM---PP  458 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~---~~  458 (615)
                      |.+++...     ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....   ..
T Consensus        82 L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~  153 (328)
T cd05593          82 LFFHLSRE-----RVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMK  153 (328)
T ss_pred             HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcccccc
Confidence            99988642     36899999999999999999999998   999999999999999999999999998754321   12


Q ss_pred             CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCc
Q 007167          459 PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI  538 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  538 (615)
                      ...++..|+|||++.+..++.++|||||||++|||++|+.||...+..+....+      ...         .......+
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~------~~~---------~~~~p~~~  218 (328)
T cd05593         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LME---------DIKFPRTL  218 (328)
T ss_pred             cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh------ccC---------CccCCCCC
Confidence            345788999999998888999999999999999999999999764432222111      111         01112234


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007167          539 EEEMVEMLQVGMACVVRMPEERP-----KMADVLKM  569 (615)
Q Consensus       539 ~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  569 (615)
                      ++++.++++   +|++.||++||     ++.|++++
T Consensus       219 ~~~~~~li~---~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         219 SADAKSLLS---GLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CHHHHHHHH---HHcCCCHHHcCCCCCCCHHHHhcC
Confidence            556666666   99999999997     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-38  Score=325.57  Aligned_cols=236  Identities=21%  Similarity=0.334  Sum_probs=190.7

Q ss_pred             cCcCCccEEEEEEEC-CCCEEEEEEecccc----CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          308 LGKGTFGTAYKAALE-DASTVVVKRLKEVN----VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       308 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      ||+|+||+||++... ++..||+|.++...    .....+.+|++++..++||||+++++++...+..++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            799999999999965 57789999986532    2234577899999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC---CCC
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM---PPP  459 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~---~~~  459 (615)
                      .+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....   ...
T Consensus        81 ~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  152 (312)
T cd05585          81 FHHLQRE-----GRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT  152 (312)
T ss_pred             HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCCCcccc
Confidence            9999642     35899999999999999999999998   999999999999999999999999999764322   223


Q ss_pred             CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      ..++..|+|||++.+..++.++||||+||++|||++|+.||......+.      .......         .......++
T Consensus       153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~------~~~~~~~---------~~~~~~~~~  217 (312)
T cd05585         153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEM------YRKILQE---------PLRFPDGFD  217 (312)
T ss_pred             ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHH------HHHHHcC---------CCCCCCcCC
Confidence            4578899999999988899999999999999999999999976432221      1111111         111122345


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 007167          540 EEMVEMLQVGMACVVRMPEERPK---MADVLKM  569 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs---~~evl~~  569 (615)
                      +++.++++   +|+..||++||+   +.|++++
T Consensus       218 ~~~~~li~---~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         218 RDAKDLLI---GLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             HHHHHHHH---HHcCCCHHHcCCCCCHHHHHcC
Confidence            66666666   999999999985   5666654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=8.6e-39  Score=330.70  Aligned_cols=237  Identities=21%  Similarity=0.319  Sum_probs=193.0

Q ss_pred             hcCcCCccEEEEEEE-CCCCEEEEEEecccc----CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          307 VLGKGTFGTAYKAAL-EDASTVVVKRLKEVN----VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      .||+|+||.||++.. .+|..||+|.++...    .....+.+|+++++.++||||+++++++...+..++||||+++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   81 (323)
T cd05595           2 LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGE   81 (323)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCc
Confidence            599999999999985 468899999987532    123456789999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---C
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---P  458 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~  458 (615)
                      |..++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......   .
T Consensus        82 L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  153 (323)
T cd05595          82 LFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMK  153 (323)
T ss_pred             HHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccc
Confidence            99888643     36899999999999999999999998   9999999999999999999999999987543221   2


Q ss_pred             CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCc
Q 007167          459 PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI  538 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  538 (615)
                      ...++..|+|||++.+..++.++|||||||++|||++|+.||...+..+....+      ..+         .......+
T Consensus       154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~------~~~---------~~~~p~~~  218 (323)
T cd05595         154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------LME---------EIRFPRTL  218 (323)
T ss_pred             cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------hcC---------CCCCCCCC
Confidence            345788999999999888999999999999999999999999765433222111      111         01111234


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007167          539 EEEMVEMLQVGMACVVRMPEERP-----KMADVLKM  569 (615)
Q Consensus       539 ~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  569 (615)
                      ++++.++++   +|++.||++||     ++.|++++
T Consensus       219 ~~~~~~li~---~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         219 SPEAKSLLA---GLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CHHHHHHHH---HHccCCHHHhCCCCCCCHHHHHcC
Confidence            566666666   99999999998     89998875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8e-39  Score=332.56  Aligned_cols=245  Identities=18%  Similarity=0.296  Sum_probs=198.6

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEecccc----CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVN----VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      +.||+|+||.||+|... +++.||+|+++...    .....+.+|++++..++||||+++++++.+.+..++||||+++|
T Consensus         7 ~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~   86 (333)
T cd05600           7 TQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGG   86 (333)
T ss_pred             EEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCC
Confidence            56999999999999975 57899999997542    12356788999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCCC
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPA  460 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  460 (615)
                      +|.+++...     ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++..........
T Consensus        87 ~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~~  158 (333)
T cd05600          87 DFRTLLNNL-----GVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV  158 (333)
T ss_pred             CHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCcccccccCCc
Confidence            999999642     36889999999999999999999998   9999999999999999999999999998776544556


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccccccc-CCCCcH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELL-RYPNIE  539 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~-~~~~~~  539 (615)
                      .++..|+|||++.+..++.++|||||||++|||++|+.||...+..+....+......        ...+... ....++
T Consensus       159 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~--------~~~~~~~~~~~~~s  230 (333)
T cd05600         159 VGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET--------LQRPVYDDPRFNLS  230 (333)
T ss_pred             ccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhcccc--------ccCCCCCccccccC
Confidence            7889999999999889999999999999999999999999875543332222110000        0000000 001234


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      +++.++++   +|+..+|++||+++|++++
T Consensus       231 ~~~~~li~---~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         231 DEAWDLIT---KLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             HHHHHHHH---HHhhChhhhcCCHHHHHhC
Confidence            55555555   9999999999999999986

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.6e-38  Score=334.83  Aligned_cols=253  Identities=24%  Similarity=0.381  Sum_probs=196.1

Q ss_pred             HHhhhcCcCCccEEEEEEE------CCCCEEEEEEeccccCC--HHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEE
Q 007167          303 ASAEVLGKGTFGTAYKAAL------EDASTVVVKRLKEVNVG--KREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMV  373 (615)
Q Consensus       303 ~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV  373 (615)
                      ...+.||+|+||.||+|..      .++..||+|+++.....  ...+.+|+++++.+ +|+|||+++++|...+..++|
T Consensus        41 ~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv  120 (374)
T cd05106          41 QFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVI  120 (374)
T ss_pred             eehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEe
Confidence            3467899999999999874      23357999999754222  34578899999999 899999999999999999999


Q ss_pred             eecCCCCChhhhhccCCC--------------------------------------------------------------
Q 007167          374 YDYFEPGSVSAMLHGRRG--------------------------------------------------------------  391 (615)
Q Consensus       374 ~e~~~~gsL~~~l~~~~~--------------------------------------------------------------  391 (615)
                      |||+++|+|.++++....                                                              
T Consensus       121 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (374)
T cd05106         121 TEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDE  200 (374)
T ss_pred             HhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccch
Confidence            999999999999864211                                                              


Q ss_pred             ---CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC-----CCCCC
Q 007167          392 ---EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP-----PAMRA  463 (615)
Q Consensus       392 ---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~-----~~~~~  463 (615)
                         ....++++....+++.|++.||+|||+.+   |+||||||+||++++++++||+|||+++.+.....     ...++
T Consensus       201 ~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~  277 (374)
T cd05106         201 EDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLP  277 (374)
T ss_pred             hccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCc
Confidence               01235788999999999999999999998   99999999999999999999999999976543221     11234


Q ss_pred             CcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHHHH
Q 007167          464 AGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEM  542 (615)
Q Consensus       464 ~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  542 (615)
                      ..|+|||++....++.++|||||||++|||++ |+.||.........  ..    ......       ........++++
T Consensus       278 ~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~--~~----~~~~~~-------~~~~~~~~~~~l  344 (374)
T cd05106         278 VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKF--YK----MVKRGY-------QMSRPDFAPPEI  344 (374)
T ss_pred             cceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHH--HH----HHHccc-------CccCCCCCCHHH
Confidence            57999999988889999999999999999997 99999764432211  11    111110       000111234455


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHHHHHHhH
Q 007167          543 VEMLQVGMACVVRMPEERPKMADVLKMVEDIR  574 (615)
Q Consensus       543 ~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~  574 (615)
                      .++++   +||+.||++||++.||+++|+++.
T Consensus       345 ~~li~---~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         345 YSIMK---MCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             HHHHH---HHcCCChhhCcCHHHHHHHHHHHh
Confidence            55554   999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.8e-38  Score=320.58  Aligned_cols=248  Identities=27%  Similarity=0.470  Sum_probs=196.9

Q ss_pred             hhhcCcCCccEEEEEEECCC------CEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAALEDA------STVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~------~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      .+.||+|+||.||+|.....      ..|++|.++....  ....+.+|+++++.++||||+++++++...+..+++|||
T Consensus        10 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~   89 (283)
T cd05048          10 LEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEY   89 (283)
T ss_pred             hhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEec
Confidence            46799999999999985432      4689998875432  235688999999999999999999999998999999999


Q ss_pred             CCCCChhhhhccCCCCC-----------CCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEe
Q 007167          377 FEPGSVSAMLHGRRGEG-----------QSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVS  445 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~  445 (615)
                      +++|+|.+++.......           ...+++.....++.|++.||+|||+.+   |+||||||+||++++++.+||+
T Consensus        90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~L~  166 (283)
T cd05048          90 LAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGLTVKIS  166 (283)
T ss_pred             CCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCCcEEEC
Confidence            99999999997532211           146889999999999999999999998   9999999999999999999999


Q ss_pred             ecccccccCCCC-----CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhh
Q 007167          446 DIGLAALMSPMP-----PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVV  519 (615)
Q Consensus       446 DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  519 (615)
                      |||+++......     ....++..|+|||.+....++.++|||||||++|||++ |..||......+....+.   .  
T Consensus       167 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~---~--  241 (283)
T cd05048         167 DFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR---S--  241 (283)
T ss_pred             CCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---c--
Confidence            999997654322     12234667999999988889999999999999999998 999998755443322211   1  


Q ss_pred             hcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 007167          520 REEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVED  572 (615)
Q Consensus       520 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  572 (615)
                        ...       .......++++.+++   .+||+.+|++||+++||+++|+.
T Consensus       242 --~~~-------~~~~~~~~~~~~~l~---~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         242 --RQL-------LPCPEDCPARVYALM---IECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             --CCc-------CCCcccCCHHHHHHH---HHHccCChhhCcCHHHHHHHHhc
Confidence              000       001123344555555   49999999999999999999975

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=343.05  Aligned_cols=250  Identities=21%  Similarity=0.372  Sum_probs=200.9

Q ss_pred             hhhcCcCCccEEEEEEECCC-CEEEEEEecccc-CCHHHHHHHHHHHhCCC-CCcccceeEE-EEe------cCeeeEEe
Q 007167          305 AEVLGKGTFGTAYKAALEDA-STVVVKRLKEVN-VGKREFEQQMEIVGGIR-HENVVALRAY-YYS------KDEKLMVY  374 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~-~~vavK~l~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~-~~~------~~~~~lV~  374 (615)
                      .+.|.+|||+.||.|....+ .+||+|++-..+ ..-+...+|+++|+.|+ |+|||.+++. ...      ..+.+|.|
T Consensus        42 ~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLm  121 (738)
T KOG1989|consen   42 EKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLM  121 (738)
T ss_pred             EEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeeh
Confidence            46799999999999997766 999999987552 23456789999999997 9999999993 322      13678999


Q ss_pred             ecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccC
Q 007167          375 DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS  454 (615)
Q Consensus       375 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~  454 (615)
                      |||.+|.|-+++..+.   ...|++..+++|+.|+++|+++||.. .|||||||||-+||||+.+++.||||||.|....
T Consensus       122 EyC~gg~Lvd~mn~Rl---q~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~  197 (738)
T KOG1989|consen  122 EYCKGGSLVDFMNTRL---QTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKI  197 (738)
T ss_pred             hhccCCcHHHHHHHHH---hccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCccccccccc
Confidence            9999999999998543   23499999999999999999999987 5789999999999999999999999999986543


Q ss_pred             CCC------------CCCCCCCcccCcccc---CCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhh
Q 007167          455 PMP------------PPAMRAAGYRAPEVT---DTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVV  519 (615)
Q Consensus       455 ~~~------------~~~~~~~~y~aPE~~---~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  519 (615)
                      ...            -....|+-|+|||++   .+...++|+|||++||+||-|+....||...+.-.++.         
T Consensus       198 ~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laIln---------  268 (738)
T KOG1989|consen  198 LSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAILN---------  268 (738)
T ss_pred             CCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeEEe---------
Confidence            221            122457889999997   45668999999999999999999999998653322111         


Q ss_pred             hcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhhc
Q 007167          520 REEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKA  578 (615)
Q Consensus       520 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~  578 (615)
                              -...++..+.+++.+.+|+.   .||+.+|++||++.||++.+.+++.-..
T Consensus       269 --------g~Y~~P~~p~ys~~l~~LI~---~mL~~nP~~RPnI~Qv~~~~~~l~~~~~  316 (738)
T KOG1989|consen  269 --------GNYSFPPFPNYSDRLKDLIR---TMLQPNPDERPNIYQVLEEIFELANKPC  316 (738)
T ss_pred             --------ccccCCCCccHHHHHHHHHH---HHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence                    01123334556666666666   9999999999999999999999986544

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=2.8e-38  Score=333.35  Aligned_cols=252  Identities=25%  Similarity=0.391  Sum_probs=196.2

Q ss_pred             HHhhhcCcCCccEEEEEEE------CCCCEEEEEEeccccC--CHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEE
Q 007167          303 ASAEVLGKGTFGTAYKAAL------EDASTVVVKRLKEVNV--GKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMV  373 (615)
Q Consensus       303 ~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV  373 (615)
                      ...+.||+|+||+||+|..      ..+..||||+++....  ..+.+.+|++++..+ +||||++++++|...+..++|
T Consensus        38 ~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv  117 (375)
T cd05104          38 SFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVI  117 (375)
T ss_pred             ehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceee
Confidence            3467899999999999963      2355799999875422  245688999999999 899999999999999999999


Q ss_pred             eecCCCCChhhhhccCCC--------------------------------------------------------------
Q 007167          374 YDYFEPGSVSAMLHGRRG--------------------------------------------------------------  391 (615)
Q Consensus       374 ~e~~~~gsL~~~l~~~~~--------------------------------------------------------------  391 (615)
                      |||+++|+|.++++....                                                              
T Consensus       118 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (375)
T cd05104         118 TEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQ  197 (375)
T ss_pred             ehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceeccc
Confidence            999999999999864321                                                              


Q ss_pred             --------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC-----
Q 007167          392 --------EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP-----  458 (615)
Q Consensus       392 --------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~-----  458 (615)
                              .....++|..+.+++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......     
T Consensus       198 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  274 (375)
T cd05104         198 DVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKG  274 (375)
T ss_pred             ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccccccC
Confidence                    01225789999999999999999999998   99999999999999999999999999986643221     


Q ss_pred             CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCC
Q 007167          459 PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN  537 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  537 (615)
                      ....+..|+|||.+.+..++.++|||||||++|||++ |..||.......  ...+++.    ....       ......
T Consensus       275 ~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~--~~~~~~~----~~~~-------~~~~~~  341 (375)
T cd05104         275 NARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS--KFYKMIK----EGYR-------MLSPEC  341 (375)
T ss_pred             CCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH--HHHHHHH----hCcc-------CCCCCC
Confidence            1123457999999998899999999999999999998 899997644322  1122111    1110       001112


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 007167          538 IEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI  573 (615)
Q Consensus       538 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l  573 (615)
                      .+.++   .+++.+|++.||++||++.||+++|++.
T Consensus       342 ~~~~l---~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         342 APSEM---YDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             CCHHH---HHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            23444   4555599999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=322.58  Aligned_cols=239  Identities=25%  Similarity=0.399  Sum_probs=198.8

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccc--cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEV--NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      ++||+|.||.||||.+. .++.||+|.+.-.  ...-+++++|+.++..++++||.+++|.+..+..++++||||.+|++
T Consensus        19 ~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv   98 (467)
T KOG0201|consen   19 ELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSV   98 (467)
T ss_pred             hhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcch
Confidence            67999999999999954 5677999998654  33346789999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---CC
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---PP  459 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~~  459 (615)
                      .+.|....     .+++....-|+.++..|+.|||.++   .+|||||+.|||+..+|.+|++|||.+..+....   .+
T Consensus        99 ~~lL~~~~-----~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~t  170 (467)
T KOG0201|consen   99 LDLLKSGN-----ILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKT  170 (467)
T ss_pred             hhhhccCC-----CCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhcccc
Confidence            99997432     4477777788999999999999998   9999999999999999999999999998876432   45


Q ss_pred             CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      .+||+-|||||++.+..|+.|+||||||++.+||.+|.+|+.......+..++-            .-..+.+.  ..++
T Consensus       171 fvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp------------k~~PP~L~--~~~S  236 (467)
T KOG0201|consen  171 FVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP------------KSAPPRLD--GDFS  236 (467)
T ss_pred             ccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc------------CCCCCccc--cccC
Confidence            678999999999998899999999999999999999999998766543322210            00011111  1456


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      +.++++++   .|++++|+.||++.+++++
T Consensus       237 ~~~kEFV~---~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  237 PPFKEFVE---ACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             HHHHHHHH---HHhhcCcccCcCHHHHhhh
Confidence            66777777   9999999999999998774

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=5.3e-38  Score=314.96  Aligned_cols=246  Identities=30%  Similarity=0.428  Sum_probs=198.4

Q ss_pred             HhhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          304 SAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       304 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      ..++||+|+||+||+|.+.+...||+|+++......+.+.+|+++++.++|+||+++++++. .+..++||||+++|+|.
T Consensus        10 ~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L~   88 (262)
T cd05071          10 LEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLL   88 (262)
T ss_pred             EeeecCCCCCCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCCCCcHH
Confidence            34679999999999999877778999999876555678999999999999999999999874 45679999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC----C
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP----P  459 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~----~  459 (615)
                      +++....   ...+++..+..++.|++.||+|||+.+   |+||||||+||++++++.++|+|||.++.+.....    .
T Consensus        89 ~~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~  162 (262)
T cd05071          89 DFLKGEM---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG  162 (262)
T ss_pred             HHHhhcc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccccccC
Confidence            9997432   236799999999999999999999998   99999999999999999999999999987654322    1


Q ss_pred             CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCc
Q 007167          460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI  538 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  538 (615)
                      ..++..|+|||+.....++.++|||||||++|||++ |+.||......+....+.      .. .          ..+..
T Consensus       163 ~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~------~~-~----------~~~~~  225 (262)
T cd05071         163 AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE------RG-Y----------RMPCP  225 (262)
T ss_pred             CcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHh------cC-C----------CCCCc
Confidence            224557999999988889999999999999999999 888997654333222110      00 0          00111


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 007167          539 EEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI  573 (615)
Q Consensus       539 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l  573 (615)
                      .+....+.+++.+|++.+|++||++.++++.|++.
T Consensus       226 ~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         226 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             cccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            12233456666699999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.5e-38  Score=326.33  Aligned_cols=247  Identities=22%  Similarity=0.381  Sum_probs=194.3

Q ss_pred             hhhcCcCCccEEEEEEEC-CCC----EEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecC
Q 007167          305 AEVLGKGTFGTAYKAALE-DAS----TVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYF  377 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  377 (615)
                      .+.||+|+||+||+|.+. ++.    .||+|.++....  ..+.+.+|+.+++.++||||++++|+|... ..++|+||+
T Consensus        12 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~   90 (316)
T cd05108          12 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM   90 (316)
T ss_pred             eeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecC
Confidence            357999999999999853 333    389999875422  245788999999999999999999999764 577999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC
Q 007167          378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP  457 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~  457 (615)
                      ++|+|.+++....    ..+++...++++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.+....
T Consensus        91 ~~g~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  163 (316)
T cd05108          91 PFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE  163 (316)
T ss_pred             CCCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccccCCC
Confidence            9999999997532    35889999999999999999999998   9999999999999999999999999998765332


Q ss_pred             CC-----CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccccccccc
Q 007167          458 PP-----AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE  531 (615)
Q Consensus       458 ~~-----~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  531 (615)
                      ..     ...+..|+|||++....++.++|||||||++|||++ |+.||.+....+..   .++.    ..       ..
T Consensus       164 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~---~~~~----~~-------~~  229 (316)
T cd05108         164 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS---SILE----KG-------ER  229 (316)
T ss_pred             cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH---HHHh----CC-------CC
Confidence            21     123457999999998899999999999999999998 99999764332221   1111    00       01


Q ss_pred             ccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          532 LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       532 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                      ....+...   .++.+++.+||..+|++||++.|++..+.++.+.
T Consensus       230 ~~~~~~~~---~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         230 LPQPPICT---IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             CCCCCCCC---HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence            11112222   3455666699999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=5.3e-38  Score=314.51  Aligned_cols=249  Identities=24%  Similarity=0.403  Sum_probs=202.5

Q ss_pred             HHHhhhcCcCCccEEEEEEECCCCEEEEEEeccccC-CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          302 RASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNV-GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       302 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      +...++||+|+||.||+|..+++..+++|.++.... ....+.+|+++++.++|+||+++++++...+..++||||+++|
T Consensus         8 y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (261)
T cd05148           8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKG   87 (261)
T ss_pred             HHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccC
Confidence            445678999999999999988889999999876543 3567889999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC--
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP--  458 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~--  458 (615)
                      +|.++++...   ...+++..+.+++.|++.|++|||+.+   |+||||||+||++++++.+||+|||.+........  
T Consensus        88 ~L~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~  161 (261)
T cd05148          88 SLLAFLRSPE---GQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS  161 (261)
T ss_pred             CHHHHHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccccc
Confidence            9999997543   246899999999999999999999998   99999999999999999999999999977643321  


Q ss_pred             -CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          459 -PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       459 -~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                       ...++..|+|||.+....++.++||||||+++|+|++ |+.||......+....+.   .   ..        ......
T Consensus       162 ~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~---~---~~--------~~~~~~  227 (261)
T cd05148         162 SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT---A---GY--------RMPCPA  227 (261)
T ss_pred             cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH---h---CC--------cCCCCC
Confidence             2224567999999988889999999999999999998 899997654333222111   0   00        011112


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI  573 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l  573 (615)
                      ..++.   +.+++.+|++.+|++|||+.|+++.|+.+
T Consensus       228 ~~~~~---~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         228 KCPQE---IYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             CCCHH---HHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            23344   44555599999999999999999999863

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-40  Score=301.79  Aligned_cols=245  Identities=20%  Similarity=0.315  Sum_probs=205.8

Q ss_pred             HHHhhhcCcCCccEEEEEEE-CCCCEEEEEEeccc---cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecC
Q 007167          302 RASAEVLGKGTFGTAYKAAL-EDASTVVVKRLKEV---NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYF  377 (615)
Q Consensus       302 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  377 (615)
                      +...++||+|.|+.||+... ..|+.+|+|.+.-.   ..+.+++.+|+.+.+.++|||||++...+.+....+||+|+|
T Consensus        13 y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m   92 (355)
T KOG0033|consen   13 YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLV   92 (355)
T ss_pred             hhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecc
Confidence            44567899999999999874 46788888776432   335678899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCC---CcEEEeecccccccC
Q 007167          378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQ---GHVCVSDIGLAALMS  454 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~---~~~kl~DfG~a~~~~  454 (615)
                      +|++|..-+-.+     ..+++..+-..+.||+++|.|+|.++   |||||+||+|+++-..   .-+|++|||+|..+.
T Consensus        93 ~G~dl~~eIV~R-----~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~  164 (355)
T KOG0033|consen   93 TGGELFEDIVAR-----EFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN  164 (355)
T ss_pred             cchHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence            999998766432     35778888899999999999999998   9999999999999543   358999999999887


Q ss_pred             CCC--CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccc
Q 007167          455 PMP--PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL  532 (615)
Q Consensus       455 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  532 (615)
                      ...  ....||++|||||++...+|+..+|||+.||+||-|+.|..||.+.+...+.+.+           ....+|..-
T Consensus       165 ~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I-----------~~g~yd~~~  233 (355)
T KOG0033|consen  165 DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQI-----------KAGAYDYPS  233 (355)
T ss_pred             CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHH-----------hccccCCCC
Confidence            433  3456899999999999999999999999999999999999999875544444333           233455555


Q ss_pred             cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007167          533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK  568 (615)
Q Consensus       533 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  568 (615)
                      ..++.++++.++++.   +|+..||.+|.|+.|+++
T Consensus       234 ~~w~~is~~Ak~Lvr---rML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  234 PEWDTVTPEAKSLIR---RMLTVNPKKRITADEALK  266 (355)
T ss_pred             cccCcCCHHHHHHHH---HHhccChhhhccHHHHhC
Confidence            567889999999999   999999999999998876

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.4e-38  Score=326.29  Aligned_cols=238  Identities=23%  Similarity=0.382  Sum_probs=192.1

Q ss_pred             hhcCcCCccEEEEEEE----CCCCEEEEEEecccc-----CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeec
Q 007167          306 EVLGKGTFGTAYKAAL----EDASTVVVKRLKEVN-----VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      +.||+|+||.||++..    ..++.||+|.++...     .....+.+|+++++.++||||+++++++..++..++||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            4699999999999975    357889999987531     1234567899999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM  456 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~  456 (615)
                      +++|+|.+++...     ..+.+..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....
T Consensus        82 ~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  153 (323)
T cd05584          82 LSGGELFMHLERE-----GIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE  153 (323)
T ss_pred             CCCchHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC
Confidence            9999999998643     35788888999999999999999998   999999999999999999999999998754322


Q ss_pred             ---CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccccccc
Q 007167          457 ---PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELL  533 (615)
Q Consensus       457 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  533 (615)
                         .....++..|+|||++.+..++.++|||||||++|||++|+.||......+..      ..+...         ...
T Consensus       154 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~------~~~~~~---------~~~  218 (323)
T cd05584         154 GTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI------DKILKG---------KLN  218 (323)
T ss_pred             CCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHH------HHHHcC---------CCC
Confidence               22345788999999998888999999999999999999999999764432211      111111         111


Q ss_pred             CCCCcHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007167          534 RYPNIEEEMVEMLQVGMACVVRMPEERP-----KMADVLKM  569 (615)
Q Consensus       534 ~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  569 (615)
                      ..+..++++.++++   +|++.+|++||     ++.+++++
T Consensus       219 ~~~~~~~~~~~li~---~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         219 LPPYLTPEARDLLK---KLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             CCCCCCHHHHHHHH---HHcccCHhHcCCCCCCCHHHHhcC
Confidence            12334555666665   99999999999     88888774

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=331.58  Aligned_cols=232  Identities=24%  Similarity=0.378  Sum_probs=194.8

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC----CHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV----GKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      ..+||+|.||.|+++..+ +++.+|||.+++...    +.+....|-+++... +||.+++++..|+.+++.+.||||+.
T Consensus       373 l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~  452 (694)
T KOG0694|consen  373 LAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVA  452 (694)
T ss_pred             EEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecC
Confidence            467999999999999965 566799999997632    234456777776666 69999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccC---C
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS---P  455 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~---~  455 (615)
                      ||++..+.+.      ..+++..+.-++..|+.||+|||+++   |||||||-+|||+|.+|++||+|||+++.--   .
T Consensus       453 Ggdm~~~~~~------~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~  523 (694)
T KOG0694|consen  453 GGDLMHHIHT------DVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD  523 (694)
T ss_pred             CCcEEEEEec------ccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCCCCC
Confidence            9996666653      36999999999999999999999998   9999999999999999999999999998643   3


Q ss_pred             CCCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCC
Q 007167          456 MPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY  535 (615)
Q Consensus       456 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  535 (615)
                      ...+.+||+.|+|||++.+..|+..+|.|||||+||||+.|+.||.+.+++++.+-+.               ..+....
T Consensus       524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~---------------~d~~~yP  588 (694)
T KOG0694|consen  524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIV---------------NDEVRYP  588 (694)
T ss_pred             ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh---------------cCCCCCC
Confidence            4566789999999999999999999999999999999999999999887777654332               1111122


Q ss_pred             CCcHHHHHHHHHHHHHcccCCCCCCCCH
Q 007167          536 PNIEEEMVEMLQVGMACVVRMPEERPKM  563 (615)
Q Consensus       536 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~  563 (615)
                      ..++.+...+++   +.+.++|++|.-+
T Consensus       589 ~~ls~ea~~il~---~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  589 RFLSKEAIAIMR---RLLRKNPEKRLGS  613 (694)
T ss_pred             CcccHHHHHHHH---HHhccCcccccCC
Confidence            256677777776   9999999999976

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=6.9e-38  Score=317.06  Aligned_cols=248  Identities=26%  Similarity=0.438  Sum_probs=198.5

Q ss_pred             HhhhcCcCCccEEEEEEECC------CCEEEEEEeccccCC--HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEee
Q 007167          304 SAEVLGKGTFGTAYKAALED------ASTVVVKRLKEVNVG--KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYD  375 (615)
Q Consensus       304 ~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  375 (615)
                      ..+.||+|+||.||+|...+      +..||||.++.....  .+.+.+|+++++.++|+||+++++++......++|||
T Consensus         9 ~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   88 (280)
T cd05049           9 LKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFE   88 (280)
T ss_pred             HHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEe
Confidence            35679999999999998643      467999998765333  4678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCC---------CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEee
Q 007167          376 YFEPGSVSAMLHGRR---------GEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSD  446 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~---------~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~D  446 (615)
                      |+++++|.++++...         ......+++.....++.|++.|++|||+.+   ++||||||+||+++.++.+||+|
T Consensus        89 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~kl~d  165 (280)
T cd05049          89 YMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVVKIGD  165 (280)
T ss_pred             cCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeEEECC
Confidence            999999999997542         122346889999999999999999999998   99999999999999999999999


Q ss_pred             cccccccCCCC-----CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhh
Q 007167          447 IGLAALMSPMP-----PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVR  520 (615)
Q Consensus       447 fG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  520 (615)
                      ||+++......     .....+..|+|||++.+..++.++|||||||++|||++ |+.||......+....+.      .
T Consensus       166 ~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~------~  239 (280)
T cd05049         166 FGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT------Q  239 (280)
T ss_pred             cccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH------c
Confidence            99997653321     12233567999999998899999999999999999998 999997655433322211      0


Q ss_pred             cccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 007167          521 EEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVE  571 (615)
Q Consensus       521 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  571 (615)
                       ...    .   ......+..+.++++   +||..+|++||++.||++.|+
T Consensus       240 -~~~----~---~~~~~~~~~~~~li~---~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         240 -GRL----L---QRPRTCPSEVYDIML---GCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             -CCc----C---CCCCCCCHHHHHHHH---HHcCCCcccCCCHHHHHHHhh
Confidence             000    0   011223445555555   999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.1e-37  Score=312.93  Aligned_cols=246  Identities=25%  Similarity=0.396  Sum_probs=199.3

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      .+.||+|+||.||+|..+ .+..|++|.++......+++.+|+++++.++|+||+++++++..++..++||||+++++|.
T Consensus        11 ~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   90 (263)
T cd05052          11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL   90 (263)
T ss_pred             eeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHH
Confidence            356999999999999865 5788999998766555677899999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCC----
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP----  459 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~----  459 (615)
                      +++....   ...+++..++.++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++.........    
T Consensus        91 ~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~  164 (263)
T cd05052          91 DYLRECN---RQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG  164 (263)
T ss_pred             HHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceeeccCC
Confidence            9986432   346899999999999999999999998   999999999999999999999999999876543221    


Q ss_pred             CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCc
Q 007167          460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI  538 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  538 (615)
                      ...+..|+|||.+.+..++.++|||||||++|||++ |..||......+....   +.    ...       ........
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~---~~----~~~-------~~~~~~~~  230 (263)
T cd05052         165 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL---LE----KGY-------RMERPEGC  230 (263)
T ss_pred             CCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH---HH----CCC-------CCCCCCCC
Confidence            122457999999988889999999999999999998 9999976433222111   11    100       01112233


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 007167          539 EEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI  573 (615)
Q Consensus       539 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l  573 (615)
                      +.++.+++.   +|++.+|++||++.|++++|+.+
T Consensus       231 ~~~~~~li~---~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         231 PPKVYELMR---ACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             CHHHHHHHH---HHccCCcccCCCHHHHHHHHHhh
Confidence            455555555   99999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=3e-39  Score=323.42  Aligned_cols=242  Identities=31%  Similarity=0.546  Sum_probs=187.5

Q ss_pred             hhcCcCCccEEEEEEEC-----CCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCC
Q 007167          306 EVLGKGTFGTAYKAALE-----DASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      +.||.|.||.||+|.+.     .+..|+||.++....  ..+.|.+|++.+++++||||++++|++...+..++||||++
T Consensus         5 ~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~   84 (259)
T PF07714_consen    5 KQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCP   84 (259)
T ss_dssp             EEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--T
T ss_pred             eEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccccc
Confidence            46999999999999976     246799999965422  24788999999999999999999999998888999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC-
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP-  457 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~-  457 (615)
                      +|+|.++|+..   ....+++..+..|+.|++.||+|||+++   |+|+||+++||++++++.+||+|||++....... 
T Consensus        85 ~g~L~~~L~~~---~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~  158 (259)
T PF07714_consen   85 GGSLDDYLKSK---NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK  158 (259)
T ss_dssp             TEBHHHHHHHT---CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred             ccccccccccc---cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence            99999999864   2347999999999999999999999997   9999999999999999999999999998773221 


Q ss_pred             ----CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccc
Q 007167          458 ----PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL  532 (615)
Q Consensus       458 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  532 (615)
                          ........|+|||.+....++.++||||||+++||+++ |+.||......+....+      .....        .
T Consensus       159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~------~~~~~--------~  224 (259)
T PF07714_consen  159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL------KQGQR--------L  224 (259)
T ss_dssp             EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH------HTTEE--------T
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc------ccccc--------c
Confidence                22234567999999988889999999999999999999 78998765433322211      11110        1


Q ss_pred             cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       533 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                      .....++..+.++   +.+||..+|++||+++|+++.|
T Consensus       225 ~~~~~~~~~~~~l---i~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  225 PIPDNCPKDIYSL---IQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             TSBTTSBHHHHHH---HHHHT-SSGGGS--HHHHHHHH
T ss_pred             eeccchhHHHHHH---HHHHcCCChhhCcCHHHHHhcC
Confidence            1112234445444   4499999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=4e-38  Score=326.93  Aligned_cols=194  Identities=21%  Similarity=0.361  Sum_probs=168.2

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      .+.||+|+||.||++... ++..||+|.+.....  ....+.+|+++++.++||||+++++++..++..++||||+++|+
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   89 (331)
T cd06649          10 ISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS   89 (331)
T ss_pred             EEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCc
Confidence            356999999999999965 577888988864321  23568899999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC-CCCC
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM-PPPA  460 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~-~~~~  460 (615)
                      |.+++...     ..+++..+..++.|++.||.|||+.+  +|+||||||+||+++.++.+||+|||++...... ....
T Consensus        90 L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  162 (331)
T cd06649          90 LDQVLKEA-----KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF  162 (331)
T ss_pred             HHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccccccC
Confidence            99999743     35889999999999999999999863  3999999999999999999999999999766432 2334


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGG  505 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~  505 (615)
                      .++..|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       163 ~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~  207 (331)
T cd06649         163 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDA  207 (331)
T ss_pred             CCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            578899999999988899999999999999999999999976543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=5.3e-38  Score=313.86  Aligned_cols=243  Identities=25%  Similarity=0.378  Sum_probs=196.6

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChhh
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSA  384 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  384 (615)
                      .+.||+|+||+||+|...++..+|+|.++........+.+|++++++++||||+++++++...+..++||||+.+|+|.+
T Consensus         9 ~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~   88 (256)
T cd05113           9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLN   88 (256)
T ss_pred             eeEecCcccceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHH
Confidence            35699999999999998877789999988665556789999999999999999999999998889999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC----CC
Q 007167          385 MLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP----PA  460 (615)
Q Consensus       385 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~----~~  460 (615)
                      ++....    ..+++..+.+++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||.++.......    ..
T Consensus        89 ~i~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~  161 (256)
T cd05113          89 YLREHG----KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGS  161 (256)
T ss_pred             HHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCC
Confidence            997432    26899999999999999999999998   99999999999999999999999999876543321    11


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      .++..|+|||...+..++.++|||||||++|||++ |+.||......+....+      ....+        .......+
T Consensus       162 ~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~------~~~~~--------~~~~~~~~  227 (256)
T cd05113         162 KFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV------SQGLR--------LYRPHLAS  227 (256)
T ss_pred             ccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH------hcCCC--------CCCCCCCC
Confidence            23456999999988889999999999999999999 99999765433222111      11110        00011123


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKMADVLKMVE  571 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  571 (615)
                      +   .+.+++.+||+.+|++||++.++++.|+
T Consensus       228 ~---~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         228 E---KVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             H---HHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            3   4455555999999999999999998874

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-39  Score=312.00  Aligned_cols=252  Identities=22%  Similarity=0.390  Sum_probs=196.5

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEeccc---cCCHHHHHHHHHHHhCCCCCcccceeEEEEe-----cCeeeEEeec
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEV---NVGKREFEQQMEIVGGIRHENVVALRAYYYS-----KDEKLMVYDY  376 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-----~~~~~lV~e~  376 (615)
                      +.||+|+||.|+.+.. ++|..||||++...   ....+...+|+.+++.++|+||+.+.+.+..     -+..|+|+|+
T Consensus        28 ~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~el  107 (359)
T KOG0660|consen   28 EPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFEL  107 (359)
T ss_pred             ccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhH
Confidence            5699999999999985 46889999998743   3335677899999999999999999998865     3578999999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM  456 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~  456 (615)
                      | ..+|...++.+     ..++.....-++.|+++||.|+|+.+   |+|||+||+|++++.+...||+|||+|+.....
T Consensus       108 M-etDL~~iik~~-----~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~  178 (359)
T KOG0660|consen  108 M-ETDLHQIIKSQ-----QDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDKF  178 (359)
T ss_pred             H-hhHHHHHHHcC-----ccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeecccc
Confidence            9 56899999743     35899999999999999999999998   999999999999999999999999999998531


Q ss_pred             -----CCCCCCCCcccCcccc-CCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccc-----
Q 007167          457 -----PPPAMRAAGYRAPEVT-DTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTA-----  525 (615)
Q Consensus       457 -----~~~~~~~~~y~aPE~~-~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----  525 (615)
                           -+..+.|..|+|||++ ....|+.+.||||.||++.||++|+.-|.+.+.-+-..++.-+-....++...     
T Consensus       179 ~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~  258 (359)
T KOG0660|consen  179 FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSE  258 (359)
T ss_pred             CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccH
Confidence                 2445678999999987 45679999999999999999999999998754322111111111111111000     


Q ss_pred             ---cccc-----ccc---cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          526 ---EVFD-----VEL---LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       526 ---~~~d-----~~~---~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                         ..+.     +..   ..+++..+...++++   +|+..||.+|+|++|++++
T Consensus       259 ~ar~yi~slp~~p~~~f~~~fp~a~p~AidLle---kmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  259 KARPYIKSLPQIPKQPFSSIFPNANPLAIDLLE---KMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHH---HHhccCccccCCHHHHhcC
Confidence               0000     000   024566677778877   9999999999999999987

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.2e-38  Score=325.87  Aligned_cols=234  Identities=24%  Similarity=0.394  Sum_probs=189.0

Q ss_pred             hhcCcCCccEEEEEEE----CCCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCC
Q 007167          306 EVLGKGTFGTAYKAAL----EDASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      +.||+|+||.||++..    .+++.||+|+++....   ....+.+|++++++++||||+++++++...+..++||||++
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~   81 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR   81 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence            4699999999999874    3578999999975422   23456789999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC--
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM--  456 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~--  456 (615)
                      +|+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....  
T Consensus        82 ~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~  153 (318)
T cd05582          82 GGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK  153 (318)
T ss_pred             CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC
Confidence            99999998642     36899999999999999999999998   999999999999999999999999998765433  


Q ss_pred             -CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCC
Q 007167          457 -PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY  535 (615)
Q Consensus       457 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  535 (615)
                       .....++..|+|||.+....++.++|||||||++|||++|+.||......+...      .+...         .....
T Consensus       154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~------~i~~~---------~~~~p  218 (318)
T cd05582         154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMT------MILKA---------KLGMP  218 (318)
T ss_pred             ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHH------HHHcC---------CCCCC
Confidence             123457888999999988889999999999999999999999997644322211      11111         11111


Q ss_pred             CCcHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 007167          536 PNIEEEMVEMLQVGMACVVRMPEERPKMAD  565 (615)
Q Consensus       536 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~e  565 (615)
                      ..+++.+.++++   +|++.||++||++.+
T Consensus       219 ~~~~~~~~~li~---~~l~~~P~~R~~a~~  245 (318)
T cd05582         219 QFLSPEAQSLLR---ALFKRNPANRLGAGP  245 (318)
T ss_pred             CCCCHHHHHHHH---HHhhcCHhHcCCCCC
Confidence            234555556665   999999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=7.9e-38  Score=323.08  Aligned_cols=237  Identities=22%  Similarity=0.348  Sum_probs=190.0

Q ss_pred             hcCcCCccEEEEEEEC-CCCEEEEEEecccc----CCHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          307 VLGKGTFGTAYKAALE-DASTVVVKRLKEVN----VGKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      +||+|+||+||+|..+ +++.||+|.++...    ...+.+..|.+++..+ +||||+++++++...+..++||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g   81 (320)
T cd05590           2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG   81 (320)
T ss_pred             eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence            5999999999999965 57889999987531    2234566788888766 6999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC---CC
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP---MP  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~---~~  457 (615)
                      +|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....   ..
T Consensus        82 ~L~~~i~~~-----~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~  153 (320)
T cd05590          82 DLMFHIQKS-----RRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTT  153 (320)
T ss_pred             hHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcc
Confidence            999988643     35889999999999999999999998   99999999999999999999999999875422   12


Q ss_pred             CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCC
Q 007167          458 PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN  537 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  537 (615)
                      ....++..|+|||++.+..++.++|||||||++|||++|+.||...+..+...      .+...         .......
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~------~i~~~---------~~~~~~~  218 (320)
T cd05590         154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFE------AILND---------EVVYPTW  218 (320)
T ss_pred             cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHH------HHhcC---------CCCCCCC
Confidence            23457889999999998889999999999999999999999997654332221      11111         1111123


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCCCH------HHHHHH
Q 007167          538 IEEEMVEMLQVGMACVVRMPEERPKM------ADVLKM  569 (615)
Q Consensus       538 ~~~~~~~l~~l~~~cl~~~P~~RPs~------~evl~~  569 (615)
                      .+++..++++   +|++.||++||++      ++++++
T Consensus       219 ~~~~~~~li~---~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         219 LSQDAVDILK---AFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             CCHHHHHHHH---HHcccCHHHCCCCCCCCCHHHHHcC
Confidence            4556666665   9999999999998      666554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-37  Score=311.34  Aligned_cols=243  Identities=24%  Similarity=0.395  Sum_probs=196.9

Q ss_pred             HhhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          304 SAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       304 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      ..+.||+|+||.||++.++++..+|+|.+.........+.+|+++++.++|+||+++++++...+..++||||+++++|.
T Consensus         8 ~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   87 (256)
T cd05059           8 FLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLL   87 (256)
T ss_pred             hhhhhccCCCceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHH
Confidence            35679999999999999887778999998765555678889999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCC-C--
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP-A--  460 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~-~--  460 (615)
                      +++....    ..+++..+..++.|++.|++|||+.+   |+||||||+||++++++.+||+|||+++........ .  
T Consensus        88 ~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~  160 (256)
T cd05059          88 NYLRERK----GKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQG  160 (256)
T ss_pred             HHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccccCC
Confidence            9997432    26899999999999999999999998   999999999999999999999999998765432211 1  


Q ss_pred             -CCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCc
Q 007167          461 -MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI  538 (615)
Q Consensus       461 -~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  538 (615)
                       ..+..|+|||.+.+..++.++||||||+++|||++ |+.||......+....   +..    .     .  ........
T Consensus       161 ~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~---~~~----~-----~--~~~~~~~~  226 (256)
T cd05059         161 TKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVES---VSA----G-----Y--RLYRPKLA  226 (256)
T ss_pred             CCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHH---HHc----C-----C--cCCCCCCC
Confidence             12346999999998889999999999999999999 8999976443322211   110    0     0  01111223


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          539 EEEMVEMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       539 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                      +.++   .+++.+|+..+|++|||+.|++++|
T Consensus       227 ~~~~---~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         227 PTEV---YTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             CHHH---HHHHHHHhcCChhhCcCHHHHHHHh
Confidence            4444   4455599999999999999999986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4.5e-38  Score=320.08  Aligned_cols=254  Identities=19%  Similarity=0.357  Sum_probs=192.7

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc--CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN--VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      .++||+|+||+||+|..+ ++..||+|.++...  .....+.+|+++++.++||||+++++++...+..++||||++ |+
T Consensus        10 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~   88 (288)
T cd07871          10 LDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SD   88 (288)
T ss_pred             eeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-cC
Confidence            357999999999999865 67889999986542  224467789999999999999999999999999999999997 48


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---C
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---P  458 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~  458 (615)
                      |.+++...    ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++......   .
T Consensus        89 l~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~  161 (288)
T cd07871          89 LKQYLDNC----GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYS  161 (288)
T ss_pred             HHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCcccc
Confidence            98888643    235788999999999999999999998   9999999999999999999999999997654322   2


Q ss_pred             CCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHH-HHHHhhhcccccc--------cc
Q 007167          459 PAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVR-WVNSVVREEWTAE--------VF  528 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~--------~~  528 (615)
                      ...++..|+|||.+.+ ..++.++||||+||++|||++|+.||...+..+....+. .......+.|...        ..
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (288)
T cd07871         162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYL  241 (288)
T ss_pred             CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccc
Confidence            3356788999998865 568999999999999999999999998755433322221 1111111111110        00


Q ss_pred             ccc------ccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          529 DVE------LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       529 d~~------~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+.      ....+..+++..++++   +|+..||.+|||++|++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~dll~---~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         242 FPQYRAQPLINHAPRLDTDGIDLLS---SLLLYETKSRISAEAALRH  285 (288)
T ss_pred             cCccCCCchHHhCCCCCHHHHHHHH---HhcCcCcccCCCHHHHhcC
Confidence            000      0011233445555555   9999999999999999865

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=8.6e-38  Score=327.41  Aligned_cols=239  Identities=23%  Similarity=0.357  Sum_probs=188.1

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      .++||+|+||+||+|... +++.||||.+.....  ..+.+.+|+++++.++|+||+++++++...+..++||||+++|+
T Consensus        79 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~  158 (353)
T PLN00034         79 VNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGS  158 (353)
T ss_pred             hhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCc
Confidence            467999999999999864 688999999865432  24568899999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---C
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---P  458 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~  458 (615)
                      |.+..         ...+.....++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++.+....   .
T Consensus       159 L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~  226 (353)
T PLN00034        159 LEGTH---------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCN  226 (353)
T ss_pred             ccccc---------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccccccc
Confidence            86532         3456778889999999999999998   9999999999999999999999999998765322   2


Q ss_pred             CCCCCCcccCccccCC-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccccccc
Q 007167          459 PAMRAAGYRAPEVTDT-----RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELL  533 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  533 (615)
                      ...++..|+|||++..     ...+.++|||||||++|||++|+.||......+.........   ..        ....
T Consensus       227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~---~~--------~~~~  295 (353)
T PLN00034        227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAIC---MS--------QPPE  295 (353)
T ss_pred             ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHh---cc--------CCCC
Confidence            3467889999998743     234568999999999999999999998443333222221110   00        0001


Q ss_pred             CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          534 RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       534 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .....++++.++++   +||..+|++||++.|++++
T Consensus       296 ~~~~~~~~l~~li~---~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        296 APATASREFRHFIS---CCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             CCCccCHHHHHHHH---HHccCChhhCcCHHHHhcC
Confidence            11234455555555   9999999999999999987

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=1.1e-37  Score=312.24  Aligned_cols=246  Identities=28%  Similarity=0.428  Sum_probs=197.9

Q ss_pred             HHhhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          303 ASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       303 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      ...++||+|+||.||+|..+++..||+|.++......+.+.+|++++++++|+|++++++++. ....++||||+++++|
T Consensus         9 ~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~~~~L   87 (260)
T cd05070           9 QLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMSKGSL   87 (260)
T ss_pred             hhhheeccccCceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecCCCcH
Confidence            345679999999999999888889999999876566778999999999999999999999875 4568999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCC---
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP---  459 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~---  459 (615)
                      .++++...   ...+++..+..++.+++.||+|||+.+   |+||||||+||++++++.++|+|||++..+......   
T Consensus        88 ~~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~  161 (260)
T cd05070          88 LDFLKDGE---GRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQ  161 (260)
T ss_pred             HHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccccc
Confidence            99997532   235899999999999999999999998   999999999999999999999999999876543211   


Q ss_pred             -CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCC
Q 007167          460 -AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN  537 (615)
Q Consensus       460 -~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  537 (615)
                       ..++..|+|||...+..++.++||||||+++|||++ |+.||......+...   ...   .. .       .......
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~---~~~---~~-~-------~~~~~~~  227 (260)
T cd05070         162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLE---QVE---RG-Y-------RMPCPQD  227 (260)
T ss_pred             CCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHH---HHH---cC-C-------CCCCCCc
Confidence             123457999999988889999999999999999999 899997644332221   111   10 0       0001112


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 007167          538 IEEEMVEMLQVGMACVVRMPEERPKMADVLKMVED  572 (615)
Q Consensus       538 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  572 (615)
                      .+..   +.+++.+|+..+|++|||++++.+.|++
T Consensus       228 ~~~~---~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         228 CPIS---LHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             CCHH---HHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence            2334   4445559999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.8e-38  Score=328.63  Aligned_cols=237  Identities=21%  Similarity=0.315  Sum_probs=192.0

Q ss_pred             hcCcCCccEEEEEEE-CCCCEEEEEEecccc----CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          307 VLGKGTFGTAYKAAL-EDASTVVVKRLKEVN----VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      .||+|+||.||++.. .++..||+|.++...    .....+.+|++++..++||||+++++++...+..++||||+++|+
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~   81 (325)
T cd05594           2 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGE   81 (325)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCc
Confidence            599999999999985 468899999997532    123456788999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC---C
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT-ENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM---P  457 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~---~  457 (615)
                      |..++...     ..+++..+..++.|++.||+|||+ .+   |+||||||+|||++.++.+||+|||+++.....   .
T Consensus        82 L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  153 (325)
T cd05594          82 LFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM  153 (325)
T ss_pred             HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCCccc
Confidence            99988643     368999999999999999999997 66   999999999999999999999999998754321   1


Q ss_pred             CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCC
Q 007167          458 PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN  537 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  537 (615)
                      ....++..|+|||++.+..++.++|||||||++|||++|+.||......+....+.      ..         .......
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~------~~---------~~~~p~~  218 (325)
T cd05594         154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL------ME---------EIRFPRT  218 (325)
T ss_pred             ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHh------cC---------CCCCCCC
Confidence            23457889999999988889999999999999999999999997654332222111      00         0111123


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007167          538 IEEEMVEMLQVGMACVVRMPEERP-----KMADVLKM  569 (615)
Q Consensus       538 ~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  569 (615)
                      .++++.++++   +|++.||++|+     ++.|++++
T Consensus       219 ~~~~~~~li~---~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         219 LSPEAKSLLS---GLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             CCHHHHHHHH---HHhhcCHHHhCCCCCCCHHHHhcC
Confidence            4556666666   99999999996     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.5e-37  Score=320.51  Aligned_cols=236  Identities=24%  Similarity=0.362  Sum_probs=186.5

Q ss_pred             hcCcCCccEEEEEEEC-CCCEEEEEEecccc----CCHHHHHHHHHHHhC-CCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          307 VLGKGTFGTAYKAALE-DASTVVVKRLKEVN----VGKREFEQQMEIVGG-IRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      +||+|+||+||+|... +++.||+|.++...    ...+.+..|.+++.. .+||||+++++++...+..++||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg   81 (316)
T cd05592           2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            5999999999999965 56789999987532    123344556666664 48999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC---C
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM---P  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~---~  457 (615)
                      +|..++...     ..+++.....++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....   .
T Consensus        82 ~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~  153 (316)
T cd05592          82 DLMFHIQSS-----GRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA  153 (316)
T ss_pred             cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCcc
Confidence            999998642     35889999999999999999999998   999999999999999999999999999764322   2


Q ss_pred             CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCC
Q 007167          458 PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN  537 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  537 (615)
                      ....+|..|+|||++.+..++.++|||||||++|||++|+.||...+..+....+      ...         .......
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i------~~~---------~~~~~~~  218 (316)
T cd05592         154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI------LND---------RPHFPRW  218 (316)
T ss_pred             ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH------HcC---------CCCCCCC
Confidence            2345788999999999888999999999999999999999999865433222111      110         0001123


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 007167          538 IEEEMVEMLQVGMACVVRMPEERPKMA-DVLK  568 (615)
Q Consensus       538 ~~~~~~~l~~l~~~cl~~~P~~RPs~~-evl~  568 (615)
                      ++++..++++   +|+..+|++||++. ++.+
T Consensus       219 ~~~~~~~ll~---~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05592         219 ISKEAKDCLS---KLFERDPTKRLGVDGDIRQ  247 (316)
T ss_pred             CCHHHHHHHH---HHccCCHHHcCCChHHHHc
Confidence            4455566665   99999999999875 5544

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=8.1e-38  Score=313.14  Aligned_cols=244  Identities=27%  Similarity=0.439  Sum_probs=198.2

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChhh
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSA  384 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  384 (615)
                      .++||+|+||.||+|..+++..||+|.+.........+.+|++++++++|+||+++++++. .+..++||||+++|+|.+
T Consensus        11 ~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~   89 (260)
T cd05067          11 VKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVD   89 (260)
T ss_pred             eeeeccCccceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHH
Confidence            4679999999999999889999999999876666788999999999999999999999874 567899999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC----CC
Q 007167          385 MLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP----PA  460 (615)
Q Consensus       385 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~----~~  460 (615)
                      ++....   ...+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++........    ..
T Consensus        90 ~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~  163 (260)
T cd05067          90 FLKTPE---GIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGA  163 (260)
T ss_pred             HHHhcC---CCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCC
Confidence            986432   346899999999999999999999988   99999999999999999999999999977653221    12


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      .++..|+|||++....++.++||||||+++||+++ |+.||...+..+.....   ..    ..       ........+
T Consensus       164 ~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~---~~----~~-------~~~~~~~~~  229 (260)
T cd05067         164 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL---ER----GY-------RMPRPDNCP  229 (260)
T ss_pred             cccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH---Hc----CC-------CCCCCCCCC
Confidence            23567999999988889999999999999999999 99999765433222111   10    00       001112233


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKMADVLKMVED  572 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  572 (615)
                      .++.+   ++.+|++.+|++||+++++++.|+.
T Consensus       230 ~~~~~---li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         230 EELYE---LMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             HHHHH---HHHHHccCChhhCCCHHHHHHHhhc
Confidence            44444   4559999999999999999999975

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.1e-37  Score=304.99  Aligned_cols=264  Identities=19%  Similarity=0.340  Sum_probs=203.4

Q ss_pred             hhhcCcCCccEEEEEE-ECCCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCc-ccceeEEEEecC------eeeEE
Q 007167          305 AEVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHEN-VVALRAYYYSKD------EKLMV  373 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~------~~~lV  373 (615)
                      .++||+|+||+||+|+ ..+|+.||+|++.-...   ......+|+-++++++|+| ||++++++...+      ..++|
T Consensus        16 ~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lv   95 (323)
T KOG0594|consen   16 VEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLV   95 (323)
T ss_pred             HHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEE
Confidence            3569999999999999 45788999999976533   2455689999999999999 999999999877      78899


Q ss_pred             eecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeeccccccc
Q 007167          374 YDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALM  453 (615)
Q Consensus       374 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~  453 (615)
                      +||++. +|..++....... ..++-.....++.|++.||+|||+++   |+||||||.||||+++|.+||+|||+|+..
T Consensus        96 fe~~d~-DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGlAra~  170 (323)
T KOG0594|consen   96 FEFLDR-DLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGLARAF  170 (323)
T ss_pred             EEeecc-cHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccchHHHh
Confidence            999954 8999987543211 34666889999999999999999998   999999999999999999999999999977


Q ss_pred             CCC---CCCCCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcc-hhhHHHHHHHhhhcccccccc
Q 007167          454 SPM---PPPAMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATGGDE-VVHLVRWVNSVVREEWTAEVF  528 (615)
Q Consensus       454 ~~~---~~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  528 (615)
                      .-+   -.....|..|+|||++.+. .|+...||||+||+++||++++..|.+..+.+ ...+.+.++....+.|.....
T Consensus       171 ~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~  250 (323)
T KOG0594|consen  171 SIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSS  250 (323)
T ss_pred             cCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccc
Confidence            632   2345678899999999776 68999999999999999999999998766522 222333333334445554332


Q ss_pred             cccc----cCCC---CcHHHH----HHHHHHHHHcccCCCCCCCCHHHHHHH--HHHh
Q 007167          529 DVEL----LRYP---NIEEEM----VEMLQVGMACVVRMPEERPKMADVLKM--VEDI  573 (615)
Q Consensus       529 d~~~----~~~~---~~~~~~----~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~l  573 (615)
                      -++.    ..++   ....+.    .+..+++.+|++.+|.+|.|++.+++|  +.++
T Consensus       251 ~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~  308 (323)
T KOG0594|consen  251 LPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSEL  308 (323)
T ss_pred             cccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccc
Confidence            2111    1111   111111    245666669999999999999999998  5444

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-38  Score=315.45  Aligned_cols=245  Identities=23%  Similarity=0.347  Sum_probs=192.4

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccC---------------CHHHHHHHHHHHhCCCCCcccceeEEEEec-
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNV---------------GKREFEQQMEIVGGIRHENVVALRAYYYSK-  367 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---------------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-  367 (615)
                      .+.||+|.||.|-+|+. .+++.||||++.+...               .-+...+|+.+|++++|||||+|+.+..+. 
T Consensus       102 ~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~  181 (576)
T KOG0585|consen  102 IKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPE  181 (576)
T ss_pred             hhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcc
Confidence            45799999999999995 4788899999864311               124678999999999999999999999775 


Q ss_pred             -CeeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEee
Q 007167          368 -DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSD  446 (615)
Q Consensus       368 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~D  446 (615)
                       +..|||+|||..|.+...=.     ....++..++++++.++..||+|||.++   ||||||||+|+|++++|++||+|
T Consensus       182 s~~~YlVley~s~G~v~w~p~-----d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIsD  253 (576)
T KOG0585|consen  182 SDKLYLVLEYCSKGEVKWCPP-----DKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKISD  253 (576)
T ss_pred             cCceEEEEEeccCCccccCCC-----CcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEeec
Confidence             57899999999887654321     1223999999999999999999999998   99999999999999999999999


Q ss_pred             cccccccCCCC--------CCCCCCCcccCccccCCCC----CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 007167          447 IGLAALMSPMP--------PPAMRAAGYRAPEVTDTRK----ATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRW  514 (615)
Q Consensus       447 fG~a~~~~~~~--------~~~~~~~~y~aPE~~~~~~----~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~  514 (615)
                      ||.+.......        ....||+.|+|||...++.    .+.+.||||+||+||.|+.|+.||.+....+..+-+  
T Consensus       254 FGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KI--  331 (576)
T KOG0585|consen  254 FGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKI--  331 (576)
T ss_pred             cceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHH--
Confidence            99987663211        2346899999999987632    367899999999999999999999875443332211  


Q ss_pred             HHHhhhcccccccccccc--cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          515 VNSVVREEWTAEVFDVEL--LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       515 ~~~~~~~~~~~~~~d~~~--~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                          .         ...+  +..+.+.+..+++++   +++++||+.|.+..+|..|..-.+.
T Consensus       332 ----v---------n~pL~fP~~pe~~e~~kDli~---~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  332 ----V---------NDPLEFPENPEINEDLKDLIK---RLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             ----h---------cCcccCCCcccccHHHHHHHH---HHhhcChhheeehhhheecceeccC
Confidence                1         1112  122334455555555   9999999999999999988765554

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=5.2e-38  Score=319.29  Aligned_cols=254  Identities=18%  Similarity=0.265  Sum_probs=192.1

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .+.||+|+||+||++..+ ++..||+|+++....   ..+.+.+|+++++.++||||+++++++..++..++||||++++
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   85 (287)
T cd07848           6 LGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKN   85 (287)
T ss_pred             EEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCC
Confidence            356999999999999975 577899999875422   2456788999999999999999999999999999999999988


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---  457 (615)
                      .+..+...     ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......   
T Consensus        86 ~l~~~~~~-----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  157 (287)
T cd07848          86 MLELLEEM-----PNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN  157 (287)
T ss_pred             HHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence            77655432     235889999999999999999999998   9999999999999999999999999998764322   


Q ss_pred             -CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH-Hhhhcc--------ccccc
Q 007167          458 -PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVN-SVVREE--------WTAEV  527 (615)
Q Consensus       458 -~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~-~~~~~~--------~~~~~  527 (615)
                       ....++..|+|||++.+..++.++|||||||++|||++|+.||......+....+.... ....+.        .....
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07848         158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL  237 (287)
T ss_pred             ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence             12346888999999988889999999999999999999999998754433222111111 000000        00000


Q ss_pred             ccccccC--------CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          528 FDVELLR--------YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       528 ~d~~~~~--------~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ..+....        ....+.++   .+++.+|++.||++|||++|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~s~~~---~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         238 RFPAVNHPQSLERRYLGILSGVL---LDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             ccCcccCcccHHHhhhcccCHHH---HHHHHHHccCCcccCCCHHHHhcC
Confidence            0000000        01123334   445559999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1e-37  Score=316.10  Aligned_cols=244  Identities=19%  Similarity=0.315  Sum_probs=192.2

Q ss_pred             cCcCCccEEEEEEEC-CCCEEEEEEeccccC----CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          308 LGKGTFGTAYKAALE-DASTVVVKRLKEVNV----GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       308 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      ||+|+||+||++..+ +++.||+|.+.....    ..+.+..|+++++.++|+||+++.+++..+...++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            799999999999864 678999999865322    124567899999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---CC
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---PP  459 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~~  459 (615)
                      .+.+.... .....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++..+....   ..
T Consensus        81 ~~~~~~~~-~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~  156 (280)
T cd05608          81 RYHIYNVD-EENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKG  156 (280)
T ss_pred             HHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccc
Confidence            98875422 22346899999999999999999999998   9999999999999999999999999997664332   22


Q ss_pred             CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      ..++..|+|||++.+..++.++|||||||++|||++|+.||..........  .......         .......+.++
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~---------~~~~~~~~~~~  225 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELKQRIL---------NDSVTYPDKFS  225 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHH--HHHHhhc---------ccCCCCcccCC
Confidence            356789999999999899999999999999999999999997644321111  0011111         11111112344


Q ss_pred             HHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007167          540 EEMVEMLQVGMACVVRMPEERP-----KMADVLKM  569 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  569 (615)
                      +++.+++.   +|++.||++||     +++|++++
T Consensus       226 ~~~~~li~---~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         226 PASKSFCE---ALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             HHHHHHHH---HHhcCCHHHhcCCCCCCHHHHhcC
Confidence            55555555   99999999999     67777765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=5.2e-38  Score=324.68  Aligned_cols=238  Identities=22%  Similarity=0.356  Sum_probs=191.0

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEecccc----CCHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVN----VGKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      ++||+|+||+||+|... +++.||+|+++...    ...+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            35999999999999865 47789999987532    2234566788888765 799999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC---
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM---  456 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~---  456 (615)
                      |+|...+...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......   
T Consensus        81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  152 (321)
T cd05591          81 GDLMFQIQRS-----RKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVT  152 (321)
T ss_pred             CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCCcc
Confidence            9999988643     35889999999999999999999998   999999999999999999999999998754322   


Q ss_pred             CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          457 PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       457 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                      .....++..|+|||++.+..++.++|||||||++|||++|+.||...+..+....      +...         ......
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~------i~~~---------~~~~p~  217 (321)
T cd05591         153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFES------ILHD---------DVLYPV  217 (321)
T ss_pred             ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHH------HHcC---------CCCCCC
Confidence            2233578899999999988899999999999999999999999986543332211      1111         111112


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCC-------CHHHHHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERP-------KMADVLKM  569 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RP-------s~~evl~~  569 (615)
                      ..+++..++++   +|+..||++||       ++++++++
T Consensus       218 ~~~~~~~~ll~---~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         218 WLSKEAVSILK---AFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CCCHHHHHHHH---HHhccCHHHcCCCCCCCCCHHHHhcC
Confidence            23455556655   99999999999       78888765

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.7e-37  Score=326.46  Aligned_cols=245  Identities=20%  Similarity=0.318  Sum_probs=191.7

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC----CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV----GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||+||++... .++.||+|+++....    ....+.+|++++.+++|+||+++++.+.+....++||||+++
T Consensus         6 ~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~g   85 (363)
T cd05628           6 LKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPG   85 (363)
T ss_pred             eEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCC
Confidence            356999999999999854 578999999975321    234577899999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      |+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++++||+|||+++.+....  
T Consensus        86 g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~  157 (363)
T cd05628          86 GDMMTLLMKK-----DTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT  157 (363)
T ss_pred             CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence            9999999743     36899999999999999999999998   9999999999999999999999999987543210  


Q ss_pred             ------------------------------------CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 007167          458 ------------------------------------PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIH  501 (615)
Q Consensus       458 ------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~  501 (615)
                                                          ....||..|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~  237 (363)
T cd05628         158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC  237 (363)
T ss_pred             cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCC
Confidence                                                12357889999999998899999999999999999999999998


Q ss_pred             CCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          502 ATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .....+....+.      .  +....   .......++++.++++.-+ .|...++..||+++|++++
T Consensus       238 ~~~~~~~~~~i~------~--~~~~~---~~p~~~~~s~~~~~li~~l-~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         238 SETPQETYKKVM------N--WKETL---IFPPEVPISEKAKDLILRF-CCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCHHHHHHHHH------c--CcCcc---cCCCcCCCCHHHHHHHHHH-cCChhhcCCCCCHHHHhCC
Confidence            654433222111      0  00000   1111123456666766522 2433445567999999997

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.3e-37  Score=321.94  Aligned_cols=236  Identities=24%  Similarity=0.362  Sum_probs=187.3

Q ss_pred             hcCcCCccEEEEEEEC-CCCEEEEEEeccccC----CHHHHHHHHH-HHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          307 VLGKGTFGTAYKAALE-DASTVVVKRLKEVNV----GKREFEQQME-IVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .||+|+||+||+|... +++.||+|++.....    ..+.+..|.. +++.++||||+++++++...+..++||||+++|
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g   81 (323)
T cd05575           2 VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGG   81 (323)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCC
Confidence            5999999999999964 688999999865321    1233444444 567899999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC---C
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM---P  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~---~  457 (615)
                      +|..++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....   .
T Consensus        82 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  153 (323)
T cd05575          82 ELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT  153 (323)
T ss_pred             CHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCcc
Confidence            999998642     36889999999999999999999998   999999999999999999999999998754322   2


Q ss_pred             CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCC
Q 007167          458 PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN  537 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  537 (615)
                      ....++..|+|||++.+..++.++|||||||++|||++|+.||...+..+...      ....         ......+.
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~------~i~~---------~~~~~~~~  218 (323)
T cd05575         154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD------NILN---------KPLRLKPN  218 (323)
T ss_pred             ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHH------HHHc---------CCCCCCCC
Confidence            23357889999999998889999999999999999999999997654322211      1111         11112234


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCCCHH----HHHH
Q 007167          538 IEEEMVEMLQVGMACVVRMPEERPKMA----DVLK  568 (615)
Q Consensus       538 ~~~~~~~l~~l~~~cl~~~P~~RPs~~----evl~  568 (615)
                      .++.+.++++   +|++.+|.+||+++    |+++
T Consensus       219 ~~~~~~~li~---~~l~~~p~~R~~~~~~~~~il~  250 (323)
T cd05575         219 ISVSARHLLE---GLLQKDRTKRLGAKDDFLEIKN  250 (323)
T ss_pred             CCHHHHHHHH---HHhhcCHHhCCCCCCCHHHHHc
Confidence            4566666666   99999999999984    5554

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=324.85  Aligned_cols=247  Identities=25%  Similarity=0.357  Sum_probs=208.3

Q ss_pred             hhhcCcCCccEEEEEEECC-CCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          305 AEVLGKGTFGTAYKAALED-ASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      ..+||-|-||.||.|.|+. .-.||||.++...+..++|..|..+|+.++|||+|+|+|+|......|||+|||.+|+|.
T Consensus       272 khKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLL  351 (1157)
T KOG4278|consen  272 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLL  351 (1157)
T ss_pred             eeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHH
Confidence            5689999999999999864 567999999998888899999999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCCCC-C
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAM-R  462 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~-~  462 (615)
                      ++|++..   ...++--..+.++.||+.|++||..++   +|||||.++|+|+.++..+||+|||++++|....++.. |
T Consensus       352 dYLRecn---r~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAG  425 (1157)
T KOG4278|consen  352 DYLRECN---RSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAG  425 (1157)
T ss_pred             HHHHHhc---hhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceecccC
Confidence            9998653   345677778899999999999999998   99999999999999999999999999999976544322 2


Q ss_pred             ---CCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCc
Q 007167          463 ---AAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI  538 (615)
Q Consensus       463 ---~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  538 (615)
                         ...|.|||-+....++.|+|||+|||+|||+.| |..||.+.+-..+..+..       .       +.++....++
T Consensus       426 AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLE-------k-------gyRM~~PeGC  491 (1157)
T KOG4278|consen  426 AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLE-------K-------GYRMDGPEGC  491 (1157)
T ss_pred             ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHh-------c-------cccccCCCCC
Confidence               356999999999899999999999999999999 999998754333333221       1       1223334455


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhH
Q 007167          539 EEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIR  574 (615)
Q Consensus       539 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~  574 (615)
                      ++.+.++   +..||+.+|.+||+++|+.+.++.+-
T Consensus       492 PpkVYeL---MraCW~WsPsDRPsFaeiHqafEtmf  524 (1157)
T KOG4278|consen  492 PPKVYEL---MRACWNWSPSDRPSFAEIHQAFETMF  524 (1157)
T ss_pred             CHHHHHH---HHHHhcCCcccCccHHHHHHHHHHHh
Confidence            5555554   45999999999999999999888765

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-37  Score=312.23  Aligned_cols=245  Identities=25%  Similarity=0.433  Sum_probs=195.9

Q ss_pred             hhhcCcCCccEEEEEEECC----CCEEEEEEeccccCC--HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALED----ASTVVVKRLKEVNVG--KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      .+.||+|+||+||+|.+..    ...|+||.++.....  ...|.+|++++++++|+||+++++++...+..++||||++
T Consensus         9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~   88 (266)
T cd05033           9 EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYME   88 (266)
T ss_pred             eeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCC
Confidence            4679999999999998743    357899988754322  4578899999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP  458 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~  458 (615)
                      +++|.+++....    ..+++..+.+++.|++.|++|||+.+   |+||||||+||++++++.++|+|||+++.......
T Consensus        89 ~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd05033          89 NGSLDKFLREND----GKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA  161 (266)
T ss_pred             CCCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence            999999997532    26899999999999999999999988   99999999999999999999999999987752111


Q ss_pred             -----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccc
Q 007167          459 -----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL  532 (615)
Q Consensus       459 -----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  532 (615)
                           ....+..|+|||.+.+..++.++||||||+++|||++ |..||......+...   .+.    ..+.       .
T Consensus       162 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~---~~~----~~~~-------~  227 (266)
T cd05033         162 TYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIK---AVE----DGYR-------L  227 (266)
T ss_pred             ceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHH---HHH----cCCC-------C
Confidence                 1123467999999988889999999999999999998 999997644332221   111    1100       0


Q ss_pred             cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 007167          533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI  573 (615)
Q Consensus       533 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l  573 (615)
                      ......++.   +.+++.+|++.+|++||+++||+++|+++
T Consensus       228 ~~~~~~~~~---l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         228 PPPMDCPSA---LYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             CCCCCCCHH---HHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            011122333   45555699999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=9.7e-38  Score=310.99  Aligned_cols=242  Identities=22%  Similarity=0.343  Sum_probs=192.2

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      +.||+|+||+||+|... +++.||+|.......  ....+.+|+++++.++||||+++++++...+..++||||+++++|
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF   80 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence            35999999999999864 688899998764322  245688999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCCC--
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPA--  460 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~~--  460 (615)
                      .+++...    ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++..........  
T Consensus        81 ~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  153 (252)
T cd05084          81 LTFLRTE----GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG  153 (252)
T ss_pred             HHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccC
Confidence            9999642    235899999999999999999999998   9999999999999999999999999987654322111  


Q ss_pred             ---CCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          461 ---MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       461 ---~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                         ..+..|+|||.+.+..++.++|||||||++|||++ |..||......+....+.       ...       ......
T Consensus       154 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~-------~~~-------~~~~~~  219 (252)
T cd05084         154 GMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIE-------QGV-------RLPCPE  219 (252)
T ss_pred             CCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHH-------cCC-------CCCCcc
Confidence               12346999999988889999999999999999998 899987544322211111       000       001111


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVE  571 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  571 (615)
                      ..++.+.   +++.+|+..+|++||++.|+.++|+
T Consensus       220 ~~~~~~~---~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         220 LCPDAVY---RLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cCCHHHH---HHHHHHcCCChhhCcCHHHHHHHHh
Confidence            2234444   4555999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=2.5e-37  Score=320.61  Aligned_cols=244  Identities=17%  Similarity=0.315  Sum_probs=191.2

Q ss_pred             hcCcCCccEEEEEEEC-CCCEEEEEEeccccC----CHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          307 VLGKGTFGTAYKAALE-DASTVVVKRLKEVNV----GKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      +||+|+||.||++... ++..||+|.++....    ..+.+.+|..++..+ +||||+++++++.+.+..++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g   81 (329)
T cd05588           2 VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGG   81 (329)
T ss_pred             eEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            5999999999999864 678899999975421    234577899999888 7999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC---CC
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP---MP  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~---~~  457 (615)
                      +|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++....   ..
T Consensus        82 ~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~  153 (329)
T cd05588          82 DLMFHMQRQ-----RKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTT  153 (329)
T ss_pred             CHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCCCcc
Confidence            999888642     36899999999999999999999998   99999999999999999999999999875321   12


Q ss_pred             CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc--hhhHHHHHHHhhhcccccccccccccCC
Q 007167          458 PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDE--VVHLVRWVNSVVREEWTAEVFDVELLRY  535 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~~~~~  535 (615)
                      ....++..|+|||++.+..++.++|||||||++|||++|+.||......+  ......++.......        .....
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~p  225 (329)
T cd05588         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEK--------QIRIP  225 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcC--------CCCCC
Confidence            23457889999999999889999999999999999999999997432211  111111221111111        11111


Q ss_pred             CCcHHHHHHHHHHHHHcccCCCCCCCC------HHHHHHH
Q 007167          536 PNIEEEMVEMLQVGMACVVRMPEERPK------MADVLKM  569 (615)
Q Consensus       536 ~~~~~~~~~l~~l~~~cl~~~P~~RPs------~~evl~~  569 (615)
                      ..++.++.++++   +|++.||.+||+      ++|++++
T Consensus       226 ~~~~~~~~~li~---~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         226 RSLSVKASSVLK---GFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             CCCCHHHHHHHH---HHhccCHHHcCCCCCCCCHHHHhcC
Confidence            234555556665   999999999997      6787764

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.2e-37  Score=310.03  Aligned_cols=244  Identities=28%  Similarity=0.417  Sum_probs=195.9

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChhh
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSA  384 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  384 (615)
                      .+.||+|+||.||+|...++..+++|++.......+.+.+|++++++++|+|++++++++. .+..++||||+++|+|.+
T Consensus        11 ~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~   89 (260)
T cd05069          11 DVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMGKGSLLD   89 (260)
T ss_pred             eeeecCcCCCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCCCCCHHH
Confidence            3569999999999999888788999998765555677899999999999999999998875 456889999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC----CC
Q 007167          385 MLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP----PA  460 (615)
Q Consensus       385 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~----~~  460 (615)
                      +++...   ...+++..+..++.|++.||+|||+.+   |+||||||+||++++++.++|+|||++........    ..
T Consensus        90 ~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~  163 (260)
T cd05069          90 FLKEGD---GKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGA  163 (260)
T ss_pred             HHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCC
Confidence            997532   235899999999999999999999998   99999999999999999999999999976643221    12


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      .++..|+|||...+..++.++|||||||++|||++ |+.||......+...   +...    ...       .......+
T Consensus       164 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~---~~~~----~~~-------~~~~~~~~  229 (260)
T cd05069         164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLE---QVER----GYR-------MPCPQGCP  229 (260)
T ss_pred             ccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HHHc----CCC-------CCCCcccC
Confidence            23567999999988889999999999999999999 999997654332221   1111    000       01112233


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKMADVLKMVED  572 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  572 (615)
                      ..+.+++   .+|+..+|++||++++|++.|++
T Consensus       230 ~~~~~li---~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         230 ESLHELM---KLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             HHHHHHH---HHHccCCcccCcCHHHHHHHHhc
Confidence            4444554   49999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.3e-37  Score=316.69  Aligned_cols=252  Identities=24%  Similarity=0.432  Sum_probs=198.6

Q ss_pred             hhhcCcCCccEEEEEEEC------CCCEEEEEEecccc-CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecC
Q 007167          305 AEVLGKGTFGTAYKAALE------DASTVVVKRLKEVN-VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYF  377 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  377 (615)
                      .+.||+|+||.||++...      ++..+|+|.+.... ...+.+.+|++++++++|+||+++++++...+..++||||+
T Consensus        10 ~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   89 (288)
T cd05093          10 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYM   89 (288)
T ss_pred             ccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcC
Confidence            457999999999999742      34568899886543 22456889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCC--------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeeccc
Q 007167          378 EPGSVSAMLHGRRG--------EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGL  449 (615)
Q Consensus       378 ~~gsL~~~l~~~~~--------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~  449 (615)
                      ++++|.+++.....        .....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+
T Consensus        90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~  166 (288)
T cd05093          90 KHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGM  166 (288)
T ss_pred             CCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEeccCCc
Confidence            99999999864321        12235899999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCCC-----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccc
Q 007167          450 AALMSPMPP-----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEW  523 (615)
Q Consensus       450 a~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  523 (615)
                      ++.......     ...++..|+|||.+.+..++.++|||||||++|||++ |+.||......+....+      .... 
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i------~~~~-  239 (288)
T cd05093         167 SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI------TQGR-  239 (288)
T ss_pred             cccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH------HcCC-
Confidence            986543221     1223567999999988889999999999999999998 99999765433322111      1110 


Q ss_pred             ccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          524 TAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       524 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                      .       .......+.+   +.+++.+|++.+|.+|||+.|+++.|+++.+.
T Consensus       240 ~-------~~~~~~~~~~---l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         240 V-------LQRPRTCPKE---VYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             c-------CCCCCCCCHH---HHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            0       0001122334   45555599999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=8.3e-38  Score=322.24  Aligned_cols=236  Identities=25%  Similarity=0.382  Sum_probs=188.1

Q ss_pred             hcCcCCccEEEEEEEC-CCCEEEEEEecccc----CCHHHHHHHHHHHhC-CCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          307 VLGKGTFGTAYKAALE-DASTVVVKRLKEVN----VGKREFEQQMEIVGG-IRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .||+|+||+||+|... +++.||||.++...    .....+..|.+++.. .+||||+++++++.+.+..++||||+++|
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g   81 (316)
T cd05619           2 MLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence            5999999999999965 46789999987541    223445667777775 48999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC---CC
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP---MP  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~---~~  457 (615)
                      +|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++....   ..
T Consensus        82 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  153 (316)
T cd05619          82 DLMFHIQSC-----HKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKT  153 (316)
T ss_pred             cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCce
Confidence            999998642     35889999999999999999999998   99999999999999999999999999875322   12


Q ss_pred             CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCC
Q 007167          458 PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN  537 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  537 (615)
                      ....++..|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.      ..       .+.  ....
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~------~~-------~~~--~~~~  218 (316)
T cd05619         154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR------MD-------NPC--YPRW  218 (316)
T ss_pred             eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hC-------CCC--CCcc
Confidence            23457889999999998889999999999999999999999997654333222211      00       000  1122


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 007167          538 IEEEMVEMLQVGMACVVRMPEERPKMA-DVLK  568 (615)
Q Consensus       538 ~~~~~~~l~~l~~~cl~~~P~~RPs~~-evl~  568 (615)
                      .+.++.+++.   +|++.+|++||++. ++.+
T Consensus       219 ~~~~~~~li~---~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         219 LTREAKDILV---KLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CCHHHHHHHH---HHhccCHhhcCCChHHHHc
Confidence            3455555555   99999999999997 6654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.7e-37  Score=313.49  Aligned_cols=248  Identities=29%  Similarity=0.476  Sum_probs=195.2

Q ss_pred             hhhcCcCCccEEEEEEE-----CCCCEEEEEEeccccCC--HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecC
Q 007167          305 AEVLGKGTFGTAYKAAL-----EDASTVVVKRLKEVNVG--KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYF  377 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  377 (615)
                      .+.||+|+||+||+|..     .++..|++|.++.....  ...+.+|++++++++||||+++++++...+..++||||+
T Consensus        10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   89 (283)
T cd05090          10 MEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYL   89 (283)
T ss_pred             eeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcC
Confidence            35799999999999984     34578999999754322  356889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCC------------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEe
Q 007167          378 EPGSVSAMLHGRRG------------EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVS  445 (615)
Q Consensus       378 ~~gsL~~~l~~~~~------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~  445 (615)
                      ++|+|.+++.....            .....+++.+...++.|++.||+|||+.+   |+||||||+||++++++.+||+
T Consensus        90 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~~~kl~  166 (283)
T cd05090          90 NQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKIS  166 (283)
T ss_pred             CCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCCcEEec
Confidence            99999999853221            11235889999999999999999999998   9999999999999999999999


Q ss_pred             ecccccccCCCC-----CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhh
Q 007167          446 DIGLAALMSPMP-----PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVV  519 (615)
Q Consensus       446 DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  519 (615)
                      |||+++......     ....++..|+|||++.+..++.++|||||||++|||++ |..||......+....+.   .  
T Consensus       167 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~---~--  241 (283)
T cd05090         167 DLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR---K--  241 (283)
T ss_pred             cccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---c--
Confidence            999997654321     12233567999999988889999999999999999998 999997654333222221   1  


Q ss_pred             hcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 007167          520 REEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVED  572 (615)
Q Consensus       520 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  572 (615)
                       ..        .+......++.+.+++.   +|++.+|++||++.+|.++|..
T Consensus       242 -~~--------~~~~~~~~~~~~~~li~---~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         242 -RQ--------LLPCSEDCPPRMYSLMT---ECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             -CC--------cCCCCCCCCHHHHHHHH---HHcccCcccCcCHHHHHHHhhc
Confidence             00        01111223445555554   9999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.6e-37  Score=328.61  Aligned_cols=244  Identities=24%  Similarity=0.350  Sum_probs=192.1

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEeccccC----CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNV----GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      +.||+|+||+||+|.. .+++.||+|++.....    ....+.+|+++++.++|+||+++++++.+.+..++||||+++|
T Consensus         7 ~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg   86 (381)
T cd05626           7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGG   86 (381)
T ss_pred             EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCC
Confidence            5699999999999985 4678899999975421    1345788999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC----
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM----  456 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~----  456 (615)
                      +|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++++||+|||+++.....    
T Consensus        87 ~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~  158 (381)
T cd05626          87 DMMSLLIRM-----EVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK  158 (381)
T ss_pred             cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence            999998643     35888899999999999999999998   999999999999999999999999997543100    


Q ss_pred             ----------------------------------------------CCCCCCCCcccCccccCCCCCCCccchhhHHHHH
Q 007167          457 ----------------------------------------------PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLL  490 (615)
Q Consensus       457 ----------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl  490 (615)
                                                                    .....+|..|+|||++.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il  238 (381)
T cd05626         159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL  238 (381)
T ss_pred             cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence                                                          0123578899999999888899999999999999


Q ss_pred             HHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          491 LELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       491 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      |||++|+.||......+....+      ..  +..   .........++++..++++-+ .|...+|..||++.|++++
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i------~~--~~~---~~~~~~~~~~s~~~~dli~~l-l~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         239 FEMLVGQPPFLAPTPTETQLKV------IN--WEN---TLHIPPQVKLSPEAVDLITKL-CCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             HHHHhCCCCCcCCCHHHHHHHH------Hc--ccc---ccCCCCCCCCCHHHHHHHHHH-ccCcccccCCCCHHHHhcC
Confidence            9999999999865433221111      00  000   011112223566777777622 2666777789999999886

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2e-37  Score=315.74  Aligned_cols=251  Identities=25%  Similarity=0.455  Sum_probs=198.3

Q ss_pred             hhcCcCCccEEEEEEEC------CCCEEEEEEeccccCC-HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCC
Q 007167          306 EVLGKGTFGTAYKAALE------DASTVVVKRLKEVNVG-KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      +.||+|+||.||++...      +...+++|.++..... .+.+.+|++++++++|+||+++++++...+..++||||++
T Consensus        11 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   90 (291)
T cd05094          11 RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMK   90 (291)
T ss_pred             eeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCC
Confidence            56999999999999743      3456888888654322 3578899999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeec
Q 007167          379 PGSVSAMLHGRRG-----------EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDI  447 (615)
Q Consensus       379 ~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Df  447 (615)
                      +++|.+++.....           .....+++..+++++.|++.|++|||+++   |+||||||+||+++.++.++|+||
T Consensus        91 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df  167 (291)
T cd05094          91 HGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDF  167 (291)
T ss_pred             CCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEECCC
Confidence            9999999964321           11235899999999999999999999998   999999999999999999999999


Q ss_pred             ccccccCCCC-----CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhc
Q 007167          448 GLAALMSPMP-----PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVRE  521 (615)
Q Consensus       448 G~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  521 (615)
                      |++.......     ....++..|+|||.+.+..++.++|||||||++|||++ |+.||......+....      ....
T Consensus       168 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~------~~~~  241 (291)
T cd05094         168 GMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIEC------ITQG  241 (291)
T ss_pred             CcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH------HhCC
Confidence            9997654322     12234567999999988889999999999999999999 9999976544332211      1111


Q ss_pred             ccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          522 EWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       522 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                      .+ ..       .....+..   +.+++.+|+..+|++||++++|+++|+++.+.
T Consensus       242 ~~-~~-------~~~~~~~~---~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         242 RV-LE-------RPRVCPKE---VYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             CC-CC-------CCccCCHH---HHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            10 00       01122333   44555599999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.5e-37  Score=313.19  Aligned_cols=249  Identities=23%  Similarity=0.369  Sum_probs=192.2

Q ss_pred             hhhcCcCCccEEEEEEECCCC---EEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEec------CeeeE
Q 007167          305 AEVLGKGTFGTAYKAALEDAS---TVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSK------DEKLM  372 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~---~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~l  372 (615)
                      .+.||+|+||.||+|...+..   .||+|.++....   ..+.+.+|+++++.++|+||+++++++...      ...++
T Consensus         4 ~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~   83 (272)
T cd05075           4 GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVV   83 (272)
T ss_pred             ccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEE
Confidence            467999999999999975433   589998865422   235678899999999999999999987532      24689


Q ss_pred             EeecCCCCChhhhhccCC-CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeeccccc
Q 007167          373 VYDYFEPGSVSAMLHGRR-GEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAA  451 (615)
Q Consensus       373 V~e~~~~gsL~~~l~~~~-~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~  451 (615)
                      ||||+++|+|.+++...+ ......+++.....++.|++.||+|||+++   |+||||||+||++++++.+||+|||+++
T Consensus        84 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  160 (272)
T cd05075          84 ILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGLSK  160 (272)
T ss_pred             EEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCccc
Confidence            999999999999874322 122346899999999999999999999987   9999999999999999999999999998


Q ss_pred             ccCCCCC-----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccc
Q 007167          452 LMSPMPP-----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTA  525 (615)
Q Consensus       452 ~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (615)
                      .+.....     ....+..|+|||......++.++|||||||++|||++ |+.||......+....+      . ...  
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~------~-~~~--  231 (272)
T cd05075         161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYL------R-QGN--  231 (272)
T ss_pred             ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH------H-cCC--
Confidence            7653321     1224567999999988889999999999999999999 89999764332221111      1 110  


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 007167          526 EVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI  573 (615)
Q Consensus       526 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l  573 (615)
                           .....+...+.+.   +++.+||+.+|++|||+.|+++.|+++
T Consensus       232 -----~~~~~~~~~~~~~---~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         232 -----RLKQPPDCLDGLY---SLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             -----CCCCCCCCCHHHH---HHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                 0111223334444   455599999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=9.2e-38  Score=321.98  Aligned_cols=237  Identities=24%  Similarity=0.365  Sum_probs=188.3

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEecccc----CCHHHHHHHHHHHhC-CCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVN----VGKREFEQQMEIVGG-IRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      ++||+|+||.||+|..+ ++..||+|.++...    .....+..|.+++.. .+||||+++++++.+++..++||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            35999999999999965 57889999987532    223455667777765 4899999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC---C
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP---M  456 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~---~  456 (615)
                      |+|..++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++....   .
T Consensus        81 g~L~~~i~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  152 (316)
T cd05620          81 GDLMFHIQDK-----GRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR  152 (316)
T ss_pred             CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCCCc
Confidence            9999988642     35889999999999999999999998   99999999999999999999999999875321   2


Q ss_pred             CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          457 PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       457 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                      .....++..|+|||++.+..++.++||||+||++|||++|+.||...+..+....+.      ..       .+..  ..
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~------~~-------~~~~--~~  217 (316)
T cd05620         153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR------VD-------TPHY--PR  217 (316)
T ss_pred             eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH------hC-------CCCC--CC
Confidence            233457889999999998899999999999999999999999997654332221111      00       0111  12


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMA-DVLK  568 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~-evl~  568 (615)
                      .++.++.++++   +|+..||++||++. ++.+
T Consensus       218 ~~~~~~~~li~---~~l~~dP~~R~~~~~~~~~  247 (316)
T cd05620         218 WITKESKDILE---KLFERDPTRRLGVVGNIRG  247 (316)
T ss_pred             CCCHHHHHHHH---HHccCCHHHcCCChHHHHc
Confidence            24556666666   99999999999985 5653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.1e-37  Score=328.01  Aligned_cols=253  Identities=24%  Similarity=0.365  Sum_probs=196.5

Q ss_pred             HhhhcCcCCccEEEEEEECC------CCEEEEEEeccccC--CHHHHHHHHHHHhCCC-CCcccceeEEEEecCeeeEEe
Q 007167          304 SAEVLGKGTFGTAYKAALED------ASTVVVKRLKEVNV--GKREFEQQMEIVGGIR-HENVVALRAYYYSKDEKLMVY  374 (615)
Q Consensus       304 ~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~  374 (615)
                      ..++||+|+||.||+|....      +..||||+++....  ..+.+.+|+++++++. |||||++++++.+.+..++||
T Consensus        41 ~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~  120 (400)
T cd05105          41 LGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIIT  120 (400)
T ss_pred             hhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEE
Confidence            45689999999999998532      34699999975422  2456889999999996 999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCC--------------------------------------------------------------
Q 007167          375 DYFEPGSVSAMLHGRRGE--------------------------------------------------------------  392 (615)
Q Consensus       375 e~~~~gsL~~~l~~~~~~--------------------------------------------------------------  392 (615)
                      ||+++|+|.++++..+..                                                              
T Consensus       121 Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (400)
T cd05105         121 EYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKY  200 (400)
T ss_pred             EecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhh
Confidence            999999999988653210                                                              


Q ss_pred             -----------------------------CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEE
Q 007167          393 -----------------------------GQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVC  443 (615)
Q Consensus       393 -----------------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~k  443 (615)
                                                   ....+++..+.+++.|++.||+|||+.+   |+||||||+||+++.++.+|
T Consensus       201 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~~~~~k  277 (400)
T cd05105         201 SDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQGKIVK  277 (400)
T ss_pred             hhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeCCCEEE
Confidence                                         1134788899999999999999999998   99999999999999999999


Q ss_pred             EeecccccccCCCC-----CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHH
Q 007167          444 VSDIGLAALMSPMP-----PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNS  517 (615)
Q Consensus       444 l~DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  517 (615)
                      |+|||+++......     ....++..|+|||.+.+..++.++|||||||++|||++ |+.||......+..  ...+  
T Consensus       278 L~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~--~~~~--  353 (400)
T cd05105         278 ICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTF--YNKI--  353 (400)
T ss_pred             EEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHH--HHHH--
Confidence            99999998654321     12234567999999988889999999999999999997 99999764332211  1111  


Q ss_pred             hhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          518 VVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       518 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                        ....       ........+.   ++.+++.+||..+|++||++.+|.++|+++.+
T Consensus       354 --~~~~-------~~~~~~~~~~---~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         354 --KSGY-------RMAKPDHATQ---EVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             --hcCC-------CCCCCccCCH---HHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence              1110       0111122333   44555559999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.7e-37  Score=320.90  Aligned_cols=232  Identities=22%  Similarity=0.321  Sum_probs=182.3

Q ss_pred             hcCcCCccEEEEEEEC-CCCEEEEEEeccccC----CHHHHHHHHH-HHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          307 VLGKGTFGTAYKAALE-DASTVVVKRLKEVNV----GKREFEQQME-IVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      +||+|+||+||+|... ++..||+|++.....    ....+.+|.. +++.++||||+++++++.+.+..++||||+++|
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (321)
T cd05603           2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG   81 (321)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            5999999999999964 678899999864321    1233445544 678899999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC---C
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM---P  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~---~  457 (615)
                      +|...+...     ..+.+.....++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....   .
T Consensus        82 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  153 (321)
T cd05603          82 ELFFHLQRE-----RCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETT  153 (321)
T ss_pred             CHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCcc
Confidence            999888632     35788888999999999999999998   999999999999999999999999998754221   1


Q ss_pred             CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCC
Q 007167          458 PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN  537 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  537 (615)
                      ....++..|+|||++.+..++.++|||||||++|||++|+.||...+..+...      ....         ......+.
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~------~i~~---------~~~~~~~~  218 (321)
T cd05603         154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD------NILH---------KPLQLPGG  218 (321)
T ss_pred             ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHH------HHhc---------CCCCCCCC
Confidence            23357889999999988889999999999999999999999997643222111      1111         11111223


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCCCHH
Q 007167          538 IEEEMVEMLQVGMACVVRMPEERPKMA  564 (615)
Q Consensus       538 ~~~~~~~l~~l~~~cl~~~P~~RPs~~  564 (615)
                      ...++.++++   +|++.+|.+||+..
T Consensus       219 ~~~~~~~li~---~~l~~~p~~R~~~~  242 (321)
T cd05603         219 KTVAACDLLV---GLLHKDQRRRLGAK  242 (321)
T ss_pred             CCHHHHHHHH---HHccCCHhhcCCCC
Confidence            3445555555   99999999999764

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.5e-37  Score=321.76  Aligned_cols=234  Identities=24%  Similarity=0.349  Sum_probs=185.7

Q ss_pred             hcCcCCccEEEEEEEC-CCCEEEEEEeccccC----CHHHHHHHH-HHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          307 VLGKGTFGTAYKAALE-DASTVVVKRLKEVNV----GKREFEQQM-EIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~-~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .||+|+||+||+|... +++.||+|++.....    ....+..|. .+++.++|+||+++++++...+..++||||+++|
T Consensus         2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05602           2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG   81 (325)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence            5999999999999965 567899999875321    122334443 3567889999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC---C
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM---P  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~---~  457 (615)
                      +|.+++...     ..+.+.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....   .
T Consensus        82 ~L~~~~~~~-----~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~  153 (325)
T cd05602          82 ELFYHLQRE-----RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTT  153 (325)
T ss_pred             cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCc
Confidence            999998643     35778888889999999999999998   999999999999999999999999998754321   2


Q ss_pred             CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCC
Q 007167          458 PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN  537 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  537 (615)
                      ....++..|+|||++.+..++.++||||+||++|||++|+.||...+..+....      ...         ......+.
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~------i~~---------~~~~~~~~  218 (325)
T cd05602         154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN------ILN---------KPLQLKPN  218 (325)
T ss_pred             ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHH------HHh---------CCcCCCCC
Confidence            234578899999999998999999999999999999999999976543322111      111         11112234


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCCCHHHH
Q 007167          538 IEEEMVEMLQVGMACVVRMPEERPKMADV  566 (615)
Q Consensus       538 ~~~~~~~l~~l~~~cl~~~P~~RPs~~ev  566 (615)
                      +++.+.++++   +|++.+|.+||++.+.
T Consensus       219 ~~~~~~~li~---~~l~~~p~~R~~~~~~  244 (325)
T cd05602         219 ITNSARHLLE---GLLQKDRTKRLGAKDD  244 (325)
T ss_pred             CCHHHHHHHH---HHcccCHHHCCCCCCC
Confidence            5566666666   9999999999988743

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3e-37  Score=319.42  Aligned_cols=237  Identities=26%  Similarity=0.382  Sum_probs=187.9

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEecccc----CCHHHHHHHHHH---HhCCCCCcccceeEEEEecCeeeEEeecC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVN----VGKREFEQQMEI---VGGIRHENVVALRAYYYSKDEKLMVYDYF  377 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~---l~~l~h~niv~l~~~~~~~~~~~lV~e~~  377 (615)
                      +.||+|+||.||+|... +++.||||+++...    ...+.+.+|.++   ++.++||||+++++++...+..++||||+
T Consensus         5 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~   84 (324)
T cd05589           5 AVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYA   84 (324)
T ss_pred             EEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCC
Confidence            56999999999999864 67899999997542    112345566554   45678999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC-
Q 007167          378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM-  456 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~-  456 (615)
                      ++|+|...++.      ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++..... 
T Consensus        85 ~~~~L~~~~~~------~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05589          85 AGGDLMMHIHT------DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG  155 (324)
T ss_pred             CCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCCC
Confidence            99999988863      25899999999999999999999998   999999999999999999999999998754321 


Q ss_pred             --CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccC
Q 007167          457 --PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLR  534 (615)
Q Consensus       457 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  534 (615)
                        .....++..|+|||.+.+..++.++|||||||++|||++|+.||......+....      +...         ....
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~------i~~~---------~~~~  220 (324)
T cd05589         156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDS------IVND---------EVRY  220 (324)
T ss_pred             CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHH------HHhC---------CCCC
Confidence              2234578899999999988899999999999999999999999976543322211      1111         0111


Q ss_pred             CCCcHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007167          535 YPNIEEEMVEMLQVGMACVVRMPEERP-----KMADVLKM  569 (615)
Q Consensus       535 ~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  569 (615)
                      ...+++.+.++++   +|+..||.+||     ++.+++++
T Consensus       221 p~~~~~~~~~li~---~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         221 PRFLSREAISIMR---RLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             CCCCCHHHHHHHH---HHhhcCHhHcCCCCCCCHHHHhhC
Confidence            1234455555555   99999999999     57777665

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.7e-37  Score=316.04  Aligned_cols=255  Identities=20%  Similarity=0.334  Sum_probs=188.1

Q ss_pred             hhhcCcCCccEEEEEEEC--CCCEEEEEEeccccC---CHHHHHHHHHHHhCC---CCCcccceeEEEEe-----cCeee
Q 007167          305 AEVLGKGTFGTAYKAALE--DASTVVVKRLKEVNV---GKREFEQQMEIVGGI---RHENVVALRAYYYS-----KDEKL  371 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~~~~~  371 (615)
                      .+.||+|+||+||+|...  ++..||+|+++....   ....+.+|+++++.+   +||||++++++|..     ....+
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~   85 (290)
T cd07862           6 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT   85 (290)
T ss_pred             eeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEE
Confidence            356999999999999863  467899998865422   234566777776655   69999999999863     34689


Q ss_pred             EEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeeccccc
Q 007167          372 MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAA  451 (615)
Q Consensus       372 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~  451 (615)
                      +||||+. ++|.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++
T Consensus        86 lv~e~~~-~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~~~  158 (290)
T cd07862          86 LVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR  158 (290)
T ss_pred             EEEccCC-CCHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccceE
Confidence            9999996 68999886432   235899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCC--CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhh-HHHHHHHhhhccccccc-
Q 007167          452 LMSPMP--PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVH-LVRWVNSVVREEWTAEV-  527 (615)
Q Consensus       452 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~-  527 (615)
                      ......  ....++..|+|||.+....++.++|||||||++|||++|+.||......+... +.........+.|..+. 
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  238 (290)
T cd07862         159 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA  238 (290)
T ss_pred             eccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhc
Confidence            765332  23356888999999988889999999999999999999999998755433222 11111111111121111 


Q ss_pred             -----cccccc-----CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          528 -----FDVELL-----RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       528 -----~d~~~~-----~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                           +.....     ..+..++...+   ++.+|++.||++|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         239 LPRQAFHSKSAQPIEKFVTDIDELGKD---LLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             ccchhccCCCCCCHHHHccCCCHHHHH---HHHHHhccCchhcCCHHHHhcC
Confidence                 000000     01223334444   4559999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2.5e-37  Score=307.62  Aligned_cols=242  Identities=25%  Similarity=0.399  Sum_probs=194.0

Q ss_pred             hhcCcCCccEEEEEEECCCCEEEEEEeccccCC--HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVG--KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      ++||+|+||.||+|..+++..||+|.+......  ...+.+|+++++.++||||+++++++...+..++||||+++++|.
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~   80 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL   80 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence            369999999999999888899999988754322  346889999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC----C
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP----P  459 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~----~  459 (615)
                      +++....    ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++........    .
T Consensus        81 ~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (250)
T cd05085          81 SFLRKKK----DELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGL  153 (250)
T ss_pred             HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCC
Confidence            9986432    35889999999999999999999998   99999999999999999999999999876543221    1


Q ss_pred             CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCc
Q 007167          460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI  538 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  538 (615)
                      ...+..|+|||++.+..++.++||||||+++||+++ |..||......+....+   .    ...       ........
T Consensus       154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~---~----~~~-------~~~~~~~~  219 (250)
T cd05085         154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQV---E----KGY-------RMSCPQKC  219 (250)
T ss_pred             CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH---H----cCC-------CCCCCCCC
Confidence            123457999999988889999999999999999998 99999765432221111   1    110       01111223


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 007167          539 EEEMVEMLQVGMACVVRMPEERPKMADVLKMVE  571 (615)
Q Consensus       539 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  571 (615)
                      +..   +.+++.+|+..+|++||++.|+++.|.
T Consensus       220 ~~~---~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         220 PDD---VYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CHH---HHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            344   444555999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.9e-37  Score=309.58  Aligned_cols=245  Identities=25%  Similarity=0.388  Sum_probs=199.5

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChhh
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSA  384 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  384 (615)
                      .+.||+|+||.||+|... ++.|++|.++......+.+.+|+++++.++|+||+++++++.+.+..++||||+++++|.+
T Consensus        11 ~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~   89 (256)
T cd05039          11 GATIGKGEFGDVMLGDYR-GQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVD   89 (256)
T ss_pred             eeeeecCCCceEEEEEec-CcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHH
Confidence            467999999999999865 7889999998665456778899999999999999999999999899999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCCCCCCC
Q 007167          385 MLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAA  464 (615)
Q Consensus       385 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~  464 (615)
                      ++....   ...+++..+..++.|++.|+.|||+.+   |+||||||+||+++.++.+||+|||.++...........+.
T Consensus        90 ~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  163 (256)
T cd05039          90 YLRSRG---RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPV  163 (256)
T ss_pred             HHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccccCCCcc
Confidence            997432   236899999999999999999999998   99999999999999999999999999987754333334456


Q ss_pred             cccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHHHHH
Q 007167          465 GYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMV  543 (615)
Q Consensus       465 ~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  543 (615)
                      .|+|||++....++.++||||||+++||+++ |+.||......+....   +.    ..+..       ......++++.
T Consensus       164 ~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~---~~----~~~~~-------~~~~~~~~~~~  229 (256)
T cd05039         164 KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPH---VE----KGYRM-------EAPEGCPPEVY  229 (256)
T ss_pred             cccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH---Hh----cCCCC-------CCccCCCHHHH
Confidence            7999999988889999999999999999997 9999976543222111   11    11100       01112334444


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 007167          544 EMLQVGMACVVRMPEERPKMADVLKMVEDI  573 (615)
Q Consensus       544 ~l~~l~~~cl~~~P~~RPs~~evl~~L~~l  573 (615)
                      +   ++.+|+..+|++||++.|++++|+.+
T Consensus       230 ~---li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         230 K---VMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             H---HHHHHhccChhhCcCHHHHHHHHhcC
Confidence            4   45599999999999999999999753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.8e-37  Score=318.71  Aligned_cols=237  Identities=24%  Similarity=0.372  Sum_probs=190.3

Q ss_pred             hcCcCCccEEEEEEEC-CCCEEEEEEecccc----CCHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          307 VLGKGTFGTAYKAALE-DASTVVVKRLKEVN----VGKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .||+|+||+||++... ++..||+|+++...    .....+.+|.+++..+ +||||+++++++...+..++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (318)
T cd05570           2 VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGG   81 (318)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            5999999999999865 57789999997542    2234567788888877 7999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC---C
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM---P  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~---~  457 (615)
                      +|..++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++.....   .
T Consensus        82 ~L~~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  153 (318)
T cd05570          82 DLMFHIQRS-----GRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTT  153 (318)
T ss_pred             CHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcc
Confidence            999988643     36899999999999999999999998   999999999999999999999999998753221   1


Q ss_pred             CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCC
Q 007167          458 PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN  537 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  537 (615)
                      ....++..|+|||++.+..++.++|||||||++|||++|+.||......+...      .+...         .......
T Consensus       154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~------~i~~~---------~~~~~~~  218 (318)
T cd05570         154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQ------SILED---------EVRYPRW  218 (318)
T ss_pred             cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHH------HHHcC---------CCCCCCc
Confidence            22347889999999999899999999999999999999999997644322211      11111         1111123


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 007167          538 IEEEMVEMLQVGMACVVRMPEERPKM-----ADVLKM  569 (615)
Q Consensus       538 ~~~~~~~l~~l~~~cl~~~P~~RPs~-----~evl~~  569 (615)
                      .+++..++++   +|+..||++||++     .+++++
T Consensus       219 ~~~~~~~li~---~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         219 LSKEAKSILK---SFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CCHHHHHHHH---HHccCCHHHcCCCCCCCHHHHhcC
Confidence            4455556555   9999999999999     888765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-37  Score=338.85  Aligned_cols=244  Identities=20%  Similarity=0.313  Sum_probs=193.0

Q ss_pred             hhhcCcCCccEEEEEEEC-C-CCEEEEEEeccccC-CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-D-ASTVVVKRLKEVNV-GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~-~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      .+.||+|+||.||+|... + +..||+|.+..... ....+.+|+++++.++|||||++++++...+..++||||+++|+
T Consensus        72 ~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~  151 (478)
T PTZ00267         72 TTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGD  151 (478)
T ss_pred             EEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCC
Confidence            457999999999999854 3 56788887644322 23457789999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC----
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP----  457 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~----  457 (615)
                      |.++++... ....++++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+....    
T Consensus       152 L~~~l~~~~-~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~  227 (478)
T PTZ00267        152 LNKQIKQRL-KEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDV  227 (478)
T ss_pred             HHHHHHHHH-hccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCcccccc
Confidence            999886432 12346889999999999999999999998   9999999999999999999999999998765322    


Q ss_pred             -CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          458 -PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       458 -~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                       ....+|.+|+|||++.+..++.++|||||||++|||++|+.||......+...      .......     +   ....
T Consensus       228 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~------~~~~~~~-----~---~~~~  293 (478)
T PTZ00267        228 ASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQ------QVLYGKY-----D---PFPC  293 (478)
T ss_pred             ccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH------HHHhCCC-----C---CCCc
Confidence             23357889999999998899999999999999999999999997644322221      1111100     0   0111


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .++.++.+++.   +|+..+|++||++.|++++
T Consensus       294 ~~s~~~~~li~---~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        294 PVSSGMKALLD---PLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             cCCHHHHHHHH---HHhccChhhCcCHHHHHhC
Confidence            33445555555   9999999999999998753

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=5.2e-37  Score=318.18  Aligned_cols=244  Identities=18%  Similarity=0.325  Sum_probs=189.4

Q ss_pred             hcCcCCccEEEEEEEC-CCCEEEEEEeccccC----CHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          307 VLGKGTFGTAYKAALE-DASTVVVKRLKEVNV----GKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .||+|+||+||+|... +++.||+|.++....    ..+.+.+|..++.++ +||||+++++++...+..++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~   81 (329)
T cd05618           2 VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGG   81 (329)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCC
Confidence            5999999999999965 577899999875421    224567788888766 8999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC---C
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM---P  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~---~  457 (615)
                      +|..++...     ..+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+++.....   .
T Consensus        82 ~L~~~~~~~-----~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~  153 (329)
T cd05618          82 DLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT  153 (329)
T ss_pred             CHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCcc
Confidence            999888642     36899999999999999999999998   999999999999999999999999998754221   2


Q ss_pred             CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc--hhhHHHHHHHhhhcccccccccccccCC
Q 007167          458 PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDE--VVHLVRWVNSVVREEWTAEVFDVELLRY  535 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~d~~~~~~  535 (615)
                      ....++..|+|||++.+..++.++|||||||++|||++|+.||......+  ......++.......        .....
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~--------~~~~p  225 (329)
T cd05618         154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK--------QIRIP  225 (329)
T ss_pred             ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcC--------CCCCC
Confidence            23457889999999999899999999999999999999999996422111  111111221111111        11111


Q ss_pred             CCcHHHHHHHHHHHHHcccCCCCCCCC------HHHHHHH
Q 007167          536 PNIEEEMVEMLQVGMACVVRMPEERPK------MADVLKM  569 (615)
Q Consensus       536 ~~~~~~~~~l~~l~~~cl~~~P~~RPs------~~evl~~  569 (615)
                      ...+.+..++++   +|++.||++||+      +.|++++
T Consensus       226 ~~~~~~~~~ll~---~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         226 RSLSVKAASVLK---SFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             CCCCHHHHHHHH---HHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            234455555555   999999999998      5677665

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.2e-38  Score=307.00  Aligned_cols=242  Identities=21%  Similarity=0.389  Sum_probs=201.7

Q ss_pred             HHHhhhcCcCCccEEEEEEE-CCCCEEEEEEeccccCCH----HHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeec
Q 007167          302 RASAEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVGK----REFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       302 ~~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~----~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      +...+.||+|.||.|-+|.. ..|+.||||.+++.....    -.+.+|+++|+.++||||+.++.+|+.++.+.|||||
T Consensus        55 yE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEY  134 (668)
T KOG0611|consen   55 YEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEY  134 (668)
T ss_pred             HHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEe
Confidence            34456799999999999984 789999999998764432    2468999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM  456 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~  456 (615)
                      ..+|.|.+++..+.     .+++.....++.||..|+.|+|.++   ++|||||-+|||+|.++++||+|||++..+...
T Consensus       135 aS~GeLYDYiSer~-----~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~  206 (668)
T KOG0611|consen  135 ASGGELYDYISERG-----SLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK  206 (668)
T ss_pred             cCCccHHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence            99999999998543     6999999999999999999999998   999999999999999999999999999887643


Q ss_pred             C--CCCCCCCcccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccccccc
Q 007167          457 P--PPAMRAAGYRAPEVTDTRKA-TQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELL  533 (615)
Q Consensus       457 ~--~~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  533 (615)
                      .  .+.+|++-|.+||+..+..| .+.+|.||+||+||.|+.|..||++.+...+      ++++.++.+          
T Consensus       207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~l------vrQIs~GaY----------  270 (668)
T KOG0611|consen  207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRL------VRQISRGAY----------  270 (668)
T ss_pred             cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHH------HHHhhcccc----------
Confidence            3  45678888999999999888 6799999999999999999999987543322      333332211          


Q ss_pred             CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          534 RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       534 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                      +.|.-+.....+++   .|+..+|++|.|+.+|..+-
T Consensus       271 rEP~~PSdA~gLIR---wmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  271 REPETPSDASGLIR---WMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             cCCCCCchHHHHHH---HHHhcCcccchhHHHHhhhh
Confidence            12222233445555   88899999999999998864

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.2e-37  Score=320.65  Aligned_cols=257  Identities=25%  Similarity=0.385  Sum_probs=199.6

Q ss_pred             HHHhhhcCcCCccEEEEEEECC--------CCEEEEEEeccccC--CHHHHHHHHHHHhCC-CCCcccceeEEEEecCee
Q 007167          302 RASAEVLGKGTFGTAYKAALED--------ASTVVVKRLKEVNV--GKREFEQQMEIVGGI-RHENVVALRAYYYSKDEK  370 (615)
Q Consensus       302 ~~~~~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~  370 (615)
                      +...+.||+|+||.||++....        ...||+|.++....  ..+.+.+|+++++++ +|+||+++++++...+..
T Consensus        14 ~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~   93 (334)
T cd05100          14 LTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPL   93 (334)
T ss_pred             eeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCce
Confidence            3446789999999999997421        23689998875322  235788999999999 799999999999999999


Q ss_pred             eEEeecCCCCChhhhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCC
Q 007167          371 LMVYDYFEPGSVSAMLHGRRG-----------EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQ  439 (615)
Q Consensus       371 ~lV~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~  439 (615)
                      ++||||+++|+|.+++.....           .....++|..+..++.|++.||+|||+.+   |+||||||+||+++++
T Consensus        94 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~~~  170 (334)
T cd05100          94 YVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVTED  170 (334)
T ss_pred             EEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCC
Confidence            999999999999999975321           12346899999999999999999999998   9999999999999999


Q ss_pred             CcEEEeecccccccCCCCC-----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHH
Q 007167          440 GHVCVSDIGLAALMSPMPP-----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVR  513 (615)
Q Consensus       440 ~~~kl~DfG~a~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~  513 (615)
                      +.+||+|||+++.......     ....+..|+|||.+.+..++.++|||||||++|||++ |..||......+....+ 
T Consensus       171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-  249 (334)
T cd05100         171 NVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL-  249 (334)
T ss_pred             CcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH-
Confidence            9999999999986643221     1122456999999988889999999999999999998 89999764433222111 


Q ss_pred             HHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhhc
Q 007167          514 WVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKA  578 (615)
Q Consensus       514 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~  578 (615)
                           ... ..       .........+   +.+++.+|++.+|++||++.|+++.|+++.....
T Consensus       250 -----~~~-~~-------~~~~~~~~~~---l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~  298 (334)
T cd05100         250 -----KEG-HR-------MDKPANCTHE---LYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS  298 (334)
T ss_pred             -----HcC-CC-------CCCCCCCCHH---HHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence                 111 00       0011122334   4455559999999999999999999999986444

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.4e-38  Score=296.76  Aligned_cols=244  Identities=20%  Similarity=0.359  Sum_probs=201.9

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccCC---------HHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEE
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVG---------KREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMV  373 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---------~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV  373 (615)
                      .++||+|..++|-++.. +.|.+.|+|++......         .++-.+|+.+|+++ .||+|+++.++|+.+...++|
T Consensus        22 keilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlV  101 (411)
T KOG0599|consen   22 KEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLV  101 (411)
T ss_pred             HHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhh
Confidence            56799999999988874 56788999998643211         13456799999998 699999999999999999999


Q ss_pred             eecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeeccccccc
Q 007167          374 YDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALM  453 (615)
Q Consensus       374 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~  453 (615)
                      +|.|+.|.|+++|...     ..+++....+|+.|+..|++|||.+.   |+|||+||+|||+|++.++||+|||++..+
T Consensus       102 Fdl~prGELFDyLts~-----VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l  173 (411)
T KOG0599|consen  102 FDLMPRGELFDYLTSK-----VTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQL  173 (411)
T ss_pred             hhhcccchHHHHhhhh-----eeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeecc
Confidence            9999999999999854     37999999999999999999999998   999999999999999999999999999988


Q ss_pred             CCCC--CCCCCCCcccCccccC------CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccc
Q 007167          454 SPMP--PPAMRAAGYRAPEVTD------TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTA  525 (615)
Q Consensus       454 ~~~~--~~~~~~~~y~aPE~~~------~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (615)
                      .+..  ...+||+||.|||.+.      ...|+..+|+||+||++|-|+.|..||....      ++-.++.+..+    
T Consensus       174 ~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk------QmlMLR~ImeG----  243 (411)
T KOG0599|consen  174 EPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK------QMLMLRMIMEG----  243 (411)
T ss_pred             CCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH------HHHHHHHHHhc----
Confidence            7654  3568999999999884      3468899999999999999999999997532      11122222222    


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          526 EVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       526 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                       .+...-+.|.++++++++++.   +|++.||.+|.|++|++.|=
T Consensus       244 -kyqF~speWadis~~~KdLIs---rlLqVdp~~Ritake~LaHp  284 (411)
T KOG0599|consen  244 -KYQFRSPEWADISATVKDLIS---RLLQVDPTKRITAKEALAHP  284 (411)
T ss_pred             -ccccCCcchhhccccHHHHHH---HHHeeCchhcccHHHHhcCh
Confidence             122333456677888888888   99999999999999999863

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-37  Score=310.19  Aligned_cols=245  Identities=29%  Similarity=0.455  Sum_probs=200.2

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChhh
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSA  384 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  384 (615)
                      .++||+|+||+||+|..+++..|+||.+.......+++.+|++++++++|+||+++++++......++||||+++++|.+
T Consensus        11 ~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~   90 (261)
T cd05034          11 ERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLD   90 (261)
T ss_pred             eeeeccCcceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHH
Confidence            45799999999999998888899999998766667889999999999999999999999998889999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC----CC
Q 007167          385 MLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP----PA  460 (615)
Q Consensus       385 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~----~~  460 (615)
                      ++....   ...+++..+..++.+++.|++|||+.+   |+|+||||+||++++++.+||+|||+++.+.....    ..
T Consensus        91 ~i~~~~---~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  164 (261)
T cd05034          91 FLKSGE---GKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGA  164 (261)
T ss_pred             HHhccc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhhhhhcc
Confidence            997532   246899999999999999999999998   99999999999999999999999999987653211    11


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      ..+..|+|||.+.+..++.++||||+|++++|+++ |+.||......+....   .....           ........+
T Consensus       165 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~---~~~~~-----------~~~~~~~~~  230 (261)
T cd05034         165 KFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQ---VERGY-----------RMPRPPNCP  230 (261)
T ss_pred             CCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HHcCC-----------CCCCCCCCC
Confidence            23457999999998889999999999999999999 9999976543322211   11000           001111223


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKMADVLKMVED  572 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  572 (615)
                      ++   +.+++.+|+..+|++||+++|+++.|+.
T Consensus       231 ~~---~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         231 EE---LYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             HH---HHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            34   4455559999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-37  Score=307.00  Aligned_cols=255  Identities=24%  Similarity=0.420  Sum_probs=194.5

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHH--HHhCCCCCcccceeEEEEecC----eeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQME--IVGGIRHENVVALRAYYYSKD----EKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~--~l~~l~h~niv~l~~~~~~~~----~~~lV~e~~~  378 (615)
                      .+.||+|.||+||+|.++ |..||||++...+  ++.+.+|.+  .-..++|+||+.+++.-..+.    +.|||++|.+
T Consensus       216 ~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srd--E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe  292 (513)
T KOG2052|consen  216 QEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRD--ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHE  292 (513)
T ss_pred             EEEecCccccceeecccc-CCceEEEEecccc--hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeeccc
Confidence            467999999999999986 6889999997654  344444444  455679999999998875543    6799999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-----cCCCCceecCCCCCCEEeCCCCcEEEeeccccccc
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT-----ENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALM  453 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-----~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~  453 (615)
                      .|||+|+|..      ..++-...++++..+|.||+|||.     +|+|.|.|||||+.|||+..++...|+|+|+|...
T Consensus       293 ~GSL~DyL~r------~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h  366 (513)
T KOG2052|consen  293 HGSLYDYLNR------NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRH  366 (513)
T ss_pred             CCcHHHHHhh------ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEe
Confidence            9999999974      369999999999999999999994     46889999999999999999999999999999776


Q ss_pred             CCC-------CCCCCCCCcccCccccCCCC----C--CCccchhhHHHHHHHHHhC----------CCCCCCCCCcc-hh
Q 007167          454 SPM-------PPPAMRAAGYRAPEVTDTRK----A--TQASDVFSFGVLLLELLTG----------KSPIHATGGDE-VV  509 (615)
Q Consensus       454 ~~~-------~~~~~~~~~y~aPE~~~~~~----~--~~~~DvwS~Gvvl~elltg----------~~p~~~~~~~~-~~  509 (615)
                      ...       ....+||.+|||||++...-    +  -..+||||||.|+||+...          +.||.+.-..+ -.
T Consensus       367 ~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~  446 (513)
T KOG2052|consen  367 DSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSF  446 (513)
T ss_pred             cccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCH
Confidence            532       34567999999999996431    1  2468999999999999753          45775432211 11


Q ss_pred             hHHHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          510 HLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                      +.++-   .+    ..+-+.+.++..=...+.+..+.+++..||..+|..|.|+--+-+.|.++.+
T Consensus       447 eeMrk---VV----Cv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  447 EEMRK---VV----CVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             HHHhc---ce----eecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhc
Confidence            11110   00    0011111221111234678889999999999999999999999999999875

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=9.2e-38  Score=325.21  Aligned_cols=253  Identities=21%  Similarity=0.355  Sum_probs=187.8

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc---CCHHHHHHHHHHHhCCCCCcccceeEEEEec-----CeeeEEee
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN---VGKREFEQQMEIVGGIRHENVVALRAYYYSK-----DEKLMVYD  375 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lV~e  375 (615)
                      .++||+|+||.||+|... ++..||||+++...   .....+.+|+++++.++||||+++++++...     ...++|||
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e   84 (338)
T cd07859           5 QEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFE   84 (338)
T ss_pred             EEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEe
Confidence            457999999999999854 68899999987432   2234678999999999999999999988643     24799999


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      |+. ++|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        85 ~~~-~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          85 LME-SDLHQVIKAN-----DDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             cCC-CCHHHHHHhc-----ccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            995 6898888632     35899999999999999999999998   99999999999999999999999999976532


Q ss_pred             CC------CCCCCCCcccCccccCC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhh-------
Q 007167          456 MP------PPAMRAAGYRAPEVTDT--RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVR-------  520 (615)
Q Consensus       456 ~~------~~~~~~~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------  520 (615)
                      ..      ....++..|+|||++.+  ..++.++|||||||++|||++|+.||...........+........       
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i  235 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV  235 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            11      22357888999999865  5789999999999999999999999976443221111110000000       


Q ss_pred             -ccccccccc---cc-----ccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          521 -EEWTAEVFD---VE-----LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       521 -~~~~~~~~d---~~-----~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                       .....+.+.   ..     ....+..++.+.+   ++.+|++.+|++|||++|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALR---LLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             hhhhHHHHHHhhcccCCCchHHhcCCCChHHHH---HHHHHcCcCcccCCCHHHHhcC
Confidence             000000000   00     0011233344444   4559999999999999999986

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-37  Score=311.13  Aligned_cols=249  Identities=24%  Similarity=0.386  Sum_probs=192.6

Q ss_pred             hhcCcCCccEEEEEEECC-CC--EEEEEEecccc--CCHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCCC
Q 007167          306 EVLGKGTFGTAYKAALED-AS--TVVVKRLKEVN--VGKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~-~~--~vavK~l~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      ++||+|+||.||+|.+.+ +.  .+++|.++...  .....+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            369999999999999754 33  46888887432  2245688999999999 799999999999999999999999999


Q ss_pred             CChhhhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecc
Q 007167          380 GSVSAMLHGRRG-----------EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIG  448 (615)
Q Consensus       380 gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG  448 (615)
                      |+|.++++....           .....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg  157 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG  157 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence            999999975431           11235889999999999999999999987   9999999999999999999999999


Q ss_pred             cccccCCCCC--CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccc
Q 007167          449 LAALMSPMPP--PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTA  525 (615)
Q Consensus       449 ~a~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (615)
                      ++........  ....+..|+|||++....++.++|||||||++|||++ |+.||......+...      .... .+. 
T Consensus       158 l~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~------~~~~-~~~-  229 (270)
T cd05047         158 LSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE------KLPQ-GYR-  229 (270)
T ss_pred             CccccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHH------HHhC-CCC-
Confidence            9864322111  1123457999999988889999999999999999997 999997644322211      1111 100 


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhH
Q 007167          526 EVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIR  574 (615)
Q Consensus       526 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~  574 (615)
                            .......+.   ++.+++.+|+..+|.+||++.|+++.|+++.
T Consensus       230 ------~~~~~~~~~---~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         230 ------LEKPLNCDD---EVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             ------CCCCCcCCH---HHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence                  001112233   3445555999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=3.6e-37  Score=312.50  Aligned_cols=249  Identities=22%  Similarity=0.376  Sum_probs=194.8

Q ss_pred             HhhhcCcCCccEEEEEEECC------CCEEEEEEeccccCC--HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEee
Q 007167          304 SAEVLGKGTFGTAYKAALED------ASTVVVKRLKEVNVG--KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYD  375 (615)
Q Consensus       304 ~~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  375 (615)
                      ..+.||+|+||.||+|...+      +..||+|+++.....  .+.+.+|+++++.++||||+++++++...+..++++|
T Consensus         9 ~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e   88 (283)
T cd05091           9 FMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFS   88 (283)
T ss_pred             HHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEE
Confidence            35679999999999998532      467999998754322  3568889999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEE
Q 007167          376 YFEPGSVSAMLHGRRG-----------EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCV  444 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl  444 (615)
                      |+.+++|.+++.....           .....+++..+.+++.|++.||+|||+.+   |+||||||+||++++++.+||
T Consensus        89 ~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~kl  165 (283)
T cd05091          89 YCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLNVKI  165 (283)
T ss_pred             cCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCceEe
Confidence            9999999999853210           11235889999999999999999999998   999999999999999999999


Q ss_pred             eecccccccCCCCC-----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHh
Q 007167          445 SDIGLAALMSPMPP-----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSV  518 (615)
Q Consensus       445 ~DfG~a~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  518 (615)
                      +|||+++.......     ...++..|+|||.+....++.++|||||||++|||++ |..||......+....+      
T Consensus       166 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i------  239 (283)
T cd05091         166 SDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI------  239 (283)
T ss_pred             cccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH------
Confidence            99999886643221     2234567999999988889999999999999999998 88898764433222211      


Q ss_pred             hhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 007167          519 VREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVED  572 (615)
Q Consensus       519 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  572 (615)
                      .....        ......+++++.++   +.+|++.+|++||+++||+..|+.
T Consensus       240 ~~~~~--------~~~~~~~~~~~~~l---i~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         240 RNRQV--------LPCPDDCPAWVYTL---MLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HcCCc--------CCCCCCCCHHHHHH---HHHHhCCCcccCCCHHHHHHHhhC
Confidence            11100        00112334445444   459999999999999999998863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.4e-37  Score=308.16  Aligned_cols=241  Identities=24%  Similarity=0.367  Sum_probs=191.9

Q ss_pred             hcCcCCccEEEEEEE---CCCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          307 VLGKGTFGTAYKAAL---EDASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~---~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .||+|+||.||+|.+   .++..+|+|+++.....   .+++.+|+.+++.++|+||+++++++. .+..++||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~   80 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG   80 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence            489999999999964   35678999998654322   456889999999999999999999885 45678999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC--
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP--  458 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~--  458 (615)
                      +|.+++...     ..+++..+.+++.|++.||+|||+.+   |+||||||.||+++.++.+||+|||+++.+.....  
T Consensus        81 ~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~  152 (257)
T cd05116          81 PLNKFLQKN-----KHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY  152 (257)
T ss_pred             cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCee
Confidence            999999642     35889999999999999999999998   99999999999999999999999999987643321  


Q ss_pred             ----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccccccccccc
Q 007167          459 ----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELL  533 (615)
Q Consensus       459 ----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  533 (615)
                          ...++..|+|||.+....++.++|||||||++|||++ |+.||......+....+.       ....       ..
T Consensus       153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~-------~~~~-------~~  218 (257)
T cd05116         153 KAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIE-------SGER-------ME  218 (257)
T ss_pred             eecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-------CCCC-------CC
Confidence                1122467999999988888999999999999999998 999997654433222211       1110       00


Q ss_pred             CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 007167          534 RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI  573 (615)
Q Consensus       534 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l  573 (615)
                      ..+..++++.++++   +|++.+|++||++.+|++.|+..
T Consensus       219 ~~~~~~~~l~~li~---~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         219 CPQRCPPEMYDLMK---LCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             CCCCCCHHHHHHHH---HHhccCchhCcCHHHHHHHHhcc
Confidence            11234455555555   99999999999999999999753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=3.2e-37  Score=311.99  Aligned_cols=244  Identities=21%  Similarity=0.344  Sum_probs=191.6

Q ss_pred             cCcCCccEEEEEEEC-CCCEEEEEEecccc----CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          308 LGKGTFGTAYKAALE-DASTVVVKRLKEVN----VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       308 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      ||+|+||+||++..+ +|+.||+|.+....    ...+.+..|++++++++||||+++++++..+.+.++||||+++|+|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            799999999999854 58899999986432    1234456799999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--CCC
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--PPA  460 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--~~~  460 (615)
                      .+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+|||++.......  ...
T Consensus        81 ~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  154 (277)
T cd05607          81 KYHIYNVG---ERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQR  154 (277)
T ss_pred             HHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeecc
Confidence            98886432   335889999999999999999999998   9999999999999999999999999987765322  233


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE  540 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  540 (615)
                      .++..|+|||++.+..++.++||||+||++|||++|+.||........  ............     ...   ....+++
T Consensus       155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~~~~~~~~~~~~-----~~~---~~~~~~~  224 (277)
T cd05607         155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--KEELKRRTLEDE-----VKF---EHQNFTE  224 (277)
T ss_pred             CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--HHHHHHHhhccc-----ccc---ccccCCH
Confidence            578899999999888899999999999999999999999975432211  111111111111     000   1123455


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          541 EMVEMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       541 ~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                      +..++++   +|++.+|++||+++|+++.+
T Consensus       225 ~~~~li~---~~L~~~P~~R~~~~~~~~~~  251 (277)
T cd05607         225 ESKDICR---LFLAKKPEDRLGSREKNDDP  251 (277)
T ss_pred             HHHHHHH---HHhccCHhhCCCCccchhhh
Confidence            6666666   99999999999997766433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.7e-37  Score=309.59  Aligned_cols=249  Identities=23%  Similarity=0.386  Sum_probs=194.7

Q ss_pred             hhhcCcCCccEEEEEEECC----CCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecCe------ee
Q 007167          305 AEVLGKGTFGTAYKAALED----ASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKDE------KL  371 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~  371 (615)
                      .+.||+|+||.||+|....    +..||+|+++.....   ...+.+|++.++.++|+||+++++++...+.      .+
T Consensus         4 ~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   83 (273)
T cd05035           4 GKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPM   83 (273)
T ss_pred             ccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccE
Confidence            4579999999999998642    367999998754322   3467899999999999999999999876554      79


Q ss_pred             EEeecCCCCChhhhhccCCC-CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccc
Q 007167          372 MVYDYFEPGSVSAMLHGRRG-EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLA  450 (615)
Q Consensus       372 lV~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a  450 (615)
                      +|+||+++|+|..++...+. .....+++.....++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++
T Consensus        84 ~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~  160 (273)
T cd05035          84 VILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADFGLS  160 (273)
T ss_pred             EEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCccce
Confidence            99999999999999865432 22346899999999999999999999988   999999999999999999999999999


Q ss_pred             cccCCCCCC-----CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccc
Q 007167          451 ALMSPMPPP-----AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWT  524 (615)
Q Consensus       451 ~~~~~~~~~-----~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  524 (615)
                      +.+......     ...+..|+|||.+....++.++|||||||++|||++ |..||......+..   .++.   ...  
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~---~~~~---~~~--  232 (273)
T cd05035         161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIY---DYLR---HGN--  232 (273)
T ss_pred             eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHH---HHHH---cCC--
Confidence            876533211     123457999999988889999999999999999999 89999765433222   1111   110  


Q ss_pred             cccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 007167          525 AEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI  573 (615)
Q Consensus       525 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l  573 (615)
                            .........++   +.+++.+|++.||++||++.|+++.|+++
T Consensus       233 ------~~~~~~~~~~~---~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         233 ------RLKQPEDCLDE---LYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             ------CCCCCcCCCHH---HHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                  00111223344   45555599999999999999999999876

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=2.4e-37  Score=314.97  Aligned_cols=251  Identities=27%  Similarity=0.408  Sum_probs=196.3

Q ss_pred             hhhcCcCCccEEEEEEEC------CCCEEEEEEeccccCC--HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAALE------DASTVVVKRLKEVNVG--KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      .+.||+|+||+||+|...      ....+++|.+......  .+.+.+|+++++.++||||+++++.+..++..++|+||
T Consensus         5 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   84 (290)
T cd05045           5 GKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEY   84 (290)
T ss_pred             cccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEe
Confidence            457999999999999853      2346888887654322  35688999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeC
Q 007167          377 FEPGSVSAMLHGRRG-------------------EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLN  437 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~  437 (615)
                      +.+|+|.+++...+.                   .....+++.....++.|++.||+|||+.+   |+||||||+||+++
T Consensus        85 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~nill~  161 (290)
T cd05045          85 AKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARNVLVA  161 (290)
T ss_pred             cCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhheEEEc
Confidence            999999999864321                   11245889999999999999999999988   99999999999999


Q ss_pred             CCCcEEEeecccccccCCCC-----CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhH
Q 007167          438 SQGHVCVSDIGLAALMSPMP-----PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHL  511 (615)
Q Consensus       438 ~~~~~kl~DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~  511 (615)
                      +++.+||+|||+++......     .....+..|+|||.+.+..++.++||||||+++|||++ |+.||......+....
T Consensus       162 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~  241 (290)
T cd05045         162 EGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNL  241 (290)
T ss_pred             CCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            99999999999997653321     11234567999999988889999999999999999999 9999976543332221


Q ss_pred             HHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          512 VRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       512 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                         +..    ..     .  .......+++   +.+++.+|++.+|++||++.|+++.|+++..
T Consensus       242 ---~~~----~~-----~--~~~~~~~~~~---~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         242 ---LKT----GY-----R--MERPENCSEE---MYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             ---HhC----CC-----C--CCCCCCCCHH---HHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence               111    00     0  0011123334   4455559999999999999999999999864

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=3e-37  Score=316.50  Aligned_cols=256  Identities=25%  Similarity=0.395  Sum_probs=200.2

Q ss_pred             HHhhhcCcCCccEEEEEEEC--------CCCEEEEEEecccc--CCHHHHHHHHHHHhCC-CCCcccceeEEEEecCeee
Q 007167          303 ASAEVLGKGTFGTAYKAALE--------DASTVVVKRLKEVN--VGKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKL  371 (615)
Q Consensus       303 ~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  371 (615)
                      ...+.||+|+||.||+|...        ++..||+|.++...  ...+.+.+|+++++.+ +||||+++++++......+
T Consensus        18 ~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~   97 (304)
T cd05101          18 TLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLY   97 (304)
T ss_pred             eecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceE
Confidence            34567999999999999741        34578999887532  2245688999999999 8999999999999999999


Q ss_pred             EEeecCCCCChhhhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCC
Q 007167          372 MVYDYFEPGSVSAMLHGRRGE-----------GQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG  440 (615)
Q Consensus       372 lV~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~  440 (615)
                      +||||+++|+|.+++......           ....++|..+..++.|++.||+|||+.+   |+||||||+||++++++
T Consensus        98 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili~~~~  174 (304)
T cd05101          98 VIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLVTENN  174 (304)
T ss_pred             EEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEEcCCC
Confidence            999999999999999754321           1235889999999999999999999998   99999999999999999


Q ss_pred             cEEEeecccccccCCCCC-----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHH
Q 007167          441 HVCVSDIGLAALMSPMPP-----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRW  514 (615)
Q Consensus       441 ~~kl~DfG~a~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~  514 (615)
                      .+||+|||+++.+.....     ...++..|+|||++.+..++.++||||||+++|||++ |..||......+....+  
T Consensus       175 ~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~--  252 (304)
T cd05101         175 VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL--  252 (304)
T ss_pred             cEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH--
Confidence            999999999987653221     1223567999999988889999999999999999998 88888664432222211  


Q ss_pred             HHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhhc
Q 007167          515 VNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKA  578 (615)
Q Consensus       515 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~  578 (615)
                          . ...       .......++.++.++   +.+||..+|++||++.|+++.|+++.....
T Consensus       253 ----~-~~~-------~~~~~~~~~~~~~~l---i~~cl~~~p~~Rps~~e~l~~l~~~~~~~~  301 (304)
T cd05101         253 ----K-EGH-------RMDKPANCTNELYMM---MRDCWHAIPSHRPTFKQLVEDLDRILTLTT  301 (304)
T ss_pred             ----H-cCC-------cCCCCCCCCHHHHHH---HHHHcccChhhCCCHHHHHHHHHHHHHhhh
Confidence                1 110       001112334455554   449999999999999999999999887543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.9e-37  Score=307.82  Aligned_cols=241  Identities=24%  Similarity=0.394  Sum_probs=190.5

Q ss_pred             cCcCCccEEEEEEEC---CCCEEEEEEeccccCC--HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          308 LGKGTFGTAYKAALE---DASTVVVKRLKEVNVG--KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       308 lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      ||+|+||.||+|.+.   .+..||+|.++.....  .+.+.+|++++++++|+||+++++++. .+..++||||+++|+|
T Consensus         3 ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~L   81 (257)
T cd05115           3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGPL   81 (257)
T ss_pred             cCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCCH
Confidence            899999999999753   3456999988754322  356889999999999999999999885 4578999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC----
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP----  458 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~----  458 (615)
                      .+++....    ..+++..+.+++.|++.||+|||+++   ++||||||+||+++.++.+||+|||++..+.....    
T Consensus        82 ~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  154 (257)
T cd05115          82 NKFLSGKK----DEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA  154 (257)
T ss_pred             HHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence            99987432    36899999999999999999999998   99999999999999999999999999976543221    


Q ss_pred             --CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCC
Q 007167          459 --PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY  535 (615)
Q Consensus       459 --~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  535 (615)
                        ....+..|+|||.+....++.++|||||||++||+++ |+.||......+...   .+....           .....
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~---~~~~~~-----------~~~~~  220 (257)
T cd05115         155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMS---FIEQGK-----------RLDCP  220 (257)
T ss_pred             cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHH---HHHCCC-----------CCCCC
Confidence              1112457999999988889999999999999999997 999997654433221   111100           00111


Q ss_pred             CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 007167          536 PNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI  573 (615)
Q Consensus       536 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l  573 (615)
                      +..++++.+++.   +||..+|++||++.+|.+.|+.+
T Consensus       221 ~~~~~~l~~li~---~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         221 AECPPEMYALMK---DCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCHHHHHHHH---HHcCCChhhCcCHHHHHHHHhhh
Confidence            233455555544   99999999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=4.1e-37  Score=311.51  Aligned_cols=246  Identities=24%  Similarity=0.343  Sum_probs=191.1

Q ss_pred             hhhcCcCCccEEEEEEEC-CCC----EEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecC
Q 007167          305 AEVLGKGTFGTAYKAALE-DAS----TVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYF  377 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  377 (615)
                      .+.||+|+||+||+|.+. ++.    .+++|.+.....  ...++..|+..+++++||||+++++++.. ...++++||+
T Consensus        12 ~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~   90 (279)
T cd05111          12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLS   90 (279)
T ss_pred             ccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeC
Confidence            467999999999999864 344    367777754322  13467778888999999999999998754 4578899999


Q ss_pred             CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC
Q 007167          378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP  457 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~  457 (615)
                      ++|+|.++++...    ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++......
T Consensus        91 ~~gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T cd05111          91 PLGSLLDHVRQHR----DSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDD  163 (279)
T ss_pred             CCCcHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence            9999999997432    36899999999999999999999998   9999999999999999999999999998664322


Q ss_pred             C-----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccccccccc
Q 007167          458 P-----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE  531 (615)
Q Consensus       458 ~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  531 (615)
                      .     ...++..|+|||.+.+..++.++|||||||++||+++ |+.||.+....+..+.+   .    ...       .
T Consensus       164 ~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~---~----~~~-------~  229 (279)
T cd05111         164 KKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLL---E----KGE-------R  229 (279)
T ss_pred             cccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH---H----CCC-------c
Confidence            1     2234567999999988889999999999999999998 99999765433322211   1    100       0


Q ss_pred             ccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          532 LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       532 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                      ........   .++.+++.+|+..+|++|||+.|+++.|..+.+
T Consensus       230 ~~~~~~~~---~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         230 LAQPQICT---IDVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             CCCCCCCC---HHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            00011112   244556669999999999999999999988765

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-37  Score=307.93  Aligned_cols=243  Identities=25%  Similarity=0.383  Sum_probs=193.1

Q ss_pred             hhcCcCCccEEEEEEECC----CCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          306 EVLGKGTFGTAYKAALED----ASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      ++||+|+||.||+|....    +..+|+|.+.....  ..+.+.+|+++++.+.|+||+++++++. .+..++||||+++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~   79 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL   79 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence            369999999999997432    25799999876544  3567889999999999999999999876 4568999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCC
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP  459 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~  459 (615)
                      |+|.+++...     ..+++..+..++.|++.|++|||..+   ++||||||+||+++.++.+||+|||+++.+......
T Consensus        80 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~  151 (257)
T cd05060          80 GPLLKYLKKR-----REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY  151 (257)
T ss_pred             CcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcc
Confidence            9999999743     26899999999999999999999998   999999999999999999999999999876433221


Q ss_pred             C------CCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccc
Q 007167          460 A------MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL  532 (615)
Q Consensus       460 ~------~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  532 (615)
                      .      .++..|+|||......++.++|||||||++|||++ |+.||......+.   ..++...    .       ..
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~---~~~~~~~----~-------~~  217 (257)
T cd05060         152 YRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEV---IAMLESG----E-------RL  217 (257)
T ss_pred             cccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHH---HHHHHcC----C-------cC
Confidence            1      12356999999988889999999999999999998 9999976543332   2222111    0       01


Q ss_pred             cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhH
Q 007167          533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIR  574 (615)
Q Consensus       533 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~  574 (615)
                      ......+..+   .+++.+|+..+|++||++.|+++.|+++.
T Consensus       218 ~~~~~~~~~l---~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         218 PRPEECPQEI---YSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             CCCCCCCHHH---HHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            1112233444   45555999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=4e-37  Score=319.87  Aligned_cols=254  Identities=27%  Similarity=0.408  Sum_probs=195.3

Q ss_pred             HHhhhcCcCCccEEEEEEEC------CCCEEEEEEeccccCC--HHHHHHHHHHHhCC-CCCcccceeEEEEec-CeeeE
Q 007167          303 ASAEVLGKGTFGTAYKAALE------DASTVVVKRLKEVNVG--KREFEQQMEIVGGI-RHENVVALRAYYYSK-DEKLM  372 (615)
Q Consensus       303 ~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~~l  372 (615)
                      ...++||+|+||.||+|...      .++.||+|+++.....  .+.+.+|++++.++ +|+||++++++|... ...++
T Consensus        10 ~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~   89 (337)
T cd05054          10 KLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMV   89 (337)
T ss_pred             hhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEE
Confidence            34578999999999999632      2468999998754221  24567899999999 899999999988754 56789


Q ss_pred             EeecCCCCChhhhhccCCCC--------------------------------------------------------CCCC
Q 007167          373 VYDYFEPGSVSAMLHGRRGE--------------------------------------------------------GQSS  396 (615)
Q Consensus       373 V~e~~~~gsL~~~l~~~~~~--------------------------------------------------------~~~~  396 (615)
                      +|||+++|+|.+++......                                                        ....
T Consensus        90 v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (337)
T cd05054          90 IVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEP  169 (337)
T ss_pred             EEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcC
Confidence            99999999999998643210                                                        0136


Q ss_pred             CCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC-----CCCCCCcccCccc
Q 007167          397 LDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP-----PAMRAAGYRAPEV  471 (615)
Q Consensus       397 l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~-----~~~~~~~y~aPE~  471 (615)
                      ++|..+.+++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++..+.....     ...++..|+|||+
T Consensus       170 l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~  246 (337)
T cd05054         170 LTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPES  246 (337)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHH
Confidence            899999999999999999999998   99999999999999999999999999987643221     1233567999999


Q ss_pred             cCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHH
Q 007167          472 TDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGM  550 (615)
Q Consensus       472 ~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~  550 (615)
                      +.+..++.++|||||||++|||++ |+.||......+.  ...    .......       ........+   ++.+++.
T Consensus       247 ~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~--~~~----~~~~~~~-------~~~~~~~~~---~~~~l~~  310 (337)
T cd05054         247 IFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE--FCR----RLKEGTR-------MRAPEYATP---EIYSIML  310 (337)
T ss_pred             hcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHH--HHH----HHhccCC-------CCCCccCCH---HHHHHHH
Confidence            999999999999999999999998 9999976433221  111    1111100       000112223   4556666


Q ss_pred             HcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          551 ACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       551 ~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                      +|++.+|++||++.|++++|+++.+
T Consensus       311 ~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         311 DCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHccCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=6.2e-37  Score=318.13  Aligned_cols=195  Identities=19%  Similarity=0.365  Sum_probs=168.0

Q ss_pred             HhhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          304 SAEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       304 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      ..++||+|+||.||++... ++..+|+|.++....  ....+.+|+++++.++|+||+++++++.++++.++||||+++|
T Consensus         9 ~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   88 (333)
T cd06650           9 KISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGG   88 (333)
T ss_pred             eeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCC
Confidence            3567999999999999965 577888888765322  2356889999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC-CCC
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM-PPP  459 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~-~~~  459 (615)
                      +|.+++...     ..+++.....++.+++.||.|||+.+  +|+||||||+||+++.++.+||+|||++..+... ...
T Consensus        89 ~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~  161 (333)
T cd06650          89 SLDQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS  161 (333)
T ss_pred             cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhcccc
Confidence            999999642     35888999999999999999999753  3999999999999999999999999999765432 233


Q ss_pred             CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 007167          460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGG  505 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~  505 (615)
                      ..++..|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       162 ~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~  207 (333)
T cd06650         162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDA  207 (333)
T ss_pred             CCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcch
Confidence            4578899999999888899999999999999999999999976543

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.8e-37  Score=313.74  Aligned_cols=248  Identities=21%  Similarity=0.376  Sum_probs=193.2

Q ss_pred             hhhcCcCCccEEEEEEEC------CCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAALE------DASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      .+.||+|+||+||+|..+      .+..||+|++.....  ...++.+|+.+++.++|+||+++++++......++||||
T Consensus        11 ~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~   90 (277)
T cd05062          11 SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL   90 (277)
T ss_pred             eeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEec
Confidence            457999999999998753      245799998864322  235688999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCC-----CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeeccccc
Q 007167          377 FEPGSVSAMLHGRRGE-----GQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAA  451 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~  451 (615)
                      +++|+|.++++.....     ....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||+++
T Consensus        91 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l~dfg~~~  167 (277)
T cd05062          91 MTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR  167 (277)
T ss_pred             CCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEECCCCCcc
Confidence            9999999998653211     1235788999999999999999999987   9999999999999999999999999987


Q ss_pred             ccCCCCC-----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccc
Q 007167          452 LMSPMPP-----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTA  525 (615)
Q Consensus       452 ~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (615)
                      .......     ...++..|+|||++.+..++.++|||||||++|||++ |..||......+....+      .... . 
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~------~~~~-~-  239 (277)
T cd05062         168 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV------MEGG-L-  239 (277)
T ss_pred             ccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH------HcCC-c-
Confidence            6543221     1233567999999988889999999999999999999 78999765433322211      1100 0 


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 007167          526 EVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVED  572 (615)
Q Consensus       526 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  572 (615)
                        .+    .....++.   +.+++.+|++.+|++||++.|++++|++
T Consensus       240 --~~----~~~~~~~~---~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         240 --LD----KPDNCPDM---LFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             --CC----CCCCCCHH---HHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence              00    01122333   4455559999999999999999999863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-37  Score=328.81  Aligned_cols=242  Identities=19%  Similarity=0.319  Sum_probs=189.8

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccC----CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNV----GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .++||+|+||+||++.. .+++.||||++.....    ..+.+.+|+++++.++||||+++++++.+.+..++||||+++
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~g   85 (377)
T cd05629           6 VKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPG   85 (377)
T ss_pred             eEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCC
Confidence            35799999999999985 4688999999865321    134578899999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      |+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+....  
T Consensus        86 g~L~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  157 (377)
T cd05629          86 GDLMTMLIKY-----DTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS  157 (377)
T ss_pred             CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence            9999998643     36888999999999999999999998   9999999999999999999999999986331100  


Q ss_pred             ------------------------------------------------CCCCCCCcccCccccCCCCCCCccchhhHHHH
Q 007167          458 ------------------------------------------------PPAMRAAGYRAPEVTDTRKATQASDVFSFGVL  489 (615)
Q Consensus       458 ------------------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvv  489 (615)
                                                                      ....+|.+|+|||++.+..++.++|||||||+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvi  237 (377)
T cd05629         158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAI  237 (377)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchh
Confidence                                                            01347888999999998889999999999999


Q ss_pred             HHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCC---CCCHHHH
Q 007167          490 LLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEE---RPKMADV  566 (615)
Q Consensus       490 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~---RPs~~ev  566 (615)
                      +|||++|+.||......+....+      ..  +....   .......++.++.++++   +|+. +|.+   |+++.|+
T Consensus       238 l~elltG~~Pf~~~~~~~~~~~i------~~--~~~~~---~~p~~~~~s~~~~dli~---~lL~-~~~~r~~r~~~~~~  302 (377)
T cd05629         238 MFECLIGWPPFCSENSHETYRKI------IN--WRETL---YFPDDIHLSVEAEDLIR---RLIT-NAENRLGRGGAHEI  302 (377)
T ss_pred             hhhhhcCCCCCCCCCHHHHHHHH------Hc--cCCcc---CCCCCCCCCHHHHHHHH---HHhc-CHhhcCCCCCHHHH
Confidence            99999999999765433221111      10  00000   11111234566667666   7886 5665   5699999


Q ss_pred             HHH
Q 007167          567 LKM  569 (615)
Q Consensus       567 l~~  569 (615)
                      +++
T Consensus       303 l~h  305 (377)
T cd05629         303 KSH  305 (377)
T ss_pred             hcC
Confidence            887

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3e-37  Score=319.57  Aligned_cols=234  Identities=23%  Similarity=0.334  Sum_probs=185.8

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEecccc----CCHHHHHHHHH-HHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEVN----VGKREFEQQME-IVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      +.||+|+||+||+|.. .+|+.||+|++....    .....+..|.. +++.++||||+++++++...+..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            3599999999999985 468899999986531    12234455554 56788999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC---C
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP---M  456 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~---~  456 (615)
                      |+|..++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....   .
T Consensus        81 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~  152 (325)
T cd05604          81 GELFFHLQRE-----RSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDT  152 (325)
T ss_pred             CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCC
Confidence            9999888642     36899999999999999999999998   99999999999999999999999999875322   1


Q ss_pred             CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          457 PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       457 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                      .....++..|+|||++.+..++.++|||||||++|||++|+.||...+..+...      ....         ......+
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~------~~~~---------~~~~~~~  217 (325)
T cd05604         153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD------NILH---------KPLVLRP  217 (325)
T ss_pred             cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHH------HHHc---------CCccCCC
Confidence            223457889999999999899999999999999999999999997654322211      1111         1111223


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMAD  565 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~e  565 (615)
                      ..+....++++   +|++.+|.+||++++
T Consensus       218 ~~~~~~~~ll~---~ll~~~p~~R~~~~~  243 (325)
T cd05604         218 GASLTAWSILE---ELLEKDRQRRLGAKE  243 (325)
T ss_pred             CCCHHHHHHHH---HHhccCHHhcCCCCC
Confidence            44555555555   999999999998863

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3e-37  Score=312.18  Aligned_cols=247  Identities=26%  Similarity=0.401  Sum_probs=193.7

Q ss_pred             hhhcCcCCccEEEEEEECC------CCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAALED------ASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      .+.||+|+||.||+|.+.+      +..|++|.+.....  ....|.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus        11 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   90 (277)
T cd05036          11 LRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLEL   90 (277)
T ss_pred             eeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEec
Confidence            3569999999999998754      45788888764422  235688999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCC--CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCC---cEEEeeccccc
Q 007167          377 FEPGSVSAMLHGRRG--EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG---HVCVSDIGLAA  451 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~---~~kl~DfG~a~  451 (615)
                      +++++|.++++..+.  .....++|..+.+++.|++.||+|||+.+   ++||||||+||+++.++   .+||+|||+++
T Consensus        91 ~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~  167 (277)
T cd05036          91 MAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIADFGMAR  167 (277)
T ss_pred             CCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEeccCcccc
Confidence            999999999975432  12236899999999999999999999998   99999999999998764   59999999998


Q ss_pred             ccCCCCC-----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccc
Q 007167          452 LMSPMPP-----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTA  525 (615)
Q Consensus       452 ~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (615)
                      .+.....     ....+..|+|||++.+..++.++|||||||++|||++ |+.||......+....+.      ...   
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~------~~~---  238 (277)
T cd05036         168 DIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVT------GGG---  238 (277)
T ss_pred             ccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH------cCC---
Confidence            7643221     1122457999999988889999999999999999997 999998655433322111      100   


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 007167          526 EVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVE  571 (615)
Q Consensus       526 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  571 (615)
                           ........+..+   .+++.+|++.+|++||++.||+++|+
T Consensus       239 -----~~~~~~~~~~~~---~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         239 -----RLDPPKGCPGPV---YRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             -----cCCCCCCCCHHH---HHHHHHHcCCCcccCcCHHHHHHHhh
Confidence                 001112233444   44555999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4e-37  Score=309.49  Aligned_cols=245  Identities=26%  Similarity=0.459  Sum_probs=194.5

Q ss_pred             hhhcCcCCccEEEEEEEC-CCC---EEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DAS---TVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~---~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      .+.||+|+||.||+|... ++.   .+++|.++....  ..+.+.+|++++++++|+||+++++++...+..++||||++
T Consensus        10 ~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   89 (268)
T cd05063          10 QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYME   89 (268)
T ss_pred             eeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCC
Confidence            467999999999999864 333   689998865422  24568899999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP  458 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~  458 (615)
                      +++|.+++...    ...+++..+..++.|++.|++|||+.+   ++||||||+||+++.++.+||+|||++........
T Consensus        90 ~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  162 (268)
T cd05063          90 NGALDKYLRDH----DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE  162 (268)
T ss_pred             CCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence            99999999643    236899999999999999999999998   99999999999999999999999999986643221


Q ss_pred             CC------CCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccccccccc
Q 007167          459 PA------MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE  531 (615)
Q Consensus       459 ~~------~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  531 (615)
                      ..      ..+..|+|||++....++.++|||||||++||+++ |+.||......+....+      ....         
T Consensus       163 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i------~~~~---------  227 (268)
T cd05063         163 GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI------NDGF---------  227 (268)
T ss_pred             cceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHH------hcCC---------
Confidence            11      12346999999988889999999999999999998 99999764432222111      1100         


Q ss_pred             ccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 007167          532 LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI  573 (615)
Q Consensus       532 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l  573 (615)
                        ..+...+....+.+++.+|+..+|++||++.+|++.|+++
T Consensus       228 --~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         228 --RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             --CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence              0111111223455666699999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=6.8e-37  Score=305.70  Aligned_cols=244  Identities=24%  Similarity=0.397  Sum_probs=195.3

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEE-ecCeeeEEeecCCCCChh
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY-SKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~-~~~~~~lV~e~~~~gsL~  383 (615)
                      .+.||+|+||.||++... +..|++|.++... ..+.+.+|++++++++|+|++++++++. .++..++|+||+++++|.
T Consensus        11 ~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~   88 (256)
T cd05082          11 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV   88 (256)
T ss_pred             eeeecccCCCeEEEEEEc-CCcEEEEEeCCCc-hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHH
Confidence            467999999999999765 6789999886433 3567889999999999999999999765 446789999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCCCCCC
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRA  463 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  463 (615)
                      ++++...   ...+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++............+
T Consensus        89 ~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  162 (256)
T cd05082          89 DYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP  162 (256)
T ss_pred             HHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccCCCCccc
Confidence            9987532   235899999999999999999999998   9999999999999999999999999998765444444456


Q ss_pred             CcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHHHH
Q 007167          464 AGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEM  542 (615)
Q Consensus       464 ~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  542 (615)
                      ..|+|||++....++.++|||||||++|||++ |+.||......+   ....+..    .+..     .  ..+..+..+
T Consensus       163 ~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~---~~~~~~~----~~~~-----~--~~~~~~~~~  228 (256)
T cd05082         163 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEK----GYKM-----D--APDGCPPVV  228 (256)
T ss_pred             eeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhc----CCCC-----C--CCCCCCHHH
Confidence            68999999988889999999999999999998 999997543222   1211111    1110     0  112334455


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 007167          543 VEMLQVGMACVVRMPEERPKMADVLKMVEDI  573 (615)
Q Consensus       543 ~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l  573 (615)
                      .+++.   +|++.+|++|||+.++++.|+++
T Consensus       229 ~~li~---~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         229 YDVMK---QCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             HHHHH---HHhcCChhhCcCHHHHHHHHhcC
Confidence            55554   99999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=6.2e-37  Score=317.06  Aligned_cols=238  Identities=21%  Similarity=0.328  Sum_probs=188.4

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEecccc----CCHHHHHHHHHHHhCCCCC-cccceeEEEEecCeeeEEeecCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVN----VGKREFEQQMEIVGGIRHE-NVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      +.||+|+||.||+|..+ .++.||+|+++...    ...+.+..|.+++..++|+ +|+++++++...+..++||||+++
T Consensus         6 ~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   85 (324)
T cd05587           6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG   85 (324)
T ss_pred             EEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCC
Confidence            56999999999999865 46789999987532    2235577888999988764 688899999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC---C
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP---M  456 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~---~  456 (615)
                      |+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....   .
T Consensus        86 g~L~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~  157 (324)
T cd05587          86 GDLMYHIQQV-----GKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKT  157 (324)
T ss_pred             CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCc
Confidence            9999998642     35889999999999999999999998   99999999999999999999999999875321   1


Q ss_pred             CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          457 PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       457 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                      .....++..|+|||++.+..++.++||||+||++|||++|+.||......+....+      ...         ......
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i------~~~---------~~~~~~  222 (324)
T cd05587         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI------MEH---------NVSYPK  222 (324)
T ss_pred             eeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH------HcC---------CCCCCC
Confidence            22335788999999999988999999999999999999999999765433222111      110         111112


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKM-----ADVLKM  569 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~-----~evl~~  569 (615)
                      ..++++.++++   +|+..+|.+|++.     +++.++
T Consensus       223 ~~~~~~~~li~---~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         223 SLSKEAVSICK---GLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             CCCHHHHHHHH---HHhhcCHHHcCCCCCCCHHHHhcC
Confidence            34555555555   9999999999986     566554

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-37  Score=327.09  Aligned_cols=242  Identities=19%  Similarity=0.347  Sum_probs=192.8

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc----CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN----VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||+||+|... +++.||||+++...    .....+.+|++++..++|+||+++++++.+++..++||||+++
T Consensus         6 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~   85 (364)
T cd05599           6 IKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPG   85 (364)
T ss_pred             EEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCC
Confidence            357999999999999965 57899999997542    1234577899999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      |+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+....  
T Consensus        86 g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  157 (364)
T cd05599          86 GDMMTLLMKK-----DTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT  157 (364)
T ss_pred             cHHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence            9999999742     35899999999999999999999998   9999999999999999999999999987543210  


Q ss_pred             ---------------------------------------CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCC
Q 007167          458 ---------------------------------------PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKS  498 (615)
Q Consensus       458 ---------------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~  498 (615)
                                                             ....+|+.|+|||++....++.++|||||||++|||++|+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~  237 (364)
T cd05599         158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYP  237 (364)
T ss_pred             cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCC
Confidence                                                   11347889999999998889999999999999999999999


Q ss_pred             CCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 007167          499 PIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPK---MADVLKM  569 (615)
Q Consensus       499 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs---~~evl~~  569 (615)
                      ||......+....   +   ..  +...   ........++++..++++   +|+. +|.+|++   ++|++++
T Consensus       238 Pf~~~~~~~~~~~---i---~~--~~~~---~~~~~~~~~s~~~~~li~---~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         238 PFCSDNPQETYRK---I---IN--WKET---LQFPDEVPLSPEAKDLIK---RLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCCHHHHHHH---H---Hc--CCCc---cCCCCCCCCCHHHHHHHH---HHcc-CHhhcCCCCCHHHHhcC
Confidence            9976543222111   1   10  0000   011111234566667666   7775 8999998   9998875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=6.6e-37  Score=308.19  Aligned_cols=249  Identities=24%  Similarity=0.364  Sum_probs=188.9

Q ss_pred             hcCcCCccEEEEEEECC---CCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          307 VLGKGTFGTAYKAALED---ASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      .||+|+||.||+|...+   +..+++|+++....  ....+.+|+.++++++||||+++++++.+....++||||+++|+
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD   81 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence            58999999999998643   35689998875432  23468889999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC----
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP----  457 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~----  457 (615)
                      |.++++..+.......++..+..++.|++.|++|||+.+   ++||||||+||+++.++++||+|||++.......    
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~  158 (269)
T cd05087          82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT  158 (269)
T ss_pred             HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence            999997544323345678888899999999999999998   9999999999999999999999999987543321    


Q ss_pred             -CCCCCCCcccCccccCCC-------CCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccc
Q 007167          458 -PPAMRAAGYRAPEVTDTR-------KATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVF  528 (615)
Q Consensus       458 -~~~~~~~~y~aPE~~~~~-------~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  528 (615)
                       ....++..|+|||++...       .++.++||||||+++|||++ |+.||......+.....      ... ......
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~------~~~-~~~~~~  231 (269)
T cd05087         159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYT------VRE-QQLKLP  231 (269)
T ss_pred             CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHH------hhc-ccCCCC
Confidence             122346679999998542       35789999999999999996 99999765433321110      000 000111


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 007167          529 DVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVE  571 (615)
Q Consensus       529 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  571 (615)
                      ++...  ...++.+.++++   +|+ .+|++|||++||++.|+
T Consensus       232 ~~~~~--~~~~~~~~~l~~---~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         232 KPRLK--LPLSDRWYEVMQ---FCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCccC--CCCChHHHHHHH---HHh-cCcccCCCHHHHHHHhc
Confidence            11111  123445555555   898 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.1e-37  Score=316.24  Aligned_cols=254  Identities=24%  Similarity=0.385  Sum_probs=195.9

Q ss_pred             hhhcCcCCccEEEEEEEC-CCC--EEEEEEecccc--CCHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DAS--TVVVKRLKEVN--VGKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~--~vavK~l~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      .+.||+|+||+||+|.++ ++.  .+++|+++...  ...+.+.+|++++.++ +|+||+++++++..++..++||||++
T Consensus        12 ~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   91 (303)
T cd05088          12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   91 (303)
T ss_pred             eeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCC
Confidence            457999999999999864 444  35777776432  2245688899999999 89999999999999999999999999


Q ss_pred             CCChhhhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeec
Q 007167          379 PGSVSAMLHGRRG-----------EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDI  447 (615)
Q Consensus       379 ~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Df  447 (615)
                      +|+|.++++....           .....+++..++.++.|++.|++|||+.+   |+||||||+||+++.++.+||+||
T Consensus        92 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~kl~df  168 (303)
T cd05088          92 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF  168 (303)
T ss_pred             CCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcEEeCcc
Confidence            9999999975431           11236899999999999999999999998   999999999999999999999999


Q ss_pred             ccccccCCCCCC--CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccc
Q 007167          448 GLAALMSPMPPP--AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWT  524 (615)
Q Consensus       448 G~a~~~~~~~~~--~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  524 (615)
                      |++.........  ...+..|+|||++.+..++.++|||||||++|||+| |..||......+....      .... . 
T Consensus       169 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~------~~~~-~-  240 (303)
T cd05088         169 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK------LPQG-Y-  240 (303)
T ss_pred             ccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHH------HhcC-C-
Confidence            998643221111  123457999999988888999999999999999998 9999976543322211      1100 0 


Q ss_pred             cccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhhc
Q 007167          525 AEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKA  578 (615)
Q Consensus       525 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~  578 (615)
                            ........++++   .+++.+|++.+|++||++.+++++|+++...+.
T Consensus       241 ------~~~~~~~~~~~~---~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         241 ------RLEKPLNCDDEV---YDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             ------cCCCCCCCCHHH---HHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence                  000111223444   445559999999999999999999998866543

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=6.8e-37  Score=305.90  Aligned_cols=246  Identities=28%  Similarity=0.459  Sum_probs=198.6

Q ss_pred             hhcCcCCccEEEEEEECC----CCEEEEEEeccccCC--HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          306 EVLGKGTFGTAYKAALED----ASTVVVKRLKEVNVG--KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      +.||+|+||.||+|...+    +..|++|.++.....  .+.+.+|++.+..++|+||+++++++......++||||+++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG   80 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence            369999999999999654    788999999866443  57788999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCC----CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC
Q 007167          380 GSVSAMLHGRRGE----GQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       380 gsL~~~l~~~~~~----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      ++|.+++......    ....+++..+.+++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||.+.....
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~  157 (262)
T cd00192          81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD  157 (262)
T ss_pred             CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence            9999999754211    1357999999999999999999999988   99999999999999999999999999987754


Q ss_pred             CC-----CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccccccc
Q 007167          456 MP-----PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD  529 (615)
Q Consensus       456 ~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  529 (615)
                      ..     ....++..|+|||.+....++.++||||+|+++|||++ |+.||......+....+   .   . ..      
T Consensus       158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~---~---~-~~------  224 (262)
T cd00192         158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYL---R---K-GY------  224 (262)
T ss_pred             ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---H---c-CC------
Confidence            32     22345678999999988889999999999999999999 69999876433222211   1   1 00      


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 007167          530 VELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVE  571 (615)
Q Consensus       530 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  571 (615)
                       ........+.+   +.+++.+|++.+|++||++.|++++|+
T Consensus       225 -~~~~~~~~~~~---~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         225 -RLPKPEYCPDE---LYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -CCCCCccCChH---HHHHHHHHccCCcccCcCHHHHHHhhC
Confidence             11111223344   445555999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=7.4e-37  Score=316.36  Aligned_cols=239  Identities=21%  Similarity=0.339  Sum_probs=188.7

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC----CHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV----GKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      .+.||+|+||+||+|... ++..||+|.++....    ..+.+..|.+++..+ +|++|+++++++...+..++||||++
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~   84 (323)
T cd05616           5 LMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVN   84 (323)
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCC
Confidence            356999999999999865 567899999875321    123456677777766 58999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC---
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP---  455 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~---  455 (615)
                      +|+|.+.+...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+++....   
T Consensus        85 ~g~L~~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~  156 (323)
T cd05616          85 GGDLMYQIQQV-----GRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV  156 (323)
T ss_pred             CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence            99999988643     35889999999999999999999998   99999999999999999999999999875432   


Q ss_pred             CCCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCC
Q 007167          456 MPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY  535 (615)
Q Consensus       456 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  535 (615)
                      ......++..|+|||++.+..++.++|||||||++|||++|+.||...+..+....+      ...         .....
T Consensus       157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i------~~~---------~~~~p  221 (323)
T cd05616         157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI------MEH---------NVAYP  221 (323)
T ss_pred             ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHH------HhC---------CCCCC
Confidence            122345788999999999989999999999999999999999999765433322211      111         11111


Q ss_pred             CCcHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 007167          536 PNIEEEMVEMLQVGMACVVRMPEERPKM-----ADVLKM  569 (615)
Q Consensus       536 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~-----~evl~~  569 (615)
                      ...++++.++++   +|++.+|.+|++.     .++.++
T Consensus       222 ~~~s~~~~~li~---~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         222 KSMSKEAVAICK---GLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             CcCCHHHHHHHH---HHcccCHHhcCCCCCCCHHHHhcC
Confidence            234555555555   9999999999984     666553

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=4.5e-37  Score=313.41  Aligned_cols=250  Identities=27%  Similarity=0.434  Sum_probs=196.7

Q ss_pred             hhhcCcCCccEEEEEEECC------CCEEEEEEeccccCC--HHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEee
Q 007167          305 AEVLGKGTFGTAYKAALED------ASTVVVKRLKEVNVG--KREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYD  375 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e  375 (615)
                      .+.||+|+||.||++...+      ...+|+|.++.....  ...+.+|++++.++ +|+||+++++++..++..++|||
T Consensus        17 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e   96 (293)
T cd05053          17 GKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVE   96 (293)
T ss_pred             eeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEE
Confidence            4579999999999998642      357899988754222  34578899999999 89999999999999999999999


Q ss_pred             cCCCCChhhhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEE
Q 007167          376 YFEPGSVSAMLHGRRG-----------EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCV  444 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl  444 (615)
                      |+++|+|.++++....           .....+++..+++++.|++.||+|||+.+   |+||||||+||++++++.+||
T Consensus        97 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~~~~~~kL  173 (293)
T cd05053          97 YAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVTEDHVMKI  173 (293)
T ss_pred             eCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEcCCCeEEe
Confidence            9999999999964321           12346899999999999999999999987   999999999999999999999


Q ss_pred             eecccccccCCCCC-----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHh
Q 007167          445 SDIGLAALMSPMPP-----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSV  518 (615)
Q Consensus       445 ~DfG~a~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  518 (615)
                      +|||+++.+.....     ....+..|+|||......++.++|||||||++|||++ |..||......+......     
T Consensus       174 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-----  248 (293)
T cd05053         174 ADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLK-----  248 (293)
T ss_pred             CccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHH-----
Confidence            99999987654321     1123457999999988889999999999999999998 999997644333222111     


Q ss_pred             hhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhH
Q 007167          519 VREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIR  574 (615)
Q Consensus       519 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~  574 (615)
                        ...       ........+.   .+.+++.+|+..+|++|||+.|+++.|+++.
T Consensus       249 --~~~-------~~~~~~~~~~---~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         249 --EGY-------RMEKPQNCTQ---ELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             --cCC-------cCCCCCCCCH---HHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence              000       0011112233   4455556999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.5e-37  Score=315.10  Aligned_cols=252  Identities=18%  Similarity=0.334  Sum_probs=188.4

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      .+.||+|+||+||+|... +++.||+|.++....  ....+.+|+++++.++||||+++++++.+.+..++||||+. ++
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~   88 (303)
T cd07869          10 LEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TD   88 (303)
T ss_pred             eeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cC
Confidence            356999999999999965 678999999875422  23457789999999999999999999999999999999995 67


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---C
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---P  458 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~  458 (615)
                      |.+++...    ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......   .
T Consensus        89 l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  161 (303)
T cd07869          89 LCQYMDKH----PGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYS  161 (303)
T ss_pred             HHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCC
Confidence            88777643    235888999999999999999999998   9999999999999999999999999987543221   2


Q ss_pred             CCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHh----hhcccccc----ccc
Q 007167          459 PAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSV----VREEWTAE----VFD  529 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~----~~d  529 (615)
                      ...++..|+|||++.+ ..++.++||||+||++|||++|+.||....+  .......+...    ....|...    .++
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (303)
T cd07869         162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKD--IQDQLERIFLVLGTPNEDTWPGVHSLPHFK  239 (303)
T ss_pred             CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCcc--HHHHHHHHHHHhCCCChhhccchhhccccc
Confidence            3356788999998865 4578899999999999999999999986432  11111111111    01111100    000


Q ss_pred             cccc---CCC---------CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          530 VELL---RYP---------NIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       530 ~~~~---~~~---------~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ++..   ...         ...++..+++   .+|++.||++|||++|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~dli---~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         240 PERFTLYSPKNLRQAWNKLSYVNHAEDLA---SKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             cccccccCCccHHHHhhccCCChHHHHHH---HHHhccCchhccCHHHHhcC
Confidence            0000   000         1123344444   49999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=4.9e-37  Score=313.90  Aligned_cols=253  Identities=22%  Similarity=0.362  Sum_probs=195.6

Q ss_pred             hhhcCcCCccEEEEEEECC-CC--EEEEEEeccccC--CHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALED-AS--TVVVKRLKEVNV--GKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~-~~--~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      .++||+|+||.||+|..++ +.  .+++|.++....  ..+.+.+|++++.++ +||||+++++++......++|+||++
T Consensus         7 ~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~   86 (297)
T cd05089           7 EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAP   86 (297)
T ss_pred             eeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecC
Confidence            3579999999999998654 33  468888874322  235688999999999 79999999999999999999999999


Q ss_pred             CCChhhhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeec
Q 007167          379 PGSVSAMLHGRRGE-----------GQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDI  447 (615)
Q Consensus       379 ~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Df  447 (615)
                      +|+|.++++.....           ....+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+||
T Consensus        87 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~df  163 (297)
T cd05089          87 YGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLASKIADF  163 (297)
T ss_pred             CCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeEEECCc
Confidence            99999999753211           1235889999999999999999999988   999999999999999999999999


Q ss_pred             ccccccCCCCCC--CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccc
Q 007167          448 GLAALMSPMPPP--AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWT  524 (615)
Q Consensus       448 G~a~~~~~~~~~--~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  524 (615)
                      |++.........  ...+..|+|||+.....++.++|||||||++|||++ |+.||......+...      ..... . 
T Consensus       164 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~------~~~~~-~-  235 (297)
T cd05089         164 GLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYE------KLPQG-Y-  235 (297)
T ss_pred             CCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHH------HHhcC-C-
Confidence            998654322111  122456999999988889999999999999999998 999997654332211      11110 0 


Q ss_pred             cccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhh
Q 007167          525 AEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVK  577 (615)
Q Consensus       525 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~  577 (615)
                            .......+++.+.+   ++.+|++.+|.+||++.++++.|+++....
T Consensus       236 ------~~~~~~~~~~~~~~---li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         236 ------RMEKPRNCDDEVYE---LMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             ------CCCCCCCCCHHHHH---HHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence                  00011223444444   445999999999999999999999887644

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=3.4e-37  Score=319.37  Aligned_cols=244  Identities=17%  Similarity=0.300  Sum_probs=190.6

Q ss_pred             hcCcCCccEEEEEEEC-CCCEEEEEEeccccC----CHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          307 VLGKGTFGTAYKAALE-DASTVVVKRLKEVNV----GKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .||+|+||+||++... +++.||+|+++....    ..+.+.+|..++.++ +||||+++++++...+..++||||+++|
T Consensus         2 ~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   81 (327)
T cd05617           2 VIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGG   81 (327)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCC
Confidence            5999999999999864 567899999975422    134577888888888 6999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC---CC
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP---MP  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~---~~  457 (615)
                      +|..++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....   ..
T Consensus        82 ~L~~~~~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  153 (327)
T cd05617          82 DLMFHMQRQ-----RKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTT  153 (327)
T ss_pred             cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCCCce
Confidence            999888632     36899999999999999999999998   99999999999999999999999999875322   12


Q ss_pred             CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCC
Q 007167          458 PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN  537 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  537 (615)
                      ....++..|+|||++.+..++.++|||||||++|||++|+.||.............++.......        .......
T Consensus       154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~--------~~~~p~~  225 (327)
T cd05617         154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEK--------PIRIPRF  225 (327)
T ss_pred             ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhC--------CCCCCCC
Confidence            23457889999999998899999999999999999999999997543222211111121111110        1111123


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCCCH------HHHHHH
Q 007167          538 IEEEMVEMLQVGMACVVRMPEERPKM------ADVLKM  569 (615)
Q Consensus       538 ~~~~~~~l~~l~~~cl~~~P~~RPs~------~evl~~  569 (615)
                      .+....++++   +|+..||++|+++      .+++++
T Consensus       226 ~~~~~~~li~---~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         226 LSVKASHVLK---GFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             CCHHHHHHHH---HHhccCHHHcCCCCCCCCHHHHHcC
Confidence            4455555555   9999999999984      566654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-38  Score=289.21  Aligned_cols=253  Identities=21%  Similarity=0.304  Sum_probs=197.3

Q ss_pred             hhhcCcCCccEEEEEE-ECCCCEEEEEEecccc-CCHHHHHHHHHHHhCCCCCcccceeEEEEec-----CeeeEEeecC
Q 007167          305 AEVLGKGTFGTAYKAA-LEDASTVVVKRLKEVN-VGKREFEQQMEIVGGIRHENVVALRAYYYSK-----DEKLMVYDYF  377 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lV~e~~  377 (615)
                      .+.||+|||+-||.++ ..++..+|+|++.-.. .+.+..++|++.-++++||||++++++...+     .+.|++++|.
T Consensus        26 ~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy  105 (302)
T KOG2345|consen   26 QRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYY  105 (302)
T ss_pred             eeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehh
Confidence            3569999999999998 6678889999997654 4567788999999999999999998887543     4589999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC
Q 007167          378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP  457 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~  457 (615)
                      ..|+|.+.+...+. +...+++.+.++|+.++++||++||+.. ++++||||||.|||+.+.+.+++.|||.+....-.-
T Consensus       106 ~~Gsl~d~i~~~k~-kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i  183 (302)
T KOG2345|consen  106 KRGSLLDEIERLKI-KGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQI  183 (302)
T ss_pred             ccccHHHHHHHHhh-cCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccccceEe
Confidence            99999999986543 3458999999999999999999999985 579999999999999999999999999987654211


Q ss_pred             ------------CCCCCCCcccCccccCC---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcc
Q 007167          458 ------------PPAMRAAGYRAPEVTDT---RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREE  522 (615)
Q Consensus       458 ------------~~~~~~~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  522 (615)
                                  ....-|..|+|||.+.-   ...++++|||||||++|+|+.|..||...-..              ++
T Consensus       184 ~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~--------------Gg  249 (302)
T KOG2345|consen  184 EGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQ--------------GG  249 (302)
T ss_pred             echHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhc--------------CC
Confidence                        11234678999999854   34689999999999999999999999743211              01


Q ss_pred             ccc-ccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhH
Q 007167          523 WTA-EVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIR  574 (615)
Q Consensus       523 ~~~-~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~  574 (615)
                      ... .+....+ .+|.-......+.+++..|++.||.+||++.|++..++++.
T Consensus       250 SlaLAv~n~q~-s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  250 SLALAVQNAQI-SIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             eEEEeeecccc-ccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            111 1111111 12222223334445555999999999999999999998764

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-38  Score=328.70  Aligned_cols=252  Identities=24%  Similarity=0.369  Sum_probs=207.9

Q ss_pred             HHHHHHhhhcCcCCccEEEEEEE-CCCC----EEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeee
Q 007167          299 DLLRASAEVLGKGTFGTAYKAAL-EDAS----TVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKL  371 (615)
Q Consensus       299 ~l~~~~~~~lG~G~fg~Vy~~~~-~~~~----~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  371 (615)
                      |....-.++||+|+||+||||.+ .+|.    +||+|++.....  ...++.+|+.+|.+++|||+++++|+|.... ..
T Consensus       695 Etelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q  773 (1177)
T KOG1025|consen  695 ETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ  773 (1177)
T ss_pred             hhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence            33333467899999999999985 3443    588888876533  3678999999999999999999999998765 88


Q ss_pred             EEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeeccccc
Q 007167          372 MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAA  451 (615)
Q Consensus       372 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~  451 (615)
                      ||++||+.|+|.++++..++    .+-.+..+.+..|||+|+.|||.+.   ++||||.++||||..-.++||.|||+++
T Consensus       774 lvtq~mP~G~LlDyvr~hr~----~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~  846 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREHRD----NIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAK  846 (1177)
T ss_pred             HHHHhcccchHHHHHHHhhc----cccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhh
Confidence            99999999999999987553    5788899999999999999999987   9999999999999999999999999999


Q ss_pred             ccCCCCCCCC-----CCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccc
Q 007167          452 LMSPMPPPAM-----RAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTA  525 (615)
Q Consensus       452 ~~~~~~~~~~-----~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (615)
                      .+.+......     ....|||-|.+..+.|+.++|||||||++||++| |..||++...+++-++.+.-.         
T Consensus       847 ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge---------  917 (1177)
T KOG1025|consen  847 LLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE---------  917 (1177)
T ss_pred             ccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc---------
Confidence            9876543322     2346999999999999999999999999999999 999999888777665554111         


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          526 EVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       526 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                           ++...   +-...++..++.+||..|++.||+++++.....++.+
T Consensus       918 -----RLsqP---piCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  918 -----RLSQP---PICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             -----cCCCC---CCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence                 12222   3344577777789999999999999999988877653

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.3e-37  Score=320.27  Aligned_cols=243  Identities=22%  Similarity=0.340  Sum_probs=191.2

Q ss_pred             hhhcCcCCccEEEEEEE----CCCCEEEEEEecccc-----CCHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEe
Q 007167          305 AEVLGKGTFGTAYKAAL----EDASTVVVKRLKEVN-----VGKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVY  374 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~-----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  374 (615)
                      .+.||+|+||+||++..    ..+..||+|+++...     ...+.+.+|++++..+ +|+||+++++++...+..++||
T Consensus         5 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (332)
T cd05614           5 LKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLIL   84 (332)
T ss_pred             EEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEE
Confidence            35799999999999875    357889999986532     1234577899999999 5999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccC
Q 007167          375 DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS  454 (615)
Q Consensus       375 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~  454 (615)
                      ||+++|+|.+++...     ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus        85 e~~~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          85 DYVSGGEMFTHLYQR-----DNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             eCCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            999999999998643     35889999999999999999999998   9999999999999999999999999997653


Q ss_pred             CCC----CCCCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccc
Q 007167          455 PMP----PPAMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD  529 (615)
Q Consensus       455 ~~~----~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  529 (615)
                      ...    ....+|..|+|||++.+. .++.++|||||||++|||++|+.||...........+  .......       +
T Consensus       157 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~--~~~~~~~-------~  227 (332)
T cd05614         157 SEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV--SRRILKC-------D  227 (332)
T ss_pred             ccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH--HHHHhcC-------C
Confidence            221    234578899999998765 4788999999999999999999999754432221111  1111110       1


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007167          530 VELLRYPNIEEEMVEMLQVGMACVVRMPEERP-----KMADVLKM  569 (615)
Q Consensus       530 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  569 (615)
                      +.  ..+.+++.+.++++   +|++.||++||     +++|++++
T Consensus       228 ~~--~~~~~~~~~~~li~---~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         228 PP--FPSFIGPEAQDLLH---KLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             CC--CCCCCCHHHHHHHH---HHcCCCHHHcCCCCCCCHHHHHcC
Confidence            11  11234556666666   99999999999     77888775

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-37  Score=312.57  Aligned_cols=244  Identities=24%  Similarity=0.361  Sum_probs=193.6

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccC----CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV----GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      ++||+|+||+||++... +++.||+|.+.....    ....+.+|+++++.++|+||+++++++..++..++||||+++|
T Consensus         6 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~   85 (285)
T cd05605           6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG   85 (285)
T ss_pred             EEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCC
Confidence            56999999999999854 678999999865321    2345678999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--C
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--P  458 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--~  458 (615)
                      +|.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+||++++++.++|+|||++.......  .
T Consensus        86 ~L~~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  159 (285)
T cd05605          86 DLKFHIYNMG---NPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR  159 (285)
T ss_pred             cHHHHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccc
Confidence            9998886422   246899999999999999999999998   9999999999999999999999999998764322  2


Q ss_pred             CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCc
Q 007167          459 PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI  538 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  538 (615)
                      ...++..|+|||++.+..++.++||||+||++|||++|+.||...........+   .......        .....+.+
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~---~~~~~~~--------~~~~~~~~  228 (285)
T cd05605         160 GRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEV---ERRVKED--------QEEYSEKF  228 (285)
T ss_pred             cccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHH---HHHhhhc--------ccccCccc
Confidence            335788999999998888999999999999999999999999865432221111   1111100        00011223


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007167          539 EEEMVEMLQVGMACVVRMPEERP-----KMADVLKM  569 (615)
Q Consensus       539 ~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  569 (615)
                      ++.+.+++.   +|+..||++||     ++++++++
T Consensus       229 ~~~~~~li~---~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         229 SEAARSICR---QLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             CHHHHHHHH---HHccCCHHHhcCCCCCCHHHHhcC
Confidence            445555555   99999999999     78888776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=326.45  Aligned_cols=242  Identities=20%  Similarity=0.371  Sum_probs=195.9

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc----CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN----VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||+||+|... +++.||+|+++...    .....+.+|++++..++|+||+++++++.+++..++||||+++
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   85 (350)
T cd05573           6 IKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPG   85 (350)
T ss_pred             EEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCC
Confidence            356999999999999965 68899999997542    2245688899999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      |+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......  
T Consensus        86 ~~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  157 (350)
T cd05573          86 GDLMNLLIRK-----DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR  157 (350)
T ss_pred             CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence            9999999743     36889999999999999999999988   9999999999999999999999999998664332  


Q ss_pred             ------------------------------CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc
Q 007167          458 ------------------------------PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDE  507 (615)
Q Consensus       458 ------------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~  507 (615)
                                                    ....+|..|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~  237 (350)
T cd05573         158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE  237 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHH
Confidence                                          22347888999999999899999999999999999999999998655322


Q ss_pred             hhhHHHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHH
Q 007167          508 VVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPK-MADVLKM  569 (615)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs-~~evl~~  569 (615)
                      ....+      ..  +....   .......+++++.+++.   +|+. +|.+||+ ++|++++
T Consensus       238 ~~~~i------~~--~~~~~---~~p~~~~~~~~~~~li~---~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         238 TYNKI------IN--WKESL---RFPPDPPVSPEAIDLIC---RLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHHH------hc--cCCcc---cCCCCCCCCHHHHHHHH---HHcc-ChhhcCCCHHHHhcC
Confidence            21111      10  00000   11112224566666665   8997 9999999 9999986

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=7e-37  Score=305.45  Aligned_cols=242  Identities=22%  Similarity=0.431  Sum_probs=196.5

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChhh
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSA  384 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  384 (615)
                      .+.||+|+||.||++.+.++..+++|.++........+.+|+++++.++|||++++++++......++||||+++++|.+
T Consensus         9 ~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~   88 (256)
T cd05112           9 VQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSD   88 (256)
T ss_pred             EeeecCcccceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHH
Confidence            35699999999999998778899999988666667789999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC----CC
Q 007167          385 MLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP----PA  460 (615)
Q Consensus       385 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~----~~  460 (615)
                      ++....    ..+++..+..++.+++.|++|||+.+   ++||||||+||+++.++.+||+|||.+........    ..
T Consensus        89 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~  161 (256)
T cd05112          89 YLRAQR----GKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGT  161 (256)
T ss_pred             HHHhCc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccccCCC
Confidence            987432    35889999999999999999999998   99999999999999999999999999876543221    11


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      ..+.+|+|||.+.+..++.++||||||+++|||++ |+.||......+.....      . ...  ....+     ...+
T Consensus       162 ~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~------~-~~~--~~~~~-----~~~~  227 (256)
T cd05112         162 KFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI------N-AGF--RLYKP-----RLAS  227 (256)
T ss_pred             ccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH------h-CCC--CCCCC-----CCCC
Confidence            23467999999988889999999999999999998 99999764432222111      1 000  00011     1123


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                      +   .+.+++.+|++.+|++||++.|++++|
T Consensus       228 ~---~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         228 Q---SVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             H---HHHHHHHHHcccChhhCCCHHHHHHhh
Confidence            3   445556699999999999999999987

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.9e-37  Score=321.79  Aligned_cols=243  Identities=20%  Similarity=0.338  Sum_probs=194.2

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC----CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV----GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||+||++... +++.||+|+++....    ..+.+.+|+++++.++|+||+++++++.+.+..++||||+++
T Consensus         6 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   85 (330)
T cd05601           6 KSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPG   85 (330)
T ss_pred             EEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCC
Confidence            356999999999999854 688999999975422    245678899999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      |+|.+++....    ..+++.....++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++..+....  
T Consensus        86 ~~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  158 (330)
T cd05601          86 GDLLSLLNRYE----DQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV  158 (330)
T ss_pred             CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence            99999997532    36899999999999999999999998   9999999999999999999999999998765332  


Q ss_pred             --CCCCCCCcccCccccC------CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccc
Q 007167          458 --PPAMRAAGYRAPEVTD------TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD  529 (615)
Q Consensus       458 --~~~~~~~~y~aPE~~~------~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  529 (615)
                        ....++..|+|||++.      ...++.++|||||||++|||++|+.||......+...      .+....   ..  
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~------~i~~~~---~~--  227 (330)
T cd05601         159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN------NIMNFQ---RF--  227 (330)
T ss_pred             eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHH------HHHcCC---Cc--
Confidence              1235788999999986      4567899999999999999999999997644322211      111110   00  


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          530 VELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       530 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ......+.+++++.++++   .|+. +|.+||++++++++
T Consensus       228 ~~~~~~~~~~~~~~~li~---~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         228 LKFPEDPKVSSDFLDLIQ---SLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             cCCCCCCCCCHHHHHHHH---HHcc-ChhhCCCHHHHhCC
Confidence            011122345566666666   8887 99999999999875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=4.3e-37  Score=311.43  Aligned_cols=251  Identities=26%  Similarity=0.409  Sum_probs=198.0

Q ss_pred             hhhcCcCCccEEEEEEECC-----CCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEe-cCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAALED-----ASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYS-KDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~  376 (615)
                      .++||+|+||.||+|...+     +..|++|+++....  ..+.+.+|++++++++|+||+++++++.. +...++++||
T Consensus        11 ~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~   90 (280)
T cd05043          11 SDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPY   90 (280)
T ss_pred             eeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEc
Confidence            4679999999999999765     67899998875422  24567889999999999999999998876 4678999999


Q ss_pred             CCCCChhhhhccCCCC---CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeeccccccc
Q 007167          377 FEPGSVSAMLHGRRGE---GQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALM  453 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~  453 (615)
                      +++|+|.+++......   ....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||+++.+
T Consensus        91 ~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~g~~~~~  167 (280)
T cd05043          91 MNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDL  167 (280)
T ss_pred             CCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCCCCcccc
Confidence            9999999998653211   1246899999999999999999999987   999999999999999999999999999866


Q ss_pred             CCCCC-----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccccc
Q 007167          454 SPMPP-----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEV  527 (615)
Q Consensus       454 ~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (615)
                      .....     ...++..|+|||++....++.++|||||||++||+++ |+.||......+   ...++..   ..     
T Consensus       168 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~---~~-----  236 (280)
T cd05043         168 FPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---MAAYLKD---GY-----  236 (280)
T ss_pred             cCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---HHHHHHc---CC-----
Confidence            43221     2234567999999988889999999999999999999 999997643322   2222211   10     


Q ss_pred             ccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          528 FDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       528 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                         ........++++   .+++.+|+..+|++|||+.|+++.|+++.+
T Consensus       237 ---~~~~~~~~~~~~---~~li~~~l~~~p~~Rps~~~~~~~l~~~~~  278 (280)
T cd05043         237 ---RLAQPINCPDEL---FAVMACCWALDPEERPSFSQLVQCLTDFHA  278 (280)
T ss_pred             ---CCCCCCcCCHHH---HHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence               011111223444   445559999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=1.1e-36  Score=322.28  Aligned_cols=253  Identities=24%  Similarity=0.384  Sum_probs=197.7

Q ss_pred             HHhhhcCcCCccEEEEEEEC------CCCEEEEEEeccccCC--HHHHHHHHHHHhCCC-CCcccceeEEEEecCeeeEE
Q 007167          303 ASAEVLGKGTFGTAYKAALE------DASTVVVKRLKEVNVG--KREFEQQMEIVGGIR-HENVVALRAYYYSKDEKLMV  373 (615)
Q Consensus       303 ~~~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV  373 (615)
                      ...++||+|+||.||+|.+.      .+..||+|+++.....  .+.+.+|++++.++. |||||++++++...+..++|
T Consensus        40 ~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv  119 (401)
T cd05107          40 VLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYII  119 (401)
T ss_pred             ehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEE
Confidence            34678999999999999854      2457999999754222  346889999999997 99999999999999999999


Q ss_pred             eecCCCCChhhhhccCCC--------------------------------------------------------------
Q 007167          374 YDYFEPGSVSAMLHGRRG--------------------------------------------------------------  391 (615)
Q Consensus       374 ~e~~~~gsL~~~l~~~~~--------------------------------------------------------------  391 (615)
                      |||+++|+|.++++..+.                                                              
T Consensus       120 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (401)
T cd05107         120 TEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTV  199 (401)
T ss_pred             EeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhh
Confidence            999999999999975321                                                              


Q ss_pred             -------------------------------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCC
Q 007167          392 -------------------------------EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG  440 (615)
Q Consensus       392 -------------------------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~  440 (615)
                                                     .....++|....+++.|++.||+|||+.+   |+||||||+|||+++++
T Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~~~~  276 (401)
T cd05107         200 KYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLICEGK  276 (401)
T ss_pred             hhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEeCCC
Confidence                                           01134788889999999999999999987   99999999999999999


Q ss_pred             cEEEeecccccccCCCC-----CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHH
Q 007167          441 HVCVSDIGLAALMSPMP-----PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRW  514 (615)
Q Consensus       441 ~~kl~DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~  514 (615)
                      .+||+|||+++......     ....++..|+|||.+....++.++|||||||++|||++ |+.||......+...  . 
T Consensus       277 ~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~--~-  353 (401)
T cd05107         277 LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY--N-  353 (401)
T ss_pred             EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH--H-
Confidence            99999999998653211     12234667999999988889999999999999999998 899997644322111  1 


Q ss_pred             HHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhH
Q 007167          515 VNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIR  574 (615)
Q Consensus       515 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~  574 (615)
                         ......       .......++.++.++++   +||..+|.+||+++||++.|+++.
T Consensus       354 ---~~~~~~-------~~~~p~~~~~~l~~li~---~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         354 ---AIKRGY-------RMAKPAHASDEIYEIMQ---KCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             ---HHHcCC-------CCCCCCCCCHHHHHHHH---HHcCCChhHCcCHHHHHHHHHHHh
Confidence               011110       01111233455555555   999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.7e-37  Score=323.34  Aligned_cols=184  Identities=22%  Similarity=0.353  Sum_probs=160.6

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      .+.||+|+||.||++... .++.||+|...     ...+.+|++++++++|||||++++++..+...++|+||+. ++|.
T Consensus        97 ~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~-----~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~  170 (391)
T PHA03212         97 LETFTPGAEGFAFACIDNKTCEHVVIKAGQ-----RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLY  170 (391)
T ss_pred             EEEEcCCCCeEEEEEEECCCCCEEEEechh-----hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHH
Confidence            467999999999999864 67889999653     3457889999999999999999999999999999999995 6888


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC----CCC
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM----PPP  459 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~----~~~  459 (615)
                      .++...     ..+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......    ...
T Consensus       171 ~~l~~~-----~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~  242 (391)
T PHA03212        171 CYLAAK-----RNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYG  242 (391)
T ss_pred             HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccccccccc
Confidence            887642     35889999999999999999999998   999999999999999999999999999754322    123


Q ss_pred             CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 007167          460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHA  502 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~  502 (615)
                      ..+|..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       243 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~  285 (391)
T PHA03212        243 WAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE  285 (391)
T ss_pred             ccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence            4578999999999888899999999999999999999988754

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.4e-37  Score=323.67  Aligned_cols=242  Identities=19%  Similarity=0.303  Sum_probs=192.6

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc----CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN----VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .++||+|+||+||++... ++..||+|.+....    ...+.+.+|+++++.++||||+++++++.+.+..++||||+++
T Consensus        48 ~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~g  127 (370)
T cd05596          48 IKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPG  127 (370)
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCC
Confidence            457999999999999865 57889999986432    2234577899999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      |+|.+++...      .++...+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.......  
T Consensus       128 g~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~  198 (370)
T cd05596         128 GDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV  198 (370)
T ss_pred             CcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence            9999998642      4778888899999999999999998   9999999999999999999999999998764322  


Q ss_pred             --CCCCCCCcccCccccCCC----CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccccc
Q 007167          458 --PPAMRAAGYRAPEVTDTR----KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE  531 (615)
Q Consensus       458 --~~~~~~~~y~aPE~~~~~----~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  531 (615)
                        ....+++.|+|||++...    .++.++|||||||++|||++|+.||.........      ..+.....     ...
T Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------~~i~~~~~-----~~~  267 (370)
T cd05596         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY------SKIMDHKN-----SLT  267 (370)
T ss_pred             cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHH------HHHHcCCC-----cCC
Confidence              234578899999998643    4788999999999999999999999864432211      11111100     011


Q ss_pred             ccCCCCcHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 007167          532 LLRYPNIEEEMVEMLQVGMACVVRMPEE--RPKMADVLKM  569 (615)
Q Consensus       532 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~~  569 (615)
                      ......++.++.++++   +|+..+|++  ||++.|++++
T Consensus       268 ~~~~~~~s~~~~~li~---~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         268 FPDDIEISKQAKDLIC---AFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             CCCcCCCCHHHHHHHH---HHccChhhccCCCCHHHHhcC
Confidence            1122234566677666   999989988  9999999876

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=6e-37  Score=314.74  Aligned_cols=254  Identities=25%  Similarity=0.396  Sum_probs=198.2

Q ss_pred             HhhhcCcCCccEEEEEEEC--------CCCEEEEEEeccccC--CHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeE
Q 007167          304 SAEVLGKGTFGTAYKAALE--------DASTVVVKRLKEVNV--GKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLM  372 (615)
Q Consensus       304 ~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  372 (615)
                      ..+.||+|+||.||++...        ++..+|+|.++....  ....+.+|++++..+ +|+||+++++++...+..++
T Consensus        22 i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~l  101 (307)
T cd05098          22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYV  101 (307)
T ss_pred             EeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEE
Confidence            3567999999999999742        234699999875422  234677899999999 79999999999999999999


Q ss_pred             EeecCCCCChhhhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCc
Q 007167          373 VYDYFEPGSVSAMLHGRRGE-----------GQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGH  441 (615)
Q Consensus       373 V~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~  441 (615)
                      ||||+++|+|.+++......           ....++|..+++++.|++.||+|||+.+   ++||||||+||+++.++.
T Consensus       102 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~  178 (307)
T cd05098         102 IVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNV  178 (307)
T ss_pred             EEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEcCCCc
Confidence            99999999999999754321           1235899999999999999999999987   999999999999999999


Q ss_pred             EEEeecccccccCCCCC-----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHH
Q 007167          442 VCVSDIGLAALMSPMPP-----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWV  515 (615)
Q Consensus       442 ~kl~DfG~a~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~  515 (615)
                      +||+|||.++.......     ....+..|+|||.+.+..++.++|||||||++|||++ |+.||......+....+.  
T Consensus       179 ~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~--  256 (307)
T cd05098         179 MKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK--  256 (307)
T ss_pred             EEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH--
Confidence            99999999976643211     1123457999999988889999999999999999998 889986543322221111  


Q ss_pred             HHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhh
Q 007167          516 NSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVK  577 (615)
Q Consensus       516 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~  577 (615)
                           ...       ........+.++.+   ++.+|+..+|++||++.||++.|+++....
T Consensus       257 -----~~~-------~~~~~~~~~~~~~~---li~~~l~~~p~~Rps~~evl~~l~~~~~~~  303 (307)
T cd05098         257 -----EGH-------RMDKPSNCTNELYM---MMRDCWHAVPSQRPTFKQLVEDLDRILALT  303 (307)
T ss_pred             -----cCC-------CCCCCCcCCHHHHH---HHHHHcccChhhCcCHHHHHHHHHHHHHHh
Confidence                 111       00111223344444   455999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=7.1e-37  Score=306.82  Aligned_cols=238  Identities=22%  Similarity=0.362  Sum_probs=184.3

Q ss_pred             hhcCcCCccEEEEEEECC-------------CCEEEEEEeccccC-CHHHHHHHHHHHhCCCCCcccceeEEEEecCeee
Q 007167          306 EVLGKGTFGTAYKAALED-------------ASTVVVKRLKEVNV-GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKL  371 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~-------------~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~  371 (615)
                      +.||+|+||.||+|...+             ...|++|.+..... ....+.+|+.+++.++||||+++++++..+...+
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~   80 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI   80 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence            358999999999998532             22578888765432 2346788899999999999999999999999999


Q ss_pred             EEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCc-------EEE
Q 007167          372 MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGH-------VCV  444 (615)
Q Consensus       372 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~-------~kl  444 (615)
                      +||||+++|+|..+++..    ...+++..+.+++.|++.||+|||+.+   |+||||||+|||++.++.       +++
T Consensus        81 lv~e~~~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l  153 (262)
T cd05077          81 MVEEFVEFGPLDLFMHRK----SDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKL  153 (262)
T ss_pred             EEEecccCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEe
Confidence            999999999999888643    235899999999999999999999998   999999999999987664       899


Q ss_pred             eecccccccCCCCCCCCCCCcccCccccC-CCCCCCccchhhHHHHHHHHH-hCCCCCCCCCCcchhhHHHHHHHhhhcc
Q 007167          445 SDIGLAALMSPMPPPAMRAAGYRAPEVTD-TRKATQASDVFSFGVLLLELL-TGKSPIHATGGDEVVHLVRWVNSVVREE  522 (615)
Q Consensus       445 ~DfG~a~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~  522 (615)
                      +|||++...... ....++..|+|||.+. +..++.++|||||||++|||+ +|+.||......+....       ... 
T Consensus       154 ~d~g~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~-------~~~-  224 (262)
T cd05077         154 SDPGIPITVLSR-QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERF-------YEG-  224 (262)
T ss_pred             CCCCCCccccCc-ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHH-------Hhc-
Confidence            999998765432 2335677899999886 466899999999999999998 58888865432221110       000 


Q ss_pred             cccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          523 WTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       523 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                              .........++   +.+++.+||+.||++||++.|+++++
T Consensus       225 --------~~~~~~~~~~~---~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         225 --------QCMLVTPSCKE---LADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             --------CccCCCCChHH---HHHHHHHHcCCChhhCcCHHHHHHhc
Confidence                    00011112334   44555599999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=9.2e-37  Score=304.81  Aligned_cols=243  Identities=26%  Similarity=0.396  Sum_probs=193.9

Q ss_pred             hhcCcCCccEEEEEEECC--CC--EEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          306 EVLGKGTFGTAYKAALED--AS--TVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~--~~--~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      ++||+|++|.||+|.+.+  ++  .||+|.+.....  ..+.+.+|++++++++|+||+++++++.. ...++||||+++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~   79 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL   79 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence            368999999999998643  22  589999876543  34678899999999999999999999988 889999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      |+|.+++.....   ..++|.....++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||+++.+....  
T Consensus        80 ~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  153 (257)
T cd05040          80 GSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDH  153 (257)
T ss_pred             CcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccccccc
Confidence            999999975421   46899999999999999999999998   9999999999999999999999999998765421  


Q ss_pred             ----CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccc
Q 007167          458 ----PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL  532 (615)
Q Consensus       458 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  532 (615)
                          ....++.+|+|||++....++.++|||||||++|||++ |+.||......+....+.   .   ..       ...
T Consensus       154 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~---~---~~-------~~~  220 (257)
T cd05040         154 YVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID---K---EG-------ERL  220 (257)
T ss_pred             eecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---h---cC-------CcC
Confidence                12235668999999988889999999999999999999 999997654333222111   1   00       001


Q ss_pred             cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 007167          533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVE  571 (615)
Q Consensus       533 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  571 (615)
                      ......+.   .+.+++.+|++.+|++||++.|+++.|.
T Consensus       221 ~~~~~~~~---~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         221 ERPEACPQ---DIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             CCCccCCH---HHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            11112233   4445555999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-37  Score=317.33  Aligned_cols=249  Identities=24%  Similarity=0.393  Sum_probs=208.1

Q ss_pred             HHHhhhcCcCCccEEEEEEECC---CC--EEEEEEeccc--cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEe
Q 007167          302 RASAEVLGKGTFGTAYKAALED---AS--TVVVKRLKEV--NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVY  374 (615)
Q Consensus       302 ~~~~~~lG~G~fg~Vy~~~~~~---~~--~vavK~l~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  374 (615)
                      ....++||.|-||.||+|...+   |.  .||||.-|..  ....+.|.+|..+|+.++|||||+++|.|.+ ...||||
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~Wivm  469 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVM  469 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEE
Confidence            3457899999999999998533   33  4888988764  3346789999999999999999999999976 4789999


Q ss_pred             ecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccC
Q 007167          375 DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS  454 (615)
Q Consensus       375 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~  454 (615)
                      |.++-|.|..+|+.++    ..++......++.|+..||+|||+..   +|||||..+|||+....-+|++|||+++.+.
T Consensus       470 EL~~~GELr~yLq~nk----~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e  542 (974)
T KOG4257|consen  470 ELAPLGELREYLQQNK----DSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLE  542 (974)
T ss_pred             ecccchhHHHHHHhcc----ccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcc
Confidence            9999999999998654    36888999999999999999999997   9999999999999999999999999999998


Q ss_pred             CCCCCCCC----CCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccccccc
Q 007167          455 PMPPPAMR----AAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD  529 (615)
Q Consensus       455 ~~~~~~~~----~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  529 (615)
                      +.......    ...|||||-+.-++++.++|||-|||-+||++. |..||.+-.+.+++..+.      .        -
T Consensus       543 d~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iE------n--------G  608 (974)
T KOG4257|consen  543 DDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIE------N--------G  608 (974)
T ss_pred             ccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEec------C--------C
Confidence            76543322    346999999999999999999999999999998 999999877766543221      0        1


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          530 VELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       530 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                      .+++..+++++.+..+.   .+||+.+|.+||++.|+...|.++..
T Consensus       609 eRlP~P~nCPp~LYslm---skcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  609 ERLPCPPNCPPALYSLM---SKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             CCCCCCCCCChHHHHHH---HHHhccCcccCCcHHHHHHHHHHHHH
Confidence            13344556666665444   49999999999999999999998876

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-37  Score=317.23  Aligned_cols=242  Identities=24%  Similarity=0.401  Sum_probs=208.9

Q ss_pred             hhhcCcCCccEEEEEEECC-CCEEEEEEeccccC----CHHHHHHHHHHHhCCC-CCcccceeEEEEecCeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALED-ASTVVVKRLKEVNV----GKREFEQQMEIVGGIR-HENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      .+.||+|.||.||++..+. |+.+|+|.+++...    ....+.+|+++|+++. |||||.+.+.|.+....++|||++.
T Consensus        40 ~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~  119 (382)
T KOG0032|consen   40 GRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCE  119 (382)
T ss_pred             hhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecC
Confidence            4679999999999999765 89999999976533    2358899999999998 9999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCC----CcEEEeecccccccC
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQ----GHVCVSDIGLAALMS  454 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~----~~~kl~DfG~a~~~~  454 (615)
                      ||.|++.+...      .+++..+..++.|++.|+.|||+.+   |+|||+||+|+|+...    +.+|++|||++....
T Consensus       120 GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~  190 (382)
T KOG0032|consen  120 GGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK  190 (382)
T ss_pred             CchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence            99999999753      2999999999999999999999998   9999999999999643    479999999999887


Q ss_pred             C--CCCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccc
Q 007167          455 P--MPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL  532 (615)
Q Consensus       455 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  532 (615)
                      .  .....+||+.|+|||++....|+..+||||+||++|.|++|..||.+....+....+      ....     ++...
T Consensus       191 ~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i------~~~~-----~~f~~  259 (382)
T KOG0032|consen  191 PGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAI------LRGD-----FDFTS  259 (382)
T ss_pred             CCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHH------HcCC-----CCCCC
Confidence            6  334567999999999999999999999999999999999999999987654443321      1121     24444


Q ss_pred             cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       533 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ..++.+++.++++++   .|+..||.+|+|+.++++|
T Consensus       260 ~~w~~is~~akd~i~---~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  260 EPWDDISESAKDFIR---KLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             CCccccCHHHHHHHH---HhcccCcccCCCHHHHhcC
Confidence            457788889999988   9999999999999999996

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=8.4e-37  Score=309.17  Aligned_cols=246  Identities=24%  Similarity=0.377  Sum_probs=193.1

Q ss_pred             hhhcCcCCccEEEEEEE-CCCC----EEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecC
Q 007167          305 AEVLGKGTFGTAYKAAL-EDAS----TVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYF  377 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~----~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  377 (615)
                      .++||+|+||+||+|.+ .++.    .||+|.++....  ..+.+.+|+.+++.++|+||+++++++.. ...++++||+
T Consensus        12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l~~~~~   90 (279)
T cd05109          12 VKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQLVTQLM   90 (279)
T ss_pred             eeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEEEEEcC
Confidence            35799999999999984 3444    479998875422  24568889999999999999999999975 4577999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC
Q 007167          378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP  457 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~  457 (615)
                      ++|+|.++++..    ...+++..++.++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++.+....
T Consensus        91 ~~g~l~~~l~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~  163 (279)
T cd05109          91 PYGCLLDYVREN----KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE  163 (279)
T ss_pred             CCCCHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeeccccc
Confidence            999999999743    236899999999999999999999998   9999999999999999999999999998765322


Q ss_pred             C-----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccccccccc
Q 007167          458 P-----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE  531 (615)
Q Consensus       458 ~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  531 (615)
                      .     ....+..|+|||...+..++.++|||||||++|||++ |+.||......+..   .++....           .
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~---~~~~~~~-----------~  229 (279)
T cd05109         164 TEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIP---DLLEKGE-----------R  229 (279)
T ss_pred             ceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHH---HHHHCCC-----------c
Confidence            1     1123457999999988889999999999999999998 99999764433222   2221100           0


Q ss_pred             ccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          532 LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       532 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                      ....+..+.+   +.+++.+||..||++||++.|+++.|+++..
T Consensus       230 ~~~~~~~~~~---~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         230 LPQPPICTID---VYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             CCCCccCCHH---HHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            0111223333   4455559999999999999999999988865

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.1e-36  Score=304.89  Aligned_cols=245  Identities=26%  Similarity=0.448  Sum_probs=196.6

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChhh
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSA  384 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  384 (615)
                      .+.||+|+||.||++..+++..+++|.++......+.+.+|+++++.++|+||+++++++.. ...++||||+++|+|.+
T Consensus        11 ~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~   89 (260)
T cd05073          11 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLD   89 (260)
T ss_pred             EeEecCccceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHH
Confidence            35799999999999998888889999887654455678899999999999999999999887 77899999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC----CC
Q 007167          385 MLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP----PA  460 (615)
Q Consensus       385 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~----~~  460 (615)
                      ++....   ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||.+........    ..
T Consensus        90 ~~~~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~  163 (260)
T cd05073          90 FLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA  163 (260)
T ss_pred             HHHhCC---ccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCC
Confidence            997532   346889999999999999999999987   99999999999999999999999999976643221    11


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      .++..|+|||++....++.++|||||||++|++++ |+.||......+..   .+..    ...       ........+
T Consensus       164 ~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~---~~~~----~~~-------~~~~~~~~~  229 (260)
T cd05073         164 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI---RALE----RGY-------RMPRPENCP  229 (260)
T ss_pred             cccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHH---HHHh----CCC-------CCCCcccCC
Confidence            23456999999988889999999999999999999 99999764432221   1111    110       011112233


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI  573 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l  573 (615)
                      .+   +.+++.+|++.+|++||++.++.+.|+.+
T Consensus       230 ~~---~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         230 EE---LYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             HH---HHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence            44   44555599999999999999999999753

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.2e-37  Score=325.72  Aligned_cols=241  Identities=24%  Similarity=0.358  Sum_probs=188.4

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccC----CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV----GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      ++||+|+||+||+|... +++.||+|++.....    ....+.+|+++++.++|+|||++++.+.+++..++||||+++|
T Consensus         7 ~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg   86 (382)
T cd05625           7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGG   86 (382)
T ss_pred             EEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCC
Confidence            56999999999999854 577899999875421    1346788999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC----
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM----  456 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~----  456 (615)
                      +|.+++...     ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++++||+|||++..+...    
T Consensus        87 ~L~~~l~~~-----~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~  158 (382)
T cd05625          87 DMMSLLIRM-----GIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (382)
T ss_pred             cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence            999998643     35788889999999999999999998   999999999999999999999999997532100    


Q ss_pred             ----------------------------------------------CCCCCCCCcccCccccCCCCCCCccchhhHHHHH
Q 007167          457 ----------------------------------------------PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLL  490 (615)
Q Consensus       457 ----------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl  490 (615)
                                                                    .....+|..|+|||++.+..++.++||||+||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil  238 (382)
T cd05625         159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  238 (382)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence                                                          0123478889999999988999999999999999


Q ss_pred             HHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCC---HHHHH
Q 007167          491 LELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPK---MADVL  567 (615)
Q Consensus       491 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs---~~evl  567 (615)
                      |||++|+.||...+..+....+  .    .  +..   .........++++..+++.   +++ .+|++|++   +.|++
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i--~----~--~~~---~~~~p~~~~~s~~~~~li~---~l~-~~p~~R~~~~~~~ei~  303 (382)
T cd05625         239 YEMLVGQPPFLAQTPLETQMKV--I----N--WQT---SLHIPPQAKLSPEASDLII---KLC-RGPEDRLGKNGADEIK  303 (382)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHH--H----c--cCC---CcCCCCcccCCHHHHHHHH---HHc-cCHhHcCCCCCHHHHh
Confidence            9999999999865432221111  0    0  000   0111112334566666665   443 48999997   88887


Q ss_pred             HH
Q 007167          568 KM  569 (615)
Q Consensus       568 ~~  569 (615)
                      ++
T Consensus       304 ~h  305 (382)
T cd05625         304 AH  305 (382)
T ss_pred             cC
Confidence            65

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.8e-36  Score=304.53  Aligned_cols=252  Identities=20%  Similarity=0.390  Sum_probs=197.4

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccC----CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNV----GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||.||+|.. .+++.||||.++....    ....+.+|+++++.++||||+++++++...+..++|+||+++
T Consensus         7 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~   86 (267)
T cd08228           7 EKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADA   86 (267)
T ss_pred             eeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCC
Confidence            45699999999999985 4788999998764321    134578899999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC-
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP-  458 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~-  458 (615)
                      |+|.+++..... ....+++.....++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++........ 
T Consensus        87 ~~L~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~  162 (267)
T cd08228          87 GDLSQMIKYFKK-QKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA  162 (267)
T ss_pred             CcHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccchhHH
Confidence            999998864321 2346888999999999999999999998   99999999999999999999999999887654221 


Q ss_pred             --CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          459 --PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       459 --~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                        ...++..|+|||.+.+..++.++||||||+++|||++|+.||...... .......+.   ...      .+... ..
T Consensus       163 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~-~~~~~~~~~---~~~------~~~~~-~~  231 (267)
T cd08228         163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LFSLCQKIE---QCD------YPPLP-TE  231 (267)
T ss_pred             HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccccc-HHHHHHHHh---cCC------CCCCC-hh
Confidence              234677899999998888899999999999999999999999653321 111221111   100      00000 01


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIR  574 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~  574 (615)
                      ..+..   +.+++.+||..+|++||++.||++.+++++
T Consensus       232 ~~~~~---~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         232 HYSEK---LRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             hcCHH---HHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            12233   445555999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.3e-36  Score=306.02  Aligned_cols=249  Identities=24%  Similarity=0.358  Sum_probs=185.8

Q ss_pred             hcCcCCccEEEEEEECC---CCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          307 VLGKGTFGTAYKAALED---ASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      .||+|+||+||+|...+   ...+++|.+.....  ....+.+|+++++.++|+||+++++++......++||||+++|+
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~   81 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD   81 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence            59999999999997543   34678887754322  23467889999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC----
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP----  457 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~----  457 (615)
                      |.+++...+.......++.....++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++.......    
T Consensus        82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~  158 (269)
T cd05042          82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT  158 (269)
T ss_pred             HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence            999997654333344678888999999999999999998   9999999999999999999999999986543221    


Q ss_pred             -CCCCCCCcccCccccCC-------CCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccc
Q 007167          458 -PPAMRAAGYRAPEVTDT-------RKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVF  528 (615)
Q Consensus       458 -~~~~~~~~y~aPE~~~~-------~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  528 (615)
                       ....++..|+|||+...       ..++.++|||||||++|||++ |..||......+....      ...+.. ....
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~------~~~~~~-~~~~  231 (269)
T cd05042         159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQ------VVREQD-IKLP  231 (269)
T ss_pred             cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHH------HhhccC-ccCC
Confidence             12234567999998642       356789999999999999999 8889876543322111      111110 0111


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 007167          529 DVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVE  571 (615)
Q Consensus       529 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  571 (615)
                      ++..  ....++...+++.   .|+ .||++||+++||++.|.
T Consensus       232 ~~~~--~~~~~~~~~~~~~---~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         232 KPQL--DLKYSDRWYEVMQ---FCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             CCcc--cccCCHHHHHHHH---HHh-cCcccccCHHHHHHHhc
Confidence            1111  1123344444444   787 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.5e-36  Score=308.08  Aligned_cols=257  Identities=22%  Similarity=0.313  Sum_probs=193.1

Q ss_pred             hhhcCcCCccEEEEEEE-----CCCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEec--CeeeEEee
Q 007167          305 AEVLGKGTFGTAYKAAL-----EDASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSK--DEKLMVYD  375 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e  375 (615)
                      .+.||+|+||+||++..     .++..||+|.++....  ..+.+.+|+++++.++||||+++++++...  ...++|||
T Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e   88 (283)
T cd05080           9 IRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIME   88 (283)
T ss_pred             ceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEec
Confidence            35799999999988642     4577899999875432  356788999999999999999999998754  35789999


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      |+++|+|.+++...      .+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++.+..
T Consensus        89 ~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          89 YVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             CCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence            99999999999632      4899999999999999999999998   99999999999999999999999999987653


Q ss_pred             CCC------CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccc
Q 007167          456 MPP------PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD  529 (615)
Q Consensus       456 ~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  529 (615)
                      ...      ...++..|+|||.+....++.++||||||+++|||++|+.||...... ......+...........+..+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK-FEEMIGPKQGQMTVVRLIELLE  238 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcch-hhhhhcccccccchhhhhhhhh
Confidence            221      122345699999998888999999999999999999999998654321 1111110000000000000011


Q ss_pred             cc--ccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhH
Q 007167          530 VE--LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIR  574 (615)
Q Consensus       530 ~~--~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~  574 (615)
                      ..  .......+.++.+   ++.+|++.+|++|||++++++.|+++.
T Consensus       239 ~~~~~~~~~~~~~~~~~---li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         239 RGMRLPCPKNCPQEVYI---LMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             cCCCCCCCCCCCHHHHH---HHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            00  1111223344444   455999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.4e-37  Score=310.67  Aligned_cols=247  Identities=23%  Similarity=0.378  Sum_probs=194.9

Q ss_pred             hhhcCcCCccEEEEEEECC------CCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAALED------ASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      .+.||+|+||.||+|...+      +..|++|.+.....  ....+.+|+++++.++|+||+++++++......++||||
T Consensus        11 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   90 (277)
T cd05032          11 IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMEL   90 (277)
T ss_pred             EeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEec
Confidence            4679999999999998643      35799999865432  234678999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCC-----CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeeccccc
Q 007167          377 FEPGSVSAMLHGRRGE-----GQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAA  451 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~-----~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~  451 (615)
                      +++|+|.+++......     ....++|..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++
T Consensus        91 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~dfg~~~  167 (277)
T cd05032          91 MAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIGDFGMTR  167 (277)
T ss_pred             CCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEECCcccch
Confidence            9999999999753321     1235789999999999999999999988   9999999999999999999999999987


Q ss_pred             ccCCCC-----CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccc
Q 007167          452 LMSPMP-----PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTA  525 (615)
Q Consensus       452 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (615)
                      .+....     ....++..|+|||.+....++.++|||||||++||+++ |+.||......+....+   .    ...  
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~---~----~~~--  238 (277)
T cd05032         168 DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFV---I----DGG--  238 (277)
T ss_pred             hhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHH---h----cCC--
Confidence            654322     12234668999999988889999999999999999998 99999765433322211   1    000  


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 007167          526 EVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVE  571 (615)
Q Consensus       526 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  571 (615)
                           ........+.++.   +++.+|++.+|++|||+.|+++.|+
T Consensus       239 -----~~~~~~~~~~~~~---~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         239 -----HLDLPENCPDKLL---ELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             -----CCCCCCCCCHHHH---HHHHHHcCCChhhCCCHHHHHHHhc
Confidence                 0001112334444   4555999999999999999999886

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=9e-37  Score=307.16  Aligned_cols=245  Identities=24%  Similarity=0.427  Sum_probs=193.9

Q ss_pred             hhhcCcCCccEEEEEEECC-C---CEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALED-A---STVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~-~---~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      .+.||+|+||.||+|.... +   ..|++|.++....  ..+.|..|+++++.++||||+++++++..++..++||||++
T Consensus         9 ~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~   88 (269)
T cd05065           9 EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFME   88 (269)
T ss_pred             EeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCC
Confidence            4679999999999998643 3   3599999875422  24578899999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP  458 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~  458 (615)
                      +|+|.+++....    ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++........
T Consensus        89 ~~~L~~~l~~~~----~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~  161 (269)
T cd05065          89 NGALDSFLRQND----GQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  161 (269)
T ss_pred             CCcHHHHHhhCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence            999999987432    35899999999999999999999998   99999999999999999999999999876543221


Q ss_pred             C--C---C---CCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccccccc
Q 007167          459 P--A---M---RAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD  529 (615)
Q Consensus       459 ~--~---~---~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  529 (615)
                      .  .   .   .+..|+|||++....++.++|||||||++||+++ |+.||......+.   ..++..    .       
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~---~~~i~~----~-------  227 (269)
T cd05065         162 DPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV---INAIEQ----D-------  227 (269)
T ss_pred             ccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHH---HHHHHc----C-------
Confidence            1  0   1   1346999999998889999999999999999987 9999976543322   222211    0       


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 007167          530 VELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI  573 (615)
Q Consensus       530 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l  573 (615)
                      ......+..+..+   .+++.+|++.+|.+||++++|+..|+.+
T Consensus       228 ~~~~~~~~~~~~~---~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         228 YRLPPPMDCPTAL---HQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             CcCCCcccCCHHH---HHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            0111112233344   4555599999999999999999998875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.4e-37  Score=325.82  Aligned_cols=242  Identities=22%  Similarity=0.332  Sum_probs=190.9

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc----CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN----VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||+||++... .++.||||.+....    .....+.+|++++++++|+||+++++.+.+++..++||||+++
T Consensus         6 ~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~   85 (376)
T cd05598           6 IKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPG   85 (376)
T ss_pred             EEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCC
Confidence            356999999999999854 57889999986432    2245678899999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC---
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM---  456 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~---  456 (615)
                      |+|.+++...     ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..+...   
T Consensus        86 g~L~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~  157 (376)
T cd05598          86 GDMMSLLIRL-----GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (376)
T ss_pred             CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence            9999999643     35788888999999999999999998   999999999999999999999999997532100   


Q ss_pred             -------------------------------------------CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHH
Q 007167          457 -------------------------------------------PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLEL  493 (615)
Q Consensus       457 -------------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~el  493 (615)
                                                                 .....+|..|+|||++.+..++.++|||||||++|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyel  237 (376)
T cd05598         158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEM  237 (376)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeeh
Confidence                                                       0123578899999999988899999999999999999


Q ss_pred             HhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCC---CHHHHHHH
Q 007167          494 LTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERP---KMADVLKM  569 (615)
Q Consensus       494 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP---s~~evl~~  569 (615)
                      ++|+.||......+....+.        .+....   .......++++..+++.   +|+ .+|.+|+   ++.|++++
T Consensus       238 l~G~~Pf~~~~~~~~~~~i~--------~~~~~~---~~~~~~~~s~~~~~li~---~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         238 LVGQPPFLADTPAETQLKVI--------NWETTL---HIPSQAKLSREASDLIL---RLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             hhCCCCCCCCCHHHHHHHHh--------ccCccc---cCCCCCCCCHHHHHHHH---HHh-cCHhhcCCCCCHHHHhCC
Confidence            99999998755433221110        010000   11112234556666665   554 4999999   89999887

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.1e-36  Score=304.51  Aligned_cols=238  Identities=26%  Similarity=0.431  Sum_probs=188.5

Q ss_pred             hhcCcCCccEEEEEEECCCC-----------EEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEe
Q 007167          306 EVLGKGTFGTAYKAALEDAS-----------TVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVY  374 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~~-----------~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  374 (615)
                      +.||+|+||.||+|...+..           .|++|.+.........+.+|+++++.++|+||+++++++.. ...++||
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~   79 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVE   79 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEE
Confidence            36999999999999976433           47778776554436788999999999999999999999988 7889999


Q ss_pred             ecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCC-------cEEEeec
Q 007167          375 DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG-------HVCVSDI  447 (615)
Q Consensus       375 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~-------~~kl~Df  447 (615)
                      ||+++|+|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++       .+||+||
T Consensus        80 e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df  152 (259)
T cd05037          80 EYVKFGPLDVFLHREK----NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP  152 (259)
T ss_pred             EcCCCCcHHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence            9999999999997532    26899999999999999999999987   99999999999999888       7999999


Q ss_pred             ccccccCCCCCCCCCCCcccCccccCCC--CCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccc
Q 007167          448 GLAALMSPMPPPAMRAAGYRAPEVTDTR--KATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWT  524 (615)
Q Consensus       448 G~a~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  524 (615)
                      |++..... .....++..|+|||++...  .++.++|||||||++|||++ |..||......+...   +..        
T Consensus       153 g~a~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~---~~~--------  220 (259)
T cd05037         153 GIPITVLS-REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKER---FYQ--------  220 (259)
T ss_pred             Cccccccc-ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHH---HHh--------
Confidence            99987654 2233456779999998776  78999999999999999999 678886654222111   111        


Q ss_pred             cccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 007167          525 AEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVE  571 (615)
Q Consensus       525 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  571 (615)
                          .......+. .   ..+.+++.+|+..+|.+||++.|+++.|+
T Consensus       221 ----~~~~~~~~~-~---~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 ----DQHRLPMPD-C---AELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             ----cCCCCCCCC-c---hHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                000001111 1   34555556999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-37  Score=316.44  Aligned_cols=242  Identities=21%  Similarity=0.402  Sum_probs=203.7

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEecCe-eeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSKDE-KLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-~~lV~e~~~~  379 (615)
                      .+.+|+|+||.++..+. .+...+++|.+.-...   ..+...+|+.++++++|||||.+.+.|..++. .+|||+|++|
T Consensus         9 ~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eG   88 (426)
T KOG0589|consen    9 LRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEG   88 (426)
T ss_pred             hhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCC
Confidence            46799999999999874 4677899999865432   24467899999999999999999999999988 9999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      |++.+.+...+   ...+++.+..+++.|++.|+.|||++.   |+|||||+.||+++.++.+||.|||+|+.+.+..  
T Consensus        89 g~l~~~i~~~k---~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~  162 (426)
T KOG0589|consen   89 GDLAQLIKEQK---GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL  162 (426)
T ss_pred             CCHHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence            99999998665   347899999999999999999999887   9999999999999999999999999999998654  


Q ss_pred             -CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          458 -PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       458 -~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                       ....||+.|+.||++.+..|..|+||||+||++|||++-+.+|...+-...+.      ++.+.     .+.+   ...
T Consensus       163 a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~------ki~~~-----~~~P---lp~  228 (426)
T KOG0589|consen  163 ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELIL------KINRG-----LYSP---LPS  228 (426)
T ss_pred             hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHH------HHhhc-----cCCC---CCc
Confidence             35678999999999999999999999999999999999999998765433321      21111     1111   123


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .++.+++.+++   .|++.+|+.||++.+++.+
T Consensus       229 ~ys~el~~lv~---~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  229 MYSSELRSLVK---SMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             cccHHHHHHHH---HHhhcCCccCCCHHHHhhC
Confidence            45666666666   9999999999999999987

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=9.5e-37  Score=331.66  Aligned_cols=244  Identities=26%  Similarity=0.398  Sum_probs=193.7

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecC--------eeeE
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKD--------EKLM  372 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--------~~~l  372 (615)
                      .+.||+|+||+||+|.. .+++.||||++......   ...+.+|+..+..++|+||++++..+...+        ..++
T Consensus        37 ~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~l  116 (496)
T PTZ00283         37 SRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIAL  116 (496)
T ss_pred             EEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEE
Confidence            35699999999999984 57899999998754332   345778999999999999999988775432        3689


Q ss_pred             EeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccc
Q 007167          373 VYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAAL  452 (615)
Q Consensus       373 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~  452 (615)
                      ||||+++|+|.++++... .....+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       117 V~Ey~~~gsL~~~l~~~~-~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~DFGls~~  192 (496)
T PTZ00283        117 VLDYANAGDLRQEIKSRA-KTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLGDFGFSKM  192 (496)
T ss_pred             EEeCCCCCcHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEEecccCee
Confidence            999999999999997533 22357899999999999999999999998   99999999999999999999999999986


Q ss_pred             cCCC-----CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccc
Q 007167          453 MSPM-----PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEV  527 (615)
Q Consensus       453 ~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (615)
                      +...     .....+|..|+|||++.+..++.++|||||||++|||++|+.||......+..      .......     
T Consensus       193 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~------~~~~~~~-----  261 (496)
T PTZ00283        193 YAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVM------HKTLAGR-----  261 (496)
T ss_pred             ccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH------HHHhcCC-----
Confidence            6432     22345788999999999988999999999999999999999999764332221      1111111     


Q ss_pred             ccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          528 FDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       528 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+   ...+.+++++.++++   +||..+|.+||++.|++++
T Consensus       262 ~~---~~~~~~~~~l~~li~---~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        262 YD---PLPPSISPEMQEIVT---ALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             CC---CCCCCCCHHHHHHHH---HHcccChhhCcCHHHHHhC
Confidence            00   012334555656555   9999999999999999875

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2e-36  Score=307.38  Aligned_cols=244  Identities=25%  Similarity=0.381  Sum_probs=192.7

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccC----CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV----GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      +.||+|+||+||+|... +++.||+|.+.....    ....+.+|+++++.++|+||+.+.+++..++..++||||++++
T Consensus         6 ~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   85 (285)
T cd05632           6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGG   85 (285)
T ss_pred             EEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCc
Confidence            46999999999999864 678899999865422    1234678999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--C
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--P  458 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--~  458 (615)
                      +|.+++....   ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||++.......  .
T Consensus        86 ~L~~~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  159 (285)
T cd05632          86 DLKFHIYNMG---NPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR  159 (285)
T ss_pred             cHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCCccc
Confidence            9998886432   336999999999999999999999998   9999999999999999999999999997654322  2


Q ss_pred             CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCc
Q 007167          459 PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI  538 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  538 (615)
                      ...++..|+|||++.+..++.++|||||||++|||++|+.||...........+.  .. ...        ......+.+
T Consensus       160 ~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~--~~-~~~--------~~~~~~~~~  228 (285)
T cd05632         160 GRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVD--RR-VLE--------TEEVYSAKF  228 (285)
T ss_pred             CCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--Hh-hhc--------cccccCccC
Confidence            3457889999999988889999999999999999999999997644322211111  11 110        000111233


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 007167          539 EEEMVEMLQVGMACVVRMPEERPK-----MADVLKM  569 (615)
Q Consensus       539 ~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~  569 (615)
                      +++..++++   +|++.+|++||+     +.|++++
T Consensus       229 ~~~~~~li~---~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         229 SEEAKSICK---MLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             CHHHHHHHH---HHccCCHhHcCCCcccChHHHHcC
Confidence            444545544   999999999999     6677765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=2.5e-36  Score=303.38  Aligned_cols=252  Identities=21%  Similarity=0.407  Sum_probs=199.3

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccC----CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNV----GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||.||++.. .++..++||.+.....    ....+.+|+++++.++|+||+++++++..++..++||||+++
T Consensus         7 ~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~   86 (267)
T cd08229           7 EKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA   86 (267)
T ss_pred             hhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCC
Confidence            46799999999999995 5789999998865321    234678899999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      ++|.+++.... .....+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++.......  
T Consensus        87 ~~L~~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd08229          87 GDLSRMIKHFK-KQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA  162 (267)
T ss_pred             CCHHHHHHHhh-ccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccCCcc
Confidence            99999986422 12346899999999999999999999998   9999999999999999999999999987764332  


Q ss_pred             -CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          458 -PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       458 -~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                       ....++..|+|||.+.+..++.++||||||+++|||++|..||...... .......+   ....      .+.. ...
T Consensus       163 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~---~~~~------~~~~-~~~  231 (267)
T cd08229         163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKI---EQCD------YPPL-PSD  231 (267)
T ss_pred             cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccch-HHHHhhhh---hcCC------CCCC-Ccc
Confidence             1235677899999998888999999999999999999999999653321 11111111   1000      0000 011


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIR  574 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~  574 (615)
                      ..++++.+++.   +|+..+|++||||.+|+++++++.
T Consensus       232 ~~~~~~~~li~---~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         232 HYSEELRQLVN---MCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             cccHHHHHHHH---HhcCCCcccCCCHHHHHHHHhhhc
Confidence            23445555554   999999999999999999998874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=8.1e-37  Score=321.36  Aligned_cols=242  Identities=19%  Similarity=0.298  Sum_probs=189.7

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc----CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN----VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||.||++... +++.||+|.+....    ...+.+.+|+++++.++||||+++++++.+++..++||||+++
T Consensus        48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~g  127 (370)
T cd05621          48 VKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPG  127 (370)
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCC
Confidence            356999999999999965 57789999986431    2234578899999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      |+|.+++...      .+++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.......  
T Consensus       128 g~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~  198 (370)
T cd05621         128 GDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV  198 (370)
T ss_pred             CcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence            9999998632      4788899999999999999999998   9999999999999999999999999998765332  


Q ss_pred             --CCCCCCCcccCccccCCC----CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccccc
Q 007167          458 --PPAMRAAGYRAPEVTDTR----KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE  531 (615)
Q Consensus       458 --~~~~~~~~y~aPE~~~~~----~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  531 (615)
                        ....+|..|+|||++...    .++.++||||+||++|||++|+.||......+...      .+.....     ...
T Consensus       199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~------~i~~~~~-----~~~  267 (370)
T cd05621         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYS------KIMDHKN-----SLN  267 (370)
T ss_pred             ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHH------HHHhCCc-----ccC
Confidence              234578999999998653    37889999999999999999999997654322111      1111100     001


Q ss_pred             ccCCCCcHHHHHHHHHHHHHcccCCCC--CCCCHHHHHHH
Q 007167          532 LLRYPNIEEEMVEMLQVGMACVVRMPE--ERPKMADVLKM  569 (615)
Q Consensus       532 ~~~~~~~~~~~~~l~~l~~~cl~~~P~--~RPs~~evl~~  569 (615)
                      ......+++..++++.   .|+..++.  .|+++.|++++
T Consensus       268 ~p~~~~~s~~~~~li~---~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         268 FPEDVEISKHAKNLIC---AFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             CCCcccCCHHHHHHHH---HHccCchhccCCCCHHHHhcC
Confidence            1111234566666666   77765544  38999999987

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.4e-37  Score=322.95  Aligned_cols=198  Identities=25%  Similarity=0.372  Sum_probs=173.7

Q ss_pred             HHhhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCHHHHHHHHHHHhCCC-C-----CcccceeEEEEecCeeeEEee
Q 007167          303 ASAEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFEQQMEIVGGIR-H-----ENVVALRAYYYSKDEKLMVYD  375 (615)
Q Consensus       303 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~-h-----~niv~l~~~~~~~~~~~lV~e  375 (615)
                      .+.++||+|+||.|-||.+. .++.||||+++....-..+-..|+.+|..++ |     -|+|++++||..+++.|||+|
T Consensus       189 ~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfE  268 (586)
T KOG0667|consen  189 EVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFE  268 (586)
T ss_pred             EEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeeh
Confidence            34578999999999999855 5888999999876544455667888998886 3     389999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCC--cEEEeeccccccc
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG--HVCVSDIGLAALM  453 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~--~~kl~DfG~a~~~  453 (615)
                      .+ .-+|.++|..++   ...++....+.|+.||+.||..||+.+   |||+||||+||||.+..  .+||+|||.+...
T Consensus       269 LL-~~NLYellK~n~---f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~  341 (586)
T KOG0667|consen  269 LL-STNLYELLKNNK---FRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCFE  341 (586)
T ss_pred             hh-hhhHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEeccccccc
Confidence            99 459999998654   446999999999999999999999998   99999999999997654  6999999999988


Q ss_pred             CCCCCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc
Q 007167          454 SPMPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDE  507 (615)
Q Consensus       454 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~  507 (615)
                      .........++-|+|||++.+.+|+.+.||||||||++||++|.+.|.+.++.+
T Consensus       342 ~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~D  395 (586)
T KOG0667|consen  342 SQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYD  395 (586)
T ss_pred             CCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHH
Confidence            877777778999999999999999999999999999999999999898766544

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.2e-36  Score=307.37  Aligned_cols=237  Identities=23%  Similarity=0.349  Sum_probs=183.3

Q ss_pred             hcCcCCccEEEEEEECC-------------------------CCEEEEEEeccccC-CHHHHHHHHHHHhCCCCCcccce
Q 007167          307 VLGKGTFGTAYKAALED-------------------------ASTVVVKRLKEVNV-GKREFEQQMEIVGGIRHENVVAL  360 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~~-------------------------~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l  360 (615)
                      .||+|+||.||+|....                         ...|++|.+..... ....+.+|+++++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            49999999999997421                         13478888865422 23467788999999999999999


Q ss_pred             eEEEEecCeeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCC
Q 007167          361 RAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG  440 (615)
Q Consensus       361 ~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~  440 (615)
                      ++++.+....++||||+++|+|..++...    ...+++..+.+++.|+++||+|||+.+   |+||||||+||+++..+
T Consensus        82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~  154 (274)
T cd05076          82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE----KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLG  154 (274)
T ss_pred             EEEEEeCCceEEEEecCCCCcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccC
Confidence            99999999999999999999999998643    236889999999999999999999997   99999999999997643


Q ss_pred             -------cEEEeecccccccCCCCCCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHH-hCCCCCCCCCCcchhhH
Q 007167          441 -------HVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELL-TGKSPIHATGGDEVVHL  511 (615)
Q Consensus       441 -------~~kl~DfG~a~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~ell-tg~~p~~~~~~~~~~~~  511 (615)
                             .+|++|||++...... ....++..|+|||.+.. ..++.++|||||||++||++ +|+.||......+....
T Consensus       155 ~~~~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~  233 (274)
T cd05076         155 LAEGTSPFIKLSDPGVSFTALSR-EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERF  233 (274)
T ss_pred             cccCccceeeecCCccccccccc-cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHH
Confidence                   3899999988654332 22346778999998865 55789999999999999995 69999976543332111


Q ss_pred             HHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          512 VRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       512 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                         ...    ..       ..  .....+   ++.+++.+||+.+|++||++.||++.|
T Consensus       234 ---~~~----~~-------~~--~~~~~~---~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         234 ---YEK----KH-------RL--PEPSCK---ELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             ---HHh----cc-------CC--CCCCCh---HHHHHHHHHcccChhhCcCHHHHHHhh
Confidence               110    00       00  011122   345555599999999999999999887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.4e-36  Score=305.38  Aligned_cols=245  Identities=27%  Similarity=0.458  Sum_probs=194.5

Q ss_pred             hhhcCcCCccEEEEEEEC----CCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALE----DASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      .+.||+|+||.||+|...    .+..+|+|.++....  ..+.+.+|++++++++||||+++++++..++..++||||++
T Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~   88 (267)
T cd05066           9 EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYME   88 (267)
T ss_pred             eeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCC
Confidence            467999999999999853    233689998865422  23578899999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP  458 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~  458 (615)
                      +++|.+++....    ..+++..+..++.|++.|++|||+.+   ++||||||+||+++.++.++++|||++..+.....
T Consensus        89 ~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd05066          89 NGSLDAFLRKHD----GQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  161 (267)
T ss_pred             CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence            999999997432    35899999999999999999999998   99999999999999999999999999987654322


Q ss_pred             CC------CCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccccccccc
Q 007167          459 PA------MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE  531 (615)
Q Consensus       459 ~~------~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  531 (615)
                      ..      ..+..|+|||.+.+..++.++|||||||++||+++ |+.||......+.   ...+..    .+       .
T Consensus       162 ~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~---~~~~~~----~~-------~  227 (267)
T cd05066         162 AAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDV---IKAIEE----GY-------R  227 (267)
T ss_pred             eeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHH---HHHHhC----CC-------c
Confidence            11      12346999999988889999999999999999887 9999976543322   211111    00       0


Q ss_pred             ccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 007167          532 LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI  573 (615)
Q Consensus       532 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l  573 (615)
                      .......++.+   .+++.+|++.+|.+||++.++++.|+++
T Consensus       228 ~~~~~~~~~~~---~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 LPAPMDCPAAL---HQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             CCCCCCCCHHH---HHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            11112233444   4455599999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2e-36  Score=303.32  Aligned_cols=245  Identities=26%  Similarity=0.412  Sum_probs=187.4

Q ss_pred             hhcCcCCccEEEEEEECC----CCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEe-cCeeeEEeecCC
Q 007167          306 EVLGKGTFGTAYKAALED----ASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYS-KDEKLMVYDYFE  378 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~~~  378 (615)
                      +.||+|+||+||+|.+.+    ...||+|++.....  ..+.+.+|+.+++.++||||+++++++.. +...++|+||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            358999999999998532    34689998854322  23567889999999999999999998764 456789999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC-
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP-  457 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~-  457 (615)
                      +|+|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++.+.... 
T Consensus        81 ~~~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~  153 (262)
T cd05058          81 HGDLRNFIRSET----HNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEY  153 (262)
T ss_pred             CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcc
Confidence            999999997432    24678888999999999999999987   9999999999999999999999999997653221 


Q ss_pred             ------CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhC-CCCCCCCCCcchhhHHHHHHHhhhcccccccccc
Q 007167          458 ------PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTG-KSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDV  530 (615)
Q Consensus       458 ------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  530 (615)
                            ....++..|+|||.+....++.++|||||||++|||++| ..||......+   ....+   ....        
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~---~~~~~---~~~~--------  219 (262)
T cd05058         154 YSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFD---ITVYL---LQGR--------  219 (262)
T ss_pred             eeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHH---hcCC--------
Confidence                  122235679999999888899999999999999999995 56665433222   22211   1110        


Q ss_pred             cccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhH
Q 007167          531 ELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIR  574 (615)
Q Consensus       531 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~  574 (615)
                      ........++.   +.+++.+||..+|++||++.|+++.|+++.
T Consensus       220 ~~~~~~~~~~~---~~~li~~cl~~~p~~Rp~~~~il~~l~~~~  260 (262)
T cd05058         220 RLLQPEYCPDP---LYEVMLSCWHPKPEMRPTFSELVSRIEQIF  260 (262)
T ss_pred             CCCCCCcCCHH---HHHHHHHHcCCChhhCCCHHHHHHHHHHHh
Confidence            00001122333   445555999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=6e-37  Score=332.74  Aligned_cols=256  Identities=18%  Similarity=0.271  Sum_probs=187.9

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCHHHHHHHHHHHhCCCC------CcccceeEEEEec-CeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFEQQMEIVGGIRH------ENVVALRAYYYSK-DEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h------~niv~l~~~~~~~-~~~~lV~e~  376 (615)
                      .++||+|+||+||+|... .+..||||+++......+++..|++++..++|      .+++++++++... .+.++|||+
T Consensus       134 ~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~  213 (467)
T PTZ00284        134 LSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPK  213 (467)
T ss_pred             EEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEec
Confidence            457999999999999864 56789999997543334456677777776654      4588899988765 578899998


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc-CCCCceecCCCCCCEEeCCCC---------------
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE-NGGKLVHGGIKASNIFLNSQG---------------  440 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~iiHrDik~~Nill~~~~---------------  440 (615)
                      + +++|.+++...     ..+++..+..|+.|++.||+|||++ +   ||||||||+|||++.++               
T Consensus       214 ~-g~~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~  284 (467)
T PTZ00284        214 Y-GPCLLDWIMKH-----GPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVTNRALPPDP  284 (467)
T ss_pred             c-CCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccccccccCCCC
Confidence            8 77888888642     3689999999999999999999974 6   99999999999998765               


Q ss_pred             -cEEEeecccccccCCCCCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhh
Q 007167          441 -HVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVV  519 (615)
Q Consensus       441 -~~kl~DfG~a~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  519 (615)
                       .+||+|||.+...........+|..|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.......
T Consensus       285 ~~vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~  364 (467)
T PTZ00284        285 CRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRL  364 (467)
T ss_pred             ceEEECCCCccccCccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCC
Confidence             4999999998765544555678999999999999999999999999999999999999998765444333332211111


Q ss_pred             hccccc--------cccccccc-----------C---CCCcHH--HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          520 REEWTA--------EVFDVELL-----------R---YPNIEE--EMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       520 ~~~~~~--------~~~d~~~~-----------~---~~~~~~--~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ...|..        ++++....           .   .....+  ....+.+++.+||+.||++|||++|+++|
T Consensus       365 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~H  438 (467)
T PTZ00284        365 PSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTH  438 (467)
T ss_pred             CHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcC
Confidence            111110        00100000           0   000000  11234566679999999999999999985

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=1.6e-36  Score=309.80  Aligned_cols=254  Identities=23%  Similarity=0.360  Sum_probs=195.5

Q ss_pred             hhhcCcCCccEEEEEEECC-----------------CCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEE
Q 007167          305 AEVLGKGTFGTAYKAALED-----------------ASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYY  365 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~-----------------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~  365 (615)
                      .+.||+|+||.||+|...+                 +..||+|.+.....  ..+.+.+|++++++++|+||+++++++.
T Consensus        10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   89 (296)
T cd05051          10 VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCT   89 (296)
T ss_pred             cccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence            4679999999999987543                 24588998875422  2457889999999999999999999999


Q ss_pred             ecCeeeEEeecCCCCChhhhhccCCCC------CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCC
Q 007167          366 SKDEKLMVYDYFEPGSVSAMLHGRRGE------GQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQ  439 (615)
Q Consensus       366 ~~~~~~lV~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~  439 (615)
                      .++..++|+||+++++|.+++......      ....+++.....++.|++.||+|||+.+   |+||||||+||+++.+
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~Nili~~~  166 (296)
T cd05051          90 VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRNCLVGKN  166 (296)
T ss_pred             cCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhceeecCC
Confidence            999999999999999999999754321      1236899999999999999999999998   9999999999999999


Q ss_pred             CcEEEeecccccccCCCC-----CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh--CCCCCCCCCCcchhhHH
Q 007167          440 GHVCVSDIGLAALMSPMP-----PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT--GKSPIHATGGDEVVHLV  512 (615)
Q Consensus       440 ~~~kl~DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt--g~~p~~~~~~~~~~~~~  512 (615)
                      +.++|+|||+++......     ....++..|+|||.+....++.++|||||||++|||++  |..||......+.   .
T Consensus       167 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~---~  243 (296)
T cd05051         167 YTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQV---I  243 (296)
T ss_pred             CceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHH---H
Confidence            999999999987654322     12234567999999988889999999999999999998  7788865443322   2


Q ss_pred             HHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 007167          513 RWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVE  571 (615)
Q Consensus       513 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  571 (615)
                      ..+...........    .....+..++   ++.+++.+|++.+|++|||+.||++.|+
T Consensus       244 ~~~~~~~~~~~~~~----~~~~~~~~~~---~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         244 ENAGHFFRDDGRQI----YLPRPPNCPK---DIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             HHHHhccccccccc----cCCCccCCCH---HHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            22211111110000    0111122233   4555666999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.6e-36  Score=308.59  Aligned_cols=250  Identities=23%  Similarity=0.381  Sum_probs=193.9

Q ss_pred             hhhcCcCCccEEEEEEECC------CCEEEEEEeccccCC--HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAALED------ASTVVVKRLKEVNVG--KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      .++||+|+||.||+|..++      +..||+|.+......  ...+.+|+.+++.++|+||+++++++.+.+..++||||
T Consensus        11 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   90 (288)
T cd05061          11 LRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMEL   90 (288)
T ss_pred             eeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeC
Confidence            4679999999999997542      457999987644322  34577899999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCC-----CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeeccccc
Q 007167          377 FEPGSVSAMLHGRRG-----EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAA  451 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~  451 (615)
                      +++|+|.+++.....     ......++....+++.|++.||.|||+++   |+||||||+||++++++.++|+|||+++
T Consensus        91 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L~Dfg~~~  167 (288)
T cd05061          91 MAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKIGDFGMTR  167 (288)
T ss_pred             CCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEECcCCccc
Confidence            999999999974321     11245678889999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCCC-----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccc
Q 007167          452 LMSPMPP-----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTA  525 (615)
Q Consensus       452 ~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (615)
                      .......     ...++..|+|||.+.+..++.++|||||||++|||++ |+.||......+....      ......  
T Consensus       168 ~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~------~~~~~~--  239 (288)
T cd05061         168 DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKF------VMDGGY--  239 (288)
T ss_pred             cccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH------HHcCCC--
Confidence            6543221     1123557999999988889999999999999999998 7889976443332211      111100  


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhH
Q 007167          526 EVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIR  574 (615)
Q Consensus       526 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~  574 (615)
                            .......++.+   .+++.+|++.+|++|||+.|+++.|++..
T Consensus       240 ------~~~~~~~~~~~---~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         240 ------LDQPDNCPERV---TDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             ------CCCCCCCCHHH---HHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence                  00011223444   44555999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.4e-36  Score=305.38  Aligned_cols=245  Identities=22%  Similarity=0.343  Sum_probs=191.2

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEecccc-CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVN-VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      .+.||+|+||.||+|.. .++..||+|++.... ...+.+++|+.+++.++||||+++++++..++..++||||+++++|
T Consensus        14 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L   93 (267)
T cd06646          14 IQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSL   93 (267)
T ss_pred             hheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcH
Confidence            46799999999999996 567889999987542 2345678899999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---CC
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---PP  459 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~~  459 (615)
                      .++++..     ..+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++.......   ..
T Consensus        94 ~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~  165 (267)
T cd06646          94 QDIYHVT-----GPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS  165 (267)
T ss_pred             HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccccccCc
Confidence            9998642     36889999999999999999999997   9999999999999999999999999998664322   22


Q ss_pred             CCCCCcccCccccC---CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          460 AMRAAGYRAPEVTD---TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       460 ~~~~~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                      ..++..|+|||.+.   ...++.++|||||||++|||++|+.||......+.....      ....    ...+......
T Consensus       166 ~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~------~~~~----~~~~~~~~~~  235 (267)
T cd06646         166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM------SKSN----FQPPKLKDKT  235 (267)
T ss_pred             cccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee------ecCC----CCCCCCcccc
Confidence            34677899999874   344788999999999999999999998654322111000      0000    0000111111


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                      .++.++.++++   +|+..+|++||++++++++|
T Consensus       236 ~~~~~~~~li~---~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         236 KWSSTFHNFVK---ISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ccCHHHHHHHH---HHhhCChhhCcCHHHHhcCC
Confidence            23344555554   99999999999999998864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=2.5e-36  Score=301.33  Aligned_cols=240  Identities=24%  Similarity=0.429  Sum_probs=193.9

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEecccc---CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVN---VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      +.||+|+||.||+|... ++..|++|.+....   ...+.+.+|+++++.++||||+++++++.+++..++||||+++++
T Consensus         6 ~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   85 (256)
T cd08529           6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGD   85 (256)
T ss_pred             EEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCc
Confidence            56999999999999864 68889999986432   234668889999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC---
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP---  458 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~---  458 (615)
                      |.++++...   ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||+++.+.....   
T Consensus        86 L~~~l~~~~---~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  159 (256)
T cd08529          86 LHKLLKMQR---GRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN  159 (256)
T ss_pred             HHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence            999997532   246899999999999999999999987   99999999999999999999999999887654322   


Q ss_pred             CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC-C
Q 007167          459 PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP-N  537 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~-~  537 (615)
                      ...++..|+|||+..+..++.++|||||||++|||++|+.||......+.   ..   .....         .....+ .
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~---~~---~~~~~---------~~~~~~~~  224 (256)
T cd08529         160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGAL---IL---KIIRG---------VFPPVSQM  224 (256)
T ss_pred             ccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH---HH---HHHcC---------CCCCCccc
Confidence            23467789999999988899999999999999999999999976542221   11   11111         000111 2


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          538 IEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       538 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ++..+   .+++.+|++.+|++||++.|++++
T Consensus       225 ~~~~~---~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         225 YSQQL---AQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             cCHHH---HHHHHHHccCCcccCcCHHHHhhC
Confidence            23344   445559999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.8e-36  Score=312.16  Aligned_cols=254  Identities=25%  Similarity=0.405  Sum_probs=198.0

Q ss_pred             HhhhcCcCCccEEEEEEEC--------CCCEEEEEEeccccCC--HHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeE
Q 007167          304 SAEVLGKGTFGTAYKAALE--------DASTVVVKRLKEVNVG--KREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLM  372 (615)
Q Consensus       304 ~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~l  372 (615)
                      ..+.||+|+||.||++...        ....+|+|.++.....  ...+.+|+++++.+ +||||+++++++...+..++
T Consensus        16 ~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~l   95 (314)
T cd05099          16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYV   95 (314)
T ss_pred             eeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEE
Confidence            4567999999999999742        2456899988754322  34678899999999 69999999999999899999


Q ss_pred             EeecCCCCChhhhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCc
Q 007167          373 VYDYFEPGSVSAMLHGRRG-----------EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGH  441 (615)
Q Consensus       373 V~e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~  441 (615)
                      ||||+++|+|.+++.....           .....++|....+++.|++.||+|||+++   |+||||||+||++++++.
T Consensus        96 v~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~~~~~  172 (314)
T cd05099          96 IVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVTEDNV  172 (314)
T ss_pred             EEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEcCCCc
Confidence            9999999999999975321           11246899999999999999999999988   999999999999999999


Q ss_pred             EEEeecccccccCCCCC-----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHH
Q 007167          442 VCVSDIGLAALMSPMPP-----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWV  515 (615)
Q Consensus       442 ~kl~DfG~a~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~  515 (615)
                      +||+|||+++.......     ....+..|+|||.+....++.++|||||||++|||++ |+.||......+....+.  
T Consensus       173 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~--  250 (314)
T cd05099         173 MKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLR--  250 (314)
T ss_pred             EEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH--
Confidence            99999999987643221     1112346999999988889999999999999999999 899997644333222111  


Q ss_pred             HHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhh
Q 007167          516 NSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVK  577 (615)
Q Consensus       516 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~  577 (615)
                           ....       .......+.++.+   ++.+|+..+|++||++.|+++.|+++....
T Consensus       251 -----~~~~-------~~~~~~~~~~l~~---li~~cl~~~p~~Rps~~~ll~~l~~~~~~~  297 (314)
T cd05099         251 -----EGHR-------MDKPSNCTHELYM---LMRECWHAVPTQRPTFKQLVEALDKVLAAV  297 (314)
T ss_pred             -----cCCC-------CCCCCCCCHHHHH---HHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence                 1100       0111233344444   455999999999999999999999987643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-36  Score=300.33  Aligned_cols=242  Identities=24%  Similarity=0.407  Sum_probs=194.3

Q ss_pred             hhcCcCCccEEEEEEECCCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      ++||+|+||.||++...+++.|++|.++....  ..+.+.+|+++++.++|+||+++++++......++||||+++++|.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~   80 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL   80 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence            36999999999999987789999998876433  2457889999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC-----
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP-----  458 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~-----  458 (615)
                      +++....    ..+++.....++.+++.|++|||+.+   ++||||||+||+++.++.+||+|||++........     
T Consensus        81 ~~l~~~~----~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~  153 (251)
T cd05041          81 TFLRKKK----NRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDG  153 (251)
T ss_pred             HHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccc
Confidence            9996432    35889999999999999999999998   99999999999999999999999999976542211     


Q ss_pred             CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCC
Q 007167          459 PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN  537 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  537 (615)
                      ....+..|+|||.+.+..++.++|||||||++|||++ |..||......+....+.       ...       .......
T Consensus       154 ~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~-------~~~-------~~~~~~~  219 (251)
T cd05041         154 LKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE-------SGY-------RMPAPQL  219 (251)
T ss_pred             cCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh-------cCC-------CCCCCcc
Confidence            1122456999999988889999999999999999999 899987654322221111       000       0011112


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 007167          538 IEEEMVEMLQVGMACVVRMPEERPKMADVLKMVE  571 (615)
Q Consensus       538 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  571 (615)
                      .+.   .+.+++.+|+..+|++||++.|+++.|+
T Consensus       220 ~~~---~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         220 CPE---EIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             CCH---HHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence            233   4455555999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.4e-36  Score=305.58  Aligned_cols=246  Identities=27%  Similarity=0.453  Sum_probs=193.6

Q ss_pred             hcCcCCccEEEEEEECC-------CCEEEEEEecccc--CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecC
Q 007167          307 VLGKGTFGTAYKAALED-------ASTVVVKRLKEVN--VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYF  377 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  377 (615)
                      .||+|+||.||+|+..+       +..+++|.+....  .....+.+|+++++.++||||+++++++...+..++||||+
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~   81 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM   81 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence            58999999999998643       2468889876542  23567889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCC--CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCC-----cEEEeecccc
Q 007167          378 EPGSVSAMLHGRRGE--GQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG-----HVCVSDIGLA  450 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~--~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~-----~~kl~DfG~a  450 (615)
                      ++++|.+++......  ....+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++     .++++|||++
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~  158 (269)
T cd05044          82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA  158 (269)
T ss_pred             CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence            999999999753221  2345889999999999999999999987   99999999999999887     8999999998


Q ss_pred             cccCCCC-----CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccc
Q 007167          451 ALMSPMP-----PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWT  524 (615)
Q Consensus       451 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  524 (615)
                      +......     .....+..|+|||.+.+..++.++|||||||++|||++ |+.||......+....+.      ..   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~------~~---  229 (269)
T cd05044         159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVT------AG---  229 (269)
T ss_pred             cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHh------cC---
Confidence            7654321     12234567999999998889999999999999999998 999997544332221111      00   


Q ss_pred             cccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 007167          525 AEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVED  572 (615)
Q Consensus       525 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  572 (615)
                           .........++.+.+   ++.+|+..+|.+||++.+|++.|++
T Consensus       230 -----~~~~~~~~~~~~~~~---li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         230 -----GRLQKPENCPDKIYQ---LMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             -----CccCCcccchHHHHH---HHHHHcCCCcccCCCHHHHHHHHhC
Confidence                 011112233444444   4559999999999999999999863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-36  Score=309.71  Aligned_cols=256  Identities=23%  Similarity=0.348  Sum_probs=193.3

Q ss_pred             HhhhcCcCCccEEEEEEECC---------------CCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEe
Q 007167          304 SAEVLGKGTFGTAYKAALED---------------ASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYS  366 (615)
Q Consensus       304 ~~~~lG~G~fg~Vy~~~~~~---------------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~  366 (615)
                      ..+.||+|+||.||++..++               ...||+|.++....  ....+.+|++++++++|+|++++++++..
T Consensus         9 ~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~   88 (295)
T cd05097           9 LKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVS   88 (295)
T ss_pred             ehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcC
Confidence            34679999999999987543               12488998865322  23568899999999999999999999999


Q ss_pred             cCeeeEEeecCCCCChhhhhccCCC-------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCC
Q 007167          367 KDEKLMVYDYFEPGSVSAMLHGRRG-------EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQ  439 (615)
Q Consensus       367 ~~~~~lV~e~~~~gsL~~~l~~~~~-------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~  439 (615)
                      .+..++||||+++++|.+++.....       .....+++..+++++.|++.||+|||+.+   ++||||||+||+++++
T Consensus        89 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nill~~~  165 (295)
T cd05097          89 DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCLVGNH  165 (295)
T ss_pred             CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEEEcCC
Confidence            9999999999999999999864311       01124789999999999999999999998   9999999999999999


Q ss_pred             CcEEEeecccccccCCCCC-----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh--CCCCCCCCCCcchhhHH
Q 007167          440 GHVCVSDIGLAALMSPMPP-----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT--GKSPIHATGGDEVVHLV  512 (615)
Q Consensus       440 ~~~kl~DfG~a~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt--g~~p~~~~~~~~~~~~~  512 (615)
                      +.+||+|||++........     ...++..|+|||......++.++|||||||+++||++  |..||.....++....+
T Consensus       166 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~  245 (295)
T cd05097         166 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENT  245 (295)
T ss_pred             CcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHH
Confidence            9999999999976543221     1123567999999988889999999999999999998  66788765443322211


Q ss_pred             HHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 007167          513 RWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVED  572 (615)
Q Consensus       513 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  572 (615)
                         ............    ....+..++   .+.+++.+|+..+|++||++.+|++.|++
T Consensus       246 ---~~~~~~~~~~~~----~~~~~~~~~---~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         246 ---GEFFRNQGRQIY----LSQTPLCPS---PVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             ---HHhhhhcccccc----CCCCCCCCH---HHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence               111111100000    001122233   45555559999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.6e-36  Score=311.44  Aligned_cols=195  Identities=25%  Similarity=0.444  Sum_probs=159.3

Q ss_pred             hhhcCcCCccEEEEEEEC---CCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEe--cCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE---DASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYS--KDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~~~  379 (615)
                      +.+||+|+||+||+|...   +++.||+|.++.... ...+.+|++++++++||||+++++++..  +...++||||+. 
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-
Confidence            357999999999999864   457899999875432 3457889999999999999999999864  356789999985 


Q ss_pred             CChhhhhccCCC----CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEe----CCCCcEEEeeccccc
Q 007167          380 GSVSAMLHGRRG----EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFL----NSQGHVCVSDIGLAA  451 (615)
Q Consensus       380 gsL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill----~~~~~~kl~DfG~a~  451 (615)
                      ++|.+++.....    .....+++.....++.|++.||+|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus        84 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~  160 (317)
T cd07868          84 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR  160 (317)
T ss_pred             CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence            578887753221    12235889999999999999999999998   9999999999999    456789999999998


Q ss_pred             ccCCCC------CCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 007167          452 LMSPMP------PPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATG  504 (615)
Q Consensus       452 ~~~~~~------~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~  504 (615)
                      ......      ....+|..|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            764321      23356888999999876 458999999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-37  Score=319.25  Aligned_cols=243  Identities=23%  Similarity=0.358  Sum_probs=201.4

Q ss_pred             HhhhcCcCCccEEEEEEECC--CC--EEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecC
Q 007167          304 SAEVLGKGTFGTAYKAALED--AS--TVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYF  377 (615)
Q Consensus       304 ~~~~lG~G~fg~Vy~~~~~~--~~--~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  377 (615)
                      ..|+||+|.||+|++|.|..  |+  .||||.++....  .-.+|.+|+.+|.+++|+|+++|+|...+ ....||+|++
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELa  192 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELA  192 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhc
Confidence            46789999999999999753  43  489999987633  35789999999999999999999999987 6789999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC
Q 007167          378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP  457 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~  457 (615)
                      +.|+|.+.|++.   ....+-......++.|||.|+.||..++   .||||+..+|+|+-....+||+|||+.+-+....
T Consensus       193 plGSLldrLrka---~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  193 PLGSLLDRLRKA---KKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             ccchHHHHHhhc---cccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            999999999862   3456788888999999999999999998   9999999999999999999999999999887654


Q ss_pred             CCCC------CCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccc
Q 007167          458 PPAM------RAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDV  530 (615)
Q Consensus       458 ~~~~------~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  530 (615)
                      ....      ....|+|||.+..++++.++|||+|||++|||+| |+.||.+....++.+.++ -             ..
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD-~-------------~e  332 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNID-A-------------GE  332 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcc-c-------------cc
Confidence            3322      2346999999999999999999999999999999 999999877655544432 0             11


Q ss_pred             cccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          531 ELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       531 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                      .+.+.+.++   +++.+++..||..+|++|||+..+.+.+
T Consensus       333 rLpRPk~cs---edIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  333 RLPRPKYCS---EDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             cCCCCCCCh---HHHHHHHHHhccCCccccccHHHHHHhH
Confidence            233444444   4555666699999999999999998544

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=4.1e-36  Score=310.71  Aligned_cols=232  Identities=20%  Similarity=0.325  Sum_probs=184.6

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEecccc----CCHHHHHHHHHHHhCCC-CCcccceeEEEEecCeeeEEeecCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVN----VGKREFEQQMEIVGGIR-HENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      +.||+|+||+||+|... +++.||+|.++...    ...+.+..|.+++..+. |++|+++++++...+..++||||+++
T Consensus         6 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~   85 (323)
T cd05615           6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNG   85 (323)
T ss_pred             EEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCC
Confidence            46999999999999864 67889999987532    12345677888888775 57788899999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC---
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM---  456 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~---  456 (615)
                      |+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....   
T Consensus        86 g~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~  157 (323)
T cd05615          86 GDLMYHIQQV-----GKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVT  157 (323)
T ss_pred             CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCCCcc
Confidence            9999998642     36899999999999999999999998   999999999999999999999999998754322   


Q ss_pred             CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          457 PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       457 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                      .....++..|+|||++.+..++.++||||+||++|||++|+.||......+....      +...         ......
T Consensus       158 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~------i~~~---------~~~~p~  222 (323)
T cd05615         158 TRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQS------IMEH---------NVSYPK  222 (323)
T ss_pred             ccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH------HHhC---------CCCCCc
Confidence            1233578899999999988899999999999999999999999976543322211      1111         111112


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKM  563 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~  563 (615)
                      ..+++..++++   +|+..+|.+|++.
T Consensus       223 ~~~~~~~~li~---~~l~~~p~~R~~~  246 (323)
T cd05615         223 SLSKEAVSICK---GLMTKHPSKRLGC  246 (323)
T ss_pred             cCCHHHHHHHH---HHcccCHhhCCCC
Confidence            33455555555   9999999999984

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.9e-36  Score=311.34  Aligned_cols=254  Identities=19%  Similarity=0.368  Sum_probs=192.3

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc--CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN--VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      .+.||+|+||+||+|..+ ++..||+|+++...  .....+.+|++++++++||||+++++++..++..++||||+++ +
T Consensus        11 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~   89 (309)
T cd07872          11 LEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-D   89 (309)
T ss_pred             EEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-C
Confidence            356999999999999865 56789999987542  2234677899999999999999999999999999999999975 7


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---C
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---P  458 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~  458 (615)
                      |.+.+...    ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++......   .
T Consensus        90 l~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  162 (309)
T cd07872          90 LKQYMDDC----GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYS  162 (309)
T ss_pred             HHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCccccc
Confidence            88877643    235889999999999999999999998   9999999999999999999999999997654322   2


Q ss_pred             CCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHH-HHhhhccccc-----cccccc
Q 007167          459 PAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWV-NSVVREEWTA-----EVFDVE  531 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~d~~  531 (615)
                      ...++..|+|||.+.+ ..++.++||||+||++|||++|+.||...+..+....+... .....+.|..     +..+..
T Consensus       163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
T cd07872         163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYN  242 (309)
T ss_pred             cccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhh
Confidence            2346788999998865 45789999999999999999999999876544333222211 1111111100     000000


Q ss_pred             ---------ccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          532 ---------LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       532 ---------~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                               ....+..+++..++++   +|+..||++|||+.|++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         243 FPKYKPQPLINHAPRLDTEGIELLT---KFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             cCccCCCchhhhccCCCHHHHHHHH---HhccCChhhCCCHHHHhcC
Confidence                     0111234455555555   9999999999999999885

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=2.6e-36  Score=305.85  Aligned_cols=247  Identities=26%  Similarity=0.413  Sum_probs=194.4

Q ss_pred             hhhcCcCCccEEEEEEEC------CCCEEEEEEecccc-CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecC
Q 007167          305 AEVLGKGTFGTAYKAALE------DASTVVVKRLKEVN-VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYF  377 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  377 (615)
                      .++||+|+||.||++...      ++..+++|.++... .....+.+|+++++.++|+||+++++++...+..++||||+
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   89 (280)
T cd05092          10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYM   89 (280)
T ss_pred             ccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecC
Confidence            467999999999999642      35578899887543 22457899999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeec
Q 007167          378 EPGSVSAMLHGRRG----------EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDI  447 (615)
Q Consensus       378 ~~gsL~~~l~~~~~----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Df  447 (615)
                      ++|+|.++++....          .....+++..+..++.|++.|++|||+.+   |+||||||+||++++++.+||+||
T Consensus        90 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~kL~df  166 (280)
T cd05092          90 RHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVVKIGDF  166 (280)
T ss_pred             CCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCEEECCC
Confidence            99999999875321          11235899999999999999999999998   999999999999999999999999


Q ss_pred             ccccccCCCCC-----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhc
Q 007167          448 GLAALMSPMPP-----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVRE  521 (615)
Q Consensus       448 G~a~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  521 (615)
                      |++..+.....     ...++..|+|||.+.+..++.++|||||||++|||++ |+.||......+....+      ...
T Consensus       167 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~------~~~  240 (280)
T cd05092         167 GMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECI------TQG  240 (280)
T ss_pred             CceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHH------HcC
Confidence            99976543221     1223567999999988889999999999999999998 99999764433322111      110


Q ss_pred             ccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 007167          522 EWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVE  571 (615)
Q Consensus       522 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  571 (615)
                      .        .......+++.+.+++.   +||+.||.+||+++||++.|+
T Consensus       241 ~--------~~~~~~~~~~~~~~li~---~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         241 R--------ELERPRTCPPEVYAIMQ---GCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             c--------cCCCCCCCCHHHHHHHH---HHccCChhhCCCHHHHHHHHh
Confidence            0        00111233445555555   999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=4.4e-36  Score=302.52  Aligned_cols=243  Identities=21%  Similarity=0.416  Sum_probs=190.7

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCHHHHHHHHHHHhCC-CCCcccceeEEEEec------CeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFEQQMEIVGGI-RHENVVALRAYYYSK------DEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~------~~~~lV~e~  376 (615)
                      .+.||+|+||.||+|... +++.||+|++.........+.+|++++.++ +|+||+++++++...      ...++||||
T Consensus        11 ~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~   90 (272)
T cd06637          11 VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEF   90 (272)
T ss_pred             HHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEc
Confidence            467999999999999864 577899999876655667888999999998 799999999998753      468999999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM  456 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~  456 (615)
                      +.+|+|.+++....   ...+++..+..++.|++.|++|||+.+   |+||||||+||++++++.++|+|||++......
T Consensus        91 ~~~~~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~  164 (272)
T cd06637          91 CGAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT  164 (272)
T ss_pred             CCCCcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCceecccc
Confidence            99999999987532   346899999999999999999999998   999999999999999999999999999865432


Q ss_pred             ---CCCCCCCCcccCccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccc
Q 007167          457 ---PPPAMRAAGYRAPEVTD-----TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVF  528 (615)
Q Consensus       457 ---~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  528 (615)
                         .....++..|+|||++.     ...++.++|||||||++|||++|+.||...........   .   .. ..     
T Consensus       165 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~---~---~~-~~-----  232 (272)
T cd06637         165 VGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL---I---PR-NP-----  232 (272)
T ss_pred             cccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH---H---hc-CC-----
Confidence               22334677899999985     33578899999999999999999999965332111100   0   00 00     


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          529 DVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       529 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ... .....+++++.+++.   +|+..+|.+|||+.|++++
T Consensus       233 ~~~-~~~~~~~~~~~~li~---~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         233 APR-LKSKKWSKKFQSFIE---SCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             CCC-CCCCCcCHHHHHHHH---HHcCCChhhCCCHHHHhhC
Confidence            000 111233445555555   9999999999999999864

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.7e-36  Score=319.91  Aligned_cols=253  Identities=21%  Similarity=0.290  Sum_probs=189.5

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEecC-----eeeEEee
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSKD-----EKLMVYD  375 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lV~e  375 (615)
                      .+.||+|+||+||++.. .+++.||+|++.....   ..+.+.+|+++++.++|+||+++++++...+     ..++|+|
T Consensus         5 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e   84 (372)
T cd07853           5 DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTE   84 (372)
T ss_pred             cceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEee
Confidence            45799999999999985 4789999999865422   2356789999999999999999999998776     7899999


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      |+. ++|.+.+..     ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus        85 ~~~-~~l~~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          85 LMQ-SDLHKIIVS-----PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             ccc-cCHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            996 578877753     236899999999999999999999998   99999999999999999999999999986543


Q ss_pred             CC----CCCCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHh-hhccc------
Q 007167          456 MP----PPAMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSV-VREEW------  523 (615)
Q Consensus       456 ~~----~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~------  523 (615)
                      ..    ....++..|+|||.+.+. .++.++||||+||++|||++|+.||...+..+....+...... ..+..      
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  235 (372)
T cd07853         156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG  235 (372)
T ss_pred             CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence            22    223457789999998764 4789999999999999999999999875543322221110000 00000      


Q ss_pred             ccccccccc----------cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          524 TAEVFDVEL----------LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       524 ~~~~~d~~~----------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ....+....          ......+++..   +++.+|++.||++|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         236 ARAHILRGPHKPPSLPVLYTLSSQATHEAV---HLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHHHhCCCCCCchHHhcccCCCCCHHHH---HHHHHhCCCChhhCcCHHHHhcC
Confidence            000000000          00112233444   45559999999999999999986

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=2.5e-36  Score=309.61  Aligned_cols=246  Identities=26%  Similarity=0.401  Sum_probs=192.3

Q ss_pred             hhhcCcCCccEEEEEEEC-CCC----EEEEEEeccccCC--HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecC
Q 007167          305 AEVLGKGTFGTAYKAALE-DAS----TVVVKRLKEVNVG--KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYF  377 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  377 (615)
                      .+.||+|+||.||+|.+. ++.    .||+|.+......  ..++.+|+.+++.++||||+++++++... ..++++||+
T Consensus        12 ~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~   90 (303)
T cd05110          12 VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLM   90 (303)
T ss_pred             ccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Cceeeehhc
Confidence            457999999999999853 343    4688887654322  34678899999999999999999998754 467899999


Q ss_pred             CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC
Q 007167          378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP  457 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~  457 (615)
                      ++|+|.+++...    ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.+....
T Consensus        91 ~~g~l~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~  163 (303)
T cd05110          91 PHGCLLDYVHEH----KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE  163 (303)
T ss_pred             CCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccccCcc
Confidence            999999998743    235889999999999999999999998   9999999999999999999999999998764322


Q ss_pred             C-----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccccccccc
Q 007167          458 P-----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE  531 (615)
Q Consensus       458 ~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  531 (615)
                      .     ....+..|+|||++.+..++.++|||||||++|||++ |+.||......+...   ++..    .       ..
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~---~~~~----~-------~~  229 (303)
T cd05110         164 KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPD---LLEK----G-------ER  229 (303)
T ss_pred             cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---HHHC----C-------CC
Confidence            1     1223567999999988889999999999999999998 999997644332222   1111    0       00


Q ss_pred             ccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          532 LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       532 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                      ....+...   .++.+++.+||..+|++||+++|+++.|+++..
T Consensus       230 ~~~~~~~~---~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~  270 (303)
T cd05110         230 LPQPPICT---IDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR  270 (303)
T ss_pred             CCCCCCCC---HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            11111222   345556669999999999999999999998764

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=4.4e-36  Score=307.51  Aligned_cols=247  Identities=24%  Similarity=0.382  Sum_probs=195.0

Q ss_pred             hhhcCcCCccEEEEEEEC------CCCEEEEEEeccccCC--HHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEee
Q 007167          305 AEVLGKGTFGTAYKAALE------DASTVVVKRLKEVNVG--KREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYD  375 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e  375 (615)
                      .+.||+|+||.||++...      .+..||+|+++.....  .+.+.+|+++++++ +|+||+++++++...+..++|||
T Consensus        40 ~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e  119 (302)
T cd05055          40 GKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITE  119 (302)
T ss_pred             cceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEE
Confidence            567999999999999741      3457999988754322  35688999999999 79999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      |+.+|+|.++++...   ...+++.++..++.|++.||+|||+.+   |+|+||||+||+++.++.++++|||+++....
T Consensus       120 ~~~~~~L~~~i~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  193 (302)
T cd05055         120 YCCYGDLLNFLRRKR---ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMN  193 (302)
T ss_pred             cCCCCcHHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccccccC
Confidence            999999999997533   234899999999999999999999998   99999999999999999999999999986643


Q ss_pred             CCC-----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccccccc
Q 007167          456 MPP-----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD  529 (615)
Q Consensus       456 ~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  529 (615)
                      ...     ...++..|+|||.+....++.++||||+||++|||++ |+.||......+..  ...+    ...+.     
T Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~--~~~~----~~~~~-----  262 (302)
T cd05055         194 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKF--YKLI----KEGYR-----  262 (302)
T ss_pred             CCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHH--HHHH----HcCCc-----
Confidence            221     1223567999999988889999999999999999998 99999765432211  1111    11110     


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 007167          530 VELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI  573 (615)
Q Consensus       530 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l  573 (615)
                        .......++++.+   ++.+|+..+|++||++.|+++.|+++
T Consensus       263 --~~~~~~~~~~~~~---li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         263 --MAQPEHAPAEIYD---IMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             --CCCCCCCCHHHHH---HHHHHcCCCchhCcCHHHHHHHHHhh
Confidence              0011122344444   45599999999999999999999875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.8e-36  Score=308.23  Aligned_cols=248  Identities=23%  Similarity=0.373  Sum_probs=194.1

Q ss_pred             hhhcCcCCccEEEEEEEC------CCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAALE------DASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      .+.||+|+||.||+|...      ++..||+|.++....  ..+.+.+|++++++++||||+++++++...+..++||||
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   89 (288)
T cd05050          10 VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEY   89 (288)
T ss_pred             cccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEec
Confidence            356999999999999853      467899998875422  245688999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCC-----------------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCC
Q 007167          377 FEPGSVSAMLHGRRG-----------------EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQ  439 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~-----------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~  439 (615)
                      +++|+|.+++.....                 .....+++..++.++.|++.||+|||+.+   ++||||||+||+++++
T Consensus        90 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~nil~~~~  166 (288)
T cd05050          90 MAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRNCLVGEN  166 (288)
T ss_pred             CCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhheEecCC
Confidence            999999999974321                 11235789999999999999999999998   9999999999999999


Q ss_pred             CcEEEeecccccccCCCC-----CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHH
Q 007167          440 GHVCVSDIGLAALMSPMP-----PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVR  513 (615)
Q Consensus       440 ~~~kl~DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~  513 (615)
                      +.++|+|||++..+....     .....+..|+|||.+.+..++.++|||||||++|||++ |..||......+...   
T Consensus       167 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~---  243 (288)
T cd05050         167 MVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIY---  243 (288)
T ss_pred             CceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH---
Confidence            999999999987654321     12223557999999988889999999999999999998 888987544332221   


Q ss_pred             HHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 007167          514 WVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVED  572 (615)
Q Consensus       514 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  572 (615)
                         ...... .       ....+..+.++.+   ++.+|++.+|++|||+.|+++.|++
T Consensus       244 ---~~~~~~-~-------~~~~~~~~~~l~~---li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         244 ---YVRDGN-V-------LSCPDNCPLELYN---LMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ---HHhcCC-C-------CCCCCCCCHHHHH---HHHHHcccCcccCCCHHHHHHHhhC
Confidence               111110 0       0011123344444   5559999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.3e-36  Score=308.60  Aligned_cols=252  Identities=26%  Similarity=0.418  Sum_probs=190.7

Q ss_pred             hhhcCcCCccEEEEEEE-----CCCCEEEEEEeccccC-CHHHHHHHHHHHhCCCCCcccceeEEEEec--CeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAAL-----EDASTVVVKRLKEVNV-GKREFEQQMEIVGGIRHENVVALRAYYYSK--DEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e~  376 (615)
                      .+.||+|+||+||++..     .++..|++|+++.... ..+.+.+|+++++.++||||+++++++...  ...++||||
T Consensus         9 ~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~   88 (284)
T cd05081           9 IQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEY   88 (284)
T ss_pred             eeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEe
Confidence            45799999999999974     3577899999875432 245788999999999999999999987543  468899999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM  456 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~  456 (615)
                      +++|+|.+++...+    ..+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++.....
T Consensus        89 ~~~~~L~~~l~~~~----~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  161 (284)
T cd05081          89 LPYGSLRDYLQKHR----ERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVLPQD  161 (284)
T ss_pred             cCCCCHHHHHHhcC----cCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence            99999999997432    35899999999999999999999998   999999999999999999999999999876432


Q ss_pred             CCC------CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcch---------hhHHHHHHHhhhc
Q 007167          457 PPP------AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEV---------VHLVRWVNSVVRE  521 (615)
Q Consensus       457 ~~~------~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~---------~~~~~~~~~~~~~  521 (615)
                      ...      ...+..|+|||++.+..++.++|||||||++|||++|..|+........         ......+......
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05081         162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN  241 (284)
T ss_pred             CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhc
Confidence            211      1123359999999888899999999999999999998877643321100         0000000000000


Q ss_pred             ccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 007167          522 EWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI  573 (615)
Q Consensus       522 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l  573 (615)
                      .       ........+++++   .+++.+||..+|++|||++||++.|+.+
T Consensus       242 ~-------~~~~~~~~~~~~~---~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         242 N-------GRLPAPPGCPAEI---YAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             C-------CcCCCCCCCCHHH---HHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            0       0011112333444   4555599999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.2e-36  Score=314.21  Aligned_cols=255  Identities=28%  Similarity=0.405  Sum_probs=194.5

Q ss_pred             HHHhhhcCcCCccEEEEEEE------CCCCEEEEEEeccccCC--HHHHHHHHHHHhCC-CCCcccceeEEEEec-Ceee
Q 007167          302 RASAEVLGKGTFGTAYKAAL------EDASTVVVKRLKEVNVG--KREFEQQMEIVGGI-RHENVVALRAYYYSK-DEKL  371 (615)
Q Consensus       302 ~~~~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~~  371 (615)
                      +...+.||+|+||+||+|..      .+++.||||+++.....  ...+.+|++++.++ +|+||+++++++... ...+
T Consensus         9 ~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~   88 (343)
T cd05103           9 LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLM   88 (343)
T ss_pred             hcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceE
Confidence            34567899999999999973      34678999999754222  34578899999999 689999999988654 4678


Q ss_pred             EEeecCCCCChhhhhccCCCC-----------------------------------------------------------
Q 007167          372 MVYDYFEPGSVSAMLHGRRGE-----------------------------------------------------------  392 (615)
Q Consensus       372 lV~e~~~~gsL~~~l~~~~~~-----------------------------------------------------------  392 (615)
                      +||||+++|+|.++++.....                                                           
T Consensus        89 lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  168 (343)
T cd05103          89 VIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQ  168 (343)
T ss_pred             EEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhh
Confidence            999999999999998643210                                                           


Q ss_pred             ---CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC-----CCCCCC
Q 007167          393 ---GQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP-----PAMRAA  464 (615)
Q Consensus       393 ---~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~-----~~~~~~  464 (615)
                         ....+++..+.+++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++........     ...++.
T Consensus       169 ~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd05103         169 EDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  245 (343)
T ss_pred             hhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCc
Confidence               0124788899999999999999999998   99999999999999999999999999976532211     122345


Q ss_pred             cccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHHHHH
Q 007167          465 GYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMV  543 (615)
Q Consensus       465 ~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  543 (615)
                      .|+|||.+.+..++.++||||||+++|||++ |..||......+.  ...    .......       ........+   
T Consensus       246 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~--~~~----~~~~~~~-------~~~~~~~~~---  309 (343)
T cd05103         246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCR----RLKEGTR-------MRAPDYTTP---  309 (343)
T ss_pred             ceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHH--HHH----HHhccCC-------CCCCCCCCH---
Confidence            7999999988889999999999999999997 9999976432211  111    1111100       000111222   


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          544 EMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       544 ~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                      ++.+++..||+.+|++||++.||+++|+.+.+
T Consensus       310 ~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         310 EMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             HHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            45666679999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-37  Score=313.70  Aligned_cols=239  Identities=26%  Similarity=0.463  Sum_probs=196.3

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEeccc-cCC---HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEV-NVG---KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      ..||+|+||.||-|.+ ++...||||++... ...   -.++..|+.+|..++|||+|.+.|+|......|+||||| -|
T Consensus        32 rEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lG  110 (948)
T KOG0577|consen   32 REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LG  110 (948)
T ss_pred             HHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hc
Confidence            4599999999999985 46678999999654 111   246889999999999999999999999999999999999 55


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCCC
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPA  460 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  460 (615)
                      +-.+++.-.    ..++.+..+..|..++++||+|||+.+   .||||||+.|||+++.|.+|++|||.|..+.+. ...
T Consensus       111 SAsDlleVh----kKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-nsF  182 (948)
T KOG0577|consen  111 SASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-NSF  182 (948)
T ss_pred             cHHHHHHHH----hccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch-hcc
Confidence            777777532    347888999999999999999999998   999999999999999999999999999877654 456


Q ss_pred             CCCCcccCcccc---CCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCC
Q 007167          461 MRAAGYRAPEVT---DTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN  537 (615)
Q Consensus       461 ~~~~~y~aPE~~---~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  537 (615)
                      +||+.|||||++   ..+.|+-|+||||+|++..||...++|+..++.......+      .++       +......+.
T Consensus       183 vGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHI------AQN-------esPtLqs~e  249 (948)
T KOG0577|consen  183 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI------AQN-------ESPTLQSNE  249 (948)
T ss_pred             cCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHH------Hhc-------CCCCCCCch
Confidence            899999999987   4578999999999999999999999998876543322111      111       112223456


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          538 IEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       538 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      +++....+++   .|+++-|.+|||.++++++
T Consensus       250 WS~~F~~Fvd---~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  250 WSDYFRNFVD---SCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             hHHHHHHHHH---HHHhhCcccCCcHHHHhhc
Confidence            6777788888   9999999999999988774

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-37  Score=318.05  Aligned_cols=241  Identities=25%  Similarity=0.413  Sum_probs=191.0

Q ss_pred             hcCcCCccEEEEEEECCC-CEEEEEEeccccC-CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChhh
Q 007167          307 VLGKGTFGTAYKAALEDA-STVVVKRLKEVNV-GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSA  384 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~~~-~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  384 (615)
                      +||+|.||+||.|++.+. ..+|||-+..... ...-+..|+.+-+.++|+|||+++|.+.++++.-|.||-.+||+|.+
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSs  661 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSS  661 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHH
Confidence            699999999999997654 4589998875432 23457789999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeC-CCCcEEEeecccccccC---CCCCCC
Q 007167          385 MLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLN-SQGHVCVSDIGLAALMS---PMPPPA  460 (615)
Q Consensus       385 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~-~~~~~kl~DfG~a~~~~---~~~~~~  460 (615)
                      +|+..-+  .-.-++.+.-.+.+||++||.|||+..   |||||||..|||++ -.|.+||+|||.++.+.   +-..+.
T Consensus       662 LLrskWG--PlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETF  736 (1226)
T KOG4279|consen  662 LLRSKWG--PLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETF  736 (1226)
T ss_pred             HHHhccC--CCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCCcccccc
Confidence            9985432  222277888889999999999999997   99999999999997 46899999999998774   334556


Q ss_pred             CCCCcccCccccCCC--CCCCccchhhHHHHHHHHHhCCCCCCCCCCcch-hhHHHHHHHhhhcccccccccccccCCCC
Q 007167          461 MRAAGYRAPEVTDTR--KATQASDVFSFGVLLLELLTGKSPIHATGGDEV-VHLVRWVNSVVREEWTAEVFDVELLRYPN  537 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~--~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  537 (615)
                      .||..|||||++..+  .|..++|||||||++.||.||++||...+.... ...+.             ++....+-...
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVG-------------myKvHP~iPee  803 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVG-------------MYKVHPPIPEE  803 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhc-------------ceecCCCCcHH
Confidence            789999999999764  489999999999999999999999986554322 11111             11111111123


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007167          538 IEEEMVEMLQVGMACVVRMPEERPKMADVLK  568 (615)
Q Consensus       538 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  568 (615)
                      ++.+.+.+   +++|+.+||.+||++.++++
T Consensus       804 lsaeak~F---ilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  804 LSAEAKNF---ILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             HHHHHHHH---HHHHcCCCcccCccHHHhcc
Confidence            34444444   45999999999999999986

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=4e-36  Score=306.95  Aligned_cols=255  Identities=22%  Similarity=0.360  Sum_probs=194.6

Q ss_pred             hhhcCcCCccEEEEEEEC-----------------CCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEE
Q 007167          305 AEVLGKGTFGTAYKAALE-----------------DASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYY  365 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-----------------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~  365 (615)
                      .+.||+|+||.||++...                 ++..||+|+++....  ....+.+|+++++.++|+||+++++++.
T Consensus        10 ~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~   89 (296)
T cd05095          10 KEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCI   89 (296)
T ss_pred             eeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            457999999999998543                 234689998875422  2457889999999999999999999999


Q ss_pred             ecCeeeEEeecCCCCChhhhhccCCCC------CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCC
Q 007167          366 SKDEKLMVYDYFEPGSVSAMLHGRRGE------GQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQ  439 (615)
Q Consensus       366 ~~~~~~lV~e~~~~gsL~~~l~~~~~~------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~  439 (615)
                      ..+..++||||+++|+|.+++......      ....+++.....++.|++.||+|||+.+   |+||||||+||+++.+
T Consensus        90 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Nili~~~  166 (296)
T cd05095          90 TSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNCLVGKN  166 (296)
T ss_pred             cCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheEEEcCC
Confidence            999999999999999999999754311      1235788999999999999999999998   9999999999999999


Q ss_pred             CcEEEeecccccccCCCCC-----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh--CCCCCCCCCCcchhhHH
Q 007167          440 GHVCVSDIGLAALMSPMPP-----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT--GKSPIHATGGDEVVHLV  512 (615)
Q Consensus       440 ~~~kl~DfG~a~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt--g~~p~~~~~~~~~~~~~  512 (615)
                      +.++|+|||+++.+.....     ....+..|+|||....+.++.++|||||||++|||++  |..||......+.... 
T Consensus       167 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~-  245 (296)
T cd05095         167 YTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQVIEN-  245 (296)
T ss_pred             CCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHHHHH-
Confidence            9999999999986643221     1123467999999888889999999999999999998  7788876544332221 


Q ss_pred             HHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 007167          513 RWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVED  572 (615)
Q Consensus       513 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  572 (615)
                        .............    ....+..++   .+.+++.+|++.||++||++.||++.|++
T Consensus       246 --~~~~~~~~~~~~~----~~~~~~~~~---~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         246 --TGEFFRDQGRQVY----LPKPALCPD---SLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             --HHHHHhhcccccc----CCCCCCCCH---HHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence              1111111111110    111122333   44455559999999999999999999863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-36  Score=300.18  Aligned_cols=241  Identities=20%  Similarity=0.329  Sum_probs=192.1

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccCC------HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecC
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVG------KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYF  377 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  377 (615)
                      .+.||+|++|.||++.. .++..|++|.+......      .+.+.+|++++++++||||+++++++.+++..++|+||+
T Consensus         7 ~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~   86 (263)
T cd06625           7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM   86 (263)
T ss_pred             cceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEEC
Confidence            46799999999999985 46889999988643211      245788999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC
Q 007167          378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP  457 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~  457 (615)
                      ++++|.+++...     ..+++....+++.|++.||.|||+.+   |+||||+|+||++++++.++|+|||+++......
T Consensus        87 ~~~~l~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~  158 (263)
T cd06625          87 PGGSVKDQLKAY-----GALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  158 (263)
T ss_pred             CCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence            999999998642     35888999999999999999999998   9999999999999999999999999997654321


Q ss_pred             ------CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccccc
Q 007167          458 ------PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE  531 (615)
Q Consensus       458 ------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  531 (615)
                            ....++..|+|||.+.+..++.++||||+|+++|||++|+.||......+..   ...   .....       .
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~---~~~---~~~~~-------~  225 (263)
T cd06625         159 SSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAI---FKI---ATQPT-------N  225 (263)
T ss_pred             cccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHH---HHH---hccCC-------C
Confidence                  1233567899999999888999999999999999999999999764322111   110   00000       0


Q ss_pred             ccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          532 LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       532 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ........+.+.++++   +|+..+|++|||+.|++++
T Consensus       226 ~~~~~~~~~~~~~li~---~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         226 PQLPSHVSPDARNFLR---RTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             CCCCccCCHHHHHHHH---HHhhcCcccCCCHHHHhhC
Confidence            0011223445555555   9999999999999999876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.8e-36  Score=306.19  Aligned_cols=253  Identities=24%  Similarity=0.353  Sum_probs=192.9

Q ss_pred             HHhhhcCcCCccEEEEEEE-----CCCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEec--CeeeEE
Q 007167          303 ASAEVLGKGTFGTAYKAAL-----EDASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSK--DEKLMV  373 (615)
Q Consensus       303 ~~~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV  373 (615)
                      ...+.||+|+||.||++..     .++..||+|.++....  ..+.+.+|+++++.++|+||+++.+++...  ...++|
T Consensus         7 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv   86 (284)
T cd05079           7 KRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLI   86 (284)
T ss_pred             hhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEE
Confidence            4456799999999999974     3577899999875422  235788999999999999999999999875  568999


Q ss_pred             eecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeeccccccc
Q 007167          374 YDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALM  453 (615)
Q Consensus       374 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~  453 (615)
                      |||+++++|.+++...    ...++|..+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+|||+++.+
T Consensus        87 ~e~~~g~~L~~~l~~~----~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~~  159 (284)
T cd05079          87 MEFLPSGSLKEYLPRN----KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAI  159 (284)
T ss_pred             EEccCCCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccccc
Confidence            9999999999998643    235899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCCC------CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc---------hhhHHHHHHHh
Q 007167          454 SPMPP------PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDE---------VVHLVRWVNSV  518 (615)
Q Consensus       454 ~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~---------~~~~~~~~~~~  518 (615)
                      .....      ...++..|+|||++.+..++.++|||||||++|||++++.|+.......         ......++...
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd05079         160 ETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVL  239 (284)
T ss_pred             ccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHH
Confidence            43221      2234556999999988889999999999999999999877653321100         00001111111


Q ss_pred             hhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 007167          519 VREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI  573 (615)
Q Consensus       519 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l  573 (615)
                      ....        .......+++.   +.+++.+|++.+|++||++.|+++.|+++
T Consensus       240 ~~~~--------~~~~~~~~~~~---~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         240 EEGK--------RLPRPPNCPEE---VYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HcCc--------cCCCCCCCCHH---HHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            1000        01111223344   44555599999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.7e-36  Score=295.16  Aligned_cols=243  Identities=20%  Similarity=0.339  Sum_probs=198.8

Q ss_pred             hhhcCcCCccEEEEEEECCC-CEEEEEEeccccCC----HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALEDA-STVVVKRLKEVNVG----KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~-~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|.-|+||++.+++. ..+|+|++.+....    ....+.|-+||+.++||.+..|++.++.++..++|||||+|
T Consensus        82 lk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpG  161 (459)
T KOG0610|consen   82 LKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPG  161 (459)
T ss_pred             HHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCC
Confidence            45799999999999998764 77899999765322    23466788999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC----
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP----  455 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~----  455 (615)
                      |+|..+++.+.   ...+++..+..++.+++.||+|||..|   ||+|||||+||||-++|++-|+||.++....-    
T Consensus       162 GdL~~LrqkQp---~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~  235 (459)
T KOG0610|consen  162 GDLHSLRQKQP---GKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTL  235 (459)
T ss_pred             ccHHHHHhhCC---CCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCee
Confidence            99999998654   457999999999999999999999998   99999999999999999999999998743210    


Q ss_pred             -----------------------------C-C-------------------------CCCCCCCcccCccccCCCCCCCc
Q 007167          456 -----------------------------M-P-------------------------PPAMRAAGYRAPEVTDTRKATQA  480 (615)
Q Consensus       456 -----------------------------~-~-------------------------~~~~~~~~y~aPE~~~~~~~~~~  480 (615)
                                                   . .                         ...+||-.|+|||++.+...+.+
T Consensus       236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsA  315 (459)
T KOG0610|consen  236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSA  315 (459)
T ss_pred             eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCch
Confidence                                         0 0                         01124556999999999999999


Q ss_pred             cchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCC
Q 007167          481 SDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEER  560 (615)
Q Consensus       481 ~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R  560 (615)
                      +|+|+|||++|||+.|+.||.+.+..+...-+  +.+           +......+..+-.++++++   +.+.+||.+|
T Consensus       316 VDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NI--v~~-----------~l~Fp~~~~vs~~akDLIr---~LLvKdP~kR  379 (459)
T KOG0610|consen  316 VDWWTFGIFLYEMLYGTTPFKGSNNKETLRNI--VGQ-----------PLKFPEEPEVSSAAKDLIR---KLLVKDPSKR  379 (459)
T ss_pred             hhHHHHHHHHHHHHhCCCCcCCCCchhhHHHH--hcC-----------CCcCCCCCcchhHHHHHHH---HHhccChhhh
Confidence            99999999999999999999998877654322  111           1122233455567777777   9999999999


Q ss_pred             CC----HHHHHHH
Q 007167          561 PK----MADVLKM  569 (615)
Q Consensus       561 Ps----~~evl~~  569 (615)
                      .-    ++||-+|
T Consensus       380 lg~~rGA~eIK~H  392 (459)
T KOG0610|consen  380 LGSKRGAAEIKRH  392 (459)
T ss_pred             hccccchHHhhcC
Confidence            98    8888664

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=4.2e-36  Score=305.10  Aligned_cols=244  Identities=23%  Similarity=0.357  Sum_probs=193.0

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC----HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG----KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      +.||+|+||+||++... +++.||+|.+......    .+.+.+|+++++.++|+||+++++.+..++..++||||+++|
T Consensus         6 ~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~   85 (285)
T cd05630           6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG   85 (285)
T ss_pred             EEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCC
Confidence            46999999999999865 6788999998654221    234678999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--C
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--P  458 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--~  458 (615)
                      +|.+++....   ...+++..+..++.|++.||.|||+.+   |+||||||+||++++++.++|+|||++.......  .
T Consensus        86 ~L~~~l~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  159 (285)
T cd05630          86 DLKFHIYHMG---EAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK  159 (285)
T ss_pred             cHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCcccc
Confidence            9999886432   235899999999999999999999987   9999999999999999999999999987654322  2


Q ss_pred             CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCc
Q 007167          459 PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI  538 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  538 (615)
                      ...++..|+|||++.+..++.++|||||||++|||++|+.||..............+.....         ..  ....+
T Consensus       160 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~---------~~--~~~~~  228 (285)
T cd05630         160 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQ---------EE--YSEKF  228 (285)
T ss_pred             CCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhh---------hh--cCccC
Confidence            23578899999999988899999999999999999999999986443221111110000000         00  11223


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 007167          539 EEEMVEMLQVGMACVVRMPEERPK-----MADVLKM  569 (615)
Q Consensus       539 ~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~  569 (615)
                      .++..++++   +|++.||++|||     ++|++++
T Consensus       229 ~~~~~~li~---~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         229 SPDARSLCK---MLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             CHHHHHHHH---HHhhcCHHHccCCCCCchHHHHcC
Confidence            445555555   999999999999     8898875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.4e-36  Score=303.89  Aligned_cols=239  Identities=21%  Similarity=0.372  Sum_probs=184.3

Q ss_pred             hhcCcCCccEEEEEEECC--------CCEEEEEEeccccC-CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeec
Q 007167          306 EVLGKGTFGTAYKAALED--------ASTVVVKRLKEVNV-GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      +.||+|+||+||+|..+.        ...|++|.+..... ..+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~   80 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY   80 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence            359999999999998542        22477787754322 235678899999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCc--------EEEeecc
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGH--------VCVSDIG  448 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~--------~kl~DfG  448 (615)
                      +++|+|.++++...    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.        ++++|||
T Consensus        81 ~~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g  153 (258)
T cd05078          81 VKFGSLDTYLKKNK----NLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG  153 (258)
T ss_pred             CCCCcHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccc
Confidence            99999999997532    26899999999999999999999998   999999999999987765        6999999


Q ss_pred             cccccCCCCCCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCC-CCCCCCCCcchhhHHHHHHHhhhcccccc
Q 007167          449 LAALMSPMPPPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGK-SPIHATGGDEVVHLVRWVNSVVREEWTAE  526 (615)
Q Consensus       449 ~a~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (615)
                      ++...... ....++..|+|||++.+ ..++.++|||||||++|||++|. .||...........   ..    .     
T Consensus       154 ~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~---~~----~-----  220 (258)
T cd05078         154 ISITVLPK-EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQF---YE----D-----  220 (258)
T ss_pred             cccccCCc-hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHH---HH----c-----
Confidence            98765432 23356778999999876 45789999999999999999984 56544322211111   00    0     


Q ss_pred             cccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 007167          527 VFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVE  571 (615)
Q Consensus       527 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  571 (615)
                          ..........++   .+++.+|++.+|++|||++|+++.|+
T Consensus       221 ----~~~~~~~~~~~~---~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 ----RHQLPAPKWTEL---ANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ----cccCCCCCcHHH---HHHHHHHhccChhhCCCHHHHHHhcC
Confidence                000111222344   44555999999999999999999873

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.8e-36  Score=325.47  Aligned_cols=254  Identities=18%  Similarity=0.331  Sum_probs=184.3

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEec--------CeeeEEee
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK--------DEKLMVYD  375 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------~~~~lV~e  375 (615)
                      .++||+|+||.||+|... .++.||||++...   .....+|+.+++.++|||||++++++...        ...++|||
T Consensus        71 ~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~---~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE  147 (440)
T PTZ00036         71 GNIIGNGSFGVVYEAICIDTSEKVAIKKVLQD---PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVME  147 (440)
T ss_pred             eEEEEeCCCEEEEEEEECCCCCEEEEEEEecC---cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEe
Confidence            467999999999999864 5789999988543   23456799999999999999999887542        24678999


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCC-cEEEeecccccccC
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG-HVCVSDIGLAALMS  454 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~-~~kl~DfG~a~~~~  454 (615)
                      |+++ +|.+++.... .....+++.....++.|++.||+|||+.+   |+||||||+|||++.++ .+||+|||+++.+.
T Consensus       148 ~~~~-~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~  222 (440)
T PTZ00036        148 FIPQ-TVHKYMKHYA-RNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL  222 (440)
T ss_pred             cCCc-cHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccccchhcc
Confidence            9975 6777664321 12346899999999999999999999998   99999999999999765 79999999998764


Q ss_pred             CCC--CCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchh-hHHHHHHHhhhcccc------
Q 007167          455 PMP--PPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVV-HLVRWVNSVVREEWT------  524 (615)
Q Consensus       455 ~~~--~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~------  524 (615)
                      ...  ....+++.|+|||++.+ ..++.++|||||||++|||++|+.||.+....+.. ..+........+...      
T Consensus       223 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~  302 (440)
T PTZ00036        223 AGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNY  302 (440)
T ss_pred             CCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhh
Confidence            322  23456888999998765 46899999999999999999999999875543222 111111110000000      


Q ss_pred             ccc-cc----cccc-CC-CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          525 AEV-FD----VELL-RY-PNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       525 ~~~-~d----~~~~-~~-~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .++ +.    ..+. .. ...++++.+++   .+||..||.+|||+.|++++
T Consensus       303 ~~~~~~~~~~~~l~~~~p~~~~~~~~~li---~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        303 ADIKFPDVKPKDLKKVFPKGTPDDAINFI---SQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             hcccCCccCchhHHHHhccCCCHHHHHHH---HHHCCCChhHCcCHHHHhCC
Confidence            000 00    0000 00 12234444444   49999999999999999975

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.7e-36  Score=304.12  Aligned_cols=253  Identities=26%  Similarity=0.444  Sum_probs=197.2

Q ss_pred             hhhcCcCCccEEEEEEEC-----CCCEEEEEEeccccCC--HHHHHHHHHHHhCCCCCcccceeEEEEe--cCeeeEEee
Q 007167          305 AEVLGKGTFGTAYKAALE-----DASTVVVKRLKEVNVG--KREFEQQMEIVGGIRHENVVALRAYYYS--KDEKLMVYD  375 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e  375 (615)
                      .+.||+|+||.||++...     .+..||||.++.....  .+.+.+|+++++.++|+||+++++++..  ....++|||
T Consensus         9 ~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   88 (284)
T cd05038           9 IKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIME   88 (284)
T ss_pred             heeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEe
Confidence            367999999999999854     3678999999866543  5679999999999999999999999987  557899999


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      |+++++|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+|||.+.....
T Consensus        89 ~~~~~~l~~~l~~~~----~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05038          89 YLPSGSLRDYLQRHR----DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVLPE  161 (284)
T ss_pred             cCCCCCHHHHHHhCc----cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence            999999999997532    25999999999999999999999998   99999999999999999999999999987753


Q ss_pred             CCC------CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchh--------hHHHHHHHhhhc
Q 007167          456 MPP------PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVV--------HLVRWVNSVVRE  521 (615)
Q Consensus       456 ~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~--------~~~~~~~~~~~~  521 (615)
                      ...      ....+..|+|||......++.++||||||++++||++|+.|+.........        .....+......
T Consensus       162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05038         162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKE  241 (284)
T ss_pred             CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHc
Confidence            221      112345699999998888999999999999999999999998654322110        001111111110


Q ss_pred             ccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhH
Q 007167          522 EWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIR  574 (615)
Q Consensus       522 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~  574 (615)
                      .       .........+   ..+.+++.+|++.+|++||++.||+++|+.++
T Consensus       242 ~-------~~~~~~~~~~---~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~  284 (284)
T cd05038         242 G-------ERLPRPPSCP---DEVYDLMKLCWEAEPQDRPSFADLILIVDRLR  284 (284)
T ss_pred             C-------CcCCCCccCC---HHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence            0       0011111222   34566666999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.2e-35  Score=298.35  Aligned_cols=252  Identities=22%  Similarity=0.410  Sum_probs=198.9

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc----CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN----VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||.||+|... +++.|++|.++...    ...+.+.+|++++++++|+|++++++++...+..++||||+++
T Consensus         7 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   86 (267)
T cd08224           7 EKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADA   86 (267)
T ss_pred             eeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCC
Confidence            356999999999999976 78999999886431    1245788999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      |+|.+++.... .....+++..+..++.+++.||.|||+.+   |+||||+|+||+++.++.++|+|||++.......  
T Consensus        87 ~~L~~~l~~~~-~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~  162 (267)
T cd08224          87 GDLSRMIKHFK-KQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA  162 (267)
T ss_pred             CCHHHHHHHhc-ccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCCCcc
Confidence            99999986432 22346899999999999999999999998   9999999999999999999999999987664322  


Q ss_pred             -CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          458 -PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       458 -~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                       ....++..|+|||.+.+..++.++|||||||++|+|++|+.||..... .   ..+.........     . .... .+
T Consensus       163 ~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~-~---~~~~~~~~~~~~-----~-~~~~-~~  231 (267)
T cd08224         163 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKM-N---LYSLCKKIEKCD-----Y-PPLP-AD  231 (267)
T ss_pred             cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCc-c---HHHHHhhhhcCC-----C-CCCC-hh
Confidence             223467789999999888899999999999999999999999965331 1   111111111100     0 0000 01


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIR  574 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~  574 (615)
                      ..+..+   .+++.+|+..+|++||++.+|+++|+++.
T Consensus       232 ~~~~~~---~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         232 HYSEEL---RDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             hcCHHH---HHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            223344   44555999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=5.5e-36  Score=298.79  Aligned_cols=242  Identities=23%  Similarity=0.406  Sum_probs=195.2

Q ss_pred             hhhcCcCCccEEEEEEECC-CCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          305 AEVLGKGTFGTAYKAALED-ASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      .+.||+|+||.||+|..++ +..+++|.++.... .+.+.+|+++++.++|+||+++++++..+...++++||+++++|.
T Consensus         8 ~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~   86 (256)
T cd06612           8 LEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVS   86 (256)
T ss_pred             hhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHH
Confidence            4579999999999999765 78899999875433 678999999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---CCC
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---PPA  460 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~~~  460 (615)
                      +++...    ...+++..+..++.|++.|+.|||+.+   |+||||+|+||+++.++.++|+|||++.......   ...
T Consensus        87 ~~l~~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~  159 (256)
T cd06612          87 DIMKIT----NKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTV  159 (256)
T ss_pred             HHHHhC----ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCccccccc
Confidence            998642    246899999999999999999999998   9999999999999999999999999998765432   223


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE  540 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  540 (615)
                      .++..|+|||++.+..++.++||||||+++|||++|+.||......+....+   .    ..     ........+.+++
T Consensus       160 ~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~---~----~~-----~~~~~~~~~~~~~  227 (256)
T cd06612         160 IGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI---P----NK-----PPPTLSDPEKWSP  227 (256)
T ss_pred             cCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh---c----cC-----CCCCCCchhhcCH
Confidence            4677899999998888999999999999999999999999764432211110   0    00     0001111112334


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          541 EMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       541 ~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ++.++   +.+|++.+|++|||+.|++++
T Consensus       228 ~~~~~---i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         228 EFNDF---VKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             HHHHH---HHHHHhcChhhCcCHHHHhcC
Confidence            44444   449999999999999999864

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4.3e-36  Score=299.55  Aligned_cols=243  Identities=24%  Similarity=0.411  Sum_probs=193.0

Q ss_pred             HhhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          304 SAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       304 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      ..+.||+|+||.||++.. .+..||+|..+.. .....+.+|+++++.++|||++++++++..+ ..++||||+++++|.
T Consensus        10 ~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~-~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~   86 (254)
T cd05083          10 LGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD-VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLV   86 (254)
T ss_pred             eeeeeccCCCCceEeccc-CCCceEEEeecCc-chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHH
Confidence            356799999999999974 5678999988643 2356788999999999999999999998654 579999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCCCCCC
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRA  463 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  463 (615)
                      +++....   ...+++..+..++.|++.|+.|||+.+   ++||||||+||+++.++.+||+|||++............+
T Consensus        87 ~~l~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~  160 (254)
T cd05083          87 NFLRTRG---RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLP  160 (254)
T ss_pred             HHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccCCCCCCC
Confidence            9997432   236889999999999999999999987   9999999999999999999999999987654433333345


Q ss_pred             CcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHHHH
Q 007167          464 AGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEM  542 (615)
Q Consensus       464 ~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  542 (615)
                      ..|+|||++.+..++.++|||||||++|||++ |+.||......+....+       ....       .......+++.+
T Consensus       161 ~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~-------~~~~-------~~~~~~~~~~~~  226 (254)
T cd05083         161 VKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV-------EKGY-------RMEPPEGCPADV  226 (254)
T ss_pred             ceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH-------hCCC-------CCCCCCcCCHHH
Confidence            67999999988889999999999999999998 99999765433221111       1111       001112234445


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 007167          543 VEMLQVGMACVVRMPEERPKMADVLKMVED  572 (615)
Q Consensus       543 ~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  572 (615)
                      .++++   +|++.+|++||++.++++.|++
T Consensus       227 ~~li~---~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         227 YVLMT---SCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             HHHHH---HHcCCChhhCcCHHHHHHHHcc
Confidence            45444   9999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=4.8e-36  Score=315.01  Aligned_cols=241  Identities=20%  Similarity=0.337  Sum_probs=189.9

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEecccc----CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVN----VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      +.||+|+||+||++..+ .++.||+|+++...    .....+.+|++++..++|+||+++++.+.+++..++||||+++|
T Consensus         7 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg   86 (360)
T cd05627           7 KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGG   86 (360)
T ss_pred             EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCc
Confidence            56999999999999865 57889999987532    12346778999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC----
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM----  456 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~----  456 (615)
                      +|.+++...     ..+++.....++.|++.||+|||+.+   |+||||||+|||++.++++||+|||+++.....    
T Consensus        87 ~L~~~l~~~-----~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~  158 (360)
T cd05627          87 DMMTLLMKK-----DTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE  158 (360)
T ss_pred             cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence            999999643     36889999999999999999999998   999999999999999999999999998754211    


Q ss_pred             ----------------------------------CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 007167          457 ----------------------------------PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHA  502 (615)
Q Consensus       457 ----------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~  502 (615)
                                                        .....+|..|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~  238 (360)
T cd05627         159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (360)
T ss_pred             cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence                                              0123578899999999998999999999999999999999999986


Q ss_pred             CCCcchhhHHHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 007167          503 TGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPK---MADVLKM  569 (615)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs---~~evl~~  569 (615)
                      ....+....+      ..  +....   .......++++.++++.   +++ .+|.+|++   +.|++++
T Consensus       239 ~~~~~~~~~i------~~--~~~~~---~~p~~~~~s~~~~~li~---~l~-~~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         239 ETPQETYRKV------MN--WKETL---VFPPEVPISEKAKDLIL---RFC-TDSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCHHHHHHHH------Hc--CCCce---ecCCCCCCCHHHHHHHH---Hhc-cChhhcCCCCCHHHHhcC
Confidence            5543322211      10  00000   11111224566666665   554 49999985   6777776

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.5e-36  Score=316.75  Aligned_cols=243  Identities=19%  Similarity=0.295  Sum_probs=190.2

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc----CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN----VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||.||++..+ +++.||+|.+....    ...+.+.+|+++++.++||||+++++++.+++..++||||+++
T Consensus        48 ~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~g  127 (371)
T cd05622          48 VKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPG  127 (371)
T ss_pred             EEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCC
Confidence            467999999999999965 57789999986431    1234577899999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      |+|.+++...      .++...+..++.|++.||+|||+.+   |+||||||+|||++.++++||+|||+++.+....  
T Consensus       128 g~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~  198 (371)
T cd05622         128 GDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV  198 (371)
T ss_pred             CcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc
Confidence            9999998632      4788888999999999999999998   9999999999999999999999999998765322  


Q ss_pred             --CCCCCCCcccCccccCCC----CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccccc
Q 007167          458 --PPAMRAAGYRAPEVTDTR----KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE  531 (615)
Q Consensus       458 --~~~~~~~~y~aPE~~~~~----~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  531 (615)
                        ....+|..|+|||++...    .++.++|||||||++|||++|+.||...+.....      ..+.....     ...
T Consensus       199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~------~~i~~~~~-----~~~  267 (371)
T cd05622         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTY------SKIMNHKN-----SLT  267 (371)
T ss_pred             cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHH------HHHHcCCC-----ccc
Confidence              234578899999998653    3789999999999999999999999764432211      11111100     011


Q ss_pred             ccCCCCcHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHHH
Q 007167          532 LLRYPNIEEEMVEMLQVGMACVVRMPEE--RPKMADVLKMV  570 (615)
Q Consensus       532 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~~L  570 (615)
                      ....+.++++.++++.   .|+..++.+  |++++|++++.
T Consensus       268 ~~~~~~~s~~~~~li~---~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         268 FPDDNDISKEAKNLIC---AFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             CCCcCCCCHHHHHHHH---HHcCChhhhcCCCCHHHHhcCc
Confidence            1222345666777766   888744433  78999999874

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=5e-36  Score=301.95  Aligned_cols=247  Identities=24%  Similarity=0.396  Sum_probs=194.8

Q ss_pred             hhhcCcCCccEEEEEEECCC----CEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALEDA----STVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~----~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      .+.||+|+||.||+|...+.    ..|++|.......  ..+.+.+|+++++.++||||+++++++.+ +..++||||++
T Consensus        11 ~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~   89 (270)
T cd05056          11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAP   89 (270)
T ss_pred             eeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCC
Confidence            46799999999999986432    4688888765432  24578899999999999999999999875 56789999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP  458 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~  458 (615)
                      +|+|.+++...    ...+++..+..++.+++.||+|||+.+   ++||||||+||+++.++.+||+|||+++.......
T Consensus        90 ~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  162 (270)
T cd05056          90 LGELRSYLQVN----KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY  162 (270)
T ss_pred             CCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecccccc
Confidence            99999999743    235899999999999999999999988   99999999999999999999999999986643321


Q ss_pred             ----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccccccccccc
Q 007167          459 ----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELL  533 (615)
Q Consensus       459 ----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  533 (615)
                          ....+..|+|||.+....++.++||||||+++||+++ |+.||......+....   +.   ...        ...
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~---~~---~~~--------~~~  228 (270)
T cd05056         163 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR---IE---NGE--------RLP  228 (270)
T ss_pred             eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH---HH---cCC--------cCC
Confidence                1122357999999988889999999999999999996 9999976544332211   11   110        111


Q ss_pred             CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          534 RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       534 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                      ..+..+.++.+++.   +|+..+|++|||+.|+++.|+++...
T Consensus       229 ~~~~~~~~~~~li~---~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         229 MPPNCPPTLYSLMT---KCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             CCCCCCHHHHHHHH---HHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            12333445555554   99999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=9.3e-36  Score=301.58  Aligned_cols=242  Identities=21%  Similarity=0.375  Sum_probs=190.1

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      ++||+|+||.||+|.. .++..||+|.+.....  ..+.+.+|++++.+++||||+++++++..++..++||||+++++|
T Consensus         7 ~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l   86 (279)
T cd06619           7 EILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSL   86 (279)
T ss_pred             eeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCCh
Confidence            5699999999999985 4678899998864322  235688999999999999999999999999999999999999998


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC-CCCCC
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM-PPPAM  461 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~  461 (615)
                      ..+.         .+++.....++.|++.||+|||+.+   |+|+||||+||+++.++.++|+|||++...... .....
T Consensus        87 ~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~  154 (279)
T cd06619          87 DVYR---------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV  154 (279)
T ss_pred             HHhh---------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCC
Confidence            6542         3678888999999999999999998   999999999999999999999999999866433 23346


Q ss_pred             CCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcch-hhHHHHHHHhhhcccccccccccccCCCCcHH
Q 007167          462 RAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEV-VHLVRWVNSVVREEWTAEVFDVELLRYPNIEE  540 (615)
Q Consensus       462 ~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  540 (615)
                      ++..|+|||++.+..++.++|||||||++|||++|+.||......+. .....+......+.      .... .....++
T Consensus       155 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------~~~~-~~~~~~~  227 (279)
T cd06619         155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED------PPVL-PVGQFSE  227 (279)
T ss_pred             CChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC------CCCC-CCCcCCH
Confidence            78899999999988899999999999999999999999975432211 11111111111110      0011 1122334


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          541 EMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       541 ~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ++.++   +.+|++.+|++||+++|++++
T Consensus       228 ~~~~l---i~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         228 KFVHF---ITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             HHHHH---HHHHhhCChhhCCCHHHHhcC
Confidence            44444   449999999999999999887

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=8.1e-36  Score=333.18  Aligned_cols=253  Identities=22%  Similarity=0.311  Sum_probs=196.4

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC----CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV----GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .++||+|+||.||+|... .++.||+|+++....    ..+.+.+|++++++++||||+++++++.+++..++||||+++
T Consensus         7 i~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eG   86 (932)
T PRK13184          7 IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEG   86 (932)
T ss_pred             EEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCC
Confidence            357999999999999865 588999999875422    135688999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCC------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeeccccccc
Q 007167          380 GSVSAMLHGRRG------EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALM  453 (615)
Q Consensus       380 gsL~~~l~~~~~------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~  453 (615)
                      |+|.+++.....      ......++....+++.|+++||+|||+.+   |+||||||+||+++.++.+||+|||+++..
T Consensus        87 GSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGLAk~i  163 (932)
T PRK13184         87 YTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGAAIFK  163 (932)
T ss_pred             CCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCcceec
Confidence            999999864211      11234678888999999999999999998   999999999999999999999999999765


Q ss_pred             CCC---------------------CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 007167          454 SPM---------------------PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLV  512 (615)
Q Consensus       454 ~~~---------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~  512 (615)
                      ...                     .....+|+.|+|||.+.+..++.++|||||||++|||++|+.||......+.... 
T Consensus       164 ~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~-  242 (932)
T PRK13184        164 KLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR-  242 (932)
T ss_pred             ccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhh-
Confidence            210                     0123578899999999988999999999999999999999999976433222110 


Q ss_pred             HHHHHhhhcccccccccc-cccCCCCcHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHhHhh
Q 007167          513 RWVNSVVREEWTAEVFDV-ELLRYPNIEEEMVEMLQVGMACVVRMPEERP-KMADVLKMVEDIRRV  576 (615)
Q Consensus       513 ~~~~~~~~~~~~~~~~d~-~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-s~~evl~~L~~l~~~  576 (615)
                      .   .         ..++ .......+++.+   .+++.+|++.||++|| +++++.+.|+.....
T Consensus       243 ~---~---------i~~P~~~~p~~~iP~~L---~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~  293 (932)
T PRK13184        243 D---V---------ILSPIEVAPYREIPPFL---SQIAMKALAVDPAERYSSVQELKQDLEPHLQG  293 (932)
T ss_pred             h---h---------ccChhhccccccCCHHH---HHHHHHHccCChhhCcCHHHHHHHHHHHHHhc
Confidence            0   0         0000 011112233444   4455599999999996 677788888777553

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.6e-36  Score=302.14  Aligned_cols=246  Identities=24%  Similarity=0.397  Sum_probs=195.0

Q ss_pred             hhhcCcCCccEEEEEEECC-CC----EEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecC
Q 007167          305 AEVLGKGTFGTAYKAALED-AS----TVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYF  377 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~-~~----~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  377 (615)
                      .+.||+|+||+||+|.+++ +.    .+|+|.++....  ....+.+|++++++++|+||+++++++.. ...++||||+
T Consensus        12 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~   90 (279)
T cd05057          12 IKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLM   90 (279)
T ss_pred             cceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecC
Confidence            4679999999999998643 33    588888765532  23568899999999999999999999987 7889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC
Q 007167          378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP  457 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~  457 (615)
                      ++|+|.++++...    ..+++.....++.|++.||+|||+.+   |+||||||+||++++++.+||+|||+++......
T Consensus        91 ~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~  163 (279)
T cd05057          91 PLGCLLDYVRNHK----DNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE  163 (279)
T ss_pred             CCCcHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence            9999999997532    35899999999999999999999987   9999999999999999999999999998765332


Q ss_pred             CC-----CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccccccccc
Q 007167          458 PP-----AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE  531 (615)
Q Consensus       458 ~~-----~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  531 (615)
                      ..     ...+..|+|||.+....++.++||||||+++||+++ |+.||......+....+   ..   ..        .
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~---~~---~~--------~  229 (279)
T cd05057         164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLL---EK---GE--------R  229 (279)
T ss_pred             cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH---hC---CC--------C
Confidence            11     112457999999988889999999999999999999 99999765433322211   10   00        0


Q ss_pred             ccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          532 LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       532 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                      ....+..+.   ++.+++.+||..+|.+||++.++++.|+++.+
T Consensus       230 ~~~~~~~~~---~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         230 LPQPPICTI---DVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             CCCCCCCCH---HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            111112223   34555569999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.1e-35  Score=301.71  Aligned_cols=255  Identities=21%  Similarity=0.355  Sum_probs=198.3

Q ss_pred             HHhhhcCcCCccEEEEEEEC-CCCEEEEEEecccc--CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          303 ASAEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN--VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       303 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      ...+.||+|+||+||++... ++..||+|.+....  ...+.+.+|+++++.++||||+++++++......++||||+++
T Consensus         8 ~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   87 (284)
T cd06620           8 ETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDC   87 (284)
T ss_pred             HHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCC
Confidence            44578999999999999865 57889999876432  2246788999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC-CC
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM-PP  458 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~-~~  458 (615)
                      ++|.+++...     ..+++.....++.+++.||.|||+..  +++||||||+||++++++.++|+|||++...... ..
T Consensus        88 ~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~  160 (284)
T cd06620          88 GSLDRIYKKG-----GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD  160 (284)
T ss_pred             CCHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhccC
Confidence            9999988642     36899999999999999999999742  2999999999999999999999999998765322 22


Q ss_pred             CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc-----chhhHHHHHHHhhhccccccccccccc
Q 007167          459 PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGD-----EVVHLVRWVNSVVREEWTAEVFDVELL  533 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~d~~~~  533 (615)
                      ...++..|+|||++.+..++.++|||||||++||+++|+.||......     .......++.....+..      +.+.
T Consensus       161 ~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~  234 (284)
T cd06620         161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPP------PRLP  234 (284)
T ss_pred             ccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccC------CCCC
Confidence            345788999999998888999999999999999999999999865432     11112222322221110      0000


Q ss_pred             CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhH
Q 007167          534 RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIR  574 (615)
Q Consensus       534 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~  574 (615)
                       ...++.+   +.+++.+|++.||++||++.|++++..-+.
T Consensus       235 -~~~~~~~---~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~  271 (284)
T cd06620         235 -SSDFPED---LRDFVDACLLKDPTERPTPQQLCAMPPFIQ  271 (284)
T ss_pred             -chhcCHH---HHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence             0112233   445555999999999999999999854443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.3e-35  Score=298.20  Aligned_cols=246  Identities=20%  Similarity=0.344  Sum_probs=191.6

Q ss_pred             HHhhhcCcCCccEEEEEEE-CCCCEEEEEEeccccC-CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          303 ASAEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNV-GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       303 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      ...+.||+|+||.||+|.. .+++.||+|.++.... ....+.+|+.+++.++||||+++++++...+..++|+||++++
T Consensus        12 ~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~   91 (267)
T cd06645          12 ELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGG   91 (267)
T ss_pred             HHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCC
Confidence            4457799999999999985 4678899998875432 2345788999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---  457 (615)
                      +|.+++...     ..+++.....++.|++.|++|||+.+   |+|+||||+||+++.++.++|+|||++.......   
T Consensus        92 ~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~  163 (267)
T cd06645          92 SLQDIYHVT-----GPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR  163 (267)
T ss_pred             cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccccc
Confidence            999998642     36899999999999999999999998   9999999999999999999999999987654321   


Q ss_pred             CCCCCCCcccCccccC---CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccC
Q 007167          458 PPAMRAAGYRAPEVTD---TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLR  534 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  534 (615)
                      ....++..|+|||++.   ...++.++|||||||++|||++|+.||............      ......    .+....
T Consensus       164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~------~~~~~~----~~~~~~  233 (267)
T cd06645         164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM------TKSNFQ----PPKLKD  233 (267)
T ss_pred             ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh------hccCCC----CCcccc
Confidence            2335678899999874   445788999999999999999999998654432211111      000000    000101


Q ss_pred             CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          535 YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       535 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ...+++.+.++   +.+|+..+|++||++++++++
T Consensus       234 ~~~~~~~~~~l---i~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         234 KMKWSNSFHHF---VKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             cCCCCHHHHHH---HHHHccCCchhCcCHHHHhcC
Confidence            11223444444   449999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=8.9e-36  Score=304.38  Aligned_cols=240  Identities=20%  Similarity=0.351  Sum_probs=192.2

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEeccccC-CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNV-GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      +.||+|+||.||+|.. .++..|++|.+..... ..+.+.+|+++++.++|+||+++++++....+.++||||+++++|.
T Consensus        26 ~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~  105 (296)
T cd06654          26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT  105 (296)
T ss_pred             EEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHH
Confidence            4699999999999985 4678999998875432 3466889999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---CCC
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---PPA  460 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~~~  460 (615)
                      +++..      ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......   ...
T Consensus       106 ~~~~~------~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~  176 (296)
T cd06654         106 DVVTE------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM  176 (296)
T ss_pred             HHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccccccccCcc
Confidence            99863      24789999999999999999999998   9999999999999999999999999987654322   223


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE  540 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  540 (615)
                      .++..|+|||.+....++.++|||||||++|||++|+.||......+..  ..+.   ...       .+.......+.+
T Consensus       177 ~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~--~~~~---~~~-------~~~~~~~~~~~~  244 (296)
T cd06654         177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL--YLIA---TNG-------TPELQNPEKLSA  244 (296)
T ss_pred             cCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhH--HHHh---cCC-------CCCCCCccccCH
Confidence            5677899999998888899999999999999999999999764432111  1100   000       001111122334


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          541 EMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       541 ~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+.+   ++.+|+..+|++||++.|++++
T Consensus       245 ~l~~---li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         245 IFRD---FLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             HHHH---HHHHHCcCCcccCcCHHHHhhC
Confidence            4444   4459999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-36  Score=309.30  Aligned_cols=247  Identities=20%  Similarity=0.325  Sum_probs=189.7

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc----CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN----VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||+||++... +++.||+|.+....    ...+.+.+|..++..++|+||+++++++.+++..++||||+++
T Consensus         6 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g   85 (331)
T cd05597           6 LKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVG   85 (331)
T ss_pred             EEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCC
Confidence            356999999999999964 57899999986421    2234578899999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC-
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP-  458 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~-  458 (615)
                      |+|.+++...    ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++..+..... 
T Consensus        86 ~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  158 (331)
T cd05597          86 GDLLTLLSKF----EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV  158 (331)
T ss_pred             CcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence            9999999642    235889999999999999999999998   99999999999999999999999999876543221 


Q ss_pred             ---CCCCCCcccCccccCC-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccc
Q 007167          459 ---PAMRAAGYRAPEVTDT-----RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDV  530 (615)
Q Consensus       459 ---~~~~~~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  530 (615)
                         ...++.+|+|||++..     ..++.++|||||||++|||++|+.||......+...      .+....   ..+..
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~------~i~~~~---~~~~~  229 (331)
T cd05597         159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------KIMNHK---EHFQF  229 (331)
T ss_pred             cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHH------HHHcCC---CcccC
Confidence               2357889999999863     457889999999999999999999997643222111      111110   00000


Q ss_pred             cccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          531 ELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       531 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      . ...+.+++++.++++-+ .|...++..||++++++++
T Consensus       230 ~-~~~~~~~~~~~~li~~l-l~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         230 P-PDVTDVSEEAKDLIRRL-ICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             C-CccCCCCHHHHHHHHHH-ccCcccccCCCCHHHHhcC
Confidence            0 01123566777777622 2444455558999999988

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.3e-35  Score=298.73  Aligned_cols=248  Identities=26%  Similarity=0.381  Sum_probs=184.7

Q ss_pred             hcCcCCccEEEEEEECCCC---EEEEEEecccc--CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          307 VLGKGTFGTAYKAALEDAS---TVVVKRLKEVN--VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~~~~---~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      .||+|+||+||+|...++.   .+++|.++...  ...+.+.+|+++++.++||||+++++++......++||||+++|+
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   81 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD   81 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence            5999999999999754433   45566665432  234678899999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC-----
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM-----  456 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~-----  456 (615)
                      |.++++.... .....++.....++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++......     
T Consensus        82 L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~  157 (268)
T cd05086          82 LKSYLSQEQW-HRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET  157 (268)
T ss_pred             HHHHHHhhhc-ccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence            9999975432 1335677788899999999999999987   999999999999999999999999998643211     


Q ss_pred             CCCCCCCCcccCccccCC-------CCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccc
Q 007167          457 PPPAMRAAGYRAPEVTDT-------RKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVF  528 (615)
Q Consensus       457 ~~~~~~~~~y~aPE~~~~-------~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  528 (615)
                      .....++..|+|||++..       ..++.++|||||||++|||++ |..||......+...      ....+. .....
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~------~~~~~~-~~~~~  230 (268)
T cd05086         158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLN------HVIKDQ-QVKLF  230 (268)
T ss_pred             ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHH------HHHhhc-ccccC
Confidence            122345778999998743       235789999999999999997 677886543322211      111111 11222


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 007167          529 DVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVE  571 (615)
Q Consensus       529 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  571 (615)
                      ++.+.  ..+.+.+.++++   .|| .+|++||+++||++.|.
T Consensus       231 ~~~~~--~~~~~~~~~l~~---~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         231 KPQLE--LPYSERWYEVLQ---FCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             CCccC--CCCcHHHHHHHH---HHh-hCcccCCCHHHHHHHhc
Confidence            22221  123455555555   898 67999999999998873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=9.3e-36  Score=301.17  Aligned_cols=240  Identities=23%  Similarity=0.361  Sum_probs=192.1

Q ss_pred             HhhhcCcCCccEEEEEEEC-CCCEEEEEEecccc--CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          304 SAEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN--VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       304 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      ..+.||+|+||.||+|.+. ++..||+|.++...  ...+.+.+|++++++++||||+++++++..+...++||||++++
T Consensus         8 ~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (277)
T cd06642           8 KLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGG   87 (277)
T ss_pred             HHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCC
Confidence            3467999999999999864 56789999886432  22356889999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---  457 (615)
                      +|.+++..      ..+++..+..++.|++.|+.|||+.+   ++|+||+|+||++++++.++++|||++..+....   
T Consensus        88 ~L~~~~~~------~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06642          88 SALDLLKP------GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             cHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcchhh
Confidence            99998853      25889999999999999999999988   9999999999999999999999999997765432   


Q ss_pred             CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCC
Q 007167          458 PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN  537 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  537 (615)
                      ....++..|+|||++.+..++.++|||||||++|||++|+.||......+....   +   . ...     .+.+  ...
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~---~---~-~~~-----~~~~--~~~  224 (277)
T cd06642         159 NTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL---I---P-KNS-----PPTL--EGQ  224 (277)
T ss_pred             hcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh---h---h-cCC-----CCCC--Ccc
Confidence            122457789999999888899999999999999999999999875433221111   0   0 000     0000  112


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          538 IEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       538 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+.++   .+++.+|++.+|++||++.|++++
T Consensus       225 ~~~~~---~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         225 YSKPF---KEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             cCHHH---HHHHHHHccCCcccCcCHHHHHHh
Confidence            23344   445559999999999999999986

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.2e-36  Score=316.21  Aligned_cols=249  Identities=17%  Similarity=0.252  Sum_probs=189.0

Q ss_pred             hhhcCcCCccEEEEEEEC---CCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE---DASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      .+.||+|+||.||++...   .+..|++|.+...    +...+|+++++.++|||||++++++......++||||+. ++
T Consensus        97 ~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~  171 (392)
T PHA03207         97 LSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CD  171 (392)
T ss_pred             EEeecCCCCeEEEEEEEcCCccceeEEEEecccc----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CC
Confidence            456999999999999753   3567899987642    345789999999999999999999999999999999995 68


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC----
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP----  457 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~----  457 (615)
                      |.+++..     ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.++|+|||++.......    
T Consensus       172 l~~~l~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~  243 (392)
T PHA03207        172 LFTYVDR-----SGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ  243 (392)
T ss_pred             HHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccccccc
Confidence            8888842     236899999999999999999999998   9999999999999999999999999997664322    


Q ss_pred             -CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccc---cc----c---
Q 007167          458 -PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEW---TA----E---  526 (615)
Q Consensus       458 -~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~----~---  526 (615)
                       ....+|..|+|||++....++.++|||||||++|||++|+.||.+.........+.-+........   ..    .   
T Consensus       244 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~  323 (392)
T PHA03207        244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCK  323 (392)
T ss_pred             ccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHH
Confidence             234578899999999988899999999999999999999999976543322221111111110000   00    0   


Q ss_pred             ----c---ccc-----cccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          527 ----V---FDV-----ELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       527 ----~---~d~-----~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                          .   ..+     ..........+   +.+++.+|+..||++||++.|++.+
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        324 HFKQYAIVLRPPYTIPPVIRKYGMHMD---VEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             HHHhhcccccCCccccchhhccCcchh---HHHHHHHHhccChhhCCCHHHHhhC
Confidence                0   000     00000112233   3444559999999999999999987

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.2e-36  Score=314.37  Aligned_cols=252  Identities=20%  Similarity=0.290  Sum_probs=188.6

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEec------CeeeEEe
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSK------DEKLMVY  374 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lV~  374 (615)
                      .+.||+|+||+||+|.. .++..||||++.....   ..+.+.+|+++++.++|+||+++++++...      ...++++
T Consensus        20 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~   99 (343)
T cd07878          20 LTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVT   99 (343)
T ss_pred             heecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEe
Confidence            46799999999999985 4678899999875322   234577899999999999999999887543      3568999


Q ss_pred             ecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccC
Q 007167          375 DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS  454 (615)
Q Consensus       375 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~  454 (615)
                      |++ +++|.+++..      ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus       100 ~~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~  169 (343)
T cd07878         100 NLM-GADLNNIVKC------QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQAD  169 (343)
T ss_pred             ecC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceecC
Confidence            988 7899888753      25899999999999999999999998   9999999999999999999999999998876


Q ss_pred             CCCCCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhH-HHHHHHhhhc---cccccc--
Q 007167          455 PMPPPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHL-VRWVNSVVRE---EWTAEV--  527 (615)
Q Consensus       455 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~---~~~~~~--  527 (615)
                      .......++..|+|||++.+ ..++.++|||||||++|||++|+.||...+..+.... .........+   ....+.  
T Consensus       170 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (343)
T cd07878         170 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHAR  249 (343)
T ss_pred             CCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHH
Confidence            65555667889999999876 5688999999999999999999999976443221111 1100000000   000000  


Q ss_pred             -ccccccC---------CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          528 -FDVELLR---------YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       528 -~d~~~~~---------~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                       +...+..         .....+.   +.+++.+|+..||++|||+.|++++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~---~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         250 KYIQSLPHMPQQDLKKIFRGANPL---AIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             HHhhccccccchhHHHhccCCCHH---HHHHHHHHcCCChhhCCCHHHHhcC
Confidence             0000000         0112223   3455559999999999999999986

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.8e-35  Score=299.98  Aligned_cols=246  Identities=20%  Similarity=0.355  Sum_probs=191.8

Q ss_pred             HHHhhhcCcCCccEEEEEEECC-CCEEEEEEecccc-CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          302 RASAEVLGKGTFGTAYKAALED-ASTVVVKRLKEVN-VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       302 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      +...+.||+|+||.||+|.... +..+++|.+.... ...+.+.+|+++++.++|+||+++++++..++..++|+||+++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~   86 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG   86 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence            3455779999999999999764 6677888876432 2245678899999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC---
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM---  456 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~---  456 (615)
                      ++|..++...    ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......   
T Consensus        87 ~~l~~~~~~~----~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~  159 (282)
T cd06643          87 GAVDAVMLEL----ERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR  159 (282)
T ss_pred             CcHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccccc
Confidence            9999988642    236899999999999999999999998   999999999999999999999999998765332   


Q ss_pred             CCCCCCCCcccCccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccccc
Q 007167          457 PPPAMRAAGYRAPEVTD-----TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE  531 (615)
Q Consensus       457 ~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  531 (615)
                      .....++..|+|||++.     ...++.++|||||||++|||++|+.||......+..  ..    ......      +.
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~--~~----~~~~~~------~~  227 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVL--LK----IAKSEP------PT  227 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHH--HH----HhhcCC------CC
Confidence            12334678899999873     345778999999999999999999999764322211  11    111110      01


Q ss_pred             ccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          532 LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       532 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ......++.++.++++   +||..+|.+||++.+++++
T Consensus       228 ~~~~~~~~~~~~~li~---~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         228 LAQPSRWSSEFKDFLK---KCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             CCCccccCHHHHHHHH---HHccCChhhCcCHHHHhcC
Confidence            1111223455555555   9999999999999999876

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-36  Score=314.24  Aligned_cols=237  Identities=22%  Similarity=0.320  Sum_probs=183.2

Q ss_pred             cCcCCccEEEEEEEC-CCCEEEEEEeccccC----CHHHHHHHHHHHhCC---CCCcccceeEEEEecCeeeEEeecCCC
Q 007167          308 LGKGTFGTAYKAALE-DASTVVVKRLKEVNV----GKREFEQQMEIVGGI---RHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       308 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      ||+|+||+||+|... +++.||||++.....    ....+..|..++...   +||||+++++++...+..++||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999864 588999999864321    112334555666554   699999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC---
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM---  456 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~---  456 (615)
                      |+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++......   
T Consensus        81 g~L~~~l~~~-----~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~  152 (330)
T cd05586          81 GELFWHLQKE-----GRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT  152 (330)
T ss_pred             ChHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCC
Confidence            9999988642     36889999999999999999999998   999999999999999999999999998754322   


Q ss_pred             CCCCCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCC
Q 007167          457 PPPAMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY  535 (615)
Q Consensus       457 ~~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  535 (615)
                      .....++..|+|||++.+. .++.++||||+||++|||++|+.||......+....+      ....       ..+. .
T Consensus       153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i------~~~~-------~~~~-~  218 (330)
T cd05586         153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI------AFGK-------VRFP-K  218 (330)
T ss_pred             ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH------HcCC-------CCCC-C
Confidence            2234578899999998654 4789999999999999999999999764432222111      1100       0110 1


Q ss_pred             CCcHHHHHHHHHHHHHcccCCCCCCC----CHHHHHHH
Q 007167          536 PNIEEEMVEMLQVGMACVVRMPEERP----KMADVLKM  569 (615)
Q Consensus       536 ~~~~~~~~~l~~l~~~cl~~~P~~RP----s~~evl~~  569 (615)
                      ...+++..++++   +|++.+|++||    ++.|++++
T Consensus       219 ~~~~~~~~~li~---~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         219 NVLSDEGRQFVK---GLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             ccCCHHHHHHHH---HHcCCCHHHCCCCCCCHHHHhcC
Confidence            123456666666   99999999998    56666663

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1e-35  Score=298.72  Aligned_cols=242  Identities=21%  Similarity=0.359  Sum_probs=193.1

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCC-------HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecC
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVG-------KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYF  377 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  377 (615)
                      .+.||+|+||+||+|...++..+|+|.++.....       ...+.+|+++++.++|+||+++++++.+.+..++||||+
T Consensus         5 ~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~   84 (265)
T cd06631           5 GEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFV   84 (265)
T ss_pred             cceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecC
Confidence            4579999999999999888899999988643211       245788999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC-
Q 007167          378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM-  456 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~-  456 (615)
                      ++++|.+++...     ..+++..+..++.|++.||+|||+.+   |+|+||+|+||++++++.++|+|||++...... 
T Consensus        85 ~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          85 PGGSISSILNRF-----GPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             CCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            999999999642     25789999999999999999999988   999999999999999999999999998765311 


Q ss_pred             --------CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccc
Q 007167          457 --------PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVF  528 (615)
Q Consensus       457 --------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  528 (615)
                              .....++..|+|||++.+..++.++|||||||++|||++|+.||...+......  ....    ..    ..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~--~~~~----~~----~~  226 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF--YIGA----HR----GL  226 (265)
T ss_pred             ccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHH--Hhhh----cc----CC
Confidence                    112346778999999988889999999999999999999999997643222111  1000    00    00


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          529 DVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       529 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+.  ....+++++.++++   +|+..+|++||++.|++++
T Consensus       227 ~~~--~~~~~~~~~~~~i~---~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         227 MPR--LPDSFSAAAIDFVT---SCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             CCC--CCCCCCHHHHHHHH---HHhcCCcccCCCHHHHhcC
Confidence            011  11234555666665   9999999999999999864

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=6.9e-36  Score=313.77  Aligned_cols=189  Identities=23%  Similarity=0.364  Sum_probs=160.4

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc---CCHHHHHHHHHHHhCCCCCcccceeEEEEecC------eeeEEe
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN---VGKREFEQQMEIVGGIRHENVVALRAYYYSKD------EKLMVY  374 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lV~  374 (615)
                      .+.||+|+||.||++... .+..||+|++....   .....+.+|+.+++.++||||+++++++...+      ..++||
T Consensus        26 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~  105 (359)
T cd07876          26 LKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM  105 (359)
T ss_pred             EEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEE
Confidence            467999999999999864 57899999986532   22456778999999999999999999986543      479999


Q ss_pred             ecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccC
Q 007167          375 DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS  454 (615)
Q Consensus       375 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~  454 (615)
                      ||+++ +|...++.       .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus       106 e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~  174 (359)
T cd07876         106 ELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAC  174 (359)
T ss_pred             eCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence            99965 56666542       4788889999999999999999998   9999999999999999999999999997653


Q ss_pred             CC--CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 007167          455 PM--PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATG  504 (615)
Q Consensus       455 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~  504 (615)
                      ..  .....++..|+|||.+.+..++.++||||+||++|||++|+.||...+
T Consensus       175 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~  226 (359)
T cd07876         175 TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD  226 (359)
T ss_pred             cCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence            32  223456888999999999899999999999999999999999998654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.2e-35  Score=306.43  Aligned_cols=194  Identities=25%  Similarity=0.449  Sum_probs=158.2

Q ss_pred             hhcCcCCccEEEEEEECC---CCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEe--cCeeeEEeecCCCC
Q 007167          306 EVLGKGTFGTAYKAALED---ASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYS--KDEKLMVYDYFEPG  380 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~~~g  380 (615)
                      .+||+|+||+||+|...+   +..||+|.++.... ...+.+|+++++.++||||+++++++..  +...++||||+++ 
T Consensus         7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-   84 (317)
T cd07867           7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-   84 (317)
T ss_pred             eEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-
Confidence            469999999999998653   46799998875432 3467889999999999999999999854  4578999999865 


Q ss_pred             ChhhhhccCCC----CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEe----CCCCcEEEeecccccc
Q 007167          381 SVSAMLHGRRG----EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFL----NSQGHVCVSDIGLAAL  452 (615)
Q Consensus       381 sL~~~l~~~~~----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill----~~~~~~kl~DfG~a~~  452 (615)
                      +|.+++.....    .....+++..+..++.|++.||+|||+.+   |+||||||+||++    +.++.+||+|||+++.
T Consensus        85 ~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07867          85 DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccceec
Confidence            77777643211    12235889999999999999999999998   9999999999999    5667899999999987


Q ss_pred             cCCCC------CCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 007167          453 MSPMP------PPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATG  504 (615)
Q Consensus       453 ~~~~~------~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~  504 (615)
                      .....      ....++..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             cCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            64322      12346788999999876 457899999999999999999999997543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.2e-35  Score=302.15  Aligned_cols=254  Identities=22%  Similarity=0.337  Sum_probs=187.4

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccC---CHHHHHHHHHHHhCC---CCCcccceeEEEEec-----CeeeEE
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV---GKREFEQQMEIVGGI---RHENVVALRAYYYSK-----DEKLMV  373 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l---~h~niv~l~~~~~~~-----~~~~lV  373 (615)
                      +.||+|+||+||+|... +++.||+|.++....   ....+.+|+++++.+   +||||+++++++...     ...++|
T Consensus         6 ~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv   85 (288)
T cd07863           6 AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLV   85 (288)
T ss_pred             eEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEE
Confidence            56999999999999865 578899998875321   123556777776655   699999999988642     457999


Q ss_pred             eecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeeccccccc
Q 007167          374 YDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALM  453 (615)
Q Consensus       374 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~  453 (615)
                      |||+. ++|.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++...
T Consensus        86 ~e~~~-~~l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~~~~  158 (288)
T cd07863          86 FEHVD-QDLRTYLDKVP---PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIY  158 (288)
T ss_pred             Ecccc-cCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCccccc
Confidence            99997 48888886432   235899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCC--CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchh-hHHHHHHHhhhccccccc---
Q 007167          454 SPMP--PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVV-HLVRWVNSVVREEWTAEV---  527 (615)
Q Consensus       454 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~---  527 (615)
                      ....  ....++..|+|||++.+..++.++||||+||++|||++|+.||......+.. ....++.......|....   
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07863         159 SCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLP  238 (288)
T ss_pred             cCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccccccc
Confidence            5332  2345678899999998888999999999999999999999999765433221 112211111111111111   


Q ss_pred             ---ccccc-----cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          528 ---FDVEL-----LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       528 ---~d~~~-----~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                         +....     ...+..+++..   +++.+|++.||++|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~---~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         239 RGAFSPRGPRPVQSVVPEIEESGA---QLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             ccccCCCCCCchHHhCcCcCHHHH---HHHHHHhccCcccCCCHHHHhcC
Confidence               00000     00122334444   44559999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=2.9e-35  Score=297.65  Aligned_cols=240  Identities=22%  Similarity=0.344  Sum_probs=192.9

Q ss_pred             HhhhcCcCCccEEEEEEEC-CCCEEEEEEecccc--CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          304 SAEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN--VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       304 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      ..+.||+|+||.||+|... .+..||+|.++...  .....+.+|+++++.++|+||+++++++.++...++||||+++|
T Consensus         8 ~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   87 (277)
T cd06640           8 KLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGG   87 (277)
T ss_pred             hhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCC
Confidence            3457999999999999865 57889999887542  22456889999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---  457 (615)
                      +|.+++..      ..+++.....++.|++.|++|||+.+   ++|+||+|+||+++.++.++|+|||++.......   
T Consensus        88 ~L~~~i~~------~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06640          88 SALDLLRA------GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             cHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcccc
Confidence            99999863      25788899999999999999999987   9999999999999999999999999997664322   


Q ss_pred             CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCC
Q 007167          458 PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN  537 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  537 (615)
                      ....++..|+|||++.+..++.++|||||||++|||++|+.||...........+      . ...          ....
T Consensus       159 ~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~------~-~~~----------~~~~  221 (277)
T cd06640         159 NTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI------P-KNN----------PPTL  221 (277)
T ss_pred             ccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh------h-cCC----------CCCC
Confidence            2234577899999998888999999999999999999999999764432221111      0 000          0001


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          538 IEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       538 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .......+.+++.+|++.+|++||++.|++++
T Consensus       222 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         222 TGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             chhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            11223344555569999999999999999887

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.8e-36  Score=301.52  Aligned_cols=245  Identities=28%  Similarity=0.467  Sum_probs=191.7

Q ss_pred             hhcCcCCccEEEEEEECC-CCEEEEEEeccccCCHHH---HHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          306 EVLGKGTFGTAYKAALED-ASTVVVKRLKEVNVGKRE---FEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~---~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      +.||+|+||+||++.... +..||+|++.........   ..+|+.++++++||||+++++++.+....++||||+++++
T Consensus         5 ~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~   84 (260)
T PF00069_consen    5 KKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGS   84 (260)
T ss_dssp             EEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEB
T ss_pred             EEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccccccc
Confidence            579999999999999764 557999999876433322   3458999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccC---CCCC
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS---PMPP  458 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~---~~~~  458 (615)
                      |.+++..     ...+++..+..++.|+++||+|||+.+   |+||||||+||++++++.++|+|||.+..+.   ....
T Consensus        85 L~~~l~~-----~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~  156 (260)
T PF00069_consen   85 LQDYLQK-----NKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFN  156 (260)
T ss_dssp             HHHHHHH-----HSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBS
T ss_pred             ccccccc-----ccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccc
Confidence            9999972     236899999999999999999999998   9999999999999999999999999997532   2223


Q ss_pred             CCCCCCcccCccccC-CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCC
Q 007167          459 PAMRAAGYRAPEVTD-TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN  537 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  537 (615)
                      ...++..|+|||.+. ...++.++||||+|+++++|++|+.||......+..........   ..     ..........
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~---~~-----~~~~~~~~~~  228 (260)
T PF00069_consen  157 PFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILK---RP-----LPSSSQQSRE  228 (260)
T ss_dssp             SSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHH---TH-----HHHHTTSHTT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccc---cc-----ccccccccch
Confidence            445678899999998 77889999999999999999999999987522222221111110   00     0000000111


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          538 IEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       538 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ..+   .+.+++.+|+..+|++||++.|++++
T Consensus       229 ~~~---~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  229 KSE---ELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             SHH---HHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             hHH---HHHHHHHHHccCChhHCcCHHHHhcC
Confidence            123   44555559999999999999999864

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.2e-35  Score=318.31  Aligned_cols=185  Identities=21%  Similarity=0.274  Sum_probs=159.7

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      .+.||+|+||.||++... .++.||||...     ...+.+|++++++++|+|||++++++...+..++||||+. ++|.
T Consensus       174 ~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~-----~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~  247 (461)
T PHA03211        174 HRALTPGSEGCVFESSHPDYPQRVVVKAGW-----YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLY  247 (461)
T ss_pred             EEEEccCCCeEEEEEEECCCCCEEEEeccc-----ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHH
Confidence            457999999999999965 46789999643     2346789999999999999999999999999999999995 6888


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC-----C
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP-----P  458 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~-----~  458 (615)
                      +++...    ...++|..+..|+.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++......     .
T Consensus       248 ~~l~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  320 (461)
T PHA03211        248 TYLGAR----LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHY  320 (461)
T ss_pred             HHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccccccccc
Confidence            887642    236999999999999999999999998   9999999999999999999999999998654321     1


Q ss_pred             CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 007167          459 PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHA  502 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~  502 (615)
                      ...+|..|+|||++.+..++.++|||||||++|||++|..|+..
T Consensus       321 ~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~  364 (461)
T PHA03211        321 GIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFS  364 (461)
T ss_pred             ccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCccc
Confidence            23578899999999998999999999999999999998776543

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.6e-35  Score=304.34  Aligned_cols=193  Identities=21%  Similarity=0.356  Sum_probs=165.3

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      .+.||+|+||.||++... ++..+++|.++....  ....+.+|++++.+++||||+++++++..+++.++||||+++++
T Consensus         6 ~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~   85 (308)
T cd06615           6 LGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGS   85 (308)
T ss_pred             EeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCc
Confidence            356999999999999865 567788888764321  13457889999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC-CCCC
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM-PPPA  460 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~-~~~~  460 (615)
                      |.++++..     ..+++.....++.|++.||.|||+..  +++||||||+||+++.++.+||+|||++...... ....
T Consensus        86 L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  158 (308)
T cd06615          86 LDQVLKKA-----GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF  158 (308)
T ss_pred             HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCcccccccccccC
Confidence            99999743     36889999999999999999999742  2999999999999999999999999998765432 2334


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATG  504 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~  504 (615)
                      .++..|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~  202 (308)
T cd06615         159 VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD  202 (308)
T ss_pred             CCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc
Confidence            56788999999988889999999999999999999999997543

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=1.2e-35  Score=296.41  Aligned_cols=242  Identities=23%  Similarity=0.379  Sum_probs=192.6

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccc--cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEV--NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      .++||+|+||.||++... ++..+++|.++..  ....+.+.+|+++++.++|+||+++++++.+++..++||||+++|+
T Consensus         5 ~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   84 (255)
T cd08219           5 LRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGD   84 (255)
T ss_pred             EEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCc
Confidence            357999999999999864 6788999988643  2234677889999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---C
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---P  458 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~  458 (615)
                      |.+++....   ...+++.....++.|++.||.|||+.+   |+|+||||+||++++++.++++|||.+.......   .
T Consensus        85 l~~~~~~~~---~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  158 (255)
T cd08219          85 LMQKIKLQR---GKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC  158 (255)
T ss_pred             HHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence            999886432   235789999999999999999999998   9999999999999999999999999997664322   2


Q ss_pred             CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCc
Q 007167          459 PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI  538 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  538 (615)
                      ...++..|+|||++.+..++.++||||||+++|+|++|+.||...+......      ...... .    .+   .....
T Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~------~~~~~~-~----~~---~~~~~  224 (255)
T cd08219         159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLIL------KVCQGS-Y----KP---LPSHY  224 (255)
T ss_pred             cccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHH------HHhcCC-C----CC---CCccc
Confidence            2346778999999988889999999999999999999999997543222111      111110 0    00   01123


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          539 EEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       539 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      +..+.+++   .+||+.+|++||++.|++..
T Consensus       225 ~~~~~~li---~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         225 SYELRSLI---KQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CHHHHHHH---HHHHhCCcccCCCHHHHhhc
Confidence            34444444   49999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-37  Score=292.81  Aligned_cols=243  Identities=21%  Similarity=0.400  Sum_probs=199.5

Q ss_pred             HhhhcCcCCccEEEEEEE-CCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          304 SAEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       304 ~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      ..++||+|+||.||||.. +.|..+|+|.+.- ..+-.++..|+.++.+++.|+||+++|.|......|+|||||..|+.
T Consensus        37 i~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV-~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSi  115 (502)
T KOG0574|consen   37 IVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV-DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSI  115 (502)
T ss_pred             HHHHhcCCcchHHHHHHHhccCcEEEEEecCc-cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcH
Confidence            356799999999999985 5688999998753 34467888999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC---CCC
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM---PPP  459 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~---~~~  459 (615)
                      .++++.++    .++.+.....++.+.++||+|||...   -||||||+.|||++.+|++|++|||.|..+.+.   ..+
T Consensus       116 SDI~R~R~----K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNT  188 (502)
T KOG0574|consen  116 SDIMRARR----KPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNT  188 (502)
T ss_pred             HHHHHHhc----CCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCc
Confidence            99998543    58999999999999999999999987   799999999999999999999999999887653   345


Q ss_pred             CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      ..||+-|||||++..-.|..++||||+|++..||..|++||.+......+..+       ..     ...+...+....+
T Consensus       189 VIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI-------PT-----~PPPTF~KPE~WS  256 (502)
T KOG0574|consen  189 VIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI-------PT-----KPPPTFKKPEEWS  256 (502)
T ss_pred             cccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec-------cC-----CCCCCCCChHhhh
Confidence            56899999999999999999999999999999999999999865432221110       00     0011111222334


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+..++++   +|+-+.|++|-|+.++++|
T Consensus       257 ~~F~DFi~---~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  257 SEFNDFIR---SCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             hHHHHHHH---HHhcCCHHHHHHHHHHhhh
Confidence            44555555   9999999999999998774

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-35  Score=311.01  Aligned_cols=184  Identities=23%  Similarity=0.350  Sum_probs=156.9

Q ss_pred             HhhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          304 SAEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       304 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      ..+.||+|+||.||+|... .+..||+|....     .....|+.++++++|+||+++++++......++|+||+. ++|
T Consensus        70 ~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~-----~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l  143 (357)
T PHA03209         70 VIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK-----GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDL  143 (357)
T ss_pred             EEEEecCCCCeEEEEEEECCCCceEEEEeCCc-----cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcH
Confidence            3567999999999999965 456788887542     234568999999999999999999999999999999994 688


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC--CCCC
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM--PPPA  460 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~--~~~~  460 (615)
                      .+++...    ...+++..+..|+.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....  ....
T Consensus       144 ~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  216 (357)
T PHA03209        144 YTYLTKR----SRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGL  216 (357)
T ss_pred             HHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccCcccccc
Confidence            8888642    246899999999999999999999998   999999999999999999999999999754322  2234


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCC
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPI  500 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~  500 (615)
                      .+|..|+|||++.+..++.++|||||||++|||+++..|+
T Consensus       217 ~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        217 AGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence            5788999999999889999999999999999999955544

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.6e-35  Score=305.94  Aligned_cols=243  Identities=19%  Similarity=0.319  Sum_probs=188.2

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEecccc----CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVN----VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      ++||+|+||+||++..+ .++.+|+|.+.+..    .....+.+|+.++..++|+||+++++++.+.+..++||||+++|
T Consensus         7 ~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g   86 (332)
T cd05623           7 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGG   86 (332)
T ss_pred             EEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCC
Confidence            56999999999999965 46779999986431    12345788999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---  457 (615)
                      +|.++++..    ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.......   
T Consensus        87 ~L~~~l~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~  159 (332)
T cd05623          87 DLLTLLSKF----EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ  159 (332)
T ss_pred             cHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence            999999742    235889999999999999999999998   9999999999999999999999999987653321   


Q ss_pred             -CCCCCCCcccCccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccccc
Q 007167          458 -PPAMRAAGYRAPEVTD-----TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE  531 (615)
Q Consensus       458 -~~~~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  531 (615)
                       ....+|..|+|||++.     ...++.++|||||||++|||++|+.||......+...      .+.....     ...
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~------~i~~~~~-----~~~  228 (332)
T cd05623         160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------KIMNHKE-----RFQ  228 (332)
T ss_pred             ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHH------HHhCCCc-----ccc
Confidence             2245788999999985     3457889999999999999999999997643322211      1111100     000


Q ss_pred             cc-CCCCcHHHHHHHHHHHHHccc--CCCCCCCCHHHHHHH
Q 007167          532 LL-RYPNIEEEMVEMLQVGMACVV--RMPEERPKMADVLKM  569 (615)
Q Consensus       532 ~~-~~~~~~~~~~~l~~l~~~cl~--~~P~~RPs~~evl~~  569 (615)
                      .. .....++++.++++   +|+.  .++..|+++.|++++
T Consensus       229 ~p~~~~~~s~~~~~li~---~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         229 FPAQVTDVSEDAKDLIR---RLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             CCCccccCCHHHHHHHH---HHccChhhhcCCCCHHHHhCC
Confidence            11 11234566777766   5554  444457899999988

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.4e-35  Score=307.81  Aligned_cols=244  Identities=21%  Similarity=0.323  Sum_probs=188.3

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc----CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN----VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||+||++... +++.||+|.+....    .....+.+|..++..++|+||+++++++.+.+..++||||+++
T Consensus         6 ~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~g   85 (331)
T cd05624           6 IKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVG   85 (331)
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCC
Confidence            356999999999999965 56789999986531    1234577889999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC-
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP-  458 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~-  458 (615)
                      |+|.+++...    ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++........ 
T Consensus        86 g~L~~~l~~~----~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  158 (331)
T cd05624          86 GDLLTLLSKF----EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV  158 (331)
T ss_pred             CcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence            9999999742    236889999999999999999999998   99999999999999999999999999977653321 


Q ss_pred             ---CCCCCCcccCccccCC-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccc
Q 007167          459 ---PAMRAAGYRAPEVTDT-----RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDV  530 (615)
Q Consensus       459 ---~~~~~~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  530 (615)
                         ...++.+|+|||++.+     ..++.++|||||||++|||++|+.||......+...      .+.....     ..
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~------~i~~~~~-----~~  227 (331)
T cd05624         159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG------KIMNHEE-----RF  227 (331)
T ss_pred             eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHH------HHHcCCC-----cc
Confidence               2357889999999865     457889999999999999999999997644322111      1111100     00


Q ss_pred             ccc-CCCCcHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 007167          531 ELL-RYPNIEEEMVEMLQVGMACVVRMPEE--RPKMADVLKM  569 (615)
Q Consensus       531 ~~~-~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~~  569 (615)
                      ... .....++++.++++   +|+..++++  |+++++++++
T Consensus       228 ~~p~~~~~~~~~~~~li~---~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         228 QFPSHITDVSEEAKDLIQ---RLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             cCCCccccCCHHHHHHHH---HHccCchhhcCCCCHHHHhcC
Confidence            000 11233456666665   777655543  5789999876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.3e-35  Score=294.55  Aligned_cols=243  Identities=24%  Similarity=0.387  Sum_probs=195.4

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEecccc---CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVN---VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .+.||+|+||.||.++. +++..+++|.+....   ...+.+.+|++++++++|+||+++++++.+.+..++||||+++|
T Consensus         5 ~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~   84 (256)
T cd08221           5 IRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGG   84 (256)
T ss_pred             eeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCC
Confidence            35799999999999884 468889999876442   22456889999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---  457 (615)
                      +|.+++....   ...+++..+..++.|++.|++|||+.+   ++||||+|+||++++++.+||+|||++.......   
T Consensus        85 ~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~  158 (256)
T cd08221          85 TLYDKIVRQK---GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA  158 (256)
T ss_pred             cHHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccccc
Confidence            9999997542   246899999999999999999999988   9999999999999999999999999998764432   


Q ss_pred             CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCC
Q 007167          458 PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN  537 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  537 (615)
                      ....++..|+|||...+..++.++||||||+++|||++|+.||......+...      ......+.     +   ..+.
T Consensus       159 ~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~------~~~~~~~~-----~---~~~~  224 (256)
T cd08221         159 ETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVV------KIVQGNYT-----P---VVSV  224 (256)
T ss_pred             cccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHH------HHHcCCCC-----C---Cccc
Confidence            23456788999999988888999999999999999999999997643322211      11111110     0   0122


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          538 IEEEMVEMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       538 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                      .+.++.+++.   +|+..+|++||++.|+++++
T Consensus       225 ~~~~~~~~i~---~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         225 YSSELISLVH---SLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             cCHHHHHHHH---HHcccCcccCCCHHHHhhCc
Confidence            3444555554   99999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.2e-35  Score=301.47  Aligned_cols=240  Identities=20%  Similarity=0.386  Sum_probs=193.7

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEecccc-CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEVN-VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      +.||.|+||+||+|.. .+++.|++|.+.... ...+.+.+|+++++.++|+||+++++++...+..++|+||+++++|.
T Consensus        25 ~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  104 (296)
T cd06655          25 EKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLT  104 (296)
T ss_pred             EEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHH
Confidence            4699999999999985 578899999886543 23567889999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---CCC
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---PPA  460 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~~~  460 (615)
                      .++..      ..+++..+..++.+++.|++|||+.+   ++||||||+||+++.++.+||+|||++.......   ...
T Consensus       105 ~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  175 (296)
T cd06655         105 DVVTE------TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM  175 (296)
T ss_pred             HHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCc
Confidence            98863      25899999999999999999999998   9999999999999999999999999987664332   223


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE  540 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  540 (615)
                      .++..|+|||.+.+..++.++|||||||++|+|++|+.||......+....   +.   ...      .+.+.....+++
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~---~~---~~~------~~~~~~~~~~~~  243 (296)
T cd06655         176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL---IA---TNG------TPELQNPEKLSP  243 (296)
T ss_pred             CCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HH---hcC------CcccCCcccCCH
Confidence            467789999999888899999999999999999999999976443221111   10   000      001111223344


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          541 EMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       541 ~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+.++++   +||..+|++||++.+++++
T Consensus       244 ~~~~li~---~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         244 IFRDFLN---RCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             HHHHHHH---HHhhcChhhCCCHHHHhhC
Confidence            5555554   9999999999999999876

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2e-35  Score=294.84  Aligned_cols=242  Identities=29%  Similarity=0.463  Sum_probs=193.6

Q ss_pred             hhcCcCCccEEEEEEECC-----CCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCC
Q 007167          306 EVLGKGTFGTAYKAALED-----ASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      +.||+|+||.||++...+     +..||+|.++....  ..+.+.+|++++..++|+||+++++++.+.+..+++|||++
T Consensus         5 ~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~   84 (258)
T smart00219        5 KKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYME   84 (258)
T ss_pred             ceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccC
Confidence            569999999999999654     37799999976543  35678899999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP  458 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~  458 (615)
                      +++|.+++.....   ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++........
T Consensus        85 ~~~l~~~~~~~~~---~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  158 (258)
T smart00219       85 GGDLLDYLRKNRP---KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY  158 (258)
T ss_pred             CCCHHHHHHhhhh---ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccccc
Confidence            9999999975321   12899999999999999999999998   99999999999999999999999999987654321


Q ss_pred             C----CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccccccccccc
Q 007167          459 P----AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELL  533 (615)
Q Consensus       459 ~----~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  533 (615)
                      .    ..++..|+|||.+....++.++||||+|++++||++ |+.||......+....   +..   ..        ...
T Consensus       159 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~---~~~---~~--------~~~  224 (258)
T smart00219      159 YKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEY---LKK---GY--------RLP  224 (258)
T ss_pred             cccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---Hhc---CC--------CCC
Confidence            1    124578999999988889999999999999999998 8888876433222221   111   10        001


Q ss_pred             CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          534 RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       534 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                      .....+.++   .+++.+|+..+|++|||+.|+++.|
T Consensus       225 ~~~~~~~~~---~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      225 KPENCPPEI---YKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             CCCcCCHHH---HHHHHHHCcCChhhCcCHHHHHhhC
Confidence            112233444   4455599999999999999998864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.8e-35  Score=305.11  Aligned_cols=193  Identities=22%  Similarity=0.334  Sum_probs=162.0

Q ss_pred             hhcCcC--CccEEEEEEE-CCCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          306 EVLGKG--TFGTAYKAAL-EDASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       306 ~~lG~G--~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      ++||+|  +||+||++.. .++..||+|+++.....   .+.+.+|+++++.++||||+++++++..++..++||||+++
T Consensus         4 ~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~   83 (327)
T cd08227           4 TVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAY   83 (327)
T ss_pred             hhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCC
Confidence            579999  7899999985 56888999998754222   34577899999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC---
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM---  456 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~---  456 (615)
                      |+|.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++++||+........   
T Consensus        84 ~~l~~~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          84 GSAKDLICTHF---MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             CcHHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            99999986432   235899999999999999999999998   999999999999999999999999865433211   


Q ss_pred             -------CCCCCCCCcccCccccCC--CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 007167          457 -------PPPAMRAAGYRAPEVTDT--RKATQASDVFSFGVLLLELLTGKSPIHATG  504 (615)
Q Consensus       457 -------~~~~~~~~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltg~~p~~~~~  504 (615)
                             .....++..|+|||++.+  ..++.++|||||||++|||++|+.||....
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  214 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMP  214 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence                   112234567999999865  458899999999999999999999997643

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.6e-35  Score=299.05  Aligned_cols=253  Identities=20%  Similarity=0.354  Sum_probs=191.7

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      +.||+|+||.||+|..+ +++.||+|++.....   ..+.+.+|+++++.++|+|++++++++......++||||+++++
T Consensus         7 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~   86 (286)
T cd07847           7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTV   86 (286)
T ss_pred             eeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccH
Confidence            46999999999999975 588999999865421   23567899999999999999999999999999999999999998


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---C
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---P  458 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~  458 (615)
                      |..++..     ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+|||++.......   .
T Consensus        87 l~~~~~~-----~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  158 (286)
T cd07847          87 LNELEKN-----PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYT  158 (286)
T ss_pred             HHHHHhC-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCccccc
Confidence            8887653     235899999999999999999999987   9999999999999999999999999998765433   1


Q ss_pred             CCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhH-HHHHHHhhhc--------ccccccc
Q 007167          459 PAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHL-VRWVNSVVRE--------EWTAEVF  528 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~--------~~~~~~~  528 (615)
                      ...++..|+|||++.+ ..++.++|||||||++|||++|+.||......+.... ..........        .+.....
T Consensus       159 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07847         159 DYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLS  238 (286)
T ss_pred             CcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccccc
Confidence            2345678999999865 4578999999999999999999999986554332211 1111111000        0000000


Q ss_pred             ccccc-------CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          529 DVELL-------RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       529 d~~~~-------~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+...       ..+..+.   .+.+++.+|++.+|++||++.|++.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~---~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         239 IPEPETREPLESKFPNISS---PALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             CCCcccccCHHHHhccCCH---HHHHHHHHHhcCCccccCCHHHHhcC
Confidence            00000       0112233   34455559999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.4e-35  Score=297.29  Aligned_cols=249  Identities=27%  Similarity=0.413  Sum_probs=191.6

Q ss_pred             hhhcCcCCccEEEEEEEC----CCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecC------eee
Q 007167          305 AEVLGKGTFGTAYKAALE----DASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKD------EKL  371 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~  371 (615)
                      .+.||+|+||+||+|.+.    .+..||||+++.....   .+.+.+|++++++++||||+++++++...+      ..+
T Consensus         4 ~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   83 (273)
T cd05074           4 GRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPM   83 (273)
T ss_pred             hhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceE
Confidence            457999999999999853    3578999998754322   356788999999999999999999886542      247


Q ss_pred             EEeecCCCCChhhhhccCC-CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccc
Q 007167          372 MVYDYFEPGSVSAMLHGRR-GEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLA  450 (615)
Q Consensus       372 lV~e~~~~gsL~~~l~~~~-~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a  450 (615)
                      +++||+.+|+|.+++...+ ......+++....+++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        84 ~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg~~  160 (273)
T cd05074          84 VILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADFGLS  160 (273)
T ss_pred             EEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECccccc
Confidence            8899999999998875332 122235789999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCC-----CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccc
Q 007167          451 ALMSPMP-----PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWT  524 (615)
Q Consensus       451 ~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  524 (615)
                      +......     ....++..|++||.+....++.++|||||||++|||++ |+.||......+..   .+..   ...  
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~---~~~~---~~~--  232 (273)
T cd05074         161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIY---NYLI---KGN--  232 (273)
T ss_pred             ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHH---HHHH---cCC--
Confidence            8664321     12223457999999988888999999999999999999 89998764432221   1111   000  


Q ss_pred             cccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 007167          525 AEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI  573 (615)
Q Consensus       525 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l  573 (615)
                            .....+...+   .+.+++.+|++.+|++||++.|+++.|+++
T Consensus       233 ------~~~~~~~~~~---~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         233 ------RLKQPPDCLE---DVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             ------cCCCCCCCCH---HHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                  0111122333   455555599999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.2e-35  Score=302.92  Aligned_cols=241  Identities=20%  Similarity=0.375  Sum_probs=193.0

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc-CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN-VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      ...||+|+||.||++... ++..||||.+.... ...+.+.+|+.+++.++|+||+++++.+...+..++||||+++++|
T Consensus        27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L  106 (292)
T cd06658          27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL  106 (292)
T ss_pred             hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence            456999999999999854 67889999886532 2245688999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---CC
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---PP  459 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~~  459 (615)
                      .+++..      ..+++.....++.|++.||+|||+.+   |+||||||+||++++++.++|+|||++.......   ..
T Consensus       107 ~~~~~~------~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~  177 (292)
T cd06658         107 TDIVTH------TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS  177 (292)
T ss_pred             HHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCce
Confidence            998853      24889999999999999999999998   9999999999999999999999999987654322   22


Q ss_pred             CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      ..++..|+|||......++.++||||||+++|||++|+.||......+....   +...         +..........+
T Consensus       178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~---~~~~---------~~~~~~~~~~~~  245 (292)
T cd06658         178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR---IRDN---------LPPRVKDSHKVS  245 (292)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhc---------CCCccccccccC
Confidence            3467789999999888899999999999999999999999975433221111   1110         111111112234


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ..+.++++   +|+..+|.+|||++|++++
T Consensus       246 ~~~~~li~---~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         246 SVLRGFLD---LMLVREPSQRATAQELLQH  272 (292)
T ss_pred             HHHHHHHH---HHccCChhHCcCHHHHhhC
Confidence            45555555   9999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-35  Score=296.48  Aligned_cols=240  Identities=23%  Similarity=0.387  Sum_probs=193.8

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc--CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN--VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      .+.||.|+||.||+|... ++..|++|.+....  .....+.+|+++++.++|+||+++++++.+....++|+||+++++
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~   85 (274)
T cd06609           6 LECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGS   85 (274)
T ss_pred             hhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCc
Confidence            457999999999999965 67889999986542  224568899999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---C
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---P  458 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~  458 (615)
                      |.++++..      .+++..+..++.|++.|+.|||+.+   ++||||+|+||++++++.++|+|||+++.+....   .
T Consensus        86 L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  156 (274)
T cd06609          86 CLDLLKPG------KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRN  156 (274)
T ss_pred             HHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeecccccccc
Confidence            99998742      6899999999999999999999998   9999999999999999999999999998776432   2


Q ss_pred             CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCc
Q 007167          459 PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI  538 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  538 (615)
                      ...++..|+|||.+.+..++.++|||||||++|||++|+.||......+....+      . ....     +.... ..+
T Consensus       157 ~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~------~-~~~~-----~~~~~-~~~  223 (274)
T cd06609         157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLI------P-KNNP-----PSLEG-NKF  223 (274)
T ss_pred             cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHh------h-hcCC-----CCCcc-ccc
Confidence            334677899999998888999999999999999999999999764432211111      0 0100     11110 113


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          539 EEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       539 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ++.+.+++   .+|+..+|++||++++++++
T Consensus       224 ~~~~~~~l---~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         224 SKPFKDFV---SLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             CHHHHHHH---HHHhhCChhhCcCHHHHhhC
Confidence            34444444   49999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.2e-35  Score=302.30  Aligned_cols=253  Identities=19%  Similarity=0.362  Sum_probs=190.3

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEecccc--CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVN--VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      +.||+|+||.||+|..+ ++..||+|.++...  .....+.+|+++++.++|+||+++++++...+..++||||++ ++|
T Consensus        12 ~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l   90 (301)
T cd07873          12 DKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDL   90 (301)
T ss_pred             eEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCH
Confidence            56999999999999865 57889999986542  224567789999999999999999999999999999999997 588


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---CC
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---PP  459 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~~  459 (615)
                      .+++...    ...+++.....++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......   ..
T Consensus        91 ~~~l~~~----~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  163 (301)
T cd07873          91 KQYLDDC----GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSN  163 (301)
T ss_pred             HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccc
Confidence            8888643    235889999999999999999999998   9999999999999999999999999997654322   22


Q ss_pred             CCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHH-HHHHHhhhcccccc-----cccccc
Q 007167          460 AMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLV-RWVNSVVREEWTAE-----VFDVEL  532 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~-----~~d~~~  532 (615)
                      ..++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+..+....+ ..+.......|...     ......
T Consensus       164 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (301)
T cd07873         164 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNY  243 (301)
T ss_pred             cceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccccccc
Confidence            345778999998765 34788999999999999999999999865433222111 11111111111100     000000


Q ss_pred             c---------CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          533 L---------RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       533 ~---------~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .         ..+..++...+++.   +|+..||.+|||+.|++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~li~---~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         244 PKYRADCLHNHAPRLDSDGAELLS---KLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             CccccccHHhhcCCCCHHHHHHHH---HHhcCCcccCcCHHHHhcC
Confidence            0         01223444555554   9999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.3e-35  Score=311.13  Aligned_cols=189  Identities=21%  Similarity=0.333  Sum_probs=160.3

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEec------CeeeEEe
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSK------DEKLMVY  374 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lV~  374 (615)
                      .+.||+|+||.||++... .++.||||++.....   ..+.+.+|+.+++.++||||+++++++...      ...++||
T Consensus        22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~  101 (355)
T cd07874          22 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM  101 (355)
T ss_pred             EEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEh
Confidence            457999999999999854 578899999875422   235677899999999999999999988643      3469999


Q ss_pred             ecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccC
Q 007167          375 DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS  454 (615)
Q Consensus       375 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~  454 (615)
                      ||+++ ++.+.+..       .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus       102 e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~~  170 (355)
T cd07874         102 ELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_pred             hhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence            99965 66666642       4788899999999999999999998   9999999999999999999999999998765


Q ss_pred             CCC--CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 007167          455 PMP--PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATG  504 (615)
Q Consensus       455 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~  504 (615)
                      ...  ....++..|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus       171 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  222 (355)
T cd07874         171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD  222 (355)
T ss_pred             CccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            432  23457889999999998889999999999999999999999997654

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=2.5e-35  Score=296.12  Aligned_cols=240  Identities=23%  Similarity=0.421  Sum_probs=191.4

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccCC----------HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEE
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVG----------KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMV  373 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~----------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV  373 (615)
                      ...||+|+||.||+|.. .++..||+|.+......          .+.+.+|+++++.++||||+++++++...+..++|
T Consensus         5 ~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   84 (267)
T cd06628           5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIF   84 (267)
T ss_pred             cceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEE
Confidence            35699999999999985 46788999988654221          14578899999999999999999999999999999


Q ss_pred             eecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeeccccccc
Q 007167          374 YDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALM  453 (615)
Q Consensus       374 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~  453 (615)
                      |||+++++|.+++...     ..+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.++|+|||.++..
T Consensus        85 ~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          85 LEYVPGGSVAALLNNY-----GAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             EEecCCCCHHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            9999999999999642     35888999999999999999999988   999999999999999999999999998876


Q ss_pred             CCCC---------CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccc
Q 007167          454 SPMP---------PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWT  524 (615)
Q Consensus       454 ~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  524 (615)
                      ....         ....++..|+|||.+.+..++.++||||+||++|||++|+.||.........   ..+..       
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~-------  226 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAI---FKIGE-------  226 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHH---HHHhc-------
Confidence            5211         1123567899999998888999999999999999999999999764322111   10000       


Q ss_pred             cccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          525 AEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       525 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                        ...+..  ....++.+.++++   +|++.+|.+||++.|++++
T Consensus       227 --~~~~~~--~~~~~~~~~~li~---~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         227 --NASPEI--PSNISSEAIDFLE---KTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             --cCCCcC--CcccCHHHHHHHH---HHccCCchhCcCHHHHhhC
Confidence              001111  1223455555555   9999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.7e-35  Score=297.44  Aligned_cols=247  Identities=21%  Similarity=0.409  Sum_probs=192.8

Q ss_pred             HhhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC--HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          304 SAEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG--KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       304 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      ..+.||+|+||.||++... .+..||+|.++.....  ...+.+|++++++++|+||+++++++...+..++||||++++
T Consensus         5 ~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (286)
T cd06622           5 VLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAG   84 (286)
T ss_pred             hhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCC
Confidence            4567999999999999965 6889999988653222  356889999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc-CCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC-CC
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE-NGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM-PP  458 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~-~~  458 (615)
                      +|..+++...  ....+++..+..++.+++.||.|||+. +   |+||||||+||+++.++.+||+|||++..+... ..
T Consensus        85 ~l~~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (286)
T cd06622          85 SLDKLYAGGV--ATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK  159 (286)
T ss_pred             CHHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCCccc
Confidence            9999887431  134689999999999999999999974 5   999999999999999999999999999766432 23


Q ss_pred             CCCCCCcccCccccCCCC------CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccc
Q 007167          459 PAMRAAGYRAPEVTDTRK------ATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL  532 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~------~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  532 (615)
                      ...++.+|+|||.+.+..      ++.++|||||||++|||++|+.||.............   ......        ..
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~--------~~  228 (286)
T cd06622         160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLS---AIVDGD--------PP  228 (286)
T ss_pred             cCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHH---HHhhcC--------CC
Confidence            345677899999985433      4789999999999999999999997643322222111   111000        00


Q ss_pred             cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       533 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ...+.+++++.++++   +|+..+|++||++.|++++
T Consensus       229 ~~~~~~~~~~~~li~---~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         229 TLPSGYSDDAQDFVA---KCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             CCCcccCHHHHHHHH---HHcccCcccCCCHHHHhcC
Confidence            011223445555555   9999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3e-35  Score=295.91  Aligned_cols=241  Identities=23%  Similarity=0.379  Sum_probs=187.7

Q ss_pred             hcCcCCccEEEEEEEC-CCCEEEEEEeccccC-CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChhh
Q 007167          307 VLGKGTFGTAYKAALE-DASTVVVKRLKEVNV-GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSA  384 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  384 (615)
                      .||+|+||.||+|... ++..|++|.+..... ..+.+.+|+++++.++|+||+++++++...+..++|+||+++++|.+
T Consensus        15 ~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~   94 (268)
T cd06624          15 VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSA   94 (268)
T ss_pred             EEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHH
Confidence            5999999999999854 567899998865432 34578899999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCC--CHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCC-CCcEEEeecccccccCCCC---C
Q 007167          385 MLHGRRGEGQSSL--DWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNS-QGHVCVSDIGLAALMSPMP---P  458 (615)
Q Consensus       385 ~l~~~~~~~~~~l--~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~-~~~~kl~DfG~a~~~~~~~---~  458 (615)
                      +++...    ..+  ++..+..++.|++.||+|||+.+   |+||||||+||+++. ++.++|+|||.+.......   .
T Consensus        95 ~l~~~~----~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~  167 (268)
T cd06624          95 LLRSKW----GPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTE  167 (268)
T ss_pred             HHHHhc----ccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccc
Confidence            997432    234  78888899999999999999998   999999999999986 6799999999987654321   2


Q ss_pred             CCCCCCcccCccccCCC--CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          459 PAMRAAGYRAPEVTDTR--KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~--~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                      ...++..|+|||++...  .++.++||||||+++|+|++|+.||.........   .+.......       .+.+  ..
T Consensus       168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~~~~~~~-------~~~~--~~  235 (268)
T cd06624         168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFKVGMFKI-------HPEI--PE  235 (268)
T ss_pred             cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhhhhhhcc-------CCCC--Cc
Confidence            23467789999998654  3788999999999999999999999754321111   000000000       0011  12


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ...+++.++++   +|+..+|++|||+.|++++
T Consensus       236 ~~~~~~~~li~---~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         236 SLSAEAKNFIL---RCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             ccCHHHHHHHH---HHcCCCchhCCCHHHHHhC
Confidence            23445555555   9999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-36  Score=299.68  Aligned_cols=239  Identities=20%  Similarity=0.366  Sum_probs=203.3

Q ss_pred             hhcCcCCccEEEEEE-ECCCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          306 EVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      +.||+|.|++|-.|+ .-.|..||||++.+.+.+   ...+.+|++-|+.++|||||+++.+......+|||+|+-.+|+
T Consensus        24 kTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GD  103 (864)
T KOG4717|consen   24 KTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGD  103 (864)
T ss_pred             hhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCch
Confidence            459999999999987 347899999999876443   5678899999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeC-CCCcEEEeecccccccCCCC--C
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLN-SQGHVCVSDIGLAALMSPMP--P  458 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~-~~~~~kl~DfG~a~~~~~~~--~  458 (615)
                      |++++-..    ...+.+....+++.||+.|+.|+|+.+   +|||||||+||.+- .-|-+|+.|||++..+.+..  .
T Consensus       104 l~DyImKH----e~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~  176 (864)
T KOG4717|consen  104 LFDYIMKH----EEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLT  176 (864)
T ss_pred             HHHHHHhh----hccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcchhh
Confidence            99999643    346999999999999999999999998   99999999999875 45889999999998776543  4


Q ss_pred             CCCCCCcccCccccCCCCCC-CccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCC
Q 007167          459 PAMRAAGYRAPEVTDTRKAT-QASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN  537 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~~~-~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  537 (615)
                      +.+|+..|-|||++.+..|+ +++||||+||+||.|++|+.||...++.+....               ++|-...-...
T Consensus       177 TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTm---------------ImDCKYtvPsh  241 (864)
T KOG4717|consen  177 TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTM---------------IMDCKYTVPSH  241 (864)
T ss_pred             cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhh---------------hhcccccCchh
Confidence            56788999999999998885 688999999999999999999998776665432               22333333345


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          538 IEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       538 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+.+++++++   .|+..||++|.+.+||+..
T Consensus       242 vS~eCrdLI~---sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  242 VSKECRDLIQ---SMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             hhHHHHHHHH---HHHhcCchhhccHHHHhcc
Confidence            6788888888   9999999999999998764

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.8e-35  Score=300.88  Aligned_cols=239  Identities=20%  Similarity=0.367  Sum_probs=192.7

Q ss_pred             hcCcCCccEEEEEEEC-CCCEEEEEEecccc-CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChhh
Q 007167          307 VLGKGTFGTAYKAALE-DASTVVVKRLKEVN-VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSA  384 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  384 (615)
                      .||+|+||.||++... ++..||+|.+.... ...+.+.+|+.+++.++||||+++++++...+..++|+||+++++|..
T Consensus        28 ~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~  107 (297)
T cd06659          28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTD  107 (297)
T ss_pred             hcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHH
Confidence            5999999999999864 68899999986432 234568899999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---CCCC
Q 007167          385 MLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---PPAM  461 (615)
Q Consensus       385 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~~~~  461 (615)
                      ++..      ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......   ....
T Consensus       108 ~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~  178 (297)
T cd06659         108 IVSQ------TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV  178 (297)
T ss_pred             HHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccccccccee
Confidence            8753      25889999999999999999999998   9999999999999999999999999987654322   2334


Q ss_pred             CCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHHH
Q 007167          462 RAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEE  541 (615)
Q Consensus       462 ~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  541 (615)
                      ++..|+|||++.+..++.++|||||||++|||++|+.||......+..   ..+..    ..     ...........+.
T Consensus       179 ~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~---~~~~~----~~-----~~~~~~~~~~~~~  246 (297)
T cd06659         179 GTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM---KRLRD----SP-----PPKLKNAHKISPV  246 (297)
T ss_pred             cCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHhc----cC-----CCCccccCCCCHH
Confidence            678899999998888999999999999999999999999754332221   11111    00     0011112233445


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          542 MVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       542 ~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      +.++++   +|++.+|++||++.|++++
T Consensus       247 l~~~i~---~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         247 LRDFLE---RMLTREPQERATAQELLDH  271 (297)
T ss_pred             HHHHHH---HHhcCCcccCcCHHHHhhC
Confidence            555555   9999999999999999996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.3e-35  Score=301.47  Aligned_cols=241  Identities=21%  Similarity=0.373  Sum_probs=193.3

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccC-CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNV-GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      .+.||+|+||.||++.. .++..||+|.+..... ..+.+.+|+.+++.++|+||+++++++...+..++||||+++++|
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L  103 (297)
T cd06656          24 FEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL  103 (297)
T ss_pred             eeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCH
Confidence            45799999999999985 5789999999875432 345678899999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---CC
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---PP  459 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~~  459 (615)
                      .+++..      ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++.......   ..
T Consensus       104 ~~~~~~------~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  174 (297)
T cd06656         104 TDVVTE------TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  174 (297)
T ss_pred             HHHHHh------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCc
Confidence            999863      25789999999999999999999998   9999999999999999999999999987664332   22


Q ss_pred             CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      ..++..|+|||.+.+..++.++|||||||++|+|++|+.||...+........      ....      .+........+
T Consensus       175 ~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~------~~~~------~~~~~~~~~~~  242 (297)
T cd06656         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLI------ATNG------TPELQNPERLS  242 (297)
T ss_pred             ccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeee------ccCC------CCCCCCccccC
Confidence            34677899999998888999999999999999999999999764332111100      0000      00111112233


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      +.+.+++   .+|+..+|++||++.|++++
T Consensus       243 ~~~~~li---~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         243 AVFRDFL---NRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             HHHHHHH---HHHccCChhhCcCHHHHhcC
Confidence            4444554   49999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=6.7e-35  Score=297.31  Aligned_cols=244  Identities=21%  Similarity=0.340  Sum_probs=189.6

Q ss_pred             HhhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC-CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          304 SAEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV-GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       304 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      ..+.||+|+||.||+|... ++..|++|.+..... ..+.+.+|+++++.++|+||+++++++..+...++||||+++++
T Consensus        16 i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   95 (292)
T cd06644          16 IIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGA   95 (292)
T ss_pred             hhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCc
Confidence            3567999999999999965 478899999865422 24567889999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---C
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---P  458 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~  458 (615)
                      |..++...    ...+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++.......   .
T Consensus        96 l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  168 (292)
T cd06644          96 VDAIMLEL----DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRD  168 (292)
T ss_pred             HHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccccccc
Confidence            99887642    235899999999999999999999987   9999999999999999999999999987543321   2


Q ss_pred             CCCCCCcccCccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccccccc
Q 007167          459 PAMRAAGYRAPEVTD-----TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELL  533 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  533 (615)
                      ...++..|+|||++.     ...++.++|||||||++|||++|+.||......+.  ..    ......      .+...
T Consensus       169 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~----~~~~~~------~~~~~  236 (292)
T cd06644         169 SFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LL----KIAKSE------PPTLS  236 (292)
T ss_pred             eecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHH--HH----HHhcCC------CccCC
Confidence            234577899999984     34467899999999999999999999975432211  11    111110      01111


Q ss_pred             CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          534 RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       534 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ....++.++.++   +.+|+..+|++||++.|++++
T Consensus       237 ~~~~~~~~~~~l---i~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         237 QPSKWSMEFRDF---LKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             CCcccCHHHHHH---HHHHhcCCcccCcCHHHHhcC
Confidence            112233444444   449999999999999999875

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=4.1e-35  Score=297.57  Aligned_cols=255  Identities=18%  Similarity=0.367  Sum_probs=190.6

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      +.||+|+||.||+|... ++..||+|+++....   ..+.+.+|+++++.++||||+++++++.+++..++||||++ ++
T Consensus         6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~   84 (285)
T cd07861           6 EKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MD   84 (285)
T ss_pred             eEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CC
Confidence            56999999999999864 688999999865422   23568899999999999999999999999999999999997 68


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---C
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---P  458 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~  458 (615)
                      |.+++....  ....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......   .
T Consensus        85 l~~~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  159 (285)
T cd07861          85 LKKYLDSLP--KGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT  159 (285)
T ss_pred             HHHHHhcCC--CCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCccccc
Confidence            888886432  2346899999999999999999999998   9999999999999999999999999987654322   2


Q ss_pred             CCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcch-hhHHHHHHHhhhccccc--cc--ccccc
Q 007167          459 PAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEV-VHLVRWVNSVVREEWTA--EV--FDVEL  532 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~--~~--~d~~~  532 (615)
                      ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+. ..............|..  ..  +....
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (285)
T cd07861         160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTF  239 (285)
T ss_pred             CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhc
Confidence            2345778999998765 4478899999999999999999999976432211 11111111000000000  00  00000


Q ss_pred             ---------cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          533 ---------LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       533 ---------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                               .....++++..++++   +|+..||++|||++||+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~---~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         240 PKWKKGSLRSAVKNLDEDGLDLLE---KMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             cccCcchhHHhcCCCCHHHHHHHH---HHhcCChhhCCCHHHHhcC
Confidence                     001223445555555   9999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.4e-35  Score=295.23  Aligned_cols=240  Identities=21%  Similarity=0.366  Sum_probs=185.6

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC------CHHHHHHHHHHHhCCCCCcccceeEEEEec--CeeeEEee
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV------GKREFEQQMEIVGGIRHENVVALRAYYYSK--DEKLMVYD  375 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e  375 (615)
                      .+.||+|+||.||+|... .+..|++|++.....      ....+.+|+++++.++||||+++++++...  ...++++|
T Consensus         7 ~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e   86 (266)
T cd06651           7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFME   86 (266)
T ss_pred             cceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEe
Confidence            467999999999999864 578999998864321      124578899999999999999999998753  56789999


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      |+++++|.+++...     ..+++.....++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++..+..
T Consensus        87 ~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~  158 (266)
T cd06651          87 YMPGGSVKDQLKAY-----GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT  158 (266)
T ss_pred             CCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence            99999999999642     25889999999999999999999987   99999999999999999999999999876543


Q ss_pred             CC------CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccc
Q 007167          456 MP------PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD  529 (615)
Q Consensus       456 ~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  529 (615)
                      ..      ....++.+|+|||.+.+..++.++|||||||++|||++|+.||......+..      .......     ..
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~------~~~~~~~-----~~  227 (266)
T cd06651         159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAI------FKIATQP-----TN  227 (266)
T ss_pred             ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHH------HHHhcCC-----CC
Confidence            11      1234677899999998888999999999999999999999999754321111      1111000     00


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          530 VELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       530 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      +.+  ...+.+...+++    +|+..+|++||+++||+++
T Consensus       228 ~~~--~~~~~~~~~~li----~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         228 PQL--PSHISEHARDFL----GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             CCC--chhcCHHHHHHH----HHhcCChhhCcCHHHHhcC
Confidence            111  111223333333    6888999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-35  Score=292.55  Aligned_cols=244  Identities=22%  Similarity=0.358  Sum_probs=192.6

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEecccc-CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVN-VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      +.||+|+||.||+|... ++..+++|.+.... ...+.+.+|+++++.++||||+++++++.+.+..+++|||+++++|.
T Consensus         9 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~   88 (262)
T cd06613           9 QRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQ   88 (262)
T ss_pred             EEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHH
Confidence            56999999999999864 56789999987542 23567889999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---CCC
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---PPA  460 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~~~  460 (615)
                      +++....    ..+++..+..++.|++.|++|||+.+   |+|+||+|+||++++++.+||+|||++.......   ...
T Consensus        89 ~~~~~~~----~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~  161 (262)
T cd06613          89 DIYQVTR----GPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSF  161 (262)
T ss_pred             HHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhhccccc
Confidence            9986432    36889999999999999999999988   9999999999999999999999999987665322   233


Q ss_pred             CCCCcccCccccCCC---CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCC
Q 007167          461 MRAAGYRAPEVTDTR---KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN  537 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~---~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  537 (615)
                      .++..|+|||.+...   .++.++||||||+++|||++|+.||......+......      ...    ...........
T Consensus       162 ~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~------~~~----~~~~~~~~~~~  231 (262)
T cd06613         162 IGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS------KSN----FPPPKLKDKEK  231 (262)
T ss_pred             cCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hcc----CCCccccchhh
Confidence            467789999998776   78899999999999999999999997644322211110      000    00000111112


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          538 IEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       538 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+.   ++.+++.+|+..+|.+||++.||+++
T Consensus       232 ~~~---~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         232 WSP---VFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             hhH---HHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            233   34555559999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.4e-35  Score=298.40  Aligned_cols=247  Identities=26%  Similarity=0.408  Sum_probs=189.4

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCHHHHHHHHHHHhCC-CCCcccceeEEEE-----ecCeeeEEeecC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFEQQMEIVGGI-RHENVVALRAYYY-----SKDEKLMVYDYF  377 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~-----~~~~~~lV~e~~  377 (615)
                      .+.||+|+||.||++... .++.+++|.++........+.+|+.+++.+ +|+||+++++++.     ..+..++||||+
T Consensus        23 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~  102 (286)
T cd06638          23 IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELC  102 (286)
T ss_pred             eeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeec
Confidence            356999999999999864 578899998876544456788999999999 6999999999884     335689999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC
Q 007167          378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP  457 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~  457 (615)
                      ++++|.++++.... ....+++..+..++.|++.||.|||+.+   |+||||||+||++++++.+||+|||+++.+....
T Consensus       103 ~~~~L~~~l~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~  178 (286)
T cd06638         103 NGGSVTDLVKGFLK-RGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR  178 (286)
T ss_pred             CCCCHHHHHHHhhc-cCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEccCCceeecccCC
Confidence            99999998864321 2346889999999999999999999987   9999999999999999999999999997664322


Q ss_pred             ---CCCCCCCcccCccccCC-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccc
Q 007167          458 ---PPAMRAAGYRAPEVTDT-----RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD  529 (615)
Q Consensus       458 ---~~~~~~~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  529 (615)
                         ....++..|+|||++..     ..++.++||||+||++|||++|+.||......+..  ..    ....      ..
T Consensus       179 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~--~~----~~~~------~~  246 (286)
T cd06638         179 LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRAL--FK----IPRN------PP  246 (286)
T ss_pred             CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHH--hh----cccc------CC
Confidence               23357788999998743     44788999999999999999999999754321111  11    0000      00


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          530 VELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       530 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                      .........+..+   .+++.+|++.+|++||++.|++++.
T Consensus       247 ~~~~~~~~~~~~~---~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         247 PTLHQPELWSNEF---NDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             CcccCCCCcCHHH---HHHHHHHccCCcccCCCHHHHhhcc
Confidence            0111111123344   4455599999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.2e-35  Score=310.60  Aligned_cols=190  Identities=21%  Similarity=0.345  Sum_probs=161.2

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc---CCHHHHHHHHHHHhCCCCCcccceeEEEEec------CeeeEEe
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN---VGKREFEQQMEIVGGIRHENVVALRAYYYSK------DEKLMVY  374 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lV~  374 (615)
                      .+.||+|+||.||++... .++.||||++....   ...+.+.+|+.+++.++||||+++++++...      ...++||
T Consensus        29 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~  108 (364)
T cd07875          29 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM  108 (364)
T ss_pred             EEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEE
Confidence            457999999999999854 57889999987542   2235677899999999999999999987543      3579999


Q ss_pred             ecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccC
Q 007167          375 DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS  454 (615)
Q Consensus       375 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~  454 (615)
                      ||+++ +|.+.+..       .+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+++...
T Consensus       109 e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~  177 (364)
T cd07875         109 ELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG  177 (364)
T ss_pred             eCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence            99965 67776642       4788899999999999999999998   9999999999999999999999999998765


Q ss_pred             CCC--CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 007167          455 PMP--PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGG  505 (615)
Q Consensus       455 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~  505 (615)
                      ...  ....++..|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus       178 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  230 (364)
T cd07875         178 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH  230 (364)
T ss_pred             CCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCH
Confidence            432  234578899999999998999999999999999999999999976543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-35  Score=296.59  Aligned_cols=246  Identities=22%  Similarity=0.390  Sum_probs=193.6

Q ss_pred             HHHhhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC-CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          302 RASAEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV-GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       302 ~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      +...+.||+|+||+||++..+ ++..||+|.++.... ..+.+.+|++++++++|+||+++++++..+...++||||+++
T Consensus         7 ~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   86 (280)
T cd06611           7 WEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDG   86 (280)
T ss_pred             HHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCC
Confidence            344567999999999999964 678899999865422 235688999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      ++|.+++...    ...+++..+..++.|++.||.|||+.+   |+|+||||+||+++.++.++|+|||++.......  
T Consensus        87 ~~L~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (280)
T cd06611          87 GALDSIMLEL----ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK  159 (280)
T ss_pred             CcHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccccc
Confidence            9999998642    236899999999999999999999998   9999999999999999999999999987654321  


Q ss_pred             -CCCCCCCcccCccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccccc
Q 007167          458 -PPAMRAAGYRAPEVTD-----TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE  531 (615)
Q Consensus       458 -~~~~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  531 (615)
                       ....++..|+|||.+.     ...++.++||||||+++|||++|+.||......+..      ........      +.
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~~~------~~  227 (280)
T cd06611         160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVL------LKILKSEP------PT  227 (280)
T ss_pred             cceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHH------HHHhcCCC------CC
Confidence             2234677899999874     334678999999999999999999999764332211      11111100      01


Q ss_pred             ccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          532 LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       532 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      +.....++.++.++++   +|+..+|.+||++.+++++
T Consensus       228 ~~~~~~~~~~~~~li~---~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         228 LDQPSKWSSSFNDFLK---SCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             cCCcccCCHHHHHHHH---HHhccChhhCcCHHHHhcC
Confidence            1111233455555555   9999999999999999886

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=3.6e-35  Score=293.17  Aligned_cols=242  Identities=22%  Similarity=0.382  Sum_probs=190.6

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEec-CeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSK-DEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lV~e~~~~  379 (615)
                      .+.||+|++|.||++..+ +++.|++|++.....   ..+.+.+|++++++++|+|++++++.+... ...++||||+++
T Consensus         5 ~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~   84 (257)
T cd08223           5 VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEG   84 (257)
T ss_pred             EEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCC
Confidence            457999999999999854 567899999865322   245678899999999999999999887644 467899999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      ++|.+++....   ...+++..+..++.+++.|++|||+.+   |+||||||+||+++.++.++|+|||++..+....  
T Consensus        85 ~~l~~~l~~~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~  158 (257)
T cd08223          85 GDLYHKLKEQK---GKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDM  158 (257)
T ss_pred             CcHHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccCCc
Confidence            99999997532   236899999999999999999999998   9999999999999999999999999998764321  


Q ss_pred             -CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          458 -PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       458 -~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                       ....++..|+|||.+.+..++.++||||||++++||++|+.||...+....      ...... ...     +.  ...
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~------~~~~~~-~~~-----~~--~~~  224 (257)
T cd08223         159 ASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL------VYRIIE-GKL-----PP--MPK  224 (257)
T ss_pred             cccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH------HHHHHh-cCC-----CC--Ccc
Confidence             223467789999999988899999999999999999999999975432211      111111 100     00  012


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ..++++.+++.   +|++.+|++||++.|++++
T Consensus       225 ~~~~~~~~li~---~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         225 DYSPELGELIA---TMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ccCHHHHHHHH---HHhccCcccCCCHHHHhcC
Confidence            23444555544   9999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=5.1e-35  Score=297.95  Aligned_cols=245  Identities=26%  Similarity=0.419  Sum_probs=189.2

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEeccccCCHHHHHHHHHHHhCC-CCCcccceeEEEEec-----CeeeEEeecCC
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVGKREFEQQMEIVGGI-RHENVVALRAYYYSK-----DEKLMVYDYFE  378 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-----~~~~lV~e~~~  378 (615)
                      +.||+|+||.||++.. .+++.+|+|.+.........+.+|+.++.++ +|||++++++++...     +..++||||++
T Consensus        28 ~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~  107 (291)
T cd06639          28 ETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCN  107 (291)
T ss_pred             EEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECC
Confidence            4699999999999986 4678899999876544456788899999998 899999999998754     35899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC-
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP-  457 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~-  457 (615)
                      +|+|.++++.... ....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++....... 
T Consensus       108 ~~sL~~~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~  183 (291)
T cd06639         108 GGSVTELVKGLLI-CGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL  183 (291)
T ss_pred             CCcHHHHHHHhhh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEeecccchhcccccc
Confidence            9999998864321 2346899999999999999999999997   9999999999999999999999999988654322 


Q ss_pred             --CCCCCCCcccCccccCCC-----CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccc
Q 007167          458 --PPAMRAAGYRAPEVTDTR-----KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDV  530 (615)
Q Consensus       458 --~~~~~~~~y~aPE~~~~~-----~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  530 (615)
                        ....++..|+|||.+...     .++.++|||||||++|||++|+.||......+..  ..+.    +. ..     +
T Consensus       184 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~--~~~~----~~-~~-----~  251 (291)
T cd06639         184 RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTL--FKIP----RN-PP-----P  251 (291)
T ss_pred             cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHH--HHHh----cC-CC-----C
Confidence              233467789999987543     3688999999999999999999999764322111  1110    00 00     0


Q ss_pred             cccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          531 ELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       531 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ..........   .+.+++.+|++.+|++||++.|++++
T Consensus       252 ~~~~~~~~~~---~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         252 TLLHPEKWCR---SFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             CCCcccccCH---HHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            0111111223   34455559999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=6.1e-35  Score=293.77  Aligned_cols=248  Identities=21%  Similarity=0.393  Sum_probs=191.5

Q ss_pred             hhhcCcCCccEEEEEEECC--CCEEEEEEecccc-----------CCHHHHHHHHHHHhC-CCCCcccceeEEEEecCee
Q 007167          305 AEVLGKGTFGTAYKAALED--ASTVVVKRLKEVN-----------VGKREFEQQMEIVGG-IRHENVVALRAYYYSKDEK  370 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~--~~~vavK~l~~~~-----------~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~  370 (615)
                      .+.||+|+||.||+|..+.  +..+|+|.+....           ....++.+|++++.+ ++|+||+++++++..++..
T Consensus         5 ~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~   84 (269)
T cd08528           5 LEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRL   84 (269)
T ss_pred             hhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeE
Confidence            4579999999999999765  6779999875321           112346678887764 7999999999999999999


Q ss_pred             eEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCceecCCCCCCEEeCCCCcEEEeeccc
Q 007167          371 LMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT-ENGGKLVHGGIKASNIFLNSQGHVCVSDIGL  449 (615)
Q Consensus       371 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~iiHrDik~~Nill~~~~~~kl~DfG~  449 (615)
                      ++||||+++++|.+++..... ....+++..+++++.|++.||.|||+ .+   ++|+||+|+||+++.++.+||+|||.
T Consensus        85 ~lv~e~~~~~~l~~~l~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          85 YIVMDLIEGAPLGEHFNSLKE-KKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             EEEEecCCCCcHHHHHHHHHh-ccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEecccc
Confidence            999999999999998854221 23468999999999999999999996 45   99999999999999999999999999


Q ss_pred             ccccCCCC--CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccc
Q 007167          450 AALMSPMP--PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEV  527 (615)
Q Consensus       450 a~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (615)
                      +.......  ....++..|+|||...+..++.++||||||+++|||++|+.||........   .   .......+    
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~---~---~~~~~~~~----  230 (269)
T cd08528         161 AKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL---A---TKIVEAVY----  230 (269)
T ss_pred             eeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH---H---HHHhhccC----
Confidence            98765432  233467789999999888899999999999999999999999965432211   1   11111110    


Q ss_pred             ccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 007167          528 FDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVED  572 (615)
Q Consensus       528 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  572 (615)
                       .+.  .....++++.++++   +|++.||++||++.|+..++++
T Consensus       231 -~~~--~~~~~~~~l~~li~---~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         231 -EPL--PEGMYSEDVTDVIT---SCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             -CcC--CcccCCHHHHHHHH---HHCCCCCccCCCHHHHHHHhcC
Confidence             000  01123345555555   9999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=6.2e-35  Score=297.27  Aligned_cols=239  Identities=18%  Similarity=0.283  Sum_probs=194.9

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC----CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV----GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||.||++... +++.||+|.++....    ..+.+.+|++++++++||||+++++++.+.+..++||||+++
T Consensus         6 ~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~   85 (290)
T cd05580           6 IKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPG   85 (290)
T ss_pred             EEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCC
Confidence            356999999999999865 678999999865321    235678899999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCC
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP  459 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~  459 (615)
                      ++|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||+|+||+++.++.+||+|||++.........
T Consensus        86 ~~L~~~~~~~-----~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~  157 (290)
T cd05580          86 GELFSHLRKS-----GRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYT  157 (290)
T ss_pred             CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCCCCC
Confidence            9999998643     36889999999999999999999988   999999999999999999999999999887665555


Q ss_pred             CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      ..++..|+|||.+.+...+.++||||||+++|+|++|+.||......+....      ....         ........+
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------~~~~---------~~~~~~~~~  222 (290)
T cd05580         158 LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEK------ILEG---------KVRFPSFFS  222 (290)
T ss_pred             CCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HhcC---------CccCCccCC
Confidence            5678899999999888889999999999999999999999976442211111      1110         111112334


Q ss_pred             HHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007167          540 EEMVEMLQVGMACVVRMPEERP-----KMADVLKM  569 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  569 (615)
                      ..+.++++   +|+..+|.+|+     +++|++++
T Consensus       223 ~~l~~li~---~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         223 PDAKDLIR---NLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             HHHHHHHH---HHccCCHHHccCcccCCHHHHHcC
Confidence            55556655   99999999999     77777655

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=5.4e-35  Score=291.86  Aligned_cols=242  Identities=21%  Similarity=0.430  Sum_probs=193.3

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .+.||+|+||.||++.. .+++.|++|++.....   ..+.+.+|++++++++|+||+++++++...++.++||||++++
T Consensus         5 ~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (256)
T cd08218           5 VKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGG   84 (256)
T ss_pred             EEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCC
Confidence            35699999999999985 4688999999865322   2357889999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---  457 (615)
                      +|.+.+....   ...+++..+.+++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++.......   
T Consensus        85 ~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~  158 (256)
T cd08218          85 DLYKKINAQR---GVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELA  158 (256)
T ss_pred             cHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhh
Confidence            9999987432   235789999999999999999999988   9999999999999999999999999997664422   


Q ss_pred             CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCC
Q 007167          458 PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN  537 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  537 (615)
                      ....++..|+|||+..+..++.++|||||||++++|++|+.||......+.      +........     . .  ....
T Consensus       159 ~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~------~~~~~~~~~-----~-~--~~~~  224 (256)
T cd08218         159 RTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL------VLKIIRGSY-----P-P--VSSH  224 (256)
T ss_pred             hhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHH------HHHHhcCCC-----C-C--Cccc
Confidence            123467789999999888899999999999999999999999975332221      111111110     0 0  1112


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          538 IEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       538 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ...++.++++   +|++.+|++||++.||+++
T Consensus       225 ~~~~~~~li~---~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         225 YSYDLRNLVS---QLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             CCHHHHHHHH---HHhhCChhhCcCHHHHhhC
Confidence            3344444444   9999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6e-36  Score=284.83  Aligned_cols=262  Identities=19%  Similarity=0.357  Sum_probs=204.8

Q ss_pred             CHHHHHHHHhhhcCcCCccEEEEEE-ECCCCEEEEEEeccccC-CHHHHHHHHHHHhCCC-CCcccceeEEEEecCeeeE
Q 007167          296 DLEDLLRASAEVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNV-GKREFEQQMEIVGGIR-HENVVALRAYYYSKDEKLM  372 (615)
Q Consensus       296 ~~~~l~~~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l  372 (615)
                      .++|+.+-+.+.||+|+|+.|--+. ...|.++|||++.+... ....+.+|++++...+ |+||++++.||++++..||
T Consensus        74 ~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYL  153 (463)
T KOG0607|consen   74 KFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYL  153 (463)
T ss_pred             hHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEE
Confidence            4788888899999999999999887 67899999999977632 2566789999999985 9999999999999999999


Q ss_pred             EeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCC---cEEEeeccc
Q 007167          373 VYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG---HVCVSDIGL  449 (615)
Q Consensus       373 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~---~~kl~DfG~  449 (615)
                      |||-|.||.|..+++.++     .+++..+.++..+||.||.+||.++   |.|||+||+|||-....   -+|||||.+
T Consensus       154 VfEKm~GGplLshI~~~~-----~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDL  225 (463)
T KOG0607|consen  154 VFEKMRGGPLLSHIQKRK-----HFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDL  225 (463)
T ss_pred             EEecccCchHHHHHHHhh-----hccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccc
Confidence            999999999999998543     7999999999999999999999998   99999999999987654   489999998


Q ss_pred             ccccCC------C----CCCCCCCCcccCcccc-----CCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcch----hh
Q 007167          450 AALMSP------M----PPPAMRAAGYRAPEVT-----DTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEV----VH  510 (615)
Q Consensus       450 a~~~~~------~----~~~~~~~~~y~aPE~~-----~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~----~~  510 (615)
                      +.-+..      .    -.+.+|+..|||||+.     ....|+.++|.||+|||+|-|++|..||.++-+.+.    ..
T Consensus       226 gSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe  305 (463)
T KOG0607|consen  226 GSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGE  305 (463)
T ss_pred             ccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCC
Confidence            754421      1    1233566679999986     345689999999999999999999999987543221    01


Q ss_pred             HHHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007167          511 LVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK  568 (615)
Q Consensus       511 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  568 (615)
                      ..+..+..+-+..-...+...-..|..++.+.++++.   ..+..|+..|.++.++++
T Consensus       306 ~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlis---nLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  306 VCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLIS---NLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             ccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHH---HHHhccHHhhhhhhhccC
Confidence            1111111111111112222222345667888888888   666799999999999887

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1e-34  Score=293.15  Aligned_cols=247  Identities=24%  Similarity=0.425  Sum_probs=192.1

Q ss_pred             hhcCcCCccEEEEEEEC------CCCEEEEEEeccccCC--HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecC
Q 007167          306 EVLGKGTFGTAYKAALE------DASTVVVKRLKEVNVG--KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYF  377 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  377 (615)
                      +.||+|+||+||+|+.+      +...|++|.+......  .+.+.+|++++++++|+||+++++++.+.+..++||||+
T Consensus        11 ~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   90 (275)
T cd05046          11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYT   90 (275)
T ss_pred             eeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEec
Confidence            45999999999999864      2356888888654332  357899999999999999999999999989999999999


Q ss_pred             CCCChhhhhccCCCCC----CCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeeccccccc
Q 007167          378 EPGSVSAMLHGRRGEG----QSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALM  453 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~----~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~  453 (615)
                      ++|+|.++++......    ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++++|||++...
T Consensus        91 ~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~~~~~~~  167 (275)
T cd05046          91 DLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLLSLSKDV  167 (275)
T ss_pred             CCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccccccccc
Confidence            9999999997543211    126899999999999999999999998   999999999999999999999999998754


Q ss_pred             CCCC----CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccc
Q 007167          454 SPMP----PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVF  528 (615)
Q Consensus       454 ~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  528 (615)
                      ....    ....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+.....      .....     
T Consensus       168 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~------~~~~~-----  236 (275)
T cd05046         168 YNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRL------QAGKL-----  236 (275)
T ss_pred             CcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHH------HcCCc-----
Confidence            3221    11233556999999988888999999999999999999 88899654432221111      10000     


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 007167          529 DVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVE  571 (615)
Q Consensus       529 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  571 (615)
                        ........++.+   .+++.+|+..+|++||++.|++++|.
T Consensus       237 --~~~~~~~~~~~l---~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         237 --ELPVPEGCPSRL---YKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             --CCCCCCCCCHHH---HHHHHHHcCCCcccCCCHHHHHHHhc
Confidence              000111233444   44555999999999999999999885

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3e-35  Score=298.69  Aligned_cols=253  Identities=22%  Similarity=0.415  Sum_probs=190.3

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      +.||+|+||.||+|..+ .++.||+|++.....   ..+.+.+|+++++.++||||+++++++..++..++||||+++++
T Consensus         7 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   86 (286)
T cd07846           7 GLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTV   86 (286)
T ss_pred             eeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccH
Confidence            57999999999999975 578999998865422   24567899999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC---
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP---  458 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~---  458 (615)
                      |..+....     ..++|..+..++.|++.||+|||+.+   |+||||+|+||++++++.++|+|||++........   
T Consensus        87 l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~  158 (286)
T cd07846          87 LDDLEKYP-----NGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYT  158 (286)
T ss_pred             HHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccC
Confidence            98877532     24899999999999999999999998   99999999999999999999999999886543221   


Q ss_pred             CCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchh-hHHHHHHHhhhccc----ccc----cc
Q 007167          459 PAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVV-HLVRWVNSVVREEW----TAE----VF  528 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~----~~~----~~  528 (615)
                      ...++..|+|||++.+ ..++.++|||||||++|||++|+.||......+.. ....+.........    ...    ..
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07846         159 DYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMR  238 (286)
T ss_pred             cccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccc
Confidence            2345778999999865 44688999999999999999999999754432211 11111111000000    000    00


Q ss_pred             cccc-------cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          529 DVEL-------LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       529 d~~~-------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+..       ...+.++..+.+   ++.+|+..+|++||++.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~---li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         239 LPEVKEIEPLEKRFPKLSGLVLD---LAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             cccccCcchHHHhCCCcCHHHHH---HHHHHhcCCcccchhHHHHhcC
Confidence            0000       012233344444   4559999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.1e-34  Score=289.71  Aligned_cols=240  Identities=24%  Similarity=0.383  Sum_probs=192.0

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccC------CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV------GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      +.||+|+||.||+|... ++..|++|.+.....      ..+.+.+|+++++.++|+||+++++++.+....++|+||++
T Consensus         6 ~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~   85 (258)
T cd06632           6 ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVP   85 (258)
T ss_pred             ceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecC
Confidence            56999999999999976 788999998865321      23568899999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC-
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP-  457 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~-  457 (615)
                      +++|.+++...     ..+++..+..++.|++.|++|||+.+   |+|+||+|+||+++.++.+||+|||++....... 
T Consensus        86 ~~~L~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~  157 (258)
T cd06632          86 GGSLAKLLKKY-----GSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSF  157 (258)
T ss_pred             CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceecccccc
Confidence            99999999642     35889999999999999999999998   9999999999999999999999999987664332 


Q ss_pred             -CCCCCCCcccCccccCCCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCC
Q 007167          458 -PPAMRAAGYRAPEVTDTRK-ATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY  535 (615)
Q Consensus       458 -~~~~~~~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  535 (615)
                       ....++..|+|||.+.... ++.++|+|||||++|+|++|+.||......+.  ...+    ......     +  ...
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~--~~~~----~~~~~~-----~--~~~  224 (258)
T cd06632         158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAA--VFKI----GRSKEL-----P--PIP  224 (258)
T ss_pred             ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHH--HHHH----HhcccC-----C--CcC
Confidence             2334677899999987766 89999999999999999999999976432111  1111    000000     0  011


Q ss_pred             CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          536 PNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       536 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      +..++.+.+++.   +|+..+|.+||++.|++++
T Consensus       225 ~~~~~~~~~li~---~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         225 DHLSDEAKDFIL---KCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             CCcCHHHHHHHH---HHhhcCcccCcCHHHHhcC
Confidence            233445555555   9999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.4e-34  Score=292.61  Aligned_cols=239  Identities=23%  Similarity=0.391  Sum_probs=191.9

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      .+.||+|+||.||+|... ++..||+|.+.....  ..+.+.+|++++++++||||+++++++..++..++||||+++++
T Consensus         9 ~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~   88 (277)
T cd06641           9 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS   88 (277)
T ss_pred             heeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCc
Confidence            456999999999999864 678899998764322  23568899999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---C
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---P  458 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~  458 (615)
                      |.+++..      ..+++.....++.+++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++.......   .
T Consensus        89 l~~~i~~------~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06641          89 ALDLLEP------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchhhhc
Confidence            9999863      25889999999999999999999998   9999999999999999999999999987664322   2


Q ss_pred             CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCc
Q 007167          459 PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI  538 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  538 (615)
                      ...++..|+|||.+.+..++.++|||||||++|+|++|+.||...........      ......      +.+  ....
T Consensus       160 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~------~~~~~~------~~~--~~~~  225 (277)
T cd06641         160 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL------IPKNNP------PTL--EGNY  225 (277)
T ss_pred             cccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH------HhcCCC------CCC--Cccc
Confidence            23467789999999888889999999999999999999999975432221111      111000      000  1123


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          539 EEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       539 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      +.++.++   +.+|+..+|.+||++.|++++
T Consensus       226 ~~~~~~~---i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         226 SKPLKEF---VEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CHHHHHH---HHHHccCChhhCcCHHHHHhC
Confidence            3444444   459999999999999999996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.1e-34  Score=292.44  Aligned_cols=245  Identities=20%  Similarity=0.374  Sum_probs=190.0

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC---C--------HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeE
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV---G--------KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLM  372 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~--------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~l  372 (615)
                      .+.||+|+||.||+|... ++..||+|.++....   .        .+.+.+|+++++.++|+|++++++++...+..++
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   85 (272)
T cd06629           6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI   85 (272)
T ss_pred             cceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEE
Confidence            457999999999999854 688999998753211   0        1357789999999999999999999999999999


Q ss_pred             EeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccc
Q 007167          373 VYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAAL  452 (615)
Q Consensus       373 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~  452 (615)
                      ||||+++|+|.++++..     ..+++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||++..
T Consensus        86 v~e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~  157 (272)
T cd06629          86 FLEYVPGGSIGSCLRTY-----GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK  157 (272)
T ss_pred             EEecCCCCcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccccc
Confidence            99999999999999743     36899999999999999999999987   99999999999999999999999999976


Q ss_pred             cCCCC-----CCCCCCCcccCccccCCCC--CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccc
Q 007167          453 MSPMP-----PPAMRAAGYRAPEVTDTRK--ATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTA  525 (615)
Q Consensus       453 ~~~~~-----~~~~~~~~y~aPE~~~~~~--~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (615)
                      .....     ....++..|+|||.+....  ++.++||||||+++||+++|+.||......+.  ...    ... ....
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~----~~~-~~~~  230 (272)
T cd06629         158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA--MFK----LGN-KRSA  230 (272)
T ss_pred             ccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHH--HHH----hhc-cccC
Confidence            54321     1234677899999987654  78999999999999999999999964332111  111    000 0001


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          526 EVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       526 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ..++..  ..+.++.++.+++.   +|+..+|++||++.||+++
T Consensus       231 ~~~~~~--~~~~~~~~~~~li~---~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         231 PPIPPD--VSMNLSPVALDFLN---ACFTINPDNRPTARELLQH  269 (272)
T ss_pred             CcCCcc--ccccCCHHHHHHHH---HHhcCChhhCCCHHHHhhC
Confidence            111111  11233455555555   9999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.4e-34  Score=290.09  Aligned_cols=243  Identities=24%  Similarity=0.413  Sum_probs=192.9

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .+.||+|+||.||+|... ++..|++|.++....   ..+.+.+|+++++.++|+||+++++++...+..++|+||++++
T Consensus         5 ~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (264)
T cd06626           5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGG   84 (264)
T ss_pred             eeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCC
Confidence            357999999999999854 688999999876544   2457889999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC--
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP--  458 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~--  458 (615)
                      +|.++++..     ..+++..+..++.+++.|++|||+.+   |+|+||+|+||++++++.+||+|||++........  
T Consensus        85 ~L~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          85 TLEELLEHG-----RILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             cHHHHHhhc-----CCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            999999742     25788999999999999999999998   99999999999999999999999999987654322  


Q ss_pred             -----CCCCCCcccCccccCCCC---CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccc
Q 007167          459 -----PAMRAAGYRAPEVTDTRK---ATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDV  530 (615)
Q Consensus       459 -----~~~~~~~y~aPE~~~~~~---~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  530 (615)
                           ...++..|+|||++....   ++.++||||||+++||+++|+.||.......  .....+..         ...+
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~--~~~~~~~~---------~~~~  225 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF--QIMFHVGA---------GHKP  225 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH--HHHHHHhc---------CCCC
Confidence                 234567899999997766   7899999999999999999999997543211  11111110         0011


Q ss_pred             cccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          531 ELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       531 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+.......+...++++   +|++.+|++||++.|++.+
T Consensus       226 ~~~~~~~~~~~~~~li~---~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         226 PIPDSLQLSPEGKDFLD---RCLESDPKKRPTASELLQH  261 (264)
T ss_pred             CCCcccccCHHHHHHHH---HHccCCcccCCCHHHHhcC
Confidence            11111222445555555   9999999999999998763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.1e-34  Score=289.39  Aligned_cols=242  Identities=20%  Similarity=0.385  Sum_probs=192.2

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .+.||+|+||.||++.. .++..+++|.+.....   ....+.+|+++++.++|+||+++++.+..++..++||||++++
T Consensus         5 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (256)
T cd08220           5 IRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGG   84 (256)
T ss_pred             EEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCC
Confidence            35699999999999985 4677899999865422   2456889999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCC-CcEEEeecccccccCCCC--
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQ-GHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~-~~~kl~DfG~a~~~~~~~--  457 (615)
                      +|.+++....   ...+++..+.+++.+++.|++|||+++   |+||||||+||+++++ +.+||+|||.+.......  
T Consensus        85 ~L~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~  158 (256)
T cd08220          85 TLAEYIQKRC---NSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA  158 (256)
T ss_pred             CHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccc
Confidence            9999997532   235899999999999999999999998   9999999999999865 468999999998765432  


Q ss_pred             CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCC
Q 007167          458 PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN  537 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  537 (615)
                      ....++..|+|||.+....++.++||||||+++|+|++|+.||...+.....   .   ....... .     .  ....
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~---~---~~~~~~~-~-----~--~~~~  224 (256)
T cd08220         159 YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALV---L---KIMSGTF-A-----P--ISDR  224 (256)
T ss_pred             cccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHH---H---HHHhcCC-C-----C--CCCC
Confidence            2234677899999998888899999999999999999999999764432211   1   1111100 0     0  0112


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          538 IEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       538 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+..+.+++.   +||..+|++|||+.|++++
T Consensus       225 ~~~~l~~li~---~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         225 YSPDLRQLIL---SMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             cCHHHHHHHH---HHccCChhhCCCHHHHhhC
Confidence            3444555554   9999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.2e-34  Score=290.37  Aligned_cols=242  Identities=23%  Similarity=0.386  Sum_probs=191.5

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEe--cCeeeEEeecCCC
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYS--KDEKLMVYDYFEP  379 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~~~  379 (615)
                      +.||+|+||.||++.. .++..|++|.+......   .+.+..|+++++.++|+||+++++++..  +...+++|||+++
T Consensus         6 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~   85 (265)
T cd08217           6 ETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEG   85 (265)
T ss_pred             eeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccC
Confidence            5699999999999985 46788999988654322   3457789999999999999999998864  3467899999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhh-----ccCCCCceecCCCCCCEEeCCCCcEEEeecccccccC
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIH-----TENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS  454 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-----~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~  454 (615)
                      ++|.+++..... ....+++.....++.+++.||+|||     +.+   |+|+||||+||++++++.+||+|||++....
T Consensus        86 ~~L~~~l~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~~~~~~  161 (265)
T cd08217          86 GDLAQLIQKCKK-ERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGLAKILG  161 (265)
T ss_pred             CCHHHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEeccccccccc
Confidence            999999975422 2357899999999999999999999     555   9999999999999999999999999998775


Q ss_pred             CCC---CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccccc
Q 007167          455 PMP---PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE  531 (615)
Q Consensus       455 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  531 (615)
                      ...   ....++..|+|||.+....++.++||||||+++++|++|+.||......+..   ..+.    ..        .
T Consensus       162 ~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~---~~~~----~~--------~  226 (265)
T cd08217         162 HDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLA---SKIK----EG--------K  226 (265)
T ss_pred             CCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHH---HHHh----cC--------C
Confidence            433   2335678899999998888999999999999999999999999865422211   1111    00        0


Q ss_pred             ccC-CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          532 LLR-YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       532 ~~~-~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ... ....+..+.+++   .+|+..+|++||++.||+++
T Consensus       227 ~~~~~~~~~~~~~~l~---~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         227 FRRIPYRYSSELNEVI---KSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             CCCCccccCHHHHHHH---HHHccCCcccCCCHHHHhhC
Confidence            101 112334444444   49999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.5e-34  Score=324.21  Aligned_cols=247  Identities=18%  Similarity=0.325  Sum_probs=187.8

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEec--CeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSK--DEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e~~~  378 (615)
                      .+.||+|+||+||++... .+..||+|.+......   ...+..|+.++..++|||||+++++|...  ...+|||||++
T Consensus        18 l~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~   97 (1021)
T PTZ00266         18 IKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCD   97 (1021)
T ss_pred             EEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCC
Confidence            356999999999999965 4567888888654222   35688999999999999999999988654  56899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCC----CCceecCCCCCCEEeCC----------------
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENG----GKLVHGGIKASNIFLNS----------------  438 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~----~~iiHrDik~~Nill~~----------------  438 (615)
                      +|+|.++|..... ....+++..++.|+.||+.||+|||+.+.    .+|+||||||+|||++.                
T Consensus        98 gGSL~~lL~k~~~-~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~n  176 (1021)
T PTZ00266         98 AGDLSRNIQKCYK-MFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLN  176 (1021)
T ss_pred             CCcHHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccC
Confidence            9999999974321 12469999999999999999999998542    24999999999999964                


Q ss_pred             -CCcEEEeecccccccCCCC--CCCCCCCcccCccccCC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHH
Q 007167          439 -QGHVCVSDIGLAALMSPMP--PPAMRAAGYRAPEVTDT--RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVR  513 (615)
Q Consensus       439 -~~~~kl~DfG~a~~~~~~~--~~~~~~~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~  513 (615)
                       ...+||+|||++..+....  ....+|+.|+|||++..  ..++.++|||||||++|||++|+.||.......  ..+.
T Consensus       177 g~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~--qli~  254 (1021)
T PTZ00266        177 GRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFS--QLIS  254 (1021)
T ss_pred             CCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHH--HHHH
Confidence             2358999999998764322  23457889999999854  458899999999999999999999997543211  1111


Q ss_pred             HHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          514 WVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       514 ~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+.    ..       +.+ ..+..+.++.+++.   .||..+|.+||++.|++.+
T Consensus       255 ~lk----~~-------p~l-pi~~~S~eL~dLI~---~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        255 ELK----RG-------PDL-PIKGKSKELNILIK---NLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             HHh----cC-------CCC-CcCCCCHHHHHHHH---HHhcCChhHCcCHHHHhcc
Confidence            111    00       011 11223445555554   9999999999999999864

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-34  Score=298.35  Aligned_cols=242  Identities=23%  Similarity=0.378  Sum_probs=191.3

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccC----CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV----GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      +.||+|+||+||++... ++..||+|.+.....    ..+.+..|+++++.++|+||+++++.+...+..++||||+.++
T Consensus         7 ~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~   86 (316)
T cd05574           7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGG   86 (316)
T ss_pred             eeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCC
Confidence            46999999999999965 488999999875432    2356788999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---  457 (615)
                      +|.+++....   ...+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++.......   
T Consensus        87 ~L~~~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~  160 (316)
T cd05574          87 ELFRLLQRQP---GKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV  160 (316)
T ss_pred             CHHHHHHhCC---CCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence            9999987432   246899999999999999999999998   9999999999999999999999999987553211   


Q ss_pred             -----------------------------CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcch
Q 007167          458 -----------------------------PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEV  508 (615)
Q Consensus       458 -----------------------------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~  508 (615)
                                                   ....++..|+|||++.+..++.++||||||+++|+|++|+.||...+..+.
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~  240 (316)
T cd05574         161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET  240 (316)
T ss_pred             ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence                                         012456779999999888899999999999999999999999976543322


Q ss_pred             hhHHHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCC----HHHHHHH
Q 007167          509 VHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPK----MADVLKM  569 (615)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs----~~evl~~  569 (615)
                      ..  .    .....       .........++.+.++++   +|+..+|++||+    ++|++++
T Consensus       241 ~~--~----~~~~~-------~~~~~~~~~~~~~~~li~---~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         241 FS--N----ILKKE-------VTFPGSPPVSSSARDLIR---KLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             HH--H----HhcCC-------ccCCCccccCHHHHHHHH---HHccCCHhHCCCchhhHHHHHcC
Confidence            11  1    11000       011111113455555555   999999999999    6666654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=9.1e-35  Score=294.70  Aligned_cols=243  Identities=22%  Similarity=0.407  Sum_probs=187.9

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccCCHHHHHHHHHHHhCC-CCCcccceeEEEEe------cCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVGKREFEQQMEIVGGI-RHENVVALRAYYYS------KDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~------~~~~~lV~e~  376 (615)
                      .+.||+|+||+||+|.. .+++.+|+|.+.........+..|+.++.++ +|+||+++++++..      .+..++||||
T Consensus        21 ~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~  100 (282)
T cd06636          21 VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEF  100 (282)
T ss_pred             heeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEe
Confidence            45799999999999996 4678899998865544456788899999988 69999999999853      4578999999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM  456 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~  456 (615)
                      +++|+|.+++...+   ...+++..+..++.|++.|++|||+.+   |+||||||+||++++++.++|+|||++......
T Consensus       101 ~~~~~L~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~  174 (282)
T cd06636         101 CGAGSVTDLVKNTK---GNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRT  174 (282)
T ss_pred             CCCCcHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCcchhhhhcc
Confidence            99999999987533   235788889999999999999999998   999999999999999999999999998765422


Q ss_pred             ---CCCCCCCCcccCccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccc
Q 007167          457 ---PPPAMRAAGYRAPEVTD-----TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVF  528 (615)
Q Consensus       457 ---~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  528 (615)
                         .....++..|+|||.+.     ...++.++|||||||++|||++|+.||......+....+      .+. .     
T Consensus       175 ~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~------~~~-~-----  242 (282)
T cd06636         175 VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI------PRN-P-----  242 (282)
T ss_pred             ccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH------hhC-C-----
Confidence               12334677899999875     345788999999999999999999999754322111110      000 0     


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          529 DVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       529 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .... ....++.++.++   +.+||..+|.+||++.|++++
T Consensus       243 ~~~~-~~~~~~~~~~~l---i~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         243 PPKL-KSKKWSKKFIDF---IEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             CCCC-cccccCHHHHHH---HHHHhCCChhhCcCHHHHhcC
Confidence            0000 111233444444   449999999999999999764

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=9.6e-35  Score=291.59  Aligned_cols=248  Identities=24%  Similarity=0.399  Sum_probs=195.2

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      .+.||+|+||+||+|... ++..+++|++.....  ..+.+.+|+++++.++|+||+++++.+..++..++|+||+++++
T Consensus         6 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~   85 (267)
T cd06610           6 IEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGS   85 (267)
T ss_pred             eeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCc
Confidence            456999999999999854 677899999865422  34678899999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC---
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP---  458 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~---  458 (615)
                      |.++++....  ...+++.....++.|++.|++|||+.+   |+||||+|+||++++++.++|+|||++..+.....   
T Consensus        86 l~~~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~  160 (267)
T cd06610          86 LLDIMKSSYP--RGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR  160 (267)
T ss_pred             HHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence            9999975321  246899999999999999999999998   99999999999999999999999999877654322   


Q ss_pred             ----CCCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccccccc
Q 007167          459 ----PAMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELL  533 (615)
Q Consensus       459 ----~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  533 (615)
                          ...++..|+|||++... .++.++|||||||++|||++|+.||......+.  ..+...    ....  .+... .
T Consensus       161 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~--~~~~~~----~~~~--~~~~~-~  231 (267)
T cd06610         161 KVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKV--LMLTLQ----NDPP--SLETG-A  231 (267)
T ss_pred             cccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhh--HHHHhc----CCCC--CcCCc-c
Confidence                22467789999998776 689999999999999999999999976543221  111111    1000  00000 0


Q ss_pred             CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          534 RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       534 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ....+++++.++++   +|+..+|++||++.|++++
T Consensus       232 ~~~~~~~~~~~li~---~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         232 DYKKYSKSFRKMIS---LCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             ccccccHHHHHHHH---HHcCCChhhCcCHHHHhhC
Confidence            01233455555555   9999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2e-34  Score=292.89  Aligned_cols=243  Identities=23%  Similarity=0.415  Sum_probs=195.7

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      .+.||+|+||.||+|... ++..|++|+++......+.+.+|+++++.++|+|++++++++...+..++|+||+++++|.
T Consensus        24 ~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~  103 (286)
T cd06614          24 LEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLT  103 (286)
T ss_pred             hHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHH
Confidence            356999999999999976 6888999999765444667889999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---CCC
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---PPA  460 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~~~  460 (615)
                      +++....    ..+++..+..++.+++.||+|||+.+   |+|+||+|+||+++.++.++|+|||++.......   ...
T Consensus       104 ~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  176 (286)
T cd06614         104 DIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV  176 (286)
T ss_pred             HHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccc
Confidence            9997532    36999999999999999999999987   9999999999999999999999999987654321   223


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE  540 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  540 (615)
                      .++..|+|||.+.+..++.++|||||||++|+|++|+.||..........  .    ..... .     ........++.
T Consensus       177 ~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~--~----~~~~~-~-----~~~~~~~~~~~  244 (286)
T cd06614         177 VGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF--L----ITTKG-I-----PPLKNPEKWSP  244 (286)
T ss_pred             cCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH--H----HHhcC-C-----CCCcchhhCCH
Confidence            45678999999988889999999999999999999999997543321111  1    10000 0     00111112344


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          541 EMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       541 ~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ++.++++   +|++.+|.+||++.|++++
T Consensus       245 ~l~~li~---~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         245 EFKDFLN---KCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             HHHHHHH---HHhccChhhCcCHHHHhhC
Confidence            5555554   9999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.4e-34  Score=295.66  Aligned_cols=253  Identities=19%  Similarity=0.330  Sum_probs=190.3

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC------HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG------KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      +.||+|+||.||+|... +++.|++|+++.....      ...+..|++++++++|+||+++++++.+.+..++||||+ 
T Consensus         6 ~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-   84 (298)
T cd07841           6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-   84 (298)
T ss_pred             eeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-
Confidence            46999999999999964 6889999999764322      345678999999999999999999999999999999999 


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC-
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP-  457 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~-  457 (615)
                      +|+|.+++....    ..+++..+..++.|+++||+|||+++   |+||||||+||+++.++.++|+|||++....... 
T Consensus        85 ~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~  157 (298)
T cd07841          85 ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR  157 (298)
T ss_pred             CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCCc
Confidence            999999997432    36999999999999999999999998   9999999999999999999999999998765432 


Q ss_pred             --CCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHH-HHHHHhhhccccc-----ccc
Q 007167          458 --PPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLV-RWVNSVVREEWTA-----EVF  528 (615)
Q Consensus       458 --~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~-----~~~  528 (615)
                        .....+..|+|||.+.+ ..++.++|||||||++|||++|..||......+....+ ..+.......+..     ...
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (298)
T cd07841         158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV  237 (298)
T ss_pred             cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence              12234667999998854 45789999999999999999998888754432221111 1110000000000     000


Q ss_pred             cccc------c-CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          529 DVEL------L-RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       529 d~~~------~-~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ....      . .....++   .+.+++.+|++.+|++|||+.|++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~---~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         238 EFKPFPPTPLKQIFPAASD---DALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccCCcchhhhcccccH---HHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            0000      0 0112233   44455559999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-36  Score=296.21  Aligned_cols=239  Identities=24%  Similarity=0.360  Sum_probs=195.0

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccc----cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEV----NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .+||+||||.||-++.+ .|+.+|.|++.+.    ..++.-...|-+++.++..+.||.+--.|+.++..++|+..|.||
T Consensus       191 RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGG  270 (591)
T KOG0986|consen  191 RVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGG  270 (591)
T ss_pred             EEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCC
Confidence            47999999999999865 5777899888543    233445678889999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--C
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--P  458 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--~  458 (615)
                      +|.-+|...   +...+++..++.++.+|+.||+|||+.+   ||.||+||+|||+|+.|+++|+|.|+|..+....  .
T Consensus       271 DLkfHiyn~---g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~  344 (591)
T KOG0986|consen  271 DLKFHIYNH---GNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIR  344 (591)
T ss_pred             ceeEEeecc---CCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCCCccc
Confidence            999999753   3467999999999999999999999998   9999999999999999999999999999886543  4


Q ss_pred             CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCc
Q 007167          459 PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI  538 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  538 (615)
                      ..+||.||||||++..+.|+...|.||+||++|||+.|+.||.......-..-+   .+..        ..........+
T Consensus       345 ~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEv---drr~--------~~~~~ey~~kF  413 (591)
T KOG0986|consen  345 GRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEV---DRRT--------LEDPEEYSDKF  413 (591)
T ss_pred             cccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHH---HHHH--------hcchhhccccc
Confidence            457999999999999999999999999999999999999999865432111111   1111        11111122456


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHH
Q 007167          539 EEEMVEMLQVGMACVVRMPEERPKMA  564 (615)
Q Consensus       539 ~~~~~~l~~l~~~cl~~~P~~RPs~~  564 (615)
                      +++.+.+.+   ..+.+||.+|.-.+
T Consensus       414 S~eakslc~---~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  414 SEEAKSLCE---GLLTKDPEKRLGCR  436 (591)
T ss_pred             CHHHHHHHH---HHHccCHHHhccCC
Confidence            788888888   77889999987544

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-34  Score=292.36  Aligned_cols=246  Identities=25%  Similarity=0.415  Sum_probs=191.0

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCHHHHHHHHHHHhCC-CCCcccceeEEEEecC------eeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFEQQMEIVGGI-RHENVVALRAYYYSKD------EKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~------~~~lV~e~  376 (615)
                      .+.||+|+||.||+|..+ +++.+++|.+.......+.+.+|+++++++ +|+||+++++++....      ..++||||
T Consensus        11 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~   90 (275)
T cd06608          11 VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMEL   90 (275)
T ss_pred             eeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEc
Confidence            457999999999999975 567899999876655567899999999999 7999999999997654      48999999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM  456 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~  456 (615)
                      +++++|.+++.... .....+++..+..++.|++.||+|||+.+   ++|+||+|+||++++++.+||+|||++......
T Consensus        91 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~  166 (275)
T cd06608          91 CGGGSVTDLVKGLR-KKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST  166 (275)
T ss_pred             CCCCcHHHHHHHHh-hcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCccceecccc
Confidence            99999999986432 12347899999999999999999999998   999999999999999999999999998765432


Q ss_pred             C---CCCCCCCcccCccccCC-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccc
Q 007167          457 P---PPAMRAAGYRAPEVTDT-----RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVF  528 (615)
Q Consensus       457 ~---~~~~~~~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  528 (615)
                      .   ....++..|+|||.+..     ..++.++|||||||+++||++|+.||..........      ..... .     
T Consensus       167 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~-~-----  234 (275)
T cd06608         167 LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALF------KIPRN-P-----  234 (275)
T ss_pred             hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHH------Hhhcc-C-----
Confidence            2   23346778999998753     346789999999999999999999997543222111      11110 0     


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          529 DVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       529 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .........+++++.++++   +|+..||++|||+.|++++
T Consensus       235 ~~~~~~~~~~~~~~~~li~---~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         235 PPTLKSPENWSKKFNDFIS---ECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             CCCCCchhhcCHHHHHHHH---HHhhcChhhCcCHHHHhcC
Confidence            0111111123345555555   9999999999999999874

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.8e-34  Score=290.98  Aligned_cols=252  Identities=21%  Similarity=0.315  Sum_probs=193.0

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEec--CeeeEEeecCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSK--DEKLMVYDYFEPG  380 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e~~~~g  380 (615)
                      +.||.|++|.||++... +++.+|+|.+.....  ....+.+|+++++.++||||+++++++...  ...++||||++++
T Consensus         7 ~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~   86 (287)
T cd06621           7 SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGG   86 (287)
T ss_pred             EEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCC
Confidence            46999999999999974 578899998875432  246688999999999999999999998654  4689999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC-CC
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP-PP  459 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~-~~  459 (615)
                      +|.+++..... ....+++.....++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++....... ..
T Consensus        87 ~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  162 (287)
T cd06621          87 SLDSIYKKVKK-RGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT  162 (287)
T ss_pred             CHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccccccccc
Confidence            99988764321 2346889999999999999999999998   9999999999999999999999999987654322 23


Q ss_pred             CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC--cchhhHHHHHHHhhhcccccccccccccCCCC
Q 007167          460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGG--DEVVHLVRWVNSVVREEWTAEVFDVELLRYPN  537 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  537 (615)
                      ..++..|+|||.+.+..++.++||||+||++|||++|+.||.....  ....+...++......     .+.........
T Consensus       163 ~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~  237 (287)
T cd06621         163 FTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNP-----ELKDEPGNGIK  237 (287)
T ss_pred             ccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCch-----hhccCCCCCCc
Confidence            3457789999999888899999999999999999999999986532  1122222222211100     00000000011


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          538 IEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       538 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .++++   .+++.+|+..+|.+|||+.|++++
T Consensus       238 ~~~~~---~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         238 WSEEF---KDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             hHHHH---HHHHHHHcCCCcccCCCHHHHHhC
Confidence            23444   445559999999999999999985

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.8e-34  Score=292.15  Aligned_cols=240  Identities=23%  Similarity=0.345  Sum_probs=184.4

Q ss_pred             hcCcCCccEEEEEEEC-CCCEEEEEEeccccCC----HHHHHHHHHH---HhCCCCCcccceeEEEEecCeeeEEeecCC
Q 007167          307 VLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG----KREFEQQMEI---VGGIRHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~---l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      +||+|+||.||++... +++.+|+|.+......    ...+.+|..+   +...+|+||+.+++++...+..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999864 5788999988654221    2233444433   334479999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC-
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP-  457 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~-  457 (615)
                      +|+|.+++...     ..+++.....++.|++.||+|||+.+   |+||||||+||++++++.++|+|||++....... 
T Consensus        81 ~~~L~~~i~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~  152 (279)
T cd05633          81 GGDLHYHLSQH-----GVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP  152 (279)
T ss_pred             CCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccCc
Confidence            99999988642     36999999999999999999999998   9999999999999999999999999987654322 


Q ss_pred             CCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          458 PPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                      ....++..|+|||.+.. ..++.++||||+||++|||++|+.||.............    ....      ....  ..+
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~----~~~~------~~~~--~~~  220 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR----MTLT------VNVE--LPD  220 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHH----Hhhc------CCcC--Ccc
Confidence            23357889999999864 557899999999999999999999997654322211111    0000      0011  112


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERP-----KMADVLKM  569 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  569 (615)
                      ..++++.++++   +|+..+|++||     +++|++++
T Consensus       221 ~~~~~~~~li~---~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         221 SFSPELKSLLE---GLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             ccCHHHHHHHH---HHhcCCHHHhcCCCCCCHHHHHhC
Confidence            34455555555   99999999999     59999886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.6e-34  Score=293.33  Aligned_cols=254  Identities=22%  Similarity=0.352  Sum_probs=192.3

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .+.||+|+||.||+|... ++..|++|++.....   ..+.+.+|++++++++|+||+++++++......++||||+ ++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~   83 (286)
T cd07832           5 LGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PS   83 (286)
T ss_pred             EeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CC
Confidence            356999999999999964 688999999875432   2457889999999999999999999999999999999999 99


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---  457 (615)
                      +|.+++....    ..+++..+..++.|+++||+|||+.+   |+|+||||+||+++.++.++|+|||++.......   
T Consensus        84 ~L~~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  156 (286)
T cd07832          84 DLSEVLRDEE----RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL  156 (286)
T ss_pred             CHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence            9999986432    46999999999999999999999998   9999999999999999999999999998765432   


Q ss_pred             -CCCCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhh-HHHHHHHhhhcccc---------c
Q 007167          458 -PPAMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVH-LVRWVNSVVREEWT---------A  525 (615)
Q Consensus       458 -~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~---------~  525 (615)
                       ....++..|+|||++.+. .++.++||||+|++++||++|+.||......+... ....+.......|.         .
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07832         157 YSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNK  236 (286)
T ss_pred             cccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhc
Confidence             233467789999998654 46899999999999999999988886544322111 11111000000000         0


Q ss_pred             ccccccc-----cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          526 EVFDVEL-----LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       526 ~~~d~~~-----~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ..+....     ...+...+++   .+++.+|+..+|++||++++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~---~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         237 ITFPESKPIPLEEIFPDASPEA---LDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             ccCCCCCcchHHHhCCCccHHH---HHHHHHHhccChhhCCCHHHHhhC
Confidence            0000000     0012233444   444559999999999999999876

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.5e-34  Score=292.08  Aligned_cols=240  Identities=20%  Similarity=0.386  Sum_probs=191.6

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEeccccC-CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNV-GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      +.||+|++|.||++.. .++..+++|++..... ..+.+.+|+.+++.++|+||+++++++...++.++|+||+++++|.
T Consensus        25 ~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~  104 (285)
T cd06648          25 VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT  104 (285)
T ss_pred             eEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHH
Confidence            5799999999999985 4678899998864422 2456788999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---CCC
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---PPA  460 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~~~  460 (615)
                      +++..      ..+++..+..++.|++.|++|||+.+   |+||||+|+||+++.++.++|+|||.+.......   ...
T Consensus       105 ~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~  175 (285)
T cd06648         105 DIVTH------TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL  175 (285)
T ss_pred             HHHHh------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccc
Confidence            99864      25889999999999999999999998   9999999999999999999999999887554321   223


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE  540 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  540 (615)
                      .++..|+|||...+..++.++|||||||++|||++|+.||......+...      ..... .     .+........+.
T Consensus       176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~------~~~~~-~-----~~~~~~~~~~~~  243 (285)
T cd06648         176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK------RIRDN-L-----PPKLKNLHKVSP  243 (285)
T ss_pred             cCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHH------HHHhc-C-----CCCCcccccCCH
Confidence            46778999999988889999999999999999999999997543222111      11110 0     001111112334


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          541 EMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       541 ~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+.++++   +|+..+|++||++.|++++
T Consensus       244 ~l~~li~---~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         244 RLRSFLD---RMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             HHHHHHH---HHcccChhhCcCHHHHccC
Confidence            4555555   9999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=5.5e-35  Score=296.54  Aligned_cols=251  Identities=21%  Similarity=0.367  Sum_probs=187.9

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      +.||+|+||.||+|... +|..|++|+++....   ....+.+|++++++++|+||+++++++.+....++|+||++ ++
T Consensus         6 ~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~   84 (284)
T cd07839           6 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QD   84 (284)
T ss_pred             EEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CC
Confidence            56999999999999964 688999999865322   23567789999999999999999999999999999999996 57


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---C
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---P  458 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~  458 (615)
                      |.+++...    ...+++.....++.|+++||.|||+.+   |+||||||+||+++.++.+||+|||+++......   .
T Consensus        85 l~~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  157 (284)
T cd07839          85 LKKYFDSC----NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS  157 (284)
T ss_pred             HHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcC
Confidence            88777532    235899999999999999999999998   9999999999999999999999999998664322   2


Q ss_pred             CCCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhh----cccc--cccccc-
Q 007167          459 PAMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVR----EEWT--AEVFDV-  530 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~----~~~~--~~~~d~-  530 (615)
                      ...++..|+|||++.+. .++.++|||||||++|||++|+.|+......+  ...+.+.....    ..|.  ....+. 
T Consensus       158 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (284)
T cd07839         158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD--DQLKRIFRLLGTPTEESWPGVSKLPDYK  235 (284)
T ss_pred             CCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH--HHHHHHHHHhCCCChHHhHHhhhccccc
Confidence            23457789999998664 46899999999999999999999865433211  11111111000    0000  000000 


Q ss_pred             ccc----------CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          531 ELL----------RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       531 ~~~----------~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ...          ..+..+++..++++   +|++.||.+|||++|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~li~---~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         236 PYPMYPATTSLVNVVPKLNSTGRDLLQ---NLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             ccCCCCCcchhhhhcccCCHHHHHHHH---HHhcCChhhcCCHHHHhcC
Confidence            000          01233455555555   9999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.8e-34  Score=290.07  Aligned_cols=244  Identities=20%  Similarity=0.383  Sum_probs=191.0

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccC-------CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNV-------GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      .+.||+|+||.||++.. .++..||+|.+.....       ..+.+.+|++++++++|+||+++++++.+.+..++|+||
T Consensus         5 ~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~   84 (268)
T cd06630           5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW   84 (268)
T ss_pred             cceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEec
Confidence            45799999999999985 5788999999864321       135678999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCC-cEEEeecccccccCC
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG-HVCVSDIGLAALMSP  455 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~-~~kl~DfG~a~~~~~  455 (615)
                      +++++|.+++...     .++++.....++.|++.||.|||+.+   ++|+||+|+||+++.++ .+||+|||.+..+..
T Consensus        85 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~  156 (268)
T cd06630          85 MAGGSVSHLLSKY-----GAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAA  156 (268)
T ss_pred             cCCCcHHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccccc
Confidence            9999999999642     36889999999999999999999998   99999999999998776 599999999877653


Q ss_pred             CC-------CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccc
Q 007167          456 MP-------PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVF  528 (615)
Q Consensus       456 ~~-------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  528 (615)
                      ..       ....++..|+|||.+.+..++.++||||+|+++++|++|+.||...........+.   ......     .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~---~~~~~~-----~  228 (268)
T cd06630         157 KGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIF---KIASAT-----T  228 (268)
T ss_pred             ccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHH---HHhccC-----C
Confidence            21       12245778999999988888999999999999999999999997543322211111   110000     0


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          529 DVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       529 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+.  ..+..++   ++.+++.+|+..+|++||++.|++++
T Consensus       229 ~~~--~~~~~~~---~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         229 APS--IPEHLSP---GLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             CCC--CchhhCH---HHHHHHHHHcCCCcccCcCHHHHhcC
Confidence            000  0112233   34445559999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.6e-34  Score=285.31  Aligned_cols=243  Identities=27%  Similarity=0.447  Sum_probs=196.5

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC-CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV-GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      .+.||+|++|.||++... ++..+++|++..... ..+.+.+|+++++.++|+|++++++++......++++||+++++|
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L   84 (253)
T cd05122           5 LEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSL   84 (253)
T ss_pred             eeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcH
Confidence            356999999999999975 688899999976543 456789999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--CCC
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--PPA  460 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--~~~  460 (615)
                      .+++....    ..+++..+..++.+++.|+.|||+.+   ++||||+|+||++++++.++|+|||.+.......  ...
T Consensus        85 ~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~  157 (253)
T cd05122          85 KDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM  157 (253)
T ss_pred             HHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeeccccccccccccccce
Confidence            99987532    46899999999999999999999987   9999999999999999999999999998776543  344


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE  540 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  540 (615)
                      .++..|+|||.+....++.++||||||+++++|++|+.||...+..+......      . ....     .......++.
T Consensus       158 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~------~-~~~~-----~~~~~~~~~~  225 (253)
T cd05122         158 VGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIA------T-NGPP-----GLRNPEKWSD  225 (253)
T ss_pred             ecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH------h-cCCC-----CcCcccccCH
Confidence            56788999999988889999999999999999999999997643222211111      0 0000     0001111234


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          541 EMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       541 ~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ++.++++   +|+..+|++|||+.|++++
T Consensus       226 ~~~~~i~---~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         226 EFKDFLK---KCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             HHHHHHH---HHccCChhhCCCHHHHhcC
Confidence            4445544   9999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.2e-34  Score=288.81  Aligned_cols=247  Identities=21%  Similarity=0.392  Sum_probs=194.4

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc--CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN--VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      .+.||+|+||.||++..+ +++.|++|++....  ...+.+.+|++++++++||||+++++++......++|+||+++++
T Consensus         6 ~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   85 (265)
T cd06605           6 LGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGS   85 (265)
T ss_pred             HHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCc
Confidence            457999999999999975 67889999887543  234568899999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC-CC
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT-ENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP-PP  459 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~-~~  459 (615)
                      |.+++....    ..+++....+++.|++.|++|||+ .+   ++|+||||+||++++++.++|+|||.+....... ..
T Consensus        86 L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~  158 (265)
T cd06605          86 LDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT  158 (265)
T ss_pred             HHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhc
Confidence            999997432    468899999999999999999999 77   9999999999999999999999999987654321 12


Q ss_pred             CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      ..++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ......+........      +.... ...+
T Consensus       159 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~------~~~~~-~~~~  230 (265)
T cd06605         159 FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPP-DGIFELLQYIVNEPP------PRLPS-GKFS  230 (265)
T ss_pred             ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccc-ccHHHHHHHHhcCCC------CCCCh-hhcC
Confidence            456778999999988889999999999999999999999997543211 111122222211100      00000 0133


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      +++.+++   .+|+..+|++|||+.|++++
T Consensus       231 ~~~~~li---~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         231 PDFQDFV---NLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             HHHHHHH---HHHcCCCchhCcCHHHHhhC
Confidence            4444444   49999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=2e-34  Score=292.95  Aligned_cols=254  Identities=23%  Similarity=0.385  Sum_probs=190.9

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .+.||+|+||.||+|..+ ++..|++|+++....   ..+.+.+|+++++.++|+||+++++++..++..++||||++++
T Consensus         6 ~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~   85 (288)
T cd07833           6 LGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERT   85 (288)
T ss_pred             EEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCC
Confidence            356999999999999965 577899998875422   2467889999999999999999999999999999999999987


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---  457 (615)
                      .+..+...     ...+++.....++.+++.|++|||+.+   ++||||+|+||++++++.+||+|||++.......   
T Consensus        86 ~l~~~~~~-----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~  157 (288)
T cd07833          86 LLELLEAS-----PGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASP  157 (288)
T ss_pred             HHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence            77666542     235899999999999999999999998   9999999999999999999999999998765432   


Q ss_pred             -CCCCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHH-HHHHhhhcccccccccc----
Q 007167          458 -PPAMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVR-WVNSVVREEWTAEVFDV----  530 (615)
Q Consensus       458 -~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~d~----  530 (615)
                       ....++..|+|||++.+. .++.++||||||+++|+|++|+.||......+...... ...............+.    
T Consensus       158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07833         158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG  237 (288)
T ss_pred             ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence             123456789999999887 78999999999999999999999997654322211111 11100000000000000    


Q ss_pred             -ccc----------CCC-CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          531 -ELL----------RYP-NIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       531 -~~~----------~~~-~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                       ...          ..+ ..+++   +.+++.+|+..+|++||++++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~---~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         238 VAFPEPSQPESLERRYPGKVSSP---ALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             cccCCCCCcHHHHHhcCCccchH---HHHHHHHHhccCchhcccHHHHhcC
Confidence             000          011 11334   4455559999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=3.7e-34  Score=289.56  Aligned_cols=241  Identities=21%  Similarity=0.341  Sum_probs=189.0

Q ss_pred             cCcCCccEEEEEEEC-CCCEEEEEEecccc----CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          308 LGKGTFGTAYKAALE-DASTVVVKRLKEVN----VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       308 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      ||+|+||+||++..+ +++.|++|.+....    .....+..|+++++.++||||+++++++...+..++||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            699999999999854 68899999886432    1234567899999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--CCC
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--PPA  460 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--~~~  460 (615)
                      .+++....   ...+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||.+.......  ...
T Consensus        81 ~~~l~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  154 (277)
T cd05577          81 KYHIYNVG---EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGR  154 (277)
T ss_pred             HHHHHHcC---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccc
Confidence            99987432   236899999999999999999999998   9999999999999999999999999987654321  223


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE  540 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  540 (615)
                      .++..|+|||++.+..++.++||||+||++++|++|+.||...........+.   ..        .........+.+++
T Consensus       155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~--------~~~~~~~~~~~~~~  223 (277)
T cd05577         155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELK---RR--------TLEMAVEYPDKFSP  223 (277)
T ss_pred             cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHH---hc--------cccccccCCccCCH
Confidence            45678999999988889999999999999999999999997654321111110   00        00011111223455


Q ss_pred             HHHHHHHHHHHcccCCCCCCC-----CHHHHHH
Q 007167          541 EMVEMLQVGMACVVRMPEERP-----KMADVLK  568 (615)
Q Consensus       541 ~~~~l~~l~~~cl~~~P~~RP-----s~~evl~  568 (615)
                      .+.++++   +|++.+|.+||     ++.++++
T Consensus       224 ~~~~li~---~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         224 EAKDLCE---ALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             HHHHHHH---HHccCChhHccCCCcccHHHHHh
Confidence            6666666   99999999999     5555654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.3e-34  Score=293.79  Aligned_cols=254  Identities=19%  Similarity=0.328  Sum_probs=189.2

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      +.||+|+||.||+|... ++..|+||+++....   ....+.+|++++++++||||+++++++.+.+..++||||+. ++
T Consensus         6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~   84 (284)
T cd07860           6 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QD   84 (284)
T ss_pred             eeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cC
Confidence            46999999999999864 688999998864322   23568899999999999999999999999999999999995 68


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---C
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---P  458 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~  458 (615)
                      |.+++....   ...+++..+..++.|++.||+|||+.+   ++||||+|+||+++.++.+||+|||++.......   .
T Consensus        85 l~~~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  158 (284)
T cd07860          85 LKKFMDASP---LSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT  158 (284)
T ss_pred             HHHHHHhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence            988886432   346899999999999999999999998   9999999999999999999999999987654322   2


Q ss_pred             CCCCCCcccCccccCCCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCcch-hhHHHHHHHhhhcccc---------cc-
Q 007167          459 PAMRAAGYRAPEVTDTRK-ATQASDVFSFGVLLLELLTGKSPIHATGGDEV-VHLVRWVNSVVREEWT---------AE-  526 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~---------~~-  526 (615)
                      ...++..|+|||.+.+.. ++.++|||||||++|||++|+.||......+. ....++........|.         .. 
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07860         159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF  238 (284)
T ss_pred             cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhc
Confidence            233567899999886544 58899999999999999999999976443211 1111111110000000         00 


Q ss_pred             --ccccccc-CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          527 --VFDVELL-RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       527 --~~d~~~~-~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                        ....... ..+..+++..++   +.+|++.||++||+++|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~l---i~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         239 PKWARQDFSKVVPPLDEDGRDL---LSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             ccccccCHHHHcccCCHHHHHH---HHHhcCCCcccCCCHHHHhcC
Confidence              0000000 012233444444   449999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=4.2e-34  Score=286.53  Aligned_cols=239  Identities=24%  Similarity=0.333  Sum_probs=190.3

Q ss_pred             cCcCCccEEEEEEEC-CCCEEEEEEecccc----CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          308 LGKGTFGTAYKAALE-DASTVVVKRLKEVN----VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       308 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      ||.|+||.||++... .++.|++|.+....    ...+.+.+|+++++.++|+||+++++++.++...++|+||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            699999999999975 47899999986542    2245688999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC--CCCC
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM--PPPA  460 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~--~~~~  460 (615)
                      .+++...     ..+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++......  ....
T Consensus        81 ~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~  152 (262)
T cd05572          81 WTILRDR-----GLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTF  152 (262)
T ss_pred             HHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccc
Confidence            9999743     25889999999999999999999988   999999999999999999999999999877543  2233


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE  540 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  540 (615)
                      .++..|+|||.+....++.++|+||+|+++|||++|+.||.....+.    ...........       .........++
T Consensus       153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~~~~~~~~~-------~~~~~~~~~~~  221 (262)
T cd05572         153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEIYNDILKGN-------GKLEFPNYIDK  221 (262)
T ss_pred             cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHHHHHHhccC-------CCCCCCcccCH
Confidence            56778999999988889999999999999999999999997654311    11111111100       01111112234


Q ss_pred             HHHHHHHHHHHcccCCCCCCCC-----HHHHHH
Q 007167          541 EMVEMLQVGMACVVRMPEERPK-----MADVLK  568 (615)
Q Consensus       541 ~~~~l~~l~~~cl~~~P~~RPs-----~~evl~  568 (615)
                      ++.++++   +||..+|++||+     ++|+++
T Consensus       222 ~~~~~i~---~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         222 AAKDLIK---QLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             HHHHHHH---HHccCChhhCcCCcccCHHHHhc
Confidence            4444444   999999999999     666665

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.4e-34  Score=293.44  Aligned_cols=241  Identities=22%  Similarity=0.381  Sum_probs=192.0

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEecccc-CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVN-VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      .+.||+|+||.||++.. .++..|++|.+.... ...+.+.+|+.+++.++||||+++++++...+..++|+||+++++|
T Consensus        24 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L  103 (293)
T cd06647          24 FEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSL  103 (293)
T ss_pred             eeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcH
Confidence            45699999999999985 467889999986432 2346688999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC---C
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP---P  459 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~---~  459 (615)
                      .+++..      ..+++..+..++.|++.|+.|||+.+   ++||||||+||+++.++.++|+|||++........   .
T Consensus       104 ~~~~~~------~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~  174 (293)
T cd06647         104 TDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  174 (293)
T ss_pred             HHHHhh------cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccccccc
Confidence            999863      24789999999999999999999998   99999999999999999999999999876644322   2


Q ss_pred             CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      ..++..|+|||.+....++.++|||||||++||+++|+.||......+....+.      ...      .+........+
T Consensus       175 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~------~~~------~~~~~~~~~~~  242 (293)
T cd06647         175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------TNG------TPELQNPEKLS  242 (293)
T ss_pred             ccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh------cCC------CCCCCCccccC
Confidence            346677999999988888999999999999999999999997644322111100      000      00010111223


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ..+.+++   .+||..+|++||++.|++.+
T Consensus       243 ~~l~~li---~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         243 AIFRDFL---NRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             HHHHHHH---HHHccCChhhCcCHHHHhcC
Confidence            3444444   49999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=5e-34  Score=285.88  Aligned_cols=243  Identities=23%  Similarity=0.417  Sum_probs=197.5

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      .+.||+|++|.||+|..+ ++..|++|++.....  ....+.+|++.+.+++|+||+++++++...+..++||||+++++
T Consensus         6 ~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~   85 (264)
T cd06623           6 VKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGS   85 (264)
T ss_pred             eeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCc
Confidence            357999999999999976 488999999876532  35678999999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC--
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT-ENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP--  458 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~--  458 (615)
                      |.+++...     ..+++..+..++.|+++|++|||+ .+   ++||||+|+||+++.++.++|+|||.+........  
T Consensus        86 L~~~l~~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~  157 (264)
T cd06623          86 LADLLKKV-----GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC  157 (264)
T ss_pred             HHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCcc
Confidence            99999743     468999999999999999999999 87   99999999999999999999999999987654332  


Q ss_pred             -CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCC
Q 007167          459 -PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN  537 (615)
Q Consensus       459 -~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  537 (615)
                       ...++..|+|||......++.++||||||+++|||++|+.||.........+....+..   ..      ...  ....
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~---~~------~~~--~~~~  226 (264)
T cd06623         158 NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD---GP------PPS--LPAE  226 (264)
T ss_pred             cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc---CC------CCC--CCcc
Confidence             23456789999999888899999999999999999999999977543222232222211   10      000  0111


Q ss_pred             -cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          538 -IEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       538 -~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                       +++.+.++++   +|+..+|++||++.|++++
T Consensus       227 ~~~~~l~~li~---~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         227 EFSPEFRDFIS---ACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             cCCHHHHHHHH---HHccCChhhCCCHHHHHhC
Confidence             3444555555   9999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.7e-34  Score=294.77  Aligned_cols=244  Identities=19%  Similarity=0.322  Sum_probs=189.8

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccC----CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV----GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      +.||+|+||.||++... .++.|++|.+.....    ..+.+.+|+++++.++||||+++++.+..++..++||||++++
T Consensus         7 ~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~   86 (305)
T cd05609           7 KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGG   86 (305)
T ss_pred             eEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCC
Confidence            56999999999999865 567899998865421    2346778999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC----
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM----  456 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~----  456 (615)
                      +|.+++...     ..+++.....++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||+++.....    
T Consensus        87 ~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~  158 (305)
T cd05609          87 DCATLLKNI-----GALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN  158 (305)
T ss_pred             cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence            999999642     36899999999999999999999998   999999999999999999999999998642100    


Q ss_pred             --------------CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcc
Q 007167          457 --------------PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREE  522 (615)
Q Consensus       457 --------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  522 (615)
                                    .....++..|+|||.+....++.++|||||||++|||++|+.||.+....+.....      ....
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~------~~~~  232 (305)
T cd05609         159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQV------ISDD  232 (305)
T ss_pred             ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------Hhcc
Confidence                          01123566899999998888999999999999999999999999764433222111      1110


Q ss_pred             cccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 007167          523 WTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVED  572 (615)
Q Consensus       523 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  572 (615)
                          ...+.  ..+..++++.++++   +|++.+|++||++.++.+.|+.
T Consensus       233 ----~~~~~--~~~~~~~~~~~li~---~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         233 ----IEWPE--GDEALPADAQDLIS---RLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             ----cCCCC--ccccCCHHHHHHHH---HHhccChhhccCccCHHHHHhC
Confidence                00000  01123445555555   9999999999997666655544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5.9e-34  Score=292.53  Aligned_cols=241  Identities=24%  Similarity=0.421  Sum_probs=187.7

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC-C---HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV-G---KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||+||+|... +++.||+|.+..... .   .+.+.+|+++++.++||||+++++++.+.+..++||||+. 
T Consensus        20 ~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-   98 (307)
T cd06607          20 LREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-   98 (307)
T ss_pred             heeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-
Confidence            467999999999999864 688999998864322 1   2467899999999999999999999999999999999996 


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCC
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP  459 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~  459 (615)
                      |++.+++....    ..+++..+..++.|++.||.|||+.+   |+||||+|+||++++++.++|+|||++...... ..
T Consensus        99 g~l~~~~~~~~----~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-~~  170 (307)
T cd06607          99 GSASDILEVHK----KPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-NS  170 (307)
T ss_pred             CCHHHHHHHcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC-CC
Confidence            57777765322    35899999999999999999999998   999999999999999999999999998765433 23


Q ss_pred             CCCCCcccCccccC---CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          460 AMRAAGYRAPEVTD---TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       460 ~~~~~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                      ..++..|+|||.+.   ...++.++||||||+++|||++|+.||..........      ...... .     +.. ...
T Consensus       171 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~------~~~~~~-~-----~~~-~~~  237 (307)
T cd06607         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQND-S-----PTL-SSN  237 (307)
T ss_pred             ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHH------HHhcCC-C-----CCC-Cch
Confidence            45677899999874   3567889999999999999999999997543221111      010000 0     000 011


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                      .+++++   .+++.+||..+|++||++.+++.+.
T Consensus       238 ~~~~~~---~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         238 DWSDYF---RNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             hhCHHH---HHHHHHHhcCChhhCcCHHHHhcCh
Confidence            123344   4445599999999999999998863

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-34  Score=292.14  Aligned_cols=255  Identities=19%  Similarity=0.366  Sum_probs=187.6

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      +.||+|+||+||+|..+ +++.||+|.+.....  ....+.+|+++++.++|+||+++++++.+++..++||||+.+ +|
T Consensus        11 ~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L   89 (291)
T cd07844          11 DKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DL   89 (291)
T ss_pred             EEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CH
Confidence            56999999999999965 678999999865322  234567899999999999999999999999999999999974 89


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---CC
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---PP  459 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~~  459 (615)
                      .+++....    ..+++.....++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++......   ..
T Consensus        90 ~~~~~~~~----~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  162 (291)
T cd07844          90 KQYMDDCG----GGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSN  162 (291)
T ss_pred             HHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCccccc
Confidence            99886432    36889999999999999999999998   9999999999999999999999999987543211   12


Q ss_pred             CCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCc-chhhHH-HHHHHhhhccccccc---------
Q 007167          460 AMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGD-EVVHLV-RWVNSVVREEWTAEV---------  527 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~---------  527 (615)
                      ..++..|+|||++.+ ..++.++||||+||++|||++|+.||...... +....+ +.+.....+.+....         
T Consensus       163 ~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (291)
T cd07844         163 EVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYS  242 (291)
T ss_pred             cccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccccccc
Confidence            235678999998865 45789999999999999999999999754421 111111 100000000000000         


Q ss_pred             ---cc-ccc-cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          528 ---FD-VEL-LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       528 ---~d-~~~-~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                         .. ..+ ...+... ...++.+++.+|+..+|++||++.|++++
T Consensus       243 ~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         243 FPFYPPRPLINHAPRLD-RIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             ccccCChhHHHhCcCCC-CchhHHHHHHHHhccCcccccCHHHHhcC
Confidence               00 000 0001111 01344556669999999999999998864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=3.9e-34  Score=287.30  Aligned_cols=240  Identities=19%  Similarity=0.325  Sum_probs=184.9

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc---CC---HHHHHHHHHHHhCCCCCcccceeEEEEec--CeeeEEee
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN---VG---KREFEQQMEIVGGIRHENVVALRAYYYSK--DEKLMVYD  375 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e  375 (615)
                      .+.||+|+||.||+|... ++..|++|.+....   ..   .+.+.+|++++++++|+||+++++++.+.  ...++|||
T Consensus         7 ~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e   86 (265)
T cd06652           7 GKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME   86 (265)
T ss_pred             eeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEE
Confidence            457999999999999864 58899999875321   11   24678899999999999999999988764  46789999


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      |+++++|.+++...     ..+++....+++.|++.||+|||+.+   |+|+||||+||+++.++.++|+|||++.....
T Consensus        87 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~  158 (265)
T cd06652          87 HMPGGSIKDQLKSY-----GALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQT  158 (265)
T ss_pred             ecCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCcccccccc
Confidence            99999999998632     25788899999999999999999998   99999999999999999999999999876542


Q ss_pred             C------CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccc
Q 007167          456 M------PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD  529 (615)
Q Consensus       456 ~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  529 (615)
                      .      .....++..|+|||.+.+..++.++|||||||++|||++|+.||........  ..    .......     .
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~--~~----~~~~~~~-----~  227 (265)
T cd06652         159 ICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAA--IF----KIATQPT-----N  227 (265)
T ss_pred             ccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHH--HH----HHhcCCC-----C
Confidence            1      1223467789999999888899999999999999999999999975422111  11    1110000     0


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          530 VELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       530 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      +.  ..+.....+.++++   +|+. +|++||+++|++++
T Consensus       228 ~~--~~~~~~~~~~~~i~---~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         228 PV--LPPHVSDHCRDFLK---RIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             CC--CchhhCHHHHHHHH---HHhc-ChhhCCCHHHHhcC
Confidence            00  11123344445554   7874 89999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=5.3e-34  Score=290.62  Aligned_cols=240  Identities=21%  Similarity=0.396  Sum_probs=192.0

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEeccccC-CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNV-GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      .+||+|+||.||++.. .++..||+|++..... ....+.+|+.+++.++|+||+++++++...+..++||||+++++|.
T Consensus        26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (292)
T cd06657          26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  105 (292)
T ss_pred             HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence            5799999999999986 4688999998854322 3456889999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---CCC
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---PPA  460 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~~~  460 (615)
                      +++..      ..+++.....++.|++.|++|||+.+   ++||||+|+||++++++.++|+|||++.......   ...
T Consensus       106 ~~~~~------~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~  176 (292)
T cd06657         106 DIVTH------TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL  176 (292)
T ss_pred             HHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccccccccc
Confidence            98753      25789999999999999999999998   9999999999999999999999999987654322   223


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE  540 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  540 (615)
                      .++.+|+|||.+.+..++.++||||+|+++|||++|+.||......+....   +....         ..........+.
T Consensus       177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~---~~~~~---------~~~~~~~~~~~~  244 (292)
T cd06657         177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM---IRDNL---------PPKLKNLHKVSP  244 (292)
T ss_pred             ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhhC---------CcccCCcccCCH
Confidence            467889999999888889999999999999999999999975433222111   11111         111111222344


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          541 EMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       541 ~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+.++++   +|+..+|.+||++.|++++
T Consensus       245 ~l~~li~---~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         245 SLKGFLD---RLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             HHHHHHH---HHHhCCcccCcCHHHHhcC
Confidence            4555554   9999999999999999885

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.7e-35  Score=316.85  Aligned_cols=261  Identities=20%  Similarity=0.304  Sum_probs=179.8

Q ss_pred             hhhcCcCCccEEEEEEECCC--CEEEEE------------------EeccccCCHHHHHHHHHHHhCCCCCcccceeEEE
Q 007167          305 AEVLGKGTFGTAYKAALEDA--STVVVK------------------RLKEVNVGKREFEQQMEIVGGIRHENVVALRAYY  364 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~--~~vavK------------------~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~  364 (615)
                      .+.||+|+||+||++..+..  ..+++|                  +++........+++|+++++.++|+|||++++++
T Consensus       153 i~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~  232 (501)
T PHA03210        153 IDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILKIEEIL  232 (501)
T ss_pred             EeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCcEeEEE
Confidence            46799999999999875421  112222                  1111111234578999999999999999999999


Q ss_pred             EecCeeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEE
Q 007167          365 YSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCV  444 (615)
Q Consensus       365 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl  444 (615)
                      ...+..++|+|++. ++|.+++..................|+.|++.||+|||+++   |+||||||+|||++.++.+||
T Consensus       233 ~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~~~~vkL  308 (501)
T PHA03210        233 RSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVL  308 (501)
T ss_pred             EECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEE
Confidence            99999999999985 56777665332211223345667789999999999999998   999999999999999999999


Q ss_pred             eecccccccCCCC----CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCC-CCCCCCcchhhHHHHHHHhh
Q 007167          445 SDIGLAALMSPMP----PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSP-IHATGGDEVVHLVRWVNSVV  519 (615)
Q Consensus       445 ~DfG~a~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p-~~~~~~~~~~~~~~~~~~~~  519 (615)
                      +|||+++.+....    ....++..|+|||++.+..++.++|||||||++|||++|+.+ +..........+.+.+....
T Consensus       309 ~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~  388 (501)
T PHA03210        309 GDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLS  388 (501)
T ss_pred             EeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcc
Confidence            9999998765432    234578899999999998999999999999999999998754 44333322222222222111


Q ss_pred             --hccccc---cc---ccc-cccCC-CCcHHHH------HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          520 --REEWTA---EV---FDV-ELLRY-PNIEEEM------VEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       520 --~~~~~~---~~---~d~-~~~~~-~~~~~~~------~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                        .+++..   ..   ++. ..... .......      .++.+++.+|+..||.+|||+.|++++
T Consensus       389 ~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        389 VCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             cChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence              010000   00   000 00000 0111111      133444559999999999999999875

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=4.9e-34  Score=291.01  Aligned_cols=254  Identities=22%  Similarity=0.359  Sum_probs=190.1

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEec--CeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSK--DEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e~~~  378 (615)
                      .+.||+|+||.||+|..+ +++.+++|.++.....   ...+.+|++++++++||||+++++++...  ...++||||+.
T Consensus        10 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~   89 (293)
T cd07843          10 LNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE   89 (293)
T ss_pred             hhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC
Confidence            467999999999999975 5788999998754322   23567899999999999999999999887  88999999997


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC-
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP-  457 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~-  457 (615)
                       ++|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++....... 
T Consensus        90 -~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  161 (293)
T cd07843          90 -HDLKSLMETMK----QPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLK  161 (293)
T ss_pred             -cCHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCcc
Confidence             58998886432    26899999999999999999999998   9999999999999999999999999998765432 


Q ss_pred             --CCCCCCCcccCccccCCCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhH-HHHHHHhhhcccc---------
Q 007167          458 --PPAMRAAGYRAPEVTDTRK-ATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHL-VRWVNSVVREEWT---------  524 (615)
Q Consensus       458 --~~~~~~~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~---------  524 (615)
                        ....++..|+|||.+.+.. ++.++||||+|+++|||++|+.||......+.... ...+.......|.         
T Consensus       162 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (293)
T cd07843         162 PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAK  241 (293)
T ss_pred             ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhc
Confidence              2234567899999986544 68899999999999999999999976543322211 1111100000000         


Q ss_pred             ----ccccccc-ccCCCC--cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          525 ----AEVFDVE-LLRYPN--IEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       525 ----~~~~d~~-~~~~~~--~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                          ....... ....+.  ..+...++++   +|++.+|++|||+.|++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~---~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         242 KKTFTKYPYNQLRKKFPALSLSDNGFDLLN---RLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             ccccccccchhhhccccccCCChHHHHHHH---HHhccCccccCCHHHHhcC
Confidence                0000000 001121  2444445555   9999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-34  Score=294.39  Aligned_cols=196  Identities=24%  Similarity=0.409  Sum_probs=163.3

Q ss_pred             hhcCcCCccEEEEEEEC---CCCEEEEEEecccc----CCHHHHHHHHHHHhCCCCCcccceeEEEEec--CeeeEEeec
Q 007167          306 EVLGKGTFGTAYKAALE---DASTVVVKRLKEVN----VGKREFEQQMEIVGGIRHENVVALRAYYYSK--DEKLMVYDY  376 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e~  376 (615)
                      +.||+|+||.||+|...   ++..||+|.+....    .....+.+|+++++.++||||+++++++.+.  +..++||||
T Consensus         6 ~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~   85 (316)
T cd07842           6 GCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDY   85 (316)
T ss_pred             EEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeC
Confidence            46999999999999965   47899999997632    1235677899999999999999999999988  789999999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCC----CCcEEEeecccccc
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNS----QGHVCVSDIGLAAL  452 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~----~~~~kl~DfG~a~~  452 (615)
                      +++ ++.+++..........+++.....++.|++.||+|||+.+   |+||||||+||+++.    ++.+||+|||++..
T Consensus        86 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~  161 (316)
T cd07842          86 AEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARL  161 (316)
T ss_pred             CCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCCccccc
Confidence            975 6777765433333347889999999999999999999998   999999999999999    89999999999987


Q ss_pred             cCCCCC------CCCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 007167          453 MSPMPP------PAMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATGG  505 (615)
Q Consensus       453 ~~~~~~------~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~  505 (615)
                      ......      ...++..|+|||.+.+. .++.++|||||||+++||++|+.||.....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~  221 (316)
T cd07842         162 FNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA  221 (316)
T ss_pred             cCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence            643221      22457789999987654 578999999999999999999999986543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=4.7e-34  Score=289.25  Aligned_cols=249  Identities=18%  Similarity=0.295  Sum_probs=185.9

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccC--CHHHHHHHHHHHhCCC-CCcccceeEEEEec--CeeeEEeecCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV--GKREFEQQMEIVGGIR-HENVVALRAYYYSK--DEKLMVYDYFEP  379 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~e~~~~  379 (615)
                      +.||+|+||.||+|... ++..||+|+++....  ......+|++++.++. |+|++++++++.+.  +..++|+||++ 
T Consensus         5 ~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-   83 (282)
T cd07831           5 GKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-   83 (282)
T ss_pred             eeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-
Confidence            56999999999999854 688899999876422  2234457888888885 99999999999987  88999999996 


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      |+|.+.+....    ..++|..+..++.|++.||+|||+.+   |+||||||+||+++. +.+||+|||+++......  
T Consensus        84 ~~l~~~l~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~  155 (282)
T cd07831          84 MNLYELIKGRK----RPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY  155 (282)
T ss_pred             ccHHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence            58888876432    36899999999999999999999998   999999999999999 999999999998764332  


Q ss_pred             CCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhh---hcccc-----cccc
Q 007167          458 PPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVV---REEWT-----AEVF  528 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~-----~~~~  528 (615)
                      ....++..|+|||.+.. ..++.++||||+||++|||++|+.||...+..+..   .+.....   .+.+.     ....
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~  232 (282)
T cd07831         156 TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQI---AKIHDVLGTPDAEVLKKFRKSRHM  232 (282)
T ss_pred             CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHH---HHHHHHcCCCCHHHHHhhcccccc
Confidence            22346778999997644 45788999999999999999999999765433222   1111111   00000     0000


Q ss_pred             cccccC---------CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          529 DVELLR---------YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       529 d~~~~~---------~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      +.....         .+..+   ..+.+++.+|+..+|++||+++|++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~---~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         233 NYNFPSKKGTGLRKLLPNAS---AEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             cccCcccccccHHHHccccc---HHHHHHHHHHhccCcccccCHHHHhhC
Confidence            000000         11223   344555559999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4.1e-34  Score=290.80  Aligned_cols=247  Identities=21%  Similarity=0.351  Sum_probs=186.2

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC--CHHHHHHHHHHHhCCC-CCcccceeEEEEecCeeeEEeecCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV--GKREFEQQMEIVGGIR-HENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .+.||+|+||.||++... ++..||+|.+.....  ....+.+|+.++.++. |+||+++++++..+...+++|||+.. 
T Consensus         9 ~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-   87 (288)
T cd06616           9 LGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-   87 (288)
T ss_pred             HHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-
Confidence            467999999999999864 578999999875422  2456788999999996 99999999999999999999999864 


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc-CCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE-NGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      ++.++...........+++....+++.+++.||+|||+. +   |+||||||+||+++.++.+||+|||+++......  
T Consensus        88 ~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  164 (288)
T cd06616          88 SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK  164 (288)
T ss_pred             CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc
Confidence            555543211111224689999999999999999999975 5   9999999999999999999999999997654322  


Q ss_pred             CCCCCCCcccCccccCCC---CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccC
Q 007167          458 PPAMRAAGYRAPEVTDTR---KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLR  534 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~~---~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  534 (615)
                      ....++..|+|||.+...   .++.++|||||||++|||++|+.||....  ....   .+.......      .+.+..
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~--~~~~---~~~~~~~~~------~~~~~~  233 (288)
T cd06616         165 TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN--SVFD---QLTQVVKGD------PPILSN  233 (288)
T ss_pred             ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc--hHHH---HHhhhcCCC------CCcCCC
Confidence            233567889999998765   68899999999999999999999997533  1111   111111110      001110


Q ss_pred             --CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          535 --YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       535 --~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                        ...++.++.++++   +|+..+|++|||++||+++
T Consensus       234 ~~~~~~~~~l~~li~---~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         234 SEEREFSPSFVNFIN---LCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             cCCCccCHHHHHHHH---HHccCChhhCcCHHHHhcC
Confidence              1123445555555   9999999999999999886

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-34  Score=292.11  Aligned_cols=255  Identities=19%  Similarity=0.331  Sum_probs=190.5

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .+.||+|++|.||+|... +|..|++|++.....   ..+.+.+|+++++.++|+|++++++++.+.+..++||||++ +
T Consensus         4 ~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~   82 (283)
T cd07835           4 VEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-L   82 (283)
T ss_pred             heEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-c
Confidence            356999999999999864 789999999865422   23568889999999999999999999999999999999995 6


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---  457 (615)
                      +|.+++....   ...+++..+..++.|+++||+|||+.+   ++||||+|+||+++.++.++|+|||++..+....   
T Consensus        83 ~l~~~~~~~~---~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~  156 (283)
T cd07835          83 DLKKYMDSSP---LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY  156 (283)
T ss_pred             CHHHHHhhCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence            8999886432   136899999999999999999999987   9999999999999999999999999997654322   


Q ss_pred             CCCCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcc-hhhHHHHHHHhhhccccc---------c
Q 007167          458 PPAMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATGGDE-VVHLVRWVNSVVREEWTA---------E  526 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~---------~  526 (615)
                      ....++..|+|||++.+. .++.++||||||+++|||++|+.||......+ .....++........|..         .
T Consensus       157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd07835         157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT  236 (283)
T ss_pred             CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence            122346789999987654 46889999999999999999999997643211 111111111110000000         0


Q ss_pred             ccc---cc-ccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          527 VFD---VE-LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       527 ~~d---~~-~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ...   .. ....+.+++.+.   +++.+|++.+|++|||++|++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~---~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         237 FPKWARQDLSKVVPNLDEDGL---DLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             cccccccchhhhcCCCCHHHH---HHHHHHhcCChhhCcCHHHHhcC
Confidence            000   00 001123334444   45559999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4.3e-34  Score=289.73  Aligned_cols=244  Identities=20%  Similarity=0.382  Sum_probs=185.1

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccC--CHHHHHHHHHH-HhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV--GKREFEQQMEI-VGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      +.||+|+||.||++... +|..||+|+++....  ....+..|++. ++..+||||+++++++..++..++||||++ |+
T Consensus         7 ~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~   85 (283)
T cd06617           7 EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TS   85 (283)
T ss_pred             EEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-cc
Confidence            46999999999999865 688999999876432  23445556664 666789999999999999999999999996 68


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc-CCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--C
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE-NGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--P  458 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--~  458 (615)
                      |.+++..... ....+++..+..++.|++.||+|||++ +   ++||||||+||+++.++.+||+|||++.......  .
T Consensus        86 l~~~l~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~  161 (283)
T cd06617          86 LDKFYKKVYD-KGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKT  161 (283)
T ss_pred             HHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence            8888764332 235789999999999999999999987 5   9999999999999999999999999998664322  2


Q ss_pred             CCCCCCcccCccccCC----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccC
Q 007167          459 PAMRAAGYRAPEVTDT----RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLR  534 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~----~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  534 (615)
                      ...++..|+|||.+.+    ..++.++|+|||||++|||++|+.||......  .....   ......      .+... 
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~--~~~~~---~~~~~~------~~~~~-  229 (283)
T cd06617         162 IDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTP--FQQLK---QVVEEP------SPQLP-  229 (283)
T ss_pred             cccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccC--HHHHH---HHHhcC------CCCCC-
Confidence            2356778999998854    44688999999999999999999999643221  11111   101000      00110 


Q ss_pred             CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          535 YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       535 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ...+++++.++++   +|+..+|++||++.|++++
T Consensus       230 ~~~~~~~l~~li~---~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         230 AEKFSPEFQDFVN---KCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             ccccCHHHHHHHH---HHccCChhhCcCHHHHhcC
Confidence            0123445555555   9999999999999999874

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-35  Score=271.70  Aligned_cols=256  Identities=20%  Similarity=0.361  Sum_probs=192.5

Q ss_pred             cccccCHHHHHHHHhhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC--CHHHHHHHHHHHhCC-CCCcccceeEEEEe
Q 007167          291 CNLVFDLEDLLRASAEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV--GKREFEQQMEIVGGI-RHENVVALRAYYYS  366 (615)
Q Consensus       291 ~~~~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~  366 (615)
                      ....-++.|+..  ...||.|+.|+|+++..+ .|..+|||.+.....  ..+.+...++++..- .+|+||+.+|||..
T Consensus        85 ~r~~~dindl~~--l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~  162 (391)
T KOG0983|consen   85 QRYQADINDLEN--LGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT  162 (391)
T ss_pred             cccccChHHhhh--HHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee
Confidence            334456666643  356999999999999965 477899999976532  234455566655544 48999999999999


Q ss_pred             cCeeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEee
Q 007167          367 KDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSD  446 (615)
Q Consensus       367 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~D  446 (615)
                      +...++.||.|.- ....++...    ..++++.-.-++...+..||.||.+++  .|+|||+||+|||+|+.|++|+||
T Consensus       163 n~dV~IcMelMs~-C~ekLlkri----k~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCD  235 (391)
T KOG0983|consen  163 NTDVFICMELMST-CAEKLLKRI----KGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCD  235 (391)
T ss_pred             CchHHHHHHHHHH-HHHHHHHHh----cCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeec
Confidence            9999999999854 456666533    236888888899999999999999876  599999999999999999999999


Q ss_pred             cccccccCCCC--CCCCCCCcccCccccCC---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhc
Q 007167          447 IGLAALMSPMP--PPAMRAAGYRAPEVTDT---RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVRE  521 (615)
Q Consensus       447 fG~a~~~~~~~--~~~~~~~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  521 (615)
                      ||++..+.+..  ....|.+.|||||.+.-   .+|+.++||||||+.++||.||+.||..-+.+ ..-+...+    .+
T Consensus       236 FGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td-Fe~ltkvl----n~  310 (391)
T KOG0983|consen  236 FGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD-FEVLTKVL----NE  310 (391)
T ss_pred             ccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc-HHHHHHHH----hc
Confidence            99998876543  23346677999999854   46889999999999999999999999874322 11111111    11


Q ss_pred             ccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          522 EWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       522 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      +      .+.+....++++...++++   .|+.+|+.+||...+++++
T Consensus       311 e------PP~L~~~~gFSp~F~~fv~---~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  311 E------PPLLPGHMGFSPDFQSFVK---DCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             C------CCCCCcccCcCHHHHHHHH---HHhhcCcccCcchHHHhcC
Confidence            1      0122222235566666666   9999999999999999876

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-34  Score=287.41  Aligned_cols=240  Identities=21%  Similarity=0.355  Sum_probs=189.5

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccc--cCCHHHHHHHHHHHhCCC---CCcccceeEEEEecCeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEV--NVGKREFEQQMEIVGGIR---HENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      .+.||+|+||.||+|.. .++..|++|.+...  ....+.+.+|+++++.++   |||++++++++..+...++||||++
T Consensus         6 ~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~   85 (277)
T cd06917           6 LELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAE   85 (277)
T ss_pred             hhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCC
Confidence            45799999999999995 56889999988653  223456888999999886   9999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC-
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP-  457 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~-  457 (615)
                      +++|.+++...      .+++.....++.|++.||.|||+.+   |+||||+|+||++++++.++|+|||++..+.... 
T Consensus        86 ~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06917          86 GGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS  156 (277)
T ss_pred             CCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence            99999998632      6899999999999999999999998   9999999999999999999999999998765432 


Q ss_pred             --CCCCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccC
Q 007167          458 --PPAMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLR  534 (615)
Q Consensus       458 --~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  534 (615)
                        ....++..|+|||.+..+ .++.++|||||||++|+|++|+.||........   +.....    .     ..+.+. 
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~---~~~~~~----~-----~~~~~~-  223 (277)
T cd06917         157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA---MMLIPK----S-----KPPRLE-  223 (277)
T ss_pred             ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh---hhcccc----C-----CCCCCC-
Confidence              223467789999988654 468899999999999999999999975432211   111000    0     001110 


Q ss_pred             CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          535 YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       535 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ......++   .+++.+|+..+|++||++.|++++
T Consensus       224 ~~~~~~~~---~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         224 DNGYSKLL---REFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             cccCCHHH---HHHHHHHcCCCcccCcCHHHHhhC
Confidence            01123344   445559999999999999999875

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.6e-34  Score=286.89  Aligned_cols=242  Identities=23%  Similarity=0.432  Sum_probs=192.4

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc---CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN---VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .+.||+|+||.||++..+ ++..||+|.+....   ...+.+.+|+++++.++|+||+++++.+......++|+||++++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~   84 (257)
T cd08225           5 IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGG   84 (257)
T ss_pred             EEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCC
Confidence            356999999999999965 57889999986532   23456789999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCC-cEEEeecccccccCCCCC-
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG-HVCVSDIGLAALMSPMPP-  458 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~-~~kl~DfG~a~~~~~~~~-  458 (615)
                      +|.+++....   ...+++..+..++.|++.||+|||+.+   |+|+||||+||++++++ .+||+|||.+........ 
T Consensus        85 ~L~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~  158 (257)
T cd08225          85 DLMKRINRQR---GVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL  158 (257)
T ss_pred             cHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCccc
Confidence            9999997532   235899999999999999999999998   99999999999999886 469999999977654321 


Q ss_pred             --CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          459 --PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       459 --~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                        ...++..|+|||......++.++||||||++++||++|+.||......+      ++.......     ...   ..+
T Consensus       159 ~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~~~~~~~~-----~~~---~~~  224 (257)
T cd08225         159 AYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ------LVLKICQGY-----FAP---ISP  224 (257)
T ss_pred             ccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH------HHHHHhccc-----CCC---CCC
Confidence              2246778999999988889999999999999999999999997543221      122211111     000   112


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ..+.++.+++   .+|+..+|++|||+.|++++
T Consensus       225 ~~~~~~~~~i---~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         225 NFSRDLRSLI---SQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             CCCHHHHHHH---HHHhccChhhCcCHHHHhhC
Confidence            3344444544   49999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=4e-35  Score=278.34  Aligned_cols=262  Identities=23%  Similarity=0.363  Sum_probs=193.5

Q ss_pred             hhhcCcCCccEEEEEEEC---C--CCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEe-cCeeeEEee
Q 007167          305 AEVLGKGTFGTAYKAALE---D--ASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYS-KDEKLMVYD  375 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~---~--~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e  375 (615)
                      ...||+|+||.||||.-.   +  ...+|+|+++.....   ....-+|+.+++.++||||+.+..++.. +...+|++|
T Consensus        29 ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fd  108 (438)
T KOG0666|consen   29 IGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFD  108 (438)
T ss_pred             cceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEeh
Confidence            456999999999999633   2  236899999865322   2346789999999999999999988877 778999999


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCC----CcEEEeeccccc
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQ----GHVCVSDIGLAA  451 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~----~~~kl~DfG~a~  451 (615)
                      |.+. +|..+++-.+......++-.....|+.||+.|+.|||++.   |+|||+||.|||+..+    |.+||+|||+++
T Consensus       109 YAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDlGlaR  184 (438)
T KOG0666|consen  109 YAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADLGLAR  184 (438)
T ss_pred             hhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecccHHH
Confidence            9987 7888887655555568999999999999999999999998   9999999999999877    899999999999


Q ss_pred             ccCCCC------CCCCCCCcccCccccCCCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCc-------chhhHHH---H
Q 007167          452 LMSPMP------PPAMRAAGYRAPEVTDTRK-ATQASDVFSFGVLLLELLTGKSPIHATGGD-------EVVHLVR---W  514 (615)
Q Consensus       452 ~~~~~~------~~~~~~~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~elltg~~p~~~~~~~-------~~~~~~~---~  514 (615)
                      .+..+-      ...+.|..|+|||.+.+.+ |+.+.||||.||++.||+|-++.|.+....       ...++.+   .
T Consensus       185 ~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~v  264 (438)
T KOG0666|consen  185 LFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEV  264 (438)
T ss_pred             HhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHH
Confidence            886532      3345688999999987754 899999999999999999999888764321       1111111   2


Q ss_pred             HHHhhhccccccc---------ccccccCCCCc--H---HHH----HHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          515 VNSVVREEWTAEV---------FDVELLRYPNI--E---EEM----VEMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       515 ~~~~~~~~~~~~~---------~d~~~~~~~~~--~---~~~----~~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                      ++....+.|..-.         -|.+...+.+.  .   +..    ..-+++..+++..||.+|.|++|++++.
T Consensus       265 LG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  265 LGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             cCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            2222222332111         11111111110  0   000    1134555599999999999999999874

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.8e-33  Score=290.33  Aligned_cols=246  Identities=25%  Similarity=0.427  Sum_probs=192.0

Q ss_pred             HhhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC----CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCC
Q 007167          304 SAEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV----GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       304 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      ..+.||+|+||.||++... ++..||+|.+.....    ....+.+|+++++.++|+|++++++++.+++..++||||+.
T Consensus        29 ~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  108 (317)
T cd06635          29 DLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL  108 (317)
T ss_pred             hhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC
Confidence            3567999999999999854 678899999864321    12467889999999999999999999999999999999996


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP  458 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~  458 (615)
                       |+|.+.+...    ...++|..+..++.+++.|+.|||+.+   |+||||+|+||+++.++.+||+|||++...... .
T Consensus       109 -g~l~~~~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~-~  179 (317)
T cd06635         109 -GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASPA-N  179 (317)
T ss_pred             -CCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCCc-c
Confidence             5787777532    235899999999999999999999998   999999999999999999999999998765432 2


Q ss_pred             CCCCCCcccCccccC---CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCC
Q 007167          459 PAMRAAGYRAPEVTD---TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY  535 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  535 (615)
                      ...++..|+|||++.   ...++.++|||||||++|||++|+.||......+...  .+.    ....       .....
T Consensus       180 ~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~--~~~----~~~~-------~~~~~  246 (317)
T cd06635         180 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY--HIA----QNES-------PTLQS  246 (317)
T ss_pred             cccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH--HHH----hccC-------CCCCC
Confidence            345778899999973   4568899999999999999999999987643222111  111    1100       00011


Q ss_pred             CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhH
Q 007167          536 PNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIR  574 (615)
Q Consensus       536 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~  574 (615)
                      ...++.+.++++   +|++.+|.+||++.|+++++..+.
T Consensus       247 ~~~~~~l~~li~---~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         247 NEWSDYFRNFVD---SCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             ccccHHHHHHHH---HHccCCcccCcCHHHHHhChhhhc
Confidence            223444555555   999999999999999999876544

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.5e-35  Score=302.35  Aligned_cols=240  Identities=23%  Similarity=0.423  Sum_probs=189.7

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEE---EEEeccccCC--HHHHHHHHHHHhCCCCCcccceeEEEEecCe--eeEEeecC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVV---VKRLKEVNVG--KREFEQQMEIVGGIRHENVVALRAYYYSKDE--KLMVYDYF  377 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~va---vK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~--~~lV~e~~  377 (615)
                      ++||+|+|-+||||.+. +|.+||   ||.-+.....  .+.|..|+++|+.|+|+|||+++.++.+...  .-+|+|.+
T Consensus        46 evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~  125 (632)
T KOG0584|consen   46 EVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELF  125 (632)
T ss_pred             hhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecc
Confidence            57999999999999854 567776   3322222222  3678999999999999999999999987654  78899999


Q ss_pred             CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCC-CcEEEeecccccccCCC
Q 007167          378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQ-GHVCVSDIGLAALMSPM  456 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~-~~~kl~DfG~a~~~~~~  456 (615)
                      ..|+|..++.+.+     .++......++.||++||.|||++ .|||||||||-.||+|+.+ |.+||+|+|+|+.+...
T Consensus       126 TSGtLr~Y~kk~~-----~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s  199 (632)
T KOG0584|consen  126 TSGTLREYRKKHR-----RVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS  199 (632)
T ss_pred             cCCcHHHHHHHhc-----cCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence            9999999997543     688889999999999999999998 4789999999999999865 89999999999988755


Q ss_pred             CC-CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC-CcchhhHHHHHHHhhhcccccccccccccC
Q 007167          457 PP-PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATG-GDEVVHLVRWVNSVVREEWTAEVFDVELLR  534 (615)
Q Consensus       457 ~~-~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  534 (615)
                      .. ...||+.|||||++. ..|.+.+||||||+-++||+|+..||..-. ..++   .+.|-   .+...     ..+.+
T Consensus       200 ~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQI---YKKV~---SGiKP-----~sl~k  267 (632)
T KOG0584|consen  200 HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQI---YKKVT---SGIKP-----AALSK  267 (632)
T ss_pred             ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHH---HHHHH---cCCCH-----HHhhc
Confidence            43 357999999999997 689999999999999999999999997432 2222   22111   11111     11222


Q ss_pred             CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          535 YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       535 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ..  .++++++++   +|+.. ..+|||+.|++++
T Consensus       268 V~--dPevr~fIe---kCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  268 VK--DPEVREFIE---KCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             cC--CHHHHHHHH---HHhcC-chhccCHHHHhhC
Confidence            22  356677776   99999 9999999999875

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-34  Score=318.79  Aligned_cols=251  Identities=25%  Similarity=0.361  Sum_probs=201.2

Q ss_pred             HHhhhcCcCCccEEEEEEEC--------CCCEEEEEEeccccC--CHHHHHHHHHHHhCC-CCCcccceeEEEEecCeee
Q 007167          303 ASAEVLGKGTFGTAYKAALE--------DASTVVVKRLKEVNV--GKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKL  371 (615)
Q Consensus       303 ~~~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~  371 (615)
                      ...+.||+|.||.|++|...        ....||||.++....  ..+.+..|+++|..+ +|+||+.++|+|..++..+
T Consensus       299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~  378 (609)
T KOG0200|consen  299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLY  378 (609)
T ss_pred             cccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceE
Confidence            34458999999999999742        145699999987533  357899999999998 6999999999999999999


Q ss_pred             EEeecCCCCChhhhhccCC---------CCCC--CCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCC
Q 007167          372 MVYDYFEPGSVSAMLHGRR---------GEGQ--SSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG  440 (615)
Q Consensus       372 lV~e~~~~gsL~~~l~~~~---------~~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~  440 (615)
                      +|+||+..|+|.++|+..+         ....  ..+...+.+.++.|||.|++||++..   ++|||+.++|||+.++.
T Consensus       379 ~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi~~~~  455 (609)
T KOG0200|consen  379 VIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLITKNK  455 (609)
T ss_pred             EEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEecCCC
Confidence            9999999999999998766         1111  23889999999999999999999997   99999999999999999


Q ss_pred             cEEEeecccccccCCCCCCC-C-----CCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCC-CcchhhHH
Q 007167          441 HVCVSDIGLAALMSPMPPPA-M-----RAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATG-GDEVVHLV  512 (615)
Q Consensus       441 ~~kl~DfG~a~~~~~~~~~~-~-----~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~-~~~~~~~~  512 (615)
                      .+||+|||+|+...+..... .     -...|||||.+....|+.|+|||||||+|||++| |..||.+.. ..+.   .
T Consensus       456 ~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l---~  532 (609)
T KOG0200|consen  456 VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEEL---L  532 (609)
T ss_pred             EEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHH---H
Confidence            99999999999765443322 1     2345999999999999999999999999999999 999997633 2222   2


Q ss_pred             HHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 007167          513 RWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI  573 (615)
Q Consensus       513 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l  573 (615)
                      ++++.-.           ++.....+.+++.   .++..||+.+|++||++.|+++.++..
T Consensus       533 ~~l~~G~-----------r~~~P~~c~~eiY---~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  533 EFLKEGN-----------RMEQPEHCSDEIY---DLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             HHHhcCC-----------CCCCCCCCCHHHH---HHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            2222111           1122233444544   555599999999999999999999985

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-34  Score=285.05  Aligned_cols=241  Identities=21%  Similarity=0.313  Sum_probs=183.9

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC----HHHHHHHHHH-HhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG----KREFEQQMEI-VGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      +.||+|+||.||+|... +++.||+|.++.....    ...+..|..+ ....+|+|++++++++..++..++|+||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            35899999999999864 6789999998654221    1233444444 4455899999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCC
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP  459 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~  459 (615)
                      ++|.+++...     ..+++..+..++.|++.||.|||+.+   ++||||+|+||++++++.++|+|||+++.... ...
T Consensus        82 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-~~~  152 (260)
T cd05611          82 GDCASLIKTL-----GGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-NKK  152 (260)
T ss_pred             CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-ccc
Confidence            9999999643     35889999999999999999999987   99999999999999999999999999876543 223


Q ss_pred             CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      ..++..|+|||.+.+..++.++||||||+++|||++|+.||......+.....      ....     .+........++
T Consensus       153 ~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~~~-----~~~~~~~~~~~~  221 (260)
T cd05611         153 FVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI------LSRR-----INWPEEVKEFCS  221 (260)
T ss_pred             CCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------Hhcc-----cCCCCcccccCC
Confidence            35677899999998888899999999999999999999999765433222111      1100     000000111334


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      +++.++++   +|+..+|++||++.++.+.
T Consensus       222 ~~~~~~i~---~~l~~~p~~R~~~~~~~~~  248 (260)
T cd05611         222 PEAVDLIN---RLLCMDPAKRLGANGYQEI  248 (260)
T ss_pred             HHHHHHHH---HHccCCHHHccCCCcHHHH
Confidence            55555555   9999999999977554443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-34  Score=293.02  Aligned_cols=247  Identities=20%  Similarity=0.388  Sum_probs=191.7

Q ss_pred             HHHHHHhhhcCcCCccEEEEEEECCCCEEEEEEeccccCC---HHHHHHHHHHHhCCC-CCcccceeEEEEecCeeeEEe
Q 007167          299 DLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVG---KREFEQQMEIVGGIR-HENVVALRAYYYSKDEKLMVY  374 (615)
Q Consensus       299 ~l~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~  374 (615)
                      .-.|...+.||+||.+.||++...+.+.||+|++.....+   -..|.+|+..|.+++ |.+||++++|-..++.+||||
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            3345556789999999999999888888999887654333   456899999999995 999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccC
Q 007167          375 DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS  454 (615)
Q Consensus       375 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~  454 (615)
                      ||- ..+|..+|..+..   ....| .+..++.|++.|+.++|+++   |||.||||.|+|+= .|.+||+|||+|..+.
T Consensus       440 E~G-d~DL~kiL~k~~~---~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlV-kG~LKLIDFGIA~aI~  510 (677)
T KOG0596|consen  440 ECG-DIDLNKILKKKKS---IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLV-KGRLKLIDFGIANAIQ  510 (677)
T ss_pred             ecc-cccHHHHHHhccC---CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence            986 5699999986432   23445 67789999999999999998   99999999999874 5789999999999886


Q ss_pred             CCC-----CCCCCCCcccCccccCCC-----------CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHh
Q 007167          455 PMP-----PPAMRAAGYRAPEVTDTR-----------KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSV  518 (615)
Q Consensus       455 ~~~-----~~~~~~~~y~aPE~~~~~-----------~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  518 (615)
                      ...     ...+||..||+||.+...           +.+.++||||+||+||+|+-|+.||...     ...+..+.  
T Consensus       511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~-----~n~~aKl~--  583 (677)
T KOG0596|consen  511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQI-----INQIAKLH--  583 (677)
T ss_pred             ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHH-----HHHHHHHH--
Confidence            543     345789999999998432           2568999999999999999999999642     21222122  


Q ss_pred             hhcccccccccccc-cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          519 VREEWTAEVFDVEL-LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       519 ~~~~~~~~~~d~~~-~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                             .+.|+.- ..+|.+++- ..+++++..|+..||++||+..|++++
T Consensus       584 -------aI~~P~~~Iefp~~~~~-~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  584 -------AITDPNHEIEFPDIPEN-DELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             -------hhcCCCccccccCCCCc-hHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence                   2223311 012222211 126666669999999999999999875

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.1e-34  Score=298.26  Aligned_cols=257  Identities=20%  Similarity=0.314  Sum_probs=189.2

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEecccc---CCHHHHHHHHHHHhCCCCCcccceeEEEEec------CeeeEEe
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVN---VGKREFEQQMEIVGGIRHENVVALRAYYYSK------DEKLMVY  374 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lV~  374 (615)
                      .+.||+|+||.||+|.. .++..||+|+++...   .....+.+|+++++.++|+||+++++++...      ...++|+
T Consensus        20 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~   99 (342)
T cd07879          20 LKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM   99 (342)
T ss_pred             EEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEe
Confidence            35799999999999985 468899999986532   1234578899999999999999999998754      2468999


Q ss_pred             ecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccC
Q 007167          375 DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS  454 (615)
Q Consensus       375 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~  454 (615)
                      ||+.. +|..++.       ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus       100 e~~~~-~l~~~~~-------~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~  168 (342)
T cd07879         100 PYMQT-DLQKIMG-------HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHAD  168 (342)
T ss_pred             ccccc-CHHHHHc-------CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence            99964 6666542       25889999999999999999999998   9999999999999999999999999998765


Q ss_pred             CCCCCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccc--------c
Q 007167          455 PMPPPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWT--------A  525 (615)
Q Consensus       455 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--------~  525 (615)
                      .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+..+....+............        .
T Consensus       169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (342)
T cd07879         169 AEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAK  248 (342)
T ss_pred             CCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchH
Confidence            44444456778999999866 45889999999999999999999999764422211111110000000000        0


Q ss_pred             ccc-------ccccc-CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhHh
Q 007167          526 EVF-------DVELL-RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM--VEDIRR  575 (615)
Q Consensus       526 ~~~-------d~~~~-~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~l~~  575 (615)
                      ...       ...+. ..+..++.+.   +++.+|++.||++||++.|++.+  ++++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         249 SYIKSLPKYPRKDFSTLFPKASPQAV---DLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             HHHhhcCCcccchHHHHhcCCCHHHH---HHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            000       00000 0122333444   45559999999999999999976  766654

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=6.6e-34  Score=290.26  Aligned_cols=258  Identities=18%  Similarity=0.303  Sum_probs=188.0

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC---CHHHHHHHHHHHhCCC-CCcccceeEEEEecCe-----eeEEe
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV---GKREFEQQMEIVGGIR-HENVVALRAYYYSKDE-----KLMVY  374 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~-----~~lV~  374 (615)
                      .+.||+|+||.||+|... +++.||+|.++....   ....+.+|+++++.++ |+||+++++++...+.     .++||
T Consensus         6 ~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~   85 (295)
T cd07837           6 LEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVF   85 (295)
T ss_pred             eeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEe
Confidence            356999999999999965 688999998765422   2356788999999995 6999999999987665     89999


Q ss_pred             ecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCC-CCcEEEeeccccccc
Q 007167          375 DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNS-QGHVCVSDIGLAALM  453 (615)
Q Consensus       375 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~-~~~~kl~DfG~a~~~  453 (615)
                      ||+++ +|.+++..........+++..+..++.|++.||+|||+.+   |+||||||+||+++. ++.+||+|||+++..
T Consensus        86 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~  161 (295)
T cd07837          86 EYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLGLGRAF  161 (295)
T ss_pred             eccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecccceec
Confidence            99985 7888886543322356899999999999999999999998   999999999999998 889999999998765


Q ss_pred             CCCC---CCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcch-hhHHHHHHHhhhcccccc--
Q 007167          454 SPMP---PPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEV-VHLVRWVNSVVREEWTAE--  526 (615)
Q Consensus       454 ~~~~---~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~--  526 (615)
                      ....   ....++..|+|||++.+ ..++.++||||||+++|||++|+.||......+. ..+...+.......+...  
T Consensus       162 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (295)
T cd07837         162 SIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSK  241 (295)
T ss_pred             CCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhh
Confidence            4321   12245678999998765 4578999999999999999999999976432211 111111110000000000  


Q ss_pred             ccc----c-----cc-cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          527 VFD----V-----EL-LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       527 ~~d----~-----~~-~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ..+    +     .+ ...+..++++.+   ++.+|+..+|.+||++.|++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         242 LRDWHEFPQWKPQDLSRAVPDLSPEGLD---LLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             ccchhhcCcccchhHHHhccccCHHHHH---HHHHHccCChhhcCCHHHHhcC
Confidence            000    0     00 001223344444   4459999999999999999865

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=8.1e-34  Score=287.88  Aligned_cols=255  Identities=21%  Similarity=0.387  Sum_probs=190.2

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEecccc--CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVN--VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      +.||+|++|.||+|... ++..||+|.++...  ...+.+.+|+++++.++|+||+++++++.+.+..++||||+++ +|
T Consensus         6 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l   84 (284)
T cd07836           6 EKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DL   84 (284)
T ss_pred             eeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cH
Confidence            56999999999999975 57889999987542  2245677899999999999999999999999999999999985 88


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---CC
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---PP  459 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~~  459 (615)
                      .+++....  ....+++..+..++.|++.||+|||+.+   ++||||||+||++++++.++|+|||++.......   ..
T Consensus        85 ~~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~  159 (284)
T cd07836          85 KKYMDTHG--VRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSN  159 (284)
T ss_pred             HHHHHhcC--CCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcccccc
Confidence            88876432  1346899999999999999999999998   9999999999999999999999999997654321   22


Q ss_pred             CCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhh-HHHHHHHhhhcccc----ccccccccc
Q 007167          460 AMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVH-LVRWVNSVVREEWT----AEVFDVELL  533 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~----~~~~d~~~~  533 (615)
                      ..++..|+|||++.+. .++.++|||||||++|||++|+.||...+..+... ..+.........+.    ...+.....
T Consensus       160 ~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (284)
T cd07836         160 EVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFP  239 (284)
T ss_pred             ccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhccccc
Confidence            3457789999988653 56889999999999999999999998655433221 11111000000000    000000000


Q ss_pred             C---------CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          534 R---------YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       534 ~---------~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .         .+..+..   +.+++.+|++.+|++||++.|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~---~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         240 RYPPQDLQQLFPHADPL---GIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             CCChHHHHHHhhhcCcH---HHHHHHHHhcCCcccCCCHHHHhcC
Confidence            0         0112233   3445559999999999999999864

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=7.7e-34  Score=295.40  Aligned_cols=253  Identities=24%  Similarity=0.349  Sum_probs=189.7

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCH---------------HHHHHHHHHHhCCCCCcccceeEEEEecC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGK---------------REFEQQMEIVGGIRHENVVALRAYYYSKD  368 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~---------------~~~~~e~~~l~~l~h~niv~l~~~~~~~~  368 (615)
                      .+.||+|+||+||+|... +++.||+|.++......               ..+.+|+++++.++|+||+++++++...+
T Consensus        14 ~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   93 (335)
T PTZ00024         14 GAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGD   93 (335)
T ss_pred             hhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCC
Confidence            467999999999999854 68899999986542211               24678999999999999999999999999


Q ss_pred             eeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecc
Q 007167          369 EKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIG  448 (615)
Q Consensus       369 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG  448 (615)
                      ..++||||+. |+|.+++...     ..+++.....++.|++.||+|||+.+   |+||||+|+||+++.++.++|+|||
T Consensus        94 ~~~lv~e~~~-~~l~~~l~~~-----~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg  164 (335)
T PTZ00024         94 FINLVMDIMA-SDLKKVVDRK-----IRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFG  164 (335)
T ss_pred             cEEEEEeccc-cCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCcc
Confidence            9999999996 6899888632     35889999999999999999999998   9999999999999999999999999


Q ss_pred             cccccCCC-----------------CCCCCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhh
Q 007167          449 LAALMSPM-----------------PPPAMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVH  510 (615)
Q Consensus       449 ~a~~~~~~-----------------~~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~  510 (615)
                      .+......                 .....++..|+|||.+.+. .++.++||||+||++|||++|+.||...+..+...
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~  244 (335)
T PTZ00024        165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG  244 (335)
T ss_pred             ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99766411                 0112346679999998764 46899999999999999999999998655432221


Q ss_pred             -HHHHHHHhhhcccccccccc-----------ccc-CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          511 -LVRWVNSVVREEWTAEVFDV-----------ELL-RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       511 -~~~~~~~~~~~~~~~~~~d~-----------~~~-~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                       +...+.......|......+           ... ..+..+++   +.+++.+|++.+|++||+++|++.+
T Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDD---AIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChH---HHHHHHHHcCCCchhccCHHHHhcC
Confidence             11111111111111111000           000 01122333   4455559999999999999999975

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=4.2e-34  Score=285.85  Aligned_cols=241  Identities=22%  Similarity=0.322  Sum_probs=192.8

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc----CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN----VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||.|+||.||++... ++..|++|.+....    ...+.+.+|++++++++||||+++++++.+....++|+||+.+
T Consensus         5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   84 (258)
T cd05578           5 LRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLG   84 (258)
T ss_pred             EEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCC
Confidence            357999999999999965 58899999987542    2246788999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      ++|.+++...     ..+++.....++.|+++||.|||+.+   ++|+||+|+||++++++.++|+|||.+.......  
T Consensus        85 ~~L~~~l~~~-----~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  156 (258)
T cd05578          85 GDLRYHLSQK-----VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT  156 (258)
T ss_pred             CCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCccc
Confidence            9999999643     36889999999999999999999998   9999999999999999999999999987765431  


Q ss_pred             CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCC
Q 007167          458 PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN  537 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  537 (615)
                      ....++..|+|||.+....++.++||||||+++|+|++|+.||.............    ....        ......+.
T Consensus       157 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~----~~~~--------~~~~~~~~  224 (258)
T cd05578         157 TSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRA----KQET--------ADVLYPAT  224 (258)
T ss_pred             cccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHH----Hhcc--------ccccCccc
Confidence            23346778999999988889999999999999999999999998765431111111    1110        00111122


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCCCH--HHHHH
Q 007167          538 IEEEMVEMLQVGMACVVRMPEERPKM--ADVLK  568 (615)
Q Consensus       538 ~~~~~~~l~~l~~~cl~~~P~~RPs~--~evl~  568 (615)
                      .+..+.++++   +|+..+|.+||++  +|+++
T Consensus       225 ~~~~~~~~i~---~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         225 WSTEAIDAIN---KLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             CcHHHHHHHH---HHccCChhHcCCccHHHHhc
Confidence            3344445554   9999999999999  66543

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=9.8e-34  Score=288.52  Aligned_cols=191  Identities=22%  Similarity=0.372  Sum_probs=160.5

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEecccc--CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEVN--VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      +.||+|+||.||+|.. .++..|++|+++...  .....+.+|+++++.++|+||+++++++..++..++|+||+. +++
T Consensus        11 ~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l   89 (291)
T cd07870          11 EKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDL   89 (291)
T ss_pred             EEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCH
Confidence            4699999999999985 468899999986542  223467889999999999999999999999999999999995 677


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---CC
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---PP  459 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~~  459 (615)
                      .+.+...    ...+.+..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++......   ..
T Consensus        90 ~~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  162 (291)
T cd07870          90 AQYMIQH----PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSS  162 (291)
T ss_pred             HHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCC
Confidence            7766532    235788888999999999999999998   9999999999999999999999999987653321   22


Q ss_pred             CCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 007167          460 AMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATG  504 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~  504 (615)
                      ..++..|+|||.+.+. .++.++|||||||++|||++|+.||....
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~  208 (291)
T cd07870         163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS  208 (291)
T ss_pred             ccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence            3457789999998653 47889999999999999999999997644

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.6e-33  Score=292.06  Aligned_cols=193  Identities=20%  Similarity=0.298  Sum_probs=160.3

Q ss_pred             hhcCcC--CccEEEEEEE-CCCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          306 EVLGKG--TFGTAYKAAL-EDASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       306 ~~lG~G--~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      +.||+|  +||+||++.. .+++.||+|.+......   .+.+.+|+.+++.++||||+++++++..++..++|+||+.+
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~   83 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY   83 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence            357777  8999999986 47899999998754322   25678899999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      |++.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++++||+.+.......  
T Consensus        84 ~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~  157 (328)
T cd08226          84 GSANSLLKTYF---PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK  157 (328)
T ss_pred             CCHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence            99999987532   235889999999999999999999988   9999999999999999999999998654332111  


Q ss_pred             --------CCCCCCCcccCccccCCC--CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 007167          458 --------PPAMRAAGYRAPEVTDTR--KATQASDVFSFGVLLLELLTGKSPIHATG  504 (615)
Q Consensus       458 --------~~~~~~~~y~aPE~~~~~--~~~~~~DvwS~Gvvl~elltg~~p~~~~~  504 (615)
                              ....++..|+|||++.+.  .++.++|||||||++|||++|+.||....
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~  214 (328)
T cd08226         158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML  214 (328)
T ss_pred             ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence                    111234569999998663  47899999999999999999999997644

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=5.8e-34  Score=285.35  Aligned_cols=239  Identities=21%  Similarity=0.393  Sum_probs=189.1

Q ss_pred             cCcCCccEEEEEEECC-CCEEEEEEeccccC----CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          308 LGKGTFGTAYKAALED-ASTVVVKRLKEVNV----GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       308 lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      ||+|+||.||++...+ +..+++|.+.....    ..+.+.+|++++++++|+||+++++.+......++||||+++++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            6899999999999764 88999999875432    245678899999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC-----
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP-----  457 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~-----  457 (615)
                      .+++...     ..+++..+..++.|++.||+|||+.+   ++||||+|+||++++++.++|+|||++.......     
T Consensus        81 ~~~l~~~-----~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  152 (265)
T cd05579          81 ASLLENV-----GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLN  152 (265)
T ss_pred             HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccc
Confidence            9999742     26899999999999999999999998   9999999999999999999999999987653321     


Q ss_pred             ------CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccccc
Q 007167          458 ------PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE  531 (615)
Q Consensus       458 ------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  531 (615)
                            ....++..|+|||......++.++||||||+++||+++|+.||......+....+      ....       ..
T Consensus       153 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~------~~~~-------~~  219 (265)
T cd05579         153 DDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNI------LNGK-------IE  219 (265)
T ss_pred             cccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------hcCC-------cC
Confidence                  1223567799999998888899999999999999999999999765433222111      1000       00


Q ss_pred             ccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          532 LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       532 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                      .......++.+.++++   +|++.+|++|||+.++.+.|
T Consensus       220 ~~~~~~~~~~~~~~i~---~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         220 WPEDVEVSDEAIDLIS---KLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             CCccccCCHHHHHHHH---HHhcCCHhhcCCCccHHHHh
Confidence            0001112445555555   99999999999995555444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.8e-33  Score=284.61  Aligned_cols=240  Identities=24%  Similarity=0.370  Sum_probs=184.1

Q ss_pred             hcCcCCccEEEEEEEC-CCCEEEEEEeccccCC----HHHHHHHH---HHHhCCCCCcccceeEEEEecCeeeEEeecCC
Q 007167          307 VLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG----KREFEQQM---EIVGGIRHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~---~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      +||+|+||.||++... .++.||+|.+......    ...+..|.   +.++...||||+++++++...+..++||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            3899999999999854 5789999988653221    12233343   34455679999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC-C
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM-P  457 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~-~  457 (615)
                      +|+|.+++...     ..+++..+..++.|++.|++|||+.+   |+||||||+||+++.++.+||+|||++...... .
T Consensus        81 g~~L~~~l~~~-----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~  152 (278)
T cd05606          81 GGDLHYHLSQH-----GVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP  152 (278)
T ss_pred             CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccCC
Confidence            99999988632     36999999999999999999999988   999999999999999999999999998765432 2


Q ss_pred             CCCCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          458 PPAMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                      ....++..|+|||.+..+ .++.++||||+||++|||++|+.||............. .  ..       ..+...  ..
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~-~--~~-------~~~~~~--~~  220 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR-M--TL-------TMAVEL--PD  220 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHH-H--hh-------ccCCCC--CC
Confidence            234578889999998754 58899999999999999999999997653322211110 0  00       001111  12


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERP-----KMADVLKM  569 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  569 (615)
                      ..+.++.++++   +|+..+|.+||     ++.|++++
T Consensus       221 ~~s~~~~~li~---~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         221 SFSPELRSLLE---GLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             cCCHHHHHHHH---HHhhcCHHhccCCCCCCHHHHHhC
Confidence            23455555555   99999999999     99999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.4e-33  Score=287.93  Aligned_cols=254  Identities=20%  Similarity=0.344  Sum_probs=187.0

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      +.||+|++|+||+|... +++.|++|.+.....   ..+.+.+|+++++.++|+||+++++++.+.+..++||||++ ++
T Consensus         8 ~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~   86 (294)
T PLN00009          8 EKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LD   86 (294)
T ss_pred             EEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-cc
Confidence            46999999999999865 688999998865422   23567889999999999999999999999999999999995 57


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCC-CCcEEEeecccccccCCCC---
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNS-QGHVCVSDIGLAALMSPMP---  457 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~-~~~~kl~DfG~a~~~~~~~---  457 (615)
                      |.+++....   ...+++.....++.|++.||+|||+++   |+||||+|+||+++. ++.+||+|||++.......   
T Consensus        87 l~~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~  160 (294)
T PLN00009         87 LKKHMDSSP---DFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF  160 (294)
T ss_pred             HHHHHHhCC---CCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence            887775322   224678888899999999999999998   999999999999985 5679999999997654321   


Q ss_pred             CCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchh-hHHHHHHHhhhccccc--cccc----
Q 007167          458 PPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVV-HLVRWVNSVVREEWTA--EVFD----  529 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~--~~~d----  529 (615)
                      ....++..|+|||++.+ ..++.++||||+||++|+|++|+.||......+.. ....+........|..  ...+    
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (294)
T PLN00009        161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSA  240 (294)
T ss_pred             ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhh
Confidence            22345778999998865 45789999999999999999999999765432221 1111111111111100  0000    


Q ss_pred             ------ccc-cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          530 ------VEL-LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       530 ------~~~-~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                            ... ...+..++++.+++.   +|++.+|++||++.|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~i~---~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        241 FPKWPPKDLATVVPTLEPAGVDLLS---KMLRLDPSKRITARAALEH  284 (294)
T ss_pred             cccCCCCCHHHhCcCCChHHHHHHH---HHccCChhhCcCHHHHhcC
Confidence                  000 011233444445444   9999999999999999875

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.3e-33  Score=290.86  Aligned_cols=258  Identities=19%  Similarity=0.238  Sum_probs=187.0

Q ss_pred             HHhhhcCcCCccEEEEEEECCCCEEEEEEeccc---cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          303 ASAEVLGKGTFGTAYKAALEDASTVVVKRLKEV---NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       303 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      ..++.+|.|+++.||++.. +++.||||++...   ....+.+.+|+++++.++|+||+++++++...+..+++|||+++
T Consensus         5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~   83 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY   83 (314)
T ss_pred             hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence            3345566666666666654 6889999998754   22245788999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      |+|.+++....   ...+++.....++.|++.||+|||+++   |+||||||+||+++.++.+||+|||.+..+....  
T Consensus        84 ~~l~~~l~~~~---~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~  157 (314)
T cd08216          84 GSCEDLLKTHF---PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKR  157 (314)
T ss_pred             CCHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccc
Confidence            99999997532   235888999999999999999999998   9999999999999999999999999886553211  


Q ss_pred             --------CCCCCCCcccCccccCC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccc---
Q 007167          458 --------PPAMRAAGYRAPEVTDT--RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWT---  524 (615)
Q Consensus       458 --------~~~~~~~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---  524 (615)
                              ....++..|+|||++..  ..++.++|||||||++|||++|+.||.......  ...............   
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~  235 (314)
T cd08216         158 QRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKST  235 (314)
T ss_pred             ccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCc
Confidence                    12234567999999865  357889999999999999999999997643221  111111100000000   


Q ss_pred             --------cc----cccccccC---CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          525 --------AE----VFDVELLR---YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       525 --------~~----~~d~~~~~---~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                              ..    ..+.....   .........++.+++.+||..+|++|||++|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         236 YPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             hhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence                    00    00000000   00001111244555669999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-33  Score=287.26  Aligned_cols=256  Identities=21%  Similarity=0.335  Sum_probs=190.8

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEecccc---CCHHHHHHHHHHHhCCCCCcccceeEEEEec--CeeeEEeecCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVN---VGKREFEQQMEIVGGIRHENVVALRAYYYSK--DEKLMVYDYFEP  379 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e~~~~  379 (615)
                      +.||+|+||.||+|... ++..+++|++....   .....+.+|+++++.++|+|++++++++...  +..++|+||+++
T Consensus         5 ~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~   84 (287)
T cd07840           5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH   84 (287)
T ss_pred             EEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc
Confidence            46999999999999965 47889999997652   2235688899999999999999999999988  889999999974


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                       +|.+++...    ...+++..+..++.|++.||+|||+.+   ++|+||||+||++++++.+||+|||++.......  
T Consensus        85 -~l~~~~~~~----~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~  156 (287)
T cd07840          85 -DLTGLLDSP----EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA  156 (287)
T ss_pred             -cHHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence             888888643    136899999999999999999999998   9999999999999999999999999998775432  


Q ss_pred             --CCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHH-HHHHHhhhccccc--cc----
Q 007167          458 --PPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLV-RWVNSVVREEWTA--EV----  527 (615)
Q Consensus       458 --~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~----  527 (615)
                        .....+..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+ +.........|..  ..    
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (287)
T cd07840         157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFE  236 (287)
T ss_pred             cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhh
Confidence              22345677999998754 45789999999999999999999999765532222111 1111111111100  00    


Q ss_pred             -ccccccCCCCc----HH-HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          528 -FDVELLRYPNI----EE-EMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       528 -~d~~~~~~~~~----~~-~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                       ...........    .. ....+.+++.+|+..+|++||++++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         237 NLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence             00000000000    00 12345666669999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.4e-33  Score=293.75  Aligned_cols=254  Identities=24%  Similarity=0.348  Sum_probs=187.3

Q ss_pred             HHhhhcCcCCccEEEEEEEC-CCCEEEEEEeccc---cCCHHHHHHHHHHHhCC-CCCcccceeEEEEec--CeeeEEee
Q 007167          303 ASAEVLGKGTFGTAYKAALE-DASTVVVKRLKEV---NVGKREFEQQMEIVGGI-RHENVVALRAYYYSK--DEKLMVYD  375 (615)
Q Consensus       303 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~--~~~~lV~e  375 (615)
                      ...+.||+|+||.||+|... ++..+|+|++...   ......+.+|+++++++ +|+||+++++++...  ...++|||
T Consensus        10 ~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e   89 (337)
T cd07852          10 EILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFE   89 (337)
T ss_pred             HHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEec
Confidence            34577999999999999965 5788999988543   12234577899999999 999999999998654  36899999


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      |++ ++|..++...      .++|..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus        90 ~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~  159 (337)
T cd07852          90 YME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSE  159 (337)
T ss_pred             ccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhcccc
Confidence            997 5898888632      6889999999999999999999998   99999999999999999999999999986643


Q ss_pred             CC--------CCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhc-----
Q 007167          456 MP--------PPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVRE-----  521 (615)
Q Consensus       456 ~~--------~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----  521 (615)
                      ..        ....++..|+|||.+.+ ..++.++||||||+++|||++|+.||......+....+.........     
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (337)
T cd07852         160 LEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIES  239 (337)
T ss_pred             ccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            22        12346778999998754 45788999999999999999999999764432221111111000000     


Q ss_pred             ---cccccccc----ccc----cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          522 ---EWTAEVFD----VEL----LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       522 ---~~~~~~~d----~~~----~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                         .....+++    ...    ...+..+.+   +.+++.+|++.+|++|||+.|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         240 IKSPFAATMLDSLPSRPRKPLDELLPKASDD---ALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHhhhHHHhhhhcccccccchhhhccCCCHH---HHHHHHHhccCCcccccCHHHHhhC
Confidence               00000000    000    001122333   4455559999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1e-33  Score=291.07  Aligned_cols=254  Identities=22%  Similarity=0.375  Sum_probs=188.1

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEec--CeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSK--DEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e~~~  378 (615)
                      .+.||+|+||.||+|... ++..||+|.++.....   ...+.+|++++++++|+||+++++++.+.  +..++||||+.
T Consensus        12 ~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~   91 (309)
T cd07845          12 LNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE   91 (309)
T ss_pred             eeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC
Confidence            356999999999999964 5889999998644221   23456899999999999999999998765  46899999996


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC-
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP-  457 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~-  457 (615)
                       ++|.+++....    ..+++..+..++.|++.||+|||+.+   ++||||||+||++++++.+||+|||++....... 
T Consensus        92 -~~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~  163 (309)
T cd07845          92 -QDLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK  163 (309)
T ss_pred             -CCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence             47888886432    46899999999999999999999998   9999999999999999999999999998765432 


Q ss_pred             --CCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHH-HHHHhhhcccc-------cc
Q 007167          458 --PPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVR-WVNSVVREEWT-------AE  526 (615)
Q Consensus       458 --~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~-------~~  526 (615)
                        .....+..|+|||.+.+ ..++.++||||+||++|||++|+.||...+..+....+. .........|.       ..
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
T cd07845         164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG  243 (309)
T ss_pred             CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccc
Confidence              12234667999999865 457899999999999999999999998655433222111 11100000000       00


Q ss_pred             cccccccC-------CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          527 VFDVELLR-------YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       527 ~~d~~~~~-------~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+......       .+..+++..+   ++.+|+..||++|||+.|++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~---li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         244 KFTLPKQPYNNLKHKFPWLSEAGLR---LLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             cccccCCCCCchHHhccccCHHHHH---HHHHHhcCChhhCcCHHHHhcC
Confidence            00000000       1112344444   4459999999999999999976

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.1e-33  Score=290.54  Aligned_cols=257  Identities=21%  Similarity=0.306  Sum_probs=186.1

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEecC--------eeeE
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSKD--------EKLM  372 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--------~~~l  372 (615)
                      .+.||+|+||.||+|... ++..||||.+.....   ....+.+|++++++++||||+++++++...+        ..++
T Consensus        17 ~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l   96 (310)
T cd07865          17 LAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYL   96 (310)
T ss_pred             EEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEE
Confidence            356999999999999965 688999998864321   1335568999999999999999999987654        3599


Q ss_pred             EeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccc
Q 007167          373 VYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAAL  452 (615)
Q Consensus       373 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~  452 (615)
                      ||||+. ++|.+.+...    ...+++.....++.|++.||+|||+.+   ++|+||||+||+++.++.+||+|||++..
T Consensus        97 v~e~~~-~~l~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~  168 (310)
T cd07865          97 VFEFCE-HDLAGLLSNK----NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLARA  168 (310)
T ss_pred             EEcCCC-cCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCccc
Confidence            999996 4788877532    235899999999999999999999998   99999999999999999999999999976


Q ss_pred             cCCCCC-------CCCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccc
Q 007167          453 MSPMPP-------PAMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWT  524 (615)
Q Consensus       453 ~~~~~~-------~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  524 (615)
                      +.....       ...++..|+|||.+.+. .++.++||||||+++|||++|+.||...........+..+.........
T Consensus       169 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (310)
T cd07865         169 FSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVW  248 (310)
T ss_pred             ccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhc
Confidence            643221       22356679999988654 3688999999999999999999999765443332222222111111100


Q ss_pred             ccc-----ccc-cccCC--CCcHH------HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          525 AEV-----FDV-ELLRY--PNIEE------EMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       525 ~~~-----~d~-~~~~~--~~~~~------~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ...     .+. .....  .....      ....+.+++.+|+..+|++|||++|++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         249 PGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             ccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            000     000 00000  00000      01234456669999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=1.6e-33  Score=287.43  Aligned_cols=244  Identities=16%  Similarity=0.219  Sum_probs=174.4

Q ss_pred             hhhcCcCCccEEEEEEECCC----CEEEEEEeccccCC---H---------HHHHHHHHHHhCCCCCcccceeEEEEecC
Q 007167          305 AEVLGKGTFGTAYKAALEDA----STVVVKRLKEVNVG---K---------REFEQQMEIVGGIRHENVVALRAYYYSKD  368 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~----~~vavK~l~~~~~~---~---------~~~~~e~~~l~~l~h~niv~l~~~~~~~~  368 (615)
                      .++||+|+||+||+|...+.    ..+++|........   +         .....+...+..++|+|++++++++....
T Consensus        17 ~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~   96 (294)
T PHA02882         17 DKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKR   96 (294)
T ss_pred             eeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEec
Confidence            45799999999999997654    34555543221111   0         01122334456778999999998776543


Q ss_pred             ----eeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEE
Q 007167          369 ----EKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCV  444 (615)
Q Consensus       369 ----~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl  444 (615)
                          ..++++|++. .++.+.+...     ...++.....++.|++.||+|||+.+   |+||||||+|||++.++.++|
T Consensus        97 ~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~~l  167 (294)
T PHA02882         97 CRMYYRFILLEKLV-ENTKEIFKRI-----KCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRGYI  167 (294)
T ss_pred             CCceEEEEEEehhc-cCHHHHHHhh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcEEE
Confidence                4477888774 3566665422     23567888999999999999999997   999999999999999999999


Q ss_pred             eecccccccCCCC----------CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC-cchhhHH-
Q 007167          445 SDIGLAALMSPMP----------PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGG-DEVVHLV-  512 (615)
Q Consensus       445 ~DfG~a~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~-~~~~~~~-  512 (615)
                      +|||+++.+....          ....+|..|+|||+..+..++.++|||||||++|||++|+.||..... .+..... 
T Consensus       168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~  247 (294)
T PHA02882        168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK  247 (294)
T ss_pred             EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence            9999997653211          123478889999999998999999999999999999999999987633 2222111 


Q ss_pred             -HHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          513 -RWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       513 -~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                       .+...+...         .. ..+..++++.++++   .|+..+|++||++.++++.+
T Consensus       248 ~~~~~~~~~~---------~~-~~~~~~~~~~~~~~---~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        248 CDFIKRLHEG---------KI-KIKNANKFIYDFIE---CVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHHHHHhhhh---------hh-ccCCCCHHHHHHHH---HHHhCCCCCCCCHHHHHHhh
Confidence             112211111         00 12334455555555   99999999999999999876

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-34  Score=297.32  Aligned_cols=253  Identities=21%  Similarity=0.346  Sum_probs=186.8

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEecccc--CCHHHHHHHHHHHhCCCCCcccceeEEEEec-----CeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVN--VGKREFEQQMEIVGGIRHENVVALRAYYYSK-----DEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lV~e~  376 (615)
                      .++||+|+||.||+|.. .+++.||+|.++...  .....+.+|++++++++|+||+++++++...     ...++|+||
T Consensus        10 ~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~   89 (336)
T cd07849          10 LSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQEL   89 (336)
T ss_pred             EEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehh
Confidence            35799999999999985 468899999986432  2245677899999999999999999887654     357999999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM  456 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~  456 (615)
                      +.+ +|.+.+..      ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus        90 ~~~-~l~~~~~~------~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  159 (336)
T cd07849          90 MET-DLYKLIKT------QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIADPE  159 (336)
T ss_pred             ccc-CHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence            964 78877753      25899999999999999999999998   999999999999999999999999999765432


Q ss_pred             C------CCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccc---ccc
Q 007167          457 P------PPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEW---TAE  526 (615)
Q Consensus       457 ~------~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~  526 (615)
                      .      ....++..|+|||.+.+ ..++.++||||+||++|||++|+.||...+...   ....+........   ...
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~---~~~~~~~~~~~~~~~~~~~  236 (336)
T cd07849         160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH---QLNLILGVLGTPSQEDLNC  236 (336)
T ss_pred             ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHHHcCCCCHHHHHH
Confidence            1      12346778999998654 568899999999999999999999997543211   1111111111000   000


Q ss_pred             cccc-------ccc---------CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHh
Q 007167          527 VFDV-------ELL---------RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM--VEDI  573 (615)
Q Consensus       527 ~~d~-------~~~---------~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~l  573 (615)
                      +.+.       ...         ..+..+++   +.+++.+|++.+|++|||+.|++++  ++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         237 IISLRARNYIKSLPFKPKVPWNKLFPNADPK---ALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             hhchhhhhHHhhcCcCCcccHHHHhcccCcH---HHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence            0000       000         01122233   4455559999999999999999998  4443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=9.1e-34  Score=295.06  Aligned_cols=259  Identities=22%  Similarity=0.376  Sum_probs=190.5

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccc---cCCHHHHHHHHHHHhCCCCCcccceeEEEEec-----CeeeEEee
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEV---NVGKREFEQQMEIVGGIRHENVVALRAYYYSK-----DEKLMVYD  375 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lV~e  375 (615)
                      .+.||+|+||+||+|.. .++..||||.++..   ......+.+|+++++.++|+||+++++++...     ...++|||
T Consensus        10 ~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e   89 (337)
T cd07858          10 IKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE   89 (337)
T ss_pred             EEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEe
Confidence            34699999999999985 46789999998753   22244667899999999999999999988654     34799999


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      |+. ++|.+++...     ..+++.....++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.....
T Consensus        90 ~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  160 (337)
T cd07858          90 LMD-TDLHQIIRSS-----QTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTSE  160 (337)
T ss_pred             CCC-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence            995 6888888632     36899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CC---CCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHH-HHHHHhhhccc-------
Q 007167          456 MP---PPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLV-RWVNSVVREEW-------  523 (615)
Q Consensus       456 ~~---~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~-------  523 (615)
                      ..   ....++..|+|||.+.. ..++.++|||||||++|+|++|+.||...+..+....+ ..+.....+.+       
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd07858         161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK  240 (337)
T ss_pred             CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence            31   22345778999998764 45889999999999999999999999764322211111 11100000000       


Q ss_pred             ccccc-------cccc-cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhHh
Q 007167          524 TAEVF-------DVEL-LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM--VEDIRR  575 (615)
Q Consensus       524 ~~~~~-------d~~~-~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~l~~  575 (615)
                      .....       +... ...+.+++++.++++   +|++.+|++|||++|++++  ++.+.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~---~~l~~~P~~Rps~~ell~h~~~~~~~~  299 (337)
T cd07858         241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLE---KMLVFDPSKRITVEEALAHPYLASLHD  299 (337)
T ss_pred             hhHHHHhcCcccccCHHHHcccCCHHHHHHHH---HHhcCChhhccCHHHHHcCcchhhhcC
Confidence            00000       0000 012233444445554   9999999999999999998  655543

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.1e-33  Score=281.20  Aligned_cols=235  Identities=20%  Similarity=0.283  Sum_probs=183.1

Q ss_pred             cCcCCccEEEEEEE-CCCCEEEEEEeccccCCHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCCCCChhhh
Q 007167          308 LGKGTFGTAYKAAL-EDASTVVVKRLKEVNVGKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFEPGSVSAM  385 (615)
Q Consensus       308 lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~  385 (615)
                      ||+|+||.||++.. .++..+|+|..........    |+.....+ +|+||+++++++...+..++||||+++|+|.++
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~----e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~   99 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI----EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDL   99 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh----hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHH
Confidence            69999999999985 4677889998865432211    22222212 699999999999999999999999999999999


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCC-cEEEeecccccccCCCCCCCCCCC
Q 007167          386 LHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG-HVCVSDIGLAALMSPMPPPAMRAA  464 (615)
Q Consensus       386 l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~-~~kl~DfG~a~~~~~~~~~~~~~~  464 (615)
                      +...     ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++ .++|+|||++....... ...++.
T Consensus       100 l~~~-----~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~-~~~~~~  170 (267)
T PHA03390        100 LKKE-----GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPS-CYDGTL  170 (267)
T ss_pred             HHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCCc-cCCCCC
Confidence            9743     27899999999999999999999998   99999999999999998 99999999988765432 335788


Q ss_pred             cccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHHHHHH
Q 007167          465 GYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVE  544 (615)
Q Consensus       465 ~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~  544 (615)
                      .|+|||++.+..++.++||||||+++|||++|+.||.....++ .....+.... .         ......+..++.+.+
T Consensus       171 ~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-~---------~~~~~~~~~~~~~~~  239 (267)
T PHA03390        171 DYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLKRQ-Q---------KKLPFIKNVSKNAND  239 (267)
T ss_pred             cccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHHhh-c---------ccCCcccccCHHHHH
Confidence            8999999988889999999999999999999999998544332 2222222211 0         111112234555666


Q ss_pred             HHHHHHHcccCCCCCCCC-HHHHHHH
Q 007167          545 MLQVGMACVVRMPEERPK-MADVLKM  569 (615)
Q Consensus       545 l~~l~~~cl~~~P~~RPs-~~evl~~  569 (615)
                      +++   +|++.+|.+||+ ++|++++
T Consensus       240 li~---~~l~~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        240 FVQ---SMLKYNINYRLTNYNEIIKH  262 (267)
T ss_pred             HHH---HHhccChhhCCchHHHHhcC
Confidence            665   999999999995 6988764

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.6e-33  Score=291.98  Aligned_cols=251  Identities=21%  Similarity=0.354  Sum_probs=188.1

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc---CCHHHHHHHHHHHhCCCCCcccceeEEEEe-cCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN---VGKREFEQQMEIVGGIRHENVVALRAYYYS-KDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||.||++... ++..||+|++....   ...+.+.+|++++..++||||+++.+++.. ....++|+||+ +
T Consensus        15 ~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~   93 (328)
T cd07856          15 LQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-G   93 (328)
T ss_pred             EEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-c
Confidence            357999999999999854 78899999886431   224567889999999999999999999876 45788999998 5


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCC
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP  459 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~  459 (615)
                      ++|..++..      ..+++.....++.|++.||+|||+.+   |+||||+|+||++++++.++|+|||.+.........
T Consensus        94 ~~L~~~~~~------~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  164 (328)
T cd07856          94 TDLHRLLTS------RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDPQMTG  164 (328)
T ss_pred             cCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCCCcCC
Confidence            689888853      25788888899999999999999998   999999999999999999999999999876554444


Q ss_pred             CCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhh-HHHHHHHhhhcccccccccc-------
Q 007167          460 AMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVH-LVRWVNSVVREEWTAEVFDV-------  530 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~d~-------  530 (615)
                      ..++..|+|||.+.+ ..++.++|||||||++|||++|+.||.......... +.+++.. ..+++.....+.       
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  243 (328)
T cd07856         165 YVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGT-PPDDVINTICSENTLRFVQ  243 (328)
T ss_pred             CcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC-CCHHHHHhccchhhHHHHh
Confidence            456778999998765 568999999999999999999999997654321111 1111100 000000000000       


Q ss_pred             ccc---------CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          531 ELL---------RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       531 ~~~---------~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+.         ..+..++++.++   +.+|++.+|++||++.|++.+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~l---i~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         244 SLPKREPVPFSEKFKNADPSAIDL---LEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hccccCCCcHHHHcCCCCHHHHHH---HHHHcCCChhhCCCHHHHhcC
Confidence            000         012233444444   449999999999999999876

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=2e-33  Score=287.72  Aligned_cols=254  Identities=24%  Similarity=0.356  Sum_probs=186.9

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc---CCHHHHHHHHHHHhCCCCCcccceeEEEEecC----------ee
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN---VGKREFEQQMEIVGGIRHENVVALRAYYYSKD----------EK  370 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----------~~  370 (615)
                      .+.||+|+||.||+|... +++.|++|+++...   .....+.+|+++++.++||||+++++++.+..          ..
T Consensus        12 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~   91 (302)
T cd07864          12 IGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAF   91 (302)
T ss_pred             eeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcE
Confidence            467999999999999975 57889999986532   22356778999999999999999999987654          78


Q ss_pred             eEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccc
Q 007167          371 LMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLA  450 (615)
Q Consensus       371 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a  450 (615)
                      ++|+||+++ ++...+...    ...+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++
T Consensus        92 ~lv~e~~~~-~l~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~  163 (302)
T cd07864          92 YLVFEYMDH-DLMGLLESG----LVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFGLA  163 (302)
T ss_pred             EEEEcccCc-cHHHHHhcC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCccccc
Confidence            999999976 677766532    236899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCC----CCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHH-HHHHhhhcccc
Q 007167          451 ALMSPMPP----PAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVR-WVNSVVREEWT  524 (615)
Q Consensus       451 ~~~~~~~~----~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~  524 (615)
                      ........    ....+..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+. .........+.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (302)
T cd07864         164 RLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWP  243 (302)
T ss_pred             ccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcc
Confidence            87653321    1234667999998754 356889999999999999999999997644322111111 11110000000


Q ss_pred             c--cc-----ccc-------cccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          525 A--EV-----FDV-------ELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       525 ~--~~-----~d~-------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .  +.     .+.       ........+..+.++++   +|+..+|.+||++.|++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~---~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         244 DVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLD---HMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             cccccccccccccccccccchhhhcCCCCHHHHHHHH---HHccCChhhCCCHHHHhcC
Confidence            0  00     000       00011223444555555   9999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.7e-33  Score=280.74  Aligned_cols=244  Identities=22%  Similarity=0.390  Sum_probs=194.4

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .++||+|+||.||++..+ ++..+++|.+.....   ....+.+|+++++.++|+||+++++++.+....++||||++++
T Consensus         5 ~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   84 (256)
T cd08530           5 LKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFG   84 (256)
T ss_pred             eeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCC
Confidence            356999999999999854 678899999875432   2346778999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC-CC
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP-PP  459 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~-~~  459 (615)
                      +|.+++.... .....+++..+..++.+++.||+|||+.+   ++|+||+|+||++++++.+|++|||++....... ..
T Consensus        85 ~L~~~~~~~~-~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~  160 (256)
T cd08530          85 DLSKAISKRK-KKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT  160 (256)
T ss_pred             CHHHHHHHHH-hhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccCCccc
Confidence            9999986532 22356899999999999999999999998   9999999999999999999999999998765432 22


Q ss_pred             CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      ..++..|+|||...+..++.++|+||+|+++|||++|+.||...+..+....+      ....     +. ..  .....
T Consensus       161 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~------~~~~-----~~-~~--~~~~~  226 (256)
T cd08530         161 QIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV------QRGK-----YP-PI--PPIYS  226 (256)
T ss_pred             ccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------hcCC-----CC-CC--chhhC
Confidence            34677899999998888999999999999999999999999765432211111      0000     00 00  01223


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .   ++.+++.+|+..+|++||++.|++++
T Consensus       227 ~---~~~~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         227 Q---DLQNFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             H---HHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            3   34555559999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=7.6e-34  Score=295.28  Aligned_cols=253  Identities=21%  Similarity=0.334  Sum_probs=186.9

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc---CCHHHHHHHHHHHhCCCCCcccceeEEEEe----cCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN---VGKREFEQQMEIVGGIRHENVVALRAYYYS----KDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lV~e~  376 (615)
                      .+.||+|+||.||+|... ++..|++|++....   ...+.+.+|+++++.++||||+++++++..    ....++||||
T Consensus        10 ~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~   89 (334)
T cd07855          10 IENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDL   89 (334)
T ss_pred             eeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEeh
Confidence            356999999999999854 68899999987542   224567789999999999999999988763    3468999999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM  456 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~  456 (615)
                      +. |+|.+++...     ..+++.....++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++......
T Consensus        90 ~~-~~l~~~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  160 (334)
T cd07855          90 ME-SDLHHIIHSD-----QPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS  160 (334)
T ss_pred             hh-hhHHHHhccC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence            95 6899888642     35899999999999999999999998   999999999999999999999999999765432


Q ss_pred             C-------CCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhh--------
Q 007167          457 P-------PPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVR--------  520 (615)
Q Consensus       457 ~-------~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------  520 (615)
                      .       ....++..|+|||.+.. ..++.++|||||||++|||++|+.||...+.......+........        
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~  240 (334)
T cd07855         161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG  240 (334)
T ss_pred             CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence            1       12346778999998755 4588999999999999999999999976543221111110000000        


Q ss_pred             cccccccccc-c-ccC------CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          521 EEWTAEVFDV-E-LLR------YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       521 ~~~~~~~~d~-~-~~~------~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .....+..+. . ...      .+..++++.++   +.+|++.+|++||++.|++.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l---i~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDL---LSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHH---HHHHccCChhhCcCHHHHHhC
Confidence            0000000000 0 000      12233444444   449999999999999999886

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=4.3e-33  Score=277.70  Aligned_cols=241  Identities=24%  Similarity=0.392  Sum_probs=194.2

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEec--CeeeEEeecCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSK--DEKLMVYDYFEP  379 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e~~~~  379 (615)
                      +.||+|++|.||+|... ++..|++|++.....   ..+.+.+|++++++++|+||+++++.+...  ...++|+||+++
T Consensus         6 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~   85 (260)
T cd06606           6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSG   85 (260)
T ss_pred             eEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCC
Confidence            56999999999999976 688999999876542   356788999999999999999999999988  889999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      ++|.+++...     ..+++..+..++.+++.|++|||+.+   ++|+||+|+||+++.++.++|+|||.+.......  
T Consensus        86 ~~L~~~~~~~-----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  157 (260)
T cd06606          86 GSLSSLLKKF-----GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG  157 (260)
T ss_pred             CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence            9999998743     27899999999999999999999987   9999999999999999999999999998776542  


Q ss_pred             ---CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccC
Q 007167          458 ---PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLR  534 (615)
Q Consensus       458 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  534 (615)
                         ....++..|+|||.......+.++||||||+++++|++|+.||.....  .....   .........     ..  .
T Consensus       158 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~---~~~~~~~~~-----~~--~  225 (260)
T cd06606         158 EGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGN--PMAAL---YKIGSSGEP-----PE--I  225 (260)
T ss_pred             ccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc--hHHHH---HhccccCCC-----cC--C
Confidence               234567789999999888899999999999999999999999976541  11111   111000000     00  0


Q ss_pred             CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          535 YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       535 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ....++++   .+++.+|+..+|++||++.|++++
T Consensus       226 ~~~~~~~l---~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         226 PEHLSEEA---KDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             CcccCHHH---HHHHHHhCcCChhhCCCHHHHhhC
Confidence            11223444   444559999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-34  Score=274.77  Aligned_cols=239  Identities=21%  Similarity=0.340  Sum_probs=199.1

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEecccc-CCHH---HHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVN-VGKR---EFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~---~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .++||+|.||.|-.++- ..++.+|+|++++.- ..++   .-..|-++|...+||.+..+.-.|+.+++.+.||||..|
T Consensus       173 LKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanG  252 (516)
T KOG0690|consen  173 LKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANG  252 (516)
T ss_pred             HHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccC
Confidence            46799999999999984 467889999998652 2222   345688899999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeeccccccc---CCC
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALM---SPM  456 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~---~~~  456 (615)
                      |.|+-+|...     ..+++.....+..+|..||.|||+++   ||.||+|-+|.|+|.+|++||+|||+++.-   +..
T Consensus       253 GeLf~HLsre-----r~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t  324 (516)
T KOG0690|consen  253 GELFFHLSRE-----RVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDT  324 (516)
T ss_pred             ceEeeehhhh-----hcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcccccce
Confidence            9999999754     36888888899999999999999988   999999999999999999999999999753   233


Q ss_pred             CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          457 PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       457 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                      ..+.+||+.|+|||++....|..++|.|.+|||+|||++|+.||...+.+....++-               ..++....
T Consensus       325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl---------------~ed~kFPr  389 (516)
T KOG0690|consen  325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELIL---------------MEDLKFPR  389 (516)
T ss_pred             eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHH---------------hhhccCCc
Confidence            456789999999999999999999999999999999999999998766655544432               11222334


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERP-----KMADVLKM  569 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  569 (615)
                      .++++.+.++.   ..+.+||.+|.     .+.||.++
T Consensus       390 ~ls~eAktLLs---GLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  390 TLSPEAKTLLS---GLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             cCCHHHHHHHH---HHhhcChHhhcCCCchhHHHHHhh
Confidence            67788888887   88899999996     45666554

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-34  Score=295.45  Aligned_cols=240  Identities=24%  Similarity=0.423  Sum_probs=192.4

Q ss_pred             hcCcCCccEEEEEEECCCCEE-EEEEeccc-cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChhh
Q 007167          307 VLGKGTFGTAYKAALEDASTV-VVKRLKEV-NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSA  384 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~~~~~v-avK~l~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  384 (615)
                      .||.|+||.||||..++.... |.|.+... ...-++|.-|+++|+.++||+||+|++.|+..+.++|+.|||.||-.+.
T Consensus        39 ELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDa  118 (1187)
T KOG0579|consen   39 ELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDA  118 (1187)
T ss_pred             hhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhH
Confidence            499999999999998766554 45655432 2234678889999999999999999999999999999999999999998


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC---CCCCCC
Q 007167          385 MLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP---MPPPAM  461 (615)
Q Consensus       385 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~---~~~~~~  461 (615)
                      ++-.-    ...+...+..-++.+++.||.|||+..   |||||||+.|||++-+|.++++|||.+.....   ......
T Consensus       119 imlEL----~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFI  191 (1187)
T KOG0579|consen  119 IMLEL----GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFI  191 (1187)
T ss_pred             HHHHh----ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHHhhhcccc
Confidence            87642    347999999999999999999999998   99999999999999999999999998754432   224557


Q ss_pred             CCCcccCccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          462 RAAGYRAPEVTD-----TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       462 ~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                      ||+.|||||+..     ...|+.++||||||++|.||..+.+|....+...+      +..+...+      .+.+....
T Consensus       192 GTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRV------llKiaKSe------PPTLlqPS  259 (1187)
T KOG0579|consen  192 GTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV------LLKIAKSE------PPTLLQPS  259 (1187)
T ss_pred             CCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHH------HHHHhhcC------CCcccCcc
Confidence            999999999874     45789999999999999999999999876443222      11111111      12333334


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLK  568 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  568 (615)
                      .++....++++   +|+.++|..||++.++++
T Consensus       260 ~Ws~~F~DfLk---~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  260 HWSRSFSDFLK---RCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             hhhhHHHHHHH---HHHhcCCccCCCHHHHhh
Confidence            55666677777   999999999999999876

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-35  Score=323.17  Aligned_cols=241  Identities=25%  Similarity=0.403  Sum_probs=194.2

Q ss_pred             hhhcCcCCccEEEEEE-ECCCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          305 AEVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      +.+||.|.||.||-|. .+.|.-.|||-++....   .-+...+|+.++..++|||+|+++|+-.+++..+|.||||++|
T Consensus      1240 g~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~G 1319 (1509)
T KOG4645|consen 1240 GNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGG 1319 (1509)
T ss_pred             ccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccC
Confidence            4679999999999998 55677789998875433   2355789999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---  457 (615)
                      +|.+++...+     -.++.....+..|++.|++|||+.|   ||||||||.||+++.+|.+|.+|||.|..+....   
T Consensus      1320 sLa~ll~~gr-----i~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~ 1391 (1509)
T KOG4645|consen 1320 SLASLLEHGR-----IEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTM 1391 (1509)
T ss_pred             cHHHHHHhcc-----hhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchhcC
Confidence            9999997433     3566777778899999999999998   9999999999999999999999999998876543   


Q ss_pred             ----CCCCCCCcccCccccCCCC---CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccc
Q 007167          458 ----PPAMRAAGYRAPEVTDTRK---ATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDV  530 (615)
Q Consensus       458 ----~~~~~~~~y~aPE~~~~~~---~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  530 (615)
                          ...+||+-|||||.+.+..   ..-+.||||+|||+.||+||+.||...+.+  .+++-.|....         .+
T Consensus      1392 ~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--~aIMy~V~~gh---------~P 1460 (1509)
T KOG4645|consen 1392 PGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--WAIMYHVAAGH---------KP 1460 (1509)
T ss_pred             CHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch--hHHHhHHhccC---------CC
Confidence                2346889999999996643   456899999999999999999999875542  12221121111         11


Q ss_pred             cccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          531 ELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       531 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+  ...++.+-.++++   +|+..||+.|.++.|++++
T Consensus      1461 q~--P~~ls~~g~dFle---~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1461 QI--PERLSSEGRDFLE---HCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             CC--chhhhHhHHHHHH---HHHhcCchhhhHHHHHHHh
Confidence            11  1135677778888   9999999999999888776

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-34  Score=250.98  Aligned_cols=254  Identities=20%  Similarity=0.357  Sum_probs=195.9

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .++||+|.||+||||+.+ .+..||+|+++-...+   .....+|+-+++.++|+|||++++....+...-+|+|||. .
T Consensus         7 mekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cd-q   85 (292)
T KOG0662|consen    7 MEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCD-Q   85 (292)
T ss_pred             HHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhh-H
Confidence            467999999999999954 5677999998754322   3567899999999999999999999999999999999995 4


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---  457 (615)
                      +|..+....    +..++-.....++.|+.+|+.++|+++   +.|||+||.|.||+.+|+.|++|||+++-++-+.   
T Consensus        86 dlkkyfdsl----ng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvrcy  158 (292)
T KOG0662|consen   86 DLKKYFDSL----NGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCY  158 (292)
T ss_pred             HHHHHHHhc----CCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceEee
Confidence            777776543    346888999999999999999999998   9999999999999999999999999999876442   


Q ss_pred             CCCCCCCcccCccccCCCC-CCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHH-HhhhcccccccccccccC
Q 007167          458 PPAMRAAGYRAPEVTDTRK-ATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVN-SVVREEWTAEVFDVELLR  534 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~d~~~~~  534 (615)
                      ...+.|..|++|.++.+.+ |++..|+||-||++.|+.. |++.|.+.+-++-...+-|+. ....+.|....--+....
T Consensus       159 saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~  238 (292)
T KOG0662|consen  159 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKP  238 (292)
T ss_pred             eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcc
Confidence            3445688999999988755 7999999999999999998 787787766544433343443 334555553322222222


Q ss_pred             CCC-------------cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          535 YPN-------------IEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       535 ~~~-------------~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      +|.             ....-+++++   +.+.-+|..|.++++++++
T Consensus       239 yp~ypattswsqivp~lns~grdllq---kll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  239 YPIYPATTSWSQIVPKLNSTGRDLLQ---KLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             cCCccccchHHHHhhhhcchhHHHHH---HHhccCcccccCHHHHhcC
Confidence            221             1122356677   4444579999999988765

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-33  Score=285.13  Aligned_cols=258  Identities=21%  Similarity=0.400  Sum_probs=191.4

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC--CHHHHHHHHHHHhCCC-CCcccceeEEEEecCeeeEEeecCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV--GKREFEQQMEIVGGIR-HENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .+.||+|+||+||+|... +++.|++|++.....  ......+|++.+++++ |+||+++++++.+++..++||||+ +|
T Consensus         4 ~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~   82 (283)
T cd07830           4 IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EG   82 (283)
T ss_pred             heeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CC
Confidence            356999999999999975 467899999875432  2334567899999999 999999999999999999999999 88


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--C
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--P  458 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--~  458 (615)
                      +|.+.+....   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||++++++.++|+|||++.......  .
T Consensus        83 ~l~~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  156 (283)
T cd07830          83 NLYQLMKDRK---GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT  156 (283)
T ss_pred             CHHHHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCCcC
Confidence            9999887532   246899999999999999999999998   9999999999999999999999999998765432  2


Q ss_pred             CCCCCCcccCccccC-CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchh-hHHHHHHHhhhccccc-----cccccc
Q 007167          459 PAMRAAGYRAPEVTD-TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVV-HLVRWVNSVVREEWTA-----EVFDVE  531 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~-----~~~d~~  531 (615)
                      ...++..|+|||++. ...++.++||||||++++||++|+.||......+.. ....++.....+.|..     ..++..
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (283)
T cd07830         157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFR  236 (283)
T ss_pred             CCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccccc
Confidence            334677899999874 445789999999999999999999999765432221 1111111111111100     000000


Q ss_pred             ccCCC--C----cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          532 LLRYP--N----IEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       532 ~~~~~--~----~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .....  .    .+....++.+++.+|++.+|++||+++|++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence            00000  0    00112345566669999999999999999865

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=5.5e-33  Score=285.49  Aligned_cols=246  Identities=24%  Similarity=0.423  Sum_probs=190.2

Q ss_pred             HHhhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC----CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecC
Q 007167          303 ASAEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV----GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYF  377 (615)
Q Consensus       303 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  377 (615)
                      ...+.||+|+||.||+|... ++..+++|.+.....    ....+.+|+++++.++|+|++++++++......++||||+
T Consensus        18 ~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   97 (308)
T cd06634          18 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYC   97 (308)
T ss_pred             HHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEcc
Confidence            34567999999999999964 577899998864311    1345778999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC
Q 007167          378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP  457 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~  457 (615)
                      . |++.+.+...    ...+++..+..++.|++.|+.|||+.+   ++||||||+||+++.++.++|+|||++...... 
T Consensus        98 ~-~~l~~~~~~~----~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-  168 (308)
T cd06634          98 L-GSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (308)
T ss_pred             C-CCHHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence            6 6888777532    235889999999999999999999997   999999999999999999999999998766543 


Q ss_pred             CCCCCCCcccCccccC---CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccC
Q 007167          458 PPAMRAAGYRAPEVTD---TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLR  534 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  534 (615)
                      ....++..|+|||.+.   ...++.++|||||||++|||++|+.||......+...      .......      +.. .
T Consensus       169 ~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~------~~~~~~~------~~~-~  235 (308)
T cd06634         169 NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQNES------PAL-Q  235 (308)
T ss_pred             ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHH------HHhhcCC------CCc-C
Confidence            2345678899999874   3457889999999999999999999986543222111      1111000      000 0


Q ss_pred             CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 007167          535 YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI  573 (615)
Q Consensus       535 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l  573 (615)
                      ....+..+.++++   +||..+|++||++.+++++-..+
T Consensus       236 ~~~~~~~~~~li~---~cl~~~P~~Rp~~~~ll~~~~~~  271 (308)
T cd06634         236 SGHWSEYFRNFVD---SCLQKIPQDRPTSEVLLKHRFVL  271 (308)
T ss_pred             cccccHHHHHHHH---HHhhCCcccCCCHHHHhhCcccc
Confidence            1123444555555   99999999999999999875433

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-35  Score=275.65  Aligned_cols=250  Identities=22%  Similarity=0.351  Sum_probs=187.1

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEeccccC--CHHHHHHHHHH-HhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNV--GKREFEQQMEI-VGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      ..||.|+||+|+|-.. +.|+.+|||+++....  +.+.+..|.+. ++.-+.||||+++|.+...+..||.||+|. .|
T Consensus        70 g~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~S  148 (361)
T KOG1006|consen   70 GEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-IS  148 (361)
T ss_pred             HHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hh
Confidence            4599999999999875 4688999999987644  34567777775 444579999999999999999999999994 46


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC--CCC
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM--PPP  459 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~--~~~  459 (615)
                      +..+-..--......+++.-.-+|...+..||.||-+..  +|||||+||+|||+|..|.+|+||||++..+...  .+.
T Consensus       149 lDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~  226 (361)
T KOG1006|consen  149 LDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTV  226 (361)
T ss_pred             HHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhh
Confidence            665433211123456888888899999999999998876  5999999999999999999999999999887543  233


Q ss_pred             CCCCCcccCccccCC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCC
Q 007167          460 AMRAAGYRAPEVTDT--RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN  537 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  537 (615)
                      ..|...|||||.+..  ..|+-++||||+|++|+|+.||+.||...+.  ..+++   ..........-..+.+-   -.
T Consensus       227 daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql---~~Vv~gdpp~l~~~~~~---~~  298 (361)
T KOG1006|consen  227 DAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQL---CQVVIGDPPILLFDKEC---VH  298 (361)
T ss_pred             ccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHH---HHHHcCCCCeecCcccc---cc
Confidence            456778999999843  3489999999999999999999999976543  22222   22222222111111110   11


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          538 IEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       538 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+.   .+..++..|+.+|-..||...++.++
T Consensus       299 ~s~---~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  299 YSF---SMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             cCH---HHHHHHHHHhhcccccCcchhhhhcC
Confidence            233   44445559999999999999998775

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-33  Score=286.33  Aligned_cols=252  Identities=20%  Similarity=0.347  Sum_probs=191.0

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      +.||+|++|.||++... ++..+++|+++....   ....+.+|++++++++|+||+++++++..++..++|+||+++ +
T Consensus         5 ~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~   83 (283)
T cd05118           5 GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-D   83 (283)
T ss_pred             eeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-C
Confidence            46999999999999864 688899999875432   245788899999999999999999999999999999999975 8


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---C
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---P  458 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~  458 (615)
                      |.+++...    ...+++..+..++.|++.||+|||+.+   |+|+||||+||+++.++.++|+|||.+.......   .
T Consensus        84 l~~~l~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~  156 (283)
T cd05118          84 LYKLIKDR----QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT  156 (283)
T ss_pred             HHHHHHhh----cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccccc
Confidence            88887642    236899999999999999999999998   9999999999999999999999999998775432   1


Q ss_pred             CCCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhh-HHHHHHHhhhccccccccc-------
Q 007167          459 PAMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVH-LVRWVNSVVREEWTAEVFD-------  529 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~d-------  529 (615)
                      ...++..|+|||.+.+. .++.++||||+|+++|+|++|+.||...+..+... ....+.......+ ....+       
T Consensus       157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  235 (283)
T cd05118         157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVW-PKFTSLARNYKF  235 (283)
T ss_pred             CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhc-ccchhhhhhhhh
Confidence            23456679999998776 68999999999999999999999997654322111 1111110000000 00000       


Q ss_pred             ----ccccC----CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          530 ----VELLR----YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       530 ----~~~~~----~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                          .....    .+..+   .++.+++.+|++.||.+||++.|++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~---~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         236 SFPKKAGMPLPKLFPNAS---PQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhccccccCHHHhhhhhC---HHHHHHHHHHhccCcccCcCHHHHhhC
Confidence                00000    11122   344555559999999999999999864

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-33  Score=277.63  Aligned_cols=240  Identities=25%  Similarity=0.446  Sum_probs=194.1

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .+.||+|++|.||++... ++..|++|.+.....   ....+.+|++++++++|+|++++++++.+.+..++||||++++
T Consensus         5 ~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~   84 (254)
T cd06627           5 GDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENG   84 (254)
T ss_pred             eeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCC
Confidence            457999999999999865 678899999976543   3456889999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC--
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP--  458 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~--  458 (615)
                      +|.+++...     ..+++..+..++.|++.|+.|||+.+   |+||||||+||+++.++.++|+|||.+........  
T Consensus        85 ~L~~~~~~~-----~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  156 (254)
T cd06627          85 SLRQIIKKF-----GPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD  156 (254)
T ss_pred             cHHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcccc
Confidence            999998643     36899999999999999999999998   99999999999999999999999999987754332  


Q ss_pred             -CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCC
Q 007167          459 -PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN  537 (615)
Q Consensus       459 -~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  537 (615)
                       ...++..|+|||...+..++.++||||+|+++++|++|+.||........  ...    .....        .....+.
T Consensus       157 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~--~~~----~~~~~--------~~~~~~~  222 (254)
T cd06627         157 ASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAA--LFR----IVQDD--------HPPLPEG  222 (254)
T ss_pred             cccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHH--HHH----HhccC--------CCCCCCC
Confidence             23467789999999887789999999999999999999999975432111  111    00000        0001123


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          538 IEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       538 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ..+.+.+++.   +|+..+|++||++.|++.+
T Consensus       223 ~~~~~~~~i~---~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         223 ISPELKDFLM---QCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             CCHHHHHHHH---HHHhCChhhCcCHHHHhcC
Confidence            3455555555   9999999999999999853

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=9e-34  Score=276.60  Aligned_cols=251  Identities=25%  Similarity=0.361  Sum_probs=203.4

Q ss_pred             hhhcCcCCccEEEEEEECC------CCEEEEEEecccc--CCHHHHHHHHHHHhCCCCCcccceeEEEEec-CeeeEEee
Q 007167          305 AEVLGKGTFGTAYKAALED------ASTVVVKRLKEVN--VGKREFEQQMEIVGGIRHENVVALRAYYYSK-DEKLMVYD  375 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lV~e  375 (615)
                      ..++-+|.||.||+|.+++      .+.|.||.++...  ..-..+.+|.-.+..+.|||+..+.+.+.++ +..+.+|.
T Consensus       289 ~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~  368 (563)
T KOG1024|consen  289 SCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYP  368 (563)
T ss_pred             hhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEe
Confidence            3468899999999997653      3456778777542  2234567788888899999999999998765 56788899


Q ss_pred             cCCCCChhhhhccCCC---CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccc
Q 007167          376 YFEPGSVSAMLHGRRG---EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAAL  452 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~---~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~  452 (615)
                      ++.-|+|..+|.-.++   .....++-.+...++.|++.|++|||+++   |||.||.++|++||+..++||+|-.+++.
T Consensus       369 ~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltDsaLSRD  445 (563)
T KOG1024|consen  369 ATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTDSALSRD  445 (563)
T ss_pred             ccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEeccchhccc
Confidence            9999999999984432   23456778888899999999999999998   99999999999999999999999999999


Q ss_pred             cCCCCCCC-----CCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccc
Q 007167          453 MSPMPPPA-----MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAE  526 (615)
Q Consensus       453 ~~~~~~~~-----~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (615)
                      +.+.++..     .+...||+||.+....|+.++|||||||++|||+| |+.||...+..|+...++...          
T Consensus       446 LFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGy----------  515 (563)
T KOG1024|consen  446 LFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGY----------  515 (563)
T ss_pred             cCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccc----------
Confidence            88766543     34667999999999999999999999999999999 999999887777665543111          


Q ss_pred             cccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          527 VFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       527 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                          ++...-+++++   ++.++.-||+.+|++||+++|++.-|.+...
T Consensus       516 ----RlaQP~NCPDe---Lf~vMacCWallpeeRPsf~Qlv~cLseF~~  557 (563)
T KOG1024|consen  516 ----RLAQPFNCPDE---LFTVMACCWALLPEERPSFSQLVICLSEFHT  557 (563)
T ss_pred             ----eecCCCCCcHH---HHHHHHHHHhcCcccCCCHHHHHHHHHHHHH
Confidence                12222345544   5666669999999999999999999988754

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=9.9e-33  Score=284.20  Aligned_cols=240  Identities=25%  Similarity=0.436  Sum_probs=187.6

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC-C---HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV-G---KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||+||+|... ++..|++|++..... .   ...+.+|+++++.++|+|++++++++.+.+..++||||+. 
T Consensus        26 ~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-  104 (313)
T cd06633          26 LHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-  104 (313)
T ss_pred             ceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-
Confidence            456999999999999864 678899999864322 1   2457789999999999999999999999999999999995 


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCC
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP  459 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~  459 (615)
                      |++.+++...    ...+++..+..++.|++.|+.|||+.+   |+||||+|+||+++.++.+||+|||++...... ..
T Consensus       105 ~~l~~~l~~~----~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~~-~~  176 (313)
T cd06633         105 GSASDLLEVH----KKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPA-NS  176 (313)
T ss_pred             CCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCCC-CC
Confidence            5777777532    236899999999999999999999998   999999999999999999999999998654332 23


Q ss_pred             CCCCCcccCccccC---CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          460 AMRAAGYRAPEVTD---TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       460 ~~~~~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                      ..++..|+|||++.   ...++.++|||||||++|||++|+.||..........      .......      +. ...+
T Consensus       177 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~------~~~~~~~------~~-~~~~  243 (313)
T cd06633         177 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQNDS------PT-LQSN  243 (313)
T ss_pred             ccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHHhcCC------CC-CCcc
Confidence            45678899999974   3567889999999999999999999997643322111      1111110      00 0112


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .++..+.++++   +|++.+|.+||++.+++++
T Consensus       244 ~~~~~l~~li~---~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         244 EWTDSFRGFVD---YCLQKIPQERPASAELLRH  273 (313)
T ss_pred             ccCHHHHHHHH---HHccCChhhCcCHHHHhcC
Confidence            23344555555   9999999999999999976

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-33  Score=282.21  Aligned_cols=255  Identities=22%  Similarity=0.337  Sum_probs=187.8

Q ss_pred             hhcCcCCccEEEEEEECC-CCEEEEEEeccccCC---HHHHHHHHHHHhCC---CCCcccceeEEEEecCe-----eeEE
Q 007167          306 EVLGKGTFGTAYKAALED-ASTVVVKRLKEVNVG---KREFEQQMEIVGGI---RHENVVALRAYYYSKDE-----KLMV  373 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~---~~~~~~e~~~l~~l---~h~niv~l~~~~~~~~~-----~~lV  373 (615)
                      +.||+|+||.||+|..+. +..||+|+++.....   ...+.+|++++.++   +|+|++++++++...+.     .+++
T Consensus         5 ~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~   84 (287)
T cd07838           5 AEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLV   84 (287)
T ss_pred             EEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEE
Confidence            469999999999999764 889999999743221   34566777766655   69999999999988776     8999


Q ss_pred             eecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeeccccccc
Q 007167          374 YDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALM  453 (615)
Q Consensus       374 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~  453 (615)
                      |||+. ++|.+++....   ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.+||+|||++..+
T Consensus        85 ~e~~~-~~l~~~l~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~~~  157 (287)
T cd07838          85 FEHVD-QDLATYLSKCP---KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIY  157 (287)
T ss_pred             ehhcc-cCHHHHHHHcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcceec
Confidence            99996 58988886432   235899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCC--CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHh---hhccccccc-
Q 007167          454 SPMP--PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSV---VREEWTAEV-  527 (615)
Q Consensus       454 ~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~-  527 (615)
                      ....  ....++..|+|||.+.+..++.++|||||||++|||++|+.||......+...  ++....   ....+.... 
T Consensus       158 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07838         158 SFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLD--KIFDVIGLPSEEEWPRNVS  235 (287)
T ss_pred             cCCcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHH--HHHHHcCCCChHhcCCCcc
Confidence            4332  22335778999999988889999999999999999999999997654332211  111111   001111110 


Q ss_pred             -----ccccccCC-CC-cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          528 -----FDVELLRY-PN-IEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       528 -----~d~~~~~~-~~-~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                           +....... .. .......+.+++.+|++.||++||++.|++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         236 LPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             cchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence                 00000000 00 01112334455569999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-33  Score=292.76  Aligned_cols=259  Identities=22%  Similarity=0.377  Sum_probs=195.5

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc---CCHHHHHHHHHHHhCCCCCcccceeEEEEecC-----eeeEEee
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN---VGKREFEQQMEIVGGIRHENVVALRAYYYSKD-----EKLMVYD  375 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-----~~~lV~e  375 (615)
                      .+.||+|+||.||+|... .+..|++|++....   ...+.+.+|+++++.++|+||+++++++...+     ..++|||
T Consensus         5 ~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e   84 (330)
T cd07834           5 LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTE   84 (330)
T ss_pred             eeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEec
Confidence            356999999999999965 48899999987542   23467889999999999999999999998775     7899999


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      |++ ++|.+++...     ..+++..+..++.+++.||+|||+.+   |+||||||.||+++.++.++|+|||++.....
T Consensus        85 ~~~-~~l~~~l~~~-----~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          85 LME-TDLHKVIKSP-----QPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             chh-hhHHHHHhCC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            997 5888888642     27999999999999999999999998   99999999999999999999999999987754


Q ss_pred             CC------CCCCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHH-HHHHHhhhcccc---
Q 007167          456 MP------PPAMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLV-RWVNSVVREEWT---  524 (615)
Q Consensus       456 ~~------~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~---  524 (615)
                      ..      ....++..|+|||.+.+. .++.++||||||+++|+|++|+.||...+..+....+ ........+.+.   
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  235 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT  235 (330)
T ss_pred             cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence            32      123456779999999877 7899999999999999999999999876543222111 111000000000   


Q ss_pred             ----ccccc---c----cc-cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhHh
Q 007167          525 ----AEVFD---V----EL-LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM--VEDIRR  575 (615)
Q Consensus       525 ----~~~~d---~----~~-~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~l~~  575 (615)
                          .+.+.   .    .. ...+..+.++.+++   .+||+.+|++||++++++++  ++.+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li---~~~l~~~P~~Rpt~~~ll~~~~~~~~~~  297 (330)
T cd07834         236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLL---EKMLVFDPKKRITADEALAHPYLAQLHD  297 (330)
T ss_pred             ccchhhHHhhcccCCcchhHHhcccCCHHHHHHH---HHHccCChhhCCCHHHHHhCccHHhhcc
Confidence                00000   0    00 00122334444444   49999999999999999986  666554

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.5e-33  Score=293.63  Aligned_cols=189  Identities=21%  Similarity=0.354  Sum_probs=160.6

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEec------CeeeEEe
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSK------DEKLMVY  374 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lV~  374 (615)
                      .+.||+|+||.||+|... +++.||+|++.....   ..+.+.+|+++++.++|+||+++++++...      ...++||
T Consensus        21 ~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~  100 (353)
T cd07850          21 LKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVM  100 (353)
T ss_pred             EEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEE
Confidence            356999999999999854 688999999864322   234577899999999999999999998643      3579999


Q ss_pred             ecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccC
Q 007167          375 DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS  454 (615)
Q Consensus       375 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~  454 (615)
                      ||+. ++|.+.+..       .+++.....++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus       101 e~~~-~~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  169 (353)
T cd07850         101 ELMD-ANLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG  169 (353)
T ss_pred             eccC-CCHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence            9995 588887752       2788899999999999999999998   9999999999999999999999999998765


Q ss_pred             CCC--CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 007167          455 PMP--PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATG  504 (615)
Q Consensus       455 ~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~  504 (615)
                      ...  ....++..|+|||.+.+..++.++|||||||++|+|++|+.||...+
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~  221 (353)
T cd07850         170 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD  221 (353)
T ss_pred             CCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence            432  22346778999999998889999999999999999999999997644

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-33  Score=276.53  Aligned_cols=232  Identities=24%  Similarity=0.359  Sum_probs=188.1

Q ss_pred             cCcCCccEEEEEEEC-CCCEEEEEEeccccC----CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          308 LGKGTFGTAYKAALE-DASTVVVKRLKEVNV----GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       308 lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      ||+|+||.||++... +++.+++|.+.....    ....+..|+++++.++|+||+++++.+..+...++||||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            699999999999965 588999999875432    234788999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC---CCC
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM---PPP  459 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~---~~~  459 (615)
                      .+++...     ..+++.....++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||.+......   ...
T Consensus        81 ~~~l~~~-----~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~  152 (250)
T cd05123          81 FSHLSKE-----GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT  152 (250)
T ss_pred             HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccC
Confidence            9999643     25899999999999999999999987   999999999999999999999999999876543   233


Q ss_pred             CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      ..++..|+|||...+...+.++|+||||+++||+++|+.||...+..+.   ..   .....         ........+
T Consensus       153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~---~~---~~~~~---------~~~~~~~~~  217 (250)
T cd05123         153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEI---YE---KILKD---------PLRFPEFLS  217 (250)
T ss_pred             CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH---HH---HHhcC---------CCCCCCCCC
Confidence            4567789999999888889999999999999999999999976443221   11   11110         111112224


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHH
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKMAD  565 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~~e  565 (615)
                      +.+.++++   +|+..||++||++.+
T Consensus       218 ~~l~~~i~---~~l~~~p~~R~~~~~  240 (250)
T cd05123         218 PEARDLIS---GLLQKDPTKRLGSGG  240 (250)
T ss_pred             HHHHHHHH---HHhcCCHhhCCCccc
Confidence            55555555   999999999999943

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-34  Score=298.04  Aligned_cols=196  Identities=28%  Similarity=0.430  Sum_probs=168.8

Q ss_pred             hhcCcCCccEEEEEE-ECCCCEEEEEEeccc--cCCHHHHHHHHHHHhCCCCCcccceeEEEEecC------eeeEEeec
Q 007167          306 EVLGKGTFGTAYKAA-LEDASTVVVKRLKEV--NVGKREFEQQMEIVGGIRHENVVALRAYYYSKD------EKLMVYDY  376 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lV~e~  376 (615)
                      +.||+|+||.||+|+ .+.|+.||||.++..  ....+...+|++++++++|+|||++++.-....      ...+||||
T Consensus        19 e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEy   98 (732)
T KOG4250|consen   19 ERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEY   98 (732)
T ss_pred             hhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEee
Confidence            569999999999999 567999999999764  233566789999999999999999998865543      56899999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEe--CCCC--cEEEeecccccc
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFL--NSQG--HVCVSDIGLAAL  452 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill--~~~~--~~kl~DfG~a~~  452 (615)
                      |.+|||...|..-  +....|++...+.++.+++.||.|||+++   |+||||||.||++  .++|  .-||+|||.|+.
T Consensus        99 C~gGsL~~~L~~P--EN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are  173 (732)
T KOG4250|consen   99 CSGGSLRKVLNSP--ENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE  173 (732)
T ss_pred             cCCCcHHHHhcCc--ccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence            9999999999743  34567999999999999999999999998   9999999999998  3444  469999999999


Q ss_pred             cCCCC--CCCCCCCcccCccccC-CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 007167          453 MSPMP--PPAMRAAGYRAPEVTD-TRKATQASDVFSFGVLLLELLTGKSPIHATGGD  506 (615)
Q Consensus       453 ~~~~~--~~~~~~~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~  506 (615)
                      +.+..  ...+||..|.+||++. .+.|+..+|.|||||++||++||..||....+.
T Consensus       174 l~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  174 LDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             CCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            87654  4567899999999998 478999999999999999999999999875543

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=7.5e-33  Score=281.87  Aligned_cols=243  Identities=21%  Similarity=0.345  Sum_probs=187.5

Q ss_pred             hhhcCcCCccEEEEEEE----CCCCEEEEEEecccc-----CCHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEe
Q 007167          305 AEVLGKGTFGTAYKAAL----EDASTVVVKRLKEVN-----VGKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVY  374 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~-----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  374 (615)
                      .+.||+|+||.||++..    .+|..||+|+++...     ...+.+.+|++++.++ +|+||+++++++..+...++||
T Consensus         5 ~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (290)
T cd05613           5 LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLIL   84 (290)
T ss_pred             eeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEE
Confidence            35699999999999985    368899999987532     1235678899999999 5999999999999989999999


Q ss_pred             ecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccC
Q 007167          375 DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS  454 (615)
Q Consensus       375 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~  454 (615)
                      ||+++++|.+++...     ..+++.....++.|++.||.|||+.+   ++||||+|+||+++.++++||+|||++....
T Consensus        85 e~~~~~~L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          85 DYINGGELFTHLSQR-----ERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             ecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            999999999998643     35888899999999999999999998   9999999999999999999999999997764


Q ss_pred             CCC----CCCCCCCcccCccccCCC--CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccc
Q 007167          455 PMP----PPAMRAAGYRAPEVTDTR--KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVF  528 (615)
Q Consensus       455 ~~~----~~~~~~~~y~aPE~~~~~--~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  528 (615)
                      ...    ....++..|+|||.+...  .++.++||||||+++|+|++|+.||.........  ..+.......       
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~--~~~~~~~~~~-------  227 (290)
T cd05613         157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ--AEISRRILKS-------  227 (290)
T ss_pred             cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH--HHHHHHhhcc-------
Confidence            322    123467789999998653  4678999999999999999999999753322111  1111111110       


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007167          529 DVELLRYPNIEEEMVEMLQVGMACVVRMPEERP-----KMADVLKM  569 (615)
Q Consensus       529 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  569 (615)
                        .......+...+.++++   +|+..+|++||     ++++++++
T Consensus       228 --~~~~~~~~~~~~~~ll~---~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         228 --EPPYPQEMSALAKDIIQ---RLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             --CCCCCccCCHHHHHHHH---HHhcCCHHHhcCCCCCCHHHHHcC
Confidence              00011223445555555   99999999997     67777664

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.6e-33  Score=286.15  Aligned_cols=245  Identities=20%  Similarity=0.390  Sum_probs=185.1

Q ss_pred             HhhhcCcCCccEEEEEEECC-CCEEEEEEeccccC--CHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCCC
Q 007167          304 SAEVLGKGTFGTAYKAALED-ASTVVVKRLKEVNV--GKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       304 ~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      ..+.||+|+||.||+|..++ +..||||+++....  ....+.+|++++.+. .|+||+++++++.+....++||||+. 
T Consensus        19 ~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-   97 (296)
T cd06618          19 NLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-   97 (296)
T ss_pred             eeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-
Confidence            35679999999999999765 88999999975432  234566677766666 49999999999999999999999985 


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc-CCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC-
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE-NGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP-  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~-  457 (615)
                      +++.+++...    ...+++..+..++.|++.|++|||+. +   |+||||+|+||++++++.+||+|||++..+.... 
T Consensus        98 ~~l~~l~~~~----~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~  170 (296)
T cd06618          98 TCLDKLLKRI----QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKA  170 (296)
T ss_pred             cCHHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCCCc
Confidence            4777776532    23789999999999999999999974 5   9999999999999999999999999997664322 


Q ss_pred             -CCCCCCCcccCccccCCCC----CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccc
Q 007167          458 -PPAMRAAGYRAPEVTDTRK----ATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL  532 (615)
Q Consensus       458 -~~~~~~~~y~aPE~~~~~~----~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  532 (615)
                       ....++..|+|||.+.+..    ++.++||||||+++|||++|+.||......  .+.   +.......      .+..
T Consensus       171 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~--~~~---~~~~~~~~------~~~~  239 (296)
T cd06618         171 KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEV---LTKILQEE------PPSL  239 (296)
T ss_pred             ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH--HHH---HHHHhcCC------CCCC
Confidence             2223567899999987554    788999999999999999999999653221  111   11111110      0011


Q ss_pred             cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       533 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                      .....+.+++.+++   .+|+..+|++||++.+++++-
T Consensus       240 ~~~~~~~~~l~~li---~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         240 PPNEGFSPDFCSFV---DLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             CCCCCCCHHHHHHH---HHHccCChhhCCCHHHHhcCh
Confidence            11112344444544   499999999999999998873

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=4.7e-33  Score=283.04  Aligned_cols=246  Identities=22%  Similarity=0.329  Sum_probs=190.5

Q ss_pred             hhhcCcCCccEEEEEEE----CCCCEEEEEEecccc-----CCHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEe
Q 007167          305 AEVLGKGTFGTAYKAAL----EDASTVVVKRLKEVN-----VGKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVY  374 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~-----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  374 (615)
                      .+.||+|+||.||++..    .++..||||.++...     ...+.+.+|++++.++ +|+||+++++.+..+...++||
T Consensus         5 ~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   84 (288)
T cd05583           5 LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLIL   84 (288)
T ss_pred             EEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEE
Confidence            35699999999999874    356789999987532     1235678899999999 5999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccC
Q 007167          375 DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS  454 (615)
Q Consensus       375 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~  454 (615)
                      ||+++|+|.+++...     ..+++.....++.|+++||+|||+.+   ++||||||+||+++.++.++|+|||+++...
T Consensus        85 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          85 DYVNGGELFTHLYQR-----EHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             ecCCCCcHHHHHhhc-----CCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            999999999998632     35889999999999999999999987   9999999999999999999999999987654


Q ss_pred             CCCC----CCCCCCcccCccccCCCC--CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccc
Q 007167          455 PMPP----PAMRAAGYRAPEVTDTRK--ATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVF  528 (615)
Q Consensus       455 ~~~~----~~~~~~~y~aPE~~~~~~--~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  528 (615)
                      ....    ...++..|+|||...+..  .+.++||||||+++|||++|+.||........  ...........       
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~~~~~~~-------  227 (288)
T cd05583         157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEISRRILKS-------  227 (288)
T ss_pred             cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHHHHHHcc-------
Confidence            3321    224677899999987655  68899999999999999999999964332111  11111111111       


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 007167          529 DVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVED  572 (615)
Q Consensus       529 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  572 (615)
                        .......++..+.+++.   +|++.+|++|||+.++.+.|+.
T Consensus       228 --~~~~~~~~~~~l~~li~---~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         228 --KPPFPKTMSAEARDFIQ---KLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             --CCCCCcccCHHHHHHHH---HHhcCCHhhccCcchHHHHhcC
Confidence              11111223445555555   9999999999999888776655

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=6.5e-33  Score=276.40  Aligned_cols=243  Identities=22%  Similarity=0.419  Sum_probs=195.2

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      +.||+|+||.||++... ++..|++|++.....   ..+.+.+|+++++.++|+|++++++.+...+..++|+||+++++
T Consensus         6 ~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~   85 (258)
T cd08215           6 KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGD   85 (258)
T ss_pred             eeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCc
Confidence            56999999999999965 678999999876432   34668899999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---C
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---P  458 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~  458 (615)
                      |.+++..... ....+++.....++.+++.||.|||+.+   ++|+||+|+||++++++.++|+|||.+.......   .
T Consensus        86 L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  161 (258)
T cd08215          86 LSQKIKKQKK-EGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAK  161 (258)
T ss_pred             HHHHHHHhhc-cCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCcceec
Confidence            9999975431 2357999999999999999999999997   9999999999999999999999999998765432   2


Q ss_pred             CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCc
Q 007167          459 PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI  538 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  538 (615)
                      ...++..|+|||......++.++||||+|+++++|++|+.||......+..      .......     .. .+  ....
T Consensus       162 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~------~~~~~~~-----~~-~~--~~~~  227 (258)
T cd08215         162 TVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELA------LKILKGQ-----YP-PI--PSQY  227 (258)
T ss_pred             ceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHH------HHHhcCC-----CC-CC--CCCC
Confidence            234567799999998888999999999999999999999999764422211      1111110     00 01  1123


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          539 EEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       539 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      +.++.++++   +|+..+|++||++.|++++
T Consensus       228 ~~~~~~~i~---~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         228 SSELRNLVS---SLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             CHHHHHHHH---HHcCCChhhCcCHHHHhcC
Confidence            344444444   9999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.9e-33  Score=290.79  Aligned_cols=238  Identities=20%  Similarity=0.331  Sum_probs=198.5

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      ..||+|.|+.|..|+. ..+..||+|.+.+..-.   ...+.+|+++|..++|||||+++.+.......++||||+.+|.
T Consensus        62 ~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge  141 (596)
T KOG0586|consen   62 KTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGE  141 (596)
T ss_pred             eeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCch
Confidence            4699999999999985 46889999999876332   2447899999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC--CCCC
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP--MPPP  459 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~--~~~~  459 (615)
                      +++++...     ..........++.|+..|++|||+++   |+|||||++|||++.++++||+|||++..+..  ...+
T Consensus       142 ~~~yl~~~-----gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt  213 (596)
T KOG0586|consen  142 LFDYLVKH-----GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQT  213 (596)
T ss_pred             hHHHHHhc-----ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecccccccc
Confidence            99999753     24555788889999999999999998   99999999999999999999999999988764  3456


Q ss_pred             CCCCCcccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCc
Q 007167          460 AMRAAGYRAPEVTDTRKA-TQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI  538 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  538 (615)
                      .++++.|.|||++.+.+| ++.+|+||+|+++|-|+.|..||++..-.+..+.+               +...+.-...+
T Consensus       214 ~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rv---------------l~gk~rIp~~m  278 (596)
T KOG0586|consen  214 FCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRV---------------LRGKYRIPFYM  278 (596)
T ss_pred             cCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchh---------------eeeeeccccee
Confidence            788999999999999887 68999999999999999999999875533322211               11111112245


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          539 EEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       539 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      +.+.+++++   +++..+|.+|++++++.++
T Consensus       279 s~dce~lLr---k~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  279 SCDCEDLLR---KFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             echhHHHHH---HhhccCccccCCHHHhhhh
Confidence            667777777   8999999999999999875

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.6e-33  Score=292.25  Aligned_cols=251  Identities=21%  Similarity=0.307  Sum_probs=186.7

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEecC------eeeEEee
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSKD------EKLMVYD  375 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lV~e  375 (615)
                      +.||+|+||.||++.. .++..||||++.....   ..+.+.+|+++++.++|+||+++++++....      ..++|||
T Consensus        21 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e  100 (343)
T cd07880          21 KQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMP  100 (343)
T ss_pred             EEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEe
Confidence            4699999999999984 4788999999864322   2346778999999999999999999987543      4589999


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      |+ +++|.+++..      ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus       101 ~~-~~~l~~~~~~------~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~  170 (343)
T cd07880         101 FM-GTDLGKLMKH------EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQTDS  170 (343)
T ss_pred             cC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence            99 7789888753      25899999999999999999999998   99999999999999999999999999987765


Q ss_pred             CCCCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchh-hHHHH--------HHHhhhccc--
Q 007167          456 MPPPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVV-HLVRW--------VNSVVREEW--  523 (615)
Q Consensus       456 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~-~~~~~--------~~~~~~~~~--  523 (615)
                      ......++..|+|||.+.+ ..++.++||||+||++|++++|+.||......... .....        .........  
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (343)
T cd07880         171 EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKN  250 (343)
T ss_pred             CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHH
Confidence            4444566888999999865 45789999999999999999999999764422111 11110        000000000  


Q ss_pred             -cccc---cccccc-CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          524 -TAEV---FDVELL-RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       524 -~~~~---~d~~~~-~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                       ...+   ....+. ..+..+.++   .+++.+|+..||++|||+.+++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~---~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         251 YVKKLPRFRKKDFRSLLPNANPLA---VNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             HHHhccccCcchHHHhccCCChHH---HHHHHHHcCCChhhCCCHHHHhcC
Confidence             0000   000000 012223334   445559999999999999999954

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.7e-33  Score=277.38  Aligned_cols=240  Identities=20%  Similarity=0.343  Sum_probs=187.6

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEecccc------CCHHHHHHHHHHHhCCCCCcccceeEEEEec--CeeeEEee
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVN------VGKREFEQQMEIVGGIRHENVVALRAYYYSK--DEKLMVYD  375 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e  375 (615)
                      .+.||+|+||.||+|.. .++..|++|.+....      ...+.+.+|++++++++|+||+++++++.+.  ...++|+|
T Consensus         7 ~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e   86 (264)
T cd06653           7 GKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVE   86 (264)
T ss_pred             eeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEE
Confidence            45799999999999985 458899999875321      1124678899999999999999999998764  45789999


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      |+++++|.+.+...     ..+++....+++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+++....
T Consensus        87 ~~~~~~L~~~~~~~-----~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  158 (264)
T cd06653          87 YMPGGSIKDQLKAY-----GALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQT  158 (264)
T ss_pred             eCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence            99999999998642     25788999999999999999999998   99999999999999999999999999976542


Q ss_pred             CC------CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccc
Q 007167          456 MP------PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD  529 (615)
Q Consensus       456 ~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  529 (615)
                      ..      ....++..|+|||.+.+..++.++|||||||++|||++|+.||......+.  ...    .....       
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~----~~~~~-------  225 (264)
T cd06653         159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAA--IFK----IATQP-------  225 (264)
T ss_pred             ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHH--HHH----HHcCC-------
Confidence            11      123467789999999888889999999999999999999999975432211  111    11000       


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          530 VELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       530 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ......+...++..++++   +|+. +|..||++.+++++
T Consensus       226 ~~~~~p~~~~~~~~~~i~---~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         226 TKPMLPDGVSDACRDFLK---QIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             CCCCCCcccCHHHHHHHH---HHhc-CcccCccHHHHhcC
Confidence            000112344566667766   8998 57999999988764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.3e-33  Score=290.87  Aligned_cols=251  Identities=21%  Similarity=0.313  Sum_probs=186.3

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEec------CeeeEEee
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSK------DEKLMVYD  375 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lV~e  375 (615)
                      +.||+|+||.||+|.. .++..||+|+++....   ..+.+.+|++++++++|+||+++++++...      ...+++++
T Consensus        23 ~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~  102 (345)
T cd07877          23 SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTH  102 (345)
T ss_pred             EEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEeh
Confidence            4699999999999985 5688999999875422   235677899999999999999999988643      34678888


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      ++ +++|.+++..      ..+++..+..++.|+++||+|||+.+   |+||||||+||++++++.+||+|||++.....
T Consensus       103 ~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~  172 (345)
T cd07877         103 LM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD  172 (345)
T ss_pred             hc-ccCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEecccccccccc
Confidence            77 7899888753      25899999999999999999999998   99999999999999999999999999987655


Q ss_pred             CCCCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccc-----
Q 007167          456 MPPPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD-----  529 (615)
Q Consensus       456 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d-----  529 (615)
                      ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+.......+..............+.+     
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  252 (345)
T cd07877         173 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN  252 (345)
T ss_pred             cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHH
Confidence            4444567888999998765 4678899999999999999999999975443221111110000000000000000     


Q ss_pred             --ccccC---------CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          530 --VELLR---------YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       530 --~~~~~---------~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                        ..+..         ....++++.+++   .+|+..+|.+||++.|++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~li---~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         253 YIQSLTQMPKMNFANVFIGANPLAVDLL---EKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HHHHhcccCCcchhhhcCCCCHHHHHHH---HHHcCCChhhcCCHHHHhcC
Confidence              00000         011234444444   49999999999999999987

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-34  Score=270.23  Aligned_cols=246  Identities=19%  Similarity=0.309  Sum_probs=193.4

Q ss_pred             HhhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCHHHHHHHHHHHhCC-CCCcccceeEEEEe----cCeeeEEeecC
Q 007167          304 SAEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFEQQMEIVGGI-RHENVVALRAYYYS----KDEKLMVYDYF  377 (615)
Q Consensus       304 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~----~~~~~lV~e~~  377 (615)
                      +.++||-|-.|.|-.+..+ .+..+|+|++.+.    ...++|+++--.. .|||||.++++|..    ....++|||.|
T Consensus        66 s~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~m  141 (400)
T KOG0604|consen   66 SWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECM  141 (400)
T ss_pred             hhhhhccccCCceEEEEeccchhhhHHHHHhcC----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecc
Confidence            4578999999999998754 6778999998754    3456777754444 69999999999864    35678999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCC---CCcEEEeecccccccC
Q 007167          378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNS---QGHVCVSDIGLAALMS  454 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~---~~~~kl~DfG~a~~~~  454 (615)
                      +||.|++.++.+.   ...+++..+..|+.||+.|+.|||+.+   |.||||||+|+|...   |..+||+|||+|+...
T Consensus       142 eGGeLfsriq~~g---~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~  215 (400)
T KOG0604|consen  142 EGGELFSRIQDRG---DQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQ  215 (400)
T ss_pred             cchHHHHHHHHcc---cccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccccccC
Confidence            9999999998653   457999999999999999999999998   999999999999964   4579999999998765


Q ss_pred             CC--CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccc
Q 007167          455 PM--PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL  532 (615)
Q Consensus       455 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  532 (615)
                      ..  -.+.+-|+.|.|||++...+|+..+|+||+||++|-|++|.+||.+..+..+-.-   .+..++    ..-+.+.-
T Consensus       216 ~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispg---Mk~rI~----~gqy~FP~  288 (400)
T KOG0604|consen  216 EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG---MKRRIR----TGQYEFPE  288 (400)
T ss_pred             CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChh---HHhHhh----ccCccCCC
Confidence            32  2344668899999999999999999999999999999999999987655322111   111111    11122222


Q ss_pred             cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       533 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      +.|...++..+++++   ..++.+|.+|.|++|++++
T Consensus       289 pEWs~VSe~aKdlIR---~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  289 PEWSCVSEAAKDLIR---KLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             hhHhHHHHHHHHHHH---HHhcCCchhheeHHHhhcC
Confidence            334556677777777   7889999999999999886

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3.1e-33  Score=282.68  Aligned_cols=239  Identities=20%  Similarity=0.381  Sum_probs=191.6

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc----CCHHHHHHHHHHHhCCC-CCcccceeEEEEecCeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN----VGKREFEQQMEIVGGIR-HENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      .+.||+|+||.||++... ++..|++|.+....    ...+.+.+|.+++.+++ |+||+++++++..++..++||||++
T Consensus         6 ~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~   85 (280)
T cd05581           6 GKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAP   85 (280)
T ss_pred             eeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCC
Confidence            356999999999999965 78899999986532    22456788999999998 9999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP  458 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~  458 (615)
                      +++|.+++...     ..+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.++++|||++........
T Consensus        86 ~~~L~~~l~~~-----~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~  157 (280)
T cd05581          86 NGELLQYIRKY-----GSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS  157 (280)
T ss_pred             CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence            99999999743     26999999999999999999999998   99999999999999999999999999887653221


Q ss_pred             -----------------------CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 007167          459 -----------------------PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWV  515 (615)
Q Consensus       459 -----------------------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  515 (615)
                                             ...++..|+|||......++.++||||||++++++++|+.||..........     
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~-----  232 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQ-----  232 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHH-----
Confidence                                   1224677999999988888999999999999999999999998654221111     


Q ss_pred             HHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCH----HHHHHH
Q 007167          516 NSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKM----ADVLKM  569 (615)
Q Consensus       516 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~----~evl~~  569 (615)
                       .....         .......+++.+.++++   +|+..+|.+||++    +|++++
T Consensus       233 -~~~~~---------~~~~~~~~~~~~~~li~---~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         233 -KILKL---------EYSFPPNFPPDAKDLIE---KLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             -HHHhc---------CCCCCCccCHHHHHHHH---HHhcCCHhhCCCcccCHHHHhcC
Confidence             11110         11111233445555555   9999999999999    777654

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-34  Score=279.51  Aligned_cols=279  Identities=21%  Similarity=0.275  Sum_probs=213.9

Q ss_pred             CCCCCceEEecccccccCHHHHHHHHhhhcCcCCccEEEEEEECC-CCEEEEEEeccccCCHHHHHHHHHHHhCCCC--C
Q 007167          279 HDKNSKLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALED-ASTVVVKRLKEVNVGKREFEQQMEIVGGIRH--E  355 (615)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h--~  355 (615)
                      .+..+.+++..+...     .-.+.....+|+|.||.|-++.++. +..||||+++....-.+...-|++++.++.+  |
T Consensus        73 dD~dGH~v~~~gD~l-----~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP  147 (415)
T KOG0671|consen   73 DDKDGHYVYQVGDIL-----TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDP  147 (415)
T ss_pred             CCCCceEEEEecccc-----ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCC
Confidence            344455666544321     1122334579999999999987543 5789999998876556677889999999842  2


Q ss_pred             ----cccceeEEEEecCeeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCC
Q 007167          356 ----NVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKA  431 (615)
Q Consensus       356 ----niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~  431 (615)
                          -+|.+.+||..+++.++|+|.+ |-|+.++|..+   +..+++..+.+.|+.|+++++++||+..   ++|-||||
T Consensus       148 ~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N---~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKP  220 (415)
T KOG0671|consen  148 NGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKEN---NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKP  220 (415)
T ss_pred             CCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccC---CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCCh
Confidence                3688899999999999999998 66999999754   3457889999999999999999999998   99999999


Q ss_pred             CCEEeCC--------------------CCcEEEeecccccccCCCCCCCCCCCcccCccccCCCCCCCccchhhHHHHHH
Q 007167          432 SNIFLNS--------------------QGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLL  491 (615)
Q Consensus       432 ~Nill~~--------------------~~~~kl~DfG~a~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~  491 (615)
                      +|||+-+                    +..+||+|||.|+.-.......+.|.-|+|||++.+..++.++||||+||+|.
T Consensus       221 ENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~  300 (415)
T KOG0671|consen  221 ENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILV  300 (415)
T ss_pred             heEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCcceeeeccccCCchheeccCcCCccCceeeeeEEE
Confidence            9999831                    23589999999998877777778899999999999999999999999999999


Q ss_pred             HHHhCCCCCCCCCCcchhhHHHHHHHhhhcc-----------------cccccccc--------ccc---CCCCcHHHHH
Q 007167          492 ELLTGKSPIHATGGDEVVHLVRWVNSVVREE-----------------WTAEVFDV--------ELL---RYPNIEEEMV  543 (615)
Q Consensus       492 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~d~--------~~~---~~~~~~~~~~  543 (615)
                      |+.+|...|...++.|....++.+.+.....                 |.....+.        -.+   .......+..
T Consensus       301 ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~  380 (415)
T KOG0671|consen  301 ELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHV  380 (415)
T ss_pred             EeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHh
Confidence            9999999999988766555554432222111                 11000000        000   0012235667


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          544 EMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       544 ~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+++++.+++..||.+|+|+.|++.+
T Consensus       381 ~LfDLl~~mL~fDP~~RiTl~EAL~H  406 (415)
T KOG0671|consen  381 QLFDLLRRMLEFDPARRITLREALSH  406 (415)
T ss_pred             HHHHHHHHHHccCccccccHHHHhcC
Confidence            88899989999999999999999875

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-33  Score=292.25  Aligned_cols=250  Identities=21%  Similarity=0.310  Sum_probs=187.4

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEecCe------eeEEee
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSKDE------KLMVYD  375 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~lV~e  375 (615)
                      ..||+|+||.||+|... ++..||+|++.....   ..+.+.+|+++++.++|+|++++++++...+.      .++|+|
T Consensus        21 ~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e  100 (343)
T cd07851          21 SPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTH  100 (343)
T ss_pred             EEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEe
Confidence            46999999999999965 578899999865321   23456789999999999999999988866554      899999


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      |+ +++|.+++..      ..+++..+..++.|++.||+|||+.+   |+||||||+||++++++.++|+|||++.....
T Consensus       101 ~~-~~~L~~~~~~------~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (343)
T cd07851         101 LM-GADLNNIVKC------QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARHTDD  170 (343)
T ss_pred             cC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccccccccc
Confidence            98 6799998863      35899999999999999999999998   99999999999999999999999999987765


Q ss_pred             CCCCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhH-HHHHHHhhhccccccc------
Q 007167          456 MPPPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHL-VRWVNSVVREEWTAEV------  527 (615)
Q Consensus       456 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~------  527 (615)
                      ......++..|+|||.+.. ..++.++|||||||++|||++|+.||......+.... ..... ...+.+...+      
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~  249 (343)
T cd07851         171 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVG-TPDEELLQKISSESAR  249 (343)
T ss_pred             cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcC-CCCHHHHhhccchhHH
Confidence            4444556778999998755 3578999999999999999999999976443221111 11000 0000000000      


Q ss_pred             --cc-------cccc-CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          528 --FD-------VELL-RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       528 --~d-------~~~~-~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                        +.       .... ..+..+++   +.+++.+|+..+|++|||+.||+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~s~~---l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         250 NYIQSLPQMPKKDFKEVFSGANPL---AIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             HHHHhccccCCCCHHHHhccCCHH---HHHHHHHhCCCChhhCCCHHHHhcC
Confidence              00       0000 01122334   4455559999999999999999876

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-32  Score=279.26  Aligned_cols=253  Identities=23%  Similarity=0.380  Sum_probs=191.5

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEecccc---CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVN---VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      +.||+|+||.||+|... +++.|++|.+....   ...+.+..|+++++.++|+|++++++++.+.+..++||||++ ++
T Consensus         5 ~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~   83 (282)
T cd07829           5 EKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MD   83 (282)
T ss_pred             hcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cC
Confidence            46999999999999965 58899999987642   224567889999999999999999999999999999999997 58


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---C
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---P  458 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~  458 (615)
                      |.+++....    ..+++..+.+++.+++.||+|||+.+   |+||||+|+||++++++.++|+|||.+.......   .
T Consensus        84 l~~~i~~~~----~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~  156 (282)
T cd07829          84 LKKYLDKRP----GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT  156 (282)
T ss_pred             HHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCccccC
Confidence            999997432    36899999999999999999999998   9999999999999999999999999998764432   1


Q ss_pred             CCCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchh-hHHHHHHHhhhcccc--ccc--ccccc
Q 007167          459 PAMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATGGDEVV-HLVRWVNSVVREEWT--AEV--FDVEL  532 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~--~~~--~d~~~  532 (615)
                      ....+..|+|||.+.+. .++.++|||||||++||+++|+.||......+.. ...+.+.......|.  ...  .+...
T Consensus       157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (282)
T cd07829         157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF  236 (282)
T ss_pred             ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence            22346679999998766 7899999999999999999999999764432211 111111110011000  000  01111


Q ss_pred             c---------CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          533 L---------RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       533 ~---------~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .         ..+..+.   .+.+++.+|+..+|++||++.|++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~---~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         237 PKFPPKDLEKVLPRLDP---EGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             cccCccchHHhcccccH---HHHHHHHHhhccCcccCCCHHHHhhC
Confidence            1         1122233   44555559999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=4.9e-33  Score=278.42  Aligned_cols=242  Identities=21%  Similarity=0.330  Sum_probs=185.5

Q ss_pred             hhhcCcCCccEEEEEEECC-CCEEEEEEecccc------CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecC
Q 007167          305 AEVLGKGTFGTAYKAALED-ASTVVVKRLKEVN------VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYF  377 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  377 (615)
                      .+.||+|+||.||++.... +..+++|.++...      .....+.+|+++++.++||||+++++++.+....++||||+
T Consensus         5 ~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~   84 (260)
T cd08222           5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYC   84 (260)
T ss_pred             eeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeC
Confidence            3579999999999998653 3445566655321      12335677899999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC
Q 007167          378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP  457 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~  457 (615)
                      ++++|.++++.... ....+++..+..++.|++.|+.|||+.+   ++|+||||+||++++ +.++|+|||++.......
T Consensus        85 ~~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          85 EGRDLDCKLEELKH-TGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             CCCCHHHHHHHHhh-cccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence            99999999864321 2347999999999999999999999998   999999999999975 569999999987764322


Q ss_pred             ---CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccC
Q 007167          458 ---PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLR  534 (615)
Q Consensus       458 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  534 (615)
                         ....++..|+|||......++.++||||||+++|+|++|+.||.....   ....   ......         ....
T Consensus       160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~---~~~~---~~~~~~---------~~~~  224 (260)
T cd08222         160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF---LSVV---LRIVEG---------PTPS  224 (260)
T ss_pred             ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHH---HHHHcC---------CCCC
Confidence               223467789999999888889999999999999999999999964321   1111   111110         0111


Q ss_pred             C-CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          535 Y-PNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       535 ~-~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      . ..++.++.+   ++.+|+..+|++||++.|++++
T Consensus       225 ~~~~~~~~~~~---li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         225 LPETYSRQLNS---IMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             CcchhcHHHHH---HHHHHhcCChhhCcCHHHHhhC
Confidence            1 123344444   4449999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1e-32  Score=283.61  Aligned_cols=254  Identities=25%  Similarity=0.363  Sum_probs=183.9

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEecC--------eeeE
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSKD--------EKLM  372 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--------~~~l  372 (615)
                      .+.||+|+||.||+|... +++.|++|++.....   ....+.+|+++++.++|+||+++++++....        ..++
T Consensus        13 ~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~l   92 (311)
T cd07866          13 LGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYM   92 (311)
T ss_pred             EEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEE
Confidence            356999999999999964 678899998864322   1345778999999999999999998875433        4699


Q ss_pred             EeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccc
Q 007167          373 VYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAAL  452 (615)
Q Consensus       373 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~  452 (615)
                      |+||+.+ ++...+...    ...+++..+..++.|+++||+|||+.+   |+||||||+||++++++.++|+|||+++.
T Consensus        93 v~~~~~~-~l~~~~~~~----~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  164 (311)
T cd07866          93 VTPYMDH-DLSGLLENP----SVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARP  164 (311)
T ss_pred             EEecCCc-CHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCccchh
Confidence            9999965 677776532    236999999999999999999999998   99999999999999999999999999976


Q ss_pred             cCCCCC--------------CCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHH-H
Q 007167          453 MSPMPP--------------PAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWV-N  516 (615)
Q Consensus       453 ~~~~~~--------------~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~-~  516 (615)
                      ......              ...++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+... .
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~  244 (311)
T cd07866         165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG  244 (311)
T ss_pred             ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            543211              1123567999998765 45789999999999999999999999765443222211111 1


Q ss_pred             Hhhhcccc-----cccc----ccccc-----CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          517 SVVREEWT-----AEVF----DVELL-----RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       517 ~~~~~~~~-----~~~~----d~~~~-----~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ......+.     ....    .....     ......   ..+.+++.+|+..+|++|||+.|++.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLG---PEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             CCChhhchhhhhcccccccccCCCCCccHHHHcccCC---hhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            00000000     0000    00000     011112   344555669999999999999999864

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-33  Score=292.12  Aligned_cols=235  Identities=21%  Similarity=0.304  Sum_probs=192.8

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccCCHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVGKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      ...+|.|+|+.|-++.. ..++..+||++.+.   ..+..+|+.++... +|+||+++.+.+.+..+.++|||++.++-+
T Consensus       327 ~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~---~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~el  403 (612)
T KOG0603|consen  327 REELGEGSFSAVKYCESSPTDQEPAVKIISKR---ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGEL  403 (612)
T ss_pred             ccccCCCCccceeeeeccccccchhheecccc---ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHH
Confidence            45699999999988874 45778999999765   33455677666655 699999999999999999999999999988


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEe-CCCCcEEEeecccccccCCCCCCCC
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFL-NSQGHVCVSDIGLAALMSPMPPPAM  461 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill-~~~~~~kl~DfG~a~~~~~~~~~~~  461 (615)
                      .+.+...+     ... ..+..|+.+++.|+.|||.+|   |+|||+||+|||+ ++.++++|+|||.++..........
T Consensus       404 l~ri~~~~-----~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~tp~  474 (612)
T KOG0603|consen  404 LRRIRSKP-----EFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCDTPA  474 (612)
T ss_pred             HHHHHhcc-----hhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchhhcccc
Confidence            88876432     222 667789999999999999998   9999999999999 6899999999999998876644556


Q ss_pred             CCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHHH
Q 007167          462 RAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEE  541 (615)
Q Consensus       462 ~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~  541 (615)
                      -|..|.|||+.....|++++|+||||++||+|++|+.||.....+  .++..   .+....           ....++++
T Consensus       475 ~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~---~i~~~~-----------~s~~vS~~  538 (612)
T KOG0603|consen  475 LTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHT---RIQMPK-----------FSECVSDE  538 (612)
T ss_pred             hhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHH---hhcCCc-----------cccccCHH
Confidence            688899999999999999999999999999999999999987665  11111   111110           11456888


Q ss_pred             HHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          542 MVEMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       542 ~~~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                      .+++++   +|++.||.+||+|.|+..+=
T Consensus       539 AKdLl~---~LL~~dP~~Rl~~~~i~~h~  564 (612)
T KOG0603|consen  539 AKDLLQ---QLLQVDPALRLGADEIGAHP  564 (612)
T ss_pred             HHHHHH---HhccCChhhCcChhhhccCc
Confidence            999999   99999999999999998774

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.2e-32  Score=271.90  Aligned_cols=220  Identities=22%  Similarity=0.268  Sum_probs=175.6

Q ss_pred             CCccEEEEEEE-CCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChhhhhccC
Q 007167          311 GTFGTAYKAAL-EDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGR  389 (615)
Q Consensus       311 G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~  389 (615)
                      |.||.||++.. .+++.||+|+++...    .+.+|...+....||||+++++++.+.+..++||||+++|+|.+++...
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~   79 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKF   79 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHh
Confidence            89999999985 467889999987542    3344555555567999999999999999999999999999999998643


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCCCCCCCcccCc
Q 007167          390 RGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAP  469 (615)
Q Consensus       390 ~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~y~aP  469 (615)
                           ..+++.....++.|++.||+|||+.+   |+||||||+||+++.++.++++|||.+............+..|+||
T Consensus        80 -----~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~y~aP  151 (237)
T cd05576          80 -----LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYCAP  151 (237)
T ss_pred             -----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCccccCC
Confidence                 25899999999999999999999998   9999999999999999999999999887766544444556779999


Q ss_pred             cccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHH
Q 007167          470 EVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVG  549 (615)
Q Consensus       470 E~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~  549 (615)
                      |......++.++||||+|+++|||++|+.|+...... ..                ...  .+...+.+++.+.++++  
T Consensus       152 E~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~~----------------~~~--~~~~~~~~~~~~~~li~--  210 (237)
T cd05576         152 EVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-IN----------------THT--TLNIPEWVSEEARSLLQ--  210 (237)
T ss_pred             cccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-cc----------------ccc--ccCCcccCCHHHHHHHH--
Confidence            9998888899999999999999999999887542210 00                000  00011233455555555  


Q ss_pred             HHcccCCCCCCCCHH
Q 007167          550 MACVVRMPEERPKMA  564 (615)
Q Consensus       550 ~~cl~~~P~~RPs~~  564 (615)
                       +|++.||++||++.
T Consensus       211 -~~l~~dp~~R~~~~  224 (237)
T cd05576         211 -QLLQFNPTERLGAG  224 (237)
T ss_pred             -HHccCCHHHhcCCC
Confidence             99999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=2.3e-32  Score=284.00  Aligned_cols=253  Identities=20%  Similarity=0.307  Sum_probs=183.1

Q ss_pred             hhhcCcCCccEEEEEEEC-C--CCEEEEEEecccc---CCHHHHHHHHHHHhCC-CCCcccceeEEEEec----CeeeEE
Q 007167          305 AEVLGKGTFGTAYKAALE-D--ASTVVVKRLKEVN---VGKREFEQQMEIVGGI-RHENVVALRAYYYSK----DEKLMV  373 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~--~~~vavK~l~~~~---~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~----~~~~lV  373 (615)
                      .+.||+|+||.||++... .  +..||+|++....   ...+.+.+|++++.++ +||||+++++++...    ...+++
T Consensus         5 ~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~   84 (332)
T cd07857           5 IKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLY   84 (332)
T ss_pred             EEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEE
Confidence            356999999999999965 3  6789999987532   1245677899999999 599999999875432    457888


Q ss_pred             eecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeeccccccc
Q 007167          374 YDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALM  453 (615)
Q Consensus       374 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~  453 (615)
                      +||+. ++|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++..
T Consensus        85 ~e~~~-~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          85 EELME-ADLHQIIRSG-----QPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             Eeccc-CCHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            89885 6899888632     36899999999999999999999998   999999999999999999999999999865


Q ss_pred             CCCC-------CCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhH-HHHH--------H
Q 007167          454 SPMP-------PPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHL-VRWV--------N  516 (615)
Q Consensus       454 ~~~~-------~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~-~~~~--------~  516 (615)
                      ....       ....++..|+|||...+ ..++.++||||+||++|+|++|+.||...+..+.... +..+        .
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS  235 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            4321       12346778999998765 4688999999999999999999999976443221111 1100        0


Q ss_pred             Hhhhcc---ccc---cccccccc-CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          517 SVVREE---WTA---EVFDVELL-RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       517 ~~~~~~---~~~---~~~d~~~~-~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ......   ...   ......+. ..+..+..   +.+++.+|++.+|++|||+.|++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPL---ALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             hhhhhhHHHHHHhccccCCcchHhhCCCCCHH---HHHHHHHHccCCcccCCCHHHHhcC
Confidence            000000   000   00000000 01222334   4445559999999999999999876

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.3e-32  Score=286.84  Aligned_cols=249  Identities=22%  Similarity=0.320  Sum_probs=181.6

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccC-CHHHHHHHHHHHhCCCCCcccceeEEEEec--------------Ce
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV-GKREFEQQMEIVGGIRHENVVALRAYYYSK--------------DE  369 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------------~~  369 (615)
                      +.||+|+||.||+|... .+..||+|.+..... ..+.+.+|+++++.++||||+++++++...              ..
T Consensus        11 ~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (342)
T cd07854          11 RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNS   90 (342)
T ss_pred             EEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccce
Confidence            56999999999999864 578999998865432 345688899999999999999998776543              35


Q ss_pred             eeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCC-CCcEEEeecc
Q 007167          370 KLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNS-QGHVCVSDIG  448 (615)
Q Consensus       370 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~-~~~~kl~DfG  448 (615)
                      .++||||++ ++|.+++..      ..+++.....++.|++.||+|||+.+   |+||||||+||+++. ++.+|++|||
T Consensus        91 ~~lv~e~~~-~~L~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl~dfg  160 (342)
T cd07854          91 VYIVQEYME-TDLANVLEQ------GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFG  160 (342)
T ss_pred             EEEEeeccc-ccHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEECCcc
Confidence            789999997 588888753      25889999999999999999999998   999999999999984 5678999999


Q ss_pred             cccccCCCC------CCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhh--
Q 007167          449 LAALMSPMP------PPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVV--  519 (615)
Q Consensus       449 ~a~~~~~~~------~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~--  519 (615)
                      .+..+....      ....++..|+|||.+.. ..++.++|||||||++|||++|+.||......+...  .......  
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~--~~~~~~~~~  238 (342)
T cd07854         161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQ--LILESVPVV  238 (342)
T ss_pred             cceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHHhcCCC
Confidence            997654321      12245678999998654 457889999999999999999999997654322111  1111000  


Q ss_pred             hcccc--------cccc-------cccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          520 REEWT--------AEVF-------DVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       520 ~~~~~--------~~~~-------d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .....        ....       .+.....+..+.+..   +++.+|+..||++|||+.|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEAL---DFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHH---HHHHHHhCCCchhccCHHHHhCC
Confidence            00000        0000       000000122334444   44559999999999999999875

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=4e-33  Score=280.65  Aligned_cols=241  Identities=20%  Similarity=0.362  Sum_probs=195.6

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEecccc---CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVN---VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .++||+|-||+||-|+. +.|+.||||++.+..   ..+..+++|+.+|..++||.||.+-..|+..+..+.|||-+.|.
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD  648 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD  648 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence            67899999999999985 579999999997653   23467889999999999999999999999999999999999776


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCC---CcEEEeecccccccCCCC
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQ---GHVCVSDIGLAALMSPMP  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~---~~~kl~DfG~a~~~~~~~  457 (615)
                      -|..+|...+    ..+++.....++.||+.||.|||.++   |+|+|+||+|||+...   -.+||||||+|+..++..
T Consensus       649 MLEMILSsEk----gRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks  721 (888)
T KOG4236|consen  649 MLEMILSSEK----GRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS  721 (888)
T ss_pred             HHHHHHHhhc----ccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh
Confidence            6666666443    46888888899999999999999998   9999999999999754   369999999999997654


Q ss_pred             --CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCC
Q 007167          458 --PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY  535 (615)
Q Consensus       458 --~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  535 (615)
                        ...+||+.|+|||++....|...-|+||.||++|--++|..||..  ++++-++++-..-+           ..-..|
T Consensus       722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFM-----------yPp~PW  788 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFM-----------YPPNPW  788 (888)
T ss_pred             hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhccccc-----------cCCCch
Confidence              456799999999999999999999999999999999999999974  33444444322111           111234


Q ss_pred             CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007167          536 PNIEEEMVEMLQVGMACVVRMPEERPKMADVLK  568 (615)
Q Consensus       536 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  568 (615)
                      ..++++..+++.   ..++..=.+|.+..+.+.
T Consensus       789 ~eis~~AidlIn---~LLqVkm~kRysvdk~ls  818 (888)
T KOG4236|consen  789 SEISPEAIDLIN---NLLQVKMRKRYSVDKSLS  818 (888)
T ss_pred             hhcCHHHHHHHH---HHHHHHHHHhcchHhhcc
Confidence            456677766666   666666677888776554

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.1e-32  Score=302.57  Aligned_cols=238  Identities=22%  Similarity=0.341  Sum_probs=171.4

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEecccc--CCHHHHHHHHHHHhCCCCCcccceeEEEEec---------------
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVN--VGKREFEQQMEIVGGIRHENVVALRAYYYSK---------------  367 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~---------------  367 (615)
                      ++||+||||.|||++.+ ||+.||||++....  .....+.+|+..+++++|||||+++..+.+.               
T Consensus       485 ~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~  564 (1351)
T KOG1035|consen  485 ELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSE  564 (1351)
T ss_pred             HHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchh
Confidence            46999999999999965 89999999997653  2345678999999999999999987554110               


Q ss_pred             --------------------------------------------------------------------------------
Q 007167          368 --------------------------------------------------------------------------------  367 (615)
Q Consensus       368 --------------------------------------------------------------------------------  367 (615)
                                                                                                      
T Consensus       565 ~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~  644 (1351)
T KOG1035|consen  565 SRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDD  644 (1351)
T ss_pred             hhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCc
Confidence                                                                                            


Q ss_pred             ------------------------CeeeEEeecCCCCChhhhhccCCCCCCCCC-CHHHHHHHHHHHHHHHHHhhccCCC
Q 007167          368 ------------------------DEKLMVYDYFEPGSVSAMLHGRRGEGQSSL-DWDTRVRIAIGAARGIAHIHTENGG  422 (615)
Q Consensus       368 ------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l-~~~~~~~i~~~ia~~l~~LH~~~~~  422 (615)
                                              ...||=||||+..++.++++.+.     .. .-...++++.+|+.||.|+|+.+  
T Consensus       645 ~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~-----~~~~~d~~wrLFreIlEGLaYIH~~g--  717 (1351)
T KOG1035|consen  645 TSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNH-----FNSQRDEAWRLFREILEGLAYIHDQG--  717 (1351)
T ss_pred             chhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcc-----cchhhHHHHHHHHHHHHHHHHHHhCc--
Confidence                                    01245577777777777776432     11 34567789999999999999998  


Q ss_pred             CceecCCCCCCEEeCCCCcEEEeecccccccC---------------------CCCCCCCCCCcccCccccCCCC---CC
Q 007167          423 KLVHGGIKASNIFLNSQGHVCVSDIGLAALMS---------------------PMPPPAMRAAGYRAPEVTDTRK---AT  478 (615)
Q Consensus       423 ~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~---------------------~~~~~~~~~~~y~aPE~~~~~~---~~  478 (615)
                       ||||||||.||++|++..+||+|||+|+...                     ...+..+||.-|+|||.+....   |+
T Consensus       718 -iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn  796 (1351)
T KOG1035|consen  718 -IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN  796 (1351)
T ss_pred             -eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence             9999999999999999999999999998721                     0123345677799999997654   99


Q ss_pred             CccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCC-cHHHHHHHHHHHHHcccCCC
Q 007167          479 QASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN-IEEEMVEMLQVGMACVVRMP  557 (615)
Q Consensus       479 ~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~-~~~~~~~l~~l~~~cl~~~P  557 (615)
                      .|+|+||+|||++||+.   ||...  .   +.+..+...-..         .++..+. ..++...-.+++..+++.||
T Consensus       797 ~KiDmYSLGIVlFEM~y---PF~Ts--M---ERa~iL~~LR~g---------~iP~~~~f~~~~~~~e~slI~~Ll~hdP  859 (1351)
T KOG1035|consen  797 SKIDMYSLGIVLFEMLY---PFGTS--M---ERASILTNLRKG---------SIPEPADFFDPEHPEEASLIRWLLSHDP  859 (1351)
T ss_pred             chhhhHHHHHHHHHHhc---cCCch--H---HHHHHHHhcccC---------CCCCCcccccccchHHHHHHHHHhcCCC
Confidence            99999999999999985   56532  1   222222222111         1111100 01111122333448999999


Q ss_pred             CCCCCHHHHHH
Q 007167          558 EERPKMADVLK  568 (615)
Q Consensus       558 ~~RPs~~evl~  568 (615)
                      .+|||+.|+++
T Consensus       860 ~kRPtA~eLL~  870 (1351)
T KOG1035|consen  860 SKRPTATELLN  870 (1351)
T ss_pred             ccCCCHHHHhh
Confidence            99999999976

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.98  E-value=7e-32  Score=303.40  Aligned_cols=138  Identities=20%  Similarity=0.387  Sum_probs=123.5

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC----HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG----KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      ++||+|+||+||+|... +++.||+|+++.....    ...+.+|++++..++|+||+++++++...+..++||||+.++
T Consensus        10 ~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~   89 (669)
T cd05610          10 KPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGG   89 (669)
T ss_pred             EEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCC
Confidence            56999999999999965 6789999998754221    256788999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeeccccc
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAA  451 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~  451 (615)
                      +|.++++..     ..+++...+.|+.||+.||+|||+.+   |+||||||+|||++.++++||+|||+++
T Consensus        90 ~L~~li~~~-----~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          90 DVKSLLHIY-----GYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             CHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999642     25888999999999999999999997   9999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=1e-33  Score=261.41  Aligned_cols=257  Identities=22%  Similarity=0.384  Sum_probs=192.1

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEecc-c-cCC-HHHHHHHHHHHhCCCCCcccceeEEEEec--------CeeeEE
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKE-V-NVG-KREFEQQMEIVGGIRHENVVALRAYYYSK--------DEKLMV  373 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~-~-~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~--------~~~~lV  373 (615)
                      .+||+|.||.||+|+.+ .|+.||+|+.-- . ..+ .....+|++++..++|+|++.++..|...        ...++|
T Consensus        23 ~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylV  102 (376)
T KOG0669|consen   23 AKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLV  102 (376)
T ss_pred             HhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeee
Confidence            46999999999999854 567788865432 1 111 24567899999999999999998887532        357999


Q ss_pred             eecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeeccccccc
Q 007167          374 YDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALM  453 (615)
Q Consensus       374 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~  453 (615)
                      |++|+. +|..+|...    ...++.....+++.++..||.|+|...   |+|||+|+.|+||+.++.+||+|||+++.+
T Consensus       103 f~~ceh-DLaGlLsn~----~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar~f  174 (376)
T KOG0669|consen  103 FDFCEH-DLAGLLSNR----KVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLARAF  174 (376)
T ss_pred             HHHhhh-hHHHHhcCc----cccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeeccccccce
Confidence            999977 788888643    246889999999999999999999987   999999999999999999999999999877


Q ss_pred             CCCC-------CCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH-hhhcccc
Q 007167          454 SPMP-------PPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNS-VVREEWT  524 (615)
Q Consensus       454 ~~~~-------~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~-~~~~~~~  524 (615)
                      +...       +..+.|..|++||.+.+ +.|+++.|||.-||++.||+||.+-+.+..+..-.++++.+-. +..+-|.
T Consensus       175 s~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP  254 (376)
T KOG0669|consen  175 STSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWP  254 (376)
T ss_pred             ecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCC
Confidence            5332       23345888999999876 5689999999999999999999999988777666666654433 3333333


Q ss_pred             ccc-------cccc-ccC--CCCcHHHHH------HHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          525 AEV-------FDVE-LLR--YPNIEEEMV------EMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       525 ~~~-------~d~~-~~~--~~~~~~~~~------~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                      .-.       +..+ +..  ...+....+      +.++++..++..||.+|+++.+++.+-
T Consensus       255 ~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~  316 (376)
T KOG0669|consen  255 NVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHD  316 (376)
T ss_pred             CcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchh
Confidence            111       1000 100  001112222      334444589999999999999998763

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=5.1e-32  Score=267.69  Aligned_cols=246  Identities=21%  Similarity=0.322  Sum_probs=190.5

Q ss_pred             hhhcCcCCccEEEEEE-ECCCCEEEEEEeccccC---CH-----HHHHHHHHHHhCCCCCcccceeEEEEec-CeeeEEe
Q 007167          305 AEVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNV---GK-----REFEQQMEIVGGIRHENVVALRAYYYSK-DEKLMVY  374 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~---~~-----~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lV~  374 (615)
                      ..+||+|||+.||||. +...+.||||+-.-...   .+     +...+|.++-+.+.||-||++++|+.-+ +..|-|+
T Consensus       468 LhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVL  547 (775)
T KOG1151|consen  468 LHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVL  547 (775)
T ss_pred             HHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeee
Confidence            4679999999999998 45667788987543221   11     3356899999999999999999999754 6788999


Q ss_pred             ecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCC---CCcEEEeeccccc
Q 007167          375 DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNS---QGHVCVSDIGLAA  451 (615)
Q Consensus       375 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~---~~~~kl~DfG~a~  451 (615)
                      |||+|.+|+-+|...     ..+++..+..|++||+.||.||.+. ++||||-||||.|||+-.   -|.+||.|||+++
T Consensus       548 EYceGNDLDFYLKQh-----klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSK  621 (775)
T KOG1151|consen  548 EYCEGNDLDFYLKQH-----KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSK  621 (775)
T ss_pred             eecCCCchhHHHHhh-----hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhh
Confidence            999999999999754     3689999999999999999999987 578999999999999853   4789999999999


Q ss_pred             ccCCCCCC----------CCCCCcccCccccCCC----CCCCccchhhHHHHHHHHHhCCCCCCCCCCc-chhhHHHHHH
Q 007167          452 LMSPMPPP----------AMRAAGYRAPEVTDTR----KATQASDVFSFGVLLLELLTGKSPIHATGGD-EVVHLVRWVN  516 (615)
Q Consensus       452 ~~~~~~~~----------~~~~~~y~aPE~~~~~----~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~-~~~~~~~~~~  516 (615)
                      .+.+.+..          ..||..|++||.+.-+    +.+.|+||||.||++|..+-|+.||...-.+ ++.+.-..+ 
T Consensus       622 IMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIl-  700 (775)
T KOG1151|consen  622 IMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTIL-  700 (775)
T ss_pred             hccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchh-
Confidence            99765432          2367789999988433    4688999999999999999999999754322 222211111 


Q ss_pred             HhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          517 SVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       517 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                               ..-...++.-|-.+.+.+++++   +|++.--++|....|+...
T Consensus       701 ---------kAtEVqFP~KPvVsseAkaFIR---RCLaYRKeDR~DV~qLA~d  741 (775)
T KOG1151|consen  701 ---------KATEVQFPPKPVVSSEAKAFIR---RCLAYRKEDRIDVQQLACD  741 (775)
T ss_pred             ---------cceeccCCCCCccCHHHHHHHH---HHHHhhhhhhhhHHHHccC
Confidence                     1111122233456678888888   9999999999888877653

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.7e-32  Score=296.12  Aligned_cols=242  Identities=22%  Similarity=0.314  Sum_probs=192.6

Q ss_pred             hhhcCcCCccEEEEEEECC-CCEEEEEEeccc----cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALED-ASTVVVKRLKEV----NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .++||+|+||.|..++.+. ++.||+|++.+.    ......|..|-++|..-+.+-||+++-.|++..+.|+|||||+|
T Consensus        80 lKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pG  159 (1317)
T KOG0612|consen   80 LKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPG  159 (1317)
T ss_pred             HHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccC
Confidence            5689999999999999764 567899999874    23356788899999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      |+|-.++...     .++++..+..++.+|+-||.-+|+.|   +|||||||.|||+|..|++||+|||.+-.+....  
T Consensus       160 GDlltLlSk~-----~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V  231 (1317)
T KOG0612|consen  160 GDLLTLLSKF-----DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV  231 (1317)
T ss_pred             chHHHHHhhc-----CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence            9999999743     26899999999999999999999998   9999999999999999999999999998776432  


Q ss_pred             --CCCCCCCcccCccccC----C-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccc
Q 007167          458 --PPAMRAAGYRAPEVTD----T-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDV  530 (615)
Q Consensus       458 --~~~~~~~~y~aPE~~~----~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  530 (615)
                        ...+||+.|.+||++.    + +.|+..+|+||+||++|||+.|..||....-.+...      .+..-   .+.+..
T Consensus       232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~------KIm~h---k~~l~F  302 (1317)
T KOG0612|consen  232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYG------KIMNH---KESLSF  302 (1317)
T ss_pred             EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHH------HHhch---hhhcCC
Confidence              4567999999999983    3 568999999999999999999999997643222111      11110   111111


Q ss_pred             cccCCCCcHHHHHHHHHHHHHcccCCCCCCCC---HHHHHHH
Q 007167          531 ELLRYPNIEEEMVEMLQVGMACVVRMPEERPK---MADVLKM  569 (615)
Q Consensus       531 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs---~~evl~~  569 (615)
                        +....++++.+++++   +.+ -+|+.|..   ++++..|
T Consensus       303 --P~~~~VSeeakdLI~---~ll-~~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  303 --PDETDVSEEAKDLIE---ALL-CDREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             --CcccccCHHHHHHHH---HHh-cChhhhcccccHHHHHhC
Confidence              112347788888887   322 35777776   7777654

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=2e-32  Score=268.52  Aligned_cols=231  Identities=22%  Similarity=0.352  Sum_probs=185.3

Q ss_pred             hhcCcCCccEEEEEEECCC-CEEEEEEeccccC----CHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCCC
Q 007167          306 EVLGKGTFGTAYKAALEDA-STVVVKRLKEVNV----GKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~-~~vavK~l~~~~~----~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+||+|+||.|-+|..+.. ..+|||++++.-.    +.+--..|-++|+.. +-|.+++++.+|+..++++.||||+.|
T Consensus       355 ~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnG  434 (683)
T KOG0696|consen  355 MVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNG  434 (683)
T ss_pred             EEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecC
Confidence            5799999999999986543 4589999986521    112223455666655 578999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccC---CC
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS---PM  456 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~---~~  456 (615)
                      |+|-.+++.     ...+.+..+..++.+||-||-+||+++   ||.||||-.||++|.+|++||+|||+++.--   ..
T Consensus       435 GDLMyhiQQ-----~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~T  506 (683)
T KOG0696|consen  435 GDLMYHIQQ-----VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVT  506 (683)
T ss_pred             chhhhHHHH-----hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccccCCcc
Confidence            999998874     235778889999999999999999998   9999999999999999999999999997532   22


Q ss_pred             CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          457 PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       457 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                      ..+.+||+.|+|||++....|+..+|.|||||+||||+.|+.||++.+++++.+.+.               +.......
T Consensus       507 TkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~---------------ehnvsyPK  571 (683)
T KOG0696|consen  507 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM---------------EHNVSYPK  571 (683)
T ss_pred             eeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH---------------HccCcCcc
Confidence            345678999999999999999999999999999999999999999877666554332               11222223


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCC
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPK  562 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs  562 (615)
                      ..+.|..++.+   ..+.+.|.+|.-
T Consensus       572 slSkEAv~ick---g~ltK~P~kRLG  594 (683)
T KOG0696|consen  572 SLSKEAVAICK---GLLTKHPGKRLG  594 (683)
T ss_pred             cccHHHHHHHH---HHhhcCCccccC
Confidence            55666666666   777788888853

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-31  Score=240.51  Aligned_cols=198  Identities=19%  Similarity=0.360  Sum_probs=161.3

Q ss_pred             HHhhhcCcCCccEEEEEEE-CCCCEEEEEEeccccC--CHHHHHHHHHHHhC-CCCCcccceeEEEEecCeeeEEeecCC
Q 007167          303 ASAEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNV--GKREFEQQMEIVGG-IRHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       303 ~~~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~-l~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      ...+.||+|++|.|-+-++ .+|..+|||+++..-.  ..+...+|+++..+ ..+|.+|.++|.+......++.||.|.
T Consensus        49 ~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~  128 (282)
T KOG0984|consen   49 VGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD  128 (282)
T ss_pred             hhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh
Confidence            3456799999999988774 4788899999986532  24556677776544 479999999999999999999999995


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP  458 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~  458 (615)
                       -||+.+-..- -+....+++...-+|+..+..||.|||++-  .+||||+||+|||++.+|++|+||||++..+.+.-.
T Consensus       129 -tSldkfy~~v-~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA  204 (282)
T KOG0984|consen  129 -TSLDKFYRKV-LKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA  204 (282)
T ss_pred             -hhHHHHHHHH-HhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehhhhH
Confidence             4777654321 123457889999999999999999999987  599999999999999999999999999988865432


Q ss_pred             C--CCCCCcccCccccCC----CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 007167          459 P--AMRAAGYRAPEVTDT----RKATQASDVFSFGVLLLELLTGKSPIHATG  504 (615)
Q Consensus       459 ~--~~~~~~y~aPE~~~~----~~~~~~~DvwS~Gvvl~elltg~~p~~~~~  504 (615)
                      .  ..|...|||||.+..    ..|+-|+||||+|+++.||.+++.||+...
T Consensus       205 kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  205 KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            2  235567999998843    368999999999999999999999998643

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-31  Score=283.52  Aligned_cols=243  Identities=23%  Similarity=0.398  Sum_probs=197.4

Q ss_pred             hhcCcCCccEEEEEE-ECCCCEEEEEEeccccCCHHHHHHHHHHHhCC-CCCcccceeEEEEe-----cCeeeEEeecCC
Q 007167          306 EVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNVGKREFEQQMEIVGGI-RHENVVALRAYYYS-----KDEKLMVYDYFE  378 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~-----~~~~~lV~e~~~  378 (615)
                      +.||+|.+|.||+++ .++++.+|+|++......+++++.|.++++.. .|||++.++|++..     ++.+|||||||.
T Consensus        25 evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~  104 (953)
T KOG0587|consen   25 EVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCG  104 (953)
T ss_pred             EEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccC
Confidence            469999999999998 56788899999887777788899999999888 69999999999864     468999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC--
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM--  456 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~--  456 (615)
                      +||.-+++....   ...+.|....-|+.+++.|+.|||...   ++|||||-.|||++.++.+|++|||.+..+...  
T Consensus       105 gGSVTDLVKn~~---g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~g  178 (953)
T KOG0587|consen  105 GGSVTDLVKNTK---GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVG  178 (953)
T ss_pred             CccHHHHHhhhc---ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeeeeeeeeecccc
Confidence            999999998655   457999999999999999999999987   999999999999999999999999999877543  


Q ss_pred             -CCCCCCCCcccCccccCC-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccc
Q 007167          457 -PPPAMRAAGYRAPEVTDT-----RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDV  530 (615)
Q Consensus       457 -~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  530 (615)
                       ..+..||+.|||||++..     ..|+.++|+||+|++..||--|.+|+.++.......      .+.+      ...+
T Consensus       179 rRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF------~IpR------NPPP  246 (953)
T KOG0587|consen  179 RRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF------LIPR------NPPP  246 (953)
T ss_pred             cccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc------cCCC------CCCc
Confidence             234568899999999854     246779999999999999999999997754432211      1111      1112


Q ss_pred             cccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          531 ELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       531 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+.++...+++..++   +..|+.+|-++||++.+++++
T Consensus       247 kLkrp~kWs~~FndF---Is~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  247 KLKRPKKWSKKFNDF---ISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             cccchhhHHHHHHHH---HHHHHhhccccCcchhhhccC
Confidence            233333444555454   449999999999999988763

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=1e-30  Score=257.56  Aligned_cols=236  Identities=26%  Similarity=0.402  Sum_probs=188.5

Q ss_pred             CccEEEEEEEC-CCCEEEEEEeccccCC--HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChhhhhcc
Q 007167          312 TFGTAYKAALE-DASTVVVKRLKEVNVG--KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHG  388 (615)
Q Consensus       312 ~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~  388 (615)
                      +||.||+|... ++..+++|++......  .+.+.+|++.+++++|+||+++++++......++++||+++++|.+++..
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~   80 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK   80 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence            58999999976 4889999998765332  57899999999999999999999999999999999999999999999874


Q ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC--CCCCCCCCcc
Q 007167          389 RRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM--PPPAMRAAGY  466 (615)
Q Consensus       389 ~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~--~~~~~~~~~y  466 (615)
                      ..     .+++..+..++.+++.++.|||+.+   ++|+||+|+||++++++.++|+|||.+......  .....++..|
T Consensus        81 ~~-----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~  152 (244)
T smart00220       81 RG-----RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEY  152 (244)
T ss_pred             cc-----CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCC
Confidence            32     3889999999999999999999997   999999999999999999999999999877653  2344567789


Q ss_pred             cCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHHHHHHHH
Q 007167          467 RAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEML  546 (615)
Q Consensus       467 ~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~  546 (615)
                      ++||......++.++||||||++++++++|..||......  .....++.....        .... .......   ++.
T Consensus       153 ~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~--~~~~~~~~~~~~--------~~~~-~~~~~~~---~~~  218 (244)
T smart00220      153 MAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL--LELFKKIGKPKP--------PFPP-PEWKISP---EAK  218 (244)
T ss_pred             CCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHhccCC--------CCcc-ccccCCH---HHH
Confidence            9999998888899999999999999999999999763221  112221111000        0000 0000233   445


Q ss_pred             HHHHHcccCCCCCCCCHHHHHHH
Q 007167          547 QVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       547 ~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      +++.+|+..+|++||++.+++++
T Consensus       219 ~~i~~~l~~~p~~Rp~~~~~~~~  241 (244)
T smart00220      219 DLIRKLLVKDPEKRLTAEEALQH  241 (244)
T ss_pred             HHHHHHccCCchhccCHHHHhhC
Confidence            55559999999999999999873

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=4.2e-30  Score=275.19  Aligned_cols=251  Identities=20%  Similarity=0.328  Sum_probs=173.5

Q ss_pred             hhhcCcCCccEEEEEEE-----------------CCCCEEEEEEeccccCC-H--------------HHHHHHHHHHhCC
Q 007167          305 AEVLGKGTFGTAYKAAL-----------------EDASTVVVKRLKEVNVG-K--------------REFEQQMEIVGGI  352 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-----------------~~~~~vavK~l~~~~~~-~--------------~~~~~e~~~l~~l  352 (615)
                      .++||+|+||+||+|.+                 .+++.||||+++..... .              +.+..|+.++.++
T Consensus       150 ~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l  229 (507)
T PLN03224        150 RDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKI  229 (507)
T ss_pred             eeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHh
Confidence            46799999999999964                 24567999998643211 1              2233466777777


Q ss_pred             CCCcc-----cceeEEEEe--------cCeeeEEeecCCCCChhhhhccCCCC-------------------CCCCCCHH
Q 007167          353 RHENV-----VALRAYYYS--------KDEKLMVYDYFEPGSVSAMLHGRRGE-------------------GQSSLDWD  400 (615)
Q Consensus       353 ~h~ni-----v~l~~~~~~--------~~~~~lV~e~~~~gsL~~~l~~~~~~-------------------~~~~l~~~  400 (615)
                      +|.++     ++++++|..        ++..++||||+++|+|.++++...+.                   ....++|.
T Consensus       230 ~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~  309 (507)
T PLN03224        230 KRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDIN  309 (507)
T ss_pred             hcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHH
Confidence            66654     677888753        35689999999999999999753211                   11245788


Q ss_pred             HHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC----CCCCCCcccCccccCCCC
Q 007167          401 TRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP----PAMRAAGYRAPEVTDTRK  476 (615)
Q Consensus       401 ~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~----~~~~~~~y~aPE~~~~~~  476 (615)
                      .+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++..+.....    ....++.|+|||.+....
T Consensus       310 ~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~  386 (507)
T PLN03224        310 VIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQ  386 (507)
T ss_pred             HHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCC
Confidence            89999999999999999998   99999999999999999999999999976543211    122367899999875322


Q ss_pred             --------------------C--CCccchhhHHHHHHHHHhCCC-CCCCCCC--cch----hhHHHHHHHhhhccccccc
Q 007167          477 --------------------A--TQASDVFSFGVLLLELLTGKS-PIHATGG--DEV----VHLVRWVNSVVREEWTAEV  527 (615)
Q Consensus       477 --------------------~--~~~~DvwS~Gvvl~elltg~~-p~~~~~~--~~~----~~~~~~~~~~~~~~~~~~~  527 (615)
                                          +  ..+.||||+||++++|++|.. ||.....  .+.    .....|-.      .....
T Consensus       387 ~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~------~~~~~  460 (507)
T PLN03224        387 SCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM------YKGQK  460 (507)
T ss_pred             CCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh------hcccC
Confidence                                1  235799999999999999875 7653211  110    01111110      00111


Q ss_pred             ccccccCCCCcHHHHHHHHHHHHHcccCCC---CCCCCHHHHHHH
Q 007167          528 FDVELLRYPNIEEEMVEMLQVGMACVVRMP---EERPKMADVLKM  569 (615)
Q Consensus       528 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P---~~RPs~~evl~~  569 (615)
                      ++  ...+...++..++++.   +++..+|   .+|+|++|+++|
T Consensus       461 ~~--~~~~d~~s~~~~dLi~---~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        461 YD--FSLLDRNKEAGWDLAC---KLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             CC--cccccccChHHHHHHH---HHhccCCCCcccCCCHHHHhCC
Confidence            11  1123344566667766   7777654   789999999976

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=3.1e-31  Score=281.60  Aligned_cols=239  Identities=24%  Similarity=0.360  Sum_probs=180.4

Q ss_pred             hhhcCcCCccE-EEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          305 AEVLGKGTFGT-AYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       305 ~~~lG~G~fg~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      .+++|.|+-|+ ||+|..+ ++.||||++-...  .+..++|+..+..- +|||||++++.-.++.+.||+.|.| ..+|
T Consensus       514 ~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~--~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL  589 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF--FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSL  589 (903)
T ss_pred             HHHcccCCCCcEEEEEeeC-CceehHHHHhhHh--HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhH
Confidence            46799999876 7999875 6899999986432  34567899998887 6999999999999999999999999 5699


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCC---C--CcEEEeecccccccCCCC
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNS---Q--GHVCVSDIGLAALMSPMP  457 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~---~--~~~kl~DfG~a~~~~~~~  457 (615)
                      .+++... ........--....+..|++.||+|||+.+   ||||||||.||||+.   +  .+++|+|||+++.+....
T Consensus       590 ~dlie~~-~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~  665 (903)
T KOG1027|consen  590 QDLIESS-GLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGK  665 (903)
T ss_pred             HHHHhcc-ccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccCCCc
Confidence            9999753 111111111334667889999999999987   999999999999976   3  479999999999886432


Q ss_pred             ------CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccc
Q 007167          458 ------PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDV  530 (615)
Q Consensus       458 ------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  530 (615)
                            ....||-||+|||++....-+.++||+|+|||+|+.++ |++||.+.-..+.    ..+    .....-.    
T Consensus       666 sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~----NIl----~~~~~L~----  733 (903)
T KOG1027|consen  666 SSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA----NIL----TGNYTLV----  733 (903)
T ss_pred             chhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh----hhh----cCcccee----
Confidence                  23457889999999998888889999999999999999 5999976433221    111    1110000    


Q ss_pred             cccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007167          531 ELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK  568 (615)
Q Consensus       531 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  568 (615)
                      .+.  +....+..+++.   +|+..+|..||++.+|+.
T Consensus       734 ~L~--~~~d~eA~dLI~---~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  734 HLE--PLPDCEAKDLIS---RMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             eec--cCchHHHHHHHH---HhcCCCcccCCCHHHHhC
Confidence            111  111226666666   999999999999999975

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=1.6e-30  Score=237.19  Aligned_cols=250  Identities=16%  Similarity=0.300  Sum_probs=189.6

Q ss_pred             HHhhhcCcCCccEEEEEE-ECCCCEEEEEEeccccCCHHHHHHHHHHHhCCC-CCcccceeEEEEecC--eeeEEeecCC
Q 007167          303 ASAEVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNVGKREFEQQMEIVGGIR-HENVVALRAYYYSKD--EKLMVYDYFE  378 (615)
Q Consensus       303 ~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~~lV~e~~~  378 (615)
                      ...+++|+|.|++||.|. ..+..+++||.++...  ++.+.+|+.+|..++ ||||+++++...+..  ...+|+||+.
T Consensus        41 eivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk--kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~  118 (338)
T KOG0668|consen   41 EIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK--KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVN  118 (338)
T ss_pred             HHHHHHcCccHhhHhcccccCCCceEEEeeechHH--HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhc
Confidence            345679999999999998 5677889999998653  678999999999997 999999999998764  5689999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCC-cEEEeecccccccCCCC
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG-HVCVSDIGLAALMSPMP  457 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~-~~kl~DfG~a~~~~~~~  457 (615)
                      +.+...+-.        .++......++.+++.||.|||+.|   |+|||+||.|++||... .++|+|+|+|.++.+..
T Consensus       119 n~Dfk~ly~--------tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~  187 (338)
T KOG0668|consen  119 NTDFKQLYP--------TLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK  187 (338)
T ss_pred             cccHHHHhh--------hhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCCCc
Confidence            877666543        5777788899999999999999999   99999999999999764 68999999999987765


Q ss_pred             CCCC--CCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccc------ccc
Q 007167          458 PPAM--RAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTA------EVF  528 (615)
Q Consensus       458 ~~~~--~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~  528 (615)
                      ...+  .++.|.-||.+.. ..|+..-|+|||||++..|+..+.||....+ ...++++.+.-...++...      -.+
T Consensus       188 eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d-N~DQLVkIakVLGt~el~~Yl~KY~i~L  266 (338)
T KOG0668|consen  188 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD-NYDQLVKIAKVLGTDELYAYLNKYQIDL  266 (338)
T ss_pred             eeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC-CHHHHHHHHHHhChHHHHHHHHHHccCC
Confidence            4433  4667899998854 5578889999999999999999999864322 1223333322221111000      001


Q ss_pred             cccccC---------C---------CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          529 DVELLR---------Y---------PNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       529 d~~~~~---------~---------~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      |++...         +         .-..+++.++++   +.+..|-.+|+|++|++.+
T Consensus       267 dp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlld---klLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  267 DPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLD---KLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             ChhHhhHhhccccccHHHhCCccccccCChHHHHHHH---HHHhhccccccchHHHhcC
Confidence            111110         0         012356667766   8899999999999999876

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.3e-31  Score=269.04  Aligned_cols=238  Identities=21%  Similarity=0.323  Sum_probs=194.9

Q ss_pred             hcCcCCccEEEEEEECCCC-EEEEEEeccccC----CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          307 VLGKGTFGTAYKAALEDAS-TVVVKRLKEVNV----GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~~~~-~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      .||-|+||.|-.+..+... .+|+|.+++...    ..+.+..|-.+|...+.|.||+++-.|.+....||+||-|-||.
T Consensus       427 TLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGE  506 (732)
T KOG0614|consen  427 TLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGE  506 (732)
T ss_pred             hcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCch
Confidence            4999999999998865433 488888876532    13456678899999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC--C
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP--P  459 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~--~  459 (615)
                      |+..|+++     ..++......++..+.+|++|||+++   ||.|||||+|+++|.+|-+||.|||+|+.+.....  +
T Consensus       507 lWTiLrdR-----g~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwT  578 (732)
T KOG0614|consen  507 LWTILRDR-----GSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWT  578 (732)
T ss_pred             hhhhhhhc-----CCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCCceee
Confidence            99999854     36888888999999999999999998   99999999999999999999999999999876543  4


Q ss_pred             CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCC-CCc
Q 007167          460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY-PNI  538 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~-~~~  538 (615)
                      .+||+.|.|||++.....+.++|.||+|+++|||++|.+||.+.+......++-  ..+-            ...+ ..+
T Consensus       579 FcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL--kGid------------~i~~Pr~I  644 (732)
T KOG0614|consen  579 FCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL--KGID------------KIEFPRRI  644 (732)
T ss_pred             ecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH--hhhh------------hhhccccc
Confidence            579999999999999999999999999999999999999999877655544331  1110            0112 234


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 007167          539 EEEMVEMLQVGMACVVRMPEERPK-----MADVLKM  569 (615)
Q Consensus       539 ~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~  569 (615)
                      .....++++   +.++.+|.+|.-     +.||.+|
T Consensus       645 ~k~a~~Lik---~LCr~~P~ERLG~~~~gI~DIkkH  677 (732)
T KOG0614|consen  645 TKTATDLIK---KLCRDNPTERLGYQKGGINDIKKH  677 (732)
T ss_pred             chhHHHHHH---HHHhcCcHhhhccccCChHHHHhh
Confidence            455555555   888899999976     5666555

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=6.2e-30  Score=280.76  Aligned_cols=255  Identities=18%  Similarity=0.233  Sum_probs=158.5

Q ss_pred             hhhcCcCCccEEEEEEECC-----CCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEE------EEecCeeeEE
Q 007167          305 AEVLGKGTFGTAYKAALED-----ASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAY------YYSKDEKLMV  373 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~------~~~~~~~~lV  373 (615)
                      .++||+|+||.||+|.+.+     +..||+|++..... .+.+..|  .+....+.+++.++..      .......++|
T Consensus       137 ~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV  213 (566)
T PLN03225        137 GKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-VEIWMNE--RVRRACPNSCADFVYGFLEPVSSKKEDEYWLV  213 (566)
T ss_pred             eEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-hHHHHHH--HHHhhchhhHHHHHHhhhcccccccCCceEEE
Confidence            4679999999999999754     68899998764321 1111111  1222223333332211      2345688999


Q ss_pred             eecCCCCChhhhhccCCCC---------------CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCC
Q 007167          374 YDYFEPGSVSAMLHGRRGE---------------GQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNS  438 (615)
Q Consensus       374 ~e~~~~gsL~~~l~~~~~~---------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~  438 (615)
                      |||+.+++|.++++.....               ............++.|++.||+|||+.+   |+||||||+|||+++
T Consensus       214 ~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLKP~NILl~~  290 (566)
T PLN03225        214 WRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSE  290 (566)
T ss_pred             EEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCCHHHEEEeC
Confidence            9999999999998743210               0001123345678999999999999997   999999999999986


Q ss_pred             -CCcEEEeecccccccCCC----CCCCCCCCcccCccccCCC----------------------CCCCccchhhHHHHHH
Q 007167          439 -QGHVCVSDIGLAALMSPM----PPPAMRAAGYRAPEVTDTR----------------------KATQASDVFSFGVLLL  491 (615)
Q Consensus       439 -~~~~kl~DfG~a~~~~~~----~~~~~~~~~y~aPE~~~~~----------------------~~~~~~DvwS~Gvvl~  491 (615)
                       ++.+||+|||+++.+...    .....++++|+|||.+...                      .++.++|||||||++|
T Consensus       291 ~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~  370 (566)
T PLN03225        291 GSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFL  370 (566)
T ss_pred             CCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHH
Confidence             579999999999865432    2234568899999965321                      2345679999999999


Q ss_pred             HHHhCCCCCCCCCCcchhhHHHHHHHhhh--ccccccc---ccccccC-CCCcHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 007167          492 ELLTGKSPIHATGGDEVVHLVRWVNSVVR--EEWTAEV---FDVELLR-YPNIEEEMVEMLQVGMACVVRMPEERPKMAD  565 (615)
Q Consensus       492 elltg~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~---~d~~~~~-~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~e  565 (615)
                      ||+++..|++.    +.......+.....  ..|....   ...+... +...........+++.+|+..||++|||++|
T Consensus       371 el~~~~~~~~~----~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta~e  446 (566)
T PLN03225        371 QMAFPNLRSDS----NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISAKA  446 (566)
T ss_pred             HHHhCcCCCch----HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCHHH
Confidence            99997766532    11111111110000  0000000   0000000 0000001112234555999999999999999


Q ss_pred             HHHH
Q 007167          566 VLKM  569 (615)
Q Consensus       566 vl~~  569 (615)
                      +++|
T Consensus       447 ~L~H  450 (566)
T PLN03225        447 ALAH  450 (566)
T ss_pred             HhCC
Confidence            9986

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=5.7e-30  Score=262.96  Aligned_cols=195  Identities=26%  Similarity=0.386  Sum_probs=165.6

Q ss_pred             hcCcCCccEEEEEEECCC-CEEEEEEeccccCC----HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          307 VLGKGTFGTAYKAALEDA-STVVVKRLKEVNVG----KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~~~-~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      -||-|+||+|.++...|. ..+|+|.+++..+-    ......|-+||...+.+-||+|+-.|++++.+|+||||++||+
T Consensus       636 ~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGD  715 (1034)
T KOG0608|consen  636 TIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGD  715 (1034)
T ss_pred             eecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCcc
Confidence            499999999999986554 45789988765322    2346778899999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccC-------
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS-------  454 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~-------  454 (615)
                      +-++|-..     .-+.+..+..++.++..|+++.|..|   +|||||||.|||||.+|++||.|||+++-+.       
T Consensus       716 mMSLLIrm-----gIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY  787 (1034)
T KOG0608|consen  716 MMSLLIRM-----GIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  787 (1034)
T ss_pred             HHHHHHHh-----ccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecccccc
Confidence            99998642     35788888889999999999999998   9999999999999999999999999985431       


Q ss_pred             --CC------------------------------------CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhC
Q 007167          455 --PM------------------------------------PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTG  496 (615)
Q Consensus       455 --~~------------------------------------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg  496 (615)
                        ..                                    ....+||..|+|||++....|+.-+|+||.||+||||+.|
T Consensus       788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g  867 (1034)
T KOG0608|consen  788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG  867 (1034)
T ss_pred             ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence              00                                    0012467779999999999999999999999999999999


Q ss_pred             CCCCCCCCCcchh
Q 007167          497 KSPIHATGGDEVV  509 (615)
Q Consensus       497 ~~p~~~~~~~~~~  509 (615)
                      +.||......+..
T Consensus       868 ~~pf~~~tp~~tq  880 (1034)
T KOG0608|consen  868 QPPFLADTPGETQ  880 (1034)
T ss_pred             CCCccCCCCCcce
Confidence            9999987765543

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=4.3e-31  Score=246.61  Aligned_cols=254  Identities=21%  Similarity=0.314  Sum_probs=188.6

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEecccc---CCHHHHHHHHHHHhCCCCCcccceeEEEEec-----CeeeEEeec
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEVN---VGKREFEQQMEIVGGIRHENVVALRAYYYSK-----DEKLMVYDY  376 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lV~e~  376 (615)
                      +.||-|+||+||.+++ ++|+.|+.|++....   ...+.+.+|+.++...+|.|++..++...-.     +++|.|+|.
T Consensus        59 RPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TEL  138 (449)
T KOG0664|consen   59 RPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTEL  138 (449)
T ss_pred             CcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHH
Confidence            3599999999999885 689999999987652   2356788999999999999999988776543     367889999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM  456 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~  456 (615)
                      |. .+|..++-.     ...++-....-+..||++||.|||+.+   |.||||||.|.|++.+-..||||||+++.....
T Consensus       139 mQ-SDLHKIIVS-----PQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d  209 (449)
T KOG0664|consen  139 MQ-SDLHKIIVS-----PQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQR  209 (449)
T ss_pred             HH-hhhhheecc-----CCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchh
Confidence            84 477777752     346888888889999999999999998   999999999999999999999999999987654


Q ss_pred             CC----CCCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHh-hhc-------cc
Q 007167          457 PP----PAMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSV-VRE-------EW  523 (615)
Q Consensus       457 ~~----~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~-------~~  523 (615)
                      ..    ..+.|..|+|||++++. .|+.+.||||.||++.||+..+..|...+.-+-.+++..+... ..+       +-
T Consensus       210 ~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGA  289 (449)
T KOG0664|consen  210 DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGA  289 (449)
T ss_pred             hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhh
Confidence            32    23346789999999875 5899999999999999999999999877654433333322111 110       00


Q ss_pred             cccccc-----cccc------CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 007167          524 TAEVFD-----VELL------RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVE  571 (615)
Q Consensus       524 ~~~~~d-----~~~~------~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  571 (615)
                      ...++.     +...      ....-..+...   +.+.++..||+.|.+.++.+.++.
T Consensus       290 k~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~---~~~~~l~~d~dkris~~~A~~~~~  345 (449)
T KOG0664|consen  290 KNHVLRAGLRAPDTQRLYKIASPDDKNHEAVD---LLQKLLHFDPDKRISVEEALQHRY  345 (449)
T ss_pred             HHHhhccCCCCCCccceeeecCCcccchHHHH---HHHHHhCCCCcccccHhhhccccc
Confidence            000110     0000      00111223333   344788999999999999988764

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=5.6e-28  Score=232.11  Aligned_cols=207  Identities=29%  Similarity=0.516  Sum_probs=179.9

Q ss_pred             cCcCCccEEEEEEECC-CCEEEEEEeccccCC--HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChhh
Q 007167          308 LGKGTFGTAYKAALED-ASTVVVKRLKEVNVG--KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSA  384 (615)
Q Consensus       308 lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  384 (615)
                      ||+|++|.||++...+ +..+++|++......  .+.+.+|++.++.++|++++++++++......++++||+.+++|.+
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~   80 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD   80 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence            6899999999999764 889999999865442  4678999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCC-CCcEEEeecccccccCCC---CCCC
Q 007167          385 MLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNS-QGHVCVSDIGLAALMSPM---PPPA  460 (615)
Q Consensus       385 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~-~~~~kl~DfG~a~~~~~~---~~~~  460 (615)
                      ++....    ..+++..+..++.++++++++||+.+   ++|+||+|.||+++. ++.++|+|||.+......   ....
T Consensus        81 ~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~  153 (215)
T cd00180          81 LLKENE----GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI  153 (215)
T ss_pred             HHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcc
Confidence            987431    36899999999999999999999998   999999999999999 899999999999877654   2334


Q ss_pred             CCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          461 MRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      .....|++||..... .++.+.|+|++|++++++                                              
T Consensus       154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------------------------  187 (215)
T cd00180         154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------------------------  187 (215)
T ss_pred             cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----------------------------------------------
Confidence            466789999998877 788999999999999998                                              


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                         ..+.+++..|+..+|++||++.++++++
T Consensus       188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ---PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ---HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence               2445555599999999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=3.6e-29  Score=255.33  Aligned_cols=191  Identities=24%  Similarity=0.386  Sum_probs=164.6

Q ss_pred             HHhhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCH---------HHHHHHHHHHhCCC---CCcccceeEEEEecCe
Q 007167          303 ASAEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGK---------REFEQQMEIVGGIR---HENVVALRAYYYSKDE  369 (615)
Q Consensus       303 ~~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~---------~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~  369 (615)
                      .+.+.+|+|+||.|+.|.++ +..+|+||.+.+.+.-.         ..+-.|+++|+.++   |+||++++++|++++.
T Consensus       564 ttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~  643 (772)
T KOG1152|consen  564 TTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDY  643 (772)
T ss_pred             eeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCe
Confidence            34578999999999999965 45678999887642211         23457999999997   9999999999999999


Q ss_pred             eeEEeecC-CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecc
Q 007167          370 KLMVYDYF-EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIG  448 (615)
Q Consensus       370 ~~lV~e~~-~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG  448 (615)
                      ++|+||-. ++.+|++++...     ..+++..+..|+.|++.|++|||+.+   |||||||-+||.++.+|-+||+|||
T Consensus       644 yyl~te~hg~gIDLFd~IE~k-----p~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfg  715 (772)
T KOG1152|consen  644 YYLETEVHGEGIDLFDFIEFK-----PRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFG  715 (772)
T ss_pred             eEEEecCCCCCcchhhhhhcc-----CccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeecc
Confidence            99999975 566999999643     46899999999999999999999998   9999999999999999999999999


Q ss_pred             cccccCCCC-CCCCCCCcccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCC
Q 007167          449 LAALMSPMP-PPAMRAAGYRAPEVTDTRKA-TQASDVFSFGVLLLELLTGKSPIH  501 (615)
Q Consensus       449 ~a~~~~~~~-~~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~p~~  501 (615)
                      .|....... ...+||.+|.|||++.+.+| ...-|||++|++||.++....||.
T Consensus       716 saa~~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  716 SAAYTKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             chhhhcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            998776543 45678999999999999887 678899999999999998888874

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.95  E-value=4e-29  Score=251.87  Aligned_cols=258  Identities=21%  Similarity=0.269  Sum_probs=199.3

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEeccccCCHHHHHHHHHHHhCCC------CCcccceeEEEEecCeeeEEeecCC
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVGKREFEQQMEIVGGIR------HENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~------h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      ...|+|-|++|.+|.. ..|.+||||++.......+.=..|+++|++|+      --++++++-.|...+++|||+|-+ 
T Consensus       438 ~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-  516 (752)
T KOG0670|consen  438 GYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-  516 (752)
T ss_pred             eccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-
Confidence            4589999999999984 45789999999987766677778999999995      348999999999999999999987 


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCC-cEEEeecccccccCCCC
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG-HVCVSDIGLAALMSPMP  457 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~-~~kl~DfG~a~~~~~~~  457 (615)
                      ..+|.++|....  ....|....+..++.|+.-||.+|-..+   |+|.||||.|||+++.. .+||||||.|.......
T Consensus       517 slNLRevLKKyG--~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~ene  591 (752)
T KOG0670|consen  517 SLNLREVLKKYG--RNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSASFASENE  591 (752)
T ss_pred             hchHHHHHHHhC--cccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCcccccccccc
Confidence            568999997543  2346788899999999999999999988   99999999999999865 68999999998776543


Q ss_pred             C-CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhc------ccccccccc
Q 007167          458 P-PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVRE------EWTAEVFDV  530 (615)
Q Consensus       458 ~-~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~d~  530 (615)
                      - ....+.-|+|||++.+..|+...|+||.||.||||.||+..|.+..+.++..+.--+...+..      ......||.
T Consensus       592 itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~  671 (752)
T KOG0670|consen  592 ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQ  671 (752)
T ss_pred             ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhccc
Confidence            2 223455699999999999999999999999999999999999998877665544433222211      111111111


Q ss_pred             --------------------------------cccC---CC-CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          531 --------------------------------ELLR---YP-NIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       531 --------------------------------~~~~---~~-~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                                                      .+..   .+ .-...+..+..+...|+..||++|.|..|+++|
T Consensus       672 d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~H  746 (752)
T KOG0670|consen  672 DLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKH  746 (752)
T ss_pred             ccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcC
Confidence                                            1111   11 112233445556669999999999999999875

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=8.7e-28  Score=241.27  Aligned_cols=259  Identities=21%  Similarity=0.325  Sum_probs=190.1

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCHHHHHHHHHHHhCCC-----C---CcccceeEEEEe----cCeee
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFEQQMEIVGGIR-----H---ENVVALRAYYYS----KDEKL  371 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~-----h---~niv~l~~~~~~----~~~~~  371 (615)
                      .++||-|-|++||++.+. ..+-||+|+.+....-.+....|+++|+.++     |   .+||+|+++|..    ..+.+
T Consensus        83 ~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVC  162 (590)
T KOG1290|consen   83 QRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVC  162 (590)
T ss_pred             EEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEE
Confidence            357999999999999854 4567999999877555667788999999884     2   479999999975    35899


Q ss_pred             EEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCC-----------C
Q 007167          372 MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQ-----------G  440 (615)
Q Consensus       372 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~-----------~  440 (615)
                      ||+|++ |.+|..+|...   ....+....+.+|+.||+.||.|||.++  +|||-||||+|||+..+           +
T Consensus       163 MVfEvL-GdnLLklI~~s---~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~e~~~~~~~~~a~  236 (590)
T KOG1290|consen  163 MVFEVL-GDNLLKLIKYS---NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCSTEIDPAKDAREAG  236 (590)
T ss_pred             EEehhh-hhHHHHHHHHh---CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeeccccchhhhhhhhc
Confidence            999999 67888888653   2446889999999999999999999998  69999999999998411           0


Q ss_pred             --------------------------------------------------------------------------------
Q 007167          441 --------------------------------------------------------------------------------  440 (615)
Q Consensus       441 --------------------------------------------------------------------------------  440 (615)
                                                                                                      
T Consensus       237 e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v  316 (590)
T KOG1290|consen  237 EATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTV  316 (590)
T ss_pred             cccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccccch
Confidence                                                                                            


Q ss_pred             ---------------------------------------------------------------------------cEEEe
Q 007167          441 ---------------------------------------------------------------------------HVCVS  445 (615)
Q Consensus       441 ---------------------------------------------------------------------------~~kl~  445 (615)
                                                                                                 ++||+
T Consensus       317 ~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIa  396 (590)
T KOG1290|consen  317 ERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIA  396 (590)
T ss_pred             hhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeEEEe
Confidence                                                                                       02222


Q ss_pred             ecccccccCCCCCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc------c-hhhHHHHHHHh
Q 007167          446 DIGLAALMSPMPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGD------E-VVHLVRWVNSV  518 (615)
Q Consensus       446 DfG~a~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~------~-~~~~~~~~~~~  518 (615)
                      |||-|-......+....|+.|+|||++.+..|++.+||||++|++|||+||...|....++      + +..++..+..+
T Consensus       397 DlGNACW~~khFT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~i  476 (590)
T KOG1290|consen  397 DLGNACWVHKHFTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKI  476 (590)
T ss_pred             eccchhhhhhhhchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhc
Confidence            2222222221112222345599999999999999999999999999999999999865432      1 23344444433


Q ss_pred             hhc-----ccccccccccc------------------cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          519 VRE-----EWTAEVFDVEL------------------LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       519 ~~~-----~~~~~~~d~~~------------------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+.     ....+.|+...                  .++....++..++.+++.-|++.+|++|||+.+.+++
T Consensus       477 Pr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~h  550 (590)
T KOG1290|consen  477 PRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKH  550 (590)
T ss_pred             cHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcC
Confidence            322     22233332211                  1223346778888899999999999999999999976

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.2e-28  Score=234.30  Aligned_cols=189  Identities=17%  Similarity=0.347  Sum_probs=161.5

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCH----HHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGK----REFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~----~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+||+|+|+.|..+++. ..+.+|+|++++.-...    +=.+.|-.+.... +||.+|.++.+|+.....+.|.||.++
T Consensus       256 ~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~g  335 (593)
T KOG0695|consen  256 RVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNG  335 (593)
T ss_pred             eeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecC
Confidence            57999999999999865 45678999987642211    1234454555444 799999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccC---CC
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS---PM  456 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~---~~  456 (615)
                      |+|--+++..     ..+++..+..+-.+|.-||.|||++|   ||.||+|-.|||+|..|++|+.|+|.++.--   +.
T Consensus       336 gdlmfhmqrq-----rklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l~~gd~  407 (593)
T KOG0695|consen  336 GDLMFHMQRQ-----RKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDT  407 (593)
T ss_pred             cceeeehhhh-----hcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCCCCCcc
Confidence            9998888754     36889999999999999999999998   9999999999999999999999999997532   23


Q ss_pred             CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 007167          457 PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHA  502 (615)
Q Consensus       457 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~  502 (615)
                      ..+.++|+.|.|||++.+..|...+|.|++||+++||+.|+.||+-
T Consensus       408 tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi  453 (593)
T KOG0695|consen  408 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI  453 (593)
T ss_pred             cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence            4566799999999999999999999999999999999999999974

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=7.4e-28  Score=225.12  Aligned_cols=250  Identities=19%  Similarity=0.319  Sum_probs=187.0

Q ss_pred             HHHhhhcCcCCccEEEEEEECC-CCEEEEEEeccccCCHHHHHHHHHHHhCC-CCCcccceeE-EEEecCeeeEEeecCC
Q 007167          302 RASAEVLGKGTFGTAYKAALED-ASTVVVKRLKEVNVGKREFEQQMEIVGGI-RHENVVALRA-YYYSKDEKLMVYDYFE  378 (615)
Q Consensus       302 ~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~-~~~~~~~~~lV~e~~~  378 (615)
                      +...+.||+|.||.+-++..+. .+.+++|.+.......++|.+|..---.+ .|.||+.-++ .|+..+.+..++||++
T Consensus        26 y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP  105 (378)
T KOG1345|consen   26 YTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAP  105 (378)
T ss_pred             hhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCc
Confidence            4456789999999999999775 45688899888777889999998754444 5899998664 4667788899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeC--CCCcEEEeecccccccCCC
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLN--SQGHVCVSDIGLAALMSPM  456 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~--~~~~~kl~DfG~a~~~~~~  456 (615)
                      .|+|.+-+..      ..+-+....+++.|++.|+.|||++.   +||||||.+||||-  +..++|+||||..+..+..
T Consensus       106 ~gdL~snv~~------~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t  176 (378)
T KOG1345|consen  106 RGDLRSNVEA------AGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT  176 (378)
T ss_pred             cchhhhhcCc------ccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccCce
Confidence            9999988864      34777888999999999999999998   99999999999983  3358999999998876654


Q ss_pred             CCCCCCCCcccCccccCCC-----CCCCccchhhHHHHHHHHHhCCCCCCCCCCc--chhhHHHHHHHhhhccccccccc
Q 007167          457 PPPAMRAAGYRAPEVTDTR-----KATQASDVFSFGVLLLELLTGKSPIHATGGD--EVVHLVRWVNSVVREEWTAEVFD  529 (615)
Q Consensus       457 ~~~~~~~~~y~aPE~~~~~-----~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~d  529 (615)
                      -.....+..|.+||.....     ...+.+|||.||++++.++||+.||+.....  .......|.++...         
T Consensus       177 V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~---------  247 (378)
T KOG1345|consen  177 VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP---------  247 (378)
T ss_pred             ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc---------
Confidence            4444456679999977432     2467889999999999999999999853322  22333334332211         


Q ss_pred             cccc-CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 007167          530 VELL-RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI  573 (615)
Q Consensus       530 ~~~~-~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l  573 (615)
                       .++ .+..+++....+++   +-+..+|++|-...++-++....
T Consensus       248 -~~P~~F~~fs~~a~r~Fk---k~lt~~~~drcki~~~kk~rk~~  288 (378)
T KOG1345|consen  248 -ALPKKFNPFSEKALRLFK---KSLTPRFKDRCKIWTAKKMRKCL  288 (378)
T ss_pred             -cCchhhcccCHHHHHHHH---HhcCCcccccchhHHHHHHHHHH
Confidence             111 12233445555555   78889999997777776665443

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.95  E-value=4e-28  Score=232.39  Aligned_cols=186  Identities=23%  Similarity=0.355  Sum_probs=154.8

Q ss_pred             hhcCcCCccEEEEEE-ECCCCEEEEEEeccc---cCCHHHHHHHHHHHhCCCCCcccceeEEEEec------CeeeEEee
Q 007167          306 EVLGKGTFGTAYKAA-LEDASTVVVKRLKEV---NVGKREFEQQMEIVGGIRHENVVALRAYYYSK------DEKLMVYD  375 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lV~e  375 (615)
                      ..+|.|.- .|.-+. .-.++.||+|++...   ....+...+|...+..++|+||++++.++.-.      .+.++|||
T Consensus        23 ~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e  101 (369)
T KOG0665|consen   23 KPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVME  101 (369)
T ss_pred             cccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHH
Confidence            45788877 455544 235788999987543   22346678999999999999999999998643      35799999


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      || .++|...++.       .++..+...|..|++.|+.|||+.+   |+||||||+||++..+..+||.|||+|+.-..
T Consensus       102 ~m-~~nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~  170 (369)
T KOG0665|consen  102 LM-DANLCQVILM-------ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTEDT  170 (369)
T ss_pred             hh-hhHHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhcccCc
Confidence            99 5688888872       4777888999999999999999998   99999999999999999999999999987654


Q ss_pred             C--CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC
Q 007167          456 M--PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHAT  503 (615)
Q Consensus       456 ~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~  503 (615)
                      .  -+..+.++.|+|||++.+..+.+.+||||.||++.||++|+.-|.+.
T Consensus       171 ~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~  220 (369)
T KOG0665|consen  171 DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK  220 (369)
T ss_pred             ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc
Confidence            3  23445678899999999888999999999999999999999999753

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=1.2e-26  Score=226.05  Aligned_cols=190  Identities=29%  Similarity=0.452  Sum_probs=166.8

Q ss_pred             hhcCcCCccEEEEEEECC-CCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          306 EVLGKGTFGTAYKAALED-ASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      +.||+|++|+||++...+ +..+++|.+.....  ..+.+.+|++.+++++|+|++++++++......++++||+++++|
T Consensus         5 ~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L   84 (225)
T smart00221        5 KKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDL   84 (225)
T ss_pred             eEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCH
Confidence            469999999999999765 78999999976543  356788999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC----C
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP----P  458 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~----~  458 (615)
                      .+++.....    .+++.....++.+++.++.+||+.+   ++|+|++|+||+++.++.++|+|||.+.......    .
T Consensus        85 ~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (225)
T smart00221       85 FDYLRKKGG----KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK  157 (225)
T ss_pred             HHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence            999975321    1889999999999999999999997   9999999999999999999999999998776543    3


Q ss_pred             CCCCCCcccCcccc-CCCCCCCccchhhHHHHHHHHHhCCCCCCC
Q 007167          459 PAMRAAGYRAPEVT-DTRKATQASDVFSFGVLLLELLTGKSPIHA  502 (615)
Q Consensus       459 ~~~~~~~y~aPE~~-~~~~~~~~~DvwS~Gvvl~elltg~~p~~~  502 (615)
                      ...++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus       158 ~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      158 TVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            33456779999998 666778899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.94  E-value=4.3e-28  Score=251.37  Aligned_cols=241  Identities=22%  Similarity=0.368  Sum_probs=192.0

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEecccc-CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEVN-VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      +.+|.|+||.|||+++ +.+...|||.++-.. ...+..++|+-+++..+|+|||.++|.+..++..+++||||.+|+|.
T Consensus        21 qrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQ  100 (829)
T KOG0576|consen   21 QRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQ  100 (829)
T ss_pred             eeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCccc
Confidence            4699999999999995 467788999987543 33566789999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC---CCCC
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM---PPPA  460 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~---~~~~  460 (615)
                      +.-|..     .++++.+...+.++..+|++|||+.+   =+|||||-.||++++.|.+|++|||.+..+...   ....
T Consensus       101 diy~~T-----gplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati~Krksf  172 (829)
T KOG0576|consen  101 DIYHVT-----GPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSF  172 (829)
T ss_pred             ceeeec-----ccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhhhhhhcc
Confidence            987742     47888899999999999999999998   789999999999999999999999998777543   2345


Q ss_pred             CCCCcccCcccc---CCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccccc-ccCCC
Q 007167          461 MRAAGYRAPEVT---DTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE-LLRYP  536 (615)
Q Consensus       461 ~~~~~y~aPE~~---~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~-~~~~~  536 (615)
                      .||+.|||||+.   ..+.|.+++|||+.|+...|+-.-+.|...........+..           ...+++. +..-.
T Consensus       173 iGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT-----------kS~~qpp~lkDk~  241 (829)
T KOG0576|consen  173 IGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT-----------KSGFQPPTLKDKT  241 (829)
T ss_pred             cCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh-----------ccCCCCCcccCCc
Confidence            689999999987   34568999999999999999988787755433222222211           1122222 22222


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLK  568 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  568 (615)
                      ...+...++++   .|+-++|++||+++.++.
T Consensus       242 kws~~fh~fvK---~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  242 KWSEFFHNFVK---GALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             cchHHHHHHHH---HHhcCCCccCCChhhhee
Confidence            44566666666   899999999999977644

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.93  E-value=3.3e-26  Score=263.77  Aligned_cols=192  Identities=19%  Similarity=0.220  Sum_probs=136.9

Q ss_pred             CCCC-CcccceeEEE-------EecCeeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCC
Q 007167          351 GIRH-ENVVALRAYY-------YSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGG  422 (615)
Q Consensus       351 ~l~h-~niv~l~~~~-------~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~  422 (615)
                      .++| +||++++++|       ...+..+.++||+ +++|.++|+..    ...+++..++.++.||++||+|||+++  
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~g--  100 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP----DRSVDAFECFHVFRQIVEIVNAAHSQG--  100 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc----cccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence            3456 6888888887       2334567778887 66999999632    246999999999999999999999998  


Q ss_pred             CceecCCCCCCEEeCC-------------------CCcEEEeecccccccCCC-------------------CCCCCCCC
Q 007167          423 KLVHGGIKASNIFLNS-------------------QGHVCVSDIGLAALMSPM-------------------PPPAMRAA  464 (615)
Q Consensus       423 ~iiHrDik~~Nill~~-------------------~~~~kl~DfG~a~~~~~~-------------------~~~~~~~~  464 (615)
                       |+||||||+||||+.                   ++.+|++|||+++.....                   .....+|+
T Consensus       101 -IvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  179 (793)
T PLN00181        101 -IVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMS  179 (793)
T ss_pred             -eeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCc
Confidence             999999999999954                   445667777776542110                   00123577


Q ss_pred             cccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHHHHHH
Q 007167          465 GYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVE  544 (615)
Q Consensus       465 ~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~  544 (615)
                      .|+|||++.+..++.++|||||||++|||++|..|+....  ....  .+...         .+.+      ........
T Consensus       180 ~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~--~~~~~---------~~~~------~~~~~~~~  240 (793)
T PLN00181        180 WYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMS--SLRHR---------VLPP------QILLNWPK  240 (793)
T ss_pred             ceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHH--HHHHh---------hcCh------hhhhcCHH
Confidence            7999999999899999999999999999999988864311  1111  00000         0010      00111223


Q ss_pred             HHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          545 MLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       545 l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ...++.+|+..+|.+||+|.|++++
T Consensus       241 ~~~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        241 EASFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             HHHHHHHhCCCChhhCcChHHHhhc
Confidence            3455668999999999999999764

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.93  E-value=9.6e-26  Score=224.01  Aligned_cols=188  Identities=27%  Similarity=0.442  Sum_probs=157.8

Q ss_pred             hhhcCcCCccEEEEEEEC----CCCEEEEEEeccccCCHHHHHHHHHHHhCCC-CCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE----DASTVVVKRLKEVNVGKREFEQQMEIVGGIR-HENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .++||+|.|++||++.+.    ....||+|.+..... ...+.+|+++|..+. +.||+++.+++..++...+|+||++.
T Consensus        41 v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~-p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H  119 (418)
T KOG1167|consen   41 VNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS-PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEH  119 (418)
T ss_pred             hccccccchhhhhhhhHhhhccccceEeeeecccccC-chHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCc
Confidence            568999999999999853    356799999865533 345889999999994 99999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCC-CcEEEeecccccccC----
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQ-GHVCVSDIGLAALMS----  454 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~-~~~kl~DfG~a~~~~----  454 (615)
                      ....++..        .++......++..+..||+|+|..|   ||||||||+|+|.+.. ++-.|+|||+|....    
T Consensus       120 ~~f~~l~~--------~l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~  188 (418)
T KOG1167|consen  120 DRFRDLYR--------SLSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ  188 (418)
T ss_pred             cCHHHHHh--------cCCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence            99888886        4778899999999999999999998   9999999999999854 678999999996210    


Q ss_pred             -------------C-----------------C-------------CCCCCCCCcccCccccCC-CCCCCccchhhHHHHH
Q 007167          455 -------------P-----------------M-------------PPPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLL  490 (615)
Q Consensus       455 -------------~-----------------~-------------~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl  490 (615)
                                   +                 .             .....||+||+|||++.. ...++++||||.||++
T Consensus       189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~  268 (418)
T KOG1167|consen  189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL  268 (418)
T ss_pred             hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence                         0                 0             011246889999999865 4468899999999999


Q ss_pred             HHHHhCCCCCCCCC
Q 007167          491 LELLTGKSPIHATG  504 (615)
Q Consensus       491 ~elltg~~p~~~~~  504 (615)
                      +-+++++.||....
T Consensus       269 Lslls~~~PFf~a~  282 (418)
T KOG1167|consen  269 LSLLSRRYPFFKAK  282 (418)
T ss_pred             ehhhccccccccCc
Confidence            99999999997543

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.92  E-value=2.5e-24  Score=202.11  Aligned_cols=170  Identities=19%  Similarity=0.299  Sum_probs=125.7

Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCC
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP  459 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~  459 (615)
                      |+|.++++..    ...++|..+..|+.|++.||+|||+.+         ||+||+++.++.+|+  ||++.......  
T Consensus         1 GsL~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~--   63 (176)
T smart00750        1 VSLADILEVR----GRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ--   63 (176)
T ss_pred             CcHHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc--
Confidence            6899999743    236999999999999999999999875         999999999999999  99998765432  


Q ss_pred             CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHH-HHHHhhhcccccccccccccCCCCc
Q 007167          460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVR-WVNSVVREEWTAEVFDVELLRYPNI  538 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~d~~~~~~~~~  538 (615)
                      ..++..|+|||++.+..++.++|||||||++|||++|+.||......  ..... +........      .........+
T Consensus        64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~--~~~~~~~~~~~~~~~------~~~~~~~~~~  135 (176)
T smart00750       64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL--SAILEILLNGMPADD------PRDRSNLESV  135 (176)
T ss_pred             CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh--cHHHHHHHHHhccCC------ccccccHHHH
Confidence            25789999999999999999999999999999999999999654321  11111 111111100      0000000011


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          539 EEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       539 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                      .+ ...+.+++.+|+..+|++||++.|+++++..+..
T Consensus       136 ~~-~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      136 SA-ARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             Hh-hhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            11 0145666669999999999999999999987754

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.90  E-value=3.1e-24  Score=200.78  Aligned_cols=243  Identities=21%  Similarity=0.346  Sum_probs=189.6

Q ss_pred             hhcCcCCccEEEEEEECCCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      .+|.+...|+.|+|++. |..+++|++.-...   ..++|..|.-.++-+.||||..++|.|.......++..||+.|+|
T Consensus       196 tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl  274 (448)
T KOG0195|consen  196 TKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL  274 (448)
T ss_pred             hhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence            35888999999999986 45677777754322   246899999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCcee-cCCCCCCEEeCCCCcEEEe--ecccccccCCCCCC
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVH-GGIKASNIFLNSQGHVCVS--DIGLAALMSPMPPP  459 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiH-rDik~~Nill~~~~~~kl~--DfG~a~~~~~~~~~  459 (615)
                      ...||+..   .-.++..++.+++.++|+|++|||+..  +++- --+.+..|++|++.+++|+  |--++.    ....
T Consensus       275 ynvlhe~t---~vvvd~sqav~faldiargmaflhsle--p~ipr~~lns~hvmidedltarismad~kfsf----qe~g  345 (448)
T KOG0195|consen  275 YNVLHEQT---SVVVDHSQAVRFALDIARGMAFLHSLE--PMIPRFYLNSKHVMIDEDLTARISMADTKFSF----QEVG  345 (448)
T ss_pred             HHHHhcCc---cEEEecchHHHHHHHHHhhHHHHhhcc--hhhhhhhcccceEEecchhhhheecccceeee----eccc
Confidence            99999653   235788899999999999999999975  3444 4688999999999998874  322221    1122


Q ss_pred             CCCCCcccCccccCCCCC---CCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          460 AMRAAGYRAPEVTDTRKA---TQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~---~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                      ....+.||+||.++..+-   -.++|+|||++++|||.|...||.+....+..-.+.  .         +-+  +..-.|
T Consensus       346 r~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkia--l---------egl--rv~ipp  412 (448)
T KOG0195|consen  346 RAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIA--L---------EGL--RVHIPP  412 (448)
T ss_pred             cccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhh--h---------ccc--cccCCC
Confidence            345678999999976553   357899999999999999999999877655432111  0         000  112356


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIR  574 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~  574 (615)
                      +++..+.+++.   -|+..||.+||.+..|+-.|++++
T Consensus       413 gis~hm~klm~---icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  413 GISRHMNKLMN---ICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             CccHHHHHHHH---HHhcCCCCcCCCcceehhhHHHhc
Confidence            77777777777   799999999999999999999875

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=1.5e-22  Score=208.35  Aligned_cols=153  Identities=16%  Similarity=0.218  Sum_probs=118.7

Q ss_pred             hhhcCcCCccEEEEEEEC--CCCEEEEEEecccc------CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAALE--DASTVVVKRLKEVN------VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      .+.||+|+||+||+|...  +++.||||++....      ...+.|.+|+++++.++|+|++..+..   .+..++||||
T Consensus        23 ~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVmE~   99 (365)
T PRK09188         23 TAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVRGW   99 (365)
T ss_pred             ccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEEEc
Confidence            457999999999999864  56778999875321      113568999999999999999963322   2468999999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCC-CCCCEEeCCCCcEEEeecccccccCC
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGI-KASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDi-k~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      +++++|... ..        ..   ...++.++++||+|||+.+   |+|||| ||+|||++.++.+||+|||+|+.+..
T Consensus       100 ~~G~~L~~~-~~--------~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~  164 (365)
T PRK09188        100 TEGVPLHLA-RP--------HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRR  164 (365)
T ss_pred             cCCCCHHHh-Cc--------cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECccceeccc
Confidence            999999632 11        00   1457889999999999998   999999 99999999999999999999987654


Q ss_pred             CC-----------CCCCCCCcccCccccCCC
Q 007167          456 MP-----------PPAMRAAGYRAPEVTDTR  475 (615)
Q Consensus       456 ~~-----------~~~~~~~~y~aPE~~~~~  475 (615)
                      ..           ....++..|+|||++...
T Consensus       165 ~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        165 RGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             CcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            32           123356679999998543

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.88  E-value=4.6e-21  Score=197.67  Aligned_cols=253  Identities=18%  Similarity=0.209  Sum_probs=187.0

Q ss_pred             hhhcCcCCccEEEEEEECCC--CEEEEEEeccccCC-HHHHHHHHHHHhCCCC----CcccceeEEE-EecCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAALEDA--STVVVKRLKEVNVG-KREFEQQMEIVGGIRH----ENVVALRAYY-YSKDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~--~~vavK~l~~~~~~-~~~~~~e~~~l~~l~h----~niv~l~~~~-~~~~~~~lV~e~  376 (615)
                      .+.||+|+||.||++.....  ..+|+|.-...... ...+..|..++..+..    +++..+++.. ......++||+.
T Consensus        23 ~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l  102 (322)
T KOG1164|consen   23 GKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSL  102 (322)
T ss_pred             eeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEec
Confidence            45799999999999996654  36777776554221 2267788888888763    5888888888 477789999998


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCC-----CcEEEeeccccc
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQ-----GHVCVSDIGLAA  451 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~-----~~~kl~DfG~a~  451 (615)
                      + |.+|.++.....   ...++-.+..+|+.|++.+|++||+.|   ++||||||.|++++..     ..+.|.|||+++
T Consensus       103 ~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar  175 (322)
T KOG1164|consen  103 L-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR  175 (322)
T ss_pred             c-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence            8 779999875432   457999999999999999999999998   9999999999999865     468999999998


Q ss_pred             ccC--CC-----------CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHh
Q 007167          452 LMS--PM-----------PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSV  518 (615)
Q Consensus       452 ~~~--~~-----------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~  518 (615)
                      ...  ..           .....||..|.++....+...+.+.|+||++.++.|+..|..||.............   ..
T Consensus       176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~---~~  252 (322)
T KOG1164|consen  176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE---KD  252 (322)
T ss_pred             cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH---HH
Confidence            321  11           112237889999999999999999999999999999999999997654332221111   11


Q ss_pred             hhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhh
Q 007167          519 VREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVK  577 (615)
Q Consensus       519 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~  577 (615)
                      .....    ...   .....+.+...+.+   .+-..+..++|....+.+.+++.....
T Consensus       253 ~~~~~----~~~---~~~~~~~~~~~~~~---~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  253 PRKLL----TDR---FGDLKPEEFAKILE---YIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             hhhhc----ccc---ccCCChHHHHHHHH---HhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            11100    000   11223344545544   444578999999999999998887654

>PLN03150 hypothetical protein; Provisional

Probab=99.86  E-value=1.6e-21  Score=216.81  Aligned_cols=149  Identities=28%  Similarity=0.555  Sum_probs=109.6

Q ss_pred             CCChhHHHHHHHHHHhcCCCCCCCCCCCCCCCC----CCcceEecCCC----CcEEEEEeCCCCcccccCCCcccCCCCc
Q 007167           23 ADPVEDKQALLDFIHNIHNSRSLNWNESSSLCK----SWTGVTCSADH----SRVVALRLPGMALRGEIPPNTIGRLSAL   94 (615)
Q Consensus        23 ~~~~~d~~al~~~k~~~~~~~~~~w~~~~~~c~----~w~gv~C~~~~----~~v~~l~l~~~~l~g~i~~~~~~~l~~L   94 (615)
                      .+.++|.+||+.+|..+..+...+|++  ++|+    .|.||.|+...    .+|+.|+|++|+|+|.+|+ .++.|++|
T Consensus       368 ~t~~~~~~aL~~~k~~~~~~~~~~W~g--~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~-~i~~L~~L  444 (623)
T PLN03150        368 KTLLEEVSALQTLKSSLGLPLRFGWNG--DPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPN-DISKLRHL  444 (623)
T ss_pred             ccCchHHHHHHHHHHhcCCcccCCCCC--CCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCH-HHhCCCCC
Confidence            456679999999999997665568974  4553    69999996321    2477888888888877777 67778888


Q ss_pred             cEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeecCCCcCCccCCCcccCC-CCCCeeeccC
Q 007167           95 QNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKL-THLSALNLAN  173 (615)
Q Consensus        95 ~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l-~~L~~l~l~~  173 (615)
                      +.|+|++|+|+|.+|..+++|++|+.|+|++|+|+|.+|..+++|++|+.|+|++|+|+|.+|..+..+ .++..+++++
T Consensus       445 ~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~  524 (623)
T PLN03150        445 QSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTD  524 (623)
T ss_pred             CEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecC
Confidence            888888888887778778888888888888888887777777777777777777777777777766543 2333444433


Q ss_pred             c
Q 007167          174 N  174 (615)
Q Consensus       174 N  174 (615)
                      |
T Consensus       525 N  525 (623)
T PLN03150        525 N  525 (623)
T ss_pred             C
Confidence            3

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.86  E-value=8.6e-21  Score=182.81  Aligned_cols=254  Identities=16%  Similarity=0.195  Sum_probs=190.6

Q ss_pred             HHhhhcCcCCccEEEEEE-ECCCCEEEEEEeccccCCHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          303 ASAEVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNVGKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       303 ~~~~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .++++||+|.||+.+.|+ +-++..||||.- ......-.+..|.+..+.+ ..+.|-.++-|-.+..+-.||+|++ |.
T Consensus        31 rVGkKIGeGsFG~lf~G~Nl~nne~VAIKfE-PrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GP  108 (449)
T KOG1165|consen   31 RVGKKIGEGSFGVLFLGKNLYNNEPVAIKFE-PRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GP  108 (449)
T ss_pred             eeccccccCcceeeecccccccCceEEEEec-cccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-Cc
Confidence            457889999999999998 567899999854 3333344566777766666 4688888887777888889999998 77


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCC-----CcEEEeecccccccCC
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQ-----GHVCVSDIGLAALMSP  455 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~-----~~~kl~DfG~a~~~~~  455 (615)
                      ||.|+..-.    ...++..++..|++|+..-++|+|++.   +|.|||||+|+||...     ..+.|+|||+|+.+.+
T Consensus       109 SLEDLFD~C----gR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  109 SLEDLFDLC----GRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             CHHHHHHHh----cCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            999887632    347999999999999999999999998   9999999999999754     3589999999998865


Q ss_pred             CCC----------CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccc
Q 007167          456 MPP----------PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTA  525 (615)
Q Consensus       456 ~~~----------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (615)
                      +.+          ...||.+||+--...++.-+.+.|.=|+|-|+++.+.|..||.+.......+..+.+...-+.....
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~  261 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIE  261 (449)
T ss_pred             ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHH
Confidence            432          3457899999998899999999999999999999999999999865444333332222211111111


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          526 EVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       526 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                      +     +  ..++++++..-++.+.   ..+-.+-|..+-+...+.++-+
T Consensus       262 ~-----L--c~g~P~efa~Yl~yvR---~L~F~E~PDYdylr~Lf~dvld  301 (449)
T KOG1165|consen  262 V-----L--CEGFPEEFATYLRYVR---RLDFFETPDYDYLRKLFDDVLD  301 (449)
T ss_pred             H-----H--HhcCHHHHHHHHHHHH---hcCcccCCCHHHHHHHHHHHHH
Confidence            1     1  1245566666666443   3456677888888777777654

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.86  E-value=2.2e-20  Score=191.97  Aligned_cols=250  Identities=24%  Similarity=0.382  Sum_probs=187.8

Q ss_pred             hhcCcCCccEEEEEEECCCCEEEEEEeccccC----CHHHHHHHHHHHhCCCCC-cccceeEEEEecCeeeEEeecCCCC
Q 007167          306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNV----GKREFEQQMEIVGGIRHE-NVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~-niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      +.||.|+||.||++...  ..+++|.+.....    ....+.+|+.+++.+.|+ +++++.+++......+++++|+.++
T Consensus         6 ~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~   83 (384)
T COG0515           6 RKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGG   83 (384)
T ss_pred             EeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCC
Confidence            46899999999999876  7889999876532    256788999999999988 7999999997777789999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCC-cEEEeecccccccCCCC--
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG-HVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~-~~kl~DfG~a~~~~~~~--  457 (615)
                      ++.+++......  ..+.......++.+++.++.|+|+.+   ++|||+||+||+++..+ .++++|||.+..+....  
T Consensus        84 ~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          84 SLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             cHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            999776532211  36888899999999999999999998   99999999999999998 79999999998664332  


Q ss_pred             -------CCCCCCCcccCccccCC---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCc-chhhHHHHHHHhhhcccccc
Q 007167          458 -------PPAMRAAGYRAPEVTDT---RKATQASDVFSFGVLLLELLTGKSPIHATGGD-EVVHLVRWVNSVVREEWTAE  526 (615)
Q Consensus       458 -------~~~~~~~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~  526 (615)
                             ....++..|+|||....   ..+....|+||+|++++++++|..||...... ........+......     
T Consensus       159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-----  233 (384)
T COG0515         159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP-----  233 (384)
T ss_pred             ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc-----
Confidence                   34467889999999987   57889999999999999999999997665431 011111111111100     


Q ss_pred             cccccccCCCCc-HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          527 VFDVELLRYPNI-EEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       527 ~~d~~~~~~~~~-~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ......  .... ......+.+++..|+..+|..|.++.+....
T Consensus       234 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         234 SLASPL--SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cccccc--CccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            000000  0000 1112234445558999999999999988775

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.86  E-value=3.2e-21  Score=228.35  Aligned_cols=154  Identities=38%  Similarity=0.675  Sum_probs=109.1

Q ss_pred             ChhHHHHHHHHHHhcCCC--CCCCCCCCCCCCCCCcceEecCCCCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCC
Q 007167           25 PVEDKQALLDFIHNIHNS--RSLNWNESSSLCKSWTGVTCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSN  102 (615)
Q Consensus        25 ~~~d~~al~~~k~~~~~~--~~~~w~~~~~~c~~w~gv~C~~~~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N  102 (615)
                      .++|..||++||+++.++  ...+|+...++| .|.||+|++ .++|+.|+|++|+++|.+++ .|..+++|+.|+|++|
T Consensus        27 ~~~~~~~l~~~~~~~~~~~~~~~~w~~~~~~c-~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~-~~~~l~~L~~L~Ls~n  103 (968)
T PLN00113         27 HAEELELLLSFKSSINDPLKYLSNWNSSADVC-LWQGITCNN-SSRVVSIDLSGKNISGKISS-AIFRLPYIQTINLSNN  103 (968)
T ss_pred             CHHHHHHHHHHHHhCCCCcccCCCCCCCCCCC-cCcceecCC-CCcEEEEEecCCCccccCCh-HHhCCCCCCEEECCCC
Confidence            457999999999999654  345898666666 999999985 56999999999999998876 7899999999999999


Q ss_pred             CCCCcCCCCcc-ccccCcEEecccccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCc
Q 007167          103 SLSGLFPSDFS-KLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLP  181 (615)
Q Consensus       103 ~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p  181 (615)
                      +++|.+|..+. ++++|++|+|++|+++|.+|.  +.+++|++|+|++|.+++.+|..++++++|+.|+|++|.+++.+|
T Consensus       104 ~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p  181 (968)
T PLN00113        104 QLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIP  181 (968)
T ss_pred             ccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCC
Confidence            99988887755 777777777777777665553  234444444444444444444444444444444444444444444


Q ss_pred             cc
Q 007167          182 RS  183 (615)
Q Consensus       182 ~~  183 (615)
                      ..
T Consensus       182 ~~  183 (968)
T PLN00113        182 NS  183 (968)
T ss_pred             hh
Confidence            43

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.84  E-value=2.4e-20  Score=172.19  Aligned_cols=191  Identities=18%  Similarity=0.265  Sum_probs=156.8

Q ss_pred             hhcCcCCccEEEEEE-ECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCC-CcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          306 EVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRH-ENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      ++||.|+||.+|.|. ..+|.+||||.-... .....+..|..+.+.+++ ..|..+..|..++++-.+|||.+ |.||.
T Consensus        21 rkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~-a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLE   98 (341)
T KOG1163|consen   21 RKIGSGSFGDIYLGISITSGEEVAIKLESSK-AKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLE   98 (341)
T ss_pred             EeecCCchhheeeeeeccCCceEEEEeeccc-CCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHH
Confidence            579999999999998 678999999975432 334456778888777764 56666777788888999999998 77999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCC---CcEEEeecccccccCCC----
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQ---GHVCVSDIGLAALMSPM----  456 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~---~~~kl~DfG~a~~~~~~----  456 (615)
                      ++..-.    ...++-.+.+.++-|+..-++|+|.++   +|||||||+|.|+.-+   ..+.++|||+|+.+.+.    
T Consensus        99 dLfnfC----~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~  171 (341)
T KOG1163|consen   99 DLFNFC----SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQ  171 (341)
T ss_pred             HHHHHH----hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhccccccc
Confidence            988643    246888999999999999999999998   9999999999999754   45889999999877542    


Q ss_pred             ------CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 007167          457 ------PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGG  505 (615)
Q Consensus       457 ------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~  505 (615)
                            .....||..|.+--...+...+.+.|+=|+|.||.+.-.|..||++...
T Consensus       172 HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka  226 (341)
T KOG1163|consen  172 HIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA  226 (341)
T ss_pred             cCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence                  2234578889888777777778899999999999999999999988654

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.84  E-value=1.2e-20  Score=178.66  Aligned_cols=138  Identities=12%  Similarity=0.186  Sum_probs=107.2

Q ss_pred             hhcCcCCccEEEEEEECCCCEEEEEEeccccCC---H-------HH-----------------HHHHHHHHhCCCCCccc
Q 007167          306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVG---K-------RE-----------------FEQQMEIVGGIRHENVV  358 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~-------~~-----------------~~~e~~~l~~l~h~niv  358 (615)
                      +.||+|+||+||+|...+|+.||||+++.....   .       ..                 ..+|++.+.++.++++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~   82 (190)
T cd05147           3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP   82 (190)
T ss_pred             CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence            469999999999999888999999999754211   0       11                 23488899999887774


Q ss_pred             ceeEEEEecCeeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh-hccCCCCceecCCCCCCEEeC
Q 007167          359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHI-HTENGGKLVHGGIKASNIFLN  437 (615)
Q Consensus       359 ~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~iiHrDik~~Nill~  437 (615)
                      ....+..  ...++||||++++++......     ...+++.....++.|++.+|.|+ |+.+   |+||||||+||+++
T Consensus        83 ~p~~~~~--~~~~iVmE~i~g~~l~~~~~~-----~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~  152 (190)
T cd05147          83 CPEPILL--KSHVLVMEFIGDDGWAAPRLK-----DAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH  152 (190)
T ss_pred             CCcEEEe--cCCEEEEEEeCCCCCcchhhh-----cCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE
Confidence            4333322  234899999998876654321     13588899999999999999999 6877   99999999999998


Q ss_pred             CCCcEEEeecccccccC
Q 007167          438 SQGHVCVSDIGLAALMS  454 (615)
Q Consensus       438 ~~~~~kl~DfG~a~~~~  454 (615)
                       ++.++|+|||+|....
T Consensus       153 -~~~v~LiDFG~a~~~~  168 (190)
T cd05147         153 -DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             -CCcEEEEEccccccCC
Confidence             4789999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=1.5e-21  Score=214.03  Aligned_cols=247  Identities=17%  Similarity=0.208  Sum_probs=175.5

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEec----cccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLK----EVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~----~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      ..++|.|++|.|+..... +....+.|...    .....   ...+..|+-+-..++|+|++..+..+.+.....-+|||
T Consensus       323 ~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~  402 (601)
T KOG0590|consen  323 GRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEY  402 (601)
T ss_pred             cceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhhc
Confidence            567999999988877633 33334444332    11111   11145567777788999998887777766666666999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM  456 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~  456 (615)
                      +++ +|+.++...     ..+.-..+-.++.|+..|+.|+|+.|   |.|||+|++|+++..++.+||+|||.+......
T Consensus       403 ~~~-Dlf~~~~~~-----~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~  473 (601)
T KOG0590|consen  403 CPY-DLFSLVMSN-----GKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYP  473 (601)
T ss_pred             ccH-HHHHHHhcc-----cccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccC
Confidence            999 999999743     25777788889999999999999999   999999999999999999999999999776533


Q ss_pred             C-------CCCCCCCcccCccccCCCCCCC-ccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccc
Q 007167          457 P-------PPAMRAAGYRAPEVTDTRKATQ-ASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVF  528 (615)
Q Consensus       457 ~-------~~~~~~~~y~aPE~~~~~~~~~-~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  528 (615)
                      .       ....++..|+|||.+....|.. ..||||.|+++..|++|+.||......+...     .......+   .-
T Consensus       474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~-----~~~~~~~~---~~  545 (601)
T KOG0590|consen  474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSF-----KTNNYSDQ---RN  545 (601)
T ss_pred             cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccch-----hhhccccc---cc
Confidence            2       2345677899999999988854 6799999999999999999998765443321     00000000   00


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          529 DVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       529 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ... ....-..........++.++++.+|.+|.|+++|++.
T Consensus       546 ~~~-~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  546 IFE-GPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             ccc-ChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence            000 0000111222333445559999999999999999863

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=5.7e-20  Score=172.10  Aligned_cols=180  Identities=16%  Similarity=0.134  Sum_probs=137.6

Q ss_pred             hhcCcCCccEEEEEEECCCCEEEEEEeccccCCHH-----HHHHHHHHHhCCC-CCcccceeEEEEecCeeeEEeecCCC
Q 007167          306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKR-----EFEQQMEIVGGIR-HENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~-----~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      ..|++|+||+||.+.. ++.+++.+.+.......+     -+.+|+++++++. |+++.+++++    +..+++|||+.|
T Consensus         8 ~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G   82 (218)
T PRK12274          8 EPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAG   82 (218)
T ss_pred             eeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecC
Confidence            4699999999997765 678888888876644322     5789999999995 5789999886    457999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCC-CCCCEEeCCCCcEEEeecccccccCCCCC
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGI-KASNIFLNSQGHVCVSDIGLAALMSPMPP  458 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDi-k~~Nill~~~~~~kl~DfG~a~~~~~~~~  458 (615)
                      .+|...+..            ....++.|++++|+++|+.+   |+|||| ||+|||++.++.++|+|||++....+...
T Consensus        83 ~~L~~~~~~------------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         83 AAMYQRPPR------------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             ccHHhhhhh------------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence            988654321            11346789999999999998   999999 79999999999999999999986554321


Q ss_pred             C----------------CCCCCcccCccccCCC-CCC-CccchhhHHHHHHHHHhCCCCCCCCCC
Q 007167          459 P----------------AMRAAGYRAPEVTDTR-KAT-QASDVFSFGVLLLELLTGKSPIHATGG  505 (615)
Q Consensus       459 ~----------------~~~~~~y~aPE~~~~~-~~~-~~~DvwS~Gvvl~elltg~~p~~~~~~  505 (615)
                      .                ...+++|++|+-..-. ..+ ...+.++-|.-+|.++|++.+..+.++
T Consensus       148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence            0                1134556666643221 222 567899999999999999998876543

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.82  E-value=7.4e-20  Score=173.80  Aligned_cols=138  Identities=16%  Similarity=0.241  Sum_probs=109.7

Q ss_pred             hhcCcCCccEEEEEEECCCCEEEEEEeccccCC---------------------------HHHHHHHHHHHhCCCCCccc
Q 007167          306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVG---------------------------KREFEQQMEIVGGIRHENVV  358 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---------------------------~~~~~~e~~~l~~l~h~niv  358 (615)
                      ..||+|+||+||+|...+|+.||||+++.....                           ...+..|.+.+.++.|+++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~   82 (190)
T cd05145           3 GCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVP   82 (190)
T ss_pred             ceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCC
Confidence            469999999999999878999999998754211                           11235788899999999886


Q ss_pred             ceeEEEEecCeeeEEeecCCCCChhhh-hccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCceecCCCCCCEEe
Q 007167          359 ALRAYYYSKDEKLMVYDYFEPGSVSAM-LHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT-ENGGKLVHGGIKASNIFL  436 (615)
Q Consensus       359 ~l~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~iiHrDik~~Nill  436 (615)
                      ....+...  ..++||||++++++... +..      ..++.....+++.+++.++.++|+ .+   |+||||||+||++
T Consensus        83 ~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~------~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll  151 (190)
T cd05145          83 VPEPILLK--KNVLVMEFIGDDGSPAPRLKD------VPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILY  151 (190)
T ss_pred             CceEEEec--CCEEEEEEecCCCchhhhhhh------ccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEE
Confidence            55544433  34899999998855433 321      246778889999999999999999 87   9999999999999


Q ss_pred             CCCCcEEEeecccccccCC
Q 007167          437 NSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       437 ~~~~~~kl~DfG~a~~~~~  455 (615)
                      + ++.++|+|||+++.+..
T Consensus       152 ~-~~~~~liDFG~a~~~~~  169 (190)
T cd05145         152 H-DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             E-CCCEEEEEcccceecCC
Confidence            9 88999999999987653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.82  E-value=1.9e-20  Score=179.20  Aligned_cols=163  Identities=14%  Similarity=0.206  Sum_probs=126.2

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHH----------HHHHHHHHhCCCCCcccceeEEEEec-------
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKRE----------FEQQMEIVGGIRHENVVALRAYYYSK-------  367 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~----------~~~e~~~l~~l~h~niv~l~~~~~~~-------  367 (615)
                      .+++|.|+||.||.+.. ++..+|+|.+.......+.          +++|++.+.+++|++|..+..++...       
T Consensus        36 ~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~  114 (232)
T PRK10359         36 IKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRY  114 (232)
T ss_pred             EEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccc
Confidence            46899999999999765 5778999999755332222          68899999999999999998886643       


Q ss_pred             -CeeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEee
Q 007167          368 -DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSD  446 (615)
Q Consensus       368 -~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~D  446 (615)
                       ...++||||++|.+|.++..         ++.    ....+++.++..+|+.+   ++|||+||+||++++++ ++|+|
T Consensus       115 ~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liD  177 (232)
T PRK10359        115 AHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIID  177 (232)
T ss_pred             cCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEE
Confidence             35789999999999987742         222    24568999999999998   99999999999999988 99999


Q ss_pred             cccccccCCCCCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHH
Q 007167          447 IGLAALMSPMPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELL  494 (615)
Q Consensus       447 fG~a~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ell  494 (615)
                      ||...........         ..+.....+..++|+||||+++....
T Consensus       178 fg~~~~~~e~~a~---------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        178 LSGKRCTAQRKAK---------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCCcccccchhhH---------HHHHHHhHhcccccccceeEeehHHH
Confidence            9987655321110         01334445667999999999877654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.80  E-value=1e-20  Score=197.66  Aligned_cols=223  Identities=23%  Similarity=0.353  Sum_probs=173.5

Q ss_pred             cCcCCccEEEEEE----ECCCCEEEEEEeccccCC---HHHHHHHHHHHhCCC-CCcccceeEEEEecCeeeEEeecCCC
Q 007167          308 LGKGTFGTAYKAA----LEDASTVVVKRLKEVNVG---KREFEQQMEIVGGIR-HENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       308 lG~G~fg~Vy~~~----~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      +|+|+||.|+.+.    .+.+.-+|+|.+++....   +.....|..++..++ ||.+|++.-.++.+...+++++|..+
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg   81 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG   81 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence            7999999998754    344666888887654211   113445777888886 99999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCC
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP  459 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~  459 (615)
                      |+|...+...     ..+++.....+...++-+++++|+.+   |+|||+|++||+++.+|++++.|||+++..-.....
T Consensus        82 g~lft~l~~~-----~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~  153 (612)
T KOG0603|consen   82 GDLFTRLSKE-----VMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA  153 (612)
T ss_pred             chhhhccccC-----CchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhhhc
Confidence            9999888643     35777777788889999999999998   999999999999999999999999999877554433


Q ss_pred             CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                       ++|..|||||++.  .....+|.||||++++||+||..||..    +....+      ..         ..+.......
T Consensus       154 -cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~I------l~---------~~~~~p~~l~  211 (612)
T KOG0603|consen  154 -CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRI------LK---------AELEMPRELS  211 (612)
T ss_pred             -ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHH------hh---------hccCCchhhh
Confidence             8899999999998  567889999999999999999999976    222111      11         1111222344


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCH
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKM  563 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~  563 (615)
                      .+..+++.   .++..+|..|.-.
T Consensus       212 ~~a~~~~~---~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  212 AEARSLFR---QLFKRNPENRLGA  232 (612)
T ss_pred             HHHHHHHH---HHHhhCHHHHhcc
Confidence            55556665   6777888888754

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.80  E-value=4.1e-19  Score=185.98  Aligned_cols=215  Identities=22%  Similarity=0.359  Sum_probs=161.3

Q ss_pred             HhCCCCCcccceeEEEEecCeeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecC
Q 007167          349 VGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGG  428 (615)
Q Consensus       349 l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrD  428 (615)
                      |+.+.|.|+.+++|.+.+....+.|.+|+..|+|.+.+...    ...++|.-...++.+++.||+|+|...  -..|+.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~----~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~   74 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE----DIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGA   74 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc----ccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeee
Confidence            35678999999999999999999999999999999999752    346899999999999999999999864  239999


Q ss_pred             CCCCCEEeCCCCcEEEeecccccccCCCCCCCC-----CCCcccCccccCCC-------CCCCccchhhHHHHHHHHHhC
Q 007167          429 IKASNIFLNSQGHVCVSDIGLAALMSPMPPPAM-----RAAGYRAPEVTDTR-------KATQASDVFSFGVLLLELLTG  496 (615)
Q Consensus       429 ik~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~-----~~~~y~aPE~~~~~-------~~~~~~DvwS~Gvvl~elltg  496 (615)
                      ++++|+++|..+.+||+|||+............     ...=|.|||.+...       ..+.+.||||||++++|+++.
T Consensus        75 l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r  154 (484)
T KOG1023|consen   75 LKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFR  154 (484)
T ss_pred             eccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhc
Confidence            999999999999999999999887753111111     12239999998653       146789999999999999999


Q ss_pred             CCCCCCCCCcch-hhHHHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          497 KSPIHATGGDEV-VHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       497 ~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                      +.||+.....+. ..++..+..     .....+.+.+....   +...+++.++..||..+|.+||++++|-..++.+..
T Consensus       155 ~~~~~~~~~~~~~~eii~~~~~-----~~~~~~rP~i~~~~---e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  155 SGPFDLRNLVEDPDEIILRVKK-----GGSNPFRPSIELLN---ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             cCccccccccCChHHHHHHHHh-----cCCCCcCcchhhhh---hcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            999986433221 223332222     11122222222111   112246666679999999999999999998888766


Q ss_pred             hh
Q 007167          576 VK  577 (615)
Q Consensus       576 ~~  577 (615)
                      ..
T Consensus       227 ~~  228 (484)
T KOG1023|consen  227 GG  228 (484)
T ss_pred             cc
Confidence            43

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.76  E-value=3.9e-19  Score=194.50  Aligned_cols=238  Identities=24%  Similarity=0.327  Sum_probs=167.3

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEecccc--CCHHHHHHHHHH--HhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVN--VGKREFEQQMEI--VGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~--~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .+.||++.|=.|.+|+.++|. |+||++-+..  ..-+.|.++++-  ...++|||++++.-+-..+...|||-+|..+ 
T Consensus        28 ~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqyvkh-  105 (1431)
T KOG1240|consen   28 VENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQYVKH-  105 (1431)
T ss_pred             ecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHHHhh-
Confidence            346999999999999988887 8889886542  233445444332  4556899999988776667777889888855 


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccC--CCCC
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS--PMPP  458 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~--~~~~  458 (615)
                      +|.|.|..+     +.+......-|+.|++.||.-+|..+   |.|||||.+||||+.-+.+.|+||..-+...  ....
T Consensus       106 nLyDRlSTR-----PFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNP  177 (1431)
T KOG1240|consen  106 NLYDRLSTR-----PFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNP  177 (1431)
T ss_pred             hhhhhhccc-----hHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCc
Confidence            888888643     35777778889999999999999998   9999999999999999999999998664331  1111


Q ss_pred             --------CCCCCCcccCccccCCC-----------CCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHh
Q 007167          459 --------PAMRAAGYRAPEVTDTR-----------KATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSV  518 (615)
Q Consensus       459 --------~~~~~~~y~aPE~~~~~-----------~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~  518 (615)
                              +..+-..|.|||.+...           ..+++.||||+|||++||++ |++||.-      -++..+-.  
T Consensus       178 adf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L------SQL~aYr~--  249 (1431)
T KOG1240|consen  178 ADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL------SQLLAYRS--  249 (1431)
T ss_pred             ccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH------HHHHhHhc--
Confidence                    11122359999987431           14678899999999999998 8888842      11111100  


Q ss_pred             hhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          519 VREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       519 ~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                            ....+++.. ...+++  ..+..+++.|++.||.+|.++++.++.
T Consensus       250 ------~~~~~~e~~-Le~Ied--~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  250 ------GNADDPEQL-LEKIED--VSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             ------cCccCHHHH-HHhCcC--ccHHHHHHHHHccCchhccCHHHHHHh
Confidence                  000111100 000111  134455558999999999999999986

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.76  E-value=5.9e-19  Score=174.07  Aligned_cols=228  Identities=19%  Similarity=0.326  Sum_probs=142.5

Q ss_pred             hhcCcCCccEEEEEEECC-CCEEEEEEeccccC----CHHHHHHHHHHHhCCCC-----------CcccceeEEEE----
Q 007167          306 EVLGKGTFGTAYKAALED-ASTVVVKRLKEVNV----GKREFEQQMEIVGGIRH-----------ENVVALRAYYY----  365 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h-----------~niv~l~~~~~----  365 (615)
                      +.||.|+++.||.+++.+ ++++|||.+.-...    +.+.+.+|.-....+.+           .-++.+ +...    
T Consensus        18 ~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~-d~~~i~~~   96 (288)
T PF14531_consen   18 RIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL-DLLRIPGK   96 (288)
T ss_dssp             EEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S-EEEEETTS
T ss_pred             cccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee-EEEEEcCC
Confidence            469999999999999764 78899998754321    23455555544443322           122221 1111    


Q ss_pred             -----ec---C-----eeeEEeecCCCCChhhhhccC--CCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCC
Q 007167          366 -----SK---D-----EKLMVYDYFEPGSVSAMLHGR--RGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIK  430 (615)
Q Consensus       366 -----~~---~-----~~~lV~e~~~~gsL~~~l~~~--~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik  430 (615)
                           ..   .     ..+++|+-+ .++|.+++..-  .......+....++.+..|+.+.+++||..|   ++|+|||
T Consensus        97 ~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHgdi~  172 (288)
T PF14531_consen   97 PPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHGDIK  172 (288)
T ss_dssp             -SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEEST-S
T ss_pred             CcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEecccc
Confidence                 11   1     235677776 56888775421  1111234556677888899999999999998   9999999


Q ss_pred             CCCEEeCCCCcEEEeecccccccCCCCCCCCCCCcccCccccCC--------CCCCCccchhhHHHHHHHHHhCCCCCCC
Q 007167          431 ASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDT--------RKATQASDVFSFGVLLLELLTGKSPIHA  502 (615)
Q Consensus       431 ~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DvwS~Gvvl~elltg~~p~~~  502 (615)
                      |+|++++.+|.++|+||+.....+........+.+|.+||....        -.++.+.|.|++|+++|.|++|+.||..
T Consensus       173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~  252 (288)
T PF14531_consen  173 PENFLLDQDGGVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGL  252 (288)
T ss_dssp             GGGEEE-TTS-EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCC
T ss_pred             eeeEEEcCCCCEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCC
Confidence            99999999999999999987766543322344577999997743        2468899999999999999999999976


Q ss_pred             CCCcchhhHHHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCC
Q 007167          503 TGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEER  560 (615)
Q Consensus       503 ~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R  560 (615)
                      ........                   ........+++.++.+++   .+++.+|++|
T Consensus       253 ~~~~~~~~-------------------~~f~~C~~~Pe~v~~LI~---~lL~~~~~~R  288 (288)
T PF14531_consen  253 SSPEADPE-------------------WDFSRCRDMPEPVQFLIR---GLLQRNPEDR  288 (288)
T ss_dssp             CGGGSTSG-------------------GGGTTSS---HHHHHHHH---HHT-SSGGGS
T ss_pred             CCcccccc-------------------ccchhcCCcCHHHHHHHH---HHccCCcccC
Confidence            43221110                   012222355667777776   8999999887

>PRK10345 hypothetical protein; Provisional

Probab=99.75  E-value=7.2e-18  Score=161.12  Aligned_cols=133  Identities=12%  Similarity=0.112  Sum_probs=102.4

Q ss_pred             hhcCcCCccEEEEEEECCCCEEEEEEeccc-cCCHHHHHHHHHHHhCC-----CCCcccceeEEEEecC---e-eeEEee
Q 007167          306 EVLGKGTFGTAYKAALEDASTVVVKRLKEV-NVGKREFEQQMEIVGGI-----RHENVVALRAYYYSKD---E-KLMVYD  375 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~~e~~~l~~l-----~h~niv~l~~~~~~~~---~-~~lV~e  375 (615)
                      +.||+|+||.||.  ..+....+||++... ....+.+.+|+++++.+     .||||++++|++.++.   . ..+|+|
T Consensus         8 ~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e   85 (210)
T PRK10345          8 SPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIAD   85 (210)
T ss_pred             ceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEec
Confidence            5699999999996  333333468887643 22356789999999999     5799999999998874   3 337899


Q ss_pred             c--CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHH-HHhhccCCCCceecCCCCCCEEeCC----CCcEEEeecc
Q 007167          376 Y--FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGI-AHIHTENGGKLVHGGIKASNIFLNS----QGHVCVSDIG  448 (615)
Q Consensus       376 ~--~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l-~~LH~~~~~~iiHrDik~~Nill~~----~~~~kl~DfG  448 (615)
                      |  +.+|+|.+++...      .+++.  ..++.+++.++ +|||+.+   |+||||||+|||++.    +..++|+||+
T Consensus        86 ~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         86 FDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             CCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            9  5579999999642      24444  35577777777 9999998   999999999999974    3479999955


Q ss_pred             ccc
Q 007167          449 LAA  451 (615)
Q Consensus       449 ~a~  451 (615)
                      .+.
T Consensus       155 G~~  157 (210)
T PRK10345        155 GES  157 (210)
T ss_pred             CCc
Confidence            443

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.72  E-value=4e-17  Score=157.98  Aligned_cols=133  Identities=17%  Similarity=0.382  Sum_probs=112.7

Q ss_pred             hhcCcCCccEEEEEEECCCCEEEEEEeccccCC---------HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeec
Q 007167          306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVG---------KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      +.||+|++|.||+|.. ++..|++|+.......         ...+.+|++++..++|+++.....++...+..++||||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~   80 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY   80 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence            4699999999999987 6678999986543211         23467899999999999998888888788889999999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccc
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAAL  452 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~  452 (615)
                      +++++|.+++...        .+ .+..++.+++.+|.++|+.+   ++|||++|.||+++ ++.++|+|||.+..
T Consensus        81 ~~G~~L~~~~~~~--------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         81 IEGEPLKDLINSN--------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             eCCcCHHHHHHhc--------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            9999999998632        12 78889999999999999998   99999999999999 78899999998764

>smart00090 RIO RIO-like kinase

Probab=99.72  E-value=4.5e-17  Score=159.49  Aligned_cols=140  Identities=14%  Similarity=0.208  Sum_probs=106.8

Q ss_pred             HhhhcCcCCccEEEEEE--ECCCCEEEEEEeccccCC-------------------------HHHHHHHHHHHhCCCCCc
Q 007167          304 SAEVLGKGTFGTAYKAA--LEDASTVVVKRLKEVNVG-------------------------KREFEQQMEIVGGIRHEN  356 (615)
Q Consensus       304 ~~~~lG~G~fg~Vy~~~--~~~~~~vavK~l~~~~~~-------------------------~~~~~~e~~~l~~l~h~n  356 (615)
                      ..+.||+|+||.||+|.  ..+|+.||+|.++.....                         ...+.+|++.+.++.+..
T Consensus        32 i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~  111 (237)
T smart00090       32 IGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAG  111 (237)
T ss_pred             hCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcC
Confidence            35679999999999998  568999999998743210                         122567999999887533


Q ss_pred             --ccceeEEEEecCeeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCE
Q 007167          357 --VVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNI  434 (615)
Q Consensus       357 --iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Ni  434 (615)
                        +.+++++    ...++||||+++++|.......     ..+.......++.|++.++++||+.+  .|+||||||+||
T Consensus       112 i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~NI  180 (237)
T smart00090      112 VPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKD-----VEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYNI  180 (237)
T ss_pred             CCCCeeeEe----cCceEEEEEecCCccccccccc-----CCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhhE
Confidence              2333332    2458999999998887654221     23555667889999999999999886  499999999999


Q ss_pred             EeCCCCcEEEeecccccccCC
Q 007167          435 FLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       435 ll~~~~~~kl~DfG~a~~~~~  455 (615)
                      +++ ++.++|+|||.+.....
T Consensus       181 li~-~~~i~LiDFg~a~~~~~  200 (237)
T smart00090      181 LVH-DGKVVIIDVSQSVELDH  200 (237)
T ss_pred             EEE-CCCEEEEEChhhhccCC
Confidence            999 88999999999876543

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.71  E-value=1.2e-17  Score=186.56  Aligned_cols=184  Identities=20%  Similarity=0.330  Sum_probs=150.3

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCC---CCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIR---HENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      ...||+|+||+||+|...+|+.||+|+-+...  ..+|.--.+++.+|+   -+.|..+...+...+.-++|+||.+.|+
T Consensus       703 ~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~--~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gt  780 (974)
T KOG1166|consen  703 SKEIGEGSYGSVYVATHSNGKLVALKVEKPPN--PWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGT  780 (974)
T ss_pred             EeeeccccceEEEEeecCCCcEEEEEeecCCC--ceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeecccccc
Confidence            35699999999999998889999999887654  344544455666665   2345555556666778899999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeC-------CCCcEEEeecccccccC
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLN-------SQGHVCVSDIGLAALMS  454 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~-------~~~~~kl~DfG~a~~~~  454 (615)
                      |.+++..     ...++|.-...+..|+++.+++||..+   |||+||||+|.||.       +..-++|+|||.+..|.
T Consensus       781 lld~~N~-----~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~  852 (974)
T KOG1166|consen  781 LLDLINT-----NKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMK  852 (974)
T ss_pred             HHHhhcc-----CCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEecccceeee
Confidence            9999973     347899999999999999999999998   99999999999994       23458999999997775


Q ss_pred             CCC-----CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCC
Q 007167          455 PMP-----PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKS  498 (615)
Q Consensus       455 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~  498 (615)
                      -..     ....+|-++-.+|+..++.++..+|.|.++-+++-|+.|+.
T Consensus       853 lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  853 LFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence            322     22345667899999999999999999999999999999874

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.70  E-value=7.5e-17  Score=154.52  Aligned_cols=129  Identities=19%  Similarity=0.332  Sum_probs=106.6

Q ss_pred             hcCcCCccEEEEEEECCCCEEEEEEeccccC--C-------HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecC
Q 007167          307 VLGKGTFGTAYKAALEDASTVVVKRLKEVNV--G-------KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYF  377 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~-------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  377 (615)
                      .||+|+||.||+|.+ ++..|++|.......  .       ...+.+|++++..++|+++.....++...+..++||||+
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   79 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI   79 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence            389999999999985 568899998654211  1       245678999999999988776666666777789999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccc
Q 007167          378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAAL  452 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~  452 (615)
                      ++++|.+++....     .       .++.+++.+|.+||+.+   ++|||++|.||+++ ++.++++|||++..
T Consensus        80 ~g~~l~~~~~~~~-----~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        80 EGKPLKDVIEEGN-----D-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCccHHHHHhhcH-----H-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999999875321     0       78999999999999998   99999999999999 88999999998865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.69  E-value=1.1e-16  Score=176.39  Aligned_cols=131  Identities=18%  Similarity=0.312  Sum_probs=107.7

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEE-eccc-cC-------CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEee
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKR-LKEV-NV-------GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYD  375 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~-l~~~-~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  375 (615)
                      .+.||+|+||+||+|.+.+.. +++|+ .... ..       ..+.+.+|++++..++|++++....++......++|||
T Consensus       338 ~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E  416 (535)
T PRK09605        338 DHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVME  416 (535)
T ss_pred             cceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEE
Confidence            467999999999999876544 33333 2221 11       12457889999999999999988888888778899999


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeeccccccc
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALM  453 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~  453 (615)
                      |+++++|.+++.             .+..++.+++++|.|||+.+   |+|||+||+||++ +++.++|+|||+++..
T Consensus       417 ~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        417 YIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             ecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            999999998874             35678999999999999998   9999999999999 6789999999998754

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.69  E-value=1.1e-16  Score=153.35  Aligned_cols=134  Identities=13%  Similarity=0.160  Sum_probs=105.1

Q ss_pred             HHhhhcCcCCccEEEEEEECCCCEEEEEEeccccCC-----------------------HHHHHHHHHHHhCCCCCc--c
Q 007167          303 ASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVG-----------------------KREFEQQMEIVGGIRHEN--V  357 (615)
Q Consensus       303 ~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-----------------------~~~~~~e~~~l~~l~h~n--i  357 (615)
                      ...+.||+|+||.||++...+|+.||||++......                       ...+.+|..++..+.|++  +
T Consensus        18 ~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v   97 (198)
T cd05144          18 SLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPV   97 (198)
T ss_pred             hcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCC
Confidence            345779999999999999888999999987542210                       123567888888887774  4


Q ss_pred             cceeEEEEecCeeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeC
Q 007167          358 VALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLN  437 (615)
Q Consensus       358 v~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~  437 (615)
                      ...++    ....++||||+++++|......           .....++.+++.++.++|+.+   |+||||||+||+++
T Consensus        98 ~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~  159 (198)
T cd05144          98 PKPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVD  159 (198)
T ss_pred             Cceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEc
Confidence            44443    2456899999999998765431           234578889999999999987   99999999999999


Q ss_pred             CCCcEEEeecccccccC
Q 007167          438 SQGHVCVSDIGLAALMS  454 (615)
Q Consensus       438 ~~~~~kl~DfG~a~~~~  454 (615)
                      +++.++|+|||.+....
T Consensus       160 ~~~~~~liDfg~~~~~~  176 (198)
T cd05144         160 DDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CCCcEEEEECCccccCC
Confidence            99999999999986554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.66  E-value=4.9e-16  Score=153.44  Aligned_cols=192  Identities=18%  Similarity=0.293  Sum_probs=130.5

Q ss_pred             CCCcccceeEEEEec---------------------------CeeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHH
Q 007167          353 RHENVVALRAYYYSK---------------------------DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRI  405 (615)
Q Consensus       353 ~h~niv~l~~~~~~~---------------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i  405 (615)
                      +|||||++.++|.+.                           ...|+||.-.+ .+|..++..+      ..+...+.-|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~------~~s~r~~~~~  346 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR------HRSYRTGRVI  346 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC------CCchHHHHHH
Confidence            699999998887431                           24578887764 4788888532      4556667778


Q ss_pred             HHHHHHHHHHhhccCCCCceecCCCCCCEEe--CCCC--cEEEeecccccccCC---------CCCCCCCCCcccCcccc
Q 007167          406 AIGAARGIAHIHTENGGKLVHGGIKASNIFL--NSQG--HVCVSDIGLAALMSP---------MPPPAMRAAGYRAPEVT  472 (615)
Q Consensus       406 ~~~ia~~l~~LH~~~~~~iiHrDik~~Nill--~~~~--~~kl~DfG~a~~~~~---------~~~~~~~~~~y~aPE~~  472 (615)
                      +.|+++|+.|||+++   |.|||+|++|||+  |+|+  ...|+|||.+---..         ..-...|...-||||+.
T Consensus       347 laQlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~  423 (598)
T KOG4158|consen  347 LAQLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIA  423 (598)
T ss_pred             HHHHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhh
Confidence            899999999999998   9999999999998  4444  478999998733221         11122244568999998


Q ss_pred             CCCCC------CCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC-CcHHHHHHH
Q 007167          473 DTRKA------TQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP-NIEEEMVEM  545 (615)
Q Consensus       473 ~~~~~------~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~-~~~~~~~~l  545 (615)
                      ....-      -.|+|.|+.|-+.||+++...||...++. ..+...+-     +        ..++..| ..++.+   
T Consensus       424 ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r~Yq-----e--------~qLPalp~~vpp~~---  486 (598)
T KOG4158|consen  424 TAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTRTYQ-----E--------SQLPALPSRVPPVA---  486 (598)
T ss_pred             hcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechhhhh-----h--------hhCCCCcccCChHH---
Confidence            65321      25899999999999999999999874322 11111110     0        1122111 222333   


Q ss_pred             HHHHHHcccCCCCCCCCHHHHHHHHH
Q 007167          546 LQVGMACVVRMPEERPKMADVLKMVE  571 (615)
Q Consensus       546 ~~l~~~cl~~~P~~RPs~~evl~~L~  571 (615)
                      .++....++.||.+|++..-....|.
T Consensus       487 rqlV~~lL~r~pskRvsp~iAANvl~  512 (598)
T KOG4158|consen  487 RQLVFDLLKRDPSKRVSPNIAANVLN  512 (598)
T ss_pred             HHHHHHHhcCCccccCCccHHHhHHH
Confidence            34444888999999999877666553

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.62  E-value=9.5e-16  Score=145.30  Aligned_cols=135  Identities=19%  Similarity=0.275  Sum_probs=96.1

Q ss_pred             hhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHH---H----------------------HHHHHHHhCCCCCc--cc
Q 007167          306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKRE---F----------------------EQQMEIVGGIRHEN--VV  358 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~---~----------------------~~e~~~l~~l~h~n--iv  358 (615)
                      +.||+|+||+||+|...+++.||||+++........   +                      ..|.+.+..+.+..  +.
T Consensus         3 ~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~   82 (187)
T cd05119           3 GPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVP   82 (187)
T ss_pred             cccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCC
Confidence            469999999999999888999999998753221111   1                      24444555543332  33


Q ss_pred             ceeEEEEecCeeeEEeecCCCCChhhh-hccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCceecCCCCCCEEe
Q 007167          359 ALRAYYYSKDEKLMVYDYFEPGSVSAM-LHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT-ENGGKLVHGGIKASNIFL  436 (615)
Q Consensus       359 ~l~~~~~~~~~~~lV~e~~~~gsL~~~-l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~iiHrDik~~Nill  436 (615)
                      +.+++    ...++||||++++.+... +....      .. .....++.+++.++.++|. .+   |+||||||+||++
T Consensus        83 ~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili  148 (187)
T cd05119          83 KPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILV  148 (187)
T ss_pred             ceEec----CCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEE
Confidence            33332    346899999998654321 21100      11 5667889999999999999 76   9999999999999


Q ss_pred             CCCCcEEEeecccccccCC
Q 007167          437 NSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       437 ~~~~~~kl~DfG~a~~~~~  455 (615)
                      + ++.++++|||.+.....
T Consensus       149 ~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119         149 D-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             E-CCcEEEEECcccccccC
Confidence            9 89999999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.61  E-value=2.2e-16  Score=162.38  Aligned_cols=120  Identities=21%  Similarity=0.326  Sum_probs=104.9

Q ss_pred             CeeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeec
Q 007167          368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDI  447 (615)
Q Consensus       368 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Df  447 (615)
                      ...++.|+++...+|.+||.+++  .....+|...+.++.|++.|++|   ++   .+|||+||.||+...+..+||.||
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~--~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDF  400 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRR--TGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDF  400 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCC--cccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhh
Confidence            35789999999999999997544  23467888899999999999999   55   899999999999999999999999


Q ss_pred             ccccccCCCC---------CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh
Q 007167          448 GLAALMSPMP---------PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT  495 (615)
Q Consensus       448 G~a~~~~~~~---------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt  495 (615)
                      |+...+....         +...+|..||+||.+.+..|+.|+||||+|++|+||+.
T Consensus       401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             hheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence            9998775433         34457888999999999999999999999999999987

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.61  E-value=5.9e-16  Score=169.86  Aligned_cols=136  Identities=23%  Similarity=0.374  Sum_probs=104.1

Q ss_pred             HHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC------------------CCCCCCCCCcccCccc
Q 007167          410 ARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP------------------MPPPAMRAAGYRAPEV  471 (615)
Q Consensus       410 a~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~------------------~~~~~~~~~~y~aPE~  471 (615)
                      +.+++|||+.+   |+|||+||+|.+|..-|++|+.|||+.+.-..                  .+...++|+.|+|||+
T Consensus       153 vla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV  229 (1205)
T KOG0606|consen  153 VLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV  229 (1205)
T ss_pred             hHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence            77899999998   99999999999999999999999999864210                  1234468999999999


Q ss_pred             cCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHH
Q 007167          472 TDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMA  551 (615)
Q Consensus       472 ~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~  551 (615)
                      +..+.|...+|+|++|+++||.+-|+.||.+...++....+-  ..  .-.|.++        ......+..++++   +
T Consensus       230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vi--sd--~i~wpE~--------dea~p~Ea~dli~---~  294 (1205)
T KOG0606|consen  230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI--SD--DIEWPEE--------DEALPPEAQDLIE---Q  294 (1205)
T ss_pred             hhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhh--hh--hcccccc--------CcCCCHHHHHHHH---H
Confidence            999999999999999999999999999999887666543221  00  0011111        1223456666666   7


Q ss_pred             cccCCCCCCCCH
Q 007167          552 CVVRMPEERPKM  563 (615)
Q Consensus       552 cl~~~P~~RPs~  563 (615)
                      .++++|.+|--.
T Consensus       295 LL~qnp~~Rlgt  306 (1205)
T KOG0606|consen  295 LLRQNPLCRLGT  306 (1205)
T ss_pred             HHHhChHhhccc
Confidence            888999888643

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.61  E-value=4.7e-15  Score=134.73  Aligned_cols=133  Identities=18%  Similarity=0.180  Sum_probs=111.9

Q ss_pred             hhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCC--CcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRH--ENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      +.||+|.++.||++...+ ..+++|....... ...+.+|++++..++|  .++.+++++....+..++++||++++.+.
T Consensus         4 ~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~   81 (155)
T cd05120           4 KLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLD   81 (155)
T ss_pred             eecccccccceEEEEecC-CeEEEEecCCCCc-hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecc
Confidence            458999999999999755 7899998865433 5678899999999976  58889998888878899999999887655


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccc
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAAL  452 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~  452 (615)
                      .+            +......++.+++++++++|.....+++|+|++|+||++++.+.++++|||.+..
T Consensus        82 ~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          82 EV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            43            4566778899999999999986444599999999999999989999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.57  E-value=2e-14  Score=141.18  Aligned_cols=137  Identities=16%  Similarity=0.216  Sum_probs=105.8

Q ss_pred             HHhhhcC-cCCccEEEEEEECCCCEEEEEEecccc--------------CCHHHHHHHHHHHhCCCCCcc--cceeEEEE
Q 007167          303 ASAEVLG-KGTFGTAYKAALEDASTVVVKRLKEVN--------------VGKREFEQQMEIVGGIRHENV--VALRAYYY  365 (615)
Q Consensus       303 ~~~~~lG-~G~fg~Vy~~~~~~~~~vavK~l~~~~--------------~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~  365 (615)
                      ..+.+|| .||.|+||++... +..++||++....              .....+.+|++++..++|+++  ++.+++..
T Consensus        34 ~~~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~  112 (239)
T PRK01723         34 QQARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARV  112 (239)
T ss_pred             hcCceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeee
Confidence            3356798 8999999999875 6789998875311              112457789999999998875  66777654


Q ss_pred             ecC----eeeEEeecCCC-CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCC
Q 007167          366 SKD----EKLMVYDYFEP-GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG  440 (615)
Q Consensus       366 ~~~----~~~lV~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~  440 (615)
                      .+.    ..++|+||+++ .+|.+++...      .++..    .+.+++.++.+||+.+   |+||||||.|||++.++
T Consensus       113 ~~~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~  179 (239)
T PRK01723        113 VRHGLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDG  179 (239)
T ss_pred             eecCcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCC
Confidence            432    23599999997 6898887532      24433    3568899999999998   99999999999999999


Q ss_pred             cEEEeeccccccc
Q 007167          441 HVCVSDIGLAALM  453 (615)
Q Consensus       441 ~~kl~DfG~a~~~  453 (615)
                      .++|+|||.+...
T Consensus       180 ~v~LIDfg~~~~~  192 (239)
T PRK01723        180 KFWLIDFDRGELR  192 (239)
T ss_pred             CEEEEECCCcccC
Confidence            9999999988653

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.52  E-value=2.7e-15  Score=164.86  Aligned_cols=243  Identities=21%  Similarity=0.318  Sum_probs=177.7

Q ss_pred             hcCcCCccEEEEEEECCC--CEEEEEEeccccCC---HHHHHHHHHHHhCCC-CCcccceeEEEEecCeeeEEeecCCCC
Q 007167          307 VLGKGTFGTAYKAALEDA--STVVVKRLKEVNVG---KREFEQQMEIVGGIR-HENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~~~--~~vavK~l~~~~~~---~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .||+|+|+.|-.......  ..+|+|.+......   .+....|..+-..+. |+|++.+++...+.+..+++.+|..++
T Consensus        27 ~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~  106 (601)
T KOG0590|consen   27 SIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGG  106 (601)
T ss_pred             cccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCccccc
Confidence            389999999988775333  34556655433211   222334666666675 999999999999999999999999999


Q ss_pred             Chhhhh-ccCCCCCCCCCCHHHHHHHHHHHHHHHHHhh-ccCCCCceecCCCCCCEEeCCCC-cEEEeecccccccCC-C
Q 007167          381 SVSAML-HGRRGEGQSSLDWDTRVRIAIGAARGIAHIH-TENGGKLVHGGIKASNIFLNSQG-HVCVSDIGLAALMSP-M  456 (615)
Q Consensus       381 sL~~~l-~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-~~~~~~iiHrDik~~Nill~~~~-~~kl~DfG~a~~~~~-~  456 (615)
                      ++++-+ +...    ...+......++.|+..++.|+| ..+   +.|||+||+|.+++..+ ..+++|||+|..+.. .
T Consensus       107 ~~f~~i~~~~~----~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~  179 (601)
T KOG0590|consen  107 SLFSKISHPDS----TGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN  179 (601)
T ss_pred             ccccccccCCc----cCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence            999988 4221    13455566778999999999999 777   99999999999999999 999999999987765 2


Q ss_pred             C-----CCCCC-CCcccCccccCCCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccc
Q 007167          457 P-----PPAMR-AAGYRAPEVTDTRK-ATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD  529 (615)
Q Consensus       457 ~-----~~~~~-~~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  529 (615)
                      .     ....+ +..|+|||...+.. .....|+||.|+++.-+++|..|+......+ .....|...         -..
T Consensus       180 g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~-~~~~~~~~~---------~~~  249 (601)
T KOG0590|consen  180 GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD-GRYSSWKSN---------KGR  249 (601)
T ss_pred             CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc-ccceeeccc---------ccc
Confidence            2     23346 88899999998854 4678899999999999999999997655433 111222111         101


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          530 VELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       530 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .....+..+.....+++.   +++..+|..|.+.+++...
T Consensus       250 ~~~~~~~~~~~~~~~~l~---k~l~~~~~~r~s~~~~~~d  286 (601)
T KOG0590|consen  250 FTQLPWNSISDQAHDLLH---KILKENPSNRLSIEELKLD  286 (601)
T ss_pred             cccCccccCChhhhhccc---ccccCCchhcccccccccc
Confidence            112233445555556555   8888999999998887543

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.50  E-value=1.1e-15  Score=134.62  Aligned_cols=122  Identities=30%  Similarity=0.506  Sum_probs=107.1

Q ss_pred             CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCccccccccccee
Q 007167           66 HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVI  145 (615)
Q Consensus        66 ~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l  145 (615)
                      ..+++.|.|++|.|+ .+|| .++.|.+|+.|++++|+++ .+|..++.|++|+.|+++-|++. .+|..|+.++.|+.|
T Consensus        32 ~s~ITrLtLSHNKl~-~vpp-nia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levl  107 (264)
T KOG0617|consen   32 MSNITRLTLSHNKLT-VVPP-NIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVL  107 (264)
T ss_pred             hhhhhhhhcccCcee-ecCC-cHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhh
Confidence            457889999999999 8999 6999999999999999999 67999999999999999999999 799999999999999


Q ss_pred             ecCCCcCCc-cCCCcccCCCCCCeeeccCccccCCCccccccCCcccc
Q 007167          146 DLSNNFFNA-SIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAF  192 (615)
Q Consensus       146 ~l~~N~l~~-~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~  192 (615)
                      ||.+|+++. .+|..|..|+.|+.|+|++|.|. .+|..++++.++.+
T Consensus       108 dltynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqi  154 (264)
T KOG0617|consen  108 DLTYNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQI  154 (264)
T ss_pred             hccccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeE
Confidence            999999884 46888888888888888888887 56666666665543

>PLN03150 hypothetical protein; Provisional

Probab=99.48  E-value=5.9e-14  Score=156.46  Aligned_cols=110  Identities=39%  Similarity=0.575  Sum_probs=102.6

Q ss_pred             CccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeecc
Q 007167           93 ALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLA  172 (615)
Q Consensus        93 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~  172 (615)
                      .++.|+|++|.++|.+|..|++|++|+.|+|++|+|+|.+|..++.+++|+.|+|++|+|+|.+|..+++|++|+.|+|+
T Consensus       419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls  498 (623)
T PLN03150        419 FIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLN  498 (623)
T ss_pred             EEEEEECCCCCccccCCHHHhCCCCCCEEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECc
Confidence            57899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CccccCCCccccccC----CcccccCCCCCCCCC
Q 007167          173 NNSLTGTLPRSLQRF----PSWAFAGNNLSSENA  202 (615)
Q Consensus       173 ~N~l~g~~p~~~~~l----~~l~~~~n~~~~~~~  202 (615)
                      +|+|+|.+|..+..+    ..+.+.+|+..|+.+
T Consensus       499 ~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p  532 (623)
T PLN03150        499 GNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIP  532 (623)
T ss_pred             CCcccccCChHHhhccccCceEEecCCccccCCC
Confidence            999999999887653    367789999888753

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.45  E-value=2.9e-13  Score=144.35  Aligned_cols=140  Identities=18%  Similarity=0.292  Sum_probs=97.7

Q ss_pred             hhcCcCCccEEEEEEECCCCEEEEEEeccccCC---------------------------H--------------HHHHH
Q 007167          306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVG---------------------------K--------------REFEQ  344 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---------------------------~--------------~~~~~  344 (615)
                      +.||.|++|+||+|++++|+.||||+.+..-..                           .              -+|.+
T Consensus       123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~  202 (437)
T TIGR01982       123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR  202 (437)
T ss_pred             cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence            469999999999999999999999998542100                           0              01333


Q ss_pred             HHHHHhCC----CCCcccceeEEE-EecCeeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHH-HHHHhhc
Q 007167          345 QMEIVGGI----RHENVVALRAYY-YSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAAR-GIAHIHT  418 (615)
Q Consensus       345 e~~~l~~l----~h~niv~l~~~~-~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~-~l~~LH~  418 (615)
                      |.+.+.++    +|.+-+.+-..+ ......++||||++|++|.+.......    ..   .+.+++..++. .+..+|.
T Consensus       203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~---~~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----GL---DRKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc----CC---CHHHHHHHHHHHHHHHHHh
Confidence            44433333    233333332222 224567999999999999887653211    12   23456666665 4678898


Q ss_pred             cCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC
Q 007167          419 ENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       419 ~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      .+   ++|+|+||.||+++++++++++|||++..+.+
T Consensus       276 ~g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       276 DG---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             CC---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            87   99999999999999999999999999987753

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.33  E-value=5.7e-12  Score=117.24  Aligned_cols=130  Identities=13%  Similarity=0.132  Sum_probs=96.2

Q ss_pred             hhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccc-eeEEEEecCeeeEEeecCCCCChhh
Q 007167          306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVA-LRAYYYSKDEKLMVYDYFEPGSVSA  384 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~-l~~~~~~~~~~~lV~e~~~~gsL~~  384 (615)
                      +.++.|.++.||++... +..|++|...........+..|++++..+.+.++++ ++.+  .....++||||+++.++..
T Consensus         4 ~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~--~~~~~~lv~e~i~G~~l~~   80 (170)
T cd05151           4 SPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYF--DPETGVLITEFIEGSELLT   80 (170)
T ss_pred             eecCCcccCceEEEEEC-CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEE--eCCCCeEEEEecCCCcccc
Confidence            35889999999999865 678999987654322345678999888886656554 4433  2334689999999987654


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccC--CCCceecCCCCCCEEeCCCCcEEEeecccccc
Q 007167          385 MLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN--GGKLVHGGIKASNIFLNSQGHVCVSDIGLAAL  452 (615)
Q Consensus       385 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~  452 (615)
                      .-             .....++.+++++++.||...  ...++|+|++|.||+++ ++.++++|||.+..
T Consensus        81 ~~-------------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          81 ED-------------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             cc-------------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            30             011245678999999999986  22359999999999999 66899999998753

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.29  E-value=5.3e-12  Score=122.49  Aligned_cols=198  Identities=20%  Similarity=0.341  Sum_probs=135.3

Q ss_pred             HHhCCCCCcccceeEEEEecC-----eeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCC
Q 007167          348 IVGGIRHENVVALRAYYYSKD-----EKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGG  422 (615)
Q Consensus       348 ~l~~l~h~niv~l~~~~~~~~-----~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~  422 (615)
                      -+-.+.|.|||+++.|+.+..     +..++.|||.-|++..+|++.+. ....+......+++.||..||.|||+. .|
T Consensus       120 nllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~-~~~a~~~~~wkkw~tqIlsal~yLhs~-~P  197 (458)
T KOG1266|consen  120 NLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKK-NQKALFQKAWKKWCTQILSALSYLHSC-DP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHH-hhhhhhHHHHHHHHHHHHhhhhhhhcc-CC
Confidence            344456999999999986543     56889999999999999986442 344577777788999999999999987 57


Q ss_pred             CceecCCCCCCEEeCCCCcEEEeecccccccCC--------CCCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHH
Q 007167          423 KLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP--------MPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELL  494 (615)
Q Consensus       423 ~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ell  494 (615)
                      +|+|+++.-+-|++..++-+||.--- -....+        ......+-++|.+||+=.....+.++|||+||.-..||.
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~a-p~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVA-PDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccC-ccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence            89999999999999999888874211 111110        001122456899999877777888999999999899998


Q ss_pred             hCCCC-CCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          495 TGKSP-IHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       495 tg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+..- -.+....+...-+.  .         .++     ...  ...-+++++   +|++..|..||+|++++.|
T Consensus       277 ilEiq~tnseS~~~~ee~ia--~---------~i~-----~le--n~lqr~~i~---kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  277 ILEIQSTNSESKVEVEENIA--N---------VII-----GLE--NGLQRGSIT---KCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             HheeccCCCcceeehhhhhh--h---------hee-----ecc--CccccCcCc---ccccCCCCCCcchhhhhcC
Confidence            77653 22211111110000  0         000     000  001123344   8999999999999998765

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.27  E-value=3.4e-12  Score=137.68  Aligned_cols=140  Identities=16%  Similarity=0.228  Sum_probs=88.1

Q ss_pred             hhcCcCCccEEEEEEECC-CCEEEEEEeccccC---------------------------C--------HH------HHH
Q 007167          306 EVLGKGTFGTAYKAALED-ASTVVVKRLKEVNV---------------------------G--------KR------EFE  343 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~---------------------------~--------~~------~~~  343 (615)
                      +.||+|++|+||+|++++ |+.||||+++..-.                           .        .+      ++.
T Consensus       125 ~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ElD~~  204 (537)
T PRK04750        125 KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHDELDLM  204 (537)
T ss_pred             hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHHhhCHH
Confidence            469999999999999987 99999999864310                           0        01      122


Q ss_pred             HHHHHHhCC----CCCcccceeEEEEe-cCeeeEEeecCCCCChhhhhcc-CCCCCCCCCCHHHHHHHHHHHHHHHHHhh
Q 007167          344 QQMEIVGGI----RHENVVALRAYYYS-KDEKLMVYDYFEPGSVSAMLHG-RRGEGQSSLDWDTRVRIAIGAARGIAHIH  417 (615)
Q Consensus       344 ~e~~~l~~l----~h~niv~l~~~~~~-~~~~~lV~e~~~~gsL~~~l~~-~~~~~~~~l~~~~~~~i~~~ia~~l~~LH  417 (615)
                      +|+.-+.++    .+.+.+.+-..+.+ ....+|||||++|+.+.+.-.- ..+.....+.......++.|       +.
T Consensus       205 ~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q-------if  277 (537)
T PRK04750        205 REAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ-------VF  277 (537)
T ss_pred             HHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH-------HH
Confidence            333322222    23333433333322 3567899999999999874211 11100011222222223333       33


Q ss_pred             ccCCCCceecCCCCCCEEeCCCC----cEEEeecccccccCC
Q 007167          418 TENGGKLVHGGIKASNIFLNSQG----HVCVSDIGLAALMSP  455 (615)
Q Consensus       418 ~~~~~~iiHrDik~~Nill~~~~----~~kl~DfG~a~~~~~  455 (615)
                      ..+   ++|+|+||.||+++.++    +++++|||+...+++
T Consensus       278 ~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        278 RDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             hCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            456   99999999999999988    999999999987754

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.26  E-value=5.7e-12  Score=132.60  Aligned_cols=239  Identities=21%  Similarity=0.212  Sum_probs=165.4

Q ss_pred             HhhhcCc--CCccEEEEEEE---CCCCEEEEEEeccccC---CHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEe
Q 007167          304 SAEVLGK--GTFGTAYKAAL---EDASTVVVKRLKEVNV---GKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVY  374 (615)
Q Consensus       304 ~~~~lG~--G~fg~Vy~~~~---~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  374 (615)
                      ....+|+  |.+|.||.+..   +++..+|+|+-+....   ....=.+|+...+.+ .|+|.++....+...+..++-+
T Consensus       118 ~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqt  197 (524)
T KOG0601|consen  118 ISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQT  197 (524)
T ss_pred             cccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeee
Confidence            3456899  99999999986   4678899988543311   122223566666666 4999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHH----HHHHhhccCCCCceecCCCCCCEEeCCC-CcEEEeeccc
Q 007167          375 DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAAR----GIAHIHTENGGKLVHGGIKASNIFLNSQ-GHVCVSDIGL  449 (615)
Q Consensus       375 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~----~l~~LH~~~~~~iiHrDik~~Nill~~~-~~~kl~DfG~  449 (615)
                      |++. .+|..+.+....    .+.....+.+..+..+    |+.++|...   ++|-|+||.||++..+ ...++.|||+
T Consensus       198 E~~~-~sl~~~~~~~~~----~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~  269 (524)
T KOG0601|consen  198 ELCG-ESLQSYCHTPCN----FLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGL  269 (524)
T ss_pred             cccc-chhHHhhhcccc----cCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcce
Confidence            9985 688887764322    2444445555556656    999999997   9999999999999999 7899999999


Q ss_pred             ccccCCCCCCC--------CCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhc
Q 007167          450 AALMSPMPPPA--------MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVRE  521 (615)
Q Consensus       450 a~~~~~~~~~~--------~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  521 (615)
                      ...+.+.....        .+...|++||...+ .++...|+|++|.|..+..++..+....-.....++-.        
T Consensus       270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~--------  340 (524)
T KOG0601|consen  270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ--------  340 (524)
T ss_pred             eEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc--------
Confidence            98886543211        34456999998865 67889999999999999999877655431111110000        


Q ss_pred             ccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007167          522 EWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK  568 (615)
Q Consensus       522 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  568 (615)
                      ..    +-.+.  ..+...+.   -....++++.+|..|++.+++..
T Consensus       341 ~~----ip~e~--~~~~s~~l---~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  341 GY----IPLEF--CEGGSSSL---RSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             cc----Cchhh--hcCcchhh---hhHHHHhcCcchhhhhHHHHHhc
Confidence            00    00011  11112222   22445899999999998888765

>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms]

Probab=99.23  E-value=6.2e-13  Score=117.31  Aligned_cols=128  Identities=29%  Similarity=0.531  Sum_probs=112.3

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEeccccccc-CCCCccccccccccee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFS-GPLPLDFSVWNNLTVI  145 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~-g~~p~~~~~l~~L~~l  145 (615)
                      .++..|++.+|++. .+|. .++.++.|+.|++.-|++. ..|..|+.++.|+.|||++|+++ ..+|..|..|+.|+.|
T Consensus        56 ~nlevln~~nnqie-~lp~-~issl~klr~lnvgmnrl~-~lprgfgs~p~levldltynnl~e~~lpgnff~m~tlral  132 (264)
T KOG0617|consen   56 KNLEVLNLSNNQIE-ELPT-SISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLTYNNLNENSLPGNFFYMTTLRAL  132 (264)
T ss_pred             hhhhhhhcccchhh-hcCh-hhhhchhhhheecchhhhh-cCccccCCCchhhhhhccccccccccCCcchhHHHHHHHH
Confidence            45678899999999 8998 7999999999999999998 77999999999999999999986 4689999999999999


Q ss_pred             ecCCCcCCccCCCcccCCCCCCeeeccCccccCCCcccccc---CCcccccCCCCCC
Q 007167          146 DLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQR---FPSWAFAGNNLSS  199 (615)
Q Consensus       146 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~---l~~l~~~~n~~~~  199 (615)
                      +|++|.|. .+|..++++++|+.|.+.+|.+- ++|..++.   +..+.+.||.+.-
T Consensus       133 yl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~v  187 (264)
T KOG0617|consen  133 YLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLTV  187 (264)
T ss_pred             HhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceeee
Confidence            99999998 68999999999999999999998 78887765   4567788888754

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.23  E-value=9e-13  Score=136.27  Aligned_cols=132  Identities=23%  Similarity=0.302  Sum_probs=110.4

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID  146 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~  146 (615)
                      ..+..|+|+.|+++ .+....+.+|+.|+.||||+|.|..+-++.+.-.++|++|+|++|+++-.-+.+|..|+.|+.|+
T Consensus       269 ~kme~l~L~~N~l~-~vn~g~lfgLt~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~Ln  347 (873)
T KOG4194|consen  269 EKMEHLNLETNRLQ-AVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELN  347 (873)
T ss_pred             cccceeecccchhh-hhhcccccccchhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhc
Confidence            35788999999998 67666888999999999999999999999999999999999999999977777888899999999


Q ss_pred             cCCCcCCccCCCcccCCCCCCeeeccCccccCCCccc------cccCCcccccCCCCCC
Q 007167          147 LSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRS------LQRFPSWAFAGNNLSS  199 (615)
Q Consensus       147 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~------~~~l~~l~~~~n~~~~  199 (615)
                      |++|.++..--..|..+++|+.|||++|.|++.|-+.      +..|..|.+.||++..
T Consensus       348 Ls~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL~l~gNqlk~  406 (873)
T KOG4194|consen  348 LSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKLRLTGNQLKS  406 (873)
T ss_pred             ccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhheeecCceeee
Confidence            9999988665667888888999999999988776543      4455567788888754

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.21  E-value=1.6e-12  Score=135.17  Aligned_cols=107  Identities=30%  Similarity=0.462  Sum_probs=84.6

Q ss_pred             cEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEeccccccc------------------
Q 007167           68 RVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFS------------------  129 (615)
Q Consensus        68 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~------------------  129 (615)
                      ..+.|+|++|++. +||...|-+|+.|-+||||+|+|. .+|+.+..|.+|++|+|++|-|.                  
T Consensus       127 n~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhm  204 (1255)
T KOG0444|consen  127 NSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHM  204 (1255)
T ss_pred             CcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhc
Confidence            4567888888887 788777888888888888888888 55777888888888888887432                  


Q ss_pred             -------CCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCcccc
Q 007167          130 -------GPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLT  177 (615)
Q Consensus       130 -------g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~  177 (615)
                             .-+|.++..|.+|..+|||.|++. .+|+.+-++++|+.|+||+|+|+
T Consensus       205 s~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it  258 (1255)
T KOG0444|consen  205 SNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT  258 (1255)
T ss_pred             ccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee
Confidence                   136677777888888888888888 57888888888888888888877

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.16  E-value=6.6e-12  Score=124.68  Aligned_cols=127  Identities=28%  Similarity=0.455  Sum_probs=107.4

Q ss_pred             cEEEEEeCCCCcccccC-----------------------CCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecc
Q 007167           68 RVVALRLPGMALRGEIP-----------------------PNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQ  124 (615)
Q Consensus        68 ~v~~l~l~~~~l~g~i~-----------------------~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~  124 (615)
                      -|+.++++.|+|. ++|                       +..+..+++|..|+|++|-+. .+|.+++.+..|+.||||
T Consensus       389 ~Vt~VnfskNqL~-elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS  466 (565)
T KOG0472|consen  389 IVTSVNFSKNQLC-ELPKRLVELKELVTDLVLSNNKISFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLS  466 (565)
T ss_pred             ceEEEecccchHh-hhhhhhHHHHHHHHHHHhhcCccccchHHHHhhhcceeeecccchhh-hcchhhhhhhhhheeccc
Confidence            3888888888776 554                       236788899999999999888 679999999999999999


Q ss_pred             cccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccccCCc---ccccCCCCC
Q 007167          125 FNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPS---WAFAGNNLS  198 (615)
Q Consensus       125 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~---l~~~~n~~~  198 (615)
                      +|+|. .+|..+..+..|+.+-.++|++....|..+.+|.+|++|||.+|.+. .||+.++++.+   +.+.||++.
T Consensus       467 ~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~tLDL~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr  541 (565)
T KOG0472|consen  467 FNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLTTLDLQNNDLQ-QIPPILGNMTNLRHLELDGNPFR  541 (565)
T ss_pred             ccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcceeccCCCchh-hCChhhccccceeEEEecCCccC
Confidence            99998 78988888888888888889998766667999999999999999999 78888877664   668999985

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.15  E-value=3.3e-10  Score=110.19  Aligned_cols=141  Identities=18%  Similarity=0.245  Sum_probs=108.8

Q ss_pred             hhcCcCCccEEEEEEECCCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCC--cccceeEEEEecC---eeeEEeecCC
Q 007167          306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHE--NVVALRAYYYSKD---EKLMVYDYFE  378 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~--niv~l~~~~~~~~---~~~lV~e~~~  378 (615)
                      +.||.|.++.||++...+|..+++|.......  ....+.+|.+++..+++.  ++.+++.+.....   ..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            35899999999999987778899998765432  356788999999998753  4566777766542   5689999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccC--------------------------------------
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN--------------------------------------  420 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--------------------------------------  420 (615)
                      +.++.+.+..      ..++...+..++.+++++|.+||+..                                      
T Consensus        84 G~~l~~~~~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (223)
T cd05154          84 GRVLRDRLLR------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAM  157 (223)
T ss_pred             CEecCCCCCC------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHH
Confidence            9888776531      24677777788888888888888531                                      


Q ss_pred             ---------------CCCceecCCCCCCEEeCC--CCcEEEeecccccc
Q 007167          421 ---------------GGKLVHGGIKASNIFLNS--QGHVCVSDIGLAAL  452 (615)
Q Consensus       421 ---------------~~~iiHrDik~~Nill~~--~~~~kl~DfG~a~~  452 (615)
                                     ...++|+|+++.||+++.  ++.+.|+||+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         158 ERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                           134799999999999998  66789999998753

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0472 consensus Leucine-rich repeat protein [Function unknown]

Probab=99.14  E-value=2.3e-12  Score=127.84  Aligned_cols=120  Identities=34%  Similarity=0.544  Sum_probs=74.6

Q ss_pred             EEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccc-cccccceeecCC
Q 007167           71 ALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFS-VWNNLTVIDLSN  149 (615)
Q Consensus        71 ~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~-~l~~L~~l~l~~  149 (615)
                      .||...|-|+ +||+ .++.+.+|.-|+|..|.|. .+| +|.++..|++|+++.|++. .+|.... ++++|.+|||.+
T Consensus       187 ~ld~~~N~L~-tlP~-~lg~l~~L~~LyL~~Nki~-~lP-ef~gcs~L~Elh~g~N~i~-~lpae~~~~L~~l~vLDLRd  261 (565)
T KOG0472|consen  187 HLDCNSNLLE-TLPP-ELGGLESLELLYLRRNKIR-FLP-EFPGCSLLKELHVGENQIE-MLPAEHLKHLNSLLVLDLRD  261 (565)
T ss_pred             hcccchhhhh-cCCh-hhcchhhhHHHHhhhcccc-cCC-CCCccHHHHHHHhcccHHH-hhHHHHhcccccceeeeccc
Confidence            3444334343 5555 4666666666666666665 345 5666666666666666666 4555544 677777777777


Q ss_pred             CcCCccCCCcccCCCCCCeeeccCccccCCCccccccC--CcccccCCCC
Q 007167          150 NFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRF--PSWAFAGNNL  197 (615)
Q Consensus       150 N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l--~~l~~~~n~~  197 (615)
                      |++. +.|+.+.-+++|.+||+|+|.++ .+|.+++++  ..+.+.|||+
T Consensus       262 Nklk-e~Pde~clLrsL~rLDlSNN~is-~Lp~sLgnlhL~~L~leGNPl  309 (565)
T KOG0472|consen  262 NKLK-EVPDEICLLRSLERLDLSNNDIS-SLPYSLGNLHLKFLALEGNPL  309 (565)
T ss_pred             cccc-cCchHHHHhhhhhhhcccCCccc-cCCcccccceeeehhhcCCch
Confidence            7777 56777777777777777777777 455566654  2344567766

>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton]

Probab=99.13  E-value=9.4e-12  Score=129.57  Aligned_cols=126  Identities=29%  Similarity=0.446  Sum_probs=106.1

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCC-CccccccCcEEecccccccCCCCccccccccccee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPS-DFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVI  145 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l  145 (615)
                      ..++.|||++|+|+ ..|. .+.+-.++.+|+||+|+|. .||. -|.+|+-|-+||||+|+|. .+|..+..|..|++|
T Consensus       103 ~dLt~lDLShNqL~-EvP~-~LE~AKn~iVLNLS~N~Ie-tIPn~lfinLtDLLfLDLS~NrLe-~LPPQ~RRL~~LqtL  178 (1255)
T KOG0444|consen  103 KDLTILDLSHNQLR-EVPT-NLEYAKNSIVLNLSYNNIE-TIPNSLFINLTDLLFLDLSNNRLE-MLPPQIRRLSMLQTL  178 (1255)
T ss_pred             ccceeeecchhhhh-hcch-hhhhhcCcEEEEcccCccc-cCCchHHHhhHhHhhhccccchhh-hcCHHHHHHhhhhhh
Confidence            45889999999999 8888 6888999999999999999 4564 5789999999999999999 688888888888999


Q ss_pred             ecCCCcCC-------------------------ccCCCcccCCCCCCeeeccCccccCCCccccccC---CcccccCCCC
Q 007167          146 DLSNNFFN-------------------------ASIPASISKLTHLSALNLANNSLTGTLPRSLQRF---PSWAFAGNNL  197 (615)
Q Consensus       146 ~l~~N~l~-------------------------~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l---~~l~~~~n~~  197 (615)
                      +|++|.+.                         ..+|.++..|.+|..+|||.|+|. .+|+.+.++   ..|.+++|.+
T Consensus       179 ~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~i  257 (1255)
T KOG0444|consen  179 KLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKI  257 (1255)
T ss_pred             hcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCce
Confidence            99888754                         237888889999999999999998 788776544   4456777765

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.11  E-value=7.8e-10  Score=103.94  Aligned_cols=136  Identities=14%  Similarity=0.212  Sum_probs=96.3

Q ss_pred             hhcCcCCccEEEEEEECC-------CCEEEEEEecccc----------------------CC-HHHH----HHHHHHHhC
Q 007167          306 EVLGKGTFGTAYKAALED-------ASTVVVKRLKEVN----------------------VG-KREF----EQQMEIVGG  351 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~-------~~~vavK~l~~~~----------------------~~-~~~~----~~e~~~l~~  351 (615)
                      ..||.|.-+.||.|...+       +..+|||..+-..                      .. .+.+    ++|++.|.+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            358999999999998553       4789999874210                      00 1122    278888888


Q ss_pred             CCC--CcccceeEEEEecCeeeEEeecCCCCChhh-hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHh-hccCCCCceec
Q 007167          352 IRH--ENVVALRAYYYSKDEKLMVYDYFEPGSVSA-MLHGRRGEGQSSLDWDTRVRIAIGAARGIAHI-HTENGGKLVHG  427 (615)
Q Consensus       352 l~h--~niv~l~~~~~~~~~~~lV~e~~~~gsL~~-~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~L-H~~~~~~iiHr  427 (615)
                      +..  -++-+++++    ...++||||+.++.+.. .+..      ..++......+..+++.+|..| |+.+   |+|+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd------~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHG  149 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKD------AKLNDEEMKNAYYQVLSMMKQLYKECN---LVHA  149 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhc------cccCHHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence            753  345555544    56789999997654422 2221      1244455667788999999999 7777   9999


Q ss_pred             CCCCCCEEeCCCCcEEEeecccccccCC
Q 007167          428 GIKASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       428 Dik~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      |+++.||+++ ++.+.|+|||.+.....
T Consensus       150 DLs~~NIL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         150 DLSEYNMLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             CCCHHHEEEE-CCcEEEEECCCceeCCC
Confidence            9999999997 46799999998876653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.10  E-value=9.5e-10  Score=117.07  Aligned_cols=162  Identities=19%  Similarity=0.282  Sum_probs=120.1

Q ss_pred             ECCCCEEEEEEeccccCC-HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChhhhhccCCCCCCCCCCH
Q 007167          321 LEDASTVVVKRLKEVNVG-KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDW  399 (615)
Q Consensus       321 ~~~~~~vavK~l~~~~~~-~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~  399 (615)
                      ..++.+|.|...+..... .....+.++.++.+|||||++++..+...+..|+|+|-+..  |...+..        +.-
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~--------l~~  103 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKE--------LGK  103 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHH--------hHH
Confidence            457788888777654331 23456778889999999999999999999999999998754  4555542        122


Q ss_pred             HHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC---CCCCCCcccCccccCCCC
Q 007167          400 DTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP---PAMRAAGYRAPEVTDTRK  476 (615)
Q Consensus       400 ~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~---~~~~~~~y~aPE~~~~~~  476 (615)
                      ....-.+.||+.||.+||+.+  .++|++|.-.-|++++.|+.||++|-++........   ....-..|..|+.+....
T Consensus       104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc
Confidence            334446789999999999777  499999999999999999999999988754433221   111122466676554322


Q ss_pred             CCCccchhhHHHHHHHHHhC
Q 007167          477 ATQASDVFSFGVLLLELLTG  496 (615)
Q Consensus       477 ~~~~~DvwS~Gvvl~elltg  496 (615)
                        -..|.|-|||+++|++.|
T Consensus       182 --~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --cchhhhhHHHHHHHHhCc
Confidence              246999999999999999

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.09  E-value=7.7e-11  Score=124.16  Aligned_cols=242  Identities=17%  Similarity=0.170  Sum_probs=167.8

Q ss_pred             hhcCcCCccEEEEEEE--CCCCEEEEEEeccccCC-H--HHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCCC
Q 007167          306 EVLGKGTFGTAYKAAL--EDASTVVVKRLKEVNVG-K--REFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~--~~~~~vavK~l~~~~~~-~--~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      ..||.|.|+.|++...  .++..|++|.+...-.. .  ..-..|+.+...+ -|.+++.....+......++=-||+++
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~  350 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEG  350 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcC
Confidence            3599999999999763  46788999988754222 1  1123455555555 488888877777777777799999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCC-CcEEEeecccccccCCCCC
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQ-GHVCVSDIGLAALMSPMPP  458 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~-~~~kl~DfG~a~~~~~~~~  458 (615)
                      +++...+.     -...++...++++..+++.++.++|+..   ++|+|+||+||++..+ +.-++.|||.++.+.-...
T Consensus       351 ~s~~l~~~-----~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~  422 (524)
T KOG0601|consen  351 GSSSLRSV-----TSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG  422 (524)
T ss_pred             cchhhhhH-----HHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccccceecc
Confidence            98876652     1235777888999999999999999988   9999999999999886 7889999999875332221


Q ss_pred             CCCCCCccc--CccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          459 PAMRAAGYR--APEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       459 ~~~~~~~y~--aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                      ....+-++.  +++......+..+.|++|||.-+.|.++|..--.....  ..                .+........+
T Consensus       423 ~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~--~~----------------~i~~~~~p~~~  484 (524)
T KOG0601|consen  423 VFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQ--SL----------------TIRSGDTPNLP  484 (524)
T ss_pred             cccccccccccchhhccccccccccccccccccccccccCcccCccccc--ce----------------eeecccccCCC
Confidence            222233344  45555566678899999999999999997653322111  00                01111122223


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                      +..   ..+..++..+...++..||.+.+...+.+..+..
T Consensus       485 ~~~---~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~~  521 (524)
T KOG0601|consen  485 GLK---LQLQVLLKVMINPDRKRRPSAVELSLHSEFYRDS  521 (524)
T ss_pred             chH---HhhhhhhhhhcCCccccchhhhhhcccchhhhhc
Confidence            222   3444555578889999999999998887766653

>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms]

Probab=99.07  E-value=5.1e-11  Score=123.55  Aligned_cols=131  Identities=21%  Similarity=0.284  Sum_probs=98.4

Q ss_pred             CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCccccccccccee
Q 007167           66 HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVI  145 (615)
Q Consensus        66 ~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l  145 (615)
                      .++++.|+|.+|-++ ++..+.+..++.|+.||||.|.|+.+--++|..-.++++|+|++|+++..--..|.++.+|.+|
T Consensus       124 sghl~~L~L~~N~I~-sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tl  202 (873)
T KOG4194|consen  124 SGHLEKLDLRHNLIS-SVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTL  202 (873)
T ss_pred             ccceeEEeeeccccc-cccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheee
Confidence            357888888888887 7777778888888888888888885544667777888888888888887666778888888888


Q ss_pred             ecCCCcCCccCCCcccCCCCCCeeeccCccccCCCc---cccccCCcccccCCCC
Q 007167          146 DLSNNFFNASIPASISKLTHLSALNLANNSLTGTLP---RSLQRFPSWAFAGNNL  197 (615)
Q Consensus       146 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p---~~~~~l~~l~~~~n~~  197 (615)
                      .|++|.++...+..|.+|++|+.|+|..|+|.-.--   ..+..|.++.+..|..
T Consensus       203 kLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I  257 (873)
T KOG4194|consen  203 KLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDI  257 (873)
T ss_pred             ecccCcccccCHHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCc
Confidence            899998887666777788888888888888862211   2233344455555543

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.04  E-value=2.2e-09  Score=97.34  Aligned_cols=129  Identities=22%  Similarity=0.350  Sum_probs=97.4

Q ss_pred             hcCcCCccEEEEEEECCCCEEEEEE-eccccCC--------HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecC
Q 007167          307 VLGKGTFGTAYKAALEDASTVVVKR-LKEVNVG--------KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYF  377 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~~~~~vavK~-l~~~~~~--------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  377 (615)
                      .+++|+-+.+|.+.+.+.. +++|. +++....        .+...+|..++.+++--.|-...-+..+.+...|+|||+
T Consensus         3 ~i~~GAEa~i~~~~~~g~~-av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I   81 (204)
T COG3642           3 LIKQGAEAIIYLTDFLGLP-AVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI   81 (204)
T ss_pred             hhhCCcceeEEeeeccCcc-eEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence            5789999999999775434 55554 3332111        233467888988887666665566677788889999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccc
Q 007167          378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAAL  452 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~  452 (615)
                      ++-.|.+.+...            +..++..+=.-+.-||..+   |+|+|+.++||++..+. +.++|||++..
T Consensus        82 ~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          82 EGELLKDALEEA------------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             CChhHHHHHHhc------------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence            999988888632            2445666666778899998   99999999999998765 99999999874

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=99.03  E-value=1.7e-10  Score=106.27  Aligned_cols=105  Identities=28%  Similarity=0.377  Sum_probs=39.8

Q ss_pred             cEEEEEeCCCCcccccCCCccc-CCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCccc-cccccccee
Q 007167           68 RVVALRLPGMALRGEIPPNTIG-RLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDF-SVWNNLTVI  145 (615)
Q Consensus        68 ~v~~l~l~~~~l~g~i~~~~~~-~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~l~~L~~l  145 (615)
                      +.+.|+|.+|.++ .|.  .++ .+.+|+.|||++|.|+.. + .+..|++|++|+|++|+++. ++..+ ..+++|+.|
T Consensus        20 ~~~~L~L~~n~I~-~Ie--~L~~~l~~L~~L~Ls~N~I~~l-~-~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~~L   93 (175)
T PF14580_consen   20 KLRELNLRGNQIS-TIE--NLGATLDKLEVLDLSNNQITKL-E-GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQEL   93 (175)
T ss_dssp             -------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT--EE
T ss_pred             ccccccccccccc-ccc--chhhhhcCCCEEECCCCCCccc-c-CccChhhhhhcccCCCCCCc-cccchHHhCCcCCEE
Confidence            5678888888888 665  365 578889999999988854 3 57788889999999999884 55444 468889999


Q ss_pred             ecCCCcCCccC-CCcccCCCCCCeeeccCccccC
Q 007167          146 DLSNNFFNASI-PASISKLTHLSALNLANNSLTG  178 (615)
Q Consensus       146 ~l~~N~l~~~~-p~~~~~l~~L~~l~l~~N~l~g  178 (615)
                      +|++|+|...- =..+..+++|+.|+|.+|.++.
T Consensus        94 ~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~~  127 (175)
T PF14580_consen   94 YLSNNKISDLNELEPLSSLPKLRVLSLEGNPVCE  127 (175)
T ss_dssp             E-TTS---SCCCCGGGGG-TT--EEE-TT-GGGG
T ss_pred             ECcCCcCCChHHhHHHHcCCCcceeeccCCcccc
Confidence            99999887421 1356678888888888888873

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=98.96  E-value=9e-11  Score=116.63  Aligned_cols=135  Identities=27%  Similarity=0.393  Sum_probs=116.0

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEeccc-ccccCCCC-cccccccccce
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQF-NSFSGPLP-LDFSVWNNLTV  144 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~-N~l~g~~p-~~~~~l~~L~~  144 (615)
                      ...+.|+|..|+|+ .||+..|+.+.+|+.||||+|+|+-+-|..|.+|.+|..|-+-+ |+|+. +| ..|++|..|+.
T Consensus        67 ~~tveirLdqN~I~-~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~-l~k~~F~gL~slqr  144 (498)
T KOG4237|consen   67 PETVEIRLDQNQIS-SIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITD-LPKGAFGGLSSLQR  144 (498)
T ss_pred             CcceEEEeccCCcc-cCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhh-hhhhHhhhHHHHHH
Confidence            45789999999999 99999999999999999999999999999999999988877766 99995 55 46999999999


Q ss_pred             eecCCCcCCccCCCcccCCCCCCeeeccCccccCCCcc-ccc---cCCcccccCCCCCCCCCCC
Q 007167          145 IDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPR-SLQ---RFPSWAFAGNNLSSENARP  204 (615)
Q Consensus       145 l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~~~---~l~~l~~~~n~~~~~~~~~  204 (615)
                      |.+.-|++.....+.|..|++|..|.|.+|.+. .|+. .|.   .++.+.++.|++-|.+.++
T Consensus       145 LllNan~i~Cir~~al~dL~~l~lLslyDn~~q-~i~~~tf~~l~~i~tlhlA~np~icdCnL~  207 (498)
T KOG4237|consen  145 LLLNANHINCIRQDALRDLPSLSLLSLYDNKIQ-SICKGTFQGLAAIKTLHLAQNPFICDCNLP  207 (498)
T ss_pred             HhcChhhhcchhHHHHHHhhhcchhcccchhhh-hhccccccchhccchHhhhcCccccccccc
Confidence            999999999988899999999999999999998 4443 444   4556777888887765443

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=98.92  E-value=1.1e-10  Score=127.22  Aligned_cols=125  Identities=28%  Similarity=0.393  Sum_probs=75.7

Q ss_pred             cEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeec
Q 007167           68 RVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL  147 (615)
Q Consensus        68 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l  147 (615)
                      .+..|+|.+|.|+-..=| .|.++.+|+.|+|++|+|.......+.+|..|++|+||+|+|+ .+|..+..+..|++|..
T Consensus       360 ~Lq~LylanN~Ltd~c~p-~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~a  437 (1081)
T KOG0618|consen  360 ALQELYLANNHLTDSCFP-VLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRA  437 (1081)
T ss_pred             HHHHHHHhcCcccccchh-hhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhh
Confidence            455566666666654444 4666666666666666666332234566666666666666666 46666666666666666


Q ss_pred             CCCcCCccCCCcccCCCCCCeeeccCcccc-CCCcccc--ccCCcccccCCC
Q 007167          148 SNNFFNASIPASISKLTHLSALNLANNSLT-GTLPRSL--QRFPSWAFAGNN  196 (615)
Q Consensus       148 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~-g~~p~~~--~~l~~l~~~~n~  196 (615)
                      .+|++. ..| .+.++++|+.+|||.|+|+ +.+|...  .+|..|.++||.
T Consensus       438 hsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~LkyLdlSGN~  487 (1081)
T KOG0618|consen  438 HSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPNLKYLDLSGNT  487 (1081)
T ss_pred             cCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcccceeeccCCc
Confidence            666666 355 5666666666666666665 3333332  355566666665

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.92  E-value=7.4e-10  Score=83.88  Aligned_cols=59  Identities=41%  Similarity=0.549  Sum_probs=25.9

Q ss_pred             CccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeecCCCc
Q 007167           93 ALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNF  151 (615)
Q Consensus        93 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~  151 (615)
                      +|++|+|++|+|+...+..|.++++|++|+|++|.++...|..|.++++|+.|++++|+
T Consensus         2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~   60 (61)
T PF13855_consen    2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN   60 (61)
T ss_dssp             TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred             cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence            34444444444443333344444444444444444443333344444444444444443

...

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.90  E-value=4.8e-10  Score=124.13  Aligned_cols=194  Identities=20%  Similarity=0.265  Sum_probs=135.5

Q ss_pred             hcCcCCccEEEEEEEC-CCCEEEEEEeccc----cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          307 VLGKGTFGTAYKAALE-DASTVVVKRLKEV----NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      -+-+|.++.++-+.-. .|...+.|.....    ....+....+-.+.-..+||-++....-+.......+|++|..+++
T Consensus       811 p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~  890 (1205)
T KOG0606|consen  811 PSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGD  890 (1205)
T ss_pred             cccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCC
Confidence            5778889988876532 2222233322211    1111222222233333456777765555555677899999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC------
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP------  455 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~------  455 (615)
                      |...||.-.     ..+..........+.++.+|||...   +.|||++|.|++...+++.++.|||......-      
T Consensus       891 ~~Skl~~~~-----~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~  962 (1205)
T KOG0606|consen  891 LPSKLHNSG-----CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD  962 (1205)
T ss_pred             chhhhhcCC-----CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccccccCcCC
Confidence            999998532     3444445556667888999999886   89999999999999999999999984422110      


Q ss_pred             ----------------------------CCCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc
Q 007167          456 ----------------------------MPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDE  507 (615)
Q Consensus       456 ----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~  507 (615)
                                                  ......+|..|.+||...+......+|+|+.|+.++|.++|..||.....+.
T Consensus       963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~ 1042 (1205)
T KOG0606|consen  963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ 1042 (1205)
T ss_pred             cccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhh
Confidence                                        0112235678999999999999999999999999999999999998866554


Q ss_pred             h
Q 007167          508 V  508 (615)
Q Consensus       508 ~  508 (615)
                      +
T Consensus      1043 ~ 1043 (1205)
T KOG0606|consen 1043 I 1043 (1205)
T ss_pred             h
Confidence            4

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.90  E-value=4.1e-08  Score=101.58  Aligned_cols=170  Identities=21%  Similarity=0.285  Sum_probs=127.5

Q ss_pred             ccEEEEEE-ECCCCEEEEEEeccccC-CHHHHHHHHHHHhCCCCCcccceeEEEE----ecCeeeEEeecCCC-CChhhh
Q 007167          313 FGTAYKAA-LEDASTVVVKRLKEVNV-GKREFEQQMEIVGGIRHENVVALRAYYY----SKDEKLMVYDYFEP-GSVSAM  385 (615)
Q Consensus       313 fg~Vy~~~-~~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~----~~~~~~lV~e~~~~-gsL~~~  385 (615)
                      -.+.||+. ..||..|+.||+...+. ....-..-+++++++.|.|||++..++.    .+...++||+|.++ ++|.+.
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~  368 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL  368 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence            36789997 56899999999943211 1112234578899999999999988886    34578999999876 466665


Q ss_pred             hccCCC----------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC
Q 007167          386 LHGRRG----------EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       386 l~~~~~----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      -.....          .......+...+.++.|+..||.++|+.|   ..-+-+.+.+|+++.+.+++|+..|+...+..
T Consensus       369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~  445 (655)
T KOG3741|consen  369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE  445 (655)
T ss_pred             HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence            443221          12334677889999999999999999998   88999999999999999999999998877654


Q ss_pred             CCCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q 007167          456 MPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSP  499 (615)
Q Consensus       456 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p  499 (615)
                      ....           -+   .--.+-|.-.||.+++-|.||..-
T Consensus       446 d~~~-----------~l---e~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  446 DPTE-----------PL---ESQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCCc-----------ch---hHHhhhhHHHHHHHHHHHhhcccc
Confidence            3311           11   123467888999999999998653

>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A

Probab=98.90  E-value=1e-09  Score=83.15  Aligned_cols=61  Identities=41%  Similarity=0.516  Sum_probs=56.7

Q ss_pred             ccCcEEecccccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccc
Q 007167          116 ENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSL  176 (615)
Q Consensus       116 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l  176 (615)
                      ++|++|+|++|+|+...+..|.++++|+.|++++|+++...|..|.++++|++|++++|+|
T Consensus         1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l   61 (61)
T PF13855_consen    1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL   61 (61)
T ss_dssp             TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred             CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence            5799999999999976667899999999999999999988889999999999999999986

...

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.88  E-value=2.5e-08  Score=99.15  Aligned_cols=140  Identities=11%  Similarity=0.112  Sum_probs=99.8

Q ss_pred             hhcCcCCccEEEEEEECCCCEEEEEEecccc------------CCHHHHHHHHHHHhCCCCCcc--cceeEEEEe-----
Q 007167          306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVN------------VGKREFEQQMEIVGGIRHENV--VALRAYYYS-----  366 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~------------~~~~~~~~e~~~l~~l~h~ni--v~l~~~~~~-----  366 (615)
                      +.+-+.....|++... +|+.|.||+.....            .....+.+|.+.+.++...+|  ..++++...     
T Consensus        28 e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~  106 (268)
T PRK15123         28 EVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA  106 (268)
T ss_pred             cEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence            4444444455777665 56789999774332            111247788888877754333  445666543     


Q ss_pred             cCeeeEEeecCCCC-ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCC-------
Q 007167          367 KDEKLMVYDYFEPG-SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNS-------  438 (615)
Q Consensus       367 ~~~~~lV~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~-------  438 (615)
                      ...-++|+|++++. +|.+++....   ....+...+..++.+++..+..||..|   |+|+|++++|||++.       
T Consensus       107 ~~~s~LVte~l~~~~sL~~~~~~~~---~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~  180 (268)
T PRK15123        107 TRTSFIITEDLAPTISLEDYCADWA---TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREE  180 (268)
T ss_pred             cceeEEEEeeCCCCccHHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCC
Confidence            23568999999886 7888875321   123456677889999999999999998   999999999999975       


Q ss_pred             CCcEEEeecccccc
Q 007167          439 QGHVCVSDIGLAAL  452 (615)
Q Consensus       439 ~~~~kl~DfG~a~~  452 (615)
                      ++.+.++||+.+..
T Consensus       181 ~~~~~LIDl~r~~~  194 (268)
T PRK15123        181 DLKLSVIDLHRAQI  194 (268)
T ss_pred             CceEEEEECCcccc
Confidence            46799999998754

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.86  E-value=1.3e-08  Score=91.83  Aligned_cols=140  Identities=16%  Similarity=0.330  Sum_probs=99.8

Q ss_pred             hhcCcCCccEEEEEEECCCCEEEEEE-eccc--------cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeec
Q 007167          306 EVLGKGTFGTAYKAALEDASTVVVKR-LKEV--------NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~~~vavK~-l~~~--------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      +++-+|+-+.|+++.+. |+..+||. +.+.        ....+...+|.+++.+++--.|.-..-++.+...-.|+|||
T Consensus        13 ~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~   91 (229)
T KOG3087|consen   13 ELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEF   91 (229)
T ss_pred             eeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEe
Confidence            45778999999999875 56656654 3221        11235567899999888766665555667777778899999


Q ss_pred             CCC-CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCC---cEEEeecccccc
Q 007167          377 FEP-GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG---HVCVSDIGLAAL  452 (615)
Q Consensus       377 ~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~---~~kl~DfG~a~~  452 (615)
                      +++ -++.+++...-.   ....-.....++..+=+.+.-||..+   |+|+||..+||++..++   .+.++|||++..
T Consensus        92 ~~g~~~vk~~i~~~~~---~~~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   92 IDGASTVKDFILSTME---DESEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             ccchhHHHHHHHHHcc---CcccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence            976 377777754321   11222223567778888899999998   99999999999997665   368999999754

>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms]

Probab=98.85  E-value=4e-10  Score=122.95  Aligned_cols=115  Identities=24%  Similarity=0.461  Sum_probs=101.8

Q ss_pred             CCCCCCCcceEecCCCCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccC
Q 007167           51 SSLCKSWTGVTCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSG  130 (615)
Q Consensus        51 ~~~c~~w~gv~C~~~~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g  130 (615)
                      ++.|  |.-..|   ..++..|+|++|+|. ++|...+.+|..|+.|+||+|.|+ .+|.++.++..|++|...+|++. 
T Consensus       372 td~c--~p~l~~---~~hLKVLhLsyNrL~-~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-  443 (1081)
T KOG0618|consen  372 TDSC--FPVLVN---FKHLKVLHLSYNRLN-SFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-  443 (1081)
T ss_pred             cccc--hhhhcc---ccceeeeeecccccc-cCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-
Confidence            4556  776666   468999999999998 999999999999999999999999 77999999999999999999999 


Q ss_pred             CCCcccccccccceeecCCCcCCcc-CCCcccCCCCCCeeeccCcc
Q 007167          131 PLPLDFSVWNNLTVIDLSNNFFNAS-IPASISKLTHLSALNLANNS  175 (615)
Q Consensus       131 ~~p~~~~~l~~L~~l~l~~N~l~~~-~p~~~~~l~~L~~l~l~~N~  175 (615)
                      .+| .+..+++|+.+|||.|+++-. +|..... ++|++|||++|.
T Consensus       444 ~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~-p~LkyLdlSGN~  487 (1081)
T KOG0618|consen  444 SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPS-PNLKYLDLSGNT  487 (1081)
T ss_pred             ech-hhhhcCcceEEecccchhhhhhhhhhCCC-cccceeeccCCc
Confidence            688 899999999999999999843 4555444 799999999997

>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A

Probab=98.84  E-value=1.1e-09  Score=100.87  Aligned_cols=116  Identities=26%  Similarity=0.411  Sum_probs=38.4

Q ss_pred             CCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCcc-ccccCcEEecccccccCCCCcccccccccceeecCCCcCC
Q 007167           75 PGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFS-KLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFN  153 (615)
Q Consensus        75 ~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~  153 (615)
                      ..+-+. .++  .+.+...+++|+|++|.|+.+  ..++ .|.+|+.|||++|.++. ++ .+..++.|+.|+|++|+|+
T Consensus         5 t~~~i~-~~~--~~~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~-l~-~l~~L~~L~~L~L~~N~I~   77 (175)
T PF14580_consen    5 TANMIE-QIA--QYNNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITK-LE-GLPGLPRLKTLDLSNNRIS   77 (175)
T ss_dssp             ------------------------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---
T ss_pred             cccccc-ccc--ccccccccccccccccccccc--cchhhhhcCCCEEECCCCCCcc-cc-CccChhhhhhcccCCCCCC
Confidence            334444 444  356667899999999999954  3576 58999999999999995 54 5888999999999999999


Q ss_pred             ccCCCcc-cCCCCCCeeeccCccccCCCc----cccccCCcccccCCCCC
Q 007167          154 ASIPASI-SKLTHLSALNLANNSLTGTLP----RSLQRFPSWAFAGNNLS  198 (615)
Q Consensus       154 ~~~p~~~-~~l~~L~~l~l~~N~l~g~~p----~~~~~l~~l~~~~n~~~  198 (615)
                      . ++..+ ..+++|+.|+|++|+|...--    ..+.+|..+.+.|||++
T Consensus        78 ~-i~~~l~~~lp~L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~  126 (175)
T PF14580_consen   78 S-ISEGLDKNLPNLQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC  126 (175)
T ss_dssp             S--CHHHHHH-TT--EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred             c-cccchHHhCCcCCEEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence            5 55445 468999999999999984211    23455667788999884

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=98.83  E-value=3e-08  Score=111.75  Aligned_cols=116  Identities=24%  Similarity=0.452  Sum_probs=69.9

Q ss_pred             EEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeecC
Q 007167           69 VVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLS  148 (615)
Q Consensus        69 v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~  148 (615)
                      .+.|+|++++|+ .+|. .+.  +.|+.|+|++|+|+ .+|..+.  .+|++|+|++|+|+ .+|..+.  .+|+.|+|+
T Consensus       180 ~~~L~L~~~~Lt-sLP~-~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls  249 (754)
T PRK15370        180 KTELRLKILGLT-TIPA-CIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELS  249 (754)
T ss_pred             ceEEEeCCCCcC-cCCc-ccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECc
Confidence            346778888887 6775 232  46788888888888 4565543  47777777777777 4565443  356666666


Q ss_pred             CCcCCccCCCcccCCCCCCeeeccCccccCCCcccc-ccCCcccccCCCCC
Q 007167          149 NNFFNASIPASISKLTHLSALNLANNSLTGTLPRSL-QRFPSWAFAGNNLS  198 (615)
Q Consensus       149 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~-~~l~~l~~~~n~~~  198 (615)
                      +|+++ .+|..+.  ++|+.|+|++|+|+ .+|..+ .+|..|.+++|.+.
T Consensus       250 ~N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~~sL~~L~Ls~N~Lt  296 (754)
T PRK15370        250 INRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLPEELRYLSVYDNSIR  296 (754)
T ss_pred             CCccC-cCChhHh--CCCCEEECcCCccC-ccccccCCCCcEEECCCCccc
Confidence            66665 4555443  35666666666665 344433 24555555555543

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=98.81  E-value=3.7e-09  Score=118.41  Aligned_cols=76  Identities=29%  Similarity=0.388  Sum_probs=56.7

Q ss_pred             ccCcEEecccccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccccC---Ccccc
Q 007167          116 ENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRF---PSWAF  192 (615)
Q Consensus       116 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l---~~l~~  192 (615)
                      .+|+.|+|++|+|++ +|...   ++|+.|+|++|+|++ +|...   .+|+.|+|++|+|+ .+|..+.++   ..+.+
T Consensus       382 ~~L~~LdLs~N~Lt~-LP~l~---s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdL  452 (788)
T PRK15387        382 SGLKELIVSGNRLTS-LPVLP---SELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNL  452 (788)
T ss_pred             cccceEEecCCcccC-CCCcc---cCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEEC
Confidence            357788888888884 66433   578888999999985 67543   46788999999998 788776554   45678


Q ss_pred             cCCCCCCC
Q 007167          193 AGNNLSSE  200 (615)
Q Consensus       193 ~~n~~~~~  200 (615)
                      ++|++.+.
T Consensus       453 s~N~Ls~~  460 (788)
T PRK15387        453 EGNPLSER  460 (788)
T ss_pred             CCCCCCch
Confidence            89988754

>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional

Probab=98.80  E-value=8.5e-09  Score=116.12  Aligned_cols=118  Identities=24%  Similarity=0.455  Sum_probs=84.4

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID  146 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~  146 (615)
                      ..++.|+|++|+|+ .+|.. +  .++|+.|+|++|+|+ .+|..+.  .+|+.|+|++|++. .+|..+.  ++|+.|+
T Consensus       199 ~~L~~L~Ls~N~Lt-sLP~~-l--~~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~N~L~-~LP~~l~--s~L~~L~  268 (754)
T PRK15370        199 EQITTLILDNNELK-SLPEN-L--QGNIKTLYANSNQLT-SIPATLP--DTIQEMELSINRIT-ELPERLP--SALQSLD  268 (754)
T ss_pred             cCCcEEEecCCCCC-cCChh-h--ccCCCEEECCCCccc-cCChhhh--ccccEEECcCCccC-cCChhHh--CCCCEEE
Confidence            36889999999999 78874 3  258899999999988 4576554  46888888888887 5776654  4788888


Q ss_pred             cCCCcCCccCCCcccCCCCCCeeeccCccccCCCcccc-ccCCcccccCCCCC
Q 007167          147 LSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSL-QRFPSWAFAGNNLS  198 (615)
Q Consensus       147 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~-~~l~~l~~~~n~~~  198 (615)
                      |++|+|+. +|..+.  ++|+.|+|++|+|++ +|..+ .++..|.+++|.+.
T Consensus       269 Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~-LP~~lp~sL~~L~Ls~N~Lt  317 (754)
T PRK15370        269 LFHNKISC-LPENLP--EELRYLSVYDNSIRT-LPAHLPSGITHLNVQSNSLT  317 (754)
T ss_pred             CcCCccCc-cccccC--CCCcEEECCCCcccc-CcccchhhHHHHHhcCCccc
Confidence            88888884 676554  478888888888874 44433 24555556666554

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.78  E-value=3.6e-07  Score=92.36  Aligned_cols=260  Identities=13%  Similarity=0.173  Sum_probs=152.7

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCC-CCCcccceeEEE----E--e-cCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGI-RHENVVALRAYY----Y--S-KDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~----~--~-~~~~~lV~e~  376 (615)
                      +..||+|+-+.+|-..  +-..-+.|+.......  .-.+.++.|... .||-+-.-+.|=    .  + .....++|..
T Consensus        16 gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa--~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~   91 (637)
T COG4248          16 GRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPA--AQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPK   91 (637)
T ss_pred             CccccCCccceeeecc--hhhchhheeecCCCch--HHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEeccc
Confidence            4569999999999743  1122334554433221  112233344443 566443312221    1  1 1225667777


Q ss_pred             CCCCC-hhhhhcc-CCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccC
Q 007167          377 FEPGS-VSAMLHG-RRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS  454 (615)
Q Consensus       377 ~~~gs-L~~~l~~-~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~  454 (615)
                      +.+.. ...+... .+...-...+|.-.++.+..+|.+.+.||..|   .+-+|+.++|+|+.+++.+.+.|-..-....
T Consensus        92 v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~  168 (637)
T COG4248          92 VSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQINA  168 (637)
T ss_pred             CCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceeecc
Confidence            65542 2222221 11223456899999999999999999999998   8889999999999999999998865433322


Q ss_pred             CC--CCCCCCCCcccCccccC-----CCCCCCccchhhHHHHHHHHHhC-CCCCCCCCC-----cchhhHHHHHHHhhhc
Q 007167          455 PM--PPPAMRAAGYRAPEVTD-----TRKATQASDVFSFGVLLLELLTG-KSPIHATGG-----DEVVHLVRWVNSVVRE  521 (615)
Q Consensus       455 ~~--~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg-~~p~~~~~~-----~~~~~~~~~~~~~~~~  521 (615)
                      ..  ..-.++...|.+||.-.     +..-+...|-|.+||++++++.| ++||.+...     ......+  ....+..
T Consensus       169 ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~I--a~g~f~y  246 (637)
T COG4248         169 NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDI--AHGRFAY  246 (637)
T ss_pred             CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhh--hcceeee
Confidence            11  11234667799999764     23346788999999999999985 999986321     0000001  0000000


Q ss_pred             c---cccccccccccCCCCcHHHHHHHHHHHHHcccCC--CCCCCCHHHHHHHHHHhHhh
Q 007167          522 E---WTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRM--PEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       522 ~---~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~--P~~RPs~~evl~~L~~l~~~  576 (615)
                      .   .....-.+.-..+....+.+..++.   +|+...  +.-||+++-.+..|..+++.
T Consensus       247 a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~---qaF~~~~~~~~RP~a~aW~aAl~al~~~  303 (637)
T COG4248         247 ASDQRRGLKPPPRSIPLSMLPPDVQALFQ---QAFTESGVATPRPTAKAWVAALDALRQQ  303 (637)
T ss_pred             chhccCCCCCCCCCCChhhcCHHHHHHHH---HHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence            0   0000000000111233456666666   788653  56899999999988887754

>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional

Probab=98.78  E-value=1.6e-08  Score=113.31  Aligned_cols=34  Identities=24%  Similarity=0.462  Sum_probs=21.0

Q ss_pred             cEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCC
Q 007167           68 RVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSG  106 (615)
Q Consensus        68 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g  106 (615)
                      +++.|+|++|+|+ .||.    .+++|++|+|++|+|+.
T Consensus       223 ~L~~L~L~~N~Lt-~LP~----lp~~Lk~LdLs~N~Lts  256 (788)
T PRK15387        223 HITTLVIPDNNLT-SLPA----LPPELRTLEVSGNQLTS  256 (788)
T ss_pred             CCCEEEccCCcCC-CCCC----CCCCCcEEEecCCccCc
Confidence            4566666666666 4554    14566666666666663

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.76  E-value=4.4e-08  Score=91.79  Aligned_cols=125  Identities=18%  Similarity=0.262  Sum_probs=80.6

Q ss_pred             EEEEEEECCCCEEEEEEeccccC----------------------C-----HHHHHHHHHHHhCCCCCc--ccceeEEEE
Q 007167          315 TAYKAALEDASTVVVKRLKEVNV----------------------G-----KREFEQQMEIVGGIRHEN--VVALRAYYY  365 (615)
Q Consensus       315 ~Vy~~~~~~~~~vavK~l~~~~~----------------------~-----~~~~~~e~~~l~~l~h~n--iv~l~~~~~  365 (615)
                      .||.|...+|..+|||..+....                      .     ....++|.+.|.++...+  +-+++++  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            48999998999999998743100                      0     123467999999997664  4555544  


Q ss_pred             ecCeeeEEeecCC--CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHH-hhccCCCCceecCCCCCCEEeCCCCcE
Q 007167          366 SKDEKLMVYDYFE--PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAH-IHTENGGKLVHGGIKASNIFLNSQGHV  442 (615)
Q Consensus       366 ~~~~~~lV~e~~~--~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~-LH~~~~~~iiHrDik~~Nill~~~~~~  442 (615)
                        ....+||||++  +..+..+....       ++......++.++...+.. +|..+   |+|+|+.+.||+++++ .+
T Consensus        79 --~~~~ivME~I~~~G~~~~~l~~~~-------~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~  145 (188)
T PF01163_consen   79 --NRNVIVMEYIGEDGVPLPRLKDVD-------LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KV  145 (188)
T ss_dssp             --ETTEEEEE--EETTEEGGCHHHCG-------GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CE
T ss_pred             --eCCEEEEEecCCCccchhhHHhcc-------ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eE
Confidence              24579999998  54444433211       1123345667777775555 46777   9999999999999988 99


Q ss_pred             EEeecccccccC
Q 007167          443 CVSDIGLAALMS  454 (615)
Q Consensus       443 kl~DfG~a~~~~  454 (615)
                      .|+|||.+....
T Consensus       146 ~iIDf~qav~~~  157 (188)
T PF01163_consen  146 YIIDFGQAVDSS  157 (188)
T ss_dssp             EE--GTTEEETT
T ss_pred             EEEecCcceecC
Confidence            999999887654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.73  E-value=8.5e-08  Score=92.34  Aligned_cols=138  Identities=22%  Similarity=0.266  Sum_probs=95.9

Q ss_pred             HHHHHhhhcCcCCccEEEEEEECCCCEEEEEEecccc-----------------------CCHHHHHHHHHHHhCCCCC-
Q 007167          300 LLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVN-----------------------VGKREFEQQMEIVGGIRHE-  355 (615)
Q Consensus       300 l~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-----------------------~~~~~~~~e~~~l~~l~h~-  355 (615)
                      ...+.++.||-|.-+.||.|...+|.++|||.-+...                       ......++|.++|.++... 
T Consensus        91 ~ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G  170 (304)
T COG0478          91 IVEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG  170 (304)
T ss_pred             hHHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence            3455678999999999999999999999999643210                       0123357899999988644 


Q ss_pred             -cccceeEEEEecCeeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCE
Q 007167          356 -NVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNI  434 (615)
Q Consensus       356 -niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Ni  434 (615)
                       .|.+.+++    +...+||||+++--|...-          ++-...-.|+..|.+-+...-..|   |||+|+.+-||
T Consensus       171 ~~VP~P~~~----nRHaVvMe~ieG~eL~~~r----------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNI  233 (304)
T COG0478         171 VKVPKPIAW----NRHAVVMEYIEGVELYRLR----------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNI  233 (304)
T ss_pred             CCCCCcccc----ccceeeeehcccceeeccc----------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheE
Confidence             66666655    5778999999885554332          111122223333333333333455   99999999999


Q ss_pred             EeCCCCcEEEeecccccccC
Q 007167          435 FLNSQGHVCVSDIGLAALMS  454 (615)
Q Consensus       435 ll~~~~~~kl~DfG~a~~~~  454 (615)
                      +++++|.+.++||--+....
T Consensus       234 lV~~dg~~~vIDwPQ~v~~~  253 (304)
T COG0478         234 LVTEDGDIVVIDWPQAVPIS  253 (304)
T ss_pred             EEecCCCEEEEeCcccccCC
Confidence            99999999999998766544

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=98.71  E-value=1.1e-09  Score=113.74  Aligned_cols=125  Identities=22%  Similarity=0.412  Sum_probs=73.6

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID  146 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~  146 (615)
                      ..++.|||+.|+++ .+|. .+..|+ |+.|-+++|+++ .+|..++.+..|..||.+.|.+. .+|..++.+.+|+.|+
T Consensus       121 ~~lt~l~ls~NqlS-~lp~-~lC~lp-Lkvli~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~  195 (722)
T KOG0532|consen  121 EALTFLDLSSNQLS-HLPD-GLCDLP-LKVLIVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLN  195 (722)
T ss_pred             hHHHHhhhccchhh-cCCh-hhhcCc-ceeEEEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHH
Confidence            34556666666666 5555 455444 566666666666 45666666666666666666665 4666666666666666


Q ss_pred             cCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccccCCc---ccccCCCCCC
Q 007167          147 LSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPS---WAFAGNNLSS  199 (615)
Q Consensus       147 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~---l~~~~n~~~~  199 (615)
                      +..|++. .+|..+..| .|..||+|+|+++ .||-.|.+|..   +.+.+|++.+
T Consensus       196 vrRn~l~-~lp~El~~L-pLi~lDfScNkis-~iPv~fr~m~~Lq~l~LenNPLqS  248 (722)
T KOG0532|consen  196 VRRNHLE-DLPEELCSL-PLIRLDFSCNKIS-YLPVDFRKMRHLQVLQLENNPLQS  248 (722)
T ss_pred             Hhhhhhh-hCCHHHhCC-ceeeeecccCcee-ecchhhhhhhhheeeeeccCCCCC
Confidence            6666665 345555543 3566666666666 56655554443   3345566543

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.69  E-value=2.7e-09  Score=102.55  Aligned_cols=125  Identities=21%  Similarity=0.300  Sum_probs=76.8

Q ss_pred             cEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeec
Q 007167           68 RVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL  147 (615)
Q Consensus        68 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l  147 (615)
                      -++.+||++|.++ .|.. +..-++.++.|+||.|+|... - .+..|.+|+.||||+|.|+ .+-..-..|-+.++|.|
T Consensus       285 ~LtelDLS~N~I~-~iDE-SvKL~Pkir~L~lS~N~i~~v-~-nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~L  359 (490)
T KOG1259|consen  285 ELTELDLSGNLIT-QIDE-SVKLAPKLRRLILSQNRIRTV-Q-NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKL  359 (490)
T ss_pred             hhhhccccccchh-hhhh-hhhhccceeEEeccccceeee-h-hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeeh
Confidence            3556777777776 5554 466667777777777777632 2 3667777777777777776 34444445666677777


Q ss_pred             CCCcCCccCCCcccCCCCCCeeeccCccccCCC-ccccccCC---cccccCCCCCC
Q 007167          148 SNNFFNASIPASISKLTHLSALNLANNSLTGTL-PRSLQRFP---SWAFAGNNLSS  199 (615)
Q Consensus       148 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~-p~~~~~l~---~l~~~~n~~~~  199 (615)
                      +.|.|...  ..+..|-+|..||+++|+|...- -..++++|   .+.+-+||+..
T Consensus       360 a~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~  413 (490)
T KOG1259|consen  360 AQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG  413 (490)
T ss_pred             hhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence            77776532  34566667777777777775210 12244444   34556666643

>PLN03210 Resistant to P

Probab=98.68  E-value=5.7e-08  Score=116.56  Aligned_cols=126  Identities=25%  Similarity=0.303  Sum_probs=68.7

Q ss_pred             cEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeec
Q 007167           68 RVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL  147 (615)
Q Consensus        68 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l  147 (615)
                      .++.|+|+++.+. .++. .+..+++|++|+|++|...+.+| .++.+++|+.|+|++|.....+|..++++++|+.|++
T Consensus       612 ~L~~L~L~~s~l~-~L~~-~~~~l~~Lk~L~Ls~~~~l~~ip-~ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L  688 (1153)
T PLN03210        612 NLVKLQMQGSKLE-KLWD-GVHSLTGLRNIDLRGSKNLKEIP-DLSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDM  688 (1153)
T ss_pred             CCcEEECcCcccc-cccc-ccccCCCCCEEECCCCCCcCcCC-ccccCCcccEEEecCCCCccccchhhhccCCCCEEeC
Confidence            4555555555555 4444 34555666666665544334444 3555666666666655544455666666666666666


Q ss_pred             CCCcCCccCCCcccCCCCCCeeeccCccccCCCccccccCCcccccCCCC
Q 007167          148 SNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNL  197 (615)
Q Consensus       148 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~n~~  197 (615)
                      ++|..-+.+|..+ ++++|+.|+|++|...+.+|....++..|.+.+|.+
T Consensus       689 ~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~~~nL~~L~L~~n~i  737 (1153)
T PLN03210        689 SRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDISTNISWLDLDETAI  737 (1153)
T ss_pred             CCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccccCCcCeeecCCCcc
Confidence            6543333455444 455666666666555555555445555555555543

syringae 6; Provisional

>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms]

Probab=98.68  E-value=1.1e-08  Score=102.03  Aligned_cols=100  Identities=23%  Similarity=0.287  Sum_probs=87.7

Q ss_pred             cccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeecCCCcCCccCCC
Q 007167           79 LRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPA  158 (615)
Q Consensus        79 l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~  158 (615)
                      ..+.-|..-|..|++|+.|+|++|.|+++-+..|.++..|++|+|..|+|.-.--..|.+++.|++|+|.+|+|+..-|.
T Consensus       261 ~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~  340 (498)
T KOG4237|consen  261 PDSICPAKCFKKLPNLRKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPG  340 (498)
T ss_pred             cCCcChHHHHhhcccceEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecc
Confidence            44455666688999999999999999999999999999999999999999866566789999999999999999988899


Q ss_pred             cccCCCCCCeeeccCccccC
Q 007167          159 SISKLTHLSALNLANNSLTG  178 (615)
Q Consensus       159 ~~~~l~~L~~l~l~~N~l~g  178 (615)
                      .|..+.+|..|+|-.|.+..
T Consensus       341 aF~~~~~l~~l~l~~Np~~C  360 (498)
T KOG4237|consen  341 AFQTLFSLSTLNLLSNPFNC  360 (498)
T ss_pred             cccccceeeeeehccCcccC
Confidence            99999999999999998864

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=98.62  E-value=3e-09  Score=109.59  Aligned_cols=131  Identities=27%  Similarity=0.333  Sum_probs=87.1

Q ss_pred             CCcEEEEEeCCCCcccccCCCcccCCCC---ccEEEcCCCCCCC----cCCCCcccc-ccCcEEecccccccCC----CC
Q 007167           66 HSRVVALRLPGMALRGEIPPNTIGRLSA---LQNLSLRSNSLSG----LFPSDFSKL-ENLTSLHLQFNSFSGP----LP  133 (615)
Q Consensus        66 ~~~v~~l~l~~~~l~g~i~~~~~~~l~~---L~~L~L~~N~l~g----~~p~~~~~l-~~L~~L~l~~N~l~g~----~p  133 (615)
                      ..+++.|+|++|.+.+..+. .+..+.+   |++|+|++|.+++    .+...+..+ ++|+.|+|++|.+++.    ++
T Consensus        80 ~~~L~~L~l~~~~~~~~~~~-~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~  158 (319)
T cd00116          80 GCGLQELDLSDNALGPDGCG-VLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALA  158 (319)
T ss_pred             cCceeEEEccCCCCChhHHH-HHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHH
Confidence            45788888888888754443 4555555   8888888888873    233445566 7888888888888743    33


Q ss_pred             cccccccccceeecCCCcCCcc----CCCcccCCCCCCeeeccCccccCCCc----c---ccccCCcccccCCCC
Q 007167          134 LDFSVWNNLTVIDLSNNFFNAS----IPASISKLTHLSALNLANNSLTGTLP----R---SLQRFPSWAFAGNNL  197 (615)
Q Consensus       134 ~~~~~l~~L~~l~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~g~~p----~---~~~~l~~l~~~~n~~  197 (615)
                      ..+..+.+|+.|+|++|.+++.    ++..+..+++|+.|+|++|.+++.-.    .   .+.++..+.+++|++
T Consensus       159 ~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~~L~~L~ls~n~l  233 (319)
T cd00116         159 KALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLKSLEVLNLGDNNL  233 (319)
T ss_pred             HHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccCCCCEEecCCCcC
Confidence            3456667888888888888742    33445556688888888888774322    1   223455666676655

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.58  E-value=2.4e-08  Score=106.94  Aligned_cols=145  Identities=28%  Similarity=0.352  Sum_probs=101.2

Q ss_pred             HHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCC------------CCCCCcccCccccCC
Q 007167          407 IGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP------------AMRAAGYRAPEVTDT  474 (615)
Q Consensus       407 ~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~------------~~~~~~y~aPE~~~~  474 (615)
                      .+++.|+.|+|...  ++||++|.|++|.++.++..||+.|+++....+....            ......|.|||++..
T Consensus       106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            35558999999876  6999999999999999999999999988665442111            012345999999988


Q ss_pred             CCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccccccccc-ccCCCCcHHHHHHHHHHHHHc
Q 007167          475 RKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE-LLRYPNIEEEMVEMLQVGMAC  552 (615)
Q Consensus       475 ~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~-~~~~~~~~~~~~~l~~l~~~c  552 (615)
                      ...+.++|+||+||++|.+.. |+.-+...+.........-.            .+-. ......++.++++-++   +.
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~------------~~~~~~~~s~~~p~el~~~l~---k~  248 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNL------------LNAGAFGYSNNLPSELRESLK---KL  248 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcc------------cccccccccccCcHHHHHHHH---HH
Confidence            788999999999999999995 55555544333322221100            0001 1111345666666666   78


Q ss_pred             ccCCCCCCCCHHHHHH
Q 007167          553 VVRMPEERPKMADVLK  568 (615)
Q Consensus       553 l~~~P~~RPs~~evl~  568 (615)
                      +..++.-||++.++..
T Consensus       249 l~~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  249 LNGDSAVRPTLDLLLS  264 (700)
T ss_pred             hcCCcccCcchhhhhc
Confidence            8899999998777643

>PRK09902 hypothetical protein; Provisional

Probab=98.53  E-value=2.1e-06  Score=81.01  Aligned_cols=137  Identities=14%  Similarity=0.178  Sum_probs=102.1

Q ss_pred             cCcCCccEEEEEEECCCCEEEEEEeccc-------cCCHHHHHHHHHHHhCCCCC--cccceeEEEE-ec----CeeeEE
Q 007167          308 LGKGTFGTAYKAALEDASTVVVKRLKEV-------NVGKREFEQQMEIVGGIRHE--NVVALRAYYY-SK----DEKLMV  373 (615)
Q Consensus       308 lG~G~fg~Vy~~~~~~~~~vavK~l~~~-------~~~~~~~~~e~~~l~~l~h~--niv~l~~~~~-~~----~~~~lV  373 (615)
                      -|+||-+.|++....+ ..+.+|+-...       +.+...|.+|...+..+..-  .+.++. ++. .+    ..-+||
T Consensus        26 ~~rgG~SgV~r~~~~g-~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         26 YRRNGMSGVQCVERNG-KKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             cCCCCcceEEEEEeCC-cEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            4678999999977654 47999987621       33567899999998888532  244444 332 21    246899


Q ss_pred             eecCCC-CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCc--EEEeecccc
Q 007167          374 YDYFEP-GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGH--VCVSDIGLA  450 (615)
Q Consensus       374 ~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~--~kl~DfG~a  450 (615)
                      +|-+++ -+|.+++....   ..+.+...+..++.++++.+.-||+.+   +.|+|+.+.||+++.++.  ++++||--+
T Consensus       104 Te~L~g~~~L~~~l~~~~---~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~  177 (216)
T PRK09902        104 TEDMAGFISIADWYAQHA---VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKS  177 (216)
T ss_pred             EEeCCCCccHHHHHhcCC---cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence            997753 58888885321   235677788899999999999999998   999999999999986666  999999866


Q ss_pred             cc
Q 007167          451 AL  452 (615)
Q Consensus       451 ~~  452 (615)
                      +.
T Consensus       178 r~  179 (216)
T PRK09902        178 RR  179 (216)
T ss_pred             ch
Confidence            53

>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily

Probab=98.51  E-value=1.2e-08  Score=105.19  Aligned_cols=131  Identities=21%  Similarity=0.231  Sum_probs=91.6

Q ss_pred             CcEEEEEeCCCCccc------ccCCCcccCCCCccEEEcCCCCCCCcCCCCcccccc---CcEEecccccccC----CCC
Q 007167           67 SRVVALRLPGMALRG------EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLEN---LTSLHLQFNSFSG----PLP  133 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g------~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~---L~~L~l~~N~l~g----~~p  133 (615)
                      ..++.++++++.+.+      .++. .+..+++|+.|+|++|.+.+..+..+..+.+   |++|+|++|++++    .+.
T Consensus        51 ~~l~~l~l~~~~~~~~~~~~~~~~~-~l~~~~~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~  129 (319)
T cd00116          51 PSLKELCLSLNETGRIPRGLQSLLQ-GLTKGCGLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLA  129 (319)
T ss_pred             CCceEEeccccccCCcchHHHHHHH-HHHhcCceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHH
Confidence            346777777776652      2223 5677888899999888888776767766666   8899998888873    233


Q ss_pred             cccccc-cccceeecCCCcCCcc----CCCcccCCCCCCeeeccCccccCC----Cccccc---cCCcccccCCCCC
Q 007167          134 LDFSVW-NNLTVIDLSNNFFNAS----IPASISKLTHLSALNLANNSLTGT----LPRSLQ---RFPSWAFAGNNLS  198 (615)
Q Consensus       134 ~~~~~l-~~L~~l~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~g~----~p~~~~---~l~~l~~~~n~~~  198 (615)
                      ..+..+ ++|+.|+|++|.+++.    ++..+..+++|+.|+|++|.+++.    ++..+.   ++..+.+++|.+.
T Consensus       130 ~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~  206 (319)
T cd00116         130 KGLKDLPPALEKLVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLT  206 (319)
T ss_pred             HHHHhCCCCceEEEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccC
Confidence            345566 7888899998888843    344566677888889988888853    333333   6677777777653

LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1).

>PLN03210 Resistant to P

Probab=98.50  E-value=3.9e-07  Score=109.41  Aligned_cols=125  Identities=22%  Similarity=0.308  Sum_probs=101.4

Q ss_pred             cEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeec
Q 007167           68 RVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL  147 (615)
Q Consensus        68 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l  147 (615)
                      .++.|++.++.++ .+|. .| .+.+|+.|+|++|.+. .+|..+..+++|+.|+|++|...+.+|. ++.+++|+.|+|
T Consensus       590 ~Lr~L~~~~~~l~-~lP~-~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L  664 (1153)
T PLN03210        590 KLRLLRWDKYPLR-CMPS-NF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKL  664 (1153)
T ss_pred             ccEEEEecCCCCC-CCCC-cC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEe
Confidence            4677777777776 7776 34 5789999999999988 5688889999999999998875567774 888999999999


Q ss_pred             CCCcCCccCCCcccCCCCCCeeeccCccccCCCccc--cccCCcccccCCCC
Q 007167          148 SNNFFNASIPASISKLTHLSALNLANNSLTGTLPRS--LQRFPSWAFAGNNL  197 (615)
Q Consensus       148 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~l~~l~~~~n~~  197 (615)
                      ++|..-..+|..+.++++|+.|++++|..-+.+|..  +.+|..|.+.+|..
T Consensus       665 ~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i~l~sL~~L~Lsgc~~  716 (1153)
T PLN03210        665 SDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGINLKSLYRLNLSGCSR  716 (1153)
T ss_pred             cCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcCCCCCCCEEeCCCCCC
Confidence            998777789999999999999999987665677764  45667777877754

syringae 6; Provisional

>PF08263 LRRNT_2: Leucine rich repeat N-terminal domain; InterPro: IPR013210 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape []

Probab=98.50  E-value=1.4e-07  Score=65.44  Aligned_cols=38  Identities=50%  Similarity=0.970  Sum_probs=27.3

Q ss_pred             ChhHHHHHHHHHHhcCCC---CCCCCCCC--CCCCCCCcceEec
Q 007167           25 PVEDKQALLDFIHNIHNS---RSLNWNES--SSLCKSWTGVTCS   63 (615)
Q Consensus        25 ~~~d~~al~~~k~~~~~~---~~~~w~~~--~~~c~~w~gv~C~   63 (615)
                      +++|++||++||+++.++   .+.+|+.+  .++| +|.||+|+
T Consensus         1 ~~~d~~aLl~~k~~l~~~~~~~l~~W~~~~~~~~C-~W~GV~Cd   43 (43)
T PF08263_consen    1 PNQDRQALLAFKKSLNNDPSGVLSSWNPSSDSDPC-SWSGVTCD   43 (43)
T ss_dssp             -HHHHHHHHHHHHCTT-SC-CCCTT--TT--S-CC-CSTTEEE-
T ss_pred             CcHHHHHHHHHHHhcccccCcccccCCCcCCCCCe-eeccEEeC
Confidence            367999999999999853   35689987  5677 89999995

LRRs occur in proteins ranging from viruses to eukaryotes, and appear to provide a structural framework for the formation of protein-protein interactions [, ].Proteins containing LRRs include tyrosine kinase receptors, cell-adhesion molecules, virulence factors, and extracellular matrix-binding glycoproteins, and are involved in a variety of biological processes, including signal transduction, cell adhesion, DNA repair, recombination, transcription, RNA processing, disease resistance, apoptosis, and the immune response []. Sequence analyses of LRR proteins suggested the existence of several different subfamilies of LRRs. The significance of this classification is that repeats from different subfamilies never occur simultaneously and have most probably evolved independently. It is, however, now clear that all major classes of LRR have curved horseshoe structures with a parallel beta sheet on the concave side and mostly helical elements on the convex side. At least six families of LRR proteins, characterised by different lengths and consensus sequences of the repeats, have been identified. Eleven-residue segments of the LRRs (LxxLxLxxN/CxL), corresponding to the beta-strand and adjacent loop regions, are conserved in LRR proteins, whereas the remaining parts of the repeats (herein termed variable) may be very different. Despite the differences, each of the variable parts contains two half-turns at both ends and a "linear" segment (as the chain follows a linear path overall), usually formed by a helix, in the middle. The concave face and the adjacent loops are the most common protein interaction surfaces on LRR proteins. 3D structure of some LRR proteins-ligand complexes show that the concave surface of LRR domain is ideal for interaction with alpha-helix, thus supporting earlier conclusions that the elongated and curved LRR structure provides an outstanding framework for achieving diverse protein-protein interactions []. Molecular modeling suggests that the conserved pattern LxxLxL, which is shorter than the previously proposed LxxLxLxxN/CxL is sufficient to impart the characteristic horseshoe curvature to proteins with 20- to 30-residue repeats []. This domain is often found at the N terminus of tandem leucine rich repeats.; PDB: 3RGZ_A 3RJ0_A 3RIZ_A 3RGX_A 1OGQ_A.

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.46  E-value=1.3e-06  Score=83.85  Aligned_cols=107  Identities=17%  Similarity=0.273  Sum_probs=82.8

Q ss_pred             HHHHHHHHHHHhCCCCC--cccceeEEEEecC----eeeEEeecCCCC-ChhhhhccCCCCCCCCCCHHHHHHHHHHHHH
Q 007167          339 KREFEQQMEIVGGIRHE--NVVALRAYYYSKD----EKLMVYDYFEPG-SVSAMLHGRRGEGQSSLDWDTRVRIAIGAAR  411 (615)
Q Consensus       339 ~~~~~~e~~~l~~l~h~--niv~l~~~~~~~~----~~~lV~e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~  411 (615)
                      .....+|.+.+..+...  .+.+.+++...+.    ..++|+|++++. +|.+++....     ..+......++.+++.
T Consensus        55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~-----~~~~~~~~~ll~~l~~  129 (206)
T PF06293_consen   55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWE-----QLDPSQRRELLRALAR  129 (206)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhc-----ccchhhHHHHHHHHHH
Confidence            34567787777766433  3456677766532    458999999874 7898886421     2555677889999999


Q ss_pred             HHHHhhccCCCCceecCCCCCCEEeCCCC---cEEEeeccccccc
Q 007167          412 GIAHIHTENGGKLVHGGIKASNIFLNSQG---HVCVSDIGLAALM  453 (615)
Q Consensus       412 ~l~~LH~~~~~~iiHrDik~~Nill~~~~---~~kl~DfG~a~~~  453 (615)
                      .+.-||+.+   |+|+|+++.|||++.+.   .+.++||+-++..
T Consensus       130 ~i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  130 LIAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            999999998   99999999999999887   8999999987654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only]

Probab=98.45  E-value=3.4e-09  Score=112.82  Aligned_cols=125  Identities=24%  Similarity=0.345  Sum_probs=98.7

Q ss_pred             cEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcc-cccccccceee
Q 007167           68 RVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWNNLTVID  146 (615)
Q Consensus        68 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~L~~l~  146 (615)
                      .+...+.+.|.|+ .+.. .+.-++.|+.|||++|+++..-  .+..|++|++|||++|+|. .+|.. ..++. |+.|+
T Consensus       165 ~L~~a~fsyN~L~-~mD~-SLqll~ale~LnLshNk~~~v~--~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~-L~~L~  238 (1096)
T KOG1859|consen  165 KLATASFSYNRLV-LMDE-SLQLLPALESLNLSHNKFTKVD--NLRRLPKLKHLDLSYNCLR-HVPQLSMVGCK-LQLLN  238 (1096)
T ss_pred             hHhhhhcchhhHH-hHHH-HHHHHHHhhhhccchhhhhhhH--HHHhcccccccccccchhc-cccccchhhhh-heeee
Confidence            3455667777776 3433 6888899999999999999653  7899999999999999999 56642 33444 99999


Q ss_pred             cCCCcCCccCCCcccCCCCCCeeeccCccccCCC---c-cccccCCcccccCCCCCCC
Q 007167          147 LSNNFFNASIPASISKLTHLSALNLANNSLTGTL---P-RSLQRFPSWAFAGNNLSSE  200 (615)
Q Consensus       147 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~---p-~~~~~l~~l~~~~n~~~~~  200 (615)
                      |++|.++..  ..+.+|++|..|||++|-|++--   | ..+..|..|.+.|||+.|.
T Consensus       239 lrnN~l~tL--~gie~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~c~  294 (1096)
T KOG1859|consen  239 LRNNALTTL--RGIENLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLCCA  294 (1096)
T ss_pred             ecccHHHhh--hhHHhhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccccC
Confidence            999999854  46889999999999999998642   2 2345667788999999875

>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton]

Probab=98.44  E-value=2.6e-08  Score=103.68  Aligned_cols=110  Identities=28%  Similarity=0.478  Sum_probs=99.1

Q ss_pred             cEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeec
Q 007167           68 RVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL  147 (615)
Q Consensus        68 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l  147 (615)
                      -+..|-+++|+++ .+|. .++.+..|..||.+.|.+. .+|..+++|.+|+.|++..|++. .+|..+..| .|..||+
T Consensus       144 pLkvli~sNNkl~-~lp~-~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~L-pLi~lDf  218 (722)
T KOG0532|consen  144 PLKVLIVSNNKLT-SLPE-EIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSL-PLIRLDF  218 (722)
T ss_pred             cceeEEEecCccc-cCCc-ccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCC-ceeeeec
Confidence            4677888999999 8998 7999999999999999999 66889999999999999999999 689888855 4899999


Q ss_pred             CCCcCCccCCCcccCCCCCCeeeccCccccCCCcccc
Q 007167          148 SNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSL  184 (615)
Q Consensus       148 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~  184 (615)
                      |.|+++ .||-.|.+|+.|++|-|.+|.|. ..|..+
T Consensus       219 ScNkis-~iPv~fr~m~~Lq~l~LenNPLq-SPPAqI  253 (722)
T KOG0532|consen  219 SCNKIS-YLPVDFRKMRHLQVLQLENNPLQ-SPPAQI  253 (722)
T ss_pred             ccCcee-ecchhhhhhhhheeeeeccCCCC-CChHHH
Confidence            999999 69999999999999999999998 556554

>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton]

Probab=98.42  E-value=4.5e-08  Score=94.26  Aligned_cols=119  Identities=27%  Similarity=0.295  Sum_probs=95.8

Q ss_pred             CCcceEecCC----CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCC
Q 007167           56 SWTGVTCSAD----HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGP  131 (615)
Q Consensus        56 ~w~gv~C~~~----~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~  131 (615)
                      +.+-|+|.+.    -..|..|+|+.|++. .+-  .+..|++|+.||||+|.++ .+-..-.+|-|.+.|.|+.|.+.. 
T Consensus       292 S~N~I~~iDESvKL~Pkir~L~lS~N~i~-~v~--nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La~N~iE~-  366 (490)
T KOG1259|consen  292 SGNLITQIDESVKLAPKLRRLILSQNRIR-TVQ--NLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLAQNKIET-  366 (490)
T ss_pred             cccchhhhhhhhhhccceeEEecccccee-eeh--hhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehhhhhHhh-
Confidence            3455777542    257899999999998 554  4888999999999999999 445566678999999999999873 


Q ss_pred             CCcccccccccceeecCCCcCCccC-CCcccCCCCCCeeeccCccccCCC
Q 007167          132 LPLDFSVWNNLTVIDLSNNFFNASI-PASISKLTHLSALNLANNSLTGTL  180 (615)
Q Consensus       132 ~p~~~~~l~~L~~l~l~~N~l~~~~-p~~~~~l~~L~~l~l~~N~l~g~~  180 (615)
                      + +.++.|=+|..||+++|+|...- -..+++|+.|+.+.|.+|.|.+.+
T Consensus       367 L-SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~~v  415 (490)
T KOG1259|consen  367 L-SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAGSV  415 (490)
T ss_pred             h-hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccccc
Confidence            2 34777888999999999998432 357899999999999999999653

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.41  E-value=2.9e-08  Score=84.97  Aligned_cols=110  Identities=25%  Similarity=0.335  Sum_probs=75.8

Q ss_pred             EEEEEeCCCCcccccCCC--cccCCCCccEEEcCCCCCCCcCCCCcccc-ccCcEEecccccccCCCCccccccccccee
Q 007167           69 VVALRLPGMALRGEIPPN--TIGRLSALQNLSLRSNSLSGLFPSDFSKL-ENLTSLHLQFNSFSGPLPLDFSVWNNLTVI  145 (615)
Q Consensus        69 v~~l~l~~~~l~g~i~~~--~~~~l~~L~~L~L~~N~l~g~~p~~~~~l-~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l  145 (615)
                      ...++|+++.|- .|+..  .+.....|+..+|++|.+. .+|+.|... +.++.|+|++|.++ .+|..+..++.|+.|
T Consensus        29 ~h~ldLssc~lm-~i~davy~l~~~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~l  105 (177)
T KOG4579|consen   29 LHFLDLSSCQLM-YIADAVYMLSKGYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSL  105 (177)
T ss_pred             hhhcccccchhh-HHHHHHHHHhCCceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhc
Confidence            345666666654 44431  2344455666688888887 456666554 47788888888888 578888888888888


Q ss_pred             ecCCCcCCccCCCcccCCCCCCeeeccCccccCCCccc
Q 007167          146 DLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRS  183 (615)
Q Consensus       146 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~  183 (615)
                      +++.|.|+ ..|.-+..|.+|..|+..+|.+. +||..
T Consensus       106 Nl~~N~l~-~~p~vi~~L~~l~~Lds~~na~~-eid~d  141 (177)
T KOG4579|consen  106 NLRFNPLN-AEPRVIAPLIKLDMLDSPENARA-EIDVD  141 (177)
T ss_pred             ccccCccc-cchHHHHHHHhHHHhcCCCCccc-cCcHH
Confidence            88888887 46777777888888888888776 55533

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.38  E-value=9.4e-07  Score=95.19  Aligned_cols=140  Identities=15%  Similarity=0.318  Sum_probs=90.2

Q ss_pred             hhcCcCCccEEEEEEECCCCEEEEEEeccccC---------------------------CH----H----------HHHH
Q 007167          306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNV---------------------------GK----R----------EFEQ  344 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---------------------------~~----~----------~~~~  344 (615)
                      +.|+.++-|+||+|++++|+.||||+.+..-.                           .-    +          ++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            56889999999999999999999999743200                           00    1          1223


Q ss_pred             HHHHHhCC----C-CCcccceeEEEEecCeeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHH-HHHhhc
Q 007167          345 QMEIVGGI----R-HENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARG-IAHIHT  418 (615)
Q Consensus       345 e~~~l~~l----~-h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~-l~~LH~  418 (615)
                      |..-+.++    + .+++.=..=|........|+|||++|-.+.+...-..    ..++   +..++..++++ +..+-.
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~----~g~d---~k~ia~~~~~~f~~q~~~  283 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS----AGID---RKELAELLVRAFLRQLLR  283 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHh----cCCC---HHHHHHHHHHHHHHHHHh
Confidence            33333322    2 3333322223334567899999999998888743211    1233   23333333333 223333


Q ss_pred             cCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC
Q 007167          419 ENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       419 ~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      .+   +.|.|.+|.||+++.++++.+.|||+...+++
T Consensus       284 dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         284 DG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             cC---ccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            45   99999999999999999999999999887764

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.37  E-value=4.8e-06  Score=81.07  Aligned_cols=138  Identities=14%  Similarity=0.207  Sum_probs=84.4

Q ss_pred             hhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCc--ccceeEEEEecCeeeEEeecCCCCC-h
Q 007167          306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHEN--VVALRAYYYSKDEKLMVYDYFEPGS-V  382 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~e~~~~gs-L  382 (615)
                      ..||+|..+.||+.   .+..+++|.... ........+|.++++.+..-.  +.+.+++....+...+|||+++|.. +
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~-~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~   82 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNP-GFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF   82 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCC-CCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence            35899999999984   245677777654 334566789999998886443  4567777777777889999998863 2


Q ss_pred             hhh---------------------hccCCCCCCCCCCHHHHHH-HHH----------HHHH-HHHHhhcc-CCCCceecC
Q 007167          383 SAM---------------------LHGRRGEGQSSLDWDTRVR-IAI----------GAAR-GIAHIHTE-NGGKLVHGG  428 (615)
Q Consensus       383 ~~~---------------------l~~~~~~~~~~l~~~~~~~-i~~----------~ia~-~l~~LH~~-~~~~iiHrD  428 (615)
                      ...                     +|.-...   ......... +..          .+.. ...+|... ..+.++|+|
T Consensus        83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~---~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD  159 (226)
T TIGR02172        83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCD---TSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGD  159 (226)
T ss_pred             hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCC---CCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecC
Confidence            111                     2211000   111111000 000          0111 11222211 123578999


Q ss_pred             CCCCCEEeCCCCcEEEeeccccc
Q 007167          429 IKASNIFLNSQGHVCVSDIGLAA  451 (615)
Q Consensus       429 ik~~Nill~~~~~~kl~DfG~a~  451 (615)
                      +.|.||++++++ +.|+||+.+.
T Consensus       160 ~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       160 FQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCCcEEEcCCC-cEEEechhcC
Confidence            999999999888 9999999764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=98.31  E-value=2.1e-07  Score=99.05  Aligned_cols=126  Identities=36%  Similarity=0.561  Sum_probs=100.6

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCC-CccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCccccccccccee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLS-ALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVI  145 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~-~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l  145 (615)
                      ..++.+++.+|+++ .|++ ..+.+. +|+.|++++|++. .+|..+.++++|+.|++++|+++ .+|...+.++.|+.|
T Consensus       116 ~~l~~L~l~~n~i~-~i~~-~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N~l~-~l~~~~~~~~~L~~L  191 (394)
T COG4886         116 TNLTSLDLDNNNIT-DIPP-LIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNL  191 (394)
T ss_pred             cceeEEecCCcccc-cCcc-ccccchhhcccccccccchh-hhhhhhhccccccccccCCchhh-hhhhhhhhhhhhhhe
Confidence            46899999999999 8988 677774 9999999999999 66778999999999999999999 688877789999999


Q ss_pred             ecCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccccCC---cccccCCCCC
Q 007167          146 DLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFP---SWAFAGNNLS  198 (615)
Q Consensus       146 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~---~l~~~~n~~~  198 (615)
                      ++++|+++ .+|.....+..|+.|.+++|++. .++..+.++.   .+...+|.+.
T Consensus       192 ~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~  245 (394)
T COG4886         192 DLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE  245 (394)
T ss_pred             eccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceee
Confidence            99999999 57777666667999999999643 3344444333   3444555543

>COG4886 Leucine-rich repeat (LRR) protein [Function unknown]

Probab=98.31  E-value=2.8e-07  Score=98.09  Aligned_cols=120  Identities=30%  Similarity=0.444  Sum_probs=101.4

Q ss_pred             EEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccc-cCcEEecccccccCCCCcccccccccceeecCC
Q 007167           71 ALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLE-NLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSN  149 (615)
Q Consensus        71 ~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~-~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~  149 (615)
                      .+++..+.+...+.  .+..++.++.|++.+|+++ .+|.....+. +|+.|++++|++. .+|..+..+++|+.|++++
T Consensus        97 ~l~~~~~~~~~~~~--~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~  172 (394)
T COG4886          97 SLDLNLNRLRSNIS--ELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF  172 (394)
T ss_pred             eeeccccccccCch--hhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCC
Confidence            57888888754444  4677789999999999999 6677888885 9999999999999 6888899999999999999


Q ss_pred             CcCCccCCCcccCCCCCCeeeccCccccCCCccc---cccCCcccccCCC
Q 007167          150 NFFNASIPASISKLTHLSALNLANNSLTGTLPRS---LQRFPSWAFAGNN  196 (615)
Q Consensus       150 N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~---~~~l~~l~~~~n~  196 (615)
                      |+++ .+|...+.+++|+.|++++|+++ .+|..   ...+..+.+++|+
T Consensus       173 N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~  220 (394)
T COG4886         173 NDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNS  220 (394)
T ss_pred             chhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCc
Confidence            9999 57777768899999999999999 66653   3448888888885

>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones]

Probab=98.26  E-value=6e-07  Score=91.06  Aligned_cols=148  Identities=17%  Similarity=0.153  Sum_probs=109.3

Q ss_pred             hHHHHHHHHHHhcCCCCCCCCCCCCCCCCCCcceEecCCCCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCC
Q 007167           27 EDKQALLDFIHNIHNSRSLNWNESSSLCKSWTGVTCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSG  106 (615)
Q Consensus        27 ~d~~al~~~k~~~~~~~~~~w~~~~~~c~~w~gv~C~~~~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g  106 (615)
                      .+...+++|.+.+++...++.+.+.-.| .|.-..-. ...+++.|.|++++|+-.=-...+..+++|..|+|..|..-+
T Consensus       159 ~nw~~v~~i~eqLp~Le~LNls~Nrl~~-~~~s~~~~-~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~  236 (505)
T KOG3207|consen  159 HNWFPVLKIAEQLPSLENLNLSSNRLSN-FISSNTTL-LLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIIL  236 (505)
T ss_pred             HhHHHHHHHHHhcccchhcccccccccC-Cccccchh-hhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccc
Confidence            4566778888888877766665555566 56644433 356889999999999732111135578999999999997444


Q ss_pred             cCCCCccccccCcEEecccccccCCCC--cccccccccceeecCCCcCCcc-CCCc-----ccCCCCCCeeeccCcccc
Q 007167          107 LFPSDFSKLENLTSLHLQFNSFSGPLP--LDFSVWNNLTVIDLSNNFFNAS-IPAS-----ISKLTHLSALNLANNSLT  177 (615)
Q Consensus       107 ~~p~~~~~l~~L~~L~l~~N~l~g~~p--~~~~~l~~L~~l~l~~N~l~~~-~p~~-----~~~l~~L~~l~l~~N~l~  177 (615)
                      .--.....+..|++|||++|++- ..+  ...+.++.|+.|+++.+.++.. +|+.     ...+++|++|+++.|++.
T Consensus       237 ~~~~~~~i~~~L~~LdLs~N~li-~~~~~~~~~~l~~L~~Lnls~tgi~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~  314 (505)
T KOG3207|consen  237 IKATSTKILQTLQELDLSNNNLI-DFDQGYKVGTLPGLNQLNLSSTGIASIAEPDVESLDKTHTFPKLEYLNISENNIR  314 (505)
T ss_pred             eecchhhhhhHHhhccccCCccc-ccccccccccccchhhhhccccCcchhcCCCccchhhhcccccceeeecccCccc
Confidence            55556777899999999999987 355  4578899999999999998853 2443     456789999999999996

>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only]

Probab=98.26  E-value=4.6e-08  Score=83.77  Aligned_cols=116  Identities=20%  Similarity=0.304  Sum_probs=88.8

Q ss_pred             CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCccccccccccee
Q 007167           66 HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVI  145 (615)
Q Consensus        66 ~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l  145 (615)
                      ..+++.++|++|++. ..|+..-..++.++.|+|++|.|+ .+|.++..++.|+.|++++|.|. ..|.-+..|.+|-.|
T Consensus        52 ~~el~~i~ls~N~fk-~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~L  128 (177)
T KOG4579|consen   52 GYELTKISLSDNGFK-KFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDML  128 (177)
T ss_pred             CceEEEEecccchhh-hCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHh
Confidence            457888999999998 788754455668899999999999 67888999999999999999998 577777789999999


Q ss_pred             ecCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccc
Q 007167          146 DLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQ  185 (615)
Q Consensus       146 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~  185 (615)
                      +..+|.+. .||-.+..-..+...++.+|.+.+.-+..+.
T Consensus       129 ds~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~klq  167 (177)
T KOG4579|consen  129 DSPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKKKLQ  167 (177)
T ss_pred             cCCCCccc-cCcHHHhccccHHHHHhcCCcccccCccccc
Confidence            99999887 5665544333444455666666666554433

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.10  E-value=3.3e-05  Score=76.34  Aligned_cols=140  Identities=18%  Similarity=0.179  Sum_probs=83.9

Q ss_pred             cCcCCc-cEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCC-CCcccceeEEEEecCeeeEEeecCCCCChhhh
Q 007167          308 LGKGTF-GTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIR-HENVVALRAYYYSKDEKLMVYDYFEPGSVSAM  385 (615)
Q Consensus       308 lG~G~f-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~  385 (615)
                      |-.|.+ ..||+...+ +..++||+.....  ...+.+|+++++.+. +--+.+++++....+..++|||+++|.++...
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~   82 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP--TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL   82 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc--ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence            444555 789998764 4678888876443  345678888887773 33345677777666678999999998777643


Q ss_pred             -------------------hccCCCCCCCCCC--HHHHHHHHH--------------------HHHHHHHHhhc----cC
Q 007167          386 -------------------LHGRRGEGQSSLD--WDTRVRIAI--------------------GAARGIAHIHT----EN  420 (615)
Q Consensus       386 -------------------l~~~~~~~~~~l~--~~~~~~i~~--------------------~ia~~l~~LH~----~~  420 (615)
                                         ||.... ...++.  ...+.....                    .+...+..|-.    ..
T Consensus        83 ~~~~~~~~~~~~l~~~l~~lH~i~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  161 (244)
T cd05150          83 WEELEPERLVDALAEALRRLHALPV-ADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEE  161 (244)
T ss_pred             hcccCHHHHHHHHHHHHHHHhcCCc-ccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcC
Confidence                               121110 000111  001100000                    01111222211    12


Q ss_pred             CCCceecCCCCCCEEeCCCCcEEEeeccccc
Q 007167          421 GGKLVHGGIKASNIFLNSQGHVCVSDIGLAA  451 (615)
Q Consensus       421 ~~~iiHrDik~~Nill~~~~~~kl~DfG~a~  451 (615)
                      .+.++|+|+.|.||+++++..+.|+||+.+.
T Consensus       162 ~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         162 DLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             ceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            3458999999999999998778899999764

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.09  E-value=1.1e-06  Score=93.32  Aligned_cols=179  Identities=18%  Similarity=0.183  Sum_probs=128.6

Q ss_pred             hcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCc-ccceeEEEEecCeeeEEeecCCCC-Chhh
Q 007167          307 VLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHEN-VVALRAYYYSKDEKLMVYDYFEPG-SVSA  384 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~n-iv~l~~~~~~~~~~~lV~e~~~~g-sL~~  384 (615)
                      -.++|+++.+||.+-...+...++.+...    ....-++++|.+++||| .+..++-+..++..+++++|+..+ +-..
T Consensus       249 ~fvK~altknpKkRptaeklL~h~fvs~~----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~  324 (829)
T KOG0576|consen  249 NFVKGALTKNPKKRPTAEKLLQHPFVSQT----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSAL  324 (829)
T ss_pred             HHHHHHhcCCCccCCChhhheeceeeccc----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccc
Confidence            37889999999986433333445544332    44556889999999999 777777777777889999999877 2211


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC--CCCCCC
Q 007167          385 MLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM--PPPAMR  462 (615)
Q Consensus       385 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~--~~~~~~  462 (615)
                      ...    .....+...+...+...-.++++|+|+.-   =+|||    ||+..+ +..+..||+....+...  .....+
T Consensus       325 ~~~----~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~~  392 (829)
T KOG0576|consen  325 EMT----VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAIG  392 (829)
T ss_pred             cCC----hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcccccccCCC
Confidence            111    11122333444556667778999999864   48998    776655 67899999999887765  344557


Q ss_pred             CCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 007167          463 AAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIH  501 (615)
Q Consensus       463 ~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~  501 (615)
                      +..++|||......+..+.|+|+.|+-..++--|-.|-.
T Consensus       393 ~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  393 TPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             CCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence            888999999999999999999999987777777766643

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.07  E-value=3.8e-05  Score=73.60  Aligned_cols=135  Identities=16%  Similarity=0.248  Sum_probs=87.2

Q ss_pred             hcCcCCccEEEEEEECCCCEEEEEEeccccCCHH--------------------H-----HHHHHHHHhCCC--CCcccc
Q 007167          307 VLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKR--------------------E-----FEQQMEIVGGIR--HENVVA  359 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~--------------------~-----~~~e~~~l~~l~--h~niv~  359 (615)
                      .|++|.-+.||+|...++..+|||+.+......+                    .     ...|+.-|.++.  +-.+-+
T Consensus        55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~  134 (268)
T COG1718          55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE  134 (268)
T ss_pred             eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence            5788999999999988899999999864311100                    0     123444444442  223333


Q ss_pred             eeEEEEecCeeeEEeecCCCCCh-hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCceecCCCCCCEEeC
Q 007167          360 LRAYYYSKDEKLMVYDYFEPGSV-SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT-ENGGKLVHGGIKASNIFLN  437 (615)
Q Consensus       360 l~~~~~~~~~~~lV~e~~~~gsL-~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~iiHrDik~~Nill~  437 (615)
                      .+++.    .-.|||||+..... .=.|.      ..++.......+..++++.+.-|-. .+   +||+||+.-|||+.
T Consensus       135 Pi~~~----~nVLvMEfIg~~g~pAP~Lk------Dv~~e~~e~~~~~~~~v~~~~~l~~~a~---LVHgDLSEyNiL~~  201 (268)
T COG1718         135 PIAFR----NNVLVMEFIGDDGLPAPRLK------DVPLELEEAEGLYEDVVEYMRRLYKEAG---LVHGDLSEYNILVH  201 (268)
T ss_pred             ceeec----CCeEEEEeccCCCCCCCCcc------cCCcCchhHHHHHHHHHHHHHHHHHhcC---cccccchhhheEEE
Confidence            34332    45699999865311 11111      1122222456667777777777766 44   99999999999999


Q ss_pred             CCCcEEEeecccccccCC
Q 007167          438 SQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       438 ~~~~~kl~DfG~a~~~~~  455 (615)
                       ++.+.|+|||-|....+
T Consensus       202 -~~~p~iID~~QaV~~~h  218 (268)
T COG1718         202 -DGEPYIIDVSQAVTIDH  218 (268)
T ss_pred             -CCeEEEEECccccccCC
Confidence             88999999998876653

>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms]

Probab=98.06  E-value=1.9e-06  Score=98.93  Aligned_cols=107  Identities=27%  Similarity=0.308  Sum_probs=81.9

Q ss_pred             CcEEEEEeCCCC--cccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccce
Q 007167           67 SRVVALRLPGMA--LRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTV  144 (615)
Q Consensus        67 ~~v~~l~l~~~~--l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~  144 (615)
                      ..++.|-+.+|.  +. .++.+.|..++.|++|||++|.=-+.+|..+++|-+|++|+|++..++ .+|..+++|+.|.+
T Consensus       545 ~~L~tLll~~n~~~l~-~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~~t~I~-~LP~~l~~Lk~L~~  622 (889)
T KOG4658|consen  545 PKLRTLLLQRNSDWLL-EISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLSDTGIS-HLPSGLGNLKKLIY  622 (889)
T ss_pred             CccceEEEeecchhhh-hcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhcccccCCCcc-ccchHHHHHHhhhe
Confidence            356777777775  33 666656777888888888887766778888888888888888888888 68888888888888


Q ss_pred             eecCCCcCCccCCCcccCCCCCCeeeccCcc
Q 007167          145 IDLSNNFFNASIPASISKLTHLSALNLANNS  175 (615)
Q Consensus       145 l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~  175 (615)
                      ||+.++.....+|..+..|.+|++|.+..-.
T Consensus       623 Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~  653 (889)
T KOG4658|consen  623 LNLEVTGRLESIPGILLELQSLRVLRLPRSA  653 (889)
T ss_pred             eccccccccccccchhhhcccccEEEeeccc
Confidence            8888877665667766778888888775544

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.05  E-value=1.6e-05  Score=74.79  Aligned_cols=104  Identities=14%  Similarity=0.190  Sum_probs=81.7

Q ss_pred             HHHHHHhCCCC-CcccceeEEEEecCeeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCC
Q 007167          344 QQMEIVGGIRH-ENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGG  422 (615)
Q Consensus       344 ~e~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~  422 (615)
                      .|.-++..+++ +++.+++|+|    ..++|.||...+++...-..  -..-..-+|..|.+|+.++++.++++++....
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~--l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~   81 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRP--LSQFLQSPWEQRAKIALQLLELLEELDHGPLG   81 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccc--cccccccCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            46777787865 5999999999    45679999988766532100  00112468999999999999999999986555


Q ss_pred             CceecCCCCCCEEeCCCCcEEEeeccccccc
Q 007167          423 KLVHGGIKASNIFLNSQGHVCVSDIGLAALM  453 (615)
Q Consensus       423 ~iiHrDik~~Nill~~~~~~kl~DfG~a~~~  453 (615)
                      .+.-.|++++|+-+++++++|++|...+...
T Consensus        82 ~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   82 FFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             cEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            6888999999999999999999999876544

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms]

Probab=98.04  E-value=1.3e-06  Score=93.52  Aligned_cols=125  Identities=23%  Similarity=0.342  Sum_probs=86.9

Q ss_pred             cEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeec
Q 007167           68 RVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL  147 (615)
Q Consensus        68 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l  147 (615)
                      .+..+++..|.+. .+-. .+..+.+|+.|+|.+|+|.+. ...+..+++|++|+|++|+++...  .+..++.|+.|++
T Consensus        73 ~l~~l~l~~n~i~-~~~~-~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~l  147 (414)
T KOG0531|consen   73 SLKELNLRQNLIA-KILN-HLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELNL  147 (414)
T ss_pred             hHHhhccchhhhh-hhhc-ccccccceeeeeccccchhhc-ccchhhhhcchheecccccccccc--chhhccchhhhee
Confidence            3445556666666 3222 477788888888888888854 333777888888888888888543  3566677888888


Q ss_pred             CCCcCCccCCCcccCCCCCCeeeccCccccCCCc---cccccCCcccccCCCCCC
Q 007167          148 SNNFFNASIPASISKLTHLSALNLANNSLTGTLP---RSLQRFPSWAFAGNNLSS  199 (615)
Q Consensus       148 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p---~~~~~l~~l~~~~n~~~~  199 (615)
                      ++|.|+..  ..+..+++|+.+++++|.++..-+   ..+.++..+.+++|....
T Consensus       148 ~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~~~~~~~l~~l~l~~n~i~~  200 (414)
T KOG0531|consen  148 SGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDELSELISLEELDLGGNSIRE  200 (414)
T ss_pred             ccCcchhc--cCCccchhhhcccCCcchhhhhhhhhhhhccchHHHhccCCchhc
Confidence            88888842  456667888888888888886555   445566666677776543

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	615
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-31
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		4e-31
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-14
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		4e-14
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		3e-10
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		7e-10
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-09
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-09
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		3e-09
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-08
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-08
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-08
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-08
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-07
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-07
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		1e-07
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-07
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-07
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-07
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-07
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		3e-07
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-07
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		3e-07
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-07
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-07
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		4e-07
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		4e-07
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-07
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-07
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-07
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-07
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-07
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-07
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-07
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-07
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		4e-07
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		5e-07
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-07
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-07
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		5e-07
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		5e-07
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		5e-07
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		5e-07
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-07
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-07
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-07
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		6e-07
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		6e-07
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-07
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		7e-07
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		7e-07
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		8e-07
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		8e-07
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		9e-07
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-06
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-06
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		1e-06
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-06
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		1e-06
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-06
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-06
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-06
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-06
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-06
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-06
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-06
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-06
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-06
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-06
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-06
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-06
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-06
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-06
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-06
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-06
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-06
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-06
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-06
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-06
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-06
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-06
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-06
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		3e-06
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-06
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-06
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-06
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		3e-06
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-06
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-06
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-06
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-06
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-06
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-06
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		4e-06
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-06
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-06
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		4e-06
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-06
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-06
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-06
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-06
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-06
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-06
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-06
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-06
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		5e-06
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		6e-06
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-06
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		6e-06
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-06
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-06
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		7e-06
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		8e-06
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		8e-06
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		8e-06
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		9e-06
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		1e-05
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-05
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-05
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-05
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-05
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-05
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-05
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-05
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-05
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-05
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-05
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-05
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-05
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-05
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-05
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-05
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-05
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-05
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-05
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		3e-05
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-05
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-05
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-05
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		3e-05
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-05
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-05
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-05
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		4e-05
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-05
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-05
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-05
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-05
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-05
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-05
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-05
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-05
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-05
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-05
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-05
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-05
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-05
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-05
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		5e-05
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		5e-05
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		6e-05
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		6e-05
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		8e-05
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		8e-05
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-05
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		9e-05
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-04
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-04
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		1e-04
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		1e-04
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-04
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-04
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-04
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-04
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-04
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-04
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-04
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-04
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-04
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-04
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-04
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-04
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-04
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-04
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		2e-04
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-04
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-04
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-04
3riz_A	772	Crystal Structure Of The Plant Steroid Receptor Bri		3e-04
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		3e-04
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-04
3rgx_A	768	Structural Insight Into Brassinosteroid Perception		3e-04
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-04
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-04
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		5e-04
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		5e-04
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		5e-04
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		6e-04
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		8e-04
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		8e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  134 bits (336), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 90/274 (32%), Positives = 141/274 (51%), Gaps = 12/274 (4%)
Query: 307 VLGKGTFGTAYKAALEDASTVVVKRLKE--VNVGKREFEQQMEIVGGIRHENVVALRAYY 364
           +LG+G FG  YK  L D + V VKRLKE     G+ +F+ ++E++    H N++ LR + 
Sbjct: 45  ILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFC 104
Query: 365 YSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKL 424
            +  E+L+VY Y   GSV++ L   R E Q  LDW  R                    K+
Sbjct: 105 MTPTERLLVYPYMANGSVASCLR-ERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKI 163
Query: 425 VHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXXXXX----EVTDTRKATQA 480
           +H  +KA+NI L+ +    V D                           E   T K+++ 
Sbjct: 164 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEK 223
Query: 481 SDVFSFGVLLLELLTGKSP--IHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI 538
           +DVF +GV+LLEL+TG+    +     D+ V L+ WV  +++E+    + DV+L    N 
Sbjct: 224 TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDL--QGNY 281
Query: 539 EEEMVE-MLQVGMACVVRMPEERPKMADVLKMVE 571
           ++E VE ++QV + C    P ERPKM++V++M+E
Sbjct: 282 KDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 315

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  133 bits (334), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 91/274 (33%), Positives = 141/274 (51%), Gaps = 12/274 (4%)
Query: 307 VLGKGTFGTAYKAALEDASTVVVKRLKE--VNVGKREFEQQMEIVGGIRHENVVALRAYY 364
           +LG+G FG  YK  L D   V VKRLKE     G+ +F+ ++E++    H N++ LR + 
Sbjct: 37  ILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC 96
Query: 365 YSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKL 424
            +  E+L+VY Y   GSV++ L   R E Q  LDW  R                    K+
Sbjct: 97  MTPTERLLVYPYMANGSVASCLR-ERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKI 155
Query: 425 VHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXXXXX----EVTDTRKATQA 480
           +H  +KA+NI L+ +    V D                           E   T K+++ 
Sbjct: 156 IHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYLSTGKSSEK 215
Query: 481 SDVFSFGVLLLELLTGKSP--IHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI 538
           +DVF +GV+LLEL+TG+    +     D+ V L+ WV  +++E+    + DV+L    N 
Sbjct: 216 TDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDL--QGNY 273
Query: 539 EEEMVE-MLQVGMACVVRMPEERPKMADVLKMVE 571
           ++E VE ++QV + C    P ERPKM++V++M+E
Sbjct: 274 KDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 122/282 (43%), Gaps = 21/282 (7%)
Query: 307 VLGKGTFGTAYKAALEDASTVVVKRLK-EVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           ++G G FG  YK  L D + V +KR   E + G  EFE ++E +   RH ++V+L  +  
Sbjct: 46  LIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD 105
Query: 366 SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLV 425
            ++E +++Y Y E G++   L+G       S+ W+ R+              T     ++
Sbjct: 106 ERNEMILIYKYMENGNLKRHLYG-SDLPTMSMSWEQRLEICIGAARGLHYLHTR---AII 161
Query: 426 HGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXXXXXEVTDTR-----KATQA 480
           H  +K+ NI L+      ++D                          D       + T+ 
Sbjct: 162 HRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEK 221
Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE- 539
           SDV+SFGV+L E+L  +S I  +   E+V+L  W           ++ D      PN+  
Sbjct: 222 SDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD------PNLAD 275
Query: 540 ----EEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVK 577
               E + +     + C+    E+RP M DVL  +E   R++
Sbjct: 276 KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 122/282 (43%), Gaps = 21/282 (7%)
Query: 307 VLGKGTFGTAYKAALEDASTVVVKRLK-EVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           ++G G FG  YK  L D + V +KR   E + G  EFE ++E +   RH ++V+L  +  
Sbjct: 46  LIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCD 105
Query: 366 SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLV 425
            ++E +++Y Y E G++   L+G       S+ W+ R+              T     ++
Sbjct: 106 ERNEMILIYKYMENGNLKRHLYG-SDLPTMSMSWEQRLEICIGAARGLHYLHTR---AII 161
Query: 426 HGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXXXXXEVTDTR-----KATQA 480
           H  +K+ NI L+      ++D                          D       + T+ 
Sbjct: 162 HRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEK 221
Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE- 539
           SDV+SFGV+L E+L  +S I  +   E+V+L  W           ++ D      PN+  
Sbjct: 222 SDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD------PNLAD 275
Query: 540 ----EEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVK 577
               E + +     + C+    E+RP M DVL  +E   R++
Sbjct: 276 KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ 317

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 69/292 (23%), Positives = 117/292 (40%), Gaps = 32/292 (10%)
Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKR---EFEQQMEIVGGIRHENVVALRA 362
           E +G G+FGT ++A     S V VK L E +       EF +++ I+  +RH N+V    
Sbjct: 43  EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGG 422
                    +V +Y   GS+  +LH  +   +  LD   R+                N  
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLH--KSGAREQLDERRRLSMAYDVAKGMNYLHNRNP- 158
Query: 423 KLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX---XXXEVTDTRKATQ 479
            +VH  +K+ N+ ++ +  V V D                          EV     + +
Sbjct: 159 PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNE 218
Query: 480 ASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP-NI 538
            SDV+SFGV+L EL T + P       +VV               A  F  + L  P N+
Sbjct: 219 KSDVYSFGVILWELATLQQPWGNLNPAQVV--------------AAVGFKCKRLEIPRNL 264
Query: 539 EEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTENRSEI 590
             ++  +++    C    P +RP  A ++ ++  +  +K+  PP   NRS++
Sbjct: 265 NPQVAAIIE---GCWTNEPWKRPSFATIMDLLRPL--IKSAVPPP--NRSDL 309

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 72/292 (24%), Positives = 120/292 (41%), Gaps = 32/292 (10%)
Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKR---EFEQQMEIVGGIRHENVVALRA 362
           E +G G+FGT ++A     S V VK L E +       EF +++ I+  +RH N+V    
Sbjct: 43  EKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG 101
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGG 422
                    +V +Y   GS+  +LH  +   +  LD   R+                N  
Sbjct: 102 AVTQPPNLSIVTEYLSRGSLYRLLH--KSGAREQLDERRRLSMAYDVAKGMNYLHNRNP- 158
Query: 423 KLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX---XXXEVTDTRKATQ 479
            +VH  +K+ N+ ++ +  V V D                          EV     + +
Sbjct: 159 PIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEPSNE 218
Query: 480 ASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP-NI 538
            SDV+SFGV+L EL T + P       +VV               A  F  + L  P N+
Sbjct: 219 KSDVYSFGVILWELATLQQPWGNLNPAQVV--------------AAVGFKCKRLEIPRNL 264
Query: 539 EEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTENRSEI 590
             ++  +++    C    P +RP  A ++ ++  +  +K+  PP   NRS++
Sbjct: 265 NPQVAAIIE---GCWTNEPWKRPSFATIMDLLRPL--IKSAVPPP--NRSDL 309

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 83/197 (42%), Gaps = 13/197 (6%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVG----KREFEQQMEIVGGIRHENVVALRAY 363
           +G+G FG  YK  + + +  V K    V++     K++F+Q+++++   +HEN+V L  +
Sbjct: 39  MGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGF 98
Query: 364 YYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGK 423
               D+  +VY Y   GS+   L     +G   L W  R                 +   
Sbjct: 99  SSDGDDLCLVYVYMPNGSLLDRLSCL--DGTPPLSWHMRCKIAQGAANGINFLHENHH-- 154
Query: 424 LVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXXXXXEVTDTR----KATQ 479
            +H  IK++NI L+      +SD                                 + T 
Sbjct: 155 -IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRGEITP 213
Query: 480 ASDVFSFGVLLLELLTG 496
            SD++SFGV+LLE++TG
Sbjct: 214 KSDIYSFGVVLLEIITG 230

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 84/197 (42%), Gaps = 13/197 (6%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVG----KREFEQQMEIVGGIRHENVVALRAY 363
           +G+G FG  YK  + + +  V K    V++     K++F+Q+++++   +HEN+V L  +
Sbjct: 39  MGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGF 98
Query: 364 YYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGK 423
               D+  +VY Y   GS+   L     +G   L W  R                 +   
Sbjct: 99  SSDGDDLCLVYVYMPNGSLLDRLSCL--DGTPPLSWHMRCKIAQGAANGINFLHENHH-- 154
Query: 424 LVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXXXXXEVTDTR----KATQ 479
            +H  IK++NI L+      +SD                                 + T 
Sbjct: 155 -IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRGEITP 213
Query: 480 ASDVFSFGVLLLELLTG 496
            SD++SFGV+LLE++TG
Sbjct: 214 KSDIYSFGVVLLEIITG 230

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/197 (25%), Positives = 85/197 (43%), Gaps = 13/197 (6%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVG----KREFEQQMEIVGGIRHENVVALRAY 363
           +G+G FG  YK  + + +  V K    V++     K++F+Q+++++   +HEN+V L  +
Sbjct: 33  MGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGF 92
Query: 364 YYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGK 423
               D+  +VY Y   GS+   L     +G   L W  R                 +   
Sbjct: 93  SSDGDDLCLVYVYMPNGSLLDRLSCL--DGTPPLSWHMRCKIAQGAANGINFLHENHH-- 148
Query: 424 LVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXXXXXEVTDTR----KATQ 479
            +H  IK++NI L+      +SD                                 + T 
Sbjct: 149 -IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRGEITP 207
Query: 480 ASDVFSFGVLLLELLTG 496
            SD++SFGV+LLE++TG
Sbjct: 208 KSDIYSFGVVLLEIITG 224

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/196 (26%), Positives = 83/196 (42%), Gaps = 13/196 (6%)
Query: 309 GKGTFGTAYKAALEDASTVVVKRLKEVNVG----KREFEQQMEIVGGIRHENVVALRAYY 364
           G+G FG  YK  + + +  V K    V++     K++F+Q++++    +HEN+V L  + 
Sbjct: 31  GEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGFS 90
Query: 365 YSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKL 424
              D+  +VY Y   GS+   L     +G   L W  R                 +    
Sbjct: 91  SDGDDLCLVYVYXPNGSLLDRLSCL--DGTPPLSWHXRCKIAQGAANGINFLHENHH--- 145
Query: 425 VHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXXXXXEVTDTR----KATQA 480
           +H  IK++NI L+      +SD                                 + T  
Sbjct: 146 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRGEITPK 205
Query: 481 SDVFSFGVLLLELLTG 496
           SD++SFGV+LLE++TG
Sbjct: 206 SDIYSFGVVLLEIITG 221

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 66/284 (23%), Positives = 107/284 (37%), Gaps = 38/284 (13%)
Query: 306 EVLGKGTFGTAYKAALEDAST-----VVVKRLKEVNVGKR--EFEQQMEIVGGIRHENVV 358
           +V+G G FG  YK  L+ +S      V +K LK     K+  +F  +  I+G   H N++
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109
Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXT 418
            L          +++ +Y E G++   L  + GE          V               
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGE----FSVLQLVGMLRGIAAGMKYLAN 165
Query: 419 ENGGKLVHGGIKASNIFLNSQGHVCVSD------IXXXXXXXXXXXXXXXXXXXXXXEVT 472
            N    VH  + A NI +NS     VSD      +                      E  
Sbjct: 166 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222
Query: 473 DTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE 531
             RK T ASDV+SFG+++ E++T G+ P       EV+  +                  +
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN-----------------D 265
Query: 532 LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
             R P   +    + Q+ M C  +    RPK AD++ +++ + R
Sbjct: 266 GFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 309

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/264 (23%), Positives = 106/264 (40%), Gaps = 31/264 (11%)
Query: 286 VFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGK------ 339
           VF E  ++ FD  ++LRA    +GKG+FG      ++   T  +  +K +N  K      
Sbjct: 5   VFDENEDVNFDHFEILRA----IGKGSFGKV--CIVQKNDTKKMYAMKYMNKQKCVERNE 58
Query: 340 -REFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLD 398
            R   ++++I+ G+ H  +V L   +  +++  MV D    G +   L       Q ++ 
Sbjct: 59  VRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHL-------QQNVH 111
Query: 399 WDTRVXXXXXXXXXXXXXXTENGGKLVHGGIKASNIFLNSQGHVCVSD--IXXXXXXXXX 456
           +                   +N  +++H  +K  NI L+  GHV ++D  I         
Sbjct: 112 FKEETVKLFICELVMALDYLQNQ-RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ 170
Query: 457 XXXXXXXXXXXXXEVTDTRKATQAS---DVFSFGVLLLELLTGKSPIH---ATGGDEVVH 510
                        E+  +RK    S   D +S GV   ELL G+ P H   +T   E+VH
Sbjct: 171 ITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH 230
Query: 511 LVRWVNSVVREEWTAEVFDVELLR 534
                       W+ E+  V LL+
Sbjct: 231 TFETTVVTYPSAWSQEM--VSLLK 252

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/275 (21%), Positives = 106/275 (38%), Gaps = 30/275 (10%)
Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           EV+G+G FG   KA    A  V +K++ E    ++ F  ++  +  + H N+V L  Y  
Sbjct: 14  EVVGRGAFGVVCKAKWR-AKDVAIKQI-ESESERKAFIVELRQLSRVNHPNIVKL--YGA 69
Query: 366 SKDEKLMVYDYFEPGSVSAMLHGRRG----EGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
             +   +V +Y E GS+  +LHG           ++ W  +               +   
Sbjct: 70  CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQC------SQGVAYLHSMQP 123
Query: 422 GKLVHGGIKASNIFLNSQGHVC-VSDIXXXXXXXXXXXXXXXXXXXXXXEVTDTRKATQA 480
             L+H  +K  N+ L + G V  + D                       EV +    ++ 
Sbjct: 124 KALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEK 183
Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
            DVFS+G++L E++T + P    GG              R  W          R P I+ 
Sbjct: 184 CDVFSWGIILWEVITRRKPFDEIGG-----------PAFRIMWAVH----NGTRPPLIKN 228
Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
               +  +   C  + P +RP M +++K++  + R
Sbjct: 229 LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 263

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/275 (21%), Positives = 105/275 (38%), Gaps = 30/275 (10%)
Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           EV+G+G FG   KA    A  V +K++ E    ++ F  ++  +  + H N+V L  Y  
Sbjct: 15  EVVGRGAFGVVCKAKWR-AKDVAIKQI-ESESERKAFIVELRQLSRVNHPNIVKL--YGA 70
Query: 366 SKDEKLMVYDYFEPGSVSAMLHGRRG----EGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
             +   +V +Y E GS+  +LHG           ++ W  +                   
Sbjct: 71  CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---- 126
Query: 422 GKLVHGGIKASNIFLNSQGHVC-VSDIXXXXXXXXXXXXXXXXXXXXXXEVTDTRKATQA 480
             L+H  +K  N+ L + G V  + D                       EV +    ++ 
Sbjct: 127 --LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSNYSEK 184
Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
            DVFS+G++L E++T + P    GG              R  W          R P I+ 
Sbjct: 185 CDVFSWGIILWEVITRRKPFDEIGG-----------PAFRIMWAVH----NGTRPPLIKN 229
Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
               +  +   C  + P +RP M +++K++  + R
Sbjct: 230 LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR 264

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 91/222 (40%), Gaps = 22/222 (9%)
Query: 292 NLVFD-LEDLLRASAEVLGKGTFGTAYKA-ALEDASTVVVKRLKEVNVGKREFEQ---QM 346
           NL F  +E  +R   + +G+G+FG A    + ED    V+K +    +  +E E+   ++
Sbjct: 17  NLYFQSMEKYVRL--QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREV 74
Query: 347 EIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRG---EGQSSLDWDTRV 403
            ++  ++H N+V  R  +       +V DY E G +   ++ ++G   +    LDW  ++
Sbjct: 75  AVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI 134
Query: 404 XXXXXXXXXXXXXXTENGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXX 463
                           +  K++H  IK+ NIFL   G V + D                 
Sbjct: 135 CLALKHV---------HDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC 185
Query: 464 X---XXXXXEVTDTRKATQASDVFSFGVLLLELLTGKSPIHA 502
                    E+ + +     SD+++ G +L EL T K    A
Sbjct: 186 IGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEA 227

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 68/303 (22%), Positives = 118/303 (38%), Gaps = 45/303 (14%)
Query: 308 LGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQM----EIVGGIRHENVVALRA 362
           LGKG FG  Y A  + +  ++ +K L +  + K   E Q+    EI   +RH N++ L  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHG-RRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
           Y++      ++ +Y   G+V   L    + + Q +  + T +                + 
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC---------HS 127
Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIX-XXXXXXXXXXXXXXXXXXXXXEVTDTRKATQA 480
            +++H  IK  N+ L S G + ++D                        E+ + R   + 
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSCHAPSSRRTTLSGTLDYLPPEMIEGRMHDEK 187
Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
            D++S GVL  E L GK P  A    E          + R E+T   F  E  R      
Sbjct: 188 VDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR------ 235
Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTENRSEISSSAATPKAT 600
           +++  L      +   P +RP + +VL           E+P  T N S+ S+S     A+
Sbjct: 236 DLISRL------LKHNPSQRPMLREVL-----------EHPWITANSSKPSNSQNKESAS 278
Query: 601 ETA 603
           + +
Sbjct: 279 KQS 281

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/202 (23%), Positives = 83/202 (41%), Gaps = 16/202 (7%)
Query: 308 LGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQM----EIVGGIRHENVVALRA 362
           LGKG FG  Y A  +++  ++ +K L +  + K   E Q+    EI   +RH N++ L  
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHG-RRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
           Y++      ++ +Y   G+V   L    + + Q +  + T +                + 
Sbjct: 76  YFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC---------HS 126
Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIX-XXXXXXXXXXXXXXXXXXXXXEVTDTRKATQA 480
            K++H  IK  N+ L S G + ++D                        E+ + R   + 
Sbjct: 127 KKVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMIEGRMHDEK 186
Query: 481 SDVFSFGVLLLELLTGKSPIHA 502
            D++S GVL  E L GK P  A
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEA 208

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 83/208 (39%), Gaps = 16/208 (7%)
Query: 308 LGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQM----EIVGGIRHENVVALRA 362
           LGKG FG  Y A  + +  ++ +K L +  + K   E Q+    EI   +RH N++ L  
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHG-RRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
           Y++      ++ +Y   G+V   L    + + Q +  + T +                + 
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC---------HS 152
Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIX-XXXXXXXXXXXXXXXXXXXXXEVTDTRKATQA 480
            +++H  IK  N+ L S G + ++D                        E+ + R   + 
Sbjct: 153 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 212
Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEV 508
            D++S GVL  E L GK P  A    E 
Sbjct: 213 VDLWSLGVLCYEFLVGKPPFEANTYQET 240

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 60/268 (22%), Positives = 105/268 (39%), Gaps = 34/268 (12%)
Query: 308 LGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQM----EIVGGIRHENVVALRA 362
           LGKG FG  Y A  + +  ++ +K L +  + K   E Q+    EI   +RH N++ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHG-RRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
           Y++      ++ +Y   G+V   L    + + Q +  + T +                + 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC---------HS 126
Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIX-XXXXXXXXXXXXXXXXXXXXXEVTDTRKATQA 480
            +++H  IK  N+ L S G + ++D                        E+ + R   + 
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 186
Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
            D++S GVL  E L GK P  A    E          + R E+T   F  E  R      
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR------ 234
Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLK 568
           +++  L      +   P +RP + +VL+
Sbjct: 235 DLISRL------LKHNPSQRPMLREVLE 256

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 83/208 (39%), Gaps = 16/208 (7%)
Query: 308 LGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQM----EIVGGIRHENVVALRA 362
           LGKG FG  Y A  + +  ++ +K L +  + K   E Q+    EI   +RH N++ L  
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 101
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHG-RRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
           Y++      ++ +Y   G+V   L    + + Q +  + T +                + 
Sbjct: 102 YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC---------HS 152
Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIX-XXXXXXXXXXXXXXXXXXXXXEVTDTRKATQA 480
            +++H  IK  N+ L S G + ++D                        E+ + R   + 
Sbjct: 153 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTLDYLPPEMIEGRMHDEK 212
Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEV 508
            D++S GVL  E L GK P  A    E 
Sbjct: 213 VDLWSLGVLCYEFLVGKPPFEANTYQET 240

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 83/208 (39%), Gaps = 16/208 (7%)
Query: 308 LGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQM----EIVGGIRHENVVALRA 362
           LGKG FG  Y A  + +  ++ +K L +  + K   E Q+    EI   +RH N++ L  
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 92
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHG-RRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
           Y++      ++ +Y   G+V   L    + + Q +  + T +                + 
Sbjct: 93  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC---------HS 143
Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIX-XXXXXXXXXXXXXXXXXXXXXEVTDTRKATQA 480
            +++H  IK  N+ L S G + ++D                        E+ + R   + 
Sbjct: 144 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 203
Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEV 508
            D++S GVL  E L GK P  A    E 
Sbjct: 204 VDLWSLGVLCYEFLVGKPPFEANTYQET 231

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 83/208 (39%), Gaps = 16/208 (7%)
Query: 308 LGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQM----EIVGGIRHENVVALRA 362
           LGKG FG  Y A  + +  ++ +K L +  + K   E Q+    EI   +RH N++ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHG-RRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
           Y++      ++ +Y   G+V   L    + + Q +  + T +                + 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC---------HS 126
Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIX-XXXXXXXXXXXXXXXXXXXXXEVTDTRKATQA 480
            +++H  IK  N+ L S G + ++D                        E+ + R   + 
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTELCGTLDYLPPEMIEGRMHDEK 186
Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEV 508
            D++S GVL  E L GK P  A    E 
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQET 214

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 83/208 (39%), Gaps = 16/208 (7%)
Query: 308 LGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQM----EIVGGIRHENVVALRA 362
           LGKG FG  Y A  + +  ++ +K L +  + K   E Q+    EI   +RH N++ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHG-RRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
           Y++      ++ +Y   G+V   L    + + Q +  + T +                + 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC---------HS 129
Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIX-XXXXXXXXXXXXXXXXXXXXXEVTDTRKATQA 480
            +++H  IK  N+ L S G + ++D                        E+ + R   + 
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 189
Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEV 508
            D++S GVL  E L GK P  A    E 
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEANTYQET 217

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 83/208 (39%), Gaps = 16/208 (7%)
Query: 308 LGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQM----EIVGGIRHENVVALRA 362
           LGKG FG  Y A  + +  ++ +K L +  + K   E Q+    EI   +RH N++ L  
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 74
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHG-RRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
           Y++      ++ +Y   G+V   L    + + Q +  + T +                + 
Sbjct: 75  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC---------HS 125
Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIX-XXXXXXXXXXXXXXXXXXXXXEVTDTRKATQA 480
            +++H  IK  N+ L S G + ++D                        E+ + R   + 
Sbjct: 126 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 185
Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEV 508
            D++S GVL  E L GK P  A    E 
Sbjct: 186 VDLWSLGVLCYEFLVGKPPFEANTYQET 213

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 70/305 (22%), Positives = 121/305 (39%), Gaps = 44/305 (14%)
Query: 306 EVLGKGTFGTAYKAALEDAS----TVVVKRLK--EVNVGKREFEQQMEIVGGIRHENVVA 359
           +V+G G FG      L+  S    +V +K LK       +R+F  +  I+G   H N++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTE 419
           L          ++V +Y E GS+ + L  R+ + Q ++    ++              ++
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTV---IQLVGMLRGIASGMKYLSD 165
Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSD------IXXXXXXXXXXXXXXXXXXXXXXEVTD 473
            G   VH  + A NI +NS     VSD      +                      E   
Sbjct: 166 MG--FVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 474 TRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
            RK T ASDV+S+G++L E+++ G+ P       +V+  V                  E 
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-----------------EG 266
Query: 533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTENRSEISS 592
            R P   +    + Q+ + C  +    RPK   ++ +++ + R    NP S +    I+S
Sbjct: 267 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR----NPGSLKI---ITS 319
Query: 593 SAATP 597
           +AA P
Sbjct: 320 AAARP 324

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/220 (22%), Positives = 90/220 (40%), Gaps = 19/220 (8%)
Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRL---KEVNVGKREFEQQMEIVGGIRHENVVALR 361
           E++G G FG  Y+A  + D   V   R    ++++       Q+ ++   ++H N++ALR
Sbjct: 13  EIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR 72
Query: 362 AYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
                +    +V ++   G ++ +L G+R      ++W  ++               E  
Sbjct: 73  GVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQI------ARGMNYLHDEAI 126
Query: 422 GKLVHGGIKASNIFL--------NSQGHVCVSDIXXXXXXXXXXXXXXXXXXXXXX-EVT 472
             ++H  +K+SNI +         S   + ++D                        EV 
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVI 186
Query: 473 DTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLV 512
                ++ SDV+S+GVLL ELLTG+ P     G  V + V
Sbjct: 187 RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV 226

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 83/208 (39%), Gaps = 16/208 (7%)
Query: 308 LGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQM----EIVGGIRHENVVALRA 362
           LGKG FG  Y A  + +  ++ +K L +  + K   E Q+    EI   +RH N++ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHG-RRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
           Y++      ++ +Y   G+V   L    + + Q +  + T +                + 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC---------HS 126
Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIX-XXXXXXXXXXXXXXXXXXXXXEVTDTRKATQA 480
            +++H  IK  N+ L S G + ++D                        E+ + R   + 
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEK 186
Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEV 508
            D++S GVL  E L GK P  A    E 
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQET 214

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/268 (22%), Positives = 104/268 (38%), Gaps = 34/268 (12%)
Query: 308 LGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQM----EIVGGIRHENVVALRA 362
           LGKG FG  Y A  + +  ++ +K L +  + K   E Q+    EI   +RH N++ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHG-RRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
           Y++      ++ +Y   G+V   L    + + Q +  + T +                + 
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC---------HS 131
Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIX-XXXXXXXXXXXXXXXXXXXXXEVTDTRKATQA 480
            +++H  IK  N+ L S G + ++D                        E  + R   + 
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEXIEGRXHDEK 191
Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
            D++S GVL  E L GK P  A    E          + R E+T   F  E  R      
Sbjct: 192 VDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR------ 239
Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLK 568
           +++  L      +   P +RP + +VL+
Sbjct: 240 DLISRL------LKHNPSQRPXLREVLE 261

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 85/208 (40%), Gaps = 16/208 (7%)
Query: 308 LGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQM----EIVGGIRHENVVALRA 362
           LGKG FG  Y A  + +  ++ +K L +  + K   E Q+    EI   +RH N++ L  
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHG-RRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
           Y++      ++ +Y   G+V   L    + + Q +  + T +                + 
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC---------HS 128
Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIX-XXXXXXXXXXXXXXXXXXXXXEVTDTRKATQA 480
            +++H  IK  N+ L S G + ++D                        E+ + R   + 
Sbjct: 129 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMIEGRMHDEK 188
Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEV 508
            D++S GVL  E L GK P  A    E 
Sbjct: 189 VDLWSLGVLCYEFLVGKPPFEANTYQET 216

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 83/208 (39%), Gaps = 16/208 (7%)
Query: 308 LGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQM----EIVGGIRHENVVALRA 362
           LGKG FG  Y A  + +  ++ +K L +  + K   E Q+    EI   +RH N++ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHG-RRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
           Y++      ++ +Y   G+V   L    + + Q +  + T +                + 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC---------HS 126
Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIX-XXXXXXXXXXXXXXXXXXXXXEVTDTRKATQA 480
            +++H  IK  N+ L S G + ++D                        E+ + R   + 
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMIEGRMHDEK 186
Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEV 508
            D++S GVL  E L GK P  A    E 
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQET 214

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 83/208 (39%), Gaps = 16/208 (7%)
Query: 308 LGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQM----EIVGGIRHENVVALRA 362
           LGKG FG  Y A  + +  ++ +K L +  + K   E Q+    EI   +RH N++ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHG-RRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
           Y++      ++ +Y   G+V   L    + + Q +  + T +                + 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC---------HS 126
Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIX-XXXXXXXXXXXXXXXXXXXXXEVTDTRKATQA 480
            +++H  IK  N+ L S G + ++D                        E+ + R   + 
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEK 186
Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEV 508
            D++S GVL  E L GK P  A    E 
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQET 214

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 83/208 (39%), Gaps = 16/208 (7%)
Query: 308 LGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQM----EIVGGIRHENVVALRA 362
           LGKG FG  Y A  + +  ++ +K L +  + K   E Q+    EI   +RH N++ L  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHG-RRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
           Y++      ++ +Y   G+V   L    + + Q +  + T +                + 
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC---------HS 127
Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIX-XXXXXXXXXXXXXXXXXXXXXEVTDTRKATQA 480
            +++H  IK  N+ L S G + ++D                        E+ + R   + 
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEK 187
Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEV 508
            D++S GVL  E L GK P  A    E 
Sbjct: 188 VDLWSLGVLCYEFLVGKPPFEANTYQET 215

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 83/208 (39%), Gaps = 16/208 (7%)
Query: 308 LGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQM----EIVGGIRHENVVALRA 362
           LGKG FG  Y A  + +  ++ +K L +  + K   E Q+    EI   +RH N++ L  
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHG-RRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
           Y++      ++ +Y   G+V   L    + + Q +  + T +                + 
Sbjct: 77  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC---------HS 127
Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIX-XXXXXXXXXXXXXXXXXXXXXEVTDTRKATQA 480
            +++H  IK  N+ L S G + ++D                        E+ + R   + 
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEK 187
Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEV 508
            D++S GVL  E L GK P  A    E 
Sbjct: 188 VDLWSLGVLCYEFLVGKPPFEANTYQET 215

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 83/208 (39%), Gaps = 16/208 (7%)
Query: 308 LGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQM----EIVGGIRHENVVALRA 362
           LGKG FG  Y A  + +  ++ +K L +  + K   E Q+    EI   +RH N++ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHG-RRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
           Y++      ++ +Y   G+V   L    + + Q +  + T +                + 
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC---------HS 131
Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIX-XXXXXXXXXXXXXXXXXXXXXEVTDTRKATQA 480
            +++H  IK  N+ L S G + ++D                        E+ + R   + 
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 191
Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEV 508
            D++S GVL  E L GK P  A    E 
Sbjct: 192 VDLWSLGVLCYEFLVGKPPFEANTYQET 219

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 60/268 (22%), Positives = 105/268 (39%), Gaps = 34/268 (12%)
Query: 308 LGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQM----EIVGGIRHENVVALRA 362
           LGKG FG  Y A  + +  ++ +K L +  + K   E Q+    EI   +RH N++ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHG-RRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
           Y++      ++ +Y   G+V   L    + + Q +  + T +                + 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC---------HS 129
Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIX-XXXXXXXXXXXXXXXXXXXXXEVTDTRKATQA 480
            +++H  IK  N+ L S G + ++D                        E+ + R   + 
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRAALCGTLDYLPPEMIEGRMHDEK 189
Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
            D++S GVL  E L GK P  A    E          + R E+T   F  E  R      
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR------ 237
Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLK 568
           +++  L      +   P +RP + +VL+
Sbjct: 238 DLISRL------LKHNPSQRPMLREVLE 259

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 83/208 (39%), Gaps = 16/208 (7%)
Query: 308 LGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQM----EIVGGIRHENVVALRA 362
           LGKG FG  Y A  + +  ++ +K L +  + K   E Q+    EI   +RH N++ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHG-RRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
           Y++      ++ +Y   G+V   L    + + Q +  + T +                + 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC---------HS 129
Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIX-XXXXXXXXXXXXXXXXXXXXXEVTDTRKATQA 480
            +++H  IK  N+ L S G + ++D                        E+ + R   + 
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 189
Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEV 508
            D++S GVL  E L GK P  A    E 
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEANTYQET 217

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 82/208 (39%), Gaps = 16/208 (7%)
Query: 308 LGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQM----EIVGGIRHENVVALRA 362
           LGKG FG  Y A  + +  ++ +K L +  + K   E Q+    EI   +RH N++ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHG-RRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
           Y++      ++ +Y   G V   L    + + Q +  + T +                + 
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYC---------HS 131
Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIX-XXXXXXXXXXXXXXXXXXXXXEVTDTRKATQA 480
            +++H  IK  N+ L S G + ++D                        E+ + R   + 
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 191
Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEV 508
            D++S GVL  E L GK P  A    E 
Sbjct: 192 VDLWSLGVLCYEFLVGKPPFEANTYQET 219

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 65/277 (23%), Positives = 110/277 (39%), Gaps = 37/277 (13%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFE---QQMEIVGGIRHENVVALRAYY 364
           +G G+FGT YK        V VK LK V+    +F+    ++ ++   RH N++    Y 
Sbjct: 44  IGSGSFGTVYKGKWH--GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYM 101
Query: 365 YSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKL 424
            +KD   +V  + E  S+   LH +  + Q     D                   +   +
Sbjct: 102 -TKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDI-------ARQTAQGMDYLHAKNI 153
Query: 425 VHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXXXXX--------EVTDTRK 476
           +H  +K++NIFL+    V + D                                + D   
Sbjct: 154 IHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNP 213
Query: 477 ATQASDVFSFGVLLLELLTGKSPI-HATGGDEVVHLV-RWVNSVVREEWTAEVFDVELLR 534
            +  SDV+S+G++L EL+TG+ P  H    D+++ +V R   S           D+  L 
Sbjct: 214 FSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASP----------DLSKL- 262
Query: 535 YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVE 571
           Y N  + M  ++     CV ++ EERP    +L  +E
Sbjct: 263 YKNCPKAMKRLV---ADCVKKVKEERPLFPQILSSIE 296

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 60/268 (22%), Positives = 105/268 (39%), Gaps = 34/268 (12%)
Query: 308 LGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQM----EIVGGIRHENVVALRA 362
           LGKG FG  Y A  + +  ++ +K L +  + K   E Q+    EI   +RH N++ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHG-RRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
           Y++      ++ +Y   G+V   L    + + Q +  + T +                + 
Sbjct: 81  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC---------HS 131
Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIX-XXXXXXXXXXXXXXXXXXXXXEVTDTRKATQA 480
            +++H  IK  N+ L S G + ++D                        E+ + R   + 
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEK 191
Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
            D++S GVL  E L GK P  A    E          + R E+T   F  E  R      
Sbjct: 192 VDLWSLGVLCYEFLVGKPPFEANTYQET------YKRISRVEFTFPDFVTEGAR------ 239
Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLK 568
           +++  L      +   P +RP + +VL+
Sbjct: 240 DLISRL------LKHNPSQRPMLREVLE 261

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 49/208 (23%), Positives = 84/208 (40%), Gaps = 16/208 (7%)
Query: 308 LGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQM----EIVGGIRHENVVALRA 362
           LGKG FG  Y A  + +  ++ +K L +  + K   E Q+    EI   +RH N++ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHG-RRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
           Y++      ++ +Y   G+V   L    + + Q +  + T +                + 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC---------HS 126
Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIX-XXXXXXXXXXXXXXXXXXXXXEVTDTRKATQA 480
            +++H  IK  N+ L S G + ++D                        E+ + R   + 
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTXLCGTLDYLPPEMIEGRMHDEK 186
Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEV 508
            D++S GVL  E L GK P  A    E 
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQET 214

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 83/208 (39%), Gaps = 16/208 (7%)
Query: 308 LGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQM----EIVGGIRHENVVALRA 362
           LGKG FG  Y A  + +  ++ +K L +  + K   E Q+    EI   +RH N++ L  
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHG-RRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
           Y++      ++ +Y   G+V   L    + + Q +  + T +                + 
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC---------HS 130
Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIX-XXXXXXXXXXXXXXXXXXXXXEVTDTRKATQA 480
            +++H  IK  N+ L S G + ++D                        E+ + R   + 
Sbjct: 131 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 190
Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEV 508
            D++S GVL  E L GK P  A    E 
Sbjct: 191 VDLWSLGVLCYEFLVGKPPFEANTYQET 218

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 85/208 (40%), Gaps = 16/208 (7%)
Query: 308 LGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQM----EIVGGIRHENVVALRA 362
           LGKG FG  Y A  + +  ++ +K L +  + K   E Q+    EI   +RH N++ L  
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 75
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHG-RRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
           Y++      ++ +Y   G+V   L    + + Q +  + T +                + 
Sbjct: 76  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC---------HS 126
Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIX-XXXXXXXXXXXXXXXXXXXXXEVTDTRKATQA 480
            +++H  IK  N+ L S G + ++D                        E+ + R   + 
Sbjct: 127 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMIEGRMHDEK 186
Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEV 508
            D++S GVL  E L GK P  A    E 
Sbjct: 187 VDLWSLGVLCYEFLVGKPPFEANTYQET 214

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 85/208 (40%), Gaps = 16/208 (7%)
Query: 308 LGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQM----EIVGGIRHENVVALRA 362
           LGKG FG  Y A  + +  ++ +K L +  + K   E Q+    EI   +RH N++ L  
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 80
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHG-RRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
           Y++      ++ +Y   G V   L    + + Q +  + T +                + 
Sbjct: 81  YFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYC---------HS 131
Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIX-XXXXXXXXXXXXXXXXXXXXXEVTDTRKATQA 480
            +++H  IK  N+ L S G + ++D                        E+ + R   + 
Sbjct: 132 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLXGTLDYLPPEMIEGRMHDEK 191
Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEV 508
            D++S GVL  E L GK P  A    E 
Sbjct: 192 VDLWSLGVLCYEFLVGKPPFEANTYQET 219

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 85/208 (40%), Gaps = 16/208 (7%)
Query: 308 LGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQM----EIVGGIRHENVVALRA 362
           LGKG FG  Y A  + +  ++ +K L +  + K   E Q+    EI   +RH N++ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHG-RRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
           Y++      ++ +Y   G+V   L    + + Q +  + T +                + 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC---------HS 129
Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIX-XXXXXXXXXXXXXXXXXXXXXEVTDTRKATQA 480
            +++H  IK  N+ L S G + ++D                        E+ + R   + 
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLCGTLDYLPPEMIEGRMHDEK 189
Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEV 508
            D++S GVL  E L GK P  A    E 
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEANTYQET 217

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 83/208 (39%), Gaps = 16/208 (7%)
Query: 308 LGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQM----EIVGGIRHENVVALRA 362
           LGKG FG  Y A  + +  ++ +K L +  + K   E Q+    EI   +RH N++ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHG-RRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
           Y++      ++ +Y   G+V   L    + + Q +  + T +                + 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC---------HS 129
Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIX-XXXXXXXXXXXXXXXXXXXXXEVTDTRKATQA 480
            +++H  IK  N+ L S G + ++D                        E+ + R   + 
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLCGTLDYLPPEMIEGRMHDEK 189
Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEV 508
            D++S GVL  E L GK P  A    E 
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEANTYQET 217

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 70/305 (22%), Positives = 121/305 (39%), Gaps = 44/305 (14%)
Query: 306 EVLGKGTFGTAYKAALEDAS----TVVVKRLK--EVNVGKREFEQQMEIVGGIRHENVVA 359
           +V+G G FG      L+  S    +V +K LK       +R+F  +  I+G   H N++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTE 419
           L          ++V +Y E GS+ + L  R+ + Q ++    ++              ++
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTV---IQLVGMLRGIASGMKYLSD 165
Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSD------IXXXXXXXXXXXXXXXXXXXXXXEVTD 473
            G   VH  + A NI +NS     VSD      +                      E   
Sbjct: 166 MG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 474 TRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
            RK T ASDV+S+G++L E+++ G+ P       +V+  V                  E 
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-----------------EG 266
Query: 533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTENRSEISS 592
            R P   +    + Q+ + C  +    RPK   ++ +++ + R    NP S +    I+S
Sbjct: 267 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR----NPGSLKI---ITS 319
Query: 593 SAATP 597
           +AA P
Sbjct: 320 AAARP 324

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 70/305 (22%), Positives = 121/305 (39%), Gaps = 44/305 (14%)
Query: 306 EVLGKGTFGTAYKAALEDAS----TVVVKRLK--EVNVGKREFEQQMEIVGGIRHENVVA 359
           +V+G G FG      L+  S    +V +K LK       +R+F  +  I+G   H N++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTE 419
           L          ++V +Y E GS+ + L  R+ + Q ++    ++              ++
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTV---IQLVGMLRGIASGMKYLSD 165
Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSD------IXXXXXXXXXXXXXXXXXXXXXXEVTD 473
            G   VH  + A NI +NS     VSD      +                      E   
Sbjct: 166 MG--YVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 474 TRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
            RK T ASDV+S+G++L E+++ G+ P       +V+  V                  E 
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-----------------EG 266
Query: 533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTENRSEISS 592
            R P   +    + Q+ + C  +    RPK   ++ +++ + R    NP S +    I+S
Sbjct: 267 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR----NPGSLKI---ITS 319
Query: 593 SAATP 597
           +AA P
Sbjct: 320 AAARP 324

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 70/305 (22%), Positives = 121/305 (39%), Gaps = 44/305 (14%)
Query: 306 EVLGKGTFGTAYKAALEDAS----TVVVKRLK--EVNVGKREFEQQMEIVGGIRHENVVA 359
           +V+G G FG      L+  S    +V +K LK       +R+F  +  I+G   H N++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTE 419
           L          ++V +Y E GS+ + L  R+ + Q ++    ++              ++
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTV---IQLVGMLRGIASGMKYLSD 165
Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSD------IXXXXXXXXXXXXXXXXXXXXXXEVTD 473
            G   VH  + A NI +NS     VSD      +                      E   
Sbjct: 166 MG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 474 TRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
            RK T ASDV+S+G++L E+++ G+ P       +V+  V                  E 
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-----------------EG 266
Query: 533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTENRSEISS 592
            R P   +    + Q+ + C  +    RPK   ++ +++ + R    NP S +    I+S
Sbjct: 267 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR----NPGSLKI---ITS 319
Query: 593 SAATP 597
           +AA P
Sbjct: 320 AAARP 324

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 70/305 (22%), Positives = 121/305 (39%), Gaps = 44/305 (14%)
Query: 306 EVLGKGTFGTAYKAALEDAS----TVVVKRLK--EVNVGKREFEQQMEIVGGIRHENVVA 359
           +V+G G FG      L+  S    +V +K LK       +R+F  +  I+G   H N++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTE 419
           L          ++V +Y E GS+ + L  R+ + Q ++    ++              ++
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTV---IQLVGMLRGIASGMKYLSD 165
Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSD------IXXXXXXXXXXXXXXXXXXXXXXEVTD 473
            G   VH  + A NI +NS     VSD      +                      E   
Sbjct: 166 MG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 474 TRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
            RK T ASDV+S+G++L E+++ G+ P       +V+  V                  E 
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-----------------EG 266
Query: 533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTENRSEISS 592
            R P   +    + Q+ + C  +    RPK   ++ +++ + R    NP S +    I+S
Sbjct: 267 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR----NPGSLKI---ITS 319
Query: 593 SAATP 597
           +AA P
Sbjct: 320 AAARP 324

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 70/305 (22%), Positives = 121/305 (39%), Gaps = 44/305 (14%)
Query: 306 EVLGKGTFGTAYKAALEDAS----TVVVKRLK--EVNVGKREFEQQMEIVGGIRHENVVA 359
           +V+G G FG      L+  S    +V +K LK       +R+F  +  I+G   H N++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTE 419
           L          ++V +Y E GS+ + L  R+ + Q ++    ++              ++
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTV---IQLVGMLRGIASGMKYLSD 165
Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSD------IXXXXXXXXXXXXXXXXXXXXXXEVTD 473
            G   VH  + A NI +NS     VSD      +                      E   
Sbjct: 166 MG--YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 474 TRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
            RK T ASDV+S+G++L E+++ G+ P       +V+  V                  E 
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-----------------EG 266
Query: 533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTENRSEISS 592
            R P   +    + Q+ + C  +    RPK   ++ +++ + R    NP S +    I+S
Sbjct: 267 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR----NPGSLKI---ITS 319
Query: 593 SAATP 597
           +AA P
Sbjct: 320 AAARP 324

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 70/305 (22%), Positives = 121/305 (39%), Gaps = 44/305 (14%)
Query: 306 EVLGKGTFGTAYKAALEDAS----TVVVKRLK--EVNVGKREFEQQMEIVGGIRHENVVA 359
           +V+G G FG      L+  S    +V +K LK       +R+F  +  I+G   H N++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTE 419
           L          ++V +Y E GS+ + L  R+ + Q ++    ++              ++
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTV---IQLVGMLRGIASGMKYLSD 165
Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSD------IXXXXXXXXXXXXXXXXXXXXXXEVTD 473
            G   VH  + A NI +NS     VSD      +                      E   
Sbjct: 166 MG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 474 TRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
            RK T ASDV+S+G++L E+++ G+ P       +V+  V                  E 
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-----------------EG 266
Query: 533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTENRSEISS 592
            R P   +    + Q+ + C  +    RPK   ++ +++ + R    NP S +    I+S
Sbjct: 267 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR----NPGSLKI---ITS 319
Query: 593 SAATP 597
           +AA P
Sbjct: 320 AAARP 324

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 70/305 (22%), Positives = 121/305 (39%), Gaps = 44/305 (14%)
Query: 306 EVLGKGTFGTAYKAALEDAS----TVVVKRLK--EVNVGKREFEQQMEIVGGIRHENVVA 359
           +V+G G FG      L+  S    +V +K LK       +R+F  +  I+G   H N++ 
Sbjct: 49  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 108
Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTE 419
           L          ++V +Y E GS+ + L  R+ + Q ++    ++              ++
Sbjct: 109 LEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTV---IQLVGMLRGIASGMKYLSD 163
Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSD------IXXXXXXXXXXXXXXXXXXXXXXEVTD 473
            G   VH  + A NI +NS     VSD      +                      E   
Sbjct: 164 MG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 221
Query: 474 TRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
            RK T ASDV+S+G++L E+++ G+ P       +V+  V                  E 
Sbjct: 222 YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-----------------EG 264
Query: 533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTENRSEISS 592
            R P   +    + Q+ + C  +    RPK   ++ +++ + R    NP S +    I+S
Sbjct: 265 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR----NPGSLKI---ITS 317
Query: 593 SAATP 597
           +AA P
Sbjct: 318 AAARP 322

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 70/305 (22%), Positives = 121/305 (39%), Gaps = 44/305 (14%)
Query: 306 EVLGKGTFGTAYKAALEDAS----TVVVKRLK--EVNVGKREFEQQMEIVGGIRHENVVA 359
           +V+G G FG      L+  S    +V +K LK       +R+F  +  I+G   H N++ 
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 81
Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTE 419
           L          ++V +Y E GS+ + L  R+ + Q ++    ++              ++
Sbjct: 82  LEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTV---IQLVGMLRGIASGMKYLSD 136
Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSD------IXXXXXXXXXXXXXXXXXXXXXXEVTD 473
            G   VH  + A NI +NS     VSD      +                      E   
Sbjct: 137 MG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 194
Query: 474 TRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
            RK T ASDV+S+G++L E+++ G+ P       +V+  V                  E 
Sbjct: 195 YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-----------------EG 237
Query: 533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTENRSEISS 592
            R P   +    + Q+ + C  +    RPK   ++ +++ + R    NP S +    I+S
Sbjct: 238 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR----NPGSLKI---ITS 290
Query: 593 SAATP 597
           +AA P
Sbjct: 291 AAARP 295

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 52.4 bits (124), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/208 (23%), Positives = 82/208 (39%), Gaps = 16/208 (7%)
Query: 308 LGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQM----EIVGGIRHENVVALRA 362
           LGKG FG  Y A  +    ++ +K L +  + K   E Q+    EI   +RH N++ L  
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 72
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHG-RRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
           Y++      ++ +Y   G+V   L    + + Q +  + T +                + 
Sbjct: 73  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC---------HS 123
Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIX-XXXXXXXXXXXXXXXXXXXXXEVTDTRKATQA 480
            +++H  IK  N+ L S G + ++D                        E+ + R   + 
Sbjct: 124 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 183
Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEV 508
            D++S GVL  E L GK P  A    E 
Sbjct: 184 VDLWSLGVLCYEFLVGKPPFEANTYQET 211

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 70/305 (22%), Positives = 121/305 (39%), Gaps = 44/305 (14%)
Query: 306 EVLGKGTFGTAYKAALEDAS----TVVVKRLK--EVNVGKREFEQQMEIVGGIRHENVVA 359
           +V+G G FG      L+  S    +V +K LK       +R+F  +  I+G   H N++ 
Sbjct: 39  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 98
Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTE 419
           L          ++V +Y E GS+ + L  R+ + Q ++    ++              ++
Sbjct: 99  LEGVVTKSKPVMIVTEYMENGSLDSFL--RKHDAQFTV---IQLVGMLRGIASGMKYLSD 153
Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSD------IXXXXXXXXXXXXXXXXXXXXXXEVTD 473
            G   VH  + A NI +NS     VSD      +                      E   
Sbjct: 154 MG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 211
Query: 474 TRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
            RK T ASDV+S+G++L E+++ G+ P       +V+  V                  E 
Sbjct: 212 YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-----------------EG 254
Query: 533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTENRSEISS 592
            R P   +    + Q+ + C  +    RPK   ++ +++ + R    NP S +    I+S
Sbjct: 255 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR----NPGSLKI---ITS 307
Query: 593 SAATP 597
           +AA P
Sbjct: 308 AAARP 312

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 83/208 (39%), Gaps = 16/208 (7%)
Query: 308 LGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQM----EIVGGIRHENVVALRA 362
           LGKG FG  Y A  + +  ++ +K L +  + K   E Q+    EI   +RH N++ L  
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 77
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHG-RRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
           Y++      ++ +Y   G+V   L    + + Q +  + T +                + 
Sbjct: 78  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC---------HS 128
Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIX-XXXXXXXXXXXXXXXXXXXXXEVTDTRKATQA 480
            +++H  IK  N+ L S G + +++                        E+ + R   + 
Sbjct: 129 KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 188
Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEV 508
            D++S GVL  E L GK P  A    E 
Sbjct: 189 VDLWSLGVLCYEFLVGKPPFEANTYQET 216

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/291 (21%), Positives = 107/291 (36%), Gaps = 50/291 (17%)
Query: 308 LGKGTFGTAYKAAL------EDASTVVVKRLKEVNVGKR-EFEQQMEIVGGIRHENVVAL 360
           LG+G FG  + A        +D   V VK LK+  +  R +F+++ E++  ++HE++V  
Sbjct: 23  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAML--HG-----------RRGEGQSSLDWDTRVXXXX 407
                  D  +MV++Y + G ++  L  HG           R+ +G+  L     +    
Sbjct: 83  YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 408 XXXXXXXXXXTENGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXXX 467
                            VH  +   N  + +   V + D                     
Sbjct: 143 ASGMVYLASQ-----HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTML 197
Query: 468 XX-----EVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVRE 521
                  E    RK T  SDV+SFGV+L E+ T GK P       EV+  +     + R 
Sbjct: 198 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERP 257
Query: 522 EWT-AEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVE 571
                EV+DV L                   C  R P++R  + ++ K++ 
Sbjct: 258 RVCPKEVYDVML------------------GCWQREPQQRLNIKEIYKILH 290

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 97/270 (35%), Gaps = 29/270 (10%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG+G FG  +       + V +K LK  N+    F Q+ +++  +RHE +V L A   S+
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 251
Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLVHG 427
           +   +V +Y   GS+   L G  G+    L     V                N    VH 
Sbjct: 252 EPIYIVTEYMSKGSLLDFLKGEMGK---YLRLPQLVDMAAQIASGMAYVERMN---YVHR 305
Query: 428 GIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQASDV 483
            ++A+NI +       V+D                           E     + T  SDV
Sbjct: 306 DLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 365
Query: 484 FSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEM 542
           +SFG+LL EL T G+ P       EV+  V                     R P   E  
Sbjct: 366 WSFGILLTELTTKGRVPYPGMVNREVLDQVE-----------------RGYRMPCPPECP 408
Query: 543 VEMLQVGMACVVRMPEERPKMADVLKMVED 572
             +  +   C  + PEERP    +   +ED
Sbjct: 409 ESLHDLMCQCWRKDPEERPTFEYLQAFLED 438

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/208 (22%), Positives = 83/208 (39%), Gaps = 16/208 (7%)
Query: 308 LGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQM----EIVGGIRHENVVALRA 362
           LGKG FG  Y A  + +  ++ +K L +  + K   E Q+    EI   +RH N++ L  
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 78
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHG-RRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
           Y++      ++ +Y   G+V   L    + + Q +  + T +                + 
Sbjct: 79  YFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYC---------HS 129
Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIX-XXXXXXXXXXXXXXXXXXXXXEVTDTRKATQA 480
            +++H  IK  N+ L S G + +++                        E+ + R   + 
Sbjct: 130 KRVIHRDIKPENLLLGSAGELKIANFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 189
Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEV 508
            D++S GVL  E L GK P  A    E 
Sbjct: 190 VDLWSLGVLCYEFLVGKPPFEANTYQET 217

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 80/202 (39%), Gaps = 16/202 (7%)
Query: 308 LGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQM----EIVGGIRHENVVALRA 362
           LGKG FG  Y A    +  ++ +K L +  + K   E Q+    EI   +RH N++ L  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHG-RRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
           Y++      ++ +Y   G+V   L    R + Q +  + T +                + 
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYC---------HS 130
Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIX-XXXXXXXXXXXXXXXXXXXXXEVTDTRKATQA 480
            +++H  IK  N+ L S G + ++D                        E+ + R   + 
Sbjct: 131 KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 190
Query: 481 SDVFSFGVLLLELLTGKSPIHA 502
            D++S GVL  E L G  P  A
Sbjct: 191 VDLWSLGVLCYEFLVGMPPFEA 212

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/273 (20%), Positives = 102/273 (37%), Gaps = 35/273 (12%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG G FG  + A     + V VK +K  ++    F  +  ++  ++H+ +V L A   +K
Sbjct: 23  LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV-TK 81
Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQ---SSLDWDTRVXXXXXXXXXXXXXXTENGGKL 424
           +   ++ ++   GS+   L    G  Q     +D+  ++                     
Sbjct: 82  EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---------NY 132
Query: 425 VHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQA 480
           +H  ++A+NI +++     ++D                           E  +    T  
Sbjct: 133 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 192
Query: 481 SDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE 539
           SDV+SFG+LL+E++T G+ P       EV+  +                     R P  E
Sbjct: 193 SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-----------------RGYRMPRPE 235
Query: 540 EEMVEMLQVGMACVVRMPEERPKMADVLKMVED 572
               E+  + M C    PEERP    +  +++D
Sbjct: 236 NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD 268

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 55/270 (20%), Positives = 102/270 (37%), Gaps = 37/270 (13%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG G FG  + A     + V VK +K  ++    F  +  ++  ++H+ +V L A   +K
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV-TK 248
Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQ---SSLDWDTRVXXXXXXXXXXXXXXTENGGKL 424
           +   ++ ++   GS+   L    G  Q     +D+  ++                     
Sbjct: 249 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---------NY 299
Query: 425 VHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXXXXXEVTDTRKATQASDVF 484
           +H  ++A+NI +++     ++D                       E  +    T  SDV+
Sbjct: 300 IHRDLRAANILVSASLVCKIADFGLARVGAKFPIKWTAP------EAINFGSFTIKSDVW 353
Query: 485 SFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMV 543
           SFG+LL+E++T G+ P       EV+  +                     R P  E    
Sbjct: 354 SFGILLMEIVTYGRIPYPGMSNPEVIRALE-----------------RGYRMPRPENCPE 396
Query: 544 EMLQVGMACVVRMPEERPKMADVLKMVEDI 573
           E+  + M C    PEERP    +  +++D 
Sbjct: 397 ELYNIMMRCWKNRPEERPTFEYIQSVLDDF 426

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 101/247 (40%), Gaps = 20/247 (8%)
Query: 305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYY 364
            +V+G G+FG  Y+A L D+  +V   +K+V   KR   ++++I+  + H N+V LR ++
Sbjct: 26  TKVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFF 83
Query: 365 YSKDEKL------MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXT 418
           YS  EK       +V DY          H  R +    + +   V               
Sbjct: 84  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIH 140
Query: 419 ENGGKLVHGGIKASNIFLNSQGHV---CVSDIXXXXXXXXXXXXXXXXXXXXXXE-VTDT 474
             G  + H  IK  N+ L+    V   C                          E +   
Sbjct: 141 SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 198
Query: 475 RKATQASDVFSFGVLLLELLTGKSPIHA--TGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
              T + DV+S G +L ELL G+ PI    +G D++V +++ + +  RE+      +   
Sbjct: 199 TDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 257
Query: 533 LRYPNIE 539
            ++P I+
Sbjct: 258 FKFPQIK 264

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 100/247 (40%), Gaps = 20/247 (8%)
Query: 305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYY 364
            +V+G G+FG  Y+A L D+  +V   +K+V   KR   ++++I+  + H N+V LR ++
Sbjct: 38  TKVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFF 95
Query: 365 YSKDEKL------MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXT 418
           YS  EK       +V DY          H  R +    + +   V               
Sbjct: 96  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIH 152
Query: 419 ENGGKLVHGGIKASNIFLNSQGHV---CVSDIXXXXXXXXXXXXXXXXXXXXXXE-VTDT 474
             G  + H  IK  N+ L+    V   C                          E +   
Sbjct: 153 SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 210
Query: 475 RKATQASDVFSFGVLLLELLTGKSPIHA--TGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
              T + DV+S G +L ELL G+ PI    +G D++V +++ + +  RE+      +   
Sbjct: 211 TDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 269
Query: 533 LRYPNIE 539
            ++P I+
Sbjct: 270 FKFPQIK 276

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/202 (23%), Positives = 80/202 (39%), Gaps = 16/202 (7%)
Query: 308 LGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQM----EIVGGIRHENVVALRA 362
           LGKG FG  Y A    +  ++ +K L +  + K   E Q+    EI   +RH N++ L  
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHG-RRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
           Y++      ++ +Y   G+V   L    R + Q +  + T +                + 
Sbjct: 80  YFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYC---------HS 130
Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIX-XXXXXXXXXXXXXXXXXXXXXEVTDTRKATQA 480
            +++H  IK  N+ L S G + ++D                        E+ + R   + 
Sbjct: 131 KRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEK 190
Query: 481 SDVFSFGVLLLELLTGKSPIHA 502
            D++S GVL  E L G  P  A
Sbjct: 191 VDLWSLGVLCYEFLVGMPPFEA 212

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 101/247 (40%), Gaps = 20/247 (8%)
Query: 305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYY 364
            +V+G G+FG  Y+A L D+  +V   +K+V   KR   ++++I+  + H N+V LR ++
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 365 YSKDEKL------MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXT 418
           YS  EK       +V DY          H  R +    + +   V               
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIH 139
Query: 419 ENGGKLVHGGIKASNIFLNSQGHV---CVSDIXXXXXXXXXXXXXXXXXXXXXXE-VTDT 474
             G  + H  IK  N+ L+    V   C                          E +   
Sbjct: 140 SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 197
Query: 475 RKATQASDVFSFGVLLLELLTGKSPIHA--TGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
              T + DV+S G +L ELL G+ PI    +G D++V +++ + +  RE+      +   
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256
Query: 533 LRYPNIE 539
            ++P I+
Sbjct: 257 FKFPQIK 263

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 101/247 (40%), Gaps = 20/247 (8%)
Query: 305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYY 364
            +V+G G+FG  Y+A L D+  +V   +K+V   KR   ++++I+  + H N+V LR ++
Sbjct: 37  TKVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFF 94
Query: 365 YSKDEKL------MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXT 418
           YS  EK       +V DY          H  R +    + +   V               
Sbjct: 95  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIH 151
Query: 419 ENGGKLVHGGIKASNIFLNSQGHV---CVSDIXXXXXXXXXXXXXXXXXXXXXXE-VTDT 474
             G  + H  IK  N+ L+    V   C                          E +   
Sbjct: 152 SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 209
Query: 475 RKATQASDVFSFGVLLLELLTGKSPIHA--TGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
              T + DV+S G +L ELL G+ PI    +G D++V +++ + +  RE+      +   
Sbjct: 210 TDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 268
Query: 533 LRYPNIE 539
            ++P I+
Sbjct: 269 FKFPQIK 275

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 101/247 (40%), Gaps = 20/247 (8%)
Query: 305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYY 364
            +V+G G+FG  Y+A L D+  +V   +K+V   KR   ++++I+  + H N+V LR ++
Sbjct: 44  TKVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFF 101
Query: 365 YSKDEKL------MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXT 418
           YS  EK       +V DY          H  R +    + +   V               
Sbjct: 102 YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIH 158
Query: 419 ENGGKLVHGGIKASNIFLNSQGHV---CVSDIXXXXXXXXXXXXXXXXXXXXXXE-VTDT 474
             G  + H  IK  N+ L+    V   C                          E +   
Sbjct: 159 SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 216
Query: 475 RKATQASDVFSFGVLLLELLTGKSPIHA--TGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
              T + DV+S G +L ELL G+ PI    +G D++V +++ + +  RE+      +   
Sbjct: 217 TDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 275
Query: 533 LRYPNIE 539
            ++P I+
Sbjct: 276 FKFPQIK 282

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 101/247 (40%), Gaps = 20/247 (8%)
Query: 305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYY 364
            +V+G G+FG  Y+A L D+  +V   +K+V   KR   ++++I+  + H N+V LR ++
Sbjct: 33  TKVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFF 90
Query: 365 YSKDEKL------MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXT 418
           YS  EK       +V DY          H  R +    + +   V               
Sbjct: 91  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIH 147
Query: 419 ENGGKLVHGGIKASNIFLNSQGHV---CVSDIXXXXXXXXXXXXXXXXXXXXXXE-VTDT 474
             G  + H  IK  N+ L+    V   C                          E +   
Sbjct: 148 SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 205
Query: 475 RKATQASDVFSFGVLLLELLTGKSPIHA--TGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
              T + DV+S G +L ELL G+ PI    +G D++V +++ + +  RE+      +   
Sbjct: 206 TDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 264
Query: 533 LRYPNIE 539
            ++P I+
Sbjct: 265 FKFPQIK 271

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 62/265 (23%), Positives = 104/265 (39%), Gaps = 37/265 (13%)
Query: 306 EVLGKGTFGTAYKAALEDASTVV-VKRLK-EVNVGKREFEQQME----IVGGIRHENVVA 359
           ++LGKG+FG  + A  +  +    +K LK +V +   + E  M     +     H  +  
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTE 419
           +   + +K+    V +Y   G +  M H      QS   +D                   
Sbjct: 83  MFCTFQTKENLFFVMEYLNGGDL--MYHI-----QSCHKFDLSRATFYAAEIILGLQFLH 135
Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXX---XXXXXEVTDTRK 476
           + G +V+  +K  NI L+  GH+ ++D                          E+   +K
Sbjct: 136 SKG-IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQK 194
Query: 477 ATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP 536
              + D +SFGVLL E+L G+SP H    +E+ H +R  N                  YP
Sbjct: 195 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF----------------YP 238
Query: 537 N-IEEEMVEMLQVGMACVVRMPEER 560
             +E+E  ++L   +   VR PE+R
Sbjct: 239 RWLEKEAKDLL---VKLFVREPEKR 260

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 101/247 (40%), Gaps = 20/247 (8%)
Query: 305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYY 364
            +V+G G+FG  Y+A L D+  +V   +K+V   KR   ++++I+  + H N+V LR ++
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 365 YSKDEKL------MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXT 418
           YS  EK       +V DY          H  R +    + +   V               
Sbjct: 83  YSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIH 139
Query: 419 ENGGKLVHGGIKASNIFLNSQGHV---CVSDIXXXXXXXXXXXXXXXXXXXXXXE-VTDT 474
             G  + H  IK  N+ L+    V   C                          E +   
Sbjct: 140 SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 197
Query: 475 RKATQASDVFSFGVLLLELLTGKSPIHA--TGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
              T + DV+S G +L ELL G+ PI    +G D++V +++ + +  RE+      +   
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256
Query: 533 LRYPNIE 539
            ++P I+
Sbjct: 257 FKFPQIK 263

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 95/229 (41%), Gaps = 20/229 (8%)
Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           +V+G G+FG  Y+A L D+  +V   +K+V  GK    ++++I+  + H N+V LR ++Y
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVA--IKKVLQGKAFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 366 SKDEKL------MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTE 419
           S  EK       +V DY          H  R +    + +   V                
Sbjct: 84  SSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 140
Query: 420 NGGKLVHGGIKASNIFLNSQGHV---CVSDIXXXXXXXXXXXXXXXXXXXXXXE-VTDTR 475
            G  + H  IK  N+ L+    V   C                          E +    
Sbjct: 141 FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGAT 198
Query: 476 KATQASDVFSFGVLLLELLTGKSPIHA--TGGDEVVHLVRWVNSVVREE 522
             T + DV+S G +L ELL G+ PI    +G D++V +++ + +  RE+
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQ 246

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 101/246 (41%), Gaps = 20/246 (8%)
Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           +V+G G+FG  Y+A L D+  +V   +K+V   KR   ++++I+  + H N+V LR ++Y
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 366 SKDEKL------MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTE 419
           S  EK       +V DY          H  R +    + +   V                
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 174
Query: 420 NGGKLVHGGIKASNIFLNSQGHV---CVSDIXXXXXXXXXXXXXXXXXXXXXXE-VTDTR 475
            G  + H  IK  N+ L+    V   C                          E +    
Sbjct: 175 FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGAT 232
Query: 476 KATQASDVFSFGVLLLELLTGKSPIHA--TGGDEVVHLVRWVNSVVREEWTAEVFDVELL 533
             T + DV+S G +L ELL G+ PI    +G D++V +++ + +  RE+      +    
Sbjct: 233 DYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 291
Query: 534 RYPNIE 539
           ++P I+
Sbjct: 292 KFPQIK 297

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/247 (22%), Positives = 99/247 (40%), Gaps = 20/247 (8%)
Query: 305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYY 364
            +V+G G+FG  Y+A L D+  +V   +K+V   KR   ++++I+  + H N+V LR ++
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 365 YSKDEKL------MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXT 418
           YS  EK       +V DY          H  R +    +     +               
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV-----IYVKLYMYQLFRSLAY 137
Query: 419 ENGGKLVHGGIKASNIFLNSQGHV---CVSDIXXXXXXXXXXXXXXXXXXXXXXE-VTDT 474
            +   + H  IK  N+ L+    V   C                          E +   
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 197
Query: 475 RKATQASDVFSFGVLLLELLTGKSPIHA--TGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
              T + DV+S G +L ELL G+ PI    +G D++V +++ + +  RE+      +   
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256
Query: 533 LRYPNIE 539
            ++P I+
Sbjct: 257 FKFPQIK 263

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 57/247 (23%), Positives = 100/247 (40%), Gaps = 20/247 (8%)
Query: 305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYY 364
            +V+G G+FG  Y+A L D+  +V   +K+V   KR   ++++I+  + H N+V LR ++
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 365 YSKDEKL------MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXT 418
           YS  EK       +V DY          H  R +    +     +               
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPV-----IYVKLYMYQLFRSLAY 137
Query: 419 ENGGKLVHGGIKASNIFLNSQGHV---CVSDIXXXXXXXXXXXXXXXXXXXXXXE-VTDT 474
            +   + H  IK  N+ L+    V   C                          E +   
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 197
Query: 475 RKATQASDVFSFGVLLLELLTGKSPIHA--TGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
              T + DV+S G +L ELL G+ PI    +G D++V +++ + +  RE+      +   
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256
Query: 533 LRYPNIE 539
            ++P I+
Sbjct: 257 FKFPQIK 263

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/246 (23%), Positives = 100/246 (40%), Gaps = 20/246 (8%)
Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           +V+G G+FG  Y+A L D+  +V   +K+V   KR   ++++I+  + H N+V LR ++Y
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 366 SKDEKL------MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTE 419
           S  EK       +V DY          H  R +    + +   V                
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 174
Query: 420 NGGKLVHGGIKASNIFLNSQGHV---CVSDIXXXXXXXXXXXXXXXXXXXXXXE-VTDTR 475
            G  + H  IK  N+ L+    V   C                          E +    
Sbjct: 175 FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 232
Query: 476 KATQASDVFSFGVLLLELLTGKSPIHA--TGGDEVVHLVRWVNSVVREEWTAEVFDVELL 533
             T + DV+S G +L ELL G+ PI    +G D++V +++ + +  RE+      +    
Sbjct: 233 DYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 291
Query: 534 RYPNIE 539
           ++P I+
Sbjct: 292 KFPQIK 297

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 61/265 (23%), Positives = 103/265 (38%), Gaps = 37/265 (13%)
Query: 306 EVLGKGTFGTAYKAALEDASTVV-VKRLK-EVNVGKREFEQQME----IVGGIRHENVVA 359
           ++LGKG+FG  + A  +  +    +K LK +V +   + E  M     +     H  +  
Sbjct: 24  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 83
Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTE 419
           +   + +K+    V +Y   G +  M H      QS   +D                   
Sbjct: 84  MFCTFQTKENLFFVMEYLNGGDL--MYHI-----QSCHKFDLSRATFYAAEIILGLQFLH 136
Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXX---XXXXXEVTDTRK 476
           + G +V+  +K  NI L+  GH+ ++D                          E+   +K
Sbjct: 137 SKG-IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQK 195
Query: 477 ATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP 536
              + D +SFGVLL E+L G+SP H    +E+ H +R  N                  YP
Sbjct: 196 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPF----------------YP 239
Query: 537 N-IEEEMVEMLQVGMACVVRMPEER 560
             +E+E  ++L   +   VR PE+R
Sbjct: 240 RWLEKEAKDLL---VKLFVREPEKR 261

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 96/270 (35%), Gaps = 29/270 (10%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG+G FG  +       + V +K LK   +    F Q+ +++  +RHE +V L A   S+
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 333
Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLVHG 427
           +   +V +Y   GS+   L G  G+    L     V                N    VH 
Sbjct: 334 EPIYIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIASGMAYVERMN---YVHR 387
Query: 428 GIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQASDV 483
            ++A+NI +       V+D                           E     + T  SDV
Sbjct: 388 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 447
Query: 484 FSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEM 542
           +SFG+LL EL T G+ P       EV+  V                     R P   E  
Sbjct: 448 WSFGILLTELTTKGRVPYPGMVNREVLDQVE-----------------RGYRMPCPPECP 490
Query: 543 VEMLQVGMACVVRMPEERPKMADVLKMVED 572
             +  +   C  + PEERP    +   +ED
Sbjct: 491 ESLHDLMCQCWRKEPEERPTFEYLQAFLED 520

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/246 (23%), Positives = 100/246 (40%), Gaps = 20/246 (8%)
Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           +V+G G+FG  Y+A L D+  +V   +K+V   KR   ++++I+  + H N+V LR ++Y
Sbjct: 62  KVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 119
Query: 366 SKDEKL------MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTE 419
           S  EK       +V DY          H  R +    + +   V                
Sbjct: 120 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 176
Query: 420 NGGKLVHGGIKASNIFLNSQGHV---CVSDIXXXXXXXXXXXXXXXXXXXXXXE-VTDTR 475
            G  + H  IK  N+ L+    V   C                          E +    
Sbjct: 177 FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 234
Query: 476 KATQASDVFSFGVLLLELLTGKSPIHA--TGGDEVVHLVRWVNSVVREEWTAEVFDVELL 533
             T + DV+S G +L ELL G+ PI    +G D++V +++ + +  RE+      +    
Sbjct: 235 DYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 293
Query: 534 RYPNIE 539
           ++P I+
Sbjct: 294 KFPQIK 299

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/246 (23%), Positives = 101/246 (41%), Gaps = 20/246 (8%)
Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           +V+G G+FG  Y+A L D+  +V   +K+V   KR   ++++I+  + H N+V LR ++Y
Sbjct: 38  KVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 95
Query: 366 SKDEKL------MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTE 419
           S  EK       +V DY          H  R +    + +   V                
Sbjct: 96  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 152
Query: 420 NGGKLVHGGIKASNIFLNSQGHV---CVSDIXXXXXXXXXXXXXXXXXXXXXXE-VTDTR 475
            G  + H  IK  N+ L+    V   C                          E +    
Sbjct: 153 FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGAT 210
Query: 476 KATQASDVFSFGVLLLELLTGKSPIHA--TGGDEVVHLVRWVNSVVREEWTAEVFDVELL 533
             T + DV+S G +L ELL G+ PI    +G D++V +++ + +  RE+      +    
Sbjct: 211 DYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 269
Query: 534 RYPNIE 539
           ++P I+
Sbjct: 270 KFPQIK 275

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 65/286 (22%), Positives = 116/286 (40%), Gaps = 34/286 (11%)
Query: 296 DLEDLLRASAEV---LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGI 352
           D+ ++ R S ++   LG G FG  +       + V +K LK   +    F ++ +I+  +
Sbjct: 2   DVWEIPRESLQLIKRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKL 61
Query: 353 RHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXX 412
           +H+ +V L A   S++   +V +Y   GS+   L  + GEG+ +L     V         
Sbjct: 62  KHDKLVQLYA-VVSEEPIYIVTEYMNKGSLLDFL--KDGEGR-ALKLPNLVDMAAQVAAG 117
Query: 413 XXXXXTENGGKLVHGGIKASNIFLNSQGHVC-VSDIXXXXXXXXXXXXXXXXXXX----X 467
                  N    +H  ++++NI + + G +C ++D                         
Sbjct: 118 MAYIERMN---YIHRDLRSANILVGN-GLICKIADFGLARLIEDNEXTARQGAKFPIKWT 173
Query: 468 XXEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAE 526
             E     + T  SDV+SFG+LL EL+T G+ P       EV+  V              
Sbjct: 174 APEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE------------- 220
Query: 527 VFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVED 572
                  R P  ++  + + ++ + C  + PEERP    +   +ED
Sbjct: 221 ----RGYRMPCPQDCPISLHELMIHCWKKDPEERPTFEYLQSFLED 262

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/247 (23%), Positives = 100/247 (40%), Gaps = 20/247 (8%)
Query: 305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYY 364
            +V+G G+FG  Y+A L D+  +V   +K+V  GK    ++++I+  + H N+V LR ++
Sbjct: 25  TKVIGNGSFGVVYQAKLCDSGELVA--IKKVLQGKAFKNRELQIMRKLDHCNIVRLRYFF 82
Query: 365 YSKDEKL------MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXT 418
           YS  EK       +V DY          H  R +    + +   V               
Sbjct: 83  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIH 139
Query: 419 ENGGKLVHGGIKASNIFLNSQGHV---CVSDIXXXXXXXXXXXXXXXXXXXXXXE-VTDT 474
             G  + H  IK  N+ L+    V   C                          E +   
Sbjct: 140 SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 197
Query: 475 RKATQASDVFSFGVLLLELLTGKSPIHA--TGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
              T + DV+S G +L ELL G+ PI    +G D++V +++ + +  RE+      +   
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 256
Query: 533 LRYPNIE 539
            ++P I+
Sbjct: 257 FKFPQIK 263

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 59/247 (23%), Positives = 101/247 (40%), Gaps = 20/247 (8%)
Query: 305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYY 364
            +V+G G+FG  Y+A L D+  +V   +K+V   KR   ++++I+  + H N+V LR ++
Sbjct: 29  TKVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFF 86
Query: 365 YSKDEKL------MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXT 418
           YS  EK       +V DY          H  R +    + +   V               
Sbjct: 87  YSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIH 143
Query: 419 ENGGKLVHGGIKASNIFLNSQGHV---CVSDIXXXXXXXXXXXXXXXXXXXXXXE-VTDT 474
             G  + H  IK  N+ L+    V   C                          E +   
Sbjct: 144 SFG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 201
Query: 475 RKATQASDVFSFGVLLLELLTGKSPIHA--TGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
              T + DV+S G +L ELL G+ PI    +G D++V +++ + +  RE+      +   
Sbjct: 202 TDYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE 260
Query: 533 LRYPNIE 539
            ++P I+
Sbjct: 261 FKFPQIK 267

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/246 (23%), Positives = 100/246 (40%), Gaps = 20/246 (8%)
Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           +V+G G+FG  Y+A L D+  +V   +K+V   KR   ++++I+  + H N+V LR ++Y
Sbjct: 31  KVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 88
Query: 366 SKDEKL------MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTE 419
           S  EK       +V DY          H  R +    + +   V                
Sbjct: 89  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 145
Query: 420 NGGKLVHGGIKASNIFLNSQGHV---CVSDIXXXXXXXXXXXXXXXXXXXXXXE-VTDTR 475
            G  + H  IK  N+ L+    V   C                          E +    
Sbjct: 146 FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 203
Query: 476 KATQASDVFSFGVLLLELLTGKSPIHA--TGGDEVVHLVRWVNSVVREEWTAEVFDVELL 533
             T + DV+S G +L ELL G+ PI    +G D++V +++ + +  RE+      +    
Sbjct: 204 DYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 262
Query: 534 RYPNIE 539
           ++P I+
Sbjct: 263 KFPQIK 268

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/300 (21%), Positives = 114/300 (38%), Gaps = 41/300 (13%)
Query: 306 EVLGKGTFGTAYKAALEDAS----TVVVKRLKE--VNVGKREFEQQMEIVGGIRHENVVA 359
           +V+G G FG      L+        V +K LK    +  +R+F  +  I+G   H N++ 
Sbjct: 14  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 73
Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTE 419
           L          +++ +Y E GS+ A L  R+ +G+ ++     +                
Sbjct: 74  LEGVVTKCKPVMIITEYMENGSLDAFL--RKNDGRFTV-----IQLVGMLRGIGSGMKYL 126
Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX------XXXEVTD 473
           +    VH  + A NI +NS     VSD                             E   
Sbjct: 127 SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 186
Query: 474 TRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
            RK T ASDV+S+G+++ E+++ G+ P       +V+  +                  E 
Sbjct: 187 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-----------------EG 229
Query: 533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTENRSEISS 592
            R P   +  + + Q+ + C  +   +RPK   ++ M++ + R    NP S +     SS
Sbjct: 230 YRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIR----NPNSLKRTGSESS 285

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/300 (21%), Positives = 114/300 (38%), Gaps = 41/300 (13%)
Query: 306 EVLGKGTFGTAYKAALEDAS----TVVVKRLKE--VNVGKREFEQQMEIVGGIRHENVVA 359
           +V+G G FG      L+        V +K LK    +  +R+F  +  I+G   H N++ 
Sbjct: 35  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 94
Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTE 419
           L          +++ +Y E GS+ A L  R+ +G+ ++     +                
Sbjct: 95  LEGVVTKCKPVMIITEYMENGSLDAFL--RKNDGRFTV-----IQLVGMLRGIGSGMKYL 147
Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX------XXXEVTD 473
           +    VH  + A NI +NS     VSD                             E   
Sbjct: 148 SDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 207
Query: 474 TRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
            RK T ASDV+S+G+++ E+++ G+ P       +V+  +                  E 
Sbjct: 208 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-----------------EG 250
Query: 533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTENRSEISS 592
            R P   +  + + Q+ + C  +   +RPK   ++ M++ + R    NP S +     SS
Sbjct: 251 YRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIR----NPNSLKRTGSESS 306

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/246 (23%), Positives = 100/246 (40%), Gaps = 20/246 (8%)
Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           +V+G G+FG  Y+A L D+  +V   +K+V   KR   ++++I+  + H N+V LR ++Y
Sbjct: 64  KVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 121
Query: 366 SKDEKL------MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTE 419
           S  EK       +V DY          H  R +    + +   V                
Sbjct: 122 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 178
Query: 420 NGGKLVHGGIKASNIFLNSQGHV---CVSDIXXXXXXXXXXXXXXXXXXXXXXE-VTDTR 475
            G  + H  IK  N+ L+    V   C                          E +    
Sbjct: 179 FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 236
Query: 476 KATQASDVFSFGVLLLELLTGKSPIHA--TGGDEVVHLVRWVNSVVREEWTAEVFDVELL 533
             T + DV+S G +L ELL G+ PI    +G D++V +++ + +  RE+      +    
Sbjct: 237 DYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 295
Query: 534 RYPNIE 539
           ++P I+
Sbjct: 296 KFPQIK 301

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 56/229 (24%), Positives = 94/229 (41%), Gaps = 20/229 (8%)
Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           +V+G G+FG  Y+A L D+  +V   +K+V  GK    ++++I+  + H N+V LR ++Y
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVA--IKKVLQGKAFKNRELQIMRKLDHCNIVRLRYFFY 83
Query: 366 SKDEKL------MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTE 419
           S  EK       +V DY          H  R +    + +   V                
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 140
Query: 420 NGGKLVHGGIKASNIFLNSQGHV---CVSDIXXXXXXXXXXXXXXXXXXXXXXE-VTDTR 475
            G  + H  IK  N+ L+    V   C                          E +    
Sbjct: 141 FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 198
Query: 476 KATQASDVFSFGVLLLELLTGKSPIHA--TGGDEVVHLVRWVNSVVREE 522
             T + DV+S G +L ELL G+ PI    +G D++V +++ + +  RE+
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQ 246

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/246 (23%), Positives = 100/246 (40%), Gaps = 20/246 (8%)
Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           +V+G G+FG  Y+A L D+  +V   +K+V   KR   ++++I+  + H N+V LR ++Y
Sbjct: 54  KVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 111
Query: 366 SKDEKL------MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTE 419
           S  EK       +V DY          H  R +    + +   V                
Sbjct: 112 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 168
Query: 420 NGGKLVHGGIKASNIFLNSQGHV---CVSDIXXXXXXXXXXXXXXXXXXXXXXE-VTDTR 475
            G  + H  IK  N+ L+    V   C                          E +    
Sbjct: 169 FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 226
Query: 476 KATQASDVFSFGVLLLELLTGKSPIHA--TGGDEVVHLVRWVNSVVREEWTAEVFDVELL 533
             T + DV+S G +L ELL G+ PI    +G D++V +++ + +  RE+      +    
Sbjct: 227 DYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 285
Query: 534 RYPNIE 539
           ++P I+
Sbjct: 286 KFPQIK 291

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 58/246 (23%), Positives = 100/246 (40%), Gaps = 20/246 (8%)
Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           +V+G G+FG  Y+A L D+  +V   +K+V   KR   ++++I+  + H N+V LR ++Y
Sbjct: 105 KVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 162
Query: 366 SKDEKL------MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTE 419
           S  EK       +V DY          H  R +    + +   V                
Sbjct: 163 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIY---VKLYMYQLFRSLAYIHS 219
Query: 420 NGGKLVHGGIKASNIFLNSQGHV---CVSDIXXXXXXXXXXXXXXXXXXXXXXE-VTDTR 475
            G  + H  IK  N+ L+    V   C                          E +    
Sbjct: 220 FG--ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 277
Query: 476 KATQASDVFSFGVLLLELLTGKSPIHA--TGGDEVVHLVRWVNSVVREEWTAEVFDVELL 533
             T + DV+S G +L ELL G+ PI    +G D++V +++ + +  RE+      +    
Sbjct: 278 DYTSSIDVWSAGCVLAELLLGQ-PIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF 336
Query: 534 RYPNIE 539
           ++P I+
Sbjct: 337 KFPQIK 342

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 80/210 (38%), Gaps = 12/210 (5%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG+G FG  +       + V +K LK   +    F Q+ +++  IRHE +V L A   S+
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHEKLVQLYA-VVSE 84
Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLVHG 427
           +   +V +Y   GS+   L G  G+    L     V                N    VH 
Sbjct: 85  EPIYIVTEYMSKGSLLDFLKGEMGK---YLRLPQLVDMAAQIASGMAYVERMN---YVHR 138
Query: 428 GIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQASDV 483
            ++A+NI +       V+D                           E     + T  SDV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 484 FSFGVLLLELLT-GKSPIHATGGDEVVHLV 512
           +SFG+LL EL T G+ P       EV+  V
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREVLDQV 228

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 96/270 (35%), Gaps = 29/270 (10%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG+G FG  +       + V +K LK   +    F Q+ +++  +RHE +V L A   S+
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 250
Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLVHG 427
           +   +V +Y   GS+   L G  G+    L     V                N    VH 
Sbjct: 251 EPIYIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIASGMAYVERMN---YVHR 304
Query: 428 GIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQASDV 483
            ++A+NI +       V+D                           E     + T  SDV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 484 FSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEM 542
           +SFG+LL EL T G+ P       EV+  V                     R P   E  
Sbjct: 365 WSFGILLTELTTKGRVPYPGMVNREVLDQVE-----------------RGYRMPCPPECP 407
Query: 543 VEMLQVGMACVVRMPEERPKMADVLKMVED 572
             +  +   C  + PEERP    +   +ED
Sbjct: 408 ESLHDLMCQCWRKEPEERPTFEYLQAFLED 437

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 64/300 (21%), Positives = 114/300 (38%), Gaps = 41/300 (13%)
Query: 306 EVLGKGTFGTAYKAALEDAS----TVVVKRLKE--VNVGKREFEQQMEIVGGIRHENVVA 359
           +V+G G FG      L+        V +K LK    +  +R+F  +  I+G   H N++ 
Sbjct: 20  KVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIH 79
Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTE 419
           L          +++ +Y E GS+ A L  R+ +G+ ++     +                
Sbjct: 80  LEGVVTKCKPVMIITEYMENGSLDAFL--RKNDGRFTV-----IQLVGMLRGIGSGMKYL 132
Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX------XXXEVTD 473
           +    VH  + A NI +NS     VSD                             E   
Sbjct: 133 SDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIA 192
Query: 474 TRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
            RK T ASDV+S+G+++ E+++ G+ P       +V+  +                  E 
Sbjct: 193 YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-----------------EG 235
Query: 533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTENRSEISS 592
            R P   +  + + Q+ + C  +   +RPK   ++ M++ + R    NP S +     SS
Sbjct: 236 YRLPPPMDCPIALHQLMLDCWQKERSDRPKFGQIVNMLDKLIR----NPNSLKRTGSESS 291

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 96/270 (35%), Gaps = 29/270 (10%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG+G FG  +       + V +K LK   +    F Q+ +++  +RHE +V L A   S+
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 250
Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLVHG 427
           +   +V +Y   GS+   L G  G+    L     V                N    VH 
Sbjct: 251 EPIYIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIASGMAYVERMN---YVHR 304
Query: 428 GIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQASDV 483
            ++A+NI +       V+D                           E     + T  SDV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 484 FSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEM 542
           +SFG+LL EL T G+ P       EV+  V                     R P   E  
Sbjct: 365 WSFGILLTELTTKGRVPYPGMVNREVLDQVE-----------------RGYRMPCPPECP 407
Query: 543 VEMLQVGMACVVRMPEERPKMADVLKMVED 572
             +  +   C  + PEERP    +   +ED
Sbjct: 408 ESLHDLMCQCWRKEPEERPTFEYLQAFLED 437

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 96/270 (35%), Gaps = 29/270 (10%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG+G FG  +       + V +K LK   +    F Q+ +++  +RHE +V L A   S+
Sbjct: 19  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 77
Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLVHG 427
           +   +V +Y   GS+   L G  G+    L     V                N    VH 
Sbjct: 78  EPIYIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIASGMAYVERMN---YVHR 131
Query: 428 GIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQASDV 483
            ++A+NI +       V+D                           E     + T  SDV
Sbjct: 132 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 191
Query: 484 FSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEM 542
           +SFG+LL EL T G+ P       EV+  V                     R P   E  
Sbjct: 192 WSFGILLTELTTKGRVPYPGMVNREVLDQVE-----------------RGYRMPCPPECP 234
Query: 543 VEMLQVGMACVVRMPEERPKMADVLKMVED 572
             +  +   C  + PEERP    +   +ED
Sbjct: 235 ESLHDLMCQCWRKEPEERPTFEYLQAFLED 264

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 62/278 (22%), Positives = 111/278 (39%), Gaps = 26/278 (9%)
Query: 306 EVLGKGTFGT---AYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRA 362
           EV+G G       AY A  ++   +    L++      E  ++++ +    H N+V+   
Sbjct: 16  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 75
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHG--RRGEGQSSLDWDTRVXXXXXXXXXXXXXXTEN 420
            +  KDE  +V      GSV  ++     +GE +S +  ++ +               +N
Sbjct: 76  SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 135
Query: 421 GGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXXX--------XXEVT 472
           G   +H  +KA NI L   G V ++D                               EV 
Sbjct: 136 GQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 193
Query: 473 D-TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE 531
           +  R     +D++SFG+  +EL TG +P H     +V+ L    +    E     V D E
Sbjct: 194 EQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE---TGVQDKE 250
Query: 532 LL-RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
           +L +Y     +M+ +      C+ + PE+RP  A++L+
Sbjct: 251 MLKKYGKSFRKMISL------CLQKDPEKRPTAAELLR 282

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 65/270 (24%), Positives = 97/270 (35%), Gaps = 29/270 (10%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG+G FG  +       + V +K LK   +    F Q+ +++  +RHE +V L A   S+
Sbjct: 16  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 74
Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLVHG 427
           +   +V +Y   GS+   L G  G+    L     V                N    VH 
Sbjct: 75  EPIXIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIASGMAYVERMN---YVHR 128
Query: 428 GIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQASDV 483
            ++A+NI +       V+D                           E     + T  SDV
Sbjct: 129 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 188
Query: 484 FSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEM 542
           +SFG+LL EL T G+ P       EV+  V                     R P   E  
Sbjct: 189 WSFGILLTELTTKGRVPYPGMVNREVLDQVE-----------------RGYRMPCPPECP 231
Query: 543 VEMLQVGMACVVRMPEERPKMADVLKMVED 572
             +  +   C  + PEERP    +   +ED
Sbjct: 232 ESLHDLMCQCWRKEPEERPTFEYLQAFLED 261

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 96/270 (35%), Gaps = 29/270 (10%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG+G FG  +       + V +K LK   +    F Q+ +++  +RHE +V L A   S+
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 81
Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLVHG 427
           +   +V +Y   GS+   L G  G+    L     V                N    VH 
Sbjct: 82  EPIYIVTEYMNKGSLLDFLKGETGK---YLRLPQLVDMSAQIASGMAYVERMN---YVHR 135
Query: 428 GIKASNIFLNSQGHVCVSDIXXXXXXX----XXXXXXXXXXXXXXXEVTDTRKATQASDV 483
            ++A+NI +       V+D                           E     + T  SDV
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDV 195
Query: 484 FSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEM 542
           +SFG+LL EL T G+ P       EV+  V                     R P   E  
Sbjct: 196 WSFGILLTELTTKGRVPYPGMVNREVLDQVE-----------------RGYRMPCPPECP 238
Query: 543 VEMLQVGMACVVRMPEERPKMADVLKMVED 572
             +  +   C  + PEERP    +   +ED
Sbjct: 239 ESLHDLMCQCWRKEPEERPTFEYLQAFLED 268

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/274 (20%), Positives = 102/274 (37%), Gaps = 35/274 (12%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG G FG  + A     + V VK +K  ++    F  +  ++  ++H+ +V L A   +K
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVV-TK 254
Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQ---SSLDWDTRVXXXXXXXXXXXXXXTENGGKL 424
           +   ++ ++   GS+   L    G  Q     +D+  ++                     
Sbjct: 255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---------NY 305
Query: 425 VHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQA 480
           +H  ++A+NI +++     ++D                           E  +    T  
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIK 365
Query: 481 SDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE 539
           SDV+SFG+LL+E++T G+ P       EV+  +                     R P  E
Sbjct: 366 SDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE-----------------RGYRMPRPE 408
Query: 540 EEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
               E+  + M C    PEERP    +  +++D 
Sbjct: 409 NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 442

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 96/270 (35%), Gaps = 29/270 (10%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG+G FG  +       + V +K LK   +    F Q+ +++  +RHE +V L A   S+
Sbjct: 23  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 81
Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLVHG 427
           +   +V +Y   GS+   L G  G+    L     V                N    VH 
Sbjct: 82  EPIYIVTEYMNKGSLLDFLKGETGK---YLRLPQLVDMSAQIASGMAYVERMN---YVHR 135
Query: 428 GIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQASDV 483
            ++A+NI +       V+D                           E     + T  SDV
Sbjct: 136 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 195
Query: 484 FSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEM 542
           +SFG+LL EL T G+ P       EV+  V                     R P   E  
Sbjct: 196 WSFGILLTELTTKGRVPYPGMVNREVLDQVE-----------------RGYRMPCPPECP 238
Query: 543 VEMLQVGMACVVRMPEERPKMADVLKMVED 572
             +  +   C  + PEERP    +   +ED
Sbjct: 239 ESLHDLMCQCWRKEPEERPTFEYLQAFLED 268

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 54/245 (22%), Positives = 102/245 (41%), Gaps = 17/245 (6%)
Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFE-----QQMEIVGGIRHENVVAL 360
           E LG GT+ T YK    + +T V   LKEV +   E       +++ ++  ++HEN+V L
Sbjct: 11  EKLGNGTYATVYKGL--NKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRL 68
Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTEN 420
               +++++  +V+++ +      M     G     L+ +  V               EN
Sbjct: 69  YDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNL-VKYFQWQLLQGLAFCHEN 127
Query: 421 GGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXXXXXEVTD----TRK 476
             K++H  +K  N+ +N +G + + D                          D    +R 
Sbjct: 128 --KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRT 185
Query: 477 ATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY- 535
            + + D++S G +L E++TGK     T  +E + L+  +     E     V   +L +Y 
Sbjct: 186 YSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSV--TKLPKYN 243
Query: 536 PNIEE 540
           PNI++
Sbjct: 244 PNIQQ 248

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 62/278 (22%), Positives = 111/278 (39%), Gaps = 26/278 (9%)
Query: 306 EVLGKGTFGT---AYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRA 362
           EV+G G       AY A  ++   +    L++      E  ++++ +    H N+V+   
Sbjct: 21  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHG--RRGEGQSSLDWDTRVXXXXXXXXXXXXXXTEN 420
            +  KDE  +V      GSV  ++     +GE +S +  ++ +               +N
Sbjct: 81  SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 140
Query: 421 GGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXXX--------XXEVT 472
           G   +H  +KA NI L   G V ++D                               EV 
Sbjct: 141 GQ--IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 198
Query: 473 D-TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE 531
           +  R     +D++SFG+  +EL TG +P H     +V+ L    +    E     V D E
Sbjct: 199 EQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLE---TGVQDKE 255
Query: 532 LL-RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
           +L +Y     +M+ +      C+ + PE+RP  A++L+
Sbjct: 256 MLKKYGKSFRKMISL------CLQKDPEKRPTAAELLR 287

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 69/305 (22%), Positives = 120/305 (39%), Gaps = 44/305 (14%)
Query: 306 EVLGKGTFGTAYKAALEDAS----TVVVKRLK--EVNVGKREFEQQMEIVGGIRHENVVA 359
           +V+G G FG      L+  S    +V +K LK       +R+F  +  I+G   H N++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTE 419
           L          ++V +  E GS+ + L  R+ + Q ++    ++              ++
Sbjct: 111 LEGVVTKSKPVMIVTEXMENGSLDSFL--RKHDAQFTV---IQLVGMLRGIASGMKYLSD 165
Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSD------IXXXXXXXXXXXXXXXXXXXXXXEVTD 473
            G   VH  + A NI +NS     VSD      +                      E   
Sbjct: 166 MGA--VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 474 TRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
            RK T ASDV+S+G++L E+++ G+ P       +V+  V                  E 
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-----------------EG 266
Query: 533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTENRSEISS 592
            R P   +    + Q+ + C  +    RPK   ++ +++ + R    NP S +    I+S
Sbjct: 267 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR----NPGSLKI---ITS 319
Query: 593 SAATP 597
           +AA P
Sbjct: 320 AAARP 324

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 80/210 (38%), Gaps = 12/210 (5%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG+G FG  +       + V +K LK   +    F Q+ +++  +RHE +V L A   S+
Sbjct: 15  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 73
Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLVHG 427
           +   +V +Y   GS+   L G  G+    L     V                N    VH 
Sbjct: 74  EPIYIVTEYMSKGSLLDFLKGEMGK---YLRLPQLVDMAAQIASGMAYVERMN---YVHR 127
Query: 428 GIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQASDV 483
            ++A+NI +       V+D                           E     + T  SDV
Sbjct: 128 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 187
Query: 484 FSFGVLLLELLT-GKSPIHATGGDEVVHLV 512
           +SFG+LL EL T G+ P       EV+  V
Sbjct: 188 WSFGILLTELTTKGRVPYPGMVNREVLDQV 217

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 80/210 (38%), Gaps = 12/210 (5%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG+G FG  +       + V +K LK   +    F Q+ +++  +RHE +V L A   S+
Sbjct: 17  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 75
Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLVHG 427
           +   +V +Y   GS+   L G  G+    L     V                N    VH 
Sbjct: 76  EPIYIVTEYMSKGSLLDFLKGEMGK---YLRLPQLVDMAAQIASGMAYVERMN---YVHR 129
Query: 428 GIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQASDV 483
            ++A+NI +       V+D                           E     + T  SDV
Sbjct: 130 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 189
Query: 484 FSFGVLLLELLT-GKSPIHATGGDEVVHLV 512
           +SFG+LL EL T G+ P       EV+  V
Sbjct: 190 WSFGILLTELTTKGRVPYPGMVNREVLDQV 219

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 96/270 (35%), Gaps = 29/270 (10%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG+G FG  +       + V +K LK   +    F Q+ +++  +RHE +V L A   S+
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 250
Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLVHG 427
           +   +V +Y   GS+   L G  G+    L     V                N    VH 
Sbjct: 251 EPIYIVGEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIASGMAYVERMN---YVHR 304
Query: 428 GIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQASDV 483
            ++A+NI +       V+D                           E     + T  SDV
Sbjct: 305 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 364
Query: 484 FSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEM 542
           +SFG+LL EL T G+ P       EV+  V                     R P   E  
Sbjct: 365 WSFGILLTELTTKGRVPYPGMVNREVLDQVE-----------------RGYRMPCPPECP 407
Query: 543 VEMLQVGMACVVRMPEERPKMADVLKMVED 572
             +  +   C  + PEERP    +   +ED
Sbjct: 408 ESLHDLMCQCWRKEPEERPTFEYLQAFLED 437

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 81/210 (38%), Gaps = 12/210 (5%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG+G FG  +       + V +K LK   +    F Q+ +++  +RHE +V L A   S+
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 84
Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLVHG 427
           +   +V +Y   GS+   L G  G+    L     V                N    VH 
Sbjct: 85  EPIYIVIEYMSKGSLLDFLKGEMGK---YLRLPQLVDMAAQIASGMAYVERMN---YVHR 138
Query: 428 GIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQASDV 483
            ++A+NI +       V+D                           E     + T  SDV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 484 FSFGVLLLELLT-GKSPIHATGGDEVVHLV 512
           +SFG+LL EL T G+ P       EV+  V
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREVLDQV 228

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 61/282 (21%), Positives = 109/282 (38%), Gaps = 37/282 (13%)
Query: 307 VLGKGTFGTAYKAALEDAST----VVVKRLK--EVNVGKREFEQQMEIVGGIRHENVVAL 360
           V+G G FG      L+        V +K LK       +R+F  +  I+G   H N++ L
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIHL 88
Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTEN 420
                     ++V +Y E GS+   L  ++ +GQ ++    ++              ++ 
Sbjct: 89  EGVVTKSKPVMIVTEYMENGSLDTFL--KKNDGQFTV---IQLVGMLRGISAGMKYLSDM 143
Query: 421 GGKLVHGGIKASNIFLNSQGHVCVSD------IXXXXXXXXXXXXXXXXXXXXXXEVTDT 474
           G   VH  + A NI +NS     VSD      +                      E    
Sbjct: 144 G--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAF 201
Query: 475 RKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELL 533
           RK T ASDV+S+G+++ E+++ G+ P       +V+  V                  E  
Sbjct: 202 RKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVE-----------------EGY 244
Query: 534 RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
           R P+  +    + Q+ + C  +    RPK  +++ M++ + R
Sbjct: 245 RLPSPMDCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKLIR 286

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 46/197 (23%), Positives = 80/197 (40%), Gaps = 10/197 (5%)
Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           E LG+G++G+ YKA  ++   +V  +   V    +E  +++ I+      +VV     Y+
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 366 SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLV 425
              +  +V +Y   GSVS ++  R      +L  D                   +  + +
Sbjct: 95  KNTDLWIVMEYCGAGSVSDIIRLR----NKTLTEDEIATILQSTLKGLEYL---HFMRKI 147
Query: 426 HGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX---XXXEVTDTRKATQASD 482
           H  IKA NI LN++GH  ++D                          EV         +D
Sbjct: 148 HRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVAD 207
Query: 483 VFSFGVLLLELLTGKSP 499
           ++S G+  +E+  GK P
Sbjct: 208 IWSLGITAIEMAEGKPP 224

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 80/210 (38%), Gaps = 12/210 (5%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG+G FG  +       + V +K LK   +    F Q+ +++  +RHE +V L A   S+
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 84
Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLVHG 427
           +   +V +Y   GS+   L G  G+    L     V                N    VH 
Sbjct: 85  EPIYIVIEYMSKGSLLDFLKGEMGK---YLRLPQLVDMAAQIASGMAYVERMN---YVHR 138
Query: 428 GIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQASDV 483
            ++A+NI +       V+D                           E     + T  SDV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 484 FSFGVLLLELLT-GKSPIHATGGDEVVHLV 512
           +SFG+LL EL T G+ P       EV+  V
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREVLDQV 228

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 80/210 (38%), Gaps = 12/210 (5%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG+G FG  +       + V +K LK   +    F Q+ +++  +RHE +V L A   S+
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 84
Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLVHG 427
           +   +V +Y   GS+   L G  G+    L     V                N    VH 
Sbjct: 85  EPIYIVTEYMSKGSLLDFLKGEMGK---YLRLPQLVDMAAQIASGMAYVERMN---YVHR 138
Query: 428 GIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQASDV 483
            ++A+NI +       V+D                           E     + T  SDV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 484 FSFGVLLLELLT-GKSPIHATGGDEVVHLV 512
           +SFG+LL EL T G+ P       EV+  V
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREVLDQV 228

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 80/210 (38%), Gaps = 12/210 (5%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG+G FG  +       + V +K LK   +    F Q+ +++  +RHE +V L A   S+
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 84
Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLVHG 427
           +   +V +Y   GS+   L G  G+    L     V                N    VH 
Sbjct: 85  EPIYIVCEYMSKGSLLDFLKGEMGK---YLRLPQLVDMAAQIASGMAYVERMN---YVHR 138
Query: 428 GIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQASDV 483
            ++A+NI +       V+D                           E     + T  SDV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 484 FSFGVLLLELLT-GKSPIHATGGDEVVHLV 512
           +SFG+LL EL T G+ P       EV+  V
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREVLDQV 228

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 119/284 (41%), Gaps = 41/284 (14%)
Query: 308 LGKGTFGTAYKAAL-EDASTVVVKRL--------KEVNVGKREFEQQMEIVGGIRHENVV 358
           +GKG FG  +K  L +D S V +K L         E+    +EF++++ I+  + H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXT 418
            L  Y    +   MV ++   G     L+ R  +    + W  ++               
Sbjct: 87  KL--YGLMHNPPRMVMEFVPCGD----LYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 419 ENGGKLVHGGIKASNIFLNS---QGHVC--VSDIXXXXXXXXXXXXXXXXXXXXXXEV-- 471
           +N   +VH  +++ NIFL S      VC  V+D                       E   
Sbjct: 141 QNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSGLLGNFQWMAPETIG 199
Query: 472 TDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVH-LVRWVNSVVREEWTAEVFDV 530
            +    T+ +D +SF ++L  +LTG+ P      DE  +  ++++N ++REE        
Sbjct: 200 AEEESYTEKADTYSFAMILYTILTGEGPF-----DEYSYGKIKFIN-MIREEG------- 246
Query: 531 ELLRYPNIEEEMVEMLQ-VGMACVVRMPEERPKMADVLKMVEDI 573
             LR P I E+    L+ V   C    P++RP  + ++K + ++
Sbjct: 247 --LR-PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 69/305 (22%), Positives = 120/305 (39%), Gaps = 44/305 (14%)
Query: 306 EVLGKGTFGTAYKAALEDAS----TVVVKRLK--EVNVGKREFEQQMEIVGGIRHENVVA 359
           +V+G G FG      L+  S    +V +K LK       +R+F  +  I+G   H N++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTE 419
           L          ++V +  E GS+ + L  R+ + Q ++    ++              ++
Sbjct: 111 LEGVVTKSKPVMIVTEXMENGSLDSFL--RKHDAQFTV---IQLVGMLRGIASGMKYLSD 165
Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSD------IXXXXXXXXXXXXXXXXXXXXXXEVTD 473
            G   VH  + A NI +NS     VSD      +                      E   
Sbjct: 166 MG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223
Query: 474 TRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
            RK T ASDV+S+G++L E+++ G+ P       +V+  V                  E 
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-----------------EG 266
Query: 533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTENRSEISS 592
            R P   +    + Q+ + C  +    RPK   ++ +++ + R    NP S +    I+S
Sbjct: 267 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR----NPGSLKI---ITS 319
Query: 593 SAATP 597
           +AA P
Sbjct: 320 AAARP 324

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/206 (23%), Positives = 81/206 (39%), Gaps = 14/206 (6%)
Query: 308 LGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQM----EIVGGIRHENVVALRA 362
           LGKG FG  Y A  + +  +V +K L +  + K   E Q+    EI   + H N++ L  
Sbjct: 31  LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGG 422
           Y+Y +    ++ +Y   G +   L       Q S  +D +                 +G 
Sbjct: 91  YFYDRRRIYLILEYAPRGELYKEL-------QKSCTFDEQRTATIMEELADALMYC-HGK 142
Query: 423 KLVHGGIKASNIFLNSQGHVCVSDIX-XXXXXXXXXXXXXXXXXXXXXEVTDTRKATQAS 481
           K++H  IK  N+ L  +G + ++D                        E+ + R   +  
Sbjct: 143 KVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMCGTLDYLPPEMIEGRMHNEKV 202
Query: 482 DVFSFGVLLLELLTGKSPIHATGGDE 507
           D++  GVL  ELL G  P  +   +E
Sbjct: 203 DLWCIGVLCYELLVGNPPFESASHNE 228

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 119/284 (41%), Gaps = 41/284 (14%)
Query: 308 LGKGTFGTAYKAAL-EDASTVVVKRL--------KEVNVGKREFEQQMEIVGGIRHENVV 358
           +GKG FG  +K  L +D S V +K L         E+    +EF++++ I+  + H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXT 418
            L  Y    +   MV ++   G     L+ R  +    + W  ++               
Sbjct: 87  KL--YGLMHNPPRMVMEFVPCGD----LYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 419 ENGGKLVHGGIKASNIFLNS---QGHVC--VSDIXXXXXXXXXXXXXXXXXXXXXXEV-- 471
           +N   +VH  +++ NIFL S      VC  V+D                       E   
Sbjct: 141 QNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSGLLGNFQWMAPETIG 199
Query: 472 TDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVH-LVRWVNSVVREEWTAEVFDV 530
            +    T+ +D +SF ++L  +LTG+ P      DE  +  ++++N ++REE        
Sbjct: 200 AEEESYTEKADTYSFAMILYTILTGEGPF-----DEYSYGKIKFIN-MIREEG------- 246
Query: 531 ELLRYPNIEEEMVEMLQ-VGMACVVRMPEERPKMADVLKMVEDI 573
             LR P I E+    L+ V   C    P++RP  + ++K + ++
Sbjct: 247 --LR-PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 69/305 (22%), Positives = 120/305 (39%), Gaps = 44/305 (14%)
Query: 306 EVLGKGTFGTAYKAALEDAS----TVVVKRLK--EVNVGKREFEQQMEIVGGIRHENVVA 359
           +V+G G FG      L+  S    +V +K LK       +R+F  +  I+G   H N++ 
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 81
Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTE 419
           L          ++V +  E GS+ + L  R+ + Q ++    ++              ++
Sbjct: 82  LEGVVTKSKPVMIVTEXMENGSLDSFL--RKHDAQFTV---IQLVGMLRGIASGMKYLSD 136
Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSD------IXXXXXXXXXXXXXXXXXXXXXXEVTD 473
            G   VH  + A NI +NS     VSD      +                      E   
Sbjct: 137 MG--YVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 194
Query: 474 TRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
            RK T ASDV+S+G++L E+++ G+ P       +V+  V                  E 
Sbjct: 195 YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-----------------EG 237
Query: 533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTENRSEISS 592
            R P   +    + Q+ + C  +    RPK   ++ +++ + R    NP S +    I+S
Sbjct: 238 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR----NPGSLKI---ITS 290
Query: 593 SAATP 597
           +AA P
Sbjct: 291 AAARP 295

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 67/284 (23%), Positives = 119/284 (41%), Gaps = 41/284 (14%)
Query: 308 LGKGTFGTAYKAAL-EDASTVVVKRL--------KEVNVGKREFEQQMEIVGGIRHENVV 358
           +GKG FG  +K  L +D S V +K L         E+    +EF++++ I+  + H N+V
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV 86
Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXT 418
            L  Y    +   MV ++   G     L+ R  +    + W  ++               
Sbjct: 87  KL--YGLMHNPPRMVMEFVPCGD----LYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN 140
Query: 419 ENGGKLVHGGIKASNIFLNS---QGHVC--VSDIXXXXXXXXXXXXXXXXXXXXXXEV-- 471
           +N   +VH  +++ NIFL S      VC  V+D                       E   
Sbjct: 141 QNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPETIG 199
Query: 472 TDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVH-LVRWVNSVVREEWTAEVFDV 530
            +    T+ +D +SF ++L  +LTG+ P      DE  +  ++++N ++REE        
Sbjct: 200 AEEESYTEKADTYSFAMILYTILTGEGPF-----DEYSYGKIKFIN-MIREEG------- 246
Query: 531 ELLRYPNIEEEMVEMLQ-VGMACVVRMPEERPKMADVLKMVEDI 573
             LR P I E+    L+ V   C    P++RP  + ++K + ++
Sbjct: 247 --LR-PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/217 (21%), Positives = 91/217 (41%), Gaps = 18/217 (8%)
Query: 306 EVLGKGTFGTAY---KAALEDASTV-VVKRLKEVNVGKRE---FEQQMEIVGGIRHENVV 358
           +VLG+G+FG  +   K +  DA  +  +K LK+  +  R+    + + +I+  + H  +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXT 418
            L   + ++ +  ++ D+   G +   L       +  +  +  V               
Sbjct: 90  KLHYAFQTEGKLYLILDFLRGGDLFTRL------SKEVMFTEEDVKFYLAELALALDHLH 143
Query: 419 ENGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXX---XXXXXXXEVTDTR 475
             G  +++  +K  NI L+ +GH+ ++D                          EV + R
Sbjct: 144 SLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR 201
Query: 476 KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLV 512
             TQ++D +SFGVL+ E+LTG  P       E + ++
Sbjct: 202 GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 238

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 63/282 (22%), Positives = 109/282 (38%), Gaps = 37/282 (13%)
Query: 307 VLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG-----KREFEQQMEIVGGIRHENVVAL 360
           V+G G FG      L+      V   +K + VG     +R+F  +  I+G   H NVV L
Sbjct: 50  VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHL 109
Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTEN 420
                     ++V ++ E G++ A L  R+ +GQ ++    ++               + 
Sbjct: 110 EGVVTRGKPVMIVIEFMENGALDAFL--RKHDGQFTV---IQLVGMLRGIAAGMRYLADM 164
Query: 421 GGKLVHGGIKASNIFLNSQGHVCVSD------IXXXXXXXXXXXXXXXXXXXXXXEVTDT 474
           G   VH  + A NI +NS     VSD      I                      E    
Sbjct: 165 G--YVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQY 222
Query: 475 RKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELL 533
           RK T ASDV+S+G+++ E+++ G+ P       +V+  +                  E  
Sbjct: 223 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIE-----------------EGY 265
Query: 534 RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
           R P   +    + Q+ + C  +   ERPK   ++ +++ + R
Sbjct: 266 RLPAPMDCPAGLHQLMLDCWQKERAERPKFEQIVGILDKMIR 307

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 64/270 (23%), Positives = 95/270 (35%), Gaps = 29/270 (10%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG+G FG  +       + V +K LK   +    F Q+ +++  +RHE +V L A   S+
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 84
Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLVHG 427
           +   +V +Y   GS+   L G  G+    L     V                N    VH 
Sbjct: 85  EPIYIVTEYMSKGSLLDFLKGEMGK---YLRLPQLVDMAAQIASGMAYVERMN---YVHR 138
Query: 428 GIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQASDV 483
            + A+NI +       V+D                           E     + T  SDV
Sbjct: 139 DLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 484 FSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEM 542
           +SFG+LL EL T G+ P       EV+  V                     R P   E  
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREVLDQVE-----------------RGYRMPCPPECP 241
Query: 543 VEMLQVGMACVVRMPEERPKMADVLKMVED 572
             +  +   C  + PEERP    +   +ED
Sbjct: 242 ESLHDLMCQCWRKDPEERPTFEYLQAFLED 271

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 79/210 (37%), Gaps = 12/210 (5%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG+G FG  +       + V +K LK   +    F Q+ +++  +RHE +V L A   S+
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 84
Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLVHG 427
           +   +V +Y   G +   L G  G+    L     V                N    VH 
Sbjct: 85  EPIYIVMEYMSKGCLLDFLKGEMGK---YLRLPQLVDMAAQIASGMAYVERMN---YVHR 138
Query: 428 GIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQASDV 483
            ++A+NI +       V+D                           E     + T  SDV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 484 FSFGVLLLELLT-GKSPIHATGGDEVVHLV 512
           +SFG+LL EL T G+ P       EV+  V
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREVLDQV 228

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 79/210 (37%), Gaps = 12/210 (5%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG+G FG  +       + V +K LK   +    F Q+ +++  +RHE +V L A   S+
Sbjct: 26  LGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VVSE 84
Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLVHG 427
           +   +V +Y   G +   L G  G+    L     V                N    VH 
Sbjct: 85  EPIYIVTEYMSKGCLLDFLKGEMGK---YLRLPQLVDMAAQIASGMAYVERMN---YVHR 138
Query: 428 GIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQASDV 483
            ++A+NI +       V+D                           E     + T  SDV
Sbjct: 139 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 198
Query: 484 FSFGVLLLELLT-GKSPIHATGGDEVVHLV 512
           +SFG+LL EL T G+ P       EV+  V
Sbjct: 199 WSFGILLTELTTKGRVPYPGMVNREVLDQV 228

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/217 (21%), Positives = 91/217 (41%), Gaps = 18/217 (8%)
Query: 306 EVLGKGTFGTAY---KAALEDASTV-VVKRLKEVNVGKRE---FEQQMEIVGGIRHENVV 358
           +VLG+G+FG  +   K +  DA  +  +K LK+  +  R+    + + +I+  + H  +V
Sbjct: 31  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 90
Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXT 418
            L   + ++ +  ++ D+   G +   L       +  +  +  V               
Sbjct: 91  KLHYAFQTEGKLYLILDFLRGGDLFTRL------SKEVMFTEEDVKFYLAELALALDHLH 144
Query: 419 ENGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXX---XXXXXXXEVTDTR 475
             G  +++  +K  NI L+ +GH+ ++D                          EV + R
Sbjct: 145 SLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR 202
Query: 476 KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLV 512
             TQ++D +SFGVL+ E+LTG  P       E + ++
Sbjct: 203 GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 239

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/217 (21%), Positives = 91/217 (41%), Gaps = 18/217 (8%)
Query: 306 EVLGKGTFGTAY---KAALEDASTV-VVKRLKEVNVGKRE---FEQQMEIVGGIRHENVV 358
           +VLG+G+FG  +   K +  DA  +  +K LK+  +  R+    + + +I+  + H  +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXT 418
            L   + ++ +  ++ D+   G +   L       +  +  +  V               
Sbjct: 90  KLHYAFQTEGKLYLILDFLRGGDLFTRL------SKEVMFTEEDVKFYLAELALALDHLH 143
Query: 419 ENGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXX---XXXXXXXEVTDTR 475
             G  +++  +K  NI L+ +GH+ ++D                          EV + R
Sbjct: 144 SLG--IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR 201
Query: 476 KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLV 512
             TQ++D +SFGVL+ E+LTG  P       E + ++
Sbjct: 202 GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI 238

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 21/68 (30%), Positives = 44/68 (64%), Gaps = 3/68 (4%)
Query: 303 ASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRA 362
            + +V+G G+FG  ++A L ++  V +K++ +    KR   ++++I+  ++H NVV L+A
Sbjct: 43  TNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQ---DKRFKNRELQIMRIVKHPNVVDLKA 99
Query: 363 YYYSKDEK 370
           ++YS  +K
Sbjct: 100 FFYSNGDK 107

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/226 (22%), Positives = 87/226 (38%), Gaps = 24/226 (10%)
Query: 308 LGKGTFGTAYKAAL------EDASTVVVKRLKEV-NVGKREFEQQMEIVGGIRHENVVAL 360
           LG+G FG  + A        +D   V VK LK+  +  +++F ++ E++  ++HE++V  
Sbjct: 21  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAML--HG------RRGEGQSSLDWDTRVXXXXXXXXX 412
                  D  +MV++Y + G ++  L  HG        G   + L     +         
Sbjct: 81  YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 413 XXXXXTENGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXXXXX--- 469
                +++    VH  +   N  +     V + D                          
Sbjct: 141 MVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 470 --EVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLV 512
             E    RK T  SDV+S GV+L E+ T GK P +    +EV+  +
Sbjct: 198 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI 243

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/273 (21%), Positives = 107/273 (39%), Gaps = 29/273 (10%)
Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           E LG G FG  +       + V VK LK+ ++    F  +  ++  ++H+ +V L A   
Sbjct: 28  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV- 86
Query: 366 SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLV 425
           +++   ++ +Y E GS+   L    G     L  +  +                N    +
Sbjct: 87  TQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERN---YI 140
Query: 426 HGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQAS 481
           H  ++A+NI ++      ++D                           E  +    T  S
Sbjct: 141 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 200
Query: 482 DVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
           DV+SFG+LL E++T G+ P       EV+  +     +VR +              N  E
Sbjct: 201 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD--------------NCPE 246
Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
           E+ +++++   C    PE+RP    +  ++ED 
Sbjct: 247 ELYQLMRL---CWKERPEDRPTFDYLRSVLEDF 276

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 96/234 (41%), Gaps = 38/234 (16%)
Query: 308 LGKGTFGTA----YKAALEDASTVV-VKRLKE-VNVGKREFEQQMEIVGGIRHENVVALR 361
           LGKG FG+     Y    ++   VV VK+L+       R+FE+++EI+  ++H+N+V  +
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 362 AYYYSKDEK--LMVYDYFEPGSVSAML--HGRRGEGQSSLDWDTRVXXXXXXXXXXXXXX 417
              YS   +   ++ +Y   GS+   L  H  R +    L + +++              
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTK---- 136
Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX------XXXEV 471
                + +H  +   NI + ++  V + D                             E 
Sbjct: 137 -----RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 472 TDTRKATQASDVFSFGVLLLELLT----GKSP----IHATGGDE-----VVHLV 512
               K + ASDV+SFGV+L EL T     KSP    +   G D+     V HL+
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 245

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/273 (21%), Positives = 107/273 (39%), Gaps = 29/273 (10%)
Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           E LG G FG  +       + V VK LK+ ++    F  +  ++  ++H+ +V L A   
Sbjct: 27  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV- 85
Query: 366 SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLV 425
           +++   ++ +Y E GS+   L    G     L  +  +                N    +
Sbjct: 86  TQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERN---YI 139
Query: 426 HGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQAS 481
           H  ++A+NI ++      ++D                           E  +    T  S
Sbjct: 140 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 199
Query: 482 DVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
           DV+SFG+LL E++T G+ P       EV+  +     +VR +              N  E
Sbjct: 200 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD--------------NCPE 245
Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
           E+ +++++   C    PE+RP    +  ++ED 
Sbjct: 246 ELYQLMRL---CWKERPEDRPTFDYLRSVLEDF 275

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/273 (21%), Positives = 107/273 (39%), Gaps = 29/273 (10%)
Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           E LG G FG  +       + V VK LK+ ++    F  +  ++  ++H+ +V L A   
Sbjct: 25  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV- 83
Query: 366 SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLV 425
           +++   ++ +Y E GS+   L    G     L  +  +                N    +
Sbjct: 84  TQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERN---YI 137
Query: 426 HGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQAS 481
           H  ++A+NI ++      ++D                           E  +    T  S
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 197
Query: 482 DVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
           DV+SFG+LL E++T G+ P       EV+  +     +VR +              N  E
Sbjct: 198 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD--------------NCPE 243
Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
           E+ +++++   C    PE+RP    +  ++ED 
Sbjct: 244 ELYQLMRL---CWKERPEDRPTFDYLRSVLEDF 273

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/272 (20%), Positives = 106/272 (38%), Gaps = 29/272 (10%)
Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           E LG G FG  +       + V VK LK+ ++    F  +  ++  ++H+ +V L A   
Sbjct: 15  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV- 73
Query: 366 SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLV 425
           +++   ++ +Y E GS+   L    G     L  +  +                N    +
Sbjct: 74  TQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERN---YI 127
Query: 426 HGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQAS 481
           H  ++A+NI ++      ++D                           E  +    T  S
Sbjct: 128 HRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 187
Query: 482 DVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
           DV+SFG+LL E++T G+ P       EV+  +     +VR +              N  E
Sbjct: 188 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD--------------NCPE 233
Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLKMVED 572
           E+ +++++   C    PE+RP    +  ++ED
Sbjct: 234 ELYQLMRL---CWKERPEDRPTFDYLRSVLED 262

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/273 (21%), Positives = 107/273 (39%), Gaps = 29/273 (10%)
Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           E LG G FG  +       + V VK LK+ ++    F  +  ++  ++H+ +V L A   
Sbjct: 21  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV- 79
Query: 366 SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLV 425
           +++   ++ +Y E GS+   L    G     L  +  +                N    +
Sbjct: 80  TQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERN---YI 133
Query: 426 HGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQAS 481
           H  ++A+NI ++      ++D                           E  +    T  S
Sbjct: 134 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 193
Query: 482 DVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
           DV+SFG+LL E++T G+ P       EV+  +     +VR +              N  E
Sbjct: 194 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD--------------NCPE 239
Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
           E+ +++++   C    PE+RP    +  ++ED 
Sbjct: 240 ELYQLMRL---CWKERPEDRPTFDYLRSVLEDF 269

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/273 (20%), Positives = 106/273 (38%), Gaps = 29/273 (10%)
Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           E LG G FG  +       + V VK LK+ ++    F  +  ++  ++H+ +V L A   
Sbjct: 29  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV- 87
Query: 366 SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLV 425
           +++   ++ +Y E GS+   L    G     L  +  +                N    +
Sbjct: 88  TQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERN---YI 141
Query: 426 HGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQAS 481
           H  ++A+NI ++      ++D                           E  +    T  S
Sbjct: 142 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 201
Query: 482 DVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
           DV+SFG+LL E++T G+ P       EV+  +     +VR +              N  E
Sbjct: 202 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD--------------NCPE 247
Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
           E+ +++++   C    PE+RP    +  ++ED 
Sbjct: 248 ELYQLMRL---CWKERPEDRPTFDYLRSVLEDF 277

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 63/298 (21%), Positives = 110/298 (36%), Gaps = 43/298 (14%)
Query: 306 EVLGKGTFGTAYKAALEDAST----VVVKRLKEVNVGK--REFEQQMEIVGGIRHENVVA 359
           +V+G G FG      L+        V +K LK     K  R+F  +  I+G   H NV+ 
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 72
Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTE 419
           L          +++ ++ E GS+ + L  R+ +GQ ++     +                
Sbjct: 73  LEGVVTKSTPVMIITEFMENGSLDSFL--RQNDGQFTV-----IQLVGMLRGIAAGMKYL 125
Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX--------XXXEV 471
                VH  + A NI +NS     VSD                               E 
Sbjct: 126 ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 185
Query: 472 TDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDV 530
              RK T ASDV+S+G+++ E+++ G+ P       +V++ +                  
Sbjct: 186 IQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE----------------- 228
Query: 531 ELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVL----KMVEDIRRVKAENPPST 584
           +  R P   +    + Q+ + C  +    RPK   ++    KM+ +   +KA  P S+
Sbjct: 229 QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLKAMAPLSS 286

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/273 (21%), Positives = 107/273 (39%), Gaps = 29/273 (10%)
Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           E LG G FG  +       + V VK LK+ ++    F  +  ++  ++H+ +V L A   
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV- 77
Query: 366 SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLV 425
           +++   ++ +Y E GS+   L    G     L  +  +                N    +
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERN---YI 131
Query: 426 HGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQAS 481
           H  ++A+NI ++      ++D                           E  +    T  S
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 482 DVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
           DV+SFG+LL E++T G+ P       EV+  +     +VR +              N  E
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD--------------NCPE 237
Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
           E+ +++++   C    PE+RP    +  ++ED 
Sbjct: 238 ELYQLMRL---CWKERPEDRPTFDYLRSVLEDF 267

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 69/290 (23%), Positives = 114/290 (39%), Gaps = 42/290 (14%)
Query: 293 LVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQ----QMEI 348
           L +D E        VLGKGT+G  Y  A  D S  V   +KE+      + Q    ++ +
Sbjct: 15  LEYDYEYDENGDRVVLGKGTYGIVY--AGRDLSNQVRIAIKEIPERDSRYSQPLHEEIAL 72
Query: 349 VGGIRHENVVALRAYYYSKDEKLMVYDYFEP---GSVSAMLHGRRGEGQSSLDWDTRVXX 405
              ++H+N+V    Y  S  E   +  + E    GS+SA+L  + G  +   D +  +  
Sbjct: 73  HKHLKHKNIVQ---YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLK---DNEQTIGF 126
Query: 406 XXXXXXXXXXXXTENGGKLVHGGIKASNIFLNS-QGHVCVSDIXXXXXXXXX---XXXXX 461
                        +N  ++VH  IK  N+ +N+  G + +SD                  
Sbjct: 127 YTKQILEGLKYLHDN--QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT 184
Query: 462 XXXXXXXXEVTDT--RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVV 519
                   E+ D   R   +A+D++S G  ++E+ TGK P +  G               
Sbjct: 185 GTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELG--------------- 229
Query: 520 REEWTAEVFDVELLR-YPNIEEEM-VEMLQVGMACVVRMPEERPKMADVL 567
             E  A +F V + + +P I E M  E     + C    P++R    D+L
Sbjct: 230 --EPQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLL 277

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/273 (20%), Positives = 106/273 (38%), Gaps = 29/273 (10%)
Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           E LG G FG  +       + V VK LK+ ++    F  +  ++  ++H+ +V L A   
Sbjct: 25  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV- 83
Query: 366 SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLV 425
           +++   ++ +Y E GS+   L    G     L  +  +                N    +
Sbjct: 84  TQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERN---YI 137
Query: 426 HGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQAS 481
           H  ++A+NI ++      ++D                           E  +    T  S
Sbjct: 138 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 197
Query: 482 DVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
           DV+SFG+LL E++T G+ P       EV+  +     +VR +              N  E
Sbjct: 198 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD--------------NCPE 243
Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
           E+ +++++   C    PE+RP    +  ++ED 
Sbjct: 244 ELYQLMRL---CWKERPEDRPTFDYLRSVLEDF 273

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 96/234 (41%), Gaps = 38/234 (16%)
Query: 308 LGKGTFGTA----YKAALEDASTVV-VKRLKE-VNVGKREFEQQMEIVGGIRHENVVALR 361
           LGKG FG+     Y    ++   VV VK+L+       R+FE+++EI+  ++H+N+V  +
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 362 AYYYSKDEK--LMVYDYFEPGSVSAML--HGRRGEGQSSLDWDTRVXXXXXXXXXXXXXX 417
              YS   +   ++ +Y   GS+   L  H  R +    L + +++              
Sbjct: 82  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---- 137
Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX------XXXEV 471
                + +H  +   NI + ++  V + D                             E 
Sbjct: 138 -----RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 192
Query: 472 TDTRKATQASDVFSFGVLLLELLT----GKSP----IHATGGDE-----VVHLV 512
               K + ASDV+SFGV+L EL T     KSP    +   G D+     V HL+
Sbjct: 193 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 246

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 96/234 (41%), Gaps = 38/234 (16%)
Query: 308 LGKGTFGTA----YKAALEDASTVV-VKRLKE-VNVGKREFEQQMEIVGGIRHENVVALR 361
           LGKG FG+     Y    ++   VV VK+L+       R+FE+++EI+  ++H+N+V  +
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 362 AYYYSKDEK--LMVYDYFEPGSVSAML--HGRRGEGQSSLDWDTRVXXXXXXXXXXXXXX 417
              YS   +   ++ +Y   GS+   L  H  R +    L + +++              
Sbjct: 77  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---- 132
Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX------XXXEV 471
                + +H  +   NI + ++  V + D                             E 
Sbjct: 133 -----RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 187
Query: 472 TDTRKATQASDVFSFGVLLLELLT----GKSP----IHATGGDE-----VVHLV 512
               K + ASDV+SFGV+L EL T     KSP    +   G D+     V HL+
Sbjct: 188 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 241

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 94/234 (40%), Gaps = 38/234 (16%)
Query: 308 LGKGTFGTA----YKAALEDASTVV-VKRLKE-VNVGKREFEQQMEIVGGIRHENVVALR 361
           LGKG FG+     Y    ++   VV VK+L+       R+FE+++EI+  ++H+N+V  +
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 362 AYYYSKDEK--LMVYDYFEPGSVSAML--HGRRGEGQSSLDWDTRVXXXXXXXXXXXXXX 417
              YS   +   ++ +Y   GS+   L  H  R +    L + +++              
Sbjct: 79  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---- 134
Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX------XXXEV 471
                + +H  +   NI + ++  V + D                             E 
Sbjct: 135 -----RYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 189
Query: 472 TDTRKATQASDVFSFGVLLLELLT----GKSP----IHATGGDE-----VVHLV 512
               K + ASDV+SFGV+L EL T     KSP    +   G D+     V HL+
Sbjct: 190 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 243

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 58/273 (21%), Positives = 107/273 (39%), Gaps = 29/273 (10%)
Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           E LG G FG  +       + V VK LK+ ++    F  +  ++  ++H+ +V L A   
Sbjct: 20  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV- 78
Query: 366 SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLV 425
           +++   ++ +Y E GS+   L    G     L  +  +                N    +
Sbjct: 79  TQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERN---YI 132
Query: 426 HGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQAS 481
           H  ++A+NI ++      ++D                           E  +    T  S
Sbjct: 133 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 192
Query: 482 DVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
           DV+SFG+LL E++T G+ P       EV+  +     +VR +              N  E
Sbjct: 193 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD--------------NCPE 238
Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
           E+ +++++   C    PE+RP    +  ++ED 
Sbjct: 239 ELYQLMRL---CWKERPEDRPTFDYLRSVLEDF 268

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/273 (20%), Positives = 106/273 (38%), Gaps = 29/273 (10%)
Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           E LG G FG  +       + V VK LK+ ++    F  +  ++  ++H+ +V L A   
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV- 77
Query: 366 SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLV 425
           +++   ++ +Y E GS+   L    G     L  +  +                N    +
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERN---YI 131
Query: 426 HGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQAS 481
           H  ++A+NI ++      ++D                           E  +    T  S
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 482 DVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
           DV+SFG+LL E++T G+ P       EV+  +     +VR +              N  E
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD--------------NCPE 237
Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
           E+ +++++   C    PE+RP    +  ++ED 
Sbjct: 238 ELYQLMRL---CWKERPEDRPTFDYLRSVLEDF 267

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 63/298 (21%), Positives = 110/298 (36%), Gaps = 43/298 (14%)
Query: 306 EVLGKGTFGTAYKAALEDAST----VVVKRLKEVNVGK--REFEQQMEIVGGIRHENVVA 359
           +V+G G FG      L+        V +K LK     K  R+F  +  I+G   H NV+ 
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 98
Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTE 419
           L          +++ ++ E GS+ + L  R+ +GQ ++     +                
Sbjct: 99  LEGVVTKSTPVMIITEFMENGSLDSFL--RQNDGQFTV-----IQLVGMLRGIAAGMKYL 151
Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX--------XXXEV 471
                VH  + A NI +NS     VSD                               E 
Sbjct: 152 ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 211
Query: 472 TDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDV 530
              RK T ASDV+S+G+++ E+++ G+ P       +V++ +                  
Sbjct: 212 IQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE----------------- 254
Query: 531 ELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVL----KMVEDIRRVKAENPPST 584
           +  R P   +    + Q+ + C  +    RPK   ++    KM+ +   +KA  P S+
Sbjct: 255 QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSLKAMAPLSS 312

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/273 (20%), Positives = 106/273 (38%), Gaps = 29/273 (10%)
Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           E LG G FG  +       + V VK LK+ ++    F  +  ++  ++H+ +V L A   
Sbjct: 24  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV- 82
Query: 366 SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLV 425
           +++   ++ +Y E GS+   L    G     L  +  +                N    +
Sbjct: 83  TQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERN---YI 136
Query: 426 HGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQAS 481
           H  ++A+NI ++      ++D                           E  +    T  S
Sbjct: 137 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 196
Query: 482 DVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
           DV+SFG+LL E++T G+ P       EV+  +     +VR +              N  E
Sbjct: 197 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD--------------NCPE 242
Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
           E+ +++++   C    PE+RP    +  ++ED 
Sbjct: 243 ELYQLMRL---CWKERPEDRPTFDYLRSVLEDF 272

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 96/234 (41%), Gaps = 38/234 (16%)
Query: 308 LGKGTFGTA----YKAALEDASTVV-VKRLKE-VNVGKREFEQQMEIVGGIRHENVVALR 361
           LGKG FG+     Y    ++   VV VK+L+       R+FE+++EI+  ++H+N+V  +
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 362 AYYYSKDEK--LMVYDYFEPGSVSAML--HGRRGEGQSSLDWDTRVXXXXXXXXXXXXXX 417
              YS   +   ++ +Y   GS+   L  H  R +    L + +++              
Sbjct: 76  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---- 131
Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX------XXXEV 471
                + +H  +   NI + ++  V + D                             E 
Sbjct: 132 -----RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 186
Query: 472 TDTRKATQASDVFSFGVLLLELLT----GKSP----IHATGGDE-----VVHLV 512
               K + ASDV+SFGV+L EL T     KSP    +   G D+     V HL+
Sbjct: 187 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 240

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 65/287 (22%), Positives = 111/287 (38%), Gaps = 36/287 (12%)
Query: 293 LVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQ----QMEI 348
           L +D E        VLGKGT+G  Y  A  D S  V   +KE+      + Q    ++ +
Sbjct: 1   LEYDYEYDENGDRVVLGKGTYGIVY--AGRDLSNQVRIAIKEIPERDSRYSQPLHEEIAL 58
Query: 349 VGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXX 408
              ++H+N+V     +       +  +    GS+SA+L  + G  +   D +  +     
Sbjct: 59  HKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLK---DNEQTIGFYTK 115
Query: 409 XXXXXXXXXTENGGKLVHGGIKASNIFLNS-QGHVCVSDIXXXXXXXXX---XXXXXXXX 464
                     +N  ++VH  IK  N+ +N+  G + +SD                     
Sbjct: 116 QILEGLKYLHDN--QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTL 173
Query: 465 XXXXXEVTDT--RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREE 522
                E+ D   R   +A+D++S G  ++E+ TGK P +  G                 E
Sbjct: 174 QYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELG-----------------E 216
Query: 523 WTAEVFDVELLR-YPNIEEEM-VEMLQVGMACVVRMPEERPKMADVL 567
             A +F V + + +P I E M  E     + C    P++R    D+L
Sbjct: 217 PQAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLL 263

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 96/234 (41%), Gaps = 38/234 (16%)
Query: 308 LGKGTFGTA----YKAALEDASTVV-VKRLKE-VNVGKREFEQQMEIVGGIRHENVVALR 361
           LGKG FG+     Y    ++   VV VK+L+       R+FE+++EI+  ++H+N+V  +
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 362 AYYYSKDEK--LMVYDYFEPGSVSAML--HGRRGEGQSSLDWDTRVXXXXXXXXXXXXXX 417
              YS   +   ++ +Y   GS+   L  H  R +    L + +++              
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---- 133
Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX------XXXEV 471
                + +H  +   NI + ++  V + D                             E 
Sbjct: 134 -----RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 188
Query: 472 TDTRKATQASDVFSFGVLLLELLT----GKSP----IHATGGDE-----VVHLV 512
               K + ASDV+SFGV+L EL T     KSP    +   G D+     V HL+
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 88/222 (39%), Gaps = 22/222 (9%)
Query: 306 EVLGKGTFGTAYKAALE----DASTVVVKRLK--EVNVGKREFEQQMEIVGGIRHENVVA 359
           EV+G G FG   +  L+      S V +K LK       +REF  +  I+G   H N++ 
Sbjct: 20  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIR 79
Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTE 419
           L     +    +++ ++ E G++ + L  R  +GQ ++    ++               E
Sbjct: 80  LEGVVTNSMPVMILTEFMENGALDSFL--RLNDGQFTV---IQLVGMLRGIASGMRYLAE 134
Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX--------XXXEV 471
                VH  + A NI +NS     VSD                               E 
Sbjct: 135 M--SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEA 192
Query: 472 TDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLV 512
              RK T ASD +S+G+++ E+++ G+ P       +V++ +
Sbjct: 193 IAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAI 234

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/273 (21%), Positives = 107/273 (39%), Gaps = 29/273 (10%)
Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           E LG G FG  +       + V VK LK+ ++    F  +  ++  ++H+ +V L A   
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV- 77
Query: 366 SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLV 425
           +++   ++ +Y E GS+   L    G     L  +  +                N    +
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERN---YI 131
Query: 426 HGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQAS 481
           H  ++A+NI ++      ++D                           E  +    T  S
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 482 DVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
           DV+SFG+LL E++T G+ P       EV+  +     +VR +              N  E
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD--------------NCPE 237
Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
           E+ +++++   C    PE+RP    +  ++ED 
Sbjct: 238 ELYQLMRL---CWKERPEDRPTFDYLRSVLEDF 267

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 96/234 (41%), Gaps = 38/234 (16%)
Query: 308 LGKGTFGTA----YKAALEDASTVV-VKRLKE-VNVGKREFEQQMEIVGGIRHENVVALR 361
           LGKG FG+     Y    ++   VV VK+L+       R+FE+++EI+  ++H+N+V  +
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 362 AYYYSKDEK--LMVYDYFEPGSVSAML--HGRRGEGQSSLDWDTRVXXXXXXXXXXXXXX 417
              YS   +   ++ +Y   GS+   L  H  R +    L + +++              
Sbjct: 83  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---- 138
Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX------XXXEV 471
                + +H  +   NI + ++  V + D                             E 
Sbjct: 139 -----RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 193
Query: 472 TDTRKATQASDVFSFGVLLLELLT----GKSP----IHATGGDE-----VVHLV 512
               K + ASDV+SFGV+L EL T     KSP    +   G D+     V HL+
Sbjct: 194 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 247

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 96/234 (41%), Gaps = 38/234 (16%)
Query: 308 LGKGTFGTA----YKAALEDASTVV-VKRLKE-VNVGKREFEQQMEIVGGIRHENVVALR 361
           LGKG FG+     Y    ++   VV VK+L+       R+FE+++EI+  ++H+N+V  +
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 362 AYYYSKDEK--LMVYDYFEPGSVSAML--HGRRGEGQSSLDWDTRVXXXXXXXXXXXXXX 417
              YS   +   ++ +Y   GS+   L  H  R +    L + +++              
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---- 164
Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX------XXXEV 471
                + +H  +   NI + ++  V + D                             E 
Sbjct: 165 -----RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 219
Query: 472 TDTRKATQASDVFSFGVLLLELLT----GKSP----IHATGGDE-----VVHLV 512
               K + ASDV+SFGV+L EL T     KSP    +   G D+     V HL+
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 273

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 57/272 (20%), Positives = 106/272 (38%), Gaps = 29/272 (10%)
Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           E LG G FG  +       + V VK LK+ ++    F  +  ++  ++H+ +V L A   
Sbjct: 14  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV- 72
Query: 366 SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLV 425
           +++   ++ +Y E GS+   L    G     L  +  +                N    +
Sbjct: 73  TQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERN---YI 126
Query: 426 HGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQAS 481
           H  ++A+NI ++      ++D                           E  +    T  S
Sbjct: 127 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 186
Query: 482 DVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
           DV+SFG+LL E++T G+ P       EV+  +     +VR +              N  E
Sbjct: 187 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD--------------NCPE 232
Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLKMVED 572
           E+ +++++   C    PE+RP    +  ++ED
Sbjct: 233 ELYQLMRL---CWKERPEDRPTFDYLRSVLED 261

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 96/234 (41%), Gaps = 38/234 (16%)
Query: 308 LGKGTFGTA----YKAALEDASTVV-VKRLKE-VNVGKREFEQQMEIVGGIRHENVVALR 361
           LGKG FG+     Y    ++   VV VK+L+       R+FE+++EI+  ++H+N+V  +
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 362 AYYYSKDEK--LMVYDYFEPGSVSAML--HGRRGEGQSSLDWDTRVXXXXXXXXXXXXXX 417
              YS   +   ++ +Y   GS+   L  H  R +    L + +++              
Sbjct: 84  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---- 139
Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX------XXXEV 471
                + +H  +   NI + ++  V + D                             E 
Sbjct: 140 -----RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 194
Query: 472 TDTRKATQASDVFSFGVLLLELLT----GKSP----IHATGGDE-----VVHLV 512
               K + ASDV+SFGV+L EL T     KSP    +   G D+     V HL+
Sbjct: 195 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 248

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 96/234 (41%), Gaps = 38/234 (16%)
Query: 308 LGKGTFGTA----YKAALEDASTVV-VKRLKE-VNVGKREFEQQMEIVGGIRHENVVALR 361
           LGKG FG+     Y    ++   VV VK+L+       R+FE+++EI+  ++H+N+V  +
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 362 AYYYSKDEK--LMVYDYFEPGSVSAML--HGRRGEGQSSLDWDTRVXXXXXXXXXXXXXX 417
              YS   +   ++ +Y   GS+   L  H  R +    L + +++              
Sbjct: 81  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---- 136
Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX------XXXEV 471
                + +H  +   NI + ++  V + D                             E 
Sbjct: 137 -----RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 472 TDTRKATQASDVFSFGVLLLELLT----GKSP----IHATGGDE-----VVHLV 512
               K + ASDV+SFGV+L EL T     KSP    +   G D+     V HL+
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 245

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 56/234 (23%), Positives = 94/234 (40%), Gaps = 38/234 (16%)
Query: 308 LGKGTFGTA----YKAALEDASTVV-VKRLKE-VNVGKREFEQQMEIVGGIRHENVVALR 361
           LGKG FG+     Y    ++   VV VK+L+       R+FE+++EI+  ++H+N+V  +
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 362 AYYYSKDEK--LMVYDYFEPGSVSAML--HGRRGEGQSSLDWDTRVXXXXXXXXXXXXXX 417
              YS   +   ++ +Y   GS+   L  H  R +    L + +++              
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---- 133
Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX------XXXEV 471
                + +H  +   NI + ++  V + D                             E 
Sbjct: 134 -----RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188
Query: 472 TDTRKATQASDVFSFGVLLLELLT----GKSP----IHATGGDE-----VVHLV 512
               K + ASDV+SFGV+L EL T     KSP    +   G D+     V HL+
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 96/234 (41%), Gaps = 38/234 (16%)
Query: 308 LGKGTFGTA----YKAALEDASTVV-VKRLKE-VNVGKREFEQQMEIVGGIRHENVVALR 361
           LGKG FG+     Y    ++   VV VK+L+       R+FE+++EI+  ++H+N+V  +
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 362 AYYYSKDEK--LMVYDYFEPGSVSAML--HGRRGEGQSSLDWDTRVXXXXXXXXXXXXXX 417
              YS   +   ++ +Y   GS+   L  H  R +    L + +++              
Sbjct: 85  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---- 140
Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX------XXXEV 471
                + +H  +   NI + ++  V + D                             E 
Sbjct: 141 -----RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 195
Query: 472 TDTRKATQASDVFSFGVLLLELLT----GKSP----IHATGGDE-----VVHLV 512
               K + ASDV+SFGV+L EL T     KSP    +   G D+     V HL+
Sbjct: 196 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 249

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 96/234 (41%), Gaps = 38/234 (16%)
Query: 308 LGKGTFGTA----YKAALEDASTVV-VKRLKE-VNVGKREFEQQMEIVGGIRHENVVALR 361
           LGKG FG+     Y    ++   VV VK+L+       R+FE+++EI+  ++H+N+V  +
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 362 AYYYSKDEK--LMVYDYFEPGSVSAML--HGRRGEGQSSLDWDTRVXXXXXXXXXXXXXX 417
              YS   +   ++ +Y   GS+   L  H  R +    L + +++              
Sbjct: 78  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---- 133
Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX------XXXEV 471
                + +H  +   NI + ++  V + D                             E 
Sbjct: 134 -----RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 188
Query: 472 TDTRKATQASDVFSFGVLLLELLT----GKSP----IHATGGDE-----VVHLV 512
               K + ASDV+SFGV+L EL T     KSP    +   G D+     V HL+
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 242

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 96/234 (41%), Gaps = 38/234 (16%)
Query: 308 LGKGTFGTA----YKAALEDASTVV-VKRLKE-VNVGKREFEQQMEIVGGIRHENVVALR 361
           LGKG FG+     Y    ++   VV VK+L+       R+FE+++EI+  ++H+N+V  +
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 362 AYYYSKDEK--LMVYDYFEPGSVSAML--HGRRGEGQSSLDWDTRVXXXXXXXXXXXXXX 417
              YS   +   ++ +Y   GS+   L  H  R +    L + +++              
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---- 151
Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX------XXXEV 471
                + +H  +   NI + ++  V + D                             E 
Sbjct: 152 -----RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 206
Query: 472 TDTRKATQASDVFSFGVLLLELLT----GKSP----IHATGGDE-----VVHLV 512
               K + ASDV+SFGV+L EL T     KSP    +   G D+     V HL+
Sbjct: 207 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 260

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 50/222 (22%), Positives = 88/222 (39%), Gaps = 22/222 (9%)
Query: 306 EVLGKGTFGTAYKAALE----DASTVVVKRLK--EVNVGKREFEQQMEIVGGIRHENVVA 359
           EV+G G FG   +  L+      S V +K LK       +REF  +  I+G   H N++ 
Sbjct: 22  EVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIR 81
Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTE 419
           L     +    +++ ++ E G++ + L  R  +GQ ++    ++               E
Sbjct: 82  LEGVVTNSMPVMILTEFMENGALDSFL--RLNDGQFTV---IQLVGMLRGIASGMRYLAE 136
Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX--------XXXEV 471
                VH  + A NI +NS     VSD                               E 
Sbjct: 137 M--SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEA 194
Query: 472 TDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLV 512
              RK T ASD +S+G+++ E+++ G+ P       +V++ +
Sbjct: 195 IAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAI 236

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/221 (20%), Positives = 86/221 (38%), Gaps = 30/221 (13%)
Query: 294 VFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKR--LKEVNVGKREFEQQMEIVGG 351
           +F   DL+    EVLGKG FG A K    +   V+V +  ++     +R F ++++++  
Sbjct: 6   IFRPSDLI--HGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRC 63
Query: 352 IRHENVVALRAYYYSKDEKL-MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXX 410
           + H NV+      Y KD++L  + +Y + G++  ++        S   W  RV       
Sbjct: 64  LEHPNVLKFIGVLY-KDKRLNFITEYIKGGTLRGIIKSM----DSQYPWSQRVSFAKDIA 118
Query: 411 XXXXXXXTENGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX---- 466
                  + N   ++H  + + N  +    +V V+D                        
Sbjct: 119 SGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPD 175
Query: 467 -------------XXXEVTDTRKATQASDVFSFGVLLLELL 494
                           E+ + R   +  DVFSFG++L E++
Sbjct: 176 RKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEII 216

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 59/274 (21%), Positives = 100/274 (36%), Gaps = 33/274 (12%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG G FG       +    V VK +KE ++ + EF Q+ + +  + H  +V        +
Sbjct: 16  LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE 75
Query: 368 DEKLMVYDYFEPGSVSAML--HGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLV 425
               +V +Y   G +   L  HG+  E    L+    V                   + +
Sbjct: 76  YPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFL---------ESHQFI 126
Query: 426 HGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQAS 481
           H  + A N  ++    V VSD                           EV    K +  S
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKS 186
Query: 482 DVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
           DV++FG+L+ E+ + GK P       EVV  V   + + R               P++  
Sbjct: 187 DVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR---------------PHLAS 231
Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLKMVEDIR 574
           + +   Q+  +C   +PE+RP    +L  +E +R
Sbjct: 232 DTI--YQIMYSCWHELPEKRPTFQQLLSSIEPLR 263

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 58/234 (24%), Positives = 96/234 (41%), Gaps = 38/234 (16%)
Query: 308 LGKGTFGTA----YKAALEDASTVV-VKRLKE-VNVGKREFEQQMEIVGGIRHENVVALR 361
           LGKG FG+     Y    ++   VV VK+L+       R+FE+++EI+  ++H+N+V  +
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 362 AYYYSKDEK--LMVYDYFEPGSVSAML--HGRRGEGQSSLDWDTRVXXXXXXXXXXXXXX 417
              YS   +   ++ +Y   GS+   L  H  R +    L + +++              
Sbjct: 96  GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---- 151
Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX------XXXEV 471
                + +H  +   NI + ++  V + D                             E 
Sbjct: 152 -----RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 206
Query: 472 TDTRKATQASDVFSFGVLLLELLT----GKSP----IHATGGDE-----VVHLV 512
               K + ASDV+SFGV+L EL T     KSP    +   G D+     V HL+
Sbjct: 207 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 260

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 57/273 (20%), Positives = 103/273 (37%), Gaps = 33/273 (12%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           +G G FG  +     +   V +K +KE ++ + +F ++ E++  + H  +V L      +
Sbjct: 35  IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQ 94
Query: 368 DEKLMVYDYFEPGSVSAMLHGRRG--EGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLV 425
               +V+++ E G +S  L  +RG    ++ L     V                    ++
Sbjct: 95  APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---------VI 145
Query: 426 HGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQAS 481
           H  + A N  +     + VSD                           EV    + +  S
Sbjct: 146 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 205
Query: 482 DVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
           DV+SFGVL+ E+ + GK P       EVV     +++  R            L  P +  
Sbjct: 206 DVWSFGVLMWEVFSEGKIPYENRSNSEVVED---ISTGFR------------LYKPRLAS 250
Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
             V   Q+   C    PE+RP  + +L+ + +I
Sbjct: 251 THV--YQIMNHCWKERPEDRPAFSRLLRQLAEI 281

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 55/283 (19%), Positives = 112/283 (39%), Gaps = 35/283 (12%)
Query: 305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKRE---FEQQMEIVGGIRHENVVALR 361
            + +G G+FGT YK        V VK L       ++   F+ ++ ++   RH N++   
Sbjct: 17  GQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 74
Query: 362 AYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
            Y  +K +  +V  + E  S+   LH      ++  +    +               ++ 
Sbjct: 75  GYS-TKPQLAIVTQWCEGSSLYHHLHA----SETKFEMKKLIDIARQTARGMDYLHAKS- 128
Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXXXXX--------EVTD 473
             ++H  +K++NIFL+    V + D                                + D
Sbjct: 129 --IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 186
Query: 474 TRKATQASDVFSFGVLLLELLTGKSPI-HATGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
           +   +  SDV++FG++L EL+TG+ P  +    D+++ +V       R   + ++  V  
Sbjct: 187 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG------RGSLSPDLSKVR- 239
Query: 533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
               N  + M  ++     C+ +  +ERP    +L  +E++ R
Sbjct: 240 ---SNCPKRMKRLM---AECLKKKRDERPSFPRILAEIEELAR 276

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 55/283 (19%), Positives = 112/283 (39%), Gaps = 35/283 (12%)
Query: 305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKRE---FEQQMEIVGGIRHENVVALR 361
            + +G G+FGT YK        V VK L       ++   F+ ++ ++   RH N++   
Sbjct: 29  GQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 362 AYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
            Y  +K +  +V  + E  S+   LH      ++  +    +               ++ 
Sbjct: 87  GYS-TKPQLAIVTQWCEGSSLYHHLHA----SETKFEMKKLIDIARQTARGMDYLHAKS- 140
Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXXXXX--------EVTD 473
             ++H  +K++NIFL+    V + D                                + D
Sbjct: 141 --IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 474 TRKATQASDVFSFGVLLLELLTGKSPI-HATGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
           +   +  SDV++FG++L EL+TG+ P  +    D+++ +V       R   + ++  V  
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG------RGSLSPDLSKVR- 251
Query: 533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
               N  + M  ++     C+ +  +ERP    +L  +E++ R
Sbjct: 252 ---SNCPKRMKRLM---AECLKKKRDERPSFPRILAEIEELAR 288

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 96/234 (41%), Gaps = 38/234 (16%)
Query: 308 LGKGTFGTA----YKAALEDASTVV-VKRLKE-VNVGKREFEQQMEIVGGIRHENVVALR 361
           LGKG FG+     Y    ++   VV VK+L+       R+FE+++EI+  ++H+N+V  +
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 362 AYYYSKDEK--LMVYDYFEPGSVSAML--HGRRGEGQSSLDWDTRVXXXXXXXXXXXXXX 417
              YS   +   ++ ++   GS+   L  H  R +    L + +++              
Sbjct: 81  GVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---- 136
Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX------XXXEV 471
                + +H  +   NI + ++  V + D                             E 
Sbjct: 137 -----RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPES 191
Query: 472 TDTRKATQASDVFSFGVLLLELLT----GKSP----IHATGGDE-----VVHLV 512
               K + ASDV+SFGV+L EL T     KSP    +   G D+     V HL+
Sbjct: 192 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLI 245

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 62/272 (22%), Positives = 101/272 (37%), Gaps = 31/272 (11%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG G FG            V +K +KE ++ + EF ++ +++  + HE +V L      +
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91
Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLVHG 427
               ++ +Y   G +   L   R   Q      T+                E+  + +H 
Sbjct: 92  RPIFIITEYMANGCLLNYLREMRHRFQ------TQQLLEMCKDVCEAMEYLES-KQFLHR 144
Query: 428 GIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXXXXX----EVTDTRKATQASDV 483
            + A N  +N QG V VSD                           EV    K +  SD+
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDI 204
Query: 484 FSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY-PNIEEE 541
           ++FGVL+ E+ + GK P             R+ NS      TAE     L  Y P++  E
Sbjct: 205 WAFGVLMWEIYSLGKMPYE-----------RFTNSE-----TAEHIAQGLRLYRPHLASE 248
Query: 542 MVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
            V    +  +C     +ERP    +L  + D+
Sbjct: 249 KV--YTIMYSCWHEKADERPTFKILLSNILDV 278

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 62/272 (22%), Positives = 101/272 (37%), Gaps = 31/272 (11%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG G FG            V +K +KE ++ + EF ++ +++  + HE +V L      +
Sbjct: 32  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 91
Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLVHG 427
               ++ +Y   G +   L   R   Q      T+                E+  + +H 
Sbjct: 92  RPIFIITEYMANGCLLNYLREMRHRFQ------TQQLLEMCKDVCEAMEYLES-KQFLHR 144
Query: 428 GIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXXXXX----EVTDTRKATQASDV 483
            + A N  +N QG V VSD                           EV    K +  SD+
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 204
Query: 484 FSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY-PNIEEE 541
           ++FGVL+ E+ + GK P             R+ NS      TAE     L  Y P++  E
Sbjct: 205 WAFGVLMWEIYSLGKMPYE-----------RFTNSE-----TAEHIAQGLRLYRPHLASE 248
Query: 542 MVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
            V    +  +C     +ERP    +L  + D+
Sbjct: 249 KV--YTIMYSCWHEKADERPTFKILLSNILDV 278

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 84/223 (37%), Gaps = 25/223 (11%)
Query: 305 AEVLGKGTFGTAYKAA-LEDASTV----VVKRLKEVNVGKR--EFEQQMEIVGGIRHENV 357
            +VLG G FGT YK   + +  TV     +K L E    K   EF  +  I+  + H ++
Sbjct: 20  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 79
Query: 358 VALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGE--GQSSLDWDTRVXXXXXXXXXXXX 415
           V L     S   +L V      G +   +H  +     Q  L+W  ++            
Sbjct: 80  VRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER-- 136
Query: 416 XXTENGGKLVHGGIKASNIFLNSQGHVCVSD-----IXXXXXXXXXXXXXXXXXXXXXXE 470
                  +LVH  + A N+ + S  HV ++D     +                      E
Sbjct: 137 -------RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 189
Query: 471 VTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLV 512
               RK T  SDV+S+GV + EL+T G  P       E+  L+
Sbjct: 190 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 232

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 84/223 (37%), Gaps = 25/223 (11%)
Query: 305 AEVLGKGTFGTAYKAA-LEDASTV----VVKRLKEVNVGKR--EFEQQMEIVGGIRHENV 357
            +VLG G FGT YK   + +  TV     +K L E    K   EF  +  I+  + H ++
Sbjct: 43  VKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHL 102
Query: 358 VALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGE--GQSSLDWDTRVXXXXXXXXXXXX 415
           V L     S   +L V      G +   +H  +     Q  L+W  ++            
Sbjct: 103 VRLLGVCLSPTIQL-VTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER-- 159
Query: 416 XXTENGGKLVHGGIKASNIFLNSQGHVCVSD-----IXXXXXXXXXXXXXXXXXXXXXXE 470
                  +LVH  + A N+ + S  HV ++D     +                      E
Sbjct: 160 -------RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALE 212
Query: 471 VTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLV 512
               RK T  SDV+S+GV + EL+T G  P       E+  L+
Sbjct: 213 CIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLL 255

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/204 (20%), Positives = 80/204 (39%), Gaps = 23/204 (11%)
Query: 308 LGKGTFGTAY---------KAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVV 358
           LG G+FG  +           A++     +V RLK+V     E      ++  + H  ++
Sbjct: 14  LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDE----RLMLSIVTHPFII 69
Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLH-GRRGEGQSSLDWDTRVXXXXXXXXXXXXXX 417
            +   +    +  M+ DY E G + ++L   +R     +  +   V              
Sbjct: 70  RMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYL------- 122
Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXXXXXEVTDTRKA 477
             +   +++  +K  NI L+  GH+ ++D                       EV  T+  
Sbjct: 123 --HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLCGTPDYIAPEVVSTKPY 180
Query: 478 TQASDVFSFGVLLLELLTGKSPIH 501
            ++ D +SFG+L+ E+L G +P +
Sbjct: 181 NKSIDWWSFGILIYEMLAGYTPFY 204

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 62/272 (22%), Positives = 101/272 (37%), Gaps = 31/272 (11%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG G FG            V +K +KE ++ + EF ++ +++  + HE +V L      +
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 76
Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLVHG 427
               ++ +Y   G +   L   R   Q      T+                E+  + +H 
Sbjct: 77  RPIFIITEYMANGCLLNYLREMRHRFQ------TQQLLEMCKDVCEAMEYLES-KQFLHR 129
Query: 428 GIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXXXXX----EVTDTRKATQASDV 483
            + A N  +N QG V VSD                           EV    K +  SD+
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDI 189
Query: 484 FSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY-PNIEEE 541
           ++FGVL+ E+ + GK P             R+ NS      TAE     L  Y P++  E
Sbjct: 190 WAFGVLMWEIYSLGKMPYE-----------RFTNSE-----TAEHIAQGLRLYRPHLASE 233
Query: 542 MVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
            V    +  +C     +ERP    +L  + D+
Sbjct: 234 KV--YTIMYSCWHEKADERPTFKILLSNILDV 263

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 62/272 (22%), Positives = 101/272 (37%), Gaps = 31/272 (11%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG G FG            V +K +KE ++ + EF ++ +++  + HE +V L      +
Sbjct: 16  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 75
Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLVHG 427
               ++ +Y   G +   L   R   Q      T+                E+  + +H 
Sbjct: 76  RPIFIITEYMANGCLLNYLREMRHRFQ------TQQLLEMCKDVCEAMEYLES-KQFLHR 128
Query: 428 GIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXXXXX----EVTDTRKATQASDV 483
            + A N  +N QG V VSD                           EV    K +  SD+
Sbjct: 129 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 188
Query: 484 FSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY-PNIEEE 541
           ++FGVL+ E+ + GK P             R+ NS      TAE     L  Y P++  E
Sbjct: 189 WAFGVLMWEIYSLGKMPYE-----------RFTNSE-----TAEHIAQGLRLYRPHLASE 232
Query: 542 MVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
            V    +  +C     +ERP    +L  + D+
Sbjct: 233 KV--YTIMYSCWHEKADERPTFKILLSNILDV 262

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 62/272 (22%), Positives = 101/272 (37%), Gaps = 31/272 (11%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG G FG            V +K +KE ++ + EF ++ +++  + HE +V L      +
Sbjct: 12  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 71
Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLVHG 427
               ++ +Y   G +   L   R   Q      T+                E+  + +H 
Sbjct: 72  RPIFIITEYMANGCLLNYLREMRHRFQ------TQQLLEMCKDVCEAMEYLES-KQFLHR 124
Query: 428 GIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXXXXX----EVTDTRKATQASDV 483
            + A N  +N QG V VSD                           EV    K +  SD+
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 184
Query: 484 FSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY-PNIEEE 541
           ++FGVL+ E+ + GK P             R+ NS      TAE     L  Y P++  E
Sbjct: 185 WAFGVLMWEIYSLGKMPYE-----------RFTNSE-----TAEHIAQGLRLYRPHLASE 228
Query: 542 MVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
            V    +  +C     +ERP    +L  + D+
Sbjct: 229 KV--YTIMYSCWHEKADERPTFKILLSNILDV 258

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/273 (20%), Positives = 102/273 (37%), Gaps = 33/273 (12%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           +G G FG  +     +   V +K ++E  + + +F ++ E++  + H  +V L      +
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 74
Query: 368 DEKLMVYDYFEPGSVSAMLHGRRG--EGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLV 425
               +V+++ E G +S  L  +RG    ++ L     V                    ++
Sbjct: 75  APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---------VI 125
Query: 426 HGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQAS 481
           H  + A N  +     + VSD                           EV    + +  S
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 185
Query: 482 DVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
           DV+SFGVL+ E+ + GK P       EVV     +++  R            L  P +  
Sbjct: 186 DVWSFGVLMWEVFSEGKIPYENRSNSEVVED---ISTGFR------------LYKPRLAS 230
Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
             V   Q+   C    PE+RP  + +L+ + +I
Sbjct: 231 THV--YQIMNHCWKERPEDRPAFSRLLRQLAEI 261

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/273 (20%), Positives = 102/273 (37%), Gaps = 33/273 (12%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           +G G FG  +     +   V +K ++E  + + +F ++ E++  + H  +V L      +
Sbjct: 13  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 72
Query: 368 DEKLMVYDYFEPGSVSAMLHGRRG--EGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLV 425
               +V+++ E G +S  L  +RG    ++ L     V                    ++
Sbjct: 73  APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---------VI 123
Query: 426 HGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQAS 481
           H  + A N  +     + VSD                           EV    + +  S
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183
Query: 482 DVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
           DV+SFGVL+ E+ + GK P       EVV     +++  R            L  P +  
Sbjct: 184 DVWSFGVLMWEVFSEGKIPYENRSNSEVVED---ISTGFR------------LYKPRLAS 228
Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
             V   Q+   C    PE+RP  + +L+ + +I
Sbjct: 229 THV--YQIMNHCWKERPEDRPAFSRLLRQLAEI 259

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/209 (20%), Positives = 81/209 (38%), Gaps = 18/209 (8%)
Query: 308 LGKGTFGTAYKAALED-----ASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRA 362
           LGKG FG  Y A  +      A  V+ K   E    + +  +++EI   +RH N++ +  
Sbjct: 22  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 363 YYYSKDEKLMVYDYFEPGSVSAML--HGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTEN 420
           Y++ +    ++ ++   G +   L  HGR  E +S+   +                   +
Sbjct: 82  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYC----------H 131
Query: 421 GGKLVHGGIKASNIFLNSQGHVCVSDIX-XXXXXXXXXXXXXXXXXXXXXEVTDTRKATQ 479
             K++H  IK  N+ +  +G + ++D                        E+ + +   +
Sbjct: 132 ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMCGTLDYLPPEMIEGKTHDE 191
Query: 480 ASDVFSFGVLLLELLTGKSPIHATGGDEV 508
             D++  GVL  E L G  P  +    E 
Sbjct: 192 KVDLWCAGVLCYEFLVGMPPFDSPSHTET 220

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/273 (20%), Positives = 102/273 (37%), Gaps = 33/273 (12%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           +G G FG  +     +   V +K ++E  + + +F ++ E++  + H  +V L      +
Sbjct: 18  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 77
Query: 368 DEKLMVYDYFEPGSVSAMLHGRRG--EGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLV 425
               +V+++ E G +S  L  +RG    ++ L     V                    ++
Sbjct: 78  APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---------VI 128
Query: 426 HGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQAS 481
           H  + A N  +     + VSD                           EV    + +  S
Sbjct: 129 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 188
Query: 482 DVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
           DV+SFGVL+ E+ + GK P       EVV     +++  R            L  P +  
Sbjct: 189 DVWSFGVLMWEVFSEGKIPYENRSNSEVVED---ISTGFR------------LYKPRLAS 233
Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
             V   Q+   C    PE+RP  + +L+ + +I
Sbjct: 234 THV--YQIMNHCWRERPEDRPAFSRLLRQLAEI 264

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 62/272 (22%), Positives = 101/272 (37%), Gaps = 31/272 (11%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG G FG            V +K +KE ++ + EF ++ +++  + HE +V L      +
Sbjct: 17  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 76
Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLVHG 427
               ++ +Y   G +   L   R   Q      T+                E+  + +H 
Sbjct: 77  RPIFIITEYMANGCLLNYLREMRHRFQ------TQQLLEMCKDVCEAMEYLES-KQFLHR 129
Query: 428 GIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXXXXX----EVTDTRKATQASDV 483
            + A N  +N QG V VSD                           EV    K +  SD+
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 189
Query: 484 FSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY-PNIEEE 541
           ++FGVL+ E+ + GK P             R+ NS      TAE     L  Y P++  E
Sbjct: 190 WAFGVLMWEIYSLGKMPYE-----------RFTNSE-----TAEHIAQGLRLYRPHLASE 233
Query: 542 MVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
            V    +  +C     +ERP    +L  + D+
Sbjct: 234 KV--YTIMYSCWHEKADERPTFKILLSNILDV 263

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 62/272 (22%), Positives = 101/272 (37%), Gaps = 31/272 (11%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           LG G FG            V +K +KE ++ + EF ++ +++  + HE +V L      +
Sbjct: 23  LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ 82
Query: 368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLVHG 427
               ++ +Y   G +   L   R   Q      T+                E+  + +H 
Sbjct: 83  RPIFIITEYMANGCLLNYLREMRHRFQ------TQQLLEMCKDVCEAMEYLES-KQFLHR 135
Query: 428 GIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXXXXX----EVTDTRKATQASDV 483
            + A N  +N QG V VSD                           EV    K +  SD+
Sbjct: 136 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 195
Query: 484 FSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY-PNIEEE 541
           ++FGVL+ E+ + GK P             R+ NS      TAE     L  Y P++  E
Sbjct: 196 WAFGVLMWEIYSLGKMPYE-----------RFTNSE-----TAEHIAQGLRLYRPHLASE 239
Query: 542 MVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
            V    +  +C     +ERP    +L  + D+
Sbjct: 240 KV--YTIMYSCWHEKADERPTFKILLSNILDV 269

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/206 (20%), Positives = 77/206 (37%), Gaps = 21/206 (10%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQM---EIVGGIRHENVVALRAYY 364
           LG G FG  YKA  ++ S +   ++ +    + E E  M   +I+    H N+V L   +
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 365 YSKDEKLMVYDYFEPGSVSA-MLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGK 423
           Y ++   ++ ++   G+V A ML   R   +S +                      +  K
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQI--------QVVCKQTLDALNYLHDNK 155
Query: 424 LVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXX--------XXXXXXXXEVTDTR 475
           ++H  +KA NI     G + ++D                               E +  R
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 215
Query: 476 KATQASDVFSFGVLLLELLTGKSPIH 501
                +DV+S G+ L+E+   + P H
Sbjct: 216 PYDYKADVWSLGITLIEMAEIEPPHH 241

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/209 (20%), Positives = 81/209 (38%), Gaps = 18/209 (8%)
Query: 308 LGKGTFGTAYKAALED-----ASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRA 362
           LGKG FG  Y A  +      A  V+ K   E    + +  +++EI   +RH N++ +  
Sbjct: 23  LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 363 YYYSKDEKLMVYDYFEPGSVSAML--HGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTEN 420
           Y++ +    ++ ++   G +   L  HGR  E +S+   +                   +
Sbjct: 83  YFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYC----------H 132
Query: 421 GGKLVHGGIKASNIFLNSQGHVCVSDIX-XXXXXXXXXXXXXXXXXXXXXEVTDTRKATQ 479
             K++H  IK  N+ +  +G + ++D                        E+ + +   +
Sbjct: 133 ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMCGTLDYLPPEMIEGKTHDE 192
Query: 480 ASDVFSFGVLLLELLTGKSPIHATGGDEV 508
             D++  GVL  E L G  P  +    E 
Sbjct: 193 KVDLWCAGVLCYEFLVGMPPFDSPSHTET 221

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 48/268 (17%), Positives = 107/268 (39%), Gaps = 31/268 (11%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYY 364
           LG G  G  +K + + +  V+ ++L  + +    + +  ++++++       +V     +
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 92
Query: 365 YSKDEKLMVYDYFEPGSVSAMLH--GRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGG 422
           YS  E  +  ++ + GS+  +L   GR  E         ++                   
Sbjct: 93  YSDGEISICMEHMDGGSLDQVLKKAGRIPE---------QILGKVSIAVIKGLTYLREKH 143
Query: 423 KLVHGGIKASNIFLNSQGHVCVSD--IXXXXXXXXXXXXXXXXXXXXXXEVTDTRKATQA 480
           K++H  +K SNI +NS+G + + D  +                       +  T  + Q 
Sbjct: 144 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ- 202
Query: 481 SDVFSFGVLLLELLTGKSPI-HATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE 539
           SD++S G+ L+E+  G+ PI   +G   +  L+ ++ +    +  + VF +E   + N  
Sbjct: 203 SDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN-- 260
Query: 540 EEMVEMLQVGMACVVRMPEERPKMADVL 567
                       C+++ P ER  +  ++
Sbjct: 261 -----------KCLIKNPAERADLKQLM 277

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/206 (21%), Positives = 78/206 (37%), Gaps = 21/206 (10%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQM---EIVGGIRHENVVALRAYY 364
           LG G FG  YKA  ++ S +   ++ +    + E E  M   +I+    H N+V L   +
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 365 YSKDEKLMVYDYFEPGSVSA-MLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGK 423
           Y ++   ++ ++   G+V A ML   R   +S +                      +  K
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQI--------QVVCKQTLDALNYLHDNK 155
Query: 424 LVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXX--------XXXXXXXXEVTDTR 475
           ++H  +KA NI     G + ++D                               E +  R
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDR 215
Query: 476 KATQASDVFSFGVLLLELLTGKSPIH 501
                +DV+S G+ L+E+   + P H
Sbjct: 216 PYDYKADVWSLGITLIEMAEIEPPHH 241

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/206 (21%), Positives = 78/206 (37%), Gaps = 21/206 (10%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQM---EIVGGIRHENVVALRAYY 364
           LG G FG  YKA  ++ S +   ++ +    + E E  M   +I+    H N+V L   +
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTK-SEEELEDYMVEIDILASCDHPNIVKLLDAF 103
Query: 365 YSKDEKLMVYDYFEPGSVSA-MLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGK 423
           Y ++   ++ ++   G+V A ML   R   +S +                      +  K
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQI--------QVVCKQTLDALNYLHDNK 155
Query: 424 LVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXX--------XXXXXXXXEVTDTR 475
           ++H  +KA NI     G + ++D                               E +  R
Sbjct: 156 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDR 215
Query: 476 KATQASDVFSFGVLLLELLTGKSPIH 501
                +DV+S G+ L+E+   + P H
Sbjct: 216 PYDYKADVWSLGITLIEMAEIEPPHH 241

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/273 (20%), Positives = 101/273 (36%), Gaps = 33/273 (12%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           +G G FG  +     +   V +K ++E  + + +F ++ E++  + H  +V L      +
Sbjct: 15  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 74
Query: 368 DEKLMVYDYFEPGSVSAMLHGRRG--EGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLV 425
               +V+++ E G +S  L  +RG    ++ L     V                    ++
Sbjct: 75  APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEE---------ASVI 125
Query: 426 HGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQAS 481
           H  + A N  +     + VSD                           EV    + +  S
Sbjct: 126 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 185
Query: 482 DVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
           DV+SFGVL+ E+ + GK P       EVV     +++  R            L  P +  
Sbjct: 186 DVWSFGVLMWEVFSEGKIPYENRSNSEVVED---ISTGFR------------LYKPRLAS 230
Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
             V   Q+   C    PE+RP  + +L+ +  I
Sbjct: 231 THV--YQIMNHCWKERPEDRPAFSRLLRQLAAI 261

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 80/209 (38%), Gaps = 25/209 (11%)
Query: 306 EVLGKGTFGTAYKAAL----EDASTVVVKRLKEVNVGKREFE---QQMEIVGGIRHENVV 358
           +VLG G FGT +K       E     V  ++ E   G++ F+     M  +G + H ++V
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGE--GQSSLDWDTRVXXXXXXXXXXXXX 416
            L         +L V  Y   GS+   +   RG    Q  L+W  ++             
Sbjct: 97  RLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL------ 149
Query: 417 XTENGGKLVHGGIKASNIFLNSQGHV-----CVSDIXXXXXXXXXXXXXXXXXXXXXXEV 471
             E+G  +VH  + A N+ L S   V      V+D+                      E 
Sbjct: 150 -EEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 206
Query: 472 TDTRKATQASDVFSFGVLLLELLT-GKSP 499
               K T  SDV+S+GV + EL+T G  P
Sbjct: 207 IHFGKYTHQSDVWSYGVTVWELMTFGAEP 235

>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 24/57 (42%), Positives = 33/57 (57%)
Query: 106 GLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISK 162
           G  P    +LENL  L L  NSFSG +P +     +L  +DL+ N FN +IPA++ K
Sbjct: 501 GEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK 557

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 57/273 (20%), Positives = 106/273 (38%), Gaps = 29/273 (10%)
Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           E LG G  G  +       + V VK LK+ ++    F  +  ++  ++H+ +V L A   
Sbjct: 19  ERLGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV- 77
Query: 366 SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLV 425
           +++   ++ +Y E GS+   L    G     L  +  +                N    +
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERN---YI 131
Query: 426 HGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQAS 481
           H  ++A+NI ++      ++D                           E  +    T  S
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKS 191
Query: 482 DVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
           DV+SFG+LL E++T G+ P       EV+  +     +VR +              N  E
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPD--------------NCPE 237
Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
           E+ +++++   C    PE+RP    +  ++ED 
Sbjct: 238 ELYQLMRL---CWKERPEDRPTFDYLRSVLEDF 267

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 80/209 (38%), Gaps = 25/209 (11%)
Query: 306 EVLGKGTFGTAYKAAL----EDASTVVVKRLKEVNVGKREFE---QQMEIVGGIRHENVV 358
           +VLG G FGT +K       E     V  ++ E   G++ F+     M  +G + H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGE--GQSSLDWDTRVXXXXXXXXXXXXX 416
            L         +L V  Y   GS+   +   RG    Q  L+W  ++             
Sbjct: 79  RLLGLCPGSSLQL-VTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYL------ 131
Query: 417 XTENGGKLVHGGIKASNIFLNSQGHV-----CVSDIXXXXXXXXXXXXXXXXXXXXXXEV 471
             E+G  +VH  + A N+ L S   V      V+D+                      E 
Sbjct: 132 -EEHG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALES 188
Query: 472 TDTRKATQASDVFSFGVLLLELLT-GKSP 499
               K T  SDV+S+GV + EL+T G  P
Sbjct: 189 IHFGKYTHQSDVWSYGVTVWELMTFGAEP 217

>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 24/57 (42%), Positives = 33/57 (57%)
Query: 106 GLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISK 162
           G  P    +LENL  L L  NSFSG +P +     +L  +DL+ N FN +IPA++ K
Sbjct: 504 GEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFK 560

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 48/274 (17%), Positives = 106/274 (38%), Gaps = 37/274 (13%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYY 364
           LG G  G  +K + + +  V+ ++L  + +    + +  ++++++       +V     +
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 73
Query: 365 YSKDEKLMVYDYFEPGSVSAMLH--GRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGG 422
           YS  E  +  ++ + GS+  +L   GR  E         ++                   
Sbjct: 74  YSDGEISICMEHMDGGSLDQVLKKAGRIPE---------QILGKVSIAVIKGLTYLREKH 124
Query: 423 KLVHGGIKASNIFLNSQGHVCVSD--IXXXXXXXXXXXXXXXXXXXXXXEVTDTRKATQA 480
           K++H  +K SNI +NS+G + + D  +                       +  T  + Q 
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ- 183
Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDE-------VVHLVRWVNSVVREEWTAEVFDVELL 533
           SD++S G+ L+E+  G+ PI      E       +  L+ ++ +    +  + VF +E  
Sbjct: 184 SDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 243
Query: 534 RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVL 567
            + N              C+++ P ER  +  ++
Sbjct: 244 DFVN-------------KCLIKNPAERADLKQLM 264

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/217 (19%), Positives = 89/217 (41%), Gaps = 18/217 (8%)
Query: 306 EVLGKGTFGTAY---KAALEDASTV-VVKRLKEVNVGKRE---FEQQMEIVGGIRHENVV 358
           +VLG+G+FG  +   K    D+  +  +K LK+  +  R+    + + +I+  + H  VV
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVV 93
Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXT 418
            L   + ++ +  ++ D+   G +   L       +  +  +  V               
Sbjct: 94  KLHYAFQTEGKLYLILDFLRGGDLFTRL------SKEVMFTEEDVKFYLAELALGLDHLH 147
Query: 419 ENGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXX---XXXXXXXEVTDTR 475
             G  +++  +K  NI L+ +GH+ ++D                          EV + +
Sbjct: 148 SLG--IIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQ 205
Query: 476 KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLV 512
             + ++D +S+GVL+ E+LTG  P       E + L+
Sbjct: 206 GHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLI 242

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 54/283 (19%), Positives = 111/283 (39%), Gaps = 35/283 (12%)
Query: 305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKRE---FEQQMEIVGGIRHENVVALR 361
            + +G G+FGT YK        V VK L       ++   F+ ++ ++   RH N++   
Sbjct: 29  GQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFM 86
Query: 362 AYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENG 421
            Y  +  +  +V  + E  S+   LH      ++  +    +               ++ 
Sbjct: 87  GYS-TAPQLAIVTQWCEGSSLYHHLHA----SETKFEMKKLIDIARQTARGMDYLHAKS- 140
Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXXXXX--------EVTD 473
             ++H  +K++NIFL+    V + D                                + D
Sbjct: 141 --IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198
Query: 474 TRKATQASDVFSFGVLLLELLTGKSPI-HATGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
           +   +  SDV++FG++L EL+TG+ P  +    D+++ +V       R   + ++  V  
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVG------RGSLSPDLSKVR- 251
Query: 533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
               N  + M  ++     C+ +  +ERP    +L  +E++ R
Sbjct: 252 ---SNCPKRMKRLM---AECLKKKRDERPSFPRILAEIEELAR 288

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/204 (23%), Positives = 82/204 (40%), Gaps = 25/204 (12%)
Query: 308 LGKGTFGTAYKAALE-----DASTVVVKRLKEVNVGK-REFEQQMEIVGGIRHENVVALR 361
           LGKG FG+      +       + V VK+L+     + R+F+++++I+  +  + +V  R
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 362 AYYYS--KDEKLMVYDYFEPGSVSAMLHGRRGEGQSS--LDWDTRVXXXXXXXXXXXXXX 417
              Y   + E  +V +Y   G +   L   R    +S  L + +++              
Sbjct: 75  GVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL------- 127
Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXXX------XXEV 471
                + VH  + A NI + S+ HV ++D                             E 
Sbjct: 128 --GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPES 185
Query: 472 TDTRKATQASDVFSFGVLLLELLT 495
                 ++ SDV+SFGV+L EL T
Sbjct: 186 LSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 56/273 (20%), Positives = 101/273 (36%), Gaps = 33/273 (12%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK 367
           +G G FG  +     +   V +K ++E  + + +F ++ E++  + H  +V L      +
Sbjct: 16  IGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ 75
Query: 368 DEKLMVYDYFEPGSVSAMLHGRRG--EGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKLV 425
               +V ++ E G +S  L  +RG    ++ L     V                    ++
Sbjct: 76  APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---------VI 126
Query: 426 HGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXX----XXXEVTDTRKATQAS 481
           H  + A N  +     + VSD                           EV    + +  S
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 186
Query: 482 DVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
           DV+SFGVL+ E+ + GK P       EVV     +++  R            L  P +  
Sbjct: 187 DVWSFGVLMWEVFSEGKIPYENRSNSEVVED---ISTGFR------------LYKPRLAS 231
Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
             V   Q+   C    PE+RP  + +L+ + +I
Sbjct: 232 THV--YQIMNHCWRERPEDRPAFSRLLRQLAEI 262

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 47/196 (23%), Positives = 75/196 (38%), Gaps = 10/196 (5%)
Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           + +GKG FG          + V VK +K  +   + F  +  ++  +RH N+V L     
Sbjct: 12  QTIGKGEFGDVMLGDYR-GNKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVIV 69
Query: 366 SKDEKL-MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGGKL 424
            +   L +V +Y   GS+   L  R   G+S L  D  +                 G   
Sbjct: 70  EEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYL---EGNNF 123
Query: 425 VHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXXXXXXXEVTDTRKATQASDVF 484
           VH  + A N+ ++      VSD                       E    +K +  SDV+
Sbjct: 124 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVW 183
Query: 485 SFGVLLLELLT-GKSP 499
           SFG+LL E+ + G+ P
Sbjct: 184 SFGILLWEIYSFGRVP 199

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 45/207 (21%), Positives = 79/207 (38%), Gaps = 23/207 (11%)
Query: 308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQ---QMEIVGGIRHENVVALRAYY 364
           LG G FG  YKA  ++   +   ++ E    + E E    ++EI+    H  +V L   Y
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETK-SEEELEDYIVEIEILATCDHPYIVKLLGAY 77
Query: 365 YSKDEKLMVYDYFEPGSV--SAMLHGRRGEGQSSLDWDTRVXXXXXXXXXXXXXXTENGG 422
           Y  D KL +   F PG    + ML   RG  +  +    R                 +  
Sbjct: 78  YH-DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFL--------HSK 128
Query: 423 KLVHGGIKASNIFLNSQGHVCVSDIXXXXXXXXXXXXXXXXX-----XXXXXEVTDTRKA 477
           +++H  +KA N+ +  +G + ++D                             + +T K 
Sbjct: 129 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 188
Query: 478 T---QASDVFSFGVLLLELLTGKSPIH 501
           T     +D++S G+ L+E+   + P H
Sbjct: 189 TPYDYKADIWSLGITLIEMAQIEPPHH 215

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	615
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	6e-78
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	6e-68
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	6e-63
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-52
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	3e-49
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	5e-30
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	7e-42
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-41
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-40
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-40
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-31
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-31
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-31
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-30
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	7e-30
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-28
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-28
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	3e-26
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	1e-25
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	2e-25
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	6e-22
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	4e-19
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-37
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-36
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-36
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-35
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-35
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-34
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-34
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-34
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	6e-34
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-33
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-32
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	9e-29
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-28
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-26
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	3e-26
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-26
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	4e-26
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-25
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	6e-25
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-24
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	4e-23
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-23
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	6e-23
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	5e-17
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-13
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	1e-12
3fxi_A	605	TLR4, htoll, TOLL-like receptor 4; leucine rich re	8e-12
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-24
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-22
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-21
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	3e-21
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-18
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	2e-18
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	6e-17
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	1e-07
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-24
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	8e-24
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-23
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	3e-23
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-23
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-23
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	5e-23
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	7e-23
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-23
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-22
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-22
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-22
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	7e-21
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	4e-20
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-19
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	3e-19
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-18
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	8e-18
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-17
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	1e-17
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-13
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	2e-04
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-22
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-22
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-22
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-22
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	4e-22
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	5e-22
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-22
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	9e-22
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-21
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-21
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	2e-21
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-21
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-21
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	2e-20
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	3e-14
3jqh_A	167	C-type lectin domain family 4 member M; DC-signr,	7e-13
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-21
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	5e-21
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	6e-21
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	6e-21
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	8e-21
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	8e-21
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-20
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	1e-20
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-20
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-20
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	1e-16
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	7e-15
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-20
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-20
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-20
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-20
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-20
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-19
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-18
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-16
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	1e-15
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	2e-13
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-13
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-11
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	8e-11
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-10
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	3e-10
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-20
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-20
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-20
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	5e-20
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	6e-20
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	9e-20
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-18
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	1e-17
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-17
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	7e-17
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-17
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	2e-16
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	6e-16
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	8e-16
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	4e-14
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	5e-07
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-19
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-19
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-19
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-18
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-17
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	3e-17
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	7e-17
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	2e-16
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	8e-16
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	4e-14
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	1e-07
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-19
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-19
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-19
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-19
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-19
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-19
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-19
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-19
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-19
3pls_A	298	Macrophage-stimulating protein receptor; protein k	6e-19
3aln_A	327	Dual specificity mitogen-activated protein kinase;	7e-19
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-18
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-18
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-18
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-18
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-15
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	5e-15
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	2e-14
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	4e-14
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-18
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	2e-18
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	2e-18
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-18
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-18
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-18
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	6e-18
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-15
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-14
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	4e-14
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	1e-13
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	5e-06
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	7e-18
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	8e-18
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	8e-18
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	9e-18
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	1e-17
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-17
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-17
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-15
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-15
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-14
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-13
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	1e-12
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	7e-11
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-10
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	3e-09
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	4e-09
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	8e-07
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	2e-06
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	9e-05
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	4e-17
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-17
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-17
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-17
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-17
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-17
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-16
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-16
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	5e-15
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-14
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-14
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	4e-12
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-11
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	2e-11
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	1e-08
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	6e-08
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	9e-17
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	9e-17
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-16
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-16
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-16
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-16
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-16
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-14
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-14
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	2e-13
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-13
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	5e-12
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	4e-09
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	1e-05
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-16
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	5e-16
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	1e-13
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-13
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	2e-12
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	7e-16
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-15
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	6e-14
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	9e-14
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	8e-13
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	9e-13
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-12
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	5e-10
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	1e-09
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	4e-09
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	7e-16
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	8e-16
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	9e-16
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-15
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-15
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	1e-15
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-14
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	2e-14
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	7e-13
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	3e-09
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-15
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-14
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	5e-12
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	1e-09
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-08
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-07
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	3e-05
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	2e-04
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-04
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	4e-04
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-15
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-15
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-15
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	6e-14
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-13
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	9e-13
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	3e-12
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	7e-12
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	2e-11
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	7e-10
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-15
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-15
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	3e-15
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-13
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	9e-12
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-10
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	2e-09
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	1e-08
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	6e-06
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-15
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-13
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	1e-12
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-11
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	2e-09
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	7e-09
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	3e-07
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	3e-15
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-15
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-15
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	5e-15
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	6e-15
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-14
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	2e-14
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-14
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	2e-14
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-14
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	6e-14
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	2e-13
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	5e-12
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-09
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	1e-05
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	2e-14
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	1e-13
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	3e-13
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	8e-13
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	4e-10
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	6e-05
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-14
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	3e-14
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	5e-14
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	8e-13
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-14
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	4e-14
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-14
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	4e-14
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	6e-14
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-13
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	9e-13
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	2e-12
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	1e-11
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	4e-14
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	2e-13
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	6e-10
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	5e-14
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-12
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-11
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-11
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	1e-10
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	3e-09
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	2e-06
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	5e-14
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	6e-14
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	6e-14
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-12
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	1e-12
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	4e-09
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-13
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	6e-13
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	9e-13
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	9e-13
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-12
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	7e-12
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	3e-11
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-10
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	2e-09
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	8e-08
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	1e-05
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	4e-05
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-13
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	5e-13
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	5e-13
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	1e-11
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	2e-06
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-13
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	5e-13
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	6e-12
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	1e-09
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	3e-08
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	2e-06
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	4e-05
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-13
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	1e-13
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-13
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-13
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	2e-13
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	5e-12
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	3e-11
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	4e-05
1o6v_A	466	Internalin A; bacterial infection, extracellular r	2e-13
1o6v_A	466	Internalin A; bacterial infection, extracellular r	3e-13
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-13
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-13
1o6v_A	466	Internalin A; bacterial infection, extracellular r	5e-13
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-12
1o6v_A	466	Internalin A; bacterial infection, extracellular r	9e-12
1o6v_A	466	Internalin A; bacterial infection, extracellular r	7e-11
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-09
1o6v_A	466	Internalin A; bacterial infection, extracellular r	4e-05
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-13
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-13
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	4e-13
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	5e-13
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	6e-13
3uqc_A	286	Probable conserved transmembrane protein; structur	6e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	9e-13
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	1e-11
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	2e-10
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	3e-08
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-12
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	1e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-12
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	2e-11
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	4e-04
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-12
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	1e-12
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	4e-12
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	9e-12
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	2e-10
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	7e-10
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	7e-06
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-12
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-11
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	2e-11
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	8e-11
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	9e-11
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-07
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	1e-06
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	4e-04
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	2e-12
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	8e-12
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	5e-09
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-12
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	5e-12
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	5e-11
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	4e-04
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	5e-12
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	5e-11
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-10
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	8e-07
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	1e-04
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	5e-12
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	5e-12
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	1e-09
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-12
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	6e-12
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	6e-12
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	7e-12
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-11
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-11
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-11
3m19_A	251	Variable lymphocyte receptor A diversity region; a	2e-11
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-11
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	3e-11
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-11
3e6j_A	229	Variable lymphocyte receptor diversity region; var	3e-11
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	7e-11
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	8e-11
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-10
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	1e-10
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-10
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	1e-10
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-10
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-10
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-10
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-10
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-10
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-10
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-10
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	3e-10
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-09
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	9e-09
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	2e-08
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	4e-10
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	5e-10
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	6e-10
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	7e-10
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	8e-10
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	9e-10
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	1e-09
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	1e-09
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	6e-04
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-09
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-09
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	1e-08
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	1e-09
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-09
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-09
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-09
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	4e-09
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	6e-09
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-08
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	8e-08
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-06
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	1e-05
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	2e-05
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	2e-09
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	5e-06
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	2e-09
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-09
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-09
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-09
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-09
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-09
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-09
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-09
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-09
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	3e-09
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	3e-09
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	3e-09
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	6e-07
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	3e-09
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	4e-09
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-09
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	4e-09
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	4e-09
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	7e-09
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	1e-08
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	2e-07
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-09
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-09
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	5e-09
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	6e-09
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	6e-09
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	7e-09
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	4e-08
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	6e-08
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	8e-08
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	1e-07
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	7e-09
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	7e-09
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	8e-09
3niz_A	311	Rhodanese family protein; structural genomics, str	9e-09
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	9e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-08
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-08
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-08
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-08
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-08
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-08
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-08
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	1e-08
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-07
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	6e-07
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-06
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	2e-05
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-08
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-08
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-08
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-08
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-08
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	3e-08
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	3e-07
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	4e-08
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	6e-08
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-07
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	1e-05
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-08
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	5e-08
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-08
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-07
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-07
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-07
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-07
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-07
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	2e-07
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-07
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-07
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-07
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	3e-04
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-07
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-07
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	5e-07
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	6e-07
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	6e-04
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-06
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-06
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	6e-06
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-05
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-05
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	3e-05
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	4e-05
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	3e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  249 bits (638), Expect = 6e-78
 Identities = 107/296 (36%), Positives = 166/296 (56%), Gaps = 25/296 (8%)

Query: 294 VFDLEDLLRA-----SAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNV--GKREFEQQM 346
            F L +L  A     +  +LG+G FG  YK  L D + V VKRLKE     G+ +F+ ++
Sbjct: 19  RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEV 78

Query: 347 EIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIA 406
           E++    H N++ LR +  +  E+L+VY Y   GSV++ L  R  E Q  LDW  R RIA
Sbjct: 79  EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP-ESQPPLDWPKRQRIA 137

Query: 407 IGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAM----- 461
           +G+ARG+A++H     K++H  +KA+NI L+ +    V D GLA LM             
Sbjct: 138 LGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM----DYKDTHVTT 193

Query: 462 RAAG---YRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATG--GDEVVHLVRWVN 516
              G   + APE   T K+++ +DVF +GV+LLEL+TG+          D+ V L+ WV 
Sbjct: 194 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK 253

Query: 517 SVVREEWTAEVFDVELL-RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVE 571
            +++E+    + DV+L   Y   +EE+ +++QV + C    P ERPKM++V++M+E
Sbjct: 254 GLLKEKKLEALVDVDLQGNYK--DEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  222 bits (569), Expect = 6e-68
 Identities = 86/318 (27%), Positives = 145/318 (45%), Gaps = 26/318 (8%)

Query: 272 KEGVSGSHDKNSKLVFFEGCNLVFDLEDLLRA-----SAEVLGKGTFGTAYKAALEDAST 326
            +  +  +D  S        +    L DL  A        ++G G FG  YK  L D + 
Sbjct: 6   SKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK 65

Query: 327 VVVKRLKEVNV-GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAM 385
           V +KR    +  G  EFE ++E +   RH ++V+L  +   ++E +++Y Y E G++   
Sbjct: 66  VALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRH 125

Query: 386 LHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVS 445
           L+G       S+ W+ R+ I IGAARG+ ++HT     ++H  +K+ NI L+      ++
Sbjct: 126 LYGS-DLPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKIT 181

Query: 446 DIGLAALMSPMPPP-----AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPI 500
           D G++   + +             GY  PE     + T+ SDV+SFGV+L E+L  +S I
Sbjct: 182 DFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAI 241

Query: 501 HATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE-----EEMVEMLQVGMACVVR 555
             +   E+V+L  W           ++ D      PN+      E + +     + C+  
Sbjct: 242 VQSLPREMVNLAEWAVESHNNGQLEQIVD------PNLADKIRPESLRKFGDTAVKCLAL 295

Query: 556 MPEERPKMADVLKMVEDI 573
             E+RP M DVL  +E  
Sbjct: 296 SSEDRPSMGDVLWKLEYA 313

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  209 bits (534), Expect = 6e-63
 Identities = 82/290 (28%), Positives = 135/290 (46%), Gaps = 23/290 (7%)

Query: 295 FDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNV-----GKREFEQQMEIV 349
           FD E  +      +G+G FG  YK  + + +TV VK+L  +        K++F+Q+++++
Sbjct: 27  FD-ERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVM 84

Query: 350 GGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGA 409
              +HEN+V L  +    D+  +VY Y   GS+   L      G   L W  R +IA GA
Sbjct: 85  AKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPPLSWHMRCKIAQGA 142

Query: 410 ARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAM--RAAG-- 465
           A GI  +H  +    +H  IK++NI L+      +SD GLA          M  R  G  
Sbjct: 143 ANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTT 199

Query: 466 -YRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWT 524
            Y APE     + T  SD++SFGV+LLE++TG   +      +   L+     +  EE T
Sbjct: 200 AYMAPEAL-RGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQ--LLLDIKEEIEDEEKT 256

Query: 525 -AEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
             +  D ++         +  M  V   C+     +RP +  V ++++++
Sbjct: 257 IEDYIDKKMNDAD--STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  182 bits (463), Expect = 1e-52
 Identities = 71/328 (21%), Positives = 122/328 (37%), Gaps = 37/328 (11%)

Query: 275 VSGSHDKNSKLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKE 334
           +   H  +S  V     NL F    L     EV  +G FG  +KA L +   V VK    
Sbjct: 1   MGHHHHHHSSGVDLGTENLYFQSMPL--QLLEVKARGRFGCVWKAQLLN-EYVAVKIFPI 57

Query: 335 VNVGKREFEQQMEIVGGIRHENVVALRAY----YYSKDEKLMVYDYFEPGSVSAMLHGRR 390
            +    + E ++  + G++HEN++              +  ++  + E GS+S  L    
Sbjct: 58  QDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN- 116

Query: 391 GEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKL-------VHGGIKASNIFLNSQGHVC 443
                 + W+    IA   ARG+A++H +  G          H  IK+ N+ L +    C
Sbjct: 117 -----VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171

Query: 444 VSDIGLAALMSPMPPPA--MRAAG---YRAPEVTD-----TRKATQASDVFSFGVLLLEL 493
           ++D GLA                G   Y APEV +      R A    D+++ G++L EL
Sbjct: 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231

Query: 494 LTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEE------MVEMLQ 547
            +  +       + ++     +      E   EV   +  R P + +       M  + +
Sbjct: 232 ASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKR-PVLRDYWQKHAGMAMLCE 290

Query: 548 VGMACVVRMPEERPKMADVLKMVEDIRR 575
               C     E R     V + +  ++R
Sbjct: 291 TIEECWDHDAEARLSAGCVGERITQMQR 318

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  173 bits (440), Expect = 3e-49
 Identities = 55/182 (30%), Positives = 86/182 (47%), Gaps = 10/182 (5%)

Query: 27  EDKQALLDFIHNIHNSRSL-NWNESSSLC-KSWTGVTCSADH--SRVVALRLPGMALRGE 82
           +DKQALL    ++ N  +L +W  ++  C ++W GV C  D    RV  L L G+ L   
Sbjct: 6   QDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65

Query: 83  IP-PNTIGRLSALQNLSLRS-NSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWN 140
            P P+++  L  L  L +   N+L G  P   +KL  L  L++   + SG +P   S   
Sbjct: 66  YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125

Query: 141 NLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWA----FAGNN 196
            L  +D S N  + ++P SIS L +L  +    N ++G +P S   F         + N 
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNR 185

Query: 197 LS 198
           L+
Sbjct: 186 LT 187

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313

 Score =  119 bits (301), Expect = 5e-30
 Identities = 41/130 (31%), Positives = 64/130 (49%), Gaps = 5/130 (3%)

Query: 69  VVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSF 128
             ++ +    L G+IPP T   L+ L  + L  N L G     F   +N   +HL  NS 
Sbjct: 176 FTSMTISRNRLTGKIPP-TFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSL 233

Query: 129 SGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRS--LQR 186
           +  L     +  NL  +DL NN    ++P  +++L  L +LN++ N+L G +P+   LQR
Sbjct: 234 AFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQR 292

Query: 187 FPSWAFAGNN 196
           F   A+A N 
Sbjct: 293 FDVSAYANNK 302

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  153 bits (388), Expect = 7e-42
 Identities = 61/322 (18%), Positives = 122/322 (37%), Gaps = 50/322 (15%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEI--VGGIRHENVVAL--- 360
           E++G+G +G  YK +L++   V VK     N  ++ F  +  I  V  + H+N+      
Sbjct: 19  ELIGRGRYGAVYKGSLDE-RPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFIVG 75

Query: 361 --RAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT 418
             R     + E L+V +Y+  GS+   L         + DW +  R+A    RG+A++HT
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLS------LHTSDWVSSCRLAHSVTRGLAYLHT 129

Query: 419 ENGG------KLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP--------PAMRAA 464
           E          + H  + + N+ + + G   +SD GL+  ++             A+   
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEV 189

Query: 465 G---YRAPEV-------TDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLV-- 512
           G   Y APEV        D   A +  D+++ G++  E+    + +          +   
Sbjct: 190 GTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQ 249

Query: 513 RWVNSVVREEWTAEVFDVELLR------YPNIEEEMVEMLQVGMACVVRMPEERPKMADV 566
             V +    E    +   E  R      +      +  + +    C  +  E R      
Sbjct: 250 TEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXA 309

Query: 567 LKMVEDIRRV--KAENPPSTEN 586
            + + ++  +  + ++   T +
Sbjct: 310 EERMAELMMIWERNKSVSPTAH 331

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  151 bits (383), Expect = 2e-41
 Identities = 68/327 (20%), Positives = 133/327 (40%), Gaps = 40/327 (12%)

Query: 296 DLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHE 355
           D +++     EV+G+G FG   KA       V +K+++  +  ++ F  ++  +  + H 
Sbjct: 6   DYKEIEVE--EVVGRGAFGVVCKAKWRA-KDVAIKQIESESE-RKAFIVELRQLSRVNHP 61

Query: 356 NVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAH 415
           N+V L  Y    +   +V +Y E GS+  +LHG              +   +  ++G+A+
Sbjct: 62  NIVKL--YGACLNPVCLVMEYAEGGSLYNVLHGAEP--LPYYTAAHAMSWCLQCSQGVAY 117

Query: 416 IHTENGGKLVHGGIKASNIFLNSQGHVC-VSDIGLAALMSPMPPPAMRAAG---YRAPEV 471
           +H+     L+H  +K  N+ L + G V  + D G A  +           G   + APEV
Sbjct: 118 LHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH---MTNNKGSAAWMAPEV 174

Query: 472 TDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE 531
            +    ++  DVFS+G++L E++T + P      DE+      +   V            
Sbjct: 175 FEGSNYSEKCDVFSWGIILWEVITRRKPF-----DEIGGPAFRIMWAVHNG--------- 220

Query: 532 LLRYP---NIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTENRS 588
             R P   N+ + +  ++     C  + P +RP M +++K++  + R      P  +   
Sbjct: 221 -TRPPLIKNLPKPIESLMT---RCWSKDPSQRPSMEEIVKIMTHLMRYF----PGADEPL 272

Query: 589 EISSSAATPKATETASSSTAHLDSFLS 615
           +     + P   +           F  
Sbjct: 273 QYPCQHSLPPGEDGRVEPYVDFAEFYR 299

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  148 bits (377), Expect = 1e-40
 Identities = 80/338 (23%), Positives = 145/338 (42%), Gaps = 38/338 (11%)

Query: 262 VKSQKKEMSLKEGVSGSHDKNSKLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAAL 321
           +K       + +    + +        +G ++     DL     E +G G+FGT ++A  
Sbjct: 1   MKHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIK--EKIGAGSFGTVHRAEW 58

Query: 322 EDASTVVVKRLKEVNVGK---REFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFE 378
              S V VK L E +       EF +++ I+  +RH N+V             +V +Y  
Sbjct: 59  HG-SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLS 117

Query: 379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNS 438
            GS+  +LH  +   +  LD   R+ +A   A+G+ ++H  N   +VH  +K+ N+ ++ 
Sbjct: 118 RGSLYRLLH--KSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDK 174

Query: 439 QGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTDTRKATQASDVFSFGVLLLELLT 495
           +  V V D GL+ L +     +  AAG   + APEV     + + SDV+SFGV+L EL T
Sbjct: 175 KYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELAT 234

Query: 496 GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP---NIEEEMVEMLQVGMAC 552
            + P       +VV  V +                   R     N+  ++  +++    C
Sbjct: 235 LQQPWGNLNPAQVVAAVGFKC----------------KRLEIPRNLNPQVAAIIE---GC 275

Query: 553 VVRMPEERPKMADVLKMVEDIRRVKAENPPSTENRSEI 590
               P +RP  A ++ ++  +     ++     NRS++
Sbjct: 276 WTNEPWKRPSFATIMDLLRPL----IKSAVPPPNRSDL 309

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  156 bits (397), Expect = 2e-40
 Identities = 44/187 (23%), Positives = 83/187 (44%), Gaps = 18/187 (9%)

Query: 27  EDKQALLDFIHNIHNSRSL-NWNESSSLCKSWTGVTCSADHSRVVALRLPGMALR---GE 82
            +   L+ F   + +   L +W+ + + C ++ GVTC     +V ++ L    L      
Sbjct: 12  REIHQLISFKDVLPDKNLLPDWSSNKNPC-TFDGVTC--RDDKVTSIDLSSKPLNVGFSA 68

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWN-- 140
           +  + +  L+ L++L L ++ ++G     F    +LTSL L  NS SGP+    S+ +  
Sbjct: 69  VSSS-LLSLTGLESLFLSNSHINGSVSG-FKCSASLTSLDLSRNSLSGPVTTLTSLGSCS 126

Query: 141 NLTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLPRSLQRFPSWA------FA 193
            L  +++S+N  +     S   KL  L  L+L+ NS++G                    +
Sbjct: 127 GLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAIS 186

Query: 194 GNNLSSE 200
           GN +S +
Sbjct: 187 GNKISGD 193

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  128 bits (325), Expect = 3e-31
 Identities = 43/133 (32%), Positives = 65/133 (48%), Gaps = 6/133 (4%)

Query: 72  LRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKL-ENLTSLHLQFNSFSG 130
           L L      GE+P +T+ ++  L+ L L  N  SG  P   + L  +L +L L  N+FSG
Sbjct: 323 LALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSG 382

Query: 131 PLPLDF--SVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFP 188
           P+  +   +  N L  + L NN F   IP ++S  + L +L+L+ N L+GT+P SL    
Sbjct: 383 PILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLS 442

Query: 189 SWAF---AGNNLS 198
                    N L 
Sbjct: 443 KLRDLKLWLNMLE 455

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  127 bits (322), Expect = 6e-31
 Identities = 41/123 (33%), Positives = 60/123 (48%), Gaps = 4/123 (3%)

Query: 79  LRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSV 138
             G+IPP T+   S L +L L  N LSG  PS    L  L  L L  N   G +P +   
Sbjct: 406 FTGKIPP-TLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMY 464

Query: 139 WNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAF---AGN 195
              L  + L  N     IP+ +S  T+L+ ++L+NN LTG +P+ + R  + A    + N
Sbjct: 465 VKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNN 524

Query: 196 NLS 198
           + S
Sbjct: 525 SFS 527

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  127 bits (321), Expect = 7e-31
 Identities = 44/123 (35%), Positives = 62/123 (50%), Gaps = 4/123 (3%)

Query: 79  LRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSV 138
           L G IP + +G LS L++L L  N L G  P +   ++ L +L L FN  +G +P   S 
Sbjct: 430 LSGTIPSS-LGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSN 488

Query: 139 WNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAF---AGN 195
             NL  I LSNN     IP  I +L +L+ L L+NNS +G +P  L    S  +     N
Sbjct: 489 CTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTN 548

Query: 196 NLS 198
             +
Sbjct: 549 LFN 551

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  124 bits (314), Expect = 6e-30
 Identities = 39/122 (31%), Positives = 59/122 (48%), Gaps = 2/122 (1%)

Query: 79  LRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSV 138
           L GEIP   +  +  L+ L L  N L+G  PS  S   NL  + L  N  +G +P     
Sbjct: 454 LEGEIPQ-ELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGR 512

Query: 139 WNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLS 198
             NL ++ LSNN F+ +IPA +     L  L+L  N   GT+P ++ +      A N ++
Sbjct: 513 LENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSG-KIAANFIA 571

Query: 199 SE 200
            +
Sbjct: 572 GK 573

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  124 bits (314), Expect = 7e-30
 Identities = 38/125 (30%), Positives = 54/125 (43%), Gaps = 6/125 (4%)

Query: 79  LRGEIPPNTIGR--LSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDF 136
             G I PN + +   + LQ L L++N  +G  P   S    L SLHL FN  SG +P   
Sbjct: 380 FSGPILPN-LCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSL 438

Query: 137 SVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAF---A 193
              + L  + L  N     IP  +  +  L  L L  N LTG +P  L    +  +   +
Sbjct: 439 GSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLS 498

Query: 194 GNNLS 198
            N L+
Sbjct: 499 NNRLT 503

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  120 bits (302), Expect = 2e-28
 Identities = 38/136 (27%), Positives = 55/136 (40%), Gaps = 8/136 (5%)

Query: 67  SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFN 126
             +  L +        IP   +G  SALQ+L +  N LSG F    S    L  L++  N
Sbjct: 200 VNLEFLDVSSNNFSTGIP--FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSN 257

Query: 127 SFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASIS-KLTHLSALNLANNSLTGTLPRSLQ 185
            F GP+P       +L  + L+ N F   IP  +S     L+ L+L+ N   G +P    
Sbjct: 258 QFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFG 315

Query: 186 RFPSWAF---AGNNLS 198
                     + NN S
Sbjct: 316 SCSLLESLALSSNNFS 331

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  118 bits (298), Expect = 6e-28
 Identities = 41/127 (32%), Positives = 58/127 (45%), Gaps = 7/127 (5%)

Query: 79  LRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FS 137
             GEIP    G    L  L L  N   G  P  F     L SL L  N+FSG LP+D   
Sbjct: 281 FTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLL 340

Query: 138 VWNNLTVIDLSNNFFNASIPASISKLT-HLSALNLANNSLTGTLPRSLQRFPSWA----- 191
               L V+DLS N F+  +P S++ L+  L  L+L++N+ +G +  +L + P        
Sbjct: 341 KMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELY 400

Query: 192 FAGNNLS 198
              N  +
Sbjct: 401 LQNNGFT 407

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  113 bits (284), Expect = 3e-26
 Identities = 42/166 (25%), Positives = 67/166 (40%), Gaps = 13/166 (7%)

Query: 32  LLDFIHNIHNSRSLNWNESSSLCKSWTGVTCSADHSRVVALRLPGMALRGEIPPNTIGRL 91
           +    H   N        S  L +           S      +      G   P T    
Sbjct: 583 MKKECHGAGNLLEFQGIRSEQLNRL----------STRNPCNITSRVYGGHTSP-TFDNN 631

Query: 92  SALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNF 151
            ++  L +  N LSG  P +   +  L  L+L  N  SG +P +      L ++DLS+N 
Sbjct: 632 GSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK 691

Query: 152 FNASIPASISKLTHLSALNLANNSLTGTLPRS--LQRFPSWAFAGN 195
            +  IP ++S LT L+ ++L+NN+L+G +P     + FP   F  N
Sbjct: 692 LDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNN 737

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  111 bits (279), Expect = 1e-25
 Identities = 43/132 (32%), Positives = 63/132 (47%), Gaps = 8/132 (6%)

Query: 79  LRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSV 138
           L GEIP   +   + L  +SL +N L+G  P    +LENL  L L  NSFSG +P +   
Sbjct: 478 LTGEIPS-GLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGD 536

Query: 139 WNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAF---AGN 195
             +L  +DL+ N FN +IPA++ K +      +A N + G     ++          AGN
Sbjct: 537 CRSLIWLDLNTNLFNGTIPAAMFKQS----GKIAANFIAGKRYVYIKNDGMKKECHGAGN 592

Query: 196 NLSSENARPPAL 207
            L  +  R   L
Sbjct: 593 LLEFQGIRSEQL 604

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score =  110 bits (277), Expect = 2e-25
 Identities = 30/123 (24%), Positives = 55/123 (44%), Gaps = 4/123 (3%)

Query: 79  LRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSV 138
            +G      + RLS     ++ S    G     F    ++  L + +N  SG +P +   
Sbjct: 596 FQGIRSEQ-LNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGS 654

Query: 139 WNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWA---FAGN 195
              L +++L +N  + SIP  +  L  L+ L+L++N L G +P+++           + N
Sbjct: 655 MPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNN 714

Query: 196 NLS 198
           NLS
Sbjct: 715 NLS 717

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 99.6 bits (249), Expect = 6e-22
 Identities = 24/134 (17%), Positives = 44/134 (32%), Gaps = 21/134 (15%)

Query: 72  LRLPGMALRGEIP-------------------PNTIGRLSALQNLSLRSN--SLSGLFPS 110
           L L      G IP                      I      +      N     G+   
Sbjct: 543 LDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSE 602

Query: 111 DFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALN 170
             ++L      ++    + G     F    ++  +D+S N  +  IP  I  + +L  LN
Sbjct: 603 QLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILN 662

Query: 171 LANNSLTGTLPRSL 184
           L +N ++G++P  +
Sbjct: 663 LGHNDISGSIPDEV 676

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768

 Score = 90.7 bits (226), Expect = 4e-19
 Identities = 23/127 (18%), Positives = 41/127 (32%), Gaps = 10/127 (7%)

Query: 79  LRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSV 138
             G IP   +G   +L  L L +N  +G  P+   K     S  +  N  +G   +    
Sbjct: 526 FSGNIPA-ELGDCRSLIWLDLNTNLFNGTIPAAMFKQ----SGKIAANFIAGKRYVYIKN 580

Query: 139 WNNLTVIDLSNNF--FNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWA---FA 193
                    + N   F       +++L+  +  N+ +    G    +     S      +
Sbjct: 581 DGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMS 640

Query: 194 GNNLSSE 200
            N LS  
Sbjct: 641 YNMLSGY 647

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  139 bits (352), Expect = 2e-37
 Identities = 74/297 (24%), Positives = 124/297 (41%), Gaps = 49/297 (16%)

Query: 296 DLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLK-----EVNVGKREFEQQMEIVG 350
           D  +L     E++G G FG  Y+A       V VK  +     +++       Q+ ++  
Sbjct: 5   DFAELTLE--EIIGIGGFGKVYRAFWIG-DEVAVKAARHDPDEDISQTIENVRQEAKLFA 61

Query: 351 GIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAA 410
            ++H N++ALR     +    +V ++   G ++ +L G+R      +  D  V  A+  A
Sbjct: 62  MLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR------IPPDILVNWAVQIA 115

Query: 411 RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVC--------VSDIGLAALMSPMPPPAMR 462
           RG+ ++H E    ++H  +K+SNI +  +            ++D GLA          M 
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR--TTKMS 173

Query: 463 AAG---YRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVV 519
           AAG   + APEV      ++ SDV+S+GVLL ELLTG+ P     G  V + V       
Sbjct: 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK--- 230

Query: 520 REEWTAEVFDVELLRYP---NIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
                        L  P      E   ++++    C    P  RP   ++L  +  I
Sbjct: 231 -------------LALPIPSTCPEPFAKLME---DCWNPDPHSRPSFTNILDQLTTI 271

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  137 bits (348), Expect = 2e-36
 Identities = 62/301 (20%), Positives = 113/301 (37%), Gaps = 43/301 (14%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAY-- 363
           + +GKG +G  +         V VK            E ++     +RHEN++   A   
Sbjct: 43  KQIGKGRYGEVWMGKWRG-EKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADI 101

Query: 364 --YYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENG 421
               S  +  ++ DY E GS+   L        ++LD  + +++A  +  G+ H+HTE  
Sbjct: 102 KGTGSWTQLYLITDYHENGSLYDYLK------STTLDAKSMLKLAYSSVSGLCHLHTEIF 155

Query: 422 G-----KLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP----PAMRAAG---YRAP 469
                  + H  +K+ NI +   G  C++D+GLA            P     G   Y  P
Sbjct: 156 STQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPP 215

Query: 470 EVTDTR------KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEW 523
           EV D        ++   +D++SFG++L E+             ++ +     +    E+ 
Sbjct: 216 EVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDM 275

Query: 524 TAEVFDVELLRYPNIEE---------EMVEMLQVGMACVVRMPEERPKMADVLKMVEDIR 574
              V  ++ LR P+            +M +++     C    P  R     V K +  + 
Sbjct: 276 REIVC-IKKLR-PSFPNRWSSDECLRQMGKLMT---ECWAHNPASRLTALRVKKTLAKMS 330

Query: 575 R 575
            
Sbjct: 331 E 331

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  134 bits (340), Expect = 1e-35
 Identities = 66/288 (22%), Positives = 125/288 (43%), Gaps = 45/288 (15%)

Query: 306 EVLGKGTFGTAYKAALEDASTVV-VKRLK--------EVNVGKREFEQQMEIVGGIRHEN 356
           + +GKG FG  +K  L    +VV +K L         E+    +EF++++ I+  + H N
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 357 VVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHI 416
           +V L       +   MV ++   G +   L  +       + W  ++R+ +  A GI ++
Sbjct: 85  IVKLYGL--MHNPPRMVMEFVPCGDLYHRLLDKAHP----IKWSVKLRLMLDIALGIEYM 138

Query: 417 HTENGGKLVHGGIKASNIFLNSQG-----HVCVSDIGLAALMSPMPPPAMRAAG---YRA 468
             +N   +VH  +++ NIFL S          V+D GL+              G   + A
Sbjct: 139 QNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS---VSGLLGNFQWMA 194

Query: 469 PEVTDTRKA--TQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAE 526
           PE     +   T+ +D +SF ++L  +LTG+ P       +    ++++N +  E     
Sbjct: 195 PETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK----IKFINMIREEG---- 246

Query: 527 VFDVELLRYPNIEEEMVEMLQVGM-ACVVRMPEERPKMADVLKMVEDI 573
                 LR P I E+    L+  +  C    P++RP  + ++K + ++
Sbjct: 247 ------LR-PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  133 bits (338), Expect = 2e-35
 Identities = 69/283 (24%), Positives = 126/283 (44%), Gaps = 37/283 (13%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKR---EFEQQMEIVGGIRHENVVALRA 362
           + +G G+FGT YK        V VK L       +    F+ ++ ++   RH N++    
Sbjct: 30  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 363 YYYSKDEKL-MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENG 421
           Y  S   +L +V  + E  S+   LH          +    + IA   ARG+ ++H ++ 
Sbjct: 88  Y--STAPQLAIVTQWCEGSSLYHHLHASET----KFEMKKLIDIARQTARGMDYLHAKS- 140

Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS--PMPPPAMRAAG---YRAPEV---TD 473
             ++H  +K++NIFL+    V + D GLA   S         + +G   + APEV    D
Sbjct: 141 --IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQD 198

Query: 474 TRKATQASDVFSFGVLLLELLTGKSP-IHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
           +   +  SDV++FG++L EL+TG+ P  +    D+++ +V      +  +          
Sbjct: 199 SNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV--GRGSLSPD--------LS 248

Query: 533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
               N  + M  ++     C+ +  +ERP    +L  +E++ R
Sbjct: 249 KVRSNCPKRMKRLM---AECLKKKRDERPSFPRILAEIEELAR 288

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  132 bits (333), Expect = 1e-34
 Identities = 62/305 (20%), Positives = 115/305 (37%), Gaps = 55/305 (18%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVV----ALR 361
           E +GKG +G  ++ + +    V VK     +      E ++     +RHEN++    +  
Sbjct: 14  ECVGKGRYGEVWRGSWQG-ENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDM 72

Query: 362 AYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENG 421
              +S  +  ++  Y E GS+   L         +LD  + +RI +  A G+AH+H E  
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYLQLT------TLDTVSCLRIVLSIASGLAHLHIEIF 126

Query: 422 G-----KLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP----MPPPAMRAAG---YRAP 469
           G      + H  +K+ NI +   G  C++D+GLA + S     +        G   Y AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186

Query: 470 EV------TDTRKATQASDVFSFGVLLLELLTGKSPIHATGG---------------DEV 508
           EV       D   + +  D+++FG++L E+                           +++
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246

Query: 509 VHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
             +V       R       F    L        + ++++    C  + P  R     + K
Sbjct: 247 RKVV--CVDQQRPNIPNRWFSDPTLT------SLAKLMK---ECWYQNPSARLTALRIKK 295

Query: 569 MVEDI 573
            +  I
Sbjct: 296 TLTKI 300

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  131 bits (331), Expect = 3e-34
 Identities = 70/324 (21%), Positives = 126/324 (38%), Gaps = 55/324 (16%)

Query: 295 FDLEDLLRASAEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVN-VGKREFEQQMEIVGGI 352
           F   DL+    EVLGKG FG A K    E    +V+K L   +   +R F ++++++  +
Sbjct: 7   FRPSDLIHG--EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL 64

Query: 353 RHENVVALRAYYYSKDEKLM-VYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAAR 411
            H NV+      Y KD++L  + +Y + G++  ++     +      W  RV  A   A 
Sbjct: 65  EHPNVLKFIGVLY-KDKRLNFITEYIKGGTLRGIIKSMDSQ----YPWSQRVSFAKDIAS 119

Query: 412 GIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR---- 467
           G+A++H+ N   ++H  + + N  +    +V V+D GLA LM             +    
Sbjct: 120 GMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176

Query: 468 -------------APEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRW 514
                        APE+ + R   +  DVFSFG++L E++   +                
Sbjct: 177 KKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA--------------- 221

Query: 515 VNSVVREEWTAEVFDVELLRYPNIEEEMVE-----MLQVGMACVVRMPEERPKMADVLKM 569
                  ++     D  L     ++             + + C    PE+RP    +   
Sbjct: 222 -----DPDYLPRTMDFGLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHW 276

Query: 570 VEDIRRVKAENPPSTENRSEISSS 593
           +E +R   A + P      ++   
Sbjct: 277 LETLRMHLAGHLPLGPQLEQLDRG 300

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  131 bits (331), Expect = 6e-34
 Identities = 64/304 (21%), Positives = 119/304 (39%), Gaps = 49/304 (16%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVV----ALR 361
           E +GKG FG  ++        V VK            E ++     +RHEN++    A  
Sbjct: 48  ESIGKGRFGEVWRGKWRG-EEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADN 106

Query: 362 AYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENG 421
               +  +  +V DY E GS+   L+      + ++  +  +++A+  A G+AH+H E  
Sbjct: 107 KDNGTWTQLWLVSDYHEHGSLFDYLN------RYTVTVEGMIKLALSTASGLAHLHMEIV 160

Query: 422 G-----KLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG-------YRAP 469
           G      + H  +K+ NI +   G  C++D+GLA            A         Y AP
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220

Query: 470 EV------TDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEW 523
           EV          ++ + +D+++ G++  E+    S     GG    + + + + V  +  
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI----GGIHEDYQLPYYDLVPSDPS 276

Query: 524 TAEVFDV---ELLRYPNIEE---------EMVEMLQVGMACVVRMPEERPKMADVLKMVE 571
             E+  V   + LR PNI            M ++++    C       R     + K + 
Sbjct: 277 VEEMRKVVCEQKLR-PNIPNRWQSCEALRVMAKIMR---ECWYANGAARLTALRIKKTLS 332

Query: 572 DIRR 575
            + +
Sbjct: 333 QLSQ 336

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  129 bits (326), Expect = 2e-33
 Identities = 62/343 (18%), Positives = 135/343 (39%), Gaps = 51/343 (14%)

Query: 267 KEMSLKEGVSGSHDKNSKLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDAST 326
             +SL    S     +   +F +  ++    E L     E++GKG FG  Y         
Sbjct: 4   MNLSLLSARSFPRKASQTSIFLQEWDI--PFEQLEIG--ELIGKGRFGQVYHGRWHG--E 57

Query: 327 VVVKRLKEVNVGK---REFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVS 383
           V ++ +      +   + F++++      RHENVV       S     ++    +  ++ 
Sbjct: 58  VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLY 117

Query: 384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVC 443
           +++   +      LD +   +IA    +G+ ++H +    ++H  +K+ N+F +  G V 
Sbjct: 118 SVVRDAK----IVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVV 169

Query: 444 VSDIGLAALMSPMPPPA----MRAA----GYRAPEVTDTRKA---------TQASDVFSF 486
           ++D GL ++   +        +R       + APE+               ++ SDVF+ 
Sbjct: 170 ITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFAL 229

Query: 487 GVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEML 546
           G +  EL   + P      + ++     + + ++            L    + +E+ ++L
Sbjct: 230 GTIWYELHAREWPFKTQPAEAIIWQ---MGTGMKPN----------LSQIGMGKEISDIL 276

Query: 547 QVGMACVVRMPEERPKMADVLKMVEDI-RRVKAENPPSTENRS 588
              + C     EERP    ++ M+E + +R +  + P    +S
Sbjct: 277 ---LFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSHPGHFWKS 316

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  125 bits (317), Expect = 1e-32
 Identities = 56/281 (19%), Positives = 110/281 (39%), Gaps = 37/281 (13%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGK---REFEQQMEIVGGIRHENVVALRA 362
             L +   G  +K   +  + +VVK LK  +      R+F ++   +    H NV+ +  
Sbjct: 16  TKLNENHSGELWKGRWQG-NDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 363 YYYSKDEK--LMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN 420
              S       ++  +   GS+  +LH         +D    V+ A+  ARG+A +HT  
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNF---VVDQSQAVKFALDMARGMAFLHTLE 131

Query: 421 GGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTRKA--- 477
              +    + + ++ ++      +S   +    S   P  M A  + APE    +     
Sbjct: 132 P-LIPRHALNSRSVMIDEDMTARISMADVK--FSFQSPGRMYAPAWVAPEALQKKPEDTN 188

Query: 478 TQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP- 536
            +++D++SF VLL EL+T + P       E+   V                    LR   
Sbjct: 189 RRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEG----------------LRPTI 232

Query: 537 --NIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
              I   + ++++    C+   P +RPK   ++ ++E ++ 
Sbjct: 233 PPGISPHVSKLMK---ICMNEDPAKRPKFDMIVPILEKMQD 270

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  115 bits (291), Expect = 9e-29
 Identities = 60/293 (20%), Positives = 123/293 (41%), Gaps = 36/293 (12%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRLKEVNVG-------KREFEQQMEIVGGIRHENV 357
           + +G+G F   Y+A  L D   V    LK+V +        + +  ++++++  + H NV
Sbjct: 38  KKIGRGQFSEVYRAACLLDGVPVA---LKKVQIFDLMDAKARADCIKEIDLLKQLNHPNV 94

Query: 358 VALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIH 417
           +   A +   +E  +V +  + G +S M+     + +  +   T  +  +     + H+H
Sbjct: 95  IKYYASFIEDNELNIVLELADAGDLSRMIK-HFKKQKRLIPERTVWKYFVQLCSALEHMH 153

Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTDT 474
           +    +++H  IK +N+F+ + G V + D+GL    S     A    G   Y +PE    
Sbjct: 154 SR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 210

Query: 475 RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLR 534
                 SD++S G LL E+   +SP +     + ++L      + + +            
Sbjct: 211 NGYNFKSDIWSLGCLLYEMAALQSPFYG----DKMNLYSLCKKIEQCD------------ 254

Query: 535 YPNIEEEMV--EMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTE 585
           YP +  +    E+ Q+   C+   PE+RP +  V  + + +    A +     
Sbjct: 255 YPPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHH 307

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  115 bits (289), Expect = 3e-28
 Identities = 63/318 (19%), Positives = 129/318 (40%), Gaps = 35/318 (11%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRLKEVNVGKREFE---QQMEIVGGIRHENVVALR 361
           + +G+G+FG A    + ED    V+K +    +  +E E   +++ ++  ++H N+V  R
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89

Query: 362 AYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENG 421
             +       +V DY E G +   ++ ++G        D  +   +     + H+H    
Sbjct: 90  ESFEENGSLYIVMDYCEGGDLFKRINAQKGV---LFQEDQILDWFVQICLALKHVHDR-- 144

Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTDTRKAT 478
            K++H  IK+ NIFL   G V + D G+A +++     A    G   Y +PE+ + +   
Sbjct: 145 -KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYN 203

Query: 479 QASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI 538
             SD+++ G +L EL T K    A     +V  +  ++                  +P +
Sbjct: 204 NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI--ISG----------------SFPPV 245

Query: 539 EEEM-VEMLQVGMACVVRMPEERPKMADVLK---MVEDIRRVKAENPPSTENRSEISSSA 594
                 ++  +      R P +RP +  +L+   + + I +  +    + E   +  S  
Sbjct: 246 SLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKF 305

Query: 595 ATPKATETASSSTAHLDS 612
            +        +S  +  S
Sbjct: 306 GSQPIPAKRPASGQNSIS 323

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  108 bits (271), Expect = 2e-26
 Identities = 60/299 (20%), Positives = 124/299 (41%), Gaps = 52/299 (17%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYY 364
           E++G G FG  +KA    D  T V+K    V     + E++++ +  + H N+V     +
Sbjct: 17  ELIGSGGFGQVFKAKHRIDGKTYVIK---RVKYNNEKAEREVKALAKLDHVNIVHYNGCW 73

Query: 365 YSKDEKL-------------MVY---DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIG 408
              D                 ++   ++ + G++   +  RRGE    LD    + +   
Sbjct: 74  DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE---KLDKVLALELFEQ 130

Query: 409 AARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG--- 465
             +G+ +IH++   KL++  +K SNIFL     V + D GL   +        R+ G   
Sbjct: 131 ITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKND-GKRTRSKGTLR 186

Query: 466 YRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTA 525
           Y +PE   ++   +  D+++ G++L ELL        T   +    +R  + ++ + +  
Sbjct: 187 YMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET--SKFFTDLR--DGIISDIFDK 242

Query: 526 EVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPST 584
           +   +           + ++L          PE+RP  +++L+ +   ++   +N   T
Sbjct: 243 KEKTL-----------LQKLLSKK-------PEDRPNTSEILRTLTVWKKSPEKNERHT 283

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  107 bits (270), Expect = 3e-26
 Identities = 56/278 (20%), Positives = 114/278 (41%), Gaps = 35/278 (12%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRLKEVNVGKREFE---QQMEIVGGIRHENVVALR 361
             +G G++G   K     D   +V K L   ++ + E +    ++ ++  ++H N+V   
Sbjct: 12  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71

Query: 362 AYYYSKDEKL--MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE 419
                +      +V +Y E G +++++     E Q  LD +  +R+       +   H  
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY-LDEEFVLRVMTQLTLALKECHRR 130

Query: 420 N--GGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTDT 474
           +  G  ++H  +K +N+FL+ + +V + D GLA +++     A    G   Y +PE  + 
Sbjct: 131 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNR 190

Query: 475 RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVR---EEWTAEVFDVE 531
               + SD++S G LL EL     P  A    E+   +       R     ++ E+ ++ 
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI--REGKFRRIPYRYSDELNEI- 247

Query: 532 LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM 569
                     +  ML +           RP + ++L+ 
Sbjct: 248 ----------ITRMLNLK-------DYHRPSVEEILEN 268

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  107 bits (270), Expect = 3e-26
 Identities = 60/275 (21%), Positives = 114/275 (41%), Gaps = 36/275 (13%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNVGKRE---FEQQMEIVGGIRHENVVALR 361
             +G+G+F T YK    E    V    L++  + K E   F+++ E++ G++H N+V   
Sbjct: 32  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 91

Query: 362 AYYYSKDEK----LMVYDYFEPGSVSAML--HGRRGEGQSSLDWDTRVRIAIGAARGIAH 415
             + S  +     ++V +    G++   L            +             +G+  
Sbjct: 92  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-------MKIKVLRSWCRQILKGLQF 144

Query: 416 IHTENGGKLVHGGIKASNIFLNS-QGHVCVSDIGLAALMSPMPPPAMRAAGY-RAPEVTD 473
           +H      ++H  +K  NIF+    G V + D+GLA L       A+       APE+ +
Sbjct: 145 LH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE 203

Query: 474 TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELL 533
             K  ++ DV++FG+ +LE+ T + P           + R V S V+     +V      
Sbjct: 204 -EKYDESVDVYAFGMCMLEMATSEYPYS--ECQNAAQIYRRVTSGVKPASFDKVAI---- 256

Query: 534 RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
                  E+ E+++    C+ +  +ER  + D+L 
Sbjct: 257 ------PEVKEIIE---GCIRQNKDERYSIKDLLN 282

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  108 bits (271), Expect = 4e-26
 Identities = 56/295 (18%), Positives = 113/295 (38%), Gaps = 50/295 (16%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRL-----KEVNVGKREFEQQMEIVGGIRHENVVA 359
           + LG+G F        L D     +KR+     ++    +RE     ++     H N++ 
Sbjct: 35  QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQRE----ADMHRLFNHPNILR 90

Query: 360 LRAYYYSKDEK----LMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAH 415
           L AY   +        ++  +F+ G++   +   + +G   L  D  + + +G  RG+  
Sbjct: 91  LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF-LTEDQILWLLLGICRGLEA 149

Query: 416 IHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---------- 465
           IH +      H  +K +NI L  +G   + D+G           + +A            
Sbjct: 150 IHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206

Query: 466 --YRAPEVTDTRK---ATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVR 520
             YRAPE+   +      + +DV+S G +L  ++ G+ P               V   V+
Sbjct: 207 ISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS-----VALAVQ 261

Query: 521 EEWTAEVFDVELLRYPNIEEEMVE-MLQVGMACVVRMPEERPKMADVLKMVEDIR 574
            + +         R+ +   +++  M+ V        P +RP +  +L  +E ++
Sbjct: 262 NQLSIPQSP----RHSSALWQLLNSMMTV-------DPHQRPHIPLLLSQLEALQ 305

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  105 bits (265), Expect = 3e-25
 Identities = 57/274 (20%), Positives = 98/274 (35%), Gaps = 41/274 (14%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRLKEVNVGKREFEQQMEIVGGI----RHENVVAL 360
             LG G++G  +K  + ED     VKR      G ++  +++  VG      +H   V  
Sbjct: 63  SRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVR- 121

Query: 361 RAYYYS--KDEKL-MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIH 417
                +  +   L +  +     S+        G    SL               +AH+H
Sbjct: 122 --LEQAWEEGGILYLQTELCG-PSLQQHCE-AWGA---SLPEAQVWGYLRDTLLALAHLH 174

Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRA--AGYRAPEVTDTR 475
           ++    LVH  +K +NIFL  +G   + D GL   +       ++     Y APE+    
Sbjct: 175 SQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELL-QG 230

Query: 476 KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY 535
               A+DVFS G+ +LE+          GG+    L       +  E+T           
Sbjct: 231 SYGTAADVFSLGLTILEVACNMEL--PHGGEGWQQL---RQGYLPPEFT----------- 274

Query: 536 PNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM 569
             +  E+  +L      +   P+ R     +L +
Sbjct: 275 AGLSSELRSVLV---MMLEPDPKLRATAEALLAL 305

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  105 bits (264), Expect = 6e-25
 Identities = 34/217 (15%), Positives = 76/217 (35%), Gaps = 26/217 (11%)

Query: 306 EVLGKGTFGTAYKA------ALEDASTVVVKRLKEVNVGKREFEQQM-EIVGGIRHENVV 358
            +LG+G F   Y+A        ++    V+K  K  N  +     Q+ E +        +
Sbjct: 71  HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130

Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT 418
              + +  ++  ++V + +  G++   ++  +   +  +     +  A+     I  +H 
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190

Query: 419 ENGGKLVHGGIKASNIFLNSQ-----------GHVCVSDIGLAALMSPMPPPAMRAA--- 464
                ++HG IK  N  L +              + + D+G +  M   P   +  A   
Sbjct: 191 CE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCE 247

Query: 465 --GYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSP 499
             G++  E+   +      D F     +  +L G   
Sbjct: 248 TSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM 284

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  107 bits (270), Expect = 1e-24
 Identities = 31/147 (21%), Positives = 56/147 (38%), Gaps = 7/147 (4%)

Query: 44  SLNWNESSSLCKSWTGVTCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNS 103
            L++N   ++  ++ G+       ++  L      L+     +    L  L  L +    
Sbjct: 379 DLSFNGVITMSSNFLGLE------QLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTH 432

Query: 104 LSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWNNLTVIDLSNNFFNASIPASISK 162
               F   F+ L +L  L +  NSF      D F+   NLT +DLS        P + + 
Sbjct: 433 TRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNS 492

Query: 163 LTHLSALNLANNSLTGTLPRSLQRFPS 189
           L+ L  LN+++N+         +   S
Sbjct: 493 LSSLQVLNMSHNNFFSLDTFPYKCLNS 519

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  102 bits (257), Expect = 4e-23
 Identities = 25/124 (20%), Positives = 41/124 (33%), Gaps = 2/124 (1%)

Query: 67  SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFN 126
                L L    LR  +   +      LQ L L    +  +    +  L +L++L L  N
Sbjct: 28  FSTKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGN 86

Query: 127 SFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGT-LPRSLQ 185
                    FS  ++L  +        +     I  L  L  LN+A+N +    LP    
Sbjct: 87  PIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFS 146

Query: 186 RFPS 189
              +
Sbjct: 147 NLTN 150

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  102 bits (256), Expect = 5e-23
 Identities = 30/113 (26%), Positives = 44/113 (38%), Gaps = 3/113 (2%)

Query: 79  LRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSV 138
            +    P+    L  L  L L    L  L P+ F+ L +L  L++  N+F       +  
Sbjct: 457 FQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKC 516

Query: 139 WNNLTVIDLSNNFFNASIPASISKL-THLSALNLANNSLTGTLPRSLQRFPSW 190
            N+L V+D S N    S    +    + L+ LNL  N    T     Q F  W
Sbjct: 517 LNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTCE--HQSFLQW 567

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score =  102 bits (256), Expect = 6e-23
 Identities = 24/108 (22%), Positives = 40/108 (37%), Gaps = 1/108 (0%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNL 142
           I       LS L  L L  N +  L    FS L +L  L     + +            L
Sbjct: 67  IEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTL 126

Query: 143 TVIDLSNNFFN-ASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPS 189
             +++++N      +P   S LT+L  L+L++N +       L+    
Sbjct: 127 KELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 83.5 bits (207), Expect = 5e-17
 Identities = 26/141 (18%), Positives = 47/141 (33%), Gaps = 12/141 (8%)

Query: 79  LRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLT----SLHLQFNSFSGPLPL 134
           ++    P     L+ L++L L SN +  ++ +D   L  +     SL L  N  +   P 
Sbjct: 136 IQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPG 195

Query: 135 DFSVWNNLTVIDLSNNFFNASIPA-SISKLTHLSALNLANNSLTGTL------PRSLQRF 187
            F     L  + L NNF + ++    I  L  L    L                 +L+  
Sbjct: 196 AFK-EIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGL 254

Query: 188 PSWAFAGNNLSSENARPPALP 208
            +       L+  +     + 
Sbjct: 255 CNLTIEEFRLAYLDYYLDDII 275

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 73.1 bits (180), Expect = 1e-13
 Identities = 26/152 (17%), Positives = 48/152 (31%), Gaps = 27/152 (17%)

Query: 72  LRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFP-SDFSKLENLTSLHLQFNSF-- 128
            RL  +    +   +    L+ + + SL S ++  +   S     ++L  ++ +F  F  
Sbjct: 262 FRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPT 321

Query: 129 --------------SGPLPLDFSVWNNLTVIDLSNNFFNAS--IPASISKLTHLSALNLA 172
                          G          +L  +DLS N  +       S    T L  L+L+
Sbjct: 322 LKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381

Query: 173 NNSLTGTLP-----RSLQRFPSWAFAGNNLSS 199
            N +            L+      F  +NL  
Sbjct: 382 FNGVITMSSNFLGLEQLEHL---DFQHSNLKQ 410

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 69.7 bits (171), Expect = 1e-12
 Identities = 19/130 (14%), Positives = 31/130 (23%), Gaps = 11/130 (8%)

Query: 79  LRGEIPPNTIGRLSALQNLSLRSNSLSG------LFPSDFSKLENLTSLHLQFNS---FS 129
               +    I  L+ L+   L                S    L NLT    +      + 
Sbjct: 212 DSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYL 271

Query: 130 GPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPS 189
             +   F+   N++   L +           S       L L N          L+    
Sbjct: 272 DDIIDLFNCLTNVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKR 329

Query: 190 WAFAGNNLSS 199
             F  N   +
Sbjct: 330 LTFTSNKGGN 339

>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605

 Score = 67.0 bits (164), Expect = 8e-12
 Identities = 29/164 (17%), Positives = 48/164 (29%), Gaps = 32/164 (19%)

Query: 66  HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGL------FPSDFSKLENLT 119
              V  L L      G +       L  L NL++    L+ L          F+ L N++
Sbjct: 226 GLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVS 285

Query: 120 SLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNA-------------------SIPASI 160
           S  L   +        ++       ++L N  F                         S 
Sbjct: 286 SFSLVSVTIERVKDFSYN--FGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSE 343

Query: 161 SKLTHLSALNLANNSLT--GTLPRSLQRFPSWA---FAGNNLSS 199
             L  L  L+L+ N L+  G   +S     S      + N + +
Sbjct: 344 VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT 387

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  107 bits (269), Expect = 1e-24
 Identities = 31/223 (13%), Positives = 60/223 (26%), Gaps = 43/223 (19%)

Query: 17  IFLPIKADPVEDKQALLDF----------IHNIHNSRSLNWNESSSLCK--SWTGVTCSA 64
           I L   A+ ++D  AL +                     NWN +  L    +  GV+ + 
Sbjct: 20  IKLSRTAEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELDMWGAQPGVSLN- 78

Query: 65  DHSRVVALRLPGMALRGEIP---------------------------PNTIGRLSALQNL 97
            + RV  L L G    G +P                           P  I    + +  
Sbjct: 79  SNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDEQK 138

Query: 98  SLRSNSLSGLFPSDFSKLE--NLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNAS 155
                     F     + +  +L    +  +     +     +    T I   +N     
Sbjct: 139 QKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNIT-F 197

Query: 156 IPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLS 198
           +  ++ +LT L    + N+              +  +A    +
Sbjct: 198 VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKT 240

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score =  100 bits (251), Expect = 3e-22
 Identities = 21/132 (15%), Positives = 39/132 (29%), Gaps = 17/132 (12%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSF--------SGPLP 133
           +        L  L ++ + +       P+    L  +  +++  N               
Sbjct: 239 KTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQAL 298

Query: 134 LDFSVWNNLTVIDLSNNFFNA-SIPASISKLTHLSALNLANNSLTGTLP-----RSLQRF 187
            D  V   + +I +  N      +  S+ K+  L  L    N L G LP       L   
Sbjct: 299 ADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLPAFGSEIKLASL 358

Query: 188 PSWAFAGNNLSS 199
                A N ++ 
Sbjct: 359 ---NLAYNQITE 367

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 98.6 bits (246), Expect = 1e-21
 Identities = 26/133 (19%), Positives = 51/133 (38%), Gaps = 15/133 (11%)

Query: 79  LRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSV 138
           L G++P    G    L +L+L  N ++ +  +     E + +L    N     +P  F  
Sbjct: 342 LEGKLP--AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY-IPNIFDA 398

Query: 139 WN--NLTVIDLSNNFFN-------ASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPS 189
            +   ++ ID S N            +  +  K  ++S++NL+NN ++            
Sbjct: 399 KSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSP 458

Query: 190 WAF---AGNNLSS 199
            +     GN L+ 
Sbjct: 459 LSSINLMGNMLTE 471

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 96.6 bits (241), Expect = 3e-21
 Identities = 32/137 (23%), Positives = 54/137 (39%), Gaps = 20/137 (14%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGL-FPSDFSKLENLTSLHLQFNSFSG-------PLP 133
           EIP N  G    ++NLS   N L  +    D   +  ++++   +N           PL 
Sbjct: 367 EIPANFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLD 426

Query: 134 LDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAF- 192
                  N++ I+LSNN  +       S  + LS++NL  N LT  +P++  +  +  F 
Sbjct: 427 PTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTE-IPKNSLKDENENFK 485

Query: 193 ----------AGNNLSS 199
                       N L+ 
Sbjct: 486 NTYLLTSIDLRFNKLTK 502

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 88.2 bits (219), Expect = 2e-18
 Identities = 19/126 (15%), Positives = 40/126 (31%), Gaps = 16/126 (12%)

Query: 85  PNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTV 144
              + RL+ L+   + ++        +  + EN      ++        L +    +LT 
Sbjct: 199 SKAVMRLTKLRQFYMGNSPFVAENICEAWENENS-----EYAQQYKTEDLKWDNLKDLTD 253

Query: 145 IDLSNNFFNASIPASISKLTHLSALNLANNSLTG--TLPRSLQRFPSWA---------FA 193
           +++ N      +P  +  L  +  +N+A N       L    Q                 
Sbjct: 254 VEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIG 313

Query: 194 GNNLSS 199
            NNL +
Sbjct: 314 YNNLKT 319

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 88.2 bits (219), Expect = 2e-18
 Identities = 22/111 (19%), Positives = 38/111 (34%), Gaps = 9/111 (8%)

Query: 81  GEIPPNTIGRLSALQNLSLRSNSLSGLFPS-DFSKLENLTSLHLQFNSFSGPLPLDFSVW 139
            +           L ++ LR N L+ L      + L  L  + L +NSFS   P      
Sbjct: 477 LKDENENFKNTYLLTSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNS 535

Query: 140 NNLTVIDLSN------NFFNASIPASISKLTHLSALNLANNSLTGTLPRSL 184
           + L    + N      N      P  I+    L+ L + +N +   +   +
Sbjct: 536 STLKGFGIRNQRDAQGNRTLREWPEGITLCPSLTQLQIGSNDIR-KVNEKI 585

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 83.6 bits (207), Expect = 6e-17
 Identities = 19/129 (14%), Positives = 41/129 (31%), Gaps = 13/129 (10%)

Query: 82  EIPPN-TIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQ------FNSFSGPLPL 134
           ++  +     L  L  + L  NS S   P+       L    ++       N      P 
Sbjct: 502 KLSDDFRATTLPYLVGIDLSYNSFSKF-PTQPLNSSTLKGFGIRNQRDAQGNRTLREWPE 560

Query: 135 DFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAG 194
             ++  +LT + + +N     +   I    ++S L++ +N         +   P      
Sbjct: 561 GITLCPSLTQLQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLSYV--CPYIEAGM 615

Query: 195 NNLSSENAR 203
             L  +  +
Sbjct: 616 YMLFYDKTQ 624

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636

 Score = 53.9 bits (130), Expect = 1e-07
 Identities = 11/72 (15%), Positives = 22/72 (30%), Gaps = 4/72 (5%)

Query: 79  LRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSV 138
              E P   I    +L  L + SN +  +         N++ L ++ N            
Sbjct: 554 TLREWPE-GITLCPSLTQLQIGSNDIRKV-NEKI--TPNISVLDIKDNPNISIDLSYVCP 609

Query: 139 WNNLTVIDLSNN 150
           +    +  L  +
Sbjct: 610 YIEAGMYMLFYD 621

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  103 bits (259), Expect = 2e-24
 Identities = 67/328 (20%), Positives = 115/328 (35%), Gaps = 62/328 (18%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRL-----KEVNVGKREFEQQMEIVGGIRHENVVA 359
            VL +G F   Y+A  +       +KRL     ++     +E     ++ G   H N+V 
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSG---HPNIVQ 90

Query: 360 LRAYYYSKDEK-------LMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARG 412
             +      E+        ++      G +   L      G   L  DT ++I     R 
Sbjct: 91  FCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG--PLSCDTVLKIFYQTCRA 148

Query: 413 IAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG------- 465
           + H+H      ++H  +K  N+ L++QG + + D G A  +S  P  +  A         
Sbjct: 149 VQHMH-RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEE 207

Query: 466 --------YRAPEVTDTRK---ATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRW 514
                   YR PE+ D        +  D+++ G +L  L   + P            +R 
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA------KLRI 261

Query: 515 VNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIR 574
           VN                 +Y      +  MLQV        PEER  +A+V+  +++I 
Sbjct: 262 VNGKYS-------IPPHDTQYTVFHSLIRAMLQVN-------PEERLSIAEVVHQLQEIA 307

Query: 575 RVKAENPPS-----TENRSEISSSAATP 597
             +  NP S      E      S+  + 
Sbjct: 308 AARNVNPKSPITELLEQNGGYGSATLSR 335

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  102 bits (257), Expect = 8e-24
 Identities = 60/280 (21%), Positives = 106/280 (37%), Gaps = 35/280 (12%)

Query: 306 EVLGKGTFGTAYKAALEDAST-VVVKRLKE--VNVGKREFEQQMEIVGGIRHENVVALRA 362
           E +G+G FG  +   L   +T V VK  +E      K +F Q+  I+    H N+V L  
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179

Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGG 422
               K    +V +  + G     L          L   T +++   AA G+ ++ ++   
Sbjct: 180 VCTQKQPIYIVMELVQGGDFLTFLRTEGAR----LRVKTLLQMVGDAAAGMEYLESKC-- 233

Query: 423 KLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YR--APEVTDTRKA 477
             +H  + A N  +  +  + +SD G++   +     A         +  APE  +  + 
Sbjct: 234 -CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRY 292

Query: 478 TQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP 536
           +  SDV+SFG+LL E  + G SP       +    V                   L    
Sbjct: 293 SSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVE--------------KGGRLPCPE 338

Query: 537 NIEEEMVE-MLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
              + +   M Q    C    P +RP  + + + ++ IR+
Sbjct: 339 LCPDAVFRLMEQ----CWAYEPGQRPSFSTIYQELQSIRK 374

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  103 bits (258), Expect = 1e-23
 Identities = 76/276 (27%), Positives = 115/276 (41%), Gaps = 31/276 (11%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
             LG+G FG  +       + V +K LK   +    F Q+ +++  +RHE +V L A   
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VV 248

Query: 366 SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLV 425
           S++   +V +Y   GS+   L G  G+    L     V +A   A G+A++   N    V
Sbjct: 249 SEEPIYIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIASGMAYVERMN---YV 302

Query: 426 HGGIKASNIFLNSQGHVCVSDIGLAALMSP----MPPPAMRAAGYRAPEVTDTRKATQAS 481
           H  ++A+NI +       V+D GLA L+          A     + APE     + T  S
Sbjct: 303 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 362

Query: 482 DVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
           DV+SFG+LL EL T G+ P       EV+  V                   +   P   E
Sbjct: 363 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVER--------------GYRMPCPPECPE 408

Query: 541 EMVE-MLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
            + + M Q    C  + PEERP    +   +ED   
Sbjct: 409 SLHDLMCQ----CWRKEPEERPTFEYLQAFLEDYFT 440

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  100 bits (251), Expect = 3e-23
 Identities = 58/298 (19%), Positives = 107/298 (35%), Gaps = 56/298 (18%)

Query: 306 EVLGKGTFGTAYKAALEDAS-----TVVVKRLKE--VNVGKREFEQQMEIVGGIRHENVV 358
           +VLG G FGT YK             V +K L+E       +E   +  ++  + + +V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 359 ALRAYYY---SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAH 415
            L              ++      G +   +   +     ++     +   +  A+G+ +
Sbjct: 81  RL----LGICLTSTVQLITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNY 132

Query: 416 IHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG-----YRAPE 470
           +       LVH  + A N+ + +  HV ++D GLA L+           G     + A E
Sbjct: 133 LEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189

Query: 471 VTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVR----EEWTA 525
               R  T  SDV+S+GV + EL+T G  P       E+  ++       R       T 
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---KGERLPQPPICTI 246

Query: 526 EVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPS 583
           +V+ +              M +    C +   + RPK  +++     +    A +P  
Sbjct: 247 DVYMI--------------MRK----CWMIDADSRPKFRELIIEFSKM----ARDPQR 282

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  102 bits (255), Expect = 3e-23
 Identities = 65/282 (23%), Positives = 117/282 (41%), Gaps = 43/282 (15%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           + LG G FG  + A     + V VK +K  ++    F  +  ++  ++H+ +V L A   
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHA-VV 252

Query: 366 SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLV 425
           +K+   ++ ++   GS+   L    G           +  +   A G+A I   N    +
Sbjct: 253 TKEPIYIITEFMAKGSLLDFLKSDEGS---KQPLPKLIDFSAQIAEGMAFIEQRN---YI 306

Query: 426 HGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR------APEVTDTRKATQ 479
           H  ++A+NI +++     ++D GLA ++           G +      APE  +    T 
Sbjct: 307 HRDLRAANILVSASLVCKIADFGLARVIE--DNEYTAREGAKFPIKWTAPEAINFGSFTI 364

Query: 480 ASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLV----RWVNSVVREEWTAEVFDVELLR 534
            SDV+SFG+LL+E++T G+ P       EV+  +    R                  + R
Sbjct: 365 KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR------------------MPR 406

Query: 535 YPNIEEEMVE-MLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
             N  EE+   M++    C    PEERP    +  +++D   
Sbjct: 407 PENCPEELYNIMMR----CWKNRPEERPTFEYIQSVLDDFYT 444

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  102 bits (255), Expect = 4e-23
 Identities = 64/281 (22%), Positives = 111/281 (39%), Gaps = 39/281 (13%)

Query: 306 EVLGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYY 364
             LG G +G  Y+   +  S  V VK LKE  +   EF ++  ++  I+H N+V L    
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 285

Query: 365 YSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKL 424
             +    ++ ++   G++   L          +     + +A   +  + ++  +N    
Sbjct: 286 TREPPFYIITEFMTYGNLLDYLRECNR---QEVSAVVLLYMATQISSAMEYLEKKN---F 339

Query: 425 VHGGIKASNIFLNSQGHVCVSDIGLAALMS----PMPPPAMRAAGYRAPEVTDTRKATQA 480
           +H  + A N  +     V V+D GL+ LM+         A     + APE     K +  
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399

Query: 481 SDVFSFGVLLLELLT-GKSPIHATGGDEVVHLV----RWVNSVVREEWTAEVFDVELLRY 535
           SDV++FGVLL E+ T G SP       +V  L+    R                  + R 
Sbjct: 400 SDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR------------------MERP 441

Query: 536 PNIEEEMVE-MLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
               E++ E M      C    P +RP  A++ +  E + +
Sbjct: 442 EGCPEKVYELMRA----CWQWNPSDRPSFAEIHQAFETMFQ 478

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 99.0 bits (247), Expect = 5e-23
 Identities = 60/294 (20%), Positives = 107/294 (36%), Gaps = 56/294 (19%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVK--RLKEVNVGKREFEQQMEIVGGIRHENVVALRA 362
           + LG+G FG  ++A    D     +K  RL    + + +  ++++ +  + H  +V    
Sbjct: 11  QCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 70

Query: 363 YYYSKDE---------KLMVY---DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAA 410
            +  K+          K+ +Y         ++   ++GR        +    + I +  A
Sbjct: 71  AWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCT--IEERERSVCLHIFLQIA 128

Query: 411 RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS------------PMPP 458
             +  +H++    L+H  +K SNIF      V V D GL   M             P   
Sbjct: 129 EAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185

Query: 459 PAMRAAG---YRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWV 515
                 G   Y +PE       +   D+FS G++L ELL        +   E V  +   
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-----PFSTQMERVRTLT-- 238

Query: 516 NSVVREEWTAEVFDVELLRYPNIEEEMVE-MLQVGMACVVRMPEERPKMADVLK 568
              VR      +F     +    E  MV+ ML          P ERP+  ++++
Sbjct: 239 --DVRNLKFPPLFT----QKYPCEYVMVQDMLSPS-------PMERPEAINIIE 279

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  101 bits (254), Expect = 7e-23
 Identities = 76/276 (27%), Positives = 115/276 (41%), Gaps = 31/276 (11%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
             LG+G FG  +       + V +K LK   +    F Q+ +++  +RHE +V L A   
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VV 331

Query: 366 SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLV 425
           S++   +V +Y   GS+   L G  G+    L     V +A   A G+A++   N    V
Sbjct: 332 SEEPIYIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIASGMAYVERMN---YV 385

Query: 426 HGGIKASNIFLNSQGHVCVSDIGLAALMSP----MPPPAMRAAGYRAPEVTDTRKATQAS 481
           H  ++A+NI +       V+D GLA L+          A     + APE     + T  S
Sbjct: 386 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 445

Query: 482 DVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
           DV+SFG+LL EL T G+ P       EV+  V                   +   P   E
Sbjct: 446 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVER--------------GYRMPCPPECPE 491

Query: 541 EMVE-MLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
            + + M Q    C  + PEERP    +   +ED   
Sbjct: 492 SLHDLMCQ----CWRKEPEERPTFEYLQAFLEDYFT 523

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 98.2 bits (245), Expect = 7e-23
 Identities = 56/298 (18%), Positives = 107/298 (35%), Gaps = 70/298 (23%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNVGKREFEQQMEIVGGI----RHENVVAL 360
           E +G G FG+ +K     D     +KR K+   G  + +  +  V       +H +VV  
Sbjct: 17  EKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVR- 75

Query: 361 RAYY--YSKDEKLMVY-DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIH 417
             Y+  +++D+ +++  +Y   GS++  +                  + +   RG+ +IH
Sbjct: 76  --YFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSY-FKEAELKDLLLQVGRGLRYIH 132

Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVS-------------------DIGLAALMSPMPP 458
           + +   LVH  IK SNIF++       +                   D+G    +S   P
Sbjct: 133 SMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS--P 187

Query: 459 PAMRAAG---YRAPEV-TDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRW 514
                 G   + A EV  +       +D+F+  + ++     +       GD+   + + 
Sbjct: 188 QVEE--GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRN--GDQWHEIRQ- 242

Query: 515 VNSVVREEWTAEVFDVELLRYPNIEE----EMVEMLQVGMACVVRMPEERPKMADVLK 568
                              R P I +    E  E+L+     +   PE RP    ++K
Sbjct: 243 ------------------GRLPRIPQVLSQEFTELLK---VMIHPDPERRPSAMALVK 279

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 97.3 bits (243), Expect = 1e-22
 Identities = 58/281 (20%), Positives = 114/281 (40%), Gaps = 41/281 (14%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           + +G G FG  +     +   V +K ++E  + + +F ++ E++  + H  +V L     
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 73

Query: 366 SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLV 425
            +    +V ++ E G +S  L  +RG        +T + + +    G+A++       ++
Sbjct: 74  EQAPICLVTEFMEHGCLSDYLRTQRGL----FAAETLLGMCLDVCEGMAYLEEAC---VI 126

Query: 426 HGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR------APEVTDTRKATQ 479
           H  + A N  +     + VSD G+   +         + G +      +PEV    + + 
Sbjct: 127 HRDLAARNCLVGENQVIKVSDFGMTRFVL--DDQYTSSTGTKFPVKWASPEVFSFSRYSS 184

Query: 480 ASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVR----EEWTAEVFDVELLR 534
            SDV+SFGVL+ E+ + GK P       EVV  +    +  R       +  V+ +    
Sbjct: 185 KSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS---TGFRLYKPRLASTHVYQI---- 237

Query: 535 YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
                     M      C    PE+RP  + +L+ + +I  
Sbjct: 238 ----------MNH----CWRERPEDRPAFSRLLRQLAEIAE 264

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  101 bits (254), Expect = 1e-22
 Identities = 30/108 (27%), Positives = 47/108 (43%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
            +P     R S L +L +  N++S L P    KL  L  L+LQ N  S      F+   N
Sbjct: 39  RLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTN 98

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPS 189
           LT + L +N           K  +L  L+L++N L+ T   +  +  +
Sbjct: 99  LTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLEN 146

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score =  100 bits (251), Expect = 2e-22
 Identities = 34/117 (29%), Positives = 50/117 (42%), Gaps = 8/117 (6%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNL 142
           + P    +L  L+ L+L+ N LS L    F+   NLT LHL  NS        F    NL
Sbjct: 64  LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNL 123

Query: 143 TVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLSS 199
             +DLS+N  +++   +  +L +L  L L+NN +            S        SS
Sbjct: 124 ITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA--------LKSEELDIFANSS 172

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 95.8 bits (239), Expect = 7e-21
 Identities = 29/125 (23%), Positives = 47/125 (37%), Gaps = 2/125 (1%)

Query: 72  LRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSG- 130
           L L    +  E+       L  +  + L  N    L  + F+ + +L  L L+  +    
Sbjct: 410 LDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNV 469

Query: 131 -PLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPS 189
              P  F    NLT++DLSNN         +  L  L  L+L +N+L      +    P 
Sbjct: 470 DSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPI 529

Query: 190 WAFAG 194
           +   G
Sbjct: 530 YFLKG 534

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 93.9 bits (234), Expect = 4e-20
 Identities = 27/110 (24%), Positives = 41/110 (37%), Gaps = 2/110 (1%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
           ++   T    + L  L L SNS+  +  + F K +NL +L L  N  S           N
Sbjct: 87  QLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLEN 146

Query: 142 LTVIDLSNNFFNASIPASIS--KLTHLSALNLANNSLTGTLPRSLQRFPS 189
           L  + LSNN   A     +     + L  L L++N +    P        
Sbjct: 147 LQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGR 196

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 90.8 bits (226), Expect = 3e-19
 Identities = 26/137 (18%), Positives = 46/137 (33%), Gaps = 16/137 (11%)

Query: 72  LRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQ------- 124
           L L    L   +  ++   L  L+   L  N++  LF      L N+  L+L+       
Sbjct: 253 LDLSYNNLNV-VGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQS 311

Query: 125 --FNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPR 182
               S        F     L  +++ +N          + L +L  L+L+N+        
Sbjct: 312 ISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFT------ 365

Query: 183 SLQRFPSWAFAGNNLSS 199
           SL+   +  F     S 
Sbjct: 366 SLRTLTNETFVSLAHSP 382

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 90.8 bits (226), Expect = 3e-19
 Identities = 28/114 (24%), Positives = 41/114 (35%), Gaps = 5/114 (4%)

Query: 81  GEIPPNTIGRL--SALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FS 137
             +   T   L  S L  L+L  N +S +    FS L +L  L L  N     L    + 
Sbjct: 368 RTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQEWR 427

Query: 138 VWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTG--TLPRSLQRFPS 189
              N+  I LS N +      S + +  L  L L   +L    + P   Q   +
Sbjct: 428 GLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSPFQPLRN 481

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 88.5 bits (220), Expect = 2e-18
 Identities = 24/115 (20%), Positives = 43/115 (37%), Gaps = 7/115 (6%)

Query: 82  EIPPNTIG--RLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVW 139
            +    +     S+L+ L L SN +    P  F  +  L  L L        L     + 
Sbjct: 159 ALKSEELDIFANSSLKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLE 218

Query: 140 ---NNLTVIDLSNNFFNASIPASIS--KLTHLSALNLANNSLTGTLPRSLQRFPS 189
               ++  + LSN+  + +   +    K T+L+ L+L+ N+L      S    P 
Sbjct: 219 LANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQ 273

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 86.2 bits (214), Expect = 8e-18
 Identities = 25/108 (23%), Positives = 50/108 (46%), Gaps = 3/108 (2%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
           ++P +     + +  L+L  N L  L  ++F++   LTSL + FN+ S   P        
Sbjct: 18  QVPDDL---PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPM 74

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPS 189
           L V++L +N  +     + +  T+L+ L+L +NS+         +  +
Sbjct: 75  LKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKN 122

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 85.8 bits (213), Expect = 1e-17
 Identities = 26/135 (19%), Positives = 46/135 (34%), Gaps = 12/135 (8%)

Query: 66  HSRVVALRLPGMALRGEIPPNTIG--RLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHL 123
           ++ +  L L    L       T    + + L  L L  N+L+ +    F+ L  L    L
Sbjct: 221 NTSIRNLSLSNSQLST-TSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFL 279

Query: 124 QFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASI---------PASISKLTHLSALNLANN 174
           ++N+             N+  ++L  +F   SI           S   L  L  LN+ +N
Sbjct: 280 EYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDN 339

Query: 175 SLTGTLPRSLQRFPS 189
            + G          +
Sbjct: 340 DIPGIKSNMFTGLIN 354

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 85.4 bits (212), Expect = 1e-17
 Identities = 27/115 (23%), Positives = 42/115 (36%), Gaps = 8/115 (6%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLS--------GLFPSDFSKLENLTSLHLQFNSFSGPLPL 134
           I  + +  L  L+ L L+ N+L+        G        L +L  L+L+ N F      
Sbjct: 495 INDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVE 554

Query: 135 DFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPS 189
            F     L +IDL  N  N    +  +    L +LNL  N +T    +       
Sbjct: 555 VFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFR 609

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 72.0 bits (177), Expect = 2e-13
 Identities = 30/110 (27%), Positives = 49/110 (44%), Gaps = 7/110 (6%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFS-VWN 140
           EIP      L  L+ + L  N+L+ L  S F+   +L SL+LQ N  +      F   + 
Sbjct: 550 EIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFR 609

Query: 141 NLTVIDLSNNFFNASIPA-----SISKLTHLSALNLANNSLTGTLPRSLQ 185
           NLT +D+  N F+ +  +     +    TH +   L+++ L  T P    
Sbjct: 610 NLTELDMRFNPFDCTCESIAWFVNWINETHTNIPELSSHYLCNT-PPHYH 658

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680

 Score = 43.8 bits (104), Expect = 2e-04
 Identities = 11/49 (22%), Positives = 21/49 (42%), Gaps = 3/49 (6%)

Query: 141 NLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPS 189
           +  V D S+      +P  +   T+++ LNL +N L      +  R+  
Sbjct: 5   SHEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQ 50

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 96.9 bits (242), Expect = 1e-22
 Identities = 62/282 (21%), Positives = 107/282 (37%), Gaps = 43/282 (15%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           + LG G FG       +    V VK +KE ++ + EF Q+ + +  + H  +V       
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCS 73

Query: 366 SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLV 425
            +    +V +Y   G +   L          L+    + +      G+A + +      +
Sbjct: 74  KEYPIYIVTEYISNGCLLNYLRSHGKG----LEPSQLLEMCYDVCEGMAFLESHQ---FI 126

Query: 426 HGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR------APEVTDTRKATQ 479
           H  + A N  ++    V VSD G+   +       + + G +      APEV    K + 
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVL--DDQYVSSVGTKFPVKWSAPEVFHYFKYSS 184

Query: 480 ASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLV----RWVNSVVREEWTAEVFDVELLR 534
            SDV++FG+L+ E+ + GK P       EVV  V    R                  L R
Sbjct: 185 KSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR------------------LYR 226

Query: 535 YPNIEEEMVE-MLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
                + + + M      C   +PE+RP    +L  +E +R 
Sbjct: 227 PHLASDTIYQIMYS----CWHELPEKRPTFQQLLSSIEPLRE 264

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 97.8 bits (244), Expect = 4e-22
 Identities = 72/316 (22%), Positives = 127/316 (40%), Gaps = 41/316 (12%)

Query: 306 EVLGKGTFGTAYKAAL----EDASTVVVKRLKE--VNVGKREFEQQMEIVGGIRHENVVA 359
           +V+G G FG      L    +   +V +K LK       +R+F  +  I+G   H N++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE 419
           L          ++V +Y E GS+ + L     +          V +  G A G+ ++   
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQ----FTVIQLVGMLRGIASGMKYLSDM 166

Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR------APEVTD 473
                VH  + A NI +NS     VSD GL  ++   P  A    G +      +PE   
Sbjct: 167 G---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIA 223

Query: 474 TRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
            RK T ASDV+S+G++L E+++ G+ P       +V+  V                  E 
Sbjct: 224 YRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVD-----------------EG 266

Query: 533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTENRSEISS 592
            R P   +    + Q+ + C  +    RPK   ++ +++ + R    NP S +  +  ++
Sbjct: 267 YRLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIR----NPGSLKIITSAAA 322

Query: 593 SAATPKATETASSSTA 608
             +     ++    T 
Sbjct: 323 RPSNLLLDQSNVDITT 338

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 96.6 bits (241), Expect = 4e-22
 Identities = 56/221 (25%), Positives = 91/221 (41%), Gaps = 20/221 (9%)

Query: 306 EVLGKGTFGTAYKAALEDAS----TVVVKRLKE--VNVGKREFEQQMEIVGGIRHENVVA 359
           +++G G  G      L         V +K LK       +R+F  +  I+G   H N++ 
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE 419
           L          ++V +Y E GS+   L    G+          V +  G   G+ ++   
Sbjct: 115 LEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQ----FTIMQLVGMLRGVGAGMRYLSDL 170

Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR------APEVTD 473
                VH  + A N+ ++S     VSD GL+ ++   P  A    G +      APE   
Sbjct: 171 G---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIA 227

Query: 474 TRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVR 513
            R  + ASDV+SFGV++ E+L  G+ P       +V+  V 
Sbjct: 228 FRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE 268

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 95.7 bits (239), Expect = 4e-22
 Identities = 57/215 (26%), Positives = 98/215 (45%), Gaps = 16/215 (7%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           E LG G FG  +       + V VK LK+ ++    F  +  ++  ++H+ +V L A   
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VV 77

Query: 366 SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLV 425
           +++   ++ +Y E GS+   L    G     L  +  + +A   A G+A I   N    +
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSG---IKLTINKLLDMAAQIAEGMAFIEERN---YI 131

Query: 426 HGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR------APEVTDTRKATQ 479
           H  ++A+NI ++      ++D GLA L+           G +      APE  +    T 
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIE--DNEYTAREGAKFPIKWTAPEAINYGTFTI 189

Query: 480 ASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVR 513
            SDV+SFG+LL E++T G+ P       EV+  + 
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 97.2 bits (242), Expect = 4e-22
 Identities = 66/371 (17%), Positives = 129/371 (34%), Gaps = 65/371 (17%)

Query: 267 KEMSLKEGVSGSHDKNSKLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDAST 326
           +E+ L E       +    +  +        +D  +     LG G  G  +K + + +  
Sbjct: 5   EELELDEQQR---KRLEAFLTQKQKVGELKDDDFEKI--SELGAGNGGVVFKVSHKPSGL 59

Query: 327 VVVKRLKEVNVGKREFEQ-QME--IVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVS 383
           V+ ++L  + +      Q   E  ++       +V     +YS  E  +  ++ + GS+ 
Sbjct: 60  VMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 119

Query: 384 AML--HGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGH 441
            +L   GR  E           +++I   +G+ ++  +   K++H  +K SNI +NS+G 
Sbjct: 120 QVLKKAGRIPEQILG-------KVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGE 170

Query: 442 VCVSDIGLAA-LMSPMPPPAMRAAG---YRAPEVTDTRKATQASDVFSFGVLLLELLTGK 497
           + + D G++  L+  M   A    G   Y +PE       +  SD++S G+ L+E+  G+
Sbjct: 171 IKLCDFGVSGQLIDSM---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 227

Query: 498 SPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN----------------IEEE 541
            PI      E+  +          E                               I  E
Sbjct: 228 YPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNE 287

Query: 542 MVEMLQVGM----------ACVVRMPEERPKMADVLK-------------MVEDIRRVKA 578
               L  G+           C+++ P ER  +  ++                  +     
Sbjct: 288 PPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCSTIG 347

Query: 579 ENPPSTENRSE 589
            N PST   + 
Sbjct: 348 LNQPSTPTHAA 358

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 95.8 bits (239), Expect = 5e-22
 Identities = 53/223 (23%), Positives = 92/223 (41%), Gaps = 30/223 (13%)

Query: 306 EVLGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYY 364
             LG G +G  Y+   +  S  V VK LKE  +   EF ++  ++  I+H N+V L    
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLG-V 77

Query: 365 YSKDEKLM-VYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGK 423
            +++     + ++   G++   L     +    +     + +A   +  + ++  +N   
Sbjct: 78  CTREPPFYIITEFMTYGNLLDYLRECNRQ---EVSAVVLLYMATQISSAMEYLEKKN--- 131

Query: 424 LVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR------------APEV 471
            +H  + A N  +     V V+D GL+ LM+           Y             APE 
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMT--------GDTYTAHAGAKFPIKWTAPES 183

Query: 472 TDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVR 513
               K +  SDV++FGVLL E+ T G SP       +V  L+ 
Sbjct: 184 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 226

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 95.4 bits (238), Expect = 5e-22
 Identities = 56/281 (19%), Positives = 106/281 (37%), Gaps = 41/281 (14%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           + LG G FG            V +K +KE ++ + EF ++ +++  + HE +V L     
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 89

Query: 366 SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLV 425
            +    ++ +Y   G +   L   R            + +       + ++ ++     +
Sbjct: 90  KQRPIFIITEYMANGCLLNYLREMRHR----FQTQQLLEMCKDVCEAMEYLESKQ---FL 142

Query: 426 HGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR------APEVTDTRKATQ 479
           H  + A N  +N QG V VSD GL+  +  +      + G +       PEV    K + 
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYV--LDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 200

Query: 480 ASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVR----EEWTAEVFDVELLR 534
            SD+++FGVL+ E+ + GK P       E    +      +R       + +V+ +    
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA---QGLRLYRPHLASEKVYTI---- 253

Query: 535 YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
                     M      C     +ERP    +L  + D+  
Sbjct: 254 ----------MYS----CWHEKADERPTFKILLSNILDVMD 280

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 95.9 bits (239), Expect = 9e-22
 Identities = 62/221 (28%), Positives = 99/221 (44%), Gaps = 21/221 (9%)

Query: 306 EVLGKGTFGTAYKAAL-----EDASTVVVKRLKE--VNVGKREFEQQMEIVGGIRHENVV 358
           +V+G G FG  YK  L     +    V +K LK       + +F  +  I+G   H N++
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109

Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT 418
            L          +++ +Y E G++   L  + GE          V +  G A G+ ++  
Sbjct: 110 RLEGVISKYKPMMIITEYMENGALDKFLREKDGE----FSVLQLVGMLRGIAAGMKYLAN 165

Query: 419 ENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR------APEVT 472
            N    VH  + A NI +NS     VSD GL+ ++   P      +G +      APE  
Sbjct: 166 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 222

Query: 473 DTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLV 512
             RK T ASDV+SFG+++ E++T G+ P       EV+  +
Sbjct: 223 SYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 263

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 95.5 bits (238), Expect = 1e-21
 Identities = 59/327 (18%), Positives = 109/327 (33%), Gaps = 52/327 (15%)

Query: 306 EVLGKGTFGTAYKAALEDAS-----TVVVKRLKE--VNVGKREFEQQMEIVGGIRHENVV 358
           +VLG G FGT YK             V +K L+E       +E   +  ++  + + +V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 359 ALRAYYY---SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAH 415
            L              ++      G +   +   +     ++     +   +  A+G+ +
Sbjct: 81  RL----LGICLTSTVQLITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNY 132

Query: 416 IHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG-----YRAPE 470
           +       LVH  + A N+ + +  HV ++D GLA L+           G     + A E
Sbjct: 133 LEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189

Query: 471 VTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVR----EEWTA 525
               R  T  SDV+S+GV + EL+T G  P       E+  ++       R       T 
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---KGERLPQPPICTI 246

Query: 526 EVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTE 585
           +V+ +              M++    C +   + RPK  +++     + R          
Sbjct: 247 DVYMI--------------MVK----CWMIDADSRPKFRELIIEFSKMARDPQRYLVIQG 288

Query: 586 NRSEISSSAATPKATETASSSTAHLDS 612
           +      S                 D 
Sbjct: 289 DERMHLPSPTDSNFYRALMDEEDMDDV 315

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 95.1 bits (237), Expect = 1e-21
 Identities = 68/322 (21%), Positives = 115/322 (35%), Gaps = 56/322 (17%)

Query: 306 EVLGKGTFGTAYKAALEDAS-----TVVVKRLKEVN--VGKREFEQQMEIVGGIRHENVV 358
           +VLG G FGT +K             V +K +++ +     +     M  +G + H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 359 ALRAYYY---SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAH 415
            L              +V  Y   GS+   +   RG     L     +   +  A+G+ +
Sbjct: 79  RL----LGLCPGSSLQLVTQYLPLGSLLDHVRQHRGA----LGPQLLLNWGVQIAKGMYY 130

Query: 416 IHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG-----YRAPE 470
           +       +VH  + A N+ L S   V V+D G+A L+ P     + +       + A E
Sbjct: 131 LEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALE 187

Query: 471 VTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVR----EEWTA 525
                K T  SDV+S+GV + EL+T G  P       EV  L+       R    +  T 
Sbjct: 188 SIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE---KGERLAQPQICTI 244

Query: 526 EVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTE 585
           +V+ V              M++    C +     RP   ++      + R    +PP   
Sbjct: 245 DVYMV--------------MVK----CWMIDENIRPTFKELANEFTRMAR----DPPRYL 282

Query: 586 NRSEISSSAATPKATETASSST 607
                S     P       ++ 
Sbjct: 283 VIKRESGPGIAPGPEPHGLTNK 304

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 93.9 bits (234), Expect = 2e-21
 Identities = 59/302 (19%), Positives = 112/302 (37%), Gaps = 58/302 (19%)

Query: 306 EVLGKGTFGTAYKAALE-----DASTVVVKRLKE-VNVGKREFEQQMEIVGGIRHENVVA 359
           + LGKG FG+      +         V VK+L+       R+FE+++EI+  ++H+N+V 
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 360 LRAYYYSKDEK--LMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIH 417
            +   YS   +   ++ +Y   GS+   L   +      +D    ++      +G+ ++ 
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYLG 131

Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR------APEV 471
           T+     +H  +   NI + ++  V + D GL  ++                    APE 
Sbjct: 132 TKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPES 188

Query: 472 TDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE 531
               K + ASDV+SFGV+L EL T      +   + +  +                    
Sbjct: 189 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN------------------ 230

Query: 532 LLRYPNIE-EEMVEMLQVG-----------------MACVVRMPEERPKMADVLKMVEDI 573
             +   +    ++E+L+                     C      +RP   D+   V+ I
Sbjct: 231 -DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 289

Query: 574 RR 575
           R 
Sbjct: 290 RD 291

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 95.5 bits (237), Expect = 2e-21
 Identities = 27/231 (11%), Positives = 56/231 (24%), Gaps = 43/231 (18%)

Query: 306 EVLGKGTFGTAYKAALEDAST-------VVVKRLKEVNVGKREFEQQMEIVGGIRHENVV 358
           E L  G     +     D          V     +          +       +  E+  
Sbjct: 68  EPLRVGDRSVVFLV--RDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPE 125

Query: 359 ALRAYY--------------------------YSKDEKLMVYDYFEPGSVSAMLH--GRR 390
             R                             Y+    L++        +  +       
Sbjct: 126 EARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFV 184

Query: 391 GEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLA 450
              +          +     R  A++ ++    LVHG     N+F+   G + + D+   
Sbjct: 185 YVFRGDEGILALHILTAQLIRLAANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSAL 241

Query: 451 ALMSPMPPPAMRAAGYRAPEVTDTRKA--TQASDVFSFGVLLLELLTGKSP 499
             +    P +     Y   E  +   A  T A + +  G+ +  +     P
Sbjct: 242 WKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 95.1 bits (237), Expect = 5e-21
 Identities = 61/288 (21%), Positives = 104/288 (36%), Gaps = 59/288 (20%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           + +GKG FG          + V VK +K  +   + F  +  ++  +RH N+V L     
Sbjct: 199 QTIGKGEFGDVMLGDYRG-NKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVIV 256

Query: 366 SKDEKLM-VYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKL 424
            +   L  V +Y   GS+   L   R  G+S L  D  ++ ++     + ++   N    
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---F 310

Query: 425 VHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMR-----AAGYR------APEVTD 473
           VH  + A N+ ++      VSD GL            +         +      APE   
Sbjct: 311 VHRDLAARNVLVSEDNVAKVSDFGLT-----------KEASSTQDTGKLPVKWTAPEALR 359

Query: 474 TRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLV----RWVNSVVREEWTAEVF 528
            +K +  SDV+SFG+LL E+ + G+ P       +VV  V    +               
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK--------------- 404

Query: 529 DVELLRYPNIEEEMVE-MLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
              +         + + M      C       RP    + + +E IR 
Sbjct: 405 ---MDAPDGCPPAVYDVMKN----CWHLDAATRPTFLQLREQLEHIRT 445

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 93.2 bits (232), Expect = 6e-21
 Identities = 64/331 (19%), Positives = 118/331 (35%), Gaps = 62/331 (18%)

Query: 306 EVLGKGTFGTAYKAALEDAS-----TVVVKRLKEVNV-GKREFEQQMEIVGGIRHENVVA 359
             LGKG FG+      +         V VK+L+      +R+F+++++I+  +  + +V 
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 360 LRAYYYSKDEK--LMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIH 417
            R   Y    +   +V +Y   G +   L   R      LD    +  +    +G+ ++ 
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRAR----LDASRLLLYSSQICKGMEYLG 144

Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR------APEV 471
           +      VH  + A NI + S+ HV ++D GLA L+       +     +      APE 
Sbjct: 145 SRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPES 201

Query: 472 TDTRKATQASDVFSFGVLLLELLT-GKSP-----------IHATGGDEVVHLVRWVNSVV 519
                 ++ SDV+SFGV+L EL T                        +  L+  +    
Sbjct: 202 LSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQ 261

Query: 520 R----EEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
           R        AEV ++              M      C    P++RP  + +   ++ +  
Sbjct: 262 RLPAPPACPAEVHEL--------------MKL----CWAPSPQDRPSFSALGPQLDMLWS 303

Query: 576 VKAENPPSTENRSEISSSAATPKATETASSS 606
                   +      + +A       + S S
Sbjct: 304 -------GSRGCETHAFTAHPEGKHHSLSFS 327

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 92.3 bits (230), Expect = 6e-21
 Identities = 54/221 (24%), Positives = 90/221 (40%), Gaps = 32/221 (14%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           + +GKG FG          + V VK +K  +   + F  +  ++  +RH N+V L     
Sbjct: 27  QTIGKGEFGDVMLGDYRG-NKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVIV 84

Query: 366 SKDEKLM-VYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKL 424
            +   L  V +Y   GS+   L   R  G+S L  D  ++ ++     + ++   N    
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYL---RSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---F 138

Query: 425 VHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMR-----AAGYR------APEVTD 473
           VH  + A N+ ++      VSD GL            +         +      APE   
Sbjct: 139 VHRDLAARNVLVSEDNVAKVSDFGLT-----------KEASSTQDTGKLPVKWTAPEALR 187

Query: 474 TRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVR 513
            +K +  SDV+SFG+LL E+ + G+ P       +VV  V 
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 228

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 92.3 bits (230), Expect = 8e-21
 Identities = 53/223 (23%), Positives = 91/223 (40%), Gaps = 25/223 (11%)

Query: 306 EVLGKGTFGTAYKAALEDAST----VVVKRLKE----VNVGKREFEQQMEIVGGIRHENV 357
           E LG G+FG   +   +  S     V VK LK           +F +++  +  + H N+
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83

Query: 358 VALRAYYYSKDEKLM-VYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHI 416
           + L  Y       +  V +    GS+   L   +G         T  R A+  A G+ ++
Sbjct: 84  IRL--YGVVLTPPMKMVTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYL 137

Query: 417 HTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR------APE 470
            ++     +H  + A N+ L ++  V + D GL   +       +     +      APE
Sbjct: 138 ESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194

Query: 471 VTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLV 512
              TR  + ASD + FGV L E+ T G+ P     G +++H +
Sbjct: 195 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 94.4 bits (234), Expect = 8e-21
 Identities = 42/353 (11%), Positives = 94/353 (26%), Gaps = 77/353 (21%)

Query: 306 EVLGKGTFGTAYKAALEDAST---VVVKRLKEVNVGKREFEQQME-------IVGGIRHE 355
            VLG+       +A   D  T     V              +QM+       ++ GI+++
Sbjct: 84  TVLGQEDPYAYLEA--TDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQ 141

Query: 356 NVVALRAYYYSKDEKL---------------------MVYDYFEPGSVSAMLHG----RR 390
               +   +    + +                       +  +     +    G      
Sbjct: 142 KQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSH 201

Query: 391 GEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLA 450
                SL    R+++ +   R +A +H      LVH  ++  +I L+ +G V ++     
Sbjct: 202 SSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHL 258

Query: 451 ALMS----PMPPPAMRAAGYRAPEVT-----DTRKATQASDVFSFGVLLLELLTGKSPIH 501
                                A  +           T A D ++ G+ +  +     P  
Sbjct: 259 VRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT 318

Query: 502 ATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERP 561
               D  +    W+                     NI + +  +L      +    E+R 
Sbjct: 319 ---DDAALGGSEWI----------------FRSCKNIPQPVRALL---EGFLRYPKEDRL 356

Query: 562 KMADVLK------MVEDIRRVKAENPPSTENRSEISSSAATPKATETASSSTA 608
                ++      +  ++           E   E  +  +     + A ++ A
Sbjct: 357 LPLQAMETPEYEQLRTELSAALPLYQTDGEPTREGGAPPSGTSQPDEAGAAEA 409

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 91.5 bits (228), Expect = 1e-20
 Identities = 60/285 (21%), Positives = 108/285 (37%), Gaps = 47/285 (16%)

Query: 308 LGKGTFGTAYKAALEDAS---TVVVKRLKE--VNVGKREFEQQMEIVGGIRHENVVALRA 362
           LG G FG+  +           V +K LK+        E  ++ +I+  + +  +V L  
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77

Query: 363 YYYSKDEKLM-VYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENG 421
               + E LM V +    G +   L G+R E    +       +    + G+ ++  +N 
Sbjct: 78  V--CQAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMGMKYLEEKN- 130

Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR------APEVTDTR 475
              VH  + A N+ L ++ +  +SD GL+  +          +  +      APE  + R
Sbjct: 131 --FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR 188

Query: 476 KATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVR----EEWTAEVFDV 530
           K +  SDV+S+GV + E L+ G+ P     G EV+     +    R     E   E++ +
Sbjct: 189 KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF---IEQGKRMECPPECPPELYAL 245

Query: 531 ELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
                         M      C +   E+RP    V + +     
Sbjct: 246 --------------MSD----CWIYKWEDRPDFLTVEQRMRACYY 272

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 91.5 bits (228), Expect = 1e-20
 Identities = 48/221 (21%), Positives = 94/221 (42%), Gaps = 23/221 (10%)

Query: 306 EVLGKGTFGTAYKAALEDAS----TVVVKRLKE--VNVGKREFEQQMEIVGGIRHENVVA 359
             +G+G FG  ++            V +K  K    +  + +F Q+   +    H ++V 
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80

Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE 419
           L     +++   ++ +    G + + L  R+      LD  + +  A   +  +A++ ++
Sbjct: 81  LIGVI-TENPVWIIMELCTLGELRSFLQVRKYS----LDLASLILYAYQLSTALAYLESK 135

Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR------APEVTD 473
                VH  I A N+ ++S   V + D GL+  M        +A+  +      APE  +
Sbjct: 136 R---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM--EDSTYYKASKGKLPIKWMAPESIN 190

Query: 474 TRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVR 513
            R+ T ASDV+ FGV + E+L  G  P      ++V+  + 
Sbjct: 191 FRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 231

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 92.4 bits (230), Expect = 1e-20
 Identities = 59/302 (19%), Positives = 112/302 (37%), Gaps = 58/302 (19%)

Query: 306 EVLGKGTFGTAYKAALE-----DASTVVVKRLKE-VNVGKREFEQQMEIVGGIRHENVVA 359
           + LGKG FG+      +         V VK+L+       R+FE+++EI+  ++H+N+V 
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 360 LRAYYYSKDEK--LMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIH 417
            +   YS   +   ++ +Y   GS+   L   +      +D    ++      +G+ ++ 
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKER----IDHIKLLQYTSQICKGMEYLG 162

Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR------APEV 471
           T+     +H  +   NI + ++  V + D GL  ++                    APE 
Sbjct: 163 TKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPES 219

Query: 472 TDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE 531
               K + ASDV+SFGV+L EL T      +   + +  +                    
Sbjct: 220 LTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGN------------------ 261

Query: 532 LLRYPNIE-EEMVEMLQVG-----------------MACVVRMPEERPKMADVLKMVEDI 573
             +   +    ++E+L+                     C      +RP   D+   V+ I
Sbjct: 262 -DKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQI 320

Query: 574 RR 575
           R 
Sbjct: 321 RD 322

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 92.3 bits (230), Expect = 1e-20
 Identities = 33/131 (25%), Positives = 54/131 (41%), Gaps = 5/131 (3%)

Query: 85  PNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTV 144
           P +I  L  L++L +R++ LS L       L  L  L L+  +     P  F     L  
Sbjct: 199 PASIANLQNLKSLKIRNSPLSAL-GPAIHHLPKLEELDLRGCTALRNYPPIFGGRAPLKR 257

Query: 145 IDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPS--WAFAGNNLSSE-- 200
           + L +     ++P  I +LT L  L+L        LP  + + P+        +L ++  
Sbjct: 258 LILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPANCIILVPPHLQAQLD 317

Query: 201 NARPPALPVQP 211
             RP A P +P
Sbjct: 318 QHRPVARPAEP 328

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 80.4 bits (199), Expect = 1e-16
 Identities = 27/109 (24%), Positives = 48/109 (44%), Gaps = 12/109 (11%)

Query: 85  PNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNS---------FSGPLPLD 135
           P+T+ + + L+ L+L  N L  L P+  + L  L  L ++             S     +
Sbjct: 120 PDTMQQFAGLETLTLARNPLRAL-PASIASLNRLRELSIRACPELTELPEPLASTDASGE 178

Query: 136 FSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSL 184
                NL  + L       S+PASI+ L +L +L + N+ L+  L  ++
Sbjct: 179 HQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAI 225

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328

 Score = 75.0 bits (185), Expect = 7e-15
 Identities = 23/102 (22%), Positives = 38/102 (37%), Gaps = 5/102 (4%)

Query: 85  PNTIGRLS--ALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNL 142
            + +   +      L LRS  L    P    +L +L  + +        LP     +  L
Sbjct: 72  ADLLEDATQPGRVALELRSVPLPQF-PDQAFRLSHLQHMTIDAAGLME-LPDTMQQFAGL 129

Query: 143 TVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSL 184
             + L+ N    ++PASI+ L  L  L++        LP  L
Sbjct: 130 ETLTLARNPL-RALPASIASLNRLRELSIRACPELTELPEPL 170

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 91.6 bits (228), Expect = 1e-20
 Identities = 62/295 (21%), Positives = 127/295 (43%), Gaps = 48/295 (16%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNVGK-REFEQQMEIVGGIRHENVVALRAY 363
            VLGKGT+G  Y    L +   + +K + E +    +   +++ +   ++H+N+V    Y
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ---Y 84

Query: 364 Y--YSKDEKLMVY-DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAA-RGIAHIHTE 419
              +S++  + ++ +    GS+SA+L  + G  + +   +  +         G+ ++H  
Sbjct: 85  LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDN---EQTIGFYTKQILEGLKYLHDN 141

Query: 420 NGGKLVHGGIKASNIFLNS-QGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEV--TD 473
               +VH  IK  N+ +N+  G + +SD G +  ++ + P      G   Y APE+    
Sbjct: 142 Q---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKG 198

Query: 474 TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELL 533
            R   +A+D++S G  ++E+ TGK P              +    + E   A +F V + 
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPP--------------FYE--LGEPQAA-MFKVGMF 241

Query: 534 RYP-----NIEEEMVEMLQVGMACVVRMPEERPKMADVLK--MVEDIRRVKAENP 581
           +       ++  E    +   + C    P++R    D+L    ++   + K   P
Sbjct: 242 KVHPEIPESMSAEAKAFI---LKCFEPDPDKRACANDLLVDEFLKVSSKKKKTQP 293

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 57/304 (18%), Positives = 105/304 (34%), Gaps = 62/304 (20%)

Query: 306 EVLGKGTFGTAYKAALE-----DASTVVVKRLKEVNVGK--REFEQQMEIVGGIRHENVV 358
             LG+G FG       +         V VK LK  + G    + ++++EI+  + HEN+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 359 ALRAYYYSKDEK--LMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHI 416
             +            ++ ++   GS+   L   + +    ++   +++ A+   +G+ ++
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK----INLKQQLKYAVQICKGMDYL 142

Query: 417 HTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR------APE 470
            +      VH  + A N+ + S+  V + D GL   +                    APE
Sbjct: 143 GSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPE 199

Query: 471 VTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD 529
                K   ASDV+SFGV L ELLT   S                          A    
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLTYCDSD---------------------SSPMALFLK 238

Query: 530 VELLRYPNIE-EEMVEMLQVG-----------------MACVVRMPEERPKMADVLKMVE 571
           +    +  +    +V  L+ G                   C    P  R    ++++  E
Sbjct: 239 MIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFE 298

Query: 572 DIRR 575
            + +
Sbjct: 299 ALLK 302

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 91.2 bits (227), Expect = 3e-20
 Identities = 70/321 (21%), Positives = 109/321 (33%), Gaps = 65/321 (20%)

Query: 306 EVLGKGTFGTAYKAAL------EDASTVVVKRLKEVNVG--KREFEQQMEIVGGIRHENV 357
             LG G FG  Y+  +           V VK L EV     + +F  +  I+    H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 358 VALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQ--SSLDWDTRVRIAIGAARGIAH 415
           V           + ++ +    G + + L   R      SSL     + +A   A G  +
Sbjct: 96  VRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155

Query: 416 IHTENGGKLVHGGIKASNIFLNSQGH---VCVSDIGLAALMSPMPPPAMRAAGYR----- 467
           +        +H  I A N  L   G      + D G+A  +        RA+ YR     
Sbjct: 156 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-------YRASYYRKGGCA 205

Query: 468 -------APEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVV 519
                   PE       T  +D +SFGVLL E+ + G  P  +    EV+  V       
Sbjct: 206 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT------ 259

Query: 520 REEWTAEVFDVELLRYP-NIEEEMVE-MLQVGMACVVRMPEERPKMADVLKMVEDIRR-- 575
                        +  P N    +   M Q    C    PE+RP  A +L+ +E   +  
Sbjct: 260 ---------SGGRMDPPKNCPGPVYRIMTQ----CWQHQPEDRPNFAIILERIEYCTQDP 306

Query: 576 ------VKAENPPSTENRSEI 590
                 +  E  P  E   ++
Sbjct: 307 DVINTALPIEYGPLVEEEEKV 327

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 93.6 bits (233), Expect = 3e-20
 Identities = 23/109 (21%), Positives = 39/109 (35%), Gaps = 1/109 (0%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
            +   +    S LQ L L    +  +    +  L +L++L L  N      P  FS   +
Sbjct: 46  ILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTS 105

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTG-TLPRSLQRFPS 189
           L  +        +     I +L  L  LN+A+N +    LP       +
Sbjct: 106 LENLVAVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTN 154

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 93.6 bits (233), Expect = 3e-20
 Identities = 26/108 (24%), Positives = 42/108 (38%), Gaps = 1/108 (0%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNL 142
           I       L  L NL L  N +    P  FS L +L +L       +            L
Sbjct: 71  IEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITL 130

Query: 143 TVIDLSNNFFN-ASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPS 189
             +++++NF +   +PA  S LT+L  ++L+ N +       LQ    
Sbjct: 131 KKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRE 178

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 90.5 bits (225), Expect = 3e-19
 Identities = 23/106 (21%), Positives = 39/106 (36%)

Query: 72  LRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGP 131
           L++ G + +     N     + L  L L    L  +    F  L  L  L++  N+    
Sbjct: 453 LKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFL 512

Query: 132 LPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLT 177
               ++   +L+ +D S N    S          L+  NL NNS+ 
Sbjct: 513 DSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAFFNLTNNSVA 558

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 88.2 bits (219), Expect = 2e-18
 Identities = 26/112 (23%), Positives = 41/112 (36%), Gaps = 1/112 (0%)

Query: 79  LRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FS 137
           L+     +    L  L  L +   +    F   F  L +L +L +  NSF      + F+
Sbjct: 411 LKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFA 470

Query: 138 VWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPS 189
              NLT +DLS              L  L  LN+++N+L         +  S
Sbjct: 471 NTTNLTFLDLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYS 522

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 81.6 bits (202), Expect = 2e-16
 Identities = 23/108 (21%), Positives = 39/108 (36%), Gaps = 3/108 (2%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
           ++P +     S+ +N+ L  N L  L    FS    L  L L            +   ++
Sbjct: 25  KVPDDI---PSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHH 81

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPS 189
           L+ + L+ N   +  P S S LT L  L      L       + +  +
Sbjct: 82  LSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLIT 129

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 79.3 bits (196), Expect = 1e-15
 Identities = 21/106 (19%), Positives = 37/106 (34%), Gaps = 4/106 (3%)

Query: 82  EIPPNT--IGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSV 138
                +      ++L++L L  N    +  ++F  LE L  L  Q ++         F  
Sbjct: 364 FSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLS 422

Query: 139 WNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSL 184
              L  +D+S              LT L+ L +A NS       ++
Sbjct: 423 LEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNV 468

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 72.4 bits (178), Expect = 2e-13
 Identities = 23/113 (20%), Positives = 38/113 (33%), Gaps = 5/113 (4%)

Query: 80  RGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFS--KLENLTSLHLQFNSFSGPLPLDFS 137
           +G I    +  L +L  L L  N+LS      +S     +L  L L FN     +  +F 
Sbjct: 339 KGSISFKKVA-LPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAII-MSANFM 396

Query: 138 VWNNLTVIDLSNNFFNASIPAS-ISKLTHLSALNLANNSLTGTLPRSLQRFPS 189
               L  +D  ++        S    L  L  L+++  +             S
Sbjct: 397 GLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTS 449

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 71.6 bits (176), Expect = 3e-13
 Identities = 22/121 (18%), Positives = 38/121 (31%), Gaps = 8/121 (6%)

Query: 79  LRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLT----SLHLQFNSFSGPLPL 134
           +     P     L+ L ++ L  N +  +  +D   L        SL +  N     +  
Sbjct: 140 IHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPIDF-IQD 198

Query: 135 DFSVWNNLTVIDLSNNFFNASIPA-SISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFA 193
                  L  + L  NF +++I    +  L  L    L          R+L+ F      
Sbjct: 199 QAFQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDE--RNLEIFEPSIME 256

Query: 194 G 194
           G
Sbjct: 257 G 257

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 65.4 bits (160), Expect = 3e-11
 Identities = 24/129 (18%), Positives = 37/129 (28%), Gaps = 24/129 (18%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSD-------------------FSKLENLTSLH 122
                    L+ +  +SL   S+  L                          L  L SL 
Sbjct: 275 SDDIVKFHCLANVSAMSLAGVSIKYLEDVPKHFKWQSLSIIRCQLKQFPTLDLPFLKSLT 334

Query: 123 LQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASIS--KLTHLSALNLANNSLTGTL 180
           L  N  S  +        +L+ +DLS N  + S   S S      L  L+L+ N     +
Sbjct: 335 LTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDLGTNSLRHLDLSFNGAI-IM 391

Query: 181 PRSLQRFPS 189
             +      
Sbjct: 392 SANFMGLEE 400

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 63.9 bits (156), Expect = 8e-11
 Identities = 17/117 (14%), Positives = 32/117 (27%), Gaps = 12/117 (10%)

Query: 72  LRLPGMALRGE-----IPPNTIGRLSALQ--NLSLRSNSLSGLFPSDFSKLENLTSLHLQ 124
            RL     + E       P+ +  L  +      L   +        F  L N++++ L 
Sbjct: 234 HRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLA 293

Query: 125 FNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLP 181
             S      +          + +         P     L  L +L L  N  + +  
Sbjct: 294 GVSIKYLEDVPKH--FKWQSLSIIRCQLK-QFPT--LDLPFLKSLTLTMNKGSISFK 345

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 62.0 bits (151), Expect = 3e-10
 Identities = 19/123 (15%), Positives = 35/123 (28%), Gaps = 10/123 (8%)

Query: 72  LRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLF------PSDFSKLENLT--SLHL 123
           L L G      I    +  L+ L    L               PS    L ++T     L
Sbjct: 209 LTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCDVTIDEFRL 268

Query: 124 QFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRS 183
            + +      + F    N++ + L+       +   + K     +L++    L       
Sbjct: 269 TYTNDFSDDIVKFHCLANVSAMSLAGVSIK-YLE-DVPKHFKWQSLSIIRCQLKQFPTLD 326

Query: 184 LQR 186
           L  
Sbjct: 327 LPF 329

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606

 Score = 62.0 bits (151), Expect = 3e-10
 Identities = 20/105 (19%), Positives = 35/105 (33%), Gaps = 10/105 (9%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSG-LFPSDFSKLENLTSLHLQFNSFSGPLPLD----- 135
            I       +  L  L+LR N  S  +  +    L  L    L    F     L+     
Sbjct: 195 FIQDQAFQGIK-LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPS 253

Query: 136 -FSVWNNLTV--IDLSNNFFNASIPASISKLTHLSALNLANNSLT 177
                 ++T+    L+     +        L ++SA++LA  S+ 
Sbjct: 254 IMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIK 298

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 91.7 bits (228), Expect = 4e-20
 Identities = 65/287 (22%), Positives = 105/287 (36%), Gaps = 43/287 (14%)

Query: 306 EVLGKGTFGTAYKAALEDAS----TVVVKRLKEVNVGK--REFEQQMEIVGGIRHENVVA 359
           EV+G+G FG  Y   L D         VK L  +       +F  +  I+    H NV++
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 360 LRAYYYSKDEKLM-VYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT 418
           L       +   + V  Y + G +   +                +   +  A+G+  + +
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGFGLQVAKGMKFLAS 210

Query: 419 ENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR-------APEV 471
           +   K VH  + A N  L+ +  V V+D GLA  M      ++             A E 
Sbjct: 211 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 267

Query: 472 TDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDV 530
             T+K T  SDV+SFGVLL EL+T G  P       ++   +                  
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL---------------QG 312

Query: 531 ELLRYP-NIEEEMVE-MLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
             L  P    + + E ML+    C     E RP  ++++  +  I  
Sbjct: 313 RRLLQPEYCPDPLYEVMLK----CWHPKAEMRPSFSELVSRISAIFS 355

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 93.1 bits (231), Expect = 5e-20
 Identities = 60/306 (19%), Positives = 111/306 (36%), Gaps = 45/306 (14%)

Query: 298 EDLLRASAEVLGKGTFGTAYKAALEDAS---TVVVKRLKE--VNVGKREFEQQMEIVGGI 352
            D L  +   LG G FG+  +           V +K LK+        E  ++ +I+  +
Sbjct: 334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQL 393

Query: 353 RHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARG 412
            +  +V L       +  ++V +    G +   L G+R E    +       +    + G
Sbjct: 394 DNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLHQVSMG 448

Query: 413 IAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR----- 467
           + ++  +N    VH  + A N+ L ++ +  +SD GL+  +          +  +     
Sbjct: 449 MKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 505

Query: 468 -APEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVR----E 521
            APE  + RK +  SDV+S+GV + E L+ G+ P     G EV+     +    R     
Sbjct: 506 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF---IEQGKRMECPP 562

Query: 522 EWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENP 581
           E   E++ +              M      C +   E+RP    V + +       A   
Sbjct: 563 ECPPELYAL--------------MSD----CWIYKWEDRPDFLTVEQRMRACYYSLASKV 604

Query: 582 PSTENR 587
                 
Sbjct: 605 EGGSAL 610

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 90.1 bits (224), Expect = 5e-20
 Identities = 54/295 (18%), Positives = 112/295 (37%), Gaps = 55/295 (18%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYY 364
            VLG+G FG   KA    D+    +K+++           ++ ++  + H+ VV   A +
Sbjct: 12  AVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAW 71

Query: 365 YSKDEKL-------------MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAAR 411
             +   +             +  +Y E G++  ++H        +   D   R+      
Sbjct: 72  LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH----SENLNQQRDEYWRLFRQILE 127

Query: 412 GIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG------ 465
            +++IH++    ++H  +K  NIF++   +V + D GLA  +          +       
Sbjct: 128 ALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184

Query: 466 -----------YRAPEV-TDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVR 513
                      Y A EV   T    +  D++S G++  E++   S      G E V++++
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST-----GMERVNILK 239

Query: 514 WVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
            + SV  E      F  +     N  +   ++++     +   P +RP    +L 
Sbjct: 240 KLRSVSIE------FPPDF--DDNKMKVEKKIIR---LLIDHDPNKRPGARTLLN 283

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 90.0 bits (224), Expect = 5e-20
 Identities = 65/287 (22%), Positives = 106/287 (36%), Gaps = 43/287 (14%)

Query: 306 EVLGKGTFGTAYKAALEDAS----TVVVKRLKEVNVGK--REFEQQMEIVGGIRHENVVA 359
           EV+G+G FG  Y   L D         VK L  +       +F  +  I+    H NV++
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 360 LRAYYYSKDEKLM-VYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT 418
           L       +   + V  Y + G +   +                +   +  A+G+ ++ +
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIGFGLQVAKGMKYLAS 146

Query: 419 ENGGKLVHGGIKASNIFLNSQGHVCVSDIGLA-ALMSPMPPPAMRAAGYR------APEV 471
           +   K VH  + A N  L+ +  V V+D GLA  +            G +      A E 
Sbjct: 147 K---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALES 203

Query: 472 TDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDV 530
             T+K T  SDV+SFGVLL EL+T G  P       ++   +                  
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL---------------QG 248

Query: 531 ELLRYP-NIEEEMVE-MLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
             L  P    + + E ML+    C     E RP  ++++  +  I  
Sbjct: 249 RRLLQPEYCPDPLYEVMLK----CWHPKAEMRPSFSELVSRISAIFS 291

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 89.6 bits (223), Expect = 6e-20
 Identities = 53/228 (23%), Positives = 92/228 (40%), Gaps = 22/228 (9%)

Query: 299 DLLRASAEVLGKGTFGTAYKAALEDAS---TVVVKRLKE---VNVGKREFEQQMEIVGGI 352
            LL    + LG G FGT  K   +      TV VK LK        K E   +  ++  +
Sbjct: 16  KLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQL 75

Query: 353 RHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARG 412
            +  +V +       +  ++V +  E G ++  L   R     ++     + +    + G
Sbjct: 76  DNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI-----IELVHQVSMG 129

Query: 413 IAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR----- 467
           + ++   N    VH  + A N+ L +Q +  +SD GL+  +             +     
Sbjct: 130 MKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 186

Query: 468 -APEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVR 513
            APE  +  K +  SDV+SFGVL+ E  + G+ P     G EV  ++ 
Sbjct: 187 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 234

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 92.4 bits (230), Expect = 9e-20
 Identities = 18/108 (16%), Positives = 32/108 (29%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
            I  +T      L  L L +N L  +  +  S  + L  L       S    +       
Sbjct: 71  WIHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKT 130

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPS 189
           L  + L +N  ++           L  L+  NN++       +     
Sbjct: 131 LESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQ 178

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 86.2 bits (214), Expect = 8e-18
 Identities = 26/122 (21%), Positives = 40/122 (32%), Gaps = 10/122 (8%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
            +    +    AL++L      +S +        + L SL+L  N  S            
Sbjct: 95  FMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEK 154

Query: 142 LTVIDLSNNFFNASIPASISKLTHLS--ALNLANNSLTGTLPRSLQRFPSWAFAGNNLSS 199
           L V+D  NN  +      +S L   +  +LNL  N + G            AF      S
Sbjct: 155 LKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIAG--------IEPGAFDSAVFQS 206

Query: 200 EN 201
            N
Sbjct: 207 LN 208

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 85.5 bits (212), Expect = 1e-17
 Identities = 28/133 (21%), Positives = 52/133 (39%), Gaps = 5/133 (3%)

Query: 72  LRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGP 131
           L L    L+ +   +    L  L+ L+L  + L       F  L  L  L+LQ N F   
Sbjct: 405 LDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKG 464

Query: 132 LPLDFSVWNNLT---VIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFP 188
                +    L    ++ LS    ++    + + L  ++ ++L++N LT +   +L    
Sbjct: 465 NIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSHLK 524

Query: 189 SWAF--AGNNLSS 199
                 A N++S 
Sbjct: 525 GIYLNLASNHISI 537

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 85.1 bits (211), Expect = 2e-17
 Identities = 30/121 (24%), Positives = 47/121 (38%), Gaps = 6/121 (4%)

Query: 85  PNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWNNLT 143
           P+ +  LS L+ L L +N    L     S   +LT L ++ N+    L         NL 
Sbjct: 294 PSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLR 353

Query: 144 VIDLSNNFFNAS--IPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWA---FAGNNLS 198
            +DLS++    S      +  L+HL +LNL+ N        + +  P       A   L 
Sbjct: 354 ELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLK 413

Query: 199 S 199
            
Sbjct: 414 V 414

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 83.1 bits (206), Expect = 7e-17
 Identities = 24/111 (21%), Positives = 45/111 (40%), Gaps = 7/111 (6%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
               N++  L  L+ L L    LS +    F+ L+ +  + L  N  +          ++
Sbjct: 466 IQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTS---SSIEALSH 522

Query: 142 LT--VIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSW 190
           L    ++L++N  +  +P+ +  L+    +NL  N L  T   S   F  W
Sbjct: 523 LKGIYLNLASNHISIILPSLLPILSQQRTINLRQNPLDCTC--SNIYFLEW 571

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 82.8 bits (205), Expect = 8e-17
 Identities = 25/107 (23%), Positives = 37/107 (34%), Gaps = 1/107 (0%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWN 140
           +     +  LS LQ+L+L  N    L    F +   L  L L F           F   +
Sbjct: 366 DCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLH 425

Query: 141 NLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRF 187
            L V++LS++  + S       L  L  LNL  N       +     
Sbjct: 426 LLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSL 472

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 81.6 bits (202), Expect = 2e-16
 Identities = 29/114 (25%), Positives = 45/114 (39%), Gaps = 3/114 (2%)

Query: 66  HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQF 125
              V ++ L        I  NT    S LQ L L +  LS L PS    L  L  L L  
Sbjct: 253 EMSVESINLQKHYFFN-ISSNTFHCFSGLQELDLTATHLSEL-PSGLVGLSTLKKLVLSA 310

Query: 126 NSFSGPLPLDFSVWNNLTVIDLSNNFFNASI-PASISKLTHLSALNLANNSLTG 178
           N F     +  S + +LT + +  N     +    +  L +L  L+L+++ +  
Sbjct: 311 NKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIET 364

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 80.1 bits (198), Expect = 6e-16
 Identities = 23/106 (21%), Positives = 40/106 (37%), Gaps = 3/106 (2%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSG-LFPSDFSKLENLTSLHLQFN--SFSGPLPLDFSV 138
            +   +     +L +LS++ N+    L       LENL  L L  +    S    L    
Sbjct: 315 NLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRN 374

Query: 139 WNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSL 184
            ++L  ++LS N   +    +  +   L  L+LA   L     +S 
Sbjct: 375 LSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSP 420

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 79.7 bits (197), Expect = 8e-16
 Identities = 22/108 (20%), Positives = 36/108 (33%), Gaps = 3/108 (2%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
           EIP       ++ + L    N L  +  + FS+L NLT L L            F   + 
Sbjct: 26  EIPGTL---PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHR 82

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPS 189
           L  + L+ N        ++S    L  L      ++      L    +
Sbjct: 83  LDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKT 130

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 74.3 bits (183), Expect = 4e-14
 Identities = 22/141 (15%), Positives = 46/141 (32%), Gaps = 10/141 (7%)

Query: 66  HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSD--FSKLENLTSLHL 123
            +  ++L L G  +   I P      +  Q+L+        +       S +++L     
Sbjct: 178 QATNLSLNLNGNDI-AGIEPG-AFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTF 235

Query: 124 QFNSFSGPLPLDFSVW--NNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLP 181
           +        P  F      ++  I+L  ++F      +    + L  L+L    L+  LP
Sbjct: 236 EDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-ELP 294

Query: 182 RSLQRFPSWAF---AGNNLSS 199
             L    +      + N   +
Sbjct: 295 SGLVGLSTLKKLVLSANKFEN 315

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606

 Score = 51.6 bits (124), Expect = 5e-07
 Identities = 17/96 (17%), Positives = 34/96 (35%), Gaps = 7/96 (7%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPL-DFSVWNN 141
                +  L  +  L+L SN +S + PS    L    +++L+ N          F  W  
Sbjct: 515 SSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQRTINLRQNPLDCTCSNIYFLEWYK 573

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLT 177
             +  L +     +          L  + L++ +L+
Sbjct: 574 ENMQKLED-----TEDTLCENPPLLRGVRLSDVTLS 604

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 89.8 bits (223), Expect = 1e-19
 Identities = 44/209 (21%), Positives = 85/209 (40%), Gaps = 32/209 (15%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYY- 364
             +G+G+FG  ++   +D  T     +K+V +      +++    G+    +V     Y 
Sbjct: 64  PRVGRGSFGEVHRM--KDKQTGFQCAVKKVRLEVFR-VEELVACAGLSSPRIVP---LYG 117

Query: 365 -YSKDEKLMVY-DYFEPGSVSAML--HGRRGEGQSSLDWDTRVRIAIGAA-RGIAHIHTE 419
              +   + ++ +  E GS+  ++   G   E +            +G A  G+ ++HT 
Sbjct: 118 AVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDR--------ALYYLGQALEGLEYLHTR 169

Query: 420 NGGKLVHGGIKASNIFLNSQGHVC-VSDIGLAALMSPMPPPAMRAAG--------YRAPE 470
               ++HG +KA N+ L+S G    + D G A  + P         G        + APE
Sbjct: 170 R---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE 226

Query: 471 VTDTRKATQASDVFSFGVLLLELLTGKSP 499
           V   +      D++S   ++L +L G  P
Sbjct: 227 VVMGKPCDAKVDIWSSCCMMLHMLNGCHP 255

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 92.6 bits (230), Expect = 1e-19
 Identities = 23/134 (17%), Positives = 38/134 (28%), Gaps = 21/134 (15%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGP---------L 132
           E    +   L  L ++ L +       P     L  L SL++  N              L
Sbjct: 481 ENEELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRL 540

Query: 133 PLDFSVWNNLTVIDLSNNFFNASIPAS--ISKLTHLSALNLANNSLTGTLP-----RSLQ 185
             D      + +  +  N      PAS  + K+  L  L+  +N +   L        L 
Sbjct: 541 ADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLEAFGTNVKLT 598

Query: 186 RFPSWAFAGNNLSS 199
                    N +  
Sbjct: 599 DL---KLDYNQIEE 609

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 91.1 bits (226), Expect = 3e-19
 Identities = 35/187 (18%), Positives = 58/187 (31%), Gaps = 37/187 (19%)

Query: 46  NWNESSSLCK--SWTGVTCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNS 103
           NWN +  L       GV    ++ RV  L L G   +G +P   IG+L+ L+ LS  ++S
Sbjct: 301 NWNFNKELDMWGDQPGVDLD-NNGRVTGLSLAGFGAKGRVPD-AIGQLTELKVLSFGTHS 358

Query: 104 LSG-------------------------LFPSDFSKLENLTSLHLQFNSFS-----GPLP 133
            +                                   + L    L  ++ +      P+ 
Sbjct: 359 ETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIK 418

Query: 134 LDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFA 193
            D  +    T I    N     I  +I +LT L  +  AN+  T           +  + 
Sbjct: 419 KDSRISLKDTQIGNLTNRIT-FISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDY- 476

Query: 194 GNNLSSE 200
                  
Sbjct: 477 -AKQYEN 482

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 88.8 bits (220), Expect = 2e-18
 Identities = 24/136 (17%), Positives = 49/136 (36%), Gaps = 20/136 (14%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFS--KLENLTSLHLQFNSFSG-----PLPL 134
           EIP +       ++ L    N L  + P+ F+   +  + S+   +N            +
Sbjct: 609 EIPEDFCAFTDQVEGLGFSHNKLKYI-PNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSM 667

Query: 135 DFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAF-- 192
           D     N + + LS N          +  + +S + L+NN +T ++P +  +     +  
Sbjct: 668 DDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMT-SIPENSLKPKDGNYKN 726

Query: 193 ---------AGNNLSS 199
                      N L+S
Sbjct: 727 TYLLTTIDLRFNKLTS 742

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 86.1 bits (213), Expect = 1e-17
 Identities = 21/115 (18%), Positives = 39/115 (33%), Gaps = 7/115 (6%)

Query: 85  PNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTV 144
              I RL+ LQ +   ++  +    +      +    +  +        L +S   +LT 
Sbjct: 441 SKAIQRLTKLQIIYFANSPFTYDNIA-----VDWEDANSDYAKQYENEELSWSNLKDLTD 495

Query: 145 IDLSNNFFNASIPASISKLTHLSALNLANNSLTG--TLPRSLQRFPSWAFAGNNL 197
           ++L N      +P  +  L  L +LN+A N       L     R       G  +
Sbjct: 496 VELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKI 550

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 84.9 bits (210), Expect = 3e-17
 Identities = 20/130 (15%), Positives = 44/130 (33%), Gaps = 16/130 (12%)

Query: 82  EIPPN-TIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVW 139
           E P + ++ ++  L  L    N +  L    F     LT L L +N     +P D  +  
Sbjct: 562 EFPASASLQKMVKLGLLDCVHNKVRHL--EAFGTNVKLTDLKLDYNQIEE-IPEDFCAFT 618

Query: 140 NNLTVIDLSNNFFNASIP--ASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAF----- 192
           + +  +  S+N     IP   +   +  + +++ + N +             +       
Sbjct: 619 DQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINAST 677

Query: 193 ---AGNNLSS 199
              + N +  
Sbjct: 678 VTLSYNEIQK 687

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 83.8 bits (207), Expect = 7e-17
 Identities = 20/107 (18%), Positives = 35/107 (32%), Gaps = 9/107 (8%)

Query: 85  PNTIGRLSALQNLSLRSNSLSGLFPS-DFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLT 143
                    L  + LR N L+ L      + L  L+++ + +N FS   P      + L 
Sbjct: 721 DGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLPYLSNMDVSYNCFSS-FPTQPLNSSQLK 779

Query: 144 VIDL------SNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSL 184
              +        N      P  I+    L  L + +N +   +   L
Sbjct: 780 AFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEKL 825

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 82.2 bits (203), Expect = 2e-16
 Identities = 19/118 (16%), Positives = 42/118 (35%), Gaps = 16/118 (13%)

Query: 81  GEIPPNTIGRLSALQNLSLRS-----NSLSGLFPSDFSKLENLTSLHLQFNSFS------ 129
           G    N    +   + ++  +     N +       F+    ++++ L  N  +      
Sbjct: 657 GSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENS 716

Query: 130 -GPLPLDFSVWNNLTVIDLSNNFFNASIPASI--SKLTHLSALNLANNSLTGTLPRSL 184
             P   ++     LT IDL  N    S+      + L +LS ++++ N  + + P   
Sbjct: 717 LKPKDGNYKNTYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS-SFPTQP 772

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 80.3 bits (198), Expect = 8e-16
 Identities = 20/128 (15%), Positives = 40/128 (31%), Gaps = 13/128 (10%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWN- 140
            +     G    L +L L  N +  +     +  + +  L    N     +P  F+  + 
Sbjct: 587 HLEA--FGTNVKLTDLKLDYNQIEEIPEDFCAFTDQVEGLGFSHNKLKY-IPNIFNAKSV 643

Query: 141 -NLTVIDLSNNFF-----NASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAF-- 192
             +  +D S N       N S      K  + S + L+ N +              +   
Sbjct: 644 YVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELFATGSPISTII 703

Query: 193 -AGNNLSS 199
            + N ++S
Sbjct: 704 LSNNLMTS 711

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 74.9 bits (184), Expect = 4e-14
 Identities = 15/128 (11%), Positives = 39/128 (30%), Gaps = 16/128 (12%)

Query: 82  EIPPN-TIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQF------NSFSGPLPL 134
            +  +     L  L N+ +  N  S   P+       L +  ++       N      P 
Sbjct: 742 SLSDDFRATTLPYLSNMDVSYNCFSSF-PTQPLNSSQLKAFGIRHQRDAEGNRILRQWPT 800

Query: 135 DFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLT----GTLPRSLQRFPSW 190
             +   +L  + + +N     +   +     L  L++A+N        ++   ++    +
Sbjct: 801 GITTCPSLIQLQIGSNDIR-KVDEKL--TPQLYILDIADNPNISIDVTSVCPYIE-AGMY 856

Query: 191 AFAGNNLS 198
               +   
Sbjct: 857 VLLYDKTQ 864

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876

 Score = 54.1 bits (130), Expect = 1e-07
 Identities = 13/91 (14%), Positives = 34/91 (37%), Gaps = 1/91 (1%)

Query: 91  LSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNN 150
            +  + L  ++        ++     N  + + + + +     +D      +T + L+  
Sbjct: 275 KAIWEALDGKNWRYYSGTINNTIHSLN-WNFNKELDMWGDQPGVDLDNNGRVTGLSLAGF 333

Query: 151 FFNASIPASISKLTHLSALNLANNSLTGTLP 181
                +P +I +LT L  L+   +S T +  
Sbjct: 334 GAKGRVPDAIGQLTELKVLSFGTHSETVSGR 364

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 92.2 bits (229), Expect = 1e-19
 Identities = 59/289 (20%), Positives = 110/289 (38%), Gaps = 52/289 (17%)

Query: 306 EVLGKGTFGTAYKAALEDAS----TVVVKRLKE--VNVGKREFEQQMEIVGGIRHENVVA 359
             +G+G FG  ++            V +K  K    +  + +F Q+   +    H ++V 
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455

Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE 419
           L     +++   ++ +    G + + L  R+      LD  + +  A   +  +A++ ++
Sbjct: 456 LIGVI-TENPVWIIMELCTLGELRSFLQVRKFS----LDLASLILYAYQLSTALAYLESK 510

Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALM----------SPMPPPAMRAAGYRAP 469
                VH  I A N+ ++S   V + D GL+  M            +P   M      AP
Sbjct: 511 R---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM------AP 561

Query: 470 EVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVF 528
           E  + R+ T ASDV+ FGV + E+L  G  P      ++V+  +                
Sbjct: 562 ESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE--------------- 606

Query: 529 DVELLRYP-NIEEEMVE-MLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
           + E L  P N    +   M +    C    P  RP+  ++   +  I  
Sbjct: 607 NGERLPMPPNCPPTLYSLMTK----CWAYDPSRRPRFTELKAQLSTILE 651

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 88.5 bits (220), Expect = 1e-19
 Identities = 49/309 (15%), Positives = 111/309 (35%), Gaps = 59/309 (19%)

Query: 306 EVLGKGTFGTAYKAALEDAS--------TVVVKRLKEVNV-GKREFEQQMEIVGGIRHEN 356
           E LG+GTF   +K    +           V++K L + +      F +   ++  + H++
Sbjct: 14  ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73

Query: 357 VVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHI 416
           +V         DE ++V ++ + GS+   L   +      ++   ++ +A   A  +  +
Sbjct: 74  LVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN----CINILWKLEVAKQLAAAMHFL 129

Query: 417 HTENGGKLVHGGIKASNIFLNSQ-------GHVC-VSDIGLAALMSPMPPPAMRAAGYR- 467
                  L+HG + A NI L  +            +SD G++  +       +     + 
Sbjct: 130 EENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-------LPKDILQE 179

Query: 468 -----APE-VTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVR 520
                 PE + + +    A+D +SFG  L E+ + G  P+ A      +      + +  
Sbjct: 180 RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPA 239

Query: 521 EEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAEN 580
            +   E+ ++              +      C+   P+ RP    +++ +  +       
Sbjct: 240 PKAA-ELANL--------------INN----CMDYEPDHRPSFRAIIRDLNSL-FTPDLV 279

Query: 581 PPSTENRSE 589
           P  + +   
Sbjct: 280 PRGSHHHHH 288

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 89.0 bits (221), Expect = 1e-19
 Identities = 59/311 (18%), Positives = 118/311 (37%), Gaps = 44/311 (14%)

Query: 274 GVSGSHDKNSKLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVVVKRLK 333
           G SGS  K +  +   G     ++ DL       +G GT G  +K        V+  +  
Sbjct: 1   GSSGSSGKQTGYLTIGGQRYQAEINDLENL--GEMGSGTCGQVWKMRFRKTGHVIAVKQM 58

Query: 334 EVNVGKREFEQ-QMEI---VGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAML--H 387
             +  K E ++  M++   +       +V     + +  +  +  +     +        
Sbjct: 59  RRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQ 118

Query: 388 GRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDI 447
           G   E           ++ +   + + ++  ++   ++H  +K SNI L+ +G + + D 
Sbjct: 119 GPIPERILG-------KMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDF 169

Query: 448 GLAA-LMSPMPPPAMRA-AG---YRAPEVTDTRKATQA-----SDVFSFGVLLLELLTGK 497
           G++  L+      A    AG   Y APE  D    T+      +DV+S G+ L+EL TG+
Sbjct: 170 GISGRLVDDK---AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226

Query: 498 SPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMP 557
            P      D        +  V++EE    +     + +    +  V+       C+ +  
Sbjct: 227 FPYKNCKTD-----FEVLTKVLQEE--PPLLPGH-MGFSGDFQSFVK------DCLTKDH 272

Query: 558 EERPKMADVLK 568
            +RPK   +L+
Sbjct: 273 RKRPKYNKLLE 283

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 88.9 bits (221), Expect = 1e-19
 Identities = 60/318 (18%), Positives = 109/318 (34%), Gaps = 76/318 (23%)

Query: 306 EVLGKGTFGTAYKAALEDAS-----TVVVKRLKEVNVGK--REFEQQMEIVGGIRHENVV 358
             LG+G FG       +  +      V VK LK     +    ++Q+++I+  + HE+++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 359 ALRAYYYSKDEK--LMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHI 416
             +            +V +Y   GS+   L          +     +  A     G+A++
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS------IGLAQLLLFAQQICEGMAYL 150

Query: 417 HTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR--------- 467
           H ++    +H  + A N+ L++   V + D GLA  +            YR         
Sbjct: 151 HAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAV------PEGHEYYRVREDGDSPV 201

Query: 468 ---APEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEW 523
              APE     K   ASDV+SFGV L ELLT   S                      +  
Sbjct: 202 FWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSS---------------------QSP 240

Query: 524 TAEVFDVELLRYPNIE-EEMVEMLQVG-----------------MACVVRMPEERPKMAD 565
             +  ++  +    +    + E+L+ G                   C       RP   +
Sbjct: 241 PTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFEN 300

Query: 566 VLKMVEDIRRVKAENPPS 583
           ++ +++ +        PS
Sbjct: 301 LIPILKTVHEKYQGQAPS 318

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 89.4 bits (222), Expect = 2e-19
 Identities = 70/320 (21%), Positives = 107/320 (33%), Gaps = 65/320 (20%)

Query: 306 EVLGKGTFGTAYKAAL------EDASTVVVKRLKEV--NVGKREFEQQMEIVGGIRHENV 357
             LG G FG  Y+  +           V VK L EV     + +F  +  I+    H+N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136

Query: 358 VALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQ--SSLDWDTRVRIAIGAARGIAH 415
           V           + ++ +    G + + L   R      SSL     + +A   A G  +
Sbjct: 137 VRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 416 IHTENGGKLVHGGIKASNIFLNSQGH---VCVSDIGLAALMSPMPPPAMRAAGYR----- 467
           +        +H  I A N  L   G      + D G+A  +        RA  YR     
Sbjct: 197 L---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI-------YRAGYYRKGGCA 246

Query: 468 -------APEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVV 519
                   PE       T  +D +SFGVLL E+ + G  P  +    EV+  V       
Sbjct: 247 MLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT------ 300

Query: 520 REEWTAEVFDVELLRYP-NIEEEMVE-MLQVGMACVVRMPEERPKMADVLKMVEDIRR-- 575
                        +  P N    +   M Q    C    PE+RP  A +L+ +E   +  
Sbjct: 301 ---------SGGRMDPPKNCPGPVYRIMTQ----CWQHQPEDRPNFAIILERIEYCTQDP 347

Query: 576 ------VKAENPPSTENRSE 589
                 +  E  P  E   +
Sbjct: 348 DVINTALPIEYGPLVEEEEK 367

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 88.5 bits (220), Expect = 2e-19
 Identities = 68/309 (22%), Positives = 114/309 (36%), Gaps = 58/309 (18%)

Query: 306 EVLGKGTFGTAYKAAL----EDASTVVVKRLKEVNVGKRE---FEQQMEIVGGIRHENVV 358
            +LGKG FG+  +A L         V VK LK   +   +   F ++   +    H +V 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 359 AL------RAYYYSKDEKLMVYDYFEPGSVSAMLHGRR-GEGQSSLDWDTRVRIAIGAAR 411
            L                +++  + + G + A L   R GE   +L   T VR  +  A 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 412 GIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR---- 467
           G+ ++   +    +H  + A N  L     VCV+D GL+  +            YR    
Sbjct: 149 GMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKI-------YSGDYYRQGCA 198

Query: 468 --------APEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSV 518
                   A E       T  SDV++FGV + E++T G++P       E+ + +      
Sbjct: 199 SKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI----- 253

Query: 519 VREEWTAEVFDVELLRYP-NIEEEMVE-MLQVGMACVVRMPEERPKMADVLKMVEDIRRV 576
                         L+ P    EE+ + M Q    C    P++RP    +   +E+I   
Sbjct: 254 ----------GGNRLKQPPECMEEVYDLMYQ----CWSADPKQRPSFTCLRMELENILGH 299

Query: 577 KAENPPSTE 585
            +    S +
Sbjct: 300 LSVLSTSQD 308

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 87.6 bits (218), Expect = 2e-19
 Identities = 59/290 (20%), Positives = 115/290 (39%), Gaps = 54/290 (18%)

Query: 306 EVLGKGTFGTAYKAALEDAS----TVVVKRLKE--VNVGKREFEQQMEIVGGIRHENVVA 359
            +LG+G FG  Y+    +       V VK  K+      K +F  +  I+  + H ++V 
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77

Query: 360 LRAYYY---SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHI 416
           L         ++   ++ + +  G +   L   +     SL   T V  ++   + +A++
Sbjct: 78  L----IGIIEEEPTWIIMELYPYGELGHYLERNKN----SLKVLTLVLYSLQICKAMAYL 129

Query: 417 HTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR------APE 470
            + N    VH  I   NI + S   V + D GL+  +        +A+  R      +PE
Sbjct: 130 ESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE--DEDYYKASVTRLPIKWMSPE 184

Query: 471 VTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVR----EEWTA 525
             + R+ T ASDV+ F V + E+L+ GK P       +V+ ++       R    +    
Sbjct: 185 SINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE---KGDRLPKPDLCPP 241

Query: 526 EVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
            ++ +              M +    C    P +RP+  +++  + D+ +
Sbjct: 242 VLYTL--------------MTR----CWDYDPSDRPRFTELVCSLSDVYQ 273

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 88.1 bits (219), Expect = 3e-19
 Identities = 52/234 (22%), Positives = 91/234 (38%), Gaps = 36/234 (15%)

Query: 306 EVLGKGTFGTAYKAALED----ASTVVVKRLKEVNVGKRE---FEQQMEIVGGIRHENVV 358
           ++LG+G FG+  +  L+     +  V VK +K  N  +RE   F  +   +    H NV+
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 359 AL-----RAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQ-SSLDWDTRVRIAIGAARG 412
            L             + +++  + + G +   L   R E     +   T ++  +  A G
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 413 IAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR----- 467
           + ++   +    +H  + A N  L     VCV+D GL+  +            YR     
Sbjct: 160 MEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKI-------YSGDYYRQGRIA 209

Query: 468 -------APEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVR 513
                  A E    R  T  SDV++FGV + E+ T G +P       E+   + 
Sbjct: 210 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL 263

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 88.1 bits (219), Expect = 3e-19
 Identities = 60/296 (20%), Positives = 106/296 (35%), Gaps = 57/296 (19%)

Query: 306 EVLGKGTFGTAYKAAL------EDASTVVVKRLKEV--NVGKREFEQQMEIVGGIRHENV 357
             LG+G+FG  Y+         E  + V +K + E      + EF  +  ++      +V
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 358 VALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGE-----GQSSLDWDTRVRIAIGAARG 412
           V L          L++ +    G + + L   R         +       +++A   A G
Sbjct: 91  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 150

Query: 413 IAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR----- 467
           +A++   N  K VH  + A N  +     V + D G+   +            YR     
Sbjct: 151 MAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI-------YETDYYRKGGKG 200

Query: 468 -------APEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVV 519
                  +PE       T  SDV+SFGV+L E+ T  + P      ++V+  V       
Sbjct: 201 LLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM------ 254

Query: 520 REEWTAEVFDVELLRYP-NIEEEMVE-MLQVGMACVVRMPEERPKMADVLKMVEDI 573
                    +  LL  P N  + + E M      C    P+ RP   +++  +++ 
Sbjct: 255 ---------EGGLLDKPDNCPDMLFELMRM----CWQYNPKMRPSFLEIISSIKEE 297

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 86.9 bits (216), Expect = 6e-19
 Identities = 53/223 (23%), Positives = 88/223 (39%), Gaps = 22/223 (9%)

Query: 306 EVLGKGTFGTAYKAALEDAS----TVVVKRLKEVNVGK--REFEQQMEIVGGIRHENVVA 359
            V+GKG FG  Y     D +       +K L  +   +    F ++  ++ G+ H NV+A
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 360 LRAYYYSKDEKLM-VYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT 418
           L       +     +  Y   G +   +   +            +   +  ARG+ ++  
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN----PTVKDLISFGLQVARGMEYLAE 142

Query: 419 ENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR-------APEV 471
           +     VH  + A N  L+    V V+D GLA  +      +++   +        A E 
Sbjct: 143 QK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALES 199

Query: 472 TDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVR 513
             T + T  SDV+SFGVLL ELLT G  P       ++ H + 
Sbjct: 200 LQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA 242

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 87.4 bits (217), Expect = 7e-19
 Identities = 64/305 (20%), Positives = 123/305 (40%), Gaps = 35/305 (11%)

Query: 278 SHDKNSKLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDASTVV-VKRLKEVN 336
           S + + KL      +  F  EDL       +G+G +G+  K   + +  ++ VKR++   
Sbjct: 2   SIESSGKLKISPEQHWDFTAEDLKDL--GEIGRGAYGSVNKMVHKPSGQIMAVKRIR-ST 58

Query: 337 VGKREFEQ-QMEI---VGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGE 392
           V ++E +Q  M++   +       +V      + + +  +  +     S           
Sbjct: 59  VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSV 117

Query: 393 GQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAA- 451
               +  +   +I +   + + H+      K++H  IK SNI L+  G++ + D G++  
Sbjct: 118 LDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQ 175

Query: 452 LMSPMPPPAMR-AAG---YRAPEVTDTRKATQA----SDVFSFGVLLLELLTGKSPIHAT 503
           L+  +   A    AG   Y APE  D   + Q     SDV+S G+ L EL TG+ P    
Sbjct: 176 LVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232

Query: 504 GGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKM 563
                  +   +  VV+ +   ++ + E   +       V        C+ +   +RPK 
Sbjct: 233 NS-----VFDQLTQVVKGD-PPQLSNSEEREFSPSFINFVN------LCLTKDESKRPKY 280

Query: 564 ADVLK 568
            ++LK
Sbjct: 281 KELLK 285

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 55/207 (26%), Positives = 91/207 (43%), Gaps = 29/207 (14%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKR--LKEVNVGKREFEQQMEIVGGIRHENVVALRA 362
           E +GKG+FG  +K         V +K   L+E      + +Q++ ++       V     
Sbjct: 28  EKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTK--- 84

Query: 363 YY--YSKDEKL-MVYDYFEPGSVSAMLHGRR-GEGQSSLDWDTRVRIAI---GAARGIAH 415
           YY  Y KD KL ++ +Y   GS   +L      E Q          IA       +G+ +
Sbjct: 85  YYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ----------IATILREILKGLDY 134

Query: 416 IHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVT 472
           +H+E   K +H  IKA+N+ L+  G V ++D G+A  ++          G   + APEV 
Sbjct: 135 LHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 191

Query: 473 DTRKATQASDVFSFGVLLLELLTGKSP 499
                   +D++S G+  +EL  G+ P
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEPP 218

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 64/301 (21%), Positives = 115/301 (38%), Gaps = 59/301 (19%)

Query: 306 EVLGKGTFGTAYKAAL------EDASTVVVKRLKEVNVG-KREFEQQMEIVGGIRHENVV 358
             LG+G FG  + A        +D   V VK LKE +   +++F+++ E++  ++H+++V
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTR----------VRIAIG 408
                       LMV++Y   G ++  L     + +     +            + +A  
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166

Query: 409 AARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR- 467
            A G+ ++    G   VH  +   N  +     V + D G++  +            YR 
Sbjct: 167 VAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI-------YSTDYYRV 216

Query: 468 -----------APEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWV 515
                       PE    RK T  SDV+SFGV+L E+ T GK P +     E +  +   
Sbjct: 217 GGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQG 276

Query: 516 NSVVR-EEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIR 574
             + R      EV+ +              M      C  R P++R  + DV   ++ + 
Sbjct: 277 RELERPRACPPEVYAI--------------MRG----CWQREPQQRHSIKDVHARLQALA 318

Query: 575 R 575
           +
Sbjct: 319 Q 319

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 86.3 bits (214), Expect = 2e-18
 Identities = 51/329 (15%), Positives = 115/329 (34%), Gaps = 49/329 (14%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKRE---FEQQMEIVGGIRH--ENVVAL 360
           + +G G     ++   E      +K +       +    +  ++  +  ++   + ++ L
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN 420
             Y  +     MV +      +++ L  ++     S+D   R          +  IH   
Sbjct: 75  YDYEITDQYIYMVMEC-GNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG 128

Query: 421 GGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP----------------MPPPAMRAA 464
              +VH  +K +N  +   G + + D G+A  M P                MPP A++  
Sbjct: 129 ---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184

Query: 465 GYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWT 524
                      K +  SDV+S G +L  +  GK+P      +++  L   ++        
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-INQISKLHAIIDP------- 236

Query: 525 AEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK---MVEDIRRVKAENP 581
               + E+      E+++ ++L+    C+ R P++R  + ++L    +      V     
Sbjct: 237 ----NHEIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 289

Query: 582 PSTENRSEISSSAATPKATETASSSTAHL 610
            +TE    +        +  +   +   L
Sbjct: 290 GTTEEMKYVLGQLVGLNSPNSILKAAKTL 318

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 85.8 bits (213), Expect = 2e-18
 Identities = 22/109 (20%), Positives = 45/109 (41%), Gaps = 5/109 (4%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGL-FPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWN 140
            +     G  S +Q L L+ N +  + F    +  + L  L+LQ+N     +      + 
Sbjct: 134 MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVV-FA 191

Query: 141 NLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPS 189
            L  +DLS+N     +         ++ ++L NN L   + ++L+   +
Sbjct: 192 KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQN 238

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 77.0 bits (190), Expect = 2e-15
 Identities = 18/109 (16%), Positives = 37/109 (33%), Gaps = 7/109 (6%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSG-PLPLDFSVWN 140
            +  +        +N+ L +N ++ L   D      +  L L+ N           +  +
Sbjct: 113 RVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169

Query: 141 NLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPS 189
            L  ++L  NF    +   +     L  L+L++N L   +    Q    
Sbjct: 170 TLEHLNLQYNFI-YDVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAG 215

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 75.4 bits (186), Expect = 5e-15
 Identities = 24/153 (15%), Positives = 43/153 (28%), Gaps = 10/153 (6%)

Query: 84  PPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLT 143
                     L++L+L+ N +  +          L +L L  N  +  +  +F     +T
Sbjct: 161 FAELAASSDTLEHLNLQYNFIYDVKGQVV--FAKLKTLDLSSNKLAF-MGPEFQSAAGVT 217

Query: 144 VIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSW----AFAGNNLSS 199
            I L NN     I  ++    +L   +L  N       R    F         A   +  
Sbjct: 218 WISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF--FSKNQRVQTVAKQTVKK 274

Query: 200 ENARPPALPVQPPVAEPSRKKSTKLSEPALLGI 232
              +       P +          L  P    +
Sbjct: 275 LTGQNEEECTVPTLGHYGAYCCEDLPAPFADRL 307

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 16/100 (16%), Positives = 39/100 (39%), Gaps = 5/100 (5%)

Query: 87  TIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID 146
            +    +++ L   +N++S +     S+ +   +++L  N  +    LD    + +  +D
Sbjct: 94  ELLVGPSIETLHAANNNISRV---SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLD 150

Query: 147 LSNNFFNA-SIPASISKLTHLSALNLANNSLTGTLPRSLQ 185
           L  N  +  +     +    L  LNL  N +   +   + 
Sbjct: 151 LKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV 189

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317

 Score = 72.7 bits (179), Expect = 4e-14
 Identities = 24/105 (22%), Positives = 40/105 (38%), Gaps = 8/105 (7%)

Query: 78  ALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFS 137
           A+  EI  N     +  +   +  +SL     S      N+  L L  N  S     D +
Sbjct: 1   AIH-EIKQN----GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLA 55

Query: 138 VWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPR 182
            +  L +++LS+N         +  L+ L  L+L NN +   L  
Sbjct: 56  PFTKLELLNLSSNVLY-ETL-DLESLSTLRTLDLNNNYVQ-ELLV 97

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 86.6 bits (214), Expect = 2e-18
 Identities = 41/307 (13%), Positives = 91/307 (29%), Gaps = 70/307 (22%)

Query: 306 EVLGKGTFGTAYKA---------AL------EDASTVVVKRLKEVNVGKREFEQ------ 344
            VLG+       +A          +      E   +  +K++KE  +  R          
Sbjct: 79  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138

Query: 345 ---------QMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHG---RRGE 392
                      ++V   + + ++ +R            + Y    S              
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 393 GQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAAL 452
              SL    R+++ +   R +A +H      LVH  ++  +I L+ +G V ++       
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255

Query: 453 MSPMPPPAMRAAGYRAPEVTDTR-----------KATQASDVFSFGVLLLELLTGKSPIH 501
                  ++    +  PE+   R             T + D ++ G+++  +     PI 
Sbjct: 256 DGARVVSSVSRG-FEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPIT 314

Query: 502 ATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERP 561
               D  +    W+    +                NI + +  +L      +    E+R 
Sbjct: 315 ---KDAALGGSEWIFRSCK----------------NIPQPVRALL---EGFLRYPKEDRL 352

Query: 562 KMADVLK 568
                ++
Sbjct: 353 LPLQAME 359

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 85.5 bits (212), Expect = 2e-18
 Identities = 51/216 (23%), Positives = 89/216 (41%), Gaps = 28/216 (12%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKR--LKEVNVGKREFEQQMEIVGGIRHENVVALRA 362
           EV+G G       A        V +KR  L++      E  ++++ +    H N+V+   
Sbjct: 21  EVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVS--- 77

Query: 363 YY--YSKDEKL-MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAI---GAARGIAHI 416
           YY  +   ++L +V      GSV  ++     +G+          IA        G+ ++
Sbjct: 78  YYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYL 137

Query: 417 HTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR--------- 467
           H       +H  +KA NI L   G V ++D G++A ++            R         
Sbjct: 138 HKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV--RKTFVGTPCW 192

Query: 468 -APEVTDTRKA-TQASDVFSFGVLLLELLTGKSPIH 501
            APEV +  +     +D++SFG+  +EL TG +P H
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH 228

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 63/291 (21%), Positives = 118/291 (40%), Gaps = 40/291 (13%)

Query: 306 EVLGKGTFGTAYKAALEDAS---TVVVKRLKEVNVGKRE----FEQQMEIVGGIRHENVV 358
           + LG G   T Y A  ED      V +K +      K E    FE+++     + H+N+V
Sbjct: 17  DKLGGGGMSTVYLA--EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIV 74

Query: 359 ALRAYYYSKDEKL--MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHI 416
           ++      +++    +V +Y E  ++S  +    G     L  DT +        GI H 
Sbjct: 75  SM--IDVDEEDDCYYLVMEYIEGPTLSEYIE-SHG----PLSVDTAINFTNQILDGIKHA 127

Query: 417 HTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP----MPPPAMRAAGYRAPEVT 472
           H +    +VH  IK  NI ++S   + + D G+A  +S          +    Y +PE  
Sbjct: 128 H-DMR--IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQA 184

Query: 473 DTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
                 + +D++S G++L E+L G+ P +   G+  V       S+  +     V +V  
Sbjct: 185 KGEATDECTDIYSIGIVLYEMLVGEPPFN---GETAV-------SIAIKHIQDSVPNVTT 234

Query: 533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPS 583
               +I + +  ++   +    +    R     + +M +D+  V  EN  +
Sbjct: 235 DVRKDIPQSLSNVI---LRATEKDKANRY--KTIQEMKDDLSSVLHENRAN 280

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 84.6 bits (210), Expect = 2e-18
 Identities = 53/206 (25%), Positives = 90/206 (43%), Gaps = 28/206 (13%)

Query: 307 VLGKGTFGTAYKA-ALEDASTVVVKRLKEVNVGKREFEQQM----EIVGGIRHENVVALR 361
            LGKG FG  Y A   +    + +K L +  + K   E Q+    EI   +RH N++ L 
Sbjct: 16  PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLY 75

Query: 362 AYYYSKDEKLMVYDYFEPGSVSAML--HGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE 419
            Y++      ++ +Y   G+V   L    +  E +++             A  +++ H++
Sbjct: 76  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTA-------TYITELANALSYCHSK 128

Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAA---G---YRAPEVTD 473
               ++H  IK  N+ L S G + ++D G +        P+ R     G   Y  PE+ +
Sbjct: 129 R---VIHRDIKPENLLLGSAGELKIADFGWSVH-----APSSRRTDLCGTLDYLPPEMIE 180

Query: 474 TRKATQASDVFSFGVLLLELLTGKSP 499
            R   +  D++S GVL  E L GK P
Sbjct: 181 GRMHDEKVDLWSLGVLCYEFLVGKPP 206

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 88.0 bits (218), Expect = 3e-18
 Identities = 52/321 (16%), Positives = 110/321 (34%), Gaps = 50/321 (15%)

Query: 306 EVLGKGTFGTAYKA--ALEDASTVVVKRLKEVN--VGKREFEQQMEIVGGIRHENVVALR 361
             +  G  G  Y A     +   VV+K L        +     + + +  + H ++V + 
Sbjct: 86  GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 362 AY--YYSKDEKLMVY---DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHI 416
            +  +  +    + Y   +Y    S+      +       L     +   +     ++++
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-------LPVAEAIAYLLEILPALSYL 198

Query: 417 HTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTRK 476
           H   G  LV+  +K  NI L ++  + + D+G  + ++          G++APE+  T  
Sbjct: 199 H-SIG--LVYNDLKPENIML-TEEQLKLIDLGAVSRIN-SFGYLYGTPGFQAPEIVRTG- 252

Query: 477 ATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP 536
            T A+D+++ G  L  L       +   G  V  L                 D  +L+  
Sbjct: 253 PTVATDIYTVGRTLAALTLDLPTRN---GRYVDGLPE---------------DDPVLKTY 294

Query: 537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAE--NPPSTENRSEISSSA 594
           +    ++         +   P +R       +M   +  V  E     +   R  +S+  
Sbjct: 295 DSYGRLL------RRAIDPDPRQRF--TTAEEMSAQLTGVLREVVAQDTGVPRPGLSTIF 346

Query: 595 ATPKATETASSSTAHLDSFLS 615
           +  ++T       AH D +L 
Sbjct: 347 SPSRSTFGVDLLVAHTDVYLD 367

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 84.2 bits (209), Expect = 4e-18
 Identities = 49/205 (23%), Positives = 87/205 (42%), Gaps = 26/205 (12%)

Query: 307 VLGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQM----EIVGGIRHENVVALR 361
            LGKG FG  Y A  +    ++ +K L +  + K   E Q+    EI   +RH N++ + 
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMY 80

Query: 362 AYYYSKDEKLMVYDYFEPGSVSAML--HGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE 419
            Y++ +    ++ ++   G +   L  HGR  E +S+             A  + + H  
Sbjct: 81  NYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSA-------TFMEELADALHYCHER 133

Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMR--AAG---YRAPEVTDT 474
               ++H  IK  N+ +  +G + ++D G +       P   R    G   Y  PE+ + 
Sbjct: 134 K---VIHRDIKPENLLMGYKGELKIADFGWSV----HAPSLRRRTMCGTLDYLPPEMIEG 186

Query: 475 RKATQASDVFSFGVLLLELLTGKSP 499
           +   +  D++  GVL  E L G  P
Sbjct: 187 KTHDEKVDLWCAGVLCYEFLVGMPP 211

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 86.1 bits (213), Expect = 6e-18
 Identities = 25/126 (19%), Positives = 49/126 (38%), Gaps = 8/126 (6%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGL-FPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWN 140
            +     G  S +Q L L+ N +  + F    +  + L  L+LQ+N     +      + 
Sbjct: 134 MLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYD-VKGQVV-FA 191

Query: 141 NLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPS---WAFAGNNL 197
            L  +DLS+N     +         ++ ++L NN L   + ++L+   +   +   GN  
Sbjct: 192 KLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGF 249

Query: 198 SSENAR 203
                R
Sbjct: 250 HCGTLR 255

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 77.2 bits (190), Expect = 4e-15
 Identities = 18/109 (16%), Positives = 37/109 (33%), Gaps = 7/109 (6%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSG-PLPLDFSVWN 140
            +  +        +N+ L +N ++ L   D      +  L L+ N           +  +
Sbjct: 113 RVSCSR---GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSD 169

Query: 141 NLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPS 189
            L  ++L  NF    +   +     L  L+L++N L   +    Q    
Sbjct: 170 TLEHLNLQYNFI-YDVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAG 215

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 75.7 bits (186), Expect = 1e-14
 Identities = 23/100 (23%), Positives = 39/100 (39%), Gaps = 7/100 (7%)

Query: 78  ALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFS 137
           A+  EI  N     +  +   +  +SL     S      N+  L L  N  S     D +
Sbjct: 1   AIH-EIKQN----GNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLA 55

Query: 138 VWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLT 177
            +  L +++LS+N         +  L+ L  L+L NN + 
Sbjct: 56  PFTKLELLNLSSNVLY-ETLD-LESLSTLRTLDLNNNYVQ 93

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 74.1 bits (182), Expect = 4e-14
 Identities = 24/150 (16%), Positives = 42/150 (28%), Gaps = 10/150 (6%)

Query: 84  PPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLT 143
                     L++L+L+ N +  +          L +L L  N  +  +  +F     +T
Sbjct: 161 FAELAASSDTLEHLNLQYNFIYDVKGQVV--FAKLKTLDLSSNKLAF-MGPEFQSAAGVT 217

Query: 144 VIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSW----AFAGNNLSS 199
            I L NN     I  ++    +L   +L  N       R    F         A   +  
Sbjct: 218 WISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDF--FSKNQRVQTVAKQTVKK 274

Query: 200 ENARPPALPVQPPVAEPSRKKSTKLSEPAL 229
              +       P +          L  P  
Sbjct: 275 LTGQNEEECTVPTLGHYGAYCCEDLPAPFA 304

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 72.6 bits (178), Expect = 1e-13
 Identities = 16/101 (15%), Positives = 39/101 (38%), Gaps = 5/101 (4%)

Query: 86  NTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVI 145
             +    +++ L   +N++S +     S+ +   +++L  N  +    LD    + +  +
Sbjct: 93  QELLVGPSIETLHAANNNISRV---SCSRGQGKKNIYLANNKITMLRDLDEGCRSRVQYL 149

Query: 146 DLSNNFFNA-SIPASISKLTHLSALNLANNSLTGTLPRSLQ 185
           DL  N  +  +     +    L  LNL  N +   +   + 
Sbjct: 150 DLKLNEIDTVNFAELAASSDTLEHLNLQYNFIY-DVKGQVV 189

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487

 Score = 48.3 bits (115), Expect = 5e-06
 Identities = 9/112 (8%), Positives = 22/112 (19%), Gaps = 5/112 (4%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGL----FPSDFSKLENLTSLHLQFNSFSGPLPLDFS 137
           ++P     RL AL+       S  G        +         +      +   +     
Sbjct: 298 DLPAPFADRLIALKRKEHALLSGQGSETERLECERENQARQREIDALKEQYRTVIDQVTL 357

Query: 138 VWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPS 189
                  ++      +  +         L             L  + +    
Sbjct: 358 RKQAKITLEQKKKALDEQVSNGRRAHAELDGTLQQAVGQI-ELQHATEEQSP 408

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 83.4 bits (207), Expect = 7e-18
 Identities = 67/302 (22%), Positives = 123/302 (40%), Gaps = 60/302 (19%)

Query: 306 EVLGKGTFGTAYKAAL------EDASTVVVKRLKEVNVG-KREFEQQMEIVGGIRHENVV 358
             LG+G FG  + A        +D   V VK LK+  +  +++F+++ E++  ++HE++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTR-----------VRIAI 407
                    D  +MV++Y + G ++  L     +    +D   R           + IA 
Sbjct: 81  KFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIAS 140

Query: 408 GAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR 467
             A G+ ++ +++    VH  +   N  + +   V + D G++  +            YR
Sbjct: 141 QIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMSRDV-------YSTDYYR 190

Query: 468 ------------APEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRW 514
                        PE    RK T  SDV+SFGV+L E+ T GK P       EV+  +  
Sbjct: 191 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ 250

Query: 515 VNSVVREEWTAEVFDVELLRYPNIEEEMVE-MLQVGMACVVRMPEERPKMADVLKMVEDI 573
                            L R     +E+ + ML     C  R P++R  + ++ K++  +
Sbjct: 251 GR--------------VLERPRVCPKEVYDVMLG----CWQREPQQRLNIKEIYKILHAL 292

Query: 574 RR 575
            +
Sbjct: 293 GK 294

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 83.9 bits (208), Expect = 8e-18
 Identities = 47/284 (16%), Positives = 104/284 (36%), Gaps = 46/284 (16%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKRE---FEQQMEIVGGIRH--ENVVAL 360
           + +G G     ++   E      +K +       +    +  ++  +  ++   + ++ L
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN 420
             Y  +     MV +      +++ L  ++     S+D   R          +  IH   
Sbjct: 94  YDYEITDQYIYMVMECGN-IDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG 147

Query: 421 GGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP----------------MPPPAMRAA 464
              +VH  +K +N  +   G + + D G+A  M P                MPP A++  
Sbjct: 148 ---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203

Query: 465 GYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWT 524
                      K +  SDV+S G +L  +  GK+P      +++  L   ++     E+ 
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-INQISKLHAIIDPNHEIEF- 261

Query: 525 AEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
                         E+++ ++L+    C+ R P++R  + ++L 
Sbjct: 262 ----------PDIPEKDLQDVLK---CCLKRDPKQRISIPELLA 292

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 85.2 bits (211), Expect = 8e-18
 Identities = 54/282 (19%), Positives = 100/282 (35%), Gaps = 47/282 (16%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRL--KEVNVGKREFEQQMEIVGGIRHENVVALRAY 363
           +VLG G  GT     + D   V VKR+  +  +   RE +   E      H NV+     
Sbjct: 30  DVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDE---HPNVIRYFCT 86

Query: 364 YYSKDEKLMVYDYFE--PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENG 421
              +      Y   E    ++   +  ++      L+    + +      G+AH+H+ N 
Sbjct: 87  EKDRQ---FQYIAIELCAATLQEYVE-QKDFAHLGLE---PITLLQQTTSGLAHLHSLN- 138

Query: 422 GKLVHGGIKASNIFLNSQGH-----VCVSDIGLAALMSPMPPPAMRAA------GYRAPE 470
             +VH  +K  NI ++           +SD GL   ++       R +      G+ APE
Sbjct: 139 --IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196

Query: 471 V---TDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAE 526
           +         T   D+FS G +   +++ G  P   +   +   L+   +          
Sbjct: 197 MLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPE--- 253

Query: 527 VFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
                     + +    E+++     +   P++RP    VLK
Sbjct: 254 ---------KHEDVIARELIE---KMIAMDPQKRPSAKHVLK 283

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 84.5 bits (209), Expect = 9e-18
 Identities = 51/329 (15%), Positives = 114/329 (34%), Gaps = 49/329 (14%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKRE---FEQQMEIVGGIRH--ENVVAL 360
           + +G G     ++   E      +K +       +    +  ++  +  ++   + ++ L
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN 420
             Y  +     MV +      +++ L  ++     S+D   R          +  IH   
Sbjct: 122 YDYEITDQYIYMVMEC-GNIDLNSWLKKKK-----SIDPWERKSYWKNMLEAVHTIHQHG 175

Query: 421 GGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP----------------MPPPAMRAA 464
              +VH  +K +N  +   G + + D G+A  M P                MPP A++  
Sbjct: 176 ---IVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231

Query: 465 GYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWT 524
                      K +  SDV+S G +L  +  GK+P      +++  L   ++     E+ 
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI-INQISKLHAIIDPNHEIEF- 289

Query: 525 AEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK---MVEDIRRVKAENP 581
                         E+++ ++L+    C+ R P++R  + ++L    +      V     
Sbjct: 290 ----------PDIPEKDLQDVLK---CCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAK 336

Query: 582 PSTENRSEISSSAATPKATETASSSTAHL 610
            +TE    +        +  +   +   L
Sbjct: 337 GTTEEMKYVLGQLVGLNSPNSILKAAKTL 365

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 82.6 bits (205), Expect = 1e-17
 Identities = 64/303 (21%), Positives = 110/303 (36%), Gaps = 63/303 (20%)

Query: 306 EVLGKGTFGTAYKAAL------EDASTVVVKRLKEV--NVGKREFEQQMEIVGGIRHENV 357
           E LG+  FG  YK  L      E    V +K LK+      + EF  +  +   ++H NV
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 358 VALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTR-----------VRIA 406
           V L           M++ Y   G +   L  R          D R           V + 
Sbjct: 75  VCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134

Query: 407 IGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGY 466
              A G+ ++   +   +VH  +   N+ +  + +V +SD+GL   +         A  Y
Sbjct: 135 AQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFREV-------YAADYY 184

Query: 467 R------------APEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVR 513
           +            APE     K +  SD++S+GV+L E+ + G  P       +VV ++R
Sbjct: 185 KLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR 244

Query: 514 WVNSVVREEWTAEVFDVELLRYP-NIEEEMVE-MLQVGMACVVRMPEERPKMADVLKMVE 571
                          + ++L  P +    +   M++    C    P  RP+  D+   + 
Sbjct: 245 ---------------NRQVLPCPDDCPAWVYALMIE----CWNEFPSRRPRFKDIHSRLR 285

Query: 572 DIR 574
              
Sbjct: 286 AWG 288

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 82.7 bits (205), Expect = 2e-17
 Identities = 70/336 (20%), Positives = 119/336 (35%), Gaps = 77/336 (22%)

Query: 306 EVLGKGTFGTAYKAALEDAS---TVVVKRLKEVNVGKRE----FEQQMEIVGGIRHENVV 358
           E+LG G     + A   D      V VK L+            F ++ +    + H  +V
Sbjct: 18  EILGFGGMSEVHLA--RDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIV 75

Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLH--------GR------RGEGQSSLDWDTRVR 404
           A             VYD  E  + +  L         G         EG   +     + 
Sbjct: 76  A-------------VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--MTPKRAIE 120

Query: 405 IAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRA- 463
           +   A + +   H +NG  ++H  +K +NI +++   V V D G+A  ++       +  
Sbjct: 121 VIADACQALNFSH-QNG--IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTA 177

Query: 464 -----AGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSV 518
                A Y +PE          SDV+S G +L E+LTG+ P     GD  V       SV
Sbjct: 178 AVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT---GDSPV-------SV 227

Query: 519 ----VREEWTAEVFDVELLR--YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVED 572
               VRE       D       +  +  ++  ++   +  + + PE R       +M  D
Sbjct: 228 AYQHVRE-------DPIPPSARHEGLSADLDAVV---LKALAKNPENRY--QTAAEMRAD 275

Query: 573 IRRVKAENPPSTENRSEISSSAATPKATETASSSTA 608
           + RV    PP       ++ +  T   +  A + + 
Sbjct: 276 LVRVHNGEPPEA--PKVLTDAERTSLLSSAAGNLSG 309

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 84.0 bits (208), Expect = 3e-17
 Identities = 29/110 (26%), Positives = 45/110 (40%), Gaps = 2/110 (1%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSG-PLPLDFSVWN 140
            I  +    L +L++L L  N LS L  S F  L +L  L+L  N +    +   F    
Sbjct: 64  TIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLT 123

Query: 141 NLTVIDLSNNFFNASIPA-SISKLTHLSALNLANNSLTGTLPRSLQRFPS 189
           NL  + + N    + I     + LT L+ L +   SL     +SL+    
Sbjct: 124 NLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRD 173

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 78.2 bits (193), Expect = 2e-15
 Identities = 30/134 (22%), Positives = 53/134 (39%), Gaps = 12/134 (8%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLF---PSDFSKLENLTSLHLQFNSFS--GPLPLDF 136
            +P +    L +L+ L L  N +   +    +      +L +L L  N            
Sbjct: 324 LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEIL 383

Query: 137 SVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLT---GTLPRSLQRFPSWAFA 193
               NLT +D+S N F+  +P S      +  LNL++  +      +P++L+       +
Sbjct: 384 LTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVL---DVS 439

Query: 194 GNNLSSENARPPAL 207
            NNL S +   P L
Sbjct: 440 NNNLDSFSLFLPRL 453

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 77.5 bits (191), Expect = 4e-15
 Identities = 23/103 (22%), Positives = 41/103 (39%), Gaps = 1/103 (0%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
            I    +   + LQ L L+S+ ++ +    F  L +L  L L  N  S      F   ++
Sbjct: 40  YIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSS 99

Query: 142 LTVIDLSNNFFNA-SIPASISKLTHLSALNLANNSLTGTLPRS 183
           L  ++L  N +    + +    LT+L  L + N      + R 
Sbjct: 100 LKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRI 142

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 73.2 bits (180), Expect = 9e-14
 Identities = 15/118 (12%), Positives = 39/118 (33%)

Query: 72  LRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGP 131
           LR+  +    EI       L++L  L +++ SL          + ++  L L  +  +  
Sbjct: 128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFL 187

Query: 132 LPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPS 189
           L +   + +++  ++L +        + +      S +       +     S      
Sbjct: 188 LEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLK 245

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 72.1 bits (177), Expect = 2e-13
 Identities = 28/117 (23%), Positives = 47/117 (40%), Gaps = 6/117 (5%)

Query: 61  TCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTS 120
           + S D S V   R    +    IP       +A+++L L  N ++ +   D     NL  
Sbjct: 1   SLSCDASGVCDGR--SRSFT-SIPSGL---TAAMKSLDLSFNKITYIGHGDLRACANLQV 54

Query: 121 LHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLT 177
           L L+ +  +      F    +L  +DLS+N  ++   +    L+ L  LNL  N   
Sbjct: 55  LILKSSRINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQ 111

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 69.4 bits (170), Expect = 1e-12
 Identities = 23/130 (17%), Positives = 44/130 (33%), Gaps = 9/130 (6%)

Query: 72  LRLPGMALRGEIPPNTIGRLSALQNLSL-RSNSLSGLFPSDFSKLENLTSLHLQFNSFSG 130
           L L G   +     +    L+ LQ L +    + S +   DF+ L +L  L ++  S   
Sbjct: 103 LNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRN 162

Query: 131 PLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSW 190
                     ++  + L  +     +      L+ +  L L + +L         RF   
Sbjct: 163 YQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLA--------RFQFS 214

Query: 191 AFAGNNLSSE 200
               + +SS 
Sbjct: 215 PLPVDEVSSP 224

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 64.0 bits (156), Expect = 7e-11
 Identities = 22/105 (20%), Positives = 39/105 (37%), Gaps = 9/105 (8%)

Query: 85  PNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTV 144
           P++      ++ L+L S  +  +       LE L   +   +SFS  LP        L  
Sbjct: 403 PDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLFLP-------RLQE 455

Query: 145 IDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPS 189
           + +S N    ++P + S    L  + ++ N L         R  S
Sbjct: 456 LYISRNKLK-TLPDA-SLFPVLLVMKISRNQLKSVPDGIFDRLTS 498

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 61.7 bits (150), Expect = 4e-10
 Identities = 18/125 (14%), Positives = 39/125 (31%), Gaps = 8/125 (6%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
           E+        +         +    +      +   +  LH+        L   +S+   
Sbjct: 252 ELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEK 311

Query: 142 LTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLPRSLQRFPSWA------FAG 194
           +  I + N+     +P S    L  L  L+L+ N +     ++     +W        + 
Sbjct: 312 VKRITVENSKVF-LVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQ 370

Query: 195 NNLSS 199
           N+L S
Sbjct: 371 NHLRS 375

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 58.6 bits (142), Expect = 3e-09
 Identities = 25/93 (26%), Positives = 39/93 (41%), Gaps = 4/93 (4%)

Query: 92  SALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNF 151
            A      RS S + + PS  +    + SL L FN  +     D     NL V+ L ++ 
Sbjct: 5   DASGVCDGRSRSFTSI-PSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSR 61

Query: 152 FNASIPASISKLTHLSALNLANNSLTGTLPRSL 184
            N     +   L  L  L+L++N L+ +L  S 
Sbjct: 62  INTIEGDAFYSLGSLEHLDLSDNHLS-SLSSSW 93

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 58.2 bits (141), Expect = 4e-09
 Identities = 14/122 (11%), Positives = 41/122 (33%), Gaps = 1/122 (0%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
                ++  +  + +L+L  +  + L       L ++  L L+  + +        V   
Sbjct: 162 NYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEV 221

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLSSEN 201
            + +       +     S ++L  L    L  + +      +L     +  + +++ SE 
Sbjct: 222 SSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVE-FDDCTLNGLGDFNPSESDVVSEL 280

Query: 202 AR 203
            +
Sbjct: 281 GK 282

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 50.9 bits (122), Expect = 8e-07
 Identities = 14/61 (22%), Positives = 19/61 (31%), Gaps = 2/61 (3%)

Query: 90  RLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSN 149
            L  LQ L +  N L  L  +       L  + +  N         F    +L  I L  
Sbjct: 449 FLPRLQELYISRNKLKTLPDASL--FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHT 506

Query: 150 N 150
           N
Sbjct: 507 N 507

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 17/126 (13%), Positives = 35/126 (27%), Gaps = 19/126 (15%)

Query: 85  PNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTV 144
              I  LS ++      N L    PS+   +  L  +                    +  
Sbjct: 247 LRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVET----------------VTIRR 290

Query: 145 IDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAF---AGNNLSSEN 201
           + +   +    +    S L  +  + + N+ +        Q   S  F   + N +  E 
Sbjct: 291 LHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEY 350

Query: 202 ARPPAL 207
            +  A 
Sbjct: 351 LKNSAC 356

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549

 Score = 44.3 bits (105), Expect = 9e-05
 Identities = 9/47 (19%), Positives = 19/47 (40%), Gaps = 2/47 (4%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSF 128
            +P  ++     L  + +  N L  +    F +L +L  + L  N +
Sbjct: 465 TLPDASL--FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTNPW 509

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 81.6 bits (202), Expect = 4e-17
 Identities = 44/213 (20%), Positives = 85/213 (39%), Gaps = 35/213 (16%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKRLK-EVNVGKREFEQQMEIVGGIRHENVVALRAY 363
             LG G FG  YKA   E  +    K ++ +      ++  ++EI+    H  +V     
Sbjct: 25  GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK---L 81

Query: 364 Y--YSKDEKL-MVYDYFEPGSVSAMLHGRRG---EGQSSLDWDTRVRIAI---GAARGIA 414
              Y  D KL ++ ++   G+V A++        E Q          I +        + 
Sbjct: 82  LGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQ----------IQVVCRQMLEALN 131

Query: 415 HIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEV 471
            +H++   +++H  +KA N+ +  +G + ++D G++A             G   + APEV
Sbjct: 132 FLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEV 188

Query: 472 TDTRKATQAS-----DVFSFGVLLLELLTGKSP 499
                          D++S G+ L+E+   + P
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIEPP 221

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 81.2 bits (201), Expect = 4e-17
 Identities = 48/206 (23%), Positives = 91/206 (44%), Gaps = 28/206 (13%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNVGKREFEQQ-MEIVGGIRHENVVALRAY 363
           E +G+G  GT Y A  +     V ++++      K+E     + ++   ++ N+V    Y
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN---Y 82

Query: 364 Y--YSKDEKL-MVYDYFEPGSVSAMLHGRR-GEGQSSLDWDTRVRIAI---GAARGIAHI 416
              Y   ++L +V +Y   GS++ ++      EGQ          IA       + +  +
Sbjct: 83  LDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ----------IAAVCRECLQALEFL 132

Query: 417 HTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTD 473
           H+     ++H  IK+ NI L   G V ++D G  A ++P         G   + APEV  
Sbjct: 133 HSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVT 189

Query: 474 TRKATQASDVFSFGVLLLELLTGKSP 499
            +      D++S G++ +E++ G+ P
Sbjct: 190 RKAYGPKVDIWSLGIMAIEMIEGEPP 215

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 81.1 bits (201), Expect = 5e-17
 Identities = 58/289 (20%), Positives = 120/289 (41%), Gaps = 46/289 (15%)

Query: 296 DLEDLLRASAEVLGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQ-QMEIVGGIR 353
           DLE +       LG+G +G   K     +  ++ VKR++   V  +E ++  M++   +R
Sbjct: 8   DLEPI-----MELGRGAYGVVEKMRHVPSGQIMAVKRIR-ATVNSQEQKRLLMDLDISMR 61

Query: 354 ---HENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAA 410
                  V      + + +  +  +  +  S+         +GQ+ +  D   +IA+   
Sbjct: 62  TVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQT-IPEDILGKIAVSIV 119

Query: 411 RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAA-LMSPMPPPAMRAAG---Y 466
           + + H+H++    ++H  +K SN+ +N+ G V + D G++  L+  +       AG   Y
Sbjct: 120 KALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA--KDIDAGCKPY 175

Query: 467 RAPEVTDTRKATQA----SDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREE 522
            APE  +     +     SD++S G+ ++EL   + P  + G        + +  VV E 
Sbjct: 176 MAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG-----TPFQQLKQVVEEP 230

Query: 523 ---WTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
                A+ F  E         +          C+ +  +ERP   ++++
Sbjct: 231 SPQLPADKFSAEF-------VDFTS------QCLKKNSKERPTYPELMQ 266

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 81.3 bits (201), Expect = 5e-17
 Identities = 58/207 (28%), Positives = 97/207 (46%), Gaps = 30/207 (14%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYY 364
           E LG+G++G+ YKA   E    V +K++  V    +E  +++ I+      +VV    YY
Sbjct: 35  EKLGEGSYGSVYKAIHKETGQIVAIKQV-PVESDLQEIIKEISIMQQCDSPHVVK---YY 90

Query: 365 --YSKDEKL-MVYDYFEPGSVSAMLHGRRG---EGQSSLDWDTRVRIAI---GAARGIAH 415
             Y K+  L +V +Y   GSVS ++  R     E +          IA       +G+ +
Sbjct: 91  GSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDE----------IATILQSTLKGLEY 140

Query: 416 IHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVT 472
           +H     + +H  IKA NI LN++GH  ++D G+A  ++          G   + APEV 
Sbjct: 141 LHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI 197

Query: 473 DTRKATQASDVFSFGVLLLELLTGKSP 499
                   +D++S G+  +E+  GK P
Sbjct: 198 QEIGYNCVADIWSLGITAIEMAEGKPP 224

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 81.5 bits (201), Expect = 6e-17
 Identities = 61/340 (17%), Positives = 103/340 (30%), Gaps = 101/340 (29%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKR-------------LKEVNV-------------- 337
           + +G+G FG  ++A    D     +KR             ++EV                
Sbjct: 12  QCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFN 71

Query: 338 -----------------------------GKREFEQQMEIVGGIRHENVVALRAYYYSKD 368
                                             +     +  +   +            
Sbjct: 72  AWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSS 131

Query: 369 EKLMVY---DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLV 425
            K+ +Y         ++   ++ R        +    + I I  A  +  +H++    L+
Sbjct: 132 PKVYLYIQMQLCRKENLKDWMNRRCS--LEDREHGVCLHIFIQIAEAVEFLHSKG---LM 186

Query: 426 HGGIKASNIFLNSQGHVCVSDIGLAALM----------SPMPPPAMRAAG-----YRAPE 470
           H  +K SNIF      V V D GL   M          +PMP  A          Y +PE
Sbjct: 187 HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE 246

Query: 471 VTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDV 530
                  +   D+FS G++L ELL   S        E V ++    + VR       F +
Sbjct: 247 QIHGNNYSHKVDIFSLGLILFELLYSFST-----QMERVRII----TDVRN----LKFPL 293

Query: 531 ELLRYPNIEEEMVE-MLQVGMACVVRMPEERPKMADVLKM 569
              +    E  MV+ ML          P ERP+  D+++ 
Sbjct: 294 LFTQKYPQEHMMVQDMLS-------PSPTERPEATDIIEN 326

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 83.2 bits (206), Expect = 6e-17
 Identities = 21/109 (19%), Positives = 37/109 (33%), Gaps = 1/109 (0%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
            +   +      LQ L L    +  +    +  L +L++L L  N         FS  ++
Sbjct: 42  HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSS 101

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLT-GTLPRSLQRFPS 189
           L  +        +     I  L  L  LN+A+N +    LP       +
Sbjct: 102 LQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTN 150

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 82.1 bits (203), Expect = 2e-16
 Identities = 22/104 (21%), Positives = 39/104 (37%), Gaps = 2/104 (1%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWN 140
                +    ++L+ L L  N +  +  S+F  LE L  L  Q ++         F    
Sbjct: 363 GCCSQSDFGTTSLKYLDLSFNGVITM-SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLR 421

Query: 141 NLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSL 184
           NL  +D+S+     +     + L+ L  L +A NS        +
Sbjct: 422 NLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDI 465

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 80.5 bits (199), Expect = 4e-16
 Identities = 29/109 (26%), Positives = 44/109 (40%), Gaps = 5/109 (4%)

Query: 84  PPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWNNL 142
             +    L  L  L +        F   F+ L +L  L +  NSF      D F+   NL
Sbjct: 413 EFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 472

Query: 143 TVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLPRS-LQRFPS 189
           T +DLS       +  +  + L+ L  LN+A+N L  ++P     R  S
Sbjct: 473 TFLDLSQCQLE-QLSPTAFNSLSSLQVLNMASNQLK-SVPDGIFDRLTS 519

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 77.1 bits (190), Expect = 5e-15
 Identities = 23/107 (21%), Positives = 45/107 (42%), Gaps = 2/107 (1%)

Query: 85  PNTIGRLSALQNLSLRSNSLSGLFP-SDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLT 143
            +    L  L++L  + ++L  +   S F  L NL  L +            F+  ++L 
Sbjct: 389 SSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLE 448

Query: 144 VIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLPRSLQRFPS 189
           V+ ++ N F  +    I ++L +L+ L+L+   L    P +     S
Sbjct: 449 VLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSS 495

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 75.9 bits (187), Expect = 1e-14
 Identities = 30/103 (29%), Positives = 47/103 (45%), Gaps = 3/103 (2%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSD-FSKLENLTSLHLQFNSFSGPLPLDFSVWN 140
                    LS+L+ L +  NS    F  D F++L NLT L L         P  F+  +
Sbjct: 435 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 494

Query: 141 NLTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLPR 182
           +L V+++++N    S+P  I  +LT L  + L  N    + PR
Sbjct: 495 SLQVLNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCPR 536

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 74.4 bits (183), Expect = 4e-14
 Identities = 20/108 (18%), Positives = 35/108 (32%), Gaps = 7/108 (6%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
            +P +T       +NL L  N L  L    F     L  L L            +   ++
Sbjct: 25  NLPFST-------KNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSH 77

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPS 189
           L+ + L+ N   +    + S L+ L  L     +L       +    +
Sbjct: 78  LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKT 125

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 68.2 bits (167), Expect = 4e-12
 Identities = 24/97 (24%), Positives = 40/97 (41%), Gaps = 5/97 (5%)

Query: 90  RLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFN--SFSGPLPLDFSVWNNLTVIDL 147
           +L +L+ L+  SN     F      L +L  L L  N  SF G          +L  +DL
Sbjct: 323 KLKSLKRLTFTSNKGGNAFS--EVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDL 380

Query: 148 SNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSL 184
           S N    ++ ++   L  L  L+  +++L      S+
Sbjct: 381 SFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSV 416

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 66.3 bits (162), Expect = 1e-11
 Identities = 26/148 (17%), Positives = 50/148 (33%), Gaps = 12/148 (8%)

Query: 72  LRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLT----SLHLQFNS 127
           L +    ++    P     L+ L++L L SN +  ++ +D   L  +     SL L  N 
Sbjct: 129 LNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNP 188

Query: 128 FSGPLPLDFSVWNNLTVIDLSNNFFNASIPA-SISKLTHLSALNLA------NNSLTGTL 180
            +  +         L  + L NNF + ++    I  L  L    L         +L    
Sbjct: 189 MNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFD 247

Query: 181 PRSLQRFPSWAFAGNNLSSENARPPALP 208
             +L+   +       L+  +     + 
Sbjct: 248 KSALEGLCNLTIEEFRLAYLDYYLDDII 275

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 65.9 bits (161), Expect = 2e-11
 Identities = 21/80 (26%), Positives = 33/80 (41%), Gaps = 2/80 (2%)

Query: 72  LRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGP 131
           L++ G + +    P+    L  L  L L    L  L P+ F+ L +L  L++  N     
Sbjct: 450 LKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKS- 508

Query: 132 LPLD-FSVWNNLTVIDLSNN 150
           +P   F    +L  I L  N
Sbjct: 509 VPDGIFDRLTSLQKIWLHTN 528

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 57.0 bits (138), Expect = 1e-08
 Identities = 28/175 (16%), Positives = 51/175 (29%), Gaps = 27/175 (15%)

Query: 36  IHNIHNSRSLNWNESSSLCKSWTGVTCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQ 95
           +H +      N        KS     C+         RL  +    +   +    L+ + 
Sbjct: 229 VHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEE---FRLAYLDYYLDDIIDLFNCLTNVS 285

Query: 96  NLSLRSNSLSGLFPSDF-------------------SKLENLTSLHLQFNSFSGPLPLDF 136
           + SL S ++  +    +                    KL++L  L    N          
Sbjct: 286 SFSLVSVTIERVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFS--E 343

Query: 137 SVWNNLTVIDLSNNFFNAS--IPASISKLTHLSALNLANNSLTGTLPRSLQRFPS 189
               +L  +DLS N  +       S    T L  L+L+ N +  T+  +      
Sbjct: 344 VDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQ 397

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570

 Score = 54.7 bits (132), Expect = 6e-08
 Identities = 22/140 (15%), Positives = 37/140 (26%), Gaps = 11/140 (7%)

Query: 72  LRLPGMALRGEIPPNTIGRLSALQNLSL------RSNSLSGLFPSDFSKLENLTSLHLQF 125
           L L        +    I  L+ L+   L         +L     S    L NLT    + 
Sbjct: 205 LTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRL 264

Query: 126 NS---FSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPR 182
                +   +   F+   N++   L +      +    S       L L N         
Sbjct: 265 AYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE-RVK-DFSYNFGWQHLELVNCKFGQFPTL 322

Query: 183 SLQRFPSWAFAGNNLSSENA 202
            L+      F  N   +  +
Sbjct: 323 KLKSLKRLTFTSNKGGNAFS 342

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 80.4 bits (199), Expect = 9e-17
 Identities = 60/298 (20%), Positives = 105/298 (35%), Gaps = 48/298 (16%)

Query: 306 EVLGKGTFGTAYKAALEDAS---TVVVKRLKEVNVGKREFEQQME----IVGGIRHENVV 358
            ++G+G  G  Y+A  ED      V +K + E       F  +M+      G ++  +VV
Sbjct: 40  RLVGRGGMGDVYEA--EDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVV 97

Query: 359 ALRAYYYSKDEKL--MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHI 416
            +  + + + +    +         ++AML  R+G     L     V I       +   
Sbjct: 98  PI--HDFGEIDGQLYVDMRLINGVDLAAMLR-RQG----PLAPPRAVAIVRQIGSALDAA 150

Query: 417 HTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG-------YRAP 469
           H   G    H  +K  NI +++     + D G+A+  +      +   G       Y AP
Sbjct: 151 H-AAG--ATHRDVKPENILVSADDFAYLVDFGIASATTD---EKLTQLGNTVGTLYYMAP 204

Query: 470 EVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD 529
           E      AT  +D+++   +L E LTG  P     GD++        SV+       +  
Sbjct: 205 ERFSESHATYRADIYALTCVLYECLTGSPPYQ---GDQL--------SVMGAHINQAIPR 253

Query: 530 VELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTENR 587
              +R P I      ++  GMA   + PE+R        +        A         
Sbjct: 254 PSTVR-PGIPVAFDAVIARGMA---KNPEDRY--VTCGDLSAAAHAALATADQDRATD 305

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 80.3 bits (199), Expect = 9e-17
 Identities = 47/208 (22%), Positives = 80/208 (38%), Gaps = 28/208 (13%)

Query: 306 EVLGKGTFGTAYKAALEDAST---VVVKRLKEVNVGKREFEQQM----EIVGGIRHENVV 358
             LGKG F   ++    DA T      K + +  + K    ++M     I   + H++VV
Sbjct: 21  RFLGKGGFAKCFEI--SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVV 78

Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAML--HGRRGEGQSSLDWDTRVRIAIGAARGIAHI 416
               ++   D   +V +     S+  +        E ++                G  ++
Sbjct: 79  GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEAR-------YYLRQIVLGCQYL 131

Query: 417 HTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMR--AAG---YRAPEV 471
           H     +++H  +K  N+FLN    V + D GLA  +        +    G   Y APEV
Sbjct: 132 HRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNYIAPEV 186

Query: 472 TDTRKATQASDVFSFGVLLLELLTGKSP 499
              +  +   DV+S G ++  LL GK P
Sbjct: 187 LSKKGHSFEVDVWSIGCIMYTLLVGKPP 214

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 80.8 bits (200), Expect = 1e-16
 Identities = 48/208 (23%), Positives = 80/208 (38%), Gaps = 28/208 (13%)

Query: 306 EVLGKGTFGTAYKAALEDAST---VVVKRLKEVNVGKREFEQQM----EIVGGIRHENVV 358
             LGKG F   ++    DA T      K + +  + K    ++M     I   + H++VV
Sbjct: 47  RFLGKGGFAKCFEI--SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVV 104

Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAML--HGRRGEGQSSLDWDTRVRIAIGAARGIAHI 416
               ++   D   +V +     S+  +        E       + R         G  ++
Sbjct: 105 GFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTE------PEAR-YYLRQIVLGCQYL 157

Query: 417 HTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMR--AAG---YRAPEV 471
           H     +++H  +K  N+FLN    V + D GLA  +        +    G   Y APEV
Sbjct: 158 HRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNYIAPEV 212

Query: 472 TDTRKATQASDVFSFGVLLLELLTGKSP 499
              +  +   DV+S G ++  LL GK P
Sbjct: 213 LSKKGHSFEVDVWSIGCIMYTLLVGKPP 240

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 81.1 bits (200), Expect = 1e-16
 Identities = 47/218 (21%), Positives = 77/218 (35%), Gaps = 36/218 (16%)

Query: 306 EVLGKG--TFGTAYKAA-LEDASTVVVKRLKEVNVGKREFEQ-QMEIV--GGIRHENVVA 359
            V+GKG     T   A        V V+R+             Q E+       H N+V 
Sbjct: 31  TVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVP 90

Query: 360 LRAYY--YSKDEKL-MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAI---GAARGI 413
              Y   +  D +L +V  +   GS   ++     +G +       + IA    G  + +
Sbjct: 91  ---YRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMN------ELAIAYILQGVLKAL 141

Query: 414 AHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP-------MPPPAMRAAG- 465
            +IH       VH  +KAS+I ++  G V +S +     M         +      +   
Sbjct: 142 DYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198

Query: 466 --YRAPEVTDTRKA--TQASDVFSFGVLLLELLTGKSP 499
             + +PEV           SD++S G+   EL  G  P
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVP 236

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 79.6 bits (197), Expect = 2e-16
 Identities = 51/239 (21%), Positives = 92/239 (38%), Gaps = 45/239 (18%)

Query: 306 EVLGKGTFGTAYKAAL---EDASTVVVKRLKE--VNVGKREFEQQMEIVGGI-RHENVVA 359
           +V+G+G FG   KA +          +KR+KE       R+F  ++E++  +  H N++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQ-----------SSLDWDTRVRIAIG 408
           L      +    +  +Y   G++   L   R               S+L     +  A  
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150

Query: 409 AARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG-YR 467
            ARG+ ++   +  + +H  + A NI +       ++D GL+           R    Y 
Sbjct: 151 VARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLS-----------RGQEVYV 196

Query: 468 ------------APEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVR 513
                       A E  +    T  SDV+S+GVLL E+++ G +P       E+   + 
Sbjct: 197 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 78.9 bits (195), Expect = 4e-16
 Identities = 50/206 (24%), Positives = 89/206 (43%), Gaps = 28/206 (13%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNVGKREFEQQ-MEIVGGIRHENVVALRAY 363
             +G+G+ G    A        V VK +      +RE     + I+   +H NVV     
Sbjct: 51  VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE---M 107

Query: 364 Y--YSKDEKL-MVYDYFEPGSVSA-MLHGRRGEGQSSLDWDTRVRIAI---GAARGIAHI 416
           Y  Y   E+L ++ ++ + G+++  +   R  E Q          IA       + +A++
Sbjct: 108 YKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQ----------IATVCEAVLQALAYL 157

Query: 417 HTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTD 473
           H +    ++H  IK+ +I L   G V +SD G  A +S   P      G   + APEV  
Sbjct: 158 HAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVIS 214

Query: 474 TRKATQASDVFSFGVLLLELLTGKSP 499
                   D++S G++++E++ G+ P
Sbjct: 215 RSLYATEVDIWSLGIMVIEMVDGEPP 240

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 79.7 bits (197), Expect = 4e-16
 Identities = 26/117 (22%), Positives = 43/117 (36%), Gaps = 4/117 (3%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNL 142
                +     L  + L  N L  +    F K++ L  L++  N     L L       L
Sbjct: 239 TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTL 297

Query: 143 TVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRS-LQRFPSWAFAGNNLS 198
            V+DLS+N     +  +  +   L  L L +NS+  TL  S      +   + N+  
Sbjct: 298 KVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWD 352

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 75.1 bits (185), Expect = 1e-14
 Identities = 23/98 (23%), Positives = 44/98 (44%), Gaps = 4/98 (4%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWN 140
           ++P   +     ++ L+L    +  +    F+    +  L++ FN+    LP   F    
Sbjct: 59  KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVP 117

Query: 141 NLTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLT 177
            LTV+ L  N  + S+P  I      L+ L+++NN+L 
Sbjct: 118 LLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE 154

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 33/120 (27%), Positives = 46/120 (38%), Gaps = 4/120 (3%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWN 140
           EI          +Q L +  N++  L P  F  +  LT L L+ N  S  LP   F    
Sbjct: 83  EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSS-LPRGIFHNTP 141

Query: 141 NLTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLSS 199
            LT + +SNN     I        T L  L L++N LT      +        + N LS+
Sbjct: 142 KLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLST 200

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 21/105 (20%), Positives = 40/105 (38%), Gaps = 5/105 (4%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
           +I  +   ++  L+ L + +N L  L       +  L  L L  N     +  +   ++ 
Sbjct: 262 KIMYHPFVKMQRLERLYISNNRLVAL-NLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDR 319

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQR 186
           L  + L +N    ++  S      L  L L++N       R+L R
Sbjct: 320 LENLYLDHNSI-VTLKLST--HHTLKNLTLSHNDWDCNSLRALFR 361

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 70.1 bits (172), Expect = 5e-13
 Identities = 15/96 (15%), Positives = 39/96 (40%), Gaps = 3/96 (3%)

Query: 90  RLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSN 149
            L+  + ++ +++++  L  +       +  L+L            F+  + +  + +  
Sbjct: 43  TLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGF 102

Query: 150 NFFNASIPASI-SKLTHLSALNLANNSLTGTLPRSL 184
           N     +P  +   +  L+ L L  N L+ +LPR +
Sbjct: 103 NAI-RYLPPHVFQNVPLLTVLVLERNDLS-SLPRGI 136

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 67.0 bits (164), Expect = 5e-12
 Identities = 25/96 (26%), Positives = 45/96 (46%), Gaps = 11/96 (11%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
            I  +T    ++LQNL L SN L+ +   D S + +L   ++ +N  S       ++   
Sbjct: 155 RIEDDTFQATTSLQNLQLSSNRLTHV---DLSLIPSLFHANVSYNLLS-----TLAIPIA 206

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLT 177
           +  +D S+N  N  +   +     L+ L L +N+LT
Sbjct: 207 VEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT 239

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 58.1 bits (141), Expect = 4e-09
 Identities = 9/101 (8%), Positives = 33/101 (32%), Gaps = 3/101 (2%)

Query: 85  PNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTV 144
            + +       ++ +   +    F  +   L N   +  + ++           +  + +
Sbjct: 14  DSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVEL 73

Query: 145 IDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLPRSL 184
           ++L++      I     +    +  L +  N++   LP  +
Sbjct: 74  LNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHV 112

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 13/87 (14%), Positives = 29/87 (33%), Gaps = 10/87 (11%)

Query: 109 PSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASI-SKLTHLS 167
            S+         +H+   +       +    NN  ++   N+     +PA++      + 
Sbjct: 14  DSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVE 72

Query: 168 ALNLANNSLTGTLPRSLQRFPSWAFAG 194
            LNL +  +            ++AFA 
Sbjct: 73  LLNLNDLQIE--------EIDTYAFAY 91

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 77.7 bits (192), Expect = 5e-16
 Identities = 32/104 (30%), Positives = 42/104 (40%), Gaps = 3/104 (2%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
           E+ P     L+ALQ L L+ N+L  L    F  L NLT L L  N  S      F   ++
Sbjct: 119 ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHS 178

Query: 142 LTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLPRSL 184
           L  + L  N     +       L  L  L L  N+L+  LP   
Sbjct: 179 LDRLLLHQNRVA-HVHPHAFRDLGRLMTLYLFANNLS-ALPTEA 220

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 38/131 (29%), Positives = 46/131 (35%), Gaps = 23/131 (17%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWN 140
            + P T   L  L  L L    L  L P  F  L  L  L+LQ N+    LP D F    
Sbjct: 95  SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLG 153

Query: 141 NLTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAG----- 194
           NLT + L  N   +S+P      L  L  L L  N +              AF       
Sbjct: 154 NLTHLFLHGNRI-SSVPERAFRGLHSLDRLLLHQNRVA--------HVHPHAFRDLGRLM 204

Query: 195 ------NNLSS 199
                 NNLS+
Sbjct: 205 TLYLFANNLSA 215

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 27/103 (26%), Positives = 39/103 (37%), Gaps = 9/103 (8%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNL 142
           IP  +       Q + L  N +S +  + F    NLT L L  N  +      F+    L
Sbjct: 30  IPAAS-------QRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82

Query: 143 TVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLPRSL 184
             +DLS+N    S+  +    L  L  L+L    L   L   L
Sbjct: 83  EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGL 124

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 29/106 (27%), Positives = 43/106 (40%), Gaps = 3/106 (2%)

Query: 72  LRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGP 131
           L L   AL+  +P +T   L  L +L L  N +S +    F  L +L  L L  N  +  
Sbjct: 134 LYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192

Query: 132 LPLDFSVWNNLTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSL 176
            P  F     L  + L  N   +++P    + L  L  L L +N  
Sbjct: 193 HPHAFRDLGRLMTLYLFANNL-SALPTEALAPLRALQYLRLNDNPW 237

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 80.6 bits (199), Expect = 7e-16
 Identities = 31/117 (26%), Positives = 46/117 (39%), Gaps = 3/117 (2%)

Query: 72  LRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGP 131
           L L        I       L  L+ L L S+ +  L P  F  L +L  L L F   S  
Sbjct: 53  LELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDA 112

Query: 132 LPLDFSVWN--NLTVIDLSNNFFNA-SIPASISKLTHLSALNLANNSLTGTLPRSLQ 185
           +  D    N   LT +DLS N   +  +  S  KL  L +++ ++N +       L+
Sbjct: 113 VLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELE 169

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 77.5 bits (191), Expect = 6e-15
 Identities = 29/120 (24%), Positives = 48/120 (40%), Gaps = 8/120 (6%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNL 142
           +       L  L+ L+L  N ++ +    F  L+NL  L+L +N        +F     +
Sbjct: 281 LNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKV 340

Query: 143 TVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWA---FAGNNLSS 199
             IDL  N        +   L  L  L+L +N+LT     ++   PS      +GN L +
Sbjct: 341 AYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLVT 395

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 74.1 bits (182), Expect = 6e-14
 Identities = 33/127 (25%), Positives = 45/127 (35%), Gaps = 9/127 (7%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLS--GLFPSDFSKLENLTSLHLQFNSFSG-PLPLDFSV 138
            + P+    L  L  L L    LS   L    F  L+ LT L L  N      L   F  
Sbjct: 87  FLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGK 146

Query: 139 WNNLTVIDLSNNFFNASIPASISKLT--HLSALNLANNSLT----GTLPRSLQRFPSWAF 192
            N+L  ID S+N         +  L    LS  +LA NSL         + +  F +   
Sbjct: 147 LNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVL 206

Query: 193 AGNNLSS 199
              ++S 
Sbjct: 207 EILDVSG 213

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 73.7 bits (181), Expect = 9e-14
 Identities = 30/118 (25%), Positives = 46/118 (38%), Gaps = 9/118 (7%)

Query: 61  TCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTS 120
           +CS D  R+   R     L  ++P      L+  + L L  N +  +  S F  LE L  
Sbjct: 1   SCSFDG-RIAFYR--FCNLT-QVPQV----LNTTERLLLSFNYIRTVTASSFPFLEQLQL 52

Query: 121 LHLQFNSFSGPLPLD-FSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLT 177
           L L        +  + F    NL ++DL ++      P +   L HL  L L    L+
Sbjct: 53  LELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLS 110

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 70.6 bits (173), Expect = 8e-13
 Identities = 35/180 (19%), Positives = 59/180 (32%), Gaps = 11/180 (6%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
           E+  +    LS LQ L L  N L+ L P  FS L  L  L L  N  +     D     N
Sbjct: 470 ELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLP--AN 527

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLP----RSLQRFPSWAFAGNNL 197
           L ++D+S N    +    +     LS L++ +N            +     +   AG   
Sbjct: 528 LEILDISRNQLL-APNPDV--FVSLSVLDITHNKFICECELSTFINWLNHTNVTIAGPPA 584

Query: 198 SSENARPPALPVQP--PVAEPSRKKSTKLSEPALLGIALGGVALAFVICALLMICRYNKQ 255
                 P +        ++     +   L         +  V L   +  +L + ++   
Sbjct: 585 DIYCVYPDSFSGVSLFSLSTEGCDEEEVLKSLKFSLFIVCTVTLTLFLMTILTVTKFRGF 644

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 70.6 bits (173), Expect = 9e-13
 Identities = 26/117 (22%), Positives = 41/117 (35%), Gaps = 13/117 (11%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
           +I       L  LQ L+L  N L  L+ S+F  L  +  + LQ N  +      F     
Sbjct: 304 KIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEK 363

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLS 198
           L  +DL +N        +I  +  +  + L+ N L           P      N + 
Sbjct: 364 LQTLDLRDNALT-----TIHFIPSIPDIFLSGNKLV--------TLPKINLTANLIH 407

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 68.3 bits (167), Expect = 4e-12
 Identities = 37/161 (22%), Positives = 60/161 (37%), Gaps = 16/161 (9%)

Query: 36  IHNIHNSRSLNW-NESSSLCKSWTGVTCSADHSRVVALRLPGMALRGEIPPNTIGRLSAL 94
           +  IH   S+     S +   +   +  +A+      + L    L        + R+  L
Sbjct: 374 LTTIHFIPSIPDIFLSGNKLVTLPKINLTANL-----IHLSENRLENLDILYFLLRVPHL 428

Query: 95  QNLSLRSNSLSGLFPSD-FSKLENLTSLHLQFNSFSGPLPLDFSVWN-----NLTVIDLS 148
           Q L L  N  S        S+  +L  L L  N        +          +L V+ L+
Sbjct: 429 QILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLN 488

Query: 149 NNFFNASIPASISKLTHLSALNLANNSLT----GTLPRSLQ 185
           +N+ N+  P   S LT L  L+L +N LT      LP +L+
Sbjct: 489 HNYLNSLPPGVFSHLTALRGLSLNSNRLTVLSHNDLPANLE 529

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 61.4 bits (149), Expect = 5e-10
 Identities = 20/137 (14%), Positives = 43/137 (31%), Gaps = 19/137 (13%)

Query: 72  LRLPGMALRGEIPPNTIGRLSALQNLSLRS-----------------NSLSGLFPSDFSK 114
             L   +L   +  +    ++  +N+ L                   N++S         
Sbjct: 179 FSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLIL 238

Query: 115 LENLTSLHLQFNSFSGPLPLDFS--VWNNLTVIDLSNNFFNASIPASISKLTHLSALNLA 172
             ++      F++   P    F+    +++  +DLS+ F  +        L  L  LNLA
Sbjct: 239 AHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLA 298

Query: 173 NNSLTGTLPRSLQRFPS 189
            N +      +     +
Sbjct: 299 YNKINKIADEAFYGLDN 315

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 60.2 bits (146), Expect = 1e-09
 Identities = 18/110 (16%), Positives = 37/110 (33%), Gaps = 2/110 (1%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLE--NLTSLHLQFNSFSGPLPLDFSVW 139
           +    ++     +       +++     + F+ L   ++  L L            F   
Sbjct: 230 KSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETL 289

Query: 140 NNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPS 189
            +L V++L+ N  N     +   L +L  LNL+ N L      +    P 
Sbjct: 290 KDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPK 339

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844

 Score = 58.7 bits (142), Expect = 4e-09
 Identities = 24/128 (18%), Positives = 50/128 (39%), Gaps = 12/128 (9%)

Query: 84  PPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLE--NLTSLHLQFNSFSGPLPLDFSVWNN 141
              + G+L++L+++   SN +  +   +   L+   L+   L  NS    + +D+    N
Sbjct: 140 LHPSFGKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMN 199

Query: 142 ------LTVIDLSNNFFNASIP-ASISKLTHLSALNLANNSLTGTL---PRSLQRFPSWA 191
                 L ++D+S N +   I     + ++   A +L              +++      
Sbjct: 200 PFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNT 259

Query: 192 FAGNNLSS 199
           FAG   SS
Sbjct: 260 FAGLARSS 267

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 78.2 bits (193), Expect = 7e-16
 Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 45/216 (20%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVK----RLKEVNVGKREFEQQMEIVGGIRHENVVAL 360
             +G G+FG  Y A  + ++  V +K      K+ N   ++  +++  +  +RH N +  
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQ- 118

Query: 361 RAYY--YSKDEKL-MVYDYFEPGSVSAMLHGRRG---EGQSSLDWDTRVRIAI---GAAR 411
             Y   Y ++    +V +Y   GS S +L   +    E +          IA    GA +
Sbjct: 119 --YRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVE----------IAAVTHGALQ 165

Query: 412 GIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP-----PPAMRAAGY 466
           G+A++H+     ++H  +KA NI L+  G V + D G A++M+P       P  M     
Sbjct: 166 GLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPYWM----- 217

Query: 467 RAPEVTDTRKATQ---ASDVFSFGVLLLELLTGKSP 499
            APEV       Q     DV+S G+  +EL   K P
Sbjct: 218 -APEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 252

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 77.2 bits (191), Expect = 8e-16
 Identities = 45/204 (22%), Positives = 84/204 (41%), Gaps = 23/204 (11%)

Query: 308 LGKGTFGTAYKAALEDAST---VVVKRLKEVNVGKREFEQQM----EIVGGIRHENVVAL 360
           LGKG+F   Y+A  E   T   V +K + +  + K    Q++    +I   ++H +++ L
Sbjct: 19  LGKGSFAGVYRA--ESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILEL 76

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN 420
             Y+   +   +V +    G ++  L  R          +           G+ ++H+  
Sbjct: 77  YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVK----PFSENEARHFMHQIITGMLYLHSHG 132

Query: 421 GGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMR--AAG---YRAPEVTDTR 475
              ++H  +  SN+ L    ++ ++D GLA  +    P        G   Y +PE+    
Sbjct: 133 ---ILHRDLTLSNLLLTRNMNIKIADFGLATQL--KMPHEKHYTLCGTPNYISPEIATRS 187

Query: 476 KATQASDVFSFGVLLLELLTGKSP 499
                SDV+S G +   LL G+ P
Sbjct: 188 AHGLESDVWSLGCMFYTLLIGRPP 211

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 78.1 bits (193), Expect = 9e-16
 Identities = 52/248 (20%), Positives = 94/248 (37%), Gaps = 50/248 (20%)

Query: 306 EVLGKGTFGTAYKAAL------EDASTVVVKRLKEV--NVGKREFEQQMEIVGGIRHENV 357
             +G+G FG  ++A        E  + V VK LKE      + +F+++  ++    + N+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 358 VALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTR--------------- 402
           V L           ++++Y   G ++  L         SL                    
Sbjct: 113 VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 172

Query: 403 ----VRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP 458
               + IA   A G+A++      K VH  +   N  +     V ++D GL+  +     
Sbjct: 173 CAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNI----- 224

Query: 459 PAMRAAGYR------------APEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGG 505
               A  Y+             PE     + T  SDV+++GV+L E+ + G  P +    
Sbjct: 225 --YSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282

Query: 506 DEVVHLVR 513
           +EV++ VR
Sbjct: 283 EEVIYYVR 290

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 77.8 bits (192), Expect = 1e-15
 Identities = 40/220 (18%), Positives = 75/220 (34%), Gaps = 33/220 (15%)

Query: 307 VLGKGTFG-------TAYKAALE--DASTVVVKRLKEVNVGKREFEQQM--------EIV 349
            L +G F             AL+  + S +  KR    +   +   +          +I+
Sbjct: 38  TLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQII 97

Query: 350 GGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAML--HGRRGEGQSS-LDWDTRVRIA 406
             I++E  +       + DE  ++Y+Y E  S+           +  +  +       I 
Sbjct: 98  TDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCII 157

Query: 407 IGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMR--AA 464
                  ++IH E    + H  +K SNI ++  G V +SD G +  M           + 
Sbjct: 158 KSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYM----VDKKIKGSR 211

Query: 465 G---YRAPEVTDTRKAT--QASDVFSFGVLLLELLTGKSP 499
           G   +  PE      +      D++S G+ L  +     P
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 79.1 bits (195), Expect = 1e-15
 Identities = 54/201 (26%), Positives = 87/201 (43%), Gaps = 15/201 (7%)

Query: 307 VLGKGTFGTAYKAALEDASTV-VVKRL-KEVNVGKREFEQQM---EIVGGIRHENVVALR 361
           VLGKG FG      +     +   K+L K+    ++     +   +I+  +    VV+L 
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLA 250

Query: 362 AYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIG-AARGIAHIHTEN 420
             Y +KD   +V      G +    H     GQ+    + R          G+  +H E 
Sbjct: 251 YAYETKDALCLVLTLMNGGDL--KFHIYH-MGQAGFP-EARAVFYAAEICCGLEDLHRER 306

Query: 421 GGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRA--AGYRAPEVTDTRKAT 478
              +V+  +K  NI L+  GH+ +SD+GLA  +        R    GY APEV    + T
Sbjct: 307 ---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYT 363

Query: 479 QASDVFSFGVLLLELLTGKSP 499
            + D ++ G LL E++ G+SP
Sbjct: 364 FSPDWWALGCLLYEMIAGQSP 384

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 79.2 bits (195), Expect = 1e-15
 Identities = 26/117 (22%), Positives = 43/117 (36%), Gaps = 4/117 (3%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNL 142
                +     L  + L  N L  +    F K++ L  L++  N     L L       L
Sbjct: 245 TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTL 303

Query: 143 TVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRS-LQRFPSWAFAGNNLS 198
            V+DLS+N     +  +  +   L  L L +NS+  TL  S      +   + N+  
Sbjct: 304 KVLDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHTLKNLTLSHNDWD 358

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 75.3 bits (185), Expect = 2e-14
 Identities = 23/98 (23%), Positives = 44/98 (44%), Gaps = 4/98 (4%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWN 140
           ++P   +     ++ L+L    +  +    F+    +  L++ FN+    LP   F    
Sbjct: 65  KLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVP 123

Query: 141 NLTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLT 177
            LTV+ L  N  + S+P  I      L+ L+++NN+L 
Sbjct: 124 LLTVLVLERNDLS-SLPRGIFHNTPKLTTLSMSNNNLE 160

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 75.0 bits (184), Expect = 2e-14
 Identities = 22/121 (18%), Positives = 45/121 (37%), Gaps = 8/121 (6%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
            +P         L  LS+ +N+L  +    F    +L +L L  N  +    +D S+  +
Sbjct: 137 SLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLTH---VDLSLIPS 193

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLSSEN 201
           L   ++S N  +     +++    +  L+ ++NS+                  NNL+   
Sbjct: 194 LFHANVSYNLLS-----TLAIPIAVEELDASHNSINVVRGPVNVELTILKLQHNNLTDTA 248

Query: 202 A 202
            
Sbjct: 249 W 249

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 70.3 bits (172), Expect = 7e-13
 Identities = 21/105 (20%), Positives = 40/105 (38%), Gaps = 5/105 (4%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
           +I  +   ++  L+ L + +N L  L       +  L  L L  N     +  +   ++ 
Sbjct: 268 KIMYHPFVKMQRLERLYISNNRLVAL-NLYGQPIPTLKVLDLSHNHLLH-VERNQPQFDR 325

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQR 186
           L  + L +N    ++  S      L  L L++N       R+L R
Sbjct: 326 LENLYLDHNSI-VTLKLST--HHTLKNLTLSHNDWDCNSLRALFR 367

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597

 Score = 59.2 bits (143), Expect = 3e-09
 Identities = 9/101 (8%), Positives = 33/101 (32%), Gaps = 3/101 (2%)

Query: 85  PNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTV 144
            + +       ++ +   +    F  +   L N   +  + ++           +  + +
Sbjct: 20  DSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVEL 79

Query: 145 IDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLPRSL 184
           ++L++      I     +    +  L +  N++   LP  +
Sbjct: 80  LNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHV 118

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 78.8 bits (194), Expect = 1e-15
 Identities = 28/126 (22%), Positives = 43/126 (34%), Gaps = 9/126 (7%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
           E+  + I  LS L+ L +  N +  L  S F   + L  L L  N       +      N
Sbjct: 35  ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLVK---ISCHPTVN 91

Query: 142 LTVIDLSNNFFNASIP--ASISKLTHLSALNLANNSLTG---TLPRSLQRFPSWAFAGNN 196
           L  +DLS N F+ ++P       ++ L  L L+   L          L         G  
Sbjct: 92  LKHLDLSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGET 150

Query: 197 LSSENA 202
              +  
Sbjct: 151 YGEKED 156

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 75.3 bits (185), Expect = 2e-14
 Identities = 29/102 (28%), Positives = 48/102 (47%), Gaps = 6/102 (5%)

Query: 90  RLSALQNLSLRSNSLSGLFPSD-FSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLS 148
           ++ +LQ L +  NS+S        S  ++L SL++  N  +  +         + V+DL 
Sbjct: 372 QMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCLPP--RIKVLDLH 429

Query: 149 NNFFNASIPASISKLTHLSALNLANNSLTGTLPR-SLQRFPS 189
           +N    SIP  + KL  L  LN+A+N L  ++P     R  S
Sbjct: 430 SNKIK-SIPKQVVKLEALQELNVASNQLK-SVPDGIFDRLTS 469

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 67.6 bits (165), Expect = 5e-12
 Identities = 25/102 (24%), Positives = 38/102 (37%), Gaps = 13/102 (12%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWNN 141
           +   T         L++  N +S L+ SD   L  L  L +  N     L +  F     
Sbjct: 19  LSQKT-------TILNISQNYISELWTSDILSLSKLRILIISHNRIQY-LDISVFKFNQE 70

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRS 183
           L  +DLS+N     I        +L  L+L+ N+    LP  
Sbjct: 71  LEYLDLSHNKL-VKIS--CHPTVNLKHLDLSFNAFD-ALPIC 108

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 26/156 (16%), Positives = 49/156 (31%), Gaps = 5/156 (3%)

Query: 36  IHNIHNSRSLNWNESSSLCKSWTGVTCSADHSRVVALRLPGMALRG----EIPPNTIGRL 91
           +       +L  N   +   S+  +     H+ V    +  + L+G         +   L
Sbjct: 216 LQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSL 275

Query: 92  SALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNF 151
            AL    + S+         +    N+   +   +       L  S  +    +D SNN 
Sbjct: 276 KALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNL 335

Query: 152 FNASIPASISKLTHLSALNLANNSLTGTLPRSLQRF 187
              ++  +   LT L  L L  N L   L +  +  
Sbjct: 336 LTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMT 370

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 56.0 bits (135), Expect = 2e-08
 Identities = 18/109 (16%), Positives = 41/109 (37%), Gaps = 3/109 (2%)

Query: 94  LQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFN 153
           + N+ L+       F    + L+ L+   +  + F  P    + +++N+ + + + +   
Sbjct: 254 ISNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTR 313

Query: 154 ASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPS---WAFAGNNLSS 199
                  SK++    L+ +NN LT T+  +              N L  
Sbjct: 314 MVHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKE 362

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 51.8 bits (124), Expect = 4e-07
 Identities = 18/85 (21%), Positives = 33/85 (38%), Gaps = 4/85 (4%)

Query: 97  LSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASI 156
           +    N L  + P D S+    T L++  N  S     D    + L ++ +S+N      
Sbjct: 5   VDRSKNGLIHV-PKDLSQ--KTTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLD 61

Query: 157 PASISKLTHLSALNLANNSLTGTLP 181
            +       L  L+L++N L   + 
Sbjct: 62  ISVFKFNQELEYLDLSHNKLV-KIS 85

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 46.0 bits (109), Expect = 3e-05
 Identities = 17/179 (9%), Positives = 47/179 (26%), Gaps = 12/179 (6%)

Query: 33  LDFIHNIHNSRSLNWNESSSLCKSWTGVTC-SADHSRVVALRLPGMALRGEIPPNTIGRL 91
           L   +          N+        +  T  + + S +  +               +   
Sbjct: 160 LQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTN 219

Query: 92  SALQNLSLRSNSLSGLFPSDFSKL---ENLTSLHLQFNSFSGPLPLDFSVWNN-----LT 143
             L NL+L +   +        +L     +    +      G L      ++      L+
Sbjct: 220 PKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALS 279

Query: 144 VIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWA---FAGNNLSS 199
           +  + ++ F           ++++  N   +           +   +    F+ N L+ 
Sbjct: 280 IHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTD 338

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 43.3 bits (102), Expect = 2e-04
 Identities = 16/63 (25%), Positives = 25/63 (39%), Gaps = 1/63 (1%)

Query: 91  LSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNN 150
              ++ L L SN +  + P    KLE L  L++  N         F    +L  I L  N
Sbjct: 420 PPRIKVLDLHSNKIKSI-PKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTN 478

Query: 151 FFN 153
            ++
Sbjct: 479 PWD 481

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 42.5 bits (100), Expect = 4e-04
 Identities = 14/44 (31%), Positives = 23/44 (52%)

Query: 85  PNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSF 128
           P  + +L ALQ L++ SN L  +    F +L +L  + L  N +
Sbjct: 437 PKQVVKLEALQELNVASNQLKSVPDGIFDRLTSLQKIWLHTNPW 480

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520

 Score = 42.5 bits (100), Expect = 4e-04
 Identities = 15/110 (13%), Positives = 33/110 (30%), Gaps = 3/110 (2%)

Query: 84  PPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDF---SVWN 140
                G +S L+ L L +  L        + L     L +   ++      +        
Sbjct: 107 ICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDPEGLQDFNTE 166

Query: 141 NLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSW 190
           +L ++  +N  F+  +  S+  + +L   N+            L      
Sbjct: 167 SLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKL 216

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 62/243 (25%), Positives = 94/243 (38%), Gaps = 45/243 (18%)

Query: 306 EVLGKGTFGTAYKAAL------EDASTVVVKRLKEV--NVGKREFEQQMEIVGGI-RHEN 356
           + LG+G FG   +A            TV VK LKE   +   R    +++I+  I  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 357 VVALRAYYYSKDEKLMV-YDYFEPGSVSAMLHGRRGEGQSSLDWDTR-----------VR 404
           VV L          LMV  ++ + G++S  L  +R E                     + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 405 IAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAA 464
            +   A+G+  +      K +H  + A NI L+ +  V + D GLA  +        +  
Sbjct: 153 YSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDI-------YKDP 202

Query: 465 GYR------------APEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHA-TGGDEVVH 510
            Y             APE    R  T  SDV+SFGVLL E+ + G SP       +E   
Sbjct: 203 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 262

Query: 511 LVR 513
            ++
Sbjct: 263 RLK 265

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 54/222 (24%), Positives = 89/222 (40%), Gaps = 28/222 (12%)

Query: 306 EVLGKGTFGTAYKAALEDASTVV-VKR-LKEVNVGKREFEQQMEIVGGIRHENVVALRAY 363
            + G+GTFGT      +     V +K+ +++     RE  Q M+ +  + H N+V L++Y
Sbjct: 29  RMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL-QIMQDLAVLHHPNIVQLQSY 87

Query: 364 YYSKDEKLM-------VYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHI 416
           +Y+  E+         V +Y  P ++             +              R I  +
Sbjct: 88  FYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQV-APPPILIKVFLFQLIRSIGCL 145

Query: 417 HTENGGKLVHGGIKASNIFLNSQGHV---CVSDIGLAALMSPMPPP----AMRAAGYRAP 469
           H  +   + H  IK  N+ +N        C  D G A  +SP  P       R   YRAP
Sbjct: 146 HLPSVN-VCHRDIKPHNVLVNEADGTLKLC--DFGSAKKLSPSEPNVAYICSRY--YRAP 200

Query: 470 EV-TDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVH 510
           E+    +  T A D++S G +  E++ G+ PI    GD    
Sbjct: 201 ELIFGNQHYTTAVDIWSVGCIFAEMMLGE-PIFR--GDNSAG 239

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 76.8 bits (190), Expect = 2e-15
 Identities = 24/97 (24%), Positives = 44/97 (45%), Gaps = 7/97 (7%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
           +I P  +  L  L NL + +N ++ +  S    L NL  L+L  ++ S   PL       
Sbjct: 80  DISP--LSNLVKLTNLYIGTNKITDI--SALQNLTNLRELYLNEDNISDISPLAN--LTK 133

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTG 178
           +  ++L  N  N S  + +S +T L+ L +  + +  
Sbjct: 134 MYSLNLGANH-NLSDLSPLSNMTGLNYLTVTESKVKD 169

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 72.6 bits (179), Expect = 6e-14
 Identities = 27/121 (22%), Positives = 47/121 (38%), Gaps = 13/121 (10%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
           ++ P  +  LS L  L + +N +S +  +    L  L  L++  N  S       +  + 
Sbjct: 235 DLSP--LANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQISDISV--LNNLSQ 288

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLP----RSLQRFPSWAFAGNNL 197
           L  + L+NN         I  LT+L+ L L+ N +T   P      +       FA   +
Sbjct: 289 LNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRPLASLSKMDSA---DFANQVI 345

Query: 198 S 198
            
Sbjct: 346 K 346

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 70.3 bits (173), Expect = 3e-13
 Identities = 22/97 (22%), Positives = 44/97 (45%), Gaps = 8/97 (8%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
           +I P  +  L++L   +   N ++ +  +  + +  L SL +  N  +   PL       
Sbjct: 191 DISP--LASLTSLHYFTAYVNQITDI--TPVANMTRLNSLKIGNNKITDLSPLANLS--Q 244

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTG 178
           LT +++  N  +  I A +  LT L  LN+ +N ++ 
Sbjct: 245 LTWLEIGTNQIS-DINA-VKDLTKLKMLNVGSNQISD 279

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 68.7 bits (169), Expect = 9e-13
 Identities = 19/92 (20%), Positives = 38/92 (41%), Gaps = 6/92 (6%)

Query: 87  TIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID 146
           T   L ++  L +    ++ +       L NL  L+L  N  +   PL       LT + 
Sbjct: 39  TQEELESITKLVVAGEKVASI--QGIEYLTNLEYLNLNGNQITDISPLSNL--VKLTNLY 94

Query: 147 LSNNFFNASIPASISKLTHLSALNLANNSLTG 178
           +  N    +  +++  LT+L  L L  ++++ 
Sbjct: 95  IGTN--KITDISALQNLTNLRELYLNEDNISD 124

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 67.2 bits (165), Expect = 3e-12
 Identities = 19/94 (20%), Positives = 40/94 (42%), Gaps = 6/94 (6%)

Query: 85  PNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTV 144
            + +  ++ L  L++  + +  +  +  + L +L SL L +N      PL      +L  
Sbjct: 148 LSPLSNMTGLNYLTVTESKVKDV--TPIANLTDLYSLSLNYNQIEDISPLAS--LTSLHY 203

Query: 145 IDLSNNFFNASIPASISKLTHLSALNLANNSLTG 178
                N      P  ++ +T L++L + NN +T 
Sbjct: 204 FTAYVNQITDITP--VANMTRLNSLKIGNNKITD 235

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 66.0 bits (162), Expect = 7e-12
 Identities = 26/123 (21%), Positives = 46/123 (37%), Gaps = 16/123 (13%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
            I    I  L+ L+ L+L  N ++ +  S  S L  LT+L++  N  +           N
Sbjct: 58  SIQG--IEYLTNLEYLNLNGNQITDI--SPLSNLVKLTNLYIGTNKITDISA--LQNLTN 111

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLP-----RSLQRFPSWAFAGNN 196
           L  + L+ +  +   P  ++ LT + +LNL  N     L        L          + 
Sbjct: 112 LRELYLNEDNISDISP--LANLTKMYSLNLGANHNLSDLSPLSNMTGLNYL---TVTESK 166

Query: 197 LSS 199
           +  
Sbjct: 167 VKD 169

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 64.5 bits (158), Expect = 2e-11
 Identities = 20/99 (20%), Positives = 41/99 (41%), Gaps = 12/99 (12%)

Query: 85  PNTIGRLSALQNLS------LRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSV 138
           P  I ++    +L+      L+  S++ +      +LE++T L +     +  +      
Sbjct: 9   PAPINQIFPDADLAEGIRAVLQKASVTDV--VTQEELESITKLVVAGEKVAS-IQ-GIEY 64

Query: 139 WNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLT 177
             NL  ++L+ N      P  +S L  L+ L +  N +T
Sbjct: 65  LTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKIT 101

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347

 Score = 59.9 bits (146), Expect = 7e-10
 Identities = 19/85 (22%), Positives = 33/85 (38%), Gaps = 6/85 (7%)

Query: 94  LQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFN 153
              L+     ++ +FP   + L       LQ  S +  +        ++T + ++     
Sbjct: 2   AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVA 57

Query: 154 ASIPASISKLTHLSALNLANNSLTG 178
            SI   I  LT+L  LNL  N +T 
Sbjct: 58  -SIQG-IEYLTNLEYLNLNGNQITD 80

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 76.6 bits (189), Expect = 2e-15
 Identities = 59/243 (24%), Positives = 96/243 (39%), Gaps = 45/243 (18%)

Query: 306 EVLGKGTFGTAYKAAL--------EDASTVVVKRLKEV--NVGKREFEQQMEIVGGI-RH 354
           + LG+G FG    A          ++A TV VK LK+        +   +ME++  I +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 355 ENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTR-----------V 403
           +N++ L           ++ +Y   G++   L  RR  G        R           V
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160

Query: 404 RIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRA 463
                 ARG+ ++      K +H  + A N+ +     + ++D GLA  +          
Sbjct: 161 SCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI-------NNI 210

Query: 464 AGYR------------APEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVH 510
             Y+            APE    R  T  SDV+SFGVL+ E+ T G SP      +E+  
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 270

Query: 511 LVR 513
           L++
Sbjct: 271 LLK 273

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 77.5 bits (191), Expect = 2e-15
 Identities = 42/231 (18%), Positives = 74/231 (32%), Gaps = 50/231 (21%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRL--KEVNVGKREFEQQMEIVGGIRHENVVALRAY 363
           ++LG G+ GT           V VKR+     ++   E +   E      H NV+     
Sbjct: 21  KILGYGSSGTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTES---DDHPNVIRYYCS 77

Query: 364 YYSKDEKLMV--------YDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAH 415
             +     +          D  E             E          + +    A G+AH
Sbjct: 78  ETTDRFLYIALELCNLNLQDLVES-------KNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 416 IHTENGGKLVHGGIKASNIFLNSQGHVC-------------VSDIGLAALMSP---MPPP 459
           +H      ++H  +K  NI +++                  +SD GL   +         
Sbjct: 131 LH-SLK--IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 460 AMRAA----GYRAPEV-------TDTRKATQASDVFSFGVLLLELLTGKSP 499
            +       G+RAPE+          R+ T++ D+FS G +   +L+    
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 76.1 bits (187), Expect = 3e-15
 Identities = 27/116 (23%), Positives = 39/116 (33%), Gaps = 11/116 (9%)

Query: 81  GEIPPNTIGRLSALQNLSLRSNSLSG-------LFPSDFSKLENLTSLHLQFNSFSGPLP 133
                  +    AL  L L  N   G       L P  F  L+ L   +    + SG   
Sbjct: 162 LNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCS 221

Query: 134 LDFSVWNNLTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLT---GTLPRSLQ 185
              +    L  +DLS+N    +  A      + L++LNL+   L      LP  L 
Sbjct: 222 ALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLS 277

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 70.7 bits (173), Expect = 2e-13
 Identities = 24/101 (23%), Positives = 39/101 (38%), Gaps = 8/101 (7%)

Query: 89  GRLSALQNLSLRSN---SLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVW-NNLTV 144
            +   LQ L+LR+    + SG+  +  +    L  L L  NS           W + L  
Sbjct: 198 LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNS 257

Query: 145 IDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQ 185
           ++LS       +P  +     LS L+L+ N L    P   +
Sbjct: 258 LNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLD-RNPSPDE 294

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 65.7 bits (160), Expect = 9e-12
 Identities = 22/106 (20%), Positives = 35/106 (33%), Gaps = 7/106 (6%)

Query: 91  LSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSV----WNNLTVID 146
              L+ LS+                  L++L L  N   G   L  ++    +  L V+ 
Sbjct: 148 KPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLA 207

Query: 147 LSNNFFNA---SIPASISKLTHLSALNLANNSLTGTLPRSLQRFPS 189
           L N           A  +    L  L+L++NSL          +PS
Sbjct: 208 LRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPS 253

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 61.8 bits (150), Expect = 2e-10
 Identities = 23/130 (17%), Positives = 45/130 (34%), Gaps = 13/130 (10%)

Query: 91  LSALQNLSLRSNSLSGLFPSDFSKL--ENLTSLHLQFNSFSGPLPLDFSVWN----NLTV 144
           +S LQ L+L +  ++G  P    +    +L  L+L+  S++        +       L V
Sbjct: 94  ISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDAWLAELQQWLKPGLKV 153

Query: 145 IDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSW-------AFAGNNL 197
           + ++           +     LS L+L++N   G         P         A     +
Sbjct: 154 LSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGM 213

Query: 198 SSENARPPAL 207
            + +    AL
Sbjct: 214 ETPSGVCSAL 223

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 25/138 (18%), Positives = 53/138 (38%), Gaps = 14/138 (10%)

Query: 84  PPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLEN---LTSLHLQFNSFSG--PLPLDFSV 138
               I +  +L+ L++R+  +         ++     L  L L+    +G  P PL  + 
Sbjct: 60  QFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEAT 119

Query: 139 WNNLTVIDLSNNFFNASIPASISKL-----THLSALNLANNSLTGTLPRSLQRFPSWAF- 192
             +L +++L N  +  +  A +++L       L  L++A           ++ FP+ +  
Sbjct: 120 GPDLNILNLRNVSWA-TRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTL 178

Query: 193 --AGNNLSSENARPPALP 208
             + N    E     AL 
Sbjct: 179 DLSDNPELGERGLISALC 196

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 20/100 (20%), Positives = 29/100 (29%), Gaps = 29/100 (29%)

Query: 79  LRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSV 138
           LR      +    S L +L+L    L  +     +KL  L                    
Sbjct: 240 LRDAAGAPSCDWPSQLNSLNLSFTGLKQVPKGLPAKLSVL-------------------- 279

Query: 139 WNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTG 178
                  DLS N  +   P S  +L  +  L+L  N    
Sbjct: 280 -------DLSYNRLD-RNP-SPDELPQVGNLSLKGNPFLD 310

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312

 Score = 47.6 bits (113), Expect = 6e-06
 Identities = 26/137 (18%), Positives = 38/137 (27%), Gaps = 10/137 (7%)

Query: 78  ALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLP---L 134
           A   E+        S    L            +D  K  +L  L ++       +    L
Sbjct: 33  AADVELYGGG---RSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGAL 89

Query: 135 DFSVWNNLTVIDLSNNFFNASIPASISKLTH--LSALNLANNSLTGTLPRSLQRFPSWAF 192
                + L  + L N     + P  + + T   L+ LNL N S        L     W  
Sbjct: 90  RVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWAT-RDAWLAELQQWLK 148

Query: 193 AG-NNLSSENARPPALP 208
            G   LS   A      
Sbjct: 149 PGLKVLSIAQAHSLNFS 165

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 77.5 bits (191), Expect = 3e-15
 Identities = 34/131 (25%), Positives = 47/131 (35%), Gaps = 3/131 (2%)

Query: 72  LRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSF-SG 130
           L++        I  NT   LS+L  L L  N    L    F+ L NL  L L   +    
Sbjct: 59  LKVEQQTPGLVIRNNTFRGLSSLIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGA 118

Query: 131 PLPLD-FSVWNNLTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLPRSLQRFP 188
            L  + F    +L ++ L +N      PAS    +     L+L  N +       L  F 
Sbjct: 119 VLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQ 178

Query: 189 SWAFAGNNLSS 199
              F    LSS
Sbjct: 179 GKHFTLLRLSS 189

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 71.7 bits (176), Expect = 2e-13
 Identities = 34/169 (20%), Positives = 58/169 (34%), Gaps = 9/169 (5%)

Query: 20  PIKADPVEDKQALLDFIHNIHNSRSLNWNESSSLC----KSWTGVTC-SADHSRVVALRL 74
             K    +     +          S ++N  SS      K     T    + S V    L
Sbjct: 223 GFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASGVKTCDL 282

Query: 75  PGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPL 134
               +   +  +     + L+ L+L  N ++ +  + F  L +L  L+L  N        
Sbjct: 283 SKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSR 341

Query: 135 DFSVWNNLTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLPR 182
            F   + L V+DLS N    ++       L +L  L L  N L  ++P 
Sbjct: 342 MFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQLK-SVPD 388

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 69.4 bits (170), Expect = 1e-12
 Identities = 23/106 (21%), Positives = 46/106 (43%), Gaps = 11/106 (10%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWN 140
           E+P +          + L  NS++ L  + FS+L++L  L ++  +    +  + F   +
Sbjct: 27  ELPAHV-------NYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLS 79

Query: 141 NLTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGT-LPRSL 184
           +L ++ L  N F   +     + L +L  L L   +L G  L  + 
Sbjct: 80  SLIILKLDYNQF-LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNF 124

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 65.5 bits (160), Expect = 2e-11
 Identities = 28/97 (28%), Positives = 38/97 (39%), Gaps = 4/97 (4%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWN 140
           +I  N    L+ L  L+L  N L  +    F  L+ L  L L +N     L    F    
Sbjct: 313 KIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLDLSYNHIRA-LGDQSFLGLP 371

Query: 141 NLTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSL 176
           NL  + L  N    S+P  I  +LT L  + L  N  
Sbjct: 372 NLKELALDTNQL-KSVPDGIFDRLTSLQKIWLHTNPW 407

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 59.0 bits (143), Expect = 2e-09
 Identities = 20/113 (17%), Positives = 44/113 (38%), Gaps = 11/113 (9%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSD-FSKLENLTSLHLQFNSFS----------GP 131
           +  N    L++L+ L LR N++  + P+  F  +     L L FN               
Sbjct: 120 LSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQG 179

Query: 132 LPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSL 184
                   +++T+ D++  +       +  K T ++ L+L+ N    ++ +  
Sbjct: 180 KHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRF 232

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 57.4 bits (139), Expect = 7e-09
 Identities = 28/161 (17%), Positives = 52/161 (32%), Gaps = 30/161 (18%)

Query: 45  LNWNESSSLCKSWTGVTCSADHSRVVALRLPGMALRGEIPPNTIG--------RLSALQN 96
           L +N+  S+C+       +        LRL  + L+ ++    +G        + +++  
Sbjct: 161 LTFNKVKSICE---EDLLNFQGKHFTLLRLSSITLQ-DMNEYWLGWEKCGNPFKNTSITT 216

Query: 97  LSLRSNSLSGLFPSDFSKLENLTSLH-------------LQFNSFSGPLPLDFS--VWNN 141
           L L  N         F      T +                  +F  P    F     + 
Sbjct: 217 LDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEASG 276

Query: 142 LTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLP 181
           +   DLS +    ++  S+ S  T L  L LA N +   + 
Sbjct: 277 VKTCDLSKSKI-FALLKSVFSHFTDLEQLTLAQNEIN-KID 315

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455

 Score = 52.1 bits (125), Expect = 3e-07
 Identities = 20/70 (28%), Positives = 23/70 (32%)

Query: 81  GEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWN 140
           G I       L  L+ L L  N +  L    F  L NL  L L  N         F    
Sbjct: 336 GSIDSRMFENLDKLEVLDLSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLT 395

Query: 141 NLTVIDLSNN 150
           +L  I L  N
Sbjct: 396 SLQKIWLHTN 405

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 76.1 bits (188), Expect = 3e-15
 Identities = 57/248 (22%), Positives = 93/248 (37%), Gaps = 50/248 (20%)

Query: 306 EVLGKGTFGTAYKAAL------EDASTVVVKRLKEV--NVGKREFEQQMEIVGGIRHENV 357
           + LG+G FG   KA           +TV VK LKE       R+   +  ++  + H +V
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 358 VALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTR--------------- 402
           + L          L++ +Y + GS+   L   R  G   L                    
Sbjct: 89  IKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALT 148

Query: 403 ----VRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP 458
               +  A   ++G+ ++      KLVH  + A NI +     + +SD GL+  +     
Sbjct: 149 MGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSRDV----- 200

Query: 459 PAMRAAGYR------------APEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGG 505
                  Y             A E       T  SDV+SFGVLL E++T G +P      
Sbjct: 201 --YEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPP 258

Query: 506 DEVVHLVR 513
           + + +L++
Sbjct: 259 ERLFNLLK 266

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 75.9 bits (187), Expect = 4e-15
 Identities = 53/226 (23%), Positives = 91/226 (40%), Gaps = 54/226 (23%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQ-QMEIV---GGIRHENVVA-- 359
           E++G GT+G  YK        +    +K ++V   E E+ + EI        H N+    
Sbjct: 30  ELVGNGTYGQVYKGRHVKTGQLAA--IKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYY 87

Query: 360 ---LRAYYYSKDEKL-MVYDYFEPGSVSAMLHGRRG----EGQSSLDWDTRVRIAI---G 408
              ++      D++L +V ++   GSV+ ++   +G    E            IA     
Sbjct: 88  GAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW----------IAYICRE 137

Query: 409 AARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYR- 467
             RG++H+H     K++H  IK  N+ L     V + D G++A +        R  G R 
Sbjct: 138 ILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD-------RTVGRRN 187

Query: 468 ---------APEVTDTRKATQAS-----DVFSFGVLLLELLTGKSP 499
                    APEV    +   A+     D++S G+  +E+  G  P
Sbjct: 188 TFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPP 233

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 75.7 bits (187), Expect = 4e-15
 Identities = 52/245 (21%), Positives = 88/245 (35%), Gaps = 48/245 (19%)

Query: 306 EVLGKGTFGTAYKAAL------EDASTVVVKRLKE--VNVGKREFEQQMEIVGGI-RHEN 356
           + LG G FG   +A        + A TV VK LK       +     +++++  +  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 357 VVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTR-------------V 403
           +V L          L++ +Y   G +   L  +R     S                   +
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 404 RIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVC-VSDIGLAALMSPMPPPAMR 462
             +   A+G+A +        +H  + A NI L + G +  + D GLA  +         
Sbjct: 149 SFSYQVAKGMAFL---ASKNCIHRDLAARNI-LLTHGRITKICDFGLARDI-------KN 197

Query: 463 AAGYR------------APEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHA-TGGDEV 508
            + Y             APE       T  SDV+S+G+ L EL + G SP        + 
Sbjct: 198 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF 257

Query: 509 VHLVR 513
             +++
Sbjct: 258 YKMIK 262

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 75.9 bits (187), Expect = 5e-15
 Identities = 58/243 (23%), Positives = 93/243 (38%), Gaps = 45/243 (18%)

Query: 306 EVLGKGTFGTAYKAAL--------EDASTVVVKRLKEV--NVGKREFEQQMEIVGGI-RH 354
           + LG+G FG    A             + V VK LK         +   +ME++  I +H
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134

Query: 355 ENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTR-----------V 403
           +N++ L           ++ +Y   G++   L  RR  G       +            V
Sbjct: 135 KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 194

Query: 404 RIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRA 463
             A   ARG+ ++      K +H  + A N+ +     + ++D GLA  +          
Sbjct: 195 SCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI-------HHI 244

Query: 464 AGYR------------APEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVH 510
             Y+            APE    R  T  SDV+SFGVLL E+ T G SP      +E+  
Sbjct: 245 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 304

Query: 511 LVR 513
           L++
Sbjct: 305 LLK 307

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 76.7 bits (189), Expect = 6e-15
 Identities = 54/280 (19%), Positives = 106/280 (37%), Gaps = 48/280 (17%)

Query: 306 EVLGKGTFGTAYKAALEDAST---VVVKRLKEVNVGKRE---FEQQMEIVGGIRHENVVA 359
           + LG G +G        D  T     +K +++ +V         +++ ++  + H N++ 
Sbjct: 43  KKLGSGAYGEVLLC--RDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMK 100

Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAML------HGRRGEGQSSLDWDTRVRIAIGAARGI 413
           L  ++  K    +V + ++ G     L        +  E  ++        I      G+
Sbjct: 101 LYDFFEDKRNYYLVMECYKGGE----LFDEIIHRMKFNEVDAA-------VIIKQVLSGV 149

Query: 414 AHIHTENGGKLVHGGIKASNIFLNSQG---HVCVSDIGLAALMSPMPPPAMRA--AGYRA 468
            ++H  N   +VH  +K  N+ L S+     + + D GL+A+         R   A Y A
Sbjct: 150 TYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIA 206

Query: 469 PEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVF 528
           PEV   +K  +  DV+S GV+L  LL G  P       E++  V               +
Sbjct: 207 PEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE-----------KGKY 254

Query: 529 DVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
             +   + N+ E   ++++     +    + R      L+
Sbjct: 255 TFDSPEWKNVSEGAKDLIK---QMLQFDSQRRISAQQALE 291

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 74.7 bits (184), Expect = 2e-14
 Identities = 60/247 (24%), Positives = 101/247 (40%), Gaps = 53/247 (21%)

Query: 306 EVLGKGTFGTAYKAAL--------EDASTVVVKRLKEV--NVGKREFEQQMEIVGGI-RH 354
           + LG+G FG    A          ++A TV VK LK+        +   +ME++  I +H
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146

Query: 355 ENVVALRAYYY---SKDEKL-MVYDYFEPGSVSAMLHGRRGEGQ-----------SSLDW 399
           +N++ L        ++D  L ++ +Y   G++   L  RR  G              + +
Sbjct: 147 KNIINL----LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF 202

Query: 400 DTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP 459
              V      ARG+ ++      K +H  + A N+ +     + ++D GLA  +      
Sbjct: 203 KDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDI------ 253

Query: 460 AMRAAGYR------------APEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGD 506
                 Y+            APE    R  T  SDV+SFGVL+ E+ T G SP      +
Sbjct: 254 -NNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312

Query: 507 EVVHLVR 513
           E+  L++
Sbjct: 313 ELFKLLK 319

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 74.2 bits (183), Expect = 2e-14
 Identities = 53/226 (23%), Positives = 87/226 (38%), Gaps = 43/226 (19%)

Query: 306 EVLGKGTFGTAYKAAL------EDASTVVVKRLKEV--NVGKREFEQQMEIVGGI-RHEN 356
           + LG G FG   +A        +    V VK LK       K     +++I+  + +HEN
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 357 VVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRR---------GEGQSSLDWDTRVRIAI 407
           +V L          L++ +Y   G +   L  +              S+      +  + 
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171

Query: 408 GAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVC-VSDIGLAALMSPMPPPAMRAAGY 466
             A+G+A +        +H  + A N+ L + GHV  + D GLA  +       M  + Y
Sbjct: 172 QVAQGMAFL---ASKNCIHRDVAARNV-LLTNGHVAKIGDFGLARDI-------MNDSNY 220

Query: 467 R------------APEVTDTRKATQASDVFSFGVLLLELLT-GKSP 499
                        APE       T  SDV+S+G+LL E+ + G +P
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 74.7 bits (184), Expect = 2e-14
 Identities = 63/210 (30%), Positives = 100/210 (47%), Gaps = 28/210 (13%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           +V+G G+FG  Y+A L D+  +V   +K+V   KR   ++++I+  + H N+V LR ++Y
Sbjct: 60  KVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 117

Query: 366 SKDEKL------MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRI-AIGAARGIAHIHT 418
           S  EK       +V DY  P +V  +        Q+      ++ +  +   R +A+IH+
Sbjct: 118 SSGEKKDEVYLNLVLDYV-PETVYRVARHYSRAKQTLPVIYVKLYMYQL--FRSLAYIHS 174

Query: 419 ENGGKLVHGGIKASNIFLNSQGHV---CVSDIGLAALMSPMPPP----AMRAAGYRAPEV 471
                + H  IK  N+ L+    V   C  D G A  +    P       R   YRAPE+
Sbjct: 175 FG---ICHRDIKPQNLLLDPDTAVLKLC--DFGSAKQLVRGEPNVSYICSRY--YRAPEL 227

Query: 472 T-DTRKATQASDVFSFGVLLLELLTGKSPI 500
                  T + DV+S G +L ELL G+ PI
Sbjct: 228 IFGATDYTSSIDVWSAGCVLAELLLGQ-PI 256

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 75.1 bits (185), Expect = 2e-14
 Identities = 59/281 (20%), Positives = 110/281 (39%), Gaps = 49/281 (17%)

Query: 306 EVLGKGTFGTAYKAALEDAST---VVVKRLKEVNVGKREFEQQM----EIVGGIRHENVV 358
            VLGKG+FG       +D  T     VK + +  V ++  ++ +    +++  + H N++
Sbjct: 32  RVLGKGSFGEVILC--KDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIM 89

Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAML------HGRRGEGQSSLDWDTRVRIAIGAARG 412
            L  ++  K    +V + +  G     L        R  E  ++       RI      G
Sbjct: 90  KLYEFFEDKGYFYLVGEVYTGGE----LFDEIISRKRFSEVDAA-------RIIRQVLSG 138

Query: 413 IAHIHTENGGKLVHGGIKASNIFLNSQG---HVCVSDIGLAALMSPMPPPAMRA--AGYR 467
           I ++H      +VH  +K  N+ L S+    ++ + D GL+           +   A Y 
Sbjct: 139 ITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYI 195

Query: 468 APEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEV 527
           APEV       +  DV+S GV+L  LL+G  P +     +++  V               
Sbjct: 196 APEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE-----------KGK 243

Query: 528 FDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
           +  EL ++  + E   ++++     +  +P  R    D L 
Sbjct: 244 YTFELPQWKKVSESAKDLIR---KMLTYVPSMRISARDALD 281

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 25/115 (21%), Positives = 48/115 (41%), Gaps = 10/115 (8%)

Query: 72  LRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGP 131
           L L G  +  ++   ++  L+ L  L L  NS+S +     +   +L  LHL  N     
Sbjct: 197 LHLDGNKIT-KVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVK- 254

Query: 132 LPLDFSVWNNLTVIDLSNNFFNASIPAS-------ISKLTHLSALNLANNSLTGT 179
           +P   +    + V+ L NN  + +I ++        +K    S ++L +N +   
Sbjct: 255 VPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW 308

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 72.3 bits (178), Expect = 6e-14
 Identities = 28/131 (21%), Positives = 45/131 (34%), Gaps = 24/131 (18%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWN 140
           EI       L  L  L L +N +S + P  F+ L  L  L+L  N     LP        
Sbjct: 66  EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKE-LPEKMPK--- 121

Query: 141 NLTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAG----- 194
            L  + +  N     +  S+ + L  +  + L  N L  +         + AF G     
Sbjct: 122 TLQELRVHENEIT-KVRKSVFNGLNQMIVVELGTNPLKSS------GIENGAFQGMKKLS 174

Query: 195 ------NNLSS 199
                  N+++
Sbjct: 175 YIRIADTNITT 185

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 70.8 bits (174), Expect = 2e-13
 Identities = 24/111 (21%), Positives = 47/111 (42%), Gaps = 5/111 (4%)

Query: 67  SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFN 126
            ++  +R+    +   IP        +L  L L  N ++ +  +    L NL  L L FN
Sbjct: 171 KKLSYIRIADTNIT-TIPQGL---PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFN 226

Query: 127 SFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLT 177
           S S       +   +L  + L+NN     +P  ++   ++  + L NN+++
Sbjct: 227 SISAVDNGSLANTPHLRELHLNNNKL-VKVPGGLADHKYIQVVYLHNNNIS 276

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 66.2 bits (162), Expect = 5e-12
 Identities = 24/108 (22%), Positives = 41/108 (37%), Gaps = 6/108 (5%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNL 142
           I       +  L  + +   +++ +         +LT LHL  N  +          NNL
Sbjct: 162 IENGAFQGMKKLSYIRIADTNITTIPQGLPP---SLTELHLDGNKITKVDAASLKGLNNL 218

Query: 143 TVIDLSNNFFNASIPA-SISKLTHLSALNLANNSLTGTLPRSLQRFPS 189
             + LS N   +++   S++   HL  L+L NN L   +P  L     
Sbjct: 219 AKLGLSFNSI-SAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKY 264

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 27/102 (26%), Positives = 45/102 (44%), Gaps = 11/102 (10%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNL 142
           +PP+T         L L++N ++ +   DF  L+NL +L L  N  S   P  F+    L
Sbjct: 50  LPPDT-------ALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKL 102

Query: 143 TVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSL 184
             + LS N     +P  +     L  L +  N +T  + +S+
Sbjct: 103 ERLYLSKNQL-KELPEKM--PKTLQELRVHENEIT-KVRKSV 140

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330

 Score = 46.9 bits (112), Expect = 1e-05
 Identities = 18/105 (17%), Positives = 34/105 (32%), Gaps = 22/105 (20%)

Query: 72  LRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGP 131
           L L    L  ++P         +Q + L +N++S +  +DF      T            
Sbjct: 245 LHLNNNKLV-KVPGGLAD-HKYIQVVYLHNNNISAIGSNDFCPPGYNTKKA--------- 293

Query: 132 LPLDFSVWNNLTVIDLSNNFFNA-SIPASI-SKLTHLSALNLANN 174
                    + + + L +N      I  S    +   +A+ L N 
Sbjct: 294 ---------SYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 31/109 (28%), Positives = 49/109 (44%), Gaps = 1/109 (0%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSD-FSKLENLTSLHLQFNSFSGPLPLDFSVWN 140
                    LS+L+ L +  NS    F  D F++L NLT L L         P  F+  +
Sbjct: 140 VAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLS 199

Query: 141 NLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPS 189
           +L V+++S+N F +        L  L  L+ + N +  +  + LQ FPS
Sbjct: 200 SLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPS 248

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 71.2 bits (175), Expect = 1e-13
 Identities = 29/104 (27%), Positives = 41/104 (39%), Gaps = 10/104 (9%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFN--SFSGPLPLDFSVWN 140
           IP +          L L SN L  L    F KL  LT L L  N  SF G          
Sbjct: 26  IPSSA-------TRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTT 78

Query: 141 NLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSL 184
           +L  +DLS N    ++ ++   L  L  L+  +++L      S+
Sbjct: 79  SLKYLDLSFNGV-ITMSSNFLGLEQLEHLDFQHSNLKQMSEFSV 121

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 69.7 bits (171), Expect = 3e-13
 Identities = 25/129 (19%), Positives = 46/129 (35%), Gaps = 22/129 (17%)

Query: 84  PPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWNNL 142
             +    L  L  L +        F   F+ L +L  L +  NSF      D F+   NL
Sbjct: 118 EFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNL 177

Query: 143 TVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAG------- 194
           T +DLS       +  +  + L+ L  LN+++N+             ++ +         
Sbjct: 178 TFLDLSQCQL-EQLSPTAFNSLSSLQVLNMSHNNFF--------SLDTFPYKCLNSLQVL 228

Query: 195 ----NNLSS 199
               N++ +
Sbjct: 229 DYSLNHIMT 237

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 68.5 bits (168), Expect = 8e-13
 Identities = 24/111 (21%), Positives = 39/111 (35%), Gaps = 4/111 (3%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLS--GLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVW 139
            +P     +L+ L  LSL SN LS  G          +L  L L FN     +  +F   
Sbjct: 42  SLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGL 100

Query: 140 NNLTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLPRSLQRFPS 189
             L  +D  ++        S+   L +L  L++++               S
Sbjct: 101 EQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 151

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 60.4 bits (147), Expect = 4e-10
 Identities = 18/81 (22%), Positives = 31/81 (38%), Gaps = 4/81 (4%)

Query: 72  LRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGP 131
           L L    L  ++ P     LS+LQ L++  N+   L    +  L +L  L    N     
Sbjct: 180 LDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMT- 237

Query: 132 LPLD--FSVWNNLTVIDLSNN 150
                     ++L  ++L+ N
Sbjct: 238 SKKQELQHFPSSLAFLNLTQN 258

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306

 Score = 44.2 bits (105), Expect = 6e-05
 Identities = 11/59 (18%), Positives = 20/59 (33%), Gaps = 2/59 (3%)

Query: 72  LRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKL-ENLTSLHLQFNSFS 129
           L +        +       L++LQ L    N +      +      +L  L+L  N F+
Sbjct: 204 LNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 28/132 (21%), Positives = 42/132 (31%), Gaps = 13/132 (9%)

Query: 72  LRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGP 131
           LR+    L   IP +       L  L L  N +  +   D  +   L  L L  N     
Sbjct: 177 LRISEAKLT-GIPKDL---PETLNELHLDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMI 232

Query: 132 LPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWA 191
                S    L  + L NN   + +PA +  L  L  + L  N++T        +     
Sbjct: 233 ENGSLSFLPTLRELHLDNNKL-SRVPAGLPDLKLLQVVYLHTNNIT--------KVGVND 283

Query: 192 FAGNNLSSENAR 203
           F       + A 
Sbjct: 284 FCPVGFGVKRAY 295

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 26/113 (23%), Positives = 40/113 (35%), Gaps = 10/113 (8%)

Query: 72  LRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGP 131
           L L    ++  I    + R S L  L L  N +  +     S L  L  LHL  N  S  
Sbjct: 198 LHLDHNKIQ-AIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLSR- 255

Query: 132 LPLDFSVWNNLTVIDLSNNFFNASIPASI-------SKLTHLSALNLANNSLT 177
           +P        L V+ L  N     +  +         K  + + ++L NN + 
Sbjct: 256 VPAGLPDLKLLQVVYLHTNNIT-KVGVNDFCPVGFGVKRAYYNGISLFNNPVP 307

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 72.7 bits (179), Expect = 5e-14
 Identities = 27/118 (22%), Positives = 48/118 (40%), Gaps = 13/118 (11%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWN 140
           E+  +    L  L  L L +N +S +    FS L  L  L++  N     +P +  S   
Sbjct: 68  ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLVE-IPPNLPS--- 123

Query: 141 NLTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNL 197
           +L  + + +N     +P  + S L +++ + +  N L  +       F   AF G  L
Sbjct: 124 SLVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENS------GFEPGAFDGLKL 174

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332

 Score = 68.9 bits (169), Expect = 8e-13
 Identities = 24/113 (21%), Positives = 38/113 (33%), Gaps = 14/113 (12%)

Query: 72  LRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFN----- 126
           L L    +R  I   ++  L  L+ L L +N LS + P+    L+ L  ++L  N     
Sbjct: 222 LGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLSRV-PAGLPDLKLLQVVYLHTNNITKV 279

Query: 127 ---SFSGPLPLDFSVWNNLTVIDLSNNFF-NASIPASI-SKLTHLSALNLANN 174
               F                I L NN      +  +    +T   A+   N 
Sbjct: 280 GVNDFCPVGF--GVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 74.9 bits (184), Expect = 4e-14
 Identities = 56/221 (25%), Positives = 88/221 (39%), Gaps = 28/221 (12%)

Query: 299 DLLRASAEVLGKGTFGTAYKAALEDASTV-VVKRL-KEVNVGKREFEQQM------EIVG 350
            + R    ++G+G FG  Y     D   +  +K L K+    K+     +       +V 
Sbjct: 192 SVHR----IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 247

Query: 351 GIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRI-AIGA 409
                 +V +   +++ D+   + D    G      H  +  G  S      +R  A   
Sbjct: 248 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGD--LHYHLSQ-HGVFSEA---DMRFYAAEI 301

Query: 410 ARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---Y 466
             G+ H+H      +V+  +K +NI L+  GHV +SD+GLA   S   P A    G   Y
Sbjct: 302 ILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS--VGTHGY 356

Query: 467 RAPEV-TDTRKATQASDVFSFGVLLLELLTGKSPIHATGGD 506
            APEV         ++D FS G +L +LL G SP       
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 397

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 74.4 bits (183), Expect = 4e-14
 Identities = 48/215 (22%), Positives = 90/215 (41%), Gaps = 28/215 (13%)

Query: 299 DLLRASAEVLGKGTFGTAYKAALEDASTV-VVKRL-KEVNVGKREFEQQM---EIVGGIR 353
              R    VLG+G FG  +   ++    +   K+L K+    ++ ++  M   +I+  + 
Sbjct: 188 LDFR----VLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243

Query: 354 HENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLH-GRRGEGQSSLDWDTRVR-----IAI 407
              +V+L   + +K +  +V      G +    H     E       + R       I  
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDI--RYHIYNVDEDNPGFQ-EPRAIFYTAQIVS 300

Query: 408 GAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLA-ALMSPMPPPAMRA--A 464
           G    + H+H  N   +++  +K  N+ L+  G+V +SD+GLA  L +        A   
Sbjct: 301 G----LEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTP 353

Query: 465 GYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSP 499
           G+ APE+    +   + D F+ GV L E++  + P
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 74.0 bits (182), Expect = 4e-14
 Identities = 30/123 (24%), Positives = 42/123 (34%), Gaps = 5/123 (4%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
            IP      LS L  L +  N +  L    F  L NL SL +  N         FS  N+
Sbjct: 94  LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNS 153

Query: 142 LTVIDLSNNFFNASIPA-SISKLTHLSALNLANNSLTGTLPRSLQRFPSWAF---AGNNL 197
           L  + L       SIP  ++S L  L  L L + ++      S +R         +    
Sbjct: 154 LEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPY 212

Query: 198 SSE 200
              
Sbjct: 213 LDT 215

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 74.0 bits (182), Expect = 4e-14
 Identities = 23/123 (18%), Positives = 49/123 (39%), Gaps = 9/123 (7%)

Query: 72  LRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGP 131
           L +    L   I       L++L+ L+L   +L+ +     S L  L  L L+  + +  
Sbjct: 133 LEVGDNDLV-YISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINAI 191

Query: 132 LPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWA 191
               F     L V+++S+  +  ++  +     +L++L++ + +LT          P  A
Sbjct: 192 RDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT--------AVPYLA 243

Query: 192 FAG 194
              
Sbjct: 244 VRH 246

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 73.6 bits (181), Expect = 6e-14
 Identities = 33/145 (22%), Positives = 56/145 (38%), Gaps = 22/145 (15%)

Query: 67  SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFN 126
           +    L L    ++  +  +       L+ L L  N +S + P  F+ L NL +L L+ N
Sbjct: 32  TETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN 90

Query: 127 SFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLPRSLQ 185
                    F+  +NLT +D+S N     +   +   L +L +L + +N L         
Sbjct: 91  RLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-------- 141

Query: 186 RFPSWAFAG-----------NNLSS 199
                AF+G            NL+S
Sbjct: 142 YISHRAFSGLNSLEQLTLEKCNLTS 166

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 72.8 bits (179), Expect = 1e-13
 Identities = 30/109 (27%), Positives = 41/109 (37%), Gaps = 2/109 (1%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
            + P     L  L+ L LRSN L  +    F+ L NLT L +  N     L   F    N
Sbjct: 70  AVEPGAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYN 129

Query: 142 LTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLPRSLQRFPS 189
           L  +++ +N     I     S L  L  L L   +LT     +L     
Sbjct: 130 LKSLEVGDNDL-VYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHG 177

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 69.7 bits (171), Expect = 9e-13
 Identities = 26/106 (24%), Positives = 45/106 (42%), Gaps = 3/106 (2%)

Query: 72  LRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGP 131
           L +    L   +P   +  L  L+ L+L  N +S +  S   +L  L  + L     +  
Sbjct: 229 LSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPISTIEGSMLHELLRLQEIQLVGGQLAVV 287

Query: 132 LPLDFSVWNNLTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSL 176
            P  F   N L V+++S N    ++  S+   + +L  L L +N L
Sbjct: 288 EPYAFRGLNYLRVLNVSGNQL-TTLEESVFHSVGNLETLILDSNPL 332

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 68.6 bits (168), Expect = 2e-12
 Identities = 26/118 (22%), Positives = 45/118 (38%), Gaps = 7/118 (5%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
            +       L  L++L +  N L  +    FS L +L  L L+  + +       S  + 
Sbjct: 118 ILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHG 177

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLSS 199
           L V+ L +   NA    S  +L  L  L +++     T+  +          G NL+S
Sbjct: 178 LIVLRLRHLNINAIRDYSFKRLYRLKVLEISHWPYLDTMTPN-------CLYGLNLTS 228

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 28/113 (24%), Positives = 44/113 (38%), Gaps = 2/113 (1%)

Query: 72  LRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGP 131
           L +        + PN +  L+ L +LS+   +L+ +       L  L  L+L +N  S  
Sbjct: 205 LEISHWPYLDTMTPNCLYGLN-LTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPISTI 263

Query: 132 LPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSL 184
                     L  I L         P +   L +L  LN++ N LT TL  S+
Sbjct: 264 EGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT-TLEESV 315

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 72.1 bits (177), Expect = 4e-14
 Identities = 26/100 (26%), Positives = 40/100 (40%), Gaps = 11/100 (11%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNL 142
           +P +T         L L  N L     +       LT L+L     +  L +       L
Sbjct: 29  LPKDT-------TILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTK-LQV-DGTLPVL 79

Query: 143 TVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPR 182
             +DLS+N    S+P     L  L+ L+++ N LT +LP 
Sbjct: 80  GTLDLSHNQL-QSLPLLGQTLPALTVLDVSFNRLT-SLPL 117

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 30/100 (30%), Positives = 43/100 (43%), Gaps = 5/100 (5%)

Query: 85  PNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWNNLT 143
           P     L AL  L +  N L+ L       L  L  L+L+ N     LP    +    L 
Sbjct: 93  PLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKT-LPPGLLTPTPKLE 151

Query: 144 VIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLPR 182
            + L+NN     +PA + + L +L  L L  NSL  T+P+
Sbjct: 152 KLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPK 189

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290

 Score = 59.7 bits (145), Expect = 6e-10
 Identities = 25/93 (26%), Positives = 34/93 (36%), Gaps = 3/93 (3%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWNN 141
           +P   +  L  LQ L L+ N L  L P   +    L  L L  N+ +  LP    +   N
Sbjct: 115 LPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE-LPAGLLNGLEN 173

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANN 174
           L  + L  N    +IP        L    L  N
Sbjct: 174 LDTLLLQENSL-YTIPKGFFGSHLLPFAFLHGN 205

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 73.6 bits (181), Expect = 5e-14
 Identities = 27/103 (26%), Positives = 41/103 (39%), Gaps = 3/103 (2%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
            I       LS L+ L+L   +L  +   + + L  L  L L  N  S   P  F    +
Sbjct: 175 YISEGAFEGLSNLRYLNLAMCNLREI--PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMH 232

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSL 184
           L  + +  +        +   L  L  +NLA+N+LT  LP  L
Sbjct: 233 LQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT-LLPHDL 274

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 68.2 bits (167), Expect = 2e-12
 Identities = 25/97 (25%), Positives = 36/97 (37%), Gaps = 1/97 (1%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
            I       L+ L  L L  N L+ +    F  L  L  L L+ N         F+   +
Sbjct: 102 TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPS 161

Query: 142 LTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLT 177
           L  +DL      + I       L++L  LNLA  +L 
Sbjct: 162 LRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR 198

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 31/120 (25%), Positives = 47/120 (39%), Gaps = 10/120 (8%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
            I  N+   L  L+ L L  N +  +    F+ L NL +L L  N  +      F   + 
Sbjct: 78  IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSK 137

Query: 142 LTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAG-NNLSS 199
           L  + L NN    SIP+   +++  L  L+L          + L      AF G +NL  
Sbjct: 138 LKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGEL-------KRLSYISEGAFEGLSNLRY 189

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 65.2 bits (159), Expect = 3e-11
 Identities = 29/113 (25%), Positives = 43/113 (38%), Gaps = 17/113 (15%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNL 142
           I  NT       + L+L  N +  +  + F  L +L  L L  N         F+   NL
Sbjct: 62  ISTNT-------RLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANL 114

Query: 143 TVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAG 194
             ++L +N    +IP      L+ L  L L NN +           PS+AF  
Sbjct: 115 NTLELFDNRL-TTIPNGAFVYLSKLKELWLRNNPIE--------SIPSYAFNR 158

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 62.8 bits (153), Expect = 1e-10
 Identities = 23/92 (25%), Positives = 38/92 (41%), Gaps = 2/92 (2%)

Query: 86  NTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVI 145
             +  L  L  L L  N LS + P  F  L +L  L +  +         F    +L  I
Sbjct: 201 PNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEI 260

Query: 146 DLSNNFFNASIPASI-SKLTHLSALNLANNSL 176
           +L++N     +P  + + L HL  ++L +N  
Sbjct: 261 NLAHNNL-TLLPHDLFTPLHHLERIHLHHNPW 291

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 58.6 bits (142), Expect = 3e-09
 Identities = 19/69 (27%), Positives = 35/69 (50%), Gaps = 2/69 (2%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWNN 141
           I P +   L  LQ L +  + +  +  + F  L++L  ++L  N+ +  LP D F+  ++
Sbjct: 222 IRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTL-LPHDLFTPLHH 280

Query: 142 LTVIDLSNN 150
           L  I L +N
Sbjct: 281 LERIHLHHN 289

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 15/57 (26%), Positives = 27/57 (47%), Gaps = 1/57 (1%)

Query: 72  LRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSF 128
           L +    ++  I  N    L +L  ++L  N+L+ L    F+ L +L  +HL  N +
Sbjct: 236 LWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 74.3 bits (182), Expect = 5e-14
 Identities = 50/220 (22%), Positives = 85/220 (38%), Gaps = 37/220 (16%)

Query: 306 EVLGKGTFGTAYKAALEDASTVV-VKRL-KEVNVGKRE-FEQQMEIVGGIRHENVVALRA 362
           E LG G FG   +   +D    V +K+  +E++   RE +  +++I+  + H NVV+ R 
Sbjct: 20  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79

Query: 363 YY------YSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHI 416
                      D  L+  +Y E G +   L+    E    L       +    +  + ++
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQF--ENCCGLKEGPIRTLLSDISSALRYL 137

Query: 417 HTENGGKLVHGGIKASNIFLNSQGHVC---VSDIGLAALM-----------SPMPPPAMR 462
           H      ++H  +K  NI L          + D+G A  +           +        
Sbjct: 138 HENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTL------- 187

Query: 463 AAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHA 502
              Y APE+ + +K T   D +SFG L  E +TG  P   
Sbjct: 188 --QYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 72.8 bits (179), Expect = 6e-14
 Identities = 47/210 (22%), Positives = 82/210 (39%), Gaps = 33/210 (15%)

Query: 306 EVLGKGTFGTAYKA-----ALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVAL 360
           E LG G FG  ++           +  +          K   + ++ I+  + H  ++ L
Sbjct: 57  EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINL 113

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLHGR---RGEGQSSLDWDTRVRIAIGAAR----GI 413
              +  K E +++ ++   G     L  R        S  +        I   R    G+
Sbjct: 114 HDAFEDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAE-------VINYMRQACEGL 162

Query: 414 AHIHTENGGKLVHGGIKASNIFLNSQG--HVCVSDIGLAALMSPMPPPAMRA--AGYRAP 469
            H+H  +   +VH  IK  NI   ++    V + D GLA  ++P     +    A + AP
Sbjct: 163 KHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAP 219

Query: 470 EVTDTRKATQASDVFSFGVLLLELLTGKSP 499
           E+ D       +D+++ GVL   LL+G SP
Sbjct: 220 EIVDREPVGFYTDMWAIGVLGYVLLSGLSP 249

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 71.2 bits (175), Expect = 6e-14
 Identities = 33/101 (32%), Positives = 47/101 (46%), Gaps = 5/101 (4%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWNN 141
           +P     RL+ L+ L L  N L  L    F +L+NL +L +  N     LP+  F    N
Sbjct: 52  LPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQA-LPIGVFDQLVN 110

Query: 142 LTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLP 181
           L  + L  N    S+P  +   LT L+ L+L  N L  +LP
Sbjct: 111 LAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLP 149

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 31/101 (30%), Positives = 47/101 (46%), Gaps = 12/101 (11%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWNN 141
           IP +T       + L L+SN LS L    F +L  L  L+L  N     LP   F    N
Sbjct: 35  IPADT-------KKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAGIFKELKN 86

Query: 142 LTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLP 181
           L  + +++N    ++P  +  +L +L+ L L  N L  +LP
Sbjct: 87  LETLWVTDNKL-QALPIGVFDQLVNLAELRLDRNQLK-SLP 125

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 67.3 bits (165), Expect = 1e-12
 Identities = 34/102 (33%), Positives = 41/102 (40%), Gaps = 5/102 (4%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWNN 141
           +P     +L  L  L L  N L  L P  F  L  LT L L +N     LP   F    +
Sbjct: 100 LPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQS-LPKGVFDKLTS 158

Query: 142 LTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLPR 182
           L  + L NN     +P     KLT L  L L NN L   +P 
Sbjct: 159 LKELRLYNNQL-KRVPEGAFDKLTELKTLKLDNNQLK-RVPE 198

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270

 Score = 56.9 bits (138), Expect = 4e-09
 Identities = 28/93 (30%), Positives = 33/93 (35%), Gaps = 2/93 (2%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNL 142
           +PP     L+ L  LSL  N L  L    F KL +L  L L  N         F     L
Sbjct: 124 LPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTEL 183

Query: 143 TVIDLSNNFFNASIPASI-SKLTHLSALNLANN 174
             + L NN     +P      L  L  L L  N
Sbjct: 184 KTLKLDNNQL-KRVPEGAFDSLEKLKMLQLQEN 215

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 72.8 bits (179), Expect = 1e-13
 Identities = 20/116 (17%), Positives = 36/116 (31%), Gaps = 8/116 (6%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
           +I    +   + L  L  ++  ++ L   D S+   L  L+L     +    LD S    
Sbjct: 287 KIKELDVTHNTQLYLLDCQAAGITEL---DLSQNPKLVYLYLNNTELTE---LDVSHNTK 340

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNL 197
           L  +   N         S+ K+  L+    A          +L           +L
Sbjct: 341 LKSLSCVNAHIQ-DFS-SVGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPDL 394

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 70.5 bits (173), Expect = 6e-13
 Identities = 26/101 (25%), Positives = 43/101 (42%), Gaps = 10/101 (9%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNL 142
           I    +   + L  L    N ++ L   D S+ + L  L+   N+ +    LD +    L
Sbjct: 161 ITKLDVTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNCDTNNITK---LDLNQNIQL 214

Query: 143 TVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRS 183
           T +D S+N     I   ++ LT L+  + + N LT  L  S
Sbjct: 215 TFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELDVS 251

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 69.7 bits (171), Expect = 9e-13
 Identities = 27/90 (30%), Positives = 42/90 (46%), Gaps = 9/90 (10%)

Query: 88  IGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL 147
           I +L+ L  L   SN+++ L   D S+  NLT L    N  +    LD +    LT ++ 
Sbjct: 60  IEKLTGLTKLICTSNNITTL---DLSQNTNLTYLACDSNKLTN---LDVTPLTKLTYLNC 113

Query: 148 SNNFFNASIPASISKLTHLSALNLANNSLT 177
             N     +   +S+   L+ LN A N+LT
Sbjct: 114 DTNKLT-KLD--VSQNPLLTYLNCARNTLT 140

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 69.7 bits (171), Expect = 9e-13
 Identities = 25/95 (26%), Positives = 44/95 (46%), Gaps = 8/95 (8%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNL 142
               +  +L+ L +L   ++S++ +  +   KL  LT L    N+ +    LD S   NL
Sbjct: 33  TDTISEEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNITT---LDLSQNTNL 87

Query: 143 TVIDLSNNFFNASIPASISKLTHLSALNLANNSLT 177
           T +   +N    ++   ++ LT L+ LN   N LT
Sbjct: 88  TYLACDSNKLT-NLD--VTPLTKLTYLNCDTNKLT 119

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 67.4 bits (165), Expect = 4e-12
 Identities = 23/90 (25%), Positives = 40/90 (44%), Gaps = 8/90 (8%)

Query: 88  IGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL 147
           +  L+ L  L+  +N L+ L   D S+   LT L+   N+ +    +D S    LT +D 
Sbjct: 102 VTPLTKLTYLNCDTNKLTKL---DVSQNPLLTYLNCARNTLT---EIDVSHNTQLTELDC 155

Query: 148 SNNFFNASIPASISKLTHLSALNLANNSLT 177
             N         ++  T L+ L+ + N +T
Sbjct: 156 HLN--KKITKLDVTPQTQLTTLDCSFNKIT 183

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 67.0 bits (164), Expect = 7e-12
 Identities = 20/91 (21%), Positives = 37/91 (40%), Gaps = 9/91 (9%)

Query: 87  TIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID 146
            + +   L  L+  +N+++ L   D ++   LT L    N  +    +D +    LT  D
Sbjct: 186 DVSQNKLLNRLNCDTNNITKL---DLNQNIQLTFLDCSSNKLTE---IDVTPLTQLTYFD 239

Query: 147 LSNNFFNASIPASISKLTHLSALNLANNSLT 177
            S N     +   +S L+ L+ L+     L 
Sbjct: 240 CSVNPLT-ELD--VSTLSKLTTLHCIQTDLL 267

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 65.1 bits (159), Expect = 3e-11
 Identities = 21/116 (18%), Positives = 33/116 (28%), Gaps = 16/116 (13%)

Query: 88  IGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL 147
           +  L+ L       N L+ L   D S L  LT+LH           +D +    L     
Sbjct: 229 VTPLTQLTYFDCSVNPLTEL---DVSTLSKLTTLHCIQTDLLE---IDLTHNTQLIYFQA 282

Query: 148 SNNFFNASIPASISKLTHLSALNLANNSLTGTLP----RSLQRFPSWAFAGNNLSS 199
                   +   ++  T L  L+     +T  L       L            L+ 
Sbjct: 283 EGCRKIKELD--VTHNTQLYLLDCQAAGIT-ELDLSQNPKLVYL---YLNNTELTE 332

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 63.2 bits (154), Expect = 1e-10
 Identities = 25/94 (26%), Positives = 39/94 (41%), Gaps = 9/94 (9%)

Query: 88  IGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL 147
           + + + L  L+  SN L+ L   D + L  LT L+   N  +    LD S    LT ++ 
Sbjct: 81  LSQNTNLTYLACDSNKLTNL---DVTPLTKLTYLNCDTNKLT---KLDVSQNPLLTYLNC 134

Query: 148 SNNFFNASIPASISKLTHLSALNLANNSLTGTLP 181
           + N     I   +S  T L+ L+   N     L 
Sbjct: 135 ARNTLT-EID--VSHNTQLTELDCHLNKKITKLD 165

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 59.3 bits (144), Expect = 2e-09
 Identities = 16/86 (18%), Positives = 33/86 (38%), Gaps = 5/86 (5%)

Query: 92  SALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNF 151
               +    +  +         +L  LTSL    +S +  +         LT +  ++N 
Sbjct: 18  DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITD-MT-GIEKLTGLTKLICTSNN 75

Query: 152 FNASIPASISKLTHLSALNLANNSLT 177
              ++   +S+ T+L+ L   +N LT
Sbjct: 76  IT-TLD--LSQNTNLTYLACDSNKLT 98

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 53.9 bits (130), Expect = 8e-08
 Identities = 23/121 (19%), Positives = 41/121 (33%), Gaps = 17/121 (14%)

Query: 86  NTIGRLSALQNLSLRSNSLSGLFPSDFSKLE---NLTSLHLQFNSFSGPLPLDFSVWNNL 142
           NT+  +    N  L               +     LT+L   FN  +    LD S    L
Sbjct: 137 NTLTEIDVSHNTQLTELDCHLNKKITKLDVTPQTQLTTLDCSFNKITE---LDVSQNKLL 193

Query: 143 TVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLP----RSLQRFPSWAFAGNNLS 198
             ++   N     +   +++   L+ L+ ++N LT  +       L  F     + N L+
Sbjct: 194 NRLNCDTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EIDVTPLTQLTYF---DCSVNPLT 246

Query: 199 S 199
            
Sbjct: 247 E 247

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 22/103 (21%), Positives = 39/103 (37%), Gaps = 15/103 (14%)

Query: 101 SNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASI 160
           + S +  FP D     +  +   +  +      +       LT +D  N+     +   I
Sbjct: 8   TQSFNDWFPDD--NFASEVAAAFEMQATD---TISEEQLATLTSLDCHNSSIT-DMTG-I 60

Query: 161 SKLTHLSALNLANNSLTGTLP----RSLQRFPSWAFAGNNLSS 199
            KLT L+ L   +N++T TL      +L      A   N L++
Sbjct: 61  EKLTGLTKLICTSNNIT-TLDLSQNTNLTYL---ACDSNKLTN 99

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457

 Score = 45.4 bits (108), Expect = 4e-05
 Identities = 15/109 (13%), Positives = 34/109 (31%), Gaps = 4/109 (3%)

Query: 88  IGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL 147
           +   + L++LS  +  +     S   K+  L +                +  NN   I +
Sbjct: 335 VSHNTKLKSLSCVNAHIQDF--SSVGKIPALNNNFEAEGQTITMPKETLT--NNSLTIAV 390

Query: 148 SNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNN 196
           S +  +        +       + A N++T     +     ++ F   N
Sbjct: 391 SPDLLDQFGNPMNIEPGDGGVYDQATNTITWENLSTDNPAVTYTFTSEN 439

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 71.7 bits (176), Expect = 1e-13
 Identities = 30/110 (27%), Positives = 47/110 (42%), Gaps = 2/110 (1%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWN 140
            I  ++   L +L++L L  N LS L  S F  L +LT L+L  N +        FS   
Sbjct: 90  TIEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLT 149

Query: 141 NLTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLPRSLQRFPS 189
            L ++ + N      I     + LT L  L +  + L    P+SL+   +
Sbjct: 150 KLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQN 199

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 69.8 bits (171), Expect = 5e-13
 Identities = 16/127 (12%), Positives = 40/127 (31%), Gaps = 13/127 (10%)

Query: 72  LRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHL-------- 123
           L +    L+    P ++  +  + +L L       L         ++  L L        
Sbjct: 179 LEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTF 237

Query: 124 QFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRS 183
            F+  S               + +++      +   +++++ L  L  + N L  ++P  
Sbjct: 238 HFSELSTGETNSLIKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLK-SVPDG 295

Query: 184 LQRFPSW 190
           +  F   
Sbjct: 296 I--FDRL 300

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 69.8 bits (171), Expect = 5e-13
 Identities = 23/153 (15%), Positives = 58/153 (37%), Gaps = 13/153 (8%)

Query: 45  LNWNESSSLCKSWTGVTCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSL 104
           L  N   +L ++    +  +  +++  LR+  M    +I       L+ L+ L + ++ L
Sbjct: 131 LLGNPYKTLGET----SLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDL 186

Query: 105 SGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASIS--- 161
               P     ++N++ L L        L +   V +++  ++L +   +    + +S   
Sbjct: 187 QSYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGE 246

Query: 162 -----KLTHLSALNLANNSLTGTLPRSLQRFPS 189
                K      + + + SL   + + L +   
Sbjct: 247 TNSLIKKFTFRNVKITDESLF-QVMKLLNQISG 278

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 65.9 bits (161), Expect = 1e-11
 Identities = 25/97 (25%), Positives = 45/97 (46%), Gaps = 11/97 (11%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWNN 141
           +           ++L L +N ++ +  SD  +  NL +L L  N  +  +  D FS   +
Sbjct: 50  LTEAV-------KSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINT-IEEDSFSSLGS 101

Query: 142 LTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLT 177
           L  +DLS N+  +++ +S    L+ L+ LNL  N   
Sbjct: 102 LEHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYK 137

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 13/70 (18%), Positives = 25/70 (35%), Gaps = 3/70 (4%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWN 140
               N++ +    +N+ +   SL  +     +++  L  L    N     +P   F    
Sbjct: 244 TGETNSLIKKFTFRNVKITDESLFQV-MKLLNQISGLLELEFSRNQLKS-VPDGIFDRLT 301

Query: 141 NLTVIDLSNN 150
           +L  I L  N
Sbjct: 302 SLQKIWLHTN 311

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 73.0 bits (179), Expect = 1e-13
 Identities = 28/119 (23%), Positives = 48/119 (40%), Gaps = 11/119 (9%)

Query: 85  PNTIGRLSALQNLSLRSNSL----SGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWN 140
                    + +L     SL    S  +    +  E++  L+L  N  +G +        
Sbjct: 393 FKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLPP-- 450

Query: 141 NLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPR-SLQRFPS--WAFAGNN 196
            + V+DL NN    SIP  ++ L  L  LN+A+N L  ++P     R  S  + +  +N
Sbjct: 451 KVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLHDN 507

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 70.7 bits (173), Expect = 5e-13
 Identities = 25/98 (25%), Positives = 38/98 (38%), Gaps = 6/98 (6%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
           E+    I  LS L+ L L  N +  L    F   ++L  L +  N     +        +
Sbjct: 66  ELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQN-IS--CCPMAS 122

Query: 142 LTVIDLSNNFFNASIP--ASISKLTHLSALNLANNSLT 177
           L  +DLS N F+  +P       LT L+ L L+     
Sbjct: 123 LRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLSAAKFR 159

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 67.2 bits (164), Expect = 6e-12
 Identities = 33/139 (23%), Positives = 51/139 (36%), Gaps = 24/139 (17%)

Query: 47  WNESSSLCKSWTGVTCSA-DHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLS 105
            + +    +  + V  S  + + V            ++PP T       + LSL  NS+S
Sbjct: 23  GSMTPFSNELESMVDYSNRNLTHVPK----------DLPPRT-------KALSLSQNSIS 65

Query: 106 GLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWNNLTVIDLSNNFFNASIPASISKLT 164
            L   D S L  L  L L  N     L    F    +L  +D+S+N    +I      + 
Sbjct: 66  ELRMPDISFLSELRVLRLSHNRIRS-LDFHVFLFNQDLEYLDVSHNRL-QNISC--CPMA 121

Query: 165 HLSALNLANNSLTGTLPRS 183
            L  L+L+ N     LP  
Sbjct: 122 SLRHLDLSFNDFD-VLPVC 139

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 59.9 bits (145), Expect = 1e-09
 Identities = 22/185 (11%), Positives = 54/185 (29%), Gaps = 7/185 (3%)

Query: 4   LPIFSAIFFLVGTIFLPIKADPVEDKQALLDFIHNIHNS--RSLNWNESSSLCKSWTGVT 61
           + +  ++  L       IK +    ++ +             ++      +  K    + 
Sbjct: 211 VQVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLF 270

Query: 62  CSADHSRVVALRLPGMALRG----EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLEN 117
                  V  L +  + +      E    +   L +L    +++        + +S    
Sbjct: 271 QFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAE 330

Query: 118 LTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLT 177
           +    L  +       +     ++ T ++ + N F  S+    S L  L  L L  N L 
Sbjct: 331 MNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK 390

Query: 178 GTLPR 182
               +
Sbjct: 391 -NFFK 394

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 55.3 bits (133), Expect = 3e-08
 Identities = 13/96 (13%), Positives = 27/96 (28%), Gaps = 1/96 (1%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNL 142
                    + +    L  +    +         + T L+   N F+  +    S    L
Sbjct: 320 SKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRL 379

Query: 143 TVIDLSNNFFNASIPASISKLTHLSALNLANNSLTG 178
             + L  N    +         ++S+L   + SL  
Sbjct: 380 QTLILQRNGL-KNFFKVALMTKNMSSLETLDVSLNS 414

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 50.3 bits (120), Expect = 2e-06
 Identities = 21/120 (17%), Positives = 44/120 (36%), Gaps = 14/120 (11%)

Query: 91  LSALQNLSLRSNSLSGL-----FPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVI 145
              ++ L++ + +++       F    + L++L   H++   F       +SV+  + + 
Sbjct: 275 PRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMNIK 334

Query: 146 DLSNN---FFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPS---WAFAGNNLSS 199
            LS +   F +   P S S  T L   N   N  T ++ +               N L +
Sbjct: 335 MLSISDTPFIHMVCPPSPSSFTFL---NFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKN 391

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562

 Score = 45.6 bits (108), Expect = 4e-05
 Identities = 15/60 (25%), Positives = 28/60 (46%), Gaps = 3/60 (5%)

Query: 94  LQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWNNLTVIDLSNNFF 152
           ++ L L +N +  + P D + L+ L  L++  N     +P   F    +L  I L +N +
Sbjct: 452 VKVLDLHNNRIMSI-PKDVTHLQALQELNVASNQLKS-VPDGVFDRLTSLQYIWLHDNPW 509

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 72.0 bits (177), Expect = 1e-13
 Identities = 54/208 (25%), Positives = 98/208 (47%), Gaps = 30/208 (14%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKR-LKEVNVGKREFEQQMEIVGGIRHENVVALRAYY 364
           +V+G G+FG  ++A L ++  V +K+ L++     RE    ++I+  ++H NVV L+A++
Sbjct: 46  KVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRFKNRE----LQIMRIVKHPNVVDLKAFF 101

Query: 365 YSKDEKL------MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAI-GAARGIAHIH 417
           YS  +K       +V +Y  P +V           Q+ +     +++ +    R +A+IH
Sbjct: 102 YSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQT-MP-MLLIKLYMYQLLRSLAYIH 158

Query: 418 TENGGKLVHGGIKASNIFLNSQGHV---CVSDIGLAALMSPMPPP----AMRAAGYRAPE 470
           +     + H  IK  N+ L+    V      D G A ++    P       R   YRAPE
Sbjct: 159 SIG---ICHRDIKPQNLLLDPPSGVLKLI--DFGSAKILIAGEPNVSYICSRY--YRAPE 211

Query: 471 VT-DTRKATQASDVFSFGVLLLELLTGK 497
           +       T   D++S G ++ EL+ G+
Sbjct: 212 LIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 72.5 bits (178), Expect = 1e-13
 Identities = 55/219 (25%), Positives = 93/219 (42%), Gaps = 21/219 (9%)

Query: 299 DLLRASAEVLGKGTFGTAYKAALEDASTVV-VKRL-KEVNVGKREFEQQM---EIVGGIR 353
           + L+    +LGKGTFG       +       +K L KEV V K E    +    ++   R
Sbjct: 151 EYLK----LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR 206

Query: 354 HENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRI-AIGAARG 412
           H  + AL+  + + D    V +Y   G +    H  R E   S D   R R         
Sbjct: 207 HPFLTALKYSFQTHDRLCFVMEYANGGEL--FFHLSR-ERVFSED---RARFYGAEIVSA 260

Query: 413 IAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAP 469
           + ++H+E    +V+  +K  N+ L+  GH+ ++D GL               G   Y AP
Sbjct: 261 LDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAP 318

Query: 470 EVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEV 508
           EV +     +A D +  GV++ E++ G+ P +    +++
Sbjct: 319 EVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 357

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 70.7 bits (174), Expect = 2e-13
 Identities = 51/205 (24%), Positives = 94/205 (45%), Gaps = 22/205 (10%)

Query: 307 VLGKGTFGTAYKAALEDASTVV-VKRL-KEVNVGKREFEQQM---EIVGGIRHENVVALR 361
           +LG+G+F T   A     S    +K L K   + + +        +++  + H   V L 
Sbjct: 37  ILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLY 96

Query: 362 AYYYSKDEKL-MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIA-IGAARGIAHIHTE 419
            + +  DEKL     Y + G +  + + R+  G       TR   A I +A  + ++H +
Sbjct: 97  -FTFQDDEKLYFGLSYAKNGEL--LKYIRK-IGSFDET-CTRFYTAEIVSA--LEYLHGK 149

Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRA-----AGYRAPEVTDT 474
               ++H  +K  NI LN   H+ ++D G A ++SP    A        A Y +PE+   
Sbjct: 150 G---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 206

Query: 475 RKATQASDVFSFGVLLLELLTGKSP 499
           + A ++SD+++ G ++ +L+ G  P
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLPP 231

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 72.2 bits (177), Expect = 2e-13
 Identities = 65/333 (19%), Positives = 119/333 (35%), Gaps = 58/333 (17%)

Query: 306 EVLGKGTFGTAYKA-----ALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVAL 360
           E LG G FG  ++          A+  V+   +     K    ++++ +  +RH  +V L
Sbjct: 163 EELGTGAFGVVHRVTERATGNNFAAKFVMTPHES---DKETVRKEIQTMSVLRHPTLVNL 219

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLHGRRG---EGQSSLDWDTRVRIAIGAAR----GI 413
              +   +E +M+Y++   G +   +        E             A+   R    G+
Sbjct: 220 HDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE-----------DEAVEYMRQVCKGL 268

Query: 414 AHIHTENGGKLVHGGIKASNIFLNSQG--HVCVSDIGLAALMSPMPPPAMRA--AGYRAP 469
            H+H  N    VH  +K  NI   ++    + + D GL A + P     +    A + AP
Sbjct: 269 CHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 325

Query: 470 EVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD 529
           EV + +     +D++S GVL   LL+G SP      DE       + +V   +W     D
Sbjct: 326 EVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET------LRNVKSCDWN---MD 376

Query: 530 VELLRYPNIEEE----MVEMLQVGMACVVRMPEERPKMADVLK---MVEDIRRVKAENPP 582
                +  I E+    + ++L       +  P  R  +   L+   +       +    P
Sbjct: 377 DSA--FSGISEDGKDFIRKLL-------LADPNTRMTIHQALEHPWLTPGNAPGRDSQIP 427

Query: 583 STENRSEISSSAATPKATETASSSTAHLDSFLS 615
           S+       S      A          + ++ S
Sbjct: 428 SSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSS 460

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 30/105 (28%), Positives = 41/105 (39%), Gaps = 7/105 (6%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGL-FPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
           +    IG L  L+ L++  N +     P  FS L NL  L L  N        D  V + 
Sbjct: 115 LENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQ 174

Query: 142 LTVI----DLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPR 182
           + ++    DLS N  N  I     K   L  L L  N L  ++P 
Sbjct: 175 MPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPD 217

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 65.8 bits (161), Expect = 5e-12
 Identities = 22/98 (22%), Positives = 37/98 (37%), Gaps = 4/98 (4%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWN 140
            +   +      LQ L L    +  +    +  L +L++L L  N     L L  FS  +
Sbjct: 42  HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQS-LALGAFSGLS 100

Query: 141 NLTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLT 177
           +L  +        AS+       L  L  LN+A+N + 
Sbjct: 101 SLQKLVAVETNL-ASLENFPIGHLKTLKELNVAHNLIQ 137

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 63.1 bits (154), Expect = 3e-11
 Identities = 21/114 (18%), Positives = 36/114 (31%), Gaps = 19/114 (16%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWNN 141
           +P +T       +NL L  N L  L    F     L  L L        +    +   ++
Sbjct: 26  LPFST-------KNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IEDGAYQSLSH 77

Query: 142 LTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAG 194
           L+ + L+ N    S+     S L+ L  L     +L            ++    
Sbjct: 78  LSTLILTGNPI-QSLALGAFSGLSSLQKLVAVETNLA--------SLENFPIGH 122

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276

 Score = 44.6 bits (106), Expect = 4e-05
 Identities = 16/72 (22%), Positives = 25/72 (34%), Gaps = 5/72 (6%)

Query: 83  IPPNTIGRLSALQ----NLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSV 138
           I    +  L  +     +L L  N ++ + P  F ++  L  L L  N         F  
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLKELALDTNQLKSVPDGIFDR 222

Query: 139 WNNLTVIDLSNN 150
             +L  I L  N
Sbjct: 223 LTSLQKIWLHTN 234

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 71.5 bits (176), Expect = 2e-13
 Identities = 22/91 (24%), Positives = 43/91 (47%), Gaps = 6/91 (6%)

Query: 88  IGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL 147
           +  L+ L  ++  +N L+ +  +    L  L  + +  N  +   PL  +   NLT + L
Sbjct: 64  VEYLNNLTQINFSNNQLTDI--TPLKNLTKLVDILMNNNQIADITPL--ANLTNLTGLTL 119

Query: 148 SNNFFNASIPASISKLTHLSALNLANNSLTG 178
            NN      P  +  LT+L+ L L++N+++ 
Sbjct: 120 FNNQITDIDP--LKNLTNLNRLELSSNTISD 148

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 71.1 bits (175), Expect = 3e-13
 Identities = 32/97 (32%), Positives = 43/97 (44%), Gaps = 8/97 (8%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
           +I P  +G L+ L  LSL  N L  +     + L NLT L L  N  S   PL       
Sbjct: 213 DITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLAPLSG--LTK 266

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTG 178
           LT + L  N  + +I   ++ LT L+ L L  N L  
Sbjct: 267 LTELKLGANQIS-NISP-LAGLTALTNLELNENQLED 301

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 70.8 bits (174), Expect = 4e-13
 Identities = 31/97 (31%), Positives = 50/97 (51%), Gaps = 8/97 (8%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
           ++ P  +  L+ L+ L + SN +S +  S  +KL NL SL    N  S   PL      N
Sbjct: 169 DLKP--LANLTTLERLDISSNKVSDI--SVLAKLTNLESLIATNNQISDITPLGIL--TN 222

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTG 178
           L  + L+ N     I  +++ LT+L+ L+LANN ++ 
Sbjct: 223 LDELSLNGNQLK-DIG-TLASLTNLTDLDLANNQISN 257

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 70.8 bits (174), Expect = 4e-13
 Identities = 28/97 (28%), Positives = 42/97 (43%), Gaps = 8/97 (8%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
            + P  +  L+ L  L L +N +S +  S  + L  LT+L L  N      P+      N
Sbjct: 257 NLAP--LSGLTKLTELKLGANQISNI--SPLAGLTALTNLELNENQLEDISPISNL--KN 310

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTG 178
           LT + L  N  +   P  +S LT L  L   NN ++ 
Sbjct: 311 LTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD 345

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 70.4 bits (173), Expect = 5e-13
 Identities = 25/104 (24%), Positives = 40/104 (38%), Gaps = 8/104 (7%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
           +I P  I  L  L  L+L  N++S +  S  S L  L  L    N  S    L      N
Sbjct: 301 DISP--ISNLKNLTYLTLYFNNISDI--SPVSSLTKLQRLFFYNNKVSDVSSLAN--LTN 354

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQ 185
           +  +   +N  +   P  ++ LT ++ L L + + T        
Sbjct: 355 INWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKA 396

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 66.9 bits (164), Expect = 7e-12
 Identities = 27/93 (29%), Positives = 46/93 (49%), Gaps = 8/93 (8%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
           +I P  +  L+ L ++ + +N ++ + P   + L NLT L L  N  +   PL      N
Sbjct: 82  DITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDPL--KNLTN 135

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANN 174
           L  ++LS+N    S  +++S LT L  L+  N 
Sbjct: 136 LNRLELSSN--TISDISALSGLTSLQQLSFGNQ 166

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 66.5 bits (163), Expect = 9e-12
 Identities = 22/92 (23%), Positives = 36/92 (39%), Gaps = 6/92 (6%)

Query: 87  TIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID 146
           +   L  +  L      +  +       L NLT ++   N  +   PL       L  I 
Sbjct: 41  SQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITPL--KNLTKLVDIL 96

Query: 147 LSNNFFNASIPASISKLTHLSALNLANNSLTG 178
           ++NN      P  ++ LT+L+ L L NN +T 
Sbjct: 97  MNNNQIADITP--LANLTNLTGLTLFNNQITD 126

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 63.8 bits (156), Expect = 7e-11
 Identities = 26/94 (27%), Positives = 40/94 (42%), Gaps = 7/94 (7%)

Query: 85  PNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTV 144
            + +  L++LQ LS   N ++ L P   + L  L  L +  N  S    L      NL  
Sbjct: 149 ISALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERLDISSNKVSDISVLAKL--TNLES 203

Query: 145 IDLSNNFFNASIPASISKLTHLSALNLANNSLTG 178
           +  +NN  +   P  +  LT+L  L+L  N L  
Sbjct: 204 LIATNNQISDITP--LGILTNLDELSLNGNQLKD 235

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 58.1 bits (141), Expect = 4e-09
 Identities = 13/90 (14%), Positives = 31/90 (34%), Gaps = 8/90 (8%)

Query: 89  GRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLS 148
           G L +      +   ++ +F    + L       L   + +  +    +  + +T +   
Sbjct: 1   GPLGS--ATITQDTPINQIFT--DTALAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQAD 54

Query: 149 NNFFNASIPASISKLTHLSALNLANNSLTG 178
                      +  L +L+ +N +NN LT 
Sbjct: 55  RL--GIKSIDGVEYLNNLTQINFSNNQLTD 82

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466

 Score = 45.7 bits (109), Expect = 4e-05
 Identities = 12/104 (11%), Positives = 36/104 (34%), Gaps = 5/104 (4%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
           ++ P  +  L+ +  L L   + +    +  + +    ++     +     P   S   +
Sbjct: 367 DLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIPNTVKNVTGALI--APATISDGGS 422

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQ 185
            T  D++ N  +          +    +     + +GT+ + L+
Sbjct: 423 YTEPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVTQPLK 465

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 71.7 bits (176), Expect = 2e-13
 Identities = 56/291 (19%), Positives = 106/291 (36%), Gaps = 59/291 (20%)

Query: 306 EVLGKGTFGTAYKAALEDAST---VVVKRLK--------------EVNVGKREFEQQMEI 348
             LG G +G       ++ +      +K +K               +     E   ++ +
Sbjct: 42  RKLGSGAYGEVLLC--KEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISL 99

Query: 349 VGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAML------HGRRGEGQSSLDWDTR 402
           +  + H N++ L   +  K    +V +++E G     L        +  E  ++      
Sbjct: 100 LKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGE----LFEQIINRHKFDECDAA------ 149

Query: 403 VRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG---HVCVSDIGLAALMSPMPPP 459
             I      GI ++H  N   +VH  IK  NI L ++    ++ + D GL++  S     
Sbjct: 150 -NIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKL 205

Query: 460 AMRA--AGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNS 517
             R   A Y APEV   +K  +  DV+S GV++  LL G  P       +++  V     
Sbjct: 206 RDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE---- 260

Query: 518 VVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
                     +  +   + NI +E  E+++     +     +R    + L 
Sbjct: 261 -------KGKYYFDFNDWKNISDEAKELIK---LMLTYDYNKRCTAEEALN 301

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 69.8 bits (171), Expect = 3e-13
 Identities = 46/305 (15%), Positives = 100/305 (32%), Gaps = 41/305 (13%)

Query: 306 EVLGKGTFGTAYKAALEDAST---VVVKRLKEVNVGKRE--FEQQMEIVGGIRHENVVAL 360
           ++LG+G     ++       T     +K    ++  +      ++ E++  + H+N+V L
Sbjct: 15  DILGQGATANVFRG--RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72

Query: 361 RAYYYSKDEKL--MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT 418
            A       +   ++ ++   GS+  +L          L     + +      G+ H+  
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGMNHLRE 130

Query: 419 ENGGKLVHGGIKASNIFL----NSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEV 471
                +VH  IK  NI      + Q    ++D G A  +       +   G   Y  P++
Sbjct: 131 NG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED-DEQFVSLYGTEEYLHPDM 186

Query: 472 --------TDTRKATQASDVFSFGVLLLELLTGKSP-IHATGGDEVVHLVR--------- 513
                      +K     D++S GV      TG  P     G      ++          
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246

Query: 514 WVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRM-PEERPKMADVLKMVED 572
            ++ V + E     +  ++    ++   +  +L   +A ++    E+            D
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306

Query: 573 IRRVK 577
           I    
Sbjct: 307 ILHRG 311

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 69.6 bits (171), Expect = 4e-13
 Identities = 52/251 (20%), Positives = 88/251 (35%), Gaps = 55/251 (21%)

Query: 306 EVLGKGTFGTAYKAAL------EDASTVVVKRLKEV--NVGKREFEQQMEIVGGI-RHEN 356
           +VLG G FG    A          +  V VK LKE   +  +     +++++  +  HEN
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110

Query: 357 VVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTR-------------- 402
           +V L           ++++Y   G +   L  +R +                        
Sbjct: 111 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170

Query: 403 ----VRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP 458
               +  A   A+G+  +        VH  + A N+ +     V + D GLA  +     
Sbjct: 171 FEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI----- 222

Query: 459 PAMRAAGYR------------APEVTDTRKATQASDVFSFGVLLLELLT-GKSP---IHA 502
             M  + Y             APE       T  SDV+S+G+LL E+ + G +P   I  
Sbjct: 223 --MSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280

Query: 503 TGGDEVVHLVR 513
                   L++
Sbjct: 281 --DANFYKLIQ 289

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 69.9 bits (171), Expect = 5e-13
 Identities = 51/319 (15%), Positives = 105/319 (32%), Gaps = 41/319 (12%)

Query: 306 EVLGKGTFGTAYKAALEDAST---VVVKRLKEVNVGKRE--FEQQMEIVGGIRHENVVAL 360
           ++LG+G     ++       T     +K    ++  +      ++ E++  + H+N+V L
Sbjct: 15  DILGQGATANVFRG--RHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKL 72

Query: 361 RAYYYSKDEKL--MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT 418
            A       +   ++ ++   GS+  +L          L     + +      G+ H+  
Sbjct: 73  FAIEEETTTRHKVLIMEFCPCGSLYTVLEEP--SNAYGLPESEFLIVLRDVVGGMNHLR- 129

Query: 419 ENGGKLVHGGIKASNIFL----NSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEV 471
           ENG  +VH  IK  NI      + Q    ++D G A  +       +   G   Y  P++
Sbjct: 130 ENG--IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ-FVSLYGTEEYLHPDM 186

Query: 472 --------TDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRW--------- 514
                      +K     D++S GV      TG  P     G      V +         
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSG 246

Query: 515 -VNSVVREEWTAEVFDVELLRYPNIEEEMVEML-QVGMACVVRMPEERPKMADVLKMVED 572
            ++ V + E     +  ++    ++   +  +L  V    +    E+            D
Sbjct: 247 AISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSD 306

Query: 573 IRRVKAENPPSTENRSEIS 591
           I      +  S +  +   
Sbjct: 307 ILHRMVIHVFSLQQMTAHK 325

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 70.5 bits (173), Expect = 6e-13
 Identities = 59/280 (21%), Positives = 108/280 (38%), Gaps = 48/280 (17%)

Query: 306 EVLGKGTFGTAYKAALEDAST---VVVKRLKEVNVGKREFE---QQMEIVGGIRHENVVA 359
            +LGKG+FG   K   +D  T     VK + + +   ++     +++E++  + H N++ 
Sbjct: 28  CMLGKGSFGEVLKC--KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85

Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAML------HGRRGEGQSSLDWDTRVRIAIGAARGI 413
           L           +V + +  G     L        R  E  ++       RI      GI
Sbjct: 86  LFEILEDSSSFYIVGELYTGGE----LFDEIIKRKRFSEHDAA-------RIIKQVFSGI 134

Query: 414 AHIHTENGGKLVHGGIKASNIFLNSQG---HVCVSDIGLAALMSPMPPPAMRA--AGYRA 468
            ++H  N   +VH  +K  NI L S+     + + D GL+           R   A Y A
Sbjct: 135 TYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIA 191

Query: 469 PEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVF 528
           PEV       +  DV+S GV+L  LL+G  P +     +++  V               +
Sbjct: 192 PEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE-----------TGKY 239

Query: 529 DVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
             +L ++  I ++  ++++     +   P  R      L+
Sbjct: 240 AFDLPQWRTISDDAKDLIR---KMLTFHPSLRITATQCLE 276

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 68.6 bits (168), Expect = 6e-13
 Identities = 31/286 (10%), Positives = 74/286 (25%), Gaps = 58/286 (20%)

Query: 306 EVLGKGTFGTAYKAALEDAS---TVVVKRLKEVNVG----KREFEQQMEIVGGIRHENVV 358
              G       ++A   D +    V +  +    V      +E   +   +  I    V 
Sbjct: 37  IFHGGVPPLQFWQA--LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94

Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT 418
            +    +++   L+V ++   GS+  +                 +R     A      H 
Sbjct: 95  RVLDVVHTRAGGLVVAEWIRGGSLQEVADTS-------PSPVGAIRAMQSLAAAADAAH- 146

Query: 419 ENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTRKAT 478
             G  +       S + ++  G V ++                               A 
Sbjct: 147 RAG--VALSIDHPSRVRVSIDGDVVLAY-----------------PATMPD-------AN 180

Query: 479 QASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI 538
              D+   G  L  LL  + P+   G    +       +    +   +  +   +   +I
Sbjct: 181 PQDDIRGIGASLYALLVNRWPLPEAGVRSGL-------APAERDTAGQPIEPADID-RDI 232

Query: 539 EEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPST 584
             ++  +       V      R        ++  +++  A    + 
Sbjct: 233 PFQISAVA---ARSVQGDGGIRSAST----LLNLMQQATAVADRTE 271

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 66.5 bits (163), Expect = 9e-13
 Identities = 18/93 (19%), Positives = 44/93 (47%), Gaps = 2/93 (2%)

Query: 88  IGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL 147
           I     +++L++ +   +    +  S L NL  L +     +     + S   +LT++D+
Sbjct: 62  IEYAHNIKDLTINNIHATNY--NPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDI 119

Query: 148 SNNFFNASIPASISKLTHLSALNLANNSLTGTL 180
           S++  + SI   I+ L  +++++L+ N     +
Sbjct: 120 SHSAHDDSILTKINTLPKVNSIDLSYNGAITDI 152

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 63.4 bits (155), Expect = 1e-11
 Identities = 16/108 (14%), Positives = 47/108 (43%), Gaps = 4/108 (3%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
                T  ++++L  ++L + +++ L  +      N+  L +     +   P+  S  +N
Sbjct: 34  STANITEAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTINNIHATNYNPI--SGLSN 89

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPS 189
           L  + +      +    ++S LT L+ L++++++   ++   +   P 
Sbjct: 90  LERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPK 137

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 60.0 bits (146), Expect = 2e-10
 Identities = 14/97 (14%), Positives = 36/97 (37%), Gaps = 5/97 (5%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSF-SGPLPLDFSVWNN 141
                +  L++L  L +  ++      +  + L  + S+ L +N   +  +PL       
Sbjct: 103 DKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPL--KTLPE 160

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTG 178
           L  +++  +  +      I     L+ L   + ++ G
Sbjct: 161 LKSLNIQFDGVH-DYRG-IEDFPKLNQLYAFSQTIGG 195

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197

 Score = 53.0 bits (128), Expect = 3e-08
 Identities = 17/94 (18%), Positives = 41/94 (43%), Gaps = 7/94 (7%)

Query: 91  LSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNN 150
             A  N  L  +S + +  +    + +LT + L   + +    ++++   N+  + ++N 
Sbjct: 22  FKAYLNGLLGQSSTANITEAQ---MNSLTYITLANINVTDLTGIEYAH--NIKDLTINNI 76

Query: 151 FFNASIPASISKLTHLSALNLANNSLTGTLPRSL 184
             +A+    IS L++L  L +    +T     +L
Sbjct: 77  --HATNYNPISGLSNLERLRIMGKDVTSDKIPNL 108

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 69.4 bits (170), Expect = 1e-12
 Identities = 54/220 (24%), Positives = 95/220 (43%), Gaps = 29/220 (13%)

Query: 299 DLLRASAEVLGKGTFGTAYKAALEDASTVV-VKRL-KEVNVGKREFEQQME---IVGGIR 353
           ++L+    V+G+G FG      L++A  V  +K L K   + + E     E   ++    
Sbjct: 77  EILK----VIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD 132

Query: 354 HENVVALRAYYYSKDEKL-MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIA-IGAAR 411
            + +  L  Y +  D  L +V DY+  G +  +    + E +   +   R  +A +  A 
Sbjct: 133 SKWITTLH-YAFQDDNNLYLVMDYYVGGDL--LTLLSKFEDRLPEEM-ARFYLAEMVIA- 187

Query: 412 GIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAA-LMSPMPPPAMRAAG---YR 467
            I  +H  +    VH  IK  NI ++  GH+ ++D G    LM      +  A G   Y 
Sbjct: 188 -IDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYI 243

Query: 468 APEV-----TDTRKATQASDVFSFGVLLLELLTGKSPIHA 502
           +PE+         +     D +S GV + E+L G++P +A
Sbjct: 244 SPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA 283

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 68.9 bits (169), Expect = 1e-12
 Identities = 57/234 (24%), Positives = 96/234 (41%), Gaps = 40/234 (17%)

Query: 299 DLLRASAEVLGKGTFGTAYKAALEDASTV---------VVKRLKEVNVGKREFEQQMEIV 349
           ++LR     +GKG+FG        D   +               EV    +E    ++I+
Sbjct: 18  EILR----AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKE----LQIM 69

Query: 350 GGIRHENVVALRAYYYSKDEKL-MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVR--IA 406
            G+ H  +V L  Y +  +E + MV D    G +    H ++       +    V+  I 
Sbjct: 70  QGLEHPFLVNLW-YSFQDEEDMFMVVDLLLGGDL--RYHLQQ-NVHFKEE---TVKLFIC 122

Query: 407 -IGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG 465
            +  A  + ++  +    ++H  +K  NI L+  GHV ++D  +AA++          AG
Sbjct: 123 ELVMA--LDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR-ETQITTMAG 176

Query: 466 ---YRAPEVTDTRKA---TQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVR 513
              Y APE+  +RK    + A D +S GV   ELL G+ P H         +V 
Sbjct: 177 TKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH 230

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 66.6 bits (163), Expect = 1e-12
 Identities = 28/102 (27%), Positives = 45/102 (44%), Gaps = 3/102 (2%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
            IPP        L+ + L +N +S L P  F  L +L SL L  N  +      F    +
Sbjct: 46  VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFS 105

Query: 142 LTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLPR 182
           L ++ L+ N  N  +       L +L+ L+L +N L  T+ +
Sbjct: 106 LQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAK 145

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 66.2 bits (162), Expect = 2e-12
 Identities = 24/102 (23%), Positives = 36/102 (35%), Gaps = 12/102 (11%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWNN 141
           +P            + L  N++  + P  FS  + L  + L  N  S  L  D F    +
Sbjct: 30  LPETI-------TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISE-LAPDAFQGLRS 81

Query: 142 LTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLPR 182
           L  + L  N     +P S+   L  L  L L  N +   L  
Sbjct: 82  LNSLVLYGNKI-TELPKSLFEGLFSLQLLLLNANKIN-CLRV 121

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 28/95 (29%), Positives = 45/95 (47%), Gaps = 4/95 (4%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWN 140
           E+ P+    L +L +L L  N ++ L  S F  L +L  L L  N  +  L +D F   +
Sbjct: 70  ELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINC-LRVDAFQDLH 128

Query: 141 NLTVIDLSNNFFNASIPASI-SKLTHLSALNLANN 174
           NL ++ L +N    +I     S L  +  ++LA N
Sbjct: 129 NLNLLSLYDNKL-QTIAKGTFSPLRAIQTMHLAQN 162

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 14/46 (30%), Positives = 20/46 (43%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSF 128
           +  +    L  L  LSL  N L  +    FS L  + ++HL  N F
Sbjct: 119 LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPF 164

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 68.0 bits (167), Expect = 1e-12
 Identities = 42/210 (20%), Positives = 86/210 (40%), Gaps = 34/210 (16%)

Query: 306 EVLGKGTFGTAYKAALEDAST---VVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRA 362
           E LG+G FG  ++    + S+    + K +K     +   ++++ I+   RH N++ L  
Sbjct: 11  EDLGRGEFGIVHRC--VETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHE 68

Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHGR---RGEGQSSLDWDTRVRIAIGAAR----GIAH 415
            + S +E +M++++         +  R        +  +        +         +  
Sbjct: 69  SFESMEELVMIFEFISGLD----IFERINTSAFELNERE-------IVSYVHQVCEALQF 117

Query: 416 IHTENGGKLVHGGIKASNIFLNSQ--GHVCVSDIGLAALMSPMPPPAMRA----AGYRAP 469
           +H+ N   + H  I+  NI   ++    + + + G A  + P      R       Y AP
Sbjct: 118 LHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN--FRLLFTAPEYYAP 172

Query: 470 EVTDTRKATQASDVFSFGVLLLELLTGKSP 499
           EV      + A+D++S G L+  LL+G +P
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSGINP 202

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 69.0 bits (169), Expect = 1e-12
 Identities = 23/97 (23%), Positives = 35/97 (36%), Gaps = 1/97 (1%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
           +I       L++L  L L  N L+ +    F  L  L  L L+ N         F+   +
Sbjct: 113 QIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPS 172

Query: 142 LTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLT 177
           L  +DL        I       L +L  LNL   ++ 
Sbjct: 173 LMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK 209

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 67.8 bits (166), Expect = 4e-12
 Identities = 32/130 (24%), Positives = 48/130 (36%), Gaps = 22/130 (16%)

Query: 82  EIPPNTIGRLSALQNLSL-RSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWN 140
            IP     R+ +L  L L     L  +    F  L NL  L+L   +    +P + +   
Sbjct: 161 SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKD-MP-NLTPLV 218

Query: 141 NLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAG------ 194
            L  +++S N F    P S   L+ L  L + N+ ++             AF G      
Sbjct: 219 GLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS--------LIERNAFDGLASLVE 270

Query: 195 -----NNLSS 199
                NNLSS
Sbjct: 271 LNLAHNNLSS 280

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 66.3 bits (162), Expect = 9e-12
 Identities = 32/129 (24%), Positives = 51/129 (39%), Gaps = 10/129 (7%)

Query: 67  SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFN 126
           S    L L    ++  I  +T   L  L+ L L  NS+  +    F+ L +L +L L  N
Sbjct: 75  SNTRYLNLMENNIQ-MIQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN 133

Query: 127 SFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLPRSLQ 185
             +      F   + L  + L NN    SIP+   +++  L  L+L          + L+
Sbjct: 134 WLTVIPSGAFEYLSKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGEL-------KKLE 185

Query: 186 RFPSWAFAG 194
                AF G
Sbjct: 186 YISEGAFEG 194

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 62.5 bits (152), Expect = 2e-10
 Identities = 21/92 (22%), Positives = 40/92 (43%), Gaps = 2/92 (2%)

Query: 86  NTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVI 145
             +  L  L+ L +  N    + P  F  L +L  L +  +  S      F    +L  +
Sbjct: 212 PNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVEL 271

Query: 146 DLSNNFFNASIPASI-SKLTHLSALNLANNSL 176
           +L++N   +S+P  + + L +L  L+L +N  
Sbjct: 272 NLAHNNL-SSLPHDLFTPLRYLVELHLHHNPW 302

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 60.5 bits (147), Expect = 7e-10
 Identities = 22/70 (31%), Positives = 37/70 (52%), Gaps = 2/70 (2%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWN 140
           EI P +   LS+L+ L + ++ +S +  + F  L +L  L+L  N+ S  LP D F+   
Sbjct: 232 EIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSS-LPHDLFTPLR 290

Query: 141 NLTVIDLSNN 150
            L  + L +N
Sbjct: 291 YLVELHLHHN 300

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452

 Score = 47.8 bits (114), Expect = 7e-06
 Identities = 18/57 (31%), Positives = 26/57 (45%), Gaps = 1/57 (1%)

Query: 72  LRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSF 128
           L +    +   I  N    L++L  L+L  N+LS L    F+ L  L  LHL  N +
Sbjct: 247 LWVMNSQVS-LIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPW 302

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 68.5 bits (168), Expect = 2e-12
 Identities = 33/126 (26%), Positives = 46/126 (36%), Gaps = 13/126 (10%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
           E+P   +  L  L  +   +NSL  L         +L S+    N     LP +      
Sbjct: 187 ELPE--LQNLPFLTAIYADNNSLKKLPDL----PLSLESIVAGNNILEE-LP-ELQNLPF 238

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLSSEN 201
           LT I   NN    ++P     L     LN+ +N LT  LP   Q       + N  S  +
Sbjct: 239 LTTIYADNNLLK-TLPDLPPSLEA---LNVRDNYLT-DLPELPQSLTFLDVSENIFSGLS 293

Query: 202 ARPPAL 207
             PP L
Sbjct: 294 ELPPNL 299

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 66.2 bits (162), Expect = 1e-11
 Identities = 28/136 (20%), Positives = 45/136 (33%), Gaps = 27/136 (19%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPS------------------DFSKLENLTSLHL 123
           ++P   +   S L+ + + +NSL  L                     +   L  LT+++ 
Sbjct: 145 KLPE--LQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEELPELQNLPFLTAIYA 202

Query: 124 QFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRS 183
             NS    LP       +L  I   NN         +  L  L+ +   NN L  TLP  
Sbjct: 203 DNNSLKK-LPDLPL---SLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDL 255

Query: 184 LQRFPSWAFAGNNLSS 199
                +     N L+ 
Sbjct: 256 PPSLEALNVRDNYLTD 271

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 65.0 bits (159), Expect = 2e-11
 Identities = 25/101 (24%), Positives = 37/101 (36%), Gaps = 10/101 (9%)

Query: 86  NTIGRL-SALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTV 144
             +  L   L+ L + +N L  L   +      L  + +  NS    LP       +L  
Sbjct: 124 KALSDLPPLLEYLGVSNNQLEKL--PELQNSSFLKIIDVDNNSLKK-LPDLPP---SLEF 177

Query: 145 IDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQ 185
           I   NN     +P  +  L  L+A+   NNSL   LP    
Sbjct: 178 IAAGNNQLE-ELP-ELQNLPFLTAIYADNNSLK-KLPDLPL 215

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 63.5 bits (155), Expect = 8e-11
 Identities = 18/114 (15%), Positives = 28/114 (24%), Gaps = 19/114 (16%)

Query: 85  PNTIGRLSALQNLSLRSNSLSGLFPSDFSKL-------------ENLTSLHLQFNSFSGP 131
           P     + +        +      P    +                   L L     S  
Sbjct: 27  PVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-S 85

Query: 132 LPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQ 185
           LP       +L  +  S N     +P     L  L   N    +L+  LP  L+
Sbjct: 86  LPELPP---HLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSD-LPPLLE 134

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 63.1 bits (154), Expect = 9e-11
 Identities = 28/109 (25%), Positives = 43/109 (39%), Gaps = 13/109 (11%)

Query: 91  LSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNN 150
             +L+ L++R N L+ L P     L  L      F+  S   P       NL  ++ S+N
Sbjct: 256 PPSLEALNVRDNYLTDL-PELPQSLTFLDVSENIFSGLSELPP-------NLYYLNASSN 307

Query: 151 FFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLSS 199
               S+      L  L   N++NN L   LP    R      + N+L+ 
Sbjct: 308 EIR-SLCDLPPSLEEL---NVSNNKLI-ELPALPPRLERLIASFNHLAE 351

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 53.8 bits (130), Expect = 1e-07
 Identities = 20/126 (15%), Positives = 40/126 (31%), Gaps = 21/126 (16%)

Query: 85  PNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTV 144
           P    RL   + L    N L+ +        +NL  LH+++N      P       ++  
Sbjct: 333 PALPPRL---ERLIASFNHLAEVPEL----PQNLKQLHVEYNPLRE-FPDIPE---SVED 381

Query: 145 IDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLSSENARP 204
           + ++++   A +P     L     L++  N L    P   +           +      P
Sbjct: 382 LRMNSHL--AEVPELPQNLKQ---LHVETNPLR-EFPDIPESVEDLRMNSERVVD----P 431

Query: 205 PALPVQ 210
                +
Sbjct: 432 YEFAHE 437

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 14/108 (12%), Positives = 29/108 (26%), Gaps = 17/108 (15%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
           E+P         L+ L +  N L    P     +E+L  ++                  N
Sbjct: 351 EVPEL----PQNLKQLHVEYNPLREF-PDIPESVEDLR-MNSHLAEVPELPQ-------N 397

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPS 189
           L  + +  N      P     +     L + +  +      + +    
Sbjct: 398 LKQLHVETNPLR-EFPDIPESVED---LRMNSERVVDPYEFAHETTDK 441

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454

 Score = 41.9 bits (99), Expect = 4e-04
 Identities = 18/130 (13%), Positives = 38/130 (29%), Gaps = 40/130 (30%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNL 142
           I P  +   + LQ     S++L+ + P +   +++ T                       
Sbjct: 3   INPRNVS-NTFLQEPLRHSSNLTEM-PVEAENVKSKTEY--------------------- 39

Query: 143 TVIDLSNNFFNASIPASISKL-------------THLSALNLANNSLTGTLPRSLQRFPS 189
                + + +  + P    +                   L L N  L+ +LP       S
Sbjct: 40  ---YNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLS-SLPELPPHLES 95

Query: 190 WAFAGNNLSS 199
              + N+L+ 
Sbjct: 96  LVASCNSLTE 105

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 34/122 (27%), Positives = 46/122 (37%), Gaps = 5/122 (4%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
            I       +  L+ L L SN L  L    FS L+ L  L L  N         F     
Sbjct: 78  FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQ 137

Query: 142 LTVIDLSNNFFNASIPA----SISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNL 197
           L  + LS N   +  P       +KL  L  L+L++N L       LQ+ P+W   G  L
Sbjct: 138 LQKLYLSQNQI-SRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYL 196

Query: 198 SS 199
            +
Sbjct: 197 HN 198

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 66.0 bits (161), Expect = 8e-12
 Identities = 32/131 (24%), Positives = 45/131 (34%), Gaps = 13/131 (9%)

Query: 72  LRLPGMALRGEIPPNTI-GRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSG 130
           L L    L   +       RL+ L +L L  N L+ +    F  + NL  L L  N    
Sbjct: 44  LDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRYLDLSSNHLHT 102

Query: 131 PLPLDFSVWNNLTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLPRSLQRFPS 189
                FS    L V+ L NN     +  +    +  L  L L+ N ++        RFP 
Sbjct: 103 LDEFLFSDLQALEVLLLYNNHI-VVVDRNAFEDMAQLQKLYLSQNQIS--------RFPV 153

Query: 190 WAFAG-NNLSS 199
                 N L  
Sbjct: 154 ELIKDGNKLPK 164

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361

 Score = 57.5 bits (139), Expect = 5e-09
 Identities = 26/101 (25%), Positives = 40/101 (39%), Gaps = 7/101 (6%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWNN 141
           +       L AL+ L L +N +  +  + F  +  L  L+L  N  S   P++     N 
Sbjct: 103 LDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISR-FPVELIKDGNK 161

Query: 142 LT---VIDLSNNFFNASIPASISKLTHLS--ALNLANNSLT 177
           L    ++DLS+N         + KL       L L NN L 
Sbjct: 162 LPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLE 202

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 51/212 (24%), Positives = 93/212 (43%), Gaps = 37/212 (17%)

Query: 306 EVLGKGTFGTAYKA-----ALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVAL 360
           E+LG G FG  +K       L+ A+ ++  R  +    K E + ++ ++  + H N++ L
Sbjct: 95  EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMK---DKEEVKNEISVMNQLDHANLIQL 151

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLHGR---RGEGQSSLDWDTRVRIAIGAAR----GI 413
              + SK++ ++V +Y + G     L  R        + LD        I   +    GI
Sbjct: 152 YDAFESKNDIVLVMEYVDGGE----LFDRIIDESYNLTELD-------TILFMKQICEGI 200

Query: 414 AHIHTENGGKLVHGGIKASNIFLNSQG--HVCVSDIGLAALMSPMPPPAMRA----AGYR 467
            H+H      ++H  +K  NI   ++    + + D GLA    P     ++       + 
Sbjct: 201 RHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKVNFGTPEFL 255

Query: 468 APEVTDTRKATQASDVFSFGVLLLELLTGKSP 499
           APEV +    +  +D++S GV+   LL+G SP
Sbjct: 256 APEVVNYDFVSFPTDMWSVGVIAYMLLSGLSP 287

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 65.1 bits (159), Expect = 5e-12
 Identities = 24/95 (25%), Positives = 41/95 (43%), Gaps = 4/95 (4%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWN 140
           +I        S +  + L SN L  +    F  LE+L +L L+ N  +  +  D F   +
Sbjct: 71  DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITC-VGNDSFIGLS 129

Query: 141 NLTVIDLSNNFFNASIPASI-SKLTHLSALNLANN 174
           ++ ++ L +N    ++       L  LS LNL  N
Sbjct: 130 SVRLLSLYDNQI-TTVAPGAFDTLHSLSTLNLLAN 163

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 61.6 bits (150), Expect = 5e-11
 Identities = 21/120 (17%), Positives = 43/120 (35%), Gaps = 13/120 (10%)

Query: 82  EIPPNTI-GRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWN 140
            +    I  +L  L+ ++  +N ++ +    F     +  + L  N         F    
Sbjct: 46  VLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLE 105

Query: 141 NLTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLSS 199
           +L  + L +N     +       L+ +  L+L +N +T T+          AF  + L S
Sbjct: 106 SLKTLMLRSNRI-TCVGNDSFIGLSSVRLLSLYDNQIT-TVAPG-------AF--DTLHS 154

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220

 Score = 41.2 bits (97), Expect = 4e-04
 Identities = 14/46 (30%), Positives = 27/46 (58%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSF 128
           +  ++   LS+++ LSL  N ++ + P  F  L +L++L+L  N F
Sbjct: 120 VGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPF 165

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 68.0 bits (166), Expect = 5e-12
 Identities = 28/118 (23%), Positives = 46/118 (38%), Gaps = 12/118 (10%)

Query: 90  RLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSN 149
             +    L++  + L+ L P       ++T+L +  N+ +  LP        L  +++S 
Sbjct: 38  LNNGNAVLNVGESGLTTL-PDCL--PAHITTLVIPDNNLTS-LPALPP---ELRTLEVSG 90

Query: 150 NFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLSSENARPPAL 207
           N    S+P     L  LS  +     L   LP  L +       GN L+S    PP L
Sbjct: 91  NQLT-SLPVLPPGLLELSIFSNPLTHLP-ALPSGLCKL---WIFGNQLTSLPVLPPGL 143

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 64.5 bits (157), Expect = 5e-11
 Identities = 35/115 (30%), Positives = 50/115 (43%), Gaps = 15/115 (13%)

Query: 72  LRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGP 131
           L + G  L   +P         LQ LS+  N L+ L P+  S+L  L + + Q  S    
Sbjct: 126 LWIFGNQLT-SLPVL----PPGLQELSVSDNQLASL-PALPSELCKLWAYNNQLTS---- 175

Query: 132 LPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQR 186
           LP+  S    L  + +S+N    S+P   S+L  L A N    SL   LP  L+ 
Sbjct: 176 LPMLPS---GLQELSVSDNQLA-SLPTLPSELYKLWAYNNRLTSLPA-LPSGLKE 225

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 63.8 bits (155), Expect = 1e-10
 Identities = 23/118 (19%), Positives = 44/118 (37%), Gaps = 9/118 (7%)

Query: 91  LSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNN 150
            S L+ L +  N L+ L          L  L +  N  +  LP    + + L  + +  N
Sbjct: 220 PSGLKELIVSGNRLTSLPVL----PSELKELMVSGNRLTS-LP---MLPSGLLSLSVYRN 271

Query: 151 FFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLSSENARPPALP 208
                +P S+  L+  + +NL  N L+    ++L+   S       +   +    + P
Sbjct: 272 QL-TRLPESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAP 328

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 51.0 bits (122), Expect = 8e-07
 Identities = 18/111 (16%), Positives = 37/111 (33%), Gaps = 5/111 (4%)

Query: 91  LSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNN 150
            S L+ L +  N L+ L P        L SL +  N  +  LP      ++ T ++L  N
Sbjct: 240 PSELKELMVSGNRLTSL-PM---LPSGLLSLSVYRNQLTR-LPESLIHLSSETTVNLEGN 294

Query: 151 FFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLSSEN 201
             +     ++ ++T     +            + +   +   A  +     
Sbjct: 295 PLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALHLAAADWLVPA 345

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622

 Score = 44.5 bits (105), Expect = 1e-04
 Identities = 12/112 (10%), Positives = 28/112 (25%), Gaps = 4/112 (3%)

Query: 85  PNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTV 144
           P ++  LS+   ++L  N LS        ++ +          F             L  
Sbjct: 277 PESLIHLSSETTVNLEGNPLSERTLQALREITSAPGYSGPIIRFDMAGASAPRETRALH- 335

Query: 145 IDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNN 196
              + ++   +     +           +N+        L R         +
Sbjct: 336 -LAAADWLVPAREGEPAPADRWHMFGQEDNA--DAFSLFLDRLSETENFIKD 384

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 66.4 bits (163), Expect = 5e-12
 Identities = 65/274 (23%), Positives = 117/274 (42%), Gaps = 67/274 (24%)

Query: 262 VKSQKKEMSLKEGVSGSHDKNSKLVFFEGCNLVFDLED--LLRASAEVLGKGTFGTAY-- 317
           ++   KE+++   V   H+K              D     LL+    VLG+G+FG  +  
Sbjct: 1   MEGSIKEIAITHHVKEGHEK-------------ADPSQFELLK----VLGQGSFGKVFLV 43

Query: 318 -KAALEDASTV-VVKRL-KEVNVGKREFEQQME--IVGGIRHENVVALRAYYYS--KDEK 370
            K +  DA  +  +K L K     +     +ME  I+  + H  +V L   +Y+   + K
Sbjct: 44  KKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL---HYAFQTEGK 100

Query: 371 L-MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVR-----IAIGAARGIAHIHTENGGKL 424
           L ++ D+   G +       + E   + +    V+     +A+     + H+H+     +
Sbjct: 101 LYLILDFLRGGDL--FTRLSK-EVMFTEE---DVKFYLAELALA----LDHLHSLG---I 147

Query: 425 VHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG----------YRAPEVTDT 474
           ++  +K  NI L+ +GH+ ++D GL+         ++              Y APEV + 
Sbjct: 148 IYRDLKPENILLDEEGHIKLTDFGLSKE-------SIDHEKKAYSFCGTVEYMAPEVVNR 200

Query: 475 RKATQASDVFSFGVLLLELLTGKSPIHATGGDEV 508
           R  TQ++D +SFGVL+ E+LTG  P       E 
Sbjct: 201 RGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKET 234

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 65.0 bits (159), Expect = 5e-12
 Identities = 25/134 (18%), Positives = 42/134 (31%), Gaps = 35/134 (26%)

Query: 54  CKSWTGVTCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFS 113
           C        +    + +    P       +PP+T       Q L L    L  +    FS
Sbjct: 10  CHQEEDFRVTCKDIQRI----PS------LPPST-------QTLKLIETHLRTIPSHAFS 52

Query: 114 KLENLTSLHLQFN---------SFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASI-SKL 163
            L N++ +++  +         SF   L         +T I++ N      I      +L
Sbjct: 53  NLPNISRIYVSIDVTLQQLESHSFYN-LS-------KVTHIEIRNTRNLTYIDPDALKEL 104

Query: 164 THLSALNLANNSLT 177
             L  L + N  L 
Sbjct: 105 PLLKFLGIFNTGLK 118

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 27/134 (20%), Positives = 48/134 (35%), Gaps = 25/134 (18%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSD--FSKLENLTSLHLQFNSFSGPLPLD-FS- 137
            I P+ +  L  L+ L + +  L  +FP        +    L +  N +   +P++ F  
Sbjct: 95  YIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITDNPYMTSIPVNAFQG 153

Query: 138 VWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAG--- 194
           + N    + L NN F  S+       T L A+ L  N       + L      AF G   
Sbjct: 154 LCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKN-------KYLTVIDKDAFGGVYS 205

Query: 195 ---------NNLSS 199
                     ++++
Sbjct: 206 GPSLLDVSQTSVTA 219

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 67.0 bits (164), Expect = 6e-12
 Identities = 45/216 (20%), Positives = 85/216 (39%), Gaps = 31/216 (14%)

Query: 307 VLGKGTFGTAYKAALEDASTVV-VKRL-KEVNVGKREFEQQME---IVGGIRHENVVALR 361
           V+G+G F       ++    V  +K + K   + + E     E   ++       +  L 
Sbjct: 68  VIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL- 126

Query: 362 AYYYS--KDEKL-MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIA-IGAARGIAHIH 417
             +++   +  L +V +Y+  G +  +    +   +   +   R  +A I  A  I  +H
Sbjct: 127 --HFAFQDENYLYLVMEYYVGGDL--LTLLSKFGERIPAEM-ARFYLAEIVMA--IDSVH 179

Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAA-LMSPMPPPAMRAAG---YRAPEV-- 471
                  VH  IK  NI L+  GH+ ++D G    L +     ++ A G   Y +PE+  
Sbjct: 180 RLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236

Query: 472 -----TDTRKATQASDVFSFGVLLLELLTGKSPIHA 502
                  T       D ++ GV   E+  G++P +A
Sbjct: 237 AVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA 272

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 66.1 bits (162), Expect = 6e-12
 Identities = 50/226 (22%), Positives = 89/226 (39%), Gaps = 58/226 (25%)

Query: 306 EVLGKGTFGTAYKAALEDAST-------VVVKR---LKEVNVGKREFEQQMEIVGGIRHE 355
           E LG G F    K    + ST        + KR        V + E E+++ I+  + H 
Sbjct: 18  EELGSGQFAIVKKC--REKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHH 75

Query: 356 NVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRI---------- 405
           NV+ L   Y ++ + +++ +          + G  GE    L +D    +          
Sbjct: 76  NVITLHDVYENRTDVVLILEL---------VSG--GE----L-FD---FLAQKESLSEEE 116

Query: 406 AIGAAR----GIAHIHTENGGKLVHGGIKASNIFLNSQ----GHVCVSDIGLAALMSPMP 457
           A    +    G+ ++HT+    + H  +K  NI L  +     H+ + D GLA  +    
Sbjct: 117 ATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV 173

Query: 458 PPAMRA----AGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSP 499
               +       + APE+ +       +D++S GV+   LL+G SP
Sbjct: 174 E--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 66.7 bits (163), Expect = 6e-12
 Identities = 47/241 (19%), Positives = 84/241 (34%), Gaps = 58/241 (24%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKR-LKEVNVGKREFEQQMEIVGGIRHENVVALRAY 363
           + LG G+FG   +   +E      +K+ L++     RE    ++I+  + H N++ L  Y
Sbjct: 13  KTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRE----LDIMKVLDHVNIIKLVDY 68

Query: 364 YYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTR--------------------V 403
           +Y+  ++                                                    +
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128

Query: 404 RIAIGAA----------------RGIAHIHTENGGKLVHGGIKASNIFLNSQGHV---CV 444
           +  I +                 R +  IH+     + H  IK  N+ +NS+ +    C 
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLC- 184

Query: 445 SDIGLAALMSPMPPP----AMRAAGYRAPEVT-DTRKATQASDVFSFGVLLLELLTGKSP 499
            D G A  + P  P       R   YRAPE+     + T + D++S G +  EL+ GK P
Sbjct: 185 -DFGSAKKLIPSEPSVAYICSRF--YRAPELMLGATEYTPSIDLWSIGCVFGELILGK-P 240

Query: 500 I 500
           +
Sbjct: 241 L 241

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 66.0 bits (161), Expect = 7e-12
 Identities = 37/249 (14%), Positives = 77/249 (30%), Gaps = 60/249 (24%)

Query: 306 EVLGKGTFGTAYKAALEDAST--------VVVKRLKEVNVGKRE-FEQQMEIVGGIRHEN 356
             +G+G++G    A   +  T        +   +++++N    E  + ++ ++  + H N
Sbjct: 32  GAIGQGSYGVVRVA--IENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPN 89

Query: 357 VVALRAYYYSKDEKLMVYDYFEPGS----VSAMLHGRRGEGQSSLDWDTRVRIAIG---- 408
           +  L   Y  +    +V +    G     ++  +    G+    +               
Sbjct: 90  IARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEA 149

Query: 409 --------------------AAR-------GIAHIHTENGGKLVHGGIKASNIFLNSQG- 440
                                +         + ++H +    + H  IK  N   ++   
Sbjct: 150 INGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKS 206

Query: 441 -HVCVSDIGLAALMSPMPPPAMRA-------AGYRAPEV--TDTRKATQASDVFSFGVLL 490
             + + D GL+     +                + APEV  T         D +S GVLL
Sbjct: 207 FEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

Query: 491 LELLTGKSP 499
             LL G  P
Sbjct: 267 HLLLMGAVP 275

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 64.9 bits (159), Expect = 1e-11
 Identities = 49/213 (23%), Positives = 84/213 (39%), Gaps = 29/213 (13%)

Query: 306 EVLGKGTFGTAYKAALEDAST---VVVKRL--KEVNVGKREFEQQMEIVGGIRHENVVAL 360
             LG G FG  +    E+ S+    V+K +      V   + E ++E++  + H N++ +
Sbjct: 28  RKLGSGAFGDVHLV--EERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKI 85

Query: 361 RAYYYSKDEKLMVYDY------FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIA 414
              +       +V +        E    +        EG  +      ++  + A   +A
Sbjct: 86  FEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVA----ELMKQMMNA---LA 138

Query: 415 HIHTENGGKLVHGGIKASNIFLNSQ---GHVCVSDIGLAALMSPMPPPAMRA--AGYRAP 469
           + H+++   +VH  +K  NI          + + D GLA L          A  A Y AP
Sbjct: 139 YFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAP 195

Query: 470 EVTDTRKATQASDVFSFGVLLLELLTGKSPIHA 502
           EV   R  T   D++S GV++  LLTG  P   
Sbjct: 196 EVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTG 227

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 65.4 bits (160), Expect = 1e-11
 Identities = 40/215 (18%), Positives = 72/215 (33%), Gaps = 34/215 (15%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKRE---FEQQM-------EI--VGGIR 353
             +  G++G        +   V +KR+       R                EI  +    
Sbjct: 28  RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH 87

Query: 354 HENVVALRAYYYSKDEKLM--VYDYFEPGSVSAM---LHGRRGEGQSSLDWDTRVR-IAI 407
           H N++ LR  +   +E  M  +Y   E      M   L     + +  +     ++    
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTEL-----MRTDLAQVIHDQRIVIS-PQHIQYFMY 141

Query: 408 GAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP----AMRA 463
               G+  +H      +VH  +   NI L     + + D  LA   +           R 
Sbjct: 142 HILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRW 198

Query: 464 AGYRAPEV-TDTRKATQASDVFSFGVLLLELLTGK 497
             YRAPE+    +  T+  D++S G ++ E+   K
Sbjct: 199 --YRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 64.6 bits (158), Expect = 2e-11
 Identities = 46/220 (20%), Positives = 84/220 (38%), Gaps = 46/220 (20%)

Query: 306 EVLGKGTFGTAYKAALEDAST-------VVVKR---LKEVNVGKREFEQQMEIVGGIRHE 355
           E LG G F    K    + ST        + KR        V + + E+++ I+  I+H 
Sbjct: 17  EELGSGQFAVVKKC--REKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHP 74

Query: 356 NVVALRAYYYSKDEKLMVYDYFEPG----SVSAMLHGRRGEGQSSLDWDTRVRIAIGAAR 411
           NV+ L   Y +K + +++ +    G     ++        E             A    +
Sbjct: 75  NVITLHEVYENKTDVILILELVAGGELFDFLAE--KESLTE-----------EEATEFLK 121

Query: 412 ----GIAHIHTENGGKLVHGGIKASNIFLNSQ----GHVCVSDIGLAALMSPMPPPAMRA 463
               G+ ++H+     + H  +K  NI L  +      + + D GLA  +        + 
Sbjct: 122 QILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE--FKN 176

Query: 464 ----AGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSP 499
                 + APE+ +       +D++S GV+   LL+G SP
Sbjct: 177 IFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251

 Score = 63.6 bits (155), Expect = 2e-11
 Identities = 43/182 (23%), Positives = 59/182 (32%), Gaps = 41/182 (22%)

Query: 54  CKSWTGVTCSADHSRV------------------VALRLPGMALRGEIPPNTIGRLSALQ 95
           C++ TG TC+     V                    L L    L   +   T   L+ L 
Sbjct: 4   CETVTGCTCNEGKKEVDCQGKSLDSVPSGIPADTEKLDLQSTGLA-TLSDATFRGLTKLT 62

Query: 96  NLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNAS 155
            L+L  N L  L    F  L  L +L L  N  +      F     L  + L  N    S
Sbjct: 63  WLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQL-KS 121

Query: 156 IPASI-SKLTHLSALNLANNSLTGTLPR-----------------SLQRFPSWAFAGNNL 197
           +P+ +  +LT L  L L  N L  ++P                   LQ  P  AF  + L
Sbjct: 122 LPSGVFDRLTKLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAF--DRL 178

Query: 198 SS 199
             
Sbjct: 179 GK 180

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 65.1 bits (159), Expect = 2e-11
 Identities = 49/226 (21%), Positives = 89/226 (39%), Gaps = 58/226 (25%)

Query: 306 EVLGKGTFGTAYKAALEDAST-------VVVKR---LKEVNVGKREFEQQMEIVGGIRHE 355
           E LG G F    K    + ST        + KR        V + E E+++ I+  + H 
Sbjct: 18  EELGSGQFAIVKKC--REKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHP 75

Query: 356 NVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRI---------- 405
           N++ L   Y ++ + +++ +          + G  GE    L +D    +          
Sbjct: 76  NIITLHDVYENRTDVVLILEL---------VSG--GE----L-FD---FLAQKESLSEEE 116

Query: 406 AIGAAR----GIAHIHTENGGKLVHGGIKASNIFLNSQ----GHVCVSDIGLAALMSPMP 457
           A    +    G+ ++HT+    + H  +K  NI L  +     H+ + D GLA  +    
Sbjct: 117 ATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV 173

Query: 458 PPAMRA----AGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSP 499
               +       + APE+ +       +D++S GV+   LL+G SP
Sbjct: 174 E--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 49/221 (22%), Positives = 79/221 (35%), Gaps = 46/221 (20%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVK-----RLKEVNVGKREFEQQMEIV------GGIR 353
            +LGKG FGT +    L D   V +K     R+   +         +E+        G  
Sbjct: 37  PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG 96

Query: 354 HENVVALRAYYYSKDEKLMVYDYFEPGS------VSAMLHGRRGEGQSSLDWDTRVRIAI 407
           H  V+ L  ++ +++  ++V +   P              G  GEG S            
Sbjct: 97  HPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSR-------CFFG 146

Query: 408 GAARGIAHIHTENGGKLVHGGIKASNIFLNSQ-GHVCVSDIGLAALMSPMP-------PP 459
                I H H+     +VH  IK  NI ++ + G   + D G  AL+   P         
Sbjct: 147 QVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRV 203

Query: 460 AMRAAGYRAPEVTDTRK-ATQASDVFSFGVLLLELLTGKSP 499
                 Y  PE     +     + V+S G+LL +++ G  P
Sbjct: 204 ------YSPPEWISRHQYHALPATVWSLGILLYDMVCGDIP 238

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 63.4 bits (155), Expect = 3e-11
 Identities = 45/222 (20%), Positives = 83/222 (37%), Gaps = 50/222 (22%)

Query: 306 EVLGKGTFGTAYKAALEDAST-------VVVKR---LKEVNVGKREFEQQMEIVGGIRHE 355
           E LG G F    K       T        + KR        V + E E+++ I+  IRH 
Sbjct: 11  EELGSGQFAIVRKC--RQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHP 68

Query: 356 NVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGR---RG---EGQSSLDWDTRVRIAIGA 409
           N++ L   + +K + +++ +    G     L      +    E             A   
Sbjct: 69  NIITLHDIFENKTDVVLILELVSGGE----LFDFLAEKESLTE-----------DEATQF 113

Query: 410 AR----GIAHIHTENGGKLVHGGIKASNIFLNSQ----GHVCVSDIGLAALMSPMPPPAM 461
            +    G+ ++H++    + H  +K  NI L  +      + + D G+A  +        
Sbjct: 114 LKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE--F 168

Query: 462 RA----AGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSP 499
           +       + APE+ +       +D++S GV+   LL+G SP
Sbjct: 169 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229

 Score = 62.8 bits (153), Expect = 3e-11
 Identities = 37/119 (31%), Positives = 49/119 (41%), Gaps = 13/119 (10%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWN 140
           ++ P     L  L+ L L SN L  L    F  L  LT L L  N  +  LP   F    
Sbjct: 54  KLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTNQLTV-LPSAVFDRLV 112

Query: 141 NLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLSS 199
           +L  + +  N     +P  I +LTHL+ L L  N         L+  P  AF  + LSS
Sbjct: 113 HLKELFMCCNKLT-ELPRGIERLTHLTHLALDQN--------QLKSIPHGAF--DRLSS 160

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 63.1 bits (154), Expect = 7e-11
 Identities = 52/222 (23%), Positives = 87/222 (39%), Gaps = 61/222 (27%)

Query: 308 LGKGTFGTAYKAALEDAST---VVVK-----RLKEVNVGK--REFEQQMEIVGGIRHENV 357
           +GKG F     A      T   V +K     +L   ++ K  RE    + I+  + H N+
Sbjct: 23  IGKGNFAKVKLA--RHILTGREVAIKIIDKTQLNPTSLQKLFRE----VRIMKILNHPNI 76

Query: 358 VALRAYYYSKDEKLMVYDYFEPGSVSAML--HGRRGEGQSSLDWDTRVRIAIGAAR---- 411
           V L     ++    ++ +Y   G V   L  HGR  E +               AR    
Sbjct: 77  VKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKE---------------ARSKFR 121

Query: 412 ----GIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP---------MPP 458
                + + H +    +VH  +KA N+ L++  ++ ++D G +   +           PP
Sbjct: 122 QIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPP 178

Query: 459 PAMRAAGYRAPEVTDTRK-ATQASDVFSFGVLLLELLTGKSP 499
                  Y APE+   +K      DV+S GV+L  L++G  P
Sbjct: 179 -------YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 213

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 62.2 bits (152), Expect = 8e-11
 Identities = 43/211 (20%), Positives = 81/211 (38%), Gaps = 30/211 (14%)

Query: 306 EVLGKGTFGTAYKAALEDAST---VVVKRLKEVNVGKRE-FEQQMEIVGGIRHENVVALR 361
             +G+G++G    A      T      K++ +  V   + F+Q++EI+  + H N++ L 
Sbjct: 15  NTIGRGSWGEVKIA--VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY 72

Query: 362 AYYYSKDEKLMVYDYFEPGS-----VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHI 416
             +    +  +V +    G      V         E  ++      ++  + A   +A+ 
Sbjct: 73  ETFEDNTDIYLVMELCTGGELFERVVH---KRVFRESDAA----RIMKDVLSA---VAYC 122

Query: 417 HTENGGKLVHGGIKASNIFLNSQGH---VCVSDIGLAALMSPMPPPAMRA--AGYRAPEV 471
           H  N   + H  +K  N    +      + + D GLAA   P      +     Y +P+V
Sbjct: 123 HKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQV 179

Query: 472 TDTRKATQASDVFSFGVLLLELLTGKSPIHA 502
            +        D +S GV++  LL G  P  A
Sbjct: 180 LE-GLYGPECDEWSAGVMMYVLLCGYPPFSA 209

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 53/215 (24%), Positives = 98/215 (45%), Gaps = 30/215 (13%)

Query: 308 LGKGTFGTAYKAALEDAST---VVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALR 361
           +G+GT+G  YKA  +D        +K+++   +     RE    + ++  ++H NV++L+
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACRE----IALLRELKHPNVISLQ 84

Query: 362 -AYYYSKDEKL-MVYDYFE---PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHI 416
             +    D K+ +++DY E      +      +  +    L       +      GI ++
Sbjct: 85  KVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYL 144

Query: 417 HTENGGKLVHGGIKASNIFL----NSQGHVCVSDIGLA-ALMSPMPPPAMRAAG-----Y 466
           H      ++H  +K +NI +      +G V ++D+G A    SP+ P A          Y
Sbjct: 145 HANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWY 201

Query: 467 RAPEV-TDTRKATQASDVFSFGVLLLELLTGKSPI 500
           RAPE+    R  T+A D+++ G +  ELLT + PI
Sbjct: 202 RAPELLLGARHYTKAIDIWAIGCIFAELLTSE-PI 235

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 61.8 bits (151), Expect = 1e-10
 Identities = 53/221 (23%), Positives = 84/221 (38%), Gaps = 54/221 (24%)

Query: 306 EVLGKGTFGTAYKAALEDAST---VVVKRLKEVNVGKREFEQQME----IVGGIRHENVV 358
           + LG GTFG       E   T   V VK L    +   +   +++     +   RH +++
Sbjct: 17  DTLGVGTFGKVKIG--EHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHII 74

Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAML--HGRRGEGQSSLDWDTRVRIAIGAAR----- 411
            L     +  +  MV +Y   G +   +  HGR  E +               AR     
Sbjct: 75  KLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEME---------------ARRLFQQ 119

Query: 412 ---GIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP---------MPPP 459
               + + H      +VH  +K  N+ L++  +  ++D GL+ +MS           P  
Sbjct: 120 ILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPN- 175

Query: 460 AMRAAGYRAPEVTDTRK-ATQASDVFSFGVLLLELLTGKSP 499
                 Y APEV   R  A    D++S GV+L  LL G  P
Sbjct: 176 ------YAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 62.9 bits (153), Expect = 1e-10
 Identities = 51/211 (24%), Positives = 83/211 (39%), Gaps = 37/211 (17%)

Query: 306 EVLGKGTFGTAYKAALEDAST---VVVKRLKEVNVGKREFEQQM-------EIV--GGIR 353
           + +G G  G    A   DA     V +K+L         F+ Q        E+V    + 
Sbjct: 68  KPIGSGAQGIVCAA--YDAVLDRNVAIKKLSRP------FQNQTHAKRAYRELVLMKCVN 119

Query: 354 HENVVALRAYY---YSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAA 410
           H+N+++L   +    + +E   VY   E   + A L       Q  LD +    +     
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMEL--MDANLCQVI---QMELDHERMSYLLYQML 174

Query: 411 RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP----AMRAAGY 466
            GI H+H+     ++H  +K SNI + S   + + D GLA               R   Y
Sbjct: 175 CGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY--Y 229

Query: 467 RAPEVTDTRKATQASDVFSFGVLLLELLTGK 497
           RAPEV       +  D++S G ++ E++  K
Sbjct: 230 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 62.2 bits (152), Expect = 1e-10
 Identities = 52/226 (23%), Positives = 92/226 (40%), Gaps = 36/226 (15%)

Query: 299 DLLRASAEVLGKGTFGTAYKAALEDASTVV-VKRL-KEVNVGKREFEQQM---EIVGGIR 353
           D L+    +LGKGTFG       +       +K L KEV + K E    +    ++   R
Sbjct: 8   DYLK----LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR 63

Query: 354 HENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIG-AARG 412
           H  + AL+  + + D    V +Y   G +    H  R E   + +   R R         
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGEL--FFHLSR-ERVFTEE---RARFYGAEIVSA 117

Query: 413 IAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG------- 465
           + ++H+ +   +V+  IK  N+ L+  GH+ ++D GL           +           
Sbjct: 118 LEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKE-------GISDGATMKTFCG 167

Query: 466 ---YRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEV 508
              Y APEV +     +A D +  GV++ E++ G+ P +    + +
Sbjct: 168 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL 213

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 61.5 bits (150), Expect = 1e-10
 Identities = 49/212 (23%), Positives = 86/212 (40%), Gaps = 30/212 (14%)

Query: 306 EVLGKGTFGTAYKAALEDAST---VVVKRLKEVNVGKREFE---QQMEIVGGIRHENVVA 359
            +LGKG+FG   K   +D  T     VK + + +   ++     +++E++  + H N++ 
Sbjct: 28  CMLGKGSFGEVLKC--KDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMK 85

Query: 360 LRAYYYSKDEKLMVYDYFEPG----SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAH 415
           L           +V + +  G     +      R  E  ++      ++        I +
Sbjct: 86  LFEILEDSSSFYIVGELYTGGELFDEIIK--RKRFSEHDAA----RIIKQVFSG---ITY 136

Query: 416 IHTENGGKLVHGGIKASNIFLNSQG---HVCVSDIGLAALMSPMPPPAMRA--AGYRAPE 470
           +H  N   +VH  +K  NI L S+     + + D GL+           R   A Y APE
Sbjct: 137 MHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE 193

Query: 471 VTDTRKATQASDVFSFGVLLLELLTGKSPIHA 502
           V       +  DV+S GV+L  LL+G  P + 
Sbjct: 194 VLR-GTYDEKCDVWSAGVILYILLSGTPPFYG 224

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 61.6 bits (150), Expect = 2e-10
 Identities = 52/239 (21%), Positives = 90/239 (37%), Gaps = 44/239 (18%)

Query: 281 KNSKLVFFEGCNLVFDLEDLLRAS-AEVLGKGTFGTAYKAALEDAST---VVVKRLKEVN 336
           +++     E  +  F +    R    + +G G  G    A   DA     V +K+L    
Sbjct: 7   RDNNFYSVEIGDSTFTVLK--RYQNLKPIGSGAQGIVCAA--YDAILERNVAIKKLSRP- 61

Query: 337 VGKREFEQQM-------EIV--GGIRHENVVALRAYY---YSKDEKLMVYDYFE--PGSV 382
                F+ Q        E+V    + H+N++ L   +    S +E   VY   E    ++
Sbjct: 62  -----FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANL 116

Query: 383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHV 442
             ++          LD +    +      GI H+H+     ++H  +K SNI + S   +
Sbjct: 117 CQVIQ-------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTL 166

Query: 443 CVSDIGLAALMSPMPPP----AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGK 497
            + D GLA               R   YRAPEV       +  D++S G ++ E++ G 
Sbjct: 167 KILDFGLARTAGTSFMMTPYVVTRY--YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 61.3 bits (149), Expect = 2e-10
 Identities = 42/218 (19%), Positives = 76/218 (34%), Gaps = 42/218 (19%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVK-----RLKEVNVGKREFEQQ----MEIVGGIRHE 355
             LG G FG  + A   E    VVVK     ++ E    +     +    + I+  + H 
Sbjct: 30  SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHA 89

Query: 356 NVVALRAYYYSKDEKLMVYDYFEPGS------VSAMLHGRRGEGQSSLDWDTRVRIAIGA 409
           N++ +   + ++    +V +    G            H R  E  +S        I    
Sbjct: 90  NIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLAS-------YIFRQL 139

Query: 410 ARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP-------PAMR 462
              + ++  ++   ++H  IK  NI +     + + D G AA +                
Sbjct: 140 VSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIE-- 194

Query: 463 AAGYRAPEVTDTRK-ATQASDVFSFGVLLLELLTGKSP 499
              Y APEV           +++S GV L  L+  ++P
Sbjct: 195 ---YCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENP 229

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 61.1 bits (149), Expect = 3e-10
 Identities = 45/227 (19%), Positives = 87/227 (38%), Gaps = 42/227 (18%)

Query: 296 DLEDLLRASAEVLGKGTFGTAYKAALEDAST-------VVVKRLKEVNVGKREFEQQMEI 348
           +  +    +++ LG+G F    +      ST        + KR +     + E   ++ +
Sbjct: 25  NFNNFYILTSKELGRGKFAVVRQC--ISKSTGQEYAAKFLKKR-RRGQDCRAEILHEIAV 81

Query: 349 VGGIRH-ENVVALRAYYYSKDEKLMVYDYFEPG----SVSAMLHGRRGEGQSSLDWDTRV 403
           +   +    V+ L   Y +  E +++ +Y   G         L     E           
Sbjct: 82  LELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSE----------- 130

Query: 404 RIAIGAAR----GIAHIHTENGGKLVHGGIKASNIFLNSQ---GHVCVSDIGLAALMSPM 456
              I   +    G+ ++H  N   +VH  +K  NI L+S    G + + D G++  +   
Sbjct: 131 NDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHA 187

Query: 457 PPPAMRA----AGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSP 499
               +R       Y APE+ +    T A+D+++ G++   LLT  SP
Sbjct: 188 CE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP 232

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 61.1 bits (149), Expect = 3e-10
 Identities = 55/216 (25%), Positives = 96/216 (44%), Gaps = 44/216 (20%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGK---------REFEQQMEIVGGIRHEN 356
           E LG GT+ T YK    + +T V   LKEV +           RE    + ++  ++HEN
Sbjct: 11  EKLGNGTYATVYKG--LNKTTGVYVALKEVKLDSEEGTPSTAIRE----ISLMKELKHEN 64

Query: 357 VVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHI 416
           +V L    +++++  +V+++ +      M     G     L+ +          +G+A  
Sbjct: 65  IVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124

Query: 417 HTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG----------- 465
           H     K++H  +K  N+ +N +G + + D GLA           RA G           
Sbjct: 125 HE---NKILHRDLKPQNLLINKRGQLKLGDFGLA-----------RAFGIPVNTFSSEVV 170

Query: 466 ---YRAPEV-TDTRKATQASDVFSFGVLLLELLTGK 497
              YRAP+V   +R  + + D++S G +L E++TGK
Sbjct: 171 TLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 61.2 bits (149), Expect = 3e-10
 Identities = 47/227 (20%), Positives = 91/227 (40%), Gaps = 28/227 (12%)

Query: 296 DLEDLLRASAEVLGKGTFGTAYKAALEDAST---VVVKRLKEVNVGKREFEQQMEIVGGI 352
            + D  + S +VLG G  G   +       T     +K L +    ++E +   +  G  
Sbjct: 25  AVTDDYQLSKQVLGLGVNGKVLEC--FHRRTGQKCALKLLYDSPKARQEVDHHWQASG-- 80

Query: 353 RHENVVALRAYY----YSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIG 408
              ++V +   Y    + K   L++ +  E G + + +  R  +  +  +    +R    
Sbjct: 81  -GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGT 139

Query: 409 AARGIAHIHTENGGKLVHGGIKASNIFLNSQGH---VCVSDIGLAALMSPMPPPAMR--- 462
           A   I  +H+ N   + H  +K  N+   S+     + ++D G A         A++   
Sbjct: 140 A---IQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA---KETTQNALQTPC 190

Query: 463 -AAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEV 508
               Y APEV    K  ++ D++S GV++  LL G  P ++  G  +
Sbjct: 191 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI 237

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 60.7 bits (148), Expect = 3e-10
 Identities = 45/237 (18%), Positives = 76/237 (32%), Gaps = 63/237 (26%)

Query: 308 LGKGTFG---------TAYKAA---------LEDASTVVVKRLKEVNVGKREFEQQMEIV 349
           +GKG++G              A         +  A        +          Q    +
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 350 GGI----------RHENVVALRAYYY--SKDEKLMVYDYFEPGSVSAML-HGRRGEGQSS 396
             +           H NVV L       ++D   MV++    G V  +       E Q  
Sbjct: 81  EQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQ-- 138

Query: 397 LDWDTRVRIAIGAAR--------GIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIG 448
                        AR        GI ++H +    ++H  IK SN+ +   GH+ ++D G
Sbjct: 139 -------------ARFYFQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFG 182

Query: 449 LAALMSPMPPPAMRAAG---YRAPEVTDTRKAT---QASDVFSFGVLLLELLTGKSP 499
           ++              G   + APE     +     +A DV++ GV L   + G+ P
Sbjct: 183 VSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 61.0 bits (148), Expect = 3e-10
 Identities = 23/118 (19%), Positives = 40/118 (33%), Gaps = 11/118 (9%)

Query: 83  IPPNTIGRLSALQNLSL-RSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
           I  +    L  L  + + ++N+L  + P  F  L NL  L +          +       
Sbjct: 70  IEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQ 129

Query: 142 LTVIDLSNNFFNASIPA-SISKLTH-LSALNLANNSLTGTLPRSLQRFPSWAFAGNNL 197
             ++D+ +N    +I   S   L+     L L  N +            + AF G  L
Sbjct: 130 KVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ--------EIHNSAFNGTQL 179

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 59.1 bits (143), Expect = 2e-09
 Identities = 20/117 (17%), Positives = 32/117 (27%), Gaps = 21/117 (17%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWNN 141
           +P N          L      L  +    FS   +L  + +  N     +  D FS    
Sbjct: 28  LPRNA-------IELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPK 80

Query: 142 LTVIDLSNNFFN--ASIPASI-SKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGN 195
           L  I +     N    I       L +L  L ++N  +           P      +
Sbjct: 81  LHEIRIEKA--NNLLYINPEAFQNLPNLQYLLISNTGIK--------HLPDVHKIHS 127

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 56.8 bits (137), Expect = 9e-09
 Identities = 22/147 (14%), Positives = 40/147 (27%), Gaps = 8/147 (5%)

Query: 72  LRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGP 131
           L L    ++ EI  +        +     +N+L  L    F        L +        
Sbjct: 159 LWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIH-- 215

Query: 132 LPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNS---LTGTLPRSLQRFP 188
             L      NL  +   + +    +P ++ KL  L   +L   S         R +    
Sbjct: 216 -SLPSYGLENLKKLRARSTYNLKKLP-TLEKLVALMEASLTYPSHCCAFANWRRQISELH 273

Query: 189 SWAFAGNNLSSENARPPALPVQPPVAE 215
                       +    A   +  +AE
Sbjct: 274 PICNKSILRQEVDYMTQARGQRSSLAE 300

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 28/122 (22%), Positives = 40/122 (32%), Gaps = 24/122 (19%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFN---------SFSGPL 132
            I P     L  LQ L + +  +  L             L +Q N         SF G L
Sbjct: 94  YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVG-L 152

Query: 133 PLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAF 192
                      ++ L+ N     I  S    T L  LNL++N        +L+  P+  F
Sbjct: 153 S------FESVILWLNKNGI-QEIHNSAFNGTQLDELNLSDN-------NNLEELPNDVF 198

Query: 193 AG 194
            G
Sbjct: 199 HG 200

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 60.3 bits (147), Expect = 4e-10
 Identities = 51/218 (23%), Positives = 84/218 (38%), Gaps = 50/218 (22%)

Query: 306 EVLGKGTFGTAYKAALEDAST---VVVKRLKEVNVGKRE-FEQQMEIVGGIRHENVVALR 361
           EVLG G F   +    +   T     +K +K+    +    E ++ ++  I+HEN+V L 
Sbjct: 15  EVLGSGAFSEVFLV--KQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLE 72

Query: 362 AYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSL-DW----------DTR--VRIAIG 408
             Y S     +V      G          GE    L D           D    ++  + 
Sbjct: 73  DIYESTTHYYLVMQLVS-G----------GE----LFDRILERGVYTEKDASLVIQQVLS 117

Query: 409 AARGIAHIHTENGGKLVHGGIKASNIFLNSQG---HVCVSDIGLAALMSPMPPPAMRAA- 464
           A   + ++H      +VH  +K  N+   +      + ++D GL+ +        M  A 
Sbjct: 118 A---VKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQNGIMSTAC 168

Query: 465 ---GYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSP 499
              GY APEV   +  ++A D +S GV+   LL G  P
Sbjct: 169 GTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPP 206

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 60.3 bits (147), Expect = 5e-10
 Identities = 50/208 (24%), Positives = 85/208 (40%), Gaps = 32/208 (15%)

Query: 306 EVLGKGTFGTAYKAALEDAST---VVVKRLKEVNVGKREFEQQMEIVGGIR--------- 353
            ++G+G++G   K    +  T   V +K+  E        + +M     +R         
Sbjct: 31  GLVGEGSYGMVMKC--RNKDTGRIVAIKKFLE------SDDDKMVKKIAMREIKLLKQLR 82

Query: 354 HENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGI 413
           HEN+V L      K    +V+++ +  ++   L          LD+    +       GI
Sbjct: 83  HENLVNLLEVCKKKKRWYLVFEFVD-HTILDDLELFPN----GLDYQVVQKYLFQIINGI 137

Query: 414 AHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLA-ALMSPMPPPAMRAAG--YRAPE 470
              H+ N   ++H  IK  NI ++  G V + D G A  L +P        A   YRAPE
Sbjct: 138 GFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPE 194

Query: 471 V-TDTRKATQASDVFSFGVLLLELLTGK 497
           +     K  +A DV++ G L+ E+  G+
Sbjct: 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 60.0 bits (146), Expect = 6e-10
 Identities = 49/227 (21%), Positives = 95/227 (41%), Gaps = 58/227 (25%)

Query: 306 EVLGKGTFGTAYKAALEDAST---VVVK-----RLKEVNVGKREFEQQMEIVGGIRHENV 357
           ++LG+G++G   +    D+ T     VK     +L+ +  G+   +++++++  +RH+NV
Sbjct: 11  DLLGEGSYGKVKEV--LDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNV 68

Query: 358 VALR--AYYYSKDEKLMVYDYFEPGSV---SAMLHGRRGEGQSSLDWDTRVRIAIGAAR- 411
           + L    Y   K +  MV +Y   G      ++   R    Q               A  
Sbjct: 69  IQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQ---------------AHG 113

Query: 412 -------GIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP------ 458
                  G+ ++H++    +VH  IK  N+ L + G + +S +G+A  + P         
Sbjct: 114 YFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT 170

Query: 459 ----PAMRAAGYRAPEVTDTRK--ATQASDVFSFGVLLLELLTGKSP 499
               PA     ++ PE+ +     +    D++S GV L  + TG  P
Sbjct: 171 SQGSPA-----FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYP 212

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149

 Score = 57.0 bits (138), Expect = 7e-10
 Identities = 31/112 (27%), Positives = 45/112 (40%), Gaps = 3/112 (2%)

Query: 67  SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFN 126
           S V  L L                   L+ LS  +  L+ +  ++  KL  L  L L  N
Sbjct: 17  SDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDN 74

Query: 127 SFSGPLPLDFSVWNNLTVIDLSNNFFNA-SIPASISKLTHLSALNLANNSLT 177
             SG L +      NLT ++LS N     S    + KL +L +L+L N  +T
Sbjct: 75  RVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVT 126

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 60.8 bits (147), Expect = 8e-10
 Identities = 49/227 (21%), Positives = 94/227 (41%), Gaps = 37/227 (16%)

Query: 299 DLLRASAEVLGKGTFGTAYKAALEDASTVV-VKRL-KEVNVGKREFEQQME----IVGGI 352
           + L     VLGKG+FG    +  +    +  VK L K+V +   + E  M     +    
Sbjct: 344 NFLM----VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 399

Query: 353 RHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGA-AR 411
           +   +  L + + + D    V +Y   G +  M H ++  G+                A 
Sbjct: 400 KPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQ-VGRFKEP---HAVFYAAEIAI 453

Query: 412 GIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG------ 465
           G+  + ++    +++  +K  N+ L+S+GH+ ++D G+           +          
Sbjct: 454 GLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE-------NIWDGVTTKTFC 503

Query: 466 ----YRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEV 508
               Y APE+   +   ++ D ++FGVLL E+L G++P      DE+
Sbjct: 504 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 550

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 59.7 bits (145), Expect = 9e-10
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 8/90 (8%)

Query: 411 RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP--AMRAAGYRA 468
           RG+ +IH+ +   ++H  +K SN+ +N    + + D GLA   +       A R   YRA
Sbjct: 143 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRW--YRA 197

Query: 469 PEV-TDTRKATQASDVFSFGVLLLELLTGK 497
           PE+  +     Q  D++S G ++ ELLTG+
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 59.5 bits (145), Expect = 1e-09
 Identities = 54/233 (23%), Positives = 94/233 (40%), Gaps = 46/233 (19%)

Query: 299 DLLRASAEVLGKGTFGT---AYKAALEDASTVV-VKRLKEVNVGKREFEQ---QME--IV 349
           +LLR    VLGKG +G      K    +   +  +K LK+  + +   +    + E  I+
Sbjct: 20  ELLR----VLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNIL 75

Query: 350 GGIRHENVVALRAYYYS--KDEKL-MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIA 406
             ++H  +V L    Y+     KL ++ +Y   G +   +   R EG    D        
Sbjct: 76  EEVKHPFIVDL---IYAFQTGGKLYLILEYLSGGEL--FMQLER-EGIFMED---TACFY 126

Query: 407 IG-AARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG 465
           +   +  + H+H +    +++  +K  NI LN QGHV ++D GL          ++    
Sbjct: 127 LAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKE-------SIHDGT 176

Query: 466 ----------YRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEV 508
                     Y APE+       +A D +S G L+ ++LTG  P       + 
Sbjct: 177 VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT 229

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 57.8 bits (140), Expect = 1e-09
 Identities = 36/120 (30%), Positives = 49/120 (40%), Gaps = 14/120 (11%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWN 140
            +P      L++L  L L  N L  L    F+KL +LT L+L  N     LP   F    
Sbjct: 42  SLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQLQS-LPNGVFDKLT 100

Query: 141 NLTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLSS 199
            L  + L+ N    S+P  +  KLT L  L L  N         L+  P   F  + L+S
Sbjct: 101 QLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQN--------QLKSVPDGVF--DRLTS 149

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208

 Score = 40.4 bits (95), Expect = 6e-04
 Identities = 23/64 (35%), Positives = 32/64 (50%), Gaps = 3/64 (4%)

Query: 119 TSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLT 177
           T L L+ NS        F    +LT + L  N    S+P  + +KLT L+ LNL+ N L 
Sbjct: 31  TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKL-QSLPNGVFNKLTSLTYLNLSTNQLQ 89

Query: 178 GTLP 181
            +LP
Sbjct: 90  -SLP 92

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 59.2 bits (144), Expect = 1e-09
 Identities = 30/101 (29%), Positives = 46/101 (45%), Gaps = 17/101 (16%)

Query: 411 RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG----- 465
           R +  +H  N   ++H  +K SN+ +NS   + V D GLA ++           G     
Sbjct: 123 RAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179

Query: 466 --------YRAPEV-TDTRKATQASDVFSFGVLLLELLTGK 497
                   YRAPEV   + K ++A DV+S G +L EL   +
Sbjct: 180 VEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 58.5 bits (142), Expect = 1e-09
 Identities = 40/129 (31%), Positives = 55/129 (42%), Gaps = 24/129 (18%)

Query: 90  RLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWNNLTVIDLS 148
            L+ L  L L  N L  L    F KL NL  L L  N     LP   F    NLT ++L+
Sbjct: 83  ELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQS-LPDGVFDKLTNLTYLNLA 141

Query: 149 NNFFNASIPASI-SKLTHLSALNLANNSLTGTLPRS-----------------LQRFPSW 190
           +N    S+P  +  KLT+L+ L+L+ N L  +LP                   L+  P  
Sbjct: 142 HNQL-QSLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQLKSVPDG 199

Query: 191 AFAGNNLSS 199
            F  + L+S
Sbjct: 200 VF--DRLTS 206

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272

 Score = 55.8 bits (135), Expect = 1e-08
 Identities = 35/96 (36%), Positives = 47/96 (48%), Gaps = 7/96 (7%)

Query: 88  IGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWNNLTVID 146
           I  L  ++ L+L  N L  +  S   +L NLT L L  N     LP   F    NL  + 
Sbjct: 59  IQYLPNVRYLALGGNKLHDI--SALKELTNLTYLILTGNQLQS-LPNGVFDKLTNLKELV 115

Query: 147 LSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLP 181
           L  N    S+P  +  KLT+L+ LNLA+N L  +LP
Sbjct: 116 LVENQL-QSLPDGVFDKLTNLTYLNLAHNQLQ-SLP 149

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168

 Score = 56.3 bits (136), Expect = 1e-09
 Identities = 30/113 (26%), Positives = 45/113 (39%), Gaps = 5/113 (4%)

Query: 67  SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFN 126
           + V  L L                   L+ LSL +  L  +  S+  KL  L  L L  N
Sbjct: 24  AAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSEN 81

Query: 127 SFSGPLPLDFSVWNNLTVIDLSNNFFN--ASIPASISKLTHLSALNLANNSLT 177
              G L +      NLT ++LS N     +++   + KL  L +L+L N  +T
Sbjct: 82  RIFGGLDMLAEKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNCEVT 133

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 26/96 (27%), Positives = 45/96 (46%), Gaps = 8/96 (8%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
            I P  +  L+ LQ LS+ +  +S L  +  + L  LT+L    N  S   PL  +   N
Sbjct: 143 NISP--LAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKADDNKISDISPL--ASLPN 196

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLT 177
           L  + L NN  +  +   ++  ++L  + L N ++T
Sbjct: 197 LIEVHLKNNQIS-DVSP-LANTSNLFIVTLTNQTIT 230

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 19/90 (21%), Positives = 38/90 (42%), Gaps = 6/90 (6%)

Query: 88  IGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL 147
           +  L+ L  L L+ N ++ L  +    L  +T L L  N       +      ++  +DL
Sbjct: 59  VQYLNNLIGLELKDNQITDL--APLKNLTKITELELSGNPLKNVSAIAG--LQSIKTLDL 114

Query: 148 SNNFFNASIPASISKLTHLSALNLANNSLT 177
           ++      +   ++ L++L  L L  N +T
Sbjct: 115 TSTQIT-DVTP-LAGLSNLQVLYLDLNQIT 142

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 22/91 (24%), Positives = 38/91 (41%), Gaps = 6/91 (6%)

Query: 87  TIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID 146
           T   L  +  LS     ++ +       L NL  L L+ N  +   PL       +T ++
Sbjct: 36  TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAPL--KNLTKITELE 91

Query: 147 LSNNFFNASIPASISKLTHLSALNLANNSLT 177
           LS N    ++ A I+ L  +  L+L +  +T
Sbjct: 92  LSGNPLK-NVSA-IAGLQSIKTLDLTSTQIT 120

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 57.4 bits (139), Expect = 4e-09
 Identities = 22/96 (22%), Positives = 45/96 (46%), Gaps = 8/96 (8%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
           ++ P  +  L+ +  L L  N L  +     + L+++ +L L     +   PL  +  +N
Sbjct: 77  DLAP--LKNLTKITELELSGNPLKNVSA--IAGLQSIKTLDLTSTQITDVTPL--AGLSN 130

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLT 177
           L V+ L  N    +I   ++ LT+L  L++ N  ++
Sbjct: 131 LQVLYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVS 164

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 57.0 bits (138), Expect = 6e-09
 Identities = 25/96 (26%), Positives = 44/96 (45%), Gaps = 8/96 (8%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
           ++ P  +  LS LQ L L  N ++ +  S  + L NL  L +     S   PL     + 
Sbjct: 121 DVTP--LAGLSNLQVLYLDLNQITNI--SPLAGLTNLQYLSIGNAQVSDLTPLANL--SK 174

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLT 177
           LT +   +N  +  I   ++ L +L  ++L NN ++
Sbjct: 175 LTTLKADDNKIS-DISP-LASLPNLIEVHLKNNQIS 208

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 55.1 bits (133), Expect = 2e-08
 Identities = 20/90 (22%), Positives = 42/90 (46%), Gaps = 6/90 (6%)

Query: 88  IGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL 147
           I  L +++ L L S  ++ +  +  + L NL  L+L  N  +   PL  +   NL  + +
Sbjct: 103 IAGLQSIKTLDLTSTQITDV--TPLAGLSNLQVLYLDLNQITNISPL--AGLTNLQYLSI 158

Query: 148 SNNFFNASIPASISKLTHLSALNLANNSLT 177
            N   +  +   ++ L+ L+ L   +N ++
Sbjct: 159 GNAQVS-DLTP-LANLSKLTTLKADDNKIS 186

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 53.5 bits (129), Expect = 8e-08
 Identities = 14/87 (16%), Positives = 36/87 (41%), Gaps = 6/87 (6%)

Query: 91  LSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNN 150
           L+    ++   ++++       + L+ +T+L       +    + +    NL  ++L +N
Sbjct: 18  LANAIKIAAGKSNVTDT--VTQADLDGITTLSAFGTGVTTIEGVQYLN--NLIGLELKDN 73

Query: 151 FFNASIPASISKLTHLSALNLANNSLT 177
                +   +  LT ++ L L+ N L 
Sbjct: 74  QIT-DLAP-LKNLTKITELELSGNPLK 98

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 21/90 (23%), Positives = 37/90 (41%), Gaps = 4/90 (4%)

Query: 88  IGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL 147
           +  LS L  L    N +S +  S  + L NL  +HL+ N  S   PL  +  +NL ++ L
Sbjct: 169 LANLSKLTTLKADDNKISDI--SPLASLPNLIEVHLKNNQISDVSPLANT--SNLFIVTL 224

Query: 148 SNNFFNASIPASISKLTHLSALNLANNSLT 177
           +N           + L   + +   + +  
Sbjct: 225 TNQTITNQPVFYNNNLVVPNVVKGPSGAPI 254

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 46.6 bits (111), Expect = 1e-05
 Identities = 12/77 (15%), Positives = 30/77 (38%), Gaps = 6/77 (7%)

Query: 101 SNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASI 160
             +++ +FP     L N   +    ++ +  +    +  + +T +         +I   +
Sbjct: 6   PTAINVIFP--DPALANAIKIAAGKSNVTDTVTQ--ADLDGITTLSAFGTGVT-TIEG-V 59

Query: 161 SKLTHLSALNLANNSLT 177
             L +L  L L +N +T
Sbjct: 60  QYLNNLIGLELKDNQIT 76

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308

 Score = 45.8 bits (109), Expect = 2e-05
 Identities = 19/98 (19%), Positives = 37/98 (37%), Gaps = 6/98 (6%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
           +I P  +  L  L  + L++N +S +  S  +   NL  + L   + +       +  N 
Sbjct: 187 DISP--LASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTITNQPVFYNN--NL 240

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGT 179
           +    +         PA+IS     ++ NL  N  +  
Sbjct: 241 VVPNVVKGPSGAPIAPATISDNGTYASPNLTWNLTSFI 278

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 59.0 bits (142), Expect = 2e-09
 Identities = 21/111 (18%), Positives = 39/111 (35%), Gaps = 12/111 (10%)

Query: 54  CKSWTGVTCSADH-----------SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSN 102
               +G+ C+ D              +  L +        +    +  L  L+NL++  +
Sbjct: 7   PHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66

Query: 103 SLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFN 153
            L  + P  F     L+ L+L FN+    L        +L  + LS N  +
Sbjct: 67  GLRFVAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLH 116

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347

 Score = 47.8 bits (113), Expect = 5e-06
 Identities = 17/78 (21%), Positives = 27/78 (34%), Gaps = 4/78 (5%)

Query: 109 PSDFSKLENLTSLHLQFNSFSGPLPL-DFSVWNNLTVIDLSNNFFNASIPASI-SKLTHL 166
                  ENLT L+++       L L D      L  + +  +     +          L
Sbjct: 24  LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGL-RFVAPDAFHFTPRL 82

Query: 167 SALNLANNSLTGTLPRSL 184
           S LNL+ N+L  +L    
Sbjct: 83  SRLNLSFNALE-SLSWKT 99

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177

 Score = 56.1 bits (136), Expect = 2e-09
 Identities = 37/119 (31%), Positives = 45/119 (37%), Gaps = 21/119 (17%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWNN 141
           IP +          L L SN L  L    F KL  LT L L  N     LP   F     
Sbjct: 26  IPSSA-------TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQS-LPDGVFDKLTK 77

Query: 142 LTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLSS 199
           LT++ L  N    S+P  +  KLT L  L L  N         L+  P   F  + L+S
Sbjct: 78  LTILYLHENKLQ-SLPNGVFDKLTQLKELALDTN--------QLKSVPDGIF--DRLTS 125

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 58.9 bits (143), Expect = 2e-09
 Identities = 27/90 (30%), Positives = 45/90 (50%), Gaps = 8/90 (8%)

Query: 411 RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP--AMRAAGYRA 468
           +G+ +IH      ++H  +K  N+ +N    + + D GLA             R   YRA
Sbjct: 139 KGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRW--YRA 193

Query: 469 PEV-TDTRKATQASDVFSFGVLLLELLTGK 497
           PEV  +  + TQ  D++S G ++ E++TGK
Sbjct: 194 PEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 39/223 (17%), Positives = 75/223 (33%), Gaps = 52/223 (23%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNVGKREFEQQME-------IVGGIRHE-- 355
            +LG G FG+ Y    + D   V +K +++  +                 ++  +     
Sbjct: 49  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 108

Query: 356 NVVALRAYYYSKDEKLMVYDYFEPGS------VSAMLHGRRGEGQSSLDWDTRVRIAIGA 409
            V+ L  ++   D  +++ +  EP              G   E  +              
Sbjct: 109 GVIRLLDWFERPDSFVLILERPEPVQDLFDFITE---RGALQEELAR-------SFFWQV 158

Query: 410 ARGIAHIHTENGGKLVHGGIKASNIFLNS-QGHVCVSDIGLAALM----------SPM-- 456
              + H H      ++H  IK  NI ++  +G + + D G  AL+          + +  
Sbjct: 159 LEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYS 215

Query: 457 PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSP 499
           PP  +R   Y                V+S G+LL +++ G  P
Sbjct: 216 PPEWIRYHRYHGRSA----------AVWSLGILLYDMVCGDIP 248

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 58.8 bits (143), Expect = 2e-09
 Identities = 61/273 (22%), Positives = 107/273 (39%), Gaps = 53/273 (19%)

Query: 262 VKSQKKEMSLKEGVSGSHDKNSKLVFFEGCNLVFDLED--LLRASAEVLGKGTFGTAYKA 319
           +   ++   +    +     + ++      N      D   L+    V+GKG+FG    A
Sbjct: 2   ISQPQEPELMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLK----VIGKGSFGKVLLA 57

Query: 320 ALEDASTVV-VKRL-KEVNVGKREFEQQME----IVGGIRHENVVALRAYYYS--KDEKL 371
             +       VK L K+  + K+E +  M     ++  ++H  +V L   ++S    +KL
Sbjct: 58  RHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL---HFSFQTADKL 114

Query: 372 -MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVR-----IAIGAARGIAHIHTENGGKLV 425
             V DY   G +    H +R E         R R     IA      + ++H+ N   +V
Sbjct: 115 YFVLDYINGGEL--FYHLQR-ERCFLEP---RARFYAAEIASA----LGYLHSLN---IV 161

Query: 426 HGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG----------YRAPEVTDTR 475
           +  +K  NI L+SQGH+ ++D GL           +              Y APEV   +
Sbjct: 162 YRDLKPENILLDSQGHIVLTDFGLCKE-------NIEHNSTTSTFCGTPEYLAPEVLHKQ 214

Query: 476 KATQASDVFSFGVLLLELLTGKSPIHATGGDEV 508
              +  D +  G +L E+L G  P ++    E+
Sbjct: 215 PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 247

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 66/294 (22%), Positives = 111/294 (37%), Gaps = 65/294 (22%)

Query: 252 YNKQDNDRIPVKSQKKEMSLKEGVSGSHDKNS-----KLVFFEGCNLVFDLED--LLRAS 304
           ++   ++     S     +  +G  G     +     +     G      +E+  LL+  
Sbjct: 3   HHHHHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLK-- 60

Query: 305 AEVLGKGTFGT---AYKAALEDASTVV-VKRLKEVNVGKREFEQQMEIVGGIRHEN---- 356
             VLG G +G      K +  D   +  +K LK     K    Q+ +     R E     
Sbjct: 61  --VLGTGAYGKVFLVRKISGHDTGKLYAMKVLK-----KATIVQKAKTTEHTRTERQVLE 113

Query: 357 -------VVALRAYYYS--KDEKL-MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVR-- 404
                  +V L   +Y+   + KL ++ DY   G +    H  +   + +      V+  
Sbjct: 114 HIRQSPFLVTL---HYAFQTETKLHLILDYINGGEL--FTHLSQ-RERFTEH---EVQIY 164

Query: 405 ---IAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAM 461
              I +     + H+H      +++  IK  NI L+S GHV ++D GL+     +     
Sbjct: 165 VGEIVLA----LEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE--FVADETE 215

Query: 462 RAA---G---YRAPEVTDTRKA--TQASDVFSFGVLLLELLTGKSPIHATGGDE 507
           RA    G   Y AP++     +   +A D +S GVL+ ELLTG SP    G   
Sbjct: 216 RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 269

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 58.5 bits (142), Expect = 2e-09
 Identities = 60/327 (18%), Positives = 130/327 (39%), Gaps = 51/327 (15%)

Query: 254 KQDNDRIPVKSQKKEMSLKEGVSGSHDKNSKLVFFEGCNLVFDLED--LLRASAEVLGKG 311
             D D    ++   + ++  G+    +  +     +  + +  L+D  LLR    V+G+G
Sbjct: 9   HHDYDIPTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSL-GLQDFDLLR----VIGRG 63

Query: 312 TFGTAYKAALEDASTV----VVKRLKEVNVGKREFEQQME----IVGGIRHENVVALRAY 363
           ++       L+    +    VVK  KE+     + +              H  +V L + 
Sbjct: 64  SYAKVLLVRLKKTDRIYAMRVVK--KELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSC 121

Query: 364 YYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIG-AARGIAHIHTENGG 422
           + ++     V +Y   G +  M H +R + +   +     R      +  + ++H     
Sbjct: 122 FQTESRLFFVIEYVNGGDL--MFHMQR-QRKLPEE---HARFYSAEISLALNYLHERG-- 173

Query: 423 KLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAA--G---YRAPEVTDTRKA 477
            +++  +K  N+ L+S+GH+ ++D G+      + P    +   G   Y APE+      
Sbjct: 174 -IIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGTPNYIAPEILRGEDY 230

Query: 478 TQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL---LR 534
             + D ++ GVL+ E++ G+SP    G  +             +     +F V L   +R
Sbjct: 231 GFSVDWWALGVLMFEMMAGRSPFDIVGSSD----------NPDQNTEDYLFQVILEKQIR 280

Query: 535 YP-NIEEEMVEMLQVGMACVVRMPEER 560
            P ++  +   +L+   + + + P+ER
Sbjct: 281 IPRSLSVKAASVLK---SFLNKDPKER 304

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 58.6 bits (142), Expect = 3e-09
 Identities = 53/225 (23%), Positives = 90/225 (40%), Gaps = 62/225 (27%)

Query: 306 EVLGKGTFGTAYKAALEDAST---VVVK-----RLKEVNVG---KREFEQQMEIVGGIRH 354
           + LG GTFG       +   T   V VK     +++ ++V    +RE    ++ +   RH
Sbjct: 22  DTLGVGTFGKVKVG--KHELTGHKVAVKILNRQKIRSLDVVGKIRRE----IQNLKLFRH 75

Query: 355 ENVVALRAYYYSKDEKLMVYDYFEPGSVSAML--HGRRGEGQSSLDWDTRVRIAIGAAR- 411
            +++ L     +  +  MV +Y   G +   +  +GR  E +               +R 
Sbjct: 76  PHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKE---------------SRR 120

Query: 412 -------GIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP--------- 455
                  G+ + H      +VH  +K  N+ L++  +  ++D GL+ +MS          
Sbjct: 121 LFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCG 177

Query: 456 MPPPAMRAAGYRAPEVTDTRK-ATQASDVFSFGVLLLELLTGKSP 499
            P        Y APEV   R  A    D++S GV+L  LL G  P
Sbjct: 178 SPN-------YAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 58.0 bits (141), Expect = 3e-09
 Identities = 42/208 (20%), Positives = 77/208 (37%), Gaps = 32/208 (15%)

Query: 306 EVLGKGTFGTAYKAALEDAST---VVVKRLKEVNVGKREFEQQMEIVGGIR--------- 353
             +G+G++G  +K    +  T   V +K+  E        +  +     +R         
Sbjct: 9   GKIGEGSYGVVFKC--RNRDTGQIVAIKKFLE------SEDDPVIKKIALREIRMLKQLK 60

Query: 354 HENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGI 413
           H N+V L   +  K    +V++Y +   +  +   +RG     +       I     + +
Sbjct: 61  HPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRG-----VPEHLVKSITWQTLQAV 115

Query: 414 AHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLA-ALMSPMPPPAMRAAG--YRAPE 470
              H  N    +H  +K  NI +     + + D G A  L  P        A   YR+PE
Sbjct: 116 NFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPE 172

Query: 471 V-TDTRKATQASDVFSFGVLLLELLTGK 497
           +     +     DV++ G +  ELL+G 
Sbjct: 173 LLVGDTQYGPPVDVWAIGCVFAELLSGV 200

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 58.0 bits (141), Expect = 3e-09
 Identities = 45/237 (18%), Positives = 84/237 (35%), Gaps = 87/237 (36%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRLKEVNVGKREFEQQMEIVGGI------------ 352
           + LG+G F T YKA        V +K++K           + E   GI            
Sbjct: 16  DFLGEGQFATVYKARDKNTNQIVAIKKIK--------LGHRSEAKDGINRTALREIKLLQ 67

Query: 353 --RHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWD-----TRVRI 405
              H N++ L   +  K    +V+D+                    ++ D         +
Sbjct: 68  ELSHPNIIGLLDAFGHKSNISLVFDF--------------------METDLEVIIKDNSL 107

Query: 406 AIGAA----------RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP 455
            +  +          +G+ ++H ++   ++H  +K +N+ L+  G + ++D GLA     
Sbjct: 108 VLTPSHIKAYMLMTLQGLEYLH-QHW--ILHRDLKPNNLLLDENGVLKLADFGLA----- 159

Query: 456 MPPPAMRAAG--------------YRAPEV-TDTRKATQASDVFSFGVLLLELLTGK 497
                 ++ G              YRAPE+    R      D+++ G +L ELL   
Sbjct: 160 ------KSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRV 210

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 58.1 bits (141), Expect = 3e-09
 Identities = 28/94 (29%), Positives = 51/94 (54%), Gaps = 10/94 (10%)

Query: 411 RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG----- 465
           RG+ +IH+ N   ++H  +K SN+ LN+   + + D GLA +  P               
Sbjct: 139 RGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195

Query: 466 -YRAPEVT-DTRKATQASDVFSFGVLLLELLTGK 497
            YRAPE+  +++  T++ D++S G +L E+L+ +
Sbjct: 196 WYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 58.1 bits (141), Expect = 3e-09
 Identities = 49/206 (23%), Positives = 89/206 (43%), Gaps = 23/206 (11%)

Query: 307 VLGKGTFGTAYKAALEDASTVV-VKRL-KEVNVGKREFEQQM---EIVGGIRHENVVALR 361
            LG G+FG       +++     +K L K+  V  ++ E  +    I+  +    +V L 
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107

Query: 362 AYYYSKDEKL-MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIA-IGAARGIAHIHTE 419
            + +  +  L MV +Y   G +    H RR  G+ S     R   A I       ++H+ 
Sbjct: 108 -FSFKDNSNLYMVMEYVAGGEM--FSHLRR-IGRFSEPH-ARFYAAQIVLT--FEYLHSL 160

Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTDTRK 476
           +   L++  +K  N+ ++ QG++ V+D G A     +        G     APE+  ++ 
Sbjct: 161 D---LIYRDLKPENLLIDQQGYIQVTDFGFA---KRVKGRTWTLCGTPEALAPEIILSKG 214

Query: 477 ATQASDVFSFGVLLLELLTGKSPIHA 502
             +A D ++ GVL+ E+  G  P  A
Sbjct: 215 YNKAVDWWALGVLIYEMAAGYPPFFA 240

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 55.8 bits (135), Expect = 3e-09
 Identities = 33/119 (27%), Positives = 44/119 (36%), Gaps = 22/119 (18%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWNN 141
           IP +          L L  N  + L P + S  ++LT + L  N  S  L    FS    
Sbjct: 29  IPRDV-------TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQ 79

Query: 142 LTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLSS 199
           L  + LS N     IP      L  L  L+L  N         +   P  AF  N+LS+
Sbjct: 80  LLTLILSYNRL-RCIPPRTFDGLKSLRLLSLHGN--------DISVVPEGAF--NDLSA 127

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193

 Score = 49.2 bits (118), Expect = 6e-07
 Identities = 23/94 (24%), Positives = 39/94 (41%), Gaps = 8/94 (8%)

Query: 85  PNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTV 144
           P  +     L  + L +N +S L    FS +  L +L L +N      P  F    +L +
Sbjct: 47  PKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLRCIPPRTFDGLKSLRL 106

Query: 145 IDLSNNFFNASIP----ASISKLTHLSALNLANN 174
           + L  N  +  +P      +S L+HL+   +  N
Sbjct: 107 LSLHGNDIS-VVPEGAFNDLSALSHLA---IGAN 136

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 52/211 (24%), Positives = 84/211 (39%), Gaps = 26/211 (12%)

Query: 307 VLGKGTFGTAYKAALEDASTVV-VKRL-KEVNVGKREFEQQME---IVGGIRHENVVALR 361
           V+G+G FG       +    V  +K L K   + + +     E   I+       VV L 
Sbjct: 76  VIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF 135

Query: 362 AYYYSKDEKL-MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIA-IGAARGIAHIHTE 419
            Y +  D  L MV +Y   G +  ++            W  R   A +  A  +  IH+ 
Sbjct: 136 -YAFQDDRYLYMVMEYMPGGDLVNLMSNYD----VPEKW-ARFYTAEVVLA--LDAIHSM 187

Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAA-G---YRAPEVTDTR 475
                +H  +K  N+ L+  GH+ ++D G    M+         A G   Y +PEV  ++
Sbjct: 188 G---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ 244

Query: 476 KA----TQASDVFSFGVLLLELLTGKSPIHA 502
                  +  D +S GV L E+L G +P +A
Sbjct: 245 GGDGYYGRECDWWSVGVFLYEMLVGDTPFYA 275

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 57.7 bits (140), Expect = 4e-09
 Identities = 45/215 (20%), Positives = 89/215 (41%), Gaps = 30/215 (13%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVG-GIRHENVVALRAYY 364
           E +G G++    +      +T +   +K ++  KR+  +++EI+    +H N++ L+  Y
Sbjct: 28  EDIGVGSYSVCKRC--IHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVY 85

Query: 365 YSKDEKLMVYDYFEPGSVSAMLHGR---RG---EGQSSLDWDTRVRIAIGAARGIAHIHT 418
                  +V +  + G     L  +   +    E ++S        +     + + ++H 
Sbjct: 86  DDGKYVYVVTELMKGGE----LLDKILRQKFFSEREAS-------AVLFTITKTVEYLHA 134

Query: 419 ENGGKLVHGGIKASNIFLNSQGH----VCVSDIGLAALMSPMPPPAMRAAG---YRAPEV 471
           +    +VH  +K SNI    +      + + D G A  +       M       + APEV
Sbjct: 135 QG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEV 191

Query: 472 TDTRKATQASDVFSFGVLLLELLTGKSPIHATGGD 506
            + +    A D++S GVLL  +LTG +P      D
Sbjct: 192 LERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD 226

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 57.7 bits (140), Expect = 4e-09
 Identities = 45/211 (21%), Positives = 78/211 (36%), Gaps = 38/211 (18%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNVGKREFEQQM-------EIV--GGIRHE 355
             +G G +G+   A        V +K+L         F+ ++       E++    ++HE
Sbjct: 30  THVGSGAYGSVCSAIDKRSGEKVAIKKLSRP------FQSEIFAKRAYRELLLLKHMQHE 83

Query: 356 NVVALR-----AYYYSKDEKL-MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGA 409
           NV+ L      A          +V  + +       L             +    +    
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYLVMPFMQ-----TDLQKIM---GLKFSEEKIQYLVYQM 135

Query: 410 ARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP--AMRAAGYR 467
            +G+ +IH+     +VH  +K  N+ +N    + + D GLA             R   YR
Sbjct: 136 LKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRW--YR 190

Query: 468 APEV-TDTRKATQASDVFSFGVLLLELLTGK 497
           APEV        Q  D++S G ++ E+LTGK
Sbjct: 191 APEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 58.4 bits (141), Expect = 4e-09
 Identities = 29/115 (25%), Positives = 45/115 (39%), Gaps = 18/115 (15%)

Query: 72  LRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGP 131
           L +   AL   +P       ++L+ L    N LS L P   +   +L  L +  N  +  
Sbjct: 85  LEITQNALI-SLPEL----PASLEYLDACDNRLSTL-PELPA---SLKHLDVDNNQLTM- 134

Query: 132 LPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQR 186
           LP    +   L  I+  NN     +P   + L  L   ++ NN LT  LP   + 
Sbjct: 135 LP---ELPALLEYINADNNQLT-MLPELPTSLEVL---SVRNNQLT-FLPELPES 181

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 57.7 bits (139), Expect = 7e-09
 Identities = 24/104 (23%), Positives = 43/104 (41%), Gaps = 14/104 (13%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
            +    +  ++    L L   +LS L P +      +T L +  N+    LP   +   +
Sbjct: 51  SLLKECL--INQFSELQLNRLNLSSL-PDNLPP--QITVLEITQNALI-SLPELPA---S 101

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQ 185
           L  +D  +N  + ++P   + L H   L++ NN LT  LP    
Sbjct: 102 LEYLDACDNRLS-TLPELPASLKH---LDVDNNQLT-MLPELPA 140

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 27/137 (19%), Positives = 48/137 (35%), Gaps = 18/137 (13%)

Query: 72  LRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGP 131
           L      L   +P       ++L++L + +N L+ L P        L  ++   N  +  
Sbjct: 105 LDACDNRLS-TLPE----LPASLKHLDVDNNQLTML-PEL---PALLEYINADNNQLTM- 154

Query: 132 LPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWA 191
           LP    +  +L V+ + NN     +P     L     L+++ N L  +LP    R     
Sbjct: 155 LP---ELPTSLEVLSVRNNQLT-FLPELPESLEA---LDVSTNLLE-SLPAVPVRNHHSE 206

Query: 192 FAGNNLSSENARPPALP 208
                      R   +P
Sbjct: 207 ETEIFFRCRENRITHIP 223

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 19/118 (16%), Positives = 41/118 (34%), Gaps = 6/118 (5%)

Query: 91  LSALQNLSLRSNSLSGLFPSDFSKLENLTS----LHLQFNSFSGPLPLDFSVWNNLTVID 146
             +L+ L + +N L  L P+   +  +          + N  +  +P +    +    I 
Sbjct: 179 PESLEALDVSTNLLESL-PAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTII 236

Query: 147 LSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLSSENARP 204
           L +N  ++ I  S+S+ T     +      + +  +        A A      EN + 
Sbjct: 237 LEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPLADAVTAWFPENKQS 294

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 57.3 bits (139), Expect = 5e-09
 Identities = 51/231 (22%), Positives = 88/231 (38%), Gaps = 75/231 (32%)

Query: 306 EVLGKGTFGTAYKAALEDAST---VVVK-----RLKEVNVG---KREFEQQMEIVGGIRH 354
           E LG+G+FG    A      T   V +K      LK+ ++    +RE    +  +  +RH
Sbjct: 15  ETLGEGSFGKVKLA--THYKTQQKVALKFISRQLLKKSDMHMRVERE----ISYLKLLRH 68

Query: 355 ENVVALRAYYYSKDEKLMV--------YDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIA 406
            +++ L     +  + +MV        +DY        +   R  E +            
Sbjct: 69  PHIIKLYDVITTPTDIVMVIEYAGGELFDYI-------VEKKRMTEDE------------ 109

Query: 407 IGAAR--------GIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP--- 455
               R         I + H      +VH  +K  N+ L+   +V ++D GL+ +M+    
Sbjct: 110 ---GRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF 163

Query: 456 ------MPPPAMRAAGYRAPEVTDTRK-ATQASDVFSFGVLLLELLTGKSP 499
                  P        Y APEV + +  A    DV+S G++L  +L G+ P
Sbjct: 164 LKTSCGSPN-------YAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLP 207

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 56.8 bits (138), Expect = 5e-09
 Identities = 46/235 (19%), Positives = 88/235 (37%), Gaps = 80/235 (34%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGK----------REFEQQMEIVGGIRHE 355
           E +G+GT+GT +KA  ++  T  +  LK V +            RE    + ++  ++H+
Sbjct: 8   EKIGEGTYGTVFKA--KNRETHEIVALKRVRLDDDDEGVPSSALRE----ICLLKELKHK 61

Query: 356 NVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWD-----TRVRIAIGAA 410
           N+V L    +S  +  +V+++                     D D           +   
Sbjct: 62  NIVRLHDVLHSDKKLTLVFEF--------------------CDQDLKKYFDSCNGDLDPE 101

Query: 411 ----------RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPA 460
                     +G+   H+ N   ++H  +K  N+ +N  G + +++ GLA          
Sbjct: 102 IVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLA---------- 148

Query: 461 MRAAG--------------YRAPEV-TDTRKATQASDVFSFGVLLLELLTGKSPI 500
            RA G              YR P+V    +  + + D++S G +  EL     P+
Sbjct: 149 -RAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 56.4 bits (137), Expect = 5e-09
 Identities = 48/217 (22%), Positives = 85/217 (39%), Gaps = 49/217 (22%)

Query: 308 LGKGTFGTAYKAALEDAST---VVVK---RLKEVNVG---KREFEQQMEIVGGIRHENVV 358
           LG+G +G    A   +  T   V VK     + V+     K+E    + I   + HENVV
Sbjct: 15  LGEGAYGEVQLA--VNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVV 68

Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAML--HGRRGEGQSSLDWDTRVRIAIGAAR----- 411
               +    + + +  +Y   G +   +       E                 A+     
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPD---------------AQRFFHQ 113

Query: 412 ---GIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAM--RAAG- 465
              G+ ++H      + H  IK  N+ L+ + ++ +SD GLA +        +  +  G 
Sbjct: 114 LMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGT 170

Query: 466 --YRAPEVTDTRK-ATQASDVFSFGVLLLELLTGKSP 499
             Y APE+   R+   +  DV+S G++L  +L G+ P
Sbjct: 171 LPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 57.4 bits (139), Expect = 6e-09
 Identities = 43/219 (19%), Positives = 81/219 (36%), Gaps = 41/219 (18%)

Query: 306 EVLGKGTFGTAYKAALEDAST---VVVKRLKEVNVGKRE---------FEQQMEIVGGIR 353
           + LG G  G    A   +  T   V ++ + +                 E ++EI+  + 
Sbjct: 141 KTLGSGACGEVKLA--FERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN 198

Query: 354 HENVVALRAYYYSKDEKLMVYDYFEPGS-----VSAMLHGRRGEGQSSLDWDTRVRIAIG 408
           H  ++ ++ ++ ++D   +V +  E G      V    + R  E                
Sbjct: 199 HPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVG---NKRLKEATCK-------LYFYQ 247

Query: 409 AARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVC---VSDIGLAALMSPMPPPAMRA-- 463
               + ++H      ++H  +K  N+ L+SQ   C   ++D G + ++            
Sbjct: 248 MLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGT 304

Query: 464 AGYRAPEV---TDTRKATQASDVFSFGVLLLELLTGKSP 499
             Y APEV     T    +A D +S GV+L   L+G  P
Sbjct: 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 343

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 57.3 bits (139), Expect = 6e-09
 Identities = 45/215 (20%), Positives = 78/215 (36%), Gaps = 34/215 (15%)

Query: 306 EVLGKGTFGTAYKAALEDAST---VVVKRLKEVNVGKREFE---QQMEIVGGIRHENVVA 359
           E LGKG F    +                +    +  R+ +   ++  I   ++H N+V 
Sbjct: 17  EELGKGAFSVVRRC--VKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVR 74

Query: 360 LRAYYYSKDEKLMVYDYFEPGS-----VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIA 414
           L      +    +++D    G      V+        E  +S      ++  + A   + 
Sbjct: 75  LHDSISEEGHHYLIFDLVTGGELFEDIVA---REYYSEADAS----HCIQQILEA---VL 124

Query: 415 HIHTENGGKLVHGGIKASNIFLNSQG---HVCVSDIGLAALMSPMPPPAMRA----AGYR 467
           H H      +VH  +K  N+ L S+     V ++D GLA  +      A        GY 
Sbjct: 125 HCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG-EQQAWFGFAGTPGYL 180

Query: 468 APEVTDTRKATQASDVFSFGVLLLELLTGKSPIHA 502
           +PEV       +  D+++ GV+L  LL G  P   
Sbjct: 181 SPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWD 215

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 57.8 bits (139), Expect = 7e-09
 Identities = 28/96 (29%), Positives = 41/96 (42%), Gaps = 8/96 (8%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
           +I P  +  L  L  L L  N +  L  S    L+ L SL L+ N  S    L       
Sbjct: 79  DIKP--LTNLKNLGWLFLDENKIKDL--SSLKDLKKLKSLSLEHNGISDINGLVH--LPQ 132

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLT 177
           L  + L NN    +    +S+LT L  L+L +N ++
Sbjct: 133 LESLYLGNN--KITDITVLSRLTKLDTLSLEDNQIS 166

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 55.5 bits (133), Expect = 4e-08
 Identities = 25/90 (27%), Positives = 41/90 (45%), Gaps = 6/90 (6%)

Query: 88  IGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL 147
           +  L  L++LSL  N +S +  +    L  L SL+L  N  +    L  S    L  + L
Sbjct: 105 LKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDITVL--SRLTKLDTLSL 160

Query: 148 SNNFFNASIPASISKLTHLSALNLANNSLT 177
            +N  +  I   ++ LT L  L L+ N ++
Sbjct: 161 EDNQIS-DIV-PLAGLTKLQNLYLSKNHIS 188

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 54.7 bits (131), Expect = 6e-08
 Identities = 13/88 (14%), Positives = 33/88 (37%), Gaps = 6/88 (6%)

Query: 90  RLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSN 149
             +     +L+  S++       ++L ++  +    +       + +    N+T + L+ 
Sbjct: 19  AFAETIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDIKSVQGIQYLP--NVTKLFLNG 74

Query: 150 NFFNASIPASISKLTHLSALNLANNSLT 177
           N     I   ++ L +L  L L  N + 
Sbjct: 75  NKLT-DIK-PLTNLKNLGWLFLDENKIK 100

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 54.3 bits (130), Expect = 8e-08
 Identities = 16/84 (19%), Positives = 32/84 (38%), Gaps = 6/84 (7%)

Query: 94  LQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFN 153
           +      S  +  +FP            +L+  S +  +  +    N++  I  +N+   
Sbjct: 1   MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVTQNE--LNSIDQIIANNSDIK 56

Query: 154 ASIPASISKLTHLSALNLANNSLT 177
            S+   I  L +++ L L  N LT
Sbjct: 57  -SVQG-IQYLPNVTKLFLNGNKLT 78

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605

 Score = 54.0 bits (129), Expect = 1e-07
 Identities = 23/89 (25%), Positives = 37/89 (41%), Gaps = 4/89 (4%)

Query: 88  IGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL 147
           + RL+ L  LSL  N +S +     + L  L +L+L  N  S    L  +   NL V++L
Sbjct: 149 LSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHISDLRAL--AGLKNLDVLEL 204

Query: 148 SNNFFNASIPASISKLTHLSALNLANNSL 176
            +           S L   + +   + SL
Sbjct: 205 FSQECLNKPINHQSNLVVPNTVKNTDGSL 233

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 56.9 bits (138), Expect = 7e-09
 Identities = 46/222 (20%), Positives = 86/222 (38%), Gaps = 34/222 (15%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNVGK--REFE--QQMEIVGGIRHENVVAL 360
             LG+G +   ++A  + +   VVVK LK V   K  RE +  + +         N++ L
Sbjct: 42  RKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR-----GGPNIITL 96

Query: 361 RAYYYSKDEKLMVY--DYFEPGSVSAMLHGRRGEGQSSLDWDTRV---RIAIGAARGIAH 415
                    +      ++        +        Q+  D+D R     I     + + +
Sbjct: 97  ADIVKDPVSRTPALVFEHVNNTDFKQLY-------QTLTDYDIRFYMYEIL----KALDY 145

Query: 416 IHTENGGKLVHGGIKASNIFLNS-QGHVCVSDIGLAALMSPMPPPAMRAAG--YRAPEV- 471
            H+     ++H  +K  N+ ++     + + D GLA    P     +R A   ++ PE+ 
Sbjct: 146 CHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELL 202

Query: 472 TDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVR 513
            D +    + D++S G +L  ++  K P    G D    LVR
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFH-GHDNYDQLVR 243

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 56.5 bits (137), Expect = 7e-09
 Identities = 48/218 (22%), Positives = 86/218 (39%), Gaps = 40/218 (18%)

Query: 301 LRASAEVLGKGTFGTAYKAALEDAST-------VVVKRLKEVNVGKREFEQQMEIVGGIR 353
           L    + LG+G+F    K       +       ++ KR  E N  ++E        G   
Sbjct: 12  LDLKDKPLGEGSFSICRKC--VHKKSNQAFAVKIISKR-MEANT-QKEITALKLCEG--- 64

Query: 354 HENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGR---RG---EGQSSLDWDTRVRIAI 407
           H N+V L   ++ +    +V +    G     L  R   +    E ++S      +R  +
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGE----LFERIKKKKHFSETEAS----YIMRKLV 116

Query: 408 GAARGIAHIHTENGGKLVHGGIKASNIFLNSQGH---VCVSDIGLAALMSPMPPPAMRAA 464
            A   ++H+H      +VH  +K  N+    +     + + D G A L  P   P     
Sbjct: 117 SA---VSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC 170

Query: 465 G---YRAPEVTDTRKATQASDVFSFGVLLLELLTGKSP 499
               Y APE+ +     ++ D++S GV+L  +L+G+ P
Sbjct: 171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVP 208

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 56.0 bits (136), Expect = 8e-09
 Identities = 49/210 (23%), Positives = 86/210 (40%), Gaps = 31/210 (14%)

Query: 306 EVLGKGTFGTAYKAALEDAST---VVVKRLKEVNVGKREFE---QQMEIVGGIRHENVVA 359
           E LGKG F    +      +T      K +    +  R+F+   ++  I   ++H N+V 
Sbjct: 12  EELGKGAFSVVRRC--VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 69

Query: 360 LRAYYYSKDEKLMVYDYFEPGS-----VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIA 414
           L      +    +V+D    G      V+        E  +S      ++  + +   IA
Sbjct: 70  LHDSIQEESFHYLVFDLVTGGELFEDIVA---REFYSEADAS----HCIQQILES---IA 119

Query: 415 HIHTENGGKLVHGGIKASNIFLNSQG---HVCVSDIGLAALMSPMPPPAMRA--AGYRAP 469
           + H+     +VH  +K  N+ L S+     V ++D GLA  ++        A   GY +P
Sbjct: 120 YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 176

Query: 470 EVTDTRKATQASDVFSFGVLLLELLTGKSP 499
           EV      ++  D+++ GV+L  LL G  P
Sbjct: 177 EVLKKDPYSKPVDIWACGVILYILLVGYPP 206

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 56.4 bits (137), Expect = 9e-09
 Identities = 52/232 (22%), Positives = 96/232 (41%), Gaps = 81/232 (34%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGK----------REFEQQMEIVGGIRHE 355
           E +G+GT+G  YKA  +D+   +V  LK + +            RE    + ++  + H 
Sbjct: 27  EKVGEGTYGVVYKA--KDSQGRIVA-LKRIRLDAEDEGIPSTAIRE----ISLLKELHHP 79

Query: 356 NVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWD-----TRVRIAIGAA 410
           N+V+L    +S+    +V+++                    ++ D        +  +  +
Sbjct: 80  NIVSLIDVIHSERCLTLVFEF--------------------MEKDLKKVLDENKTGLQDS 119

Query: 411 ----------RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPA 460
                     RG+AH H      ++H  +K  N+ +NS G + ++D GLA          
Sbjct: 120 QIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLA---------- 166

Query: 461 MRAAG--------------YRAPEV-TDTRKATQASDVFSFGVLLLELLTGK 497
            RA G              YRAP+V   ++K + + D++S G +  E++TGK
Sbjct: 167 -RAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 56.5 bits (137), Expect = 9e-09
 Identities = 56/280 (20%), Positives = 114/280 (40%), Gaps = 48/280 (17%)

Query: 299 DLLRASAEVLGKGTFGTAYKAALEDASTV----VVKRLKEVNVGKREFEQQME----IVG 350
           DLLR    V+G+G++       L+    +    VVK  KE+     + +           
Sbjct: 12  DLLR----VIGRGSYAKVLLVRLKKTDRIYAMKVVK--KELVNDDEDIDWVQTEKHVFEQ 65

Query: 351 GIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIG-A 409
              H  +V L + + ++     V +Y   G +  M H +R + +   +     R      
Sbjct: 66  ASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL--MFHMQR-QRKLPEE---HARFYSAEI 119

Query: 410 ARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAA--G-- 465
           +  + ++H      +++  +K  N+ L+S+GH+ ++D G+      + P    +   G  
Sbjct: 120 SLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE--GLRPGDTTSTFCGTP 174

Query: 466 -YRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWT 524
            Y APE+        + D ++ GVL+ E++ G+SP    G  +             +   
Sbjct: 175 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSD----------NPDQNTE 224

Query: 525 AEVFDVEL---LRYP-NIEEEMVEMLQVGMACVVRMPEER 560
             +F V L   +R P ++  +   +L+   + + + P+ER
Sbjct: 225 DYLFQVILEKQIRIPRSLSVKAASVLK---SFLNKDPKER 261

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 56.5 bits (136), Expect = 1e-08
 Identities = 40/183 (21%), Positives = 64/183 (34%), Gaps = 23/183 (12%)

Query: 330 KRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGR 389
                       F Q  + VG I  +    L +   S+      +   +  S        
Sbjct: 123 NEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAP 182

Query: 390 RGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGL 449
               +  L  +  +  +   A+G+  + +      +H  + A NI L+ +  V + D GL
Sbjct: 183 EDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGL 239

Query: 450 AALMSPMPPPAMRAAGYR------------APEVTDTRKATQASDVFSFGVLLLELLT-G 496
           A  +        +   Y             APE    R  T  SDV+SFGVLL E+ + G
Sbjct: 240 ARDI-------YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 292

Query: 497 KSP 499
            SP
Sbjct: 293 ASP 295

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 56.0 bits (136), Expect = 1e-08
 Identities = 48/215 (22%), Positives = 95/215 (44%), Gaps = 35/215 (16%)

Query: 299 DLLRASAEVLGKGTFGTAYKAALEDASTVV-VKRL-KEVNVGKREFEQQM---EIVGGIR 353
            +LR     LG G+FG  +            +K L KE+ V  ++ E       ++  + 
Sbjct: 9   QILR----TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT 64

Query: 354 HENVVALRAYYYSKDEKL-MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIA-IGAAR 411
           H  ++ +    +   +++ M+ DY E G +      R+   +       +   A +  A 
Sbjct: 65  HPFIIRMW-GTFQDAQQIFMIMDYIEGGEL--FSLLRK-SQRFPNP-VAKFYAAEVCLA- 118

Query: 412 GIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM-------PPPAMRAA 464
            + ++H+++   +++  +K  NI L+  GH+ ++D G A  +  +       P       
Sbjct: 119 -LEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPD------ 168

Query: 465 GYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSP 499
            Y APEV  T+   ++ D +SFG+L+ E+L G +P
Sbjct: 169 -YIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 202

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 56.1 bits (136), Expect = 1e-08
 Identities = 28/95 (29%), Positives = 51/95 (53%), Gaps = 11/95 (11%)

Query: 411 RGIAHIHTENGGKLVHGGIKASNIFLNSQG-HVCVSDIGLAALMSPMPPPAMRAAG---- 465
           RG+ +IH+ N   ++H  +K +N+F+N++   + + D GLA +M P        +     
Sbjct: 131 RGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187

Query: 466 --YRAPEVT-DTRKATQASDVFSFGVLLLELLTGK 497
             YR+P +       T+A D+++ G +  E+LTGK
Sbjct: 188 KWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 55.6 bits (135), Expect = 1e-08
 Identities = 50/232 (21%), Positives = 89/232 (38%), Gaps = 81/232 (34%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGK----------REFEQQMEIVGGIRHE 355
           E +G+GT+G  YKA  ++        LK++ + K          RE     E+    +H 
Sbjct: 8   EKIGEGTYGVVYKA--QNNYGETFA-LKKIRLEKEDEGIPSTTIREISILKEL----KHS 60

Query: 356 NVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWD-----TRVRIAIGAA 410
           N+V L    ++K   ++V+++                    LD D           + + 
Sbjct: 61  NIVKLYDVIHTKKRLVLVFEH--------------------LDQDLKKLLDVCEGGLESV 100

Query: 411 ----------RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPA 460
                      GIA+ H      ++H  +K  N+ +N +G + ++D GLA          
Sbjct: 101 TAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLA---------- 147

Query: 461 MRAAG--------------YRAPEV-TDTRKATQASDVFSFGVLLLELLTGK 497
            RA G              YRAP+V   ++K +   D++S G +  E++ G 
Sbjct: 148 -RAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 56.1 bits (136), Expect = 1e-08
 Identities = 51/260 (19%), Positives = 88/260 (33%), Gaps = 88/260 (33%)

Query: 288 FEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAALEDAST---VVVKRLKEVNVGKREFEQ 344
              C+ V   E L       +G+GTFG  +KA      T   V +K++          E 
Sbjct: 10  CPFCDEVSKYEKL-----AKIGQGTFGEVFKA--RHRKTGQKVALKKVL--------MEN 54

Query: 345 QME-----------IVGGIRHENVVALR-------AYYYSKDEKL-MVYDY--------- 376
           + E           I+  ++HENVV L        + Y      + +V+D+         
Sbjct: 55  EKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLL 114

Query: 377 ------FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIK 430
                 F    +  ++                         G+ +IH      ++H  +K
Sbjct: 115 SNVLVKFTLSEIKRVMQ------M--------------LLNGLYYIHRNK---ILHRDMK 151

Query: 431 ASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---------YRAPEV-TDTRKATQA 480
           A+N+ +   G + ++D GLA   S       +            YR PE+    R     
Sbjct: 152 AANVLITRDGVLKLADFGLARAFS--LAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPP 209

Query: 481 SDVFSFGVLLLELLTGKSPI 500
            D++  G ++ E+ T   PI
Sbjct: 210 IDLWGAGCIMAEMWTRS-PI 228

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 48/220 (21%), Positives = 87/220 (39%), Gaps = 39/220 (17%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVN--VGKREFEQQMEIVGGIRHENVVALRAY 363
             LG+G     Y+   +   T     LK +   V K+    ++ ++  + H N++ L+  
Sbjct: 59  SELGRGATSIVYRC--KQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEI 116

Query: 364 YYSKDEKLMVYDYFEPGS-----VSAMLHGRRGEGQSSLDWDTRVRIAIGAAR----GIA 414
           + +  E  +V +    G      V     G   E           R A  A +     +A
Sbjct: 117 FETPTEISLVLELVTGGELFDRIVE---KGYYSE-----------RDAADAVKQILEAVA 162

Query: 415 HIHTENGGKLVHGGIKASNIFLNSQG---HVCVSDIGLAALMSPMPPPAMRA----AGYR 467
           ++H ENG  +VH  +K  N+   +      + ++D GL+ ++       M+      GY 
Sbjct: 163 YLH-ENG--IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE--HQVLMKTVCGTPGYC 217

Query: 468 APEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDE 507
           APE+          D++S G++   LL G  P +   GD+
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ 257

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 55.0 bits (133), Expect = 1e-08
 Identities = 18/97 (18%), Positives = 36/97 (37%), Gaps = 11/97 (11%)

Query: 86  NTIGRLSALQNLSLRS-----NSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWN 140
           N +  L+ + +  L       N L          L+NL  L ++ N     + L     +
Sbjct: 95  NRLKNLNGIPSACLSRLFLDNNELRDT--DSLIHLKNLEILSIRNNKLKSIVML--GFLS 150

Query: 141 NLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLT 177
            L V+DL  N    +    +++L  ++ ++L      
Sbjct: 151 KLEVLDLHGN--EITNTGGLTRLKKVNWIDLTGQKCV 185

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 24/90 (26%), Positives = 37/90 (41%), Gaps = 7/90 (7%)

Query: 88  IGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL 147
           +  L+ L+ LS+  N L  L   +      L+ L L  N       L      NL ++ +
Sbjct: 81  LKDLTKLEELSVNRNRLKNL---NGIPSACLSRLFLDNNELRDTDSLIHLK--NLEILSI 135

Query: 148 SNNFFNASIPASISKLTHLSALNLANNSLT 177
            NN    SI   +  L+ L  L+L  N +T
Sbjct: 136 RNNKLK-SIV-MLGFLSKLEVLDLHGNEIT 163

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 50.4 bits (121), Expect = 6e-07
 Identities = 22/93 (23%), Positives = 36/93 (38%), Gaps = 13/93 (13%)

Query: 88  IGRLSALQNLSLRSNSLSGLFPSDFSKLE---NLTSLHLQFNSFSGPLPLDFSVWNNLTV 144
           +   + L+ L L  N +S     D S L+    L  L +  N       +  +    L+ 
Sbjct: 59  MQFFTNLKELHLSHNQIS-----DLSPLKDLTKLEELSVNRNRLKNLNGIPSA---CLSR 110

Query: 145 IDLSNNFFNASIPASISKLTHLSALNLANNSLT 177
           + L NN        S+  L +L  L++ NN L 
Sbjct: 111 LFLDNN--ELRDTDSLIHLKNLEILSIRNNKLK 141

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 14/79 (17%), Positives = 32/79 (40%), Gaps = 6/79 (7%)

Query: 99  LRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPA 158
            R   ++ +FP     L N    +L   S +  +       + +   +  N+    S+  
Sbjct: 4   QRPTPINQVFP--DPGLANAVKQNLGKQSVTDLVSQ--KELSGVQNFNGDNSNIQ-SLA- 57

Query: 159 SISKLTHLSALNLANNSLT 177
            +   T+L  L+L++N ++
Sbjct: 58  GMQFFTNLKELHLSHNQIS 76

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263

 Score = 45.4 bits (108), Expect = 2e-05
 Identities = 17/90 (18%), Positives = 30/90 (33%), Gaps = 4/90 (4%)

Query: 88  IGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL 147
           +  L  L+ LS+R+N L  +       L  L  L L  N  +    L  +    +  IDL
Sbjct: 124 LIHLKNLEILSIRNNKLKSI--VMLGFLSKLEVLDLHGNEITNTGGL--TRLKKVNWIDL 179

Query: 148 SNNFFNASIPASISKLTHLSALNLANNSLT 177
           +             +L   + +   +    
Sbjct: 180 TGQKCVNEPVKYQPELYITNTVKDPDGRWI 209

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 55.7 bits (135), Expect = 2e-08
 Identities = 69/295 (23%), Positives = 119/295 (40%), Gaps = 63/295 (21%)

Query: 299 DLLRASAEVLGKGTFGTAYKAALEDASTVV-VKRL-KEVNVGKREFEQQME----IVGGI 352
            L +    +LGKG+FG  + A  +  +    +K L K+V +   + E  M     +    
Sbjct: 20  ILHK----MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 75

Query: 353 RHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGA-AR 411
            H  +  +   + +K+    V +Y   G +  M H +    +  L    R          
Sbjct: 76  EHPFLTHMFCTFQTKENLFFVMEYLNGGDL--MYHIQS-CHKFDLS---RATFYAAEIIL 129

Query: 412 GIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG------ 465
           G+  +H++    +V+  +K  NI L+  GH+ ++D G+           M          
Sbjct: 130 GLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKE-------NMLGDAKTNTFC 179

Query: 466 ----YRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVRE 521
               Y APE+   +K   + D +SFGVLL E+L G+SP H    +E+       +S+  +
Sbjct: 180 GTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL------FHSIRMD 233

Query: 522 EWTAEVFDVELLRYP-NIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
                        YP  +E+E  ++L       VR PE+R      L +  DIR+
Sbjct: 234 N----------PFYPRWLEKEAKDLLV---KLFVREPEKR------LGVRGDIRQ 269

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 55.3 bits (134), Expect = 2e-08
 Identities = 50/227 (22%), Positives = 95/227 (41%), Gaps = 37/227 (16%)

Query: 299 DLLRASAEVLGKGTFGTAYKAALEDASTVV-VKRL-KEVNVGKREFEQQM-E---IVGGI 352
           + L     VLGKG+FG    +  +    +  VK L K+V +   + E  M E   +    
Sbjct: 23  NFLM----VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG 78

Query: 353 RHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGA-AR 411
           +   +  L + + + D    V +Y   G +  M H ++  G+                A 
Sbjct: 79  KPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQ-VGRFKEP---HAVFYAAEIAI 132

Query: 412 GIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG------ 465
           G+  + ++    +++  +K  N+ L+S+GH+ ++D G+           +          
Sbjct: 133 GLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKE-------NIWDGVTTKTFC 182

Query: 466 ----YRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEV 508
               Y APE+   +   ++ D ++FGVLL E+L G++P      DE+
Sbjct: 183 GTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 229

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 49/224 (21%), Positives = 84/224 (37%), Gaps = 63/224 (28%)

Query: 308 LGKGTFGTAYKAALEDAST---VVVK---RLKEVNVG---KREFEQQMEIVGGIRHENVV 358
           LG+G +G    A   +  T   V VK     + V+     K+E    + I   + HENVV
Sbjct: 15  LGEGAYGEVQLA--VNRVTEEAVAVKIVDMKRAVDCPENIKKE----ICINKMLNHENVV 68

Query: 359 ALRAYYYSKDEKLMV---------YDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGA 409
               +    + + +          +D  EP            E                 
Sbjct: 69  KFYGHRREGNIQYLFLEYCSGGELFDRIEP-------DIGMPEPD--------------- 106

Query: 410 AR--------GIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAM 461
           A+        G+ ++H      + H  IK  N+ L+ + ++ +SD GLA +        +
Sbjct: 107 AQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163

Query: 462 --RAAG---YRAPEVTDTRK-ATQASDVFSFGVLLLELLTGKSP 499
             +  G   Y APE+   R+   +  DV+S G++L  +L G+ P
Sbjct: 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELP 207

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 49/210 (23%), Positives = 86/210 (40%), Gaps = 31/210 (14%)

Query: 306 EVLGKGTFGTAYKAALEDAST---VVVKRLKEVNVGKREFE---QQMEIVGGIRHENVVA 359
           E LGKG F    +      +T      K +    +  R+F+   ++  I   ++H N+V 
Sbjct: 35  EELGKGAFSVVRRC--VHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVR 92

Query: 360 LRAYYYSKDEKLMVYDYFEPGS-----VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIA 414
           L      +    +V+D    G      V+        E  +S      ++  + +   IA
Sbjct: 93  LHDSIQEESFHYLVFDLVTGGELFEDIVA---REFYSEADAS----HCIQQILES---IA 142

Query: 415 HIHTENGGKLVHGGIKASNIFLNSQG---HVCVSDIGLAALMSPMPPPAMRA--AGYRAP 469
           + H+     +VH  +K  N+ L S+     V ++D GLA  ++        A   GY +P
Sbjct: 143 YCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 199

Query: 470 EVTDTRKATQASDVFSFGVLLLELLTGKSP 499
           EV      ++  D+++ GV+L  LL G  P
Sbjct: 200 EVLKKDPYSKPVDIWACGVILYILLVGYPP 229

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 55.0 bits (133), Expect = 3e-08
 Identities = 44/219 (20%), Positives = 81/219 (36%), Gaps = 33/219 (15%)

Query: 306 EVLGKGTFGTAYKAALEDAST-------VVVKR--LKEVNVGKREFEQQMEIVGGIRHEN 356
           EV+GKG F    +    +  T       +V          +   + +++  I   ++H +
Sbjct: 30  EVIGKGPFSVVRRC--INRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPH 87

Query: 357 VVALRAYYYSKDEKLMVYDYFEPGS-----VSAMLHGRRGEGQSSLDWDTRVRIAIGAAR 411
           +V L   Y S     MV+++ +        V        G   S       +R  + A  
Sbjct: 88  IVELLETYSSDGMLYMVFEFMDGADLCFEIVK---RADAGFVYSEAVASHYMRQILEA-- 142

Query: 412 GIAHIHTENGGKLVHGGIKASNIFLNSQGH---VCVSDIGLAALMSPMPPPAMRA----A 464
            + + H +N   ++H  +K   + L S+ +   V +   G+A  +               
Sbjct: 143 -LRYCH-DNN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE-SGLVAGGRVGTP 197

Query: 465 GYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHAT 503
            + APEV       +  DV+  GV+L  LL+G  P + T
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 53.1 bits (128), Expect = 3e-08
 Identities = 27/120 (22%), Positives = 47/120 (39%), Gaps = 22/120 (18%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSD-FSKLENLTSLHLQFNSFSGPLPLD-FSVWN 140
           IP +T         L L  N L  +     F +L +L  L L+ N  +G +  + F   +
Sbjct: 27  IPLHT-------TELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGAS 78

Query: 141 NLTVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLSS 199
           ++  + L  N     I   +   L  L  LNL +N ++  +          +F   +L+S
Sbjct: 79  HIQELQLGENKIK-EISNKMFLGLHQLKTLNLYDNQIS-CVMPG-------SF--EHLNS 127

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192

 Score = 50.4 bits (121), Expect = 3e-07
 Identities = 28/105 (26%), Positives = 44/105 (41%), Gaps = 4/105 (3%)

Query: 72  LRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGP 131
           L L    L         GRL  L  L L+ N L+G+ P+ F    ++  L L  N     
Sbjct: 34  LLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKIKE- 92

Query: 132 LPLD-FSVWNNLTVIDLSNNFFNASIPASI-SKLTHLSALNLANN 174
           +    F   + L  ++L +N  +  +       L  L++LNLA+N
Sbjct: 93  ISNKMFLGLHQLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 54.3 bits (131), Expect = 4e-08
 Identities = 23/90 (25%), Positives = 37/90 (41%), Gaps = 4/90 (4%)

Query: 88  IGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL 147
           + RL+ L  LSL  N +S +     + L  L +L+L  N  S    L  +   NL V++L
Sbjct: 152 LSRLTKLDTLSLEDNQISDI--VPLAGLTKLQNLYLSKNHISDLRAL--AGLKNLDVLEL 207

Query: 148 SNNFFNASIPASISKLTHLSALNLANNSLT 177
            +           S L   + +   + SL 
Sbjct: 208 FSQECLNKPINHQSNLVVPNTVKNTDGSLV 237

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 53.5 bits (129), Expect = 6e-08
 Identities = 13/88 (14%), Positives = 33/88 (37%), Gaps = 6/88 (6%)

Query: 90  RLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSN 149
             +     +L+  S++       ++L ++  +    +       + +    N+T + L+ 
Sbjct: 22  AFAETIKDNLKKKSVTDA--VTQNELNSIDQIIANNSDIKSVQGIQYLP--NVTKLFLNG 77

Query: 150 NFFNASIPASISKLTHLSALNLANNSLT 177
           N     I   ++ L +L  L L  N + 
Sbjct: 78  NKLT-DIK-PLANLKNLGWLFLDENKVK 103

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 52.7 bits (127), Expect = 1e-07
 Identities = 26/90 (28%), Positives = 38/90 (42%), Gaps = 6/90 (6%)

Query: 88  IGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL 147
           +  L  L  L L  N +  L  S    L+ L SL L+ N  S    L       L  + L
Sbjct: 86  LANLKNLGWLFLDENKVKDL--SSLKDLKKLKSLSLEHNGISDINGLVHLP--QLESLYL 141

Query: 148 SNNFFNASIPASISKLTHLSALNLANNSLT 177
            NN    +    +S+LT L  L+L +N ++
Sbjct: 142 GNN--KITDITVLSRLTKLDTLSLEDNQIS 169

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291

 Score = 46.2 bits (110), Expect = 1e-05
 Identities = 14/82 (17%), Positives = 29/82 (35%), Gaps = 6/82 (7%)

Query: 96  NLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNAS 155
                   +  +F             +L+  S +  +    +  N++  I  +N+    S
Sbjct: 6   ETITVPTPIKQIFS--DDAFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIK-S 60

Query: 156 IPASISKLTHLSALNLANNSLT 177
           +   I  L +++ L L  N LT
Sbjct: 61  VQG-IQYLPNVTKLFLNGNKLT 81

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 54.1 bits (131), Expect = 4e-08
 Identities = 51/222 (22%), Positives = 78/222 (35%), Gaps = 50/222 (22%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQM-------EI-----VGGIR 353
             +G G +GT YKA   D  +     LK V V                E+     +    
Sbjct: 15  AEIGVGAYGTVYKA--RDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFE 72

Query: 354 HENVVALR----AYYYSKDEKL-MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIG 408
           H NVV L          ++ K+ +V+++ +   +   L      G   L  +T   +   
Sbjct: 73  HPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPG---LPAETIKDLMRQ 128

Query: 409 AARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG--- 465
             RG+  +H      +VH  +K  NI + S G V ++D GLA           R      
Sbjct: 129 FLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLA-----------RIYSYQM 174

Query: 466 ----------YRAPEVTDTRKATQASDVFSFGVLLLELLTGK 497
                     YRAPEV          D++S G +  E+   K
Sbjct: 175 ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 54.3 bits (131), Expect = 5e-08
 Identities = 42/217 (19%), Positives = 86/217 (39%), Gaps = 34/217 (15%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKRLK-----------EVNVGKREFEQQMEIVGGIR 353
             LG G F T + A  + + + V +K ++           E+ + +R  +        + 
Sbjct: 25  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 84

Query: 354 HENVVALRAYYYSKDEKL----MVYDYFEP--GSVSAMLHGRRGEGQSSLDWDTRVR-IA 406
             +++ L  ++  K        MV   FE    ++ A++      G         V+ I+
Sbjct: 85  ANHILKLLDHFNHKGPNGVHVVMV---FEVLGENLLALIKKYEHRGIPL----IYVKQIS 137

Query: 407 IGAARGIAHIHTENGGKLVHGGIKASNIFLN------SQGHVCVSDIGLAALMSPMPPPA 460
                G+ ++H   G  ++H  IK  N+ +       +   + ++D+G A         +
Sbjct: 138 KQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 195

Query: 461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGK 497
           ++   YR+PEV         +D++S   L+ EL+TG 
Sbjct: 196 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 54.2 bits (131), Expect = 6e-08
 Identities = 50/227 (22%), Positives = 91/227 (40%), Gaps = 37/227 (16%)

Query: 299 DLLRASAEVLGKGTFGTAYKAALEDASTVV-VKRL-KEVNVGKREFEQQM-E---IVGGI 352
           + +R    VLGKG+FG    A +++   +  VK L K+V +   + E  M E   +    
Sbjct: 26  EFIR----VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR 81

Query: 353 RHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIG-AAR 411
            H  +  L   + + D    V ++   G +  M H ++   +       R R        
Sbjct: 82  NHPFLTQLFCCFQTPDRLFFVMEFVNGGDL--MFHIQK-SRRFDEA---RARFYAAEIIS 135

Query: 412 GIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG------ 465
            +  +H +    +++  +K  N+ L+ +GH  ++D G+           +          
Sbjct: 136 ALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE-------GICNGVTTATFC 185

Query: 466 ----YRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEV 508
               Y APE+        A D ++ GVLL E+L G +P  A   D++
Sbjct: 186 GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL 232

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 53.0 bits (128), Expect = 1e-07
 Identities = 45/231 (19%), Positives = 86/231 (37%), Gaps = 79/231 (34%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGK---------REFEQQMEIVGGIRHEN 356
           + LG+GT+ T YK   +    +V   LKE+ +           RE    + ++  ++H N
Sbjct: 8   DKLGEGTYATVYKGKSKLTDNLVA--LKEIRLEHEEGAPCTAIRE----VSLLKDLKHAN 61

Query: 357 VVALRAYYYSKDEKLMVYDY---------------FEPGSVSAMLHGRRGEGQSSLDWDT 401
           +V L    +++    +V++Y                   +V   L       Q       
Sbjct: 62  IVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLF------Q------- 108

Query: 402 RVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAM 461
                    RG+A+ H +    ++H  +K  N+ +N +G + ++D GLA           
Sbjct: 109 -------LLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLA----------- 147

Query: 462 RAAG--------------YRAPEV-TDTRKATQASDVFSFGVLLLELLTGK 497
           RA                YR P++   +   +   D++  G +  E+ TG+
Sbjct: 148 RAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 45/283 (15%), Positives = 84/283 (29%), Gaps = 85/283 (30%)

Query: 279 HDKNSKLVFFEGCNLVFDLED---LLRASAEVLGKGTFGTAYKAALEDASTVV-VKRLKE 334
           H  + +   +        + D   +      ++G+G++G  Y A  ++    V +K++  
Sbjct: 6   HHSSGRENLYFQGIKNVHVPDNYIIKH----LIGRGSYGYVYLAYDKNTEKNVAIKKVNR 61

Query: 335 VNVGKREFEQQM-------EI--VGGIRHENVVALRAYYYSKDEKLM--VYDYFEPGSVS 383
           +      FE  +       EI  +  ++ + ++ L       D      +Y   E     
Sbjct: 62  M------FEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEI---- 111

Query: 384 AMLHGRRGEGQSSLDWDTRVRIAIGAA--------------RGIAHIHTENGGKLVHGGI 429
                         D D +                       G   IH      ++H  +
Sbjct: 112 -------------ADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDL 155

Query: 430 KASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG------------------------ 465
           K +N  LN    V V D GLA  ++      +                            
Sbjct: 156 KPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTR 215

Query: 466 -YRAPEV-TDTRKATQASDVFSFGVLLLELLTGKSPIHATGGD 506
            YRAPE+       T++ D++S G +  ELL           +
Sbjct: 216 WYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 52.6 bits (127), Expect = 1e-07
 Identities = 44/223 (19%), Positives = 84/223 (37%), Gaps = 46/223 (20%)

Query: 306 EVLGKGTFGTAYKAALEDAST---VVVK----------RLKEVNVGKREFEQQMEIVGGI 352
           E+LG+G      +       T     VK            +EV   +    ++++I+  +
Sbjct: 23  EILGRGVSSVVRRC--IHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKV 80

Query: 353 -RHENVVALRAYYYSKDEKLMVYDYFEPGS-----VSAMLHGRRGEGQSSLDWDTRVRIA 406
             H N++ L+  Y +     +V+D  + G                E ++       +R  
Sbjct: 81  SGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETR----KIMRAL 133

Query: 407 IGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMR---- 462
           +     I  +H  N   +VH  +K  NI L+   ++ ++D G +  + P     +R    
Sbjct: 134 LEV---ICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK--LREVCG 185

Query: 463 AAGYRAPEV------TDTRKATQASDVFSFGVLLLELLTGKSP 499
              Y APE+       +     +  D++S GV++  LL G  P
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 52.8 bits (127), Expect = 2e-07
 Identities = 31/112 (27%), Positives = 49/112 (43%), Gaps = 28/112 (25%)

Query: 411 RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG----- 465
           + I ++H+     L+H  +K SNI LN++ HV V+D GL+     +              
Sbjct: 120 KVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176

Query: 466 -------------------YRAPEV-TDTRKATQASDVFSFGVLLLELLTGK 497
                              YRAPE+   + K T+  D++S G +L E+L GK
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 52.8 bits (127), Expect = 2e-07
 Identities = 58/223 (26%), Positives = 94/223 (42%), Gaps = 30/223 (13%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRH---------E 355
           +V+GKG+FG   KA   +    V +K ++  N  KR   Q  E +  + H          
Sbjct: 103 KVIGKGSFGQVVKAYDHKVHQHVALKMVR--NE-KRFHRQAAEEIRILEHLRKQDKDNTM 159

Query: 356 NVVALRAYYYSKDEKLMVYDYFEPGSVSA--MLHGRRGEGQSSLDWDTRVR-IAIGAARG 412
           NV+ +   +  ++   M    FE  S++   ++   + +G S       VR  A    + 
Sbjct: 160 NVIHMLENFTFRNHICMT---FELLSMNLYELIKKNKFQGFSL----PLVRKFAHSILQC 212

Query: 413 IAHIHTENGGKLVHGGIKASNIFLNSQGH--VCVSDIGLAALMSPMPPPAMRAAGYRAPE 470
           +  +H      ++H  +K  NI L  QG   + V D G +          +++  YRAPE
Sbjct: 213 LDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPE 269

Query: 471 VTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVR 513
           V    +     D++S G +L ELLTG  P+   G DE   L  
Sbjct: 270 VILGARYGMPIDMWSLGCILAELLTGY-PLLP-GEDEGDQLAC 310

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567

 Score = 52.8 bits (126), Expect = 2e-07
 Identities = 34/168 (20%), Positives = 54/168 (32%), Gaps = 17/168 (10%)

Query: 17  IFLPIKADPVEDKQALLDFIHNIHNSRSLNWNESSSLCKSWTGVT--CSADHSRVVALRL 74
           I L    DP+  ++  L +   +     +       L   +         +++ V  L L
Sbjct: 389 ILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHL 448

Query: 75  PGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFN---SFSGP 131
               L   +    + +L  + +L L  N L  L P   + L  L  L    N   +  G 
Sbjct: 449 AHKDLT-VLCH--LEQLLLVTHLDLSHNRLRAL-PPALAALRCLEVLQASDNALENVDG- 503

Query: 132 LPLDFSVWNNLTVIDLSNNFFNASIPA--SISKLTHLSALNLANNSLT 177
                +    L  + L NN       A   +     L  LNL  NSL 
Sbjct: 504 ----VANLPRLQELLLCNNRLQ-QSAAIQPLVSCPRLVLLNLQGNSLC 546

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 43/214 (20%), Positives = 84/214 (39%), Gaps = 23/214 (10%)

Query: 306 EVLGKGTFGTAYKAALEDAST---VVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRA 362
           +VLG G  G   +    +  T     +K L++    +RE E            ++V +  
Sbjct: 68  QVLGLGINGKVLQI--FNKRTQEKFALKMLQDCPKARREVELHWRASQ---CPHIVRIVD 122

Query: 363 YY----YSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT 418
            Y      +   L+V +  + G + + +  R  +  +  +    ++    A   I ++H+
Sbjct: 123 VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA---IQYLHS 179

Query: 419 ENGGKLVHGGIKASNIFLNSQGH---VCVSDIGLAALMSPMPPPAMRA--AGYRAPEVTD 473
            N   + H  +K  N+   S+     + ++D G A   +             Y APEV  
Sbjct: 180 IN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG 236

Query: 474 TRKATQASDVFSFGVLLLELLTGKSPIHATGGDE 507
             K  ++ D++S GV++  LL G  P ++  G  
Sbjct: 237 PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 270

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 52.2 bits (126), Expect = 2e-07
 Identities = 48/220 (21%), Positives = 80/220 (36%), Gaps = 48/220 (21%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGK----------REFEQQMEIVGGIRHE 355
             +G+G +G  +KA  +  +      LK V V            RE      +     H 
Sbjct: 17  AEIGEGAYGKVFKA-RDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETF-EHP 74

Query: 356 NVVALR----AYYYSKDEKL-MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAA 410
           NVV L          ++ KL +V+++ +   ++  L      G   +  +T   +     
Sbjct: 75  NVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPG---VPTETIKDMMFQLL 130

Query: 411 RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG----- 465
           RG+  +H+     +VH  +K  NI + S G + ++D GLA           R        
Sbjct: 131 RGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLA-----------RIYSFQMAL 176

Query: 466 --------YRAPEVTDTRKATQASDVFSFGVLLLELLTGK 497
                   YRAPEV          D++S G +  E+   K
Sbjct: 177 TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 52.5 bits (126), Expect = 3e-07
 Identities = 48/258 (18%), Positives = 81/258 (31%), Gaps = 83/258 (32%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNVGKREFEQQM-------EI--VGGIRHE 355
            ++G G++G   +A    +   V +K++  V      FE  +       EI  +  + H+
Sbjct: 59  HLIGTGSYGHVCEAYDKLEKRVVAIKKILRV------FEDLIDCKRILREIAILNRLNHD 112

Query: 356 NVVALRAYYYSKDEKLM--VYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAA--- 410
           +VV +      KD +    +Y   E                   D D +           
Sbjct: 113 HVVKVLDIVIPKDVEKFDELYVVLE-----------------IADSDFKKLFRTPVYLTE 155

Query: 411 -----------RGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP 459
                       G+ ++H+     ++H  +K +N  +N    V V D GLA  +      
Sbjct: 156 LHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENG 212

Query: 460 AMRAAG------------------------------YRAPEV-TDTRKATQASDVFSFGV 488
             +                                 YRAPE+       T+A DV+S G 
Sbjct: 213 NSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGC 272

Query: 489 LLLELLTGKSPIHATGGD 506
           +  ELL       A   D
Sbjct: 273 IFAELLNMIKENVAYHAD 290

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 50.0 bits (120), Expect = 3e-07
 Identities = 18/89 (20%), Positives = 31/89 (34%), Gaps = 5/89 (5%)

Query: 91  LSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNN 150
           L     +    N +  L    F  L  L +L +  N              +LT + L+NN
Sbjct: 41  LDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNN 98

Query: 151 FFN--ASIPASISKLTHLSALNLANNSLT 177
                  +   ++ L  L+ L +  N +T
Sbjct: 99  SLVELGDL-DPLASLKSLTYLCILRNPVT 126

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176

 Score = 41.2 bits (97), Expect = 3e-04
 Identities = 16/64 (25%), Positives = 26/64 (40%), Gaps = 1/64 (1%)

Query: 88  IGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDF-SVWNNLTVID 146
              L  L+ L + +N +  +       L +LT L L  NS      LD  +   +LT + 
Sbjct: 60  FPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLC 119

Query: 147 LSNN 150
           +  N
Sbjct: 120 ILRN 123

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 51.8 bits (124), Expect = 3e-07
 Identities = 40/273 (14%), Positives = 74/273 (27%), Gaps = 86/273 (31%)

Query: 377 FEP--GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNI 434
           FE     +   +     +G   L      +I     +G+ ++HT+    ++H  IK  NI
Sbjct: 124 FEVLGHHLLKWIIKSNYQG---LPLPCVKKIIQQVLQGLDYLHTKCR--IIHTDIKPENI 178

Query: 435 FLNSQGHVCVSDIGLAALMSPMPPPAMRAAG----------------------------- 465
            L+            A        P    +                              
Sbjct: 179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIA 238

Query: 466 --------------------YRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGG 505
                               YR+ EV         +D++S   +  EL TG        G
Sbjct: 239 DLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSG 298

Query: 506 DEVV----HLVRWV--------NSVVREEWTAEVFD--VELLRYPNI------------- 538
           +E      H+   +          +V  +++ E F    +L     +             
Sbjct: 299 EEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKY 358

Query: 539 ---EEEMVEMLQVGMACVVRMPEERPKMADVLK 568
              +EE        +  +  +PE+R   A+ L+
Sbjct: 359 EWSQEEAAGFTDFLLPMLELIPEKRATAAECLR 391

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 51.6 bits (124), Expect = 4e-07
 Identities = 49/221 (22%), Positives = 79/221 (35%), Gaps = 60/221 (27%)

Query: 308 LGKGTFGTAYKAALEDAST---VVVK-----RLKEVNVGKREFEQQMEIVGGIRHENVVA 359
           +G G FG A      D  T   V VK        + NV +RE    +     +RH N+V 
Sbjct: 28  IGSGNFGVARLM--RDKLTKELVAVKYIERGAAIDENV-QRE----IINHRSLRHPNIVR 80

Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAML--HGRRGEGQSSLDWDTRVRIAIGAAR------ 411
            +    +     ++ +Y   G +   +   GR  E +               AR      
Sbjct: 81  FKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDE---------------ARFFFQQL 125

Query: 412 --GIAHIHTENGGKLVHGGIKASNIFL--NSQGHVCVSDIGLAALMSP--MP------PP 459
             G+++ H+     + H  +K  N  L  +    + + D G +        P      P 
Sbjct: 126 LSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPA 182

Query: 460 AMRAAGYRAPEVTDTRK-ATQASDVFSFGVLLLELLTGKSP 499
                 Y APEV   ++   + +DV+S GV L  +L G  P
Sbjct: 183 ------YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYP 217

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 50.8 bits (122), Expect = 5e-07
 Identities = 47/221 (21%), Positives = 87/221 (39%), Gaps = 45/221 (20%)

Query: 306 EVLGKGTFGTAYKAALEDAST-------VVVKRLKEVNVGKRE-----FEQQMEIVGGIR 353
           + LG G  G    A   +  T       ++ KR   +   +        E ++EI+  + 
Sbjct: 16  KTLGSGACGEVKLA--FERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN 73

Query: 354 HENVVALRAYYYSKDEKLMVYDYFEPGS-----VSAMLHGRRGEGQSSLDWDTRVRIAIG 408
           H  ++ ++ ++ ++D   +V +  E G      V    + R  E    L         + 
Sbjct: 74  HPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVG---NKRLKEATCKL----YFYQMLL 125

Query: 409 AARGIAHIHTENGGKLVHGGIKASNIFLNSQG---HVCVSDIGLAALMSPMPPPAMRAA- 464
           A   + ++H      ++H  +K  N+ L+SQ     + ++D G + ++       MR   
Sbjct: 126 A---VQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL--MRTLC 177

Query: 465 ---GYRAPEV---TDTRKATQASDVFSFGVLLLELLTGKSP 499
               Y APEV     T    +A D +S GV+L   L+G  P
Sbjct: 178 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP 218

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198

 Score = 49.3 bits (118), Expect = 6e-07
 Identities = 28/90 (31%), Positives = 47/90 (52%), Gaps = 5/90 (5%)

Query: 88  IGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL 147
           +  L A ++L+L +N++  +  S  S +ENL  L L  N       LD +V + L  + +
Sbjct: 44  LSTLKACKHLALSTNNIEKI--SSLSGMENLRILSLGRNLIKKIENLD-AVADTLEELWI 100

Query: 148 SNNFFNASIPASISKLTHLSALNLANNSLT 177
           S N    S+ + I KL +L  L ++NN +T
Sbjct: 101 SYNQIA-SL-SGIEKLVNLRVLYMSNNKIT 128

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 41/236 (17%), Positives = 79/236 (33%), Gaps = 84/236 (35%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGK----------REFEQQMEIVGGIRHE 355
             LG+GT+G  YKA   D  T     +K + +            RE    + ++  ++H 
Sbjct: 40  TKLGEGTYGEVYKA--IDTVTNETVAIKRIRLEHEEEGVPGTAIRE----VSLLKELQHR 93

Query: 356 NVVALRAYYYSKDEKLMVYDY--------------FEPGSVSAMLHGRRGEGQSSLDWDT 401
           N++ L++  +      ++++Y                   + + L+      Q       
Sbjct: 94  NIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLY------Q------- 140

Query: 402 RVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNS-----QGHVCVSDIGLAALMSPM 456
                     G+   H+      +H  +K  N+ L+         + + D GLA      
Sbjct: 141 -------LINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLA------ 184

Query: 457 PPPAMRAAG--------------YRAPEV-TDTRKATQASDVFSFGVLLLELLTGK 497
                RA G              YR PE+   +R  + + D++S   +  E+L   
Sbjct: 185 -----RAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 50.6 bits (120), Expect = 1e-06
 Identities = 47/421 (11%), Positives = 101/421 (23%), Gaps = 136/421 (32%)

Query: 269 MSLKEGVSGSHDKNSKLVFFEG------CNLVFDLEDLLRA---SAEV---LGKGT---- 312
           M  + G      K+   VF +       C    D++D+ ++     E+   +        
Sbjct: 7   MDFETGEHQYQYKDILSVFEDAFVDNFDCK---DVQDMPKSILSKEEIDHIIMSKDAVSG 63

Query: 313 ----FGT-------AYKAALEDASTV----VVKRLKEVNVGK----REFEQQMEIVGGI- 352
               F T         +  +E+   +    ++  +K          R + +Q + +    
Sbjct: 64  TLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDN 123

Query: 353 ---------RHENVVALRAYYYS-KDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTR 402
                    R +  + LR      +  K ++            + G  G G++ +     
Sbjct: 124 QVFAKYNVSRLQPYLKLRQALLELRPAKNVL------------IDGVLGSGKTWV----- 166

Query: 403 VRIAIGAARGIAHIHTENGGKLVH----GGIKASNIFLNSQGHVCVS-DIGLAALMSPMP 457
              A+        +  +   K +         +    L     +    D    +      
Sbjct: 167 ---ALDVCLSYK-VQCKMDFK-IFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSS 221

Query: 458 PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNS 517
                    R   +    +    S  +   +L+L                V         
Sbjct: 222 NIK-----LRIHSIQAELRRLLKSKPYENCLLVL--------------LNV-----Q--- 254

Query: 518 VVREEWTAEVFDVE---LL--RYPNIEEEMVEMLQVGMACVVRMPEERPKM--------- 563
                     F++    LL  R+  +     + L       + +      +         
Sbjct: 255 ---NAKAWNAFNLSCKILLTTRFKQV----TDFLSAATTTHISLDHHSMTLTPDEVKSLL 307

Query: 564 ADVLKM-VEDIRR-VKAENP----------PSTENRSEISSSAATPKATETASSSTAHLD 611
              L    +D+ R V   NP                 +        K T    SS   L+
Sbjct: 308 LKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLE 367

Query: 612 S 612
            
Sbjct: 368 P 368

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 41.8 bits (97), Expect = 6e-04
 Identities = 29/161 (18%), Positives = 57/161 (35%), Gaps = 34/161 (21%)

Query: 39  IHNSRSLNWNESSSLCKSWTGVTCSADHSRVVALRLP-GMALRGE---IPPNTIGRLSAL 94
            H+S +L  +E  SL   +       D  R V    P  +++  E       T      +
Sbjct: 292 DHHSMTLTPDEVKSLLLKYLDCRPQ-DLPREVLTTNPRRLSIIAESIRDGLATWDNWKHV 350

Query: 95  QN---LSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFS-----GPLPLD-FSV-WNNLTV 144
                 ++  +SL+ L P+++ K+         F+  S       +P    S+ W ++  
Sbjct: 351 NCDKLTTIIESSLNVLEPAEYRKM---------FDRLSVFPPSAHIPTILLSLIWFDVIK 401

Query: 145 IDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQ 185
            D+            ++KL   S +       T ++P S+ 
Sbjct: 402 SDVMV---------VVNKLHKYSLVEKQPKESTISIP-SIY 432

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 49.7 bits (119), Expect = 1e-06
 Identities = 47/224 (20%), Positives = 82/224 (36%), Gaps = 49/224 (21%)

Query: 306 EVLGKGTFGTAYKAALEDAST---VVVK-------RLKEVNVGKREFEQQMEI-----VG 350
           +V+G+G      +      +T     VK       RL    + +     + E      V 
Sbjct: 100 DVIGRGVSSVVRRC--VHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVA 157

Query: 351 GIRHENVVALRAYYYSKDEKLMVYDYFEPGS-----VSAMLHGRRGEGQSSLDWDTRVRI 405
           G  H +++ L   Y S     +V+D    G                E ++     + +R 
Sbjct: 158 G--HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETR----SIMRS 208

Query: 406 AIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRA-- 463
            + A   ++ +H  N   +VH  +K  NI L+    + +SD G +  + P     +R   
Sbjct: 209 LLEA---VSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK--LRELC 260

Query: 464 --AGYRAPEV------TDTRKATQASDVFSFGVLLLELLTGKSP 499
              GY APE+             +  D+++ GV+L  LL G  P
Sbjct: 261 GTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 48.8 bits (117), Expect = 2e-06
 Identities = 62/313 (19%), Positives = 114/313 (36%), Gaps = 66/313 (21%)

Query: 296 DLEDLLRASAEVLGKGTFGTAYKAALEDAST-------VVVKR-LKEVNVGKREFEQQME 347
             ED+ +   +VLG+G           +  T       ++ K+     +   RE E   +
Sbjct: 9   RFEDVYQLQEDVLGEGAHARVQTC--INLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQ 66

Query: 348 IVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRR--GEGQSSLDWDTRVRI 405
             G   H NV+ L  ++  +D   +V++    GS+ + +H RR   E ++S      V+ 
Sbjct: 67  CQG---HRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEAS----VVVQD 119

Query: 406 AIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVC---VSDIGLAALMSPMPPPAMR 462
              A   +  +H +    + H  +K  NI       V    + D  L + +      +  
Sbjct: 120 VASA---LDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPI 173

Query: 463 A----------AGYRAPEV-----TDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDE 507
           +          A Y APEV      +     +  D++S GV+L  LL+G  P     G +
Sbjct: 174 STPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD 233

Query: 508 VVHLVRWVNSVVREEWTAEVFD-VELLRY-------PNIEEE----MVEMLQVGMACVVR 555
                 W            +F+ ++  +Y        +I       + ++L       VR
Sbjct: 234 ----CGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLL-------VR 282

Query: 556 MPEERPKMADVLK 568
             ++R   A VL+
Sbjct: 283 DAKQRLSAAQVLQ 295

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362

 Score = 48.0 bits (113), Expect = 6e-06
 Identities = 20/113 (17%), Positives = 37/113 (32%), Gaps = 16/113 (14%)

Query: 89  GRLSALQNLSL---RSNSLSGLFPSDFS------KLENLTSLHLQFNSFSGPLPLDFS-- 137
             L  L+ L L     +       + F       +  NL  L +        +   F   
Sbjct: 216 SDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLES 275

Query: 138 -VWNNLTVIDLSNNFFN----ASIPASISKLTHLSALNLANNSLTGTLPRSLQ 185
            +   L  +D+S           +   + K+ HL  +N+  N L+  + + LQ
Sbjct: 276 DILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQ 328

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 46.5 bits (111), Expect = 1e-05
 Identities = 41/216 (18%), Positives = 78/216 (36%), Gaps = 48/216 (22%)

Query: 306 EVLGKGTFGTAYKAALEDAST---VVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRA 362
           +VLG G  G   +    +  T     +K L++    +RE E            ++V +  
Sbjct: 24  QVLGLGINGKVLQI--FNKRTQEKFALKMLQDCPKARREVELHWRASQ---CPHIVRIVD 78

Query: 363 YY----YSKDEKLMVYDYFEPG----SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIA 414
            Y      +   L+V +  + G     +         E ++S      ++    A   I 
Sbjct: 79  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS----EIMKSIGEA---IQ 131

Query: 415 HIHTENGGKLVHGGIKASNIFLNSQGH---VCVSDIGLAALMSPMPPPAMRAAGYRAPEV 471
           ++H+ N   + H  +K  N+   S+     + ++D G                   A E 
Sbjct: 132 YLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF------------------AKET 170

Query: 472 TDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDE 507
           T   K  ++ D++S GV++  LL G  P ++  G  
Sbjct: 171 TG-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 205

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 60/268 (22%), Positives = 108/268 (40%), Gaps = 41/268 (15%)

Query: 264 SQKKEMSLKEGVSGSHDKNSKLVFFEGCNLVFDLEDLLRASAEVLGKGTFGTAYKAA-LE 322
           S KKE  +     G  D N   +   G   +   E        ++GKG+FG   KA    
Sbjct: 25  SHKKERKVYN--DGYDDDNYDYIVKNGEKWMDRYEID-----SLIGKGSFGQVVKAYDRV 77

Query: 323 DASTVVVKRLKEVNVGKREFEQ-QMEIVGGI-----------RHENVVALRAYYYSKDEK 370
           +   V +K +K  N  K    Q Q+E+   +           ++  +V L+ ++  ++  
Sbjct: 78  EQEWVAIKIIK--NK-KAFLNQAQIEV--RLLELMNKHDTEMKY-YIVHLKRHFMFRNHL 131

Query: 371 LMVYDYFEPGSVS--AMLHGRRGEGQSSLDWDTRVR-IAIGAARGIAHIHTENGGKLVHG 427
            +V   FE  S +   +L      G S        R  A      +  + T     ++H 
Sbjct: 132 CLV---FEMLSYNLYDLLRNTNFRGVSL----NLTRKFAQQMCTALLFLATPELS-IIHC 183

Query: 428 GIKASNIFLNSQGH--VCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTRKATQASDVFS 485
            +K  NI L +     + + D G +  +       +++  YR+PEV        A D++S
Sbjct: 184 DLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWS 243

Query: 486 FGVLLLELLTGKSPIHATGGDEVVHLVR 513
            G +L+E+ TG+ P+ + G +EV  + +
Sbjct: 244 LGCILVEMHTGE-PLFS-GANEVDQMNK 269

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170

 Score = 43.8 bits (104), Expect = 3e-05
 Identities = 34/118 (28%), Positives = 44/118 (37%), Gaps = 43/118 (36%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNL 142
           IP  T       Q L L  N ++ L P  F +L  LT L L                N L
Sbjct: 28  IPTTT-------QVLYLYDNQITKLEPGVFDRLTQLTRLDLD--------------NNQL 66

Query: 143 TVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLSS 199
           T            +PA +  KLT L+ L+L +N         L+  P  AF  +NL S
Sbjct: 67  T-----------VLPAGVFDKLTQLTQLSLNDN--------QLKSIPRGAF--DNLKS 103

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174

 Score = 43.8 bits (104), Expect = 4e-05
 Identities = 32/118 (27%), Positives = 44/118 (37%), Gaps = 43/118 (36%)

Query: 83  IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNL 142
           IP +        Q L L +N ++ L P  F  L NL  L+                 N L
Sbjct: 31  IPTDK-------QRLWLNNNQITKLEPGVFDHLVNLQQLYFN--------------SNKL 69

Query: 143 TVIDLSNNFFNASIPASI-SKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLSS 199
           T           +IP  +  KLT L+ L+L +N         L+  P  AF  +NL S
Sbjct: 70  T-----------AIPTGVFDKLTQLTQLDLNDN--------HLKSIPRGAF--DNLKS 106

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386

 Score = 42.4 bits (100), Expect = 3e-04
 Identities = 19/113 (16%), Positives = 37/113 (32%), Gaps = 13/113 (11%)

Query: 78  ALRGEIPPNTIGRLSALQNLSLRSNSLSG----LFPSDFSKLENLTSLHLQFNSF----- 128
           AL+             L+++    N L       +   F     L ++ +  N       
Sbjct: 145 ALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGI 204

Query: 129 SGPLPLDFSVWNNLTVIDLSNNFFNA----SIPASISKLTHLSALNLANNSLT 177
              L    +    L V+DL +N F      ++  ++    +L  L L +  L+
Sbjct: 205 EHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 257

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	615
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.95
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.93
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.92
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.89
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.89
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.88
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.86
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.82
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.81
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.8
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.79
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.78
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.77
3rgz_A	768	Protein brassinosteroid insensitive 1; phytohormon	99.76
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.76
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.73
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.72
1w8a_A	192	SLIT protein; signaling protein, secreted protein,	99.7
1ogq_A	313	PGIP-2, polygalacturonase inhibiting protein; inhi	99.69
3m19_A	251	Variable lymphocyte receptor A diversity region; a	99.69
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.68
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.68
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.67
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.66
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.66
2wfh_A	193	SLIT homolog 2 protein C-product; developmental pr	99.65
2v70_A	220	SLIT-2, SLIT homolog 2 protein N-product; neurogen	99.64
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.64
2o6q_A	270	Variable lymphocyte receptor A; leucine-rich repea	99.63
4fcg_A	328	Uncharacterized protein; structural genomics, PSI-	99.62
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.62
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.62
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.62
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.61
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.61
2o6r_A	177	Variable lymphocyte receptor B; leucine-rich repea	99.61
2xot_A	361	Amphoterin-induced protein 1; cell adhesion, neuro	99.61
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.61
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.6
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.6
2o6s_A	208	Variable lymphocyte receptor B; leucine-rich repea	99.6
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.6
2v9t_B	220	SLIT homolog 2 protein N-product; structural prote	99.6
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.6
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.6
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.6
3v47_A	455	TOLL-like receptor 5B and variable lymphocyte REC	99.6
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.59
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.59
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.59
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.59
1ozn_A	285	Reticulon 4 receptor; NOGO receptor, MAD, myelinat	99.59
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.59
3rfs_A	272	Internalin B, repeat modules, variable lymphocyte	99.59
3e6j_A	229	Variable lymphocyte receptor diversity region; var	99.58
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.56
4g8a_A	635	TOLL-like receptor 4; leucine rich repeat MD-2 rel	99.56
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.56
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.55
2z62_A	276	TOLL-like receptor 4, variable lymphocyte recepto;	99.55
3vq2_A	606	TLR4, TOLL-like receptor 4; leucine rich repeat MD	99.55
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.54
1p9a_G	290	Platelet glycoprotein IB alpha chain precursor; pl	99.54
3oja_B	597	Anopheles plasmodium-responsive leucine-rich REPE	99.53
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.53
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.53
3j0a_A	844	TOLL-like receptor 5; membrane protein, leucine-ri	99.53
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.53
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.52
4b8c_D	727	Glucose-repressible alcohol dehydrogenase transcr	99.52
3zyj_A	440	Leucine-rich repeat-containing protein 4C; cell ad	99.52
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.52
2z66_A	306	Variable lymphocyte receptor B, TOLL-like recepto;	99.52
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.52
3zyi_A	452	Leucine-rich repeat-containing protein 4; cell adh	99.52
3o6n_A	390	APL1; leucine-rich repeat, protein binding; HET: N	99.52
4eco_A	636	Uncharacterized protein; leucine-rich repeats, pro	99.51
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.51
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.51
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.49
2z63_A	570	TOLL-like receptor 4, variable lymphocyte recepto;	99.48
4ezg_A	197	Putative uncharacterized protein; internalin-A, le	99.48
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.48
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.48
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.47
4ecn_A	876	Leucine-rich repeat protein; leucine-rich repeats,	99.47
1wwl_A	312	Monocyte differentiation antigen CD14; LPS, immune	99.47
1ziw_A	680	TOLL-like receptor 3; innate immunity, immune syst	99.47
3t6q_A	606	CD180 antigen; protein-protein complex, leucine ri	99.47
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.46
3g39_A	170	Variable lymphocyte receptor VLRB.2D; antibody, X-	99.45
2id5_A	477	Lingo-1, leucine rich repeat neuronal 6A; CNS-spec	99.45
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.45
1xku_A	330	Decorin; proteoglycan, leucine-rich repeat, struct	99.45
3a79_B	562	TLR6, VLRB.59, TOLL-like receptor 6, variable lymp	99.44
4glp_A	310	Monocyte differentiation antigen CD14; alpha beta	99.44
2r9u_A	174	Variable lymphocyte receptor; adaptive immunity, V	99.43
2ell_A	168	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.43
2z80_A	353	TOLL-like receptor 2, variable lymphocyte recepto;	99.43
2xwt_C	239	Thyrotropin receptor; signaling protein-immune sys	99.42
2z7x_B	520	TOLL-like receptor 1, variable lymphocyte recepto;	99.42
3oja_A	487	Leucine-rich immune molecule 1; coiled-coil, helix	99.41
2ft3_A	332	Biglycan; proteoglycan, dimer interface, structura	99.41
2je0_A	149	Acidic leucine-rich nuclear phosphoprotein 32 FAM	99.39
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.39
2z81_A	549	CD282 antigen, TOLL-like receptor 2, variable lymp	99.39
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.38
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.37
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.36
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.36
1h6u_A	308	Internalin H; cell adhesion, leucine rich repeat,	99.35
1h6t_A	291	Internalin B; cell adhesion, leucine rich repeat,	99.35
2ifg_A	347	High affinity nerve growth factor receptor; TRK, T	99.34
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.34
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.33
1dce_A	567	Protein (RAB geranylgeranyltransferase alpha subun	99.32
1xeu_A	263	Internalin C; cellular invasion, leucine-rich repe	99.32
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.31
1a9n_A	176	U2A', U2A'; complex (nuclear protein/RNA), RNA, sn	99.3
1m9s_A	605	Internalin B; cell invasion, GW domains, SH3 domai	99.3
3cvr_A	571	Invasion plasmid antigen; leucine rich repeat and	99.29
1ds9_A	198	Outer arm dynein; leucine-rich repeat, beta-BETA-a	99.29
3o53_A	317	Protein LRIM1, AGAP006348-PA; leucine-rich repeat,	99.29
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.27
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.27
1jl5_A	454	Outer protein YOPM; leucine-rich repeat, molecular	99.26
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.26
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.25
3bz5_A	457	Internalin-J, INLJ; leucine rich repeat (LRR), cys	99.24
1o6v_A	466	Internalin A; bacterial infection, extracellular r	99.22
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.21
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.2
4fmz_A	347	Internalin; leucine rich repeat, structural genomi	99.17
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.15
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.14
3goz_A	362	Leucine-rich repeat-containing protein; LEGL7, NES	99.14
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.13
2ca6_A	386	RAN GTPase-activating protein 1; GAP, GTPase activ	99.09
2ast_B	336	S-phase kinase-associated protein 2; SCF-substrate	99.09
4ay9_X	350	Follicle-stimulating hormone receptor; hormone-rec	99.09
3g06_A	622	SSPH2 (leucine-rich repeat protein); E3 ubiquitin	99.07
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	99.06
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.02
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	98.87
1z7x_W	461	Ribonuclease inhibitor; leucine-rich repeat, enzym	98.86
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.77
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	98.77
3rw6_A	267	Nuclear RNA export factor 1; retroviral constituti	98.64
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	98.59
3sb4_A	329	Hypothetical leucine rich repeat protein; LRR, rig	98.58
3un9_A	372	NLR family member X1; leucine rich repeat (LRR), a	98.56
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.47
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.41
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	98.35
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.34
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.34
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.33
3ogk_B	592	Coronatine-insensitive protein 1; leucine rich rep	98.22
1io0_A	185	Tropomodulin; LRR protein, right-handed super-heli	98.19
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.15
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.14
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	98.06
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	98.03
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.96
2p1m_B	594	Transport inhibitor response 1 protein; F-BOX, leu	97.93
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.83
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	97.81
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.79
2ra8_A	362	Uncharacterized protein Q64V53_bacfr; WGR domain,	97.77
4fdw_A	401	Leucine rich hypothetical protein; putative cell s	97.73
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.5
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.47
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.44
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.29
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	97.21
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.12
3rfe_A	130	Platelet glycoprotein IB beta chain; platelet surf	97.12
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.05
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.0
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	96.98
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	96.91
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.91
4gt6_A	394	Cell surface protein; leucine rich repeats, putati	96.74
3e4g_A	176	ATP synthase subunit S, mitochondrial; leucine-ric	96.71
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	96.66
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	96.53
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	96.4
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.39
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	96.36
4fs7_A	394	Uncharacterized protein; leucine-rich repeats, pro	96.29
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.24
4h09_A	379	Hypothetical leucine rich repeat protein; two LRR_	96.08
1pgv_A	197	TMD-1, tropomodulin TMD-1; structural genomics, PS	95.96
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	95.74
3mes_A	424	Choline kinase; malaria, structural genomics, stru	93.98
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	93.69
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	90.58
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	90.38
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	90.04
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	89.85
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	86.62

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.3e-53  Score=438.00  Aligned_cols=252  Identities=25%  Similarity=0.411  Sum_probs=201.9

Q ss_pred             hhhcCcCCccEEEEEEEC------CCCEEEEEEeccccC-CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecC
Q 007167          305 AEVLGKGTFGTAYKAALE------DASTVVVKRLKEVNV-GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYF  377 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  377 (615)
                      .++||+|+||+||+|+++      +++.||||+++.... ..++|.+|++++++++|||||+++|+|.+.+..+||||||
T Consensus        46 ~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~  125 (329)
T 4aoj_A           46 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYM  125 (329)
T ss_dssp             EEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             EEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence            357999999999999864      467899999976432 3467999999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCC----------CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeec
Q 007167          378 EPGSVSAMLHGRRGE----------GQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDI  447 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Df  447 (615)
                      ++|+|.++++.....          ...+++|..+++|+.|+|.||+|||+.+   ||||||||+|||+++++++||+||
T Consensus       126 ~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~Ki~DF  202 (329)
T 4aoj_A          126 RHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVVKIGDF  202 (329)
T ss_dssp             TTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCC
T ss_pred             CCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcEEEccc
Confidence            999999999754321          2346999999999999999999999987   999999999999999999999999


Q ss_pred             ccccccCCCC-----CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhc
Q 007167          448 GLAALMSPMP-----PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVRE  521 (615)
Q Consensus       448 G~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  521 (615)
                      |+++......     ....+|+.|||||++.+..++.++|||||||++|||+| |+.||......+....+.      ..
T Consensus       203 Gla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~------~g  276 (329)
T 4aoj_A          203 GMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCIT------QG  276 (329)
T ss_dssp             C----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHH------HT
T ss_pred             ccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHH------cC
Confidence            9998764332     23457889999999999999999999999999999999 999998765444332221      11


Q ss_pred             ccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          522 EWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       522 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                      .        .+...+.+++++.+++.   +||+.||++||||+||+++|+.+.+.
T Consensus       277 ~--------~~~~p~~~~~~~~~li~---~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          277 R--------ELERPRACPPEVYAIMR---GCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             C--------CCCCCTTCCHHHHHHHH---HHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             C--------CCCCcccccHHHHHHHH---HHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            1        11122345555555555   99999999999999999999998763

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3.8e-54  Score=437.91  Aligned_cols=249  Identities=24%  Similarity=0.378  Sum_probs=203.3

Q ss_pred             hhcCcCCccEEEEEEEC------CCCEEEEEEecccc--CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecC
Q 007167          306 EVLGKGTFGTAYKAALE------DASTVVVKRLKEVN--VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYF  377 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  377 (615)
                      +.||+|+||+||+|.+.      +++.||||+++...  ...++|.+|++++++++|||||+++|+|.+++..+||||||
T Consensus        32 ~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~  111 (308)
T 4gt4_A           32 EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYC  111 (308)
T ss_dssp             EEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             eEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcC
Confidence            56999999999999863      46789999997542  23578999999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEee
Q 007167          378 EPGSVSAMLHGRRGE-----------GQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSD  446 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~D  446 (615)
                      ++|+|.++|+.....           ....++|..+++|+.|||.||+|||+++   ||||||||+|||+++++++||+|
T Consensus       112 ~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~~Ki~D  188 (308)
T 4gt4_A          112 SHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISD  188 (308)
T ss_dssp             SSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECC
T ss_pred             CCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCCEEECC
Confidence            999999999753211           1246999999999999999999999998   99999999999999999999999


Q ss_pred             cccccccCCC-----CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhh
Q 007167          447 IGLAALMSPM-----PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVR  520 (615)
Q Consensus       447 fG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  520 (615)
                      ||+++.....     .....+|++|||||++.++.|+.++|||||||++|||+| |+.||.+.+..++...+.      .
T Consensus       189 FGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~------~  262 (308)
T 4gt4_A          189 LGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIR------N  262 (308)
T ss_dssp             SCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHH------T
T ss_pred             cccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH------c
Confidence            9999876432     223457889999999999999999999999999999999 899998765544332221      1


Q ss_pred             cccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhH
Q 007167          521 EEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIR  574 (615)
Q Consensus       521 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~  574 (615)
                      ..        .....+.+++++.+   ++.+||+.||++||||.||+++|+...
T Consensus       263 ~~--------~~~~p~~~~~~~~~---li~~C~~~dP~~RPs~~ei~~~L~a~~  305 (308)
T 4gt4_A          263 RQ--------VLPCPDDCPAWVYA---LMIECWNEFPSRRPRFKDIHSRLRAWG  305 (308)
T ss_dssp             TC--------CCCCCTTCCHHHHH---HHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             CC--------CCCCcccchHHHHH---HHHHHcCCChhHCcCHHHHHHHHHhcc
Confidence            10        11122344455544   555999999999999999999998653

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=4.7e-54  Score=435.35  Aligned_cols=252  Identities=25%  Similarity=0.446  Sum_probs=205.3

Q ss_pred             hhhcCcCCccEEEEEEEC------CCCEEEEEEeccccC-CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecC
Q 007167          305 AEVLGKGTFGTAYKAALE------DASTVVVKRLKEVNV-GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYF  377 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  377 (615)
                      .+.||+|+||+||+|++.      ++..||||+++.... ..++|.+|++++++++|||||+++|+|.+++..+||||||
T Consensus        18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~   97 (299)
T 4asz_A           18 KRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYM   97 (299)
T ss_dssp             EEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred             eeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcC
Confidence            356999999999999864      467899999976432 3567999999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCC--------CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeeccc
Q 007167          378 EPGSVSAMLHGRR--------GEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGL  449 (615)
Q Consensus       378 ~~gsL~~~l~~~~--------~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~  449 (615)
                      ++|+|.++|+...        ......++|..+++|+.|+|.||+|||+++   |+||||||+|||+++++++||+|||+
T Consensus        98 ~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki~DFGl  174 (299)
T 4asz_A           98 KHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKIGDFGM  174 (299)
T ss_dssp             TTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCSC
T ss_pred             CCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEECCccc
Confidence            9999999997532        123457999999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCC-----CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccc
Q 007167          450 AALMSPMP-----PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEW  523 (615)
Q Consensus       450 a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  523 (615)
                      |+......     ....+|+.|||||++.+..|+.++|||||||++|||+| |+.||...+..++...+.      ... 
T Consensus       175 a~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~------~~~-  247 (299)
T 4asz_A          175 SRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT------QGR-  247 (299)
T ss_dssp             HHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH------HTC-
T ss_pred             ceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH------cCC-
Confidence            98764332     22346889999999999999999999999999999999 999998765544332221      111 


Q ss_pred             ccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          524 TAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       524 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                             .....+.+++++.+++.   +||+.||++|||++||++.|+++.+.
T Consensus       248 -------~~~~p~~~~~~~~~li~---~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          248 -------VLQRPRTCPQEVYELML---GCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             -------CCCCCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -------CCCCCccchHHHHHHHH---HHcCCChhHCcCHHHHHHHHHHHHhc
Confidence                   11122345555555555   99999999999999999999998764

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.2e-52  Score=423.23  Aligned_cols=248  Identities=28%  Similarity=0.462  Sum_probs=197.1

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      .++||+|+||+||+|++++  .||||+++.....   .+.|.+|++++++++|||||+++|++.+ +..+||||||++|+
T Consensus        41 ~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGs  117 (307)
T 3omv_A           41 STRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSS  117 (307)
T ss_dssp             EEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCB
T ss_pred             eeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCC
Confidence            4579999999999998754  6999999755333   3568999999999999999999998854 57899999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC-----
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM-----  456 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~-----  456 (615)
                      |.++|+...    ..++|..+..|+.|+|.||+|||+++   ||||||||+|||+++++++||+|||+|+.....     
T Consensus       118 L~~~l~~~~----~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~  190 (307)
T 3omv_A          118 LYKHLHVQE----TKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQ  190 (307)
T ss_dssp             HHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC---------
T ss_pred             HHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCccee
Confidence            999997532    36999999999999999999999987   999999999999999999999999999876432     


Q ss_pred             CCCCCCCCcccCccccCC---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccccccc
Q 007167          457 PPPAMRAAGYRAPEVTDT---RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELL  533 (615)
Q Consensus       457 ~~~~~~~~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  533 (615)
                      .....||+.|||||++.+   ..|+.++|||||||++|||+||+.||...+..+...  ..+.    ..    ...+.+.
T Consensus       191 ~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~--~~~~----~~----~~~p~~~  260 (307)
T 3omv_A          191 VEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQII--FMVG----RG----YASPDLS  260 (307)
T ss_dssp             ---CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHH--HHHH----TT----CCCCCST
T ss_pred             ecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHH--HHHh----cC----CCCCCcc
Confidence            223468999999999853   468999999999999999999999998655432211  1111    11    1111211


Q ss_pred             C-CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          534 R-YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       534 ~-~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                      . .+.+++++.+++.   +||+.||++||||.||+++|+.++.
T Consensus       261 ~~~~~~~~~l~~li~---~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          261 KLYKNCPKAMKRLVA---DCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             TSCTTSCHHHHHHHH---HHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             cccccchHHHHHHHH---HHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            1 2344555555554   9999999999999999999998875

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.1e-51  Score=423.45  Aligned_cols=240  Identities=21%  Similarity=0.396  Sum_probs=202.6

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccc-cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEV-NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      +.||+|+||+||+|..+ +|+.||||++... ....+.+.+|+++++.++|||||++++++.+++..||||||+++|+|.
T Consensus        80 ~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~  159 (346)
T 4fih_A           80 IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  159 (346)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHH
T ss_pred             EEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHH
Confidence            46999999999999965 6889999999654 334567899999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC---CCCC
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM---PPPA  460 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~---~~~~  460 (615)
                      +++...      .+++..+..++.|++.||+|||+++   ||||||||+|||++.++++||+|||+|+.+...   ....
T Consensus       160 ~~l~~~------~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~  230 (346)
T 4fih_A          160 DIVTHT------RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL  230 (346)
T ss_dssp             HHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred             HHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCccccc
Confidence            999742      5899999999999999999999998   999999999999999999999999999877543   2456


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE  540 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  540 (615)
                      +||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+..+....+   .   ..      ..+.+..++.+++
T Consensus       231 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i---~---~~------~~~~~~~~~~~s~  298 (346)
T 4fih_A          231 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---R---DN------LPPRLKNLHKVSP  298 (346)
T ss_dssp             CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---H---HS------SCCCCSCGGGSCH
T ss_pred             ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH---H---cC------CCCCCCccccCCH
Confidence            7999999999999999999999999999999999999999865433322221   1   11      1112222334566


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          541 EMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       541 ~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      +++++++   +||..||++|||++|+++|
T Consensus       299 ~~~dli~---~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          299 SLKGFLD---RLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             HHHHHHH---HHSCSSTTTSCCHHHHTTC
T ss_pred             HHHHHHH---HHcCCChhHCcCHHHHhcC
Confidence            7777766   9999999999999999876

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.3e-51  Score=418.55  Aligned_cols=245  Identities=19%  Similarity=0.235  Sum_probs=204.1

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      .++||+|+||+||+|..+ +|+.||||+++...    ...+|+++++.++|||||++++++.+++..+|||||+++|+|.
T Consensus        63 ~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~  138 (336)
T 4g3f_A           63 QPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLG  138 (336)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEETTT----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHH
T ss_pred             CcEeccCCCeEEEEEEECCCCCEEEEEEECHHH----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHH
Confidence            356999999999999965 68899999997532    2347999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCC-cEEEeecccccccCCCC-----
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG-HVCVSDIGLAALMSPMP-----  457 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~-~~kl~DfG~a~~~~~~~-----  457 (615)
                      ++|+..     ..+++..+..++.|++.||+|||+++   ||||||||+|||++.++ ++||+|||+|+.+....     
T Consensus       139 ~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~  210 (336)
T 4g3f_A          139 QLIKQM-----GCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL  210 (336)
T ss_dssp             HHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC---------
T ss_pred             HHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccce
Confidence            999743     36999999999999999999999998   99999999999999987 69999999998775321     


Q ss_pred             ---CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccC
Q 007167          458 ---PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLR  534 (615)
Q Consensus       458 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  534 (615)
                         ...+||+.|||||++.+..|+.++|||||||++|||++|+.||...+..+....+.      .+..      +....
T Consensus       211 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~------~~~~------~~~~~  278 (336)
T 4g3f_A          211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIA------SEPP------PIREI  278 (336)
T ss_dssp             ---CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHH------HSCC------GGGGS
T ss_pred             ecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH------cCCC------Cchhc
Confidence               22468999999999999999999999999999999999999998766555443221      1110      00112


Q ss_pred             CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          535 YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       535 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                      .+.+++++.++++   +||+.||++|||+.|++++|......
T Consensus       279 ~~~~s~~~~~li~---~~L~~dP~~R~sa~el~~~l~~~l~~  317 (336)
T 4g3f_A          279 PPSCAPLTAQAIQ---EGLRKEPVHRASAMELRRKVGKALQE  317 (336)
T ss_dssp             CTTSCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CccCCHHHHHHHH---HHccCCHhHCcCHHHHHHHHHHHHhh
Confidence            3456677777777   99999999999999999999887653

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.8e-52  Score=423.84  Aligned_cols=261  Identities=22%  Similarity=0.324  Sum_probs=196.4

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecC----eeeEEeecCCCC
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKD----EKLMVYDYFEPG  380 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lV~e~~~~g  380 (615)
                      .++||+|+||+||+|++ .|+.||||+++........++.|+..+.+++|||||+++++|.+++    ..+||||||++|
T Consensus         8 ~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~g   86 (303)
T 3hmm_A            8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHG   86 (303)
T ss_dssp             EEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTC
T ss_pred             EEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCC
Confidence            35799999999999998 4789999999754332333445666667889999999999998764    579999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccC-----CCCceecCCCCCCEEeCCCCcEEEeecccccccCC
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN-----GGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      +|.++|+..      .++|..+.+++.|+|.||+|||+++     .++|+||||||+|||++.++++||+|||+|+....
T Consensus        87 sL~~~l~~~------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~  160 (303)
T 3hmm_A           87 SLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS  160 (303)
T ss_dssp             BHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred             cHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccC
Confidence            999999743      5999999999999999999999872     33599999999999999999999999999987643


Q ss_pred             CC-------CCCCCCCcccCccccCCC------CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchh--------hHHHH
Q 007167          456 MP-------PPAMRAAGYRAPEVTDTR------KATQASDVFSFGVLLLELLTGKSPIHATGGDEVV--------HLVRW  514 (615)
Q Consensus       456 ~~-------~~~~~~~~y~aPE~~~~~------~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~--------~~~~~  514 (615)
                      ..       ....||+.|||||++.+.      .++.++|||||||++|||+||+.||......+..        .....
T Consensus       161 ~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~  240 (303)
T 3hmm_A          161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEE  240 (303)
T ss_dssp             TTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHH
T ss_pred             CCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHH
Confidence            22       234689999999998654      3678999999999999999998877543321110        00011


Q ss_pred             HHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          515 VNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       515 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                      +.....    ....++.++......+....+.+++.+||+.||++||||.||++.|+++.+.
T Consensus       241 ~~~~~~----~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          241 MRKVVC----EQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             HHHHHT----TSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHh----cccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            111111    1112222221111124455667777799999999999999999999998764

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.8e-51  Score=420.01  Aligned_cols=242  Identities=21%  Similarity=0.414  Sum_probs=196.5

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .+.||+|+||+||+|+.. +|+.||||++......   .+.+.+|++++++++|||||++++++.+++..||||||+++|
T Consensus        29 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg  108 (350)
T 4b9d_A           29 LQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGG  108 (350)
T ss_dssp             EEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTC
T ss_pred             eEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCC
Confidence            457999999999999964 6899999999765433   356889999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---  457 (615)
                      +|.++|...+   ...+++..+..|+.||+.||+|||+++   |+||||||+|||++.++++||+|||+|+.+....   
T Consensus       109 ~L~~~i~~~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~  182 (350)
T 4b9d_A          109 DLFKRINAQK---GVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA  182 (350)
T ss_dssp             BHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHH
T ss_pred             cHHHHHHHcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCcccc
Confidence            9999997543   336789999999999999999999998   9999999999999999999999999998775421   


Q ss_pred             CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCC
Q 007167          458 PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN  537 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  537 (615)
                      ...+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+..+...      .+......        .....
T Consensus       183 ~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~------~i~~~~~~--------~~~~~  248 (350)
T 4b9d_A          183 RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL------KIISGSFP--------PVSLH  248 (350)
T ss_dssp             HHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------HHHHTCCC--------CCCTT
T ss_pred             cccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH------HHHcCCCC--------CCCcc
Confidence            23468999999999999999999999999999999999999998654333222      22221110        11234


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          538 IEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       538 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ++++++++++   +||+.||++|||++|++++
T Consensus       249 ~s~~~~~li~---~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          249 YSYDLRSLVS---QLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             SCHHHHHHHH---HHTCSSGGGSCCHHHHHTS
T ss_pred             CCHHHHHHHH---HHccCChhHCcCHHHHhcC
Confidence            5667777666   9999999999999999875

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.1e-50  Score=423.89  Aligned_cols=240  Identities=21%  Similarity=0.396  Sum_probs=203.8

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEecccc-CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVN-VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      ++||+|+||+||+|..+ +|+.||||++.... ...+.+.+|+++|+.++|||||+++++|.+++..|||||||++|+|.
T Consensus       157 ~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~  236 (423)
T 4fie_A          157 IKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT  236 (423)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHH
T ss_pred             eEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHH
Confidence            56999999999999965 68899999997543 33567899999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC---CCCC
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM---PPPA  460 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~---~~~~  460 (615)
                      +++...      .+++..+..|+.||+.||+|||+++   ||||||||+|||++.++++||+|||+|+.+...   ....
T Consensus       237 ~~i~~~------~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~  307 (423)
T 4fie_A          237 DIVTHT------RMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL  307 (423)
T ss_dssp             HHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCC
T ss_pred             HHHhcc------CCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCcccccc
Confidence            999642      5899999999999999999999998   999999999999999999999999999877543   2345


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE  540 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  540 (615)
                      +||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+   .   ..      ..+.+.....+++
T Consensus       308 ~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i---~---~~------~~~~~~~~~~~s~  375 (423)
T 4fie_A          308 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI---R---DN------LPPRLKNLHKVSP  375 (423)
T ss_dssp             EECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---H---HS------CCCCCSCTTSSCH
T ss_pred             ccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH---H---cC------CCCCCcccccCCH
Confidence            7899999999999999999999999999999999999999765433322221   1   11      1122233445677


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          541 EMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       541 ~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      +++++++   +||..||++|||+.|+++|
T Consensus       376 ~~~dli~---~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          376 SLKGFLD---RLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             HHHHHHH---HHSCSSTTTSCCHHHHTTC
T ss_pred             HHHHHHH---HHcCCChhHCcCHHHHhcC
Confidence            7777777   9999999999999999876

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=3.5e-50  Score=404.15  Aligned_cols=242  Identities=23%  Similarity=0.414  Sum_probs=193.0

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEe----cCeeeEEeecC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYS----KDEKLMVYDYF  377 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lV~e~~  377 (615)
                      ++||+|+||+||+|.+. .+..||+|++......   .+.|.+|++++++++|||||+++++|.+    ++..+||||||
T Consensus        32 ~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~  111 (290)
T 3fpq_A           32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM  111 (290)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECC
T ss_pred             eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCC
Confidence            46999999999999965 5788999999765333   3568899999999999999999999875    34579999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCC-CCcEEEeecccccccCCC
Q 007167          378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNS-QGHVCVSDIGLAALMSPM  456 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~-~~~~kl~DfG~a~~~~~~  456 (615)
                      ++|+|.++++..     ..+++..+..++.|++.||+|||+++ ++|+||||||+|||++. ++++||+|||+|+.....
T Consensus       112 ~gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~  185 (290)
T 3fpq_A          112 TSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  185 (290)
T ss_dssp             CSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             CCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCCC
Confidence            999999999743     36999999999999999999999885 35999999999999984 789999999999865433


Q ss_pred             -CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCC
Q 007167          457 -PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY  535 (615)
Q Consensus       457 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  535 (615)
                       ....+||+.|||||++.+ .|+.++|||||||++|||+||+.||.......  .+...+   .....     ....  .
T Consensus       186 ~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~--~~~~~i---~~~~~-----~~~~--~  252 (290)
T 3fpq_A          186 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRV---TSGVK-----PASF--D  252 (290)
T ss_dssp             SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHH---TTTCC-----CGGG--G
T ss_pred             ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH--HHHHHH---HcCCC-----CCCC--C
Confidence             234568999999999865 69999999999999999999999997543321  111111   11100     0011  1


Q ss_pred             CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          536 PNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       536 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ...++++.++++   +||+.||++|||++|+++|
T Consensus       253 ~~~~~~~~~li~---~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          253 KVAIPEVKEIIE---GCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             GCCCHHHHHHHH---HHSCSSGGGSCCHHHHHTS
T ss_pred             ccCCHHHHHHHH---HHccCChhHCcCHHHHhcC
Confidence            123455666655   9999999999999999875

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1e-50  Score=410.03  Aligned_cols=239  Identities=18%  Similarity=0.299  Sum_probs=201.6

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccc----cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEV----NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||+||+|+.. +++.||||++...    ....+.+.+|++++++++|||||++++++.+++..++||||+++
T Consensus        37 ~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~g  116 (311)
T 4aw0_A           37 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN  116 (311)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             EEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCC
Confidence            467999999999999964 6889999999653    23356789999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC---
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM---  456 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~---  456 (615)
                      |+|.+++...     ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++++||+|||+|+.+...   
T Consensus       117 G~L~~~i~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~  188 (311)
T 4aw0_A          117 GELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  188 (311)
T ss_dssp             EEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred             CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence            9999999743     36999999999999999999999998   999999999999999999999999999987532   


Q ss_pred             --CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccC
Q 007167          457 --PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLR  534 (615)
Q Consensus       457 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  534 (615)
                        ....+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+..+....      +....         ...
T Consensus       189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~------i~~~~---------~~~  253 (311)
T 4aw0_A          189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAK------IIKLE---------YDF  253 (311)
T ss_dssp             CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHHTC---------CCC
T ss_pred             ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------HHcCC---------CCC
Confidence              2345789999999999998999999999999999999999999986543333221      11111         111


Q ss_pred             CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          535 YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       535 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ...++++++++++   +|+..||++|||++|++.+
T Consensus       254 p~~~s~~~~dli~---~lL~~dp~~R~t~~e~~~~  285 (311)
T 4aw0_A          254 PEKFFPKARDLVE---KLLVLDATKRLGCEEMEGY  285 (311)
T ss_dssp             CTTCCHHHHHHHH---HHSCSSGGGSTTSGGGTCH
T ss_pred             CcccCHHHHHHHH---HHccCCHhHCcChHHHcCC
Confidence            2345667777776   9999999999999998654

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5.5e-50  Score=399.21  Aligned_cols=238  Identities=20%  Similarity=0.308  Sum_probs=186.9

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEecccc----CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVN----VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||+||+|.. .+++.||||++....    ...+.+.+|+++++.++|||||++++++.+++..++||||+ +
T Consensus        18 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~   96 (275)
T 3hyh_A           18 VKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-G   96 (275)
T ss_dssp             EEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-C
T ss_pred             EEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-C
Confidence            35799999999999985 468999999997542    22457899999999999999999999999999999999999 6


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      |+|.+++...     ..+++..+..++.|++.||+|||+++   |+||||||+|||+++++++||+|||+|+......  
T Consensus        97 g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~  168 (275)
T 3hyh_A           97 NELFDYIVQR-----DKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFL  168 (275)
T ss_dssp             EEHHHHHHHS-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC---------
T ss_pred             CCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCCCcc
Confidence            8999998743     36999999999999999999999998   9999999999999999999999999998765432  


Q ss_pred             CCCCCCCcccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          458 PPAMRAAGYRAPEVTDTRKA-TQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                      ....||+.|+|||++.+..+ +.++||||+||++|||++|+.||.+.+..+...      .+....         .....
T Consensus       169 ~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~------~i~~~~---------~~~p~  233 (275)
T 3hyh_A          169 KTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFK------NISNGV---------YTLPK  233 (275)
T ss_dssp             ------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHTC---------CCCCT
T ss_pred             CCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHH------HHHcCC---------CCCCC
Confidence            34578999999999988776 689999999999999999999997644322222      111111         11123


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .++++++++++   +|++.||++|||++|++++
T Consensus       234 ~~s~~~~~li~---~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          234 FLSPGAAGLIK---RMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             TSCHHHHHHHH---HHSCSSGGGSCCHHHHHHC
T ss_pred             CCCHHHHHHHH---HHccCChhHCcCHHHHHcC
Confidence            45667777666   9999999999999999885

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.3e-50  Score=417.16  Aligned_cols=255  Identities=27%  Similarity=0.394  Sum_probs=203.6

Q ss_pred             hhhcCcCCccEEEEEEECC------CCEEEEEEeccccC--CHHHHHHHHHHHhCCCC-CcccceeEEEEec-CeeeEEe
Q 007167          305 AEVLGKGTFGTAYKAALED------ASTVVVKRLKEVNV--GKREFEQQMEIVGGIRH-ENVVALRAYYYSK-DEKLMVY  374 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~-~~~~lV~  374 (615)
                      .+.||+|+||+||+|.+..      ++.||||+++....  ..+.|.+|++++.+++| ||||+++|+|.+. +..++||
T Consensus        69 ~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~  148 (353)
T 4ase_A           69 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV  148 (353)
T ss_dssp             EEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEE
T ss_pred             eeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEE
Confidence            4679999999999998643      35799999976432  24578999999999965 8999999999765 5689999


Q ss_pred             ecCCCCChhhhhccCCC-----------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEE
Q 007167          375 DYFEPGSVSAMLHGRRG-----------EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVC  443 (615)
Q Consensus       375 e~~~~gsL~~~l~~~~~-----------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~k  443 (615)
                      |||++|+|.++|+..+.           .....++|..+..|+.|||.||+|||+++   ||||||||+|||+++++++|
T Consensus       149 Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~vK  225 (353)
T 4ase_A          149 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVK  225 (353)
T ss_dssp             ECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred             EcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCccCccceeeCCCCCEE
Confidence            99999999999975432           11346899999999999999999999998   99999999999999999999


Q ss_pred             EeecccccccCCCCC-----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHH
Q 007167          444 VSDIGLAALMSPMPP-----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNS  517 (615)
Q Consensus       444 l~DfG~a~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  517 (615)
                      |+|||+|+.+.....     ...+|+.|||||++.+..|+.++|||||||++|||+| |+.||.+....+..  ...+. 
T Consensus       226 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~--~~~i~-  302 (353)
T 4ase_A          226 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRLK-  302 (353)
T ss_dssp             ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--HHHHH-
T ss_pred             ECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHH--HHHHH-
Confidence            999999987654322     2346788999999999999999999999999999998 99999875543321  11111 


Q ss_pred             hhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhhc
Q 007167          518 VVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKA  578 (615)
Q Consensus       518 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~  578 (615)
                         +..       .+...+.+++++.+++   .+||+.||++|||+.||+++|+++.+...
T Consensus       303 ---~g~-------~~~~p~~~~~~~~~li---~~c~~~dP~~RPt~~eil~~L~~llq~~~  350 (353)
T 4ase_A          303 ---EGT-------RMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNLLQANA  350 (353)
T ss_dssp             ---HTC-------CCCCCTTCCHHHHHHH---HHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             ---cCC-------CCCCCccCCHHHHHHH---HHHcCcChhHCcCHHHHHHHHHHHHHHhh
Confidence               110       1112233455555554   49999999999999999999999876543

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.1e-50  Score=405.62  Aligned_cols=239  Identities=23%  Similarity=0.373  Sum_probs=191.9

Q ss_pred             hhhcCcCCccEEEEEEEC----CCCEEEEEEecccc---CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecC
Q 007167          305 AEVLGKGTFGTAYKAALE----DASTVVVKRLKEVN---VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYF  377 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  377 (615)
                      .+.||+|+||+||+|+..    .++.||||+++...   .....+.+|++++++++|||||++++++.+++..++||||+
T Consensus        29 ~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~  108 (304)
T 3ubd_A           29 LKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFL  108 (304)
T ss_dssp             EEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCC
T ss_pred             EEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcC
Confidence            457999999999999852    46789999997542   12346889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC-
Q 007167          378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM-  456 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~-  456 (615)
                      ++|+|.+++...     ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++++||+|||+|+..... 
T Consensus       109 ~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  180 (304)
T 3ubd_A          109 RGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  180 (304)
T ss_dssp             TTCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred             CCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence            999999999743     36999999999999999999999998   999999999999999999999999999875432 


Q ss_pred             --CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccC
Q 007167          457 --PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLR  534 (615)
Q Consensus       457 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  534 (615)
                        .....||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+..+....+      ...         ....
T Consensus       181 ~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i------~~~---------~~~~  245 (304)
T 3ubd_A          181 KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMI------LKA---------KLGM  245 (304)
T ss_dssp             CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHC---------CCCC
T ss_pred             ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHH------HcC---------CCCC
Confidence              23457899999999999999999999999999999999999999875543332221      111         1112


Q ss_pred             CCCcHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 007167          535 YPNIEEEMVEMLQVGMACVVRMPEERPKM-----ADVLKM  569 (615)
Q Consensus       535 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~-----~evl~~  569 (615)
                      ...+++++.++++   +||+.||++|||+     +|+++|
T Consensus       246 p~~~s~~~~~li~---~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          246 PQFLSPEAQSLLR---MLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             CTTSCHHHHHHHH---HHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             CCcCCHHHHHHHH---HHcccCHHHCCCCCcCCHHHHHcC
Confidence            2345677777776   9999999999984     677654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=8.8e-48  Score=389.95  Aligned_cols=241  Identities=22%  Similarity=0.355  Sum_probs=181.4

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecC------------e
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKD------------E  369 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------------~  369 (615)
                      .+.||+|+||+||+|..+ +++.||||+++....  ..+.+.+|++++++++|||||++++++.+.+            .
T Consensus        10 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~   89 (299)
T 4g31_A           10 IQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVY   89 (299)
T ss_dssp             EEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEE
T ss_pred             eeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcE
Confidence            357999999999999964 688999999875432  2356889999999999999999999997654            3


Q ss_pred             eeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeeccc
Q 007167          370 KLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGL  449 (615)
Q Consensus       370 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~  449 (615)
                      .++||||+++|+|.+++....  .....++..++.|+.|++.||+|||+++   |+||||||+|||++.++++||+|||+
T Consensus        90 l~ivmE~~~gg~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~DFGl  164 (299)
T 4g31_A           90 LYIQMQLCRKENLKDWMNGRC--TIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGL  164 (299)
T ss_dssp             EEEEEECCCSCCHHHHHHTCC--SGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCCC
T ss_pred             EEEEEecCCCCcHHHHHHhcC--CCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEccCcc
Confidence            689999999999999997542  2234677888999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCC---------------CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHH
Q 007167          450 AALMSPMP---------------PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRW  514 (615)
Q Consensus       450 a~~~~~~~---------------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~  514 (615)
                      |+.+....               ...+||+.|||||++.+..|+.++|||||||++|||++   ||....  +   ....
T Consensus       165 a~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~---~~~~  236 (299)
T 4g31_A          165 VTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--E---RVRT  236 (299)
T ss_dssp             C--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--H---HHHH
T ss_pred             ceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--H---HHHH
Confidence            98775321               12358999999999999999999999999999999996   775321  1   1111


Q ss_pred             HHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          515 VNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       515 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      +.......           ..+..........+++.+||+.||++|||+.|++++
T Consensus       237 ~~~~~~~~-----------~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          237 LTDVRNLK-----------FPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             HHHHHTTC-----------CCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHhcCC-----------CCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            11111100           001111222233445559999999999999999874

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.6e-46  Score=391.64  Aligned_cols=253  Identities=20%  Similarity=0.321  Sum_probs=195.1

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEec------CeeeEEe
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSK------DEKLMVY  374 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lV~  374 (615)
                      .+.||+|+||+||+|..+ +|+.||||+++.....   .+.+.+|+++|+.++|||||++++++...      +..||||
T Consensus        59 ~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivm  138 (398)
T 4b99_A           59 IETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVL  138 (398)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEE
T ss_pred             EEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEE
Confidence            357999999999999964 6899999999765333   34578999999999999999999997643      5789999


Q ss_pred             ecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccC
Q 007167          375 DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS  454 (615)
Q Consensus       375 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~  454 (615)
                      |||+ |+|.+++...     ..+++..+..++.|++.||+|||+++   ||||||||+|||++.++.+||+|||+|+.+.
T Consensus       139 E~~~-g~L~~~i~~~-----~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~  209 (398)
T 4b99_A          139 DLME-SDLHQIIHSS-----QPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGLC  209 (398)
T ss_dssp             ECCS-EEHHHHHTSS-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred             eCCC-CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeecc
Confidence            9995 7899999743     37999999999999999999999998   9999999999999999999999999998764


Q ss_pred             CC-------CCCCCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccc
Q 007167          455 PM-------PPPAMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAE  526 (615)
Q Consensus       455 ~~-------~~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (615)
                      ..       ....+||+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+..+....+.-............
T Consensus       210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~  289 (398)
T 4b99_A          210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA  289 (398)
T ss_dssp             ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred             cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence            21       2345789999999998765 569999999999999999999999987654443332221111111000000


Q ss_pred             cc-------ccccc---------CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          527 VF-------DVELL---------RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       527 ~~-------d~~~~---------~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ..       ...+.         ..+..+++..++++   +||..||++|||++|+++|
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~---~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLG---RMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHH---HHSCSSTTTSCCHHHHTTS
T ss_pred             hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHH---HHCcCChhHCcCHHHHhcC
Confidence            00       00000         12334566666666   9999999999999999886

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.9e-45  Score=382.79  Aligned_cols=188  Identities=25%  Similarity=0.439  Sum_probs=163.5

Q ss_pred             hhhcCcCCccEEEEEEEC----CCCEEEEEEeccccCCHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE----DASTVVVKRLKEVNVGKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||+||+|+.+    .++.||+|++.... ....+.+|+++++.+ +|||||++++++.++++.++||||+++
T Consensus        26 ~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g  104 (361)
T 4f9c_A           26 EDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEH  104 (361)
T ss_dssp             EEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCC
T ss_pred             EEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCc
Confidence            357999999999999853    35689999986543 356688999999988 699999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCC-CcEEEeecccccccCCCC-
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQ-GHVCVSDIGLAALMSPMP-  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~-~~~kl~DfG~a~~~~~~~-  457 (615)
                      |+|.+++.        .+++..+..++.|++.||+|||+++   |+||||||+|||++.+ +++||+|||+|+...... 
T Consensus       105 ~~L~~~~~--------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~  173 (361)
T 4f9c_A          105 ESFLDILN--------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKI  173 (361)
T ss_dssp             CCHHHHHT--------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSC
T ss_pred             ccHHHHHc--------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccc
Confidence            99999984        4889999999999999999999998   9999999999999877 799999999997653221 


Q ss_pred             ------------------------------CCCCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 007167          458 ------------------------------PPAMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATG  504 (615)
Q Consensus       458 ------------------------------~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~  504 (615)
                                                    ...+||+.|+|||++.+. .|+.++||||+||++|||++|+.||....
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~  251 (361)
T 4f9c_A          174 ELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS  251 (361)
T ss_dssp             GGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence                                          224689999999998765 58999999999999999999999997543

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.4e-44  Score=396.24  Aligned_cols=242  Identities=23%  Similarity=0.346  Sum_probs=197.9

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccc----cCCHHHHH---HHHHHHhCCCCCcccceeEEEEecCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEV----NVGKREFE---QQMEIVGGIRHENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~---~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      .++||+|+||+||+|+.+ +|+.||||++++.    ......+.   +++++++.++|||||++++++.+.+..|+||||
T Consensus       194 ~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy  273 (689)
T 3v5w_A          194 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL  273 (689)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             EEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEec
Confidence            357999999999999965 6889999999653    22223333   346778888999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM  456 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~  456 (615)
                      ++||+|.++|...     ..+++..+..++.||+.||+|||+++   ||||||||+|||++.+|++||+|||+|+.+...
T Consensus       274 ~~GGdL~~~l~~~-----~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~  345 (689)
T 3v5w_A          274 MNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK  345 (689)
T ss_dssp             CCSCBHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             CCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence            9999999999743     36999999999999999999999998   999999999999999999999999999877543


Q ss_pred             -CCCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccC
Q 007167          457 -PPPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLR  534 (615)
Q Consensus       457 -~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  534 (615)
                       ....+||+.|||||++.. ..|+.++||||+||++|||++|+.||.+....+...+....   ..         .....
T Consensus       346 ~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i---~~---------~~~~~  413 (689)
T 3v5w_A          346 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT---LT---------MAVEL  413 (689)
T ss_dssp             CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHH---HH---------CCCCC
T ss_pred             CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhh---cC---------CCCCC
Confidence             345689999999999964 57999999999999999999999999865544333222211   11         11222


Q ss_pred             CCCcHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 007167          535 YPNIEEEMVEMLQVGMACVVRMPEERPK-----MADVLKM  569 (615)
Q Consensus       535 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~  569 (615)
                      +..++++++++++   +|+..||.+|++     ++||.+|
T Consensus       414 p~~~S~~a~dLI~---~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          414 PDSFSPELRSLLE---GLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             CTTSCHHHHHHHH---HHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             CccCCHHHHHHHH---HHccCCHhHCCCCCCCCHHHHhcC
Confidence            3456777877777   999999999998     6888765

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.5e-43  Score=364.56  Aligned_cols=267  Identities=30%  Similarity=0.511  Sum_probs=223.8

Q ss_pred             hhcCcCCccEEEEEEECCCCEEEEEEeccccC-CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChhh
Q 007167          306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNV-GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSA  384 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  384 (615)
                      +.||+|+||+||+|..+++..||||++..... ..+.+.+|+++++.++||||+++++++.+.+..++||||+++|+|.+
T Consensus        45 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~  124 (321)
T 2qkw_B           45 FLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKR  124 (321)
T ss_dssp             CCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGG
T ss_pred             ceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHH
Confidence            56999999999999988899999999876533 35678999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC-----CC
Q 007167          385 MLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP-----PP  459 (615)
Q Consensus       385 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~-----~~  459 (615)
                      ++.... .....++|..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++......     ..
T Consensus       125 ~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  200 (321)
T 2qkw_B          125 HLYGSD-LPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTV  200 (321)
T ss_dssp             GSSSSC-CCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCC
T ss_pred             HHhccC-CCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeecccccccccccccccccc
Confidence            997543 22346999999999999999999999998   9999999999999999999999999998654322     22


Q ss_pred             CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      ..++..|+|||.+.+..++.++|||||||++|||++|+.||......+......|.............+++.... ....
T Consensus       201 ~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  279 (321)
T 2qkw_B          201 VKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLAD-KIRP  279 (321)
T ss_dssp             CEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTT-CSCH
T ss_pred             cCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhcc-ccCH
Confidence            346788999999988889999999999999999999999998877766667777766555544444555544322 2234


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhh
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVK  577 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~  577 (615)
                      +....+.+++.+||+.||++|||+.|++++|+.+.+..
T Consensus       280 ~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~~  317 (321)
T 2qkw_B          280 ESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRLQ  317 (321)
T ss_dssp             HHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             HHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhcc
Confidence            55667777778999999999999999999999987654

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=1.8e-44  Score=397.84  Aligned_cols=244  Identities=23%  Similarity=0.430  Sum_probs=203.0

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC-CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV-GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      .+.||+|+||+||+|..+ +|+.||+|+++.... ..+.+.+|+++|+.++|||||++++++.+++..+||||||++|+|
T Consensus       162 ~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L  241 (573)
T 3uto_A          162 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL  241 (573)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBH
T ss_pred             EEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcH
Confidence            467999999999999964 688999999875432 346688999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCC--CcEEEeecccccccCCCC--C
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQ--GHVCVSDIGLAALMSPMP--P  458 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~--~~~kl~DfG~a~~~~~~~--~  458 (615)
                      .++|....    ..+++..+..++.||+.||+|||+++   |+||||||+|||++.+  +.+||+|||+|+.+....  .
T Consensus       242 ~~~i~~~~----~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~  314 (573)
T 3uto_A          242 FEKVADEH----NKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK  314 (573)
T ss_dssp             HHHHTCTT----SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEE
T ss_pred             HHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCCcee
Confidence            99986432    36999999999999999999999998   9999999999999854  899999999999876543  2


Q ss_pred             CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCc
Q 007167          459 PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI  538 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  538 (615)
                      ..+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+..+....+      ....+     ......++.+
T Consensus       315 ~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i------~~~~~-----~~~~~~~~~~  383 (573)
T 3uto_A          315 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV------KSCDW-----NMDDSAFSGI  383 (573)
T ss_dssp             EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------HTTCC-----CCCSGGGTTS
T ss_pred             eeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHH------HhCCC-----CCCcccccCC
Confidence            346899999999999999999999999999999999999999875544332222      11111     1111123456


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          539 EEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       539 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      +++.+++++   +||..||.+|||+.|+++|
T Consensus       384 s~~~~dli~---~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          384 SEDGKDFIR---KLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             CHHHHHHHH---TTSCSSGGGSCCHHHHHHS
T ss_pred             CHHHHHHHH---HHccCChhHCcCHHHHhcC
Confidence            677777776   9999999999999999885

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=3.2e-43  Score=362.87  Aligned_cols=267  Identities=38%  Similarity=0.670  Sum_probs=220.2

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      .+.||+|+||+||+|...+++.||||+++....  ....+.+|+++++.++||||+++++++...+..++||||+++|+|
T Consensus        35 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  114 (326)
T 3uim_A           35 KNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSV  114 (326)
T ss_dssp             TTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBH
T ss_pred             ceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCH
Confidence            467999999999999988899999999976422  234689999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC----C
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP----P  458 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~----~  458 (615)
                      .++++... .....++|..+..++.|++.||+|||+...++|+||||||+||+++.++.+||+|||+++......    .
T Consensus       115 ~~~l~~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  193 (326)
T 3uim_A          115 ASCLRERP-ESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT  193 (326)
T ss_dssp             HHHHHCCS-TTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEEC
T ss_pred             HHHHHhcc-ccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccccccc
Confidence            99998643 234569999999999999999999999932339999999999999999999999999998765332    2


Q ss_pred             CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCC--CCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          459 PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHAT--GGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                      ...+|..|+|||.+.+..++.++|||||||++|||++|+.||...  ..........|+.............+..... .
T Consensus       194 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~  272 (326)
T 3uim_A          194 AVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQG-N  272 (326)
T ss_dssp             CCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTT-S
T ss_pred             cccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhcc-c
Confidence            334788999999998888999999999999999999999999632  1223345566776666665555555544432 2


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI  573 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l  573 (615)
                      ...+....+.+++.+|++.||.+|||+.||+++|++.
T Consensus       273 ~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          273 YKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             CCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             cCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            3456677888888899999999999999999999874

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.8e-43  Score=361.82  Aligned_cols=263  Identities=22%  Similarity=0.314  Sum_probs=200.3

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecC----eeeEEeecCCCC
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKD----EKLMVYDYFEPG  380 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lV~e~~~~g  380 (615)
                      .++||+|+||+||+|... ++.||||+++........+++|+.++++++|||||++++++....    ..++||||+++|
T Consensus        29 ~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g  107 (322)
T 3soc_A           29 LEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKG  107 (322)
T ss_dssp             EEEEECSTTCEEEEEEET-TEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTC
T ss_pred             hheecccCceEEEEEEEC-CCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCC
Confidence            357999999999999876 689999999765444556677899999999999999999998754    369999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc----------CCCCceecCCCCCCEEeCCCCcEEEeecccc
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE----------NGGKLVHGGIKASNIFLNSQGHVCVSDIGLA  450 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~----------~~~~iiHrDik~~Nill~~~~~~kl~DfG~a  450 (615)
                      +|.++++..      .++|..+..++.|++.||+|||+.          +   |+||||||+|||++.++.+||+|||++
T Consensus       108 ~L~~~l~~~------~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill~~~~~~kL~DFg~a  178 (322)
T 3soc_A          108 SLSDFLKAN------VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLLKNNLTACIADFGLA  178 (322)
T ss_dssp             BHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             CHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEECCCCeEEEccCCcc
Confidence            999999742      499999999999999999999998          6   999999999999999999999999999


Q ss_pred             cccCCCC-----CCCCCCCcccCccccCCC-----CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhh
Q 007167          451 ALMSPMP-----PPAMRAAGYRAPEVTDTR-----KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVR  520 (615)
Q Consensus       451 ~~~~~~~-----~~~~~~~~y~aPE~~~~~-----~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  520 (615)
                      +......     ....+|..|+|||++.+.     .++.++|||||||++|||++|+.||....................
T Consensus       179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  258 (322)
T 3soc_A          179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS  258 (322)
T ss_dssp             EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred             cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence            7765322     224578899999998763     456688999999999999999999987554332221111000000


Q ss_pred             cc-----cccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhh
Q 007167          521 EE-----WTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVK  577 (615)
Q Consensus       521 ~~-----~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~  577 (615)
                      ..     .......+.+............+.+++.+||+.||++|||+.||++.|+++.+..
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~~  320 (322)
T 3soc_A          259 LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRLT  320 (322)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             hhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            00     0000001111000001123344666666999999999999999999999998643

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.4e-42  Score=355.32  Aligned_cols=254  Identities=28%  Similarity=0.441  Sum_probs=197.3

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      .+.||+|+||+||+|.. .++.||||++......   .+.+.+|++++++++||||+++++++.+.+..++||||+++|+
T Consensus        42 ~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~  120 (309)
T 3p86_A           42 KEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS  120 (309)
T ss_dssp             EEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCB
T ss_pred             eeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCc
Confidence            46799999999999987 5788999999765433   2468899999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC---CC
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM---PP  458 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~---~~  458 (615)
                      |.+++....  ....+++..+..++.|++.||+|||+.+ ++|+||||||+||+++.++.+||+|||+++.....   ..
T Consensus       121 L~~~l~~~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  197 (309)
T 3p86_A          121 LYRLLHKSG--AREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK  197 (309)
T ss_dssp             HHHHHHSTT--HHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC-------------
T ss_pred             HHHHHhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCccccccccccc
Confidence            999997532  1224899999999999999999999985 34999999999999999999999999999765433   23


Q ss_pred             CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCc
Q 007167          459 PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI  538 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  538 (615)
                      ...+|..|+|||.+.+..++.++|||||||++|||++|+.||......+....+.   .   ..       ........+
T Consensus       198 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~---~---~~-------~~~~~~~~~  264 (309)
T 3p86_A          198 SAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVG---F---KC-------KRLEIPRNL  264 (309)
T ss_dssp             ----CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHH---H---SC-------CCCCCCTTS
T ss_pred             cCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---h---cC-------CCCCCCccC
Confidence            3457889999999999899999999999999999999999998654433222111   0   00       011112344


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhhc
Q 007167          539 EEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKA  578 (615)
Q Consensus       539 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~  578 (615)
                      ++++.++++   +||..+|++|||++|+++.|+.+.+...
T Consensus       265 ~~~l~~li~---~~l~~dP~~Rps~~~ll~~L~~~~~~~~  301 (309)
T 3p86_A          265 NPQVAAIIE---GCWTNEPWKRPSFATIMDLLRPLIKSAV  301 (309)
T ss_dssp             CHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred             CHHHHHHHH---HHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence            555555555   9999999999999999999999987543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.6e-42  Score=346.04  Aligned_cols=247  Identities=22%  Similarity=0.411  Sum_probs=206.9

Q ss_pred             hhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChhhh
Q 007167          306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAM  385 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~  385 (615)
                      +.||+|+||+||+|...++..||+|++.......+.+.+|++++++++||||+++++++.+++..++||||+++|+|.++
T Consensus        16 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   95 (269)
T 4hcu_A           16 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY   95 (269)
T ss_dssp             EEEEECSSCEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHH
T ss_pred             heecCCCccEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHH
Confidence            56999999999999998889999999987777788899999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC----CCCCC
Q 007167          386 LHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM----PPPAM  461 (615)
Q Consensus       386 l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~----~~~~~  461 (615)
                      +....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....    .....
T Consensus        96 l~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  168 (269)
T 4hcu_A           96 LRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK  168 (269)
T ss_dssp             HHTTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTT
T ss_pred             HHhcC----cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccccccCcc
Confidence            97532    36899999999999999999999998   999999999999999999999999999876532    22334


Q ss_pred             CCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHH
Q 007167          462 RAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE  540 (615)
Q Consensus       462 ~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  540 (615)
                      ++..|+|||.+.+..++.++||||+|+++|||++ |+.||......+....+      ...        .........++
T Consensus       169 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~------~~~--------~~~~~~~~~~~  234 (269)
T 4hcu_A          169 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI------STG--------FRLYKPRLAST  234 (269)
T ss_dssp             CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH------HTT--------CCCCCCTTSCH
T ss_pred             cccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHH------hcC--------ccCCCCCcCCH
Confidence            5678999999988889999999999999999999 99999865443322211      110        00111122345


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          541 EMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       541 ~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                      ++.++++   +|++.+|++||++.|++++|+++.+.
T Consensus       235 ~~~~li~---~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          235 HVYQIMN---HCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             HHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHH---HHccCCcccCcCHHHHHHHHHHHHHc
Confidence            5555555   99999999999999999999999864

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.5e-42  Score=362.52  Aligned_cols=254  Identities=25%  Similarity=0.422  Sum_probs=204.7

Q ss_pred             hhhcCcCCccEEEEEEEC--------CCCEEEEEEeccccC--CHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEE
Q 007167          305 AEVLGKGTFGTAYKAALE--------DASTVVVKRLKEVNV--GKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMV  373 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV  373 (615)
                      .+.||+|+||+||+|...        ++..||||+++....  ..+.+.+|+++++.+ +||||+++++++.+.+..++|
T Consensus        86 ~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  165 (370)
T 2psq_A           86 GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI  165 (370)
T ss_dssp             EEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEE
Confidence            457999999999999852        345799999975432  235688999999999 899999999999999999999


Q ss_pred             eecCCCCChhhhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcE
Q 007167          374 YDYFEPGSVSAMLHGRRGE-----------GQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHV  442 (615)
Q Consensus       374 ~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~  442 (615)
                      |||+++|+|.+++......           ....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+
T Consensus       166 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~  242 (370)
T 2psq_A          166 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVM  242 (370)
T ss_dssp             EECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCE
T ss_pred             EEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEECCCCCE
Confidence            9999999999999754321           1245899999999999999999999998   9999999999999999999


Q ss_pred             EEeecccccccCCCC-----CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 007167          443 CVSDIGLAALMSPMP-----PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVN  516 (615)
Q Consensus       443 kl~DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  516 (615)
                      ||+|||+++......     ....++..|+|||++.+..++.++|||||||++|||++ |+.||......+....+.   
T Consensus       243 kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~---  319 (370)
T 2psq_A          243 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK---  319 (370)
T ss_dssp             EECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH---
T ss_pred             EEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh---
Confidence            999999998765432     22234678999999988899999999999999999999 999998765444332211   


Q ss_pred             HhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhhc
Q 007167          517 SVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKA  578 (615)
Q Consensus       517 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~  578 (615)
                      .    ..       .......+++++.++++   +||..+|++||++.|+++.|+++.....
T Consensus       320 ~----~~-------~~~~~~~~~~~l~~li~---~~l~~dP~~Rpt~~ell~~L~~il~~~~  367 (370)
T 2psq_A          320 E----GH-------RMDKPANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRILTLTT  367 (370)
T ss_dssp             T----TC-------CCCCCTTSCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             c----CC-------CCCCCCCCCHHHHHHHH---HHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            1    00       01112234455555555   9999999999999999999999886543

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=4.6e-42  Score=351.67  Aligned_cols=249  Identities=25%  Similarity=0.438  Sum_probs=203.3

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc-CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN-VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      .++||+|+||+||+|... ++..||+|++.... ...+.+.+|+++++.++||||+++++++.+++..++||||+++|+|
T Consensus        15 ~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L   94 (310)
T 3s95_A           15 GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL   94 (310)
T ss_dssp             EEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred             cceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcH
Confidence            457999999999999965 58889999886532 2356789999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC----
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP----  458 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~----  458 (615)
                      .+++...    ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.......    
T Consensus        95 ~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  167 (310)
T 3s95_A           95 RGIIKSM----DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG  167 (310)
T ss_dssp             HHHHHHC----CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC--------
T ss_pred             HHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccccccccc
Confidence            9999753    236999999999999999999999998   99999999999999999999999999987643221    


Q ss_pred             -------------CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchh---hHHHHHHHhhhcc
Q 007167          459 -------------PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVV---HLVRWVNSVVREE  522 (615)
Q Consensus       459 -------------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~---~~~~~~~~~~~~~  522 (615)
                                   ...+|..|+|||.+.+..++.++|||||||++|||++|..||.........   ........     
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~-----  242 (310)
T 3s95_A          168 LRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR-----  242 (310)
T ss_dssp             ------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH-----
T ss_pred             cccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc-----
Confidence                         345788999999999999999999999999999999999998764332211   11111100     


Q ss_pred             cccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhhc
Q 007167          523 WTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKA  578 (615)
Q Consensus       523 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~  578 (615)
                              .  ..+.+++++.+++   .+|++.||++|||+.|+++.|++++....
T Consensus       243 --------~--~~~~~~~~l~~li---~~~l~~dP~~Rps~~~l~~~L~~l~~~~~  285 (310)
T 3s95_A          243 --------Y--CPPNCPPSFFPIT---VRCCDLDPEKRPSFVKLEHWLETLRMHLA  285 (310)
T ss_dssp             --------T--CCTTCCTTHHHHH---HHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             --------c--CCCCCCHHHHHHH---HHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence                    0  1123334444444   49999999999999999999999987554

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.3e-41  Score=351.67  Aligned_cols=264  Identities=15%  Similarity=0.153  Sum_probs=208.9

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccCCHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVGKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      .+.||+|+||+||+|.. .+++.||||.+.... ..+.+.+|+++++.+ +||||+++++++...+..++||||+ +++|
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L   91 (330)
T 2izr_A           14 GKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS-RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSL   91 (330)
T ss_dssp             EEECCC-CTTSEEEEEETTTTEEEEEEEEETTC-SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred             EEEeeccCCceEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCH
Confidence            35699999999999996 578889999987543 245688999999999 9999999999999999999999999 9999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCc-----EEEeecccccccCCCC
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGH-----VCVSDIGLAALMSPMP  457 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~-----~kl~DfG~a~~~~~~~  457 (615)
                      .+++...    ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.     +||+|||+++.+....
T Consensus        92 ~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~  164 (330)
T 2izr_A           92 EDLFDLC----DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE  164 (330)
T ss_dssp             HHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTT
T ss_pred             HHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCC
Confidence            9999753    236999999999999999999999998   999999999999999887     9999999998764322


Q ss_pred             ----------CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccc
Q 007167          458 ----------PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEV  527 (615)
Q Consensus       458 ----------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (615)
                                ....+|..|+|||++.+..++.++|||||||++|||++|+.||......+.......+.........   
T Consensus       165 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~---  241 (330)
T 2izr_A          165 TKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPI---  241 (330)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCH---
T ss_pred             CCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCH---
Confidence                      2446789999999999999999999999999999999999999886655544443333221111000   


Q ss_pred             ccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhhcCCCCCCCccc
Q 007167          528 FDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTENRS  588 (615)
Q Consensus       528 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~~~~~~~~~~~  588 (615)
                         .. .....+ +   +.+++..|+..+|.+||++.+|++.|+++.+...........+.
T Consensus       242 ---~~-~~~~~p-~---~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~  294 (330)
T 2izr_A          242 ---EV-LCENFP-E---MATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYMFDYEYDWI  294 (330)
T ss_dssp             ---HH-HTTTCH-H---HHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred             ---HH-HhccCh-H---HHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCCCCCCccCC
Confidence               00 011223 4   44455599999999999999999999998775543333333333

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=6.1e-42  Score=345.85  Aligned_cols=249  Identities=22%  Similarity=0.366  Sum_probs=204.4

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChhh
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSA  384 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  384 (615)
                      .+.||+|+||+||++...++..||+|+++......+.+.+|++++..++||||+++++++.+.+..++||||+++|+|.+
T Consensus        29 ~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~  108 (283)
T 3gen_A           29 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN  108 (283)
T ss_dssp             EEECC---CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHH
T ss_pred             HhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHH
Confidence            35699999999999999988899999998777778889999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC----CCCC
Q 007167          385 MLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM----PPPA  460 (615)
Q Consensus       385 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~----~~~~  460 (615)
                      ++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......    ....
T Consensus       109 ~l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  181 (283)
T 3gen_A          109 YLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS  181 (283)
T ss_dssp             HHHCGG----GCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTST
T ss_pred             HHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccccccccCC
Confidence            997532    35999999999999999999999998   999999999999999999999999999876432    2233


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      .++..|+|||.+.+..++.++||||+|+++|||++ |+.||......+....+.      ...        ........+
T Consensus       182 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~------~~~--------~~~~~~~~~  247 (283)
T 3gen_A          182 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA------QGL--------RLYRPHLAS  247 (283)
T ss_dssp             TSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH------TTC--------CCCCCTTCC
T ss_pred             ccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh------ccc--------CCCCCCcCC
Confidence            45678999999988889999999999999999998 999998755433222111      100        001112234


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhh
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVK  577 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~  577 (615)
                      +.+.+++   .+||+.+|++|||++|++++|+++.+.+
T Consensus       248 ~~l~~li---~~~l~~~p~~Rps~~~ll~~L~~~~~~e  282 (283)
T 3gen_A          248 EKVYTIM---YSCWHEKADERPTFKILLSNILDVMDEE  282 (283)
T ss_dssp             HHHHHHH---HHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHHHHHH---HHHccCChhHCcCHHHHHHHHHHHhhcc
Confidence            4454544   4999999999999999999999987643

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2e-41  Score=348.79  Aligned_cols=240  Identities=20%  Similarity=0.360  Sum_probs=198.0

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEecccc-CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVN-VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      +.||+|+||+||+|... +|+.||||++.... ...+.+.+|+++++.++||||+++++++...+..++||||+++|+|.
T Consensus        51 ~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~  130 (321)
T 2c30_A           51 VKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT  130 (321)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHH
T ss_pred             EEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHH
Confidence            36999999999999976 78999999997543 34567889999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC---CCCC
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM---PPPA  460 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~---~~~~  460 (615)
                      +++..      ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......   ....
T Consensus       131 ~~l~~------~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~  201 (321)
T 2c30_A          131 DIVSQ------VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL  201 (321)
T ss_dssp             HHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred             HHHHh------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccc
Confidence            99863      25899999999999999999999998   999999999999999999999999999876543   2344


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE  540 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  540 (615)
                      .+|..|+|||++.+..++.++|||||||++|||++|+.||......+.   ...+....         .+........++
T Consensus       202 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~---~~~~~~~~---------~~~~~~~~~~~~  269 (321)
T 2c30_A          202 VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQA---MKRLRDSP---------PPKLKNSHKVSP  269 (321)
T ss_dssp             CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHHHSS---------CCCCTTGGGSCH
T ss_pred             cCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHhcCC---------CCCcCccccCCH
Confidence            678899999999988999999999999999999999999976443222   11111110         011111122345


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          541 EMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       541 ~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ++.++++   +|++.||++|||+.|++++
T Consensus       270 ~l~~li~---~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          270 VLRDFLE---RMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             HHHHHHH---HHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHH---HHccCChhhCcCHHHHhcC
Confidence            5555555   9999999999999999886

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=2.2e-42  Score=356.50  Aligned_cols=249  Identities=23%  Similarity=0.400  Sum_probs=201.0

Q ss_pred             hhhcCcCCccEEEEEEEC----CCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALE----DASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      .+.||+|+||+||+|.+.    .+..||||+++....  ..+.+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus        54 ~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  133 (325)
T 3kul_A           54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYME  133 (325)
T ss_dssp             EEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCT
T ss_pred             eeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCC
Confidence            357999999999999974    344699999975422  24578999999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP  458 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~  458 (615)
                      +|+|.++++..    ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.......
T Consensus       134 ~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  206 (325)
T 3kul_A          134 NGSLDTFLRTH----DGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPD  206 (325)
T ss_dssp             TCBHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC----
T ss_pred             CCcHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCcccccccCcc
Confidence            99999999643    236999999999999999999999998   99999999999999999999999999987754321


Q ss_pred             ------CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccccccccc
Q 007167          459 ------PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE  531 (615)
Q Consensus       459 ------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  531 (615)
                            ...+|..|+|||++.+..++.++|||||||++|||++ |+.||......+....+.      ..        ..
T Consensus       207 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~------~~--------~~  272 (325)
T 3kul_A          207 AAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE------EG--------YR  272 (325)
T ss_dssp             CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH------TT--------CC
T ss_pred             ceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH------cC--------CC
Confidence                  1224567999999988889999999999999999999 999997755443322211      10        01


Q ss_pred             ccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhh
Q 007167          532 LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVK  577 (615)
Q Consensus       532 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~  577 (615)
                      ......+++++.+++.   +||..||++|||+.||++.|+.+.+..
T Consensus       273 ~~~~~~~~~~l~~li~---~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          273 LPAPMGCPHALHQLML---DCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             CCCCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             CCCCCCcCHHHHHHHH---HHccCChhhCcCHHHHHHHHHHHHhCc
Confidence            1112234455555554   999999999999999999999998644

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=6e-42  Score=343.07  Aligned_cols=247  Identities=24%  Similarity=0.386  Sum_probs=205.2

Q ss_pred             hhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChhhh
Q 007167          306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAM  385 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~  385 (615)
                      +.||+|+||+||+|..+++..||+|+++......+.+.+|++++..++||||+++++++.+.+..++||||+++++|.++
T Consensus        14 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   93 (268)
T 3sxs_A           14 KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNY   93 (268)
T ss_dssp             EEEEEETTEEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHH
T ss_pred             eeeccCCCceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHH
Confidence            56999999999999999888999999987776788899999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC----CCCC
Q 007167          386 LHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP----PPAM  461 (615)
Q Consensus       386 l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~----~~~~  461 (615)
                      +....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......    ....
T Consensus        94 l~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  166 (268)
T 3sxs_A           94 LRSHG----KGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTK  166 (268)
T ss_dssp             HHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCC
T ss_pred             HHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCC
Confidence            97532    35899999999999999999999998   9999999999999999999999999998765432    1223


Q ss_pred             CCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHH
Q 007167          462 RAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE  540 (615)
Q Consensus       462 ~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  540 (615)
                      ++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+      ....        ........++
T Consensus       167 ~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~------~~~~--------~~~~~~~~~~  232 (268)
T 3sxs_A          167 FPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV------SQGH--------RLYRPHLASD  232 (268)
T ss_dssp             CCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH------HTTC--------CCCCCTTSCH
T ss_pred             cCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH------HcCC--------CCCCCCcChH
Confidence            4567999999988889999999999999999999 99999765543322111      1100        0111122344


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          541 EMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       541 ~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                      ++.++++   +|++.+|++|||+.|++++|+.+++.
T Consensus       233 ~l~~li~---~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          233 TIYQIMY---SCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             HHHHHHH---HTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             HHHHHHH---HHcCCChhhCcCHHHHHHHHHHhhhc
Confidence            5555544   99999999999999999999998753

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.4e-41  Score=366.09  Aligned_cols=248  Identities=24%  Similarity=0.395  Sum_probs=204.4

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecC-eeeEEeecCCCCChh
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKD-EKLMVYDYFEPGSVS  383 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-~~~lV~e~~~~gsL~  383 (615)
                      .+.||+|+||+||+|... ++.||||+++... ..+.|.+|++++++++|||||++++++...+ ..++||||+++|+|.
T Consensus       198 ~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~  275 (450)
T 1k9a_A          198 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV  275 (450)
T ss_dssp             EEEEEECSSEEEEEEEET-TEEEEEEEESSCT-TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHH
T ss_pred             EeeecCcCCeeEEEEEec-CCeEEEEEeCCch-HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHH
Confidence            357999999999999876 6799999997654 4578999999999999999999999988765 789999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCCCCCC
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRA  463 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  463 (615)
                      ++++...   ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++..........++
T Consensus       276 ~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  349 (450)
T 1k9a_A          276 DYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP  349 (450)
T ss_dssp             HHHHHHC---TTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC------CCC
T ss_pred             HHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCcccccccccCCCCC
Confidence            9997532   235799999999999999999999998   9999999999999999999999999998765444444567


Q ss_pred             CcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHHHH
Q 007167          464 AGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEM  542 (615)
Q Consensus       464 ~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  542 (615)
                      ..|+|||.+.+..++.++|||||||++|||++ |+.||......+....+.      . ..       .......+++++
T Consensus       350 ~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~------~-~~-------~~~~p~~~~~~l  415 (450)
T 1k9a_A          350 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE------K-GY-------KMDAPDGCPPAV  415 (450)
T ss_dssp             TTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHH------T-TC-------CCCCCTTCCHHH
T ss_pred             cceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH------c-CC-------CCCCCCcCCHHH
Confidence            88999999998899999999999999999998 999998766555433221      1 10       111223445566


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhh
Q 007167          543 VEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVK  577 (615)
Q Consensus       543 ~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~  577 (615)
                      .++++   +||..||++|||+.|+++.|+++....
T Consensus       416 ~~li~---~cl~~dp~~Rpt~~~l~~~L~~i~~~~  447 (450)
T 1k9a_A          416 YDVMK---NCWHLDAATRPTFLQLREQLEHIRTHE  447 (450)
T ss_dssp             HHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             HHHHH---HHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence            55555   999999999999999999999987643

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=7.8e-42  Score=347.85  Aligned_cols=240  Identities=21%  Similarity=0.377  Sum_probs=197.6

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEeccc-cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEV-NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      +.||+|+||+||+|.. .+++.||||++... ....+.+.+|+.+++.++||||+++++++...+..++||||+++|+|.
T Consensus        26 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~  105 (297)
T 3fxz_A           26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT  105 (297)
T ss_dssp             EEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHH
T ss_pred             eeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHH
Confidence            5699999999999985 57889999998654 334667899999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---CCC
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---PPA  460 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~~~  460 (615)
                      +++...      .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......   ...
T Consensus       106 ~~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  176 (297)
T 3fxz_A          106 DVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM  176 (297)
T ss_dssp             HHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred             HHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCc
Confidence            999742      5899999999999999999999998   9999999999999999999999999998765432   234


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE  540 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  540 (615)
                      .+|..|+|||.+.+..++.++|||||||++|||++|+.||......+....+      .....      +.......+++
T Consensus       177 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~------~~~~~------~~~~~~~~~~~  244 (297)
T 3fxz_A          177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI------ATNGT------PELQNPEKLSA  244 (297)
T ss_dssp             CSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH------HHHCS------CCCSCGGGSCH
T ss_pred             cCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCCC------CCCCCccccCH
Confidence            6788999999999889999999999999999999999999765432221111      11100      01111123345


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          541 EMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       541 ~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+.++++   +||+.||++|||+.|++++
T Consensus       245 ~~~~li~---~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          245 IFRDFLN---RCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             HHHHHHH---HHSCSSTTTSCCHHHHTTC
T ss_pred             HHHHHHH---HHccCChhHCcCHHHHhhC
Confidence            5555555   9999999999999999875

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=8.8e-42  Score=352.12  Aligned_cols=238  Identities=20%  Similarity=0.311  Sum_probs=197.5

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      +.||+|+||.||+|.. .+|+.||||++......   .+.+.+|+++++.++||||+++++++...+..++||||+++|+
T Consensus        21 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~  100 (328)
T 3fe3_A           21 KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGE  100 (328)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCB
T ss_pred             EEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCc
Confidence            5699999999999996 57899999999765333   3457899999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--CC
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--PP  459 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--~~  459 (615)
                      |.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......  ..
T Consensus       101 L~~~l~~~-----~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  172 (328)
T 3fe3_A          101 VFDYLVAH-----GRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDA  172 (328)
T ss_dssp             HHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGT
T ss_pred             HHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcccc
Confidence            99999643     35899999999999999999999998   9999999999999999999999999998765432  34


Q ss_pred             CCCCCcccCccccCCCCCC-CccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCc
Q 007167          460 AMRAAGYRAPEVTDTRKAT-QASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI  538 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~~-~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  538 (615)
                      ..+|+.|+|||++.+..+. .++||||+||++|||++|+.||.+.+..+....      .....         .......
T Consensus       173 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~------i~~~~---------~~~p~~~  237 (328)
T 3fe3_A          173 FCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER------VLRGK---------YRIPFYM  237 (328)
T ss_dssp             TSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHHCC---------CCCCTTS
T ss_pred             ccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHH------HHhCC---------CCCCCCC
Confidence            5688999999999887764 799999999999999999999986543322221      11111         1111234


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          539 EEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       539 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ++++.++++   +|+..||.+|||++|++++
T Consensus       238 s~~~~~li~---~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          238 STDCENLLK---RFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             CHHHHHHHH---HHCCSSTTTSCCHHHHTTC
T ss_pred             CHHHHHHHH---HHCCCChhHCcCHHHHhcC
Confidence            556666666   9999999999999999886

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.9e-42  Score=371.06  Aligned_cols=247  Identities=26%  Similarity=0.446  Sum_probs=204.9

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChhh
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSA  384 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  384 (615)
                      .+.||+|+||+||+|.++++..||||+++......+.|.+|+++++.++|||||++++++. .+..++||||+++|+|.+
T Consensus       193 ~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~  271 (454)
T 1qcf_A          193 EKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLD  271 (454)
T ss_dssp             EEEEECCSSEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHH
T ss_pred             EEEcccCCceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHH
Confidence            3579999999999999988899999999876667889999999999999999999999986 667899999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC----CCCC
Q 007167          385 MLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM----PPPA  460 (615)
Q Consensus       385 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~----~~~~  460 (615)
                      +++...   ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....    ....
T Consensus       272 ~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~  345 (454)
T 1qcf_A          272 FLKSDE---GSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA  345 (454)
T ss_dssp             HHHSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSS
T ss_pred             HHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCC
Confidence            997532   235889999999999999999999998   999999999999999999999999999876532    1223


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      .++..|+|||.+....++.++|||||||++|||++ |+.||......+....+   ..   .        ........++
T Consensus       346 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i---~~---~--------~~~~~~~~~~  411 (454)
T 1qcf_A          346 KFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRAL---ER---G--------YRMPRPENCP  411 (454)
T ss_dssp             SSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH---HH---T--------CCCCCCTTSC
T ss_pred             cccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH---Hc---C--------CCCCCCCCCC
Confidence            35678999999988889999999999999999999 99999875543332221   11   1        0111123344


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                      +++.+++   .+||..||++|||+++|++.|+++..
T Consensus       412 ~~l~~li---~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          412 EELYNIM---MRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             HHHHHHH---HHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             HHHHHHH---HHHccCChhHCcCHHHHHHHHHHHHh
Confidence            5555554   49999999999999999999998864

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=3.3e-42  Score=361.89  Aligned_cols=248  Identities=26%  Similarity=0.450  Sum_probs=191.4

Q ss_pred             hhhcCcCCccEEEEEEEC----CCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALE----DASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      .+.||+|+||+||+|...    ++..||||+++....  ..+.|.+|++++++++||||+++++++.+.+..++||||++
T Consensus        50 ~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  129 (373)
T 2qol_A           50 DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYME  129 (373)
T ss_dssp             CEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred             eeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCC
Confidence            457999999999999864    567899999975422  24578999999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP  458 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~  458 (615)
                      +|+|.++++..    ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus       130 ~~sL~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  202 (373)
T 2qol_A          130 NGSLDSFLRKH----DAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPE  202 (373)
T ss_dssp             TCBHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             CCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCccccccccCCc
Confidence            99999999743    236999999999999999999999998   99999999999999999999999999987654321


Q ss_pred             C------CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccccccccc
Q 007167          459 P------AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE  531 (615)
Q Consensus       459 ~------~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  531 (615)
                      .      ..++..|+|||++.+..++.++|||||||++|||++ |+.||......+....+   ..    ..       .
T Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i---~~----~~-------~  268 (373)
T 2qol_A          203 AAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAV---DE----GY-------R  268 (373)
T ss_dssp             -----------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHH---HT----TE-------E
T ss_pred             cceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---Hc----CC-------C
Confidence            1      123567999999988899999999999999999998 99999765543322211   11    00       1


Q ss_pred             ccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          532 LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       532 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                      .......++++   .+++.+||+.||++||++.||+++|+++.+.
T Consensus       269 ~~~~~~~~~~l---~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          269 LPPPMDCPAAL---YQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             CCCCTTCBHHH---HHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCCCccccHHH---HHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence            11112333444   4455599999999999999999999998763

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=4e-41  Score=345.64  Aligned_cols=238  Identities=21%  Similarity=0.358  Sum_probs=201.2

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccc----cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEV----NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      +.||+|+||+||+|... +++.||+|+++..    ....+.+.+|..+++.++||||+++++++.+.+..++||||+++|
T Consensus        12 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg   91 (318)
T 1fot_A           12 RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGG   91 (318)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCC
Confidence            56999999999999965 6889999999753    223566788999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCCC
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPA  460 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  460 (615)
                      +|.+++...     ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++++||+|||+++.........
T Consensus        92 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~~~  163 (318)
T 1fot_A           92 ELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTL  163 (318)
T ss_dssp             BHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCCC
T ss_pred             CHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCCccccc
Confidence            999999743     36899999999999999999999998   9999999999999999999999999999877666667


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE  540 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  540 (615)
                      .+|+.|+|||++.+..++.++||||+||++|||++|+.||...+..+..      ..+...         .....+..++
T Consensus       164 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~------~~i~~~---------~~~~p~~~~~  228 (318)
T 1fot_A          164 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTY------EKILNA---------ELRFPPFFNE  228 (318)
T ss_dssp             CSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHHC---------CCCCCTTSCH
T ss_pred             cCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHH------HHHHhC---------CCCCCCCCCH
Confidence            7899999999999989999999999999999999999999765432221      111111         1111234556


Q ss_pred             HHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007167          541 EMVEMLQVGMACVVRMPEERP-----KMADVLKM  569 (615)
Q Consensus       541 ~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  569 (615)
                      ++.++++   +|+..||++||     +++|++++
T Consensus       229 ~~~~li~---~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          229 DVKDLLS---RLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             HHHHHHH---HHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHHHHHH---HHhccCHHHcCCCcCCCHHHHhcC
Confidence            6666666   99999999999     89999865

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=2.8e-41  Score=352.63  Aligned_cols=243  Identities=21%  Similarity=0.354  Sum_probs=199.8

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC-------CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV-------GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      .+.||+|+||+||+|... +|..||+|.++....       ..+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus        17 ~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~   96 (361)
T 2yab_A           17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILEL   96 (361)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEc
Confidence            357999999999999965 688999999976432       246789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCC----cEEEeecccccc
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG----HVCVSDIGLAAL  452 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~----~~kl~DfG~a~~  452 (615)
                      +++|+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++    .+||+|||++..
T Consensus        97 ~~gg~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~  168 (361)
T 2yab_A           97 VSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE  168 (361)
T ss_dssp             CCSCBHHHHHTTC-----SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCEE
T ss_pred             CCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCceE
Confidence            9999999999642     36999999999999999999999998   99999999999998877    799999999987


Q ss_pred             cCCCC--CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccc
Q 007167          453 MSPMP--PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDV  530 (615)
Q Consensus       453 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  530 (615)
                      .....  ....+|+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+....+      ....     ++.
T Consensus       169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i------~~~~-----~~~  237 (361)
T 2yab_A          169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI------TAVS-----YDF  237 (361)
T ss_dssp             CCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------HTTC-----CCC
T ss_pred             cCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhcC-----CCC
Confidence            75432  3456899999999999889999999999999999999999999875443322211      1110     011


Q ss_pred             cccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          531 ELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       531 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ....++.+++++.++++   +|+..||++|||+.|++++
T Consensus       238 ~~~~~~~~s~~~~~li~---~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          238 DEEFFSQTSELAKDFIR---KLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             CHHHHTTSCHHHHHHHH---HHSCSSTTTSCCHHHHHTS
T ss_pred             CchhccCCCHHHHHHHH---HHCCCChhHCcCHHHHhcC
Confidence            11112344566666666   9999999999999999863

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=6e-41  Score=342.72  Aligned_cols=272  Identities=28%  Similarity=0.487  Sum_probs=213.8

Q ss_pred             cccCHHHHHHHHh-----------hhcCcCCccEEEEEEECCCCEEEEEEecccc-----CCHHHHHHHHHHHhCCCCCc
Q 007167          293 LVFDLEDLLRASA-----------EVLGKGTFGTAYKAALEDASTVVVKRLKEVN-----VGKREFEQQMEIVGGIRHEN  356 (615)
Q Consensus       293 ~~~~~~~l~~~~~-----------~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-----~~~~~~~~e~~~l~~l~h~n  356 (615)
                      ..|.+.++..++.           +.||+|+||+||+|.. +++.||||++....     ...+.+.+|+++++.++|||
T Consensus        13 ~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   91 (307)
T 2nru_A           13 HSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN   91 (307)
T ss_dssp             EECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred             CcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence            3466777776662           5799999999999986 57899999986532     12467889999999999999


Q ss_pred             ccceeEEEEecCeeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEe
Q 007167          357 VVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFL  436 (615)
Q Consensus       357 iv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill  436 (615)
                      |+++++++.+.+..++||||+++|+|.+++....  ....+++..+..++.|++.||+|||+.+   |+||||||+||++
T Consensus        92 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili  166 (307)
T 2nru_A           92 LVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLD--GTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL  166 (307)
T ss_dssp             BCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGG--GCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred             eEEEEEEEecCCceEEEEEecCCCcHHHHHHhcc--CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence            9999999999999999999999999999997532  2346999999999999999999999998   9999999999999


Q ss_pred             CCCCcEEEeecccccccCCCC-----CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhH
Q 007167          437 NSQGHVCVSDIGLAALMSPMP-----PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHL  511 (615)
Q Consensus       437 ~~~~~~kl~DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~  511 (615)
                      +.++.+||+|||++.......     ....++..|+|||.+.+ .++.++||||||+++|||++|+.||......+....
T Consensus       167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~  245 (307)
T 2nru_A          167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLD  245 (307)
T ss_dssp             CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTH
T ss_pred             cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHH
Confidence            999999999999998765422     23357889999998865 578999999999999999999999987554433222


Q ss_pred             HHHHHHhhhc-ccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          512 VRWVNSVVRE-EWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       512 ~~~~~~~~~~-~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                      +  ....... ....+.++..+..  ........+.+++.+|+..+|.+|||+.||+++|+++..
T Consensus       246 ~--~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          246 I--KEEIEDEEKTIEDYIDKKMND--ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             H--HHHHHTTSCCHHHHSCSSCSC--CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             H--HHHhhhhhhhhhhhccccccc--cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            1  1111111 1112222322222  224445566777779999999999999999999999864

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=8.2e-41  Score=345.93  Aligned_cols=238  Identities=21%  Similarity=0.325  Sum_probs=198.4

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccc----cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEV----NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      +.||+|+||+||+|..+ +++.||+|+++..    ......+.+|+++++.++||||+++++++...+..++||||+++|
T Consensus        11 ~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg   90 (337)
T 1o6l_A           11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   90 (337)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             EEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCC
Confidence            56999999999999965 6889999999753    234567889999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC---C
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM---P  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~---~  457 (615)
                      +|.+++...     ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++++||+|||+++.....   .
T Consensus        91 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~  162 (337)
T 1o6l_A           91 ELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM  162 (337)
T ss_dssp             BHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred             cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcc
Confidence            999999743     36899999999999999999999998   999999999999999999999999999864322   2


Q ss_pred             CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCC
Q 007167          458 PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN  537 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  537 (615)
                      ....+|+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....      +...         .......
T Consensus       163 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~------i~~~---------~~~~p~~  227 (337)
T 1o6l_A          163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL------ILME---------EIRFPRT  227 (337)
T ss_dssp             CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHHC---------CCCCCTT
T ss_pred             cccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHH------HHcC---------CCCCCCC
Confidence            344678999999999998999999999999999999999999976543322211      1111         1111224


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007167          538 IEEEMVEMLQVGMACVVRMPEERP-----KMADVLKM  569 (615)
Q Consensus       538 ~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  569 (615)
                      +++++.++++   +|++.||++||     +++|++++
T Consensus       228 ~s~~~~~li~---~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          228 LSPEAKSLLA---GLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             SCHHHHHHHH---HHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             CCHHHHHHHH---HHhhcCHHHhcCCCCCCHHHHHcC
Confidence            5566666666   99999999999     89999886

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.8e-42  Score=363.19  Aligned_cols=248  Identities=23%  Similarity=0.366  Sum_probs=201.9

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      .+.||+|+||+||+|.+. +++.||||.++....  ..+.|.+|+++++.++||||+++++++...+..++||||+++|+
T Consensus       119 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~  198 (377)
T 3cbl_A          119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD  198 (377)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCB
T ss_pred             eeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCC
Confidence            457999999999999976 788999999875422  13468899999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC---
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP---  458 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~---  458 (615)
                      |.++++..    ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......   
T Consensus       199 L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~  271 (377)
T 3cbl_A          199 FLTFLRTE----GARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAAS  271 (377)
T ss_dssp             HHHHHHHH----GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECC
T ss_pred             HHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeec
Confidence            99999743    235899999999999999999999998   99999999999999999999999999986543211   


Q ss_pred             --CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCC
Q 007167          459 --PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY  535 (615)
Q Consensus       459 --~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  535 (615)
                        ...++..|+|||.+....++.++|||||||++|||++ |+.||......+....+   ..    .       ......
T Consensus       272 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~---~~----~-------~~~~~~  337 (377)
T 3cbl_A          272 GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV---EK----G-------GRLPCP  337 (377)
T ss_dssp             SSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHH---HT----T-------CCCCCC
T ss_pred             CCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---Hc----C-------CCCCCC
Confidence              1123567999999988889999999999999999998 99999876543332221   11    0       011112


Q ss_pred             CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          536 PNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       536 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                      ..+++++.++++   +||+.||++|||++|+++.|+++.+.
T Consensus       338 ~~~~~~l~~li~---~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          338 ELCPDAVFRLME---QCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             TTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHH---HHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            234455555554   99999999999999999999999763

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=4.5e-41  Score=344.54  Aligned_cols=253  Identities=23%  Similarity=0.399  Sum_probs=194.9

Q ss_pred             hhcCcCCccEEEEEEECCCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      +.||+|+||+||+|...+++.||+|+++.....   .+.+.+|+++++.++||||+++++++.+.+..++||||++ |+|
T Consensus        27 ~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~l  105 (311)
T 3niz_A           27 EKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDL  105 (311)
T ss_dssp             EEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-EEH
T ss_pred             hhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-CCH
Confidence            569999999999999988999999999754322   3568899999999999999999999999999999999997 478


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC---CCC
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM---PPP  459 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~---~~~  459 (615)
                      .+.+...    ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.....   ...
T Consensus       106 ~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  178 (311)
T 3niz_A          106 KKVLDEN----KTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH  178 (311)
T ss_dssp             HHHHHTC----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---C
T ss_pred             HHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCCcccccC
Confidence            8887643    235899999999999999999999998   999999999999999999999999999876532   233


Q ss_pred             CCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHH-HHHHHhhhccccc------------
Q 007167          460 AMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLV-RWVNSVVREEWTA------------  525 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~------------  525 (615)
                      ..+|..|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+ ..+.......|..            
T Consensus       179 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (311)
T 3niz_A          179 EVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTF  258 (311)
T ss_dssp             CCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCC
T ss_pred             CcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhccc
Confidence            457889999999876 56899999999999999999999999876655443222 1111111111110            


Q ss_pred             cccccc--ccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          526 EVFDVE--LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       526 ~~~d~~--~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ..+...  ....+.+++++.++++   +|++.||++|||++|++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          259 QVFEKKPWSSIIPGFCQEGIDLLS---NMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             CCCCCCCHHHHSTTCCHHHHHHHH---HHSCSCTTTSCCHHHHHTS
T ss_pred             ccccCCcHHHhCcccCHHHHHHHH---HHcCCChhHCCCHHHHhcC
Confidence            000000  0001233445555555   9999999999999999875

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.1e-41  Score=350.61  Aligned_cols=245  Identities=21%  Similarity=0.358  Sum_probs=200.1

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      .+.||+|+||+||+|... ++..||+|.++........+.+|+++++.++||||+++++++.+.+..++||||+++|+|.
T Consensus        10 ~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~   89 (321)
T 1tki_A           10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIF   89 (321)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHH
T ss_pred             eeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHH
Confidence            356999999999999965 5778999998755444567889999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCC--CCcEEEeecccccccCCCC--CC
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNS--QGHVCVSDIGLAALMSPMP--PP  459 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~--~~~~kl~DfG~a~~~~~~~--~~  459 (615)
                      +++...    ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.  ++.+||+|||+++......  ..
T Consensus        90 ~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~  162 (321)
T 1tki_A           90 ERINTS----AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL  162 (321)
T ss_dssp             HHHTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEE
T ss_pred             HHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcccc
Confidence            999643    236899999999999999999999998   999999999999997  7899999999998875432  22


Q ss_pred             CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      ..+|+.|+|||++.+..++.++||||+||++|||++|+.||......+....+      .....     +.....++.++
T Consensus       163 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i------~~~~~-----~~~~~~~~~~s  231 (321)
T 1tki_A          163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI------MNAEY-----TFDEEAFKEIS  231 (321)
T ss_dssp             EESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HHTCC-----CCCHHHHTTSC
T ss_pred             ccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHH------HcCCC-----CCChhhhccCC
Confidence            34788999999998888899999999999999999999999875443322211      11110     11111123445


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                      +++.++++   +|+..||++|||+.|++++-
T Consensus       232 ~~~~~li~---~~L~~dp~~Rpt~~e~l~hp  259 (321)
T 1tki_A          232 IEAMDFVD---RLLVKERKSRMTASEALQHP  259 (321)
T ss_dssp             HHHHHHHH---TTSCSSGGGSCCHHHHHHSH
T ss_pred             HHHHHHHH---HHcCCChhHCcCHHHHhcCh
Confidence            56666655   99999999999999999863

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.6e-41  Score=350.13  Aligned_cols=246  Identities=25%  Similarity=0.363  Sum_probs=195.7

Q ss_pred             hhcCcCCccEEEEEEEC-CCCE----EEEEEecccc--CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCC
Q 007167          306 EVLGKGTFGTAYKAALE-DAST----VVVKRLKEVN--VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~----vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      +.||+|+||+||+|.+. ++..    |++|.+....  .....+.+|+.+++.++||||+++++++. .+..++||||++
T Consensus        19 ~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~   97 (325)
T 3kex_A           19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLP   97 (325)
T ss_dssp             EEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCT
T ss_pred             eeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCC
Confidence            56999999999999864 3443    7788775432  22356788999999999999999999986 567899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC-
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP-  457 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~-  457 (615)
                      +|+|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        98 ~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  170 (325)
T 3kex_A           98 LGSLLDHVRQHR----GALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK  170 (325)
T ss_dssp             TCBSHHHHHSSG----GGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT
T ss_pred             CCCHHHHHHHcc----ccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccCcccc
Confidence            999999997532    36889999999999999999999998   9999999999999999999999999998775432 


Q ss_pred             ----CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccc
Q 007167          458 ----PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL  532 (615)
Q Consensus       458 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  532 (615)
                          ....++.+|+|||.+.+..++.++|||||||++|||++ |+.||......+....+.   ..   .        ..
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~---~~---~--------~~  236 (325)
T 3kex_A          171 QLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE---KG---E--------RL  236 (325)
T ss_dssp             CCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHH---TT---C--------BC
T ss_pred             cccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHH---cC---C--------CC
Confidence                22335678999999988889999999999999999999 999998766554433322   10   0        01


Q ss_pred             cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       533 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                      ......+.++.+   ++.+||..||.+||++.|++++|+++...
T Consensus       237 ~~~~~~~~~~~~---li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          237 AQPQICTIDVYM---VMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             CCCTTBCTTTTH---HHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             CCCCcCcHHHHH---HHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            111122333344   44599999999999999999999998653

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=2e-41  Score=369.08  Aligned_cols=248  Identities=25%  Similarity=0.397  Sum_probs=206.6

Q ss_pred             hhhcCcCCccEEEEEEECC-CCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          305 AEVLGKGTFGTAYKAALED-ASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      .+.||+|+||+||+|.++. +..||||.++......+.|.+|++++++++|||||+++++|...+..++||||+++|+|.
T Consensus       225 ~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~  304 (495)
T 1opk_A          225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL  304 (495)
T ss_dssp             EEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred             eeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHH
Confidence            4579999999999999765 788999999877666788999999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC----CC
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP----PP  459 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~----~~  459 (615)
                      ++++...   ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++......    ..
T Consensus       305 ~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~  378 (495)
T 1opk_A          305 DYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG  378 (495)
T ss_dssp             HHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTT
T ss_pred             HHHHhcC---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCCceeecCC
Confidence            9997532   346899999999999999999999998   9999999999999999999999999998765322    12


Q ss_pred             CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCc
Q 007167          460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI  538 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  538 (615)
                      ..++..|+|||.+....++.++|||||||++|||++ |+.||......+....+   ..    .       ........+
T Consensus       379 ~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~---~~----~-------~~~~~~~~~  444 (495)
T 1opk_A          379 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL---EK----D-------YRMERPEGC  444 (495)
T ss_dssp             CCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH---HT----T-------CCCCCCTTC
T ss_pred             CcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHH---Hc----C-------CCCCCCCCC
Confidence            234568999999988889999999999999999999 99999876544433222   11    0       011122344


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          539 EEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       539 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                      ++++.+++.   +||+.||++|||+.||++.|+.+..
T Consensus       445 ~~~l~~li~---~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          445 PEKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             CHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             CHHHHHHHH---HHcCcChhHCcCHHHHHHHHHHHHh
Confidence            555555555   9999999999999999999998753

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=8.3e-41  Score=341.95  Aligned_cols=253  Identities=25%  Similarity=0.470  Sum_probs=193.9

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChhh
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSA  384 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  384 (615)
                      .+.||+|+||+||+|... ++.||||++... ...+.+.+|++++++++||||+++++++.  +..++||||+++|+|.+
T Consensus        13 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~~~~L~~   88 (307)
T 2eva_A           13 EEVVGRGAFGVVCKAKWR-AKDVAIKQIESE-SERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAEGGSLYN   88 (307)
T ss_dssp             EEEEECCSSSEEEEEEET-TEEEEEEECSST-THHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCTTCBHHH
T ss_pred             eeEeecCCCceEEEEEEC-CeeEEEEEecCh-hHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCCCCCHHH
Confidence            357999999999999875 688999998643 23567899999999999999999999876  45899999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCc-EEEeecccccccCCCCCCCCCC
Q 007167          385 MLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGH-VCVSDIGLAALMSPMPPPAMRA  463 (615)
Q Consensus       385 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~-~kl~DfG~a~~~~~~~~~~~~~  463 (615)
                      +++...  ....+++..+..++.|+++||+|||+.+..+|+||||||+||+++.++. +||+|||++...........++
T Consensus        89 ~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~~~~gt  166 (307)
T 2eva_A           89 VLHGAE--PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGS  166 (307)
T ss_dssp             HHHCSS--SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------CC
T ss_pred             HHhccC--CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccccccCCCC
Confidence            997542  2235789999999999999999999943223999999999999998886 7999999998776555555689


Q ss_pred             CcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHHHHH
Q 007167          464 AGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMV  543 (615)
Q Consensus       464 ~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~  543 (615)
                      ..|+|||.+.+..++.++||||||+++|||++|+.||........ ... +  ......        .......+++.+.
T Consensus       167 ~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~-~--~~~~~~--------~~~~~~~~~~~l~  234 (307)
T 2eva_A          167 AAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF-RIM-W--AVHNGT--------RPPLIKNLPKPIE  234 (307)
T ss_dssp             TTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHH-HHH-H--HHHTTC--------CCCCBTTCCHHHH
T ss_pred             CceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHH-HHH-H--HHhcCC--------CCCcccccCHHHH
Confidence            999999999998999999999999999999999999976543321 111 1  111100        0011123445555


Q ss_pred             HHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhhc
Q 007167          544 EMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKA  578 (615)
Q Consensus       544 ~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~  578 (615)
                      ++++   +|++.||++|||+.|++++|+.+.+...
T Consensus       235 ~li~---~~l~~dp~~Rps~~ell~~L~~~~~~~~  266 (307)
T 2eva_A          235 SLMT---RCWSKDPSQRPSMEEIVKIMTHLMRYFP  266 (307)
T ss_dssp             HHHH---HHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred             HHHH---HHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence            5555   9999999999999999999999987554

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.7e-41  Score=335.57  Aligned_cols=248  Identities=22%  Similarity=0.405  Sum_probs=206.1

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChhh
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSA  384 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  384 (615)
                      .+.||+|+||.||+|...++..||+|+++......+.+.+|+++++.++||||+++++++.+.+..++||||+++++|.+
T Consensus        13 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~   92 (267)
T 3t9t_A           13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSD   92 (267)
T ss_dssp             EEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHH
T ss_pred             eeEecCCCceeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHH
Confidence            35699999999999999888899999998776677889999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC----CCCC
Q 007167          385 MLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM----PPPA  460 (615)
Q Consensus       385 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~----~~~~  460 (615)
                      ++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......    ....
T Consensus        93 ~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~  165 (267)
T 3t9t_A           93 YLRTQR----GLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT  165 (267)
T ss_dssp             HHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTST
T ss_pred             HHhhCc----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccccccccccccc
Confidence            997532    36899999999999999999999998   999999999999999999999999999876432    1233


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      .++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+      ... .       ........+
T Consensus       166 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i------~~~-~-------~~~~~~~~~  231 (267)
T 3t9t_A          166 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI------STG-F-------RLYKPRLAS  231 (267)
T ss_dssp             TCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH------HTT-C-------CCCCCTTSC
T ss_pred             cccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHH------hcC-C-------cCCCCccCc
Confidence            45678999999988889999999999999999999 89999765433222111      111 0       011112334


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                      +++.++++   +|+..+|++||++.|++++|+++.+.
T Consensus       232 ~~l~~li~---~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          232 THVYQIMN---HCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             HHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HHHHHHHH---HHccCChhhCcCHHHHHHHHHHHHhc
Confidence            55555555   99999999999999999999999863

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.7e-41  Score=354.54  Aligned_cols=256  Identities=25%  Similarity=0.399  Sum_probs=205.2

Q ss_pred             hhhcCcCCccEEEEEEEC--------CCCEEEEEEeccccCC--HHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEE
Q 007167          305 AEVLGKGTFGTAYKAALE--------DASTVVVKRLKEVNVG--KREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMV  373 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV  373 (615)
                      .+.||+|+||+||+|...        .+..||||+++.....  .+.+.+|+++++.+ +||||+++++++..++..++|
T Consensus        74 ~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv  153 (382)
T 3tt0_A           74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI  153 (382)
T ss_dssp             EEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEE
Confidence            356999999999999852        2357999999765322  35688999999999 899999999999999999999


Q ss_pred             eecCCCCChhhhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcE
Q 007167          374 YDYFEPGSVSAMLHGRRGE-----------GQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHV  442 (615)
Q Consensus       374 ~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~  442 (615)
                      |||+++|+|.+++......           ....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+
T Consensus       154 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~  230 (382)
T 3tt0_A          154 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVM  230 (382)
T ss_dssp             EECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCE
T ss_pred             EEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEEEcCCCcE
Confidence            9999999999999754321           1246999999999999999999999998   9999999999999999999


Q ss_pred             EEeecccccccCCCC-----CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 007167          443 CVSDIGLAALMSPMP-----PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVN  516 (615)
Q Consensus       443 kl~DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  516 (615)
                      ||+|||+++......     ....++.+|+|||++.+..++.++|||||||++|||++ |+.||......+....   +.
T Consensus       231 kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~---~~  307 (382)
T 3tt0_A          231 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL---LK  307 (382)
T ss_dssp             EECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH---HH
T ss_pred             EEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HH
Confidence            999999998765432     22335678999999998899999999999999999999 9999976543332221   11


Q ss_pred             HhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhhcCC
Q 007167          517 SVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAEN  580 (615)
Q Consensus       517 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~~~  580 (615)
                      ...           .......+++++.++++   +||+.||++|||++||+++|+++.......
T Consensus       308 ~~~-----------~~~~~~~~~~~l~~li~---~~l~~dP~~Rps~~ell~~L~~~~~~~~~~  357 (382)
T 3tt0_A          308 EGH-----------RMDKPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRIVALTSNQ  357 (382)
T ss_dssp             TTC-----------CCCCCSSCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred             cCC-----------CCCCCccCCHHHHHHHH---HHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence            110           01112234455555555   999999999999999999999998765433

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=2.5e-41  Score=348.95  Aligned_cols=246  Identities=22%  Similarity=0.376  Sum_probs=195.0

Q ss_pred             hhhcCcCCccEEEEEEEC-CCC----EEEEEEeccc--cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecC
Q 007167          305 AEVLGKGTFGTAYKAALE-DAS----TVVVKRLKEV--NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYF  377 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  377 (615)
                      .++||+|+||+||+|.+. ++.    +||+|.++..  ....+.+.+|++++++++||||+++++++.... .++|+||+
T Consensus        20 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~   98 (327)
T 3poz_A           20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLM   98 (327)
T ss_dssp             EEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECC
T ss_pred             ceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEec
Confidence            357999999999999854 343    3588887643  234578999999999999999999999998754 78899999


Q ss_pred             CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC
Q 007167          378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP  457 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~  457 (615)
                      .+|+|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++......
T Consensus        99 ~~g~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~  171 (327)
T 3poz_A           99 PFGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  171 (327)
T ss_dssp             TTCBHHHHHHHST----TSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTC
T ss_pred             CCCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEccCCc
Confidence            9999999997532    36999999999999999999999998   9999999999999999999999999998765432


Q ss_pred             C-----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccccccccc
Q 007167          458 P-----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE  531 (615)
Q Consensus       458 ~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  531 (615)
                      .     ...+|..|+|||.+.+..++.++|||||||++|||++ |+.||......+....+.   ...           .
T Consensus       172 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~---~~~-----------~  237 (327)
T 3poz_A          172 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---KGE-----------R  237 (327)
T ss_dssp             C-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH---TTC-----------C
T ss_pred             ccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHH---cCC-----------C
Confidence            2     2234668999999999899999999999999999999 999998765544333221   100           1


Q ss_pred             ccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          532 LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       532 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                      ....+..+.++   .+++.+||+.+|++||++.|++++|+.+..
T Consensus       238 ~~~~~~~~~~~---~~li~~~l~~~p~~Rps~~ell~~l~~~~~  278 (327)
T 3poz_A          238 LPQPPICTIDV---YMIMVKCWMIDADSRPKFRELIIEFSKMAR  278 (327)
T ss_dssp             CCCCTTBCHHH---HHHHHHHTCSCGGGSCCHHHHHHHHHHHHT
T ss_pred             CCCCccCCHHH---HHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            11122334444   455559999999999999999999999875

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.1e-41  Score=345.43  Aligned_cols=243  Identities=22%  Similarity=0.354  Sum_probs=198.8

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC-------CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV-------GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      .+.||+|+||+||+|... ++..||+|.++....       ..+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~   95 (326)
T 2y0a_A           16 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL   95 (326)
T ss_dssp             EEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             ceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEc
Confidence            567999999999999965 588999999875422       356789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCC----cEEEeecccccc
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG----HVCVSDIGLAAL  452 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~----~~kl~DfG~a~~  452 (615)
                      +++|+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++    .+||+|||+++.
T Consensus        96 ~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~  167 (326)
T 2y0a_A           96 VAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  167 (326)
T ss_dssp             CCSCBHHHHHTTS-----SCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             CCCCCHHHHHHhc-----CCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence            9999999999642     36999999999999999999999998   99999999999999887    899999999987


Q ss_pred             cCCC--CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccc
Q 007167          453 MSPM--PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDV  530 (615)
Q Consensus       453 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  530 (615)
                      ....  .....+|+.|+|||++.+..++.++|||||||++|||++|+.||......+....+.      ....     ..
T Consensus       168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~------~~~~-----~~  236 (326)
T 2y0a_A          168 IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS------AVNY-----EF  236 (326)
T ss_dssp             CCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH------HTCC-----CC
T ss_pred             CCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH------hcCC-----Cc
Confidence            7532  234568899999999998899999999999999999999999997654333222111      0000     00


Q ss_pred             cccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          531 ELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       531 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .....+..++++.++++   +|+..||++|||+.|++++
T Consensus       237 ~~~~~~~~~~~~~~li~---~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          237 EDEYFSNTSALAKDFIR---RLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             CHHHHTTSCHHHHHHHH---HHSCSSGGGSCCHHHHHHS
T ss_pred             CccccccCCHHHHHHHH---HHccCChhhCCCHHHHhcC
Confidence            00011233455555555   9999999999999999985

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=1.5e-41  Score=366.15  Aligned_cols=248  Identities=29%  Similarity=0.433  Sum_probs=200.7

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChhh
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSA  384 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  384 (615)
                      .+.||+|+||+||+|.++++..||||+++......+.|.+|++++++++||||+++++++.+ +..++||||+++|+|.+
T Consensus       189 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~  267 (452)
T 1fmk_A          189 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLD  267 (452)
T ss_dssp             EEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHH
T ss_pred             eeeecCCCCeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHH
Confidence            35699999999999999888889999998766667889999999999999999999999866 67899999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC----CCC
Q 007167          385 MLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP----PPA  460 (615)
Q Consensus       385 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~----~~~  460 (615)
                      ++....   ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++......    ...
T Consensus       268 ~l~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~  341 (452)
T 1fmk_A          268 FLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA  341 (452)
T ss_dssp             HHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred             HHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCC
Confidence            997432   235899999999999999999999998   9999999999999999999999999998765322    122


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      .++..|+|||.+....++.++|||||||++|||++ |+.||......+....+.      ..        ......+.++
T Consensus       342 ~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~------~~--------~~~~~~~~~~  407 (452)
T 1fmk_A          342 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE------RG--------YRMPCPPECP  407 (452)
T ss_dssp             -CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH------TT--------CCCCCCTTSC
T ss_pred             cccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHH------cC--------CCCCCCCCCC
Confidence            34668999999988899999999999999999999 999998755433322211      11        0111123344


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                      +.+.+++.   +||+.+|++|||++++++.|+++...
T Consensus       408 ~~l~~li~---~cl~~dP~~Rpt~~~l~~~L~~~~~~  441 (452)
T 1fmk_A          408 ESLHDLMC---QCWRKEPEERPTFEYLQAFLEDYFTS  441 (452)
T ss_dssp             HHHHHHHH---HHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             HHHHHHHH---HHccCChhhCcCHHHHHHHHHHHhcc
Confidence            55555554   99999999999999999999988643

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=6.8e-41  Score=348.54  Aligned_cols=238  Identities=18%  Similarity=0.246  Sum_probs=200.8

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccc----cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEV----NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      +.||+|+||.||+|... +++.||+|+++..    ....+.+.+|+++++.++||||+++++++.+.+..++||||+++|
T Consensus        47 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg  126 (350)
T 1rdq_E           47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG  126 (350)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             EEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCC
Confidence            56999999999999965 6889999998653    223467889999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCCC
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPA  460 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  460 (615)
                      +|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++++||+|||+++.........
T Consensus       127 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~~~  198 (350)
T 1rdq_E          127 EMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL  198 (350)
T ss_dssp             BHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCCC
T ss_pred             cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCCcccc
Confidence            999999743     25899999999999999999999998   9999999999999999999999999999887666666


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE  540 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  540 (615)
                      .+|+.|+|||++.+..++.++|||||||++|||++|+.||......+...      .+...         .......+++
T Consensus       199 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~------~i~~~---------~~~~p~~~~~  263 (350)
T 1rdq_E          199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYE------KIVSG---------KVRFPSHFSS  263 (350)
T ss_dssp             EECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHC---------CCCCCTTCCH
T ss_pred             cCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHH------HHHcC---------CCCCCCCCCH
Confidence            78999999999999899999999999999999999999997654332221      11111         1111224456


Q ss_pred             HHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 007167          541 EMVEMLQVGMACVVRMPEERPK-----MADVLKM  569 (615)
Q Consensus       541 ~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~  569 (615)
                      ++.++++   +|++.||.+||+     ++|++++
T Consensus       264 ~~~~li~---~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          264 DLKDLLR---NLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             HHHHHHH---HHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHHHHHH---HHhhcCHHhccCCccCCHHHHHhC
Confidence            6666666   999999999998     8888775

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.9e-40  Score=335.96  Aligned_cols=254  Identities=13%  Similarity=0.165  Sum_probs=204.6

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEeccccCCHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVGKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      +.||+|+||+||+|.. .+++.||||++.... ..+.+.+|++++..+ +|+|++++++++.+....++||||+ +++|.
T Consensus        16 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~   93 (298)
T 1csn_A           16 RRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLE   93 (298)
T ss_dssp             EEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred             EEEeecCCEEEEEEEECCCCcEEEEEEeccCC-ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHH
Confidence            5699999999999995 578899999986442 345688999999999 7999999999999999999999999 99999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCc-----EEEeecccccccCCCC-
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGH-----VCVSDIGLAALMSPMP-  457 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~-----~kl~DfG~a~~~~~~~-  457 (615)
                      +++...    ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.     +||+|||+++...... 
T Consensus        94 ~~l~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~  166 (298)
T 1csn_A           94 DLLDLC----GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT  166 (298)
T ss_dssp             HHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred             HHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccc
Confidence            999753    235999999999999999999999998   999999999999987776     9999999998765321 


Q ss_pred             ---------CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccc
Q 007167          458 ---------PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVF  528 (615)
Q Consensus       458 ---------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  528 (615)
                               ....+|..|+|||.+.+..++.++|||||||++|||++|+.||..............+..........   
T Consensus       167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---  243 (298)
T 1csn_A          167 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR---  243 (298)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH---
T ss_pred             cccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHH---
Confidence                     23457889999999999899999999999999999999999998765443333332222111110000   


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhhc
Q 007167          529 DVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKA  578 (615)
Q Consensus       529 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~  578 (615)
                        .  ..+.+++++.++++   +|++.+|++||+++||++.|+++.+...
T Consensus       244 --~--~~~~~~~~l~~li~---~~l~~dp~~RP~~~~l~~~l~~~~~~~~  286 (298)
T 1csn_A          244 --E--LCAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKVLERLN  286 (298)
T ss_dssp             --H--HTTTSCHHHHHHHH---HHHHCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             --H--HHhhCcHHHHHHHH---HHhcCCcccCCCHHHHHHHHHHHHHhcC
Confidence              0  11234455555555   9999999999999999999999987544

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=6.6e-41  Score=359.02  Aligned_cols=243  Identities=19%  Similarity=0.314  Sum_probs=198.8

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .+.||+|+||+||+|.. .+++.||+|++......   .+.+.+|+++++.++|||||++++++.+.+..++||||+++|
T Consensus        16 ~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg   95 (444)
T 3soa_A           16 FEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGG   95 (444)
T ss_dssp             EEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCC
T ss_pred             EEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCC
Confidence            46799999999999986 46788999998754322   356889999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeC---CCCcEEEeecccccccCCCC
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLN---SQGHVCVSDIGLAALMSPMP  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~---~~~~~kl~DfG~a~~~~~~~  457 (615)
                      +|.+.+...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++   .++.+||+|||++.......
T Consensus        96 ~L~~~i~~~-----~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~  167 (444)
T 3soa_A           96 ELFEDIVAR-----EYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ  167 (444)
T ss_dssp             BHHHHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred             CHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence            999998743     36999999999999999999999998   99999999999998   46789999999998775432


Q ss_pred             ---CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccC
Q 007167          458 ---PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLR  534 (615)
Q Consensus       458 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  534 (615)
                         ....+|++|+|||++.+..++.++||||+||++|+|++|+.||...+..+....+.      ..     ..+.....
T Consensus       168 ~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~------~~-----~~~~~~~~  236 (444)
T 3soa_A          168 QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIK------AG-----AYDFPSPE  236 (444)
T ss_dssp             CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH------HT-----CCCCCTTT
T ss_pred             ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHH------hC-----CCCCCccc
Confidence               23468999999999999899999999999999999999999997654333322211      11     11112222


Q ss_pred             CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          535 YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       535 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ++.+++++.++++   +|+..||++|||+.|++++
T Consensus       237 ~~~~s~~~~~li~---~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          237 WDTVTPEAKDLIN---KMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             TTTSCHHHHHHHH---HHSCSSTTTSCCHHHHHHS
T ss_pred             cccCCHHHHHHHH---HHcCCChhHCCCHHHHhcC
Confidence            3455667766666   9999999999999999985

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=3.8e-41  Score=342.98  Aligned_cols=250  Identities=24%  Similarity=0.437  Sum_probs=189.6

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhC--CCCCcccceeEEEEec----CeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGG--IRHENVVALRAYYYSK----DEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~----~~~~lV~e~~~  378 (615)
                      .+.||+|+||+||+|.. +++.||||++....  ...+.+|.+++..  ++||||+++++++...    ...++||||++
T Consensus        13 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~   89 (301)
T 3q4u_A           13 LECVGKGRYGEVWRGSW-QGENVAVKIFSSRD--EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHE   89 (301)
T ss_dssp             EEEEEECSSEEEEEEEE-TTEEEEEEEECGGG--HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCT
T ss_pred             EEeeccCCCcEEEEEEE-CCEEEEEEEecccc--chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhcc
Confidence            35799999999999987 57899999986542  3455556666555  7999999999997653    45799999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhh--------ccCCCCceecCCCCCCEEeCCCCcEEEeecccc
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIH--------TENGGKLVHGGIKASNIFLNSQGHVCVSDIGLA  450 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--------~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a  450 (615)
                      +|+|.++++.      ..+++..+.+++.|++.||+|||        +.+   |+||||||+|||++.++.+||+|||++
T Consensus        90 ~g~L~~~l~~------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~a  160 (301)
T 3q4u_A           90 MGSLYDYLQL------TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIADLGLA  160 (301)
T ss_dssp             TCBHHHHHTT------CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CCCHHHHHhh------cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEeeCCCe
Confidence            9999999953      26999999999999999999999        776   999999999999999999999999999


Q ss_pred             cccCCCC-------CCCCCCCcccCccccCCC------CCCCccchhhHHHHHHHHHhC----------CCCCCCCCCcc
Q 007167          451 ALMSPMP-------PPAMRAAGYRAPEVTDTR------KATQASDVFSFGVLLLELLTG----------KSPIHATGGDE  507 (615)
Q Consensus       451 ~~~~~~~-------~~~~~~~~y~aPE~~~~~------~~~~~~DvwS~Gvvl~elltg----------~~p~~~~~~~~  507 (615)
                      +......       ....+|..|+|||++.+.      .++.++|||||||++|||++|          +.||......+
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~  240 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND  240 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence            7654322       233678999999999776      345799999999999999999          88886543322


Q ss_pred             -hhhHHHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 007167          508 -VVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI  573 (615)
Q Consensus       508 -~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l  573 (615)
                       ......   .......    ..+..............+.+++.+||+.||++|||+.||++.|+++
T Consensus       241 ~~~~~~~---~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          241 PSFEDMR---KVVCVDQ----QRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             CCHHHHH---HHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             cchhhhh---HHHhccC----CCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence             111111   1110000    0011100000122344566666699999999999999999999986

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.5e-41  Score=354.61  Aligned_cols=253  Identities=25%  Similarity=0.363  Sum_probs=201.2

Q ss_pred             hhhcCcCCccEEEEEEEC------CCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAALE------DASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      .+.||+|+||+||+|.+.      ++..||||+++....  ....+.+|+.++++++||||+++++++.+....++||||
T Consensus        76 ~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  155 (367)
T 3l9p_A           76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLEL  155 (367)
T ss_dssp             EEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             eeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEe
Confidence            356999999999999853      456799999975422  245688999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCC--CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCC---cEEEeeccccc
Q 007167          377 FEPGSVSAMLHGRRG--EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG---HVCVSDIGLAA  451 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~---~~kl~DfG~a~  451 (615)
                      +++|+|.+++...+.  .....+++..++.++.|++.||+|||+.+   |+||||||+|||++.++   .+||+|||+++
T Consensus       156 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~  232 (367)
T 3l9p_A          156 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR  232 (367)
T ss_dssp             CTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHH
T ss_pred             CCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECCCcccc
Confidence            999999999975432  22346899999999999999999999998   99999999999999554   59999999997


Q ss_pred             ccCC-----CCCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccc
Q 007167          452 LMSP-----MPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTA  525 (615)
Q Consensus       452 ~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (615)
                      ....     ......+|..|+|||++.+..++.++|||||||++|||++ |+.||......+....+.      ...   
T Consensus       233 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~------~~~---  303 (367)
T 3l9p_A          233 DIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT------SGG---  303 (367)
T ss_dssp             HHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH------TTC---
T ss_pred             ccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH------cCC---
Confidence            5422     1222346788999999988899999999999999999998 999998755433322211      110   


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhh
Q 007167          526 EVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVK  577 (615)
Q Consensus       526 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~  577 (615)
                           .......+++++.+++   .+||+.+|++||++.||+++|+.+....
T Consensus       304 -----~~~~~~~~~~~l~~li---~~~l~~dP~~Rps~~eil~~l~~~~~~~  347 (367)
T 3l9p_A          304 -----RMDPPKNCPGPVYRIM---TQCWQHQPEDRPNFAIILERIEYCTQDP  347 (367)
T ss_dssp             -----CCCCCTTCCHHHHHHH---HHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             -----CCCCCccCCHHHHHHH---HHHcCCCHhHCcCHHHHHHHHHHHhhCh
Confidence                 0111223444555544   4999999999999999999999987643

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.4e-40  Score=338.10  Aligned_cols=250  Identities=20%  Similarity=0.345  Sum_probs=198.1

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC----HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG----KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      +.||+|+||+||+|... ++..||+|++......    .+.+.+|+++++.++||||+++++++.+.+..++||||+++|
T Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~   96 (294)
T 4eqm_A           17 DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGP   96 (294)
T ss_dssp             EEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred             EEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCC
Confidence            56999999999999864 6889999998654222    356889999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---  457 (615)
                      +|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++......   
T Consensus        97 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  168 (294)
T 4eqm_A           97 TLSEYIESH-----GPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ  168 (294)
T ss_dssp             BHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred             CHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCccccccccccc
Confidence            999999743     36899999999999999999999998   9999999999999999999999999998765432   


Q ss_pred             -CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          458 -PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       458 -~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                       ....+|..|+|||.+.+..++.++||||+|+++|||++|+.||......+..  .    ......    .........+
T Consensus       169 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~--~----~~~~~~----~~~~~~~~~~  238 (294)
T 4eqm_A          169 TNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA--I----KHIQDS----VPNVTTDVRK  238 (294)
T ss_dssp             ------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH--H----HHHSSC----CCCHHHHSCT
T ss_pred             cCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH--H----HHhhcc----CCCcchhccc
Confidence             2235788999999999988999999999999999999999999765432211  1    111111    0000011123


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHhHhh
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERP-KMADVLKMVEDIRRV  576 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RP-s~~evl~~L~~l~~~  576 (615)
                      .+++.+.+++.   +|++.||++|| +++++.+.|+.+...
T Consensus       239 ~~~~~l~~li~---~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          239 DIPQSLSNVIL---RATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             TSCHHHHHHHH---HHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             CCCHHHHHHHH---HHhcCCHhHccccHHHHHHHHHHHHhh
Confidence            34455555555   99999999999 999999999887543

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.8e-41  Score=337.00  Aligned_cols=245  Identities=28%  Similarity=0.428  Sum_probs=188.5

Q ss_pred             hhcCcCCccEEEEEEECCCCEEEEEEeccccC-----CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNV-----GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      +.||+|+||+||+|... +..||||+++....     ..+.+.+|+++++.++||||+++++++.+.+..++||||++++
T Consensus        13 ~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   91 (271)
T 3dtc_A           13 EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGG   91 (271)
T ss_dssp             EEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTE
T ss_pred             eeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCC
Confidence            57999999999999975 78999999875422     2467889999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCC--------CCcEEEeecccccc
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNS--------QGHVCVSDIGLAAL  452 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~--------~~~~kl~DfG~a~~  452 (615)
                      +|.+++..      ..+++..+..++.|++.||+|||+.+..+|+||||||+||+++.        ++.+||+|||++..
T Consensus        92 ~L~~~~~~------~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~  165 (271)
T 3dtc_A           92 PLNRVLSG------KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLARE  165 (271)
T ss_dssp             EHHHHHTS------SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---
T ss_pred             CHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccc
Confidence            99999853      36899999999999999999999987556899999999999986        67899999999987


Q ss_pred             cCCCC-CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccccc
Q 007167          453 MSPMP-PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE  531 (615)
Q Consensus       453 ~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  531 (615)
                      ..... ....++..|+|||.+.+..++.++||||||+++|||++|+.||......+....+      .....       .
T Consensus       166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~------~~~~~-------~  232 (271)
T 3dtc_A          166 WHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGV------AMNKL-------A  232 (271)
T ss_dssp             ----------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHH------HTSCC-------C
T ss_pred             cccccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhh------hcCCC-------C
Confidence            65432 2345788999999998888999999999999999999999999865432221111      11100       0


Q ss_pred             ccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 007167          532 LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI  573 (615)
Q Consensus       532 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l  573 (615)
                      .......++++.++++   +|++.+|++|||+.|++++|+++
T Consensus       233 ~~~~~~~~~~~~~li~---~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          233 LPIPSTCPEPFAKLME---DCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             CCCCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             CCCCcccCHHHHHHHH---HHhcCCcccCcCHHHHHHHHhcC
Confidence            1112234455555555   99999999999999999999864

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.4e-40  Score=348.75  Aligned_cols=269  Identities=20%  Similarity=0.233  Sum_probs=201.0

Q ss_pred             hhhcCcCCccEEEEEEECC------CCEEEEEEeccccC------------CHHHHHHHHHHHhCCCCCcccceeEEEEe
Q 007167          305 AEVLGKGTFGTAYKAALED------ASTVVVKRLKEVNV------------GKREFEQQMEIVGGIRHENVVALRAYYYS  366 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~------------~~~~~~~e~~~l~~l~h~niv~l~~~~~~  366 (615)
                      .+.||+|+||+||+|.+..      ++.||||++.....            ....+.+|+..++.++||||+++++++..
T Consensus        40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~  119 (364)
T 3op5_A           40 GLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLH  119 (364)
T ss_dssp             EEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEE
T ss_pred             EEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeee
Confidence            3579999999999998765      36799999865421            01123345566778899999999999977


Q ss_pred             c----CeeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeC--CCC
Q 007167          367 K----DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLN--SQG  440 (615)
Q Consensus       367 ~----~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~--~~~  440 (615)
                      .    ...++||||+ +++|.+++...    ...+++..+..|+.|++.||+|||+.+   |+||||||+|||++  .++
T Consensus       120 ~~~~~~~~~lv~e~~-g~~L~~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~~~~~  191 (364)
T 3op5_A          120 DKNGKSYRFMIMDRF-GSDLQKIYEAN----AKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPD  191 (364)
T ss_dssp             EETTEEEEEEEEECE-EEEHHHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEESSCTT
T ss_pred             ccCCcceEEEEEeCC-CCCHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEecCCCC
Confidence            5    4589999999 99999999753    246999999999999999999999998   99999999999999  889


Q ss_pred             cEEEeecccccccCCCC----------CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhh
Q 007167          441 HVCVSDIGLAALMSPMP----------PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVH  510 (615)
Q Consensus       441 ~~kl~DfG~a~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~  510 (615)
                      .+||+|||+++.+....          ....+|..|+|||++.+..++.++|||||||++|||++|+.||........  
T Consensus       192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~--  269 (364)
T 3op5_A          192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPK--  269 (364)
T ss_dssp             CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHH--
T ss_pred             eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHH--
Confidence            99999999997764321          223478899999999998999999999999999999999999986443322  


Q ss_pred             HHHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhhcCCCCCCCccc
Q 007167          511 LVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTENRS  588 (615)
Q Consensus       511 ~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~~~~~~~~~~~  588 (615)
                      .+.+....... ...++++..+. ....++++.++++   .||..+|++||++.++++.|+++.............+.
T Consensus       270 ~~~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~li~---~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~~~~dw~  342 (364)
T 3op5_A          270 YVRDSKIRYRE-NIASLMDKCFP-AANAPGEIAKYME---TVKLLDYTEKPLYENLRDILLQGLKAIGSKDDGKLDLS  342 (364)
T ss_dssp             HHHHHHHHHHH-CHHHHHHHHSC-TTCCCHHHHHHHH---HHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCCCCCCC-
T ss_pred             HHHHHHHHhhh-hHHHHHHHhcc-cccCHHHHHHHHH---HHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcCCccceE
Confidence            11111111111 11122222221 1334455555555   99999999999999999999998775544333333333

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=9.9e-41  Score=349.20  Aligned_cols=243  Identities=21%  Similarity=0.329  Sum_probs=197.6

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .+.||+|+||.||+|..+ ++..||+|++......   .+.+.+|+++++.++||||+++++++.+.+..++||||+++|
T Consensus        34 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg  113 (362)
T 2bdw_A           34 KEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG  113 (362)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             eeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCC
Confidence            567999999999999865 6889999999765433   346789999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCC---cEEEeecccccccCCCC
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG---HVCVSDIGLAALMSPMP  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~---~~kl~DfG~a~~~~~~~  457 (615)
                      +|.+.+...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++   .+||+|||++.......
T Consensus       114 ~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~  185 (362)
T 2bdw_A          114 ELFEDIVAR-----EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE  185 (362)
T ss_dssp             BHHHHHTTC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC
T ss_pred             CHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc
Confidence            999998643     36899999999999999999999998   99999999999998654   59999999998776432


Q ss_pred             --CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCC
Q 007167          458 --PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY  535 (615)
Q Consensus       458 --~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  535 (615)
                        ....+|+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+      ....     ++.....+
T Consensus       186 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i------~~~~-----~~~~~~~~  254 (362)
T 2bdw_A          186 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQI------KAGA-----YDYPSPEW  254 (362)
T ss_dssp             SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHTC-----CCCCTTGG
T ss_pred             ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------HhCC-----CCCCcccc
Confidence              2346889999999999889999999999999999999999999765433222211      1111     11111112


Q ss_pred             CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          536 PNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       536 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ..+++++.+++.   +|+..||++||++.|++++
T Consensus       255 ~~~~~~~~~li~---~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          255 DTVTPEAKSLID---SMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             GGSCHHHHHHHH---HHSCSSGGGSCCHHHHTTS
T ss_pred             cCCCHHHHHHHH---HHcCCChhhCcCHHHHhcC
Confidence            234455666555   9999999999999999875

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=6.3e-40  Score=337.23  Aligned_cols=267  Identities=16%  Similarity=0.220  Sum_probs=202.9

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEecccc--CCHHHHHHHHHHHhCCCCCcccceeEEEEecC--eeeEEeecCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVN--VGKREFEQQMEIVGGIRHENVVALRAYYYSKD--EKLMVYDYFEPG  380 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lV~e~~~~g  380 (615)
                      ++||+|+||+||+|... +++.||||+++...  ...+.+.+|++++++++||||+++++++....  ..++||||+++|
T Consensus        15 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~   94 (319)
T 4euu_A           15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCG   94 (319)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTC
T ss_pred             EEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCC
Confidence            56999999999999976 48899999997542  34567889999999999999999999998765  779999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEe----CCCCcEEEeecccccccCCC
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFL----NSQGHVCVSDIGLAALMSPM  456 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill----~~~~~~kl~DfG~a~~~~~~  456 (615)
                      +|.+++.....  ...+++..+..++.|++.||+|||+.+   |+||||||+||++    +.++.+||+|||+++.....
T Consensus        95 ~L~~~l~~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~  169 (319)
T 4euu_A           95 SLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD  169 (319)
T ss_dssp             BHHHHHHSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTT
T ss_pred             CHHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCceecCCC
Confidence            99999975432  234999999999999999999999998   9999999999999    78888999999999877543


Q ss_pred             C--CCCCCCCcccCccccC--------CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc-hhhHHHHHHHhhhccccc
Q 007167          457 P--PPAMRAAGYRAPEVTD--------TRKATQASDVFSFGVLLLELLTGKSPIHATGGDE-VVHLVRWVNSVVREEWTA  525 (615)
Q Consensus       457 ~--~~~~~~~~y~aPE~~~--------~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~  525 (615)
                      .  ....+|..|+|||++.        +..++.++|||||||++|||++|+.||....... ....+..+..........
T Consensus       170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~  249 (319)
T 4euu_A          170 EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAIS  249 (319)
T ss_dssp             CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCE
T ss_pred             CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccch
Confidence            3  2345788999999875        5678999999999999999999999997644322 122221111111111110


Q ss_pred             cc---------ccccccCCCC-cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhh
Q 007167          526 EV---------FDVELLRYPN-IEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVK  577 (615)
Q Consensus       526 ~~---------~d~~~~~~~~-~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~  577 (615)
                      .+         ....+..... .......+.+++.+|++.||++|||++|++++..+..-..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~~  311 (319)
T 4euu_A          250 GVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRG  311 (319)
T ss_dssp             EEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC--
T ss_pred             hhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhcC
Confidence            00         0011111111 1233344555666999999999999999999998866443

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=7.9e-41  Score=351.28  Aligned_cols=243  Identities=23%  Similarity=0.395  Sum_probs=194.3

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEecccc-CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEVN-VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      ++||+|+||+||+|.. .++..||+|+++... ...+.+.+|++++++++||||+++++++.+.+..++||||+++|+|.
T Consensus        95 ~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~  174 (373)
T 2x4f_A           95 EILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELF  174 (373)
T ss_dssp             EECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEH
T ss_pred             eEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHH
Confidence            4699999999999986 468899999997643 23567899999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEe--CCCCcEEEeecccccccCCCC--CC
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFL--NSQGHVCVSDIGLAALMSPMP--PP  459 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill--~~~~~~kl~DfG~a~~~~~~~--~~  459 (615)
                      +++...    ...+++..+..++.|++.||+|||+.+   |+||||||+|||+  +.++.+||+|||+++.+....  ..
T Consensus       175 ~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~  247 (373)
T 2x4f_A          175 DRIIDE----SYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV  247 (373)
T ss_dssp             HHHHHT----GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCC
T ss_pred             HHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCcccccc
Confidence            988643    235899999999999999999999998   9999999999999  677899999999998775432  33


Q ss_pred             CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      ..+|++|+|||++.+..++.++|||||||++|||++|+.||......+..      ..+....+.     .....++.++
T Consensus       248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~------~~i~~~~~~-----~~~~~~~~~~  316 (373)
T 2x4f_A          248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETL------NNILACRWD-----LEDEEFQDIS  316 (373)
T ss_dssp             CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHH------HHHHHTCCC-----SCSGGGTTSC
T ss_pred             ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHH------HHHHhccCC-----CChhhhccCC
Confidence            45889999999999888999999999999999999999999865433221      122221111     1111123445


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      +++.++++   +|++.||.+|||+.|++++
T Consensus       317 ~~~~~li~---~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          317 EEAKEFIS---KLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             HHHHHHHH---TTSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHH---HHcCCChhhCCCHHHHhcC
Confidence            66666666   9999999999999999984

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=6.4e-41  Score=350.63  Aligned_cols=197  Identities=21%  Similarity=0.324  Sum_probs=174.3

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccCCHHHHHHHHHHHhCCC-----CCcccceeEEEEecCeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVGKREFEQQMEIVGGIR-----HENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      .++||+|+||+||+|.. .+++.||||+++......+.+..|+++++.++     ||||+++++++...+..++||||+ 
T Consensus        40 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-  118 (360)
T 3llt_A           40 IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-  118 (360)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-
T ss_pred             EEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-
Confidence            35799999999999996 46788999999765444566788999999886     999999999999999999999999 


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCC--------------------
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNS--------------------  438 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~--------------------  438 (615)
                      +++|.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.                    
T Consensus       119 ~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~  192 (360)
T 3llt_A          119 GPSLYEIITRNN---YNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ  192 (360)
T ss_dssp             CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEE
T ss_pred             CCCHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhccccccccc
Confidence            999999997543   235899999999999999999999998   999999999999986                    


Q ss_pred             -----CCcEEEeecccccccCCCCCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcch
Q 007167          439 -----QGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEV  508 (615)
Q Consensus       439 -----~~~~kl~DfG~a~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~  508 (615)
                           ++.+||+|||+++..........+|..|+|||++.+..++.++|||||||++|||++|+.||......+.
T Consensus       193 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  267 (360)
T 3llt_A          193 IYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEH  267 (360)
T ss_dssp             EEEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             ccccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHH
Confidence                 7899999999999877666667789999999999999999999999999999999999999987654443

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.1e-40  Score=341.68  Aligned_cols=251  Identities=27%  Similarity=0.393  Sum_probs=202.9

Q ss_pred             hhhcCcCCccEEEEEEE------CCCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAAL------EDASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      .+.||+|+||.||+|..      .++..||||+++....  ..+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus        28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  107 (314)
T 2ivs_A           28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEY  107 (314)
T ss_dssp             EEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             eeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEee
Confidence            35799999999999985      2457899999975432  235688999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeC
Q 007167          377 FEPGSVSAMLHGRRGE-------------------GQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLN  437 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~  437 (615)
                      +++|+|.+++......                   ....+++..+..++.|++.||+|||+.+   |+||||||+||+++
T Consensus       108 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dikp~NIli~  184 (314)
T 2ivs_A          108 AKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVA  184 (314)
T ss_dssp             CTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEE
T ss_pred             cCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---CcccccchheEEEc
Confidence            9999999999754321                   1234899999999999999999999998   99999999999999


Q ss_pred             CCCcEEEeecccccccCCCC-----CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhH
Q 007167          438 SQGHVCVSDIGLAALMSPMP-----PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHL  511 (615)
Q Consensus       438 ~~~~~kl~DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~  511 (615)
                      .++.+||+|||+++......     ....++..|+|||.+.+..++.++|||||||++|||++ |+.||......+....
T Consensus       185 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  264 (314)
T 2ivs_A          185 EGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNL  264 (314)
T ss_dssp             TTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred             CCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence            99999999999998765432     22345677999999988889999999999999999999 9999987655443322


Q ss_pred             HHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          512 VRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       512 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                      +.   ...           .......+++++.++++   +|++.||++||++.|++++|+++..
T Consensus       265 ~~---~~~-----------~~~~~~~~~~~~~~li~---~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          265 LK---TGH-----------RMERPDNCSEEMYRLML---QCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             HH---TTC-----------CCCCCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hh---cCC-----------cCCCCccCCHHHHHHHH---HHccCChhhCcCHHHHHHHHHHHHh
Confidence            21   100           01112234555555555   9999999999999999999999865

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.9e-40  Score=337.73  Aligned_cols=240  Identities=22%  Similarity=0.364  Sum_probs=189.1

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC---------------------------CHHHHHHHHHHHhCCCCCc
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV---------------------------GKREFEQQMEIVGGIRHEN  356 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---------------------------~~~~~~~e~~~l~~l~h~n  356 (615)
                      .+.||+|+||+||+|... +++.||||++.....                           ..+.+.+|+++++.++|||
T Consensus        18 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   97 (298)
T 2zv2_A           18 KDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPN   97 (298)
T ss_dssp             EEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTT
T ss_pred             EeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCC
Confidence            356999999999999864 578899999865421                           1246889999999999999


Q ss_pred             ccceeEEEEe--cCeeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCE
Q 007167          357 VVALRAYYYS--KDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNI  434 (615)
Q Consensus       357 iv~l~~~~~~--~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Ni  434 (615)
                      |+++++++.+  .+..++||||+++|+|.+++..      ..+++..+..++.|++.||+|||+.+   |+||||||+||
T Consensus        98 iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Ni  168 (298)
T 2zv2_A           98 VVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTL------KPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNL  168 (298)
T ss_dssp             BCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCS------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGE
T ss_pred             CCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHE
Confidence            9999999987  5688999999999999887642      36999999999999999999999998   99999999999


Q ss_pred             EeCCCCcEEEeecccccccCCCC---CCCCCCCcccCccccCCCC---CCCccchhhHHHHHHHHHhCCCCCCCCCCcch
Q 007167          435 FLNSQGHVCVSDIGLAALMSPMP---PPAMRAAGYRAPEVTDTRK---ATQASDVFSFGVLLLELLTGKSPIHATGGDEV  508 (615)
Q Consensus       435 ll~~~~~~kl~DfG~a~~~~~~~---~~~~~~~~y~aPE~~~~~~---~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~  508 (615)
                      +++.++.+||+|||+++......   ....+|..|+|||.+.+..   ++.++|||||||++|||++|+.||........
T Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  248 (298)
T 2zv2_A          169 LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL  248 (298)
T ss_dssp             EECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH
Confidence            99999999999999998765432   3346788999999997655   37789999999999999999999976432211


Q ss_pred             hhHHHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          509 VHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       509 ~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                         .   .......       ......+.+++++.++++   +||+.||++|||+.|++++
T Consensus       249 ---~---~~~~~~~-------~~~~~~~~~~~~l~~li~---~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          249 ---H---SKIKSQA-------LEFPDQPDIAEDLKDLIT---RMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             ---H---HHHHHCC-------CCCCSSSCCCHHHHHHHH---HHTCSCTTTSCCHHHHTTC
T ss_pred             ---H---HHHhccc-------CCCCCccccCHHHHHHHH---HHhhcChhhCCCHHHHhcC
Confidence               1   1111110       011122344566666655   9999999999999999865

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-41  Score=348.98  Aligned_cols=252  Identities=21%  Similarity=0.379  Sum_probs=201.5

Q ss_pred             hhhcCcCCccEEEEEEEC------CCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAALE------DASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      .+.||+|+||.||+|...      +++.||||+++....  ..+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus        52 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~  131 (343)
T 1luf_A           52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEY  131 (343)
T ss_dssp             EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             eeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEec
Confidence            356999999999999974      347899999975432  245688999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeC
Q 007167          377 FEPGSVSAMLHGRRGE-------------------GQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLN  437 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~-------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~  437 (615)
                      +++|+|.+++......                   ....+++..++.++.|++.||+|||+.+   |+||||||+||+++
T Consensus       132 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~  208 (343)
T 1luf_A          132 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVG  208 (343)
T ss_dssp             CTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred             CCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEC
Confidence            9999999999753211                   1257999999999999999999999998   99999999999999


Q ss_pred             CCCcEEEeecccccccCCC-----CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhH
Q 007167          438 SQGHVCVSDIGLAALMSPM-----PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHL  511 (615)
Q Consensus       438 ~~~~~kl~DfG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~  511 (615)
                      .++.+||+|||+++.....     .....++..|+|||.+.+..++.++|||||||++|||++ |+.||......+....
T Consensus       209 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~  288 (343)
T 1luf_A          209 ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYY  288 (343)
T ss_dssp             GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred             CCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHH
Confidence            9999999999999765422     223346778999999988889999999999999999999 9999976543332221


Q ss_pred             HHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          512 VRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       512 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                      +      .....        ......+++++.++++   +||..||++||++.|++++|+++.+.
T Consensus       289 ~------~~~~~--------~~~~~~~~~~l~~li~---~~l~~~p~~Rps~~~~~~~L~~~~~~  336 (343)
T 1luf_A          289 V------RDGNI--------LACPENCPLELYNLMR---LCWSKLPADRPSFCSIHRILQRMCER  336 (343)
T ss_dssp             H------HTTCC--------CCCCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHTTC-
T ss_pred             H------hCCCc--------CCCCCCCCHHHHHHHH---HHcccCcccCCCHHHHHHHHHHHHhh
Confidence            1      11100        0111234455555555   99999999999999999999998753

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.3e-41  Score=351.15  Aligned_cols=239  Identities=21%  Similarity=0.334  Sum_probs=194.4

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccc----cCCHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEV----NVGKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      .++||+|+||+||+|..+ +++.||||+++..    ....+.+.+|.+++..+ +||||+++++++.+.+..++||||++
T Consensus        28 ~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~  107 (353)
T 3txo_A           28 IRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVN  107 (353)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCC
T ss_pred             EEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCC
Confidence            357999999999999965 5789999999753    22345678899999988 79999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC---
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP---  455 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~---  455 (615)
                      +|+|.+++...     ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++++||+|||+++....   
T Consensus       108 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~  179 (353)
T 3txo_A          108 GGDLMFHIQKS-----RRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV  179 (353)
T ss_dssp             SCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred             CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecccCCc
Confidence            99999999753     36999999999999999999999998   99999999999999999999999999986432   


Q ss_pred             CCCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCC
Q 007167          456 MPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY  535 (615)
Q Consensus       456 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  535 (615)
                      ......+|+.|+|||++.+..++.++||||+||++|||++|+.||...+..+....+      ...         .....
T Consensus       180 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i------~~~---------~~~~p  244 (353)
T 3txo_A          180 TTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAI------LND---------EVVYP  244 (353)
T ss_dssp             ------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHC---------CCCCC
T ss_pred             cccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHH------HcC---------CCCCC
Confidence            223446899999999998888999999999999999999999999875543332211      111         11112


Q ss_pred             CCcHHHHHHHHHHHHHcccCCCCCCCCH------HHHHHH
Q 007167          536 PNIEEEMVEMLQVGMACVVRMPEERPKM------ADVLKM  569 (615)
Q Consensus       536 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~------~evl~~  569 (615)
                      ...++++.++++   +|+..||++||++      +|+++|
T Consensus       245 ~~~~~~~~~li~---~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          245 TWLHEDATGILK---SFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             TTSCHHHHHHHH---HHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             CCCCHHHHHHHH---HHhhhCHHHccCCcccCCHHHHhhC
Confidence            234566666666   9999999999998      777764

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=7.3e-41  Score=348.90  Aligned_cols=247  Identities=19%  Similarity=0.333  Sum_probs=197.3

Q ss_pred             HhhhcCcCCccEEEEEEEC-CCCEEEEEEeccc------cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeec
Q 007167          304 SAEVLGKGTFGTAYKAALE-DASTVVVKRLKEV------NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       304 ~~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      ..+.||+|+||+||+|..+ +++.||||++...      ....+.+.+|+++++.++||||+++++++.+++..++||||
T Consensus        28 ~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~  107 (351)
T 3c0i_A           28 LCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEF  107 (351)
T ss_dssp             EEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred             EeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeC
Confidence            3567999999999999864 6889999998642      12367799999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCc---EEEeeccccccc
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGH---VCVSDIGLAALM  453 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~---~kl~DfG~a~~~  453 (615)
                      +++|+|.+.+..... ....+++..+..++.|++.||+|||+++   |+||||||+|||++.++.   +||+|||++...
T Consensus       108 ~~g~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~  183 (351)
T 3c0i_A          108 MDGADLCFEIVKRAD-AGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL  183 (351)
T ss_dssp             CSSCBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTCEEC
T ss_pred             CCCCCHHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcceeEe
Confidence            999999988864321 2335899999999999999999999998   999999999999987654   999999999877


Q ss_pred             CCCC---CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccc
Q 007167          454 SPMP---PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDV  530 (615)
Q Consensus       454 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  530 (615)
                      ....   ....+|+.|+|||++.+..++.++|||||||++|||++|+.||..... +   .   ...+.....     ..
T Consensus       184 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~---~---~~~i~~~~~-----~~  251 (351)
T 3c0i_A          184 GESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-R---L---FEGIIKGKY-----KM  251 (351)
T ss_dssp             CTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH-H---H---HHHHHHTCC-----CC
T ss_pred             cCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH-H---H---HHHHHcCCC-----CC
Confidence            5432   234688999999999988899999999999999999999999976321 1   1   111111110     00


Q ss_pred             cccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          531 ELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       531 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ....++.+++++.++++   +|+..||++|||+.|++++
T Consensus       252 ~~~~~~~~s~~~~~li~---~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          252 NPRQWSHISESAKDLVR---RMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             CHHHHTTSCHHHHHHHH---HHTCSSTTTSCCHHHHHTS
T ss_pred             CccccccCCHHHHHHHH---HHCCCChhHCcCHHHHhcC
Confidence            00111234455656555   9999999999999999874

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1.5e-40  Score=343.63  Aligned_cols=239  Identities=20%  Similarity=0.308  Sum_probs=196.5

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccc----cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEV----NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||+||+|.. .+++.||||++...    ......+.+|+++++.++||||+++++++...+..++||||+ +
T Consensus        14 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~   92 (336)
T 3h4j_B           14 RETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-G   92 (336)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-C
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-C
Confidence            35699999999999996 57889999998643    223457899999999999999999999999999999999999 7


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      |+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++.......  
T Consensus        93 g~l~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~  164 (336)
T 3h4j_B           93 GELFDYIVEK-----KRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFL  164 (336)
T ss_dssp             EEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTT
T ss_pred             CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCCccc
Confidence            8999988643     36999999999999999999999998   9999999999999999999999999998765432  


Q ss_pred             CCCCCCCcccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          458 PPAMRAAGYRAPEVTDTRKA-TQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                      ....+|+.|+|||.+.+..+ +.++||||+||++|||++|+.||......+....               +.........
T Consensus       165 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~---------------i~~~~~~~p~  229 (336)
T 3h4j_B          165 KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKK---------------VNSCVYVMPD  229 (336)
T ss_dssp             CCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCC---------------CCSSCCCCCT
T ss_pred             ccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHH---------------HHcCCCCCcc
Confidence            34568899999999988776 7899999999999999999999976543322110               0011111122


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                      ..++++.++++   +|+..||.+|||++|++++-
T Consensus       230 ~~s~~~~~li~---~~L~~dP~~Rpt~~eil~hp  260 (336)
T 3h4j_B          230 FLSPGAQSLIR---RMIVADPMQRITIQEIRRDP  260 (336)
T ss_dssp             TSCHHHHHHHH---TTSCSSGGGSCCHHHHTTCH
T ss_pred             cCCHHHHHHHH---HHcCCChhHCcCHHHHHhCh
Confidence            34566666666   99999999999999999873

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.7e-40  Score=336.36  Aligned_cols=253  Identities=21%  Similarity=0.368  Sum_probs=194.5

Q ss_pred             hhcCcCCccEEEEEEECCCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      +.||+|+||+||+|...+++.||+|+++....   ..+.+.+|+++++.++||||+++++++...+..++||||+++ +|
T Consensus         8 ~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l   86 (288)
T 1ob3_A            8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DL   86 (288)
T ss_dssp             EEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EH
T ss_pred             hhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CH
Confidence            56999999999999998899999999865422   236788999999999999999999999999999999999975 89


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---CC
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---PP  459 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~~  459 (615)
                      .+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++......   ..
T Consensus        87 ~~~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (288)
T 1ob3_A           87 KKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH  159 (288)
T ss_dssp             HHHHHTST----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred             HHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcccccccc
Confidence            99887432    36899999999999999999999998   9999999999999999999999999998765322   23


Q ss_pred             CCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhH-HHHHHHhhhccccc----cccccccc
Q 007167          460 AMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHL-VRWVNSVVREEWTA----EVFDVELL  533 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~----~~~d~~~~  533 (615)
                      ..+|..|+|||.+.+ ..++.++||||+||++|||++|+.||......+.... .+.+.......|..    ..+++...
T Consensus       160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T 1ob3_A          160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT  239 (288)
T ss_dssp             --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred             ccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccc
Confidence            457889999999876 4589999999999999999999999987543322211 11111111111110    00111111


Q ss_pred             ---------CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          534 ---------RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       534 ---------~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                               ..+..++++.++++   +|++.||++|||++|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          240 VYEPLPWESFLKGLDESGIDLLS---KMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             CCCCCCGGGTCCSCCHHHHHHHH---HHTCSSTTTSCCHHHHHTS
T ss_pred             cccCccHHHHhhhcCHHHHHHHH---HHcCCCcccCCCHHHHhcC
Confidence                     11234555555555   9999999999999999875

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=2.9e-40  Score=339.50  Aligned_cols=258  Identities=21%  Similarity=0.386  Sum_probs=189.3

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc--CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN--VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      .+.||+|+||+||+|... +++.||+|+++...  ...+.+.+|+++++.++||||+++++++..++..++||||++ |+
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~   88 (317)
T 2pmi_A           10 LEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-ND   88 (317)
T ss_dssp             ---------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CB
T ss_pred             eeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CC
Confidence            467999999999999864 68899999987542  234678899999999999999999999999999999999998 69


Q ss_pred             hhhhhccCC-CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC---C
Q 007167          382 VSAMLHGRR-GEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM---P  457 (615)
Q Consensus       382 L~~~l~~~~-~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~---~  457 (615)
                      |.+++.... ......+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....   .
T Consensus        89 L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (317)
T 2pmi_A           89 LKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF  165 (317)
T ss_dssp             HHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCC
T ss_pred             HHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecCCCcccC
Confidence            999886432 122346899999999999999999999998   999999999999999999999999999876532   2


Q ss_pred             CCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHH-HHHHhhhcccccc----ccccc
Q 007167          458 PPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVR-WVNSVVREEWTAE----VFDVE  531 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~----~~d~~  531 (615)
                      ....+|..|+|||++.+ ..++.++|||||||++|||++|+.||......+....+. .........|...    .+.+.
T Consensus       166 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  245 (317)
T 2pmi_A          166 SSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPN  245 (317)
T ss_dssp             CCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTT
T ss_pred             CCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccc
Confidence            33467889999999876 468999999999999999999999998755433322221 1110000001000    00000


Q ss_pred             cc--------------CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          532 LL--------------RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       532 ~~--------------~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ..              .....++++.++++   +|++.||++|||+.|++++
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~---~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          246 IQQRPPRDLRQVLQPHTKEPLDGNLMDFLH---GLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             CCCCCCCCSHHHHGGGCSSCCCHHHHHHHH---HHSCSSGGGSCCHHHHTTS
T ss_pred             cccccchhHHHhhcccccccCCHHHHHHHH---HHCCCCcccCCCHHHHhCC
Confidence            00              01123445555555   9999999999999999876

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=4.1e-41  Score=351.78  Aligned_cols=254  Identities=27%  Similarity=0.403  Sum_probs=200.3

Q ss_pred             hhhcCcCCccEEEEEEE------CCCCEEEEEEeccccC--CHHHHHHHHHHHhCC-CCCcccceeEEEEecC-eeeEEe
Q 007167          305 AEVLGKGTFGTAYKAAL------EDASTVVVKRLKEVNV--GKREFEQQMEIVGGI-RHENVVALRAYYYSKD-EKLMVY  374 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~~lV~  374 (615)
                      .+.||+|+||.||+|.+      .+++.||||+++....  ..+.+.+|++++.++ +||||+++++++.+.+ ..++||
T Consensus        27 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~  106 (359)
T 3vhe_A           27 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV  106 (359)
T ss_dssp             EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred             ceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEE
Confidence            35799999999999974      2456899999976432  235689999999999 7999999999998765 489999


Q ss_pred             ecCCCCChhhhhccCCCCC-------------------------------------------------------------
Q 007167          375 DYFEPGSVSAMLHGRRGEG-------------------------------------------------------------  393 (615)
Q Consensus       375 e~~~~gsL~~~l~~~~~~~-------------------------------------------------------------  393 (615)
                      ||+++|+|.++++......                                                             
T Consensus       107 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (359)
T 3vhe_A          107 EFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLY  186 (359)
T ss_dssp             ECCTTEEHHHHHHTTTTSBCSCC------------------------------------------------------CTT
T ss_pred             EecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchh
Confidence            9999999999997643210                                                             


Q ss_pred             CCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC-----CCCCCCCcccC
Q 007167          394 QSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP-----PPAMRAAGYRA  468 (615)
Q Consensus       394 ~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~-----~~~~~~~~y~a  468 (615)
                      ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++......     ....+|..|+|
T Consensus       187 ~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~a  263 (359)
T 3vhe_A          187 KDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA  263 (359)
T ss_dssp             TTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCC
T ss_pred             ccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEC
Confidence            122899999999999999999999998   9999999999999999999999999998764322     22345778999


Q ss_pred             ccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHHHHHHHHH
Q 007167          469 PEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQ  547 (615)
Q Consensus       469 PE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~  547 (615)
                      ||++.+..++.++|||||||++|||++ |+.||......+...  ..+.    ...       ........++++.+++ 
T Consensus       264 PE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~--~~~~----~~~-------~~~~~~~~~~~l~~li-  329 (359)
T 3vhe_A          264 PETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC--RRLK----EGT-------RMRAPDYTTPEMYQTM-  329 (359)
T ss_dssp             HHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH--HHHH----HTC-------CCCCCTTCCHHHHHHH-
T ss_pred             hhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHH--HHHH----cCC-------CCCCCCCCCHHHHHHH-
Confidence            999988889999999999999999998 999998755433211  1111    100       0111123345555554 


Q ss_pred             HHHHcccCCCCCCCCHHHHHHHHHHhHhhh
Q 007167          548 VGMACVVRMPEERPKMADVLKMVEDIRRVK  577 (615)
Q Consensus       548 l~~~cl~~~P~~RPs~~evl~~L~~l~~~~  577 (615)
                        .+||+.||.+|||+.|++++|+++....
T Consensus       330 --~~~l~~dP~~Rps~~ell~~L~~~~~~~  357 (359)
T 3vhe_A          330 --LDCWHGEPSQRPTFSELVEHLGNLLQAN  357 (359)
T ss_dssp             --HHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             --HHHccCChhhCCCHHHHHHHHHHHHHHh
Confidence              4999999999999999999999998654

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=6.8e-41  Score=345.03  Aligned_cols=242  Identities=21%  Similarity=0.325  Sum_probs=193.7

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc--CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN--VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      .+.||+|+||+||+|... +++.||||++....  ...+.+.+|+++++.++||||+++++++.+.+..++||||+++|+
T Consensus        12 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~   91 (323)
T 3tki_A           12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE   91 (323)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEE
T ss_pred             eeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCc
Confidence            356999999999999965 78899999986442  224678899999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC-----
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM-----  456 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~-----  456 (615)
                      |.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.+...     
T Consensus        92 L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  163 (323)
T 3tki_A           92 LFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  163 (323)
T ss_dssp             GGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             HHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence            99999743     35999999999999999999999998   999999999999999999999999999765322     


Q ss_pred             CCCCCCCCcccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCC
Q 007167          457 PPPAMRAAGYRAPEVTDTRKA-TQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY  535 (615)
Q Consensus       457 ~~~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  535 (615)
                      .....+|..|+|||++.+..+ +.++|||||||++|||++|+.||........ ....|.....           .....
T Consensus       164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~~~-----------~~~~~  231 (323)
T 3tki_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKKT-----------YLNPW  231 (323)
T ss_dssp             BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHHTTCT-----------TSTTG
T ss_pred             cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhcccc-----------cCCcc
Confidence            124467889999999977665 7799999999999999999999986544321 1111111100           00011


Q ss_pred             CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          536 PNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       536 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ..+++++.++++   +|+..||++|||+.|++++
T Consensus       232 ~~~~~~~~~li~---~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          232 KKIDSAPLALLH---KILVENPSARITIPDIKKD  262 (323)
T ss_dssp             GGSCHHHHHHHH---HHSCSSTTTSCCHHHHTTC
T ss_pred             ccCCHHHHHHHH---HHccCChhhCcCHHHHhhC
Confidence            223455555555   9999999999999999886

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1.2e-40  Score=338.66  Aligned_cols=255  Identities=24%  Similarity=0.414  Sum_probs=196.0

Q ss_pred             hhhcCcCCccEEEEEEE-----CCCCEEEEEEeccccC-CHHHHHHHHHHHhCCCCCcccceeEEEEec--CeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAAL-----EDASTVVVKRLKEVNV-GKREFEQQMEIVGGIRHENVVALRAYYYSK--DEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e~  376 (615)
                      .+.||+|+||+||+|.+     .+++.||||+++.... ..+.+.+|+++++.++||||+++++++...  ...++||||
T Consensus        15 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~   94 (295)
T 3ugc_A           15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY   94 (295)
T ss_dssp             EEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEEC
T ss_pred             hheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEe
Confidence            35699999999999984     3678899999975432 235788999999999999999999998654  568999999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM  456 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~  456 (615)
                      +++|+|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....
T Consensus        95 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  167 (295)
T 3ugc_A           95 LPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQD  167 (295)
T ss_dssp             CTTCBHHHHHHHCG----GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC-----
T ss_pred             CCCCCHHHHHHhcc----cccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccccCC
Confidence            99999999997542    35899999999999999999999998   999999999999999999999999999876532


Q ss_pred             C------CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc---------chhhHHHHHHHhhhc
Q 007167          457 P------PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGD---------EVVHLVRWVNSVVRE  521 (615)
Q Consensus       457 ~------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~---------~~~~~~~~~~~~~~~  521 (615)
                      .      ....++..|+|||.+.+..++.++||||||+++|||++|..|+......         ........+......
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (295)
T 3ugc_A          168 KEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN  247 (295)
T ss_dssp             --------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHT
T ss_pred             cceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhc
Confidence            2      1223456699999998889999999999999999999999998653211         000000011111111


Q ss_pred             ccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          522 EWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       522 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                      .       ........+++++.++++   +||+.||++|||+.|+++.|+++++.
T Consensus       248 ~-------~~~~~~~~~~~~l~~li~---~~l~~dp~~Rps~~el~~~L~~l~~~  292 (295)
T 3ugc_A          248 N-------GRLPRPDGCPDEIYMIMT---ECWNNNVNQRPSFRDLALRVDQIRDN  292 (295)
T ss_dssp             T-------CCCCCCTTCCHHHHHHHH---HHSCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             c-------CcCCCCcCcCHHHHHHHH---HHcCCChhhCCCHHHHHHHHHHHHHh
Confidence            0       011122344555555555   99999999999999999999999763

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=4e-41  Score=370.05  Aligned_cols=247  Identities=30%  Similarity=0.442  Sum_probs=204.4

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChhh
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSA  384 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  384 (615)
                      .++||+|+||+||+|.++++..||||+++......+.|.+|+++++.++|+|||++++++.+ +..++||||+++|+|.+
T Consensus       272 ~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~  350 (535)
T 2h8h_A          272 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLD  350 (535)
T ss_dssp             EEEEEECSSEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHH
T ss_pred             heecccCCCeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHH
Confidence            45799999999999999888889999998766667889999999999999999999999866 67899999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC----CCCC
Q 007167          385 MLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM----PPPA  460 (615)
Q Consensus       385 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~----~~~~  460 (615)
                      +++...   ...+++..+..|+.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....    ....
T Consensus       351 ~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~  424 (535)
T 2h8h_A          351 FLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA  424 (535)
T ss_dssp             HHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCST
T ss_pred             HHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCC
Confidence            997432   235899999999999999999999998   999999999999999999999999999876532    1223


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      .++..|+|||.+....++.++|||||||++|||++ |+.||......+....+.      . ..       .+.....++
T Consensus       425 ~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~------~-~~-------~~~~~~~~~  490 (535)
T 2h8h_A          425 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE------R-GY-------RMPCPPECP  490 (535)
T ss_dssp             TSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHH------T-TC-------CCCCCTTCC
T ss_pred             cCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH------c-CC-------CCCCCCCCC
Confidence            45678999999988889999999999999999999 999998755433322221      1 10       111123344


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                      +++.+++.   +||+.||++|||++||+++|+++..
T Consensus       491 ~~l~~li~---~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          491 ESLHDLMC---QCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             HHHHHHHH---HHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             HHHHHHHH---HHcCCChhHCcCHHHHHHHHHHHhh
Confidence            55555554   9999999999999999999998764

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=5.1e-40  Score=345.24  Aligned_cols=241  Identities=22%  Similarity=0.358  Sum_probs=197.5

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccc----cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEV----NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||.||++... +++.||+|++...    ....+.+.+|+++++.++|||||++++++.+.+..++||||+.+
T Consensus        20 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~g   99 (384)
T 4fr4_A           20 LRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLG   99 (384)
T ss_dssp             EEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCC
Confidence            357999999999999965 5778999998643    23356788999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC--C
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM--P  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~--~  457 (615)
                      |+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++++||+|||+++.+...  .
T Consensus       100 g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  171 (384)
T 4fr4_A          100 GDLRYHLQQN-----VHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI  171 (384)
T ss_dssp             EEHHHHHHTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCB
T ss_pred             CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCCCce
Confidence            9999999743     36999999999999999999999998   999999999999999999999999999876543  2


Q ss_pred             CCCCCCCcccCccccCC---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccC
Q 007167          458 PPAMRAAGYRAPEVTDT---RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLR  534 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  534 (615)
                      ....+|+.|+|||++..   ..++.++|||||||++|||++|+.||..................            ....
T Consensus       172 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~------------~~~~  239 (384)
T 4fr4_A          172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT------------VVTY  239 (384)
T ss_dssp             CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC------------CCCC
T ss_pred             eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc------------ccCC
Confidence            34568999999999864   45899999999999999999999999865544433333222110            1111


Q ss_pred             CCCcHHHHHHHHHHHHHcccCCCCCCCC-HHHHHH
Q 007167          535 YPNIEEEMVEMLQVGMACVVRMPEERPK-MADVLK  568 (615)
Q Consensus       535 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs-~~evl~  568 (615)
                      ...+++++.++++   +|+..||.+||+ ++++.+
T Consensus       240 p~~~s~~~~~li~---~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          240 PSAWSQEMVSLLK---KLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             CTTSCHHHHHHHH---HHSCSSGGGSCCSHHHHHT
T ss_pred             CCcCCHHHHHHHH---HHhcCCHhHhcccHHHHHc
Confidence            2344566666666   999999999998 777665

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2e-40  Score=346.85  Aligned_cols=245  Identities=18%  Similarity=0.263  Sum_probs=190.0

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChhh
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSA  384 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  384 (615)
                      +.||+|+||+||++... +++.||||++.......+.+.+|+.+++.++||||+++++++.+.+..++||||+++|+|.+
T Consensus        26 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~  105 (361)
T 3uc3_A           26 KDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYE  105 (361)
T ss_dssp             EEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHH
T ss_pred             EEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHH
Confidence            56999999999999975 68899999998765556789999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCc--EEEeecccccccCC--CCCCC
Q 007167          385 MLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGH--VCVSDIGLAALMSP--MPPPA  460 (615)
Q Consensus       385 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~--~kl~DfG~a~~~~~--~~~~~  460 (615)
                      ++...     ..+++..+..++.|++.||+|||+++   |+||||||+||+++.++.  +||+|||+++....  .....
T Consensus       106 ~l~~~-----~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~  177 (361)
T 3uc3_A          106 RICNA-----GRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKST  177 (361)
T ss_dssp             HHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC------------
T ss_pred             HHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCC
Confidence            99643     25999999999999999999999998   999999999999987765  99999999975432  22345


Q ss_pred             CCCCcccCccccCCCCCCCc-cchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          461 MRAAGYRAPEVTDTRKATQA-SDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~-~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      .+|+.|+|||++.+..++.+ +||||+||++|||++|+.||......+..  ...+.......       ........++
T Consensus       178 ~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~~~~~~~~~~-------~~~~~~~~~s  248 (361)
T 3uc3_A          178 VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RKTIQRILSVK-------YSIPDDIRIS  248 (361)
T ss_dssp             ---CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HHHHHHHHTTC-------CCCCTTSCCC
T ss_pred             cCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HHHHHHHhcCC-------CCCCCcCCCC
Confidence            68899999999987777655 89999999999999999999875443221  11122221111       0111122345


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                      +++.++++   +||..||++|||+.|++++-
T Consensus       249 ~~~~~li~---~~L~~dP~~Rps~~ell~hp  276 (361)
T 3uc3_A          249 PECCHLIS---RIFVADPATRISIPEIKTHS  276 (361)
T ss_dssp             HHHHHHHH---HHSCSCTTTSCCHHHHHTSH
T ss_pred             HHHHHHHH---HHccCChhHCcCHHHHHhCc
Confidence            66666666   99999999999999999873

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=7e-41  Score=347.45  Aligned_cols=238  Identities=24%  Similarity=0.395  Sum_probs=195.8

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccc----cCCHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEV----NVGKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      .+.||+|+||+||+|..+ +++.||+|+++..    ....+.+..|.+++..+ +||||+++++++.+.+..++||||++
T Consensus        22 ~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~  101 (345)
T 1xjd_A           22 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN  101 (345)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCC
Confidence            357999999999999975 5788999999753    23355677888888876 89999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC---
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP---  455 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~---  455 (615)
                      +|+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++++||+|||+++....   
T Consensus       102 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~  173 (345)
T 1xjd_A          102 GGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA  173 (345)
T ss_dssp             TCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcccCCC
Confidence            99999999743     36899999999999999999999998   99999999999999999999999999986432   


Q ss_pred             CCCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCC
Q 007167          456 MPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY  535 (615)
Q Consensus       456 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  535 (615)
                      ......+|+.|+|||++.+..++.++||||+||++|||++|+.||...+..+....+      ....         ....
T Consensus       174 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i------~~~~---------~~~p  238 (345)
T 1xjd_A          174 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI------RMDN---------PFYP  238 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCC---------CCCC
T ss_pred             cccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHH------HhCC---------CCCC
Confidence            223456899999999999989999999999999999999999999865433322221      1110         1111


Q ss_pred             CCcHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 007167          536 PNIEEEMVEMLQVGMACVVRMPEERPKMA-DVLK  568 (615)
Q Consensus       536 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~-evl~  568 (615)
                      ..+++++.++++   +|+..||++||++. |+++
T Consensus       239 ~~~s~~~~~li~---~lL~~dp~~R~~~~~~i~~  269 (345)
T 1xjd_A          239 RWLEKEAKDLLV---KLFVREPEKRLGVRGDIRQ  269 (345)
T ss_dssp             TTSCHHHHHHHH---HHSCSSGGGSBTTBSCGGG
T ss_pred             cccCHHHHHHHH---HHhcCCHhHcCCChHHHHc
Confidence            234566666666   99999999999997 7754

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=6.1e-40  Score=331.92  Aligned_cols=247  Identities=23%  Similarity=0.416  Sum_probs=196.8

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEeccccCC--------HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeec
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVG--------KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~--------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      +.||+|+||+||+|.. .+++.||+|++......        .+.+.+|+++++.++||||+++++++.+..  ++||||
T Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~  102 (287)
T 4f0f_A           25 KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEF  102 (287)
T ss_dssp             EECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEEC
T ss_pred             hccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEe
Confidence            5699999999999996 47889999998654221        157889999999999999999999986554  699999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCc-----EEEeeccccc
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGH-----VCVSDIGLAA  451 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~-----~kl~DfG~a~  451 (615)
                      +++|+|.+.+...    ...+++..+..++.|++.||+|||+.+ ++|+||||||+||+++.++.     +||+|||+++
T Consensus       103 ~~~~~L~~~l~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~  177 (287)
T 4f0f_A          103 VPCGDLYHRLLDK----AHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ  177 (287)
T ss_dssp             CTTCBHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCB
T ss_pred             cCCCCHHHHHhcc----cCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCCCccc
Confidence            9999999988643    246999999999999999999999985 34999999999999988776     9999999998


Q ss_pred             ccCCCCCCCCCCCcccCccccC--CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccc
Q 007167          452 LMSPMPPPAMRAAGYRAPEVTD--TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD  529 (615)
Q Consensus       452 ~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  529 (615)
                      ..........++..|+|||.+.  ...++.++|||||||++|||++|+.||......+.....    .......     .
T Consensus       178 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~----~~~~~~~-----~  248 (287)
T 4f0f_A          178 QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFIN----MIREEGL-----R  248 (287)
T ss_dssp             CCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHH----HHHHSCC-----C
T ss_pred             cccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHH----HHhccCC-----C
Confidence            7666555567889999999983  455789999999999999999999999875544332111    1111111     0


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 007167          530 VELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI  573 (615)
Q Consensus       530 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l  573 (615)
                      +  .....+++++.++++   +||+.||++|||+.|+++.|+++
T Consensus       249 ~--~~~~~~~~~l~~li~---~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          249 P--TIPEDCPPRLRNVIE---LCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             C--CCCTTSCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             C--CCCcccCHHHHHHHH---HHhcCChhhCcCHHHHHHHHHhC
Confidence            0  112234455555555   99999999999999999999864

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.8e-40  Score=334.83  Aligned_cols=247  Identities=23%  Similarity=0.396  Sum_probs=190.4

Q ss_pred             hhhcCcCCccEEEEEEECC----CCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALED----ASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      .+.||+|+||+||+|....    +..||+|+++....  ..+.+.+|+++++.++||||+++++++ ..+..++||||++
T Consensus        20 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~   98 (281)
T 1mp8_A           20 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWIIMELCT   98 (281)
T ss_dssp             EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEEEEECCT
T ss_pred             EeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEEEEecCC
Confidence            4579999999999998643    44699999875422  245688999999999999999999998 4567899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC-
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP-  457 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~-  457 (615)
                      +|+|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++...... 
T Consensus        99 ~~~L~~~l~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (281)
T 1mp8_A           99 LGELRSFLQVRK----YSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY  171 (281)
T ss_dssp             TEEHHHHHHHTT----TTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------------
T ss_pred             CCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccCcccc
Confidence            999999997432    36899999999999999999999998   9999999999999999999999999998765432 


Q ss_pred             ---CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccccccccccc
Q 007167          458 ---PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELL  533 (615)
Q Consensus       458 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  533 (615)
                         ....++..|+|||.+....++.++|||||||++|||++ |+.||......+....+.      ...        ...
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~------~~~--------~~~  237 (281)
T 1mp8_A          172 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE------NGE--------RLP  237 (281)
T ss_dssp             -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH------TTC--------CCC
T ss_pred             cccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHH------cCC--------CCC
Confidence               12234668999999988889999999999999999997 999998765444322211      110        011


Q ss_pred             CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          534 RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       534 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                      ..+.+++++.++++   +|+..||++|||+.|++++|+++.+.
T Consensus       238 ~~~~~~~~l~~li~---~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          238 MPPNCPPTLYSLMT---KCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             CCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHH---HHccCChhhCcCHHHHHHHHHHHHHH
Confidence            12344555555555   99999999999999999999998764

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.7e-40  Score=350.13  Aligned_cols=245  Identities=17%  Similarity=0.318  Sum_probs=194.5

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC----HHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG----KREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      .++||+|+||+||+|+.+ +++.||+|+++.....    .+.+.+|..++.++ +|||||++++++.+.+..++||||++
T Consensus        57 ~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~  136 (396)
T 4dc2_A           57 LRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN  136 (396)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCC
Confidence            357999999999999976 4678999999764322    24577899988876 89999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC---
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP---  455 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~---  455 (615)
                      +|+|..++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++++||+|||+++....   
T Consensus       137 gg~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~  208 (396)
T 4dc2_A          137 GGDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD  208 (396)
T ss_dssp             TCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             CCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccCCC
Confidence            99999999743     36999999999999999999999998   99999999999999999999999999986322   


Q ss_pred             CCCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchh--hHHHHH-HHhhhcccccccccccc
Q 007167          456 MPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVV--HLVRWV-NSVVREEWTAEVFDVEL  532 (615)
Q Consensus       456 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~d~~~  532 (615)
                      ......+|+.|+|||++.+..++.++|||||||++|||++|+.||......+..  .....+ ..+..         ...
T Consensus       209 ~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~---------~~~  279 (396)
T 4dc2_A          209 TTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE---------KQI  279 (396)
T ss_dssp             CBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH---------CCC
T ss_pred             ccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc---------ccc
Confidence            233456899999999999999999999999999999999999999754322110  000111 11111         111


Q ss_pred             cCCCCcHHHHHHHHHHHHHcccCCCCCCCCH------HHHHHH
Q 007167          533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKM------ADVLKM  569 (615)
Q Consensus       533 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~------~evl~~  569 (615)
                      .....+++++.++++   +||+.||++||++      +|++++
T Consensus       280 ~~p~~~s~~~~~li~---~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          280 RIPRSLSVKAASVLK---SFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             CCCTTSCHHHHHHHH---HHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             CCCCcCCHHHHHHHH---HHhcCCHhHcCCCCCCCCHHHHhcC
Confidence            122345666666666   9999999999985      677664

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.1e-40  Score=333.94  Aligned_cols=248  Identities=27%  Similarity=0.458  Sum_probs=203.4

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChhh
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSA  384 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  384 (615)
                      .+.||+|+||+||+|...++..||||.++......+.+.+|+++++.++||||+++++++. .+..++||||+++++|.+
T Consensus        18 ~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~   96 (279)
T 1qpc_A           18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVD   96 (279)
T ss_dssp             EEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHH
T ss_pred             eeeecCCCCeEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecCCCCCHHH
Confidence            3569999999999999988889999999877666788999999999999999999999986 456899999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC----CCC
Q 007167          385 MLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP----PPA  460 (615)
Q Consensus       385 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~----~~~  460 (615)
                      ++....   ...+++..+..++.|++.||+|||+.+   |+||||||+||++++++.+||+|||++.......    ...
T Consensus        97 ~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  170 (279)
T 1qpc_A           97 FLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA  170 (279)
T ss_dssp             HTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTC
T ss_pred             HHhcCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCC
Confidence            996432   125899999999999999999999998   9999999999999999999999999998765432    223


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      .++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....   +.   .. .       .......++
T Consensus       171 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~---~~---~~-~-------~~~~~~~~~  236 (279)
T 1qpc_A          171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN---LE---RG-Y-------RMVRPDNCP  236 (279)
T ss_dssp             CCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH---HH---TT-C-------CCCCCTTCC
T ss_pred             CCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHH---Hh---cc-c-------CCCCccccc
Confidence            34668999999988888999999999999999999 9999976543332211   11   10 0       011122344


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                      +++.++++   +|+..+|++|||+.|+++.|+++...
T Consensus       237 ~~l~~li~---~~l~~~p~~Rps~~~l~~~l~~~~~~  270 (279)
T 1qpc_A          237 EELYQLMR---LCWKERPEDRPTFDYLRSVLEDFFTA  270 (279)
T ss_dssp             HHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHH---HHhccChhhCCCHHHHHHHHHHHHHh
Confidence            55555555   99999999999999999999998754

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.8e-40  Score=335.94  Aligned_cols=248  Identities=25%  Similarity=0.382  Sum_probs=205.6

Q ss_pred             hhcCcCCccEEEEEEECC-CCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChhh
Q 007167          306 EVLGKGTFGTAYKAALED-ASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSA  384 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  384 (615)
                      +.||+|+||+||+|.... +..||+|.++......+.+.+|+++++.++||||+++++++.+.+..++||||+++++|.+
T Consensus        19 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~   98 (288)
T 3kfa_A           19 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD   98 (288)
T ss_dssp             EESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHH
T ss_pred             eecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHH
Confidence            569999999999999764 7789999998765556789999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC----CC
Q 007167          385 MLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP----PA  460 (615)
Q Consensus       385 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~----~~  460 (615)
                      ++....   ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++........    ..
T Consensus        99 ~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  172 (288)
T 3kfa_A           99 YLRECN---RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA  172 (288)
T ss_dssp             HHHHCC---TTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTE
T ss_pred             HHHhcc---cCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCC
Confidence            997532   346999999999999999999999998   99999999999999999999999999987654322    12


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      .++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+.   ...           .......++
T Consensus       173 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~---~~~-----------~~~~~~~~~  238 (288)
T 3kfa_A          173 KFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE---KDY-----------RMERPEGCP  238 (288)
T ss_dssp             EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH---TTC-----------CCCCCTTCC
T ss_pred             ccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh---ccC-----------CCCCCCCCC
Confidence            34567999999988889999999999999999999 999998765444332221   100           111123344


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                      +++.++++   +|+..||.+|||+.|+++.|+.+...
T Consensus       239 ~~l~~li~---~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          239 EKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             HHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHH---HHhCCChhhCcCHHHHHHHHHHHHHh
Confidence            55555555   99999999999999999999998754

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=2.1e-40  Score=341.33  Aligned_cols=251  Identities=26%  Similarity=0.394  Sum_probs=190.2

Q ss_pred             hhhcCcCCccEEEEEEECCCC----EEEEEEecccc---CCHHHHHHHHHHHhCCCCCcccceeEEEEecCee------e
Q 007167          305 AEVLGKGTFGTAYKAALEDAS----TVVVKRLKEVN---VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEK------L  371 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~----~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~------~  371 (615)
                      .+.||+|+||+||+|......    .||||+++...   ...+.+.+|+++++.++||||+++++++...+..      +
T Consensus        28 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~  107 (323)
T 3qup_A           28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPM  107 (323)
T ss_dssp             EEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEE
T ss_pred             eceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccE
Confidence            467999999999999865432    79999987542   2246788999999999999999999999877655      9


Q ss_pred             EEeecCCCCChhhhhccCCC-CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccc
Q 007167          372 MVYDYFEPGSVSAMLHGRRG-EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLA  450 (615)
Q Consensus       372 lV~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a  450 (615)
                      +||||+++|+|.+++..... .....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus       108 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~kl~Dfg~a  184 (323)
T 3qup_A          108 VILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLS  184 (323)
T ss_dssp             EEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC-
T ss_pred             EEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCEEEeecccc
Confidence            99999999999999964332 12236899999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCCCC-----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccc
Q 007167          451 ALMSPMPP-----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWT  524 (615)
Q Consensus       451 ~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  524 (615)
                      +.......     ...++..|+|||.+.+..++.++|||||||++|||++ |+.||......+....+.      ...  
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~------~~~--  256 (323)
T 3qup_A          185 RKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI------GGN--  256 (323)
T ss_dssp             ----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH------TTC--
T ss_pred             ccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh------cCC--
Confidence            87643321     2234667999999988889999999999999999999 999998765544332211      100  


Q ss_pred             cccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          525 AEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       525 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                            .....+..++++.++++   +|++.||++|||+.|+++.|+++..
T Consensus       257 ------~~~~~~~~~~~l~~li~---~~l~~dp~~Rps~~~l~~~l~~~l~  298 (323)
T 3qup_A          257 ------RLKQPPECMEEVYDLMY---QCWSADPKQRPSFTCLRMELENILG  298 (323)
T ss_dssp             ------CCCCCTTCCHHHHHHHH---HTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ------CCCCCCccCHHHHHHHH---HHccCChhhCcCHHHHHHHHHHHHH
Confidence                  11112334455555555   9999999999999999999999976

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5e-40  Score=340.29  Aligned_cols=257  Identities=23%  Similarity=0.385  Sum_probs=193.2

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCC--CCCcccceeEEEEec----CeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGI--RHENVVALRAYYYSK----DEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l--~h~niv~l~~~~~~~----~~~~lV~e~~~  378 (615)
                      .+.||+|+||+||+|... ++.||||++....  ...+.+|.+++...  +||||+++++++...    ...++||||++
T Consensus        42 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~  118 (337)
T 3mdy_A           42 VKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTE--EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHE  118 (337)
T ss_dssp             EEEEEEETTEEEEEEEET-TEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCT
T ss_pred             EeEeecCCCeEEEEEEEC-CceEEEEEEeccc--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccC
Confidence            567999999999999876 7899999986543  34455566666554  899999999999887    68899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccC-----CCCceecCCCCCCEEeCCCCcEEEeeccccccc
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN-----GGKLVHGGIKASNIFLNSQGHVCVSDIGLAALM  453 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~  453 (615)
                      +|+|.++++..      .+++..+..++.|++.||+|||+.+     .++|+||||||+||+++.++.+||+|||+++.+
T Consensus       119 ~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~  192 (337)
T 3mdy_A          119 NGSLYDYLKST------TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF  192 (337)
T ss_dssp             TCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CCcHHHHhhcc------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceee
Confidence            99999999642      5899999999999999999999881     112999999999999999999999999999766


Q ss_pred             CCCC-------CCCCCCCcccCccccCCCCCCCc------cchhhHHHHHHHHHhC----------CCCCCCCCCcch-h
Q 007167          454 SPMP-------PPAMRAAGYRAPEVTDTRKATQA------SDVFSFGVLLLELLTG----------KSPIHATGGDEV-V  509 (615)
Q Consensus       454 ~~~~-------~~~~~~~~y~aPE~~~~~~~~~~------~DvwS~Gvvl~elltg----------~~p~~~~~~~~~-~  509 (615)
                      ....       ....+|..|+|||++.+.....+      +|||||||++|||++|          +.||......+. .
T Consensus       193 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~  272 (337)
T 3mdy_A          193 ISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSY  272 (337)
T ss_dssp             C---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCH
T ss_pred             ccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCch
Confidence            4322       23467889999999987766655      9999999999999999          666654332211 1


Q ss_pred             hHHHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhh
Q 007167          510 HLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVK  577 (615)
Q Consensus       510 ~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~  577 (615)
                      ...   ........    ..+.............++.+++.+||+.||++|||+.||+++|+++.+..
T Consensus       273 ~~~---~~~~~~~~----~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          273 EDM---REIVCIKK----LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             HHH---HHHHTTSC----CCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             hhh---HHHHhhhc----cCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            111   11111000    01111100001133445566666999999999999999999999998754

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=3e-40  Score=340.92  Aligned_cols=246  Identities=22%  Similarity=0.381  Sum_probs=193.5

Q ss_pred             hhcCcCCccEEEEEEEC-CCCE----EEEEEeccc--cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCC
Q 007167          306 EVLGKGTFGTAYKAALE-DAST----VVVKRLKEV--NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~----vavK~l~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      ++||+|+||+||+|... ++..    |++|.+...  ....+.+.+|+++++.++||||+++++++.... .++|+||+.
T Consensus        21 ~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~   99 (327)
T 3lzb_A           21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMP   99 (327)
T ss_dssp             EEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCS
T ss_pred             EEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecC
Confidence            56999999999999854 4443    577777543  234678999999999999999999999998754 788999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP  458 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~  458 (615)
                      +|+|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.......
T Consensus       100 ~g~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~  172 (327)
T 3lzb_A          100 FGCLLDYVREHK----DNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  172 (327)
T ss_dssp             SCBHHHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred             CCcHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence            999999997532    36899999999999999999999998   99999999999999999999999999987643221


Q ss_pred             -----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccc
Q 007167          459 -----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL  532 (615)
Q Consensus       459 -----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  532 (615)
                           ...++..|+|||.+.+..++.++|||||||++|||++ |+.||......+....+.   .    .       ...
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~---~----~-------~~~  238 (327)
T 3lzb_A          173 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---K----G-------ERL  238 (327)
T ss_dssp             -------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH---T----T-------CCC
T ss_pred             cccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH---c----C-------CCC
Confidence                 2234667999999998899999999999999999999 999998765544333221   1    0       011


Q ss_pred             cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       533 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                      ...+..++++.++++   +||..||.+||++.|+++.|+++...
T Consensus       239 ~~~~~~~~~l~~li~---~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          239 PQPPICTIDVYMIMR---KCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             CCCTTBCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             CCCccCCHHHHHHHH---HHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            112334455555555   99999999999999999999998753

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=9.3e-41  Score=353.96  Aligned_cols=241  Identities=20%  Similarity=0.293  Sum_probs=198.1

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccc----cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEV----NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      ++||+|+||+||+|..+ +++.||+|+++..    ....+.+.+|+++++.++|||||++++++.+.+..++||||+++|
T Consensus        75 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg  154 (410)
T 3v8s_A           75 KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGG  154 (410)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTE
T ss_pred             EEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCC
Confidence            57999999999999976 5788999998653    223456889999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---  457 (615)
                      +|.++++..      .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++++||+|||+++......   
T Consensus       155 ~L~~~l~~~------~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~  225 (410)
T 3v8s_A          155 DLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR  225 (410)
T ss_dssp             EHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEE
T ss_pred             cHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccCCccc
Confidence            999999642      4889999999999999999999998   9999999999999999999999999998765432   


Q ss_pred             -CCCCCCCcccCccccCCCC----CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccc
Q 007167          458 -PPAMRAAGYRAPEVTDTRK----ATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL  532 (615)
Q Consensus       458 -~~~~~~~~y~aPE~~~~~~----~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  532 (615)
                       ....+|+.|+|||++....    ++.++|||||||++|||++|+.||...+..+....+  +....         ....
T Consensus       226 ~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i--~~~~~---------~~~~  294 (410)
T 3v8s_A          226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKI--MNHKN---------SLTF  294 (410)
T ss_dssp             CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--HTHHH---------HCCC
T ss_pred             ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHH--Hhccc---------cccC
Confidence             3456899999999987654    789999999999999999999999865433322211  11000         0111


Q ss_pred             cCCCCcHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 007167          533 LRYPNIEEEMVEMLQVGMACVVRMPEE--RPKMADVLKM  569 (615)
Q Consensus       533 ~~~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~~  569 (615)
                      ...+.++++++++++   +|+..+|.+  ||+++||++|
T Consensus       295 p~~~~~s~~~~~li~---~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          295 PDDNDISKEAKNLIC---AFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             CTTCCCCHHHHHHHH---HHSSCGGGCTTSSCHHHHHTS
T ss_pred             CCcccccHHHHHHHH---HHccChhhhCCCCCHHHHhcC
Confidence            222356677777777   999988988  9999999986

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3e-40  Score=330.74  Aligned_cols=248  Identities=22%  Similarity=0.354  Sum_probs=199.0

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEec--CeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSK--DEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e~~~~  379 (615)
                      .+.||+|+||+||+|..+ +..||||+++.....   .+.+.+|+++++.++||||+++++++.+.  ...++||||+++
T Consensus        15 ~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~   93 (271)
T 3kmu_A           15 LTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPY   93 (271)
T ss_dssp             EEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTT
T ss_pred             HHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCC
Confidence            356999999999999985 788999999765333   35688999999999999999999999887  778999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCC
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP  459 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~  459 (615)
                      |+|.++++...   ...+++..+..++.|++.||+|||+.+ ++|+||||||+||+++.++.++|+|||++.....  ..
T Consensus        94 ~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~--~~  167 (271)
T 3kmu_A           94 GSLYNVLHEGT---NFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSFQS--PG  167 (271)
T ss_dssp             CBHHHHHHSCS---SCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC--TT
T ss_pred             CcHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeeecc--cC
Confidence            99999997532   236899999999999999999999874 3599999999999999999999999998765432  34


Q ss_pred             CCCCCcccCccccCCCCCCC---ccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          460 AMRAAGYRAPEVTDTRKATQ---ASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~~~---~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                      ..+|..|+|||.+.+..++.   ++|||||||++|||++|+.||......+....      ......     .+  ....
T Consensus       168 ~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~------~~~~~~-----~~--~~~~  234 (271)
T 3kmu_A          168 RMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMK------VALEGL-----RP--TIPP  234 (271)
T ss_dssp             CBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHH------HHHSCC-----CC--CCCT
T ss_pred             ccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHH------HHhcCC-----CC--CCCC
Confidence            46789999999997765544   79999999999999999999976543322111      111110     01  1122


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                      ..++++.++++   +||+.||++|||++|+++.|+++.+
T Consensus       235 ~~~~~~~~li~---~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          235 GISPHVSKLMK---ICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             TCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             CCCHHHHHHHH---HHcCCChhhCcCHHHHHHHHHHhhc
Confidence            34555555555   9999999999999999999998864

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-40  Score=347.41  Aligned_cols=253  Identities=25%  Similarity=0.381  Sum_probs=192.9

Q ss_pred             hhhcCcCCccEEEEEEEC--CC--CEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEe-cCeeeEEeecC
Q 007167          305 AEVLGKGTFGTAYKAALE--DA--STVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYS-KDEKLMVYDYF  377 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~--~~--~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~~  377 (615)
                      .++||+|+||+||+|.+.  ++  ..||||.++....  ..+.+.+|++++++++||||+++++++.. ++..++||||+
T Consensus        94 ~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~  173 (373)
T 3c1x_A           94 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  173 (373)
T ss_dssp             EEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECC
T ss_pred             CcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECC
Confidence            357999999999999853  22  3588998875432  24678899999999999999999999765 45789999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC
Q 007167          378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP  457 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~  457 (615)
                      ++|+|.+++...    ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.+....
T Consensus       174 ~~g~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          174 KHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             TTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             CCCCHHHHHhhc----ccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccccc
Confidence            999999999743    235889999999999999999999998   9999999999999999999999999998664322


Q ss_pred             -------CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccccccc
Q 007167          458 -------PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD  529 (615)
Q Consensus       458 -------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  529 (615)
                             ....++..|+|||.+.+..++.++|||||||++|||++ |..||......+....+.      ...       
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~------~~~-------  313 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------QGR-------  313 (373)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHH------TTC-------
T ss_pred             cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHH------cCC-------
Confidence                   12234667999999988899999999999999999999 788887765544332221      110       


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhhcCCC
Q 007167          530 VELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENP  581 (615)
Q Consensus       530 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~~~~  581 (615)
                       .......+++.+.+++.   +||..+|++||++.|+++.|+++........
T Consensus       314 -~~~~p~~~~~~l~~li~---~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~  361 (373)
T 3c1x_A          314 -RLLQPEYCPDPLYEVML---KCWHPKAEMRPSFSELVSRISAIFSTFIGEH  361 (373)
T ss_dssp             -CCCCCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHTCCSCC
T ss_pred             -CCCCCCCCCHHHHHHHH---HHcCCChhhCcCHHHHHHHHHHHHHhccccc
Confidence             01112234455555544   9999999999999999999999987554333

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=3.6e-40  Score=343.17  Aligned_cols=238  Identities=21%  Similarity=0.334  Sum_probs=196.1

Q ss_pred             hhcCcCCccEEEEEEECC-CCEEEEEEeccc----cCCHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCCC
Q 007167          306 EVLGKGTFGTAYKAALED-ASTVVVKRLKEV----NVGKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      ++||+|+||+||+|..+. ++.||+|+++..    ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus        26 ~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~g  105 (353)
T 2i0e_A           26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNG  105 (353)
T ss_dssp             EEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred             EEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCC
Confidence            579999999999999764 678999999753    23356678899999988 899999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC---C
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP---M  456 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~---~  456 (615)
                      |+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++++||+|||+++....   .
T Consensus       106 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  177 (353)
T 2i0e_A          106 GDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT  177 (353)
T ss_dssp             CBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred             CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcc
Confidence            9999999743     25899999999999999999999998   99999999999999999999999999986432   2


Q ss_pred             CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          457 PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       457 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                      .....+|+.|+|||++.+..++.++|||||||++|||++|+.||...+..+...      .+...         ......
T Consensus       178 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~------~i~~~---------~~~~p~  242 (353)
T 2i0e_A          178 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQ------SIMEH---------NVAYPK  242 (353)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHC---------CCCCCT
T ss_pred             cccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHH------HHHhC---------CCCCCC
Confidence            234568999999999999899999999999999999999999998654333222      11111         111123


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPK-----MADVLKM  569 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~  569 (615)
                      .+++++.++++   +|+..||++||+     ++|++++
T Consensus       243 ~~s~~~~~li~---~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          243 SMSKEAVAICK---GLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             TSCHHHHHHHH---HHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             CCCHHHHHHHH---HHhhcCHHHcCCCCCCCHHHHhcC
Confidence            45566666666   999999999995     5777765

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.3e-40  Score=365.27  Aligned_cols=247  Identities=22%  Similarity=0.366  Sum_probs=200.1

Q ss_pred             hcCcCCccEEEEEEEC---CCCEEEEEEecccc--CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          307 VLGKGTFGTAYKAALE---DASTVVVKRLKEVN--VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      .||+|+||+||+|.++   ++..||||+++...  ...+.+.+|+++++.++|||||++++++.. +..++||||+++|+
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~  421 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP  421 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCB
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCc
Confidence            5999999999999864   45679999998642  346789999999999999999999999976 56899999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC---
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP---  458 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~---  458 (615)
                      |.+++...    ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.+.....   
T Consensus       422 L~~~l~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~  494 (613)
T 2ozo_A          422 LHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT  494 (613)
T ss_dssp             HHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC-------
T ss_pred             HHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceee
Confidence            99999743    346999999999999999999999998   99999999999999999999999999987653221   


Q ss_pred             ---CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccC
Q 007167          459 ---PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLR  534 (615)
Q Consensus       459 ---~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  534 (615)
                         ...++..|+|||++....++.++|||||||++|||++ |+.||......+....+.      ...        .+..
T Consensus       495 ~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~------~~~--------~~~~  560 (613)
T 2ozo_A          495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE------QGK--------RMEC  560 (613)
T ss_dssp             -------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHH------TTC--------CCCC
T ss_pred             eccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHH------cCC--------CCCC
Confidence               1123568999999988899999999999999999998 999998766554433221      110        1111


Q ss_pred             CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhhc
Q 007167          535 YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKA  578 (615)
Q Consensus       535 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~  578 (615)
                      .+.+++++.+++.   +||..+|++||++.||++.|+.+-....
T Consensus       561 p~~~~~~l~~li~---~cl~~dP~~RPs~~~l~~~L~~~~~~~~  601 (613)
T 2ozo_A          561 PPECPPELYALMS---DCWIYKWEDRPDFLTVEQRMRACYYSLA  601 (613)
T ss_dssp             CTTCCHHHHHHHH---HTTCSSTTTSCCHHHHHHHHHHHHHHHS
T ss_pred             CCcCCHHHHHHHH---HHcCCChhHCcCHHHHHHHHHHHHHHhc
Confidence            2334455555554   9999999999999999999999865443

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.4e-40  Score=340.50  Aligned_cols=239  Identities=22%  Similarity=0.354  Sum_probs=189.2

Q ss_pred             hhhcCcCCccEEEEEEE----CCCCEEEEEEecccc-----CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEee
Q 007167          305 AEVLGKGTFGTAYKAAL----EDASTVVVKRLKEVN-----VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYD  375 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  375 (615)
                      .+.||+|+||+||++..    .+++.||+|+++...     .....+.+|+++++.++||||+++++++...+..++|||
T Consensus        22 ~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e  101 (327)
T 3a62_A           22 LRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILE  101 (327)
T ss_dssp             EEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             EEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEe
Confidence            35799999999999986    478899999997542     123457789999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      |+++|+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       102 ~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  173 (327)
T 3a62_A          102 YLSGGELFMQLERE-----GIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESIH  173 (327)
T ss_dssp             CCTTEEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred             CCCCCcHHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence            99999999999743     35889999999999999999999998   99999999999999999999999999976432


Q ss_pred             C---CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccc
Q 007167          456 M---PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL  532 (615)
Q Consensus       456 ~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  532 (615)
                      .   .....+|..|+|||++.+..++.++|||||||++|||++|+.||......+...      .+...         ..
T Consensus       174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~------~i~~~---------~~  238 (327)
T 3a62_A          174 DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID------KILKC---------KL  238 (327)
T ss_dssp             -----CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------HHHHT---------CC
T ss_pred             CCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHH------HHHhC---------CC
Confidence            2   234467899999999998889999999999999999999999998654332221      11111         11


Q ss_pred             cCCCCcHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007167          533 LRYPNIEEEMVEMLQVGMACVVRMPEERP-----KMADVLKM  569 (615)
Q Consensus       533 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  569 (615)
                      ...+..++++.++++   +|+..||++||     ++.|++++
T Consensus       239 ~~p~~~~~~~~~li~---~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          239 NLPPYLTQEARDLLK---KLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             CCCTTSCHHHHHHHH---HHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             CCCCCCCHHHHHHHH---HHHhcCHhhccCCCCCCHHHHHcC
Confidence            112344566666666   99999999999     78888775

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=5.9e-40  Score=333.00  Aligned_cols=253  Identities=20%  Similarity=0.356  Sum_probs=191.9

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      +.||+|+||+||+|... +++.||||+++.....   .+.+.+|++++++++||||+++++++.+++..++||||+++ +
T Consensus         8 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~   86 (292)
T 3o0g_A            8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-D   86 (292)
T ss_dssp             EEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-E
T ss_pred             eEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-C
Confidence            56999999999999975 5888999999754322   36688999999999999999999999999999999999976 5


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC---CC
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM---PP  458 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~---~~  458 (615)
                      +.+.+...    ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.....   ..
T Consensus        87 l~~~~~~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (292)
T 3o0g_A           87 LKKYFDSC----NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             HHHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCC
T ss_pred             HHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCcccccc
Confidence            55555432    236999999999999999999999998   999999999999999999999999999876532   23


Q ss_pred             CCCCCCcccCccccCCCC-CCCccchhhHHHHHHHHHhCCCCCCCCCC-cchhhH-HHHHHHhhhcccccccccc-----
Q 007167          459 PAMRAAGYRAPEVTDTRK-ATQASDVFSFGVLLLELLTGKSPIHATGG-DEVVHL-VRWVNSVVREEWTAEVFDV-----  530 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~elltg~~p~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~d~-----  530 (615)
                      ...+|..|+|||++.+.. ++.++||||+||++|||++|+.||..... .+.... .+.......+.|....-.+     
T Consensus       160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  239 (292)
T 3o0g_A          160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY  239 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred             CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccccc
Confidence            345688999999987765 79999999999999999998888644322 111111 1111111111111000000     


Q ss_pred             --------cccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          531 --------ELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       531 --------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                              .....+..+++..++++   +|++.||++|||++|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          240 PMYPATTSLVNVVPKLNATGRDLLQ---NLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CCCCTTCCCTTTSTTCCHHHHHHHH---HHSCSSGGGSCCHHHHHTS
T ss_pred             ccccCCcchhhcccccChHHHHHHH---HHhccChhhCCCHHHHhcC
Confidence                    00011234556666666   9999999999999999875

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=2.2e-40  Score=342.99  Aligned_cols=255  Identities=25%  Similarity=0.422  Sum_probs=202.6

Q ss_pred             hhhcCcCCccEEEEEEEC--------CCCEEEEEEeccccC--CHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEE
Q 007167          305 AEVLGKGTFGTAYKAALE--------DASTVVVKRLKEVNV--GKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMV  373 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV  373 (615)
                      .+.||+|+||+||+|...        ++..||||+++....  ..+.+.+|+++++.+ +||||+++++++...+..++|
T Consensus        40 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv  119 (334)
T 2pvf_A           40 GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVI  119 (334)
T ss_dssp             EEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEE
T ss_pred             eeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEE
Confidence            457999999999999863        467899999975432  235688999999999 899999999999999999999


Q ss_pred             eecCCCCChhhhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcE
Q 007167          374 YDYFEPGSVSAMLHGRRGE-----------GQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHV  442 (615)
Q Consensus       374 ~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~  442 (615)
                      |||+++|+|.+++......           ....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+
T Consensus       120 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~  196 (334)
T 2pvf_A          120 VEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLVTENNVM  196 (334)
T ss_dssp             EECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred             EECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEEcCCCCE
Confidence            9999999999999864321           1235899999999999999999999998   9999999999999999999


Q ss_pred             EEeecccccccCCCC-----CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 007167          443 CVSDIGLAALMSPMP-----PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVN  516 (615)
Q Consensus       443 kl~DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  516 (615)
                      ||+|||+++......     ....++..|+|||++.+..++.++|||||||++|||++ |+.||......+....   +.
T Consensus       197 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~---~~  273 (334)
T 2pvf_A          197 KIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKL---LK  273 (334)
T ss_dssp             EECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH---HH
T ss_pred             EEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHH---Hh
Confidence            999999998765432     22345678999999988889999999999999999999 9999976543332221   11


Q ss_pred             HhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhhcC
Q 007167          517 SVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAE  579 (615)
Q Consensus       517 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~~  579 (615)
                      .   ..        .......+++++.++++   +||..+|.+|||+.|++++|+++......
T Consensus       274 ~---~~--------~~~~~~~~~~~l~~li~---~~l~~dp~~Rps~~ell~~L~~l~~~~~~  322 (334)
T 2pvf_A          274 E---GH--------RMDKPANCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRILTLTTN  322 (334)
T ss_dssp             H---TC--------CCCCCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             c---CC--------CCCCCccCCHHHHHHHH---HHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence            1   10        00112234455555555   99999999999999999999999876543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.8e-40  Score=342.37  Aligned_cols=243  Identities=17%  Similarity=0.314  Sum_probs=183.0

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      .+.||+|+||+||+|... +++.||||+++... ..+.+.+|++++++++||||+++++++.+.+..++||||+++|+|.
T Consensus        58 ~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~  136 (349)
T 2w4o_A           58 ESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELF  136 (349)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEC-----------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred             eeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHH
Confidence            356999999999999976 57789999997543 3567889999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCC---CCcEEEeecccccccCCCC--C
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNS---QGHVCVSDIGLAALMSPMP--P  458 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~---~~~~kl~DfG~a~~~~~~~--~  458 (615)
                      +++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.   ++.+||+|||+++......  .
T Consensus       137 ~~l~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~  208 (349)
T 2w4o_A          137 DRIVEK-----GYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK  208 (349)
T ss_dssp             HHHTTC-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------------
T ss_pred             HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCcccccc
Confidence            999643     35899999999999999999999998   999999999999975   8899999999998765432  3


Q ss_pred             CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCc
Q 007167          459 PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI  538 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  538 (615)
                      ...+|..|+|||++.+..++.++|||||||++|||++|+.||......+.  .   ...+.....     ......++..
T Consensus       209 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~--~---~~~i~~~~~-----~~~~~~~~~~  278 (349)
T 2w4o_A          209 TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF--M---FRRILNCEY-----YFISPWWDEV  278 (349)
T ss_dssp             ----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH--H---HHHHHTTCC-----CCCTTTTTTS
T ss_pred             cccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHH--H---HHHHHhCCC-----ccCCchhhhC
Confidence            34578999999999998999999999999999999999999976543321  1   111111110     0001112344


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          539 EEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       539 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ++++.++++   +|+..||++|||+.|++++
T Consensus       279 ~~~~~~li~---~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          279 SLNAKDLVR---KLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             CHHHHHHHH---TTSCSSGGGSCCHHHHHHS
T ss_pred             CHHHHHHHH---HHccCChhhCcCHHHHhcC
Confidence            556666655   9999999999999999875

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-40  Score=342.33  Aligned_cols=247  Identities=27%  Similarity=0.456  Sum_probs=194.4

Q ss_pred             hhcCcCCccEEEEEEECC-----CCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCC
Q 007167          306 EVLGKGTFGTAYKAALED-----ASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~-----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      +.||+|+||+||+|....     +..||||+++....  ....+.+|+++++.++||||+++++++.+.+..++||||++
T Consensus        50 ~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~  129 (333)
T 1mqb_A           50 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYME  129 (333)
T ss_dssp             EEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             cEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCC
Confidence            579999999999998643     23599999975432  23568899999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP  458 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~  458 (615)
                      +|+|.+++...    ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.......
T Consensus       130 ~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  202 (333)
T 1mqb_A          130 NGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  202 (333)
T ss_dssp             TEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred             CCcHHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhccccc
Confidence            99999999743    236999999999999999999999998   99999999999999999999999999987654321


Q ss_pred             ------CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccccccccc
Q 007167          459 ------PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE  531 (615)
Q Consensus       459 ------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  531 (615)
                            ...++..|+|||.+.+..++.++|||||||++|||++ |+.||......+....+      ....        .
T Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~------~~~~--------~  268 (333)
T 1mqb_A          203 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI------NDGF--------R  268 (333)
T ss_dssp             --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH------HTTC--------C
T ss_pred             cccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHH------HCCC--------c
Confidence                  1223567999999988889999999999999999999 99999765433322111      1110        1


Q ss_pred             ccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          532 LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       532 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                      .......++++.++++   +||+.+|++||++.|++++|+++...
T Consensus       269 ~~~~~~~~~~l~~li~---~~l~~~p~~Rps~~~l~~~L~~~~~~  310 (333)
T 1mqb_A          269 LPTPMDCPSAIYQLMM---QCWQQERARRPKFADIVSILDKLIRA  310 (333)
T ss_dssp             CCCCTTCBHHHHHHHH---HHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CCCcccCCHHHHHHHH---HHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            1112234455555544   99999999999999999999998763

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.3e-40  Score=343.27  Aligned_cols=246  Identities=19%  Similarity=0.350  Sum_probs=178.2

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCHHHHHHHHHHHhCCC-CCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFEQQMEIVGGIR-HENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      +.||+|+||+||+|... +++.||||++...  ....+.+|++++..++ ||||+++++++.+....++||||+++|+|.
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~   94 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR--MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELF   94 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGG--GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHH
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChh--hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHH
Confidence            56999999999999975 6889999999643  3567889999999997 999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCC---cEEEeecccccccCCCC---
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG---HVCVSDIGLAALMSPMP---  457 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~---~~kl~DfG~a~~~~~~~---  457 (615)
                      +++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++   .+||+|||+++......   
T Consensus        95 ~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~  166 (325)
T 3kn6_A           95 ERIKKK-----KHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPL  166 (325)
T ss_dssp             HHHHHC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-----
T ss_pred             HHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcc
Confidence            999753     36999999999999999999999998   99999999999997765   89999999998765432   


Q ss_pred             CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcch-hhHHHHHHHhhhcccccccccccccCCC
Q 007167          458 PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEV-VHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                      ....+|..|+|||++.+..++.++|||||||++|||++|+.||........ .........+.....     ......++
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~-----~~~~~~~~  241 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF-----SFEGEAWK  241 (325)
T ss_dssp             -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC-----CCCSHHHH
T ss_pred             cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC-----CCCccccc
Confidence            234568899999999998999999999999999999999999986543211 111122222221111     00000112


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+++++.++++   +|+..||++|||+.|++++
T Consensus       242 ~~s~~~~~li~---~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          242 NVSQEAKDLIQ---GLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             TSCHHHHHHHH---HHHCCCTTTCCCTTTSTTC
T ss_pred             CCCHHHHHHHH---HHCCCChhHCCCHHHHhcC
Confidence            33455555555   9999999999999999865

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-40  Score=347.15  Aligned_cols=244  Identities=22%  Similarity=0.402  Sum_probs=198.4

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc-CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN-VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      .+.||+|+||+||+|... +++.||+|.+.... .....+.+|+++++.++||||+++++++.+.+..++||||+++|+|
T Consensus        56 ~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L  135 (387)
T 1kob_A           56 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL  135 (387)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBH
T ss_pred             EEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcH
Confidence            357999999999999865 67889999987542 2345788999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCC--CCcEEEeecccccccCCCC--C
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNS--QGHVCVSDIGLAALMSPMP--P  458 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~--~~~~kl~DfG~a~~~~~~~--~  458 (615)
                      .+++...    ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.  ++.+||+|||+++......  .
T Consensus       136 ~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~  208 (387)
T 1kob_A          136 FDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK  208 (387)
T ss_dssp             HHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred             HHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCCccee
Confidence            9998743    236899999999999999999999998   999999999999974  4789999999998775432  2


Q ss_pred             CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCc
Q 007167          459 PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI  538 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  538 (615)
                      ...+|..|+|||++.+..++.++|||||||++|||++|+.||......+...      .+....+.     ........+
T Consensus       209 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~------~i~~~~~~-----~~~~~~~~~  277 (387)
T 1kob_A          209 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQ------NVKRCDWE-----FDEDAFSSV  277 (387)
T ss_dssp             EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH------HHHHCCCC-----CCSSTTTTS
T ss_pred             eeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHH------HHHhCCCC-----CCccccccC
Confidence            2357899999999999889999999999999999999999998654322221      11111111     111122345


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          539 EEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       539 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ++++.++++   +|+..||++|||+.|++++
T Consensus       278 s~~~~~li~---~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          278 SPEAKDFIK---NLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             CHHHHHHHH---TTSCSSGGGSCCHHHHHTS
T ss_pred             CHHHHHHHH---HHcCCChhHCcCHHHHhhC
Confidence            566666666   9999999999999999986

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=4.1e-40  Score=349.12  Aligned_cols=244  Identities=18%  Similarity=0.321  Sum_probs=189.4

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCHHHHHHHHHHH-hCCCCCcccceeEEEEe----cCeeeEEeecCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFEQQMEIV-GGIRHENVVALRAYYYS----KDEKLMVYDYFEP  379 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~~lV~e~~~~  379 (615)
                      ++||+|+||+||++... +++.||||+++.    ...+.+|++++ +..+||||+++++++..    ....++||||+++
T Consensus        68 ~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~g  143 (400)
T 1nxk_A           68 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG  143 (400)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred             ceeeeccCeEEEEEEECCCCCEEEEEEeCc----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCC
Confidence            46999999999999965 578899999964    34677888876 45589999999999876    5678999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCC---CCcEEEeecccccccCCC
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNS---QGHVCVSDIGLAALMSPM  456 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~---~~~~kl~DfG~a~~~~~~  456 (615)
                      |+|.+++....   ...+++..+..|+.|++.||+|||+.+   |+||||||+|||++.   ++.+||+|||+++.....
T Consensus       144 g~L~~~l~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~  217 (400)
T 1nxk_A          144 GELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH  217 (400)
T ss_dssp             EEHHHHHHCC------CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTCEECC--
T ss_pred             CcHHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccccccCCC
Confidence            99999997532   246999999999999999999999998   999999999999998   789999999999876532


Q ss_pred             --CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchh-hHHHHHHHhhhccccccccccccc
Q 007167          457 --PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVV-HLVRWVNSVVREEWTAEVFDVELL  533 (615)
Q Consensus       457 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~d~~~~  533 (615)
                        .....+|..|+|||++.+..++.++|||||||++|||++|+.||......... .....+.   ...     ++....
T Consensus       218 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~---~~~-----~~~~~~  289 (400)
T 1nxk_A          218 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR---MGQ-----YEFPNP  289 (400)
T ss_dssp             ---------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHH---HTC-----CCCCTT
T ss_pred             CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHH---cCc-----ccCCCc
Confidence              23446789999999999999999999999999999999999999875543221 1111111   000     111111


Q ss_pred             CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          534 RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       534 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                      .+..+++++.++++   +||..||++|||+.|++++-
T Consensus       290 ~~~~~s~~~~~li~---~~L~~dP~~Rpt~~eil~hp  323 (400)
T 1nxk_A          290 EWSEVSEEVKMLIR---NLLKTEPTQRMTITEFMNHP  323 (400)
T ss_dssp             TTTTSCHHHHHHHH---TTSCSSGGGSCCHHHHHHSH
T ss_pred             ccccCCHHHHHHHH---HHCCCChhHCcCHHHHhcCc
Confidence            22345666666666   99999999999999999874

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=2.4e-40  Score=333.41  Aligned_cols=248  Identities=24%  Similarity=0.389  Sum_probs=194.5

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEec-CeeeEEeecCCCCChh
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK-DEKLMVYDYFEPGSVS  383 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lV~e~~~~gsL~  383 (615)
                      .+.||+|+||+||++... ++.||||.++... ..+.+.+|+++++.++||||+++++++.+. +..++||||+++|+|.
T Consensus        26 ~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~-~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~  103 (278)
T 1byg_A           26 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA-TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV  103 (278)
T ss_dssp             EEEEEECSSCEEEEEEET-TEEEEEEECCCCC---HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHH
T ss_pred             EeEEecCCCceEEEEEEc-CCEEEEEEecchh-HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHH
Confidence            357999999999999875 7899999987543 456789999999999999999999997654 4789999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCCCCCC
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRA  463 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  463 (615)
                      +++....   ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++...........++
T Consensus       104 ~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~  177 (278)
T 1byg_A          104 DYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP  177 (278)
T ss_dssp             HHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------------CC
T ss_pred             HHHHhcc---cccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccccccCCCcc
Confidence            9997432   124889999999999999999999998   9999999999999999999999999998776554455678


Q ss_pred             CcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHHHH
Q 007167          464 AGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEM  542 (615)
Q Consensus       464 ~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  542 (615)
                      ..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+   .    ...       ........++++
T Consensus       178 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~---~----~~~-------~~~~~~~~~~~l  243 (278)
T 1byg_A          178 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRV---E----KGY-------KMDAPDGCPPAV  243 (278)
T ss_dssp             TTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHH---T----TTC-------CCCCCTTCCHHH
T ss_pred             ccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH---h----cCC-------CCCCcccCCHHH
Confidence            88999999988889999999999999999998 99999875543332211   1    100       011123345555


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhh
Q 007167          543 VEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVK  577 (615)
Q Consensus       543 ~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~  577 (615)
                      .++++   +||+.||++||++.|+++.|+++....
T Consensus       244 ~~li~---~~l~~~p~~Rps~~~l~~~L~~i~~~~  275 (278)
T 1byg_A          244 YEVMK---NCWHLDAAMRPSFLQLREQLEHIKTHE  275 (278)
T ss_dssp             HHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             HHHHH---HHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence            55555   999999999999999999999997643

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.2e-40  Score=331.99  Aligned_cols=247  Identities=22%  Similarity=0.362  Sum_probs=201.1

Q ss_pred             hcCcCCccEEEEEEEC---CCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          307 VLGKGTFGTAYKAALE---DASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      .||+|+||+||+|...   ++..||||+++....  ..+.+.+|+++++.++||||+++++++ ..+..++||||+++++
T Consensus        17 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~   95 (287)
T 1u59_A           17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGP   95 (287)
T ss_dssp             EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEE
T ss_pred             cccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCC
Confidence            6999999999999854   567899999976422  245688999999999999999999999 5567899999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC----
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP----  457 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~----  457 (615)
                      |.+++...    ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......    
T Consensus        96 L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  168 (287)
T 1u59_A           96 LHKFLVGK----REEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT  168 (287)
T ss_dssp             HHHHHTTC----TTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEEC
T ss_pred             HHHHHHhC----CccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeeccCcceee
Confidence            99999643    246999999999999999999999998   9999999999999999999999999998775322    


Q ss_pred             --CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccC
Q 007167          458 --PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLR  534 (615)
Q Consensus       458 --~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  534 (615)
                        ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+   ..   ..        ....
T Consensus       169 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i---~~---~~--------~~~~  234 (287)
T 1u59_A          169 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI---EQ---GK--------RMEC  234 (287)
T ss_dssp             CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHH---HT---TC--------CCCC
T ss_pred             ccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH---hc---CC--------cCCC
Confidence              12234678999999988889999999999999999998 99999876544332221   11   10        0111


Q ss_pred             CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhhc
Q 007167          535 YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKA  578 (615)
Q Consensus       535 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~  578 (615)
                      .+..++++.++++   +||..+|++||++.|++++|+++.....
T Consensus       235 ~~~~~~~l~~li~---~~l~~~p~~Rps~~~l~~~l~~~~~~~~  275 (287)
T 1u59_A          235 PPECPPELYALMS---DCWIYKWEDRPDFLTVEQRMRACYYSLA  275 (287)
T ss_dssp             CTTCCHHHHHHHH---HTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             CCCcCHHHHHHHH---HHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence            2344555555555   9999999999999999999999976543

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=1.1e-39  Score=351.98  Aligned_cols=239  Identities=22%  Similarity=0.342  Sum_probs=198.1

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc----CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN----VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||.||+|... +|+.||||++....    ...+.+.+|+++++.++||||+++++++...+..++||||+++
T Consensus        21 ~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~g  100 (476)
T 2y94_A           21 GDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSG  100 (476)
T ss_dssp             EEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSS
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCC
Confidence            356999999999999975 78999999996532    2345788999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      |+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.......  
T Consensus       101 g~L~~~l~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~  172 (476)
T 2y94_A          101 GELFDYICKN-----GRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL  172 (476)
T ss_dssp             EEHHHHTTSS-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCB
T ss_pred             CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhccccccc
Confidence            9999999642     36999999999999999999999998   9999999999999999999999999998775432  


Q ss_pred             CCCCCCCcccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          458 PPAMRAAGYRAPEVTDTRKA-TQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                      ....+|+.|+|||++.+..+ +.++||||+||++|||++|+.||......+...      .+...         ......
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~------~i~~~---------~~~~p~  237 (476)
T 2y94_A          173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFK------KICDG---------IFYTPQ  237 (476)
T ss_dssp             CCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHH------HHHTT---------CCCCCT
T ss_pred             cccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHH------HHhcC---------CcCCCc
Confidence            34568899999999988765 689999999999999999999998654332221      11111         111122


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ..++++.++++   +|+..||++|||+.|++++
T Consensus       238 ~~s~~~~~Li~---~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          238 YLNPSVISLLK---HMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             TCCHHHHHHHH---HHTCSSTTTSCCHHHHHTC
T ss_pred             cCCHHHHHHHH---HHcCCCchhCcCHHHHHhC
Confidence            34556666665   9999999999999999985

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.5e-40  Score=337.83  Aligned_cols=253  Identities=25%  Similarity=0.394  Sum_probs=202.7

Q ss_pred             hhhcCcCCccEEEEEEE------CCCCEEEEEEeccccC--CHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEee
Q 007167          305 AEVLGKGTFGTAYKAAL------EDASTVVVKRLKEVNV--GKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYD  375 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e  375 (615)
                      .+.||+|+||+||+|..      .++..||||+++....  ..+.+.+|+++++++ +||||+++++++...+..++|||
T Consensus        28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e  107 (313)
T 1t46_A           28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE  107 (313)
T ss_dssp             EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             HHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEe
Confidence            35799999999999985      3467899999975432  246788999999999 99999999999999999999999


Q ss_pred             cCCCCChhhhhccCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcE
Q 007167          376 YFEPGSVSAMLHGRRG-------------EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHV  442 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~-------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~  442 (615)
                      |+++|+|.+++.....             .....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+
T Consensus       108 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~  184 (313)
T 1t46_A          108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRIT  184 (313)
T ss_dssp             CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEE
T ss_pred             cCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEcCCCCE
Confidence            9999999999975432             11235899999999999999999999998   9999999999999999999


Q ss_pred             EEeecccccccCCCCC-----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 007167          443 CVSDIGLAALMSPMPP-----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVN  516 (615)
Q Consensus       443 kl~DfG~a~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  516 (615)
                      ||+|||++........     ...++..|+|||.+.+..++.++||||||+++|||++ |+.||......+..  ...+.
T Consensus       185 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~--~~~~~  262 (313)
T 1t46_A          185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKF--YKMIK  262 (313)
T ss_dssp             EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHH--HHHHH
T ss_pred             EEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHH--HHHhc
Confidence            9999999987754332     2234567999999988889999999999999999999 99999875543321  11111


Q ss_pred             HhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          517 SVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       517 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                      .    ..       ........++++.++++   +|+..||.+|||+.|++++|+++...
T Consensus       263 ~----~~-------~~~~~~~~~~~l~~li~---~~l~~dp~~Rps~~ell~~L~~~~~~  308 (313)
T 1t46_A          263 E----GF-------RMLSPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIEKQISE  308 (313)
T ss_dssp             H----TC-------CCCCCTTSCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             c----CC-------CCCCcccCCHHHHHHHH---HHcCCCchhCcCHHHHHHHHHHHHHH
Confidence            1    10       00112234455555555   99999999999999999999998764

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=6.7e-40  Score=340.50  Aligned_cols=244  Identities=17%  Similarity=0.325  Sum_probs=193.8

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC----HHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG----KREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      +.||+|+||.||+|+.+ +++.||+|+++.....    .+.+.+|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus        15 ~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~g   94 (345)
T 3a8x_A           15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   94 (345)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             EEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCC
Confidence            56999999999999975 5788999999765322    24577899999887 899999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC---C
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP---M  456 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~---~  456 (615)
                      |+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++++||+|||+++....   .
T Consensus        95 g~L~~~l~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~  166 (345)
T 3a8x_A           95 GDLMFHMQRQ-----RKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDT  166 (345)
T ss_dssp             CBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCC
T ss_pred             CcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCCCCc
Confidence            9999999743     36899999999999999999999998   99999999999999999999999999986432   2


Q ss_pred             CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchh--hHHHHH-HHhhhccccccccccccc
Q 007167          457 PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVV--HLVRWV-NSVVREEWTAEVFDVELL  533 (615)
Q Consensus       457 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~--~~~~~~-~~~~~~~~~~~~~d~~~~  533 (615)
                      .....+|+.|+|||++.+..++.++||||+||++|||++|+.||......+..  .....+ ..+...         ...
T Consensus       167 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~---------~~~  237 (345)
T 3a8x_A          167 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEK---------QIR  237 (345)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHC---------CCC
T ss_pred             ccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcC---------CCC
Confidence            23456899999999999989999999999999999999999999753321110  000111 111111         111


Q ss_pred             CCCCcHHHHHHHHHHHHHcccCCCCCCCCH------HHHHHH
Q 007167          534 RYPNIEEEMVEMLQVGMACVVRMPEERPKM------ADVLKM  569 (615)
Q Consensus       534 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~------~evl~~  569 (615)
                      ....+++++.++++   +|+..||++||++      .|+++|
T Consensus       238 ~p~~~s~~~~~li~---~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          238 IPRSLSVKAASVLK---SFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             CCTTSCHHHHHHHH---HHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             CCCCCCHHHHHHHH---HHhcCCHhHCCCCCCcCCHHHHhcC
Confidence            12345566666666   9999999999995      677664

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.3e-39  Score=336.22  Aligned_cols=240  Identities=20%  Similarity=0.364  Sum_probs=189.1

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc--CCHHHHHHHHHHHhCCCCCcccceeEEEEecC-------------
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN--VGKREFEQQMEIVGGIRHENVVALRAYYYSKD-------------  368 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~-------------  368 (615)
                      .+.||+|+||+||+|... +++.||||+++...  ...+.+.+|++++++++||||+++++++.+..             
T Consensus        11 ~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~   90 (332)
T 3qd2_B           11 IQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWL   90 (332)
T ss_dssp             EEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC---
T ss_pred             eeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhh
Confidence            457999999999999976 78999999997543  23567899999999999999999999986543             


Q ss_pred             --------------------------------------------eeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHH
Q 007167          369 --------------------------------------------EKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVR  404 (615)
Q Consensus       369 --------------------------------------------~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~  404 (615)
                                                                  ..++||||+++|+|.+++....  ......+..+..
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~  168 (332)
T 3qd2_B           91 KDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC--SLEDREHGVCLH  168 (332)
T ss_dssp             -----------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC--SGGGSCHHHHHH
T ss_pred             ccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc--CccchhhHHHHH
Confidence                                                        3799999999999999998543  234567888999


Q ss_pred             HHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---------------CCCCCCCcccCc
Q 007167          405 IAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---------------PPAMRAAGYRAP  469 (615)
Q Consensus       405 i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---------------~~~~~~~~y~aP  469 (615)
                      ++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+++......               ....+|..|+||
T Consensus       169 i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP  245 (332)
T 3qd2_B          169 IFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP  245 (332)
T ss_dssp             HHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCH
T ss_pred             HHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccCh
Confidence            9999999999999998   9999999999999999999999999998775431               223578899999


Q ss_pred             cccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC-CcHHHHHHHHHH
Q 007167          470 EVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP-NIEEEMVEMLQV  548 (615)
Q Consensus       470 E~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~-~~~~~~~~l~~l  548 (615)
                      |++.+..++.++|||||||++|||++|..|+..     ......   .....            ..+ .......++.++
T Consensus       246 E~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~---~~~~~------------~~~~~~~~~~~~~~~l  305 (332)
T 3qd2_B          246 EQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIIT---DVRNL------------KFPLLFTQKYPQEHMM  305 (332)
T ss_dssp             HHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHH---HHHTT------------CCCHHHHHHCHHHHHH
T ss_pred             HHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHH---Hhhcc------------CCCcccccCChhHHHH
Confidence            999988999999999999999999998776421     111111   11100            011 111222334555


Q ss_pred             HHHcccCCCCCCCCHHHHHHH
Q 007167          549 GMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       549 ~~~cl~~~P~~RPs~~evl~~  569 (615)
                      +.+|++.||++|||+.|++++
T Consensus       306 i~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          306 VQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             HHHHHCSSGGGSCCHHHHHHS
T ss_pred             HHHHccCCCCcCCCHHHHhhc
Confidence            669999999999999999875

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=2.2e-39  Score=329.05  Aligned_cols=255  Identities=15%  Similarity=0.186  Sum_probs=199.8

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEE-EecCeeeEEeecCCCCCh
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYY-YSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lV~e~~~~gsL  382 (615)
                      .+.||+|+||+||+|.. .+++.||||++.... ....+.+|+++++.++|++++..+.++ ...+..++||||+ +++|
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L   91 (296)
T 4hgt_A           14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSL   91 (296)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEEEEC----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred             eeeecCCCCeEEEEEEEcCCCceEEEEeecccc-cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCH
Confidence            45799999999999996 567889999875432 234688999999999988887776666 5667889999999 9999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEe---CCCCcEEEeecccccccCCCC--
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFL---NSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill---~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      .+++...    ...+++..+..++.|++.||+|||+.+   |+||||||+||++   +.++.+||+|||+++......  
T Consensus        92 ~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~  164 (296)
T 4hgt_A           92 EDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  164 (296)
T ss_dssp             HHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred             HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccC
Confidence            9999743    235999999999999999999999998   9999999999999   788999999999998765432  


Q ss_pred             --------CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccc
Q 007167          458 --------PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD  529 (615)
Q Consensus       458 --------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  529 (615)
                              ....+|..|+|||.+.+..++.++|||||||++|||++|+.||..............+........      
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~------  238 (296)
T 4hgt_A          165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP------  238 (296)
T ss_dssp             CBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC------
T ss_pred             ccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccch------
Confidence                    234578899999999998999999999999999999999999987655433333222211110000      


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhhc
Q 007167          530 VELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKA  578 (615)
Q Consensus       530 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~  578 (615)
                       .......+++++.++++   +|++.+|++|||+.|+++.|+++.....
T Consensus       239 -~~~~~~~~~~~l~~li~---~~l~~~p~~Rpt~~~l~~~l~~~~~~~~  283 (296)
T 4hgt_A          239 -IEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             -HHHHTTTSCHHHHHHHH---HHHTSCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             -hhhhhccCCHHHHHHHH---HHHhcCCCCCCCHHHHHHHHHHHHHHhC
Confidence             00001233445555555   9999999999999999999999987654

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.7e-40  Score=352.03  Aligned_cols=244  Identities=19%  Similarity=0.317  Sum_probs=197.6

Q ss_pred             hhhcCcCCccEEEEEEECC-CCEEEEEEeccc----cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALED-ASTVVVKRLKEV----NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .++||+|+||+||+|..++ ++.||+|+++..    ......+.+|.+++..++||||++++++|.+.+..++||||+++
T Consensus        79 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~g  158 (437)
T 4aw2_A           79 LKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVG  158 (437)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             EEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCC
Confidence            3579999999999999765 678999999753    22234588999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      |+|.+++...    ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++++||+|||+++......  
T Consensus       159 g~L~~~l~~~----~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~  231 (437)
T 4aw2_A          159 GDLLTLLSKF----EDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV  231 (437)
T ss_dssp             CBHHHHHHTT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE
T ss_pred             CcHHHHHHHc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc
Confidence            9999999753    236999999999999999999999998   9999999999999999999999999997765432  


Q ss_pred             --CCCCCCCcccCccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccc
Q 007167          458 --PPAMRAAGYRAPEVTD-----TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDV  530 (615)
Q Consensus       458 --~~~~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  530 (615)
                        ....+|++|+|||++.     ...++.++|||||||++|||++|+.||...+..+....+.  .....         .
T Consensus       232 ~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~--~~~~~---------~  300 (437)
T 4aw2_A          232 QSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM--NHKER---------F  300 (437)
T ss_dssp             ECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--THHHH---------C
T ss_pred             ccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhh--hcccc---------c
Confidence              2346899999999986     4568999999999999999999999998754433322111  10000         0


Q ss_pred             cccC-CCCcHHHHHHHHHHHHHcccCCCCC--CCCHHHHHHH
Q 007167          531 ELLR-YPNIEEEMVEMLQVGMACVVRMPEE--RPKMADVLKM  569 (615)
Q Consensus       531 ~~~~-~~~~~~~~~~l~~l~~~cl~~~P~~--RPs~~evl~~  569 (615)
                      ..+. .+.++++++++++   +|+..+|++  ||+++|++++
T Consensus       301 ~~p~~~~~~s~~~~dLi~---~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          301 QFPTQVTDVSENAKDLIR---RLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             CCCSSCCCSCHHHHHHHH---TTSSCGGGCTTTTTTHHHHTS
T ss_pred             cCCcccccCCHHHHHHHH---HHhcccccccCCCCHHHHhCC
Confidence            1111 1345677777777   888888888  9999999886

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=8.7e-40  Score=329.43  Aligned_cols=240  Identities=24%  Similarity=0.395  Sum_probs=194.9

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccc----cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEV----NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||+||+|... ++..||+|++...    ......+.+|+++++.++||||+++++++.+.+..++||||+++
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   93 (279)
T 3fdn_A           14 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL   93 (279)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             eeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCC
Confidence            356999999999999865 5668999998643    22356788999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC-CC
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM-PP  458 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~-~~  458 (615)
                      |+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++...... ..
T Consensus        94 ~~l~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~~  165 (279)
T 3fdn_A           94 GTVYRELQKL-----SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT  165 (279)
T ss_dssp             EEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred             CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCccccc
Confidence            9999999743     35899999999999999999999998   999999999999999999999999998665433 23


Q ss_pred             CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCc
Q 007167          459 PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI  538 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  538 (615)
                      ...++..|+|||.+.+..++.++||||||+++|||++|+.||......+....+.      ..         ........
T Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------~~---------~~~~~~~~  230 (279)
T 3fdn_A          166 DLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS------RV---------EFTFPDFV  230 (279)
T ss_dssp             --CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH------HT---------CCCCCTTS
T ss_pred             ccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH------hC---------CCCCCCcC
Confidence            4467889999999999889999999999999999999999998654333222111      00         01111234


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          539 EEEMVEMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       539 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                      ++.+.++++   +|++.||++|||+.|++++-
T Consensus       231 ~~~~~~li~---~~l~~~p~~Rps~~e~l~h~  259 (279)
T 3fdn_A          231 TEGARDLIS---RLLKHNPSQRPMLREVLEHP  259 (279)
T ss_dssp             CHHHHHHHH---HHCCSSGGGSCCHHHHHHCH
T ss_pred             CHHHHHHHH---HHhccChhhCCCHHHHhhCc
Confidence            455555555   99999999999999999973

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=9.7e-40  Score=342.39  Aligned_cols=245  Identities=15%  Similarity=0.228  Sum_probs=199.8

Q ss_pred             hhcCcCCccEEEEEE------ECCCCEEEEEEeccccCCHHHHHHHHHHHhCCC---CCcccceeEEEEecCeeeEEeec
Q 007167          306 EVLGKGTFGTAYKAA------LEDASTVVVKRLKEVNVGKREFEQQMEIVGGIR---HENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~------~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      ++||+|+||+||+|.      ...++.||||+++..  ...++.+|++++..++   |+||+++++++...+..++||||
T Consensus        71 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~  148 (365)
T 3e7e_A           71 HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA--NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGEL  148 (365)
T ss_dssp             EEEEECSSEEEEEEEC-------CCCCEEEEEESSC--CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECC
T ss_pred             EEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC--ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEec
Confidence            569999999999993      456889999999753  4667888888888887   99999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCC-----------CCcEEEe
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNS-----------QGHVCVS  445 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~-----------~~~~kl~  445 (615)
                      +++|+|.++++.........+++..+..|+.|++.||+|||+.+   |+||||||+|||++.           ++.+||+
T Consensus       149 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~  225 (365)
T 3e7e_A          149 YSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAGLALI  225 (365)
T ss_dssp             CCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC------CTTEEEC
T ss_pred             cCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCccccccccCCEEEe
Confidence            99999999997543333457999999999999999999999998   999999999999998           8999999


Q ss_pred             ecccccccCC-----CCCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhh
Q 007167          446 DIGLAALMSP-----MPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVR  520 (615)
Q Consensus       446 DfG~a~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~  520 (615)
                      |||+++.+..     ......+|.+|+|||++.+..++.++|||||||++|||++|+.||.........           
T Consensus       226 DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-----------  294 (365)
T 3e7e_A          226 DLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK-----------  294 (365)
T ss_dssp             CCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-----------
T ss_pred             eCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee-----------
Confidence            9999976531     123456899999999999989999999999999999999999999654322110           


Q ss_pred             cccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCC-CCHHHHHHHHHHhHhhh
Q 007167          521 EEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEER-PKMADVLKMVEDIRRVK  577 (615)
Q Consensus       521 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~R-Ps~~evl~~L~~l~~~~  577 (615)
                             ........ ...+.+.++++   .|++.+|.+| |+++++.+.|+++....
T Consensus       295 -------~~~~~~~~-~~~~~~~~~~~---~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          295 -------PEGLFRRL-PHLDMWNEFFH---VMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             -------ECSCCTTC-SSHHHHHHHHH---HHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             -------echhcccc-CcHHHHHHHHH---HHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence                   01111111 23566666666   8999999988 68889999998877644

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.4e-39  Score=334.99  Aligned_cols=243  Identities=22%  Similarity=0.378  Sum_probs=198.3

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC-------CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV-------GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      .+.||+|+||.||+|... ++..||+|.++....       ..+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus        17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   96 (321)
T 2a2a_A           17 GEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILEL   96 (321)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             eeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEc
Confidence            467999999999999965 688999999875422       356799999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCC----cEEEeecccccc
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG----HVCVSDIGLAAL  452 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~----~~kl~DfG~a~~  452 (615)
                      +++++|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++    .+||+|||++..
T Consensus        97 ~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~  168 (321)
T 2a2a_A           97 VSGGELFDFLAQK-----ESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE  168 (321)
T ss_dssp             CCSCBHHHHHHTC-----SCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCEE
T ss_pred             CCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCcccee
Confidence            9999999999742     36899999999999999999999998   99999999999999888    799999999987


Q ss_pred             cCCCC--CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccc
Q 007167          453 MSPMP--PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDV  530 (615)
Q Consensus       453 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  530 (615)
                      .....  ....++..|+|||.+.+..++.++|||||||++|||++|+.||......+....+      .....   .++.
T Consensus       169 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i------~~~~~---~~~~  239 (321)
T 2a2a_A          169 IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI------TSVSY---DFDE  239 (321)
T ss_dssp             CCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------HTTCC---CCCH
T ss_pred             cCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------Hhccc---ccCh
Confidence            75432  3345788999999999889999999999999999999999999765433322111      11000   0011


Q ss_pred             cccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          531 ELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       531 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ..  .+..++.+.++++   +|+..||++|||+.|++++
T Consensus       240 ~~--~~~~~~~~~~li~---~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          240 EF--FSHTSELAKDFIR---KLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             HH--HTTCCHHHHHHHH---TTSCSSTTTSCCHHHHHHS
T ss_pred             hh--hcccCHHHHHHHH---HHcCCChhhCcCHHHHhcC
Confidence            11  1233455555555   9999999999999999874

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.3e-40  Score=341.35  Aligned_cols=254  Identities=22%  Similarity=0.337  Sum_probs=199.3

Q ss_pred             hhhcCcCCccEEEEEEE------CCCCEEEEEEecccc--CCHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEee
Q 007167          305 AEVLGKGTFGTAYKAAL------EDASTVVVKRLKEVN--VGKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYD  375 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e  375 (615)
                      .+.||+|+||+||+|..      .++..||||.++...  ...+.+.+|++++.++ +||||+++++++...+..++|||
T Consensus        50 ~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e  129 (344)
T 1rjb_A           50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE  129 (344)
T ss_dssp             EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             eeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEe
Confidence            46799999999999986      235579999997542  2346789999999999 89999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeC
Q 007167          376 YFEPGSVSAMLHGRRGE------------------GQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLN  437 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~  437 (615)
                      |+++|+|.+++......                  ....+++..+..++.|++.||+|||+.+   |+||||||+||+++
T Consensus       130 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~  206 (344)
T 1rjb_A          130 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVT  206 (344)
T ss_dssp             CCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEE
T ss_pred             cCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEEc
Confidence            99999999999754321                  1134899999999999999999999998   99999999999999


Q ss_pred             CCCcEEEeecccccccCCCCC-----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhH
Q 007167          438 SQGHVCVSDIGLAALMSPMPP-----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHL  511 (615)
Q Consensus       438 ~~~~~kl~DfG~a~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~  511 (615)
                      .++.+||+|||++........     ...++..|+|||.+.+..++.++|||||||++|||++ |+.||......+... 
T Consensus       207 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~-  285 (344)
T 1rjb_A          207 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFY-  285 (344)
T ss_dssp             TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHH-
T ss_pred             CCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHH-
Confidence            999999999999986643322     2234667999999988889999999999999999998 999998765433211 


Q ss_pred             HHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhh
Q 007167          512 VRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVK  577 (615)
Q Consensus       512 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~  577 (615)
                       ..+.    ...       ........++++.++++   +||..||.+|||+.|++++|+.+....
T Consensus       286 -~~~~----~~~-------~~~~~~~~~~~l~~li~---~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          286 -KLIQ----NGF-------KMDQPFYATEEIYIIMQ---SCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             -HHHH----TTC-------CCCCCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             -HHHh----cCC-------CCCCCCCCCHHHHHHHH---HHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence             1111    110       01112234455555555   999999999999999999999986543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=6e-40  Score=337.30  Aligned_cols=257  Identities=22%  Similarity=0.340  Sum_probs=200.2

Q ss_pred             hhhcCcCCccEEEEEEEC-----CCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEec--CeeeEEee
Q 007167          305 AEVLGKGTFGTAYKAALE-----DASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSK--DEKLMVYD  375 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-----~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e  375 (615)
                      .+.||+|+||+||++.+.     +++.||||+++....  ..+.+.+|+++++.++||||+++++++.+.  ...++|||
T Consensus        36 ~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e  115 (318)
T 3lxp_A           36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVME  115 (318)
T ss_dssp             EEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEEC
T ss_pred             hheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEe
Confidence            357999999999988643     578899999976432  245688999999999999999999999884  57899999


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      |+++|+|.+++...      .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus       116 ~~~~~~L~~~l~~~------~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  186 (318)
T 3lxp_A          116 YVPLGSLRDYLPRH------SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  186 (318)
T ss_dssp             CCTTCBHHHHGGGS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECCT
T ss_pred             cccCCcHHHHHhhC------CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCccccccccc
Confidence            99999999999743      4899999999999999999999998   99999999999999999999999999987754


Q ss_pred             CC------CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc---------hhhHHHHHHHhhh
Q 007167          456 MP------PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDE---------VVHLVRWVNSVVR  520 (615)
Q Consensus       456 ~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~---------~~~~~~~~~~~~~  520 (615)
                      ..      ....++..|+|||.+.+..++.++||||||+++|||++|+.||.......         ...... +.....
T Consensus       187 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  265 (318)
T 3lxp_A          187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLR-LTELLE  265 (318)
T ss_dssp             TCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHH-HHHHHH
T ss_pred             cccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHH-HHHHHh
Confidence            32      22345677999999988888999999999999999999999997532110         000000 111111


Q ss_pred             cccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhhcCCC
Q 007167          521 EEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENP  581 (615)
Q Consensus       521 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~~~~  581 (615)
                      ..       ........+++++.++++   +||+.||++|||+.|+++.|+.+.+...+..
T Consensus       266 ~~-------~~~~~~~~~~~~l~~li~---~~l~~dP~~Rps~~ell~~L~~l~~~~~~~~  316 (318)
T 3lxp_A          266 RG-------ERLPRPDKCPAEVYHLMK---NCWETEASFRPTFENLIPILKTVHEKYQGQA  316 (318)
T ss_dssp             TT-------CCCCCCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHHHHC--
T ss_pred             cc-------cCCCCCccccHHHHHHHH---HHcCCCcccCcCHHHHHHHHHHHHHhhccCC
Confidence            00       011112234455555555   9999999999999999999999987555433

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.6e-40  Score=369.78  Aligned_cols=244  Identities=24%  Similarity=0.354  Sum_probs=197.1

Q ss_pred             hhcCcCCccEEEEEEEC---CCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          306 EVLGKGTFGTAYKAALE---DASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      +.||+|+||+||+|.+.   .++.||||+++.....   .+++.+|+++++.++|||||++++++.. +..++||||+++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~  453 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL  453 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCC
Confidence            46999999999999653   4578999999764322   4679999999999999999999999964 568899999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC-
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP-  458 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~-  458 (615)
                      |+|.+++...     ..+++..+..|+.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.+..... 
T Consensus       454 g~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~  525 (635)
T 4fl3_A          454 GPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  525 (635)
T ss_dssp             EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----
T ss_pred             CCHHHHHhhC-----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccc
Confidence            9999999743     36899999999999999999999998   99999999999999999999999999987754321 


Q ss_pred             -----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccc
Q 007167          459 -----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL  532 (615)
Q Consensus       459 -----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  532 (615)
                           ...++..|+|||++....++.++|||||||++|||++ |+.||......+....+.   .   ..        ..
T Consensus       526 ~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~---~---~~--------~~  591 (635)
T 4fl3_A          526 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE---K---GE--------RM  591 (635)
T ss_dssp             ---------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH---T---TC--------CC
T ss_pred             cccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH---c---CC--------CC
Confidence                 2234567999999998899999999999999999998 999998765544332221   1   00        11


Q ss_pred             cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       533 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                      .....+++++.++++   +||..||++||++.+|++.|+++-.
T Consensus       592 ~~p~~~~~~l~~li~---~cl~~dP~~RPs~~~l~~~L~~~~~  631 (635)
T 4fl3_A          592 GCPAGCPREMYDLMN---LCWTYDVENRPGFAAVELRLRNYYY  631 (635)
T ss_dssp             CCCTTCCHHHHHHHH---HHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCHHHHHHHH---HHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            112234455555555   9999999999999999999998754

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=3.8e-40  Score=354.84  Aligned_cols=239  Identities=21%  Similarity=0.322  Sum_probs=189.5

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccc----cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEV----NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .++||+|+||.||+|... +++.||||+++..    ......+.+|+++++.++||||+++++++...+..++||||+++
T Consensus       153 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~  232 (446)
T 4ejn_A          153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG  232 (446)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSS
T ss_pred             eEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCC
Confidence            457999999999999864 6889999999753    22235577899999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT-ENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM--  456 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~--  456 (615)
                      |+|.+++...     ..+++..+..++.|++.||+|||+ .+   |+||||||+|||++.++.+||+|||+++.....  
T Consensus       233 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  304 (446)
T 4ejn_A          233 GELFFHLSRE-----RVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA  304 (446)
T ss_dssp             CBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred             CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCCCc
Confidence            9999999743     368999999999999999999998 77   999999999999999999999999999864322  


Q ss_pred             -CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCC
Q 007167          457 -PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY  535 (615)
Q Consensus       457 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  535 (615)
                       .....+|.+|+|||++.+..++.++|||||||++|||++|+.||...+..+....+      ...         .....
T Consensus       305 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i------~~~---------~~~~p  369 (446)
T 4ejn_A          305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI------LME---------EIRFP  369 (446)
T ss_dssp             --CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHC---------CCCCC
T ss_pred             ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH------HhC---------CCCCC
Confidence             23456899999999999889999999999999999999999999765433322211      111         11112


Q ss_pred             CCcHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007167          536 PNIEEEMVEMLQVGMACVVRMPEERP-----KMADVLKM  569 (615)
Q Consensus       536 ~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  569 (615)
                      ..+++++.++++   +||+.||.+||     +++|+++|
T Consensus       370 ~~~~~~~~~li~---~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          370 RTLGPEAKSLLS---GLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             TTSCHHHHHHHH---HHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ccCCHHHHHHHH---HHcccCHHHhCCCCCCCHHHHHhC
Confidence            234566666666   99999999999     99999875

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1e-39  Score=332.73  Aligned_cols=252  Identities=23%  Similarity=0.372  Sum_probs=196.9

Q ss_pred             hhhcCcCCccEEEEEEE-----CCCCEEEEEEecccc--CCHHHHHHHHHHHhCCCCCcccceeEEEEec--CeeeEEee
Q 007167          305 AEVLGKGTFGTAYKAAL-----EDASTVVVKRLKEVN--VGKREFEQQMEIVGGIRHENVVALRAYYYSK--DEKLMVYD  375 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~--~~~~lV~e  375 (615)
                      .+.||+|+||.||+|.+     .+++.||||+++...  ...+.+.+|+++++.++||||+++++++...  ...++|||
T Consensus        26 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e  105 (302)
T 4e5w_A           26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME  105 (302)
T ss_dssp             EEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEE
T ss_pred             hhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEE
Confidence            35699999999999983     467889999997542  3357789999999999999999999999876  66899999


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      |+++|+|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.....
T Consensus       106 ~~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  178 (302)
T 4e5w_A          106 FLPSGSLKEYLPKNK----NKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIET  178 (302)
T ss_dssp             CCTTCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             eCCCCcHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECcccccccccC
Confidence            999999999996432    35899999999999999999999998   99999999999999999999999999987754


Q ss_pred             CC------CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC---------cchhhHHHHHHHhhh
Q 007167          456 MP------PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGG---------DEVVHLVRWVNSVVR  520 (615)
Q Consensus       456 ~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~---------~~~~~~~~~~~~~~~  520 (615)
                      ..      ....+|..|+|||.+.+..++.++||||+|+++|||++|+.|+.....         .............. 
T Consensus       179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  257 (302)
T 4e5w_A          179 DKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLK-  257 (302)
T ss_dssp             TCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHH-
T ss_pred             CCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHh-
Confidence            32      233466779999999888889999999999999999999998653210         00000111111110 


Q ss_pred             cccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhH
Q 007167          521 EEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIR  574 (615)
Q Consensus       521 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~  574 (615)
                      ..       ......+.+++++.++++   +||+.||.+|||+.|+++.|+++.
T Consensus       258 ~~-------~~~~~~~~~~~~l~~li~---~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          258 EG-------KRLPCPPNCPDEVYQLMR---KCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             TT-------CCCCCCTTCCHHHHHHHH---HTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cc-------CCCCCCCCCCHHHHHHHH---HHcCCCCCCCCCHHHHHHHHHHHh
Confidence            00       011112344555555555   999999999999999999999875

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=4.1e-39  Score=327.14  Aligned_cols=256  Identities=15%  Similarity=0.179  Sum_probs=200.7

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEE-EecCeeeEEeecCCCCCh
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYY-YSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~-~~~~~~~lV~e~~~~gsL  382 (615)
                      .+.||+|+||+||+|.. .+++.||||++.... ..+.+.+|+++++.++|++++..+.++ ...+..++||||+ +++|
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L   91 (296)
T 3uzp_A           14 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSL   91 (296)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEEESCS-SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred             EEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc-chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCH
Confidence            35699999999999996 578899999986543 245688999999999998877766665 5567889999999 9999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEe---CCCCcEEEeecccccccCCCC--
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFL---NSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill---~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      .+++....    ..+++..+..++.|++.||+|||+++   |+||||||+||++   +.++.+||+|||++.......  
T Consensus        92 ~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~  164 (296)
T 3uzp_A           92 EDLFNFCS----RKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  164 (296)
T ss_dssp             HHHHHHTT----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred             HHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence            99997432    36999999999999999999999998   9999999999999   488899999999998765432  


Q ss_pred             --------CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccc
Q 007167          458 --------PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD  529 (615)
Q Consensus       458 --------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  529 (615)
                              ....++..|+|||.+.+..++.++|||||||++|||++|+.||......+.......+.........     
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~-----  239 (296)
T 3uzp_A          165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI-----  239 (296)
T ss_dssp             CBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH-----
T ss_pred             cccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCch-----
Confidence                    2345788999999999989999999999999999999999999875543322222211111100000     


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhhcC
Q 007167          530 VELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAE  579 (615)
Q Consensus       530 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~~  579 (615)
                      ..  ..+.+++++.++++   +||+.||++|||+.|+++.|+++......
T Consensus       240 ~~--~~~~~~~~l~~li~---~~l~~dp~~Rps~~~l~~~l~~~~~~~~~  284 (296)
T 3uzp_A          240 EV--LCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             HH--HTTTSCHHHHHHHH---HHHTSCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             HH--HHhhCCHHHHHHHH---HHHhcCcCcCCCHHHHHHHHHHHHHhcCC
Confidence            00  01233455555555   99999999999999999999999875543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-39  Score=332.31  Aligned_cols=255  Identities=22%  Similarity=0.328  Sum_probs=194.4

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccC------CHHHHHHHHHHHhCCC---CCcccceeEEEEecC-----e
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNV------GKREFEQQMEIVGGIR---HENVVALRAYYYSKD-----E  369 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~------~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~-----~  369 (615)
                      .+.||+|+||+||+|.. .+++.||||+++....      ....+.+|+++++.++   ||||+++++++....     .
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~   93 (308)
T 3g33_A           14 VAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIK   93 (308)
T ss_dssp             EEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEE
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCcee
Confidence            35699999999999995 5688999999874321      1346778888777664   999999999998765     5


Q ss_pred             eeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeeccc
Q 007167          370 KLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGL  449 (615)
Q Consensus       370 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~  449 (615)
                      .++||||+. |+|.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+
T Consensus        94 ~~lv~e~~~-~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~  166 (308)
T 3g33_A           94 VTLVFEHVD-QDLRTYLDKAP---PPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGL  166 (308)
T ss_dssp             EEEEEECCC-CBHHHHHHTCC---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECSCSC
T ss_pred             EEEEehhhh-cCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEeeCcc
Confidence            799999996 69999997543   235999999999999999999999998   99999999999999999999999999


Q ss_pred             ccccCCCC--CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHH-HHHHHhhhcccccc
Q 007167          450 AALMSPMP--PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLV-RWVNSVVREEWTAE  526 (615)
Q Consensus       450 a~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~  526 (615)
                      ++......  ....+|..|+|||++.+..++.++|||||||++|||++|+.||......+....+ ..........|...
T Consensus       167 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  246 (308)
T 3g33_A          167 ARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD  246 (308)
T ss_dssp             TTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSS
T ss_pred             ccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccch
Confidence            98765432  2345788999999998889999999999999999999999999875543332221 11111111112111


Q ss_pred             ccccc--c---------cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          527 VFDVE--L---------LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       527 ~~d~~--~---------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ...+.  .         ...+.+++++.+++.   +|++.||++|||+.|++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          247 VSLPRGAFPPRGPRPVQSVVPEMEESGAQLLL---EMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             CSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHH---HHTCSSTTTSCCHHHHHTS
T ss_pred             hhccccccCCCCCCcHHHhCccccHHHHHHHH---HHhcCCCccCCCHHHHhcC
Confidence            10000  0         011234455555555   9999999999999999875

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=1.4e-39  Score=327.52  Aligned_cols=242  Identities=19%  Similarity=0.327  Sum_probs=195.9

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccc-cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEV-NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      .+.||+|+||+||+|... ++..||+|++... ....+.+.+|+++++.++||||+++++++.+.+..++||||+++++|
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   93 (277)
T 3f3z_A           14 ENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGEL   93 (277)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBH
T ss_pred             eeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcH
Confidence            467999999999999975 4668999998765 34467899999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEe---CCCCcEEEeecccccccCCCC--
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFL---NSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill---~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      .+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||++   +.++.+||+|||++.......  
T Consensus        94 ~~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~  165 (277)
T 3f3z_A           94 FERVVHK-----RVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMM  165 (277)
T ss_dssp             HHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCB
T ss_pred             HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccch
Confidence            9998743     35899999999999999999999998   9999999999999   788999999999998765432  


Q ss_pred             CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCC
Q 007167          458 PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN  537 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  537 (615)
                      ....+|..|+|||.+.+. ++.++||||||+++|||++|+.||......+....+.      ....     .........
T Consensus       166 ~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~------~~~~-----~~~~~~~~~  233 (277)
T 3f3z_A          166 RTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIR------EGTF-----TFPEKDWLN  233 (277)
T ss_dssp             CCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCCC-----CCCHHHHTT
T ss_pred             hccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHH------hCCC-----CCCchhhhc
Confidence            344678899999998654 8999999999999999999999998754333222111      1100     000000112


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          538 IEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       538 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .++++.++++   +|++.||++|||+.|++++
T Consensus       234 ~~~~~~~li~---~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          234 VSPQAESLIR---RLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             SCHHHHHHHH---HHTCSSTTTSCCHHHHTTS
T ss_pred             CCHHHHHHHH---HHccCChhhCcCHHHHhcC
Confidence            3445555555   9999999999999999875

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1.6e-39  Score=328.18  Aligned_cols=242  Identities=21%  Similarity=0.339  Sum_probs=197.5

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      +.||+|+||+||+|... ++..||+|++......   .+.+.+|++++++++||||+++++++...+..++||||+++|+
T Consensus        12 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~   91 (284)
T 3kk8_A           12 EELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGE   91 (284)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             hhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCC
Confidence            56999999999999865 5889999999765433   3557889999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCc---EEEeecccccccCCCC-
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGH---VCVSDIGLAALMSPMP-  457 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~---~kl~DfG~a~~~~~~~-  457 (615)
                      |.+.+...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.   +||+|||++....... 
T Consensus        92 l~~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (284)
T 3kk8_A           92 LFEDIVAR-----EFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  163 (284)
T ss_dssp             HHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred             HHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence            99988643     36899999999999999999999998   999999999999987655   9999999998765433 


Q ss_pred             -CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          458 -PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       458 -~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                       ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||......+....+.      ..     ..........
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~------~~-----~~~~~~~~~~  232 (284)
T 3kk8_A          164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK------AG-----AYDYPSPEWD  232 (284)
T ss_dssp             CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HT-----CCCCCTTTTT
T ss_pred             ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHH------hc-----cccCCchhhc
Confidence             23467889999999999899999999999999999999999997654333222111      11     0111111223


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ..++++.++++   +|++.||++|||+.|++++
T Consensus       233 ~~~~~~~~li~---~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          233 TVTPEAKSLID---SMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             TSCHHHHHHHH---HHSCSSTTTSCCHHHHTTS
T ss_pred             ccCHHHHHHHH---HHcccChhhCCCHHHHhcC
Confidence            44556666655   9999999999999999986

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=6.6e-40  Score=339.42  Aligned_cols=257  Identities=22%  Similarity=0.373  Sum_probs=187.9

Q ss_pred             hhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHH--HhCCCCCcccceeEEEEec-----CeeeEEeecCC
Q 007167          306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEI--VGGIRHENVVALRAYYYSK-----DEKLMVYDYFE  378 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~--l~~l~h~niv~l~~~~~~~-----~~~~lV~e~~~  378 (615)
                      +.||+|+||+||+|+. +++.||||++....  ...+..|.++  +..++||||+++++++...     ...++||||++
T Consensus        19 ~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~   95 (336)
T 3g2f_A           19 ELIGRGRYGAVYKGSL-DERPVAVKVFSFAN--RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYP   95 (336)
T ss_dssp             EEEEECSSEEEEEEEE-TTEEEEEEEEEGGG--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCT
T ss_pred             eecccCCCeEEEEEEE-CCeEEEEEEeeccc--hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCC
Confidence            5699999999999986 57899999997543  3344444444  4458999999999876532     25689999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc---------CCCCceecCCCCCCEEeCCCCcEEEeeccc
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE---------NGGKLVHGGIKASNIFLNSQGHVCVSDIGL  449 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~---------~~~~iiHrDik~~Nill~~~~~~kl~DfG~  449 (615)
                      +|+|.+++...      ..++..+.+++.|++.||+|||+.         +   |+||||||+|||++.++.+||+|||+
T Consensus        96 ~g~L~~~l~~~------~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL~DFG~  166 (336)
T 3g2f_A           96 NGSLXKYLSLH------TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVISDFGL  166 (336)
T ss_dssp             TCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEECCCTT
T ss_pred             CCcHHHHHhhc------ccchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEEeeccc
Confidence            99999999643      358999999999999999999998         6   99999999999999999999999999


Q ss_pred             ccccCCCC-----------CCCCCCCcccCccccCC-------CCCCCccchhhHHHHHHHHHhCCCCCCCCCC-cchhh
Q 007167          450 AALMSPMP-----------PPAMRAAGYRAPEVTDT-------RKATQASDVFSFGVLLLELLTGKSPIHATGG-DEVVH  510 (615)
Q Consensus       450 a~~~~~~~-----------~~~~~~~~y~aPE~~~~-------~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~-~~~~~  510 (615)
                      ++.+....           ....+|..|+|||++.+       ..++.++|||||||++|||++|+.||..... .+...
T Consensus       167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~  246 (336)
T 3g2f_A          167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM  246 (336)
T ss_dssp             CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCC
T ss_pred             eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHH
Confidence            98764321           13357889999999976       3456789999999999999999777654322 11110


Q ss_pred             HHH----------HHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhh
Q 007167          511 LVR----------WVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVK  577 (615)
Q Consensus       511 ~~~----------~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~  577 (615)
                      ...          ..............+...   ++........+.+++.+||+.||++|||++|+++.|+++...-
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~  320 (336)
T 3g2f_A          247 AFQTEVGNHPTFEDMQVLVSREKQRPKFPEA---WKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIW  320 (336)
T ss_dssp             TTHHHHCSSCCHHHHHHHHTTSCCCCCCCTT---CCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCC
T ss_pred             hhhcccCCCchHHHHHhhhcccccCCCCCcc---cccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHH
Confidence            000          000001100000011111   1111223344556666999999999999999999999998633

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=4.4e-40  Score=337.14  Aligned_cols=249  Identities=21%  Similarity=0.330  Sum_probs=189.0

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccCC----HHHHHHHHHHHhCCCCCcccceeEEEEecCe----eeEEee
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVG----KREFEQQMEIVGGIRHENVVALRAYYYSKDE----KLMVYD  375 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~----~~lV~e  375 (615)
                      .+.||+|+||+||+|.. .+++.||||+++.....    ...+.+|+++++.++||||+++++++.....    .++|||
T Consensus        17 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e   96 (311)
T 3ork_A           17 GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME   96 (311)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEE
T ss_pred             EEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEe
Confidence            35799999999999996 57888999999764322    2467899999999999999999999876643    399999


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      |+++|+|.++++..     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus        97 ~~~g~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  168 (311)
T 3ork_A           97 YVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIAD  168 (311)
T ss_dssp             CCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-----
T ss_pred             cCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcccccc
Confidence            99999999999743     36899999999999999999999998   99999999999999999999999999987643


Q ss_pred             CC------CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccc
Q 007167          456 MP------PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD  529 (615)
Q Consensus       456 ~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  529 (615)
                      ..      ....+|..|+|||.+.+..++.++|||||||++|||++|+.||......+...      .......     .
T Consensus       169 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~------~~~~~~~-----~  237 (311)
T 3ork_A          169 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY------QHVREDP-----I  237 (311)
T ss_dssp             -------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------HHHHCCC-----C
T ss_pred             cccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHH------HHhcCCC-----C
Confidence            22      12347889999999998899999999999999999999999997654322211      1111110     0


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHH-HHHHhHh
Q 007167          530 VELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK-MVEDIRR  575 (615)
Q Consensus       530 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~-~L~~l~~  575 (615)
                      +.....+.+++++.+++.   +||+.||++||+..++++ .+.++..
T Consensus       238 ~~~~~~~~~~~~l~~li~---~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          238 PPSARHEGLSADLDAVVL---KALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             CHHHHSTTCCHHHHHHHH---HHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             CcccccCCCCHHHHHHHH---HHHhcCHhhChhhHHHHHHHHHHHhc
Confidence            011112234455555555   999999999997666554 4444433

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=333.97  Aligned_cols=253  Identities=20%  Similarity=0.344  Sum_probs=192.8

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      +.||+|+||+||+|... +++.||+|++......   .+.+.+|+++++.++||||+++++++.+.+..++||||+++++
T Consensus         9 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   88 (311)
T 4agu_A            9 GKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTV   88 (311)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEH
T ss_pred             eEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCch
Confidence            56999999999999975 4889999998665333   3567899999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---C
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---P  458 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~  458 (615)
                      |.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......   .
T Consensus        89 l~~~~~~~-----~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (311)
T 4agu_A           89 LHELDRYQ-----RGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD  160 (311)
T ss_dssp             HHHHHHTS-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             HHHHHhhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccC
Confidence            99988643     35899999999999999999999998   9999999999999999999999999998765332   2


Q ss_pred             CCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHh---------hhccccccc-
Q 007167          459 PAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSV---------VREEWTAEV-  527 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~-  527 (615)
                      ...++..|+|||.+.+ ..++.++||||+|+++|||++|+.||......+....+......         ....+.... 
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (311)
T 4agu_A          161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK  240 (311)
T ss_dssp             -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred             CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence            3457888999999865 56899999999999999999999999876544333222211000         000000000 


Q ss_pred             -ccc-----cccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          528 -FDV-----ELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       528 -~d~-----~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                       .++     .....+..++++.+++   .+|++.||++|||++|++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li---~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          241 IPDPEDMEPLELKFPNISYPALGLL---KGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             CCCCSSCCCHHHHCTTCCHHHHHHH---HHHCCSSTTTSCCHHHHHTS
T ss_pred             CCCccccchhhhhcccccHHHHHHH---HHHccCChhhcCCHHHHhcC
Confidence             000     0001233444454544   49999999999999999875

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.4e-39  Score=342.47  Aligned_cols=197  Identities=22%  Similarity=0.345  Sum_probs=170.5

Q ss_pred             hhhcCcC--CccEEEEEEEC-CCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCC
Q 007167          305 AEVLGKG--TFGTAYKAALE-DASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G--~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      .++||+|  +||+||+|... +++.||||+++.....   .+.+.+|+++++.++|||||++++++.+++..++||||++
T Consensus        30 ~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~  109 (389)
T 3gni_B           30 LTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA  109 (389)
T ss_dssp             EEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCT
T ss_pred             EecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccC
Confidence            3569999  99999999976 6889999999765333   3567789999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC---
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP---  455 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~---  455 (615)
                      +|+|.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||.+.....   
T Consensus       110 ~~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~  183 (389)
T 3gni_B          110 YGSAKDLICTHF---MDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQ  183 (389)
T ss_dssp             TCBHHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEECEETTE
T ss_pred             CCCHHHHHhhhc---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceeeccccc
Confidence            999999997542   235899999999999999999999998   99999999999999999999999998864421   


Q ss_pred             -------CCCCCCCCCcccCccccCC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc
Q 007167          456 -------MPPPAMRAAGYRAPEVTDT--RKATQASDVFSFGVLLLELLTGKSPIHATGGDE  507 (615)
Q Consensus       456 -------~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~  507 (615)
                             ......+|..|+|||++.+  ..++.++|||||||++|||++|+.||......+
T Consensus       184 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~  244 (389)
T 3gni_B          184 RQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ  244 (389)
T ss_dssp             ECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTT
T ss_pred             cccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHH
Confidence                   1223357888999999987  578999999999999999999999998755433

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.2e-40  Score=337.23  Aligned_cols=247  Identities=20%  Similarity=0.372  Sum_probs=192.6

Q ss_pred             hhhcCcCCccEEEEEEECC-C-------CEEEEEEecccc-CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEee
Q 007167          305 AEVLGKGTFGTAYKAALED-A-------STVVVKRLKEVN-VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYD  375 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~-~-------~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  375 (615)
                      .+.||+|+||+||+|.... +       ..||+|++.... ...+.+.+|+++++.++||||+++++++.+.+..++|||
T Consensus        13 ~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   92 (289)
T 4fvq_A           13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQE   92 (289)
T ss_dssp             EEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEE
T ss_pred             eeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEE
Confidence            3569999999999998553 2       469999986543 335678999999999999999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCc--------EEEeec
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGH--------VCVSDI  447 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~--------~kl~Df  447 (615)
                      |+++|+|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.        +||+||
T Consensus        93 ~~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Df  165 (289)
T 4fvq_A           93 FVKFGSLDTYLKKNK----NCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDP  165 (289)
T ss_dssp             CCTTCBHHHHHHHTG----GGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEECCC
T ss_pred             CCCCCCHHHHHHhCC----CCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeeeccC
Confidence            999999999997532    34899999999999999999999998   999999999999998887        999999


Q ss_pred             ccccccCCCCCCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCC-CCCCCCCcchhhHHHHHHHhhhccccc
Q 007167          448 GLAALMSPMPPPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKS-PIHATGGDEVVHLVRWVNSVVREEWTA  525 (615)
Q Consensus       448 G~a~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (615)
                      |++...... ....++..|+|||.+.+ ..++.++|||||||++|||++|.. ||........   ......        
T Consensus       166 g~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~---~~~~~~--------  233 (289)
T 4fvq_A          166 GISITVLPK-DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK---LQFYED--------  233 (289)
T ss_dssp             CSCTTTSCH-HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH---HHHHHT--------
T ss_pred             cccccccCc-cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH---HHHhhc--------
Confidence            998765432 12246778999999977 678999999999999999999554 4443222111   111110        


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhhc
Q 007167          526 EVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKA  578 (615)
Q Consensus       526 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~  578 (615)
                           ........++++.+++   .+||+.||++|||+.|++++|+++.....
T Consensus       234 -----~~~~~~~~~~~l~~li---~~~l~~dp~~Rps~~~ll~~l~~l~~p~~  278 (289)
T 4fvq_A          234 -----RHQLPAPKAAELANLI---NNCMDYEPDHRPSFRAIIRDLNSLFTPDL  278 (289)
T ss_dssp             -----TCCCCCCSSCTTHHHH---HHHSCSSGGGSCCHHHHHHHHHTCC----
T ss_pred             -----cCCCCCCCCHHHHHHH---HHHcCCChhHCcCHHHHHHHHHHhcCCCC
Confidence                 0001112233344444   49999999999999999999999887544

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-39  Score=329.32  Aligned_cols=250  Identities=26%  Similarity=0.363  Sum_probs=197.4

Q ss_pred             hhhcCcCCccEEEEEEECC-CC---EEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCee-eEEeecC
Q 007167          305 AEVLGKGTFGTAYKAALED-AS---TVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEK-LMVYDYF  377 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~-~~---~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~-~lV~e~~  377 (615)
                      .++||+|+||+||+|...+ +.   .||+|.++....  ..+.+.+|+++++.++||||+++++++.+.+.. ++||||+
T Consensus        26 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~  105 (298)
T 3pls_A           26 DRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYM  105 (298)
T ss_dssp             EEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCC
T ss_pred             CceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecc
Confidence            3579999999999998532 22   699999875432  235688999999999999999999999876655 9999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC-
Q 007167          378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM-  456 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~-  456 (615)
                      .+|+|.+++...    ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++..... 
T Consensus       106 ~~~~L~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          106 CHGDLLQFIRSP----QRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             TTCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             cCCCHHHHHhcc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            999999999753    346899999999999999999999998   999999999999999999999999999765332 


Q ss_pred             ------CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCC-CCCCCCcchhhHHHHHHHhhhccccccccc
Q 007167          457 ------PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSP-IHATGGDEVVHLVRWVNSVVREEWTAEVFD  529 (615)
Q Consensus       457 ------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  529 (615)
                            .....++..|+|||.+.+..++.++||||||+++|||++|..| |......+....+   ....          
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~---~~~~----------  245 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFL---AQGR----------  245 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHH---HTTC----------
T ss_pred             ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHh---hcCC----------
Confidence                  1233456789999999998999999999999999999996555 4443333322211   1100          


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhhc
Q 007167          530 VELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKA  578 (615)
Q Consensus       530 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~  578 (615)
                       ........++++.++++   +|+..+|.+|||++|+++.|+++.....
T Consensus       246 -~~~~~~~~~~~l~~li~---~~l~~~p~~Rps~~~ll~~l~~~~~~l~  290 (298)
T 3pls_A          246 -RLPQPEYCPDSLYQVMQ---QCWEADPAVRPTFRVLVGEVEQIVSALL  290 (298)
T ss_dssp             -CCCCCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHHCC
T ss_pred             -CCCCCccchHHHHHHHH---HHccCChhhCcCHHHHHHHHHHHHHHHh
Confidence             01112234455555555   9999999999999999999999987554

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3e-39  Score=330.70  Aligned_cols=260  Identities=21%  Similarity=0.408  Sum_probs=194.2

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccC----CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNV----GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||.||+|.. .+++.||+|+++....    ..+.+.+|+++++.++||||+++++++...+..++||||+++
T Consensus        37 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~  116 (310)
T 2wqm_A           37 EKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA  116 (310)
T ss_dssp             EEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCS
T ss_pred             EEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCC
Confidence            35699999999999986 5789999999975322    235688999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      |+|.+++..... ....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......  
T Consensus       117 ~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  192 (310)
T 2wqm_A          117 GDLSRMIKHFKK-QKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA  192 (310)
T ss_dssp             CBHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC------------
T ss_pred             CCHHHHHHHhcc-cccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCcc
Confidence            999999864221 2346899999999999999999999998   9999999999999999999999999998765432  


Q ss_pred             -CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          458 -PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       458 -~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                       ....++..|+|||.+.+..++.++||||||+++|||++|+.||...... ......   ........      .. ...
T Consensus       193 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~---~~~~~~~~------~~-~~~  261 (310)
T 2wqm_A          193 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCK---KIEQCDYP------PL-PSD  261 (310)
T ss_dssp             ------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC-HHHHHH---HHHTTCSC------CC-CTT
T ss_pred             ccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh-HHHHHH---HhhcccCC------CC-ccc
Confidence             2335788899999999889999999999999999999999999754322 111111   11111100      00 112


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhhcCCCC
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPP  582 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~~~~~  582 (615)
                      .+++++.++++   +||..||++|||+.||+++|+++.....+.+.
T Consensus       262 ~~~~~l~~li~---~~l~~dp~~Rps~~~il~~l~~l~~~~~~~~~  304 (310)
T 2wqm_A          262 HYSEELRQLVN---MCINPDPEKRPDVTYVYDVAKRMHACTASSLE  304 (310)
T ss_dssp             TSCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHHHC----
T ss_pred             ccCHHHHHHHH---HHcCCChhhCCCHHHHHHHHHHHHHhhhhhhh
Confidence            34455555555   99999999999999999999999987765443

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3e-39  Score=326.03  Aligned_cols=251  Identities=23%  Similarity=0.403  Sum_probs=199.5

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC-------CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV-------GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      .+.||+|+||+||+|... +++.||+|.++....       ..+.+.+|+++++.++||||+++++++.+.+..++||||
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   89 (283)
T 3bhy_A           10 GEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILEL   89 (283)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             HHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEee
Confidence            467999999999999976 688999999875421       356789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCC----cEEEeecccccc
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG----HVCVSDIGLAAL  452 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~----~~kl~DfG~a~~  452 (615)
                      +++++|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++    .+||+|||++..
T Consensus        90 ~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~  161 (283)
T 3bhy_A           90 VSGGELFDFLAEK-----ESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK  161 (283)
T ss_dssp             CCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             cCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence            9999999999643     36899999999999999999999998   99999999999999877    899999999987


Q ss_pred             cCCCC--CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccc
Q 007167          453 MSPMP--PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDV  530 (615)
Q Consensus       453 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  530 (615)
                      .....  ....++..|+|||.+.+..++.++||||||+++|||++|+.||......+....+      .....   .++.
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~------~~~~~---~~~~  232 (283)
T 3bhy_A          162 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI------SAVNY---DFDE  232 (283)
T ss_dssp             CC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HTTCC---CCCH
T ss_pred             ccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHh------Hhccc---CCcc
Confidence            65432  2345788999999999889999999999999999999999999765433222111      10000   0000


Q ss_pred             cccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhHhhh
Q 007167          531 ELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM--VEDIRRVK  577 (615)
Q Consensus       531 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~l~~~~  577 (615)
                      .  ..+..++.+.++++   +|+..||++||++.|++++  ++.++...
T Consensus       233 ~--~~~~~~~~~~~li~---~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  276 (283)
T 3bhy_A          233 E--YFSNTSELAKDFIR---RLLVKDPKRRMTIAQSLEHSWIKAIRRRN  276 (283)
T ss_dssp             H--HHTTCCHHHHHHHH---TTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred             h--hcccCCHHHHHHHH---HHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence            0  11233445555555   9999999999999999984  56665443

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.1e-39  Score=336.75  Aligned_cols=244  Identities=21%  Similarity=0.357  Sum_probs=196.2

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccC---CHHHHHHHHHHHhCCC-CCcccceeEEEEecCeeeEEeecCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV---GKREFEQQMEIVGGIR-HENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      +.||+|+||+||+|... +++.||+|+++....   ....+.+|+.++..++ ||||+++++++.+.+..++||||+++|
T Consensus        35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~  114 (327)
T 3lm5_A           35 KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGG  114 (327)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTE
T ss_pred             ceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCC
Confidence            67999999999999865 688999999876432   3567889999999994 699999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCC---CCcEEEeecccccccCCCC
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNS---QGHVCVSDIGLAALMSPMP  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~---~~~~kl~DfG~a~~~~~~~  457 (615)
                      +|.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.   ++.+||+|||+++......
T Consensus       115 ~L~~~~~~~~---~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~  188 (327)
T 3lm5_A          115 EIFSLCLPEL---AEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC  188 (327)
T ss_dssp             EGGGGGSSCC----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC----
T ss_pred             cHHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc
Confidence            9999986432   346999999999999999999999998   999999999999998   7899999999998775432


Q ss_pred             --CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCC
Q 007167          458 --PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY  535 (615)
Q Consensus       458 --~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  535 (615)
                        ....++..|+|||++.+..++.++|||||||++|||++|+.||......+....+.   ..        .........
T Consensus       189 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~---~~--------~~~~~~~~~  257 (327)
T 3lm5_A          189 ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNIS---QV--------NVDYSEETF  257 (327)
T ss_dssp             -----CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH---HT--------CCCCCTTTT
T ss_pred             ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHH---hc--------ccccCchhh
Confidence              23467899999999999999999999999999999999999997754433222111   00        001111122


Q ss_pred             CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          536 PNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       536 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      +..++.+.++++   +|++.||++|||++|++++
T Consensus       258 ~~~~~~~~~li~---~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          258 SSVSQLATDFIQ---SLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             TTSCHHHHHHHH---HHSCSSGGGSCCHHHHTTC
T ss_pred             cccCHHHHHHHH---HHcCCChhhCcCHHHHhCC
Confidence            344556656555   9999999999999999876

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=6.8e-40  Score=343.54  Aligned_cols=234  Identities=24%  Similarity=0.368  Sum_probs=185.4

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccC----CHHHHHHHHHH-HhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV----GKREFEQQMEI-VGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~-l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      +.||+|+||+||+|+.+ ++..||+|+++....    ....+.+|..+ ++.++||||+++++++.+.+..++||||+++
T Consensus        44 ~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~g  123 (373)
T 2r5t_A           44 KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING  123 (373)
T ss_dssp             EEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred             EEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCC
Confidence            56999999999999975 577899999976532    22345566665 5678999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC---C
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP---M  456 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~---~  456 (615)
                      |+|.+++...     ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++++||+|||+++....   .
T Consensus       124 g~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~  195 (373)
T 2r5t_A          124 GELFYHLQRE-----RCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNST  195 (373)
T ss_dssp             CBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCC
T ss_pred             CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccCCCc
Confidence            9999999743     36889999999999999999999998   99999999999999999999999999986432   2


Q ss_pred             CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          457 PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       457 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                      .....+|+.|+|||++.+..++.++|||||||++|||++|+.||...+..+...      .+...         .....+
T Consensus       196 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~------~i~~~---------~~~~~~  260 (373)
T 2r5t_A          196 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD------NILNK---------PLQLKP  260 (373)
T ss_dssp             CCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHH------HHHHS---------CCCCCS
T ss_pred             cccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH------HHHhc---------ccCCCC
Confidence            334568999999999999999999999999999999999999997654333221      11111         111223


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMAD  565 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~e  565 (615)
                      .+++++.++++   +|++.||.+||++.+
T Consensus       261 ~~~~~~~~li~---~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          261 NITNSARHLLE---GLLQKDRTKRLGAKD  286 (373)
T ss_dssp             SSCHHHHHHHH---HHTCSSGGGSTTTTT
T ss_pred             CCCHHHHHHHH---HHcccCHHhCCCCCC
Confidence            45666666666   999999999999853

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.8e-40  Score=336.97  Aligned_cols=253  Identities=19%  Similarity=0.357  Sum_probs=190.6

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC--HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG--KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      +.||+|+||+||+|... +++.||+|+++.....  ...+.+|+++++.++||||+++++++...+..++||||++ |+|
T Consensus         8 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l   86 (324)
T 3mtl_A            8 DKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDL   86 (324)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEH
T ss_pred             EEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCH
Confidence            56999999999999975 6889999998754221  2245679999999999999999999999999999999997 589


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---CC
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---PP  459 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~~  459 (615)
                      .+++...    ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++......   ..
T Consensus        87 ~~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  159 (324)
T 3mtl_A           87 KQYLDDC----GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN  159 (324)
T ss_dssp             HHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred             HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCCcccccc
Confidence            8888743    236899999999999999999999998   9999999999999999999999999998665322   23


Q ss_pred             CCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHH-HHHhhhcccccccccc-------
Q 007167          460 AMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRW-VNSVVREEWTAEVFDV-------  530 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~d~-------  530 (615)
                      ..+|..|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+.. +.....+.|....-..       
T Consensus       160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
T 3mtl_A          160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNY  239 (324)
T ss_dssp             ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCC
T ss_pred             ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccccc
Confidence            356889999999876 5689999999999999999999999987654433322211 1111111111110000       


Q ss_pred             -------cccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          531 -------ELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       531 -------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                             .....+.+++++.++++   +|++.||++|||++|++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          240 PKYRAEALLSHAPRLDSDGADLLT---KLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             CCCCCCCHHHHCTTSCHHHHHHHH---HHSCSSGGGSCCHHHHTTS
T ss_pred             ccccchhhhhhcCCCCHHHHHHHH---HHcCcCcccCCCHHHHhcC
Confidence                   00112234455555555   9999999999999999985

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1e-39  Score=337.89  Aligned_cols=233  Identities=20%  Similarity=0.289  Sum_probs=193.8

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccC---------CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEe
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNV---------GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVY  374 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  374 (615)
                      .+.||+|+||+||+|.. .+++.||||+++....         ..+.+.+|+++++.++||||+++++++.+.+..++||
T Consensus        29 ~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~  108 (335)
T 3dls_A           29 MSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVM  108 (335)
T ss_dssp             EEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             EeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEE
Confidence            46799999999999985 4678899999976532         2345778999999999999999999999999999999


Q ss_pred             ecCCCC-ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeeccccccc
Q 007167          375 DYFEPG-SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALM  453 (615)
Q Consensus       375 e~~~~g-sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~  453 (615)
                      ||+.+| +|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++..
T Consensus       109 e~~~~g~~l~~~~~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  180 (335)
T 3dls_A          109 EKHGSGLDLFAFIDRH-----PRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYL  180 (335)
T ss_dssp             ECCTTSCBHHHHHHTC-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EeCCCCccHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence            999777 999999743     36999999999999999999999998   999999999999999999999999999877


Q ss_pred             CCCC--CCCCCCCcccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccc
Q 007167          454 SPMP--PPAMRAAGYRAPEVTDTRKA-TQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDV  530 (615)
Q Consensus       454 ~~~~--~~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  530 (615)
                      ....  ....+|..|+|||++.+..+ +.++|||||||++|||++|+.||......                     ...
T Consensus       181 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---------------------~~~  239 (335)
T 3dls_A          181 ERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET---------------------VEA  239 (335)
T ss_dssp             CTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG---------------------TTT
T ss_pred             CCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH---------------------Hhh
Confidence            5433  23457899999999988776 78999999999999999999999652110                     001


Q ss_pred             cccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          531 ELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       531 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .......+++++.++++   +|++.||++|||+.|++++
T Consensus       240 ~~~~~~~~~~~l~~li~---~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          240 AIHPPYLVSKELMSLVS---GLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             CCCCSSCCCHHHHHHHH---HHTCSSGGGSCCHHHHHHC
T ss_pred             ccCCCcccCHHHHHHHH---HHccCChhhCcCHHHHhcC
Confidence            11112234556666655   9999999999999999987

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.1e-39  Score=329.17  Aligned_cols=248  Identities=23%  Similarity=0.385  Sum_probs=197.2

Q ss_pred             hhhcCcCCccEEEEEEECC----CCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALED----ASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      .+.||+|+||+||+|...+    +..||+|.++....  ..+.+.+|+++++.++||||+++++++.+ +..++||||++
T Consensus        17 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~   95 (281)
T 3cc6_A           17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWIIMELYP   95 (281)
T ss_dssp             EEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEEEEECCT
T ss_pred             EEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEEEEecCC
Confidence            3579999999999998543    23599999875422  24678899999999999999999999764 46789999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC-
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP-  457 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~-  457 (615)
                      +++|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++....... 
T Consensus        96 ~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  168 (281)
T 3cc6_A           96 YGELGHYLERNK----NSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY  168 (281)
T ss_dssp             TCBHHHHHHHHT----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-----
T ss_pred             CCCHHHHHHhcc----ccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccccccc
Confidence            999999997532    35899999999999999999999998   9999999999999999999999999998765432 


Q ss_pred             ---CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccccccccccc
Q 007167          458 ---PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELL  533 (615)
Q Consensus       458 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  533 (615)
                         ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+.   .   ..        ...
T Consensus       169 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~---~---~~--------~~~  234 (281)
T 3cc6_A          169 YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLE---K---GD--------RLP  234 (281)
T ss_dssp             ----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHH---H---TC--------CCC
T ss_pred             cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHh---c---CC--------CCC
Confidence               22335678999999988889999999999999999998 999998655544332221   1   00        011


Q ss_pred             CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhh
Q 007167          534 RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVK  577 (615)
Q Consensus       534 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~  577 (615)
                      .....++.+.++++   +|+..||++||++.|++++|+++.+..
T Consensus       235 ~~~~~~~~l~~li~---~~l~~~p~~Rps~~ell~~L~~~~~~~  275 (281)
T 3cc6_A          235 KPDLCPPVLYTLMT---RCWDYDPSDRPRFTELVCSLSDVYQME  275 (281)
T ss_dssp             CCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHH---HHccCCchhCcCHHHHHHHHHHHHHhh
Confidence            12234455555555   999999999999999999999987643

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.5e-39  Score=338.41  Aligned_cols=241  Identities=25%  Similarity=0.440  Sum_probs=194.7

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccCC----HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVG----KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||+||+|.. .+++.||||++......    .+.+.+|+++++.++||||+++++++...+..++||||+. 
T Consensus        59 ~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-  137 (348)
T 1u5q_A           59 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-  137 (348)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred             eeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-
Confidence            35799999999999996 57888999999754322    2467899999999999999999999999999999999997 


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCC
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP  459 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~  459 (615)
                      |+|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++...... ..
T Consensus       138 g~l~~~l~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~-~~  209 (348)
T 1u5q_A          138 GSASDLLEVHK----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-NS  209 (348)
T ss_dssp             EEHHHHHHHHT----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-CC
T ss_pred             CCHHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCCC-Cc
Confidence            68888875332    36899999999999999999999998   999999999999999999999999999876543 34


Q ss_pred             CCCCCcccCccccC---CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          460 AMRAAGYRAPEVTD---TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       460 ~~~~~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                      ..+|..|+|||++.   ...++.++|||||||++|||++|+.||......+..      ........      +. ....
T Consensus       210 ~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~------~~~~~~~~------~~-~~~~  276 (348)
T 1u5q_A          210 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL------YHIAQNES------PA-LQSG  276 (348)
T ss_dssp             CCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHSCC------CC-CCCT
T ss_pred             ccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH------HHHHhcCC------CC-CCCC
Confidence            56899999999983   567899999999999999999999999765432211      11111110      00 1112


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                      .+++.+.++++   +||+.||++|||++|++++.
T Consensus       277 ~~~~~l~~li~---~~l~~dP~~Rps~~~ll~h~  307 (348)
T 1u5q_A          277 HWSEYFRNFVD---SCLQKIPQDRPTSEVLLKHR  307 (348)
T ss_dssp             TSCHHHHHHHH---HHTCSSGGGSCCHHHHTTCH
T ss_pred             CCCHHHHHHHH---HHcccChhhCcCHHHHhhCh
Confidence            34555656555   99999999999999998864

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.1e-39  Score=330.00  Aligned_cols=245  Identities=24%  Similarity=0.378  Sum_probs=191.5

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc--CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN--VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      .+.||+|+||+||++... ++..||+|++....  ...+.+.+|+++++.++||||+++++++.+.+..++||||+++|+
T Consensus        27 ~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~  106 (285)
T 3is5_A           27 KRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGE  106 (285)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCB
T ss_pred             cceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCc
Confidence            467999999999999964 67899999987643  345789999999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEe---CCCCcEEEeecccccccCCC--
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFL---NSQGHVCVSDIGLAALMSPM--  456 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill---~~~~~~kl~DfG~a~~~~~~--  456 (615)
                      |.+.+..... ....+++..+..++.|++.||+|||+.+   |+||||||+||++   +.++.+||+|||++......  
T Consensus       107 L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~  182 (285)
T 3is5_A          107 LLERIVSAQA-RGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH  182 (285)
T ss_dssp             HHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC------
T ss_pred             HHHHHHhhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecCCccc
Confidence            9999864321 1246999999999999999999999998   9999999999999   45678999999999876533  


Q ss_pred             CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          457 PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       457 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                      .....++..|+|||.+. ..++.++||||||+++|||++|+.||......+......+      ...   ..  .. ...
T Consensus       183 ~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~------~~~---~~--~~-~~~  249 (285)
T 3is5_A          183 STNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATY------KEP---NY--AV-ECR  249 (285)
T ss_dssp             ----CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH------CCC---CC--CC---C
T ss_pred             CcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhcc------CCc---cc--cc-ccC
Confidence            23445788999999986 4688999999999999999999999986543332221110      000   00  00 111


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ..++++.++++   +|++.||++|||+.|++++
T Consensus       250 ~~~~~~~~li~---~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          250 PLTPQAVDLLK---QMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             CCCHHHHHHHH---HHTCSCTTTSCCHHHHHTS
T ss_pred             cCCHHHHHHHH---HHccCChhhCcCHHHHhcC
Confidence            23455555555   9999999999999999874

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=1.9e-39  Score=332.56  Aligned_cols=252  Identities=23%  Similarity=0.369  Sum_probs=191.1

Q ss_pred             hhhcCcCCccEEEEEEEC----CCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecCe-----eeE
Q 007167          305 AEVLGKGTFGTAYKAALE----DASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKDE-----KLM  372 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----~~l  372 (615)
                      .+.||+|+||+||+|...    .+..||+|+++.....   .+.+.+|++++++++||||+++++++.+.+.     .++
T Consensus        39 ~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~  118 (313)
T 3brb_A           39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMV  118 (313)
T ss_dssp             EEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEE
T ss_pred             ccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEE
Confidence            457999999999999854    2347999998755333   3568899999999999999999999987653     499


Q ss_pred             EeecCCCCChhhhhccCCC-CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeeccccc
Q 007167          373 VYDYFEPGSVSAMLHGRRG-EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAA  451 (615)
Q Consensus       373 V~e~~~~gsL~~~l~~~~~-~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~  451 (615)
                      ||||+++|+|.+++..... .....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||+++
T Consensus       119 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kl~Dfg~~~  195 (313)
T 3brb_A          119 ILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTVCVADFGLSK  195 (313)
T ss_dssp             EEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCEEECSCSCC-
T ss_pred             EEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEEeecCcce
Confidence            9999999999999853321 23457999999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCCC-----CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccc
Q 007167          452 LMSPMP-----PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTA  525 (615)
Q Consensus       452 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (615)
                      ......     ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+.      ...   
T Consensus       196 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~------~~~---  266 (313)
T 3brb_A          196 KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL------HGH---  266 (313)
T ss_dssp             ---------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH------TTC---
T ss_pred             ecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH------cCC---
Confidence            764322     22335678999999988889999999999999999999 899998765443322111      100   


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          526 EVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       526 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                           .......+++++.+++.   +|+..+|.+|||+.|++++|+++.+.
T Consensus       267 -----~~~~~~~~~~~l~~li~---~~l~~dp~~Rps~~~l~~~L~~l~~~  309 (313)
T 3brb_A          267 -----RLKQPEDCLDELYEIMY---SCWRTDPLDRPTFSVLRLQLEKLLES  309 (313)
T ss_dssp             -----CCCCBTTCCHHHHHHHH---HTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----CCCCCccccHHHHHHHH---HHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                 00111233445555544   99999999999999999999998764

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.6e-39  Score=325.69  Aligned_cols=240  Identities=19%  Similarity=0.350  Sum_probs=177.5

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEecccc----CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVN----VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||+||+|.. .+++.||||.+....    ...+.+.+|+++++.++||||+++++++.+.+..++||||+++
T Consensus        16 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   95 (278)
T 3cok_A           16 GNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHN   95 (278)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             eeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCC
Confidence            35699999999999996 578899999986432    2246788999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      ++|.+++...    ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......  
T Consensus        96 ~~L~~~l~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  168 (278)
T 3cok_A           96 GEMNRYLKNR----VKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEK  168 (278)
T ss_dssp             EEHHHHHHTC----SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-----
T ss_pred             CcHHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCc
Confidence            9999999743    246899999999999999999999998   9999999999999999999999999998765322  


Q ss_pred             -CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          458 -PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       458 -~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                       ....++..|+|||.+.+..++.++||||||+++|||++|+.||......+....      .         .........
T Consensus       169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------~---------~~~~~~~~~  233 (278)
T 3cok_A          169 HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK------V---------VLADYEMPS  233 (278)
T ss_dssp             -----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----------C---------CSSCCCCCT
T ss_pred             ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH------H---------hhcccCCcc
Confidence             234578899999999888899999999999999999999999976543322110      0         001111122


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .++.++.++++   +|++.||++|||+.|++++
T Consensus       234 ~~~~~~~~li~---~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          234 FLSIEAKDLIH---QLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             TSCHHHHHHHH---HHSCSSGGGSCCHHHHTTS
T ss_pred             ccCHHHHHHHH---HHcccCHhhCCCHHHHhcC
Confidence            34455555555   9999999999999999875

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=9.9e-40  Score=340.58  Aligned_cols=258  Identities=16%  Similarity=0.191  Sum_probs=200.7

Q ss_pred             hhhcCcCCccEEEEEEECC---------CCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccc---------------e
Q 007167          305 AEVLGKGTFGTAYKAALED---------ASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVA---------------L  360 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~---------------l  360 (615)
                      .+.||+|+||+||+|....         ++.||+|.+...    +.+.+|++++++++||||++               +
T Consensus        47 ~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~  122 (352)
T 2jii_A           47 KSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTC  122 (352)
T ss_dssp             EEEEEEETTEEEEEEEECC-----------CEEEEEEETT----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCC
T ss_pred             EEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc----chHHHHHHHHHHhcccchhhhhhhhccCCccCccch
Confidence            3569999999999999764         788999998743    46889999999999999998               6


Q ss_pred             eEEEEe-cCeeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCC
Q 007167          361 RAYYYS-KDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQ  439 (615)
Q Consensus       361 ~~~~~~-~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~  439 (615)
                      ++++.. +...++||||+ +++|.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.+
T Consensus       123 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl~~~~  195 (352)
T 2jii_A          123 MGFGVHQDKYRFLVLPSL-GRSLQSALDVSP---KHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPE  195 (352)
T ss_dssp             CEEEEETTTEEEEEEECC-CEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEEEETT
T ss_pred             hhccccCCcEEEEEecCC-CcCHHHHHHhCC---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEEcCC
Confidence            788876 67889999999 999999997542   246999999999999999999999998   9999999999999999


Q ss_pred             C--cEEEeecccccccCCCC----------CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc
Q 007167          440 G--HVCVSDIGLAALMSPMP----------PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDE  507 (615)
Q Consensus       440 ~--~~kl~DfG~a~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~  507 (615)
                      +  .+||+|||+++.+....          ....+|..|+|||.+.+..++.++|||||||++|||++|+.||.......
T Consensus       196 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~  275 (352)
T 2jii_A          196 DQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNT  275 (352)
T ss_dssp             EEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             CCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCH
Confidence            8  89999999997764321          22357889999999999899999999999999999999999998754221


Q ss_pred             hhhHHHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhhcCC
Q 007167          508 VVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAEN  580 (615)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~~~  580 (615)
                       .............  .....+ .......+++++.++++   +|+..||++||++.|+++.|+++.......
T Consensus       276 -~~~~~~~~~~~~~--~~~~~~-~~~~~~~~~~~l~~li~---~~l~~dp~~Rps~~~l~~~L~~~~~~~~~~  341 (352)
T 2jii_A          276 -EDIMKQKQKFVDK--PGPFVG-PCGHWIRPSETLQKYLK---VVMALTYEEKPPYAMLRNNLEALLQDLRVS  341 (352)
T ss_dssp             -HHHHHHHHHHHHS--CCCEEC-TTSCEECCCHHHHHHHH---HHHTCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             -HHHHHHHHhccCC--hhhhhh-hccccCCCcHHHHHHHH---HHHhCChhhCCCHHHHHHHHHHHHHhcCCC
Confidence             1111111111110  011111 00011233556666655   999999999999999999999998765433

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.9e-39  Score=334.78  Aligned_cols=253  Identities=24%  Similarity=0.411  Sum_probs=200.0

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCE--EEEEEeccc--cCCHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DAST--VVVKRLKEV--NVGKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~--vavK~l~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      .+.||+|+||.||+|... ++..  |++|+++..  ....+.+.+|++++.++ +||||+++++++.+.+..++||||++
T Consensus        30 ~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~  109 (327)
T 1fvr_A           30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP  109 (327)
T ss_dssp             EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             eeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCC
Confidence            457999999999999864 4554  489988753  22346789999999999 89999999999999999999999999


Q ss_pred             CCChhhhhccCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeec
Q 007167          379 PGSVSAMLHGRR-----------GEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDI  447 (615)
Q Consensus       379 ~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Df  447 (615)
                      +|+|.+++....           ......+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+||
T Consensus       110 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kL~Df  186 (327)
T 1fvr_A          110 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF  186 (327)
T ss_dssp             TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCT
T ss_pred             CCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeEEEccc
Confidence            999999997542           012347999999999999999999999998   999999999999999999999999


Q ss_pred             ccccccCCC--CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccc
Q 007167          448 GLAALMSPM--PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWT  524 (615)
Q Consensus       448 G~a~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  524 (615)
                      |+++.....  .....++..|+|||.+.+..++.++|||||||++|||++ |+.||......+...      ..... . 
T Consensus       187 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~------~~~~~-~-  258 (327)
T 1fvr_A          187 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE------KLPQG-Y-  258 (327)
T ss_dssp             TCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH------HGGGT-C-
T ss_pred             CcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHH------HhhcC-C-
Confidence            999754322  222345778999999988888999999999999999998 999997654322211      11111 0 


Q ss_pred             cccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhh
Q 007167          525 AEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVK  577 (615)
Q Consensus       525 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~  577 (615)
                            .......+++++.++++   +|+..+|.+|||+.|++++|+++....
T Consensus       259 ------~~~~~~~~~~~l~~li~---~~l~~dp~~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          259 ------RLEKPLNCDDEVYDLMR---QCWREKPYERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             ------CCCCCTTBCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             ------CCCCCCCCCHHHHHHHH---HHccCChhhCcCHHHHHHHHHHHHHhh
Confidence                  11112244555555555   999999999999999999999998754

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.5e-39  Score=329.27  Aligned_cols=250  Identities=26%  Similarity=0.383  Sum_probs=195.6

Q ss_pred             hhhcCcCCccEEEEEEECCC----CEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEe-cCeeeEEeecC
Q 007167          305 AEVLGKGTFGTAYKAALEDA----STVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYS-KDEKLMVYDYF  377 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~----~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~~  377 (615)
                      .++||+|+||+||+|...+.    ..||+|.++....  ..+.+.+|++++++++||||+++++++.. ++..++||||+
T Consensus        30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~  109 (298)
T 3f66_A           30 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  109 (298)
T ss_dssp             EEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECC
T ss_pred             cceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCC
Confidence            35799999999999986432    2588998875432  23568899999999999999999999654 56789999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC
Q 007167          378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP  457 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~  457 (615)
                      ++|+|.+++...    ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++......
T Consensus       110 ~~~~L~~~l~~~----~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  182 (298)
T 3f66_A          110 KHGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  182 (298)
T ss_dssp             TTCBHHHHHHCT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred             CCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECcccccccccccc
Confidence            999999999743    246899999999999999999999998   9999999999999999999999999998664321


Q ss_pred             -------CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccccccc
Q 007167          458 -------PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD  529 (615)
Q Consensus       458 -------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  529 (615)
                             ....++..|+|||.+.+..++.++||||+|+++|||++ |..||......+....+.      ...       
T Consensus       183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~------~~~-------  249 (298)
T 3f66_A          183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL------QGR-------  249 (298)
T ss_dssp             GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHH------TTC-------
T ss_pred             hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHh------cCC-------
Confidence                   22335678999999988889999999999999999999 566666554433322111      000       


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhhc
Q 007167          530 VELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKA  578 (615)
Q Consensus       530 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~  578 (615)
                       ........++.+.++++   +|+..+|++|||++|+++.|+++.....
T Consensus       250 -~~~~~~~~~~~l~~li~---~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          250 -RLLQPEYCPDPLYEVML---KCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             -CCCCCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             -CCCCCccCCHHHHHHHH---HHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence             01111233445555544   9999999999999999999999887443

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2e-39  Score=328.72  Aligned_cols=248  Identities=26%  Similarity=0.481  Sum_probs=187.7

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      .+.||+|+||+||+|...  ..||||+++.....   .+.+.+|+++++.++||||+++++++ .....++||||+++++
T Consensus        29 ~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~  105 (289)
T 3og7_A           29 GQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSS  105 (289)
T ss_dssp             EEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEE
T ss_pred             eeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCc
Confidence            356999999999999864  36999999765433   35688999999999999999999965 5567899999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC----
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP----  457 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~----  457 (615)
                      |.+++...    ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......    
T Consensus       106 L~~~l~~~----~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  178 (289)
T 3og7_A          106 LYHHLHAS----ETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ  178 (289)
T ss_dssp             HHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------------
T ss_pred             HHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccccccccc
Confidence            99999643    246999999999999999999999998   9999999999999999999999999997654321    


Q ss_pred             -CCCCCCCcccCccccC---CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccccccc
Q 007167          458 -PPAMRAAGYRAPEVTD---TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELL  533 (615)
Q Consensus       458 -~~~~~~~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  533 (615)
                       ....++..|+|||.+.   ...++.++||||||+++|||++|+.||......+.  ....+...   .     ..+...
T Consensus       179 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~~~~~---~-----~~~~~~  248 (289)
T 3og7_A          179 FEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ--IIEMVGRG---S-----LSPDLS  248 (289)
T ss_dssp             -----CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHH--HHHHHHHT---S-----CCCCTT
T ss_pred             ccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHH--HHHHhccc---c-----cCcchh
Confidence             2335788999999986   56678899999999999999999999987544322  11111111   0     011111


Q ss_pred             C-CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          534 R-YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       534 ~-~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                      . ...+++++.++++   +|++.+|++|||+.|+++.|+++.+
T Consensus       249 ~~~~~~~~~l~~li~---~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          249 KVRSNCPKRMKRLMA---ECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             SSCTTSCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             hccccCCHHHHHHHH---HHccCChhhCCCHHHHHHHHHHHhh
Confidence            1 1234455555555   9999999999999999999998864

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.6e-39  Score=355.61  Aligned_cols=243  Identities=24%  Similarity=0.350  Sum_probs=200.3

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccc----cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEV----NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      ++||+|+||.||+|..+ +|+.||+|++...    ......+.+|+++++.++|||||++++++.+.+..++||||+++|
T Consensus       190 ~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg  269 (576)
T 2acx_A          190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGG  269 (576)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             EEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCC
Confidence            46999999999999975 6889999999653    233566889999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--C
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--P  458 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--~  458 (615)
                      +|.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++++||+|||+++......  .
T Consensus       270 ~L~~~l~~~~---~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~~  343 (576)
T 2acx_A          270 DLKFHIYHMG---QAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK  343 (576)
T ss_dssp             BHHHHHHSSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCEE
T ss_pred             cHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccCcccc
Confidence            9999997532   235999999999999999999999998   9999999999999999999999999998775432  3


Q ss_pred             CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhh-HHHHHHHhhhcccccccccccccCCCC
Q 007167          459 PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVH-LVRWVNSVVREEWTAEVFDVELLRYPN  537 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~d~~~~~~~~  537 (615)
                      ...+|+.|+|||++.+..++.++|||||||++|||++|+.||.......... +...+..   .         .......
T Consensus       344 ~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~---~---------~~~~p~~  411 (576)
T 2acx_A          344 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE---V---------PEEYSER  411 (576)
T ss_dssp             CCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHH---C---------CCCCCTT
T ss_pred             ccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhc---c---------cccCCcc
Confidence            4568999999999998889999999999999999999999998754332211 1111111   0         0111234


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007167          538 IEEEMVEMLQVGMACVVRMPEERP-----KMADVLKM  569 (615)
Q Consensus       538 ~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  569 (615)
                      +++++.++++   +|+..||.+||     +++||++|
T Consensus       412 ~s~~~~dLI~---~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          412 FSPQARSLCS---QLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             SCHHHHHHHH---HHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             CCHHHHHHHH---HhccCCHHHcCCCCCCCHHHHHhC
Confidence            5566667666   99999999999     78898875

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.5e-39  Score=329.81  Aligned_cols=244  Identities=24%  Similarity=0.351  Sum_probs=195.5

Q ss_pred             hcCcCCccEEEEEEE---CCCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          307 VLGKGTFGTAYKAAL---EDASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~---~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .||+|+||+||+|.+   ..+..||||+++.....   .+.+.+|+++++.++||||+++++++ ..+..++||||++++
T Consensus        24 ~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~  102 (291)
T 1xbb_A           24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELG  102 (291)
T ss_dssp             EEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTE
T ss_pred             ccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCC
Confidence            699999999999964   34678999999754322   46788999999999999999999999 567789999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC--
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP--  458 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~--  458 (615)
                      +|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++........  
T Consensus       103 ~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  174 (291)
T 1xbb_A          103 PLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY  174 (291)
T ss_dssp             EHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEE
T ss_pred             CHHHHHHhC-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcc
Confidence            999999753     35899999999999999999999998   99999999999999999999999999987654321  


Q ss_pred             ----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccccccccccc
Q 007167          459 ----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELL  533 (615)
Q Consensus       459 ----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  533 (615)
                          ...++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+   ..   ..        ...
T Consensus       175 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~---~~---~~--------~~~  240 (291)
T 1xbb_A          175 KAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAML---EK---GE--------RMG  240 (291)
T ss_dssp             EC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH---HT---TC--------CCC
T ss_pred             cccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH---Hc---CC--------CCC
Confidence                1234577999999988888999999999999999999 99999875543322211   11   00        011


Q ss_pred             CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          534 RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       534 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                      ....+++++.++++   +||..||++||++.|+++.|+++-..
T Consensus       241 ~~~~~~~~l~~li~---~~l~~dp~~Rps~~~l~~~L~~~~~~  280 (291)
T 1xbb_A          241 CPAGCPREMYDLMN---LCWTYDVENRPGFAAVELRLRNYYYD  280 (291)
T ss_dssp             CCTTCCHHHHHHHH---HHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHH---HHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            12234455555555   99999999999999999999998653

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.2e-39  Score=334.38  Aligned_cols=248  Identities=20%  Similarity=0.318  Sum_probs=189.8

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEecccc-CCHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEVN-VGKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      ++||+|+||+||+|.. .+++.||||++.... ...+.+.+|++++.++ +||||+++++++.+.+..++||||+++|+|
T Consensus        19 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   98 (316)
T 2ac3_A           19 DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI   98 (316)
T ss_dssp             CCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBH
T ss_pred             ceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcH
Confidence            4699999999999985 478899999997653 3357789999999885 799999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCc---EEEeecccccccCCC---
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGH---VCVSDIGLAALMSPM---  456 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~---~kl~DfG~a~~~~~~---  456 (615)
                      .+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.   +||+|||++......   
T Consensus        99 ~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~  170 (316)
T 2ac3_A           99 LSHIHKR-----RHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDC  170 (316)
T ss_dssp             HHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC--------
T ss_pred             HHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcc
Confidence            9999753     36899999999999999999999998   999999999999998776   999999998765321   


Q ss_pred             -------CCCCCCCCcccCccccCC-----CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhh---------HHHHH
Q 007167          457 -------PPPAMRAAGYRAPEVTDT-----RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVH---------LVRWV  515 (615)
Q Consensus       457 -------~~~~~~~~~y~aPE~~~~-----~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~---------~~~~~  515 (615)
                             .....+|..|+|||++..     ..++.++|||||||++|||++|+.||......+...         .....
T Consensus       171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  250 (316)
T 2ac3_A          171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLF  250 (316)
T ss_dssp             -----------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHH
T ss_pred             ccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHH
Confidence                   112347889999999864     457899999999999999999999998754322100         00011


Q ss_pred             HHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          516 NSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       516 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ..+....     ..........+++++.++++   +|+..||++|||+.|++++
T Consensus       251 ~~i~~~~-----~~~~~~~~~~~~~~~~~li~---~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          251 ESIQEGK-----YEFPDKDWAHISCAAKDLIS---KLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHCC-----CCCCHHHHTTSCHHHHHHHH---HHSCSSTTTSCCHHHHHHS
T ss_pred             HHHhccC-----cccCchhcccCCHHHHHHHH---HHhhCChhhCCCHHHHhcC
Confidence            1111110     00000001223445555555   9999999999999999885

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-39  Score=340.75  Aligned_cols=251  Identities=20%  Similarity=0.326  Sum_probs=190.2

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecC------eeeEEee
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKD------EKLMVYD  375 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lV~e  375 (615)
                      +.||+|+||+||+|.. .+|+.||||++......   .+.+.+|+++++.++||||+++++++...+      ..++|||
T Consensus        31 ~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e  110 (367)
T 1cm8_A           31 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMP  110 (367)
T ss_dssp             EEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEE
T ss_pred             EEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEe
Confidence            5699999999999996 46889999998654322   356789999999999999999999997653      4599999


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      |+ +++|.+++..      ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus       111 ~~-~~~L~~~~~~------~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  180 (367)
T 1cm8_A          111 FM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADS  180 (367)
T ss_dssp             CC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             cC-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccccccc
Confidence            99 8899999874      25899999999999999999999998   99999999999999999999999999998776


Q ss_pred             CCCCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccc--------
Q 007167          456 MPPPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAE--------  526 (615)
Q Consensus       456 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--------  526 (615)
                      ......+|..|+|||++.+ ..++.++||||+||++|||++|+.||.+.+..+....+.-............        
T Consensus       181 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~  260 (367)
T 1cm8_A          181 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN  260 (367)
T ss_dssp             SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHH
T ss_pred             ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHH
Confidence            6566678999999999876 6789999999999999999999999986543222211111000000000000        


Q ss_pred             -------ccccccc-CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          527 -------VFDVELL-RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       527 -------~~d~~~~-~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                             ....... ..+..++++.++++   +|+..||++|||++|++++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~ll~---~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          261 YMKGLPELEKKDFASILTNASPLAVNLLE---KMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HHHHSCCCCCCCGGGTCTTCCHHHHHHHH---HHSCSSTTTSCCHHHHHHS
T ss_pred             HHHhCCCCCCCCHHHHCCCCCHHHHHHHH---HHccCChhHCCCHHHHhcC
Confidence                   0000010 12344566666666   9999999999999999985

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=9.6e-40  Score=349.49  Aligned_cols=196  Identities=21%  Similarity=0.342  Sum_probs=171.1

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCHHHHHHHHHHHhCC------CCCcccceeEEEEecCeeeEEeecC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFEQQMEIVGGI------RHENVVALRAYYYSKDEKLMVYDYF  377 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l------~h~niv~l~~~~~~~~~~~lV~e~~  377 (615)
                      .++||+|+||+||+|... +++.||||+++......+.+.+|++++..+      +|+||+++++++...+..++||||+
T Consensus       102 ~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~  181 (429)
T 3kvw_A          102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELL  181 (429)
T ss_dssp             EEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCC
T ss_pred             EEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEecc
Confidence            457999999999999865 578899999976544446677888877766      5779999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCc--EEEeecccccccCC
Q 007167          378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGH--VCVSDIGLAALMSP  455 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~--~kl~DfG~a~~~~~  455 (615)
                      . ++|.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.  +||+|||++.....
T Consensus       182 ~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~  254 (429)
T 3kvw_A          182 S-MNLYELIKKNK---FQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ  254 (429)
T ss_dssp             C-CBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred             C-CCHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccceecCC
Confidence            5 68999987543   235899999999999999999999998   999999999999999987  99999999988776


Q ss_pred             CCCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc
Q 007167          456 MPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDE  507 (615)
Q Consensus       456 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~  507 (615)
                      ......+|..|+|||++.+..++.++|||||||++|||++|+.||...+..+
T Consensus       255 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~  306 (429)
T 3kvw_A          255 RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD  306 (429)
T ss_dssp             CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence            6666778999999999998899999999999999999999999998765433

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=5.4e-41  Score=353.50  Aligned_cols=243  Identities=16%  Similarity=0.234  Sum_probs=188.7

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEeccc----cCCHHHHHHHH---HHHhCCCCCccccee-------EEEEecCe-
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEV----NVGKREFEQQM---EIVGGIRHENVVALR-------AYYYSKDE-  369 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~e~---~~l~~l~h~niv~l~-------~~~~~~~~-  369 (615)
                      +.||+|+||+||+|.. .+++.||||++...    ....+.+.+|+   ++++.++|||||+++       +++.+.+. 
T Consensus        79 ~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~  158 (377)
T 3byv_A           79 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK  158 (377)
T ss_dssp             EEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSC
T ss_pred             ceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCc
Confidence            5699999999999995 56899999999743    12246788999   556666899999998       77665532 


Q ss_pred             ----------------eeEEeecCCCCChhhhhccCCC--CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCC
Q 007167          370 ----------------KLMVYDYFEPGSVSAMLHGRRG--EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKA  431 (615)
Q Consensus       370 ----------------~~lV~e~~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~  431 (615)
                                      .++||||+ +|+|.+++.....  .....+++..+..|+.|++.||+|||+.+   |+||||||
T Consensus       159 ~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDikp  234 (377)
T 3byv_A          159 KMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRP  234 (377)
T ss_dssp             SEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCG
T ss_pred             cccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCH
Confidence                            78999999 6899999975321  11234557888999999999999999998   99999999


Q ss_pred             CCEEeCCCCcEEEeecccccccCCCCCCCCCCCcccCccccCCC-----------CCCCccchhhHHHHHHHHHhCCCCC
Q 007167          432 SNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTR-----------KATQASDVFSFGVLLLELLTGKSPI  500 (615)
Q Consensus       432 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~DvwS~Gvvl~elltg~~p~  500 (615)
                      +|||++.++.+||+|||+++..........+ ..|+|||++.+.           .++.++|||||||++|||++|+.||
T Consensus       235 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf  313 (377)
T 3byv_A          235 VDIVLDQRGGVFLTGFEHLVRDGARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI  313 (377)
T ss_dssp             GGEEECTTCCEEECCGGGCEETTCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC
T ss_pred             HHEEEcCCCCEEEEechhheecCCcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCC
Confidence            9999999999999999999876554445556 899999999877           7999999999999999999999999


Q ss_pred             CCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHH--HHHHhHh
Q 007167          501 HATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK--MVEDIRR  575 (615)
Q Consensus       501 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~--~L~~l~~  575 (615)
                      ......+....                   .....+.+++++.++++   +||+.||++|||+.|+++  .+++++.
T Consensus       314 ~~~~~~~~~~~-------------------~~~~~~~~~~~~~~li~---~~L~~dp~~Rpt~~e~l~hp~f~~~~~  368 (377)
T 3byv_A          314 TKDAALGGSEW-------------------IFRSCKNIPQPVRALLE---GFLRYPKEDRLLPLQAMETPEYEQLRT  368 (377)
T ss_dssp             ------CCSGG-------------------GGSSCCCCCHHHHHHHH---HHTCSSGGGCCCHHHHHTSHHHHHHHH
T ss_pred             cccccccchhh-------------------hhhhccCCCHHHHHHHH---HHcCCCchhCCCHHHHhhChHHHHHHH
Confidence            76543322111                   01112345566666665   999999999999999997  4444443

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=8.4e-40  Score=340.15  Aligned_cols=255  Identities=19%  Similarity=0.216  Sum_probs=190.9

Q ss_pred             hhhcCcCCccEEEEEEEC----CCCEEEEEEeccccC------------CHHHHHHHHHHHhCCCCCcccceeEEEEe--
Q 007167          305 AEVLGKGTFGTAYKAALE----DASTVVVKRLKEVNV------------GKREFEQQMEIVGGIRHENVVALRAYYYS--  366 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~----~~~~vavK~l~~~~~------------~~~~~~~e~~~l~~l~h~niv~l~~~~~~--  366 (615)
                      .+.||+|+||+||+|...    .+..||+|+......            ....+.+|+..++.++||||+++++++..  
T Consensus        42 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~  121 (345)
T 2v62_A           42 GKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEF  121 (345)
T ss_dssp             EEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEES
T ss_pred             EeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeeccccccc
Confidence            357999999999999975    567899999875421            12346678888999999999999999988  


Q ss_pred             --cCeeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCC--cE
Q 007167          367 --KDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG--HV  442 (615)
Q Consensus       367 --~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~--~~  442 (615)
                        ....++||||+ +++|.+++....     .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++  .+
T Consensus       122 ~~~~~~~lv~e~~-~~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~  192 (345)
T 2v62_A          122 KGRSYRFMVMERL-GIDLQKISGQNG-----TFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQV  192 (345)
T ss_dssp             SSCEEEEEEEECE-EEEHHHHCBGGG-----BCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTTSE
T ss_pred             CCCcEEEEEEecc-CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCCcE
Confidence              67899999999 999999997432     6999999999999999999999998   99999999999999887  99


Q ss_pred             EEeecccccccCCCC----------CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 007167          443 CVSDIGLAALMSPMP----------PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLV  512 (615)
Q Consensus       443 kl~DfG~a~~~~~~~----------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~  512 (615)
                      ||+|||+++.+....          ....+|..|+|||++.+..++.++|||||||++|||++|+.||.........  .
T Consensus       193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~--~  270 (345)
T 2v62_A          193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA--V  270 (345)
T ss_dssp             EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH--H
T ss_pred             EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH--H
Confidence            999999998764221          2335788999999999888999999999999999999999999653322211  1


Q ss_pred             HHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          513 RWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       513 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                      ................ .. .....+++++.++++   +||..||++||+++||++.|+++..
T Consensus       271 ~~~~~~~~~~~~~~~~-~~-~~~~~~~~~l~~li~---~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          271 QTAKTNLLDELPQSVL-KW-APSGSSCCEIAQFLV---CAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHHHHHHHHTTTHHHH-HH-SCTTSCCHHHHHHHH---HHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HHHHHhhcccccHHHH-hh-ccccccHHHHHHHHH---HHhhcCcccCCCHHHHHHHHhccCC
Confidence            1111111111110000 00 001134455555555   9999999999999999999988754

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.9e-40  Score=339.73  Aligned_cols=248  Identities=18%  Similarity=0.245  Sum_probs=191.4

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccc------cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecC
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEV------NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYF  377 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~------~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  377 (615)
                      .+.||+|+||+||+|.. .++..||+|++...      ....+.+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus        31 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~  110 (345)
T 3hko_A           31 KGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELC  110 (345)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             cceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCC
Confidence            56799999999999986 46778999998643      122467889999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCC-----------------------------------CCCCCCHHHHHHHHHHHHHHHHHhhccCCC
Q 007167          378 EPGSVSAMLHGRRGE-----------------------------------GQSSLDWDTRVRIAIGAARGIAHIHTENGG  422 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~-----------------------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~  422 (615)
                      ++|+|.+++......                                   ....+++..+..++.|++.||+|||+.+  
T Consensus       111 ~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--  188 (345)
T 3hko_A          111 HGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG--  188 (345)
T ss_dssp             CSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             CCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC--
Confidence            999999998521100                                   0112456778889999999999999998  


Q ss_pred             CceecCCCCCCEEeCCCC--cEEEeecccccccCCC-------CCCCCCCCcccCccccCC--CCCCCccchhhHHHHHH
Q 007167          423 KLVHGGIKASNIFLNSQG--HVCVSDIGLAALMSPM-------PPPAMRAAGYRAPEVTDT--RKATQASDVFSFGVLLL  491 (615)
Q Consensus       423 ~iiHrDik~~Nill~~~~--~~kl~DfG~a~~~~~~-------~~~~~~~~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~  491 (615)
                       |+||||||+||+++.++  .+||+|||+++.+...       .....+|..|+|||.+.+  ..++.++|||||||++|
T Consensus       189 -ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~  267 (345)
T 3hko_A          189 -ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLH  267 (345)
T ss_dssp             -EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHH
T ss_pred             -ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHH
Confidence             99999999999998776  8999999999865321       123457889999999865  67899999999999999


Q ss_pred             HHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          492 ELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       492 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ||++|+.||......+....      ......     .........+++++.++++   +|++.+|++||++.|++++
T Consensus       268 el~~g~~pf~~~~~~~~~~~------~~~~~~-----~~~~~~~~~~~~~~~~li~---~~l~~~p~~Rps~~~~l~h  331 (345)
T 3hko_A          268 LLLMGAVPFPGVNDADTISQ------VLNKKL-----CFENPNYNVLSPLARDLLS---NLLNRNVDERFDAMRALQH  331 (345)
T ss_dssp             HHHHSSCSSCCSSHHHHHHH------HHHCCC-----CTTSGGGGGSCHHHHHHHH---HHSCSCTTTSCCHHHHHHS
T ss_pred             HHHHCCCCCCCCChHHHHHH------HHhccc-----ccCCcccccCCHHHHHHHH---HHcCCChhHCCCHHHHhcC
Confidence            99999999976554332211      111110     0000111223455555555   9999999999999999985

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=4e-39  Score=351.55  Aligned_cols=246  Identities=20%  Similarity=0.339  Sum_probs=199.5

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccc----cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEV----NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      ++||+|+||+||+|..+ +++.||+|++...    ......+.+|+++++.++||||+++++++.+.+..++||||+++|
T Consensus       191 ~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg  270 (543)
T 3c4z_A          191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGG  270 (543)
T ss_dssp             EEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTC
T ss_pred             EEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCC
Confidence            46999999999999975 6889999999653    233467889999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---  457 (615)
                      +|.+++.... .....+++..+..++.|++.||+|||+.+   |+||||||+|||++.++++||+|||+++.+....   
T Consensus       271 ~L~~~l~~~~-~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~  346 (543)
T 3c4z_A          271 DIRYHIYNVD-EDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT  346 (543)
T ss_dssp             BHHHHHHTSS-TTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCB
T ss_pred             CHHHHHHHhh-cccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccCCCccc
Confidence            9999997532 22346999999999999999999999998   9999999999999999999999999998775432   


Q ss_pred             CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCC
Q 007167          458 PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN  537 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  537 (615)
                      ....+|+.|+|||++.+..++.++|||||||++|||++|+.||..........  .....+...         .....+.
T Consensus       347 ~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~--~~~~~i~~~---------~~~~p~~  415 (543)
T 3c4z_A          347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--ELKQRVLEQ---------AVTYPDK  415 (543)
T ss_dssp             CCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHH--HHHHHHHHC---------CCCCCTT
T ss_pred             ccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHH--HHHHHHhhc---------ccCCCcc
Confidence            23478999999999999899999999999999999999999998754322111  111111111         1111234


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 007167          538 IEEEMVEMLQVGMACVVRMPEERPKM-----ADVLKM  569 (615)
Q Consensus       538 ~~~~~~~l~~l~~~cl~~~P~~RPs~-----~evl~~  569 (615)
                      +++++.++++   +|+..||++||++     +|++++
T Consensus       416 ~s~~~~~li~---~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          416 FSPASKDFCE---ALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             SCHHHHHHHH---HHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             cCHHHHHHHH---HhccCCHhHCCCCcccCHHHHHcC
Confidence            5666767666   9999999999975     666653

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.3e-39  Score=330.37  Aligned_cols=250  Identities=18%  Similarity=0.271  Sum_probs=192.5

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC----HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG----KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||+||+|... +++.||+|++......    .+.+.+|+++++.++||||+++++++..++..++||||+++
T Consensus        39 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~  118 (309)
T 2h34_A           39 RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLING  118 (309)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCC
T ss_pred             EEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCC
Confidence            356999999999999965 6788999999754222    35688999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      ++|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......  
T Consensus       119 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  190 (309)
T 2h34_A          119 VDLAAMLRRQ-----GPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT  190 (309)
T ss_dssp             EEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred             CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence            9999999743     36899999999999999999999998   9999999999999999999999999997765432  


Q ss_pred             --CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCC
Q 007167          458 --PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY  535 (615)
Q Consensus       458 --~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  535 (615)
                        ....++..|+|||.+.+..++.++||||||+++|||++|+.||.......       +........     .......
T Consensus       191 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~~~~~~~~-----~~~~~~~  258 (309)
T 2h34_A          191 QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSV-------MGAHINQAI-----PRPSTVR  258 (309)
T ss_dssp             ------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHH-------HHHHHHSCC-----CCGGGTS
T ss_pred             cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHH-------HHHHhccCC-----CCccccC
Confidence              23357888999999998889999999999999999999999997643211       111111110     0011112


Q ss_pred             CCcHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHhHhhh
Q 007167          536 PNIEEEMVEMLQVGMACVVRMPEERP-KMADVLKMVEDIRRVK  577 (615)
Q Consensus       536 ~~~~~~~~~l~~l~~~cl~~~P~~RP-s~~evl~~L~~l~~~~  577 (615)
                      +.+++++.++++   +||..||++|| +++++++.|++.....
T Consensus       259 ~~~~~~l~~li~---~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          259 PGIPVAFDAVIA---RGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             TTCCTHHHHHHH---HHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             CCCCHHHHHHHH---HhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence            344555656555   99999999999 9999999999876544

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=345.71  Aligned_cols=242  Identities=19%  Similarity=0.283  Sum_probs=195.2

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEecccc----CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVN----VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      ++||+|+||+||++..+ +++.||||++++..    ...+.+.+|.+++..++||||+++++++.+.+..++||||+++|
T Consensus        67 ~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg  146 (412)
T 2vd5_A           67 KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGG  146 (412)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             EEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCC
Confidence            57999999999999975 68899999996532    12345788999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---  457 (615)
                      +|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++++||+|||+++......   
T Consensus       147 ~L~~~l~~~~----~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~  219 (412)
T 2vd5_A          147 DLLTLLSKFG----ERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVR  219 (412)
T ss_dssp             BHHHHHHHHS----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEE
T ss_pred             cHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccCCCccc
Confidence            9999997432    36899999999999999999999998   9999999999999999999999999998775432   


Q ss_pred             -CCCCCCCcccCccccC-------CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccc
Q 007167          458 -PPAMRAAGYRAPEVTD-------TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD  529 (615)
Q Consensus       458 -~~~~~~~~y~aPE~~~-------~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  529 (615)
                       ....+|+.|+|||++.       ...++.++|||||||++|||++|+.||...+..+....+.  .....         
T Consensus       220 ~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~--~~~~~---------  288 (412)
T 2vd5_A          220 SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV--HYKEH---------  288 (412)
T ss_dssp             CSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH--THHHH---------
T ss_pred             cceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHH--hcccC---------
Confidence             2346899999999986       3568999999999999999999999998754433322111  10000         


Q ss_pred             ccccC-CCCcHHHHHHHHHHHHHcccCCCCCC---CCHHHHHHH
Q 007167          530 VELLR-YPNIEEEMVEMLQVGMACVVRMPEER---PKMADVLKM  569 (615)
Q Consensus       530 ~~~~~-~~~~~~~~~~l~~l~~~cl~~~P~~R---Ps~~evl~~  569 (615)
                      ..... ...++++++++++   +|+. +|++|   |+++|+++|
T Consensus       289 ~~~p~~~~~~s~~~~dli~---~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          289 LSLPLVDEGVPEEARDFIQ---RLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             CCCC----CCCHHHHHHHH---TTSS-CGGGCTTTTTHHHHHTS
T ss_pred             cCCCccccCCCHHHHHHHH---HHcC-ChhhcCCCCCHHHHhcC
Confidence            00110 1245667777777   9998 99988   699999875

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=8e-40  Score=337.66  Aligned_cols=256  Identities=24%  Similarity=0.407  Sum_probs=197.9

Q ss_pred             hhhcCcCCccEEEEEEE-----CCCCEEEEEEeccccC-CHHHHHHHHHHHhCCCCCcccceeEEEEe--cCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAAL-----EDASTVVVKRLKEVNV-GKREFEQQMEIVGGIRHENVVALRAYYYS--KDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~  376 (615)
                      .+.||+|+||+||+|.+     .++..||||++..... ..+.+.+|++++++++||||+++++++..  ....++||||
T Consensus        28 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~  107 (327)
T 3lxl_A           28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEY  107 (327)
T ss_dssp             EEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEEC
T ss_pred             hhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEee
Confidence            35799999999999984     4678899999975432 24568999999999999999999999874  4568999999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM  456 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~  456 (615)
                      +++|+|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus       108 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  180 (327)
T 3lxl_A          108 LPSGCLRDFLQRHR----ARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLD  180 (327)
T ss_dssp             CTTCBHHHHHHHHG----GGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred             cCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence            99999999997532    25899999999999999999999998   999999999999999999999999999876533


Q ss_pred             C------CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcch--------hhHHHHHHHhhhcc
Q 007167          457 P------PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEV--------VHLVRWVNSVVREE  522 (615)
Q Consensus       457 ~------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~--------~~~~~~~~~~~~~~  522 (615)
                      .      ....++..|+|||.+.+..++.++||||||+++|||++|+.||........        ......+.......
T Consensus       181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (327)
T 3lxl_A          181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG  260 (327)
T ss_dssp             CSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTT
T ss_pred             CccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcc
Confidence            2      223456779999999888889999999999999999999999865321100        00000001111000


Q ss_pred             cccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhh
Q 007167          523 WTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVK  577 (615)
Q Consensus       523 ~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~  577 (615)
                             ......+.+++++.++++   +|++.||++|||+.|++++|+.+....
T Consensus       261 -------~~~~~~~~~~~~l~~li~---~~l~~dP~~Rps~~ell~~L~~~~~~~  305 (327)
T 3lxl_A          261 -------QRLPAPPACPAEVHELMK---LCWAPSPQDRPSFSALGPQLDMLWSGS  305 (327)
T ss_dssp             -------CCCCCCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHC----
T ss_pred             -------cCCCCCCcccHHHHHHHH---HHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence                   011112344555555555   999999999999999999999987544

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=6.3e-40  Score=340.26  Aligned_cols=244  Identities=19%  Similarity=0.313  Sum_probs=194.8

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      .+.||+|+||+||++..+ +++.||||+++....   ...+|++++.++ +||||+++++++.+.+..++||||+++|+|
T Consensus        27 ~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~---~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L  103 (342)
T 2qr7_A           27 KEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR---DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL  103 (342)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC---CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             EEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC---ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcH
Confidence            467999999999999975 578899999975432   345688888777 799999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCC----CcEEEeecccccccCCCC-
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQ----GHVCVSDIGLAALMSPMP-  457 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~----~~~kl~DfG~a~~~~~~~-  457 (615)
                      .+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||+.++    +.+||+|||+++...... 
T Consensus       104 ~~~i~~~-----~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~  175 (342)
T 2qr7_A          104 LDKILRQ-----KFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG  175 (342)
T ss_dssp             HHHHHTC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC
T ss_pred             HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC
Confidence            9999743     36899999999999999999999998   9999999999998543    359999999998764332 


Q ss_pred             --CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCC
Q 007167          458 --PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY  535 (615)
Q Consensus       458 --~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  535 (615)
                        ....+|..|+|||++.+..++.++|||||||++|||++|+.||..........+...+   ....     ++.....+
T Consensus       176 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i---~~~~-----~~~~~~~~  247 (342)
T 2qr7_A          176 LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARI---GSGK-----FSLSGGYW  247 (342)
T ss_dssp             CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHH---HHCC-----CCCCSTTT
T ss_pred             ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHH---ccCC-----cccCcccc
Confidence              3446788999999998777899999999999999999999999864433322222211   1111     11111123


Q ss_pred             CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          536 PNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       536 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                      +.+++++.++++   +|+..||++||++.|++++-
T Consensus       248 ~~~s~~~~~li~---~~L~~dP~~R~t~~~il~hp  279 (342)
T 2qr7_A          248 NSVSDTAKDLVS---KMLHVDPHQRLTAALVLRHP  279 (342)
T ss_dssp             TTSCHHHHHHHH---HHTCSSTTTSCCHHHHTTSH
T ss_pred             ccCCHHHHHHHH---HHCCCChhHCcCHHHHhcCC
Confidence            455677777766   99999999999999999863

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=4e-39  Score=350.69  Aligned_cols=242  Identities=22%  Similarity=0.364  Sum_probs=197.7

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccc---cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEV---NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~---~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .++||+|+||+||+|... +++.||||++...   ......+.+|+++++.++||||+++++++.+....++||||+++|
T Consensus        27 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~  106 (486)
T 3mwu_A           27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG  106 (486)
T ss_dssp             EEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             eEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCC
Confidence            467999999999999965 6889999998643   334677899999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeC---CCCcEEEeecccccccCCCC
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLN---SQGHVCVSDIGLAALMSPMP  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~---~~~~~kl~DfG~a~~~~~~~  457 (615)
                      +|.+.+...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++   .++.+||+|||+++......
T Consensus       107 ~L~~~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~  178 (486)
T 3mwu_A          107 ELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT  178 (486)
T ss_dssp             BHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred             cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence            999988643     36899999999999999999999998   99999999999995   45679999999998765432


Q ss_pred             --CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCC
Q 007167          458 --PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY  535 (615)
Q Consensus       458 --~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  535 (615)
                        ....+|+.|+|||++.+ .++.++||||+||++|+|++|+.||......+....+      ....     +......+
T Consensus       179 ~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i------~~~~-----~~~~~~~~  246 (486)
T 3mwu_A          179 KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRV------ETGK-----YAFDLPQW  246 (486)
T ss_dssp             ---CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHTC-----CCSCSGGG
T ss_pred             ccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCC-----CCCCCccc
Confidence              34468899999999876 5899999999999999999999999875443322221      1111     11111222


Q ss_pred             CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          536 PNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       536 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ..+++++.++++   +|+..||.+|||+.|++++
T Consensus       247 ~~~s~~~~~li~---~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          247 RTISDDAKDLIR---KMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             GGSCHHHHHHHH---HHTCSSTTTSCCHHHHHHC
T ss_pred             CCCCHHHHHHHH---HHcCCChhhCcCHHHHhcC
Confidence            344566666666   9999999999999999987

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=8e-39  Score=345.80  Aligned_cols=253  Identities=16%  Similarity=0.228  Sum_probs=199.5

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccCCHHHHHHHHHHHhCCCC-CcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVGKREFEQQMEIVGGIRH-ENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      .++||+|+||+||+|.. .+++.||||++.... ....+.+|+++++.++| +++..+..++...+..++||||+ +++|
T Consensus        12 ~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL   89 (483)
T 3sv0_A           12 GRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT-KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSL   89 (483)
T ss_dssp             CCCCEECSSCEEEEEEETTTCCEEEEEEEETTC-SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred             EEEEeeCCCEEEEEEEECCCCcEEEEEEecccc-ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCH
Confidence            35799999999999996 568899999876543 23468899999999987 45556666677788899999999 9999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEe---CCCCcEEEeecccccccCCCCC-
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFL---NSQGHVCVSDIGLAALMSPMPP-  458 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill---~~~~~~kl~DfG~a~~~~~~~~-  458 (615)
                      .+++...    ...+++..++.|+.||+.||+|||+++   |+||||||+|||+   +.++.+||+|||+++.+..... 
T Consensus        90 ~~ll~~~----~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (483)
T 3sv0_A           90 EDLFNFC----SRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH  162 (483)
T ss_dssp             HHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred             HHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence            9999743    236999999999999999999999998   9999999999999   6889999999999987654322 


Q ss_pred             ---------CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccc
Q 007167          459 ---------PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD  529 (615)
Q Consensus       459 ---------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  529 (615)
                               ...+|..|+|||++.+..++.++|||||||++|||++|+.||..............+...........   
T Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~---  239 (483)
T 3sv0_A          163 QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEA---  239 (483)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHH---
T ss_pred             cccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHH---
Confidence                     44578899999999999999999999999999999999999988665444333332222111110000   


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          530 VELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       530 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                        +  ...+++++.+++   ..||..+|++||++.+|++.|+++...
T Consensus       240 --l--~~~~p~~l~~li---~~cl~~dP~~RPs~~el~~~L~~l~~~  279 (483)
T 3sv0_A          240 --L--CRGYPTEFASYF---HYCRSLRFDDKPDYSYLKRLFRDLFIR  279 (483)
T ss_dssp             --H--HTTSCHHHHHHH---HHHHTCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             --H--hcCCcHHHHHHH---HHHhcCChhhCcCHHHHHHHHHHHHHH
Confidence              0  122334454444   499999999999999999999998653

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=4.4e-39  Score=325.17  Aligned_cols=239  Identities=19%  Similarity=0.368  Sum_probs=197.5

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccc----cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEV----NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||.||+|... ++..||+|.+...    ....+.+.+|+++++.++||||+++++++.+.+..++||||+++
T Consensus        19 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   98 (284)
T 2vgo_A           19 GRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR   98 (284)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             eheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCC
Confidence            356999999999999975 5678999998643    22356789999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC-CC
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM-PP  458 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~-~~  458 (615)
                      |+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++...... ..
T Consensus        99 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  170 (284)
T 2vgo_A           99 GELYKELQKH-----GRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR  170 (284)
T ss_dssp             EEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSSCBC
T ss_pred             CcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcccccc
Confidence            9999999743     25899999999999999999999998   999999999999999999999999998766432 23


Q ss_pred             CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCc
Q 007167          459 PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI  538 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  538 (615)
                      ...++..|+|||.+.+..++.++||||||+++|||++|+.||......+...      .....         .....+.+
T Consensus       171 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~~~~~---------~~~~~~~~  235 (284)
T 2vgo_A          171 TMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHR------RIVNV---------DLKFPPFL  235 (284)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH------HHHTT---------CCCCCTTS
T ss_pred             cccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHH------HHhcc---------ccCCCCcC
Confidence            4467889999999999889999999999999999999999997654322211      11110         11112334


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          539 EEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       539 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ++++.++++   +|++.||.+||++.|++++
T Consensus       236 ~~~~~~li~---~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          236 SDGSKDLIS---KLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             CHHHHHHHH---HHSCSSGGGSCCHHHHHTC
T ss_pred             CHHHHHHHH---HHhhcCHhhCCCHHHHhhC
Confidence            556666655   9999999999999999986

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.3e-39  Score=334.95  Aligned_cols=255  Identities=22%  Similarity=0.382  Sum_probs=197.1

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhC--CCCCcccceeEEEEecC----eeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGG--IRHENVVALRAYYYSKD----EKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~--l~h~niv~l~~~~~~~~----~~~lV~e~~~  378 (615)
                      .+.||+|+||+||+|.. +++.||||++...  ..+.+.+|.+++..  ++||||+++++++....    ..++||||++
T Consensus        47 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~--~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~  123 (342)
T 1b6c_B           47 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSR--EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHE  123 (342)
T ss_dssp             EEEEEEETTEEEEEEEE-TTEEEEEEEECGG--GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCT
T ss_pred             EeeecCCCCcEEEEEEE-cCccEEEEEeCch--hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecC
Confidence            46799999999999987 4889999999643  24567788888876  78999999999998876    7899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhh--------ccCCCCceecCCCCCCEEeCCCCcEEEeecccc
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIH--------TENGGKLVHGGIKASNIFLNSQGHVCVSDIGLA  450 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--------~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a  450 (615)
                      +|+|.+++...      .+++..+..++.|++.||+|||        +.+   |+||||||+||+++.++++||+|||++
T Consensus       124 ~g~L~~~l~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~  194 (342)
T 1b6c_B          124 HGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLA  194 (342)
T ss_dssp             TCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CCcHHHHHhcc------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEECCCc
Confidence            99999999742      5899999999999999999999        666   999999999999999999999999999


Q ss_pred             cccCCCC-------CCCCCCCcccCccccCCCC------CCCccchhhHHHHHHHHHhC----------CCCCCCCCCcc
Q 007167          451 ALMSPMP-------PPAMRAAGYRAPEVTDTRK------ATQASDVFSFGVLLLELLTG----------KSPIHATGGDE  507 (615)
Q Consensus       451 ~~~~~~~-------~~~~~~~~y~aPE~~~~~~------~~~~~DvwS~Gvvl~elltg----------~~p~~~~~~~~  507 (615)
                      .......       ....++..|+|||.+.+..      ++.++|||||||++|||++|          +.||......+
T Consensus       195 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~  274 (342)
T 1b6c_B          195 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  274 (342)
T ss_dssp             EEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCc
Confidence            7765432       3346788999999987653      33689999999999999999          78887643321


Q ss_pred             hhhHHHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhh
Q 007167          508 VVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVK  577 (615)
Q Consensus       508 ~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~  577 (615)
                      . ....+........     ..+.+.......+....+.+++.+||+.||++|||+.||+++|+++.+..
T Consensus       275 ~-~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~  338 (342)
T 1b6c_B          275 P-SVEEMRKVVCEQK-----LRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  338 (342)
T ss_dssp             C-CHHHHHHHHTTSC-----CCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             c-cHHHHHHHHHHHH-----hCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence            1 1111111111111     11111100001234455666777999999999999999999999998643

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=6.1e-39  Score=332.28  Aligned_cols=239  Identities=21%  Similarity=0.328  Sum_probs=196.1

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC----CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV----GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||.||++... +++.||+|.+.....    ..+.+.+|+++++.++||||+++++++.+.+..++||||+++
T Consensus        46 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  125 (335)
T 2owb_A           46 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR  125 (335)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCC
Confidence            356999999999999975 467899999865422    245688999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC---
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM---  456 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~---  456 (615)
                      ++|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......   
T Consensus       126 ~~L~~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  197 (335)
T 2owb_A          126 RSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER  197 (335)
T ss_dssp             CBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             CCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceecccCccc
Confidence            9999998643     36899999999999999999999998   999999999999999999999999999876532   


Q ss_pred             CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          457 PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       457 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                      .....++..|+|||.+.+..++.++||||||+++|||++|+.||......+....+      ....         .....
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~------~~~~---------~~~~~  262 (335)
T 2owb_A          198 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI------KKNE---------YSIPK  262 (335)
T ss_dssp             BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HHTC---------CCCCT
T ss_pred             ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH------hcCC---------CCCCc
Confidence            22345788999999998888999999999999999999999999764432221111      1110         11112


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+++++.++++   +||+.||++||++.|++++
T Consensus       263 ~~~~~~~~li~---~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          263 HINPVAASLIQ---KMLQTDPTARPTINELLND  292 (335)
T ss_dssp             TSCHHHHHHHH---HHTCSSGGGSCCGGGGGGS
T ss_pred             cCCHHHHHHHH---HHccCChhHCcCHHHHhcC
Confidence            34455555555   9999999999999999986

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.8e-39  Score=343.18  Aligned_cols=191  Identities=27%  Similarity=0.431  Sum_probs=155.3

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccCC---HHHHHHHHHHHhCCC-CCcccceeEEEEecC--eeeEEeecC
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVG---KREFEQQMEIVGGIR-HENVVALRAYYYSKD--EKLMVYDYF  377 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~--~~~lV~e~~  377 (615)
                      .+.||+|+||+||+|.. .+++.||||++......   .+.+.+|+.++..+. ||||+++++++...+  ..++||||+
T Consensus        14 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~   93 (388)
T 3oz6_A           14 VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM   93 (388)
T ss_dssp             EEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECC
T ss_pred             EEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEeccc
Confidence            35799999999999986 46889999998654222   345778999999997 999999999998654  689999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC-
Q 007167          378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM-  456 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~-  456 (615)
                      + |+|..++..      ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+... 
T Consensus        94 ~-~~L~~~~~~------~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  163 (388)
T 3oz6_A           94 E-TDLHAVIRA------NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR  163 (388)
T ss_dssp             S-EEHHHHHHH------TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred             C-cCHHHHHHc------CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence            7 689998864      25899999999999999999999998   999999999999999999999999999865321 


Q ss_pred             -----------------------CCCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 007167          457 -----------------------PPPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGG  505 (615)
Q Consensus       457 -----------------------~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~  505 (615)
                                             .....+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~  236 (388)
T 3oz6_A          164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSST  236 (388)
T ss_dssp             CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence                                   122357889999999876 6789999999999999999999999987553

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.9e-39  Score=340.76  Aligned_cols=265  Identities=17%  Similarity=0.236  Sum_probs=202.4

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEecccc--CCHHHHHHHHHHHhCCCCCcccceeEEEEecC--eeeEEeecCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVN--VGKREFEQQMEIVGGIRHENVVALRAYYYSKD--EKLMVYDYFEPG  380 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lV~e~~~~g  380 (615)
                      ++||+|+||+||+|... +++.||||+++...  ...+.+.+|++++++++||||+++++++...+  ..++||||+++|
T Consensus        15 ~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g   94 (396)
T 4eut_A           15 DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCG   94 (396)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTE
T ss_pred             EEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCC
Confidence            56999999999999976 48899999997542  34567889999999999999999999998765  679999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEe----CCCCcEEEeecccccccCCC
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFL----NSQGHVCVSDIGLAALMSPM  456 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill----~~~~~~kl~DfG~a~~~~~~  456 (615)
                      +|.+++.....  ...+++..+..++.|++.||+|||+.+   |+||||||+||++    +.++.+||+|||+++.....
T Consensus        95 ~L~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~  169 (396)
T 4eut_A           95 SLYTVLEEPSN--AYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD  169 (396)
T ss_dssp             EHHHHTTSGGG--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCG
T ss_pred             CHHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceEccCC
Confidence            99999975431  234999999999999999999999998   9999999999999    78888999999999877543


Q ss_pred             C--CCCCCCCcccCccccCC--------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc-hhhHH-HHHHHhhhcccc
Q 007167          457 P--PPAMRAAGYRAPEVTDT--------RKATQASDVFSFGVLLLELLTGKSPIHATGGDE-VVHLV-RWVNSVVREEWT  524 (615)
Q Consensus       457 ~--~~~~~~~~y~aPE~~~~--------~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~-~~~~~-~~~~~~~~~~~~  524 (615)
                      .  ....+|..|+|||++..        ..++.++|||||||++|||++|+.||....... ....+ ..+..... ...
T Consensus       170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~-~~~  248 (396)
T 4eut_A          170 EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS-GAI  248 (396)
T ss_dssp             GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCT-TCC
T ss_pred             CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCc-ccc
Confidence            2  34457899999998854        457789999999999999999999997644322 11211 11111111 110


Q ss_pred             ccc---------ccccccCCCC-cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          525 AEV---------FDVELLRYPN-IEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       525 ~~~---------~d~~~~~~~~-~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                      ..+         .......... .......+.+++.+|++.||++||++.|+++.++++...
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          249 SGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             EEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             hhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            000         0011111111 133334455566699999999999999999999998754

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=4.6e-39  Score=328.38  Aligned_cols=243  Identities=21%  Similarity=0.356  Sum_probs=195.4

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC-CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV-GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      .+.||+|+||+||++... +++.||+|.++.... ..+.+.+|+++++.++||||+++++++.+.+..++||||+++++|
T Consensus        14 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   93 (304)
T 2jam_A           14 MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL   93 (304)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred             eeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccH
Confidence            467999999999999965 688999999976532 345688999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEe---CCCCcEEEeecccccccCCCC-C
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFL---NSQGHVCVSDIGLAALMSPMP-P  458 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill---~~~~~~kl~DfG~a~~~~~~~-~  458 (615)
                      .+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||++   +.++.+||+|||++....... .
T Consensus        94 ~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~  165 (304)
T 2jam_A           94 FDRILER-----GVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS  165 (304)
T ss_dssp             HHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTTH
T ss_pred             HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCccc
Confidence            9998643     25899999999999999999999998   9999999999999   788999999999987654321 1


Q ss_pred             CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCc
Q 007167          459 PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI  538 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  538 (615)
                      ...++..|+|||.+.+..++.++||||+||++|||++|+.||......+...      .+....     ........+.+
T Consensus       166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~------~i~~~~-----~~~~~~~~~~~  234 (304)
T 2jam_A          166 TACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFE------KIKEGY-----YEFESPFWDDI  234 (304)
T ss_dssp             HHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHCC-----CCCCTTTTTTS
T ss_pred             cccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHH------HHHcCC-----CCCCccccccC
Confidence            2347889999999998889999999999999999999999997654322221      111111     01111112344


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          539 EEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       539 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ++++.+++.   +|+..||++|||+.|++++
T Consensus       235 ~~~~~~li~---~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          235 SESAKDFIC---HLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             CHHHHHHHH---HHHCSSTTTSCCHHHHHTS
T ss_pred             CHHHHHHHH---HHcCCChhHCcCHHHHhcC
Confidence            556666555   9999999999999999986

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.3e-39  Score=342.96  Aligned_cols=258  Identities=20%  Similarity=0.284  Sum_probs=197.5

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCHHHHHHHHHHHhCCC--------CCcccceeEEEE----ecCeee
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFEQQMEIVGGIR--------HENVVALRAYYY----SKDEKL  371 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~--------h~niv~l~~~~~----~~~~~~  371 (615)
                      .++||+|+||+||+|... +++.||||+++......+.+.+|+++++.++        |+||+++++++.    .....+
T Consensus        42 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~  121 (397)
T 1wak_A           42 IRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHIC  121 (397)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEE
T ss_pred             EEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEE
Confidence            457999999999999854 5778999999765444567889999998885        788999999998    456889


Q ss_pred             EEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc-CCCCceecCCCCCCEEeCCCC----------
Q 007167          372 MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE-NGGKLVHGGIKASNIFLNSQG----------  440 (615)
Q Consensus       372 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~iiHrDik~~Nill~~~~----------  440 (615)
                      +||||+ +++|.+.+....   ...+++..+..++.|++.||+|||++ +   |+||||||+|||++.++          
T Consensus       122 lv~e~~-~~~l~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~~~~~~~  194 (397)
T 1wak_A          122 MVFEVL-GHHLLKWIIKSN---YQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIRRLAAEA  194 (397)
T ss_dssp             EEECCC-CCBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHHHHHHHH
T ss_pred             EEEecc-CccHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhhhhhhhh
Confidence            999999 556666665322   24699999999999999999999998 7   99999999999999775          


Q ss_pred             ---------------------------------------cEEEeecccccccCCCCCCCCCCCcccCccccCCCCCCCcc
Q 007167          441 ---------------------------------------HVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTRKATQAS  481 (615)
Q Consensus       441 ---------------------------------------~~kl~DfG~a~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  481 (615)
                                                             .+||+|||++...........+|..|+|||++.+..++.++
T Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  274 (397)
T 1wak_A          195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIGSGYNTPA  274 (397)
T ss_dssp             C---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHTSCCCTHH
T ss_pred             HHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcCCCCCcHH
Confidence                                                   79999999998877666666789999999999988899999


Q ss_pred             chhhHHHHHHHHHhCCCCCCCCCCcchhhHHHH---HHHhhh---------ccccccccccc------------------
Q 007167          482 DVFSFGVLLLELLTGKSPIHATGGDEVVHLVRW---VNSVVR---------EEWTAEVFDVE------------------  531 (615)
Q Consensus       482 DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~---~~~~~~---------~~~~~~~~d~~------------------  531 (615)
                      |||||||++|||++|+.||......+.......   +.....         ..+..+.+...                  
T Consensus       275 DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (397)
T 1wak_A          275 DIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVL  354 (397)
T ss_dssp             HHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHH
T ss_pred             HHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhh
Confidence            999999999999999999987654432211111   111100         00111111000                  


Q ss_pred             ccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          532 LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       532 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .............+.+++.+||+.||++|||++|++++
T Consensus       355 ~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          355 VEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             HHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             hhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence            00111224445566777779999999999999999875

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=6.1e-39  Score=349.91  Aligned_cols=242  Identities=20%  Similarity=0.376  Sum_probs=194.1

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc---CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN---VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .+.||+|+||+||+|... ++..||+|+++...   .....+.+|+++++.++|||||++++++.+....++||||+++|
T Consensus        42 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g  121 (494)
T 3lij_A           42 VKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG  121 (494)
T ss_dssp             EEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSC
T ss_pred             eeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCC
Confidence            467999999999999975 67889999987542   23567899999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCC---CcEEEeecccccccCCCC
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQ---GHVCVSDIGLAALMSPMP  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~---~~~kl~DfG~a~~~~~~~  457 (615)
                      +|.+.+...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++..   +.+||+|||++.......
T Consensus       122 ~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~  193 (494)
T 3lij_A          122 ELFDEIIHR-----MKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK  193 (494)
T ss_dssp             BHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB
T ss_pred             cHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc
Confidence            999988643     36899999999999999999999998   9999999999999764   559999999998765432


Q ss_pred             --CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCC
Q 007167          458 --PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY  535 (615)
Q Consensus       458 --~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  535 (615)
                        ....+|+.|+|||++. ..++.++||||+||++|+|++|+.||......+....+.      ...     .......+
T Consensus       194 ~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~------~~~-----~~~~~~~~  261 (494)
T 3lij_A          194 KMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE------KGK-----YTFDSPEW  261 (494)
T ss_dssp             CBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HTC-----CCCCSGGG
T ss_pred             cccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------hCC-----CCCCchhc
Confidence              3456899999999986 468999999999999999999999998755433322221      111     11111123


Q ss_pred             CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          536 PNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       536 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      +.+++++.++++   +|+..||.+|||+.|++++
T Consensus       262 ~~~s~~~~~li~---~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          262 KNVSEGAKDLIK---QMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             TTSCHHHHHHHH---HHTCSSTTTSCCHHHHHTC
T ss_pred             ccCCHHHHHHHH---HHCCCChhhCccHHHHhcC
Confidence            345566666666   9999999999999999976

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=4e-39  Score=334.75  Aligned_cols=241  Identities=19%  Similarity=0.342  Sum_probs=188.2

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCC---HHHHHHHHHHHhCCCC--CcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVG---KREFEQQMEIVGGIRH--ENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||+||++...+++.||||++......   .+.+.+|++++..++|  +||+++++++..++..++||| +.+
T Consensus        14 ~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~   92 (343)
T 3dbq_A           14 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN   92 (343)
T ss_dssp             EEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CCS
T ss_pred             EEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CCC
Confidence            3569999999999999888999999998755333   3568899999999976  999999999999999999999 568


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      |+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++ ++.+||+|||+++......  
T Consensus        93 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~  163 (343)
T 3dbq_A           93 IDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  163 (343)
T ss_dssp             EEHHHHHHHS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred             CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence            8999999753     36899999999999999999999998   99999999999997 6789999999998765432  


Q ss_pred             ---CCCCCCCcccCccccCC-----------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccc
Q 007167          458 ---PPAMRAAGYRAPEVTDT-----------RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEW  523 (615)
Q Consensus       458 ---~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  523 (615)
                         ....+|+.|+|||++.+           ..++.++|||||||++|||++|+.||......     ...+........
T Consensus       164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~-----~~~~~~~~~~~~  238 (343)
T 3dbq_A          164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAIIDPNH  238 (343)
T ss_dssp             ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSH-----HHHHHHHHCTTS
T ss_pred             ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhH-----HHHHHHHhcCCc
Confidence               23457999999999854           66889999999999999999999999754321     111111111110


Q ss_pred             ccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          524 TAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       524 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                             ........++++.++++   +||..||++|||+.|++++-
T Consensus       239 -------~~~~~~~~~~~l~~li~---~~L~~dp~~Rpt~~e~l~hp  275 (343)
T 3dbq_A          239 -------EIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPELLAHP  275 (343)
T ss_dssp             -------CCCCCCCSCHHHHHHHH---HHTCSSTTTSCCHHHHHTSH
T ss_pred             -------ccCCcccCCHHHHHHHH---HHcCCChhHCCCHHHHHhCc
Confidence                   01111223344555555   99999999999999999874

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=9.1e-39  Score=322.43  Aligned_cols=242  Identities=22%  Similarity=0.404  Sum_probs=197.2

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEe----------------c
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYS----------------K  367 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----------------~  367 (615)
                      .+.||+|+||.||+|... +++.||+|+++..   .+.+.+|+++++.++||||+++++++..                .
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~   92 (284)
T 2a19_B           16 IELIGSGGFGQVFKAKHRIDGKTYVIKRVKYN---NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKT   92 (284)
T ss_dssp             EEEEECSSSCCEEEEEETTTCCEEEEEEEECC---SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEE
T ss_pred             eeeeccCCceEEEEEEEcCCCeEEEEEEeccc---cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCc
Confidence            467999999999999976 7899999999753   3567899999999999999999999864                3


Q ss_pred             CeeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeec
Q 007167          368 DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDI  447 (615)
Q Consensus       368 ~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Df  447 (615)
                      ...++||||+++|+|.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+||
T Consensus        93 ~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Df  166 (284)
T 2a19_B           93 KCLFIQMEFCDKGTLEQWIEKRR---GEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDF  166 (284)
T ss_dssp             EEEEEEECCCCSCBHHHHHHHGG---GSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCC
T ss_pred             ceEEEEEeccCCCCHHHHHhhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCEEECcc
Confidence            45799999999999999997542   236899999999999999999999998   999999999999999999999999


Q ss_pred             ccccccCCCC--CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccc
Q 007167          448 GLAALMSPMP--PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTA  525 (615)
Q Consensus       448 G~a~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (615)
                      |++.......  ....++..|+|||.+.+..++.++||||||+++|||++|..|+...     .   .+.......    
T Consensus       167 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~-----~---~~~~~~~~~----  234 (284)
T 2a19_B          167 GLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET-----S---KFFTDLRDG----  234 (284)
T ss_dssp             TTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH-----H---HHHHHHHTT----
T ss_pred             hhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH-----H---HHHHHhhcc----
Confidence            9998775432  3345788999999998888999999999999999999999887421     1   111111110    


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhh
Q 007167          526 EVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVK  577 (615)
Q Consensus       526 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~  577 (615)
                           .+  ...+++.+.++++   +|+..||++|||+.|++++|+.+.+..
T Consensus       235 -----~~--~~~~~~~~~~li~---~~l~~dp~~Rps~~e~l~~l~~~~~~~  276 (284)
T 2a19_B          235 -----II--SDIFDKKEKTLLQ---KLLSKKPEDRPNTSEILRTLTVWKKSP  276 (284)
T ss_dssp             -----CC--CTTSCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred             -----cc--cccCCHHHHHHHH---HHccCChhhCcCHHHHHHHHHHHhhCC
Confidence                 00  1223445555555   999999999999999999999987643

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.8e-39  Score=331.27  Aligned_cols=237  Identities=21%  Similarity=0.263  Sum_probs=183.8

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCH---HHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGK---REFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~---~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .++||+|+||+||+|... +++.||||++.......   ..+..|+..+..+ +||||+++++++.+.+..++||||+ +
T Consensus        62 ~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~  140 (311)
T 3p1a_A           62 LSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-G  140 (311)
T ss_dssp             EEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-C
T ss_pred             eheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-C
Confidence            467999999999999976 78999999987543332   2334455444444 8999999999999999999999999 7


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      ++|.+++....    ..++|..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.......  
T Consensus       141 ~~L~~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~  213 (311)
T 3p1a_A          141 PSLQQHCEAWG----ASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAG  213 (311)
T ss_dssp             CBHHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC-----
T ss_pred             CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccCCCC
Confidence            79999887532    36999999999999999999999998   9999999999999999999999999998775432  


Q ss_pred             CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCC
Q 007167          458 PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN  537 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  537 (615)
                      ....+|.+|+|||++.+ .++.++|||||||++|||++|..|+....   ...      .....     ...+..  ...
T Consensus       214 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~------~~~~~-----~~~~~~--~~~  276 (311)
T 3p1a_A          214 EVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---GWQ------QLRQG-----YLPPEF--TAG  276 (311)
T ss_dssp             -CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHH------HHTTT-----CCCHHH--HTT
T ss_pred             cccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHH------HHhcc-----CCCccc--ccC
Confidence            23457899999999876 78999999999999999999977765321   111      00000     011111  122


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          538 IEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       538 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      +++++.++++   +|++.||++|||+.|++++
T Consensus       277 ~~~~l~~li~---~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          277 LSSELRSVLV---MMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             SCHHHHHHHH---HHSCSSTTTSCCHHHHHTS
T ss_pred             CCHHHHHHHH---HHcCCChhhCcCHHHHHhC
Confidence            3445555555   9999999999999999875

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=6.2e-39  Score=336.12  Aligned_cols=242  Identities=19%  Similarity=0.355  Sum_probs=193.8

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC---------HHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEe
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG---------KREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVY  374 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---------~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  374 (615)
                      +.||+|+||.||+|... +|+.||||++......         .+.+.+|+++++++ +||||+++++++......++||
T Consensus       100 ~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~  179 (365)
T 2y7j_A          100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVF  179 (365)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEE
T ss_pred             eEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEE
Confidence            68999999999999975 7899999998654211         34577899999998 7999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccC
Q 007167          375 DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS  454 (615)
Q Consensus       375 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~  454 (615)
                      ||+++|+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++..+.
T Consensus       180 e~~~g~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~  251 (365)
T 2y7j_A          180 DLMRKGELFDYLTEK-----VALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLE  251 (365)
T ss_dssp             CCCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EeCCCCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence            999999999999743     36899999999999999999999998   9999999999999999999999999998775


Q ss_pred             CCC--CCCCCCCcccCccccCC------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccc
Q 007167          455 PMP--PPAMRAAGYRAPEVTDT------RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAE  526 (615)
Q Consensus       455 ~~~--~~~~~~~~y~aPE~~~~------~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  526 (615)
                      ...  ....+|..|+|||++.+      ..++.++|||||||++|||++|+.||......+....      +....    
T Consensus       252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~------i~~~~----  321 (365)
T 2y7j_A          252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRM------IMEGQ----  321 (365)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHHTC----
T ss_pred             CCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHH------HHhCC----
Confidence            432  34467899999998852      3578899999999999999999999976432222111      11110    


Q ss_pred             cccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          527 VFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       527 ~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                       .......+...++++.++++   +|+..||++|||+.|++++
T Consensus       322 -~~~~~~~~~~~~~~~~~li~---~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          322 -YQFSSPEWDDRSSTVKDLIS---RLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             -CCCCHHHHSSSCHHHHHHHH---HHSCSSTTTSCCHHHHHHS
T ss_pred             -CCCCCcccccCCHHHHHHHH---HHcCCChhHCcCHHHHhcC
Confidence             00000111233444555555   9999999999999999875

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.1e-39  Score=334.23  Aligned_cols=258  Identities=18%  Similarity=0.285  Sum_probs=199.2

Q ss_pred             hhhcCcCCccEEEEEEE--CCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCC------cccceeEEEEecCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAAL--EDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHE------NVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~--~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~------niv~l~~~~~~~~~~~lV~e~  376 (615)
                      .+.||+|+||+||+|..  .+++.||||+++......+.+.+|+++++.++|+      +++++++++...+..++||||
T Consensus        19 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~   98 (339)
T 1z57_A           19 VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFEL   98 (339)
T ss_dssp             EEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcC
Confidence            35699999999999986  3678899999976544456788899998888665      499999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCC------------------
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNS------------------  438 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~------------------  438 (615)
                      + +++|.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.                  
T Consensus        99 ~-~~~l~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~  171 (339)
T 1z57_A           99 L-GLSTYDFIKENG---FLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKRDERTL  171 (339)
T ss_dssp             C-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----CEEEEE
T ss_pred             C-CCCHHHHHHhcC---CCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCccccccccc
Confidence            9 889999997532   236899999999999999999999998   999999999999987                  


Q ss_pred             -CCcEEEeecccccccCCCCCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 007167          439 -QGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNS  517 (615)
Q Consensus       439 -~~~~kl~DfG~a~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  517 (615)
                       ++.+||+|||+++..........+|..|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.....
T Consensus       172 ~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  251 (339)
T 1z57_A          172 INPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILG  251 (339)
T ss_dssp             SCCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHC
T ss_pred             cCCCceEeeCcccccCccccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence             6689999999998877666666789999999999998999999999999999999999999987654443332222111


Q ss_pred             hhhccc-----ccccccccccC---------------------CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          518 VVREEW-----TAEVFDVELLR---------------------YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       518 ~~~~~~-----~~~~~d~~~~~---------------------~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ......     ....+......                     .........++.+++.+|++.||.+|||+.|++++
T Consensus       252 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  329 (339)
T 1z57_A          252 PLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKH  329 (339)
T ss_dssp             SCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             CCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcC
Confidence            100000     00000000000                     00111223455566669999999999999999875

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.1e-38  Score=332.46  Aligned_cols=257  Identities=22%  Similarity=0.306  Sum_probs=193.1

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEe--------cCeeeE
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYS--------KDEKLM  372 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~~~~~l  372 (615)
                      .+.||+|+||+||+|.. .+++.||||++.....   ....+.+|+++++.++||||+++++++..        .+..++
T Consensus        22 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~l  101 (351)
T 3mi9_A           22 LAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYL  101 (351)
T ss_dssp             EEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEE
T ss_pred             EEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEE
Confidence            35799999999999997 5788999999865422   24567899999999999999999999987        346899


Q ss_pred             EeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccc
Q 007167          373 VYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAAL  452 (615)
Q Consensus       373 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~  452 (615)
                      ||||+++ +|.+.+....    ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.
T Consensus       102 v~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  173 (351)
T 3mi9_A          102 VFDFCEH-DLAGLLSNVL----VKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARA  173 (351)
T ss_dssp             EEECCSE-EHHHHHHCTT----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEeccCC-CHHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence            9999975 7777776432    35999999999999999999999998   99999999999999999999999999987


Q ss_pred             cCCC-------CCCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccc
Q 007167          453 MSPM-------PPPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWT  524 (615)
Q Consensus       453 ~~~~-------~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  524 (615)
                      +...       .....+|..|+|||++.+ ..++.++|||||||++|||++|+.||......+....+............
T Consensus       174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  253 (351)
T 3mi9_A          174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW  253 (351)
T ss_dssp             CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence            6421       123356888999999876 45799999999999999999999999876544433333222111111111


Q ss_pred             cccccccc--------cCCCCcHHHH------HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          525 AEVFDVEL--------LRYPNIEEEM------VEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       525 ~~~~d~~~--------~~~~~~~~~~------~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ........        .......+..      ..+.+++.+|++.||++|||++|++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             TTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            11100000        0011111111      224556669999999999999999986

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=4.6e-39  Score=343.25  Aligned_cols=242  Identities=19%  Similarity=0.327  Sum_probs=184.0

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC---------CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEe
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV---------GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVY  374 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  374 (615)
                      .+.||+|+||+||+|... +++.||||++.....         ....+.+|++++++++||||+++++++. .+..++||
T Consensus       140 ~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~~~~~lv~  218 (419)
T 3i6u_A          140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-AEDYYIVL  218 (419)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-SSEEEEEE
T ss_pred             EeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCceEEEE
Confidence            467999999999999864 578999999865321         1235789999999999999999999975 45689999


Q ss_pred             ecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCC---CcEEEeeccccc
Q 007167          375 DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQ---GHVCVSDIGLAA  451 (615)
Q Consensus       375 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~---~~~kl~DfG~a~  451 (615)
                      ||+++|+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.+   +.+||+|||+++
T Consensus       219 e~~~~g~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~  290 (419)
T 3i6u_A          219 ELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK  290 (419)
T ss_dssp             ECCTTCBGGGGTSSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred             EcCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeecccce
Confidence            999999999998643     36999999999999999999999998   9999999999999754   459999999998


Q ss_pred             ccCCCC--CCCCCCCcccCccccCC---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcch-hhHHHHHHHhhhccccc
Q 007167          452 LMSPMP--PPAMRAAGYRAPEVTDT---RKATQASDVFSFGVLLLELLTGKSPIHATGGDEV-VHLVRWVNSVVREEWTA  525 (615)
Q Consensus       452 ~~~~~~--~~~~~~~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~  525 (615)
                      ......  ....+|..|+|||++.+   ..++.++|||||||++|||++|+.||........ ...+.   .    ..  
T Consensus       291 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~---~----~~--  361 (419)
T 3i6u_A          291 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT---S----GK--  361 (419)
T ss_dssp             SCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHH---T----TC--
T ss_pred             ecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHh---c----CC--
Confidence            875432  34467899999999853   5678899999999999999999999986543322 11111   0    00  


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          526 EVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       526 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                        .......++.+++++.++++   +|+..||++|||+.|++++
T Consensus       362 --~~~~~~~~~~~~~~~~~li~---~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          362 --YNFIPEVWAEVSEKALDLVK---KLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             --CCCCHHHHTTSCHHHHHHHH---HHSCSSTTTSCCHHHHHHS
T ss_pred             --CCCCchhhcccCHHHHHHHH---HHccCChhHCcCHHHHhCC
Confidence              00000011233445555555   9999999999999999885

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.8e-39  Score=351.88  Aligned_cols=242  Identities=22%  Similarity=0.395  Sum_probs=199.0

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccc----cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEV----NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .++||+|+||+||+|... +++.||||++...    ....+.+.+|+++++.++||||+++++++.+.+..++||||+.+
T Consensus        31 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~  110 (484)
T 3nyv_A           31 QRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG  110 (484)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             eeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCC
Confidence            467999999999999975 7889999998654    23467789999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEe---CCCCcEEEeecccccccCCC
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFL---NSQGHVCVSDIGLAALMSPM  456 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill---~~~~~~kl~DfG~a~~~~~~  456 (615)
                      |+|.+.+...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||+   +.++.+||+|||+++.+...
T Consensus       111 ~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  182 (484)
T 3nyv_A          111 GELFDEIISR-----KRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS  182 (484)
T ss_dssp             CBHHHHHHTC-----SCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred             CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence            9999998743     36899999999999999999999998   9999999999999   56789999999999877543


Q ss_pred             CC--CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccC
Q 007167          457 PP--PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLR  534 (615)
Q Consensus       457 ~~--~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  534 (615)
                      ..  ...+|+.|+|||++.+ .++.++||||+||++|+|++|+.||......+....+      ....     +......
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i------~~~~-----~~~~~~~  250 (484)
T 3nyv_A          183 KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKV------EKGK-----YTFELPQ  250 (484)
T ss_dssp             CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHCC-----CCCCSGG
T ss_pred             cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHH------HcCC-----CCCCCcc
Confidence            32  2357899999999866 6899999999999999999999999875543322221      1111     1111122


Q ss_pred             CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          535 YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       535 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      +..+++++.++++   +|+..+|.+|||+.|++++
T Consensus       251 ~~~~s~~~~~li~---~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          251 WKKVSESAKDLIR---KMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             GGGSCHHHHHHHH---HHTCSSGGGSCCHHHHHTS
T ss_pred             cccCCHHHHHHHH---HHCCCChhHCcCHHHHhhC
Confidence            2344566666666   9999999999999999986

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=5.6e-39  Score=351.06  Aligned_cols=242  Identities=23%  Similarity=0.388  Sum_probs=195.3

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc--------------CCHHHHHHHHHHHhCCCCCcccceeEEEEecCe
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN--------------VGKREFEQQMEIVGGIRHENVVALRAYYYSKDE  369 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--------------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~  369 (615)
                      .++||+|+||+||+|... ++..||+|+++...              ...+.+.+|+++++.++||||+++++++.+...
T Consensus        41 ~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~  120 (504)
T 3q5i_A           41 VRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY  120 (504)
T ss_dssp             EEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred             EeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence            357999999999999965 57889999987542              224678899999999999999999999999999


Q ss_pred             eeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCC---cEEEee
Q 007167          370 KLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG---HVCVSD  446 (615)
Q Consensus       370 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~---~~kl~D  446 (615)
                      .++||||+++|+|.+.+...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++   .+||+|
T Consensus       121 ~~lv~e~~~gg~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~D  192 (504)
T 3q5i_A          121 FYLVTEFYEGGELFEQIINR-----HKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIVD  192 (504)
T ss_dssp             EEEEEECCTTCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEECC
T ss_pred             EEEEEecCCCCcHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEEE
Confidence            99999999999999998643     36999999999999999999999998   99999999999998776   699999


Q ss_pred             cccccccCCCC--CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccc
Q 007167          447 IGLAALMSPMP--PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWT  524 (615)
Q Consensus       447 fG~a~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  524 (615)
                      ||++.......  ....+|+.|+|||++.+ .++.++||||+||++|+|++|+.||......+....+.      ...  
T Consensus       193 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~------~~~--  263 (504)
T 3q5i_A          193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVE------KGK--  263 (504)
T ss_dssp             CTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HCC--
T ss_pred             CCCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH------cCC--
Confidence            99998775432  34568999999999874 68999999999999999999999998755443322221      111  


Q ss_pred             cccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          525 AEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       525 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                         +......++.+++++.++++   +|+..||.+|||++|++++
T Consensus       264 ---~~~~~~~~~~~s~~~~~li~---~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          264 ---YYFDFNDWKNISDEAKELIK---LMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             ---CCCCHHHHTTSCHHHHHHHH---HHTCSSTTTSCCHHHHHTS
T ss_pred             ---CCCCccccCCCCHHHHHHHH---HHcCCChhHCCCHHHHhcC
Confidence               01111112344566666666   9999999999999999986

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=2.3e-39  Score=332.24  Aligned_cols=255  Identities=27%  Similarity=0.398  Sum_probs=200.6

Q ss_pred             hhhcCcCCccEEEEEEE------CCCCEEEEEEeccccC--CHHHHHHHHHHHhCC-CCCcccceeEEEEecC-eeeEEe
Q 007167          305 AEVLGKGTFGTAYKAAL------EDASTVVVKRLKEVNV--GKREFEQQMEIVGGI-RHENVVALRAYYYSKD-EKLMVY  374 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~-~~~lV~  374 (615)
                      .+.||+|+||+||+|..      .+++.||||+++....  ..+.+.+|++++..+ +||||+++++++...+ ..++||
T Consensus        32 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~  111 (316)
T 2xir_A           32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV  111 (316)
T ss_dssp             EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEE
T ss_pred             eeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEE
Confidence            45799999999999974      3457899999976432  235688999999999 7999999999998765 589999


Q ss_pred             ecCCCCChhhhhccCCCCC-----------CCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEE
Q 007167          375 DYFEPGSVSAMLHGRRGEG-----------QSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVC  443 (615)
Q Consensus       375 e~~~~gsL~~~l~~~~~~~-----------~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~k  443 (615)
                      ||+++|+|.+++.......           ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+|
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~k  188 (316)
T 2xir_A          112 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVK  188 (316)
T ss_dssp             ECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEE
T ss_pred             EcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEE
Confidence            9999999999997543210           123889999999999999999999998   99999999999999999999


Q ss_pred             EeecccccccCCCCC-----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHH
Q 007167          444 VSDIGLAALMSPMPP-----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNS  517 (615)
Q Consensus       444 l~DfG~a~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~  517 (615)
                      |+|||+++.......     ...++..|+|||.+.+..++.++|||||||++|||++ |+.||......+..  ...+..
T Consensus       189 l~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~--~~~~~~  266 (316)
T 2xir_A          189 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRLKE  266 (316)
T ss_dssp             ECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH--HHHHHH
T ss_pred             ECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHH--HHHhcc
Confidence            999999987654322     2234678999999988889999999999999999998 99999775533221  111111


Q ss_pred             hhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhhc
Q 007167          518 VVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKA  578 (615)
Q Consensus       518 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~  578 (615)
                          ..       ........++++.+++.   +||+.||.+|||+.|++++|+.+.+...
T Consensus       267 ----~~-------~~~~~~~~~~~l~~li~---~~l~~dp~~Rps~~ell~~L~~~~~~~~  313 (316)
T 2xir_A          267 ----GT-------RMRAPDYTTPEMYQTML---DCWHGEPSQRPTFSELVEHLGNLLQANA  313 (316)
T ss_dssp             ----TC-------CCCCCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             ----Cc-------cCCCCCCCCHHHHHHHH---HHcCCChhhCcCHHHHHHHHHHHHhhhc
Confidence                00       01111233445555544   9999999999999999999999987543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.3e-39  Score=351.67  Aligned_cols=190  Identities=21%  Similarity=0.327  Sum_probs=158.8

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEec------CeeeEEe
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSK------DEKLMVY  374 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lV~  374 (615)
                      .+.||+|+||+||+|... +++.||||++.....   ..+.+.+|+++++.++|||||++++++...      ...++||
T Consensus        67 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~  146 (464)
T 3ttj_A           67 LKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM  146 (464)
T ss_dssp             EEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEE
T ss_pred             EEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEE
Confidence            457999999999999864 578899999975422   245678999999999999999999999654      3579999


Q ss_pred             ecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccC
Q 007167          375 DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS  454 (615)
Q Consensus       375 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~  454 (615)
                      ||+++ +|.+.+..       .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       147 E~~~~-~l~~~~~~-------~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~  215 (464)
T 3ttj_A          147 ELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG  215 (464)
T ss_dssp             ECCSE-EHHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred             eCCCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence            99976 46666642       4889999999999999999999998   9999999999999999999999999998775


Q ss_pred             CC--CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 007167          455 PM--PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGG  505 (615)
Q Consensus       455 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~  505 (615)
                      ..  .....+|+.|+|||++.+..++.++||||+||++|||++|+.||.+.+.
T Consensus       216 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~  268 (464)
T 3ttj_A          216 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY  268 (464)
T ss_dssp             -CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            43  2345689999999999999999999999999999999999999987543

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=2.7e-39  Score=334.06  Aligned_cols=251  Identities=16%  Similarity=0.293  Sum_probs=184.7

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .+.||+|+||+||+|... +++.||||+++.....   .+.+.+|+++++.++||||+++++++.+.+..++||||++ |
T Consensus        39 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~  117 (329)
T 3gbz_A           39 ITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-N  117 (329)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-E
T ss_pred             EEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-C
Confidence            357999999999999854 6788999999754322   3457799999999999999999999999999999999997 5


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEe-----CCCCcEEEeecccccccCC
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFL-----NSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill-----~~~~~~kl~DfG~a~~~~~  455 (615)
                      +|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||+     +.++.+||+|||+++....
T Consensus       118 ~L~~~~~~~-----~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~  189 (329)
T 3gbz_A          118 DLKKYMDKN-----PDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI  189 (329)
T ss_dssp             EHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred             CHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence            999998743     25899999999999999999999998   9999999999999     4556699999999987653


Q ss_pred             CC---CCCCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhh---hcccccccc
Q 007167          456 MP---PPAMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVV---REEWTAEVF  528 (615)
Q Consensus       456 ~~---~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  528 (615)
                      ..   ....+|..|+|||++.+. .++.++|||||||++|||++|+.||......+...  .......   ...|.....
T Consensus       190 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  267 (329)
T 3gbz_A          190 PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLF--KIFEVLGLPDDTTWPGVTA  267 (329)
T ss_dssp             ----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH--HHHHHHCCCCTTTSTTGGG
T ss_pred             cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHH--HHHHHhCCCchhhhhhhhh
Confidence            22   234568899999998774 48999999999999999999999997654332221  1111110   000100000


Q ss_pred             ----cccccCC--C--------CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          529 ----DVELLRY--P--------NIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       529 ----d~~~~~~--~--------~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                          .......  .        ..++++.   +++.+|++.||++|||++|++++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          268 LPDWKQSFPKFRGKTLKRVLGALLDDEGL---DLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             STTCCTTCCCCCCCCHHHHHGGGSCHHHH---HHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhhhhhccccHhhhcccccCHHHH---HHHHHHccCChhhCCCHHHHhCC
Confidence                0000000  0        0234444   45559999999999999999875

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2e-39  Score=335.46  Aligned_cols=252  Identities=22%  Similarity=0.355  Sum_probs=181.9

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc-CCHHHHHHHHHHHhCCC-CCcccceeEEEEe--------cCeeeEE
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN-VGKREFEQQMEIVGGIR-HENVVALRAYYYS--------KDEKLMV  373 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--------~~~~~lV  373 (615)
                      .++||+|+||+||+|... +++.||||++.... ...+.+.+|+.++.++. ||||+++++++..        ....++|
T Consensus        33 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv  112 (337)
T 3ll6_A           33 RRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLL  112 (337)
T ss_dssp             EEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEE
T ss_pred             EEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEE
Confidence            457999999999999964 68899999986542 22456889999999996 9999999999953        3357999


Q ss_pred             eecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeeccccccc
Q 007167          374 YDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALM  453 (615)
Q Consensus       374 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~  453 (615)
                      |||+. |+|.+++....  ....+++..+..++.|++.||+|||+.+ ++|+||||||+|||++.++.+||+|||+++..
T Consensus       113 ~e~~~-g~L~~~l~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~  188 (337)
T 3ll6_A          113 TELCK-GQLVEFLKKME--SRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDFGSATTI  188 (337)
T ss_dssp             EECCS-EEHHHHHHHHH--TTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCCTTCBCC
T ss_pred             EEecC-CCHHHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecCccceec
Confidence            99995 79999886422  1236999999999999999999999874 34999999999999999999999999999876


Q ss_pred             CCCCC---------------CCCCCCcccCcccc---CCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHH
Q 007167          454 SPMPP---------------PAMRAAGYRAPEVT---DTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWV  515 (615)
Q Consensus       454 ~~~~~---------------~~~~~~~y~aPE~~---~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~  515 (615)
                      .....               ...++..|+|||++   ....++.++|||||||++|||++|+.||......+..      
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~------  262 (337)
T 3ll6_A          189 SHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIV------  262 (337)
T ss_dssp             SSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------------
T ss_pred             cccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhh------
Confidence            54221               23467889999998   5667889999999999999999999999754322111      


Q ss_pred             HHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhhcCC
Q 007167          516 NSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAEN  580 (615)
Q Consensus       516 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~~~  580 (615)
                      ...         .  .........+.+.++   +.+||+.||++|||+.|++++|+++.......
T Consensus       263 ~~~---------~--~~~~~~~~~~~~~~l---i~~~l~~~p~~Rps~~e~l~~l~~~~~~~~~~  313 (337)
T 3ll6_A          263 NGK---------Y--SIPPHDTQYTVFHSL---IRAMLQVNPEERLSIAEVVHQLQEIAAARNVN  313 (337)
T ss_dssp             ------------C--CCCTTCCSSGGGHHH---HHHHSCSSGGGSCCHHHHHHHHHHHHHHTTCC
T ss_pred             cCc---------c--cCCcccccchHHHHH---HHHHccCChhhCcCHHHHHHHHHHHHhccCCC
Confidence            000         0  001112223334444   44999999999999999999999998765433

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=9.5e-39  Score=321.14  Aligned_cols=239  Identities=20%  Similarity=0.299  Sum_probs=188.8

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccc----cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEV----NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||.||+|... +++.||||++...    ....+.+.+|+++++.++||||+++++++...+..++||||+++
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~   95 (276)
T 2h6d_A           16 GDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG   95 (276)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCS
T ss_pred             EeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCC
Confidence            356999999999999975 7889999998643    22346788999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      ++|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......  
T Consensus        96 ~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  167 (276)
T 2h6d_A           96 GELFDYICKH-----GRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL  167 (276)
T ss_dssp             CBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred             CcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCCcce
Confidence            9999999743     25899999999999999999999998   9999999999999999999999999998765432  


Q ss_pred             CCCCCCCcccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          458 PPAMRAAGYRAPEVTDTRKA-TQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                      ....++..|+|||.+.+..+ +.++||||||+++|||++|+.||......+....+      ...         ......
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~------~~~---------~~~~~~  232 (276)
T 2h6d_A          168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKI------RGG---------VFYIPE  232 (276)
T ss_dssp             ---------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHC---------CCCCCT
T ss_pred             ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHh------hcC---------cccCch
Confidence            23456888999999987665 68999999999999999999999764332221111      110         000112


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ..++++.++++   +|++.||++|||+.|++++
T Consensus       233 ~~~~~l~~li~---~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          233 YLNRSVATLLM---HMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             TSCHHHHHHHH---HHTCSSGGGSCCHHHHHHS
T ss_pred             hcCHHHHHHHH---HHccCChhhCCCHHHHHhC
Confidence            33455555555   9999999999999999986

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=1.6e-38  Score=322.78  Aligned_cols=240  Identities=21%  Similarity=0.324  Sum_probs=196.4

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC----CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV----GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||+||++... +++.||+|.+.....    ..+.+.+|+++++.++||||+++++++.+.+..++||||+++
T Consensus        20 ~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   99 (294)
T 2rku_A           20 GRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR   99 (294)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             EEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCC
Confidence            356999999999999976 467899999865422    245678899999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC---
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM---  456 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~---  456 (615)
                      ++|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......   
T Consensus       100 ~~L~~~~~~~-----~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  171 (294)
T 2rku_A          100 RSLLELHKRR-----KALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER  171 (294)
T ss_dssp             CBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceecccCccc
Confidence            9999988643     36899999999999999999999998   999999999999999999999999999876432   


Q ss_pred             CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          457 PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       457 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                      .....++..|+|||.+.+..++.++||||||+++|||++|+.||......+....      ....         ......
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~------~~~~---------~~~~~~  236 (294)
T 2rku_A          172 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLR------IKKN---------EYSIPK  236 (294)
T ss_dssp             BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH------HHTT---------CCCCCT
T ss_pred             cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH------Hhhc---------cCCCcc
Confidence            2234578899999999988899999999999999999999999976543222111      1111         111112


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                      ..++++.++++   +|+..||++|||++|++++-
T Consensus       237 ~~~~~~~~li~---~~l~~~p~~Rps~~~ll~~~  267 (294)
T 2rku_A          237 HINPVAASLIQ---KMLQTDPTARPTINELLNDE  267 (294)
T ss_dssp             TSCHHHHHHHH---HHTCSSGGGSCCGGGGGGSH
T ss_pred             ccCHHHHHHHH---HHcccChhhCcCHHHHhhCh
Confidence            34455555555   99999999999999999863

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.6e-38  Score=319.29  Aligned_cols=242  Identities=21%  Similarity=0.329  Sum_probs=195.3

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      .+.||+|+||+||+|... +++.||||++.....  ..+.+.+|+++++.++||||+++++++.+.+..++||||+++++
T Consensus        12 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   91 (276)
T 2yex_A           12 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE   91 (276)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred             EEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCc
Confidence            457999999999999975 688999999865432  24678899999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC-----
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM-----  456 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~-----  456 (615)
                      |.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||.+......     
T Consensus        92 L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  163 (276)
T 2yex_A           92 LFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  163 (276)
T ss_dssp             GGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             HHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence            99998642     36899999999999999999999998   999999999999999999999999999765321     


Q ss_pred             CCCCCCCCcccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCC
Q 007167          457 PPPAMRAAGYRAPEVTDTRKA-TQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY  535 (615)
Q Consensus       457 ~~~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  535 (615)
                      .....++..|+|||.+.+..+ +.++||||||+++|||++|+.||........ ....|.....           .....
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~~~-----------~~~~~  231 (276)
T 2yex_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKKT-----------YLNPW  231 (276)
T ss_dssp             BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHTTCT-----------TSTTG
T ss_pred             ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhhccc-----------ccCch
Confidence            233457889999999987665 7799999999999999999999987543321 1112211100           00011


Q ss_pred             CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          536 PNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       536 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ..+++.+.++++   +|+..||++|||+.|++++
T Consensus       232 ~~~~~~~~~li~---~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          232 KKIDSAPLALLH---KILVENPSARITIPDIKKD  262 (276)
T ss_dssp             GGSCHHHHHHHH---HHSCSSTTTSCCHHHHTTC
T ss_pred             hhcCHHHHHHHH---HHCCCCchhCCCHHHHhcC
Confidence            233455555555   9999999999999999875

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.2e-39  Score=337.19  Aligned_cols=253  Identities=23%  Similarity=0.343  Sum_probs=199.8

Q ss_pred             hhhcCcCCccEEEEEEECC------CCEEEEEEeccccC--CHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEee
Q 007167          305 AEVLGKGTFGTAYKAALED------ASTVVVKRLKEVNV--GKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYD  375 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e  375 (615)
                      .+.||+|+||+||+|....      ...||+|.++....  ..+.+.+|+++++.+ +||||+++++++.+.+..++|||
T Consensus        51 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e  130 (333)
T 2i1m_A           51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITE  130 (333)
T ss_dssp             EEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             eeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEe
Confidence            4679999999999998643      24799999976432  245688999999999 89999999999999999999999


Q ss_pred             cCCCCChhhhhccCCC---------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEee
Q 007167          376 YFEPGSVSAMLHGRRG---------EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSD  446 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~---------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~D  446 (615)
                      |+++|+|.+++.....         .....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|
T Consensus       131 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~D  207 (333)
T 2i1m_A          131 YCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGD  207 (333)
T ss_dssp             CCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEEEGGGEEEBCC
T ss_pred             cCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEECCCCeEEECc
Confidence            9999999999874321         01235899999999999999999999998   99999999999999999999999


Q ss_pred             cccccccCCCCC-----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhh
Q 007167          447 IGLAALMSPMPP-----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVR  520 (615)
Q Consensus       447 fG~a~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  520 (615)
                      ||++........     ...++..|+|||.+.+..++.++|||||||++|||++ |+.||......+...  ..+..   
T Consensus       208 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~--~~~~~---  282 (333)
T 2i1m_A          208 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY--KLVKD---  282 (333)
T ss_dssp             CGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH--HHHHH---
T ss_pred             cccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH--HHHhc---
Confidence            999986643221     2234668999999988889999999999999999999 999998654433211  11111   


Q ss_pred             cccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          521 EEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       521 ~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                       ..       ........++++.++++   +||+.||.+|||+.|++++|+++...
T Consensus       283 -~~-------~~~~~~~~~~~l~~li~---~~l~~~p~~Rps~~~l~~~L~~~~~~  327 (333)
T 2i1m_A          283 -GY-------QMAQPAFAPKNIYSIMQ---ACWALEPTHRPTFQQICSFLQEQAQE  327 (333)
T ss_dssp             -TC-------CCCCCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -CC-------CCCCCCCCCHHHHHHHH---HHhccChhhCcCHHHHHHHHHHHHHh
Confidence             10       00111223445555544   99999999999999999999998754

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4.3e-39  Score=332.21  Aligned_cols=253  Identities=24%  Similarity=0.355  Sum_probs=197.1

Q ss_pred             hhhcCcCCccEEEEEEE------CCCCEEEEEEecccc--CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAAL------EDASTVVVKRLKEVN--VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      .+.||+|+||+||+|..      .++..||||++....  .....+.+|+.+++.++||||+++++++...+..++||||
T Consensus        35 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  114 (327)
T 2yfx_A           35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMEL  114 (327)
T ss_dssp             EEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             EEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEec
Confidence            35699999999999983      346789999996442  2245688999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCC--CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCC---CCcEEEeeccccc
Q 007167          377 FEPGSVSAMLHGRRG--EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNS---QGHVCVSDIGLAA  451 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~--~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~---~~~~kl~DfG~a~  451 (615)
                      +++|+|.+++.....  .....+++..+..++.|++.||+|||+.+   |+||||||+||+++.   +..+||+|||++.
T Consensus       115 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~  191 (327)
T 2yfx_A          115 MAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR  191 (327)
T ss_dssp             CTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECCCHHHH
T ss_pred             CCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEECcccccc
Confidence            999999999975432  12245899999999999999999999998   999999999999994   4569999999997


Q ss_pred             ccCCCC-----CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccc
Q 007167          452 LMSPMP-----PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTA  525 (615)
Q Consensus       452 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (615)
                      ......     ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....   +.   ...   
T Consensus       192 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~---~~---~~~---  262 (327)
T 2yfx_A          192 DIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF---VT---SGG---  262 (327)
T ss_dssp             HHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH---HH---TTC---
T ss_pred             ccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHH---Hh---cCC---
Confidence            553221     22345778999999988889999999999999999998 9999976543322221   11   110   


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhh
Q 007167          526 EVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVK  577 (615)
Q Consensus       526 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~  577 (615)
                           .......+++.+.++++   +||..||.+||++.|++++|+.+....
T Consensus       263 -----~~~~~~~~~~~l~~li~---~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          263 -----RMDPPKNCPGPVYRIMT---QCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             -----CCCCCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             -----CCCCCCCCCHHHHHHHH---HHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence                 00112234455555555   999999999999999999999987633

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=5.5e-39  Score=347.08  Aligned_cols=182  Identities=23%  Similarity=0.350  Sum_probs=146.4

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEec-----CeeeEEee
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSK-----DEKLMVYD  375 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lV~e  375 (615)
                      .++||+|+||+||+|... +++.||||++......   .+.+.+|+++++.++|||||++++++...     ...++|||
T Consensus        58 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e  137 (458)
T 3rp9_A           58 RHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLE  137 (458)
T ss_dssp             CCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEC
T ss_pred             eeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEe
Confidence            457999999999999855 6889999999754322   35688999999999999999999999543     56899999


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      |+ +|+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       138 ~~-~~~L~~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~  208 (458)
T 3rp9_A          138 IA-DSDFKKLFRTP-----VYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVDY  208 (458)
T ss_dssp             CC-SEEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTTS
T ss_pred             cc-ccchhhhcccC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhccC
Confidence            98 57899998642     36999999999999999999999998   99999999999999999999999999987642


Q ss_pred             CC------------------------------CCCCCCCcccCcccc-CCCCCCCccchhhHHHHHHHHHh
Q 007167          456 MP------------------------------PPAMRAAGYRAPEVT-DTRKATQASDVFSFGVLLLELLT  495 (615)
Q Consensus       456 ~~------------------------------~~~~~~~~y~aPE~~-~~~~~~~~~DvwS~Gvvl~ellt  495 (615)
                      ..                              ....+|+.|+|||++ ....++.++|||||||++|||++
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          209 PENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             CTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             ccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence            21                              223568889999976 55679999999999999999999

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=3.9e-39  Score=333.13  Aligned_cols=254  Identities=23%  Similarity=0.399  Sum_probs=192.0

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .++||+|+||+||+|... +++.||||++......   .+.+.+|+++++.++||||+++++++.+.+..++||||++++
T Consensus        30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~  109 (331)
T 4aaa_A           30 LGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHT  109 (331)
T ss_dssp             EEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEE
T ss_pred             eeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcc
Confidence            357999999999999975 4889999998655433   345778999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---  457 (615)
                      +|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++......   
T Consensus       110 ~l~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  181 (331)
T 4aaa_A          110 ILDDLELFP-----NGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY  181 (331)
T ss_dssp             HHHHHHHST-----TCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred             hHHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCcccc
Confidence            998887532     35999999999999999999999998   9999999999999999999999999998764322   


Q ss_pred             CCCCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHH-HHHHh--------hhccccccc
Q 007167          458 PPAMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVR-WVNSV--------VREEWTAEV  527 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~-~~~~~--------~~~~~~~~~  527 (615)
                      ....++..|+|||.+.+. .++.++||||+||++|||++|+.||......+....+. .....        .........
T Consensus       182 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (331)
T 4aaa_A          182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV  261 (331)
T ss_dssp             --CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTC
T ss_pred             CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccc
Confidence            334578899999998775 68999999999999999999999998755433221111 00000        000000000


Q ss_pred             cccccc-------CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          528 FDVELL-------RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       528 ~d~~~~-------~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ..+...       ..+.+++++.++++   +||+.||++|||+.|++++
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~l~~li~---~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          262 RLPEIKEREPLERRYPKLSEVVIDLAK---KCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             CCCCCSSCCCHHHHSTTSCHHHHHHHH---HHTCSSGGGSCCGGGGGGS
T ss_pred             cCccccccchhhhcccchhHHHHHHHH---HHhccCcccCCCHHHHhcC
Confidence            001110       12234455555555   9999999999999999875

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4.8e-39  Score=330.13  Aligned_cols=250  Identities=22%  Similarity=0.387  Sum_probs=194.5

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEecccc-CCHHHHHHHHHHHhCCCCCcccceeEEEEe----cCeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVN-VGKREFEQQMEIVGGIRHENVVALRAYYYS----KDEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lV~e~~~  378 (615)
                      .+.||+|+||.||++.. .+++.||||++.... ...+.+.+|+++++.++||||+++++++..    ....++||||++
T Consensus        34 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~  113 (317)
T 2buj_A           34 IQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFK  113 (317)
T ss_dssp             EEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCT
T ss_pred             EEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCC
Confidence            45799999999999996 578899999886532 234678899999999999999999999973    347899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP  458 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~  458 (615)
                      +|+|.+++..... ....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++........
T Consensus       114 ~~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~  189 (317)
T 2buj_A          114 RGTLWNEIERLKD-KGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVE  189 (317)
T ss_dssp             TCBHHHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEESCEEEE
T ss_pred             CCcHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhcccccc
Confidence            9999999975321 2347999999999999999999999998   99999999999999999999999999876542111


Q ss_pred             ------------CCCCCCcccCccccCCCC---CCCccchhhHHHHHHHHHhCCCCCCCCC--CcchhhHHHHHHHhhhc
Q 007167          459 ------------PAMRAAGYRAPEVTDTRK---ATQASDVFSFGVLLLELLTGKSPIHATG--GDEVVHLVRWVNSVVRE  521 (615)
Q Consensus       459 ------------~~~~~~~y~aPE~~~~~~---~~~~~DvwS~Gvvl~elltg~~p~~~~~--~~~~~~~~~~~~~~~~~  521 (615)
                                  ...++..|+|||.+....   ++.++|||||||++|||++|+.||....  .......   ..    .
T Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~---~~----~  262 (317)
T 2buj_A          190 GSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA---VQ----N  262 (317)
T ss_dssp             SHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHH---HH----C
T ss_pred             cccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHH---hh----c
Confidence                        123578899999987654   6889999999999999999999996421  1111110   00    0


Q ss_pred             ccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          522 EWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       522 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                             .......+..++++.++++   +||+.||.+|||+.|++++|+.+..
T Consensus       263 -------~~~~~~~~~~~~~l~~li~---~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          263 -------QLSIPQSPRHSSALWQLLN---SMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             -------C--CCCCTTSCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             -------cCCCCccccCCHHHHHHHH---HHhhcChhhCCCHHHHHHHhhhcCC
Confidence                   0011112334455555555   9999999999999999999998864

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=5.2e-39  Score=336.12  Aligned_cols=192  Identities=20%  Similarity=0.378  Sum_probs=168.1

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      +.||+|+||+||+|... ++..||+|++.....  ..+.+.+|+++++.++||||+++++++.+++..++||||+++|+|
T Consensus        39 ~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L  118 (360)
T 3eqc_A           39 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL  118 (360)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBH
T ss_pred             eeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCH
Confidence            46999999999999975 678899999875422  245688999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc-CCCCceecCCCCCCEEeCCCCcEEEeecccccccCC-CCCCC
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE-NGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP-MPPPA  460 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~-~~~~~  460 (615)
                      .+++...     ..+++..+..++.+++.||+|||+. +   |+||||||+||+++.++.+||+|||++..... .....
T Consensus       119 ~~~l~~~-----~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  190 (360)
T 3eqc_A          119 DQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF  190 (360)
T ss_dssp             HHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC----
T ss_pred             HHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccccccCC
Confidence            9999753     2589999999999999999999986 6   99999999999999999999999999875532 22344


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCC
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGG  505 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~  505 (615)
                      .++..|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       191 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  235 (360)
T 3eqc_A          191 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA  235 (360)
T ss_dssp             CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH
T ss_pred             CCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            678999999999998999999999999999999999999986543

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=9.2e-39  Score=359.70  Aligned_cols=239  Identities=21%  Similarity=0.326  Sum_probs=197.8

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccc----cCCHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEV----NVGKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      .++||+|+||+||+|... +++.||||+++..    ....+.+..|.+++..+ +||||+++++++.+.+..++||||++
T Consensus       346 ~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~  425 (674)
T 3pfq_A          346 LMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVN  425 (674)
T ss_dssp             EEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCC
T ss_pred             EEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcC
Confidence            357999999999999965 5778999999753    23345678899999988 79999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC---
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP---  455 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~---  455 (615)
                      +|+|.++++..     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++++||+|||+++....   
T Consensus       426 gg~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~  497 (674)
T 3pfq_A          426 GGDLMYHIQQV-----GRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV  497 (674)
T ss_dssp             SCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC
T ss_pred             CCcHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccCCc
Confidence            99999999753     36999999999999999999999998   99999999999999999999999999986432   


Q ss_pred             CCCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCC
Q 007167          456 MPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY  535 (615)
Q Consensus       456 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  535 (615)
                      ......+|+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+      ...         .....
T Consensus       498 ~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i------~~~---------~~~~p  562 (674)
T 3pfq_A          498 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI------MEH---------NVAYP  562 (674)
T ss_dssp             CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HSS---------CCCCC
T ss_pred             ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHH------HhC---------CCCCC
Confidence            223456899999999999999999999999999999999999999875443332211      111         11122


Q ss_pred             CCcHHHHHHHHHHHHHcccCCCCCCCCH-----HHHHHH
Q 007167          536 PNIEEEMVEMLQVGMACVVRMPEERPKM-----ADVLKM  569 (615)
Q Consensus       536 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~-----~evl~~  569 (615)
                      ..+++++.++++   +|+..||++||++     +||+++
T Consensus       563 ~~~s~~~~~li~---~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          563 KSMSKEAVAICK---GLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             TTSCHHHHHHHH---HHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             ccCCHHHHHHHH---HHccCCHHHCCCCCCCcHHHHhcC
Confidence            345667777766   9999999999998     777664

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.2e-38  Score=336.87  Aligned_cols=241  Identities=19%  Similarity=0.342  Sum_probs=188.9

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCC---HHHHHHHHHHHhCCC--CCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVG---KREFEQQMEIVGGIR--HENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||+||++...+++.||||++......   .+.+.+|+++++.++  ||||+++++++...+..++||| +.+
T Consensus        61 ~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~  139 (390)
T 2zmd_A           61 LKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGN  139 (390)
T ss_dssp             EEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCS
T ss_pred             EEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCC
Confidence            4579999999999999888999999998754332   356889999999996  5999999999999999999999 568


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      ++|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++ ++.+||+|||+++.+....  
T Consensus       140 ~~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~  210 (390)
T 2zmd_A          140 IDLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  210 (390)
T ss_dssp             EEHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred             CCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence            8999999753     26889999999999999999999998   99999999999996 5889999999998765322  


Q ss_pred             ---CCCCCCCcccCccccCC-----------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccc
Q 007167          458 ---PPAMRAAGYRAPEVTDT-----------RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEW  523 (615)
Q Consensus       458 ---~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  523 (615)
                         ....+|+.|+|||++.+           ..++.++|||||||++|||++|+.||......     ...+........
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-----~~~~~~~~~~~~  285 (390)
T 2zmd_A          211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQ-----ISKLHAIIDPNH  285 (390)
T ss_dssp             ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCH-----HHHHHHHHCTTS
T ss_pred             ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHH-----HHHHHHHhCccc
Confidence               24468999999999854           36889999999999999999999999754321     111111111110


Q ss_pred             ccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          524 TAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       524 ~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                             ........++++.++++   +||..||++|||+.|++++-
T Consensus       286 -------~~~~~~~~~~~~~~li~---~~L~~dP~~Rps~~ell~hp  322 (390)
T 2zmd_A          286 -------EIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPELLAHP  322 (390)
T ss_dssp             -------CCCCCCCSCHHHHHHHH---HHTCSSTTTSCCHHHHHTSH
T ss_pred             -------cCCCCccchHHHHHHHH---HHcccChhhCCCHHHHhhCc
Confidence                   00111122344555554   99999999999999999863

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.5e-39  Score=333.07  Aligned_cols=251  Identities=21%  Similarity=0.363  Sum_probs=200.3

Q ss_pred             hhhcCcCCccEEEEEEEC------CCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAALE------DASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      .+.||+|+||+||+|...      .+..||||.+.....  ....+.+|+++++.++||||+++++++.+.+..++||||
T Consensus        30 ~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~  109 (322)
T 1p4o_A           30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL  109 (322)
T ss_dssp             EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             eeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEe
Confidence            457999999999999854      367899999975432  234688999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCC-----CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeeccccc
Q 007167          377 FEPGSVSAMLHGRRG-----EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAA  451 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~-----~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~  451 (615)
                      +++|+|.+++.....     .....+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||+++
T Consensus       110 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~~kl~Dfg~~~  186 (322)
T 1p4o_A          110 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR  186 (322)
T ss_dssp             CTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCC
T ss_pred             CCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCeEEECcCcccc
Confidence            999999999974321     11245799999999999999999999998   9999999999999999999999999997


Q ss_pred             ccCCCC-----CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccc
Q 007167          452 LMSPMP-----PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTA  525 (615)
Q Consensus       452 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (615)
                      ......     ....++..|+|||.+.+..++.++||||||+++|||++ |+.||......+....+      .....  
T Consensus       187 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~------~~~~~--  258 (322)
T 1p4o_A          187 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV------MEGGL--  258 (322)
T ss_dssp             GGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH------HTTCC--
T ss_pred             ccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH------HcCCc--
Confidence            654322     12234678999999988889999999999999999999 89999765433222111      11100  


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          526 EVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       526 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                            .......++++.++++   +|+..+|.+|||+.|++++|+++..
T Consensus       259 ------~~~~~~~~~~l~~li~---~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          259 ------LDKPDNCPDMLFELMR---MCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             ------CCCCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             ------CCCCCCCCHHHHHHHH---HHcCCCcccCcCHHHHHHHHHHhhc
Confidence                  0112234455555555   9999999999999999999988754

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-39  Score=337.00  Aligned_cols=244  Identities=21%  Similarity=0.342  Sum_probs=194.4

Q ss_pred             hhhcCcCCccEEEEEEE----CCCCEEEEEEecccc-----CCHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEe
Q 007167          305 AEVLGKGTFGTAYKAAL----EDASTVVVKRLKEVN-----VGKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVY  374 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~~-----~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  374 (615)
                      .++||+|+||+||++..    .+++.||||+++...     ...+.+.+|++++..+ +||||+++++++...+..++||
T Consensus        59 ~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~  138 (355)
T 1vzo_A           59 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL  138 (355)
T ss_dssp             EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEE
T ss_pred             EEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEe
Confidence            45799999999999987    468899999987532     2345677899999999 6999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccC
Q 007167          375 DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS  454 (615)
Q Consensus       375 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~  454 (615)
                      ||+++|+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       139 e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  210 (355)
T 1vzo_A          139 DYINGGELFTHLSQR-----ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFV  210 (355)
T ss_dssp             CCCCSCBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             ecCCCCCHHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence            999999999999743     26899999999999999999999998   9999999999999999999999999998664


Q ss_pred             CC----CCCCCCCCcccCccccCC--CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccc
Q 007167          455 PM----PPPAMRAAGYRAPEVTDT--RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVF  528 (615)
Q Consensus       455 ~~----~~~~~~~~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  528 (615)
                      ..    .....+|..|+|||++.+  ..++.++|||||||++|||++|+.||..........  .+.......       
T Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~--~~~~~~~~~-------  281 (355)
T 1vzo_A          211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA--EISRRILKS-------  281 (355)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH--HHHHHHHHC-------
T ss_pred             cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHH--HHHHHHhcc-------
Confidence            32    123457899999999975  347899999999999999999999998654332221  111111111       


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHHH
Q 007167          529 DVELLRYPNIEEEMVEMLQVGMACVVRMPEERP-----KMADVLKMV  570 (615)
Q Consensus       529 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~L  570 (615)
                        .....+.+++.+.++++   +||..||++||     +++|++++.
T Consensus       282 --~~~~~~~~~~~~~~li~---~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          282 --EPPYPQEMSALAKDLIQ---RLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             --CCCCCTTSCHHHHHHHH---HHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             --CCCCCcccCHHHHHHHH---HHhhhCHHHhcCCCCCCHHHHHcCc
Confidence              11112334455555555   99999999999     999998874

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.2e-39  Score=339.44  Aligned_cols=252  Identities=21%  Similarity=0.314  Sum_probs=175.6

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEec------CeeeEEe
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSK------DEKLMVY  374 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lV~  374 (615)
                      .+.||+|+||+||+|.. .+|+.||||++......   .+.+.+|+++++.++||||+++++++...      ...++|+
T Consensus        34 ~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~  113 (367)
T 2fst_X           34 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT  113 (367)
T ss_dssp             EEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEE
T ss_pred             eeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEe
Confidence            35799999999999985 46788999998654322   45678999999999999999999999754      5679999


Q ss_pred             ecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccC
Q 007167          375 DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS  454 (615)
Q Consensus       375 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~  454 (615)
                      ||+ +++|.+++..      ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus       114 e~~-~~~L~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~  183 (367)
T 2fst_X          114 HLM-GADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTA  183 (367)
T ss_dssp             ECC-CEECC-----------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC--------
T ss_pred             ccc-CCCHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence            999 7899998863      35999999999999999999999998   9999999999999999999999999998876


Q ss_pred             CCCCCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccc----
Q 007167          455 PMPPPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD----  529 (615)
Q Consensus       455 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d----  529 (615)
                      .......+|..|+|||++.+ ..++.++||||+||++|||++|+.||.+.+..+....+.-+...........+..    
T Consensus       184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~  263 (367)
T 2fst_X          184 DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR  263 (367)
T ss_dssp             -------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHH
T ss_pred             ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHH
Confidence            65555678999999999876 6789999999999999999999999987543322221111100000000000000    


Q ss_pred             ---cccc---------CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          530 ---VELL---------RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       530 ---~~~~---------~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                         ..+.         ..+..++++.++++   +|+..||++|||+.|++++
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~---~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          264 NYIQSLTQMPKMNFANVFIGANPLAVDLLE---KMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHHHTSCCCCCCCHHHHTTTCCHHHHHHHH---HHSCSSGGGSCCHHHHHTS
T ss_pred             HHHhccCCCCCCCHHHHCCCCCHHHHHHHH---HhCCCCcccCcCHHHHhcC
Confidence               0000         01233445555555   9999999999999999986

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1e-38  Score=329.19  Aligned_cols=255  Identities=24%  Similarity=0.415  Sum_probs=198.4

Q ss_pred             hhhcCcCCccEEEEEEE-----CCCCEEEEEEeccccC-CHHHHHHHHHHHhCCCCCcccceeEEEEecC--eeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAAL-----EDASTVVVKRLKEVNV-GKREFEQQMEIVGGIRHENVVALRAYYYSKD--EKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-----~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~--~~~lV~e~  376 (615)
                      .+.||+|+||.||++..     .+++.||||++..... ..+.+.+|+++++.++||||+++++++...+  ..++||||
T Consensus        46 ~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~  125 (326)
T 2w1i_A           46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEY  125 (326)
T ss_dssp             EEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECC
T ss_pred             eeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEEC
Confidence            35799999999999984     3678899999976432 2457899999999999999999999987654  78999999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM  456 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~  456 (615)
                      +++|+|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus       126 ~~~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~  198 (326)
T 2w1i_A          126 LPYGSLRDYLQKHK----ERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQD  198 (326)
T ss_dssp             CTTCBHHHHHHHST----TSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCSS
T ss_pred             CCCCCHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhcccc
Confidence            99999999997532    35899999999999999999999998   999999999999999999999999999877543


Q ss_pred             C------CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc---------chhhHHHHHHHhhhc
Q 007167          457 P------PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGD---------EVVHLVRWVNSVVRE  521 (615)
Q Consensus       457 ~------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~---------~~~~~~~~~~~~~~~  521 (615)
                      .      ....++..|+|||.+.+..++.++||||||+++|||++|+.||......         ........+......
T Consensus       199 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (326)
T 2w1i_A          199 KEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKN  278 (326)
T ss_dssp             CSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHT
T ss_pred             ccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhc
Confidence            2      1233566799999998888899999999999999999999998642100         000000011111111


Q ss_pred             ccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          522 EWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       522 ~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                      .       ........+++++.++++   +||+.||++|||+.|+++.|+++++.
T Consensus       279 ~-------~~~~~~~~~~~~l~~li~---~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          279 N-------GRLPRPDGCPDEIYMIMT---ECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             T-------CCCCCCTTCCHHHHHHHH---HHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             C-------CCCCCCCcccHHHHHHHH---HHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            0       011112344455555555   99999999999999999999999864

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=1.6e-38  Score=324.21  Aligned_cols=241  Identities=23%  Similarity=0.387  Sum_probs=198.3

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc--CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN--VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      .+.||+|+||+||+|... +++.||+|++....  ...+.+.+|+++++.++||||+++++++.+....++||||+++++
T Consensus        27 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~  106 (303)
T 3a7i_A           27 LEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGS  106 (303)
T ss_dssp             EEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred             hhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCc
Confidence            356999999999999864 68899999987542  335778999999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---C
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---P  458 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~  458 (615)
                      |.+++..      ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.......   .
T Consensus       107 L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  177 (303)
T 3a7i_A          107 ALDLLEP------GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN  177 (303)
T ss_dssp             HHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBC
T ss_pred             HHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccccccC
Confidence            9999863      36899999999999999999999998   9999999999999999999999999998765432   2


Q ss_pred             CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCc
Q 007167          459 PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI  538 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  538 (615)
                      ...++..|+|||.+.+..++.++||||||+++|||++|+.||......+....   +.   ... .     +.  ....+
T Consensus       178 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~---~~---~~~-~-----~~--~~~~~  243 (303)
T 3a7i_A          178 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFL---IP---KNN-P-----PT--LEGNY  243 (303)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH---HH---HSC-C-----CC--CCSSC
T ss_pred             ccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHH---hh---cCC-C-----CC--Ccccc
Confidence            34578889999999988899999999999999999999999976543222111   11   100 0     00  11234


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 007167          539 EEEMVEMLQVGMACVVRMPEERPKMADVLKMVE  571 (615)
Q Consensus       539 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  571 (615)
                      ++.+.++++   +||..+|++|||+.|++++.-
T Consensus       244 ~~~l~~li~---~~l~~dp~~Rps~~~ll~~~~  273 (303)
T 3a7i_A          244 SKPLKEFVE---ACLNKEPSFRPTAKELLKHKF  273 (303)
T ss_dssp             CHHHHHHHH---HHCCSSGGGSCCHHHHTTCHH
T ss_pred             CHHHHHHHH---HHcCCChhhCcCHHHHhhChh
Confidence            455555555   999999999999999998754

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.1e-39  Score=342.64  Aligned_cols=247  Identities=11%  Similarity=0.086  Sum_probs=177.3

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC----HHHHHHH---HHHHhCCCCCccccee-------EEEEec--
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG----KREFEQQ---MEIVGGIRHENVVALR-------AYYYSK--  367 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e---~~~l~~l~h~niv~l~-------~~~~~~--  367 (615)
                      .+.||+|+||+||+|.+. +++.||||+++.....    .+.+.+|   +++++. +||||++++       +++...  
T Consensus        67 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~~~  145 (371)
T 3q60_A           67 VEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQSQ  145 (371)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEETTS
T ss_pred             eeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecCCC
Confidence            357999999999999965 7889999999875432    3456677   456666 799988754       555443  


Q ss_pred             ---------------CeeeEEeecCCCCChhhhhccCCCCCCCCCCHHHH------HHHHHHHHHHHHHhhccCCCCcee
Q 007167          368 ---------------DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTR------VRIAIGAARGIAHIHTENGGKLVH  426 (615)
Q Consensus       368 ---------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~------~~i~~~ia~~l~~LH~~~~~~iiH  426 (615)
                                     ...++||||++ |+|.+++....    ..+.+..+      ..++.|++.||+|||+++   |+|
T Consensus       146 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~----~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---ivH  217 (371)
T 3q60_A          146 PPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD----FVYVFRGDEGILALHILTAQLIRLAANLQSKG---LVH  217 (371)
T ss_dssp             CSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH----HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EEE
T ss_pred             CCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc----cccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Ccc
Confidence                           23799999998 89999997532    13455555      778899999999999998   999


Q ss_pred             cCCCCCCEEeCCCCcEEEeecccccccCCCCCCCCCCCcccCccccCC--CCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 007167          427 GGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDT--RKATQASDVFSFGVLLLELLTGKSPIHATG  504 (615)
Q Consensus       427 rDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltg~~p~~~~~  504 (615)
                      |||||+|||++.++.+||+|||+++..........+|..|+|||++.+  ..++.++|||||||++|||++|+.||....
T Consensus       218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~  297 (371)
T 3q60_A          218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT  297 (371)
T ss_dssp             TTCSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred             CcCCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence            999999999999999999999999877654434456789999999987  678999999999999999999999998754


Q ss_pred             CcchhhHHHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          505 GDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       505 ~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .........   ...   .............+.+++++.++++   +||+.||++|||+.|++++
T Consensus       298 ~~~~~~~~~---~~~---~~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          298 PGIKGSWKR---PSL---RVPGTDSLAFGSCTPLPDFVKTLIG---RFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             TTCTTCCCB---CCT---TSCCCCSCCCTTSSCCCHHHHHHHH---HHTCSSTTTCCCHHHHTTS
T ss_pred             cccccchhh---hhh---hhccccccchhhccCCCHHHHHHHH---HHcCCChhhCCCHHHHhcC
Confidence            322110000   000   0000001111122355666666666   9999999999999999863

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=1.5e-38  Score=322.76  Aligned_cols=244  Identities=23%  Similarity=0.386  Sum_probs=193.2

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEeccccC-CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNV-GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      .+||+|+||+||+|.. .++..||||.+..... ..+.+.+|+++++.++||||+++++++...+..++||||+++++|.
T Consensus        28 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~  107 (295)
T 2clq_A           28 VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLS  107 (295)
T ss_dssp             CEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHH
T ss_pred             EEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHH
Confidence            3699999999999996 4678899999876532 3567899999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCC-CCcEEEeecccccccCCC---CCC
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNS-QGHVCVSDIGLAALMSPM---PPP  459 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~-~~~~kl~DfG~a~~~~~~---~~~  459 (615)
                      +++....  ....+++..+..++.|++.||+|||+.+   |+||||||+||+++. ++.+||+|||++......   ...
T Consensus       108 ~~l~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~  182 (295)
T 2clq_A          108 ALLRSKW--GPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET  182 (295)
T ss_dssp             HHHHHTT--CCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CC
T ss_pred             HHHHhhc--cCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccc
Confidence            9997542  2345788999999999999999999998   999999999999987 899999999999876532   233


Q ss_pred             CCCCCcccCccccCCC--CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCC
Q 007167          460 AMRAAGYRAPEVTDTR--KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN  537 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~--~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~  537 (615)
                      ..++..|+|||.+...  .++.++||||||+++|||++|+.||......+.. ... . ...  .     ..+.  ....
T Consensus       183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~-~~~-~-~~~--~-----~~~~--~~~~  250 (295)
T 2clq_A          183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAA-MFK-V-GMF--K-----VHPE--IPES  250 (295)
T ss_dssp             CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHH-HHH-H-HHH--C-----CCCC--CCTT
T ss_pred             cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHH-HHh-h-ccc--c-----cccc--cccc
Confidence            4578899999998654  3789999999999999999999999754332211 110 0 000  0     0011  1223


Q ss_pred             cHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          538 IEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       538 ~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .++++.++++   +||..||++||++.|++++
T Consensus       251 ~~~~~~~li~---~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          251 MSAEAKAFIL---KCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             SCHHHHHHHH---HTTCSSTTTSCCHHHHHTS
T ss_pred             CCHHHHHHHH---HHccCChhhCCCHHHHhcC
Confidence            4555555555   9999999999999999875

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=7.7e-39  Score=336.25  Aligned_cols=251  Identities=20%  Similarity=0.317  Sum_probs=189.1

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecCee------eEEe
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKDEK------LMVY  374 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~------~lV~  374 (615)
                      .+.||+|+||+||+|... +++.||||++......   .+.+.+|+++++.++||||+++++++...+..      ++||
T Consensus        47 ~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~  126 (371)
T 4exu_A           47 PTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVM  126 (371)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEE
T ss_pred             EeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEE
Confidence            356999999999999865 6889999999764333   35678999999999999999999999877654      9999


Q ss_pred             ecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccC
Q 007167          375 DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS  454 (615)
Q Consensus       375 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~  454 (615)
                      ||+. ++|.+.+..       .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++...
T Consensus       127 e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~  195 (371)
T 4exu_A          127 PFMQ-TDLQKIMGM-------EFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHAD  195 (371)
T ss_dssp             ECCC-EEHHHHTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred             cccc-ccHHHHhhc-------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence            9997 688887742       4899999999999999999999998   9999999999999999999999999998877


Q ss_pred             CCCCCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccc----
Q 007167          455 PMPPPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD----  529 (615)
Q Consensus       455 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d----  529 (615)
                      .......+|..|+|||.+.+ ..++.++|||||||++|||++|+.||...+..+....+.-........+.....+    
T Consensus       196 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  275 (371)
T 4exu_A          196 AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAK  275 (371)
T ss_dssp             ----CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHH
T ss_pred             cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhh
Confidence            66666678999999999877 6789999999999999999999999987543332221111000000000000000    


Q ss_pred             ---ccc---------cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          530 ---VEL---------LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       530 ---~~~---------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                         ..+         ...+..++++.++++   +|++.||++|||+.|++++
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          276 SYIQSLPQTPRKDFTQLFPRASPQAADLLE---KMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHHHHSCCCCCCCHHHHSTTSCHHHHHHHH---HHSCSCTTTSCCHHHHHTS
T ss_pred             hhhhccCCCcchhHHHhccccChHHHHHHH---HHCCCChhhcCCHHHHhcC
Confidence               000         001233455555555   9999999999999999886

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=2.6e-38  Score=326.65  Aligned_cols=248  Identities=17%  Similarity=0.295  Sum_probs=190.8

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccCCHHHHHHHHHHHhCCC-CCcccceeEEEEe--cCeeeEEeecCCCC
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVGKREFEQQMEIVGGIR-HENVVALRAYYYS--KDEKLMVYDYFEPG  380 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~--~~~~~lV~e~~~~g  380 (615)
                      .+.||+|+||+||+|.. .+++.||||+++.  ...+.+.+|+++++.++ ||||+++++++.+  ....++||||++++
T Consensus        41 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~--~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~  118 (330)
T 3nsz_A           41 VRKLGRGKYSEVFEAINITNNEKVVVKILKP--VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT  118 (330)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEECS--CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCC
T ss_pred             EEEecccCCeEEEEEEECCCCcEEEEEEecc--cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCch
Confidence            35799999999999985 5788999999874  33678999999999997 9999999999988  56789999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCC-cEEEeecccccccCCCC--
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG-HVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~-~~kl~DfG~a~~~~~~~--  457 (615)
                      +|.+++.        .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++ .+||+|||+++......  
T Consensus       119 ~l~~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~  187 (330)
T 3nsz_A          119 DFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY  187 (330)
T ss_dssp             CHHHHGG--------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCC
T ss_pred             hHHHHHH--------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCcc
Confidence            9999985        3888999999999999999999998   99999999999999776 89999999998765432  


Q ss_pred             CCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccc------ccccc
Q 007167          458 PPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTA------EVFDV  530 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~d~  530 (615)
                      ....++..|+|||.+.+ ..++.++|||||||++|||++|+.||...... ...+..............      ...++
T Consensus       188 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  266 (330)
T 3nsz_A          188 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN-YDQLVRIAKVLGTEDLYDYIDKYNIELDP  266 (330)
T ss_dssp             CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSH-HHHHHHHHHHHCHHHHHHHHHHTTCCCCT
T ss_pred             ccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCch-HHHHHHHHHhcCCchhhhHHHHhcccccc
Confidence            33457888999999876 66899999999999999999999999653321 111111111100000000      00000


Q ss_pred             ---------------cccC---CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          531 ---------------ELLR---YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       531 ---------------~~~~---~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                                     ....   ...+++++.++++   +|++.||++|||++|++++
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLD---KLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             HHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHH---TTSCSSGGGSCCHHHHHTS
T ss_pred             chhhhhhhccccchhhhccccccccCCHHHHHHHH---HHhcCCcccCCCHHHHhcC
Confidence                           0000   0113455555555   9999999999999999985

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.9e-38  Score=323.87  Aligned_cols=242  Identities=24%  Similarity=0.415  Sum_probs=192.2

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      .+.||+|+||+||+|... +++.||+|.+.... ..+.+.+|++++..++||||+++++++...+..++||||+++|+|.
T Consensus        34 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~  112 (314)
T 3com_A           34 LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVS  112 (314)
T ss_dssp             EEECC----CEEEEEEETTTCCEEEEEEEETTS-CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHH
T ss_pred             heeeccCCCeEEEEEEECCCCCEEEEEecCchH-HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHH
Confidence            357999999999999975 58899999997543 3567899999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC---CCCC
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM---PPPA  460 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~---~~~~  460 (615)
                      +++...    ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++......   ....
T Consensus       113 ~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  185 (314)
T 3com_A          113 DIIRLR----NKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTV  185 (314)
T ss_dssp             HHHHHH----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCC
T ss_pred             HHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCcc
Confidence            998632    236899999999999999999999998   999999999999999999999999999776533   2234


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE  540 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  540 (615)
                      .++..|+|||.+.+..++.++||||||+++|||++|+.||......+...   .+   ... .     .........+++
T Consensus       186 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~---~~---~~~-~-----~~~~~~~~~~~~  253 (314)
T 3com_A          186 IGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIF---MI---PTN-P-----PPTFRKPELWSD  253 (314)
T ss_dssp             CSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH---HH---HHS-C-----CCCCSSGGGSCH
T ss_pred             CCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHH---HH---hcC-C-----CcccCCcccCCH
Confidence            57888999999998889999999999999999999999997644222111   11   100 0     001111112334


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          541 EMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       541 ~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+.++++   +|+..||.+|||+.|++++
T Consensus       254 ~l~~li~---~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          254 NFTDFVK---QCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             HHHHHHH---HHTCSCTTTSCCHHHHTTS
T ss_pred             HHHHHHH---HHccCChhhCcCHHHHHhC
Confidence            5555555   9999999999999999875

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=3.5e-39  Score=342.98  Aligned_cols=195  Identities=24%  Similarity=0.436  Sum_probs=153.2

Q ss_pred             hhhcCcCCccEEEEEEEC---CCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEe--cCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE---DASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYS--KDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~~~  379 (615)
                      +++||+|+||+||+|..+   ++..||||++..... ...+.+|+++++.++|||||++++++..  ....++||||++ 
T Consensus        26 g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-  103 (405)
T 3rgf_A           26 GCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-  103 (405)
T ss_dssp             SCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-
T ss_pred             CcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-
Confidence            457999999999999965   477899999975433 4568899999999999999999999965  568899999996 


Q ss_pred             CChhhhhccCC----CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEe----CCCCcEEEeeccccc
Q 007167          380 GSVSAMLHGRR----GEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFL----NSQGHVCVSDIGLAA  451 (615)
Q Consensus       380 gsL~~~l~~~~----~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill----~~~~~~kl~DfG~a~  451 (615)
                      |+|.+++....    ......+++..+..++.|++.||+|||+.+   |+||||||+|||+    +.++.+||+|||+++
T Consensus       104 ~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~  180 (405)
T 3rgf_A          104 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR  180 (405)
T ss_dssp             EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECCTTCCC
T ss_pred             CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEECCCce
Confidence            57887775321    112235899999999999999999999998   9999999999999    677899999999998


Q ss_pred             ccCCC------CCCCCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 007167          452 LMSPM------PPPAMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATG  504 (615)
Q Consensus       452 ~~~~~------~~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~  504 (615)
                      .....      .....+|..|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          181 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             ----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             ecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence            76532      1234578899999998774 58999999999999999999999997654

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-38  Score=331.06  Aligned_cols=252  Identities=20%  Similarity=0.354  Sum_probs=191.8

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC------HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG------KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYF  377 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  377 (615)
                      .+.||+|+||+||+|... +++.||||+++.....      .+.+.+|+++++.++||||+++++++.+.+..++||||+
T Consensus        15 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~   94 (346)
T 1ua2_A           15 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   94 (346)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             EeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcC
Confidence            467999999999999965 5889999998753211      246789999999999999999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC
Q 007167          378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP  457 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~  457 (615)
                      ++ +|.+++...    ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++......
T Consensus        95 ~~-~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (346)
T 1ua2_A           95 ET-DLEVIIKDN----SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  166 (346)
T ss_dssp             SE-EHHHHHTTC----CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             CC-CHHHHHHhc----CcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceeccCCc
Confidence            75 888888643    236888999999999999999999998   9999999999999999999999999998765332


Q ss_pred             ---CCCCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHh---hhcccccccccc
Q 007167          458 ---PPAMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSV---VREEWTAEVFDV  530 (615)
Q Consensus       458 ---~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~d~  530 (615)
                         ....+|..|+|||.+.+. .++.++|||||||++|||++|+.||......+..  ...+...   ..+.|......+
T Consensus       167 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~  244 (346)
T 1ua2_A          167 RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL--TRIFETLGTPTEEQWPDMCSLP  244 (346)
T ss_dssp             CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HHHHHHHCCCCTTTSSSTTSST
T ss_pred             ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH--HHHHHHcCCCChhhhhhhccCc
Confidence               334678899999998654 4789999999999999999999999765433222  1111111   111111110000


Q ss_pred             cc---cC---------CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          531 EL---LR---------YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       531 ~~---~~---------~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ..   ..         .+..++++.++++   +|+..||++|||+.|++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          245 DYVTFKSFPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQALKM  292 (346)
T ss_dssp             TCCCCCCCCCCCHHHHCTTCCHHHHHHHH---HHHCSSTTTSCCHHHHHTS
T ss_pred             ccccccccCCCChHHhhccCCHHHHHHHH---HHhccChhhCCCHHHHhcC
Confidence            00   00         1223344555555   9999999999999999987

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=9.5e-39  Score=338.16  Aligned_cols=259  Identities=22%  Similarity=0.383  Sum_probs=190.0

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCe------eeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDE------KLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~lV~e~~~  378 (615)
                      .++||+|+||+||+|...++..||+|++....   ....+|+++++.++||||+++++++.....      .++||||++
T Consensus        45 ~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~---~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~  121 (394)
T 4e7w_A           45 CKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK---RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVP  121 (394)
T ss_dssp             EEEEEEETTEEEEEEEETTTEEEEEEEEECCT---TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCS
T ss_pred             eEEEeeCCCeEEEEEEECCCCeEEEEEEecCc---chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccC
Confidence            35799999999999998888889999886432   223479999999999999999999976543      789999998


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeC-CCCcEEEeecccccccCCC-
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLN-SQGHVCVSDIGLAALMSPM-  456 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~-~~~~~kl~DfG~a~~~~~~-  456 (615)
                      ++.+....+...  ....+++..+..++.|++.||+|||+.+   |+||||||+|||++ .++.+||+|||+++..... 
T Consensus       122 ~~l~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~  196 (394)
T 4e7w_A          122 ETVYRASRHYAK--LKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE  196 (394)
T ss_dssp             EEHHHHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC
T ss_pred             ccHHHHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC
Confidence            754443332111  1346899999999999999999999998   99999999999999 7999999999999876433 


Q ss_pred             -CCCCCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchh-hHHHHHHHhhhc-------ccccc
Q 007167          457 -PPPAMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATGGDEVV-HLVRWVNSVVRE-------EWTAE  526 (615)
Q Consensus       457 -~~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~-------~~~~~  526 (615)
                       .....+|+.|+|||++.+. .++.++||||+||++|||++|+.||.+.+..+.. .+++.+.....+       .+...
T Consensus       197 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~  276 (394)
T 4e7w_A          197 PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEH  276 (394)
T ss_dssp             CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSS
T ss_pred             CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhh
Confidence             2344678899999998664 5899999999999999999999999875533222 122211110000       00000


Q ss_pred             cccc----c--ccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhH
Q 007167          527 VFDV----E--LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM--VEDIR  574 (615)
Q Consensus       527 ~~d~----~--~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~l~  574 (615)
                      .+..    .  ....+..++++.++++   +||..||.+|||+.|+++|  +++++
T Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~R~t~~e~l~hp~f~~~~  329 (394)
T 4e7w_A          277 KFPQIRPHPFSKVFRPRTPPDAIDLIS---RLLEYTPSARLTAIEALCHPFFDELR  329 (394)
T ss_dssp             CCCCCCCCCHHHHSCTTCCHHHHHHHH---HHCCSSGGGSCCHHHHHTSGGGSTTT
T ss_pred             ccccccCCcHHHhccccCCHHHHHHHH---HHhCCChhhCCCHHHHhcChhhhhhc
Confidence            0000    0  0001123455555555   9999999999999999986  44443

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.7e-38  Score=332.09  Aligned_cols=258  Identities=18%  Similarity=0.288  Sum_probs=193.6

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccCCHHHHHHHHHHHhCCC-----------CCcccceeEEEEecC----
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVGKREFEQQMEIVGGIR-----------HENVVALRAYYYSKD----  368 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~~~----  368 (615)
                      .+.||+|+||+||+|.. .+++.||||++.......+.+.+|++++.+++           |+||+++++++...+    
T Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~  103 (373)
T 1q8y_A           24 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGV  103 (373)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEE
T ss_pred             EEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCc
Confidence            35699999999999996 46888999999765444567888999988876           899999999998654    


Q ss_pred             eeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc-CCCCceecCCCCCCEEeC------CCCc
Q 007167          369 EKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE-NGGKLVHGGIKASNIFLN------SQGH  441 (615)
Q Consensus       369 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~iiHrDik~~Nill~------~~~~  441 (615)
                      ..++||||+ +++|.+++....   ...+++..+..++.|++.||+|||++ +   |+||||||+|||++      ..+.
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~~~~~  176 (373)
T 1q8y_A          104 HVVMVFEVL-GENLLALIKKYE---HRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQ  176 (373)
T ss_dssp             EEEEEECCC-CEEHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEE
T ss_pred             eEEEEEecC-CCCHHHHHHHhh---ccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCcCcce
Confidence            789999999 899999997532   23589999999999999999999998 7   99999999999994      4458


Q ss_pred             EEEeecccccccCCCCCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhh--
Q 007167          442 VCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVV--  519 (615)
Q Consensus       442 ~kl~DfG~a~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~--  519 (615)
                      +||+|||++...........+|..|+|||++.+..++.++|||||||++|||++|+.||..............+..+.  
T Consensus       177 ~kl~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  256 (373)
T 1q8y_A          177 IKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL  256 (373)
T ss_dssp             EEECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHH
T ss_pred             EEEcccccccccCCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHh
Confidence            999999999888766666678999999999998889999999999999999999999998654322111111111110  


Q ss_pred             -hc---------ccccccccc------------------cccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          520 -RE---------EWTAEVFDV------------------ELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       520 -~~---------~~~~~~~d~------------------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                       ..         .+....+..                  .............++.+++.+||+.||++|||++|++++
T Consensus       257 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  334 (373)
T 1q8y_A          257 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH  334 (373)
T ss_dssp             HCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred             cCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhC
Confidence             00         000000000                  000111123444566667779999999999999999886

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=6e-38  Score=317.84  Aligned_cols=242  Identities=23%  Similarity=0.397  Sum_probs=189.7

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEe----cCeeeEEeecC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYS----KDEKLMVYDYF  377 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lV~e~~  377 (615)
                      +.||+|+||+||+|... ++..||+|.+......   .+.+.+|+++++.++||||+++++++..    +...++||||+
T Consensus        32 ~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~  111 (290)
T 1t4h_A           32 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM  111 (290)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred             eeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEec
Confidence            46999999999999864 5778999998765333   3568899999999999999999999876    34689999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeC-CCCcEEEeecccccccCCC
Q 007167          378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLN-SQGHVCVSDIGLAALMSPM  456 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~-~~~~~kl~DfG~a~~~~~~  456 (615)
                      ++|+|.+++...     ..+++..+..++.|++.||+|||+.+ ++|+||||||+||+++ .++.+||+|||++......
T Consensus       112 ~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~  185 (290)
T 1t4h_A          112 TSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  185 (290)
T ss_dssp             CSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             CCCCHHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc
Confidence            999999999743     36899999999999999999999885 3499999999999998 7899999999999765543


Q ss_pred             C-CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCC
Q 007167          457 P-PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY  535 (615)
Q Consensus       457 ~-~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  535 (615)
                      . ....++..|+|||.+.+ .++.++||||+||++|+|++|+.||.......  ....   ....... ..    ..  .
T Consensus       186 ~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~---~~~~~~~-~~----~~--~  252 (290)
T 1t4h_A          186 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYR---RVTSGVK-PA----SF--D  252 (290)
T ss_dssp             SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHH---HHTTTCC-CG----GG--G
T ss_pred             ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH--HHHH---HHhccCC-cc----cc--C
Confidence            2 23457889999998864 58999999999999999999999997643321  1111   1111100 00    00  1


Q ss_pred             CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          536 PNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       536 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ....+++.+   ++.+||..||.+|||+.|++++
T Consensus       253 ~~~~~~l~~---li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          253 KVAIPEVKE---IIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             GCCCHHHHH---HHHHHSCSSGGGSCCHHHHHTS
T ss_pred             CCCCHHHHH---HHHHHccCChhhCCCHHHHhhC
Confidence            112244444   4459999999999999999875

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.6e-38  Score=330.77  Aligned_cols=250  Identities=20%  Similarity=0.295  Sum_probs=195.4

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCH------------------HHHHHHHHHHhCCCCCcccceeEEEEe
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGK------------------REFEQQMEIVGGIRHENVVALRAYYYS  366 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~------------------~~~~~e~~~l~~l~h~niv~l~~~~~~  366 (615)
                      .+.||+|+||.||+|.. +++.||||++.......                  +.+.+|+++++.++||||+++++++.+
T Consensus        36 ~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~  114 (348)
T 2pml_X           36 IRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITN  114 (348)
T ss_dssp             EEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEES
T ss_pred             EEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEee
Confidence            35699999999999998 88999999987542111                  789999999999999999999999999


Q ss_pred             cCeeeEEeecCCCCChhhh------hccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCceecCCCCCCEEeCCC
Q 007167          367 KDEKLMVYDYFEPGSVSAM------LHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT-ENGGKLVHGGIKASNIFLNSQ  439 (615)
Q Consensus       367 ~~~~~lV~e~~~~gsL~~~------l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~iiHrDik~~Nill~~~  439 (615)
                      .+..++||||+++|+|.++      +...   ....+++..+..++.|++.||+|||+ .+   |+||||||+||+++.+
T Consensus       115 ~~~~~lv~e~~~~~~L~~~~~~~~~l~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~~  188 (348)
T 2pml_X          115 YDEVYIIYEYMENDSILKFDEYFFVLDKN---YTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDKN  188 (348)
T ss_dssp             SSEEEEEEECCTTCBSSEESSSEESSCSS---SCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECTT
T ss_pred             CCeEEEEEeccCCCcHHHHHHHhhhhhhc---cccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcCC
Confidence            9999999999999999998      5431   13579999999999999999999998 87   9999999999999999


Q ss_pred             CcEEEeecccccccCCC-CCCCCCCCcccCccccCCC-CCCC-ccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHH
Q 007167          440 GHVCVSDIGLAALMSPM-PPPAMRAAGYRAPEVTDTR-KATQ-ASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVN  516 (615)
Q Consensus       440 ~~~kl~DfG~a~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~-~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~  516 (615)
                      +.+||+|||.+...... .....++..|+|||.+.+. .++. ++|||||||++|||++|+.||.......  .....+ 
T Consensus       189 ~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~~~~i-  265 (348)
T 2pml_X          189 GRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV--ELFNNI-  265 (348)
T ss_dssp             SCEEECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH--HHHHHH-
T ss_pred             CcEEEeccccccccccccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHH-
Confidence            99999999999876432 2344678899999999877 5665 9999999999999999999998654421  111111 


Q ss_pred             Hhhhcccccc----ccccccc------CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          517 SVVREEWTAE----VFDVELL------RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       517 ~~~~~~~~~~----~~d~~~~------~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                        ........    .+.....      ..+..++++.++++   +|+..||.+|||+.|++++
T Consensus       266 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~---~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          266 --RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLK---LFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             --TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHH---HHCCSSGGGSCCHHHHHTS
T ss_pred             --hccCcCCccchhhhhccccccccccchhhcCHHHHHHHH---HHccCChhhCCCHHHHhcC
Confidence              11100000    0000000      01234455555555   9999999999999999884

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=6.4e-39  Score=322.90  Aligned_cols=249  Identities=20%  Similarity=0.325  Sum_probs=193.8

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEe--cCeeeEEeecCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYS--KDEKLMVYDYFEP  379 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~~~  379 (615)
                      +.||+|+||+||++... +++.||+|++......   .+.+.+|+++++.++||||+++++++.+  ....++||||+++
T Consensus        12 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~   91 (279)
T 2w5a_A           12 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEG   91 (279)
T ss_dssp             EEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTT
T ss_pred             hhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCC
Confidence            56999999999999965 6889999999754332   3568899999999999999999998865  5688999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccC--CCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN--GGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~  457 (615)
                      |+|.+++..... ....+++..+..++.|++.||+|||+.+  ..+|+||||||+||+++.++.+||+|||++.......
T Consensus        92 ~~L~~~l~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~  170 (279)
T 2w5a_A           92 GDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT  170 (279)
T ss_dssp             EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---C
T ss_pred             CCHHHHHHhhcc-cCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecccc
Confidence            999999975321 2345999999999999999999999986  2349999999999999999999999999998765432


Q ss_pred             C---CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccC
Q 007167          458 P---PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLR  534 (615)
Q Consensus       458 ~---~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  534 (615)
                      .   ...++..|+|||.+.+..++.++||||||+++|||++|+.||......+....      +.... ..     .  .
T Consensus       171 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~------i~~~~-~~-----~--~  236 (279)
T 2w5a_A          171 SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK------IREGK-FR-----R--I  236 (279)
T ss_dssp             HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHHTC-CC-----C--C
T ss_pred             ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHH------Hhhcc-cc-----c--C
Confidence            1   22468889999999888899999999999999999999999986543222111      11111 00     0  1


Q ss_pred             CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHH
Q 007167          535 YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVED  572 (615)
Q Consensus       535 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~  572 (615)
                      ...+++++.++++   +||+.||++||++.|+++++..
T Consensus       237 ~~~~~~~l~~li~---~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          237 PYRYSDELNEIIT---RMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             CTTSCHHHHHHHH---HHTCSSGGGSCCHHHHHTSTTC
T ss_pred             CcccCHHHHHHHH---HHcCCCcccCCCHHHHHhChhh
Confidence            1234455555555   9999999999999999987643

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=6.3e-38  Score=319.91  Aligned_cols=240  Identities=20%  Similarity=0.370  Sum_probs=189.3

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc-----CCHHHHHHHHHHHhCCCCCcccceeEEEEe--cCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN-----VGKREFEQQMEIVGGIRHENVVALRAYYYS--KDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-----~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~  376 (615)
                      .+.||+|+||.||++... ++..||+|+++...     ...+.+.+|+++++.++||||+++++++..  ....++||||
T Consensus        10 ~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~   89 (305)
T 2wtk_C           10 GDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEY   89 (305)
T ss_dssp             CCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEEC
T ss_pred             eeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehh
Confidence            357999999999999964 67899999987531     234678999999999999999999999853  4578999999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM  456 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~  456 (615)
                      ++++ |.+++....   ...+++..+..++.|++.||+|||+++   |+||||||+||+++.++.+||+|||++......
T Consensus        90 ~~~~-l~~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~  162 (305)
T 2wtk_C           90 CVCG-MQEMLDSVP---EKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPF  162 (305)
T ss_dssp             CSEE-HHHHHHHST---TCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred             ccCC-HHHHHHhCc---ccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence            9876 777775432   346899999999999999999999998   999999999999999999999999999876532


Q ss_pred             C-----CCCCCCCcccCccccCCCC--CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccc
Q 007167          457 P-----PPAMRAAGYRAPEVTDTRK--ATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD  529 (615)
Q Consensus       457 ~-----~~~~~~~~y~aPE~~~~~~--~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  529 (615)
                      .     ....++..|+|||.+.+..  ++.++||||||+++|||++|+.||......+...      ......       
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~i~~~~-------  229 (305)
T 2wtk_C          163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFE------NIGKGS-------  229 (305)
T ss_dssp             CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH------HHHHCC-------
T ss_pred             ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHH------HHhcCC-------
Confidence            1     2345788999999987644  3779999999999999999999997643222211      111110       


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          530 VELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       530 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                        .......++.+.++++   +|+..||++|||++|++++
T Consensus       230 --~~~~~~~~~~l~~li~---~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          230 --YAIPGDCGPPLSDLLK---GMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             --CCCCSSSCHHHHHHHH---HHTCSSTTTSCCHHHHHHS
T ss_pred             --CCCCCccCHHHHHHHH---HHccCChhhCCCHHHHhcC
Confidence              1111234455555555   9999999999999999987

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-38  Score=326.43  Aligned_cols=242  Identities=21%  Similarity=0.411  Sum_probs=190.5

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEeccccCCHHHHHHHHHHHhCC-CCCcccceeEEEEe------cCeeeEEeecC
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVGKREFEQQMEIVGGI-RHENVVALRAYYYS------KDEKLMVYDYF  377 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~------~~~~~lV~e~~  377 (615)
                      +.||+|+||.||+|.. .+++.||||++.......+.+.+|+++++++ +||||+++++++..      .+..++||||+
T Consensus        30 ~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~  109 (326)
T 2x7f_A           30 ELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFC  109 (326)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECC
T ss_pred             EEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcC
Confidence            5699999999999996 4788999999976666677899999999998 79999999999987      46789999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC-
Q 007167          378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM-  456 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~-  456 (615)
                      ++|+|.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++...... 
T Consensus       110 ~~~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  183 (326)
T 2x7f_A          110 GAGSVTDLIKNTK---GNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV  183 (326)
T ss_dssp             TTEEHHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCTTTC------
T ss_pred             CCCcHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCEEEeeCcCceecCcCc
Confidence            9999999997542   246899999999999999999999998   999999999999999999999999999876432 


Q ss_pred             --CCCCCCCCcccCccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccc
Q 007167          457 --PPPAMRAAGYRAPEVTD-----TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD  529 (615)
Q Consensus       457 --~~~~~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  529 (615)
                        .....++..|+|||.+.     ...++.++|||||||++|||++|+.||......+...      .......      
T Consensus       184 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~------~~~~~~~------  251 (326)
T 2x7f_A          184 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALF------LIPRNPA------  251 (326)
T ss_dssp             -------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHSCC------
T ss_pred             cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHH------HhhcCcc------
Confidence              22345788999999986     5668999999999999999999999997644322111      1111100      


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          530 VELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       530 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      +. .....+++.+.++++   +||..||.+||++.|++++
T Consensus       252 ~~-~~~~~~~~~l~~li~---~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          252 PR-LKSKKWSKKFQSFIE---SCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             CC-CSCSCSCHHHHHHHH---HHCCSSGGGSCCHHHHHTS
T ss_pred             cc-CCccccCHHHHHHHH---HHhccChhhCCCHHHHhhC
Confidence            00 112334556666665   9999999999999999884

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=6.7e-39  Score=324.74  Aligned_cols=249  Identities=24%  Similarity=0.407  Sum_probs=188.5

Q ss_pred             hhhcCcCCccEEEEEEEC--CCC--EEEEEEeccccC----CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAALE--DAS--TVVVKRLKEVNV----GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~--~~~--~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      .+.||+|+||+||+|.+.  ++.  .||||+++....    ..+.+.+|+++++.++||||+++++++.... .++|+||
T Consensus        23 ~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~  101 (291)
T 1u46_A           23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTEL  101 (291)
T ss_dssp             EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEEC
T ss_pred             eeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEec
Confidence            357999999999999853  333  589998875421    2457889999999999999999999997654 8899999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM  456 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~  456 (615)
                      +++|+|.+++....    ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus       102 ~~~~~L~~~l~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  174 (291)
T 1u46_A          102 APLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN  174 (291)
T ss_dssp             CTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred             ccCCCHHHHHHhcc----CCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEcccccccccccc
Confidence            99999999997532    35899999999999999999999998   999999999999999999999999999877543


Q ss_pred             CC------CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccccccc
Q 007167          457 PP------PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD  529 (615)
Q Consensus       457 ~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  529 (615)
                      ..      ...++..|+|||.+.+..++.++||||||+++|||++ |+.||......+...      ......       
T Consensus       175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~------~~~~~~-------  241 (291)
T 1u46_A          175 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILH------KIDKEG-------  241 (291)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH------HHHTSC-------
T ss_pred             ccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHH------HHHccC-------
Confidence            21      2335668999999988888999999999999999999 999997654333221      111111       


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhh
Q 007167          530 VELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVK  577 (615)
Q Consensus       530 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~  577 (615)
                      ........+++++.+++.   +|+..+|++|||+.|++++|+++....
T Consensus       242 ~~~~~~~~~~~~l~~li~---~~l~~~p~~Rps~~~l~~~l~~~~~~~  286 (291)
T 1u46_A          242 ERLPRPEDCPQDIYNVMV---QCWAHKPEDRPTFVALRDFLLEAQPTD  286 (291)
T ss_dssp             CCCCCCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             CCCCCCcCcCHHHHHHHH---HHccCCcccCcCHHHHHHHHHHhCccc
Confidence            011112234455555555   999999999999999999999887533

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=3.6e-38  Score=324.56  Aligned_cols=241  Identities=21%  Similarity=0.370  Sum_probs=186.5

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC---------CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEe
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV---------GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVY  374 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~  374 (615)
                      .+.||+|+||.||+|... +++.||||.+.....         ....+.+|+++++.++||||+++++++...+ .++||
T Consensus        15 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~   93 (322)
T 2ycf_A           15 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVL   93 (322)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEE
T ss_pred             eeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEE
Confidence            467999999999999965 578899999864321         1235789999999999999999999987654 89999


Q ss_pred             ecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCc---EEEeeccccc
Q 007167          375 DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGH---VCVSDIGLAA  451 (615)
Q Consensus       375 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~---~kl~DfG~a~  451 (615)
                      ||+++|+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.   +||+|||+++
T Consensus        94 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~  165 (322)
T 2ycf_A           94 ELMEGGELFDKVVGN-----KRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK  165 (322)
T ss_dssp             ECCTTEETHHHHSTT-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTCE
T ss_pred             ecCCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCccce
Confidence            999999999998642     36899999999999999999999998   999999999999987654   9999999998


Q ss_pred             ccCCCC--CCCCCCCcccCcccc---CCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc-hhhHHHHHHHhhhccccc
Q 007167          452 LMSPMP--PPAMRAAGYRAPEVT---DTRKATQASDVFSFGVLLLELLTGKSPIHATGGDE-VVHLVRWVNSVVREEWTA  525 (615)
Q Consensus       452 ~~~~~~--~~~~~~~~y~aPE~~---~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~  525 (615)
                      ......  ....++..|+|||++   ....++.++|||||||++|||++|+.||....... ....+.   .   ...  
T Consensus       166 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~---~---~~~--  237 (322)
T 2ycf_A          166 ILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT---S---GKY--  237 (322)
T ss_dssp             ECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHH---H---TCC--
T ss_pred             ecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHH---h---Ccc--
Confidence            765432  123478899999996   35678999999999999999999999997654332 111111   0   000  


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007167          526 EVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK  568 (615)
Q Consensus       526 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  568 (615)
                       .+.+..  ....++++.++++   +|+..||++||++.|+++
T Consensus       238 -~~~~~~--~~~~~~~~~~li~---~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          238 -NFIPEV--WAEVSEKALDLVK---KLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             -CCCHHH--HTTSCHHHHHHHH---HHSCSSTTTSCCHHHHHT
T ss_pred             -ccCchh--hhhcCHHHHHHHH---HHcccCHhhCCCHHHHhh
Confidence             000000  1223444555554   999999999999999985

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.3e-38  Score=321.68  Aligned_cols=240  Identities=20%  Similarity=0.286  Sum_probs=191.0

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC---CHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV---GKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||+||+|... +++.||+|+++....   ....+.+|+..+..+ +||||+++++++.+++..++||||+++
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   95 (289)
T 1x8b_A           16 LEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNG   95 (289)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTT
T ss_pred             hhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCC
Confidence            467999999999999975 789999999975422   245678899999888 999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCC-------------------C
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQ-------------------G  440 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~-------------------~  440 (615)
                      |+|.+++..... ....+++..+..++.|++.||+|||+.+   |+||||||+||+++.+                   .
T Consensus        96 ~~L~~~l~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~  171 (289)
T 1x8b_A           96 GSLADAISENYR-IMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV  171 (289)
T ss_dssp             CBHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC--------------------CC
T ss_pred             CcHHHHHHhhcc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccccCCce
Confidence            999999975321 1246899999999999999999999998   9999999999999844                   4


Q ss_pred             cEEEeecccccccCCCCCCCCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhh
Q 007167          441 HVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVV  519 (615)
Q Consensus       441 ~~kl~DfG~a~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~  519 (615)
                      .+||+|||.+....... ...++..|+|||.+.+. .++.++|||||||++|||++|+.++...   +....      ..
T Consensus       172 ~~kl~Dfg~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~~------~~  241 (289)
T 1x8b_A          172 MFKIGDLGHVTRISSPQ-VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG---DQWHE------IR  241 (289)
T ss_dssp             CEEECCCTTCEETTCSC-CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS---HHHHH------HH
T ss_pred             EEEEcccccccccCCcc-ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch---hHHHH------HH
Confidence            79999999998776543 34688999999999765 5668999999999999999999876432   11111      11


Q ss_pred             hcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          520 REEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       520 ~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .. ..     +.  ....+++++.++++   +|+..||++|||+.|++++
T Consensus       242 ~~-~~-----~~--~~~~~~~~~~~li~---~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          242 QG-RL-----PR--IPQVLSQEFTELLK---VMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             TT-CC-----CC--CSSCCCHHHHHHHH---HHTCSSGGGSCCHHHHHTC
T ss_pred             cC-CC-----CC--CCcccCHHHHHHHH---HHhCCCcccCCCHHHHhhC
Confidence            10 00     01  11234556666655   9999999999999999875

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.8e-38  Score=333.33  Aligned_cols=198  Identities=19%  Similarity=0.309  Sum_probs=167.7

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCHHHHHHHHHHHhCCC-CC-----cccceeEEEEecCeeeEEeecC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFEQQMEIVGGIR-HE-----NVVALRAYYYSKDEKLMVYDYF  377 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~-h~-----niv~l~~~~~~~~~~~lV~e~~  377 (615)
                      .+.||+|+||+||+|... +++.||||+++........+.+|++++..++ |+     +|+++++++...+..++||||+
T Consensus        59 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~  138 (382)
T 2vx3_A           59 DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEML  138 (382)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECC
T ss_pred             EEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecC
Confidence            457999999999999865 5778999999754433456778888887774 44     4999999999999999999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeC--CCCcEEEeecccccccCC
Q 007167          378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLN--SQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~--~~~~~kl~DfG~a~~~~~  455 (615)
                      + |+|.+++....   ...+++..+..++.|++.||.|||.+ ..+|+||||||+|||++  .++.+||+|||+++....
T Consensus       139 ~-~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~  213 (382)
T 2vx3_A          139 S-YNLYDLLRNTN---FRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ  213 (382)
T ss_dssp             C-CBHHHHHHHTT---TSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred             C-CCHHHHHhhcC---cCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc
Confidence            6 59999997542   23589999999999999999999952 11399999999999994  578899999999998876


Q ss_pred             CCCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcc
Q 007167          456 MPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDE  507 (615)
Q Consensus       456 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~  507 (615)
                      ......+|..|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus       214 ~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~  265 (382)
T 2vx3_A          214 RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVD  265 (382)
T ss_dssp             CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            6666778999999999999899999999999999999999999998755433

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.3e-38  Score=324.44  Aligned_cols=254  Identities=25%  Similarity=0.392  Sum_probs=179.9

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccc--cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEV--NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      .+.||+|+||+||+|.. .+++.||||++...  ....+.+.+|+++++.++||||+++++++...+..++||||+++|+
T Consensus        20 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~   99 (303)
T 2vwi_A           20 QEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGS   99 (303)
T ss_dssp             EEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCB
T ss_pred             hheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCc
Confidence            35799999999999985 46889999988653  2234668899999999999999999999999999999999999999


Q ss_pred             hhhhhccCC---CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC-
Q 007167          382 VSAMLHGRR---GEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP-  457 (615)
Q Consensus       382 L~~~l~~~~---~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~-  457 (615)
                      |.+++....   ......+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++....... 
T Consensus       100 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~  176 (303)
T 2vwi_A          100 VLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGD  176 (303)
T ss_dssp             HHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHHHCC----
T ss_pred             hHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchheeccCCC
Confidence            999986421   112346899999999999999999999998   9999999999999999999999999997664321 


Q ss_pred             -------CCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccc
Q 007167          458 -------PPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD  529 (615)
Q Consensus       458 -------~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  529 (615)
                             ....++..|+|||.+.. ..++.++||||||+++|||++|+.||......+....  .... ..........+
T Consensus       177 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~--~~~~-~~~~~~~~~~~  253 (303)
T 2vwi_A          177 ITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML--TLQN-DPPSLETGVQD  253 (303)
T ss_dssp             -----------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH--HHTS-SCCCTTC----
T ss_pred             ccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH--Hhcc-CCCcccccccc
Confidence                   22357888999999865 5689999999999999999999999987554332211  0000 00000000111


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          530 VELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       530 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ..  ....+++++.++++   +||+.||.+||++.|++++
T Consensus       254 ~~--~~~~~~~~~~~li~---~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          254 KE--MLKKYGKSFRKMIS---LCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             -C--CCCCCCHHHHHHHH---HHCCSSGGGSCCHHHHHTS
T ss_pred             ch--hhhhhhHHHHHHHH---HHccCChhhCcCHHHHhhC
Confidence            11  12234455555555   9999999999999999875

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.3e-38  Score=340.02  Aligned_cols=254  Identities=24%  Similarity=0.331  Sum_probs=186.5

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecC------eeeEEeecC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKD------EKLMVYDYF  377 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lV~e~~  377 (615)
                      .++||+|+||+||+|.+. +++.||||++...   ...+.+|+++++.++|||||++++++....      ..++||||+
T Consensus        59 ~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~---~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~  135 (420)
T 1j1b_A           59 TKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD---KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV  135 (420)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEECC---TTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECC
T ss_pred             eeEEeeCCCEEEEEEEECCCCcEEEEEEeccc---chhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcc
Confidence            357999999999999975 5889999998653   233457999999999999999999986531      367999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCC-CcEEEeecccccccCCC
Q 007167          378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQ-GHVCVSDIGLAALMSPM  456 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~-~~~kl~DfG~a~~~~~~  456 (615)
                      ++ ++.+.+.... .....+++..+..++.|++.||+|||+.+   |+||||||+|||++.+ +.+||+|||+++.+...
T Consensus       136 ~~-~l~~~~~~~~-~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~  210 (420)
T 1j1b_A          136 PE-TVYRVARHYS-RAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG  210 (420)
T ss_dssp             CE-EHHHHHHHHH-HTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             cc-cHHHHHHHHh-hccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhhhcccC
Confidence            75 6666554211 12346999999999999999999999998   9999999999999965 57899999999876432


Q ss_pred             --CCCCCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchh-hHHHHHHHhhhcccc------cc
Q 007167          457 --PPPAMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATGGDEVV-HLVRWVNSVVREEWT------AE  526 (615)
Q Consensus       457 --~~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~-~~~~~~~~~~~~~~~------~~  526 (615)
                        .....+|..|+|||++.+. .++.++|||||||++|||++|+.||.+....+.. .+++.+.....+.+.      .+
T Consensus       211 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~  290 (420)
T 1j1b_A          211 EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTE  290 (420)
T ss_dssp             CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCC
T ss_pred             CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhh
Confidence              2344678999999998764 6899999999999999999999999875432221 222211110000000      00


Q ss_pred             ccccccc-------CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          527 VFDVELL-------RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       527 ~~d~~~~-------~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ..-+.+.       ..+..++++.++++   +||..||++|||+.|++++
T Consensus       291 ~~~p~~~~~~~~~~~~~~~~~~~~~Li~---~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          291 FKFPQIKAHPWTKVFRPRTPPEAIALCS---RLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             CCCCCCCCCCHHHHSCTTSCHHHHHHHH---HHSCSSGGGSCCHHHHHTS
T ss_pred             hccCccCCCCHHHhcCCCCCHHHHHHHH---HhccCChhHCCCHHHHhCC
Confidence            0000000       01223445555555   9999999999999999975

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.9e-38  Score=334.72  Aligned_cols=260  Identities=19%  Similarity=0.312  Sum_probs=190.5

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEec----------------
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK----------------  367 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~----------------  367 (615)
                      .+.||+|+||+||+|.. .+++.||||++....   ....+|+++++.++|||||++++++...                
T Consensus        12 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~---~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~   88 (383)
T 3eb0_A           12 GKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP---RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNK   88 (383)
T ss_dssp             EEEEECC-CEEEEEEEETTTCCEEEEEEEECCT---TSCCHHHHHHTTCCCTTBCCEEEEEEEC----------------
T ss_pred             EEEEEeccCEEEEEEEECCCCCEEEEEEEecCc---chHHHHHHHHHHcCCCCccchhheeeecCccccccccccccccc
Confidence            35799999999999986 578999999986542   2345799999999999999999998543                


Q ss_pred             ----------------------CeeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCce
Q 007167          368 ----------------------DEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLV  425 (615)
Q Consensus       368 ----------------------~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~ii  425 (615)
                                            ...++||||++ |+|.+.+..... ....+++..+..++.|++.||+|||+.+   |+
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~g---i~  163 (383)
T 3eb0_A           89 LGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIR-SGRSIPMNLISIYIYQLFRAVGFIHSLG---IC  163 (383)
T ss_dssp             ---------------------CCEEEEEECCCS-EEHHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EE
T ss_pred             ccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCc---Cc
Confidence                                  34789999997 588877753211 2346999999999999999999999998   99


Q ss_pred             ecCCCCCCEEeC-CCCcEEEeecccccccCCC--CCCCCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCC
Q 007167          426 HGGIKASNIFLN-SQGHVCVSDIGLAALMSPM--PPPAMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIH  501 (615)
Q Consensus       426 HrDik~~Nill~-~~~~~kl~DfG~a~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~  501 (615)
                      ||||||+||+++ .++.+||+|||+++.+...  .....+|..|+|||.+.+. .++.++||||+||++|||++|+.||.
T Consensus       164 H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~  243 (383)
T 3eb0_A          164 HRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFS  243 (383)
T ss_dssp             CSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             cCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCC
Confidence            999999999998 6889999999999876443  2344578899999998764 48999999999999999999999998


Q ss_pred             CCCCcchhh-HHHHHHHhhhcccc------cccccccc-------cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHH
Q 007167          502 ATGGDEVVH-LVRWVNSVVREEWT------AEVFDVEL-------LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVL  567 (615)
Q Consensus       502 ~~~~~~~~~-~~~~~~~~~~~~~~------~~~~d~~~-------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl  567 (615)
                      +....+... ++..+.....+.+.      .+..-+..       ......++++.++++   +|+..||++|||+.|++
T Consensus       244 ~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~R~t~~e~l  320 (383)
T 3eb0_A          244 GETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLE---QILRYEPDLRINPYEAM  320 (383)
T ss_dssp             CSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHH---HHCCSSGGGSCCHHHHH
T ss_pred             CCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHH---HHccCChhhCCCHHHHh
Confidence            754433221 11111110000000      00000000       011223445555555   99999999999999999


Q ss_pred             HH--HHHhHh
Q 007167          568 KM--VEDIRR  575 (615)
Q Consensus       568 ~~--L~~l~~  575 (615)
                      ++  +++++.
T Consensus       321 ~hp~f~~~~~  330 (383)
T 3eb0_A          321 AHPFFDHLRN  330 (383)
T ss_dssp             TSGGGHHHHH
T ss_pred             cCHHHHHHHh
Confidence            64  445543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.6e-38  Score=329.53  Aligned_cols=258  Identities=17%  Similarity=0.255  Sum_probs=196.6

Q ss_pred             hhhcCcCCccEEEEEEEC-CC-CEEEEEEeccccCCHHHHHHHHHHHhCCCCCc------ccceeEEEEecCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAALE-DA-STVVVKRLKEVNVGKREFEQQMEIVGGIRHEN------VVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~-~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~n------iv~l~~~~~~~~~~~lV~e~  376 (615)
                      .+.||+|+||+||+|... ++ ..||+|+++......+.+.+|+++++.++|++      ++.+.+++...+..++||||
T Consensus        24 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~  103 (355)
T 2eu9_A           24 VGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFEL  103 (355)
T ss_dssp             EEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEEC
T ss_pred             EEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEec
Confidence            356999999999999864 34 68999999765444567888999999887665      89999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEe-------------------C
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFL-------------------N  437 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill-------------------~  437 (615)
                      + ++++.+.+....   ...+++..+..++.|++.||+|||+.+   |+||||||+|||+                   +
T Consensus       104 ~-~~~l~~~l~~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~  176 (355)
T 2eu9_A          104 L-GKNTFEFLKENN---FQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSCEEKSV  176 (355)
T ss_dssp             C-CCBHHHHHHHTT---TCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CCCEEEE
T ss_pred             c-CCChHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeccccccccccccccccccc
Confidence            9 667777775432   236899999999999999999999998   9999999999999                   5


Q ss_pred             CCCcEEEeecccccccCCCCCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHH
Q 007167          438 SQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNS  517 (615)
Q Consensus       438 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~  517 (615)
                      .++.+||+|||+++..........+|..|+|||++.+..++.++|||||||++|||++|+.||......+....+.....
T Consensus       177 ~~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~  256 (355)
T 2eu9_A          177 KNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILG  256 (355)
T ss_dssp             SCCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             CCCcEEEeecCccccccccccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence            67899999999998877666667789999999999998999999999999999999999999987654433322222111


Q ss_pred             hhhcccc-----ccccccc---------------------ccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          518 VVREEWT-----AEVFDVE---------------------LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       518 ~~~~~~~-----~~~~d~~---------------------~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .....+.     ...+...                     ............++.+++.+||+.||++|||+.|++++
T Consensus       257 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  334 (355)
T 2eu9_A          257 PIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLH  334 (355)
T ss_dssp             CCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             CCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            1000000     0000000                     00000111223355566669999999999999999865

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.3e-38  Score=333.80  Aligned_cols=251  Identities=21%  Similarity=0.353  Sum_probs=192.0

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEec-----CeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSK-----DEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lV~e~  376 (615)
                      .+.||+|+||+||+|... ++..||||++.....  ..+.+.+|++++..++||||+++++++...     ...++||||
T Consensus        32 ~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~  111 (364)
T 3qyz_A           32 LSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL  111 (364)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEEC
T ss_pred             EEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcc
Confidence            356999999999999865 677899999975322  235688999999999999999999999765     368999999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM  456 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~  456 (615)
                      ++ |+|.+++...      .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++......
T Consensus       112 ~~-~~L~~~l~~~------~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~  181 (364)
T 3qyz_A          112 ME-TDLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD  181 (364)
T ss_dssp             CS-EEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred             cC-cCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence            97 5899988642      5899999999999999999999998   999999999999999999999999999876532


Q ss_pred             ------CCCCCCCCcccCccccC-CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHH-HHHHhhhcccccccc
Q 007167          457 ------PPPAMRAAGYRAPEVTD-TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVR-WVNSVVREEWTAEVF  528 (615)
Q Consensus       457 ------~~~~~~~~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~  528 (615)
                            .....+|..|+|||++. ...++.++||||+||++|||++|+.||......+....+. .+.....+. .....
T Consensus       182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~~  260 (364)
T 3qyz_A          182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQED-LNCII  260 (364)
T ss_dssp             GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHH-HHTCC
T ss_pred             CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHH-HHHhh
Confidence                  12346788999999864 4558999999999999999999999998765544332221 111000000 00000


Q ss_pred             ------------ccc----ccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          529 ------------DVE----LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       529 ------------d~~----~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                                  ...    ....+..++++.++++   +|++.||++|||+.|++++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHH---HHTCSSTTTSCCHHHHHTS
T ss_pred             hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHH---HHcCCChhhCCCHHHHhcC
Confidence                        000    0001233455555555   9999999999999999986

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2.4e-38  Score=331.32  Aligned_cols=253  Identities=15%  Similarity=0.268  Sum_probs=185.4

Q ss_pred             hhcCcCCccEEEEEEECCCCEEEEEEeccccCC------------HHHHHHHHHHHhCCCCCcccceeEEEEec-----C
Q 007167          306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVG------------KREFEQQMEIVGGIRHENVVALRAYYYSK-----D  368 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~------------~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~  368 (615)
                      +.||+|+||.||+|...++..||||++......            .+.+.+|+++++.++||||+++++++...     .
T Consensus        28 ~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~  107 (362)
T 3pg1_A           28 RFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMH  107 (362)
T ss_dssp             EEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCC
T ss_pred             EEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcc
Confidence            579999999999999888999999998653221            16788999999999999999999998653     3


Q ss_pred             eeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecc
Q 007167          369 EKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIG  448 (615)
Q Consensus       369 ~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG  448 (615)
                      ..++||||++ |+|.+.+...    ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||
T Consensus       108 ~~~lv~e~~~-~~l~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg  179 (362)
T 3pg1_A          108 KLYLVTELMR-TDLAQVIHDQ----RIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFN  179 (362)
T ss_dssp             EEEEEEECCS-EEHHHHHHCT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCTT
T ss_pred             eEEEEEccCC-CCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEEEEecC
Confidence            5799999997 6888888743    236999999999999999999999998   9999999999999999999999999


Q ss_pred             cccccCCC--CCCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHH-HHHHHhhhcc--
Q 007167          449 LAALMSPM--PPPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLV-RWVNSVVREE--  522 (615)
Q Consensus       449 ~a~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~--  522 (615)
                      +++.....  .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||......+....+ ........+.  
T Consensus       180 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  259 (362)
T 3pg1_A          180 LAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVV  259 (362)
T ss_dssp             C---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             cccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhh
Confidence            99765432  233457888999999876 67899999999999999999999999875433322211 1110000000  


Q ss_pred             -----ccccccccccc---------CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          523 -----WTAEVFDVELL---------RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       523 -----~~~~~~d~~~~---------~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                           ...+.+.....         ..+..++.+.+++   .+|++.||++|||+.|++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li---~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          260 MFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLI---AKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHH---HHHTCSSGGGSCCHHHHHTS
T ss_pred             hccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHH---HHHhcCChhhCCCHHHHHcC
Confidence                 00000000000         1122334444444   49999999999999999986

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.1e-38  Score=327.70  Aligned_cols=247  Identities=21%  Similarity=0.370  Sum_probs=189.6

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEecccc---CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVN---VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      .+.||+|+||+||+|...+  .||+|+++...   ...+.+.+|+++++.++||||+++++++.+.+..++||||+++++
T Consensus        38 ~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~  115 (319)
T 2y4i_B           38 GELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRT  115 (319)
T ss_dssp             CCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEE
T ss_pred             eeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCc
Confidence            3579999999999998754  59999987542   223567889999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC-----
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM-----  456 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~-----  456 (615)
                      |.+++...    ...+++..+..++.|++.||+|||+.+   |+||||||+||+++ ++.+||+|||++......     
T Consensus       116 L~~~l~~~----~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~  187 (319)
T 2y4i_B          116 LYSVVRDA----KIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRR  187 (319)
T ss_dssp             HHHHTTSS----CCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC----------
T ss_pred             HHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCcccccccccccc
Confidence            99999743    236899999999999999999999998   99999999999998 679999999998765321     


Q ss_pred             ---CCCCCCCCcccCccccCC---------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccc
Q 007167          457 ---PPPAMRAAGYRAPEVTDT---------RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWT  524 (615)
Q Consensus       457 ---~~~~~~~~~y~aPE~~~~---------~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  524 (615)
                         .....++..|+|||.+..         ..++.++|||||||++|||++|+.||......+....+      ....  
T Consensus       188 ~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~------~~~~--  259 (319)
T 2y4i_B          188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM------GTGM--  259 (319)
T ss_dssp             CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH------HTTC--
T ss_pred             ccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh------ccCC--
Confidence               122346788999999864         35788999999999999999999999765433222111      1110  


Q ss_pred             cccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhh
Q 007167          525 AEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVK  577 (615)
Q Consensus       525 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~  577 (615)
                          .+.. ....+++++.+++.   +||..+|++|||+.|++++|+++....
T Consensus       260 ----~~~~-~~~~~~~~l~~li~---~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          260 ----KPNL-SQIGMGKEISDILL---FCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             ----CCCC-CCSSCCTTHHHHHH---HHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             ----CCCC-CcCCCCHHHHHHHH---HHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence                0111 11123344555554   999999999999999999999988654

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=3.9e-38  Score=328.67  Aligned_cols=250  Identities=19%  Similarity=0.309  Sum_probs=188.7

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecCe------eeEEee
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKDE------KLMVYD  375 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~------~~lV~e  375 (615)
                      +.||+|+||+||+|... +|+.||||++......   .+.+.+|+.+++.++||||+++++++.....      .++|||
T Consensus        30 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e  109 (353)
T 3coi_A           30 THVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMP  109 (353)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEE
T ss_pred             eeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEec
Confidence            56999999999999964 6889999999754332   3567899999999999999999999987654      499999


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      |+. |+|.+++..       .+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++....
T Consensus       110 ~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  178 (353)
T 3coi_A          110 FMQ-TDLQKIMGL-------KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADA  178 (353)
T ss_dssp             CCS-EEGGGTTTS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC---
T ss_pred             ccc-CCHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCCCC
Confidence            997 688887742       4899999999999999999999998   99999999999999999999999999987765


Q ss_pred             CCCCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccc------
Q 007167          456 MPPPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVF------  528 (615)
Q Consensus       456 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------  528 (615)
                      ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||...+..+....+.-........+...+.      
T Consensus       179 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  258 (353)
T 3coi_A          179 EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKS  258 (353)
T ss_dssp             -----CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHH
T ss_pred             CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHH
Confidence            5555678899999999876 678999999999999999999999998755332222111100000000000000      


Q ss_pred             ---------ccccc-CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          529 ---------DVELL-RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       529 ---------d~~~~-~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                               ..... ..+..++++.++++   +|+..||++|||+.|++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          259 YIQSLPQTPRKDFTQLFPRASPQAADLLE---KMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             HHHTSCBCSSCCTTTTCTTSCHHHHHHHH---HHSCSCTTTSCCHHHHHTS
T ss_pred             HHHhCcCCCCccHHHhcCCcCHHHHHHHH---HHcCCCcccCCCHHHHhcC
Confidence                     00000 12334556666665   9999999999999999876

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=9.1e-38  Score=316.06  Aligned_cols=242  Identities=22%  Similarity=0.366  Sum_probs=194.5

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc---CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN---VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .+.||+|+||+||+|... +++.||+|++....   ...+.+.+|++++++++||||+++++++.+.+..++||||++++
T Consensus        27 ~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~  106 (287)
T 2wei_A           27 VCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG  106 (287)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred             eEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCC
Confidence            467999999999999975 68899999986542   34567899999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCC---CcEEEeecccccccCCCC
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQ---GHVCVSDIGLAALMSPMP  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~---~~~kl~DfG~a~~~~~~~  457 (615)
                      +|.+.+...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.+   +.+||+|||++.......
T Consensus       107 ~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~  178 (287)
T 2wei_A          107 ELFDEIIKR-----KRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT  178 (287)
T ss_dssp             BHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS
T ss_pred             CHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecCCC
Confidence            999988643     25899999999999999999999998   9999999999999764   479999999998765432


Q ss_pred             C--CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCC
Q 007167          458 P--PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY  535 (615)
Q Consensus       458 ~--~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  535 (615)
                      .  ...++..|+|||.+.+ .++.++||||||+++|+|++|+.||......+...      ......     ........
T Consensus       179 ~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------~~~~~~-----~~~~~~~~  246 (287)
T 2wei_A          179 KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK------RVETGK-----YAFDLPQW  246 (287)
T ss_dssp             SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHCC-----CCCCSGGG
T ss_pred             ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHH------HHHcCC-----CCCCchhh
Confidence            2  2235778999999875 48999999999999999999999997654332221      111111     11111122


Q ss_pred             CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          536 PNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       536 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ..+++++.++++   +|+..||++|||+.|++++
T Consensus       247 ~~~~~~~~~li~---~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          247 RTISDDAKDLIR---KMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             TTSCHHHHHHHH---HHTCSSGGGSCCHHHHHHS
T ss_pred             hhcCHHHHHHHH---HHcccChhhCcCHHHHhcC
Confidence            344555555555   9999999999999999985

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.8e-38  Score=338.68  Aligned_cols=188  Identities=21%  Similarity=0.344  Sum_probs=159.0

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEec-----CeeeEEee
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSK-----DEKLMVYD  375 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lV~e  375 (615)
                      .+.||+|+||+||+|... +++.||||+++.....   .+.+.+|+++++.++||||+++++++...     ...++|||
T Consensus        31 ~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e  110 (432)
T 3n9x_A           31 KHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLE  110 (432)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEE
T ss_pred             EEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEe
Confidence            357999999999999965 5778999999754322   35688999999999999999999999776     57899999


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      |++ |+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++....
T Consensus       111 ~~~-~~L~~~~~~~-----~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~~~  181 (432)
T 3n9x_A          111 IAD-SDLKKLFKTP-----IFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTINS  181 (432)
T ss_dssp             CCS-EEHHHHHHSS-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC--
T ss_pred             cCC-cCHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcccccc
Confidence            986 6999999742     36999999999999999999999998   99999999999999999999999999987643


Q ss_pred             CC-------------------------CCCCCCCcccCcccc-CCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 007167          456 MP-------------------------PPAMRAAGYRAPEVT-DTRKATQASDVFSFGVLLLELLTGKSPIH  501 (615)
Q Consensus       456 ~~-------------------------~~~~~~~~y~aPE~~-~~~~~~~~~DvwS~Gvvl~elltg~~p~~  501 (615)
                      ..                         ....+|+.|+|||++ ....++.++||||+||++|||++|..||.
T Consensus       182 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~  253 (432)
T 3n9x_A          182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHI  253 (432)
T ss_dssp             -----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTC
T ss_pred             cccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccc
Confidence            21                         344678899999986 55669999999999999999998655543

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=2.9e-38  Score=321.94  Aligned_cols=242  Identities=21%  Similarity=0.367  Sum_probs=189.0

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccc-cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEV-NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~-~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      +.||+|+||+||+|... ++..||+|.+... ....+.+.+|+++++.++||||+++++++...+..++||||+++++|.
T Consensus        25 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~  104 (302)
T 2j7t_A           25 GELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVD  104 (302)
T ss_dssp             EEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHH
T ss_pred             ceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHH
Confidence            56999999999999976 5788999998754 334577899999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC---CCCCC
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP---MPPPA  460 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~---~~~~~  460 (615)
                      +++...    ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++.....   .....
T Consensus       105 ~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  177 (302)
T 2j7t_A          105 AIMLEL----DRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF  177 (302)
T ss_dssp             HHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC----
T ss_pred             HHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccccccccc
Confidence            988642    235899999999999999999999998   99999999999999999999999998754321   12234


Q ss_pred             CCCCcccCcccc-----CCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCC
Q 007167          461 MRAAGYRAPEVT-----DTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY  535 (615)
Q Consensus       461 ~~~~~y~aPE~~-----~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  535 (615)
                      .++..|+|||.+     ....++.++||||||+++|||++|+.||......+..      .........      .....
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~~~~~~~~~------~~~~~  245 (302)
T 2j7t_A          178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL------LKIAKSDPP------TLLTP  245 (302)
T ss_dssp             -CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH------HHHHHSCCC------CCSSG
T ss_pred             cCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHH------HHHhccCCc------ccCCc
Confidence            678899999998     4667899999999999999999999999765432211      111111100      01111


Q ss_pred             CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          536 PNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       536 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ..++.++.++++   +|+..||++|||+.|++++
T Consensus       246 ~~~~~~l~~li~---~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          246 SKWSVEFRDFLK---IALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             GGSCHHHHHHHH---HHSCSCTTTSCCHHHHTTS
T ss_pred             cccCHHHHHHHH---HHcccChhhCCCHHHHhcC
Confidence            223344555555   9999999999999999874

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=7.6e-38  Score=328.69  Aligned_cols=189  Identities=21%  Similarity=0.352  Sum_probs=156.5

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecC------eeeEEe
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKD------EKLMVY  374 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lV~  374 (615)
                      .+.||+|+||+||+|... +++.||||++......   .+.+.+|+++++.++||||+++++++...+      ..++||
T Consensus        30 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~  109 (371)
T 2xrw_A           30 LKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM  109 (371)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEE
T ss_pred             eeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEE
Confidence            356999999999999864 6788999999754322   356789999999999999999999997664      789999


Q ss_pred             ecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccC
Q 007167          375 DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS  454 (615)
Q Consensus       375 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~  454 (615)
                      ||++ |+|.+.+..       .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++...
T Consensus       110 e~~~-~~l~~~~~~-------~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~  178 (371)
T 2xrw_A          110 ELMD-ANLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG  178 (371)
T ss_dssp             ECCS-EEHHHHHHS-------CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred             EcCC-CCHHHHHhh-------ccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence            9997 578888752       4889999999999999999999998   9999999999999999999999999998765


Q ss_pred             CC--CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCC
Q 007167          455 PM--PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATG  504 (615)
Q Consensus       455 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~  504 (615)
                      ..  .....+|..|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus       179 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  230 (371)
T 2xrw_A          179 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD  230 (371)
T ss_dssp             -----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            43  233467889999999999899999999999999999999999998754

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.6e-38  Score=329.58  Aligned_cols=257  Identities=22%  Similarity=0.312  Sum_probs=180.1

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCe-------eeEEeec
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDE-------KLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-------~~lV~e~  376 (615)
                      .+.||+|+||+||+|... ++..||||++.........+.++++.++.++||||+++++++...+.       .++||||
T Consensus        28 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~  107 (360)
T 3e3p_A           28 ERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEY  107 (360)
T ss_dssp             C----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEEC
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeec
Confidence            357999999999999974 68899999987655545567788888899999999999999976543       7899999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhh--ccCCCCceecCCCCCCEEeCC-CCcEEEeeccccccc
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIH--TENGGKLVHGGIKASNIFLNS-QGHVCVSDIGLAALM  453 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH--~~~~~~iiHrDik~~Nill~~-~~~~kl~DfG~a~~~  453 (615)
                      +++ +|...+.... .....+++..+..++.|++.||.|||  +.+   |+||||||+|||++. ++.+||+|||+++..
T Consensus       108 ~~~-~l~~~~~~~~-~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~  182 (360)
T 3e3p_A          108 VPD-TLHRCCRNYY-RRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLCDFGSAKKL  182 (360)
T ss_dssp             CSC-BHHHHHHHHH-TTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEECCCTTCBCC
T ss_pred             ccc-cHHHHHHHHh-hcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEeeCCCceec
Confidence            976 5554443211 12346889999999999999999999  777   999999999999997 899999999999877


Q ss_pred             CCCC--CCCCCCCcccCccccCCCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHH-HHHH--------Hhhhc
Q 007167          454 SPMP--PPAMRAAGYRAPEVTDTRK-ATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLV-RWVN--------SVVRE  521 (615)
Q Consensus       454 ~~~~--~~~~~~~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~-~~~~--------~~~~~  521 (615)
                      ....  ....+|..|+|||++.+.. ++.++|||||||++|||++|+.||......+....+ +.+.        .....
T Consensus       183 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (360)
T 3e3p_A          183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPS  262 (360)
T ss_dssp             CTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTT
T ss_pred             CCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccc
Confidence            5433  2345788999999986544 899999999999999999999999875543322221 1110        00000


Q ss_pred             cccccccccc-------cc-CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          522 EWTAEVFDVE-------LL-RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       522 ~~~~~~~d~~-------~~-~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .......+..       .. .....++++.++   +.+|++.||++|||+.|++++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l---i~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          263 HTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDL---LSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             CCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHH---HHHHTCSSGGGSCCHHHHTTS
T ss_pred             hhhccccccccCCcccccchhhccccHHHHHH---HHHHhccCccccCCHHHHhcC
Confidence            0000000000       00 011134444444   459999999999999999986

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=3.8e-38  Score=320.38  Aligned_cols=242  Identities=19%  Similarity=0.348  Sum_probs=192.9

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccC----------CHHHHHHHHHHHhCCC-CCcccceeEEEEecCeeeEE
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV----------GKREFEQQMEIVGGIR-HENVVALRAYYYSKDEKLMV  373 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~----------~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV  373 (615)
                      +.||+|+||.||+|... +++.||||.++....          ..+.+.+|++++++++ ||||+++++++...+..++|
T Consensus        23 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv  102 (298)
T 1phk_A           23 EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLV  102 (298)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             eeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEE
Confidence            56999999999999975 578899999865421          1345778999999995 99999999999999999999


Q ss_pred             eecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeeccccccc
Q 007167          374 YDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALM  453 (615)
Q Consensus       374 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~  453 (615)
                      |||+++++|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++...
T Consensus       103 ~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  174 (298)
T 1phk_A          103 FDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQL  174 (298)
T ss_dssp             EECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EeccCCCcHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchhhc
Confidence            9999999999999743     36899999999999999999999998   999999999999999999999999999876


Q ss_pred             CCCC--CCCCCCCcccCccccC------CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccc
Q 007167          454 SPMP--PPAMRAAGYRAPEVTD------TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTA  525 (615)
Q Consensus       454 ~~~~--~~~~~~~~y~aPE~~~------~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (615)
                      ....  ....++..|+|||.+.      ...++.++||||||+++|||++|+.||......+...      .......  
T Consensus       175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~------~~~~~~~--  246 (298)
T 1phk_A          175 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLR------MIMSGNY--  246 (298)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHHTCC--
T ss_pred             CCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHH------HHhcCCc--
Confidence            5432  3345788999999874      4567899999999999999999999997644322211      1111110  


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          526 EVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       526 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                         .......+.+++++.++++   +|+..||++|||+.|++++
T Consensus       247 ---~~~~~~~~~~~~~l~~li~---~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          247 ---QFGSPEWDDYSDTVKDLVS---RFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             ---CCCTTTGGGSCHHHHHHHH---HHCCSSGGGSCCHHHHTTS
T ss_pred             ---ccCcccccccCHHHHHHHH---HHccCCcccCCCHHHHHhC
Confidence               0001111223445555555   9999999999999999874

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=7.8e-38  Score=322.33  Aligned_cols=255  Identities=20%  Similarity=0.326  Sum_probs=193.7

Q ss_pred             hhhcCcCCccEEEEEEE--CCCCEEEEEEeccccC---CHHHHHHHHHHHhCC---CCCcccceeEEEE-----ecCeee
Q 007167          305 AEVLGKGTFGTAYKAAL--EDASTVVVKRLKEVNV---GKREFEQQMEIVGGI---RHENVVALRAYYY-----SKDEKL  371 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~--~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l---~h~niv~l~~~~~-----~~~~~~  371 (615)
                      .+.||+|+||+||+|..  .+++.||+|+++....   ....+.+|+++++.+   +||||+++++++.     .....+
T Consensus        16 ~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~   95 (326)
T 1blx_A           16 VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLT   95 (326)
T ss_dssp             EEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEE
T ss_pred             eeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEE
Confidence            35699999999999997  4678899999875422   234567787777665   8999999999997     456789


Q ss_pred             EEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeeccccc
Q 007167          372 MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAA  451 (615)
Q Consensus       372 lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~  451 (615)
                      +||||+. |+|.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++
T Consensus        96 lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~Dfg~~~  168 (326)
T 1blx_A           96 LVFEHVD-QDLTTYLDKVP---EPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR  168 (326)
T ss_dssp             EEEECCS-CBHHHHHHHSC---TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             EEEecCC-CCHHHHHHhcc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEecCcccc
Confidence            9999997 69999987542   235899999999999999999999998   9999999999999999999999999998


Q ss_pred             ccCCC--CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHH-HHHHHhhhcccccccc
Q 007167          452 LMSPM--PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLV-RWVNSVVREEWTAEVF  528 (615)
Q Consensus       452 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  528 (615)
                      .....  .....++..|+|||.+.+..++.++|||||||++|||++|+.||......+....+ ..........|.....
T Consensus       169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  248 (326)
T 1blx_A          169 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA  248 (326)
T ss_dssp             CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred             cccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccc
Confidence            76532  23345788999999999889999999999999999999999999875433222111 1111111111211110


Q ss_pred             cc----------cc-cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          529 DV----------EL-LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       529 d~----------~~-~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+          .. ...+.+++++.+++.   +|+..||++|||+.|++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          249 LPRQAFHSKSAQPIEKFVTDIDELGKDLLL---KCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             SCGGGSCCCCCCCGGGTCCSCCHHHHHHHH---HHSCSSTTTSCCHHHHHTS
T ss_pred             cchhhhcccCcchhhhccccCCHHHHHHHH---HHcCCCcccCCCHHHHhcC
Confidence            00          00 112345566666665   9999999999999999875

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.8e-38  Score=320.02  Aligned_cols=244  Identities=20%  Similarity=0.354  Sum_probs=177.8

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      +.||+|+||+||+|.. .+++.||+|+++.....   .+.+.++...++.++||||+++++++.+.+..++||||++ |+
T Consensus        13 ~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~   91 (290)
T 3fme_A           13 MELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TS   91 (290)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EE
T ss_pred             HhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cc
Confidence            5699999999999996 47888999999754222   2234445556888899999999999999999999999997 58


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc-CCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--C
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE-NGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--P  458 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--~  458 (615)
                      |.+++..... ....+++..+..++.|++.||+|||++ +   |+||||||+||+++.++.+||+|||+++......  .
T Consensus        92 l~~~l~~~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  167 (290)
T 3fme_A           92 LDKFYKQVID-KGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD  167 (290)
T ss_dssp             HHHHHHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------------
T ss_pred             hHHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccccccccc
Confidence            8887754211 234799999999999999999999998 7   9999999999999999999999999998765432  2


Q ss_pred             CCCCCCcccCcccc----CCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccC
Q 007167          459 PAMRAAGYRAPEVT----DTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLR  534 (615)
Q Consensus       459 ~~~~~~~y~aPE~~----~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  534 (615)
                      ...++..|+|||.+    ....++.++||||+||++|||++|+.||...... ......    ......      +. ..
T Consensus       168 ~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~----~~~~~~------~~-~~  235 (290)
T 3fme_A          168 IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP-FQQLKQ----VVEEPS------PQ-LP  235 (290)
T ss_dssp             --CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCH-HHHHHH----HHHSCC------CC-CC
T ss_pred             ccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCch-HHHHHH----HhccCC------CC-cc
Confidence            33578899999996    5567899999999999999999999999753321 111111    111110      00 01


Q ss_pred             CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          535 YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       535 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ....++++.+++.   +|++.||++|||+.|++++
T Consensus       236 ~~~~~~~~~~li~---~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          236 ADKFSAEFVDFTS---QCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             TTTSCHHHHHHHH---HHTCSSGGGSCCHHHHTTS
T ss_pred             cccCCHHHHHHHH---HHhhcChhhCcCHHHHHhC
Confidence            1234455555555   9999999999999999984

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=5.3e-38  Score=352.46  Aligned_cols=247  Identities=23%  Similarity=0.385  Sum_probs=197.3

Q ss_pred             hhhcCcCCccEEEEEEECC----CCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALED----ASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      .+.||+|+||+||+|.+..    +..||||+++....  ..+.+.+|+.+++.++||||+++++++. ++..++||||++
T Consensus       395 ~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~  473 (656)
T 2j0j_A          395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCT  473 (656)
T ss_dssp             EEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred             eeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCC
Confidence            4679999999999998643    45689998875422  2367889999999999999999999984 567899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP  458 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~  458 (615)
                      +|+|.+++...    ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.......
T Consensus       474 ~g~L~~~l~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~  546 (656)
T 2j0j_A          474 LGELRSFLQVR----KFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY  546 (656)
T ss_dssp             TCBHHHHHHHT----TTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCCC---
T ss_pred             CCcHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecCCCcc
Confidence            99999999743    235899999999999999999999998   99999999999999999999999999987754321


Q ss_pred             ----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccccccccccc
Q 007167          459 ----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELL  533 (615)
Q Consensus       459 ----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  533 (615)
                          ...++..|+|||.+.+..++.++|||||||++|||++ |+.||......+....+   .   ...        ...
T Consensus       547 ~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i---~---~~~--------~~~  612 (656)
T 2j0j_A          547 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI---E---NGE--------RLP  612 (656)
T ss_dssp             -------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH---H---HTC--------CCC
T ss_pred             eeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---H---cCC--------CCC
Confidence                2234678999999988889999999999999999997 99999875443322211   1   110        111


Q ss_pred             CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          534 RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       534 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                      ..+.+++.+.+++.   +||..||++|||+.|+++.|+++.+.
T Consensus       613 ~~~~~~~~l~~li~---~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          613 MPPNCPPTLYSLMT---KCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             CCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCccccHHHHHHHH---HHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            12344455555555   99999999999999999999998654

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=5.7e-38  Score=325.07  Aligned_cols=246  Identities=18%  Similarity=0.299  Sum_probs=168.5

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEe----cCeeeEEeecCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYS----KDEKLMVYDYFEPG  380 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lV~e~~~~g  380 (615)
                      ++||+|+||+||+|... +++.||||++...   .....+....+..++||||+++++++..    +...++||||+++|
T Consensus        35 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg  111 (336)
T 3fhr_A           35 QVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGG  111 (336)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEESS---HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTE
T ss_pred             eeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HHHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCC
Confidence            46999999999999976 6889999998653   2222333344667799999999999976    44589999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCC---CCcEEEeecccccccCCCC
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNS---QGHVCVSDIGLAALMSPMP  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~---~~~~kl~DfG~a~~~~~~~  457 (615)
                      +|.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.   ++.+||+|||+++......
T Consensus       112 ~L~~~l~~~~---~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~  185 (336)
T 3fhr_A          112 ELFSRIQERG---DQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA  185 (336)
T ss_dssp             EHHHHHHTC----CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEEC----
T ss_pred             CHHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccceeccccc
Confidence            9999997542   246999999999999999999999998   999999999999986   4559999999998765432


Q ss_pred             -CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          458 -PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       458 -~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                       ....+|..|+|||++....++.++|||||||++|||++|+.||.............  ....     ..........+.
T Consensus       186 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~--~~~~-----~~~~~~~~~~~~  258 (336)
T 3fhr_A          186 LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMK--RRIR-----LGQYGFPNPEWS  258 (336)
T ss_dssp             ------------------CHHHHHHHHHHHHHHHHHHHHSSCCC----------------------------CCCTTTST
T ss_pred             cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHH--Hhhh-----ccccccCchhhc
Confidence             33457889999999988889999999999999999999999997654433211100  0000     000011111223


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                      .+++++.++++   +|+..||++|||+.|++++-
T Consensus       259 ~~~~~~~~li~---~~L~~dP~~Rpt~~ell~hp  289 (336)
T 3fhr_A          259 EVSEDAKQLIR---LLLKTDPTERLTITQFMNHP  289 (336)
T ss_dssp             TCCHHHHHHHH---HHSCSSGGGSCCHHHHHHSH
T ss_pred             cCCHHHHHHHH---HHCCCChhHCcCHHHHhcCc
Confidence            44556666555   99999999999999999863

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.9e-37  Score=315.57  Aligned_cols=242  Identities=22%  Similarity=0.370  Sum_probs=184.1

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEe-------------cCee
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYS-------------KDEK  370 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-------------~~~~  370 (615)
                      .+.||+|+||+||+|... +++.||||+++......+.+.+|+++++.++||||+++++++.+             ....
T Consensus        11 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~   90 (303)
T 1zy4_A           11 IAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTL   90 (303)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEE
T ss_pred             hheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCce
Confidence            457999999999999964 78899999997654445678899999999999999999999865             3567


Q ss_pred             eEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccc
Q 007167          371 LMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLA  450 (615)
Q Consensus       371 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a  450 (615)
                      ++||||+++|+|.+++...    ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||++
T Consensus        91 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~  163 (303)
T 1zy4_A           91 FIQMEYCENGTLYDLIHSE----NLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLA  163 (303)
T ss_dssp             EEEEECCCSCBHHHHHHHS----CGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCCC
T ss_pred             EEEEecCCCCCHHHhhhcc----ccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEeeCcch
Confidence            9999999999999999743    235788999999999999999999998   999999999999999999999999999


Q ss_pred             cccCCC-----------------CCCCCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHH
Q 007167          451 ALMSPM-----------------PPPAMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLV  512 (615)
Q Consensus       451 ~~~~~~-----------------~~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~  512 (615)
                      ......                 .....++..|+|||.+.+. .++.++|||||||++|||++   ||....  +.... 
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~--~~~~~-  237 (303)
T 1zy4_A          164 KNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGM--ERVNI-  237 (303)
T ss_dssp             SCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHHH-
T ss_pred             hhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCch--hHHHH-
Confidence            876421                 1223467889999998764 68999999999999999998   554311  11111 


Q ss_pred             HHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          513 RWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       513 ~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                        ........   ..+.+.  .....++.+.++++   +|++.||.+|||+.|++++
T Consensus       238 --~~~~~~~~---~~~~~~--~~~~~~~~~~~li~---~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          238 --LKKLRSVS---IEFPPD--FDDNKMKVEKKIIR---LLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             --HHHHHSTT---CCCCTT--CCTTTSHHHHHHHH---HHTCSSGGGSCCHHHHHHS
T ss_pred             --HHhccccc---cccCcc--ccccchHHHHHHHH---HHHhcCcccCcCHHHHhCC
Confidence              11111100   000011  11223344455554   9999999999999999874

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=6.5e-38  Score=321.70  Aligned_cols=249  Identities=24%  Similarity=0.386  Sum_probs=182.3

Q ss_pred             hhcCcCCccEEEEEEECC-CCEEEEEEecccc-CCHHHHHHHHHHHhCCCCCcccceeEEEE--------------ecCe
Q 007167          306 EVLGKGTFGTAYKAALED-ASTVVVKRLKEVN-VGKREFEQQMEIVGGIRHENVVALRAYYY--------------SKDE  369 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~--------------~~~~  369 (615)
                      +.||+|+||+||+|.... ++.||+|++.... ...+.+.+|+++++.++||||+++++++.              +...
T Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~   96 (320)
T 2i6l_A           17 KPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNS   96 (320)
T ss_dssp             EECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSE
T ss_pred             EEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCc
Confidence            569999999999999764 7889999987542 22467889999999999999999999873              3467


Q ss_pred             eeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeC-CCCcEEEeecc
Q 007167          370 KLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLN-SQGHVCVSDIG  448 (615)
Q Consensus       370 ~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~-~~~~~kl~DfG  448 (615)
                      .++||||++ |+|.+++..      ..+++..+..++.|++.||+|||+.+   |+||||||+||+++ +++.+||+|||
T Consensus        97 ~~lv~e~~~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~Dfg  166 (320)
T 2i6l_A           97 VYIVQEYME-TDLANVLEQ------GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFG  166 (320)
T ss_dssp             EEEEEECCS-EEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred             eeEEeeccC-CCHHHHhhc------CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEEccCc
Confidence            899999997 699999863      35889999999999999999999998   99999999999997 56799999999


Q ss_pred             cccccCCCC------CCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhh--
Q 007167          449 LAALMSPMP------PPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVV--  519 (615)
Q Consensus       449 ~a~~~~~~~------~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~--  519 (615)
                      +++......      ....++..|+|||.+.. ..++.++|||||||++|||++|+.||......+....+  +....  
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~--~~~~~~~  244 (320)
T 2i6l_A          167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLI--LESIPVV  244 (320)
T ss_dssp             TCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH--HHHSCCC
T ss_pred             cccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHH--HHhcCCC
Confidence            998764321      22235778999998755 67899999999999999999999999875432221111  11100  


Q ss_pred             hccccccc-------ccccc--------cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          520 REEWTAEV-------FDVEL--------LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       520 ~~~~~~~~-------~d~~~--------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ......+.       .....        ...+.+++++.++++   +|++.||++|||+.|++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLE---QILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHH---TTSCSSGGGSCCHHHHHTS
T ss_pred             chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHH---HHcCCCccccCCHHHHhCC
Confidence            00000000       00000        011234455555555   9999999999999999886

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.5e-37  Score=333.11  Aligned_cols=244  Identities=19%  Similarity=0.303  Sum_probs=179.8

Q ss_pred             hhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCCCCChhh
Q 007167          306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFEPGSVSA  384 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  384 (615)
                      ++||+|+||+||.+...+|+.||||++....  .+.+.+|++++.++ +|||||++++++.+++..++||||+. |+|.+
T Consensus        21 ~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~   97 (434)
T 2rio_A           21 KILGYGSSGTVVFQGSFQGRPVAVKRMLIDF--CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQD   97 (434)
T ss_dssp             EEEEECSTTCEEEEEESSSSEEEEEEEEGGG--HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHH
T ss_pred             CeEeeCCCeEEEEEEEECCeEEEEEEEcHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHH
Confidence            5699999999988777789999999986532  45678899999876 89999999999999999999999995 69999


Q ss_pred             hhccCCCCCC--CCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCC-------------CcEEEeeccc
Q 007167          385 MLHGRRGEGQ--SSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQ-------------GHVCVSDIGL  449 (615)
Q Consensus       385 ~l~~~~~~~~--~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~-------------~~~kl~DfG~  449 (615)
                      ++........  ...++..+..++.|++.||+|||+.+   |+||||||+|||++.+             +++||+|||+
T Consensus        98 ~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~  174 (434)
T 2rio_A           98 LVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGL  174 (434)
T ss_dssp             HHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTT
T ss_pred             HHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEEEccccc
Confidence            9975432111  11233456789999999999999998   9999999999999754             4899999999


Q ss_pred             ccccCCCC-------CCCCCCCcccCccccCC-------CCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHH
Q 007167          450 AALMSPMP-------PPAMRAAGYRAPEVTDT-------RKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRW  514 (615)
Q Consensus       450 a~~~~~~~-------~~~~~~~~y~aPE~~~~-------~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~  514 (615)
                      ++.+....       ....+|.+|+|||++.+       ..++.++|||||||++|||++ |+.||......+    ...
T Consensus       175 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~----~~i  250 (434)
T 2rio_A          175 CKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE----SNI  250 (434)
T ss_dssp             CEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH----HHH
T ss_pred             ceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH----HHH
Confidence            98775432       12357889999999865       568999999999999999999 999997543322    111


Q ss_pred             HHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007167          515 VNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK  568 (615)
Q Consensus       515 ~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  568 (615)
                      +....         +..............++.+++.+|++.||.+|||+.||++
T Consensus       251 ~~~~~---------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          251 IRGIF---------SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             HHTCC---------CCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hcCCC---------CcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            11110         0000011111222234455555999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.4e-37  Score=320.88  Aligned_cols=249  Identities=18%  Similarity=0.326  Sum_probs=171.9

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC--HHHHHHHHH-HHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG--KREFEQQME-IVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~--~~~~~~e~~-~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .+.||+|+||.||+|... +++.||||+++.....  ...+..|+. +++.++||||+++++++...+..++||||+++ 
T Consensus        27 ~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-  105 (327)
T 3aln_A           27 LGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-  105 (327)
T ss_dssp             -CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-
T ss_pred             hheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-
Confidence            356999999999999975 6888999999764322  234555555 77888999999999999999999999999975 


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc-CCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE-NGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      +|.+++..........+++..+..++.|++.||.|||+. +   |+||||||+||+++.++.+||+|||+++......  
T Consensus       106 ~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  182 (327)
T 3aln_A          106 SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK  182 (327)
T ss_dssp             EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC-------
T ss_pred             ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceeccccccc
Confidence            788777532212234789999999999999999999998 7   9999999999999999999999999998765432  


Q ss_pred             CCCCCCCcccCcccc----CCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccccccc
Q 007167          458 PPAMRAAGYRAPEVT----DTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELL  533 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~----~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  533 (615)
                      ....++..|+|||.+    .+..++.++|||||||++|||++|+.||.......  .   .+......    ........
T Consensus       183 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~---~~~~~~~~----~~~~~~~~  253 (327)
T 3aln_A          183 TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF--D---QLTQVVKG----DPPQLSNS  253 (327)
T ss_dssp             -----------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC------------CCCCCS----CCCCCCCC
T ss_pred             ccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH--H---HHHHHhcC----CCCCCCCc
Confidence            223578899999998    45668999999999999999999999997643210  0   00000000    00000000


Q ss_pred             CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          534 RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       534 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ....+++++.++++   +||..||++||++.|++++
T Consensus       254 ~~~~~~~~l~~li~---~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          254 EEREFSPSFINFVN---LCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             SSCCCCHHHHHHHH---HHTCSSGGGSCCHHHHTTS
T ss_pred             ccccCCHHHHHHHH---HHhhCChhhCcCHHHHHhC
Confidence            11234555555555   9999999999999999875

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.3e-37  Score=324.54  Aligned_cols=251  Identities=21%  Similarity=0.328  Sum_probs=189.0

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEec-----CeeeEEeecC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSK-----DEKLMVYDYF  377 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lV~e~~  377 (615)
                      +.||+|+||+||+|... +++.||||+++....  ....+.+|+++++.++||||+++++++...     ...++||||+
T Consensus        17 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~   96 (353)
T 2b9h_A           17 SLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM   96 (353)
T ss_dssp             EEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCC
T ss_pred             eEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEecc
Confidence            56999999999999965 678899999964322  235678999999999999999999998764     6789999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC
Q 007167          378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP  457 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~  457 (615)
                      . |+|.+++..      ..+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++......
T Consensus        97 ~-~~L~~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  166 (353)
T 2b9h_A           97 Q-TDLHRVIST------QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESA  166 (353)
T ss_dssp             S-EEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECC---
T ss_pred             C-ccHHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccccccccc
Confidence            6 689998864      25899999999999999999999998   9999999999999999999999999998765321


Q ss_pred             -------------CCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhh-cc
Q 007167          458 -------------PPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVR-EE  522 (615)
Q Consensus       458 -------------~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~-~~  522 (615)
                                   ....+|..|+|||++.. ..++.++|||||||++|||++|+.||......+....+.-...... ..
T Consensus       167 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
T 2b9h_A          167 ADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN  246 (353)
T ss_dssp             -------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTT
T ss_pred             ccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhc
Confidence                         12356888999998754 6789999999999999999999999987543222111110000000 00


Q ss_pred             ccccccc-------ccc---------cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          523 WTAEVFD-------VEL---------LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       523 ~~~~~~d-------~~~---------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .......       ..+         ...+..++++.++++   +|+..||++|||+.|++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~---~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQ---RMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             TTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHH---HHSCSSGGGSCCHHHHHTS
T ss_pred             cccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHH---HhcCcCcccCCCHHHHhcC
Confidence            0000000       000         011234455555555   9999999999999999885

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.1e-37  Score=329.88  Aligned_cols=239  Identities=19%  Similarity=0.273  Sum_probs=178.0

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      .++||+|+||+||.....+++.||||++....  ...+.+|+++++.+ +|||||++++++.+.+..++||||+. |+|.
T Consensus        29 ~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~--~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~  105 (432)
T 3p23_A           29 KDVLGHGAEGTIVYRGMFDNRDVAVKRILPEC--FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQ  105 (432)
T ss_dssp             EEEEEECGGGCEEEEEESSSSEEEEEEECTTT--EEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHH
T ss_pred             CCeeecCcCEEEEEEEEeCCeEEEEEEECHHH--HHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHH
Confidence            35799999999776666788999999996432  23467899999998 79999999999999999999999996 6999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCC-----CCcEEEeecccccccCCC--
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNS-----QGHVCVSDIGLAALMSPM--  456 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~-----~~~~kl~DfG~a~~~~~~--  456 (615)
                      +++.....    ...+..+..++.|++.||+|||+.+   |+||||||+|||++.     ...+||+|||+++.....  
T Consensus       106 ~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~  178 (432)
T 3p23_A          106 EYVEQKDF----AHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH  178 (432)
T ss_dssp             HHHHSSSC----CCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-----
T ss_pred             HHHHhcCC----CccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc
Confidence            99975432    2344456789999999999999998   999999999999953     336889999999876532  


Q ss_pred             ----CCCCCCCCcccCccccC---CCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccc
Q 007167          457 ----PPPAMRAAGYRAPEVTD---TRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVF  528 (615)
Q Consensus       457 ----~~~~~~~~~y~aPE~~~---~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  528 (615)
                          .....+|.+|+|||++.   ...++.++|||||||++|||++ |+.||........    ...   . ......  
T Consensus       179 ~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~----~~~---~-~~~~~~--  248 (432)
T 3p23_A          179 SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQA----NIL---L-GACSLD--  248 (432)
T ss_dssp             -------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHH----HHH---T-TCCCCT--
T ss_pred             ceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHH----HHH---h-ccCCcc--
Confidence                22345899999999997   4567889999999999999999 9999965332211    110   0 000000  


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHH
Q 007167          529 DVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK  568 (615)
Q Consensus       529 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~  568 (615)
                        ........+..+.   +++.+|++.||++|||+.||++
T Consensus       249 --~~~~~~~~~~~~~---~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          249 --CLHPEKHEDVIAR---ELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             --TSCTTCHHHHHHH---HHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --ccCccccccHHHH---HHHHHHHhCCHhhCCCHHHHHh
Confidence              0001112233344   4555999999999999999985

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=8.8e-38  Score=321.43  Aligned_cols=233  Identities=19%  Similarity=0.394  Sum_probs=189.9

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccC-------CHHHHHHHHHHHhCCC--CCcccceeEEEEecCeeeEEe
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNV-------GKREFEQQMEIVGGIR--HENVVALRAYYYSKDEKLMVY  374 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lV~  374 (615)
                      .+.||+|+||+||+|.. .+++.||||+++....       ..+.+.+|++++++++  |+||+++++++...+..++|+
T Consensus        48 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~  127 (320)
T 3a99_A           48 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL  127 (320)
T ss_dssp             EEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred             EEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEE
Confidence            35699999999999985 4678899999975432       1245678999999986  599999999999999999999


Q ss_pred             ecCCC-CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeC-CCCcEEEeecccccc
Q 007167          375 DYFEP-GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLN-SQGHVCVSDIGLAAL  452 (615)
Q Consensus       375 e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~-~~~~~kl~DfG~a~~  452 (615)
                      ||+.+ ++|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++ +++.+||+|||+++.
T Consensus       128 e~~~~~~~L~~~l~~~-----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~  199 (320)
T 3a99_A          128 ERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGAL  199 (320)
T ss_dssp             ECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EcCCCCccHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence            99976 8999999743     36899999999999999999999998   99999999999999 788999999999987


Q ss_pred             cCCCC-CCCCCCCcccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccc
Q 007167          453 MSPMP-PPAMRAAGYRAPEVTDTRKA-TQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDV  530 (615)
Q Consensus       453 ~~~~~-~~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  530 (615)
                      ..... ....+|..|+|||++.+..+ +.++|||||||++|||++|+.||....     ...       ..         
T Consensus       200 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~-----~~~-------~~---------  258 (320)
T 3a99_A          200 LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EII-------RG---------  258 (320)
T ss_dssp             CCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHH-------HC---------
T ss_pred             cccccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh-----hhh-------cc---------
Confidence            75432 33457889999999876665 678999999999999999999996421     000       00         


Q ss_pred             cccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          531 ELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       531 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .......+++++.++++   +||..||++|||+.|++++
T Consensus       259 ~~~~~~~~~~~~~~li~---~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          259 QVFFRQRVSSECQHLIR---WCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             CCCCSSCCCHHHHHHHH---HHTCSSGGGSCCHHHHHTS
T ss_pred             cccccccCCHHHHHHHH---HHccCChhhCcCHHHHhcC
Confidence            01112234555555555   9999999999999999875

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1e-36  Score=312.41  Aligned_cols=240  Identities=19%  Similarity=0.334  Sum_probs=186.8

Q ss_pred             hhcCcCCccEEEEEEECCCCEEEEEEeccccCC---HHHHHHHHHHHhCCC--CCcccceeEEEEecCeeeEEeecCCCC
Q 007167          306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVG---KREFEQQMEIVGGIR--HENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      +.||+|+||.||++...+++.||||++......   .+.+.+|++++.+++  |+||+++++++...+..++||| +.++
T Consensus        34 ~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~  112 (313)
T 3cek_A           34 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNI  112 (313)
T ss_dssp             EEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSE
T ss_pred             EEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCC
Confidence            569999999999999888999999999754333   356789999999997  5999999999999999999999 5688


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---  457 (615)
                      +|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||++++ +.+||+|||+++......   
T Consensus       113 ~L~~~l~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~  183 (313)
T 3cek_A          113 DLNSWLKKK-----KSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSV  183 (313)
T ss_dssp             EHHHHHHHC-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC--------
T ss_pred             cHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeeccccccccCccccc
Confidence            999999743     36899999999999999999999998   999999999999964 899999999998765432   


Q ss_pred             --CCCCCCCcccCccccCC-----------CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccc
Q 007167          458 --PPAMRAAGYRAPEVTDT-----------RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWT  524 (615)
Q Consensus       458 --~~~~~~~~y~aPE~~~~-----------~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  524 (615)
                        ....++..|+|||.+.+           ..++.++|||||||++|||++|+.||.......     ..+........ 
T Consensus       184 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----~~~~~~~~~~~-  257 (313)
T 3cek_A          184 VKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----SKLHAIIDPNH-  257 (313)
T ss_dssp             ------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HHHHHHHCTTS-
T ss_pred             cccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-----HHHHHHHhccc-
Confidence              23357889999999865           467889999999999999999999997543211     11111111110 


Q ss_pred             cccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          525 AEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       525 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                            ........++++.++++   +||..||++||++.|++++-
T Consensus       258 ------~~~~~~~~~~~l~~li~---~~l~~dp~~Rps~~ell~h~  294 (313)
T 3cek_A          258 ------EIEFPDIPEKDLQDVLK---CCLKRDPKQRISIPELLAHP  294 (313)
T ss_dssp             ------CCCCCCCSCHHHHHHHH---HHTCSSTTTSCCHHHHHTSH
T ss_pred             ------ccCCcccchHHHHHHHH---HHccCCcccCcCHHHHhcCc
Confidence                  00111223445555555   99999999999999999874

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.3e-36  Score=307.44  Aligned_cols=227  Identities=14%  Similarity=0.060  Sum_probs=177.2

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC----HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG----KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      +.||+|+||+||+|... +++.||||++......    .+.+.+|++++..++||||+++++++.+++..++||||++++
T Consensus        37 ~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~  116 (286)
T 3uqc_A           37 IFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGG  116 (286)
T ss_dssp             EEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEE
T ss_pred             EEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCC
Confidence            46999999999999975 4889999999765332    267889999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCCC
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPA  460 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  460 (615)
                      +|.+++...       .......+++.|++.||+|||+.+   |+||||||+|||++.++.+||+++|            
T Consensus       117 ~L~~~l~~~-------~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~------------  174 (286)
T 3uqc_A          117 SLQEVADTS-------PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA------------  174 (286)
T ss_dssp             EHHHHHTTC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC------------
T ss_pred             CHHHHHhcC-------CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc------------
Confidence            999999531       344568889999999999999998   9999999999999999999998544            


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE  540 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  540 (615)
                           |++       .++.++|||||||++|||++|+.||......+......        ..............+.+++
T Consensus       175 -----~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~  234 (286)
T 3uqc_A          175 -----TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE--------RDTAGQPIEPADIDRDIPF  234 (286)
T ss_dssp             -----CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECC--------BCTTSCBCCHHHHCTTSCH
T ss_pred             -----ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHH--------HHhccCCCChhhcccCCCH
Confidence                 333       36889999999999999999999998755432110000        0000000000011234455


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhhc
Q 007167          541 EMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKA  578 (615)
Q Consensus       541 ~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~  578 (615)
                      ++.++++   +||+.||++| |+.|+++.|+++.....
T Consensus       235 ~l~~li~---~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          235 QISAVAA---RSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             HHHHHHH---HHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             HHHHHHH---HHcccCCccC-CHHHHHHHHHHHhccCC
Confidence            6656555   9999999999 99999999999886543

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-37  Score=316.92  Aligned_cols=233  Identities=21%  Similarity=0.385  Sum_probs=183.9

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccC-------CHHHHHHHHHHHhCC----CCCcccceeEEEEecCeeeE
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNV-------GKREFEQQMEIVGGI----RHENVVALRAYYYSKDEKLM  372 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~-------~~~~~~~e~~~l~~l----~h~niv~l~~~~~~~~~~~l  372 (615)
                      .+.||+|+||.||+|.. .+++.||||++.....       ....+.+|++++.++    +|+||+++++++...+..++
T Consensus        36 ~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~  115 (312)
T 2iwi_A           36 GPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFML  115 (312)
T ss_dssp             EEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEE
T ss_pred             eeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEE
Confidence            45799999999999985 4688999999965422       123456788888887    89999999999999999999


Q ss_pred             Eeec-CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeC-CCCcEEEeecccc
Q 007167          373 VYDY-FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLN-SQGHVCVSDIGLA  450 (615)
Q Consensus       373 V~e~-~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~-~~~~~kl~DfG~a  450 (615)
                      |+|| +.+++|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+||+++ .++.+||+|||++
T Consensus       116 v~e~~~~~~~L~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~dfg~~  187 (312)
T 2iwi_A          116 VLERPLPAQDLFDYITEK-----GPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSG  187 (312)
T ss_dssp             EEECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECCCSSC
T ss_pred             EEEecCCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEEcchh
Confidence            9999 7899999999753     25899999999999999999999998   99999999999999 8899999999999


Q ss_pred             cccCCCC-CCCCCCCcccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccc
Q 007167          451 ALMSPMP-PPAMRAAGYRAPEVTDTRKA-TQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVF  528 (615)
Q Consensus       451 ~~~~~~~-~~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  528 (615)
                      ....... ....++..|+|||++.+..+ +.++||||||+++|||++|+.||....     ...   .            
T Consensus       188 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~-----~~~---~------------  247 (312)
T 2iwi_A          188 ALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ-----EIL---E------------  247 (312)
T ss_dssp             EECCSSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HHH---H------------
T ss_pred             hhcccCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH-----HHh---h------------
Confidence            8775432 33457889999999876665 458999999999999999999996421     000   0            


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          529 DVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       529 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                       .........++++.++++   +|++.+|++|||+.|++++
T Consensus       248 -~~~~~~~~~~~~~~~li~---~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          248 -AELHFPAHVSPDCCALIR---RCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             -TCCCCCTTSCHHHHHHHH---HHTCSSTTTSCCHHHHHHS
T ss_pred             -hccCCcccCCHHHHHHHH---HHccCChhhCcCHHHHhcC
Confidence             011112234455555555   9999999999999999875

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=2.5e-36  Score=309.80  Aligned_cols=243  Identities=19%  Similarity=0.325  Sum_probs=173.2

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCH---HHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGK---REFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~---~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      .+.||+|+||+||+|... +++.||||++.......   +.+.++..+++.++||||+++++++.+.+..++||||+ ++
T Consensus        30 ~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~  108 (318)
T 2dyl_A           30 LGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GT  108 (318)
T ss_dssp             EEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SE
T ss_pred             cceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CC
Confidence            356999999999999975 68899999997543222   23444555788889999999999999999999999999 55


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc-CCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE-NGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      .+..+....    ...+++..+..++.|++.||+|||+. +   |+||||||+||+++.++.+||+|||++.......  
T Consensus       109 ~~~~l~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~  181 (318)
T 2dyl_A          109 CAEKLKKRM----QGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK  181 (318)
T ss_dssp             EHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             cHHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCCccc
Confidence            555555422    23689999999999999999999995 7   9999999999999999999999999997664332  


Q ss_pred             CCCCCCCcccCccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccc
Q 007167          458 PPAMRAAGYRAPEVTD-----TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL  532 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  532 (615)
                      ....++..|+|||.+.     ...++.++|||||||++|||++|+.||.......  ..   +........      +..
T Consensus       182 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~---~~~~~~~~~------~~~  250 (318)
T 2dyl_A          182 DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF--EV---LTKVLQEEP------PLL  250 (318)
T ss_dssp             -----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HH---HHHHHHSCC------CCC
T ss_pred             cccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH--HH---HHHHhccCC------CCC
Confidence            2345788999999984     4568899999999999999999999997633211  11   111111110      111


Q ss_pred             cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       533 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .....+++++.++++   +||..||.+||+++|++++
T Consensus       251 ~~~~~~~~~l~~li~---~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          251 PGHMGFSGDFQSFVK---DCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             CSSSCCCHHHHHHHH---HHTCSCTTTSCCHHHHTTS
T ss_pred             CccCCCCHHHHHHHH---HHccCChhHCcCHHHHhhC
Confidence            112234556656555   9999999999999999885

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=1.3e-36  Score=323.82  Aligned_cols=237  Identities=15%  Similarity=0.169  Sum_probs=176.7

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEecccc----CCHHHHHHHHHHHhCCCC-Ccccc--------------------
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEVN----VGKREFEQQMEIVGGIRH-ENVVA--------------------  359 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~----~~~~~~~~e~~~l~~l~h-~niv~--------------------  359 (615)
                      ++||+|+||+||+|.+ .+|+.||||+++...    ...+.+.+|+.+++.++| +|...                    
T Consensus        84 ~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (413)
T 3dzo_A           84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKK  163 (413)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC--
T ss_pred             cccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCC
Confidence            5699999999999995 468999999987332    224678899999999977 32211                    


Q ss_pred             -eeEEEEe-----cCeeeEEeecCCCCChhhhhccCC--CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCC
Q 007167          360 -LRAYYYS-----KDEKLMVYDYFEPGSVSAMLHGRR--GEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKA  431 (615)
Q Consensus       360 -l~~~~~~-----~~~~~lV~e~~~~gsL~~~l~~~~--~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~  431 (615)
                       +..++..     ....+++|+++ +++|.+++....  ......+++..+..++.|++.||+|||+++   |+||||||
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---iiHrDiKp  239 (413)
T 3dzo_A          164 KMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRP  239 (413)
T ss_dssp             -------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EECSCCCG
T ss_pred             ccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCccc
Confidence             1111111     12356667665 689999884210  112346889999999999999999999998   99999999


Q ss_pred             CCEEeCCCCcEEEeecccccccCCCCCCCCCCCcccCcccc----------CCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 007167          432 SNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEVT----------DTRKATQASDVFSFGVLLLELLTGKSPIH  501 (615)
Q Consensus       432 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~DvwS~Gvvl~elltg~~p~~  501 (615)
                      +|||++.++.+||+|||+++..........+ ..|+|||++          ....++.++|||||||++|||++|+.||.
T Consensus       240 ~NILl~~~~~~kL~DFG~a~~~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~  318 (413)
T 3dzo_A          240 VDIVLDQRGGVFLTGFEHLVRDGASAVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT  318 (413)
T ss_dssp             GGEEECTTCCEEECCGGGCEETTEEECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCC
T ss_pred             ceEEEecCCeEEEEeccceeecCCccccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCC
Confidence            9999999999999999999877655455566 899999998          55568889999999999999999999997


Q ss_pred             CCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          502 ATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       502 ~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .....+...                   ..+...+.+++++.++++   +||+.||++||++.|++++
T Consensus       319 ~~~~~~~~~-------------------~~~~~~~~~~~~~~~li~---~~l~~dP~~Rpt~~~~l~~  364 (413)
T 3dzo_A          319 DDAALGGSE-------------------WIFRSCKNIPQPVRALLE---GFLRYPKEDRLLPLQAMET  364 (413)
T ss_dssp             TTGGGSCSG-------------------GGGSSCCCCCHHHHHHHH---HHTCSSGGGSCCHHHHTTS
T ss_pred             CcchhhhHH-------------------HHHhhcccCCHHHHHHHH---HHccCChhhCcCHHHHHhC
Confidence            644322211                   111122344566666655   9999999999998887654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=8.2e-36  Score=303.63  Aligned_cols=226  Identities=17%  Similarity=0.314  Sum_probs=173.6

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEeccccCCHHHHHHHHHHH-hCCCCCcccceeEEEEe----cCeeeEEeecCCC
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVGKREFEQQMEIV-GGIRHENVVALRAYYYS----KDEKLMVYDYFEP  379 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l-~~l~h~niv~l~~~~~~----~~~~~lV~e~~~~  379 (615)
                      ++||+|+||.||+|.. .+++.||+|+++.    ...+.+|++++ +..+||||+++++++..    ....++||||+++
T Consensus        24 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~   99 (299)
T 3m2w_A           24 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG   99 (299)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCS
T ss_pred             cccccCCCeEEEEEEEcCCCcEEEEEEecc----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCC
Confidence            4699999999999986 4688999999964    34677888887 66699999999999987    6778999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCC---CCcEEEeecccccccCCC
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNS---QGHVCVSDIGLAALMSPM  456 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~---~~~~kl~DfG~a~~~~~~  456 (615)
                      |+|.+++....   ...+++..+..++.|++.||+|||+.+   |+||||||+||+++.   ++.+||+|||++..... 
T Consensus       100 ~~L~~~l~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~-  172 (299)
T 3m2w_A          100 GELFSRIQDRG---DQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG-  172 (299)
T ss_dssp             CBHHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT-
T ss_pred             CcHHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccccccccc-
Confidence            99999997532   246999999999999999999999998   999999999999998   78999999999875432 


Q ss_pred             CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          457 PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       457 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                                        ..++.++|||||||++|||++|+.||......+.....       .................
T Consensus       173 ------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~  227 (299)
T 3m2w_A          173 ------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM-------KTRIRMGQYEFPNPEWS  227 (299)
T ss_dssp             ------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCS-------CCSSCTTCCSSCHHHHT
T ss_pred             ------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHH-------HHHHhhccccCCchhcc
Confidence                              34678999999999999999999999764432211000       00000000000000012


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKMV  570 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L  570 (615)
                      .+++++.++++   +|+..||++|||+.|++++-
T Consensus       228 ~~~~~~~~li~---~~l~~dP~~Rps~~e~l~hp  258 (299)
T 3m2w_A          228 EVSEEVKMLIR---NLLKTEPTQRMTITEFMNHP  258 (299)
T ss_dssp             TSCHHHHHHHH---HHTCSSTTTSCCHHHHHTSH
T ss_pred             cCCHHHHHHHH---HHcccChhhCCCHHHHhcCh
Confidence            34455555555   99999999999999999863

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=5.6e-36  Score=330.74  Aligned_cols=260  Identities=22%  Similarity=0.316  Sum_probs=194.3

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEe------cCeeeEEee
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYS------KDEKLMVYD  375 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~------~~~~~lV~e  375 (615)
                      .+.||+|+||+||+|.. .++..||||+++....  ..+.+.+|++++++++||||+++++++..      .+..++|||
T Consensus        19 ~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmE   98 (676)
T 3qa8_A           19 KERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAME   98 (676)
T ss_dssp             CCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEE
T ss_pred             EEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEE
Confidence            46799999999999986 4688999999875422  24568899999999999999999999765      667899999


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCc---EEEeecccccc
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGH---VCVSDIGLAAL  452 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~---~kl~DfG~a~~  452 (615)
                      |+++|+|.+++....  ....+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.   +||+|||++..
T Consensus        99 y~~ggsL~~~L~~~~--~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~  173 (676)
T 3qa8_A           99 YCEGGDLRKYLNQFE--NCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE  173 (676)
T ss_dssp             CCSSCBHHHHHHSSS--CTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCCCCB
T ss_pred             eCCCCCHHHHHHhcc--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEcccccccc
Confidence            999999999997543  2335888999999999999999999998   999999999999997664   99999999987


Q ss_pred             cCCCC--CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccc---
Q 007167          453 MSPMP--PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEV---  527 (615)
Q Consensus       453 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  527 (615)
                      .....  ....++..|+|||.+.+..++.++|||||||++|||++|+.||.....     ...|.............   
T Consensus       174 ~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~-----~~~~~~~i~~~~~~~~~~~~  248 (676)
T 3qa8_A          174 LDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ-----PVQWHGKVREKSNEHIVVYD  248 (676)
T ss_dssp             TTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCH-----HHHSSTTCC------CCSCC
T ss_pred             cccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccc-----hhhhhhhhhcccchhhhhhh
Confidence            75432  334678899999999999999999999999999999999999975321     11111111100000000   


Q ss_pred             -------ccccccC----CCCcHHHHHHHHHHHHHcccCCCCCCCCHHH-----HHHHHHHhHhhh
Q 007167          528 -------FDVELLR----YPNIEEEMVEMLQVGMACVVRMPEERPKMAD-----VLKMVEDIRRVK  577 (615)
Q Consensus       528 -------~d~~~~~----~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~e-----vl~~L~~l~~~~  577 (615)
                             +......    .+.+++.+.++++   +|+..||++|||+.|     ..+.++++....
T Consensus       249 ~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~---~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k  311 (676)
T 3qa8_A          249 DLTGAVKFSSVLPTPNHLSGILAGKLERWLQ---CMLMWHQRQRGTDPQNPNVGCFQALDSILSLK  311 (676)
T ss_dssp             CCSSSCCCCSSSCCSCCCCGGGHHHHHHHHH---HHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred             hhccccccccccCCchhhchhhhHHHHHHHH---HHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence                   0011110    1124455555555   999999999999988     556666666544

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.5e-35  Score=335.43  Aligned_cols=233  Identities=16%  Similarity=0.223  Sum_probs=184.1

Q ss_pred             hhhcCcCCccEEEEEEEC--CCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCe-----eeEEee
Q 007167          305 AEVLGKGTFGTAYKAALE--DASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDE-----KLMVYD  375 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~--~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~-----~~lV~e  375 (615)
                      .++||+|+||+||+|.+.  +++.||||++.....  ....+.+|++++++++||||+++++++...+.     .++|||
T Consensus        85 ~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E  164 (681)
T 2pzi_A           85 KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVME  164 (681)
T ss_dssp             EEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEE
T ss_pred             EEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEE
Confidence            356999999999999975  578999999865322  23567899999999999999999999988765     699999


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      |+++++|.+++..       .++|..+..++.|++.||+|||+.+   |+||||||+|||++.+ .+||+|||+++....
T Consensus       165 ~~~g~~L~~~~~~-------~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~  233 (681)
T 2pzi_A          165 YVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRINS  233 (681)
T ss_dssp             CCCCEECC----C-------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEETTC
T ss_pred             eCCCCcHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhccc
Confidence            9999999987742       5899999999999999999999998   9999999999999986 899999999987765


Q ss_pred             CCCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCC
Q 007167          456 MPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY  535 (615)
Q Consensus       456 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  535 (615)
                      . ....+|++|+|||++.+. ++.++|||||||++|||++|..||.........                        ..
T Consensus       234 ~-~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~------------------------~~  287 (681)
T 2pzi_A          234 F-GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP------------------------ED  287 (681)
T ss_dssp             C-SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC------------------------TT
T ss_pred             C-CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccc------------------------cc
Confidence            4 445689999999998664 488999999999999999999888642211100                        00


Q ss_pred             CCcHHHHHHHHHHHHHcccCCCCCCCC-HHHHHHHHHHhH
Q 007167          536 PNIEEEMVEMLQVGMACVVRMPEERPK-MADVLKMVEDIR  574 (615)
Q Consensus       536 ~~~~~~~~~l~~l~~~cl~~~P~~RPs-~~evl~~L~~l~  574 (615)
                      .........+.+++.+|++.||++||+ ++++.+.|..+.
T Consensus       288 ~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          288 DPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             CHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence            000111124455566999999999994 666666666653

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=5.2e-35  Score=302.81  Aligned_cols=187  Identities=14%  Similarity=0.147  Sum_probs=156.5

Q ss_pred             HHHhhhcCcCCccEEEEEEECCCCEEEEEEeccccC---------CHHHHHHHHHHHhCCC---------CCcccceeEE
Q 007167          302 RASAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNV---------GKREFEQQMEIVGGIR---------HENVVALRAY  363 (615)
Q Consensus       302 ~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---------~~~~~~~e~~~l~~l~---------h~niv~l~~~  363 (615)
                      +...+.||+|+||+||+|.. +++.||||+++....         ..+.+.+|+++++.++         |||||++.+.
T Consensus        22 y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~  100 (336)
T 2vuw_A           22 LQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSV  100 (336)
T ss_dssp             HHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEE
T ss_pred             chheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcce
Confidence            44567899999999999987 679999999975421         1367889999988885         7777777766


Q ss_pred             EE------------------------------ecCeeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHH
Q 007167          364 YY------------------------------SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGI  413 (615)
Q Consensus       364 ~~------------------------------~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l  413 (615)
                      +.                              ..+..++||||+++|++.+.+..      ..+++..+..++.|++.||
T Consensus       101 ~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~------~~~~~~~~~~i~~qi~~aL  174 (336)
T 2vuw_A          101 HCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT------KLSSLATAKSILHQLTASL  174 (336)
T ss_dssp             EEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT------TCCCHHHHHHHHHHHHHHH
T ss_pred             eEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh------cCCCHHHHHHHHHHHHHHH
Confidence            43                              26789999999999977776642      3589999999999999999


Q ss_pred             HHhh-ccCCCCceecCCCCCCEEeCCCC--------------------cEEEeecccccccCCCCCCCCCCCcccCcccc
Q 007167          414 AHIH-TENGGKLVHGGIKASNIFLNSQG--------------------HVCVSDIGLAALMSPMPPPAMRAAGYRAPEVT  472 (615)
Q Consensus       414 ~~LH-~~~~~~iiHrDik~~Nill~~~~--------------------~~kl~DfG~a~~~~~~~~~~~~~~~y~aPE~~  472 (615)
                      +||| +.+   |+||||||+|||++.++                    .+||+|||+|+.....  ...+|..|+|||++
T Consensus       175 ~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~--~~~gt~~y~aPE~~  249 (336)
T 2vuw_A          175 AVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG--IVVFCDVSMDEDLF  249 (336)
T ss_dssp             HHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT--EEECCCCTTCSGGG
T ss_pred             HHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC--cEEEeecccChhhh
Confidence            9999 888   99999999999999887                    8999999999877543  34688999999999


Q ss_pred             CCCCCCCccchhhHHHH-HHHHHhCCCCCC
Q 007167          473 DTRKATQASDVFSFGVL-LLELLTGKSPIH  501 (615)
Q Consensus       473 ~~~~~~~~~DvwS~Gvv-l~elltg~~p~~  501 (615)
                      .+.. +.++||||+|++ .+++++|..||.
T Consensus       250 ~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~  278 (336)
T 2vuw_A          250 TGDG-DYQFDIYRLMKKENNNRWGEYHPYS  278 (336)
T ss_dssp             CCCS-SHHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred             cCCC-ccceehhhhhCCCCcccccccCCCc
Confidence            8766 889999998777 777888999984

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.95  E-value=3.5e-29  Score=275.88  Aligned_cols=180  Identities=14%  Similarity=0.046  Sum_probs=126.4

Q ss_pred             cCcCCccEEEEEE-ECCCCEEEEEEecccc-----------CCHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEe
Q 007167          308 LGKGTFGTAYKAA-LEDASTVVVKRLKEVN-----------VGKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVY  374 (615)
Q Consensus       308 lG~G~fg~Vy~~~-~~~~~~vavK~l~~~~-----------~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~  374 (615)
                      .+.|++|.+..++ .--|..++||.+....           ...++|.+|+++|+++ .|+||+++++++++++..||||
T Consensus       242 ~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVM  321 (569)
T 4azs_A          242 PYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVM  321 (569)
T ss_dssp             -C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEE
T ss_pred             cccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEE
Confidence            5667777666554 3347889999996531           1125689999999999 7999999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccC
Q 007167          375 DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS  454 (615)
Q Consensus       375 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~  454 (615)
                      ||++|++|.++|...     .+++..   +|+.||+.||+|+|+++   ||||||||+|||+++++++||+|||+|+...
T Consensus       322 Eyv~G~~L~d~i~~~-----~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~  390 (569)
T 4azs_A          322 EKLPGRLLSDMLAAG-----EEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTP  390 (569)
T ss_dssp             ECCCSEEHHHHHHTT-----CCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC
T ss_pred             ecCCCCcHHHHHHhC-----CCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCC
Confidence            999999999999743     245543   58999999999999998   9999999999999999999999999998775


Q ss_pred             CCCC---CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCC
Q 007167          455 PMPP---PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSP  499 (615)
Q Consensus       455 ~~~~---~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p  499 (615)
                      ....   ..++|++|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus       391 ~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          391 QDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             ---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             CCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            4322   2347889999999875 467789999999998887665444

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.93  E-value=3e-26  Score=234.43  Aligned_cols=174  Identities=32%  Similarity=0.543  Sum_probs=158.5

Q ss_pred             CCChhHHHHHHHHHHhcCCCC-CCCCCCCCCCCCC--CcceEecCCC--CcEEEEEeCCCCccc--ccCCCcccCCCCcc
Q 007167           23 ADPVEDKQALLDFIHNIHNSR-SLNWNESSSLCKS--WTGVTCSADH--SRVVALRLPGMALRG--EIPPNTIGRLSALQ   95 (615)
Q Consensus        23 ~~~~~d~~al~~~k~~~~~~~-~~~w~~~~~~c~~--w~gv~C~~~~--~~v~~l~l~~~~l~g--~i~~~~~~~l~~L~   95 (615)
                      .|.++|++||++||+++.++. ..+|+.+.++| .  |.||+|+...  ++|+.|+|++++++|  .+|+ .|+++++|+
T Consensus         2 ~c~~~~~~aL~~~k~~~~~~~~l~~W~~~~~~C-~~~w~gv~C~~~~~~~~l~~L~L~~~~l~~~~~~~~-~l~~l~~L~   79 (313)
T 1ogq_A            2 LCNPQDKQALLQIKKDLGNPTTLSSWLPTTDCC-NRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS-SLANLPYLN   79 (313)
T ss_dssp             CSCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTT-TTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCG-GGGGCTTCS
T ss_pred             CCCHHHHHHHHHHHHhcCCcccccCCCCCCCCC-cCCCcceEeCCCCCCceEEEEECCCCCccCCcccCh-hHhCCCCCC
Confidence            578899999999999997654 45898777777 6  9999998654  899999999999999  8988 899999999


Q ss_pred             EEEcCC-CCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCc
Q 007167           96 NLSLRS-NSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANN  174 (615)
Q Consensus        96 ~L~L~~-N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N  174 (615)
                      +|+|++ |.+++.+|..|+++++|++|+|++|++++.+|..|..+++|++|+|++|++++.+|..+.++++|++|+|++|
T Consensus        80 ~L~L~~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N  159 (313)
T 1ogq_A           80 FLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGN  159 (313)
T ss_dssp             EEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSS
T ss_pred             eeeCCCCCcccccCChhHhcCCCCCEEECcCCeeCCcCCHHHhCCCCCCEEeCCCCccCCcCChHHhcCCCCCeEECcCC
Confidence            999995 9999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCccccccC----CcccccCCCCC
Q 007167          175 SLTGTLPRSLQRF----PSWAFAGNNLS  198 (615)
Q Consensus       175 ~l~g~~p~~~~~l----~~l~~~~n~~~  198 (615)
                      +++|.+|..+.++    ..+.+++|.+.
T Consensus       160 ~l~~~~p~~l~~l~~~L~~L~L~~N~l~  187 (313)
T 1ogq_A          160 RISGAIPDSYGSFSKLFTSMTISRNRLT  187 (313)
T ss_dssp             CCEEECCGGGGCCCTTCCEEECCSSEEE
T ss_pred             cccCcCCHHHhhhhhcCcEEECcCCeee
Confidence            9999999888655    45778888775

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.92  E-value=1.3e-26  Score=253.99  Aligned_cols=178  Identities=12%  Similarity=0.202  Sum_probs=144.9

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCC---------HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEee
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVG---------KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYD  375 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~---------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e  375 (615)
                      .++||+|+||+||+|. ..+..+++|+.......         .+.+.+|++++++++||||+++..++...+..++|||
T Consensus       341 ~~~LG~G~fg~Vy~~~-~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE  419 (540)
T 3en9_A          341 EHLIGKGAEADIKRDS-YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS  419 (540)
T ss_dssp             -------CCEEEEEEE-CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred             CCEEeeCCCEEEEEEE-ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence            5689999999999995 45688999886543211         2347899999999999999987777778888999999


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      |+++|+|.+++..             +..++.|++.||+|||+++   |+||||||+|||++.  ++||+|||+++....
T Consensus       420 ~~~ggsL~~~l~~-------------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          420 YINGKLAKDVIED-------------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             CCCSEEHHHHSTT-------------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             CCCCCCHHHHHHH-------------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            9999999999963             4579999999999999998   999999999999999  999999999998765


Q ss_pred             CC----------CCCCCCCcccCccccCC--CCCCCccchhhHHHHHHHHHhCCCCCC
Q 007167          456 MP----------PPAMRAAGYRAPEVTDT--RKATQASDVFSFGVLLLELLTGKSPIH  501 (615)
Q Consensus       456 ~~----------~~~~~~~~y~aPE~~~~--~~~~~~~DvwS~Gvvl~elltg~~p~~  501 (615)
                      ..          ....+|+.|+|||++..  ..|+..+|+|+..+-..+-+.++.+|.
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            32          13357889999999976  567888999999999999888887774

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.89  E-value=4e-24  Score=244.94  Aligned_cols=173  Identities=24%  Similarity=0.386  Sum_probs=152.6

Q ss_pred             CcCCChhHHHHHHHHHHhcCCCCCCCCCCCC-----CC-CCCC------------cceEecCCCCcEEEEEeCCCCcccc
Q 007167           21 IKADPVEDKQALLDFIHNIHNSRSLNWNESS-----SL-CKSW------------TGVTCSADHSRVVALRLPGMALRGE   82 (615)
Q Consensus        21 ~~~~~~~d~~al~~~k~~~~~~~~~~w~~~~-----~~-c~~w------------~gv~C~~~~~~v~~l~l~~~~l~g~   82 (615)
                      .+++..+|++||++||+++.++   +|+.+.     ++ ||+|            .||+|+. .++|+.|+|++++|+|.
T Consensus       263 ~~~~~~~d~~ALl~~k~~l~~~---~W~~~~~~~~~~~~~C~W~~~~~~~~w~~~~GV~C~~-~~~V~~L~Ls~~~L~G~  338 (876)
T 4ecn_A          263 ETAEYIKDYKALKAIWEALDGK---NWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDN-NGRVTGLSLAGFGAKGR  338 (876)
T ss_dssp             CCCHHHHHHHHHHHHHHHTTGG---GCCCCCSSCSSCCCCCSCCCSSCGGGTTCCTTEEECT-TSCEEEEECTTTCCEEE
T ss_pred             ccccchHHHHHHHHHHHHcCCC---CCCcCCCcccccCCccccccccccccccCcCceEecC-CCCEEEEECccCCCCCc
Confidence            3445567999999999999776   787654     45 1499            9999986 68999999999999999


Q ss_pred             cCCCcccCCCCccEEEc-CCCCCCCc------------------------------------------------------
Q 007167           83 IPPNTIGRLSALQNLSL-RSNSLSGL------------------------------------------------------  107 (615)
Q Consensus        83 i~~~~~~~l~~L~~L~L-~~N~l~g~------------------------------------------------------  107 (615)
                      +|+ .|++|++|++|+| ++|.++|.                                                      
T Consensus       339 ip~-~l~~L~~L~~LdLss~N~lsG~~~~~~~~~~~~l~~~~l~~lr~~~~~~~l~~~~~~~~s~l~~~~l~~~~~~~~i  417 (876)
T 4ecn_A          339 VPD-AIGQLTELKVLSFGTHSETVSGRLFGDEELTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPI  417 (876)
T ss_dssp             ECG-GGGGCTTCCEEESCCTTHHHHTTCBTTBCCCSSCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHTCTTSCCC
T ss_pred             Cch-HHhccccceEeeecccccccccccccccccccccchhHHHHHHHhhhhhhhccCcchhhhHHHHHHhhhCcccccc
Confidence            998 8999999999999 77766554                                                      


Q ss_pred             ----------------------CCCCccccccCcEEecccccccC-----------------CCCcccc--cccccceee
Q 007167          108 ----------------------FPSDFSKLENLTSLHLQFNSFSG-----------------PLPLDFS--VWNNLTVID  146 (615)
Q Consensus       108 ----------------------~p~~~~~l~~L~~L~l~~N~l~g-----------------~~p~~~~--~l~~L~~l~  146 (615)
                                            +|..|++|++|++|+|++|+|+|                 .+|..++  ++++|+.|+
T Consensus       418 ~~~~~l~l~~l~l~~~~N~L~~IP~~l~~L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~~l~f~~L~~L~~L~  497 (876)
T 4ecn_A          418 KKDSRISLKDTQIGNLTNRITFISKAIQRLTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVE  497 (876)
T ss_dssp             CCCCCCCCCTTTTTCCSCEEEEECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEE
T ss_pred             ccccccchhhceeccccCcccchhHHHhcCCCCCEEECcCCcCCCCcccccccccccccccccCChhhhhccCCCCCEEE
Confidence                                  88899999999999999999998                 4999988  999999999


Q ss_pred             cCCCcCCccCCCcccCCCCCCeeeccCcc-ccC-CCccccc----------cCCcccccCCCCC
Q 007167          147 LSNNFFNASIPASISKLTHLSALNLANNS-LTG-TLPRSLQ----------RFPSWAFAGNNLS  198 (615)
Q Consensus       147 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~-l~g-~~p~~~~----------~l~~l~~~~n~~~  198 (615)
                      |++|++.|.+|..++++++|+.|+|++|+ |+| .+|..++          ++..|.+++|.+.
T Consensus       498 Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~  561 (876)
T 4ecn_A          498 LYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE  561 (876)
T ss_dssp             EESCTTCCSCCGGGGGCSSCCEEECTTCTTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC
T ss_pred             CcCCCCCccChHHHhCCCCCCEEECcCCCCcccccchHHHHhhhhcccccCCccEEEeeCCcCC
Confidence            99999999999999999999999999998 999 8887654          5667888898886

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.89  E-value=6.1e-24  Score=238.36  Aligned_cols=172  Identities=24%  Similarity=0.403  Sum_probs=153.4

Q ss_pred             CCChhHHHHHHHHHHhcCCCCC----------CCCCCCCCCCCCC---cceEecCCCCcEEEEEeCCCCcccccCCCccc
Q 007167           23 ADPVEDKQALLDFIHNIHNSRS----------LNWNESSSLCKSW---TGVTCSADHSRVVALRLPGMALRGEIPPNTIG   89 (615)
Q Consensus        23 ~~~~~d~~al~~~k~~~~~~~~----------~~w~~~~~~c~~w---~gv~C~~~~~~v~~l~l~~~~l~g~i~~~~~~   89 (615)
                      +....|++||.+|+.++.++.+          .+|+.+.++| .|   .||+|+.. ++|+.|+|++++++|.+|+ .|+
T Consensus        26 ~~~~~d~~aL~~~~~~~~~~~w~~~~~~~~~~~~W~~~~~~c-~w~~~~GV~C~~~-~~V~~L~L~~~~l~g~lp~-~l~  102 (636)
T 4eco_A           26 AEYIKDYLALKEIWDALNGKNWSQQGFGTQPGANWNFNKELD-MWGAQPGVSLNSN-GRVTGLSLEGFGASGRVPD-AIG  102 (636)
T ss_dssp             CHHHHHHHHHHHHHHHTTGGGCCCCC------CCCCCSSCGG-GTTCCTTEEECTT-CCEEEEECTTSCCEEEECG-GGG
T ss_pred             hhHHHHHHHHHHHHHHcCCCCcccCCcCCccCCCCCCCCCcc-cccCCCCeEEcCC-CCEEEEEecCcccCCcCCh-HHh
Confidence            3445799999999999865532          2798777777 89   99999864 8999999999999999998 899


Q ss_pred             CCCCccEEEcCCC-------------------------------------------------------------------
Q 007167           90 RLSALQNLSLRSN-------------------------------------------------------------------  102 (615)
Q Consensus        90 ~l~~L~~L~L~~N-------------------------------------------------------------------  102 (615)
                      +|++|++|+|++|                                                                   
T Consensus       103 ~L~~L~~L~Ls~N~~~~~~~~~~~~~~~~~~~~~~~~~l~l~l~~~~l~~~~~~~~~~~~~~l~~~~l~~~~~~~~~~~~  182 (636)
T 4eco_A          103 QLTELEVLALGSHGEKVNERLFGPKGISANMSDEQKQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRIT  182 (636)
T ss_dssp             GCTTCCEEESCCGGGGGTCCSBSTTSBCTTCCHHHHHHHHTHHHHHHTCCCGGGGSCHHHHHHHHHCTTSCCCCCCCCCC
T ss_pred             cCccceEEECcCCccccCCccccccccccCchHHHHHHHHhhHHHhhhccCchhhHHHHHHHHhhcCccccccccccccc
Confidence            9999999999988                                                                   


Q ss_pred             -----------CCCCcCCCCccccccCcEEecccccccCC-----------------CCcccc--cccccceeecCCCcC
Q 007167          103 -----------SLSGLFPSDFSKLENLTSLHLQFNSFSGP-----------------LPLDFS--VWNNLTVIDLSNNFF  152 (615)
Q Consensus       103 -----------~l~g~~p~~~~~l~~L~~L~l~~N~l~g~-----------------~p~~~~--~l~~L~~l~l~~N~l  152 (615)
                                 +++| +|..|+++++|++|+|++|+|+|.                 +|..++  ++++|++|+|++|++
T Consensus       183 l~~l~l~~~~n~l~~-ip~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~~l~~~~l~~L~~L~L~~n~l  261 (636)
T 4eco_A          183 LKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPN  261 (636)
T ss_dssp             CCTTTTTCCSCEEEE-ECGGGGGCTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTSCCCGGGCTTCCEEEEECCTT
T ss_pred             hhhhhhccccCCCcc-CCHHHhcccCCCEEECcCCccccccccccccccccchhcccCchhhhhcccCCCCEEEecCCcC
Confidence                       4446 899999999999999999999996                 999999  999999999999999


Q ss_pred             CccCCCcccCCCCCCeeeccCcc-ccC-CCcccc---------ccCCcccccCCCCC
Q 007167          153 NASIPASISKLTHLSALNLANNS-LTG-TLPRSL---------QRFPSWAFAGNNLS  198 (615)
Q Consensus       153 ~~~~p~~~~~l~~L~~l~l~~N~-l~g-~~p~~~---------~~l~~l~~~~n~~~  198 (615)
                      .|.+|..++++++|+.|+|++|+ ++| .+|..+         .++..|.+++|.+.
T Consensus       262 ~~~~p~~l~~l~~L~~L~Ls~n~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~  318 (636)
T 4eco_A          262 LTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK  318 (636)
T ss_dssp             CSSCCTTTTTCSSCCEEECTTCTTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS
T ss_pred             CccChHHHhcCCCCCEEECcCCCCCccccchHHHHhhhccccCCCCCEEECCCCcCC
Confidence            99999999999999999999999 999 899776         56677888999886

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.88  E-value=4.1e-23  Score=236.83  Aligned_cols=177  Identities=21%  Similarity=0.328  Sum_probs=131.6

Q ss_pred             cCcCCChhHHHHHHHHHHhcCCCC-CCCCCCCCCCCCCCcceEecCCCCcEEEEEeCCCCcccc---cCC----------
Q 007167           20 PIKADPVEDKQALLDFIHNIHNSR-SLNWNESSSLCKSWTGVTCSADHSRVVALRLPGMALRGE---IPP----------   85 (615)
Q Consensus        20 ~~~~~~~~d~~al~~~k~~~~~~~-~~~w~~~~~~c~~w~gv~C~~~~~~v~~l~l~~~~l~g~---i~~----------   85 (615)
                      +.+.+.++|++||++||+++.++. +.+|+.+.+|| +|.||+|+  .++|+.|+|+++++.|.   +|+          
T Consensus         5 ~~~~~~~~~~~all~~k~~~~~~~~l~~W~~~~~~C-~w~gv~C~--~~~v~~L~L~~~~l~g~~~~l~~~l~~L~~L~~   81 (768)
T 3rgz_A            5 SPSQSLYREIHQLISFKDVLPDKNLLPDWSSNKNPC-TFDGVTCR--DDKVTSIDLSSKPLNVGFSAVSSSLLSLTGLES   81 (768)
T ss_dssp             ---CCHHHHHHHHHHHHTTCSCTTSSTTCCTTSCGG-GSTTEEEE--TTEEEEEECTTSCCCEEHHHHHHHTTTCTTCCE
T ss_pred             ccccCCHHHHHHHHHHHhhCCCcccccCCCCCCCCc-CCcceEEC--CCcEEEEECCCCCcCCccCccChhHhccCcccc
Confidence            334456789999999999997653 56898666666 89999998  68999999999999987   654          


Q ss_pred             ------------CcccCCCCccEEEcCCCCCCCcCCC--CccccccCcEEecccccccCCCCccc-ccccccceeecCCC
Q 007167           86 ------------NTIGRLSALQNLSLRSNSLSGLFPS--DFSKLENLTSLHLQFNSFSGPLPLDF-SVWNNLTVIDLSNN  150 (615)
Q Consensus        86 ------------~~~~~l~~L~~L~L~~N~l~g~~p~--~~~~l~~L~~L~l~~N~l~g~~p~~~-~~l~~L~~l~l~~N  150 (615)
                                  ..|+++++|++|||++|.++|.+|.  .|++|++|++|+|++|.+++.+|..+ .++++|++|+|++|
T Consensus        82 l~~~~~~~~~l~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n  161 (768)
T 3rgz_A           82 LFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSAN  161 (768)
T ss_dssp             EECTTSCEEECCCCCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSS
T ss_pred             cCCcCCCcCCCchhhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCC
Confidence                        3577778888888888888887777  78888888888888888887777665 67777777787777


Q ss_pred             cCCccCCCc---ccCCCCCCeeeccCccccCCCcc-ccccCCcccccCCCCCC
Q 007167          151 FFNASIPAS---ISKLTHLSALNLANNSLTGTLPR-SLQRFPSWAFAGNNLSS  199 (615)
Q Consensus       151 ~l~~~~p~~---~~~l~~L~~l~l~~N~l~g~~p~-~~~~l~~l~~~~n~~~~  199 (615)
                      ++++..|..   +.++++|+.|+|++|.+++.+|. .+.++..+.+++|.+..
T Consensus       162 ~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~l~~L~~L~Ls~n~l~~  214 (768)
T 3rgz_A          162 SISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFLDVSSNNFST  214 (768)
T ss_dssp             CCEEETHHHHHHTTCCTTCCEEECCSSEEESCCBCTTCTTCCEEECCSSCCCS
T ss_pred             ccCCcCChhhhhhccCCCCCEEECCCCcccccCCcccCCcCCEEECcCCcCCC
Confidence            777766655   56666666666666666665553 24455555666665543

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.86  E-value=1.4e-22  Score=203.70  Aligned_cols=138  Identities=12%  Similarity=0.204  Sum_probs=112.8

Q ss_pred             hhcCcCCccEEEEEEECCCCEEEEEEeccccC-------------------CHHHHHHHHHHHhCCCCCcccceeEEEEe
Q 007167          306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNV-------------------GKREFEQQMEIVGGIRHENVVALRAYYYS  366 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~-------------------~~~~~~~e~~~l~~l~h~niv~l~~~~~~  366 (615)
                      +.||+|+||.||+|...+|+.||+|.++....                   ....+.+|++++++++  | +++.+++..
T Consensus        96 ~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~  172 (282)
T 1zar_A           96 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAW  172 (282)
T ss_dssp             EEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEE
T ss_pred             CEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEec
Confidence            67999999999999997789999999964321                   1345889999999998  5 666665543


Q ss_pred             cCeeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEee
Q 007167          367 KDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSD  446 (615)
Q Consensus       367 ~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~D  446 (615)
                       +..++||||+++|+|.+ +..           .....++.|++.||+|||+.+   |+||||||+|||++ ++.+||+|
T Consensus       173 -~~~~lvmE~~~g~~L~~-l~~-----------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~D  235 (282)
T 1zar_A          173 -EGNAVLMELIDAKELYR-VRV-----------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIID  235 (282)
T ss_dssp             -ETTEEEEECCCCEEGGG-CCC-----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECC
T ss_pred             -cceEEEEEecCCCcHHH-cch-----------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEE
Confidence             56799999999999998 531           123469999999999999998   99999999999999 99999999


Q ss_pred             cccccccCCCCCCCCCCCcccCccccC
Q 007167          447 IGLAALMSPMPPPAMRAAGYRAPEVTD  473 (615)
Q Consensus       447 fG~a~~~~~~~~~~~~~~~y~aPE~~~  473 (615)
                      ||+++...          .|.|||++.
T Consensus       236 FG~a~~~~----------~~~a~e~l~  252 (282)
T 1zar_A          236 FPQSVEVG----------EEGWREILE  252 (282)
T ss_dssp             CTTCEETT----------STTHHHHHH
T ss_pred             CCCCeECC----------CCCHHHHHH
Confidence            99987442          367888774

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.82  E-value=9.3e-21  Score=194.88  Aligned_cols=173  Identities=22%  Similarity=0.340  Sum_probs=145.8

Q ss_pred             CcCCChhHHHHHHHHHHhcCCCC---CCCCC----CCCCCCCCCcceEec--------CCCCcEEEEEeCCCCcccccCC
Q 007167           21 IKADPVEDKQALLDFIHNIHNSR---SLNWN----ESSSLCKSWTGVTCS--------ADHSRVVALRLPGMALRGEIPP   85 (615)
Q Consensus        21 ~~~~~~~d~~al~~~k~~~~~~~---~~~w~----~~~~~c~~w~gv~C~--------~~~~~v~~l~l~~~~l~g~i~~   85 (615)
                      .+++..+|++||++||..+..+.   ..+|.    ...++| .|.|+.|.        ....+|+.|+|++|+++ .+|+
T Consensus        21 ~~~~~~~~~~aLl~~k~~~~~~~~~~~~~w~~~~~~~~~~~-~~~g~~~~~~~~~l~~~~~~~l~~L~L~~n~l~-~lp~   98 (328)
T 4fcg_A           21 GSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANSNNPQIE-TRTGRALKATADLLEDATQPGRVALELRSVPLP-QFPD   98 (328)
T ss_dssp             --CCCCCHHHHHHHHHHHHHHCCTTHHHHHHHHTTTCTTSC-CSHHHHHHHHHHHHHHHTSTTCCEEEEESSCCS-SCCS
T ss_pred             ccccCchHHHHHHHHHHhccCCchhhhhhhccccccccccc-ccCCcchhhhHHHHhcccccceeEEEccCCCch-hcCh
Confidence            34556789999999999884322   23683    344566 89999995        23478999999999999 8998


Q ss_pred             CcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeecCCCcCCccCCCcccC---
Q 007167           86 NTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISK---  162 (615)
Q Consensus        86 ~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~---  162 (615)
                       .++++++|++|+|++|.++ .+|..|+++++|++|+|++|+++ .+|..++++++|+.|+|++|++.+.+|..+..   
T Consensus        99 -~l~~l~~L~~L~L~~n~l~-~lp~~~~~l~~L~~L~Ls~n~l~-~lp~~l~~l~~L~~L~L~~n~~~~~~p~~~~~~~~  175 (328)
T 4fcg_A           99 -QAFRLSHLQHMTIDAAGLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDA  175 (328)
T ss_dssp             -CGGGGTTCSEEEEESSCCC-CCCSCGGGGTTCSEEEEESCCCC-CCCGGGGGCTTCCEEEEEEETTCCCCCSCSEEEC-
T ss_pred             -hhhhCCCCCEEECCCCCcc-chhHHHhccCCCCEEECCCCccc-cCcHHHhcCcCCCEEECCCCCCccccChhHhhccc
Confidence             6888999999999999999 88999999999999999999999 78999999999999999999999999988765   


Q ss_pred             ------CCCCCeeeccCccccCCCcccccc---CCcccccCCCCCC
Q 007167          163 ------LTHLSALNLANNSLTGTLPRSLQR---FPSWAFAGNNLSS  199 (615)
Q Consensus       163 ------l~~L~~l~l~~N~l~g~~p~~~~~---l~~l~~~~n~~~~  199 (615)
                            +++|+.|+|++|+|+ .+|..+.+   +..|.+++|.+..
T Consensus       176 ~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~  220 (328)
T 4fcg_A          176 SGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA  220 (328)
T ss_dssp             CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC
T ss_pred             hhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc
Confidence                  999999999999999 88877665   4456788888764

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.81  E-value=1.1e-19  Score=176.90  Aligned_cols=152  Identities=26%  Similarity=0.292  Sum_probs=131.2

Q ss_pred             CCCCCCCCCCCcceEecCC---------CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCcccccc
Q 007167           47 WNESSSLCKSWTGVTCSAD---------HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLEN  117 (615)
Q Consensus        47 w~~~~~~c~~w~gv~C~~~---------~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~  117 (615)
                      |+...+.| +|++|.|+..         ...++.|+|++|++++..| ..|..+++|++|+|++|+|++..+..|.++++
T Consensus        12 ~~~~~~~C-s~~~v~c~~~~l~~ip~~~~~~L~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~L~~N~l~~i~~~~~~~l~~   89 (229)
T 3e6j_A           12 ACPSQCSC-SGTTVDCRSKRHASVPAGIPTNAQILYLHDNQITKLEP-GVFDSLINLKELYLGSNQLGALPVGVFDSLTQ   89 (229)
T ss_dssp             CCCTTCEE-ETTEEECTTSCCSSCCSCCCTTCSEEECCSSCCCCCCT-TTTTTCTTCCEEECCSSCCCCCCTTTTTTCTT
T ss_pred             cCCCCCEE-eCCEeEccCCCcCccCCCCCCCCCEEEcCCCccCccCH-HHhhCccCCcEEECCCCCCCCcChhhcccCCC
Confidence            55566777 8999999852         2468899999999995444 48999999999999999998776777899999


Q ss_pred             CcEEecccccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccc---cCCcccccC
Q 007167          118 LTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQ---RFPSWAFAG  194 (615)
Q Consensus       118 L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l~~~~  194 (615)
                      |++|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+.++++|+.|+|++|+|++..+..|.   ++..+.+.+
T Consensus        90 L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~  168 (229)
T 3e6j_A           90 LTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSIPHGAFDRLSSLTHAYLFG  168 (229)
T ss_dssp             CCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECTT
T ss_pred             cCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeC
Confidence            999999999999877777899999999999999999 6899999999999999999999977665555   555677899


Q ss_pred             CCCCCCC
Q 007167          195 NNLSSEN  201 (615)
Q Consensus       195 n~~~~~~  201 (615)
                      |++.|..
T Consensus       169 N~~~c~c  175 (229)
T 3e6j_A          169 NPWDCEC  175 (229)
T ss_dssp             SCBCTTB
T ss_pred             CCccCCc
Confidence            9997753

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.80  E-value=1.1e-19  Score=175.60  Aligned_cols=150  Identities=17%  Similarity=0.248  Sum_probs=132.4

Q ss_pred             CCCCCCCcceEecCCC---------CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEE
Q 007167           51 SSLCKSWTGVTCSADH---------SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSL  121 (615)
Q Consensus        51 ~~~c~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L  121 (615)
                      .+.| .|..+.|++..         ..++.|+|++|++++..+...|..+++|++|+|++|+|++..|..|.++++|++|
T Consensus         8 ~C~C-~~~~l~~s~n~l~~iP~~~~~~~~~L~L~~N~l~~~~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~L   86 (220)
T 2v70_A            8 KCRC-EGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEI   86 (220)
T ss_dssp             TCEE-ETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCCEECCCCCGGGCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred             CCEE-CCCEeEeCCCCcccCccCCCCCCCEEEcCCCcCCccCchhhhccCCCCCEEECCCCcCCEECHHHhCCCCCCCEE
Confidence            3445 79999997532         3577999999999976666679999999999999999999888899999999999


Q ss_pred             ecccccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccccC---CcccccCCCCC
Q 007167          122 HLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRF---PSWAFAGNNLS  198 (615)
Q Consensus       122 ~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l---~~l~~~~n~~~  198 (615)
                      +|++|+|++..|..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..+   ..+.+++|++.
T Consensus        87 ~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  166 (220)
T 2v70_A           87 LLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLANPFN  166 (220)
T ss_dssp             ECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEEECTTSCCCCBCTTTTTTCTTCCEEECCSCCEE
T ss_pred             ECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEEECCCCcCCEECHHHhcCCCCCCEEEecCcCCc
Confidence            999999998888889999999999999999999889999999999999999999999888887654   56778999998


Q ss_pred             CCC
Q 007167          199 SEN  201 (615)
Q Consensus       199 ~~~  201 (615)
                      |..
T Consensus       167 c~c  169 (220)
T 2v70_A          167 CNC  169 (220)
T ss_dssp             CSG
T ss_pred             CCC
Confidence            763

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.79  E-value=2.3e-19  Score=173.50  Aligned_cols=149  Identities=23%  Similarity=0.321  Sum_probs=131.1

Q ss_pred             CCCCCCCcceEecCC---------CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEE
Q 007167           51 SSLCKSWTGVTCSAD---------HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSL  121 (615)
Q Consensus        51 ~~~c~~w~gv~C~~~---------~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L  121 (615)
                      .+.| .|..|.|...         ...++.|+|++|+++ .+++..|..+++|++|+|++|+|++..|..|.++++|++|
T Consensus         8 ~C~C-~~~~v~c~~~~l~~iP~~l~~~l~~L~l~~n~i~-~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~~l~~L~~L   85 (220)
T 2v9t_B            8 ACTC-SNNIVDCRGKGLTEIPTNLPETITEIRLEQNTIK-VIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSL   85 (220)
T ss_dssp             TSEE-ETTEEECTTSCCSSCCSSCCTTCCEEECCSSCCC-EECTTSSTTCTTCCEEECCSSCCCEECTTTTTTCSSCCEE
T ss_pred             CCEE-CCCEEEcCCCCcCcCCCccCcCCCEEECCCCcCC-CcCHhHhhCCCCCCEEECCCCcCCCcCHHHhhCCcCCCEE
Confidence            3445 7999999752         146899999999999 6777689999999999999999999999999999999999


Q ss_pred             ecccccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCcccccc---CCcccccCCCCC
Q 007167          122 HLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQR---FPSWAFAGNNLS  198 (615)
Q Consensus       122 ~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~---l~~l~~~~n~~~  198 (615)
                      +|++|+|++..+..|..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|..   +..+.+.+|++.
T Consensus        86 ~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~  165 (220)
T 2v9t_B           86 VLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQNPFI  165 (220)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCEE
T ss_pred             ECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEECHHHHhCCCCCCEEEeCCCCcC
Confidence            99999999766666899999999999999999988999999999999999999999887766654   556778999998


Q ss_pred             CCC
Q 007167          199 SEN  201 (615)
Q Consensus       199 ~~~  201 (615)
                      |..
T Consensus       166 c~c  168 (220)
T 2v9t_B          166 CDC  168 (220)
T ss_dssp             CSG
T ss_pred             CCC
Confidence            753

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.78  E-value=1.3e-18  Score=166.54  Aligned_cols=147  Identities=25%  Similarity=0.304  Sum_probs=127.8

Q ss_pred             CCCCCCcceEecCC---------CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEe
Q 007167           52 SLCKSWTGVTCSAD---------HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLH  122 (615)
Q Consensus        52 ~~c~~w~gv~C~~~---------~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~  122 (615)
                      +.| .|.+|.|+..         ..+++.|+|++|+++ .+++..|+.+++|++|+|++|++++..+..|.++++|++|+
T Consensus         5 C~C-~~~~v~c~~~~l~~~p~~~~~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~   82 (208)
T 2o6s_A            5 CSC-SGTTVECYSQGRTSVPTGIPAQTTYLDLETNSLK-SLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLN   82 (208)
T ss_dssp             CEE-ETTEEECCSSCCSSCCSCCCTTCSEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CEE-CCCEEEecCCCccCCCCCCCCCCcEEEcCCCccC-cCChhhhcccccCcEEECCCCccCccChhhcCCCCCcCEEE
Confidence            445 8999999753         246899999999999 67776899999999999999999987777789999999999


Q ss_pred             cccccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccc---cCCcccccCCCCCC
Q 007167          123 LQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQ---RFPSWAFAGNNLSS  199 (615)
Q Consensus       123 l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l~~~~n~~~~  199 (615)
                      |++|++++..+..|..+++|+.|+|++|+|++..+..+.++++|+.|+|++|++++..+..+.   ++..+.+++|++.+
T Consensus        83 Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~  162 (208)
T 2o6s_A           83 LSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDC  162 (208)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCC
T ss_pred             CCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEEECCCCccceeCHHHhccCCCccEEEecCCCeec
Confidence            999999987777789999999999999999987777889999999999999999977665554   55667889998876


Q ss_pred             C
Q 007167          200 E  200 (615)
Q Consensus       200 ~  200 (615)
                      .
T Consensus       163 ~  163 (208)
T 2o6s_A          163 T  163 (208)
T ss_dssp             C
T ss_pred             C
Confidence            5

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.77  E-value=4e-19  Score=176.12  Aligned_cols=132  Identities=15%  Similarity=0.167  Sum_probs=102.1

Q ss_pred             hhcCcCCccEEEEEEE-CCCCE--EEEEEeccccCC-------------------------HHHHHHHHHHHhCCCCCcc
Q 007167          306 EVLGKGTFGTAYKAAL-EDAST--VVVKRLKEVNVG-------------------------KREFEQQMEIVGGIRHENV  357 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~--vavK~l~~~~~~-------------------------~~~~~~e~~~l~~l~h~ni  357 (615)
                      +.||+|+||.||+|.. .+|+.  ||||+++.....                         ...+.+|++.+.+++|+++
T Consensus        53 ~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i  132 (258)
T 1zth_A           53 GVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGV  132 (258)
T ss_dssp             EEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             CEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCC
Confidence            5699999999999997 68888  999987543111                         1257889999999988865


Q ss_pred             --cceeEEEEecCeeeEEeecCCC-C----ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhh-ccCCCCceecCC
Q 007167          358 --VALRAYYYSKDEKLMVYDYFEP-G----SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIH-TENGGKLVHGGI  429 (615)
Q Consensus       358 --v~l~~~~~~~~~~~lV~e~~~~-g----sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH-~~~~~~iiHrDi  429 (615)
                        ..++++    +..++||||+.+ |    +|.++...        .++.....++.|++.||.||| +.+   |+||||
T Consensus       133 ~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDl  197 (258)
T 1zth_A          133 SVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--------LKELDVEGIFNDVVENVKRLYQEAE---LVHADL  197 (258)
T ss_dssp             CCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--------GGGSCHHHHHHHHHHHHHHHHHTSC---EECSSC
T ss_pred             CCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--------cChHHHHHHHHHHHHHHHHHHHHCC---EEeCCC
Confidence              333332    367899999942 4    56655431        223456789999999999999 887   999999


Q ss_pred             CCCCEEeCCCCcEEEeecccccccC
Q 007167          430 KASNIFLNSQGHVCVSDIGLAALMS  454 (615)
Q Consensus       430 k~~Nill~~~~~~kl~DfG~a~~~~  454 (615)
                      ||+|||+++  .++|+|||+|....
T Consensus       198 kp~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          198 SEYNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             STTSEEESS--SEEECCCTTCEETT
T ss_pred             CHHHEEEcC--cEEEEECcccccCC
Confidence            999999998  99999999997653

>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A*

Probab=99.76  E-value=4.8e-19  Score=203.08  Aligned_cols=135  Identities=28%  Similarity=0.469  Sum_probs=126.4

Q ss_pred             EEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeecCCCc
Q 007167           72 LRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNF  151 (615)
Q Consensus        72 l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~  151 (615)
                      +++..+.++|.+|. .++.+++|++|||++|+++|.+|..|++|++|+.|+|++|+|+|.+|..|+++++|+.|||++|+
T Consensus       613 ~~l~~~~~~g~~~~-~~~~l~~L~~LdLs~N~l~g~ip~~l~~l~~L~~L~Ls~N~l~g~ip~~l~~L~~L~~LdLs~N~  691 (768)
T 3rgz_A          613 CNITSRVYGGHTSP-TFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNK  691 (768)
T ss_dssp             SCTTSCEEEEECCC-SCSSSBCCCEEECCSSCCBSCCCGGGGGCTTCCEEECCSSCCCSCCCGGGGGCTTCCEEECCSSC
T ss_pred             cccccceecccCch-hhhccccccEEECcCCcccccCCHHHhccccCCEEeCcCCccCCCCChHHhCCCCCCEEECCCCc
Confidence            45666889999998 79999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCccCCCcccCCCCCCeeeccCccccCCCccc--cccCCcccccCCCCCCCCCCCCCC
Q 007167          152 FNASIPASISKLTHLSALNLANNSLTGTLPRS--LQRFPSWAFAGNNLSSENARPPAL  207 (615)
Q Consensus       152 l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~l~~l~~~~n~~~~~~~~~~~~  207 (615)
                      ++|.+|..+.++++|++|+|++|+|+|.||..  |..++...|.||+..|+.|.++|.
T Consensus       692 l~g~ip~~l~~l~~L~~L~ls~N~l~g~iP~~~~~~~~~~~~~~gN~~Lcg~~l~~C~  749 (768)
T 3rgz_A          692 LDGRIPQAMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCD  749 (768)
T ss_dssp             CEECCCGGGGGCCCCSEEECCSSEEEEECCSSSSGGGSCGGGGCSCTEEESTTSCCCC
T ss_pred             ccCcCChHHhCCCCCCEEECcCCcccccCCCchhhccCCHHHhcCCchhcCCCCcCCC
Confidence            99999999999999999999999999999964  678888899999999998877664

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.76  E-value=3.9e-18  Score=161.14  Aligned_cols=129  Identities=26%  Similarity=0.370  Sum_probs=104.9

Q ss_pred             CCCCCCcceEecCC---------CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEe
Q 007167           52 SLCKSWTGVTCSAD---------HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLH  122 (615)
Q Consensus        52 ~~c~~w~gv~C~~~---------~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~  122 (615)
                      ..| .|..+.|+..         ...++.|+|++|++++..+...|+.+++|++|+|++|+|++..|..|.++++|++|+
T Consensus         6 C~C-~~~~l~~s~~~l~~ip~~~~~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~   84 (192)
T 1w8a_A            6 CHC-EGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQ   84 (192)
T ss_dssp             SEE-ETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEE
T ss_pred             CEE-CCCEEEcCCCCcCcCccCCCCCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHcCCcccCCEEE
Confidence            345 7888888742         136788888888888443333588888888888888888888888888888888888


Q ss_pred             cccccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCc
Q 007167          123 LQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLP  181 (615)
Q Consensus       123 l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p  181 (615)
                      |++|+|++..|..|.++++|+.|+|++|+|++.+|..+..+++|+.|+|++|.+++..+
T Consensus        85 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  143 (192)
T 1w8a_A           85 LGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH  143 (192)
T ss_dssp             CCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred             CCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcCc
Confidence            88888888777778888888888888888888888888888888888888888888766

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.73  E-value=1.6e-17  Score=163.90  Aligned_cols=133  Identities=23%  Similarity=0.266  Sum_probs=111.9

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID  146 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~  146 (615)
                      ..++.|+|++|++++ +++..|+++++|++|+|++|.|++..|..|.++++|++|+|++|++++..+..|..+++|+.|+
T Consensus        35 ~~l~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  113 (251)
T 3m19_A           35 ADTEKLDLQSTGLAT-LSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLY  113 (251)
T ss_dssp             TTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCEEEccCCCcCc-cCHhHhcCcccCCEEECCCCcCCccCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEE
Confidence            357889999999984 5555799999999999999999988888899999999999999999987777889999999999


Q ss_pred             cCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccc---cCCcccccCCCCCCC
Q 007167          147 LSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQ---RFPSWAFAGNNLSSE  200 (615)
Q Consensus       147 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l~~~~n~~~~~  200 (615)
                      |++|+|++..+..+.++++|+.|+|++|+|++..+..|.   ++..|.+++|.+...
T Consensus       114 L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  170 (251)
T 3m19_A          114 LGGNQLKSLPSGVFDRLTKLKELRLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSV  170 (251)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred             cCCCcCCCcChhHhccCCcccEEECcCCcCCccCHHHcCcCcCCCEEECCCCcCCcc
Confidence            999999987777788899999999999999977665564   455677888887643

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.72  E-value=1.8e-17  Score=154.38  Aligned_cols=128  Identities=27%  Similarity=0.352  Sum_probs=90.5

Q ss_pred             CCCCCCcceEecCCC---------CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEe
Q 007167           52 SLCKSWTGVTCSADH---------SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLH  122 (615)
Q Consensus        52 ~~c~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~  122 (615)
                      ..| +|.++.|+...         ..++.|+|++|+++ .+++..|+.+++|++|+|++|+|++..+..|.++++|++|+
T Consensus         5 C~C-~~~~l~~~~~~l~~~p~~~~~~l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~   82 (177)
T 2o6r_A            5 CSC-SGTEIRCNSKGLTSVPTGIPSSATRLELESNKLQ-SLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFDKLTKLTILY   82 (177)
T ss_dssp             CEE-ETTEEECCSSCCSSCCTTCCTTCSEEECCSSCCC-CCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CEe-CCCEEEecCCCCccCCCCCCCCCcEEEeCCCccc-EeCHHHhcCcccccEEECCCCcceEeChhHccCCCccCEEE
Confidence            345 79999997421         35677777777777 45555667777777777777777766566677777777777


Q ss_pred             cccccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCc
Q 007167          123 LQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLP  181 (615)
Q Consensus       123 l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p  181 (615)
                      |++|+|++..+..|..+++|+.|+|++|+|++..+..+.++++|+.|+|++|.+++..|
T Consensus        83 l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~  141 (177)
T 2o6r_A           83 LHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  141 (177)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCHH
T ss_pred             CCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeeccCc
Confidence            77777776655566777777777777777776555556677777777777777776655

>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7

Probab=99.70  E-value=5.7e-17  Score=153.09  Aligned_cols=135  Identities=24%  Similarity=0.366  Sum_probs=118.1

Q ss_pred             cceEecCCCCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCC-CccccccCcEEecccccccCCCCccc
Q 007167           58 TGVTCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPS-DFSKLENLTSLHLQFNSFSGPLPLDF  136 (615)
Q Consensus        58 ~gv~C~~~~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~-~~~~l~~L~~L~l~~N~l~g~~p~~~  136 (615)
                      .+..|..     +.+++++++|+ .||. .+.  .+|++|+|++|+|++..+. .|.++++|++|+|++|+|++..|..|
T Consensus         4 ~~C~C~~-----~~l~~s~~~l~-~ip~-~~~--~~l~~L~l~~n~i~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~   74 (192)
T 1w8a_A            4 AMCHCEG-----TTVDCTGRGLK-EIPR-DIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAF   74 (192)
T ss_dssp             TTSEEET-----TEEECTTSCCS-SCCS-CCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTT
T ss_pred             CCCEECC-----CEEEcCCCCcC-cCcc-CCC--CCCCEEECCCCcCCccCCccccccCCCCCEEECCCCCCCCcCHhHc
Confidence            4567753     47899999997 8987 343  3899999999999988765 49999999999999999999989999


Q ss_pred             ccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCcccccc---CCcccccCCCCCCCC
Q 007167          137 SVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQR---FPSWAFAGNNLSSEN  201 (615)
Q Consensus       137 ~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~---l~~l~~~~n~~~~~~  201 (615)
                      .++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++.+|..|..   +..+.+++|++.|..
T Consensus        75 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c  142 (192)
T 1w8a_A           75 EGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNC  142 (192)
T ss_dssp             TTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSG
T ss_pred             CCcccCCEEECCCCcCCccCHHHhcCCCCCCEEECCCCcCCeeCHHHhhcCCCCCEEEeCCCCccCcC
Confidence            99999999999999999998989999999999999999999999987765   456778999997653

>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8

Probab=99.69  E-value=1.3e-17  Score=170.15  Aligned_cols=134  Identities=31%  Similarity=0.455  Sum_probs=78.0

Q ss_pred             cEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeec
Q 007167           68 RVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL  147 (615)
Q Consensus        68 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l  147 (615)
                      .++.|+|++|.++|.+|. .++.++ |++|+|++|.+++.+|..|.++++|++|+|++|++++.+|. +..+++|+.|+|
T Consensus       175 ~L~~L~L~~N~l~~~~~~-~~~~l~-L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~-~~~l~~L~~L~L  251 (313)
T 1ogq_A          175 LFTSMTISRNRLTGKIPP-TFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGK-VGLSKNLNGLDL  251 (313)
T ss_dssp             TCCEEECCSSEEEEECCG-GGGGCC-CSEEECCSSEEEECCGGGCCTTSCCSEEECCSSEECCBGGG-CCCCTTCCEEEC
T ss_pred             cCcEEECcCCeeeccCCh-HHhCCc-ccEEECcCCcccCcCCHHHhcCCCCCEEECCCCceeeecCc-ccccCCCCEEEC
Confidence            344444444444444443 344443 55555555555555555555555666666666666554443 555666666666


Q ss_pred             CCCcCCccCCCcccCCCCCCeeeccCccccCCCccc--cccCCcccccCCCCCCCCCCC
Q 007167          148 SNNFFNASIPASISKLTHLSALNLANNSLTGTLPRS--LQRFPSWAFAGNNLSSENARP  204 (615)
Q Consensus       148 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~l~~l~~~~n~~~~~~~~~  204 (615)
                      ++|+|+|.+|..+.++++|+.|+|++|+|+|.+|..  +.++..+.+.+|+..|+.|.+
T Consensus       252 s~N~l~~~~p~~l~~l~~L~~L~Ls~N~l~~~ip~~~~l~~L~~l~l~~N~~lc~~p~~  310 (313)
T 1ogq_A          252 RNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSPLP  310 (313)
T ss_dssp             CSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEESTTSS
T ss_pred             cCCcccCcCChHHhcCcCCCEEECcCCcccccCCCCccccccChHHhcCCCCccCCCCC
Confidence            666766666777777777777777777777666654  344555666777766655443

>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A

Probab=99.69  E-value=1.1e-16  Score=157.97  Aligned_cols=134  Identities=22%  Similarity=0.294  Sum_probs=119.9

Q ss_pred             CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCccccccccccee
Q 007167           66 HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVI  145 (615)
Q Consensus        66 ~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l  145 (615)
                      ..+++.|+|++|.+++ +++..|..+++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|..+++|+.|
T Consensus        58 l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  136 (251)
T 3m19_A           58 LTKLTWLNLDYNQLQT-LSAGVFDDLTELGTLGLANNQLASLPLGVFDHLTQLDKLYLGGNQLKSLPSGVFDRLTKLKEL  136 (251)
T ss_dssp             CTTCCEEECTTSCCCC-CCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             cccCCEEECCCCcCCc-cCHhHhccCCcCCEEECCCCcccccChhHhcccCCCCEEEcCCCcCCCcChhHhccCCcccEE
Confidence            3689999999999995 555589999999999999999998888889999999999999999998777778999999999


Q ss_pred             ecCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccc---cCCcccccCCCCCCC
Q 007167          146 DLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQ---RFPSWAFAGNNLSSE  200 (615)
Q Consensus       146 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l~~~~n~~~~~  200 (615)
                      +|++|+|++..|..+.++++|+.|+|++|+|++..+..|.   ++..+.+.+|++.|.
T Consensus       137 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~c~  194 (251)
T 3m19_A          137 RLNTNQLQSIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGKLQTITLFGNQFDCS  194 (251)
T ss_dssp             ECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCTT
T ss_pred             ECcCCcCCccCHHHcCcCcCCCEEECCCCcCCccCHHHHhCCCCCCEEEeeCCceeCC
Confidence            9999999987777899999999999999999987776665   455678899999775

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.68  E-value=2.3e-16  Score=157.39  Aligned_cols=129  Identities=26%  Similarity=0.298  Sum_probs=77.8

Q ss_pred             EEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeecC
Q 007167           69 VVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLS  148 (615)
Q Consensus        69 v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~  148 (615)
                      ++.|+|++|+++ .+++..|+++++|++|+|++|.++...+..|.++++|++|+|++|++++..+..|..+++|+.|+|+
T Consensus        39 l~~L~l~~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~  117 (270)
T 2o6q_A           39 TKKLDLQSNKLS-SLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLD  117 (270)
T ss_dssp             CSEEECCSSCCS-CCCTTSSSSCTTCCEEECCSSCCSCCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECC
T ss_pred             CCEEECcCCCCC-eeCHHHhcCCCCCCEEECCCCccCeeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECC
Confidence            556666666666 4444456666666666666666665544445666666666666666665545556666666666666


Q ss_pred             CCcCCccCCCcccCCCCCCeeeccCccccCCCccccc---cCCcccccCCCCC
Q 007167          149 NNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQ---RFPSWAFAGNNLS  198 (615)
Q Consensus       149 ~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l~~~~n~~~  198 (615)
                      +|++++..|..|.++++|+.|+|++|+|++..+..|.   ++..+.+++|.+.
T Consensus       118 ~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~  170 (270)
T 2o6q_A          118 RNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQLK  170 (270)
T ss_dssp             SSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred             CCccCeeCHHHhCcCcCCCEEECCCCcCCccCHhHccCCcccceeEecCCcCc
Confidence            6666665555566666666666666666654443333   3344455566553

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.68  E-value=2.6e-16  Score=157.16  Aligned_cols=129  Identities=29%  Similarity=0.328  Sum_probs=74.0

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID  146 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~  146 (615)
                      .+++.|+|++|.+++ ++  .++.+++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|+.+++|+.|+
T Consensus        63 ~~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  139 (272)
T 3rfs_A           63 PNVRYLALGGNKLHD-IS--ALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLN  139 (272)
T ss_dssp             TTCCEEECTTSCCCC-CG--GGTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCcEEECCCCCCCC-ch--hhcCCCCCCEEECCCCccCccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEE
Confidence            355666666666653 22  455666666666666666655555556666666666666666655555556666666666


Q ss_pred             cCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccc---cCCcccccCCCCC
Q 007167          147 LSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQ---RFPSWAFAGNNLS  198 (615)
Q Consensus       147 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l~~~~n~~~  198 (615)
                      |++|++++..|..+.++++|+.|+|++|++++..+..+.   ++..+.+.+|.+.
T Consensus       140 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~  194 (272)
T 3rfs_A          140 LAHNQLQSLPKGVFDKLTNLTELDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLK  194 (272)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCS
T ss_pred             CCCCccCccCHHHhccCccCCEEECCCCCcCccCHHHhcCCccCCEEECCCCcCC
Confidence            666666655555555666666666666666655443333   3334455555554

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.67  E-value=1.5e-16  Score=150.22  Aligned_cols=126  Identities=24%  Similarity=0.321  Sum_probs=104.2

Q ss_pred             EEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeecCCC
Q 007167           71 ALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNN  150 (615)
Q Consensus        71 ~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N  150 (615)
                      .+++++++|+ .+|.. +  .++|++|+|++|+|+ .+|..|.++++|++|+|++|+|++..|..|.++++|+.|+|++|
T Consensus        14 ~l~~~~~~l~-~ip~~-~--~~~l~~L~L~~n~i~-~ip~~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N   88 (193)
T 2wfh_A           14 VVRCSNKGLK-VLPKG-I--PRDVTELYLDGNQFT-LVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYN   88 (193)
T ss_dssp             EEECTTSCCS-SCCSC-C--CTTCCEEECCSSCCC-SCCGGGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSS
T ss_pred             EEEcCCCCCC-cCCCC-C--CCCCCEEECCCCcCc-hhHHHhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEECCCC
Confidence            4667778887 78763 3  368899999999998 67888999999999999999999877788999999999999999


Q ss_pred             cCCccCCCcccCCCCCCeeeccCccccCCCccccc---cCCcccccCCCCCCCC
Q 007167          151 FFNASIPASISKLTHLSALNLANNSLTGTLPRSLQ---RFPSWAFAGNNLSSEN  201 (615)
Q Consensus       151 ~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l~~~~n~~~~~~  201 (615)
                      +|++..|..|.++++|+.|+|++|+|++..+..|.   ++..+.+.+|++.|..
T Consensus        89 ~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c  142 (193)
T 2wfh_A           89 RLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDC  142 (193)
T ss_dssp             CCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSG
T ss_pred             ccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCC
Confidence            99988888899999999999999999966555554   4556778899988763

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.66  E-value=2.6e-16  Score=163.94  Aligned_cols=147  Identities=24%  Similarity=0.272  Sum_probs=124.3

Q ss_pred             CCCCCCCcceEecCC---------CCcEEEEEeCCCCcccccCCCccc-CCCCccEEEcCCCCCCCcCCCCccccccCcE
Q 007167           51 SSLCKSWTGVTCSAD---------HSRVVALRLPGMALRGEIPPNTIG-RLSALQNLSLRSNSLSGLFPSDFSKLENLTS  120 (615)
Q Consensus        51 ~~~c~~w~gv~C~~~---------~~~v~~l~l~~~~l~g~i~~~~~~-~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~  120 (615)
                      .+.| .|..+.|...         ...++.|+|++|+|+ .+++..+. ++++|++|+|++|+|++..|..|.++++|++
T Consensus        15 ~C~C-~~~~l~c~~~~l~~iP~~~~~~l~~L~Ls~N~l~-~l~~~~~~~~l~~L~~L~L~~N~i~~i~~~~~~~l~~L~~   92 (361)
T 2xot_A           15 NCLC-ASNILSCSKQQLPNVPQSLPSYTALLDLSHNNLS-RLRAEWTPTRLTNLHSLLLSHNHLNFISSEAFVPVPNLRY   92 (361)
T ss_dssp             TCEE-ETTEEECCSSCCSSCCSSCCTTCSEEECCSSCCC-EECTTSSSSCCTTCCEEECCSSCCCEECTTTTTTCTTCCE
T ss_pred             CCEE-CCCEEEeCCCCcCccCccCCCCCCEEECCCCCCC-ccChhhhhhcccccCEEECCCCcCCccChhhccCCCCCCE
Confidence            3445 6888888742         234788999999999 56665777 9999999999999999888889999999999


Q ss_pred             EecccccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCccc------cccCCcccccC
Q 007167          121 LHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRS------LQRFPSWAFAG  194 (615)
Q Consensus       121 L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~------~~~l~~l~~~~  194 (615)
                      |+|++|+|++..+..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..+..      +.+|..|.+++
T Consensus        93 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~  172 (361)
T 2xot_A           93 LDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSS  172 (361)
T ss_dssp             EECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCSCCGGGTC----CTTCCEEECCS
T ss_pred             EECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEEECCCCcCCeeCHHHhcCcccCCcCCEEECCC
Confidence            999999999877778999999999999999999988999999999999999999999644433      34566778888


Q ss_pred             CCCCC
Q 007167          195 NNLSS  199 (615)
Q Consensus       195 n~~~~  199 (615)
                      |.+..
T Consensus       173 N~l~~  177 (361)
T 2xot_A          173 NKLKK  177 (361)
T ss_dssp             SCCCC
T ss_pred             CCCCc
Confidence            88753

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.66  E-value=2.3e-16  Score=176.47  Aligned_cols=132  Identities=20%  Similarity=0.223  Sum_probs=118.3

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID  146 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~  146 (615)
                      ..++.|+|++|+|+ .||+..|.++++|++|||++|+|++..|..|.+|++|++|+|++|+|++..|..|.+|++|++|+
T Consensus        52 ~~~~~LdLs~N~i~-~l~~~~f~~l~~L~~L~Ls~N~i~~i~~~~f~~L~~L~~L~Ls~N~l~~l~~~~f~~L~~L~~L~  130 (635)
T 4g8a_A           52 FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV  130 (635)
T ss_dssp             TTCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECGGGGTTCTTCCEEE
T ss_pred             cCCCEEEeeCCCCC-CCCHHHHhCCCCCCEEECCCCcCCCcChhHhcCCCCCCEEEccCCcCCCCCHHHhcCCCCCCEEE
Confidence            46899999999999 78877899999999999999999998888999999999999999999987677899999999999


Q ss_pred             cCCCcCCccCCCcccCCCCCCeeeccCccccC-CCccccc---cCCcccccCCCCCC
Q 007167          147 LSNNFFNASIPASISKLTHLSALNLANNSLTG-TLPRSLQ---RFPSWAFAGNNLSS  199 (615)
Q Consensus       147 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g-~~p~~~~---~l~~l~~~~n~~~~  199 (615)
                      |++|+|++..+..|+++++|+.|+|++|.+++ .+|..+.   ++..+.+++|.+..
T Consensus       131 Ls~N~l~~l~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~  187 (635)
T 4g8a_A          131 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS  187 (635)
T ss_dssp             CTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCE
T ss_pred             CCCCcCCCCChhhhhcCcccCeeccccCccccCCCchhhccchhhhhhcccCccccc
Confidence            99999998777889999999999999999986 4666655   45567788998754

>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens}

Probab=99.65  E-value=5.2e-16  Score=146.55  Aligned_cols=127  Identities=25%  Similarity=0.345  Sum_probs=114.1

Q ss_pred             CCCCCCcceEecCC---------CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEe
Q 007167           52 SLCKSWTGVTCSAD---------HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLH  122 (615)
Q Consensus        52 ~~c~~w~gv~C~~~---------~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~  122 (615)
                      +.| .|..+.|+..         ...++.|+|++|+++ .+|. .|.++++|++|+|++|.|++..|..|.+|++|++|+
T Consensus         8 C~C-~~~~l~~~~~~l~~ip~~~~~~l~~L~L~~n~i~-~ip~-~~~~l~~L~~L~Ls~N~i~~i~~~~f~~l~~L~~L~   84 (193)
T 2wfh_A            8 CTC-LDTVVRCSNKGLKVLPKGIPRDVTELYLDGNQFT-LVPK-ELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLI   84 (193)
T ss_dssp             CEE-ETTEEECTTSCCSSCCSCCCTTCCEEECCSSCCC-SCCG-GGGGCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CEe-CCCEEEcCCCCCCcCCCCCCCCCCEEECCCCcCc-hhHH-HhhcccCCCEEECCCCcCCEeCHhHccCCCCCCEEE
Confidence            344 7888888742         247899999999999 8885 899999999999999999999888999999999999


Q ss_pred             cccccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCc
Q 007167          123 LQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLP  181 (615)
Q Consensus       123 l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p  181 (615)
                      |++|+|++..|..|..+++|+.|+|++|+|++..+..|..+++|+.|+|++|.+.+...
T Consensus        85 Ls~N~l~~i~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~~~C~c~  143 (193)
T 2wfh_A           85 LSYNRLRCIPPRTFDGLKSLRLLSLHGNDISVVPEGAFNDLSALSHLAIGANPLYCDCN  143 (193)
T ss_dssp             CCSSCCCBCCTTTTTTCTTCCEEECCSSCCCBCCTTTTTTCTTCCEEECCSSCEECSGG
T ss_pred             CCCCccCEeCHHHhCCCCCCCEEECCCCCCCeeChhhhhcCccccEEEeCCCCeecCCc
Confidence            99999999888899999999999999999998767789999999999999999987544

>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens}

Probab=99.64  E-value=4.8e-16  Score=150.02  Aligned_cols=115  Identities=21%  Similarity=0.270  Sum_probs=108.2

Q ss_pred             CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCccccccccccee
Q 007167           66 HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVI  145 (615)
Q Consensus        66 ~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l  145 (615)
                      ..+++.|+|++|.|+ .+++..|+.+++|++|+|++|.|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|
T Consensus        56 l~~L~~L~L~~N~i~-~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  134 (220)
T 2v70_A           56 LPQLRKINFSNNKIT-DIEEGAFEGASGVNEILLTSNRLENVQHKMFKGLESLKTLMLRSNRITCVGNDSFIGLSSVRLL  134 (220)
T ss_dssp             CTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCCCCGGGGTTCSSCCEEECTTSCCCCBCTTSSTTCTTCSEE
T ss_pred             CCCCCEEECCCCcCC-EECHHHhCCCCCCCEEECCCCccCccCHhHhcCCcCCCEEECCCCcCCeECHhHcCCCccCCEE
Confidence            467999999999999 5666689999999999999999999988889999999999999999999889999999999999


Q ss_pred             ecCCCcCCccCCCcccCCCCCCeeeccCccccCCCc
Q 007167          146 DLSNNFFNASIPASISKLTHLSALNLANNSLTGTLP  181 (615)
Q Consensus       146 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p  181 (615)
                      +|++|+|++..|..|..+++|+.|+|++|.+++..+
T Consensus       135 ~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~c~c~  170 (220)
T 2v70_A          135 SLYDNQITTVAPGAFDTLHSLSTLNLLANPFNCNCY  170 (220)
T ss_dssp             ECTTSCCCCBCTTTTTTCTTCCEEECCSCCEECSGG
T ss_pred             ECCCCcCCEECHHHhcCCCCCCEEEecCcCCcCCCc
Confidence            999999999889999999999999999999998766

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.64  E-value=1.3e-15  Score=153.47  Aligned_cols=128  Identities=26%  Similarity=0.293  Sum_probs=72.9

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID  146 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~  146 (615)
                      .+++.|+|++|.++ .++.  .+.+++|++|+|++|+|+ .+|..+.++++|++|+|++|+|++..|..|.++++|+.|+
T Consensus        55 ~~L~~L~L~~n~l~-~~~~--~~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~l~~N~l~~l~~~~~~~l~~L~~L~  130 (290)
T 1p9a_G           55 TRLTQLNLDRAELT-KLQV--DGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELY  130 (290)
T ss_dssp             TTCCEEECTTSCCC-EEEC--CSCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEE
T ss_pred             CCCCEEECCCCccC-cccC--CCCCCcCCEEECCCCcCC-cCchhhccCCCCCEEECCCCcCcccCHHHHcCCCCCCEEE
Confidence            45666666666666 3443  255666666666666665 4455566666666666666666654445566666666666


Q ss_pred             cCCCcCCccCCCcccCCCCCCeeeccCccccCCCcccc---ccCCcccccCCCCC
Q 007167          147 LSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSL---QRFPSWAFAGNNLS  198 (615)
Q Consensus       147 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~---~~l~~l~~~~n~~~  198 (615)
                      |++|+|++..+..|..+++|+.|+|++|+|++..+..|   .++..+.+++|.+.
T Consensus       131 L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~  185 (290)
T 1p9a_G          131 LKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY  185 (290)
T ss_dssp             CTTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             CCCCCCCccChhhcccccCCCEEECCCCcCCccCHHHhcCcCCCCEEECCCCcCC
Confidence            66666665545555566666666666666664333332   23344555555554

>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri}

Probab=99.63  E-value=1.4e-15  Score=151.65  Aligned_cols=132  Identities=26%  Similarity=0.331  Sum_probs=104.7

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID  146 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~  146 (615)
                      .+++.|+|++|.++ .+++..|..+++|++|+|++|.+++..+..|.++++|++|+|++|++++..|..|..+++|+.|+
T Consensus        61 ~~L~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~  139 (270)
T 2o6q_A           61 TKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLS  139 (270)
T ss_dssp             TTCCEEECCSSCCS-CCCTTTTSSCTTCCEEECCSSCCCCCCTTTTTTCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCCEEECCCCccC-eeChhhhcCCCCCCEEECCCCcCCcCCHhHcccccCCCEEECCCCccCeeCHHHhCcCcCCCEEE
Confidence            56888888888888 67776778888888888888888877777788888888888888888877777788888888888


Q ss_pred             cCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccc---cCCcccccCCCCCC
Q 007167          147 LSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQ---RFPSWAFAGNNLSS  199 (615)
Q Consensus       147 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l~~~~n~~~~  199 (615)
                      |++|+|++..+..+..+++|+.|+|++|++++..+..|.   ++..+.+++|.+..
T Consensus       140 Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~  195 (270)
T 2o6q_A          140 LGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKR  195 (270)
T ss_dssp             CCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCCSC
T ss_pred             CCCCcCCccCHhHccCCcccceeEecCCcCcEeChhHhccCCCcCEEECCCCcCCc
Confidence            888888876666678888888888888888876665554   45556677787653

>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV}

Probab=99.62  E-value=5.9e-16  Score=158.96  Aligned_cols=132  Identities=23%  Similarity=0.273  Sum_probs=113.0

Q ss_pred             CcEEEEEeCCCCcccccCCCccc---------CCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccc
Q 007167           67 SRVVALRLPGMALRGEIPPNTIG---------RLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFS  137 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~---------~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~  137 (615)
                      .+++.|+|++|++.|.+|. .++         .+++|++|+|++|+|+ .+|..|+++++|++|+|++|++++ +|..++
T Consensus       150 ~~L~~L~L~~n~~~~~~p~-~~~~~~~~~~~~~l~~L~~L~L~~n~l~-~lp~~l~~l~~L~~L~L~~N~l~~-l~~~l~  226 (328)
T 4fcg_A          150 NRLRELSIRACPELTELPE-PLASTDASGEHQGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLSA-LGPAIH  226 (328)
T ss_dssp             TTCCEEEEEEETTCCCCCS-CSEEEC-CCCEEESTTCCEEEEEEECCC-CCCGGGGGCTTCCEEEEESSCCCC-CCGGGG
T ss_pred             cCCCEEECCCCCCccccCh-hHhhccchhhhccCCCCCEEECcCCCcC-cchHhhcCCCCCCEEEccCCCCCc-Cchhhc
Confidence            5789999999888888887 444         4899999999999999 788889999999999999999995 777899


Q ss_pred             cccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccccCC---cccccCCCCCCCC
Q 007167          138 VWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFP---SWAFAGNNLSSEN  201 (615)
Q Consensus       138 ~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~---~l~~~~n~~~~~~  201 (615)
                      .+++|+.|+|++|++.+.+|..+.++++|+.|+|++|++.+.+|..+.+++   .+.+++|++....
T Consensus       227 ~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~~p~~~~~l~~L~~L~L~~n~~~~~i  293 (328)
T 4fcg_A          227 HLPKLEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRL  293 (328)
T ss_dssp             GCTTCCEEECTTCTTCCBCCCCTTCCCCCCEEECTTCTTCCBCCTTGGGCTTCCEEECTTCTTCCCC
T ss_pred             cCCCCCEEECcCCcchhhhHHHhcCCCCCCEEECCCCCchhhcchhhhcCCCCCEEeCCCCCchhhc
Confidence            999999999999999999999999999999999999999999998776554   5667888876543

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.62  E-value=2.6e-16  Score=141.92  Aligned_cols=121  Identities=26%  Similarity=0.305  Sum_probs=108.2

Q ss_pred             CcEEEEEeCCCCcc-cccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCccccccccccee
Q 007167           67 SRVVALRLPGMALR-GEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVI  145 (615)
Q Consensus        67 ~~v~~l~l~~~~l~-g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l  145 (615)
                      .+++.|++++|+++ |.+|. .++.+++|++|+|++|.+++.  ..+.++++|++|+|++|++++.+|..+..+++|+.|
T Consensus        17 ~~l~~L~l~~n~l~~~~~~~-~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L   93 (149)
T 2je0_A           17 SDVKELVLDNSRSNEGKLEG-LTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHL   93 (149)
T ss_dssp             GGCSEEECTTCBCBTTBCCS-CCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCEE
T ss_pred             ccCeEEEccCCcCChhHHHH-HHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCEE
Confidence            57899999999999 88987 789999999999999999987  789999999999999999998899989899999999


Q ss_pred             ecCCCcCCcc-CCCcccCCCCCCeeeccCccccCCCc---cccccCCcc
Q 007167          146 DLSNNFFNAS-IPASISKLTHLSALNLANNSLTGTLP---RSLQRFPSW  190 (615)
Q Consensus       146 ~l~~N~l~~~-~p~~~~~l~~L~~l~l~~N~l~g~~p---~~~~~l~~l  190 (615)
                      +|++|++++. .|..+.++++|+.|++++|++++..+   ..+..++.|
T Consensus        94 ~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L  142 (149)
T 2je0_A           94 NLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTNLNDYRENVFKLLPQL  142 (149)
T ss_dssp             ECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGGSTTHHHHHHHHCTTC
T ss_pred             ECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccchHHHHHHHHHHCCCc
Confidence            9999999974 35889999999999999999997765   456555554

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.62  E-value=5.8e-16  Score=151.43  Aligned_cols=149  Identities=16%  Similarity=0.259  Sum_probs=122.6

Q ss_pred             CCCCCCCCCCCcceE--ecC------CCCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCC-CCCcCCCCcccccc
Q 007167           47 WNESSSLCKSWTGVT--CSA------DHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNS-LSGLFPSDFSKLEN  117 (615)
Q Consensus        47 w~~~~~~c~~w~gv~--C~~------~~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~-l~g~~p~~~~~l~~  117 (615)
                      |.+..+.|..|.++.  |..      -...++.|+|++|+++ .+++..|+.+++|++|+|++|. +++..+..|.++++
T Consensus         3 ~cp~~C~C~~~~~~~v~c~~l~~ip~~~~~l~~L~l~~n~l~-~i~~~~~~~l~~L~~L~l~~n~~l~~i~~~~f~~l~~   81 (239)
T 2xwt_C            3 CSSPPCECHQEEDFRVTCKDIQRIPSLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLSK   81 (239)
T ss_dssp             CCSSSCSEEECSTTEEEECSCSSCCCCCTTCCEEEEESCCCS-EECTTTTTTCTTCCEEEEECCSSCCEECTTTEESCTT
T ss_pred             CCCCCCeeCCCCcceeEccCccccCCCCCcccEEEEeCCcce-EECHHHccCCCCCcEEeCCCCCCcceeCHhHcCCCcC
Confidence            344445564446555  864      2247899999999999 6777689999999999999997 88777778999999


Q ss_pred             CcEEeccc-ccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCC---eeeccCc-cccCCCccccccCC----
Q 007167          118 LTSLHLQF-NSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLS---ALNLANN-SLTGTLPRSLQRFP----  188 (615)
Q Consensus       118 L~~L~l~~-N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~---~l~l~~N-~l~g~~p~~~~~l~----  188 (615)
                      |++|+|++ |++++..+..|.++++|+.|+|++|++++ +|. +.++++|+   .|++++| ++++..+..|..++    
T Consensus        82 L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~~L~~L~l~~N~~l~~i~~~~~~~l~~L~~  159 (239)
T 2xwt_C           82 VTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTDIFFILEITDNPYMTSIPVNAFQGLCNETL  159 (239)
T ss_dssp             CCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCCSEEEEEEESCTTCCEECTTTTTTTBSSEE
T ss_pred             CcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccccccEEECCCCcchhhcCcccccchhccee
Confidence            99999999 99997777889999999999999999997 776 88899998   9999999 99876666666554    


Q ss_pred             cccccCCCCC
Q 007167          189 SWAFAGNNLS  198 (615)
Q Consensus       189 ~l~~~~n~~~  198 (615)
                      .+.+++|.+.
T Consensus       160 ~L~l~~n~l~  169 (239)
T 2xwt_C          160 TLKLYNNGFT  169 (239)
T ss_dssp             EEECCSCCCC
T ss_pred             EEEcCCCCCc
Confidence            6667888775

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.62  E-value=6.3e-16  Score=172.05  Aligned_cols=155  Identities=16%  Similarity=0.195  Sum_probs=120.4

Q ss_pred             CCCCCCCCCCCCC---CcceEecC----------------CCCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCC
Q 007167           44 SLNWNESSSLCKS---WTGVTCSA----------------DHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSL  104 (615)
Q Consensus        44 ~~~w~~~~~~c~~---w~gv~C~~----------------~~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l  104 (615)
                      ..+|.++.+||..   |.++.|+.                ....+..++++++.++ .+|+..++.+++|++|+|++|.|
T Consensus         9 l~~~~~~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~l~l~~l~~l~l~~~~l~-~lp~~~~~~l~~L~~L~L~~n~l   87 (597)
T 3oja_B            9 VKPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQI   87 (597)
T ss_dssp             --CCCSEECCCCC--CCSEEECSCEECSSCCCCEESCSSGGGCCCSEEEESSCEES-EECTHHHHHCCCCSEEECTTSCC
T ss_pred             ccCCCCCCcCcccCcCceeEecCceecccccccccCcccccCCCceEEEeeCCCCC-CcCHHHHccCCCCcEEECCCCCC
Confidence            3468776666643   65555541                0134577888888887 78877788899999999999999


Q ss_pred             CCcCCCCccccccCcEEecccccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCcccc
Q 007167          105 SGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSL  184 (615)
Q Consensus       105 ~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~  184 (615)
                      ++..|..|+++++|++|+|++|.+++..|..|+++++|+.|+|++|.|++..+..|.++++|++|+|++|.|++..|..|
T Consensus        88 ~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~  167 (597)
T 3oja_B           88 EEIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTF  167 (597)
T ss_dssp             CEECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTT
T ss_pred             CCCChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEEeeCCcCCCCChhhh
Confidence            98888889999999999999999998878888899999999999999997656667889999999999999998888766


Q ss_pred             ccC---CcccccCCCCCC
Q 007167          185 QRF---PSWAFAGNNLSS  199 (615)
Q Consensus       185 ~~l---~~l~~~~n~~~~  199 (615)
                      ..+   ..|.+++|.+..
T Consensus       168 ~~l~~L~~L~L~~N~l~~  185 (597)
T 3oja_B          168 QATTSLQNLQLSSNRLTH  185 (597)
T ss_dssp             TTCTTCCEEECTTSCCSB
T ss_pred             hcCCcCcEEECcCCCCCC
Confidence            544   456678887654

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.61  E-value=8.3e-16  Score=141.62  Aligned_cols=129  Identities=25%  Similarity=0.231  Sum_probs=111.9

Q ss_pred             CcEEEEEeCCCCcc-cccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCccccccccccee
Q 007167           67 SRVVALRLPGMALR-GEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVI  145 (615)
Q Consensus        67 ~~v~~l~l~~~~l~-g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l  145 (615)
                      .+++.|+|++|+++ |.+|. .+..+++|++|+|++|.+++.  ..|..+++|++|+|++|++++.+|..+..+++|+.|
T Consensus        24 ~~L~~L~l~~n~l~~~~i~~-~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L  100 (168)
T 2ell_A           24 AAVRELVLDNCKSNDGKIEG-LTAEFVNLEFLSLINVGLISV--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHL  100 (168)
T ss_dssp             TSCSEEECCSCBCBTTBCSS-CCGGGGGCCEEEEESSCCCCC--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEE
T ss_pred             ccCCEEECCCCCCChhhHHH-HHHhCCCCCEEeCcCCCCCCh--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEE
Confidence            57999999999998 88987 689999999999999999977  789999999999999999998889888889999999


Q ss_pred             ecCCCcCCccC-CCcccCCCCCCeeeccCccccCCCc---cccc---cCCcccccCCCCC
Q 007167          146 DLSNNFFNASI-PASISKLTHLSALNLANNSLTGTLP---RSLQ---RFPSWAFAGNNLS  198 (615)
Q Consensus       146 ~l~~N~l~~~~-p~~~~~l~~L~~l~l~~N~l~g~~p---~~~~---~l~~l~~~~n~~~  198 (615)
                      +|++|+|++.. +..+..+++|+.|+|++|.+++..+   ..+.   ++..+.+.+|...
T Consensus       101 ~Ls~N~l~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~  160 (168)
T 2ell_A          101 NLSGNKLKDISTLEPLKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ  160 (168)
T ss_dssp             ECBSSSCCSSGGGGGGSSCSCCCEEECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC
T ss_pred             eccCCccCcchhHHHHhcCCCCCEEEeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh
Confidence            99999999742 2789999999999999999997655   3444   4555667777653

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.61  E-value=1.2e-15  Score=163.78  Aligned_cols=135  Identities=21%  Similarity=0.214  Sum_probs=121.7

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID  146 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~  146 (615)
                      ..++.|+|++|++++.+|. .++.+++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|..+++|+.|+
T Consensus       275 ~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~  353 (455)
T 3v47_A          275 SGVKTCDLSKSKIFALLKS-VFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLGSIDSRMFENLDKLEVLD  353 (455)
T ss_dssp             SCCCEEECCSSCCCEECTT-TTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECGGGGTTCTTCCEEE
T ss_pred             cCceEEEecCccccccchh-hcccCCCCCEEECCCCcccccChhHhcCcccCCEEECCCCccCCcChhHhcCcccCCEEE
Confidence            4789999999999966665 899999999999999999999999999999999999999999988889999999999999


Q ss_pred             cCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccc---cCCcccccCCCCCCCCC
Q 007167          147 LSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQ---RFPSWAFAGNNLSSENA  202 (615)
Q Consensus       147 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l~~~~n~~~~~~~  202 (615)
                      |++|++++..|..+.++++|++|+|++|+|++..+..+.   ++..+.+++|++.|..+
T Consensus       354 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~  412 (455)
T 3v47_A          354 LSYNHIRALGDQSFLGLPNLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCSCP  412 (455)
T ss_dssp             CCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCTT
T ss_pred             CCCCcccccChhhccccccccEEECCCCccccCCHhHhccCCcccEEEccCCCcccCCC
Confidence            999999998899999999999999999999976665544   56677899999988753

>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri}

Probab=99.61  E-value=4e-15  Score=138.31  Aligned_cols=134  Identities=26%  Similarity=0.302  Sum_probs=113.8

Q ss_pred             cceEecCCCCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccc
Q 007167           58 TGVTCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFS  137 (615)
Q Consensus        58 ~gv~C~~~~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~  137 (615)
                      .+..|+     .+.+++++++++ .+|.. +  .++|+.|+|++|++++..+..|.++++|++|+|++|++++..+..|.
T Consensus         3 ~~C~C~-----~~~l~~~~~~l~-~~p~~-~--~~~l~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~   73 (177)
T 2o6r_A            3 SRCSCS-----GTEIRCNSKGLT-SVPTG-I--PSSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQIQSLPDGVFD   73 (177)
T ss_dssp             TTCEEE-----TTEEECCSSCCS-SCCTT-C--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTT
T ss_pred             CCCEeC-----CCEEEecCCCCc-cCCCC-C--CCCCcEEEeCCCcccEeCHHHhcCcccccEEECCCCcceEeChhHcc
Confidence            345674     357889999998 78763 3  47899999999999988777899999999999999999987777789


Q ss_pred             cccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccc---cCCcccccCCCCCCC
Q 007167          138 VWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQ---RFPSWAFAGNNLSSE  200 (615)
Q Consensus       138 ~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l~~~~n~~~~~  200 (615)
                      .+++|+.|+|++|+|++..+..+.++++|+.|+|++|+|++..+..+.   ++..+.+++|++.|.
T Consensus        74 ~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~  139 (177)
T 2o6r_A           74 KLTKLTILYLHENKLQSLPNGVFDKLTQLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  139 (177)
T ss_dssp             TCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             CCCccCEEECCCCCccccCHHHhhCCcccCEEECcCCcceEeCHHHhcCCcccCEEEecCCCeecc
Confidence            999999999999999987777889999999999999999976665444   556678899988764

>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus}

Probab=99.61  E-value=5.9e-16  Score=161.22  Aligned_cols=135  Identities=27%  Similarity=0.226  Sum_probs=117.4

Q ss_pred             CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCccccccccccee
Q 007167           66 HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVI  145 (615)
Q Consensus        66 ~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l  145 (615)
                      ..+++.|+|++|+|+ .+++..|.++++|++|+|++|+|++..+..|.++++|++|+|++|+|++..|..|..+++|+.|
T Consensus        63 l~~L~~L~L~~N~i~-~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L  141 (361)
T 2xot_A           63 LTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIVVVDRNAFEDMAQLQKL  141 (361)
T ss_dssp             CTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred             ccccCEEECCCCcCC-ccChhhccCCCCCCEEECCCCcCCcCCHHHhCCCcCCCEEECCCCcccEECHHHhCCcccCCEE
Confidence            467999999999999 6776689999999999999999998888889999999999999999998889999999999999


Q ss_pred             ecCCCcCCccCCCcc---cCCCCCCeeeccCccccCCCccccccCC-----cccccCCCCCCCC
Q 007167          146 DLSNNFFNASIPASI---SKLTHLSALNLANNSLTGTLPRSLQRFP-----SWAFAGNNLSSEN  201 (615)
Q Consensus       146 ~l~~N~l~~~~p~~~---~~l~~L~~l~l~~N~l~g~~p~~~~~l~-----~l~~~~n~~~~~~  201 (615)
                      +|++|+|++..+..+   .++++|+.|+|++|+|++..+..+..++     .+.+.+|++.|.+
T Consensus       142 ~L~~N~l~~l~~~~~~~~~~l~~L~~L~L~~N~l~~l~~~~~~~l~~~~l~~l~l~~N~~~C~C  205 (361)
T 2xot_A          142 YLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPLECDC  205 (361)
T ss_dssp             ECCSSCCCSCCGGGTC----CTTCCEEECCSSCCCCCCHHHHHHSCHHHHTTEECCSSCEECCH
T ss_pred             ECCCCcCCeeCHHHhcCcccCCcCCEEECCCCCCCccCHHHhhhccHhhcceEEecCCCccCCc
Confidence            999999997444444   6799999999999999976656666664     4788999998764

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.61  E-value=1.3e-15  Score=157.20  Aligned_cols=134  Identities=11%  Similarity=0.122  Sum_probs=95.7

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccC---------------CHHHH--------HHHHHHHhCCCCCccccee
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNV---------------GKREF--------EQQMEIVGGIRHENVVALR  361 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---------------~~~~~--------~~e~~~l~~l~h~niv~l~  361 (615)
                      .+.||+|+||.||+|...+|+.||||+++....               .....        .+|...|.++.+.++.-..
T Consensus       100 ~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~  179 (397)
T 4gyi_A          100 GSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPE  179 (397)
T ss_dssp             EEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCC
T ss_pred             cCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCe
Confidence            457999999999999999999999998753210               01111        2355555555443332211


Q ss_pred             EEEEecCeeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCC-
Q 007167          362 AYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG-  440 (615)
Q Consensus       362 ~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~-  440 (615)
                      -+..  ...+|||||++++.|..+...           .....++.|++.+|.|||+.+   ||||||||.|||+++++ 
T Consensus       180 p~~~--~~~~LVME~i~G~~L~~l~~~-----------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd  243 (397)
T 4gyi_A          180 PIAQ--SRHTIVMSLVDALPMRQVSSV-----------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKD  243 (397)
T ss_dssp             EEEE--ETTEEEEECCSCEEGGGCCCC-----------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEEC
T ss_pred             eeec--cCceEEEEecCCccHhhhccc-----------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCC
Confidence            1211  234799999999888765431           123567899999999999998   99999999999998876 


Q ss_pred             ---------cEEEeecccccccC
Q 007167          441 ---------HVCVSDIGLAALMS  454 (615)
Q Consensus       441 ---------~~kl~DfG~a~~~~  454 (615)
                               .+.|+||+-+....
T Consensus       244 ~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          244 AEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             SSCTTSEEEEEEECCCTTCEETT
T ss_pred             cccccccccceEEEEeCCcccCC
Confidence                     38999999876544

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.60  E-value=1.3e-15  Score=153.09  Aligned_cols=132  Identities=28%  Similarity=0.297  Sum_probs=107.8

Q ss_pred             CcEEEEEeCCCC-cccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCccccccccccee
Q 007167           67 SRVVALRLPGMA-LRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVI  145 (615)
Q Consensus        67 ~~v~~l~l~~~~-l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l  145 (615)
                      .+++.|+|++|. ++ .+++..+..+++|++|+|++|.+++..|..|.++++|++|+|++|++++..+..|+.+++|+.|
T Consensus        80 ~~L~~L~l~~n~~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  158 (285)
T 1ozn_A           80 ALLEQLDLSDNAQLR-SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHL  158 (285)
T ss_dssp             TTCCEEECCSCTTCC-CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             cCCCEEeCCCCCCcc-ccCHHHhcCCcCCCEEECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEE
Confidence            578889999887 55 6666678888999999999999988888888888999999999999887666678888889999


Q ss_pred             ecCCCcCCccCCCcccCCCCCCeeeccCccccCCCcccccc---CCcccccCCCCCC
Q 007167          146 DLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQR---FPSWAFAGNNLSS  199 (615)
Q Consensus       146 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~---l~~l~~~~n~~~~  199 (615)
                      +|++|++++..+..+.++++|+.|+|++|.+++..|..|.+   +..+.+++|.+..
T Consensus       159 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  215 (285)
T 1ozn_A          159 FLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSA  215 (285)
T ss_dssp             ECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSC
T ss_pred             ECCCCcccccCHHHhcCccccCEEECCCCcccccCHhHccCcccccEeeCCCCcCCc
Confidence            99999888766667888888999999999888877777654   4456678887754

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.60  E-value=3.3e-15  Score=138.00  Aligned_cols=108  Identities=25%  Similarity=0.319  Sum_probs=97.3

Q ss_pred             EEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeecCC
Q 007167           70 VALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSN  149 (615)
Q Consensus        70 ~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~  149 (615)
                      +.|++++|+|+ .+|.. +  .++|++|+|++|+|++..|..|.++++|++|+|++|+|++..|..|..+++|+.|+|++
T Consensus        12 ~~l~~s~n~l~-~ip~~-~--~~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           12 TTVDCSGKSLA-SVPTG-I--PTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             TEEECTTSCCS-SCCSC-C--CTTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CEEEeCCCCcC-ccCcc-C--CCCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence            35777888898 68873 4  38899999999999999999999999999999999999987777789999999999999


Q ss_pred             CcCCccCCCcccCCCCCCeeeccCccccCCCc
Q 007167          150 NFFNASIPASISKLTHLSALNLANNSLTGTLP  181 (615)
Q Consensus       150 N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p  181 (615)
                      |+|++..|..|.++++|+.|+|++|.+++..+
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c~  119 (170)
T 3g39_A           88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCACS  119 (170)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCBCTTBG
T ss_pred             CccCEeCHHHhcCCCCCCEEEeCCCCCCCCch
Confidence            99998777789999999999999999997755

>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri}

Probab=99.60  E-value=1.5e-15  Score=145.22  Aligned_cols=131  Identities=24%  Similarity=0.257  Sum_probs=114.7

Q ss_pred             CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCccccccccccee
Q 007167           66 HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVI  145 (615)
Q Consensus        66 ~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l  145 (615)
                      ..+++.|+|++|+++ .+++..|..+++|++|+|++|+|++..+..|.++++|++|+|++|++++..+..|..+++|+.|
T Consensus        51 l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L  129 (208)
T 2o6s_A           51 LTSLTQLYLGGNKLQ-SLPNGVFNKLTSLTYLNLSTNQLQSLPNGVFDKLTQLKELALNTNQLQSLPDGVFDKLTQLKDL  129 (208)
T ss_dssp             CTTCSEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEE
T ss_pred             cccCcEEECCCCccC-ccChhhcCCCCCcCEEECCCCcCCccCHhHhcCccCCCEEEcCCCcCcccCHhHhccCCcCCEE
Confidence            367999999999999 6777678999999999999999998877779999999999999999998777779999999999


Q ss_pred             ecCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccccCCcccccCCCCCCCC
Q 007167          146 DLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLSSEN  201 (615)
Q Consensus       146 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~n~~~~~~  201 (615)
                      +|++|++++..+..+.++++|+.|+|++|.+++..|    ++..+...+|.+.+..
T Consensus       130 ~l~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~~----~l~~L~~~~n~~~g~i  181 (208)
T 2o6s_A          130 RLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTCP----GIRYLSEWINKHSGVV  181 (208)
T ss_dssp             ECCSSCCSCCCTTTTTTCTTCCEEECCSCCBCCCTT----TTHHHHHHHHHCTTTB
T ss_pred             ECCCCccceeCHHHhccCCCccEEEecCCCeecCCC----CHHHHHHHHHhCCcee
Confidence            999999998777778999999999999999998765    4556666777765543

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.60  E-value=8.7e-16  Score=161.64  Aligned_cols=154  Identities=16%  Similarity=0.202  Sum_probs=121.2

Q ss_pred             CCCCCCCCCCCCCcceEecC-------------------CCCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCC
Q 007167           45 LNWNESSSLCKSWTGVTCSA-------------------DHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLS  105 (615)
Q Consensus        45 ~~w~~~~~~c~~w~gv~C~~-------------------~~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~  105 (615)
                      .+|....+||+.|.+..|..                   ....++.|+++++.++ .+|+..+..+++|++|+|++|.++
T Consensus         4 ~~~~~~~~C~~~~~~~~c~~~~~~i~~~~~~~~~~~~~~~l~~l~~l~l~~~~l~-~l~~~~~~~l~~L~~L~L~~n~i~   82 (390)
T 3o6n_A            4 KPRQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQVELLNLNDLQIE   82 (390)
T ss_dssp             ---CCEECBCC------EEEESCEECSSCCCCEESCSSGGGCCCSEEEEESCEES-EECTHHHHHCCCCSEEECTTSCCC
T ss_pred             CCCCCccceehhhhhhccceeeeeeecccccccccccccccCCceEEEecCCchh-hCChhHhcccccCcEEECCCCccc
Confidence            46776666676555554421                   0145778999999988 788877899999999999999999


Q ss_pred             CcCCCCccccccCcEEecccccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccc
Q 007167          106 GLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQ  185 (615)
Q Consensus       106 g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~  185 (615)
                      +..|..|.++++|++|+|++|++++..|..|+++++|+.|+|++|+++...+..+.++++|++|+|++|.+++..|..+.
T Consensus        83 ~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~  162 (390)
T 3o6n_A           83 EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNLERIEDDTFQ  162 (390)
T ss_dssp             EECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCBCCTTTTS
T ss_pred             ccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEECCCCccCccChhhcc
Confidence            88888999999999999999999988888899999999999999999965455578999999999999999988777665


Q ss_pred             c---CCcccccCCCCCC
Q 007167          186 R---FPSWAFAGNNLSS  199 (615)
Q Consensus       186 ~---l~~l~~~~n~~~~  199 (615)
                      .   +..+.+++|.+..
T Consensus       163 ~l~~L~~L~l~~n~l~~  179 (390)
T 3o6n_A          163 ATTSLQNLQLSSNRLTH  179 (390)
T ss_dssp             SCTTCCEEECCSSCCSB
T ss_pred             CCCCCCEEECCCCcCCc
Confidence            4   5566788887754

>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A

Probab=99.60  E-value=6.1e-15  Score=142.27  Aligned_cols=134  Identities=22%  Similarity=0.287  Sum_probs=116.9

Q ss_pred             cceEecCCCCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccc
Q 007167           58 TGVTCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFS  137 (615)
Q Consensus        58 ~gv~C~~~~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~  137 (615)
                      .+..|..     ..+++++++++ .||. .+.  ++|+.|+|++|+|++..+..|.++++|++|+|++|++++..|..|.
T Consensus         7 ~~C~C~~-----~~v~c~~~~l~-~iP~-~l~--~~l~~L~l~~n~i~~i~~~~~~~l~~L~~L~Ls~N~i~~~~~~~~~   77 (220)
T 2v9t_B            7 AACTCSN-----NIVDCRGKGLT-EIPT-NLP--ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQ   77 (220)
T ss_dssp             TTSEEET-----TEEECTTSCCS-SCCS-SCC--TTCCEEECCSSCCCEECTTSSTTCTTCCEEECCSSCCCEECTTTTT
T ss_pred             CCCEECC-----CEEEcCCCCcC-cCCC-ccC--cCCCEEECCCCcCCCcCHhHhhCCCCCCEEECCCCcCCCcCHHHhh
Confidence            4577863     36889999999 8887 343  7899999999999988888999999999999999999998899999


Q ss_pred             cccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCcccccc---CCcccccCCCCCCC
Q 007167          138 VWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQR---FPSWAFAGNNLSSE  200 (615)
Q Consensus       138 ~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~---l~~l~~~~n~~~~~  200 (615)
                      ++++|+.|+|++|+|++..+..|.++++|+.|+|++|+|++..|..|..   +..|.+++|.+...
T Consensus        78 ~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  143 (220)
T 2v9t_B           78 GLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKINCLRVDAFQDLHNLNLLSLYDNKLQTI  143 (220)
T ss_dssp             TCSSCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCC
T ss_pred             CCcCCCEEECCCCcCCccCHhHccCCCCCCEEECCCCCCCEeCHHHcCCCCCCCEEECCCCcCCEE
Confidence            9999999999999999766667899999999999999999988887765   55677899988654

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.60  E-value=1.2e-15  Score=158.29  Aligned_cols=150  Identities=25%  Similarity=0.347  Sum_probs=120.8

Q ss_pred             CCCCCCCCCCCcceEecCC-----------CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCcccc
Q 007167           47 WNESSSLCKSWTGVTCSAD-----------HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKL  115 (615)
Q Consensus        47 w~~~~~~c~~w~gv~C~~~-----------~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l  115 (615)
                      |......| .|.|+ |+..           ..+++.|+|++|+++ .+++..|.++++|++|+|++|++++..|..|.++
T Consensus        23 ~~~~~~~C-~~~~~-c~~~~~~l~~iP~~~~~~L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l   99 (353)
T 2z80_A           23 SNQASLSC-DRNGI-CKGSSGSLNSIPSGLTEAVKSLDLSNNRIT-YISNSDLQRCVNLQALVLTSNGINTIEEDSFSSL   99 (353)
T ss_dssp             ----CCEE-CTTSE-EECCSTTCSSCCTTCCTTCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTSCCCEECTTTTTTC
T ss_pred             CCccCCCC-CCCeE-eeCCCCCcccccccccccCcEEECCCCcCc-ccCHHHhccCCCCCEEECCCCccCccCHhhcCCC
Confidence            44445566 79887 6532           247899999999999 5777689999999999999999999888899999


Q ss_pred             ccCcEEecccccccCCCCcccccccccceeecCCCcCCccCC-CcccCCCCCCeeeccCcc-ccCCCccccccC---Ccc
Q 007167          116 ENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIP-ASISKLTHLSALNLANNS-LTGTLPRSLQRF---PSW  190 (615)
Q Consensus       116 ~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p-~~~~~l~~L~~l~l~~N~-l~g~~p~~~~~l---~~l  190 (615)
                      ++|++|+|++|++++..+..|.++++|+.|+|++|++++..+ ..+.++++|+.|++++|+ +++..|..|.++   ..+
T Consensus       100 ~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~l~~L~~L  179 (353)
T 2z80_A          100 GSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEEL  179 (353)
T ss_dssp             TTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEE
T ss_pred             CCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcccCchhhhccCCCCcEEECCCCccccccCHHHccCCCCCCEE
Confidence            999999999999996544559999999999999999996433 478999999999999995 665556666655   456


Q ss_pred             cccCCCCCC
Q 007167          191 AFAGNNLSS  199 (615)
Q Consensus       191 ~~~~n~~~~  199 (615)
                      .+++|.+..
T Consensus       180 ~l~~n~l~~  188 (353)
T 2z80_A          180 EIDASDLQS  188 (353)
T ss_dssp             EEEETTCCE
T ss_pred             ECCCCCcCc
Confidence            778887754

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.60  E-value=5.7e-15  Score=136.90  Aligned_cols=115  Identities=23%  Similarity=0.332  Sum_probs=100.2

Q ss_pred             cceEecCCCCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccc
Q 007167           58 TGVTCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFS  137 (615)
Q Consensus        58 ~gv~C~~~~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~  137 (615)
                      .+..|..     +.+++++++|+ .+|. .+.  ++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|.
T Consensus         8 ~~C~C~~-----~~l~~~~n~l~-~iP~-~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~   78 (174)
T 2r9u_A            8 SQCSCDQ-----TLVNCQNIRLA-SVPA-GIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFD   78 (174)
T ss_dssp             TTSEECS-----SEEECCSSCCS-SCCS-CCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTT
T ss_pred             CCCEECC-----cEEEeCCCCCC-ccCC-CcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhC
Confidence            3456642     47899999997 8987 343  8999999999999999999999999999999999999986666689


Q ss_pred             cccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCc
Q 007167          138 VWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLP  181 (615)
Q Consensus       138 ~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p  181 (615)
                      .+++|+.|+|++|+|++..+..|.++++|+.|+|++|.+....+
T Consensus        79 ~l~~L~~L~L~~N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~~~  122 (174)
T 2r9u_A           79 KLTQLTQLDLNDNHLKSIPRGAFDNLKSLTHIYLYNNPWDCECR  122 (174)
T ss_dssp             TCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCBCTTBG
T ss_pred             CcchhhEEECCCCccceeCHHHhccccCCCEEEeCCCCcccccc
Confidence            99999999999999998666679999999999999999996543

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.60  E-value=7.4e-16  Score=174.71  Aligned_cols=168  Identities=24%  Similarity=0.284  Sum_probs=76.5

Q ss_pred             ChhHHHHHHHHHHhcCCC---CCCCCCCCCCCCCCCcceEecCCCCcEEEEEeCC------------------CCccc--
Q 007167           25 PVEDKQALLDFIHNIHNS---RSLNWNESSSLCKSWTGVTCSADHSRVVALRLPG------------------MALRG--   81 (615)
Q Consensus        25 ~~~d~~al~~~k~~~~~~---~~~~w~~~~~~c~~w~gv~C~~~~~~v~~l~l~~------------------~~l~g--   81 (615)
                      ...++++|+++.......   ...+|.....++..|.++.++.  .+++.|+|.+                  +.|.+  
T Consensus       130 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~--~~~~~l~L~~n~~~~~~~~~l~~l~Ls~~~i~~~~  207 (727)
T 4b8c_D          130 VDCTKQALMEMADTLTDSKTAKKQQPTGDSTPSGTATNSAVST--PLTPKIELFANGKDEANQALLQHKKLSQYSIDEDD  207 (727)
T ss_dssp             --CCCHHHHHHHHHHHHHHTTC----------------------------------------------------------
T ss_pred             cccchhhhhhhhhhcccccCcccCCCcCCCCccccCCCceecC--CccceEEeeCCCCCcchhhHhhcCccCcccccCcc
Confidence            345788999998776432   2234654444444787776653  2333333322                  22221  


Q ss_pred             ------ccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeecCCCcCCcc
Q 007167           82 ------EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNAS  155 (615)
Q Consensus        82 ------~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~  155 (615)
                            .+++..+..++.|+.|+|++|.+. .+|..+.+|++|++|+|++|+|+ .+|..|+.|++|+.|+|++|+|+ .
T Consensus       208 ~~~n~~~~~~~~~~~l~~L~~L~Ls~n~l~-~l~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~  284 (727)
T 4b8c_D          208 DIENRMVMPKDSKYDDQLWHALDLSNLQIF-NISANIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-S  284 (727)
T ss_dssp             --------------CCCCCCEEECTTSCCS-CCCGGGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-S
T ss_pred             ccccceecChhhhccCCCCcEEECCCCCCC-CCChhhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-c
Confidence                  122334556666666666666666 45555556666666666666666 56666666666666666666666 4


Q ss_pred             CCCcccCCCCCCeeeccCccccCCCccccccC---CcccccCCCCC
Q 007167          156 IPASISKLTHLSALNLANNSLTGTLPRSLQRF---PSWAFAGNNLS  198 (615)
Q Consensus       156 ~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l---~~l~~~~n~~~  198 (615)
                      +|..|++|++|++|+|++|.|+ .+|..|+++   ..|.+++|++.
T Consensus       285 lp~~~~~l~~L~~L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~  329 (727)
T 4b8c_D          285 LPAELGSCFQLKYFYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLE  329 (727)
T ss_dssp             CCSSGGGGTTCSEEECCSSCCC-CCCSSTTSCTTCCCEECTTSCCC
T ss_pred             cChhhcCCCCCCEEECCCCCCC-ccChhhhcCCCccEEeCCCCccC
Confidence            5666666666666666666665 555555433   33445566554

>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A*

Probab=99.60  E-value=1.8e-15  Score=162.59  Aligned_cols=144  Identities=24%  Similarity=0.300  Sum_probs=122.0

Q ss_pred             CCcc--eEecCCC--------CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcC-CCCccccccCcEEecc
Q 007167           56 SWTG--VTCSADH--------SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLF-PSDFSKLENLTSLHLQ  124 (615)
Q Consensus        56 ~w~g--v~C~~~~--------~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~-p~~~~~l~~L~~L~l~  124 (615)
                      .|.+  |.|+...        .+++.|+|++|.+++..| ..|+++++|++|+|++|.+.+.+ |..|.++++|++|+|+
T Consensus         9 ~~~~~~~~c~~~~l~~lp~l~~~l~~L~Ls~n~i~~~~~-~~~~~l~~L~~L~L~~n~~~~~i~~~~~~~l~~L~~L~Ls   87 (455)
T 3v47_A            9 SVIGYNAICINRGLHQVPELPAHVNYVDLSLNSIAELNE-TSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLD   87 (455)
T ss_dssp             EEETTEEECCSSCCSSCCCCCTTCCEEECCSSCCCEECT-TTTSSCTTCCEEECCCCSTTCEECTTTTTTCTTCCEEECT
T ss_pred             EEEccccCcCCCCcccCCCCCCccCEEEecCCccCcCCh-hHhccCccccEEECcCCcccceECcccccccccCCEEeCC
Confidence            4544  7776432        578999999999995444 48999999999999999998776 4679999999999999


Q ss_pred             cccccCCCCcccccccccceeecCCCcCCccCCCc--ccCCCCCCeeeccCccccCCCccc-c---ccCCcccccCCCCC
Q 007167          125 FNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPAS--ISKLTHLSALNLANNSLTGTLPRS-L---QRFPSWAFAGNNLS  198 (615)
Q Consensus       125 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~--~~~l~~L~~l~l~~N~l~g~~p~~-~---~~l~~l~~~~n~~~  198 (615)
                      +|++++..|..|+++++|++|+|++|++++.+|..  +.++++|+.|+|++|++++..|.. +   .++..+.+++|.+.
T Consensus        88 ~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~~l~~L~~L~L~~n~l~  167 (455)
T 3v47_A           88 YNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKVK  167 (455)
T ss_dssp             TCTTCEECTTTTTTCTTCCEEECTTSCCBTHHHHSSTTTTCTTCCEEECCSSBCCSCCCCGGGGGCTTCCEEECTTCCBS
T ss_pred             CCccCccChhhccCcccCCEEeCCCCCCCccccCcccccCcccCCEEECCCCccCccCcccccCCCCcccEEeCCCCccc
Confidence            99999988999999999999999999999866555  999999999999999999888865 4   45566778888875


Q ss_pred             CC
Q 007167          199 SE  200 (615)
Q Consensus       199 ~~  200 (615)
                      ..
T Consensus       168 ~~  169 (455)
T 3v47_A          168 SI  169 (455)
T ss_dssp             CC
T ss_pred             cc
Confidence            43

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.59  E-value=1.8e-15  Score=153.60  Aligned_cols=135  Identities=21%  Similarity=0.250  Sum_probs=110.8

Q ss_pred             CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccC-CCCcccccccccce
Q 007167           66 HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSG-PLPLDFSVWNNLTV  144 (615)
Q Consensus        66 ~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~  144 (615)
                      ..+++.|+|++|++++..+...+..+++|++|+|++|.+++..|..|.++++|++|+|++|.+++ .+|..+..+++|+.
T Consensus       100 l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~  179 (306)
T 2z66_A          100 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF  179 (306)
T ss_dssp             CTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCE
T ss_pred             CCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEEECCCCccccccchhHHhhCcCCCE
Confidence            35788899999988844433578889999999999999988888888889999999999999886 57888888999999


Q ss_pred             eecCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccc---cCCcccccCCCCCCC
Q 007167          145 IDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQ---RFPSWAFAGNNLSSE  200 (615)
Q Consensus       145 l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l~~~~n~~~~~  200 (615)
                      |+|++|++++..|..+.++++|+.|+|++|++++..+..+.   ++..+.+++|.+...
T Consensus       180 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  238 (306)
T 2z66_A          180 LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTS  238 (306)
T ss_dssp             EECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBCCSGGGTTCTTCCEEECTTSCCCBC
T ss_pred             EECCCCCcCCcCHHHhcCCCCCCEEECCCCccCccChhhccCcccCCEeECCCCCCccc
Confidence            99999999988788888899999999999999876665554   555677888887654

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.59  E-value=4.9e-15  Score=148.12  Aligned_cols=132  Identities=20%  Similarity=0.223  Sum_probs=113.3

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID  146 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~  146 (615)
                      ..++.|+|++|+++ .+++..|.++++|++|+|++|.+++..+..|.++++|++|+|++|++++..|..|.++++|+.|+
T Consensus        28 ~~l~~L~ls~n~l~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  106 (276)
T 2z62_A           28 FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV  106 (276)
T ss_dssp             TTCCEEECTTCCCC-EECTTTTTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred             CCccEEECCCCccc-ccCHhHhccccCCcEEECCCCcCCccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEE
Confidence            35899999999999 56655799999999999999999988888899999999999999999988888899999999999


Q ss_pred             cCCCcCCccCCCcccCCCCCCeeeccCccccC-CCccccccC---CcccccCCCCCC
Q 007167          147 LSNNFFNASIPASISKLTHLSALNLANNSLTG-TLPRSLQRF---PSWAFAGNNLSS  199 (615)
Q Consensus       147 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g-~~p~~~~~l---~~l~~~~n~~~~  199 (615)
                      +++|++++..+..+.++++|+.|+|++|++++ .+|..+.++   ..+.+++|.+..
T Consensus       107 l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~  163 (276)
T 2z62_A          107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS  163 (276)
T ss_dssp             CTTSCCCCSTTCCCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCE
T ss_pred             CCCCCccccCchhcccCCCCCEEECcCCccceecCchhhccCCCCCEEECCCCCCCc
Confidence            99999998777789999999999999999987 368776654   456678887643

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.59  E-value=3.4e-15  Score=166.47  Aligned_cols=132  Identities=20%  Similarity=0.223  Sum_probs=118.2

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID  146 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~  146 (615)
                      .+++.|+|++|+++ .+++..|+++++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..|+++++|++|+
T Consensus        32 ~~l~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~i~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~  110 (606)
T 3vq2_A           32 SSTKNIDLSFNPLK-ILKSYSFSNFSELQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLV  110 (606)
T ss_dssp             TTCCEEECTTSCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCCCCTTSSTTCTTCCEEE
T ss_pred             CCcCEEECCCCCcC-EeChhhccCCccCcEEeCCCCcccccCHHHhhchhhcCEeECCCCcccccChhhcCCcccCCEEE
Confidence            57899999999999 45555899999999999999999999899999999999999999999998899999999999999


Q ss_pred             cCCCcCCccCCCcccCCCCCCeeeccCccccC-CCccccccCC---cccccCCCCCC
Q 007167          147 LSNNFFNASIPASISKLTHLSALNLANNSLTG-TLPRSLQRFP---SWAFAGNNLSS  199 (615)
Q Consensus       147 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g-~~p~~~~~l~---~l~~~~n~~~~  199 (615)
                      |++|++++..|..++++++|++|+|++|.+++ .+|..+++++   .+.+++|.+..
T Consensus       111 L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~Ls~n~l~~  167 (606)
T 3vq2_A          111 AVETKLASLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQT  167 (606)
T ss_dssp             CTTSCCCCSSSSCCTTCTTCCEEECCSSCCCCCCCCGGGGTCTTCCEEECCSSCCCE
T ss_pred             ccCCccccccccccCCCCCCCEEeCCCCcccceechHhHhhcCCCCEEEccCCccee
Confidence            99999998877899999999999999999986 6788776554   56678887754

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.59  E-value=2.4e-15  Score=162.63  Aligned_cols=143  Identities=23%  Similarity=0.280  Sum_probs=124.2

Q ss_pred             CCcceEecCC---------CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccc
Q 007167           56 SWTGVTCSAD---------HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFN  126 (615)
Q Consensus        56 ~w~gv~C~~~---------~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N  126 (615)
                      .|..|.|...         ...++.|+|++|+++ .+++..|.++++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus        12 ~~~~v~c~~~~l~~ip~~~~~~l~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~i~~~~~~~~~~l~~L~~L~L~~n   90 (477)
T 2id5_A           12 QDRAVLCHRKRFVAVPEGIPTETRLLDLGKNRIK-TLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSN   90 (477)
T ss_dssp             TTTEEECCSCCCSSCCSCCCTTCSEEECCSSCCC-EECTTTTTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             CCCEEEeCCCCcCcCCCCCCCCCcEEECCCCccc-eECHhHccCCCCCCEEECCCCccCEeChhhhhCCccCCEEECCCC
Confidence            4778899742         246889999999999 455558999999999999999999999999999999999999999


Q ss_pred             cccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCcccccc---CCcccccCCCCCC
Q 007167          127 SFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQR---FPSWAFAGNNLSS  199 (615)
Q Consensus       127 ~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~---l~~l~~~~n~~~~  199 (615)
                      ++++..+..|.++++|+.|+|++|++++..|..|.++++|+.|+|++|.+++..|..|.+   |..|.+++|.+..
T Consensus        91 ~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~  166 (477)
T 2id5_A           91 RLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTS  166 (477)
T ss_dssp             CCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEEECCTTCCEECTTSSTTCTTCCEEEEESCCCSS
T ss_pred             cCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEEECCCCccceeChhhccCCCCCCEEECCCCcCcc
Confidence            999766667899999999999999999998999999999999999999999887777654   4556778887654

>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A*

Probab=99.59  E-value=6e-15  Score=148.21  Aligned_cols=131  Identities=22%  Similarity=0.271  Sum_probs=114.8

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEeccccc-ccCCCCccccccccccee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNS-FSGPLPLDFSVWNNLTVI  145 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~-l~g~~p~~~~~l~~L~~l  145 (615)
                      ..++.|+|++|+++ .+++..|+.+++|++|+|++|.+++..|..|.++++|++|+|++|. ++...|..|..+++|+.|
T Consensus        32 ~~l~~L~l~~n~i~-~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~~l~~~~~~~~~~l~~L~~L  110 (285)
T 1ozn_A           32 AASQRIFLHGNRIS-HVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTL  110 (285)
T ss_dssp             TTCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCCCCCTTTTTTCTTCCEE
T ss_pred             CCceEEEeeCCcCC-ccCHHHcccCCCCCEEECCCCccceeCHhhcCCccCCCEEeCCCCCCccccCHHHhcCCcCCCEE
Confidence            57899999999999 5666689999999999999999998889999999999999999997 777668889999999999


Q ss_pred             ecCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccc---cCCcccccCCCCC
Q 007167          146 DLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQ---RFPSWAFAGNNLS  198 (615)
Q Consensus       146 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l~~~~n~~~  198 (615)
                      +|++|++++..|..+.++++|+.|+|++|++++..+..|.   ++..+.+++|.+.
T Consensus       111 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~  166 (285)
T 1ozn_A          111 HLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRIS  166 (285)
T ss_dssp             ECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC
T ss_pred             ECCCCcCCEECHhHhhCCcCCCEEECCCCcccccCHhHhccCCCccEEECCCCccc
Confidence            9999999988888999999999999999999977666554   5556778888775

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.59  E-value=1.3e-15  Score=167.64  Aligned_cols=144  Identities=20%  Similarity=0.271  Sum_probs=122.7

Q ss_pred             CCCCCcceEecCC-----------CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEE
Q 007167           53 LCKSWTGVTCSAD-----------HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSL  121 (615)
Q Consensus        53 ~c~~w~gv~C~~~-----------~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L  121 (615)
                      .| .|.|+ |+..           ..+++.|+|++|++++ +++..|+++++|++|+|++|++++..|..|.++++|++|
T Consensus         3 ~C-~~~~~-c~~~~~~l~~ip~~~~~~L~~L~Ls~n~l~~-~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L   79 (549)
T 2z81_A            3 SC-DASGV-CDGRSRSFTSIPSGLTAAMKSLDLSFNKITY-IGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHL   79 (549)
T ss_dssp             EE-CTTSE-EECTTSCCSSCCSCCCTTCCEEECCSSCCCE-ECSSTTSSCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             cC-CCCce-EECCCCccccccccCCCCccEEECcCCccCc-cChhhhhcCCcccEEECCCCCcCccChhhccccccCCEE
Confidence            46 79988 8632           2479999999999995 444589999999999999999999988999999999999


Q ss_pred             ecccccccCCCCcccccccccceeecCCCcCCc-cCCCcccCCCCCCeeeccCccccCCCc-cccccCC---cccccCCC
Q 007167          122 HLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNA-SIPASISKLTHLSALNLANNSLTGTLP-RSLQRFP---SWAFAGNN  196 (615)
Q Consensus       122 ~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~-~~p~~~~~l~~L~~l~l~~N~l~g~~p-~~~~~l~---~l~~~~n~  196 (615)
                      +|++|++++..|..|+++++|++|+|++|++++ .+|..+.++++|+.|++++|++.+.+| ..|.+++   .+.+++|.
T Consensus        80 ~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~  159 (549)
T 2z81_A           80 DLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALS  159 (549)
T ss_dssp             ECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCEEEEEESSSCCEECTTTTTTCCEEEEEEEEETT
T ss_pred             ECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccEEECCCCccccccCHhhhhcccccCeeeccCCc
Confidence            999999998777779999999999999999997 367889999999999999999766776 4565544   56778887


Q ss_pred             CCC
Q 007167          197 LSS  199 (615)
Q Consensus       197 ~~~  199 (615)
                      +..
T Consensus       160 l~~  162 (549)
T 2z81_A          160 LRN  162 (549)
T ss_dssp             CCE
T ss_pred             ccc
Confidence            754

>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A

Probab=99.59  E-value=6.7e-15  Score=146.87  Aligned_cols=136  Identities=28%  Similarity=0.323  Sum_probs=120.8

Q ss_pred             CCCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccce
Q 007167           65 DHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTV  144 (615)
Q Consensus        65 ~~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~  144 (615)
                      ...+++.|+|++|+++ .+++..|+.+++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|+.+++|+.
T Consensus        83 ~l~~L~~L~L~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~  161 (272)
T 3rfs_A           83 ELTNLTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLNLAHNQLQSLPKGVFDKLTNLTE  161 (272)
T ss_dssp             TCTTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCE
T ss_pred             CCCCCCEEECCCCccC-ccChhHhcCCcCCCEEECCCCcCCccCHHHhccCCCCCEEECCCCccCccCHHHhccCccCCE
Confidence            3468999999999999 566667899999999999999999888888999999999999999999877778899999999


Q ss_pred             eecCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccc---cCCcccccCCCCCCCC
Q 007167          145 IDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQ---RFPSWAFAGNNLSSEN  201 (615)
Q Consensus       145 l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l~~~~n~~~~~~  201 (615)
                      |+|++|++++..|..+.++++|+.|+|++|++++..|..+.   ++..+.+.+|++.|..
T Consensus       162 L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~~~~~~  221 (272)
T 3rfs_A          162 LDLSYNQLQSLPEGVFDKLTQLKDLRLYQNQLKSVPDGVFDRLTSLQYIWLHDNPWDCTC  221 (272)
T ss_dssp             EECCSSCCCCCCTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCCT
T ss_pred             EECCCCCcCccCHHHhcCCccCCEEECCCCcCCccCHHHHhCCcCCCEEEccCCCccccC
Confidence            99999999988888889999999999999999988876655   4556778999987653

>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus}

Probab=99.58  E-value=9e-15  Score=141.99  Aligned_cols=134  Identities=30%  Similarity=0.378  Sum_probs=115.1

Q ss_pred             CcceEecCCCCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCccc
Q 007167           57 WTGVTCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDF  136 (615)
Q Consensus        57 w~gv~C~~~~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~  136 (615)
                      |..-.|+.     +.++.++++++ .+|.. +  .++|++|+|++|+|++..|..|.++++|++|+|++|+|++..+..|
T Consensus        14 ~~~~~Cs~-----~~v~c~~~~l~-~ip~~-~--~~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~   84 (229)
T 3e6j_A           14 PSQCSCSG-----TTVDCRSKRHA-SVPAG-I--PTNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVF   84 (229)
T ss_dssp             CTTCEEET-----TEEECTTSCCS-SCCSC-C--CTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTT
T ss_pred             CCCCEEeC-----CEeEccCCCcC-ccCCC-C--CCCCCEEEcCCCccCccCHHHhhCccCCcEEECCCCCCCCcChhhc
Confidence            55567752     35889999998 88873 3  3899999999999999999999999999999999999987666778


Q ss_pred             ccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCcccccc---CCcccccCCCCCCC
Q 007167          137 SVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQR---FPSWAFAGNNLSSE  200 (615)
Q Consensus       137 ~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~---l~~l~~~~n~~~~~  200 (615)
                      ..+++|+.|+|++|+|++..+..|..+++|+.|+|++|+|+ .+|..+..   +..|.+++|.+...
T Consensus        85 ~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~  150 (229)
T 3e6j_A           85 DSLTQLTVLDLGTNQLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLKSI  150 (229)
T ss_dssp             TTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCC-SCCTTGGGCTTCSEEECCSSCCCCC
T ss_pred             ccCCCcCEEECCCCcCCccChhHhCcchhhCeEeccCCccc-ccCcccccCCCCCEEECCCCcCCcc
Confidence            99999999999999999877778899999999999999999 78876654   55677899988643

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.56  E-value=1.1e-14  Score=156.50  Aligned_cols=144  Identities=19%  Similarity=0.203  Sum_probs=121.8

Q ss_pred             CCcceEecCC---------CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccc
Q 007167           56 SWTGVTCSAD---------HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFN  126 (615)
Q Consensus        56 ~w~gv~C~~~---------~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N  126 (615)
                      .|..|.|...         ..+++.|+|++|++++ +++..|.++++|++|+|++|.|++..|..|.++++|++|+|++|
T Consensus        55 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~~-~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~L~~n  133 (452)
T 3zyi_A           55 QFSKVVCTRRGLSEVPQGIPSNTRYLNLMENNIQM-IQADTFRHLHHLEVLQLGRNSIRQIEVGAFNGLASLNTLELFDN  133 (452)
T ss_dssp             SSCEEECCSSCCSSCCSCCCTTCSEEECCSSCCCE-ECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSS
T ss_pred             CCcEEEECCCCcCccCCCCCCCccEEECcCCcCce-ECHHHcCCCCCCCEEECCCCccCCcChhhccCcccCCEEECCCC
Confidence            3677888642         2478999999999995 55558999999999999999999999999999999999999999


Q ss_pred             cccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCcc-cc---ccCCcccccCCCCCCC
Q 007167          127 SFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPR-SL---QRFPSWAFAGNNLSSE  200 (615)
Q Consensus       127 ~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~~---~~l~~l~~~~n~~~~~  200 (615)
                      +|++..+..|..+++|+.|+|++|+|++..+..|.++++|+.|+|++|+..+.+|. .|   .++..|.+++|.+...
T Consensus       134 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~  211 (452)
T 3zyi_A          134 WLTVIPSGAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM  211 (452)
T ss_dssp             CCSBCCTTTSSSCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC
T ss_pred             cCCccChhhhcccCCCCEEECCCCCcceeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc
Confidence            99987777799999999999999999987777899999999999999655556654 34   4566777888887643

>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A*

Probab=99.56  E-value=6e-15  Score=164.93  Aligned_cols=134  Identities=22%  Similarity=0.306  Sum_probs=118.5

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCC-CCcCCCCccccccCcEEecccccccCCCCccccccccccee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSL-SGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVI  145 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l-~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l  145 (615)
                      ..+..++++.|.+.+..+. .+..++.|+.|+|++|++ .+.+|..|..+++|++|+|++|+|++.+|..|.++++|+.|
T Consensus       445 ~~l~~l~ls~n~l~~~~~~-~~~~~~~L~~L~Ls~N~~~~~~~~~~~~~l~~L~~L~Ls~N~L~~l~~~~f~~l~~L~~L  523 (635)
T 4g8a_A          445 RNLIYLDISHTHTRVAFNG-IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVL  523 (635)
T ss_dssp             TTCCEEECTTSCCEECCTT-TTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             ccccccccccccccccccc-ccccchhhhhhhhhhcccccccCchhhhhccccCEEECCCCccCCcChHHHcCCCCCCEE
Confidence            4677888999999855554 789999999999999974 45678899999999999999999999999999999999999


Q ss_pred             ecCCCcCCccCCCcccCCCCCCeeeccCccccCCCcccccc----CCcccccCCCCCCCC
Q 007167          146 DLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQR----FPSWAFAGNNLSSEN  201 (615)
Q Consensus       146 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~----l~~l~~~~n~~~~~~  201 (615)
                      +|++|+|++..|..|.++++|+.|+|++|+|++..|..+..    +..+.+++|++.|.+
T Consensus       524 ~Ls~N~l~~l~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~l~~~L~~L~L~~Np~~C~C  583 (635)
T 4g8a_A          524 NMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFACTC  583 (635)
T ss_dssp             ECTTSCCCBCCCGGGTTCTTCCEEECTTSCCCBCCSSCTTCCCTTCCEEECTTCCBCCSG
T ss_pred             ECCCCcCCCCChhHHhCCCCCCEEECCCCcCCCCCHHHHHhhhCcCCEEEeeCCCCcccC
Confidence            99999999988889999999999999999999999988754    556789999999874

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.56  E-value=4.4e-15  Score=171.93  Aligned_cols=134  Identities=21%  Similarity=0.207  Sum_probs=115.6

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCC-----CcCCCCccccccCcEEecccccccCCCCcccccccc
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLS-----GLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN  141 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~-----g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~  141 (615)
                      .+++.|+|++|++++..+...+..+++|+.|+|++|.++     +..|..|.++++|++|+|++|+|++.+|..|.++++
T Consensus       426 ~~L~~L~Ls~N~l~~~~~~~~~~~~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~  505 (844)
T 3j0a_A          426 PHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTA  505 (844)
T ss_dssp             TTCCEEEEESCCCCCCCSSSSSCSCTTCCBCEEESCCCSSSCCSCCCSSCSSCBCCEECCCCCHHHHTTCCTTSSSSCCS
T ss_pred             CccceeeCCCCcccccccccccccCCccccccCCCCccccccccccchhhhcCcccccEEECCCCcccccChhHccchhh
Confidence            467788888888885544445667888889999998887     445567899999999999999999988999999999


Q ss_pred             cceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccccCCcccccCCCCCCCCC
Q 007167          142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLSSENA  202 (615)
Q Consensus       142 L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~n~~~~~~~  202 (615)
                      |+.|+|++|+|++..|..+.  ++|+.|+|++|+|++.+|..|.++..+.+++|++.|.++
T Consensus       506 L~~L~Ls~N~l~~l~~~~~~--~~L~~L~Ls~N~l~~~~~~~~~~L~~l~l~~Np~~C~c~  564 (844)
T 3j0a_A          506 LRGLSLNSNRLTVLSHNDLP--ANLEILDISRNQLLAPNPDVFVSLSVLDITHNKFICECE  564 (844)
T ss_dssp             CSEEEEESCCCSSCCCCCCC--SCCCEEEEEEECCCCCCSCCCSSCCEEEEEEECCCCSSS
T ss_pred             hheeECCCCCCCccChhhhh--ccccEEECCCCcCCCCChhHhCCcCEEEecCCCcccccc
Confidence            99999999999987776665  799999999999999999999999999999999988653

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.55  E-value=9.7e-15  Score=162.75  Aligned_cols=142  Identities=18%  Similarity=0.167  Sum_probs=122.8

Q ss_pred             CcceEecCC---------CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEeccccc
Q 007167           57 WTGVTCSAD---------HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNS  127 (615)
Q Consensus        57 w~gv~C~~~---------~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~  127 (615)
                      +..+.|...         ...++.|+|++|.++ .+++..|+++++|++|+|++|.+++..|..|.++++|++|+|++|+
T Consensus        14 ~~~~~c~~~~l~~iP~~l~~~l~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L~Ls~n~   92 (606)
T 3t6q_A           14 NKTYNCENLGLNEIPGTLPNSTECLEFSFNVLP-TIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLDTLVLTANP   92 (606)
T ss_dssp             TTEEECTTSCCSSCCTTSCTTCCEEECTTCCCS-EECTTTSTTCTTCSEEECTTCCCCEECTTTTTTCTTCCEEECTTCC
T ss_pred             CceEECCCCCcccCcCCCCCcCcEEEccCCccC-cCChhHhccCccceEEECCCCccceeChhhccCccccCeeeCCCCc
Confidence            456778642         247899999999999 5555589999999999999999999999999999999999999999


Q ss_pred             ccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCC-Cccc--cccCCcccccCCCCCC
Q 007167          128 FSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGT-LPRS--LQRFPSWAFAGNNLSS  199 (615)
Q Consensus       128 l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~-~p~~--~~~l~~l~~~~n~~~~  199 (615)
                      +++..|..|+++++|++|+|++|++++..|..+.++++|++|+|++|++++. +|..  +.++..+.+++|.+..
T Consensus        93 l~~~~~~~~~~l~~L~~L~L~~n~i~~l~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~  167 (606)
T 3t6q_A           93 LIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHY  167 (606)
T ss_dssp             CSEECTTTTSSCTTCCEEECTTSCCSCGGGSCCTTCTTCCEEECCSSCCCCCCCCTTCCCTTCCEEECCSSCCCE
T ss_pred             ccccChhhhcccccccEeeccccCcccCCcchhccCCcccEEECCCCcccccCcccccCCcccCEEEcccCcccc
Confidence            9998899999999999999999999987788999999999999999999974 3443  3456677788887753

>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A*

Probab=99.55  E-value=6.2e-15  Score=147.34  Aligned_cols=133  Identities=21%  Similarity=0.289  Sum_probs=114.7

Q ss_pred             CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCccccccccccee
Q 007167           66 HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVI  145 (615)
Q Consensus        66 ~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l  145 (615)
                      ..+++.|+|++|.++ .+++..|.++++|++|+|++|.+++..|..|.++++|++|+|++|++++..+..++.+++|+.|
T Consensus        51 l~~L~~L~l~~n~l~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  129 (276)
T 2z62_A           51 FPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL  129 (276)
T ss_dssp             CTTCSEEECTTCCCC-EECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEECTTSCCCCSTTCCCTTCTTCCEE
T ss_pred             ccCCcEEECCCCcCC-ccCHHHccCCcCCCEEECCCCccCccChhhhcCCccccEEECCCCCccccCchhcccCCCCCEE
Confidence            467999999999998 5666689999999999999999998888899999999999999999998777789999999999


Q ss_pred             ecCCCcCCcc-CCCcccCCCCCCeeeccCccccCCCccccccCC-------cccccCCCCCC
Q 007167          146 DLSNNFFNAS-IPASISKLTHLSALNLANNSLTGTLPRSLQRFP-------SWAFAGNNLSS  199 (615)
Q Consensus       146 ~l~~N~l~~~-~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~-------~l~~~~n~~~~  199 (615)
                      +|++|++++. +|..+.++++|+.|+|++|++++..+..+..+.       .+.+++|.+..
T Consensus       130 ~l~~n~l~~~~l~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~l~l~L~ls~n~l~~  191 (276)
T 2z62_A          130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF  191 (276)
T ss_dssp             ECCSSCCCCCCCCGGGGGCTTCCEEECCSSCCCEECGGGGHHHHTCTTCCEEEECCSSCCCE
T ss_pred             ECcCCccceecCchhhccCCCCCEEECCCCCCCcCCHHHhhhhhhccccceeeecCCCcccc
Confidence            9999999874 689999999999999999999987776665433       45667777643

>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A*

Probab=99.55  E-value=6.5e-15  Score=164.18  Aligned_cols=132  Identities=21%  Similarity=0.194  Sum_probs=95.3

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccC-CCCccccccccccee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSG-PLPLDFSVWNNLTVI  145 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~l  145 (615)
                      .+++.|+|++|.+++..|...+..+++|++|+|++|.+++.+|..|.++++|++|+|++|++++ .+|..|+.+++|+.|
T Consensus       399 ~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L  478 (606)
T 3vq2_A          399 EELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFL  478 (606)
T ss_dssp             TTCCEEECTTSEEESTTTTTTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEE
T ss_pred             CCCCeeECCCCccCCccChhhhhccccCCEEECcCCCCCccchhhhcCCCCCCEEECCCCcCCCcchHHhhccCCCCCEE
Confidence            4677777777777766553467777777777777777777777777777777777777777776 367777777777777


Q ss_pred             ecCCCcCCccCCCcccCCCCCCeeeccCccccCCCcccccc---CCcccccCCCCC
Q 007167          146 DLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQR---FPSWAFAGNNLS  198 (615)
Q Consensus       146 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~---l~~l~~~~n~~~  198 (615)
                      +|++|++++.+|..+.++++|+.|+|++|++++.+|..+.+   +..+.+++|++.
T Consensus       479 ~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~l~~N~l~  534 (606)
T 3vq2_A          479 DLSKCQLEQISWGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIE  534 (606)
T ss_dssp             ECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCEEGGGTTTCTTCCEEECTTSCCC
T ss_pred             ECCCCcCCccChhhhcccccCCEEECCCCcCCCcCHHHccCCCcCCEEECCCCcCc
Confidence            77777777777777777777777777777777776766654   344556677664

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.54  E-value=2.2e-14  Score=147.49  Aligned_cols=140  Identities=20%  Similarity=0.320  Sum_probs=120.2

Q ss_pred             CCcceEecCC---------CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccc
Q 007167           56 SWTGVTCSAD---------HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFN  126 (615)
Q Consensus        56 ~w~gv~C~~~---------~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N  126 (615)
                      .|..+.|+..         ...++.|+|++|+++ .+++..|.++++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus        34 ~l~~l~~~~~~l~~ip~~~~~~l~~L~l~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n  112 (332)
T 2ft3_A           34 HLRVVQCSDLGLKAVPKEISPDTTLLDLQNNDIS-ELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKN  112 (332)
T ss_dssp             ETTEEECCSSCCSSCCSCCCTTCCEEECCSSCCC-EECTTTTTTCTTCCEEECCSSCCCEECGGGSTTCTTCCEEECCSS
T ss_pred             cCCEEECCCCCccccCCCCCCCCeEEECCCCcCC-ccCHhHhhCCCCCcEEECCCCccCccCHhHhhCcCCCCEEECCCC
Confidence            7999999742         247899999999999 566668999999999999999999998999999999999999999


Q ss_pred             cccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCcccc--CCCccccc--cCCcccccCCCCCC
Q 007167          127 SFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLT--GTLPRSLQ--RFPSWAFAGNNLSS  199 (615)
Q Consensus       127 ~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~--g~~p~~~~--~l~~l~~~~n~~~~  199 (615)
                      +++ .+|..+.  ++|+.|+|++|++++..+..+.++++|+.|++++|.++  +..|..+.  ++..+.+++|.+..
T Consensus       113 ~l~-~l~~~~~--~~L~~L~l~~n~i~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~L~~L~l~~n~l~~  186 (332)
T 2ft3_A          113 HLV-EIPPNLP--SSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLTG  186 (332)
T ss_dssp             CCC-SCCSSCC--TTCCEEECCSSCCCCCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSCCCSCCBCCSSBCSS
T ss_pred             cCC-ccCcccc--ccCCEEECCCCccCccCHhHhCCCccCCEEECCCCccccCCCCcccccCCccCEEECcCCCCCc
Confidence            999 6777665  89999999999999876777999999999999999996  46666665  56677888887754

>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A

Probab=99.54  E-value=2.3e-14  Score=144.30  Aligned_cols=129  Identities=28%  Similarity=0.313  Sum_probs=86.7

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID  146 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~  146 (615)
                      ..++.|+|++|.+++ +++..|..+++|++|+|++|.|++..+ . +.+++|++|+|++|+|+ .+|..+..+++|+.|+
T Consensus        31 ~~l~~L~L~~N~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~-~-~~l~~L~~L~Ls~N~l~-~l~~~~~~l~~L~~L~  106 (290)
T 1p9a_G           31 KDTTILHLSENLLYT-FSLATLMPYTRLTQLNLDRAELTKLQV-D-GTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLD  106 (290)
T ss_dssp             TTCCEEECTTSCCSE-EEGGGGTTCTTCCEEECTTSCCCEEEC-C-SCCTTCCEEECCSSCCS-SCCCCTTTCTTCCEEE
T ss_pred             CCCCEEEcCCCcCCc-cCHHHhhcCCCCCEEECCCCccCcccC-C-CCCCcCCEEECCCCcCC-cCchhhccCCCCCEEE
Confidence            356677777777763 333367777777777777777775433 2 66777777777777777 5676777777777777


Q ss_pred             cCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccc---cCCcccccCCCCCC
Q 007167          147 LSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQ---RFPSWAFAGNNLSS  199 (615)
Q Consensus       147 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l~~~~n~~~~  199 (615)
                      |++|+|++..|..|.++++|+.|+|++|+|++..+..|.   ++..|.+++|.+..
T Consensus       107 l~~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~  162 (290)
T 1p9a_G          107 VSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTE  162 (290)
T ss_dssp             CCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCSC
T ss_pred             CCCCcCcccCHHHHcCCCCCCEEECCCCCCCccChhhcccccCCCEEECCCCcCCc
Confidence            777777766666677777777777777777765554443   44455667776653

>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.53  E-value=2.3e-14  Score=159.40  Aligned_cols=132  Identities=24%  Similarity=0.204  Sum_probs=119.4

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID  146 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~  146 (615)
                      .+++.|+|++|.+++ +++..|+.+++|++|+|++|.|++..|..|+++++|++|+|++|.|++..+..|+++++|+.|+
T Consensus        75 ~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~  153 (597)
T 3oja_B           75 RQVELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS  153 (597)
T ss_dssp             CCCSEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             CCCcEEECCCCCCCC-CChHHhcCCCCCCEEECCCCcCCCCCHHHHcCCCCCCEEEeeCCCCCCCCHHHhccCCCCCEEE
Confidence            578999999999995 5555899999999999999999999888999999999999999999976666689999999999


Q ss_pred             cCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccccCCcccccCCCCCC
Q 007167          147 LSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLSS  199 (615)
Q Consensus       147 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~n~~~~  199 (615)
                      |++|.|++..|..|.++++|+.|+|++|.|++..+..+.++..+.+++|.+..
T Consensus       154 Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~l~~L~~L~l~~n~l~~  206 (597)
T 3oja_B          154 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLST  206 (597)
T ss_dssp             CCSSCCCBCCTTTTTTCTTCCEEECTTSCCSBCCGGGCTTCSEEECCSSCCSE
T ss_pred             eeCCcCCCCChhhhhcCCcCcEEECcCCCCCCcChhhhhhhhhhhcccCcccc
Confidence            99999999999999999999999999999998777778888888888887653

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.53  E-value=2.1e-14  Score=162.38  Aligned_cols=132  Identities=27%  Similarity=0.338  Sum_probs=115.0

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID  146 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~  146 (615)
                      .+++.|+|++|+++ .+++..|+++++|++|+|++|.+++..|..|+++++|++|+|++|++++..+..|+++++|++|+
T Consensus        25 ~~l~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~  103 (680)
T 1ziw_A           25 TNITVLNLTHNQLR-RLPAANFTRYSQLTSLDVGFNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELH  103 (680)
T ss_dssp             TTCSEEECCSSCCC-CCCGGGGGGGTTCSEEECCSSCCCCCCTTHHHHCTTCCEEECCSSCCCCCCTTTTTTCTTCSEEE
T ss_pred             CCCcEEECCCCCCC-CcCHHHHhCCCcCcEEECCCCccCccCHHHHhcccCcCEEECCCCccCccChhhhccCCCCCEEE
Confidence            57899999999999 56666899999999999999999999999999999999999999999965555799999999999


Q ss_pred             cCCCcCCccCCCcccCCCCCCeeeccCccccCCCcccccc---CCcccccCCCCCC
Q 007167          147 LSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQR---FPSWAFAGNNLSS  199 (615)
Q Consensus       147 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~---l~~l~~~~n~~~~  199 (615)
                      |++|++++..|..|.++++|++|+|++|.+++..|..+.+   +..+.+++|.+..
T Consensus       104 L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~  159 (680)
T 1ziw_A          104 LMSNSIQKIKNNPFVKQKNLITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQA  159 (680)
T ss_dssp             CCSSCCCCCCSCTTTTCTTCCEEECCSSCCSCCCCCSSSCCTTCCEEECCSSCCCC
T ss_pred             CCCCccCccChhHccccCCCCEEECCCCcccccCchhhcccccCCEEEccCCcccc
Confidence            9999999877788999999999999999999888876654   4556778887654

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.53  E-value=1.7e-14  Score=159.44  Aligned_cols=132  Identities=24%  Similarity=0.267  Sum_probs=65.4

Q ss_pred             EEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEeccccccc-CCCCcccccccccceeec
Q 007167           69 VVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFS-GPLPLDFSVWNNLTVIDL  147 (615)
Q Consensus        69 v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~-g~~p~~~~~l~~L~~l~l  147 (615)
                      ++.|+|++|.+++..+...+..+++|++|+|++|.+++..|..|.++++|++|+|++|.++ +.+|..+..+++|+.|+|
T Consensus       398 L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~p~~~~~l~~L~~L~l  477 (570)
T 2z63_A          398 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDL  477 (570)
T ss_dssp             CCEEECTTSEEESCTTSCTTTTCTTCCEEECTTSCCEECCTTTTTTCTTCCEEECTTCEEGGGEECSCCTTCTTCCEEEC
T ss_pred             CCEEEccCCccccccchhhhhcCCCCCEEeCcCCcccccchhhhhcCCcCcEEECcCCcCccccchhhhhcccCCCEEEC
Confidence            3344444444443333334445555555555555555555555555555555555555554 345555555555555555


Q ss_pred             CCCcCCccCCCcccCCCCCCeeeccCccccCCCcccccc---CCcccccCCCCCCC
Q 007167          148 SNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQR---FPSWAFAGNNLSSE  200 (615)
Q Consensus       148 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~---l~~l~~~~n~~~~~  200 (615)
                      ++|++++..|..+.++++|+.|+|++|++++..|..|.+   +..+.+++|++.|.
T Consensus       478 ~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~N~~~~~  533 (570)
T 2z63_A          478 SQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTNPWDCS  533 (570)
T ss_dssp             TTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTTTTTCTTCCEEECCSSCBCCC
T ss_pred             CCCccccCChhhhhcccCCCEEeCCCCcCCCCCHHHhhcccCCcEEEecCCcccCC
Confidence            555555544555555555555555555555544443332   22334455555443

>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens}

Probab=99.53  E-value=2.3e-14  Score=165.86  Aligned_cols=140  Identities=21%  Similarity=0.152  Sum_probs=90.7

Q ss_pred             CCcceEecCCCCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcC-CCCccccccCcEEecccccccCCCCc
Q 007167           56 SWTGVTCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLF-PSDFSKLENLTSLHLQFNSFSGPLPL  134 (615)
Q Consensus        56 ~w~gv~C~~~~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~-p~~~~~l~~L~~L~l~~N~l~g~~p~  134 (615)
                      +|..|.+  ...+++.|+|++|.+++..| ..|+++++|++|+|++|.+.+.+ |..|.+|++|++|+|++|.+++..|.
T Consensus        15 ~L~~vP~--lp~~l~~LdLs~N~i~~i~~-~~~~~l~~L~~LdLs~n~~~~~i~~~~f~~L~~L~~L~Ls~N~l~~~~p~   91 (844)
T 3j0a_A           15 NLTQVPQ--VLNTTERLLLSFNYIRTVTA-SSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSKIYFLHPD   91 (844)
T ss_dssp             CSSCCCS--SCTTCCEEEEESCCCCEECS-SSCSSCCSCSEEEECTTCCCCEECTTTTSSCTTCCEEECTTCCCCEECTT
T ss_pred             CCCCCCC--CCCCcCEEECCCCcCCccCh-hHCcccccCeEEeCCCCCCccccCHHHhcCCCCCCEEECCCCcCcccCHh
Confidence            5666665  34567777777777774333 36777777777777777555555 56677777777777777777766677


Q ss_pred             ccccccccceeecCCCcCCccCCCc--ccCCCCCCeeeccCccccCCCc-cccc---cCCcccccCCCCC
Q 007167          135 DFSVWNNLTVIDLSNNFFNASIPAS--ISKLTHLSALNLANNSLTGTLP-RSLQ---RFPSWAFAGNNLS  198 (615)
Q Consensus       135 ~~~~l~~L~~l~l~~N~l~~~~p~~--~~~l~~L~~l~l~~N~l~g~~p-~~~~---~l~~l~~~~n~~~  198 (615)
                      .|+++++|+.|+|++|++++.+|..  +.++++|+.|+|++|.+++..| ..|+   +|..|.+++|.+.
T Consensus        92 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~~L~~L~~L~Ls~N~l~~~~~~~~~~~L~~L~~L~Ls~N~i~  161 (844)
T 3j0a_A           92 AFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF  161 (844)
T ss_dssp             SSCSCSSCCCEECTTCCCSSCCSTTCCCSSCSSCCEEEEESCCCCCCCCCGGGGTCSSCCEEEEESSCCC
T ss_pred             HccCCcccCEeeCcCCCCCcccccCccccccCCCCEEECCCCcccccccchhHhhCCCCCEEECCCCcCC
Confidence            7777777777777777777655544  6677777777777777766544 2333   3334455666553

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.53  E-value=2.4e-14  Score=153.13  Aligned_cols=131  Identities=22%  Similarity=0.271  Sum_probs=73.5

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCC-------------------------CCCCCcCCCCccccccCcEE
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRS-------------------------NSLSGLFPSDFSKLENLTSL  121 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~-------------------------N~l~g~~p~~~~~l~~L~~L  121 (615)
                      .+++.|+|++|.++ .+++..|.++++|++|+|++                         |+++ .+| .+.++++|++|
T Consensus       136 ~~L~~L~L~~N~i~-~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~-~~~-~~~~l~~L~~L  212 (440)
T 3zyj_A          136 SKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIP-NLTPLIKLDEL  212 (440)
T ss_dssp             SSCCEEECCSCCCC-EECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCS-SCC-CCTTCSSCCEE
T ss_pred             ccCceeeCCCCccc-ccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCc-ccc-ccCCCcccCEE
Confidence            46777777777776 44444455555555555554                         4444 223 34455555555


Q ss_pred             ecccccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccc---cCCcccccCCCCC
Q 007167          122 HLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQ---RFPSWAFAGNNLS  198 (615)
Q Consensus       122 ~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l~~~~n~~~  198 (615)
                      +|++|++++..|..|.++++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+..|.   ++..+.+.+|++.
T Consensus       213 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  292 (440)
T 3zyj_A          213 DLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPWN  292 (440)
T ss_dssp             ECTTSCCCEECTTTTTTCTTCCEEECTTCCCCEECTTSSTTCTTCCEEECTTSCCCCCCTTTTSSCTTCCEEECCSSCEE
T ss_pred             ECCCCccCccChhhhccCccCCEEECCCCceeEEChhhhcCCCCCCEEECCCCCCCccChhHhccccCCCEEEcCCCCcc
Confidence            5555555555555556666666666666666655555566666666666666666644444333   3334455666665


Q ss_pred             CC
Q 007167          199 SE  200 (615)
Q Consensus       199 ~~  200 (615)
                      |.
T Consensus       293 Cd  294 (440)
T 3zyj_A          293 CN  294 (440)
T ss_dssp             CS
T ss_pred             CC
Confidence            54

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.52  E-value=1.2e-14  Score=157.54  Aligned_cols=125  Identities=18%  Similarity=0.175  Sum_probs=66.3

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccc-ccccccee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFS-VWNNLTVI  145 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~-~l~~L~~l  145 (615)
                      ..++.|+|++|.+++..+.    .+++|+.|+|++|.|++..|..|+++++|++|+|++|.|++.+|..+. .+++|+.|
T Consensus        99 ~~L~~L~L~~N~l~~~~~~----~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~l~~~l~~L~~L  174 (487)
T 3oja_A           99 PSIETLHAANNNISRVSCS----RGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHL  174 (487)
T ss_dssp             TTCCEEECCSSCCCCEEEC----CCSSCEEEECCSSCCCSGGGBCGGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEE
T ss_pred             CCcCEEECcCCcCCCCCcc----ccCCCCEEECCCCCCCCCCchhhcCCCCCCEEECCCCCCCCcChHHHhhhCCcccEE
Confidence            3455555555555532221    245556666666666655555566666666666666666655555554 45566666


Q ss_pred             ecCCCcCCccCCCcccCCCCCCeeeccCccccCCCcccc---ccCCcccccCCCCC
Q 007167          146 DLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSL---QRFPSWAFAGNNLS  198 (615)
Q Consensus       146 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~---~~l~~l~~~~n~~~  198 (615)
                      +|++|.|++. |. +..+++|+.|+|++|.|++..|. +   .++..+.+++|.+.
T Consensus       175 ~Ls~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~~~~~-~~~l~~L~~L~Ls~N~l~  227 (487)
T 3oja_A          175 NLQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGPE-FQSAAGVTWISLRNNKLV  227 (487)
T ss_dssp             ECTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECGG-GGGGTTCSEEECTTSCCC
T ss_pred             ecCCCccccc-cc-cccCCCCCEEECCCCCCCCCCHh-HcCCCCccEEEecCCcCc
Confidence            6666666554 21 22355566666666666543332 3   23344455555554

>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C}

Probab=99.52  E-value=5e-15  Score=167.89  Aligned_cols=131  Identities=24%  Similarity=0.339  Sum_probs=117.6

Q ss_pred             CCCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccce
Q 007167           65 DHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTV  144 (615)
Q Consensus        65 ~~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~  144 (615)
                      ....++.|+|++|.+. .||. .+..+++|++|+|++|.|+ .+|..|++|++|++|+|++|+|+ .+|..|+.|++|+.
T Consensus       222 ~l~~L~~L~Ls~n~l~-~l~~-~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~  297 (727)
T 4b8c_D          222 DDQLWHALDLSNLQIF-NISA-NIFKYDFLTRLYLNGNSLT-ELPAEIKNLSNLRVLDLSHNRLT-SLPAELGSCFQLKY  297 (727)
T ss_dssp             CCCCCCEEECTTSCCS-CCCG-GGGGCCSCSCCBCTTSCCS-CCCGGGGGGTTCCEEECTTSCCS-SCCSSGGGGTTCSE
T ss_pred             cCCCCcEEECCCCCCC-CCCh-hhcCCCCCCEEEeeCCcCc-ccChhhhCCCCCCEEeCcCCcCC-ccChhhcCCCCCCE
Confidence            3467899999999999 8998 5679999999999999999 88999999999999999999999 78999999999999


Q ss_pred             eecCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccccCC----cccccCCCCCCC
Q 007167          145 IDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFP----SWAFAGNNLSSE  200 (615)
Q Consensus       145 l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~----~l~~~~n~~~~~  200 (615)
                      |+|++|.|+ .+|..|++|++|+.|+|++|.|+|.+|..+..+.    .+.+.+|.+...
T Consensus       298 L~L~~N~l~-~lp~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~~~~~l~l~~N~l~~~  356 (727)
T 4b8c_D          298 FYFFDNMVT-TLPWEFGNLCNLQFLGVEGNPLEKQFLKILTEKSVTGLIFYLRDNRPEIP  356 (727)
T ss_dssp             EECCSSCCC-CCCSSTTSCTTCCCEECTTSCCCSHHHHHHHHHHHHHHHHHHHHCCCCCC
T ss_pred             EECCCCCCC-ccChhhhcCCCccEEeCCCCccCCCChHHHhhcchhhhHHhhccCcccCc
Confidence            999999998 6899999999999999999999999998876543    245678877654

>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens}

Probab=99.52  E-value=2.7e-14  Score=152.72  Aligned_cols=143  Identities=20%  Similarity=0.233  Sum_probs=120.5

Q ss_pred             CCcceEecCC---------CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccc
Q 007167           56 SWTGVTCSAD---------HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFN  126 (615)
Q Consensus        56 ~w~gv~C~~~---------~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N  126 (615)
                      .|..|.|...         ...++.|+|++|+++ .+++..|.++++|++|+|++|.|++..|..|.++++|++|+|++|
T Consensus        44 ~~~~v~c~~~~l~~iP~~~~~~l~~L~L~~n~i~-~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n  122 (440)
T 3zyj_A           44 QFSKVICVRKNLREVPDGISTNTRLLNLHENQIQ-IIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDN  122 (440)
T ss_dssp             TSCEEECCSCCCSSCCSCCCTTCSEEECCSCCCC-EECTTTTSSCSSCCEEECCSSCCCEECGGGGTTCSSCCEEECCSS
T ss_pred             CCCEEEeCCCCcCcCCCCCCCCCcEEEccCCcCC-eeCHHHhhCCCCCCEEECCCCcCCccChhhccCCccCCEEECCCC
Confidence            4677888742         246789999999999 566568999999999999999999988899999999999999999


Q ss_pred             cccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCcc-cc---ccCCcccccCCCCCC
Q 007167          127 SFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPR-SL---QRFPSWAFAGNNLSS  199 (615)
Q Consensus       127 ~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~-~~---~~l~~l~~~~n~~~~  199 (615)
                      +|++..+..|..+++|+.|+|++|+|++..+..|.++++|+.|+|++|+..+.++. .|   .+|..|.+++|.+..
T Consensus       123 ~l~~~~~~~~~~l~~L~~L~L~~N~i~~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~  199 (440)
T 3zyj_A          123 RLTTIPNGAFVYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLRE  199 (440)
T ss_dssp             CCSSCCTTTSCSCSSCCEEECCSCCCCEECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCSSCCEEECTTSCCSS
T ss_pred             cCCeeCHhHhhccccCceeeCCCCcccccCHHHhhhCcccCEeCCCCCCCcceeCcchhhcccccCeecCCCCcCcc
Confidence            99976667899999999999999999987778899999999999999665555554 34   455667788887753

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.52  E-value=1.2e-14  Score=137.70  Aligned_cols=126  Identities=17%  Similarity=0.219  Sum_probs=61.3

Q ss_pred             cEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeec
Q 007167           68 RVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL  147 (615)
Q Consensus        68 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l  147 (615)
                      +++.|+|++|.++ .++  .+..+++|++|+|++|.+++..|..|.++++|++|+|++|++++..|..++.+++|+.|+|
T Consensus        67 ~L~~L~l~~n~~~-~~~--~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~Ls~n~i~~~~~~~l~~l~~L~~L~L  143 (197)
T 4ezg_A           67 NIKDLTINNIHAT-NYN--PISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDL  143 (197)
T ss_dssp             TCSEEEEESCCCS-CCG--GGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEECCSSBCBGGGHHHHTTCSSCCEEEC
T ss_pred             CCCEEEccCCCCC-cch--hhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEEecCCccCcHhHHHHhhCCCCCEEEc
Confidence            4555555555443 222  3555555555555555555545555555555555555555555545555555555555555


Q ss_pred             CCCcCCccCCCcccCCCCCCeeeccCccccCCCc-cccccCCcccccCCCC
Q 007167          148 SNNFFNASIPASISKLTHLSALNLANNSLTGTLP-RSLQRFPSWAFAGNNL  197 (615)
Q Consensus       148 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p-~~~~~l~~l~~~~n~~  197 (615)
                      ++|.+.+.+| .+.++++|+.|++++|++++..+ ..+.++..+.+.+|++
T Consensus       144 ~~n~~i~~~~-~l~~l~~L~~L~l~~n~i~~~~~l~~l~~L~~L~l~~N~i  193 (197)
T 4ezg_A          144 SYNGAITDIM-PLKTLPELKSLNIQFDGVHDYRGIEDFPKLNQLYAFSQTI  193 (197)
T ss_dssp             CSCTBCCCCG-GGGGCSSCCEEECTTBCCCCCTTGGGCSSCCEEEECBC--
T ss_pred             cCCCCccccH-hhcCCCCCCEEECCCCCCcChHHhccCCCCCEEEeeCccc
Confidence            5555222333 35555555555555555554211 1123333444455543

>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri}

Probab=99.52  E-value=2.2e-14  Score=145.63  Aligned_cols=132  Identities=20%  Similarity=0.270  Sum_probs=111.5

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCC-CCccccccCcEEecccccccCCCCccccccccccee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFP-SDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVI  145 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l  145 (615)
                      .+++.|+|++|.++ .+|. .+..+++|++|+|++|.+++..+ ..+.++++|++|+|++|.+++..|..+..+++|+.|
T Consensus        78 ~~L~~L~Ls~n~i~-~l~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  155 (306)
T 2z66_A           78 TSLKYLDLSFNGVI-TMSS-NFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVL  155 (306)
T ss_dssp             SCCCEEECCSCSEE-EEEE-EEETCTTCCEEECTTSEEESSTTTTTTTTCTTCCEEECTTSCCEECSTTTTTTCTTCCEE
T ss_pred             cccCEEECCCCccc-cChh-hcCCCCCCCEEECCCCcccccccchhhhhccCCCEEECCCCcCCccchhhcccCcCCCEE
Confidence            57888999999988 6776 58889999999999999987755 578899999999999999998888889999999999


Q ss_pred             ecCCCcCCc-cCCCcccCCCCCCeeeccCccccCCCcccccc---CCcccccCCCCCCC
Q 007167          146 DLSNNFFNA-SIPASISKLTHLSALNLANNSLTGTLPRSLQR---FPSWAFAGNNLSSE  200 (615)
Q Consensus       146 ~l~~N~l~~-~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~---l~~l~~~~n~~~~~  200 (615)
                      +|++|.+++ .+|..+..+++|+.|+|++|++++..|..+..   +..+.+++|.+...
T Consensus       156 ~l~~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~  214 (306)
T 2z66_A          156 KMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSL  214 (306)
T ss_dssp             ECTTCEEGGGEECSCCTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECTTSCCSBC
T ss_pred             ECCCCccccccchhHHhhCcCCCEEECCCCCcCCcCHHHhcCCCCCCEEECCCCccCcc
Confidence            999999987 57888999999999999999999877777654   45667788887543

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.52  E-value=5.9e-15  Score=150.37  Aligned_cols=134  Identities=20%  Similarity=0.233  Sum_probs=106.3

Q ss_pred             CcEEEEEeCCCCcccccCCCcc-cCCCCccEEEcCCCCCCCcCCCCcccc-----ccCcEEecccccccCCCCccccccc
Q 007167           67 SRVVALRLPGMALRGEIPPNTI-GRLSALQNLSLRSNSLSGLFPSDFSKL-----ENLTSLHLQFNSFSGPLPLDFSVWN  140 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~-~~l~~L~~L~L~~N~l~g~~p~~~~~l-----~~L~~L~l~~N~l~g~~p~~~~~l~  140 (615)
                      .+++.|+|++|+++|.+|...+ +.+++|++|+|++|++++. |..++++     ++|++|+|++|++++..|..|+.++
T Consensus        95 ~~L~~L~L~~n~l~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~-~~~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~  173 (312)
T 1wwl_A           95 SGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATR-DAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFP  173 (312)
T ss_dssp             SCCCEEEEEEEBCBSCCCCCSSSCCSCCCSEEEEESCBCSSS-SSHHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCS
T ss_pred             CCccEEEccCCcccchhHHHHHHhcCCCccEEEccCCCCcch-hHHHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCC
Confidence            4688889999999888887432 8888999999999999887 8888887     8899999999999887778888899


Q ss_pred             ccceeecCCCcCCcc--CCCcc--cCCCCCCeeeccCccccC--CCccc----cccCCcccccCCCCCCCC
Q 007167          141 NLTVIDLSNNFFNAS--IPASI--SKLTHLSALNLANNSLTG--TLPRS----LQRFPSWAFAGNNLSSEN  201 (615)
Q Consensus       141 ~L~~l~l~~N~l~~~--~p~~~--~~l~~L~~l~l~~N~l~g--~~p~~----~~~l~~l~~~~n~~~~~~  201 (615)
                      +|+.|+|++|++.|.  +|..+  .++++|+.|+|++|+|++  .++..    +.++..|.+++|.+....
T Consensus       174 ~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~  244 (312)
T 1wwl_A          174 ALSTLDLSDNPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAA  244 (312)
T ss_dssp             SCCEEECCSCTTCHHHHHHHHSCTTSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSC
T ss_pred             CCCEEECCCCCcCcchHHHHHHHhccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCccc
Confidence            999999999988775  23344  788889999999998883  23322    357778888888876543

>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A

Probab=99.52  E-value=2.8e-14  Score=153.18  Aligned_cols=132  Identities=21%  Similarity=0.281  Sum_probs=77.1

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCc-------------------------cEEEcCCCCCCCcCCCCccccccCcEE
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSAL-------------------------QNLSLRSNSLSGLFPSDFSKLENLTSL  121 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L-------------------------~~L~L~~N~l~g~~p~~~~~l~~L~~L  121 (615)
                      .+++.|+|++|.++ .+++..|.++++|                         ++|+|++|++++. | .+..+++|++|
T Consensus       147 ~~L~~L~L~~N~l~-~~~~~~~~~l~~L~~L~l~~~~~l~~i~~~~~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L  223 (452)
T 3zyi_A          147 SKLRELWLRNNPIE-SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIKDM-P-NLTPLVGLEEL  223 (452)
T ss_dssp             TTCCEEECCSCCCC-EECTTTTTTCTTCCEEECCCCTTCCEECTTTTTTCTTCCEEECTTSCCSSC-C-CCTTCTTCCEE
T ss_pred             CCCCEEECCCCCcc-eeCHhHHhcCCcccEEeCCCCCCccccChhhccCCCCCCEEECCCCccccc-c-cccccccccEE
Confidence            46778888888777 5555445555554                         4555555555432 2 34555555555


Q ss_pred             ecccccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccc---cCCcccccCCCCC
Q 007167          122 HLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQ---RFPSWAFAGNNLS  198 (615)
Q Consensus       122 ~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l~~~~n~~~  198 (615)
                      +|++|+|++..|..|.++++|+.|+|++|++++..|..|.++++|+.|+|++|+|++..+..|.   ++..+.+.+|++.
T Consensus       224 ~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~Np~~  303 (452)
T 3zyi_A          224 EMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIERNAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHNPWN  303 (452)
T ss_dssp             ECTTSCCSEECGGGGTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCSCCCTTSSTTCTTCCEEECCSSCEE
T ss_pred             ECcCCcCcccCcccccCccCCCEEEeCCCcCceECHHHhcCCCCCCEEECCCCcCCccChHHhccccCCCEEEccCCCcC
Confidence            5666666555555666666666666666666665566666666666666666666654444433   3344556666665


Q ss_pred             CCC
Q 007167          199 SEN  201 (615)
Q Consensus       199 ~~~  201 (615)
                      |.+
T Consensus       304 CdC  306 (452)
T 3zyi_A          304 CDC  306 (452)
T ss_dssp             CST
T ss_pred             CCC
Confidence            543

>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae}

Probab=99.52  E-value=4.7e-14  Score=148.33  Aligned_cols=132  Identities=25%  Similarity=0.215  Sum_probs=118.2

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID  146 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~  146 (615)
                      .+++.|+|++|.++ .+++..|+.+++|++|+|++|.+++..|..|+++++|++|+|++|+++...+..|.++++|+.|+
T Consensus        69 ~~L~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~l~~~~~~~l~~L~~L~  147 (390)
T 3o6n_A           69 RQVELLNLNDLQIE-EIDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLS  147 (390)
T ss_dssp             CCCSEEECTTSCCC-EECTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEE
T ss_pred             ccCcEEECCCCccc-ccChhhccCCCCcCEEECCCCCCCcCCHHHhcCCCCCCEEECCCCccCcCCHHHhcCCCCCcEEE
Confidence            57899999999999 56666899999999999999999999888999999999999999999964444579999999999


Q ss_pred             cCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccccCCcccccCCCCCC
Q 007167          147 LSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLSS  199 (615)
Q Consensus       147 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~n~~~~  199 (615)
                      |++|++++..|..+.++++|+.|+|++|++++.-...+.++..+.+++|.+..
T Consensus       148 L~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~L~~L~l~~n~l~~  200 (390)
T 3o6n_A          148 MSNNNLERIEDDTFQATTSLQNLQLSSNRLTHVDLSLIPSLFHANVSYNLLST  200 (390)
T ss_dssp             CCSSCCCBCCTTTTSSCTTCCEEECCSSCCSBCCGGGCTTCSEEECCSSCCSE
T ss_pred             CCCCccCccChhhccCCCCCCEEECCCCcCCccccccccccceeecccccccc
Confidence            99999999888899999999999999999998766777888888888887643

>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697}

Probab=99.51  E-value=4.2e-15  Score=166.56  Aligned_cols=130  Identities=19%  Similarity=0.341  Sum_probs=116.7

Q ss_pred             CCcEEEEEeCCCCcccc-----------------cCCCccc--CCCCccEEEcCCCCCCCcCCCCccccccCcEEecccc
Q 007167           66 HSRVVALRLPGMALRGE-----------------IPPNTIG--RLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFN  126 (615)
Q Consensus        66 ~~~v~~l~l~~~~l~g~-----------------i~~~~~~--~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N  126 (615)
                      -.+++.|+|++|.++|.                 +|. .++  ++++|++|+|++|++.|.+|..|+++++|++|+|++|
T Consensus       205 l~~L~~L~Ls~n~l~~~~~~~~~~~~~~~~~~~~ip~-~l~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n  283 (636)
T 4eco_A          205 LTKLRQFYMGNSPFVAENICEAWENENSEYAQQYKTE-DLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACN  283 (636)
T ss_dssp             CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS-CCCGGGCTTCCEEEEECCTTCSSCCTTTTTCSSCCEEECTTC
T ss_pred             ccCCCEEECcCCccccccccccccccccchhcccCch-hhhhcccCCCCEEEecCCcCCccChHHHhcCCCCCEEECcCC
Confidence            46789999999999986                 888 788  9999999999999999999999999999999999999


Q ss_pred             c-ccC-CCCcccccc------cccceeecCCCcCCccCCC--cccCCCCCCeeeccCccccCCCccccc---cCCccccc
Q 007167          127 S-FSG-PLPLDFSVW------NNLTVIDLSNNFFNASIPA--SISKLTHLSALNLANNSLTGTLPRSLQ---RFPSWAFA  193 (615)
Q Consensus       127 ~-l~g-~~p~~~~~l------~~L~~l~l~~N~l~~~~p~--~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l~~~  193 (615)
                      + ++| .+|..++.+      ++|+.|+|++|+++ .+|.  .++++++|+.|+|++|+++|.+| .+.   ++..+.++
T Consensus       284 ~~l~~~~lp~~~~~L~~~~~l~~L~~L~L~~n~l~-~ip~~~~l~~l~~L~~L~L~~N~l~g~ip-~~~~l~~L~~L~L~  361 (636)
T 4eco_A          284 RGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLK-TFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLA  361 (636)
T ss_dssp             TTSCHHHHHHHHHHHHHSGGGGTCCEEECCSSCCS-SCCCHHHHTTCTTCCEEECCSCCCEEECC-CCEEEEEESEEECC
T ss_pred             CCCccccchHHHHhhhccccCCCCCEEECCCCcCC-ccCchhhhccCCCCCEEeCcCCcCccchh-hhCCCCCCCEEECC
Confidence            8 998 899988887      99999999999999 7898  89999999999999999999999 665   44566778


Q ss_pred             CCCCC
Q 007167          194 GNNLS  198 (615)
Q Consensus       194 ~n~~~  198 (615)
                      +|.+.
T Consensus       362 ~N~l~  366 (636)
T 4eco_A          362 YNQIT  366 (636)
T ss_dssp             SSEEE
T ss_pred             CCccc
Confidence            88765

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.51  E-value=2.4e-14  Score=157.50  Aligned_cols=109  Identities=24%  Similarity=0.243  Sum_probs=100.4

Q ss_pred             cEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeec
Q 007167           68 RVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL  147 (615)
Q Consensus        68 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l  147 (615)
                      .++.|+|++|+|++ +|.  |+.+++|+.|+|++|+|+ .+|..|++|++|+.|+|++|+|++ +| .++.+++|+.|+|
T Consensus       442 ~L~~L~Ls~n~l~~-lp~--~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~L  515 (567)
T 1dce_A          442 DVRVLHLAHKDLTV-LCH--LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLL  515 (567)
T ss_dssp             TCSEEECTTSCCSS-CCC--GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEEC
T ss_pred             CceEEEecCCCCCC-CcC--ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEEC
Confidence            47789999999995 774  999999999999999999 789999999999999999999997 77 8999999999999


Q ss_pred             CCCcCCccC-CCcccCCCCCCeeeccCccccCCCcc
Q 007167          148 SNNFFNASI-PASISKLTHLSALNLANNSLTGTLPR  182 (615)
Q Consensus       148 ~~N~l~~~~-p~~~~~l~~L~~l~l~~N~l~g~~p~  182 (615)
                      ++|+|++.+ |..++++++|+.|+|++|+|++.+|.
T Consensus       516 s~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~~~~  551 (567)
T 1dce_A          516 CNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGI  551 (567)
T ss_dssp             CSSCCCSSSTTGGGGGCTTCCEEECTTSGGGGSSSC
T ss_pred             CCCCCCCCCCcHHHhcCCCCCEEEecCCcCCCCccH
Confidence            999999877 99999999999999999999987663

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.51  E-value=3.8e-14  Score=146.55  Aligned_cols=111  Identities=22%  Similarity=0.254  Sum_probs=97.6

Q ss_pred             CCCCcceEecCCCCcEEEEEeCCC-CcccccCCCcccCCCCccEEEcCC-CCCCCcCCCCccccccCcEEecccccccCC
Q 007167           54 CKSWTGVTCSADHSRVVALRLPGM-ALRGEIPPNTIGRLSALQNLSLRS-NSLSGLFPSDFSKLENLTSLHLQFNSFSGP  131 (615)
Q Consensus        54 c~~w~gv~C~~~~~~v~~l~l~~~-~l~g~i~~~~~~~l~~L~~L~L~~-N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~  131 (615)
                      | .|.+|.|+            ++ +|+ .||.  |..+++|++|+|++ |.|++..|..|.+|++|++|+|++|+|++.
T Consensus         8 C-~~~~v~~~------------~~n~l~-~ip~--l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~   71 (347)
T 2ifg_A            8 H-GSSGLRCT------------RDGALD-SLHH--LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFV   71 (347)
T ss_dssp             S-SSSCEECC------------SSCCCT-TTTT--SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEE
T ss_pred             c-cCCEEEcC------------CCCCCC-ccCC--CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCcccee
Confidence            5 67777775            34 677 6887  99999999999996 999999889999999999999999999999


Q ss_pred             CCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCc
Q 007167          132 LPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLP  181 (615)
Q Consensus       132 ~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p  181 (615)
                      .|..|.+|++|+.|+|++|+|++..|..+..++ |+.|+|++|.|.....
T Consensus        72 ~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~~-L~~l~l~~N~~~c~c~  120 (347)
T 2ifg_A           72 APDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLHCSCA  120 (347)
T ss_dssp             CTTGGGSCSCCCEEECCSSCCSCCCSTTTCSCC-CCEEECCSSCCCCCGG
T ss_pred             CHHHhcCCcCCCEEeCCCCccceeCHHHcccCC-ceEEEeeCCCccCCCc
Confidence            999999999999999999999986666666665 9999999999996543

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.49  E-value=1.4e-13  Score=141.30  Aligned_cols=140  Identities=22%  Similarity=0.308  Sum_probs=118.6

Q ss_pred             CCcceEecCC---------CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccc
Q 007167           56 SWTGVTCSAD---------HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFN  126 (615)
Q Consensus        56 ~w~gv~C~~~---------~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N  126 (615)
                      .|+.+.|+..         ...++.|+|++|+++ .+++..|+++++|++|+|++|.+++..|..|.++++|++|+|++|
T Consensus        32 ~l~~l~~~~~~l~~lp~~~~~~l~~L~L~~n~i~-~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n  110 (330)
T 1xku_A           32 HLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKN  110 (330)
T ss_dssp             ETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSS
T ss_pred             CCeEEEecCCCccccCccCCCCCeEEECCCCcCC-EeChhhhccCCCCCEEECCCCcCCeeCHHHhcCCCCCCEEECCCC
Confidence            7999999742         246889999999999 566668999999999999999999999999999999999999999


Q ss_pred             cccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccC--CCccccc---cCCcccccCCCCCC
Q 007167          127 SFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTG--TLPRSLQ---RFPSWAFAGNNLSS  199 (615)
Q Consensus       127 ~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g--~~p~~~~---~l~~l~~~~n~~~~  199 (615)
                      +++ .+|..+.  ++|+.|++++|++++..+..+.++++|+.|++++|.++.  ..+..+.   ++..+.+++|.+..
T Consensus       111 ~l~-~l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~  185 (330)
T 1xku_A          111 QLK-ELPEKMP--KTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT  185 (330)
T ss_dssp             CCS-BCCSSCC--TTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS
T ss_pred             cCC-ccChhhc--ccccEEECCCCcccccCHhHhcCCccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc
Confidence            999 5777665  789999999999998777788999999999999999963  5666554   44556678887753

>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens}

Probab=99.48  E-value=8.3e-14  Score=153.89  Aligned_cols=132  Identities=20%  Similarity=0.223  Sum_probs=107.8

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID  146 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~  146 (615)
                      .+++.|+|++|+++ .+++..|.++++|++|+|++|++++..|..|.++++|++|+|++|++++..|..|+++++|++|+
T Consensus        28 ~~l~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~n~i~~i~~~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~  106 (570)
T 2z63_A           28 FSTKNLDLSFNPLR-HLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLV  106 (570)
T ss_dssp             SSCCEEECCSCCCC-EECTTTTTTCSSCCEEECTTCCCCEECTTTTTTCTTCCEEECTTCCCCEECTTTTTTCTTCCEEE
T ss_pred             ccccEEEccCCccC-ccChhHhhCCCCceEEECCCCcCCccCcccccCchhCCEEeCcCCcCCccCHhhhcCcccccccc
Confidence            46888999999988 45555788899999999999999888788888999999999999998887778888899999999


Q ss_pred             cCCCcCCccCCCcccCCCCCCeeeccCccccC-CCcccccc---CCcccccCCCCCC
Q 007167          147 LSNNFFNASIPASISKLTHLSALNLANNSLTG-TLPRSLQR---FPSWAFAGNNLSS  199 (615)
Q Consensus       147 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g-~~p~~~~~---l~~l~~~~n~~~~  199 (615)
                      |++|++++..+..++++++|++|+|++|.+++ .+|..|++   +..+.+++|.+..
T Consensus       107 L~~n~l~~l~~~~~~~l~~L~~L~L~~n~l~~~~lp~~~~~l~~L~~L~l~~n~l~~  163 (570)
T 2z63_A          107 AVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS  163 (570)
T ss_dssp             CTTSCCCCSTTCSCTTCTTCCEEECCSSCCCCCCCCGGGGGCTTCCEEECTTSCCCE
T ss_pred             ccccccccCCCccccccccccEEecCCCccceecChhhhcccCCCCEEeCcCCccce
Confidence            99999887666578888899999999998887 57877654   4456677777643

>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes}

Probab=99.48  E-value=5.5e-14  Score=133.01  Aligned_cols=128  Identities=16%  Similarity=0.260  Sum_probs=111.0

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID  146 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~  146 (615)
                      .+++.|+|++|+++ .+|  .+..+++|++|+|++|.++.  +..+.++++|++|+|++|++++..|..++.+++|+.|+
T Consensus        44 ~~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~l~~n~~~~--~~~l~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~  118 (197)
T 4ezg_A           44 NSLTYITLANINVT-DLT--GIEYAHNIKDLTINNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLD  118 (197)
T ss_dssp             HTCCEEEEESSCCS-CCT--TGGGCTTCSEEEEESCCCSC--CGGGTTCTTCCEEEEECTTCBGGGSCCCTTCTTCCEEE
T ss_pred             CCccEEeccCCCcc-ChH--HHhcCCCCCEEEccCCCCCc--chhhhcCCCCCEEEeECCccCcccChhhcCCCCCCEEE
Confidence            46889999999999 787  48999999999999997763  34899999999999999999988899999999999999


Q ss_pred             cCCCcCCccCCCcccCCCCCCeeeccCccccCCCcc--ccccCCcccccCCCCCC
Q 007167          147 LSNNFFNASIPASISKLTHLSALNLANNSLTGTLPR--SLQRFPSWAFAGNNLSS  199 (615)
Q Consensus       147 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~--~~~~l~~l~~~~n~~~~  199 (615)
                      |++|++++..|..+.++++|+.|+|++|.+.+.+|.  .+.++..+.+++|.+..
T Consensus       119 Ls~n~i~~~~~~~l~~l~~L~~L~L~~n~~i~~~~~l~~l~~L~~L~l~~n~i~~  173 (197)
T 4ezg_A          119 ISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPLKTLPELKSLNIQFDGVHD  173 (197)
T ss_dssp             CCSSBCBGGGHHHHTTCSSCCEEECCSCTBCCCCGGGGGCSSCCEEECTTBCCCC
T ss_pred             ecCCccCcHhHHHHhhCCCCCEEEccCCCCccccHhhcCCCCCCEEECCCCCCcC
Confidence            999999998899999999999999999994445662  23455667788888754

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.48  E-value=4.2e-14  Score=154.95  Aligned_cols=135  Identities=24%  Similarity=0.352  Sum_probs=111.5

Q ss_pred             CCCCCCCCCC----CCcce-EecCCCCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcE
Q 007167           46 NWNESSSLCK----SWTGV-TCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTS  120 (615)
Q Consensus        46 ~w~~~~~~c~----~w~gv-~C~~~~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~  120 (615)
                      +|..+..+|.    .|.|+ .|..  ++++.|+|++|+|++ ||.. +  +++|++|+|++|+|+ .+|   ..+++|++
T Consensus        35 ~W~~~~~~~~~~~~~~~~l~~C~~--~~L~~L~Ls~n~L~~-lp~~-l--~~~L~~L~Ls~N~l~-~ip---~~l~~L~~  104 (571)
T 3cvr_A           35 KWEKQALPGENRNEAVSLLKECLI--NQFSELQLNRLNLSS-LPDN-L--PPQITVLEITQNALI-SLP---ELPASLEY  104 (571)
T ss_dssp             HHHTTCCTTCCHHHHHHHHHHHHH--TTCSEEECCSSCCSC-CCSC-C--CTTCSEEECCSSCCS-CCC---CCCTTCCE
T ss_pred             HHhccCCccccccchhhhcccccc--CCccEEEeCCCCCCc-cCHh-H--cCCCCEEECcCCCCc-ccc---cccCCCCE
Confidence            4655566673    49999 7863  579999999999995 8874 4  378999999999999 667   45789999


Q ss_pred             EecccccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccccCCcccccCCCCCC
Q 007167          121 LHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLSS  199 (615)
Q Consensus       121 L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~n~~~~  199 (615)
                      |+|++|+|++ +|. +.+  +|+.|+|++|+|++ +|.   .+++|+.|+|++|+|++ +|..+.++..|.+++|.+..
T Consensus       105 L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-lp~~l~~L~~L~Ls~N~L~~  174 (571)
T 3cvr_A          105 LDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYINADNNQLTM-LPELPTSLEVLSVRNNQLTF  174 (571)
T ss_dssp             EECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSC
T ss_pred             EEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEeCCCCccCc-CCCcCCCcCEEECCCCCCCC
Confidence            9999999997 787 665  89999999999997 676   67899999999999996 77777788888899988765

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.48  E-value=4.3e-14  Score=143.82  Aligned_cols=131  Identities=19%  Similarity=0.226  Sum_probs=108.6

Q ss_pred             CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCc--C--CCCccccccCcEEecccccccCCCCc----ccc
Q 007167           66 HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGL--F--PSDFSKLENLTSLHLQFNSFSGPLPL----DFS  137 (615)
Q Consensus        66 ~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~--~--p~~~~~l~~L~~L~l~~N~l~g~~p~----~~~  137 (615)
                      ..+++.|+|++|+++ .+++..|+.+++|++|+|++|++.+.  +  +..++++++|++|+|++|+++. +|.    .++
T Consensus       144 ~~~L~~L~Ls~n~l~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~  221 (310)
T 4glp_A          144 KPGLKVLSIAQAHSP-AFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHKFPAIQNLALRNTGMET-PTGVCAALAA  221 (310)
T ss_dssp             CSCCCEEEEECCSSC-CCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTSSCCCCSCBCCSSCCCC-HHHHHHHHHH
T ss_pred             ccCCCEEEeeCCCcc-hhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhcCCCCCEEECCCCCCCc-hHHHHHHHHh
Confidence            458999999999998 55555899999999999999998763  2  2335789999999999999973 444    257


Q ss_pred             cccccceeecCCCcCCccCCCcccCC---CCCCeeeccCccccCCCcccc-ccCCcccccCCCCCC
Q 007167          138 VWNNLTVIDLSNNFFNASIPASISKL---THLSALNLANNSLTGTLPRSL-QRFPSWAFAGNNLSS  199 (615)
Q Consensus       138 ~l~~L~~l~l~~N~l~~~~p~~~~~l---~~L~~l~l~~N~l~g~~p~~~-~~l~~l~~~~n~~~~  199 (615)
                      .+++|+.|+|++|+|++.+|..+..+   ++|+.|+|++|+|+ .+|..+ .++..+.+++|.+..
T Consensus       222 ~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~-~lp~~~~~~L~~L~Ls~N~l~~  286 (310)
T 4glp_A          222 AGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE-QVPKGLPAKLRVLDLSSNRLNR  286 (310)
T ss_dssp             HTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC-SCCSCCCSCCSCEECCSCCCCS
T ss_pred             cCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC-chhhhhcCCCCEEECCCCcCCC
Confidence            88999999999999999888888877   69999999999999 667654 578888999998875

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.47  E-value=8.2e-14  Score=153.86  Aligned_cols=127  Identities=22%  Similarity=0.206  Sum_probs=107.4

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID  146 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~  146 (615)
                      .+++.|+|++|+++ .+++..|+++++|++|+|++|++++..|..|.++++|++|+|++|+++ .+|..  .+++|+.|+
T Consensus        52 ~~L~~L~Ls~N~i~-~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~  127 (562)
T 3a79_B           52 PRTKALSLSQNSIS-ELRMPDISFLSELRVLRLSHNRIRSLDFHVFLFNQDLEYLDVSHNRLQ-NISCC--PMASLRHLD  127 (562)
T ss_dssp             TTCCEEECCSSCCC-CCCGGGTTTCTTCCEEECCSCCCCEECTTTTTTCTTCCEEECTTSCCC-EECSC--CCTTCSEEE
T ss_pred             CCcCEEECCCCCcc-ccChhhhccCCCccEEECCCCCCCcCCHHHhCCCCCCCEEECCCCcCC-ccCcc--ccccCCEEE
Confidence            57889999999998 566568999999999999999999888888999999999999999998 57776  789999999


Q ss_pred             cCCCcCCc-cCCCcccCCCCCCeeeccCccccCCCccccccC--CcccccCCCC
Q 007167          147 LSNNFFNA-SIPASISKLTHLSALNLANNSLTGTLPRSLQRF--PSWAFAGNNL  197 (615)
Q Consensus       147 l~~N~l~~-~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l--~~l~~~~n~~  197 (615)
                      |++|++++ .+|..++++++|+.|+|++|++++.....+.++  ..+.+++|.+
T Consensus       128 Ls~N~l~~l~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~L~~n~l  181 (562)
T 3a79_B          128 LSFNDFDVLPVCKEFGNLTKLTFLGLSAAKFRQLDLLPVAHLHLSCILLDLVSY  181 (562)
T ss_dssp             CCSSCCSBCCCCGGGGGCTTCCEEEEECSBCCTTTTGGGTTSCEEEEEEEESSC
T ss_pred             CCCCCccccCchHhhcccCcccEEecCCCccccCchhhhhhceeeEEEeecccc
Confidence            99999987 356889999999999999999987544555556  6777888877

>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron}

Probab=99.47  E-value=2.3e-14  Score=164.24  Aligned_cols=129  Identities=17%  Similarity=0.255  Sum_probs=115.1

Q ss_pred             CCcEEEEEeCCCCccc-----------------ccCCCccc--CCCCccEEEcCCCCCCCcCCCCccccccCcEEecccc
Q 007167           66 HSRVVALRLPGMALRG-----------------EIPPNTIG--RLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFN  126 (615)
Q Consensus        66 ~~~v~~l~l~~~~l~g-----------------~i~~~~~~--~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N  126 (615)
                      -.+++.|+|++|.|+|                 .||. .++  ++++|++|+|++|++.|.+|..|++|++|++|+|++|
T Consensus       447 L~~L~~L~Ls~N~Lsg~~i~~~~~~~s~n~~~g~iP~-~l~f~~L~~L~~L~Ls~N~l~~~iP~~l~~L~~L~~L~Ls~N  525 (876)
T 4ecn_A          447 LTKLQIIYFANSPFTYDNIAVDWEDANSDYAKQYENE-ELSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACN  525 (876)
T ss_dssp             CTTCCEEEEESCCCCGGGBSSSCSCTTSHHHHHHTTS-CCCGGGCTTCCEEEEESCTTCCSCCGGGGGCSSCCEEECTTC
T ss_pred             CCCCCEEECcCCcCCCCcccccccccccccccccCCh-hhhhccCCCCCEEECcCCCCCccChHHHhCCCCCCEEECcCC
Confidence            3678999999999998                 4888 677  9999999999999999999999999999999999999


Q ss_pred             c-ccC-CCCccccccc-------ccceeecCCCcCCccCCC--cccCCCCCCeeeccCccccCCCccccccCC---cccc
Q 007167          127 S-FSG-PLPLDFSVWN-------NLTVIDLSNNFFNASIPA--SISKLTHLSALNLANNSLTGTLPRSLQRFP---SWAF  192 (615)
Q Consensus       127 ~-l~g-~~p~~~~~l~-------~L~~l~l~~N~l~~~~p~--~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~---~l~~  192 (615)
                      + |+| .+|..++.++       +|+.|+|++|+|+ .+|.  .+.++++|+.|+|++|+++ .+| .|++++   .|.+
T Consensus       526 ~~lsg~~iP~~i~~L~~~~~~l~~L~~L~Ls~N~L~-~ip~~~~l~~L~~L~~L~Ls~N~l~-~lp-~~~~L~~L~~L~L  602 (876)
T 4ecn_A          526 RGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLE-EFPASASLQKMVKLGLLDCVHNKVR-HLE-AFGTNVKLTDLKL  602 (876)
T ss_dssp             TTSCHHHHHHHHHHHHHCTTTTTTCCEEECCSSCCC-BCCCHHHHTTCTTCCEEECTTSCCC-BCC-CCCTTSEESEEEC
T ss_pred             CCcccccchHHHHhhhhcccccCCccEEEeeCCcCC-ccCChhhhhcCCCCCEEECCCCCcc-cch-hhcCCCcceEEEC
Confidence            8 998 8998887776       9999999999999 7898  8999999999999999999 888 666544   5677


Q ss_pred             cCCCCC
Q 007167          193 AGNNLS  198 (615)
Q Consensus       193 ~~n~~~  198 (615)
                      ++|.+.
T Consensus       603 s~N~l~  608 (876)
T 4ecn_A          603 DYNQIE  608 (876)
T ss_dssp             CSSCCS
T ss_pred             cCCccc
Confidence            888876

>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus}

Probab=99.47  E-value=2.4e-14  Score=145.87  Aligned_cols=131  Identities=20%  Similarity=0.196  Sum_probs=87.3

Q ss_pred             CCcEEEEEeCCCCcccccCCCcccCC-----CCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCC--CCccc--
Q 007167           66 HSRVVALRLPGMALRGEIPPNTIGRL-----SALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGP--LPLDF--  136 (615)
Q Consensus        66 ~~~v~~l~l~~~~l~g~i~~~~~~~l-----~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~--~p~~~--  136 (615)
                      ..+++.|+|++|++++. |. .++.+     ++|++|+|++|++++..|..|+++++|++|+|++|+++|.  +|..+  
T Consensus       120 l~~L~~L~Ls~N~l~~~-~~-~~~~l~~~~~~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~  197 (312)
T 1wwl_A          120 GPDLNILNLRNVSWATR-DA-WLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGLISALCP  197 (312)
T ss_dssp             SCCCSEEEEESCBCSSS-SS-HHHHHHTTCCTTCCEEEEESCSCCCCCTTTCCCCSSCCEEECCSCTTCHHHHHHHHSCT
T ss_pred             CCCccEEEccCCCCcch-hH-HHHHHHHhhcCCCcEEEeeCCCCccchHHHhccCCCCCEEECCCCCcCcchHHHHHHHh
Confidence            34677788888887754 43 56665     7778888888887777777777777788888887777664  23333  


Q ss_pred             ccccccceeecCCCcCCc--cCC-CcccCCCCCCeeeccCccccCCCcc-c---cccCCcccccCCCCC
Q 007167          137 SVWNNLTVIDLSNNFFNA--SIP-ASISKLTHLSALNLANNSLTGTLPR-S---LQRFPSWAFAGNNLS  198 (615)
Q Consensus       137 ~~l~~L~~l~l~~N~l~~--~~p-~~~~~l~~L~~l~l~~N~l~g~~p~-~---~~~l~~l~~~~n~~~  198 (615)
                      ..+++|+.|+|++|+|++  .++ ..+.++++|+.|+|++|++++.+|. .   +.++..|.+++|.+.
T Consensus       198 ~~l~~L~~L~L~~N~l~~~~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~Ls~N~l~  266 (312)
T 1wwl_A          198 LKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLK  266 (312)
T ss_dssp             TSCTTCCEEECTTSCCCCHHHHHHHHHHTTCCCSEEECTTSCCCSSCCCSCCCCCTTCCEEECTTSCCS
T ss_pred             ccCCCCCEEECCCCcCcchHHHHHHHHhcCCCCCEEECCCCcCCcccchhhhhhcCCCCEEECCCCccC
Confidence            667777777777777773  122 2334667777777777777766542 2   245556667777665

>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A*

Probab=99.47  E-value=9.8e-14  Score=156.83  Aligned_cols=135  Identities=22%  Similarity=0.264  Sum_probs=102.5

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCC--------CCccccccCcEEecccccccCCCCccccc
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFP--------SDFSKLENLTSLHLQFNSFSGPLPLDFSV  138 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p--------~~~~~l~~L~~L~l~~N~l~g~~p~~~~~  138 (615)
                      .+++.|+|++|+++ .+++..|..+++|++|+|++|.+++..+        ..|.++++|++|+|++|+++...+..|.+
T Consensus       480 ~~L~~L~Ls~N~l~-~i~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~~~~~l~~L~~L~L~~N~l~~i~~~~~~~  558 (680)
T 1ziw_A          480 RNLTILDLSNNNIA-NINDDMLEGLEKLEILDLQHNNLARLWKHANPGGPIYFLKGLSHLHILNLESNGFDEIPVEVFKD  558 (680)
T ss_dssp             TTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCGGGGSTTSTTSCCCTTTTCTTCCEEECCSSCCCCCCTTTTTT
T ss_pred             CCCCEEECCCCCCC-cCChhhhccccccCEEeCCCCCccccchhhccCCcchhhcCCCCCCEEECCCCCCCCCCHHHccc
Confidence            45777888888887 5665577888888888888888775421        23677888888888888888433346888


Q ss_pred             ccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCccc----cccCCcccccCCCCCCCCC
Q 007167          139 WNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRS----LQRFPSWAFAGNNLSSENA  202 (615)
Q Consensus       139 l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~----~~~l~~l~~~~n~~~~~~~  202 (615)
                      +++|+.|+|++|++++..+..|.++++|+.|+|++|+|++..|..    +.++..+.+++|++.|.+.
T Consensus       559 l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~~~L~~l~l~~N~~~c~c~  626 (680)
T 1ziw_A          559 LFELKIIDLGLNNLNTLPASVFNNQVSLKSLNLQKNLITSVEKKVFGPAFRNLTELDMRFNPFDCTCE  626 (680)
T ss_dssp             CTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECTTSCCCBCCHHHHHHHHTTCSEEECTTCCCCBCCC
T ss_pred             ccCcceeECCCCCCCcCCHhHhCCCCCCCEEECCCCcCCccChhHhcccccccCEEEccCCCcccCCc
Confidence            888888888888888766666788888888888888888777753    4567778888999888754

>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A*

Probab=99.47  E-value=1.3e-13  Score=153.72  Aligned_cols=131  Identities=19%  Similarity=0.157  Sum_probs=69.8

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCC-ccccccCcEEecccccccCCCCccccccccccee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSD-FSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVI  145 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~-~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l  145 (615)
                      .+++.|+|++|.+++..|. .|+.+++|++|+|++|.+++..|.. |.++++|++|+|++|.+++..|..+..+++|+.|
T Consensus       376 ~~L~~L~l~~n~l~~~~~~-~~~~l~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L  454 (606)
T 3t6q_A          376 SHLQSLNLSYNEPLSLKTE-AFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHL  454 (606)
T ss_dssp             TTCCEEECCSCSCEEECTT-TTTTCTTCSEEECTTCCEECCTTCCTTTTCTTCCEEECTTCCCBTTCTTTTTTCTTCCEE
T ss_pred             CCCCEEECCCCcCCcCCHH-HhcCCccCCeEECCCCcCCCcccchhhhCcccCCEEECCCCccCCcCHHHHhCCCCCCEE
Confidence            4556666666666533332 5555666666666666655554433 5555556666666655555555555555555555


Q ss_pred             ecCCCcCCcc---CCCcccCCCCCCeeeccCccccCCCccccccC---CcccccCCCCC
Q 007167          146 DLSNNFFNAS---IPASISKLTHLSALNLANNSLTGTLPRSLQRF---PSWAFAGNNLS  198 (615)
Q Consensus       146 ~l~~N~l~~~---~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l---~~l~~~~n~~~  198 (615)
                      +|++|++++.   .+..+..+++|+.|+|++|++++.+|..|..+   ..+.+++|.+.
T Consensus       455 ~L~~n~l~~~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~  513 (606)
T 3t6q_A          455 NLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLT  513 (606)
T ss_dssp             ECTTCBCGGGEECSSCGGGGCTTCCEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCC
T ss_pred             ECCCCCCCccccccchhhccCCCccEEECCCCccCccChhhhccccCCCEEECCCCccC
Confidence            5555555541   12345555555555555555555555444332   23344555443

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.46  E-value=1.1e-13  Score=128.53  Aligned_cols=124  Identities=20%  Similarity=0.227  Sum_probs=101.3

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCC-CccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCccccccccccee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLS-ALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVI  145 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~-~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l  145 (615)
                      ..++.|+|++|+++ .++.  +..+. +|++|+|++|.|++.  ..|.++++|++|+|++|+|++..|..+..+++|+.|
T Consensus        19 ~~L~~L~l~~n~l~-~i~~--~~~~~~~L~~L~Ls~N~l~~~--~~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L   93 (176)
T 1a9n_A           19 VRDRELDLRGYKIP-VIEN--LGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL   93 (176)
T ss_dssp             TSCEEEECTTSCCC-SCCC--GGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred             CCceEEEeeCCCCc-hhHH--hhhcCCCCCEEECCCCCCCcc--cccccCCCCCEEECCCCcccccCcchhhcCCCCCEE
Confidence            47899999999999 6753  55555 999999999999976  689999999999999999996544556999999999


Q ss_pred             ecCCCcCCccCCC--cccCCCCCCeeeccCccccCCCccc----cccC---CcccccCCCC
Q 007167          146 DLSNNFFNASIPA--SISKLTHLSALNLANNSLTGTLPRS----LQRF---PSWAFAGNNL  197 (615)
Q Consensus       146 ~l~~N~l~~~~p~--~~~~l~~L~~l~l~~N~l~g~~p~~----~~~l---~~l~~~~n~~  197 (615)
                      +|++|+|+ .+|.  .+.++++|+.|+|++|.++ .+|..    +..+   ..+.+.+|..
T Consensus        94 ~L~~N~i~-~~~~~~~l~~l~~L~~L~l~~N~i~-~~~~~~~~~~~~l~~L~~Ld~~~n~~  152 (176)
T 1a9n_A           94 ILTNNSLV-ELGDLDPLASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVKL  152 (176)
T ss_dssp             ECCSCCCC-CGGGGGGGGGCTTCCEEECCSSGGG-GSTTHHHHHHHHCTTCSEETTEECCH
T ss_pred             ECCCCcCC-cchhhHhhhcCCCCCEEEecCCCCC-CcHhHHHHHHHHCCccceeCCCcCCH
Confidence            99999997 4676  8899999999999999998 45653    4444   4455555543

>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D

Probab=99.45  E-value=2.5e-13  Score=125.21  Aligned_cols=105  Identities=22%  Similarity=0.238  Sum_probs=92.4

Q ss_pred             ccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccC
Q 007167           94 LQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLAN  173 (615)
Q Consensus        94 L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~  173 (615)
                      .+.|++++|+|+. +|..+.  ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|.++++|+.|+|++
T Consensus        11 ~~~l~~s~n~l~~-ip~~~~--~~l~~L~L~~N~i~~~~~~~~~~l~~L~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~   87 (170)
T 3g39_A           11 GTTVDCSGKSLAS-VPTGIP--TTTQVLYLYDNQITKLEPGVFDRLTQLTRLDLDNNQLTVLPAGVFDKLTQLTQLSLND   87 (170)
T ss_dssp             TTEEECTTSCCSS-CCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CCEEEeCCCCcCc-cCccCC--CCCcEEEcCCCcCCccChhhhcCcccCCEEECCCCCcCccChhhccCCCCCCEEECCC
Confidence            5789999999995 687764  8999999999999998899999999999999999999987777889999999999999


Q ss_pred             ccccCCCccccc---cCCcccccCCCCCCCC
Q 007167          174 NSLTGTLPRSLQ---RFPSWAFAGNNLSSEN  201 (615)
Q Consensus       174 N~l~g~~p~~~~---~l~~l~~~~n~~~~~~  201 (615)
                      |+|++..+..|.   ++..+.+++|++.|..
T Consensus        88 N~l~~~~~~~~~~l~~L~~L~L~~N~~~c~c  118 (170)
T 3g39_A           88 NQLKSIPRGAFDNLKSLTHIWLLNNPWDCAC  118 (170)
T ss_dssp             SCCCCCCTTTTTTCTTCCEEECCSSCBCTTB
T ss_pred             CccCEeCHHHhcCCCCCCEEEeCCCCCCCCc
Confidence            999987776565   4556778999998763

>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens}

Probab=99.45  E-value=1.3e-13  Score=149.05  Aligned_cols=133  Identities=24%  Similarity=0.245  Sum_probs=115.8

Q ss_pred             CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCccccccccccee
Q 007167           66 HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVI  145 (615)
Q Consensus        66 ~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l  145 (615)
                      ..+++.|+|++|.+++..| ..|+++++|++|+|++|.+++..+..|.++++|++|+|++|++++..|..|..+++|+.|
T Consensus        55 l~~L~~L~L~~n~i~~~~~-~~~~~l~~L~~L~L~~n~l~~~~~~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~L  133 (477)
T 2id5_A           55 FPHLEELELNENIVSAVEP-GAFNNLFNLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSL  133 (477)
T ss_dssp             CTTCCEEECTTSCCCEECT-TTTTTCTTCCEEECCSSCCCSCCTTSSTTCTTCCEEECTTSCCCEECTTTTTTCTTCCEE
T ss_pred             CCCCCEEECCCCccCEeCh-hhhhCCccCCEEECCCCcCCccCcccccCCCCCCEEECCCCccccCChhHccccccCCEE
Confidence            4679999999999995444 489999999999999999997777779999999999999999999889999999999999


Q ss_pred             ecCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccc---cCCcccccCCCCCC
Q 007167          146 DLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQ---RFPSWAFAGNNLSS  199 (615)
Q Consensus       146 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l~~~~n~~~~  199 (615)
                      +|++|.+++..|..|.++++|+.|+|++|++++..+..|.   ++..+.+.+|.+..
T Consensus       134 ~l~~n~l~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~i~~  190 (477)
T 2id5_A          134 EVGDNDLVYISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNINA  190 (477)
T ss_dssp             EECCTTCCEECTTSSTTCTTCCEEEEESCCCSSCCHHHHTTCTTCCEEEEESCCCCE
T ss_pred             ECCCCccceeChhhccCCCCCCEEECCCCcCcccChhHhcccCCCcEEeCCCCcCcE
Confidence            9999999998899999999999999999999976655444   55566778887644

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.45  E-value=4.9e-14  Score=154.09  Aligned_cols=127  Identities=22%  Similarity=0.217  Sum_probs=111.0

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID  146 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~  146 (615)
                      .+++.|+|++|+++ .+++..|.++++|++|+|++|++++..|..|.++++|++|+|++|+++ .+|..  .+++|++|+
T Consensus        21 ~~L~~L~Ls~n~i~-~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~-~lp~~--~l~~L~~L~   96 (520)
T 2z7x_B           21 QKTTILNISQNYIS-ELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KISCH--PTVNLKHLD   96 (520)
T ss_dssp             TTCSEEECCSSCCC-CCCHHHHTTCTTCCEEECCSSCCCEEEGGGGTTCTTCCEEECCSSCCC-EEECC--CCCCCSEEE
T ss_pred             ccccEEECCCCccc-ccChhhccccccccEEecCCCccCCcChHHhhcccCCCEEecCCCcee-ecCcc--ccCCccEEe
Confidence            57999999999999 455558999999999999999999988999999999999999999999 57776  899999999


Q ss_pred             cCCCcCCc-cCCCcccCCCCCCeeeccCccccCCCccccccC--CcccccCCCC
Q 007167          147 LSNNFFNA-SIPASISKLTHLSALNLANNSLTGTLPRSLQRF--PSWAFAGNNL  197 (615)
Q Consensus       147 l~~N~l~~-~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l--~~l~~~~n~~  197 (615)
                      |++|++++ .+|..++++++|++|+|++|++++.....+.++  ..+.+++|.+
T Consensus        97 L~~N~l~~~~~p~~~~~l~~L~~L~L~~n~l~~~~~~~l~~L~L~~L~l~~n~l  150 (520)
T 2z7x_B           97 LSFNAFDALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGET  150 (520)
T ss_dssp             CCSSCCSSCCCCGGGGGCTTCCEEEEEESSCCGGGGGGGTTSCEEEEEEEECTT
T ss_pred             ccCCccccccchhhhccCCcceEEEecCcccchhhccccccceeeEEEeecccc
Confidence            99999997 578999999999999999999987554556666  7777888877

>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A*

Probab=99.45  E-value=2.6e-13  Score=139.22  Aligned_cols=131  Identities=24%  Similarity=0.330  Sum_probs=106.3

Q ss_pred             CCcEEEEEeCCCCccc-ccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccce
Q 007167           66 HSRVVALRLPGMALRG-EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTV  144 (615)
Q Consensus        66 ~~~v~~l~l~~~~l~g-~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~  144 (615)
                      ..+++.|+|++|.++. .+.+..+..+++|++|+|++|.++. +|..+.  ++|++|+|++|++++..|..|..+++|+.
T Consensus       144 l~~L~~L~l~~n~l~~~~~~~~~~~~l~~L~~L~l~~n~l~~-l~~~~~--~~L~~L~l~~n~l~~~~~~~~~~l~~L~~  220 (330)
T 1xku_A          144 LNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNITT-IPQGLP--PSLTELHLDGNKITKVDAASLKGLNNLAK  220 (330)
T ss_dssp             CTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCCS-CCSSCC--TTCSEEECTTSCCCEECTGGGTTCTTCCE
T ss_pred             CccccEEECCCCcCCccCcChhhccCCCCcCEEECCCCcccc-CCcccc--ccCCEEECCCCcCCccCHHHhcCCCCCCE
Confidence            3578899999998863 2444578899999999999999885 565554  78999999999999887888999999999


Q ss_pred             eecCCCcCCccCCCcccCCCCCCeeeccCccccCCCcccccc---CCcccccCCCCCCC
Q 007167          145 IDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQR---FPSWAFAGNNLSSE  200 (615)
Q Consensus       145 l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~---l~~l~~~~n~~~~~  200 (615)
                      |+|++|++++..|..+.++++|+.|+|++|+++ .+|..+..   +..+.+++|++...
T Consensus       221 L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~N~l~-~lp~~l~~l~~L~~L~l~~N~i~~~  278 (330)
T 1xku_A          221 LGLSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAI  278 (330)
T ss_dssp             EECCSSCCCEECTTTGGGSTTCCEEECCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCC
T ss_pred             EECCCCcCceeChhhccCCCCCCEEECCCCcCc-cCChhhccCCCcCEEECCCCcCCcc
Confidence            999999999877778888999999999999998 77776654   44567788887654

>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus}

Probab=99.44  E-value=1.6e-13  Score=151.51  Aligned_cols=110  Identities=24%  Similarity=0.266  Sum_probs=75.3

Q ss_pred             cCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccC--CCCcccccccccceeecCCCcCCccCCC-cccCCCC
Q 007167           89 GRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSG--PLPLDFSVWNNLTVIDLSNNFFNASIPA-SISKLTH  165 (615)
Q Consensus        89 ~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g--~~p~~~~~l~~L~~l~l~~N~l~~~~p~-~~~~l~~  165 (615)
                      +.+++|++|+|++|.+++.+|..|.++++|++|+|++|++++  .+|..+..+++|+.|+|++|++++.+|. .+..+++
T Consensus       350 ~~l~~L~~L~l~~n~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~~l~~  429 (562)
T 3a79_B          350 PSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLKNFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAES  429 (562)
T ss_dssp             SSCCCCCEEECCSSCCCTTTTTTCCSCSSCCEEECCSSCCCBTTHHHHTTTTCTTCCEEECTTSCCBSCCSSCCCCCCTT
T ss_pred             cCCCCceEEECCCCccccchhhhhcccCCCCEEECCCCCcCCcccchhhhcCCCCCCEEECCCCcCCCccChhhhcCccc
Confidence            556677777777777777777777777777777777777775  2345567777777777777777764544 3666677


Q ss_pred             CCeeeccCccccCCCcccc-ccCCcccccCCCCC
Q 007167          166 LSALNLANNSLTGTLPRSL-QRFPSWAFAGNNLS  198 (615)
Q Consensus       166 L~~l~l~~N~l~g~~p~~~-~~l~~l~~~~n~~~  198 (615)
                      |+.|+|++|++++.+|..+ .++..+.+++|.+.
T Consensus       430 L~~L~l~~n~l~~~~~~~l~~~L~~L~L~~N~l~  463 (562)
T 3a79_B          430 ILVLNLSSNMLTGSVFRCLPPKVKVLDLHNNRIM  463 (562)
T ss_dssp             CCEEECCSSCCCGGGGSSCCTTCSEEECCSSCCC
T ss_pred             CCEEECCCCCCCcchhhhhcCcCCEEECCCCcCc
Confidence            7777777777777666666 36666667776654

>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens}

Probab=99.44  E-value=9e-14  Score=141.42  Aligned_cols=132  Identities=20%  Similarity=0.119  Sum_probs=109.5

Q ss_pred             CCcEEEEEeCCCCcccccCC---CcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCC--C--Cccccc
Q 007167           66 HSRVVALRLPGMALRGEIPP---NTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGP--L--PLDFSV  138 (615)
Q Consensus        66 ~~~v~~l~l~~~~l~g~i~~---~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~--~--p~~~~~  138 (615)
                      ..+++.|+|++|.+++.++.   ..+..+++|++|+|++|.+++..|..|+++++|++|+|++|++.+.  +  +..++.
T Consensus       116 ~~~L~~L~Ls~n~i~~~~~~~~~~~~~~~~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~~~~  195 (310)
T 4glp_A          116 GLALSSLRLRNVSWATGRSWLAELQQWLKPGLKVLSIAQAHSPAFSCEQVRAFPALTSLDLSDNPGLGERGLMAALCPHK  195 (310)
T ss_dssp             CBCCSSCEEESCCCSSTTSSHHHHHTTBCSCCCEEEEECCSSCCCCTTSCCCCTTCCEEECCSCTTCHHHHHHTTSCTTS
T ss_pred             CCCCCEEEeecccccchhhhhHHHHhhhccCCCEEEeeCCCcchhhHHHhccCCCCCEEECCCCCCccchhhhHHHhhhc
Confidence            45789999999999976552   2456799999999999999999889999999999999999998753  2  233578


Q ss_pred             ccccceeecCCCcCCccCCC----cccCCCCCCeeeccCccccCCCccccc------cCCcccccCCCCC
Q 007167          139 WNNLTVIDLSNNFFNASIPA----SISKLTHLSALNLANNSLTGTLPRSLQ------RFPSWAFAGNNLS  198 (615)
Q Consensus       139 l~~L~~l~l~~N~l~~~~p~----~~~~l~~L~~l~l~~N~l~g~~p~~~~------~l~~l~~~~n~~~  198 (615)
                      +++|++|+|++|+++. +|.    .+.++++|+.|+|++|+|++.+|..+.      ++..|.+++|.+.
T Consensus       196 l~~L~~L~Ls~N~l~~-l~~~~~~l~~~l~~L~~L~Ls~N~l~~~~p~~~~~~~~~~~L~~L~Ls~N~l~  264 (310)
T 4glp_A          196 FPAIQNLALRNTGMET-PTGVCAALAAAGVQPHSLDLSHNSLRATVNPSAPRCMWSSALNSLNLSFAGLE  264 (310)
T ss_dssp             SCCCCSCBCCSSCCCC-HHHHHHHHHHHTCCCSSEECTTSCCCCCCCSCCSSCCCCTTCCCEECCSSCCC
T ss_pred             CCCCCEEECCCCCCCc-hHHHHHHHHhcCCCCCEEECCCCCCCccchhhHHhccCcCcCCEEECCCCCCC
Confidence            9999999999999984 333    257889999999999999998886653      5667888999887

>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus}

Probab=99.43  E-value=4.3e-13  Score=124.17  Aligned_cols=104  Identities=20%  Similarity=0.224  Sum_probs=90.8

Q ss_pred             ccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccC
Q 007167           94 LQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLAN  173 (615)
Q Consensus        94 L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~  173 (615)
                      -+.+++++|+|+ .+|..+.  ++|++|+|++|+|++..|..|.++++|+.|+|++|+|++..+..|.++++|+.|+|++
T Consensus        14 ~~~l~~~~n~l~-~iP~~~~--~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~i~~~~~~~l~~L~~L~L~~   90 (174)
T 2r9u_A           14 QTLVNCQNIRLA-SVPAGIP--TDKQRLWLNNNQITKLEPGVFDHLVNLQQLYFNSNKLTAIPTGVFDKLTQLTQLDLND   90 (174)
T ss_dssp             SSEEECCSSCCS-SCCSCCC--TTCSEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCS
T ss_pred             CcEEEeCCCCCC-ccCCCcC--CCCcEEEeCCCCccccCHHHhcCCcCCCEEECCCCCCCccChhHhCCcchhhEEECCC
Confidence            378999999997 6787775  8999999999999998899999999999999999999986666789999999999999


Q ss_pred             ccccCCCccccc---cCCcccccCCCCCCC
Q 007167          174 NSLTGTLPRSLQ---RFPSWAFAGNNLSSE  200 (615)
Q Consensus       174 N~l~g~~p~~~~---~l~~l~~~~n~~~~~  200 (615)
                      |+|++..+..|.   ++..+.+.+|++.|.
T Consensus        91 N~l~~l~~~~~~~l~~L~~L~L~~N~~~c~  120 (174)
T 2r9u_A           91 NHLKSIPRGAFDNLKSLTHIYLYNNPWDCE  120 (174)
T ss_dssp             SCCCCCCTTTTTTCTTCSEEECCSSCBCTT
T ss_pred             CccceeCHHHhccccCCCEEEeCCCCcccc
Confidence            999976665555   555678899999765

>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A

Probab=99.43  E-value=1.2e-13  Score=127.12  Aligned_cols=112  Identities=22%  Similarity=0.196  Sum_probs=99.3

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCC-Cccccccccccee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPL-PLDFSVWNNLTVI  145 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~-p~~~~~l~~L~~l  145 (615)
                      .+++.|+|++|.+++ +  ..++.+++|++|+|++|++++.+|..+.++++|++|+|++|++++.. +..+..+++|+.|
T Consensus        49 ~~L~~L~l~~n~l~~-~--~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~l~~l~~L~~L  125 (168)
T 2ell_A           49 VNLEFLSLINVGLIS-V--SNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDISTLEPLKKLECLKSL  125 (168)
T ss_dssp             GGCCEEEEESSCCCC-C--SSCCCCSSCCEEEEESCCCCSCCCHHHHHCTTCCEEECBSSSCCSSGGGGGGSSCSCCCEE
T ss_pred             CCCCEEeCcCCCCCC-h--hhhccCCCCCEEECcCCcCchHHHHHHhhCCCCCEEeccCCccCcchhHHHHhcCCCCCEE
Confidence            579999999999995 4  37999999999999999999988988888999999999999999632 2789999999999


Q ss_pred             ecCCCcCCccCC---CcccCCCCCCeeeccCccccCCCcc
Q 007167          146 DLSNNFFNASIP---ASISKLTHLSALNLANNSLTGTLPR  182 (615)
Q Consensus       146 ~l~~N~l~~~~p---~~~~~l~~L~~l~l~~N~l~g~~p~  182 (615)
                      +|++|.+++..+   ..+..+++|+.|++++|.+. .+|.
T Consensus       126 ~l~~N~l~~~~~~~~~~~~~l~~L~~L~l~~n~~~-~~~~  164 (168)
T 2ell_A          126 DLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ-EAPD  164 (168)
T ss_dssp             ECCSSGGGTSTTHHHHHHTTCSSCCEETTEETTSC-BCCS
T ss_pred             EeeCCcCcchHHHHHHHHHhCccCcEecCCCCChh-hccc
Confidence            999999997554   48899999999999999987 4554

>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens}

Probab=99.43  E-value=1.2e-13  Score=143.31  Aligned_cols=130  Identities=26%  Similarity=0.305  Sum_probs=112.2

Q ss_pred             CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCc--ccccccccc
Q 007167           66 HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPL--DFSVWNNLT  143 (615)
Q Consensus        66 ~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~--~~~~l~~L~  143 (615)
                      ..+++.|+|++|++++ +++..|+++++|++|+|++|++++..+..|.++++|++|+|++|++++ +|.  .+..+++|+
T Consensus        75 l~~L~~L~L~~n~l~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~L~~n~l~~-l~~~~~~~~l~~L~  152 (353)
T 2z80_A           75 CVNLQALVLTSNGINT-IEEDSFSSLGSLEHLDLSYNYLSNLSSSWFKPLSSLTFLNLLGNPYKT-LGETSLFSHLTKLQ  152 (353)
T ss_dssp             CTTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECCSSCCSSCCHHHHTTCTTCSEEECTTCCCSS-SCSSCSCTTCTTCC
T ss_pred             CCCCCEEECCCCccCc-cCHhhcCCCCCCCEEECCCCcCCcCCHhHhCCCccCCEEECCCCCCcc-cCchhhhccCCCCc
Confidence            4689999999999995 555589999999999999999997655569999999999999999995 555  799999999


Q ss_pred             eeecCCC-cCCccCCCcccCCCCCCeeeccCccccCCCccccccCC---cccccCCCC
Q 007167          144 VIDLSNN-FFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFP---SWAFAGNNL  197 (615)
Q Consensus       144 ~l~l~~N-~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~---~l~~~~n~~  197 (615)
                      .|++++| .+++..|..+.++++|+.|++++|++++..|..+.+++   .+.+++|.+
T Consensus       153 ~L~l~~n~~~~~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~l~~l~~L~~L~l~~n~l  210 (353)
T 2z80_A          153 ILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQH  210 (353)
T ss_dssp             EEEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCSEEEEEEEECSCS
T ss_pred             EEECCCCccccccCHHHccCCCCCCEEECCCCCcCccCHHHHhccccCCeecCCCCcc
Confidence            9999999 57777788999999999999999999998888877665   455677755

>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C*

Probab=99.42  E-value=1.4e-13  Score=134.28  Aligned_cols=129  Identities=15%  Similarity=0.253  Sum_probs=110.4

Q ss_pred             CCcEEEEEeCCCC-cccccCCCcccCCCCccEEEcCC-CCCCCcCCCCccccccCcEEecccccccCCCCcccccccccc
Q 007167           66 HSRVVALRLPGMA-LRGEIPPNTIGRLSALQNLSLRS-NSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLT  143 (615)
Q Consensus        66 ~~~v~~l~l~~~~-l~g~i~~~~~~~l~~L~~L~L~~-N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~  143 (615)
                      ..+++.|+|++|+ ++ .+++..|..+++|++|+|++ |++++..+..|.++++|++|+|++|++++ +|. |..+++|+
T Consensus        54 l~~L~~L~l~~n~~l~-~i~~~~f~~l~~L~~L~l~~~n~l~~i~~~~f~~l~~L~~L~l~~n~l~~-lp~-~~~l~~L~  130 (239)
T 2xwt_C           54 LPNISRIYVSIDVTLQ-QLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLKM-FPD-LTKVYSTD  130 (239)
T ss_dssp             CTTCCEEEEECCSSCC-EECTTTEESCTTCCEEEEEEETTCCEECTTSEECCTTCCEEEEEEECCCS-CCC-CTTCCBCC
T ss_pred             CCCCcEEeCCCCCCcc-eeCHhHcCCCcCCcEEECCCCCCeeEcCHHHhCCCCCCCEEeCCCCCCcc-ccc-cccccccc
Confidence            4679999999997 77 78877899999999999998 99998877889999999999999999996 776 88888888


Q ss_pred             ---eeecCCC-cCCccCCCcccCCCCCC-eeeccCccccCCCcccc---ccCCcccccCCC-CC
Q 007167          144 ---VIDLSNN-FFNASIPASISKLTHLS-ALNLANNSLTGTLPRSL---QRFPSWAFAGNN-LS  198 (615)
Q Consensus       144 ---~l~l~~N-~l~~~~p~~~~~l~~L~-~l~l~~N~l~g~~p~~~---~~l~~l~~~~n~-~~  198 (615)
                         .|++++| ++++..+..|.++++|+ .|++++|+++ .+|...   .++..+.+++|+ +.
T Consensus       131 ~L~~L~l~~N~~l~~i~~~~~~~l~~L~~~L~l~~n~l~-~i~~~~~~~~~L~~L~L~~n~~l~  193 (239)
T 2xwt_C          131 IFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAVYLNKNKYLT  193 (239)
T ss_dssp             SEEEEEEESCTTCCEECTTTTTTTBSSEEEEECCSCCCC-EECTTTTTTCEEEEEECTTCTTCC
T ss_pred             cccEEECCCCcchhhcCcccccchhcceeEEEcCCCCCc-ccCHhhcCCCCCCEEEcCCCCCcc
Confidence               9999999 99987777899999999 9999999998 666543   245667788885 54

>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens}

Probab=99.42  E-value=2e-13  Score=149.27  Aligned_cols=131  Identities=21%  Similarity=0.303  Sum_probs=110.7

Q ss_pred             CCCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCC--cCCCCccccccCcEEecccccccCCCCcc-cccccc
Q 007167           65 DHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSG--LFPSDFSKLENLTSLHLQFNSFSGPLPLD-FSVWNN  141 (615)
Q Consensus        65 ~~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g--~~p~~~~~l~~L~~L~l~~N~l~g~~p~~-~~~l~~  141 (615)
                      ....++.|+|++|.+++.+|. .++.+++|++|+|++|++++  .+|..|.++++|++|+|++|++++.+|.. +..+++
T Consensus       322 ~l~~L~~L~Ls~n~l~~~~~~-~~~~l~~L~~L~L~~N~l~~l~~~~~~~~~l~~L~~L~Ls~N~l~~~l~~~~~~~l~~  400 (520)
T 2z7x_B          322 KISPFLHLDFSNNLLTDTVFE-NCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKS  400 (520)
T ss_dssp             SCCCCCEEECCSSCCCTTTTT-TCCCCSSCCEEECCSSCCCBHHHHHHHHTTCTTCCEEECCSSCCBCCGGGCSCCCCTT
T ss_pred             hCCcccEEEeECCccChhhhh-hhccCCCCCEEEccCCccCccccchHHHhhCCCCCEEECCCCcCCcccccchhccCcc
Confidence            346789999999999987776 78999999999999999997  56788999999999999999999867764 888899


Q ss_pred             cceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccc---cCCcccccCCCCCC
Q 007167          142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQ---RFPSWAFAGNNLSS  199 (615)
Q Consensus       142 L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l~~~~n~~~~  199 (615)
                      |+.|+|++|++++.+|..+.  ++|+.|+|++|+|+ .+|..+.   ++..+.+++|.+..
T Consensus       401 L~~L~Ls~N~l~~~~~~~l~--~~L~~L~Ls~N~l~-~ip~~~~~l~~L~~L~L~~N~l~~  458 (520)
T 2z7x_B          401 LLSLNMSSNILTDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQLKS  458 (520)
T ss_dssp             CCEEECCSSCCCGGGGGSCC--TTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC
T ss_pred             CCEEECcCCCCCcchhhhhc--ccCCEEECCCCccc-ccchhhhcCCCCCEEECCCCcCCc
Confidence            99999999999988887765  68999999999998 7777654   44566788888763

>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae}

Probab=99.41  E-value=1.7e-13  Score=148.42  Aligned_cols=31  Identities=19%  Similarity=0.189  Sum_probs=25.6

Q ss_pred             CHHHHHHHHHHHhCCCCCcccceeEEEEecC
Q 007167          338 GKREFEQQMEIVGGIRHENVVALRAYYYSKD  368 (615)
Q Consensus       338 ~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~  368 (615)
                      +.++|..|++++++++|+|+|+++|||....
T Consensus       322 g~~eF~~Eve~L~~i~HrNLV~L~gyC~s~~  352 (487)
T 3oja_A          322 GSETERLECERENQARQREIDALKEQYRTVI  352 (487)
T ss_dssp             ---CHHHHHHHHHHHHHHHHHHHHHHTCCCC
T ss_pred             cHHHHHHHHHHHhcccccchhhHHHHhcChH
Confidence            3678999999999999999999999996643

>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus}

Probab=99.41  E-value=6.1e-13  Score=136.59  Aligned_cols=125  Identities=24%  Similarity=0.397  Sum_probs=60.0

Q ss_pred             EEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCC--CcCCCCccccccCcEEecccccccCCCCcccccccccceee
Q 007167           69 VVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLS--GLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID  146 (615)
Q Consensus        69 v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~--g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~  146 (615)
                      ++.|+|++|.++ .+++..|+.+++|++|+|++|.++  +..|..|..+ +|++|+|++|++++ +|..+.  ++|+.|+
T Consensus       125 L~~L~l~~n~i~-~~~~~~~~~l~~L~~L~l~~n~l~~~~~~~~~~~~l-~L~~L~l~~n~l~~-l~~~~~--~~L~~L~  199 (332)
T 2ft3_A          125 LVELRIHDNRIR-KVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGL-KLNYLRISEAKLTG-IPKDLP--ETLNELH  199 (332)
T ss_dssp             CCEEECCSSCCC-CCCSGGGSSCSSCCEEECCSCCCBGGGSCTTSSCSC-CCSCCBCCSSBCSS-CCSSSC--SSCSCCB
T ss_pred             CCEEECCCCccC-ccCHhHhCCCccCCEEECCCCccccCCCCcccccCC-ccCEEECcCCCCCc-cCcccc--CCCCEEE
Confidence            444444444444 334334555555555555555553  2444444444 33333333333332 222221  3555555


Q ss_pred             cCCCcCCccCCCcccCCCCCCeeeccCccccCCCcccccc---CCcccccCCCCC
Q 007167          147 LSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQR---FPSWAFAGNNLS  198 (615)
Q Consensus       147 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~---l~~l~~~~n~~~  198 (615)
                      |++|++++..|..+.++++|+.|+|++|++++..|..+..   +..+.+++|.+.
T Consensus       200 l~~n~i~~~~~~~l~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~  254 (332)
T 2ft3_A          200 LDHNKIQAIELEDLLRYSKLYRLGLGHNQIRMIENGSLSFLPTLRELHLDNNKLS  254 (332)
T ss_dssp             CCSSCCCCCCTTSSTTCTTCSCCBCCSSCCCCCCTTGGGGCTTCCEEECCSSCCC
T ss_pred             CCCCcCCccCHHHhcCCCCCCEEECCCCcCCcCChhHhhCCCCCCEEECCCCcCe
Confidence            5566666555555666666666666666666555444432   333445555543

>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A

Probab=99.39  E-value=3.7e-13  Score=121.05  Aligned_cols=108  Identities=19%  Similarity=0.238  Sum_probs=94.6

Q ss_pred             CCCCccEEEcCCCCCC-CcCCCCccccccCcEEecccccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCe
Q 007167           90 RLSALQNLSLRSNSLS-GLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSA  168 (615)
Q Consensus        90 ~l~~L~~L~L~~N~l~-g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~  168 (615)
                      ..++|+.|+|++|.++ +.+|..+..+++|++|+|++|.+++.  ..++.+++|+.|+|++|++++.+|..+.++++|+.
T Consensus        15 ~~~~l~~L~l~~n~l~~~~~~~~~~~l~~L~~L~l~~n~l~~~--~~~~~l~~L~~L~Ls~n~i~~~~~~~~~~l~~L~~   92 (149)
T 2je0_A           15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTH   92 (149)
T ss_dssp             CGGGCSEEECTTCBCBTTBCCSCCTTCTTCCEEECTTSCCCCC--TTCCCCTTCCEEECCSSCCCSCTHHHHHHCTTCCE
T ss_pred             CCccCeEEEccCCcCChhHHHHHHhhcCCCcEEECcCCCCCCc--hhhhcCCCCCEEECCCCcccchHHHHhhhCCCCCE
Confidence            3578999999999999 89999999999999999999999975  78999999999999999999888988888999999


Q ss_pred             eeccCccccCC-Cccccc---cCCcccccCCCCCC
Q 007167          169 LNLANNSLTGT-LPRSLQ---RFPSWAFAGNNLSS  199 (615)
Q Consensus       169 l~l~~N~l~g~-~p~~~~---~l~~l~~~~n~~~~  199 (615)
                      |++++|++++. .|..+.   ++..+.+++|++..
T Consensus        93 L~ls~N~i~~~~~~~~~~~l~~L~~L~l~~N~l~~  127 (149)
T 2je0_A           93 LNLSGNKIKDLSTIEPLKKLENLKSLDLFNCEVTN  127 (149)
T ss_dssp             EECTTSCCCSHHHHGGGGGCTTCCEEECTTCGGGG
T ss_pred             EECCCCcCCChHHHHHHhhCCCCCEEeCcCCcccc
Confidence            99999999973 335554   45567788887753

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.39  E-value=2.8e-13  Score=138.22  Aligned_cols=125  Identities=18%  Similarity=0.195  Sum_probs=89.5

Q ss_pred             cEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCccc-ccccccceee
Q 007167           68 RVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDF-SVWNNLTVID  146 (615)
Q Consensus        68 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~-~~l~~L~~l~  146 (615)
                      .++.|+|++|.+++ +++   ..+++|++|+|++|.+++..|..|.++++|++|+|++|.+++..|..+ ..+++|+.|+
T Consensus       100 ~L~~L~l~~n~l~~-~~~---~~~~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~  175 (317)
T 3o53_A          100 SIETLHAANNNISR-VSC---SRGQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLN  175 (317)
T ss_dssp             TCCEEECCSSCCSE-EEE---CCCSSCEEEECCSSCCCSGGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEE
T ss_pred             CcCEEECCCCccCC-cCc---cccCCCCEEECCCCCCCCccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEE
Confidence            44555555555553 222   236778888888888888877788888888888888888887766666 4688888888


Q ss_pred             cCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccc---cCCcccccCCCCCC
Q 007167          147 LSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQ---RFPSWAFAGNNLSS  199 (615)
Q Consensus       147 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l~~~~n~~~~  199 (615)
                      |++|++++. |. ...+++|+.|+|++|+|++..+ .+.   ++..+.+++|.+..
T Consensus       176 L~~N~l~~~-~~-~~~l~~L~~L~Ls~N~l~~l~~-~~~~l~~L~~L~L~~N~l~~  228 (317)
T 3o53_A          176 LQYNFIYDV-KG-QVVFAKLKTLDLSSNKLAFMGP-EFQSAAGVTWISLRNNKLVL  228 (317)
T ss_dssp             CTTSCCCEE-EC-CCCCTTCCEEECCSSCCCEECG-GGGGGTTCSEEECTTSCCCE
T ss_pred             CCCCcCccc-cc-ccccccCCEEECCCCcCCcchh-hhcccCcccEEECcCCcccc
Confidence            888888864 33 3357888888888888885433 343   45566778887753

>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A*

Probab=99.39  E-value=2.3e-13  Score=149.70  Aligned_cols=122  Identities=25%  Similarity=0.277  Sum_probs=106.4

Q ss_pred             CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccC-CCCcccccccccce
Q 007167           66 HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSG-PLPLDFSVWNNLTV  144 (615)
Q Consensus        66 ~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g-~~p~~~~~l~~L~~  144 (615)
                      -.+++.|+|++|++++ +++..|+.+++|++|+|++|.+++..|..|+++++|++|+|++|++++ .+|..++++++|+.
T Consensus        49 l~~L~~L~Ls~n~i~~-~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~  127 (549)
T 2z81_A           49 CANLQVLILKSSRINT-IEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQT  127 (549)
T ss_dssp             CTTCCEEECTTSCCCE-ECTTTTTTCTTCCEEECTTSCCCSCCHHHHTTCTTCCEEECTTCCCSSSCSSCSCTTCTTCCE
T ss_pred             CCcccEEECCCCCcCc-cChhhccccccCCEEECCCCccCccCHHHhccCCCCcEEECCCCcccccchhhhhhccCCccE
Confidence            4679999999999995 555589999999999999999998888789999999999999999987 46788999999999


Q ss_pred             eecCCCcCCccCC-CcccCCCCCCeeeccCccccCCCccccccCC
Q 007167          145 IDLSNNFFNASIP-ASISKLTHLSALNLANNSLTGTLPRSLQRFP  188 (615)
Q Consensus       145 l~l~~N~l~~~~p-~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~  188 (615)
                      |+|++|++.+.+| ..+.++++|+.|++++|++++.+|..+..++
T Consensus       128 L~L~~n~~~~~~~~~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~  172 (549)
T 2z81_A          128 LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIR  172 (549)
T ss_dssp             EEEEESSSCCEECTTTTTTCCEEEEEEEEETTCCEECTTTTTTCS
T ss_pred             EECCCCccccccCHhhhhcccccCeeeccCCcccccChhhhhccc
Confidence            9999999555565 6899999999999999999998887765544

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.38  E-value=1.3e-12  Score=131.51  Aligned_cols=124  Identities=28%  Similarity=0.422  Sum_probs=93.0

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID  146 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~  146 (615)
                      .+++.|+|++|++++ +++  ++.+++|++|+|++|.+++. | .+.++++|++|+|++|++++ + ..+..+++|+.|+
T Consensus        68 ~~L~~L~L~~n~l~~-~~~--l~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~L~~n~i~~-~-~~l~~l~~L~~L~  140 (291)
T 1h6t_A           68 PNVTKLFLNGNKLTD-IKP--LANLKNLGWLFLDENKVKDL-S-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLY  140 (291)
T ss_dssp             TTCCEEECCSSCCCC-CGG--GTTCTTCCEEECCSSCCCCG-G-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEE
T ss_pred             CCCCEEEccCCccCC-Ccc--cccCCCCCEEECCCCcCCCC-h-hhccCCCCCEEECCCCcCCC-C-hhhcCCCCCCEEE
Confidence            578888888888884 544  78888888888888888863 3 48888888888888888886 3 4677888888888


Q ss_pred             cCCCcCCccCCCcccCCCCCCeeeccCccccCCCc-cccccCCcccccCCCCCC
Q 007167          147 LSNNFFNASIPASISKLTHLSALNLANNSLTGTLP-RSLQRFPSWAFAGNNLSS  199 (615)
Q Consensus       147 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p-~~~~~l~~l~~~~n~~~~  199 (615)
                      |++|++++.  ..+..+++|+.|+|++|++++..| ..+.++..|.+++|.+..
T Consensus       141 l~~n~l~~~--~~l~~l~~L~~L~L~~N~l~~~~~l~~l~~L~~L~L~~N~i~~  192 (291)
T 1h6t_A          141 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD  192 (291)
T ss_dssp             CCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCB
T ss_pred             ccCCcCCcc--hhhccCCCCCEEEccCCccccchhhcCCCccCEEECCCCcCCC
Confidence            888888864  567888888888888888886655 113345556677777644

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.37  E-value=1.7e-12  Score=128.64  Aligned_cols=102  Identities=25%  Similarity=0.394  Sum_probs=47.4

Q ss_pred             cEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeec
Q 007167           68 RVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL  147 (615)
Q Consensus        68 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l  147 (615)
                      +++.|+|++|+++ .+++  ++.+++|++|+|++|++++. |. +.. ++|++|+|++|++++ +| .+..+++|+.|+|
T Consensus        64 ~L~~L~L~~N~i~-~~~~--l~~l~~L~~L~L~~N~l~~l-~~-~~~-~~L~~L~L~~N~l~~-~~-~l~~l~~L~~L~L  135 (263)
T 1xeu_A           64 NLKELHLSHNQIS-DLSP--LKDLTKLEELSVNRNRLKNL-NG-IPS-ACLSRLFLDNNELRD-TD-SLIHLKNLEILSI  135 (263)
T ss_dssp             TCCEEECCSSCCC-CCGG--GTTCSSCCEEECCSSCCSCC-TT-CCC-SSCCEEECCSSCCSB-SG-GGTTCTTCCEEEC
T ss_pred             CCCEEECCCCccC-CChh--hccCCCCCEEECCCCccCCc-Cc-ccc-CcccEEEccCCccCC-Ch-hhcCcccccEEEC
Confidence            4445555555544 2332  44455555555555555432 21 111 445555555555543 22 3445555555555


Q ss_pred             CCCcCCccCCCcccCCCCCCeeeccCccccCC
Q 007167          148 SNNFFNASIPASISKLTHLSALNLANNSLTGT  179 (615)
Q Consensus       148 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~  179 (615)
                      ++|+|++. | .+..+++|+.|+|++|++++.
T Consensus       136 s~N~i~~~-~-~l~~l~~L~~L~L~~N~i~~~  165 (263)
T 1xeu_A          136 RNNKLKSI-V-MLGFLSKLEVLDLHGNEITNT  165 (263)
T ss_dssp             TTSCCCBC-G-GGGGCTTCCEEECTTSCCCBC
T ss_pred             CCCcCCCC-h-HHccCCCCCEEECCCCcCcch
Confidence            55555542 2 344455555555555555543

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.36  E-value=7.7e-13  Score=134.37  Aligned_cols=127  Identities=22%  Similarity=0.403  Sum_probs=103.2

Q ss_pred             CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCccccccccccee
Q 007167           66 HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVI  145 (615)
Q Consensus        66 ~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l  145 (615)
                      ..+++.|+|++|.+++ ++  .+..+++|++|+|++|++++. | .+.++++|++|+|++|++++..+  +..+++|+.|
T Consensus        84 l~~L~~L~L~~n~l~~-~~--~~~~l~~L~~L~l~~n~l~~~-~-~l~~l~~L~~L~l~~n~l~~~~~--l~~l~~L~~L  156 (308)
T 1h6u_A           84 LTKITELELSGNPLKN-VS--AIAGLQSIKTLDLTSTQITDV-T-PLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYL  156 (308)
T ss_dssp             CCSCCEEECCSCCCSC-CG--GGTTCTTCCEEECTTSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEE
T ss_pred             CCCCCEEEccCCcCCC-ch--hhcCCCCCCEEECCCCCCCCc-h-hhcCCCCCCEEECCCCccCcCcc--ccCCCCccEE
Confidence            4678999999999984 54  589999999999999999975 4 38999999999999999986443  8899999999


Q ss_pred             ecCCCcCCccCCCcccCCCCCCeeeccCccccCCCc-cccccCCcccccCCCCCCCC
Q 007167          146 DLSNNFFNASIPASISKLTHLSALNLANNSLTGTLP-RSLQRFPSWAFAGNNLSSEN  201 (615)
Q Consensus       146 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p-~~~~~l~~l~~~~n~~~~~~  201 (615)
                      +|++|++++. |. +.++++|+.|+|++|++++..+ ..+.++..+.+++|.+....
T Consensus       157 ~l~~n~l~~~-~~-l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~L~~N~l~~~~  211 (308)
T 1h6u_A          157 SIGNAQVSDL-TP-LANLSKLTTLKADDNKISDISPLASLPNLIEVHLKNNQISDVS  211 (308)
T ss_dssp             ECCSSCCCCC-GG-GTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTTSCCCBCG
T ss_pred             EccCCcCCCC-hh-hcCCCCCCEEECCCCccCcChhhcCCCCCCEEEccCCccCccc
Confidence            9999999974 33 8899999999999999986554 23455667778888876543

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.36  E-value=1e-12  Score=135.68  Aligned_cols=122  Identities=19%  Similarity=0.319  Sum_probs=57.6

Q ss_pred             cEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeec
Q 007167           68 RVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL  147 (615)
Q Consensus        68 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l  147 (615)
                      +++.+++++|.+++ +++  +..+++|++|+|++|.+++..+  +..+++|++|+|++|.+++ + ..+..+++|+.|++
T Consensus       200 ~L~~L~l~~n~l~~-~~~--~~~~~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~-~-~~~~~l~~L~~L~l  272 (347)
T 4fmz_A          200 SLHYFTAYVNQITD-ITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQISD-I-NAVKDLTKLKMLNV  272 (347)
T ss_dssp             TCCEEECCSSCCCC-CGG--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-C-GGGTTCTTCCEEEC
T ss_pred             ccceeecccCCCCC-Cch--hhcCCcCCEEEccCCccCCCcc--hhcCCCCCEEECCCCccCC-C-hhHhcCCCcCEEEc
Confidence            44555555555542 222  4455555555555555554322  4555555555555555543 2 23445555555555


Q ss_pred             CCCcCCccCCCcccCCCCCCeeeccCccccCCCccccc---cCCcccccCCCCC
Q 007167          148 SNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQ---RFPSWAFAGNNLS  198 (615)
Q Consensus       148 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l~~~~n~~~  198 (615)
                      ++|++++.  ..+..+++|+.|+|++|++++..|..+.   ++..+.+++|++.
T Consensus       273 ~~n~l~~~--~~~~~l~~L~~L~L~~n~l~~~~~~~l~~l~~L~~L~L~~n~l~  324 (347)
T 4fmz_A          273 GSNQISDI--SVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHIT  324 (347)
T ss_dssp             CSSCCCCC--GGGGGCTTCSEEECCSSCCCGGGHHHHHTCTTCSEEECCSSSCC
T ss_pred             cCCccCCC--hhhcCCCCCCEEECcCCcCCCcChhHhhccccCCEEEccCCccc
Confidence            55555532  2344455555555555555544443332   2233344455443

>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1

Probab=99.35  E-value=2e-12  Score=131.29  Aligned_cols=126  Identities=21%  Similarity=0.380  Sum_probs=107.1

Q ss_pred             CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCccccccccccee
Q 007167           66 HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVI  145 (615)
Q Consensus        66 ~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l  145 (615)
                      ..+++.|+|++|.++ .+++  +..+++|++|+|++|.+++. | .+.++++|++|+|++|++++ +|. +..+++|+.|
T Consensus        62 l~~L~~L~L~~n~i~-~~~~--~~~l~~L~~L~L~~n~l~~~-~-~~~~l~~L~~L~l~~n~l~~-~~~-l~~l~~L~~L  134 (308)
T 1h6u_A           62 LNNLIGLELKDNQIT-DLAP--LKNLTKITELELSGNPLKNV-S-AIAGLQSIKTLDLTSTQITD-VTP-LAGLSNLQVL  134 (308)
T ss_dssp             CTTCCEEECCSSCCC-CCGG--GTTCCSCCEEECCSCCCSCC-G-GGTTCTTCCEEECTTSCCCC-CGG-GTTCTTCCEE
T ss_pred             cCCCCEEEccCCcCC-CChh--HccCCCCCEEEccCCcCCCc-h-hhcCCCCCCEEECCCCCCCC-chh-hcCCCCCCEE
Confidence            368999999999998 5665  89999999999999999974 4 79999999999999999997 453 9999999999


Q ss_pred             ecCCCcCCccCCCcccCCCCCCeeeccCccccCCCc-cccccCCcccccCCCCCCC
Q 007167          146 DLSNNFFNASIPASISKLTHLSALNLANNSLTGTLP-RSLQRFPSWAFAGNNLSSE  200 (615)
Q Consensus       146 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p-~~~~~l~~l~~~~n~~~~~  200 (615)
                      +|++|++++..+  +.++++|+.|+|++|++++..+ ..+.++..|.+++|.+...
T Consensus       135 ~l~~n~l~~~~~--l~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~~  188 (308)
T 1h6u_A          135 YLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDI  188 (308)
T ss_dssp             ECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCCC
T ss_pred             ECCCCccCcCcc--ccCCCCccEEEccCCcCCCChhhcCCCCCCEEECCCCccCcC
Confidence            999999997544  8999999999999999997544 2234566778899988654

>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A

Probab=99.35  E-value=1.6e-12  Score=130.88  Aligned_cols=124  Identities=23%  Similarity=0.317  Sum_probs=106.7

Q ss_pred             CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCccccccccccee
Q 007167           66 HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVI  145 (615)
Q Consensus        66 ~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l  145 (615)
                      ..+++.|+|++|.+++ ++  .++.+++|++|+|++|++++.  ..+.++++|++|+|++|++++.  ..+..+++|+.|
T Consensus        89 l~~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~L~~n~i~~~--~~l~~l~~L~~L~l~~n~l~~~--~~l~~l~~L~~L  161 (291)
T 1h6t_A           89 LKNLGWLFLDENKVKD-LS--SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTL  161 (291)
T ss_dssp             CTTCCEEECCSSCCCC-GG--GGTTCTTCCEEECTTSCCCCC--GGGGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEE
T ss_pred             CCCCCEEECCCCcCCC-Ch--hhccCCCCCEEECCCCcCCCC--hhhcCCCCCCEEEccCCcCCcc--hhhccCCCCCEE
Confidence            4679999999999984 55  499999999999999999975  4799999999999999999975  679999999999


Q ss_pred             ecCCCcCCccCCCcccCCCCCCeeeccCccccCCCcc--ccccCCcccccCCCCCC
Q 007167          146 DLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPR--SLQRFPSWAFAGNNLSS  199 (615)
Q Consensus       146 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~--~~~~l~~l~~~~n~~~~  199 (615)
                      +|++|++++..|  +..+++|+.|+|++|+|++ +|.  .+.++..+.+++|++..
T Consensus       162 ~L~~N~l~~~~~--l~~l~~L~~L~L~~N~i~~-l~~l~~l~~L~~L~l~~n~i~~  214 (291)
T 1h6t_A          162 SLEDNQISDIVP--LAGLTKLQNLYLSKNHISD-LRALAGLKNLDVLELFSQECLN  214 (291)
T ss_dssp             ECCSSCCCCCGG--GTTCTTCCEEECCSSCCCB-CGGGTTCTTCSEEEEEEEEEEC
T ss_pred             EccCCccccchh--hcCCCccCEEECCCCcCCC-ChhhccCCCCCEEECcCCcccC
Confidence            999999998655  9999999999999999996 443  23455667788998754

>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7

Probab=99.34  E-value=1.4e-12  Score=134.67  Aligned_cols=105  Identities=20%  Similarity=0.226  Sum_probs=93.3

Q ss_pred             cEEEcCCC-CCCCcCCCCccccccCcEEeccc-ccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeecc
Q 007167           95 QNLSLRSN-SLSGLFPSDFSKLENLTSLHLQF-NSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLA  172 (615)
Q Consensus        95 ~~L~L~~N-~l~g~~p~~~~~l~~L~~L~l~~-N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~  172 (615)
                      ..+++++| +|++ +|. |..+++|++|+|++ |+|++..|..|++|++|+.|+|++|+|++..|..|.+|++|+.|+|+
T Consensus        11 ~~v~~~~~n~l~~-ip~-l~~~~~L~~L~l~~~n~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~l~   88 (347)
T 2ifg_A           11 SGLRCTRDGALDS-LHH-LPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLS   88 (347)
T ss_dssp             SCEECCSSCCCTT-TTT-SCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECC
T ss_pred             CEEEcCCCCCCCc-cCC-CCCCCCeeEEEccCCCCCCCcChhHhccccCCCEEECCCCccceeCHHHhcCCcCCCEEeCC
Confidence            35789998 8995 788 99999999999996 99998877899999999999999999999999999999999999999


Q ss_pred             CccccCCCcccccc--CCcccccCCCCCCCC
Q 007167          173 NNSLTGTLPRSLQR--FPSWAFAGNNLSSEN  201 (615)
Q Consensus       173 ~N~l~g~~p~~~~~--l~~l~~~~n~~~~~~  201 (615)
                      +|+|++..+..|..  |..|.+.+|++.|.+
T Consensus        89 ~N~l~~~~~~~~~~~~L~~l~l~~N~~~c~c  119 (347)
T 2ifg_A           89 FNALESLSWKTVQGLSLQELVLSGNPLHCSC  119 (347)
T ss_dssp             SSCCSCCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred             CCccceeCHHHcccCCceEEEeeCCCccCCC
Confidence            99999766665544  678889999998754

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.34  E-value=8.4e-15  Score=138.83  Aligned_cols=85  Identities=28%  Similarity=0.358  Sum_probs=40.4

Q ss_pred             ccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCC
Q 007167           88 IGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLS  167 (615)
Q Consensus        88 ~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~  167 (615)
                      ++.+++|++|+|++|.+++ +| .+.++++|++|+|++|+++ .+|..+..+++|+.|+|++|++++ +| .+.++++|+
T Consensus        44 ~~~l~~L~~L~ls~n~l~~-l~-~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~  118 (198)
T 1ds9_A           44 LSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLR  118 (198)
T ss_dssp             HHHTTTCSEEECSEEEESC-CC-CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSS
T ss_pred             HhcCCCCCEEECCCCCCcc-cc-ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCC
Confidence            4444445555555554443 33 4444455555555555444 344444444445555555554443 23 344444455


Q ss_pred             eeeccCcccc
Q 007167          168 ALNLANNSLT  177 (615)
Q Consensus       168 ~l~l~~N~l~  177 (615)
                      .|+|++|+++
T Consensus       119 ~L~l~~N~i~  128 (198)
T 1ds9_A          119 VLYMSNNKIT  128 (198)
T ss_dssp             EEEESEEECC
T ss_pred             EEECCCCcCC
Confidence            5555555444

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.33  E-value=1.3e-12  Score=135.28  Aligned_cols=142  Identities=16%  Similarity=0.141  Sum_probs=93.4

Q ss_pred             CCcceEecCC---------CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCC-CCccccccCcE-Eecc
Q 007167           56 SWTGVTCSAD---------HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFP-SDFSKLENLTS-LHLQ  124 (615)
Q Consensus        56 ~w~gv~C~~~---------~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p-~~~~~l~~L~~-L~l~  124 (615)
                      +|..|.|+..         ...++.|+|++|+|+ .||++.|.++++|++|+|++|.+.+.+| ..|.+|++|++ ++++
T Consensus        10 ~~~~v~C~~~~Lt~iP~~l~~~l~~L~Ls~N~i~-~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~L~~l~~~l~~~   88 (350)
T 4ay9_X           10 SNRVFLCQESKVTEIPSDLPRNAIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEK   88 (350)
T ss_dssp             ETTEEEEESTTCCSCCTTCCTTCSEEEEESCCCS-EECTTSSTTCTTCCEEEEECCTTCCEECTTSBCSCTTCCEEEEEE
T ss_pred             eCCEEEecCCCCCccCcCcCCCCCEEEccCCcCC-CcCHHHHcCCCCCCEEECcCCCCCCccChhHhhcchhhhhhhccc
Confidence            7888888642         135677777777777 6777677777777777777777766555 35677777654 5566


Q ss_pred             cccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccC-ccccCCCccccccC----CcccccCCCCC
Q 007167          125 FNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLAN-NSLTGTLPRSLQRF----PSWAFAGNNLS  198 (615)
Q Consensus       125 ~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~-N~l~g~~p~~~~~l----~~l~~~~n~~~  198 (615)
                      +|++++..|..|..+++|+.|++++|++++..+..+....++..|++.+ |++....+..|..+    ..+.+++|.+.
T Consensus        89 ~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~~~~l~~l~l~~~~~i~~l~~~~f~~~~~~l~~L~L~~N~i~  167 (350)
T 4ay9_X           89 ANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ  167 (350)
T ss_dssp             ETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCC
T ss_pred             CCcccccCchhhhhccccccccccccccccCCchhhcccchhhhhhhccccccccccccchhhcchhhhhhcccccccc
Confidence            6777766667777777777777777777766555566666666777754 44543333333332    23555666553

>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A*

Probab=99.32  E-value=2.4e-12  Score=141.53  Aligned_cols=103  Identities=26%  Similarity=0.382  Sum_probs=92.6

Q ss_pred             CccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeecc
Q 007167           93 ALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLA  172 (615)
Q Consensus        93 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~  172 (615)
                      .|+.|+|++|+|++ +|. |++|++|+.|+|++|+|+ .+|..|+++++|+.|+|++|+|++ +| .++++++|+.|+|+
T Consensus       442 ~L~~L~Ls~n~l~~-lp~-~~~l~~L~~L~Ls~N~l~-~lp~~~~~l~~L~~L~Ls~N~l~~-lp-~l~~l~~L~~L~Ls  516 (567)
T 1dce_A          442 DVRVLHLAHKDLTV-LCH-LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLC  516 (567)
T ss_dssp             TCSEEECTTSCCSS-CCC-GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECC
T ss_pred             CceEEEecCCCCCC-CcC-ccccccCcEeecCccccc-ccchhhhcCCCCCEEECCCCCCCC-Cc-ccCCCCCCcEEECC
Confidence            47789999999997 576 999999999999999999 799999999999999999999997 77 89999999999999


Q ss_pred             CccccCCC-ccccccCC---cccccCCCCCCC
Q 007167          173 NNSLTGTL-PRSLQRFP---SWAFAGNNLSSE  200 (615)
Q Consensus       173 ~N~l~g~~-p~~~~~l~---~l~~~~n~~~~~  200 (615)
                      +|+|++.+ |..++.++   .|.+++|++...
T Consensus       517 ~N~l~~~~~p~~l~~l~~L~~L~L~~N~l~~~  548 (567)
T 1dce_A          517 NNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQE  548 (567)
T ss_dssp             SSCCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred             CCCCCCCCCcHHHhcCCCCCEEEecCCcCCCC
Confidence            99999887 88776554   567899988654

>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes}

Probab=99.32  E-value=3.2e-12  Score=126.65  Aligned_cols=124  Identities=23%  Similarity=0.302  Sum_probs=104.7

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID  146 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~  146 (615)
                      .+++.|+|++|+++ .++  .++.+++|++|+|++|+|++..|  +.++++|++|+|++|++++ +|....  ++|+.|+
T Consensus        41 ~~L~~L~l~~n~i~-~l~--~l~~l~~L~~L~L~~N~i~~~~~--l~~l~~L~~L~L~~N~l~~-l~~~~~--~~L~~L~  112 (263)
T 1xeu_A           41 SGVQNFNGDNSNIQ-SLA--GMQFFTNLKELHLSHNQISDLSP--LKDLTKLEELSVNRNRLKN-LNGIPS--ACLSRLF  112 (263)
T ss_dssp             TTCSEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCSSCCEEECCSSCCSC-CTTCCC--SSCCEEE
T ss_pred             CcCcEEECcCCCcc-cch--HHhhCCCCCEEECCCCccCCChh--hccCCCCCEEECCCCccCC-cCcccc--CcccEEE
Confidence            57889999999998 777  58999999999999999997655  9999999999999999996 554333  9999999


Q ss_pred             cCCCcCCccCCCcccCCCCCCeeeccCccccCCCc-cccccCCcccccCCCCCCC
Q 007167          147 LSNNFFNASIPASISKLTHLSALNLANNSLTGTLP-RSLQRFPSWAFAGNNLSSE  200 (615)
Q Consensus       147 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p-~~~~~l~~l~~~~n~~~~~  200 (615)
                      |++|++++ +| .+.++++|+.|+|++|+|++..+ ..+.++..|.+++|.+...
T Consensus       113 L~~N~l~~-~~-~l~~l~~L~~L~Ls~N~i~~~~~l~~l~~L~~L~L~~N~i~~~  165 (263)
T 1xeu_A          113 LDNNELRD-TD-SLIHLKNLEILSIRNNKLKSIVMLGFLSKLEVLDLHGNEITNT  165 (263)
T ss_dssp             CCSSCCSB-SG-GGTTCTTCCEEECTTSCCCBCGGGGGCTTCCEEECTTSCCCBC
T ss_pred             ccCCccCC-Ch-hhcCcccccEEECCCCcCCCChHHccCCCCCEEECCCCcCcch
Confidence            99999997 44 69999999999999999997521 1245566778899988665

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.31  E-value=4.1e-12  Score=140.57  Aligned_cols=124  Identities=28%  Similarity=0.420  Sum_probs=87.7

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID  146 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~  146 (615)
                      .+++.|+|++|.|++ +++  +..+++|+.|+|++|.|++. | .|.+|++|+.|+|++|+|++ + ..+..|++|+.|+
T Consensus        65 ~~L~~L~Ls~N~l~~-~~~--l~~l~~L~~L~Ls~N~l~~l-~-~l~~l~~L~~L~Ls~N~l~~-l-~~l~~l~~L~~L~  137 (605)
T 1m9s_A           65 PNVTKLFLNGNKLTD-IKP--LTNLKNLGWLFLDENKIKDL-S-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLY  137 (605)
T ss_dssp             TTCCEEECTTSCCCC-CGG--GGGCTTCCEEECCSSCCCCC-T-TSTTCTTCCEEECTTSCCCC-C-GGGGGCTTCSEEE
T ss_pred             CCCCEEEeeCCCCCC-Chh--hccCCCCCEEECcCCCCCCC-h-hhccCCCCCEEEecCCCCCC-C-ccccCCCccCEEE
Confidence            567788888888874 443  77788888888888887753 3 67778888888888888775 3 3577777788888


Q ss_pred             cCCCcCCccCCCcccCCCCCCeeeccCccccCCCc-cccccCCcccccCCCCCC
Q 007167          147 LSNNFFNASIPASISKLTHLSALNLANNSLTGTLP-RSLQRFPSWAFAGNNLSS  199 (615)
Q Consensus       147 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p-~~~~~l~~l~~~~n~~~~  199 (615)
                      |++|+|++.  ..+..+++|+.|+|++|+|++..| ..+.+|..|.+++|.+..
T Consensus       138 Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~~~~l~~l~~L~~L~Ls~N~i~~  189 (605)
T 1m9s_A          138 LGNNKITDI--TVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHISD  189 (605)
T ss_dssp             CCSSCCCCC--GGGGSCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCB
T ss_pred             CCCCccCCc--hhhcccCCCCEEECcCCcCCCchhhccCCCCCEEECcCCCCCC
Confidence            888877764  567777777888888887776655 113344556677776654

>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4

Probab=99.30  E-value=1.2e-12  Score=121.25  Aligned_cols=106  Identities=20%  Similarity=0.196  Sum_probs=94.4

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCc--ccccccccce
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPL--DFSVWNNLTV  144 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~--~~~~l~~L~~  144 (615)
                      .+++.|+|++|++++ + + .|+.+++|++|+|++|.|++..|..|.++++|++|+|++|+++ .+|.  .+..+++|+.
T Consensus        42 ~~L~~L~Ls~N~l~~-~-~-~l~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~i~-~~~~~~~l~~l~~L~~  117 (176)
T 1a9n_A           42 DQFDAIDFSDNEIRK-L-D-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV-ELGDLDPLASLKSLTY  117 (176)
T ss_dssp             TCCSEEECCSSCCCE-E-C-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEECCSCCCC-CGGGGGGGGGCTTCCE
T ss_pred             CCCCEEECCCCCCCc-c-c-ccccCCCCCEEECCCCcccccCcchhhcCCCCCEEECCCCcCC-cchhhHhhhcCCCCCE
Confidence            379999999999995 4 3 6999999999999999999765555699999999999999997 5776  8999999999


Q ss_pred             eecCCCcCCccCCCc----ccCCCCCCeeeccCcccc
Q 007167          145 IDLSNNFFNASIPAS----ISKLTHLSALNLANNSLT  177 (615)
Q Consensus       145 l~l~~N~l~~~~p~~----~~~l~~L~~l~l~~N~l~  177 (615)
                      |+|++|.++. +|..    +..+++|+.|++++|.+.
T Consensus       118 L~l~~N~i~~-~~~~~~~~~~~l~~L~~Ld~~~n~~~  153 (176)
T 1a9n_A          118 LCILRNPVTN-KKHYRLYVIYKVPQVRVLDFQKVKLK  153 (176)
T ss_dssp             EECCSSGGGG-STTHHHHHHHHCTTCSEETTEECCHH
T ss_pred             EEecCCCCCC-cHhHHHHHHHHCCccceeCCCcCCHH
Confidence            9999999984 6764    899999999999999886

>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A

Probab=99.30  E-value=4.3e-12  Score=140.37  Aligned_cols=125  Identities=22%  Similarity=0.307  Sum_probs=107.8

Q ss_pred             CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCccccccccccee
Q 007167           66 HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVI  145 (615)
Q Consensus        66 ~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l  145 (615)
                      ..+++.|+|++|.|++ ++  .+..+++|+.|+|++|.|++.  +.+.+|++|+.|+|++|+|++.  ..+..|++|+.|
T Consensus        86 l~~L~~L~Ls~N~l~~-l~--~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L~Ls~N~l~~l--~~l~~l~~L~~L  158 (605)
T 1m9s_A           86 LKNLGWLFLDENKIKD-LS--SLKDLKKLKSLSLEHNGISDI--NGLVHLPQLESLYLGNNKITDI--TVLSRLTKLDTL  158 (605)
T ss_dssp             CTTCCEEECCSSCCCC-CT--TSTTCTTCCEEECTTSCCCCC--GGGGGCTTCSEEECCSSCCCCC--GGGGSCTTCSEE
T ss_pred             CCCCCEEECcCCCCCC-Ch--hhccCCCCCEEEecCCCCCCC--ccccCCCccCEEECCCCccCCc--hhhcccCCCCEE
Confidence            4679999999999984 55  599999999999999999974  4699999999999999999975  679999999999


Q ss_pred             ecCCCcCCccCCCcccCCCCCCeeeccCccccCCCcc--ccccCCcccccCCCCCCC
Q 007167          146 DLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPR--SLQRFPSWAFAGNNLSSE  200 (615)
Q Consensus       146 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~--~~~~l~~l~~~~n~~~~~  200 (615)
                      +|++|+|++..|  +..+++|+.|+|++|+|++. |.  .+.+|..|.+.+|++...
T Consensus       159 ~Ls~N~l~~~~~--l~~l~~L~~L~Ls~N~i~~l-~~l~~l~~L~~L~L~~N~l~~~  212 (605)
T 1m9s_A          159 SLEDNQISDIVP--LAGLTKLQNLYLSKNHISDL-RALAGLKNLDVLELFSQECLNK  212 (605)
T ss_dssp             ECCSSCCCCCGG--GTTCTTCCEEECCSSCCCBC-GGGTTCTTCSEEECCSEEEECC
T ss_pred             ECcCCcCCCchh--hccCCCCCEEECcCCCCCCC-hHHccCCCCCEEEccCCcCcCC
Confidence            999999998766  99999999999999999974 42  244566677889987543

>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A}

Probab=99.29  E-value=7.8e-12  Score=136.91  Aligned_cols=114  Identities=27%  Similarity=0.355  Sum_probs=86.5

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID  146 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~  146 (615)
                      .+++.|+|++|+|+ .||    +.+++|++|+|++|+|++ +|. |.+  +|++|+|++|+|++ +|.   .+++|+.|+
T Consensus        80 ~~L~~L~Ls~N~l~-~ip----~~l~~L~~L~Ls~N~l~~-ip~-l~~--~L~~L~Ls~N~l~~-lp~---~l~~L~~L~  146 (571)
T 3cvr_A           80 PQITVLEITQNALI-SLP----ELPASLEYLDACDNRLST-LPE-LPA--SLKHLDVDNNQLTM-LPE---LPALLEYIN  146 (571)
T ss_dssp             TTCSEEECCSSCCS-CCC----CCCTTCCEEECCSSCCSC-CCC-CCT--TCCEEECCSSCCSC-CCC---CCTTCCEEE
T ss_pred             CCCCEEECcCCCCc-ccc----cccCCCCEEEccCCCCCC-cch-hhc--CCCEEECCCCcCCC-CCC---cCccccEEe
Confidence            46888888888888 777    346888888888888887 676 665  88888888888886 666   577888888


Q ss_pred             cCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccccCCcccccCCCCC
Q 007167          147 LSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLS  198 (615)
Q Consensus       147 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~n~~~  198 (615)
                      |++|+|++ +|.   .+++|+.|+|++|+|++ +|....++..|.+++|.+.
T Consensus       147 Ls~N~l~~-lp~---~l~~L~~L~Ls~N~L~~-lp~l~~~L~~L~Ls~N~L~  193 (571)
T 3cvr_A          147 ADNNQLTM-LPE---LPTSLEVLSVRNNQLTF-LPELPESLEALDVSTNLLE  193 (571)
T ss_dssp             CCSSCCSC-CCC---CCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCS
T ss_pred             CCCCccCc-CCC---cCCCcCEEECCCCCCCC-cchhhCCCCEEECcCCCCC
Confidence            88888886 665   46778888888888886 6652245666777777765

>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A

Probab=99.29  E-value=2.9e-14  Score=135.06  Aligned_cols=126  Identities=22%  Similarity=0.288  Sum_probs=107.3

Q ss_pred             CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCccccccccccee
Q 007167           66 HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVI  145 (615)
Q Consensus        66 ~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l  145 (615)
                      ..+++.|+|++|++++ +|  .+..+++|++|+|++|.++ .+|..+..+++|++|+|++|++++ +| .+..+++|+.|
T Consensus        47 l~~L~~L~ls~n~l~~-l~--~~~~l~~L~~L~l~~n~l~-~l~~~~~~~~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L  120 (198)
T 1ds9_A           47 LKACKHLALSTNNIEK-IS--SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVL  120 (198)
T ss_dssp             TTTCSEEECSEEEESC-CC--CHHHHTTCCEEEEEEEEEC-SCSSHHHHHHHCSEEEEEEEECCC-HH-HHHHHHHSSEE
T ss_pred             CCCCCEEECCCCCCcc-cc--ccccCCCCCEEECCCCCcc-cccchhhcCCcCCEEECcCCcCCc-CC-ccccCCCCCEE
Confidence            3579999999999995 77  6999999999999999999 678888889999999999999997 56 68999999999


Q ss_pred             ecCCCcCCccCC-CcccCCCCCCeeeccCccccCCCccc----------cccCCccc-ccCCCC
Q 007167          146 DLSNNFFNASIP-ASISKLTHLSALNLANNSLTGTLPRS----------LQRFPSWA-FAGNNL  197 (615)
Q Consensus       146 ~l~~N~l~~~~p-~~~~~l~~L~~l~l~~N~l~g~~p~~----------~~~l~~l~-~~~n~~  197 (615)
                      +|++|++++..+ ..+..+++|+.|++++|.+++.+|..          +..++.|. +.+|++
T Consensus       121 ~l~~N~i~~~~~~~~l~~l~~L~~L~l~~N~l~~~~~~~~~~~~~~~~~~~~l~~L~~Ld~~~i  184 (198)
T 1ds9_A          121 YMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLDGMPV  184 (198)
T ss_dssp             EESEEECCCHHHHHHHTTTTTCSEEEECSCHHHHHHHTTTTHHHHHHHHHHHCSSCSEECCGGG
T ss_pred             ECCCCcCCchhHHHHHhcCCCCCEEEecCCccccccccccchHHHHHHHHHhCCCcEEECCccc
Confidence            999999996432 47899999999999999999887753          55666554 345554

>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae}

Probab=99.29  E-value=1.6e-12  Score=132.62  Aligned_cols=137  Identities=20%  Similarity=0.293  Sum_probs=112.6

Q ss_pred             cceEecCCCCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCcc-ccccCcEEecccccccCCCCccc
Q 007167           58 TGVTCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFS-KLENLTSLHLQFNSFSGPLPLDF  136 (615)
Q Consensus        58 ~gv~C~~~~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~-~l~~L~~L~l~~N~l~g~~p~~~  136 (615)
                      .++.+.. ...++.|+|++|.+++ +++..++.+++|++|+|++|.+++..|..+. ++++|++|+|++|++++. |. .
T Consensus       112 ~~~~~~~-~~~L~~L~l~~N~l~~-~~~~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~~l~~L~~L~L~~N~l~~~-~~-~  187 (317)
T 3o53_A          112 SRVSCSR-GQGKKNIYLANNKITM-LRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDV-KG-Q  187 (317)
T ss_dssp             SEEEECC-CSSCEEEECCSSCCCS-GGGBCTGGGSSEEEEECTTSCCCEEEGGGGGGGTTTCCEEECTTSCCCEE-EC-C
T ss_pred             CCcCccc-cCCCCEEECCCCCCCC-ccchhhhccCCCCEEECCCCCCCcccHHHHhhccCcCCEEECCCCcCccc-cc-c
Confidence            3444433 4579999999999995 5555799999999999999999998887774 799999999999999965 43 3


Q ss_pred             ccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccc---cCCcccccCCCCCCC
Q 007167          137 SVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQ---RFPSWAFAGNNLSSE  200 (615)
Q Consensus       137 ~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l~~~~n~~~~~  200 (615)
                      ..+++|+.|+|++|++++ +|..+..+++|+.|+|++|+|+ .+|..+.   ++..+.+++|++.|.
T Consensus       188 ~~l~~L~~L~Ls~N~l~~-l~~~~~~l~~L~~L~L~~N~l~-~l~~~~~~l~~L~~L~l~~N~~~~~  252 (317)
T 3o53_A          188 VVFAKLKTLDLSSNKLAF-MGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCG  252 (317)
T ss_dssp             CCCTTCCEEECCSSCCCE-ECGGGGGGTTCSEEECTTSCCC-EECTTCCCCTTCCEEECTTCCCBHH
T ss_pred             cccccCCEEECCCCcCCc-chhhhcccCcccEEECcCCccc-chhhHhhcCCCCCEEEccCCCccCc
Confidence            458999999999999997 5556999999999999999999 5776665   455677899999753

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.27  E-value=1.8e-11  Score=131.29  Aligned_cols=116  Identities=23%  Similarity=0.265  Sum_probs=60.5

Q ss_pred             cEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeec
Q 007167           68 RVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL  147 (615)
Q Consensus        68 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l  147 (615)
                      +++.|+|++|++++ +|  .++.+++|++|+|++|+|++. |  ++++++|++|+|++|+|++ +|  ++++++|+.|+|
T Consensus        43 ~L~~L~Ls~n~l~~-~~--~l~~l~~L~~L~Ls~n~l~~~-~--~~~l~~L~~L~Ls~N~l~~-~~--~~~l~~L~~L~L  113 (457)
T 3bz5_A           43 TLTSLDCHNSSITD-MT--GIEKLTGLTKLICTSNNITTL-D--LSQNTNLTYLACDSNKLTN-LD--VTPLTKLTYLNC  113 (457)
T ss_dssp             TCCEEECCSSCCCC-CT--TGGGCTTCSEEECCSSCCSCC-C--CTTCTTCSEEECCSSCCSC-CC--CTTCTTCCEEEC
T ss_pred             CCCEEEccCCCccc-Ch--hhcccCCCCEEEccCCcCCeE-c--cccCCCCCEEECcCCCCce-ee--cCCCCcCCEEEC
Confidence            45555555555553 33  355555555555555555543 2  5555555555555555554 22  555555555555


Q ss_pred             CCCcCCccCCCcccCCCCCCeeeccCccccCCCccccccCCcccccCC
Q 007167          148 SNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGN  195 (615)
Q Consensus       148 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~n  195 (615)
                      ++|++++ +|  ++++++|+.|++++|+|++.--..+.++..+.+++|
T Consensus       114 ~~N~l~~-l~--~~~l~~L~~L~l~~N~l~~l~l~~l~~L~~L~l~~n  158 (457)
T 3bz5_A          114 DTNKLTK-LD--VSQNPLLTYLNCARNTLTEIDVSHNTQLTELDCHLN  158 (457)
T ss_dssp             CSSCCSC-CC--CTTCTTCCEEECTTSCCSCCCCTTCTTCCEEECTTC
T ss_pred             CCCcCCe-ec--CCCCCcCCEEECCCCccceeccccCCcCCEEECCCC
Confidence            5555554 33  555555555555555555431122333334444444

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.27  E-value=7.5e-13  Score=141.90  Aligned_cols=127  Identities=20%  Similarity=0.197  Sum_probs=60.7

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccc------------------------------
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLE------------------------------  116 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~------------------------------  116 (615)
                      .+++.|++++|++ |.||+ .++++++|++|+|++|.++|.+|..++++.                              
T Consensus        11 ~~L~~L~l~~n~l-~~iP~-~i~~L~~L~~L~l~~n~~~~~~p~~~~~l~~L~~l~l~~c~~~~l~~L~l~~~~l~~lp~   88 (454)
T 1jl5_A           11 TFLQEPLRHSSNL-TEMPV-EAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGLSSLPE   88 (454)
T ss_dssp             -------------------------CCHHHHHHHHHHHHHTSCTTSCCCHHHHHHHHHHHHHHTCSEEECTTSCCSCCCS
T ss_pred             ccchhhhcccCch-hhCCh-hHhcccchhhhhccCCcccccCCcccccchhcchhhhhhhhccCCCEEEecCCccccCCC
Confidence            3455566666666 46665 456666666666665555555555555443                              


Q ss_pred             ---cCcEEecccccccCCCCccccc----------------c-cccceeecCCCcCCccCCCcccCCCCCCeeeccCccc
Q 007167          117 ---NLTSLHLQFNSFSGPLPLDFSV----------------W-NNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSL  176 (615)
Q Consensus       117 ---~L~~L~l~~N~l~g~~p~~~~~----------------l-~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l  176 (615)
                         +|++|+|++|++++ +|..+.+                + ++|++|+|++|++++ +| .++++++|++|++++|++
T Consensus        89 ~~~~L~~L~l~~n~l~~-lp~~~~~L~~L~l~~n~l~~l~~~~~~L~~L~L~~n~l~~-lp-~~~~l~~L~~L~l~~N~l  165 (454)
T 1jl5_A           89 LPPHLESLVASCNSLTE-LPELPQSLKSLLVDNNNLKALSDLPPLLEYLGVSNNQLEK-LP-ELQNSSFLKIIDVDNNSL  165 (454)
T ss_dssp             CCTTCSEEECCSSCCSS-CCCCCTTCCEEECCSSCCSCCCSCCTTCCEEECCSSCCSS-CC-CCTTCTTCCEEECCSSCC
T ss_pred             CcCCCCEEEccCCcCCc-cccccCCCcEEECCCCccCcccCCCCCCCEEECcCCCCCC-Cc-ccCCCCCCCEEECCCCcC
Confidence               45555555555554 4432211                1 356666666666665 55 466667777777777777


Q ss_pred             cCCCccccccCCcccccCCCCCC
Q 007167          177 TGTLPRSLQRFPSWAFAGNNLSS  199 (615)
Q Consensus       177 ~g~~p~~~~~l~~l~~~~n~~~~  199 (615)
                      ++ +|..+.++..+.+++|.+..
T Consensus       166 ~~-lp~~~~~L~~L~L~~n~l~~  187 (454)
T 1jl5_A          166 KK-LPDLPPSLEFIAAGNNQLEE  187 (454)
T ss_dssp             SC-CCCCCTTCCEEECCSSCCSS
T ss_pred             cc-cCCCcccccEEECcCCcCCc
Confidence            64 56666666666666666543

>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A

Probab=99.26  E-value=1.9e-11  Score=130.98  Aligned_cols=117  Identities=25%  Similarity=0.279  Sum_probs=66.3

Q ss_pred             cEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeec
Q 007167           68 RVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL  147 (615)
Q Consensus        68 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l  147 (615)
                      +++.|+|++|++++ +|  .|+++++|++|+|++|++++ +|..+   .+|++|+|++|++++ +| .++++++|+.|++
T Consensus       132 ~L~~L~L~~n~l~~-lp--~~~~l~~L~~L~l~~N~l~~-lp~~~---~~L~~L~L~~n~l~~-l~-~~~~l~~L~~L~l  202 (454)
T 1jl5_A          132 LLEYLGVSNNQLEK-LP--ELQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLEE-LP-ELQNLPFLTAIYA  202 (454)
T ss_dssp             TCCEEECCSSCCSS-CC--CCTTCTTCCEEECCSSCCSC-CCCCC---TTCCEEECCSSCCSS-CC-CCTTCTTCCEEEC
T ss_pred             CCCEEECcCCCCCC-Cc--ccCCCCCCCEEECCCCcCcc-cCCCc---ccccEEECcCCcCCc-Cc-cccCCCCCCEEEC
Confidence            45566666666663 55  26666666666666666664 34332   356666666666664 44 4666666666666


Q ss_pred             CCCcCCccCCCcccCCCCCCeeeccCccccCCCccccc---cCCcccccCCCCCC
Q 007167          148 SNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQ---RFPSWAFAGNNLSS  199 (615)
Q Consensus       148 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l~~~~n~~~~  199 (615)
                      ++|++++ +|...   ++|+.|++++|+++ .+|. +.   ++..+.+++|.+..
T Consensus       203 ~~N~l~~-l~~~~---~~L~~L~l~~n~l~-~lp~-~~~l~~L~~L~l~~N~l~~  251 (454)
T 1jl5_A          203 DNNSLKK-LPDLP---LSLESIVAGNNILE-ELPE-LQNLPFLTTIYADNNLLKT  251 (454)
T ss_dssp             CSSCCSS-CCCCC---TTCCEEECCSSCCS-SCCC-CTTCTTCCEEECCSSCCSS
T ss_pred             CCCcCCc-CCCCc---CcccEEECcCCcCC-cccc-cCCCCCCCEEECCCCcCCc
Confidence            6666664 33322   35555666666655 4553 33   34455667776653

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.26  E-value=7.9e-12  Score=134.56  Aligned_cols=124  Identities=27%  Similarity=0.365  Sum_probs=74.9

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID  146 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~  146 (615)
                      .+++.|+|++|.+++. ++  +..+++|++|+|++|.+++..|  +..+++|++|+|++|++++..|  +..+++|+.|+
T Consensus       243 ~~L~~L~l~~n~l~~~-~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~--~~~l~~L~~L~  315 (466)
T 1o6v_A          243 TNLTDLDLANNQISNL-AP--LSGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLEDISP--ISNLKNLTYLT  315 (466)
T ss_dssp             TTCSEEECCSSCCCCC-GG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCSCCGG--GGGCTTCSEEE
T ss_pred             CCCCEEECCCCccccc-hh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeEEcCCCcccCchh--hcCCCCCCEEE
Confidence            4567777777777643 32  6667777777777777765433  6666777777777777665433  56666666666


Q ss_pred             cCCCcCCccCCCcccCCCCCCeeeccCccccCCCc-cccccCCcccccCCCCCC
Q 007167          147 LSNNFFNASIPASISKLTHLSALNLANNSLTGTLP-RSLQRFPSWAFAGNNLSS  199 (615)
Q Consensus       147 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p-~~~~~l~~l~~~~n~~~~  199 (615)
                      |++|++++..|  +..+++|+.|++++|++++... ..+.++..+.+++|++..
T Consensus       316 L~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n~l~~  367 (466)
T 1o6v_A          316 LYFNNISDISP--VSSLTKLQRLFFYNNKVSDVSSLANLTNINWLSAGHNQISD  367 (466)
T ss_dssp             CCSSCCSCCGG--GGGCTTCCEEECCSSCCCCCGGGTTCTTCCEEECCSSCCCB
T ss_pred             CcCCcCCCchh--hccCccCCEeECCCCccCCchhhccCCCCCEEeCCCCccCc
Confidence            66666666544  5566666666666666665411 112333444556665543

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.25  E-value=3.9e-12  Score=141.00  Aligned_cols=136  Identities=21%  Similarity=0.309  Sum_probs=94.6

Q ss_pred             CCCCCCCCCCCCcceEec------CCCCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCc
Q 007167           46 NWNESSSLCKSWTGVTCS------ADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLT  119 (615)
Q Consensus        46 ~w~~~~~~c~~w~gv~C~------~~~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~  119 (615)
                      .|....++| .|+|..|.      .....++.|++++|+|+ .||. .+.  ++|++|+|++|+|+ .+|.   .+++|+
T Consensus        14 ~W~~~~~~~-~~~~r~~~~~~~~~c~~~~l~~L~ls~n~L~-~lp~-~l~--~~L~~L~L~~N~l~-~lp~---~l~~L~   84 (622)
T 3g06_A           14 AWRRAAPAE-ESRGRAAVVQKMRACLNNGNAVLNVGESGLT-TLPD-CLP--AHITTLVIPDNNLT-SLPA---LPPELR   84 (622)
T ss_dssp             HHHHTCCGG-GHHHHHHHHHHHHHHHHHCCCEEECCSSCCS-CCCS-CCC--TTCSEEEECSCCCS-CCCC---CCTTCC
T ss_pred             HHHhcCCcc-hhccccccCcccccccCCCCcEEEecCCCcC-ccCh-hhC--CCCcEEEecCCCCC-CCCC---cCCCCC
Confidence            465555555 78664321      11235788888888888 8877 343  78888888888888 4565   567888


Q ss_pred             EEecccccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccccCCcccccCCCCCC
Q 007167          120 SLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLSS  199 (615)
Q Consensus       120 ~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~n~~~~  199 (615)
                      +|+|++|+|++ +|.   .+++|+.|+|++|+|++ +|.   .+++|+.|+|++|+|++ +|..+.++..|.+++|.+..
T Consensus        85 ~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~~-l~~---~l~~L~~L~L~~N~l~~-lp~~l~~L~~L~Ls~N~l~~  155 (622)
T 3g06_A           85 TLEVSGNQLTS-LPV---LPPGLLELSIFSNPLTH-LPA---LPSGLCKLWIFGNQLTS-LPVLPPGLQELSVSDNQLAS  155 (622)
T ss_dssp             EEEECSCCCSC-CCC---CCTTCCEEEECSCCCCC-CCC---CCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSSCCSC
T ss_pred             EEEcCCCcCCc-CCC---CCCCCCEEECcCCcCCC-CCC---CCCCcCEEECCCCCCCc-CCCCCCCCCEEECcCCcCCC
Confidence            88888888884 665   56778888888888875 444   45677777777777774 66666677777777776643

>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes}

Probab=99.24  E-value=2.3e-11  Score=130.43  Aligned_cols=121  Identities=20%  Similarity=0.240  Sum_probs=88.6

Q ss_pred             CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCccccccccccee
Q 007167           66 HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVI  145 (615)
Q Consensus        66 ~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l  145 (615)
                      ..+++.|+|++|++++ ++   ++.+++|++|+|++|...+.+  .+..+++|++|+|++|++++ +|  ++.+++|+.|
T Consensus       126 l~~L~~L~l~~N~l~~-l~---l~~l~~L~~L~l~~n~~~~~~--~~~~l~~L~~L~ls~n~l~~-l~--l~~l~~L~~L  196 (457)
T 3bz5_A          126 NPLLTYLNCARNTLTE-ID---VSHNTQLTELDCHLNKKITKL--DVTPQTQLTTLDCSFNKITE-LD--VSQNKLLNRL  196 (457)
T ss_dssp             CTTCCEEECTTSCCSC-CC---CTTCTTCCEEECTTCSCCCCC--CCTTCTTCCEEECCSSCCCC-CC--CTTCTTCCEE
T ss_pred             CCcCCEEECCCCccce-ec---cccCCcCCEEECCCCCccccc--ccccCCcCCEEECCCCccce-ec--cccCCCCCEE
Confidence            3578889999998885 43   677888888888888666665  47778888888888888886 55  7777788888


Q ss_pred             ecCCCcCCccCCCcccCCCCCCeeeccCccccCCCc-cccccCCcccccCCCCCC
Q 007167          146 DLSNNFFNASIPASISKLTHLSALNLANNSLTGTLP-RSLQRFPSWAFAGNNLSS  199 (615)
Q Consensus       146 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p-~~~~~l~~l~~~~n~~~~  199 (615)
                      ++++|++++.   .+.++++|+.|+|++|+|++ +| ..+.++..+.+++|++..
T Consensus       197 ~l~~N~l~~~---~l~~l~~L~~L~Ls~N~l~~-ip~~~l~~L~~L~l~~N~l~~  247 (457)
T 3bz5_A          197 NCDTNNITKL---DLNQNIQLTFLDCSSNKLTE-IDVTPLTQLTYFDCSVNPLTE  247 (457)
T ss_dssp             ECCSSCCSCC---CCTTCTTCSEEECCSSCCSC-CCCTTCTTCSEEECCSSCCSC
T ss_pred             ECcCCcCCee---ccccCCCCCEEECcCCcccc-cCccccCCCCEEEeeCCcCCC
Confidence            8888888764   37777788888888888876 44 234455566677777654

>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A

Probab=99.22  E-value=2.4e-11  Score=130.82  Aligned_cols=126  Identities=33%  Similarity=0.448  Sum_probs=106.3

Q ss_pred             CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCccccccccccee
Q 007167           66 HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVI  145 (615)
Q Consensus        66 ~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l  145 (615)
                      ..+++.|+|++|++++ ++  .+..+++|++|+|++|.+++..|  +.++++|++|+|++|++++..|  +..+++|+.|
T Consensus       220 l~~L~~L~l~~n~l~~-~~--~l~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~l~~L~~L  292 (466)
T 1o6v_A          220 LTNLDELSLNGNQLKD-IG--TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNL  292 (466)
T ss_dssp             CTTCCEEECCSSCCCC-CG--GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGG--GTTCTTCSEE
T ss_pred             cCCCCEEECCCCCccc-ch--hhhcCCCCCEEECCCCccccchh--hhcCCCCCEEECCCCccCcccc--ccCCCccCeE
Confidence            3578999999999984 53  58899999999999999998765  8999999999999999997544  8899999999


Q ss_pred             ecCCCcCCccCCCcccCCCCCCeeeccCccccCCCc-cccccCCcccccCCCCCCC
Q 007167          146 DLSNNFFNASIPASISKLTHLSALNLANNSLTGTLP-RSLQRFPSWAFAGNNLSSE  200 (615)
Q Consensus       146 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p-~~~~~l~~l~~~~n~~~~~  200 (615)
                      +|++|++++..|  +.++++|+.|+|++|++++..| ..+.++..+.+++|.+...
T Consensus       293 ~L~~n~l~~~~~--~~~l~~L~~L~L~~n~l~~~~~~~~l~~L~~L~l~~n~l~~~  346 (466)
T 1o6v_A          293 ELNENQLEDISP--ISNLKNLTYLTLYFNNISDISPVSSLTKLQRLFFYNNKVSDV  346 (466)
T ss_dssp             ECCSSCCSCCGG--GGGCTTCSEEECCSSCCSCCGGGGGCTTCCEEECCSSCCCCC
T ss_pred             EcCCCcccCchh--hcCCCCCCEEECcCCcCCCchhhccCccCCEeECCCCccCCc
Confidence            999999998554  8899999999999999998776 2345667778899987654

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.21  E-value=8.8e-13  Score=138.40  Aligned_cols=87  Identities=22%  Similarity=0.364  Sum_probs=43.0

Q ss_pred             CCccEEEcCCCCCC-CcCC---CCccccccCcEEeccccccc--C---CCCcccccccccceeecCCCcCC----ccCCC
Q 007167           92 SALQNLSLRSNSLS-GLFP---SDFSKLENLTSLHLQFNSFS--G---PLPLDFSVWNNLTVIDLSNNFFN----ASIPA  158 (615)
Q Consensus        92 ~~L~~L~L~~N~l~-g~~p---~~~~~l~~L~~L~l~~N~l~--g---~~p~~~~~l~~L~~l~l~~N~l~----~~~p~  158 (615)
                      ++|++|+|++|+++ +.+|   ..|.++++|++|+|++|+++  |   .+|..+..+++|+.|+|++|.|+    +.+|.
T Consensus       159 ~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~  238 (386)
T 2ca6_A          159 PPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAI  238 (386)
T ss_dssp             CCCCEEECCSSCCTGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHH
T ss_pred             CCCcEEECCCCCCCcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHH
Confidence            45555555555554 2233   23444555555555555554  2   23334445555555555555553    34444


Q ss_pred             cccCCCCCCeeeccCccccC
Q 007167          159 SISKLTHLSALNLANNSLTG  178 (615)
Q Consensus       159 ~~~~l~~L~~l~l~~N~l~g  178 (615)
                      .+..+++|+.|+|++|.+++
T Consensus       239 ~l~~~~~L~~L~L~~n~i~~  258 (386)
T 2ca6_A          239 ALKSWPNLRELGLNDCLLSA  258 (386)
T ss_dssp             HGGGCTTCCEEECTTCCCCH
T ss_pred             HHccCCCcCEEECCCCCCch
Confidence            55555555555555555543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.20  E-value=4.7e-11  Score=118.06  Aligned_cols=134  Identities=14%  Similarity=0.063  Sum_probs=104.3

Q ss_pred             hcCcCCccEEEEEEECCCCEEEEEEecccc-CCHHHHHHHHHHHhCCC-CCcccceeEEEEecCeeeEEeecCCCCChhh
Q 007167          307 VLGKGTFGTAYKAALEDASTVVVKRLKEVN-VGKREFEQQMEIVGGIR-HENVVALRAYYYSKDEKLMVYDYFEPGSVSA  384 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  384 (615)
                      .++.|+.+.||++... +..+++|+..... .....+.+|+++++.+. +..+.++++++...+..++||||++|.+|.+
T Consensus        21 ~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~   99 (263)
T 3tm0_A           21 DTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSE   99 (263)
T ss_dssp             CCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHH
T ss_pred             eccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhh
Confidence            4677788999998754 6889999987532 23456889999998884 6778889999998889999999999999887


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccC--------------------------------------------
Q 007167          385 MLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN--------------------------------------------  420 (615)
Q Consensus       385 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--------------------------------------------  420 (615)
                      .+..          ......++.++++++..||+..                                            
T Consensus       100 ~~~~----------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (263)
T 3tm0_A          100 EYED----------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRE  169 (263)
T ss_dssp             HCCT----------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHH
T ss_pred             ccCC----------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHH
Confidence            6421          1123467889999999999810                                            


Q ss_pred             ------------CCCceecCCCCCCEEeCCCCcEEEeeccccc
Q 007167          421 ------------GGKLVHGGIKASNIFLNSQGHVCVSDIGLAA  451 (615)
Q Consensus       421 ------------~~~iiHrDik~~Nill~~~~~~kl~DfG~a~  451 (615)
                                  .+.++|+|+++.||+++++..+.|+||+.+.
T Consensus       170 l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          170 LYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                        1348999999999999876666799999764

>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B}

Probab=99.17  E-value=3.9e-11  Score=123.74  Aligned_cols=121  Identities=21%  Similarity=0.376  Sum_probs=65.5

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID  146 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~  146 (615)
                      ..++.|++++|.++ .+++  +..+++|+.|++++|.+++..+  +..+++|++|+|++|++++. |. +..+++|+.|+
T Consensus       177 ~~L~~L~l~~n~l~-~~~~--~~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~n~l~~~-~~-~~~l~~L~~L~  249 (347)
T 4fmz_A          177 TDLYSLSLNYNQIE-DISP--LASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDL-SP-LANLSQLTWLE  249 (347)
T ss_dssp             TTCSEEECTTSCCC-CCGG--GGGCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC-GG-GTTCTTCCEEE
T ss_pred             CCCCEEEccCCccc-cccc--ccCCCccceeecccCCCCCCch--hhcCCcCCEEEccCCccCCC-cc-hhcCCCCCEEE
Confidence            34556666666555 3332  5556666666666666654433  55566666666666666543 22 55566666666


Q ss_pred             cCCCcCCccCCCcccCCCCCCeeeccCccccCCCc--cccccCCcccccCCCC
Q 007167          147 LSNNFFNASIPASISKLTHLSALNLANNSLTGTLP--RSLQRFPSWAFAGNNL  197 (615)
Q Consensus       147 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p--~~~~~l~~l~~~~n~~  197 (615)
                      |++|.+++.  ..+..+++|+.|++++|++++. |  ..+.++..+.+++|.+
T Consensus       250 l~~n~l~~~--~~~~~l~~L~~L~l~~n~l~~~-~~~~~l~~L~~L~L~~n~l  299 (347)
T 4fmz_A          250 IGTNQISDI--NAVKDLTKLKMLNVGSNQISDI-SVLNNLSQLNSLFLNNNQL  299 (347)
T ss_dssp             CCSSCCCCC--GGGTTCTTCCEEECCSSCCCCC-GGGGGCTTCSEEECCSSCC
T ss_pred             CCCCccCCC--hhHhcCCCcCEEEccCCccCCC-hhhcCCCCCCEEECcCCcC
Confidence            666666542  2455556666666666666543 2  1123344455555554

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.15  E-value=5.1e-12  Score=131.35  Aligned_cols=131  Identities=26%  Similarity=0.279  Sum_probs=89.1

Q ss_pred             CcEEEEEeCCCCcccccCC----CcccCCC-CccEEEcCCCCCCCcCCCCcccc-----ccCcEEecccccccCCCCccc
Q 007167           67 SRVVALRLPGMALRGEIPP----NTIGRLS-ALQNLSLRSNSLSGLFPSDFSKL-----ENLTSLHLQFNSFSGPLPLDF  136 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~----~~~~~l~-~L~~L~L~~N~l~g~~p~~~~~l-----~~L~~L~l~~N~l~g~~p~~~  136 (615)
                      ..++.|+|++|.++ .++.    ..|..++ +|++|+|++|.+++..+..|..+     ++|++|+|++|++++..+..+
T Consensus        22 ~~L~~L~Ls~n~l~-~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~~~~~~~l  100 (362)
T 3goz_A           22 HGVTSLDLSLNNLY-SISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVTSLNLSGNFLSYKSSDEL  100 (362)
T ss_dssp             TTCCEEECTTSCGG-GSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHH
T ss_pred             CCceEEEccCCCCC-hHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCCCccEEECcCCcCChHHHHHH
Confidence            34778888888877 4443    3566777 78888888888887767667665     778888888888876666544


Q ss_pred             ccc-----cccceeecCCCcCCccCCCccc----C-CCCCCeeeccCccccCCCcccc--------ccCCcccccCCCCC
Q 007167          137 SVW-----NNLTVIDLSNNFFNASIPASIS----K-LTHLSALNLANNSLTGTLPRSL--------QRFPSWAFAGNNLS  198 (615)
Q Consensus       137 ~~l-----~~L~~l~l~~N~l~~~~p~~~~----~-l~~L~~l~l~~N~l~g~~p~~~--------~~l~~l~~~~n~~~  198 (615)
                      ...     ++|+.|+|++|+|++..+..+.    . .++|+.|+|++|.+++..+..+        .++..|.+++|.+.
T Consensus       101 ~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~n~l~  180 (362)
T 3goz_A          101 VKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLA  180 (362)
T ss_dssp             HHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGGGSCHHHHHHHHHTSCTTCCEEECTTSCGG
T ss_pred             HHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCCHHHHHHHHHHHhcCCccccEeeecCCCCc
Confidence            443     7788888888888765554433    2 2578888888888875433222        25666777777664

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.14  E-value=3e-12  Score=131.43  Aligned_cols=107  Identities=21%  Similarity=0.236  Sum_probs=48.6

Q ss_pred             EEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCc-CCCCccccccCcEEecccccccCCCCcccccccccceeec
Q 007167           69 VVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGL-FPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL  147 (615)
Q Consensus        69 v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~-~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l  147 (615)
                      ++.+++++|.+++.++.  +..+++|++|+|++|.+++. +|..+.++++|++|+|++|.+++.+|..++.+++|+.|+|
T Consensus        72 l~~L~l~~n~l~~~~~~--~~~~~~L~~L~L~~~~l~~~~~~~~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L  149 (336)
T 2ast_B           72 VIAFRCPRSFMDQPLAE--HFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNL  149 (336)
T ss_dssp             CSEEECTTCEECSCCCS--CCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEEC
T ss_pred             ceEEEcCCccccccchh--hccCCCCCEEEccCCCcCHHHHHHHHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEEC
Confidence            44444444444433322  33444444444444444433 4444444444444444444444444444444444444444


Q ss_pred             CCC-cCCcc-CCCcccCCCCCCeeeccCc-ccc
Q 007167          148 SNN-FFNAS-IPASISKLTHLSALNLANN-SLT  177 (615)
Q Consensus       148 ~~N-~l~~~-~p~~~~~l~~L~~l~l~~N-~l~  177 (615)
                      ++| .+++. +|..+.++++|+.|+|++| .++
T Consensus       150 ~~~~~l~~~~l~~~~~~~~~L~~L~l~~~~~l~  182 (336)
T 2ast_B          150 SGCSGFSEFALQTLLSSCSRLDELNLSWCFDFT  182 (336)
T ss_dssp             TTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCC
T ss_pred             CCCCCCCHHHHHHHHhcCCCCCEEcCCCCCCcC
Confidence            444 34431 3333444444444444444 444

>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp}

Probab=99.14  E-value=6.1e-12  Score=130.82  Aligned_cols=127  Identities=20%  Similarity=0.256  Sum_probs=107.7

Q ss_pred             EEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCC----CCccccc-cCcEEecccccccCCCCcccccc-----c
Q 007167           71 ALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFP----SDFSKLE-NLTSLHLQFNSFSGPLPLDFSVW-----N  140 (615)
Q Consensus        71 ~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p----~~~~~l~-~L~~L~l~~N~l~g~~p~~~~~l-----~  140 (615)
                      ..+|+.|+++|.+|. .+...++|++|||++|.+++..+    ..|.+++ +|++|+|++|++++..+..+..+     +
T Consensus         2 ~~~ls~n~~~~~~~~-~~~~~~~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~   80 (362)
T 3goz_A            2 NYKLTLHPGSNPVEE-FTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPA   80 (362)
T ss_dssp             EEECCCCTTCCHHHH-HHTSCTTCCEEECTTSCGGGSCHHHHHHHHHTCCTTCCEEECCSSCGGGSCHHHHHHHHHTSCT
T ss_pred             ccccccccchHHHHH-HHhCCCCceEEEccCCCCChHHHHHHHHHHHhCCCceeEEECcCCCCCHHHHHHHHHHHhccCC
Confidence            467899999998886 66777779999999999998776    7788898 99999999999998888888876     9


Q ss_pred             ccceeecCCCcCCccCCCcccC----C-CCCCeeeccCccccCCCcccc--------ccCCcccccCCCCC
Q 007167          141 NLTVIDLSNNFFNASIPASISK----L-THLSALNLANNSLTGTLPRSL--------QRFPSWAFAGNNLS  198 (615)
Q Consensus       141 ~L~~l~l~~N~l~~~~p~~~~~----l-~~L~~l~l~~N~l~g~~p~~~--------~~l~~l~~~~n~~~  198 (615)
                      +|+.|+|++|++++..+..+..    + ++|+.|+|++|+|++..+..+        .++..|.+++|.+.
T Consensus        81 ~L~~L~Ls~n~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~~~~~~~l~~~l~~~~~~L~~L~Ls~N~l~  151 (362)
T 3goz_A           81 NVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSLNLRGNDLG  151 (362)
T ss_dssp             TCCEEECCSSCGGGSCHHHHHHHHHTSCTTCCEEECCSSCGGGSCHHHHHHHHTTSCTTCCEEECTTSCGG
T ss_pred             CccEEECcCCcCChHHHHHHHHHHHhCCCCccEEECcCCcCCcHHHHHHHHHHHhCCCceeEEEccCCcCC
Confidence            9999999999999877765444    4 899999999999997766543        36778889998875

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.13  E-value=8.4e-11  Score=115.81  Aligned_cols=130  Identities=11%  Similarity=0.075  Sum_probs=97.0

Q ss_pred             cC-cCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCc--ccceeEEEEecCeeeEEeecCCCCChhh
Q 007167          308 LG-KGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHEN--VVALRAYYYSKDEKLMVYDYFEPGSVSA  384 (615)
Q Consensus       308 lG-~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~n--iv~l~~~~~~~~~~~lV~e~~~~gsL~~  384 (615)
                      ++ .|..+.||++...+|..+++|.....  ....+.+|+++++.+.+.+  +.+++++....+..++||||++|.++. 
T Consensus        27 ~~~gg~~~~v~~~~~~~g~~~vlK~~~~~--~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~-  103 (264)
T 1nd4_A           27 QTIGCSDAAVFRLSAQGRPVLFVKTDLSG--ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL-  103 (264)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSC--TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT-
T ss_pred             cccCCCCceEEEEecCCCCeEEEEeCCcc--cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC-
Confidence            44 45569999998777888999987643  2356788999888885444  456888888777889999999998874 


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccC--------------------------------------------
Q 007167          385 MLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN--------------------------------------------  420 (615)
Q Consensus       385 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--------------------------------------------  420 (615)
                       ...        .+   ...++.++++.+..||+..                                            
T Consensus       104 -~~~--------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (264)
T 1nd4_A          104 -SSH--------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF  171 (264)
T ss_dssp             -TSC--------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred             -cCc--------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHH
Confidence             211        11   2256677777888888642                                            


Q ss_pred             -----------CCCceecCCCCCCEEeCCCCcEEEeecccccc
Q 007167          421 -----------GGKLVHGGIKASNIFLNSQGHVCVSDIGLAAL  452 (615)
Q Consensus       421 -----------~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~  452 (615)
                                 ...++|+|++|.||+++++..+.|+|||.+..
T Consensus       172 ~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          172 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                       12399999999999998876677999998753

>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A

Probab=99.09  E-value=4.8e-12  Score=132.76  Aligned_cols=133  Identities=19%  Similarity=0.266  Sum_probs=104.2

Q ss_pred             CCcEEEEEeCCCCccc----ccCCCcccCCCCccEEEcCCCCCCCcCCCCc----ccc---------ccCcEEecccccc
Q 007167           66 HSRVVALRLPGMALRG----EIPPNTIGRLSALQNLSLRSNSLSGLFPSDF----SKL---------ENLTSLHLQFNSF  128 (615)
Q Consensus        66 ~~~v~~l~l~~~~l~g----~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~----~~l---------~~L~~L~l~~N~l  128 (615)
                      ..+++.|+|++|.+++    .++. .+..+++|++|+|++|.+++..+..+    ..+         ++|++|+|++|++
T Consensus        93 ~~~L~~L~Ls~n~l~~~~~~~l~~-~l~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~l~~~~~~~~~~~L~~L~L~~n~l  171 (386)
T 2ca6_A           93 CPKLHTVRLSDNAFGPTAQEPLID-FLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRL  171 (386)
T ss_dssp             CTTCCEEECCSCCCCTTTHHHHHH-HHHHCTTCCEEECCSSCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCEEECCSSCC
T ss_pred             CCcccEEECCCCcCCHHHHHHHHH-HHHhCCCCCEEECcCCCCCHHHHHHHHHHHHHHhhhhhcccCCCCcEEECCCCCC
Confidence            3678999999999986    4665 68889999999999999975544444    344         8999999999999


Q ss_pred             c-CCCC---cccccccccceeecCCCcCC--c---cCCCcccCCCCCCeeeccCcccc----CCCccccc---cCCcccc
Q 007167          129 S-GPLP---LDFSVWNNLTVIDLSNNFFN--A---SIPASISKLTHLSALNLANNSLT----GTLPRSLQ---RFPSWAF  192 (615)
Q Consensus       129 ~-g~~p---~~~~~l~~L~~l~l~~N~l~--~---~~p~~~~~l~~L~~l~l~~N~l~----g~~p~~~~---~l~~l~~  192 (615)
                      + +.+|   ..+..+++|+.|+|++|+|+  |   .+|..+.++++|+.|+|++|.++    +.+|..+.   ++..|.+
T Consensus       172 ~~~~~~~l~~~l~~~~~L~~L~L~~n~l~~~g~~~l~~~~l~~~~~L~~L~Ls~n~l~~~g~~~l~~~l~~~~~L~~L~L  251 (386)
T 2ca6_A          172 ENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGL  251 (386)
T ss_dssp             TGGGHHHHHHHHHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEEC
T ss_pred             CcHHHHHHHHHHHhCCCcCEEECcCCCCCHhHHHHHHHHHhhcCCCccEEECcCCCCCcHHHHHHHHHHccCCCcCEEEC
Confidence            7 4556   46778899999999999998  3   45658888999999999999996    56776554   4556778


Q ss_pred             cCCCCCC
Q 007167          193 AGNNLSS  199 (615)
Q Consensus       193 ~~n~~~~  199 (615)
                      ++|.+..
T Consensus       252 ~~n~i~~  258 (386)
T 2ca6_A          252 NDCLLSA  258 (386)
T ss_dssp             TTCCCCH
T ss_pred             CCCCCch
Confidence            8887743

>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A

Probab=99.09  E-value=6.3e-12  Score=129.00  Aligned_cols=129  Identities=23%  Similarity=0.276  Sum_probs=101.8

Q ss_pred             CcEEEEEeCCCCcccc-cCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccc-cccC-CCCcccccccccc
Q 007167           67 SRVVALRLPGMALRGE-IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFN-SFSG-PLPLDFSVWNNLT  143 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~-i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N-~l~g-~~p~~~~~l~~L~  143 (615)
                      .+++.|+|++|.+++. ++. .+..+++|++|+|++|.+++..|..|+++++|++|+|++| .+++ .+|..+..+++|+
T Consensus        93 ~~L~~L~L~~~~l~~~~~~~-~~~~~~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~L~~~~~l~~~~l~~~~~~~~~L~  171 (336)
T 2ast_B           93 FRVQHMDLSNSVIEVSTLHG-ILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLD  171 (336)
T ss_dssp             BCCCEEECTTCEECHHHHHH-HHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCC
T ss_pred             CCCCEEEccCCCcCHHHHHH-HHhhCCCCCEEeCcCcccCHHHHHHHhcCCCCCEEECCCCCCCCHHHHHHHHhcCCCCC
Confidence            5788999999988865 665 6888899999999999988888888888999999999998 6775 3677788888899


Q ss_pred             eeecCCC-cCCcc-CCCcccCCC-CCCeeeccCc--ccc-CCCccc---cccCCcccccCCC
Q 007167          144 VIDLSNN-FFNAS-IPASISKLT-HLSALNLANN--SLT-GTLPRS---LQRFPSWAFAGNN  196 (615)
Q Consensus       144 ~l~l~~N-~l~~~-~p~~~~~l~-~L~~l~l~~N--~l~-g~~p~~---~~~l~~l~~~~n~  196 (615)
                      .|+|++| .+++. +|..+.+++ +|+.|+|++|  .++ +.+|..   +.++..|.+++|.
T Consensus       172 ~L~l~~~~~l~~~~~~~~~~~l~~~L~~L~l~~~~~~~~~~~l~~~~~~~~~L~~L~l~~~~  233 (336)
T 2ast_B          172 ELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSV  233 (336)
T ss_dssp             EEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCT
T ss_pred             EEcCCCCCCcChHHHHHHHHhcccCCCEEEeCCCcccCCHHHHHHHHhhCCCCCEEeCCCCC
Confidence            9999988 88864 577778888 8888888888  455 445543   3456667777777

>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C*

Probab=99.09  E-value=1.4e-10  Score=119.80  Aligned_cols=118  Identities=18%  Similarity=0.174  Sum_probs=98.1

Q ss_pred             eEecCCCCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCc-cccc
Q 007167           60 VTCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPL-DFSV  138 (615)
Q Consensus        60 v~C~~~~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~-~~~~  138 (615)
                      ..|+.   +  .++.++++|+ .||.+ +  .++|++|+|++|+|+...+..|.+|++|++|+|++|++.+.+|. .|.+
T Consensus         7 C~C~~---~--~v~C~~~~Lt-~iP~~-l--~~~l~~L~Ls~N~i~~i~~~~f~~l~~L~~L~Ls~N~i~~~i~~~~f~~   77 (350)
T 4ay9_X            7 CHCSN---R--VFLCQESKVT-EIPSD-L--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSN   77 (350)
T ss_dssp             SEEET---T--EEEEESTTCC-SCCTT-C--CTTCSEEEEESCCCSEECTTSSTTCTTCCEEEEECCTTCCEECTTSBCS
T ss_pred             cEeeC---C--EEEecCCCCC-ccCcC-c--CCCCCEEEccCCcCCCcCHHHHcCCCCCCEEECcCCCCCCccChhHhhc
Confidence            46753   2  4678899999 89874 4  46899999999999976667899999999999999999877775 6889


Q ss_pred             ccccce-eecCCCcCCccCCCcccCCCCCCeeeccCccccCCCcccccc
Q 007167          139 WNNLTV-IDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQR  186 (615)
Q Consensus       139 l~~L~~-l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~  186 (615)
                      +++|+. +++++|++++..|..|.++++|++|++++|+|++..+..+..
T Consensus        78 L~~l~~~l~~~~N~l~~l~~~~f~~l~~L~~L~l~~n~l~~~~~~~~~~  126 (350)
T 4ay9_X           78 LPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIH  126 (350)
T ss_dssp             CTTCCEEEEEEETTCCEECTTSBCCCTTCCEEEEEEECCSSCCCCTTCC
T ss_pred             chhhhhhhcccCCcccccCchhhhhccccccccccccccccCCchhhcc
Confidence            988765 677789999888999999999999999999999766554433

>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium}

Probab=99.07  E-value=4.2e-10  Score=124.64  Aligned_cols=53  Identities=23%  Similarity=0.397  Sum_probs=25.5

Q ss_pred             cEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEeccccccc
Q 007167           68 RVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFS  129 (615)
Q Consensus        68 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~  129 (615)
                      +++.|+|++|+|+ .||.    .+++|++|+|++|+|++ +|.   .+++|++|+|++|+++
T Consensus        62 ~L~~L~L~~N~l~-~lp~----~l~~L~~L~Ls~N~l~~-lp~---~l~~L~~L~Ls~N~l~  114 (622)
T 3g06_A           62 HITTLVIPDNNLT-SLPA----LPPELRTLEVSGNQLTS-LPV---LPPGLLELSIFSNPLT  114 (622)
T ss_dssp             TCSEEEECSCCCS-CCCC----CCTTCCEEEECSCCCSC-CCC---CCTTCCEEEECSCCCC
T ss_pred             CCcEEEecCCCCC-CCCC----cCCCCCEEEcCCCcCCc-CCC---CCCCCCEEECcCCcCC
Confidence            4555555555555 4443    24455555555555542 333   3344444444444444

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=99.06  E-value=3.9e-12  Score=124.99  Aligned_cols=136  Identities=21%  Similarity=0.227  Sum_probs=96.4

Q ss_pred             CCCCCcceEecCCCCcEEEEEeCC---CCcccccCCCc-----------------------ccCCCCccE--EEcCCCCC
Q 007167           53 LCKSWTGVTCSADHSRVVALRLPG---MALRGEIPPNT-----------------------IGRLSALQN--LSLRSNSL  104 (615)
Q Consensus        53 ~c~~w~gv~C~~~~~~v~~l~l~~---~~l~g~i~~~~-----------------------~~~l~~L~~--L~L~~N~l  104 (615)
                      .| .|.|+.|+.+..+|+.+...+   ..+.|.++++.                       |...+.|..  ++++.|..
T Consensus        77 l~-~~~g~i~~~~~~ki~~~v~~~~~~~~~~~~l~~~~~~~Lk~~l~~ryn~~~~~LdLs~l~~dp~L~~~~l~l~~N~~  155 (267)
T 3rw6_A           77 LK-AVNYKILDRENRRISIIINSSAPPHTILNELKPEQVEQLKLIMSKRYDGSQQALDLKGLRSDPDLVAQNIDVVLNRR  155 (267)
T ss_dssp             HH-HTTSSCBCTTSCBCCCEEEECCCCHHHHTSCCHHHHHHHHHHHHHTEETTTTEEECTTGGGCHHHHHTTCCCCTTSH
T ss_pred             HH-hcCcEEECCCCCEEEEEEecCCCcccccccCCHHHHHHHHHHHHhccchhccccCHHHcCCCcchhhcCccccCCHH
Confidence            45 799999997777887776665   34555555332                       333333444  56666633


Q ss_pred             C---CcCCCCccccccCcEEecccccccC--CCCcccccccccceeecCCCcCCccCCCcccCCC--CCCeeeccCcccc
Q 007167          105 S---GLFPSDFSKLENLTSLHLQFNSFSG--PLPLDFSVWNNLTVIDLSNNFFNASIPASISKLT--HLSALNLANNSLT  177 (615)
Q Consensus       105 ~---g~~p~~~~~l~~L~~L~l~~N~l~g--~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~--~L~~l~l~~N~l~  177 (615)
                      .   +.++....++++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..+..++  +|+.|+|++|.++
T Consensus       156 ~~~~~~l~i~~~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~  233 (267)
T 3rw6_A          156 SCMAATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLC  233 (267)
T ss_dssp             HHHHHHHHHHHHHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTG
T ss_pred             HHHHHHHHHHHhhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCc
Confidence            2   2222223568899999999999998  5667788999999999999999975  3455555  8999999999999


Q ss_pred             CCCcc-------ccccCCccc
Q 007167          178 GTLPR-------SLQRFPSWA  191 (615)
Q Consensus       178 g~~p~-------~~~~l~~l~  191 (615)
                      +.+|.       .+..++.|.
T Consensus       234 ~~~~~~~~y~~~il~~~P~L~  254 (267)
T 3rw6_A          234 DTFRDQSTYISAIRERFPKLL  254 (267)
T ss_dssp             GGCSSHHHHHHHHHHHCTTCC
T ss_pred             cccCcchhHHHHHHHHCcccC
Confidence            88773       245566554

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.02  E-value=6.5e-10  Score=115.21  Aligned_cols=138  Identities=16%  Similarity=0.226  Sum_probs=103.7

Q ss_pred             hcCcCCccEEEEEEECCCCEEEEEEec--ccc--CCHHHHHHHHHHHhCCC--CCcccceeEEEEec---CeeeEEeecC
Q 007167          307 VLGKGTFGTAYKAALEDASTVVVKRLK--EVN--VGKREFEQQMEIVGGIR--HENVVALRAYYYSK---DEKLMVYDYF  377 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~~~~~vavK~l~--~~~--~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~---~~~~lV~e~~  377 (615)
                      .++.|.++.||+....+ ..+++|+..  ...  .....+.+|.++++.+.  +..+.++++++.+.   +..++||||+
T Consensus        45 ~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v  123 (359)
T 3dxp_A           45 QFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFV  123 (359)
T ss_dssp             ECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECC
T ss_pred             EcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEec
Confidence            48889999999988654 678888775  322  22457888999998886  45678888888766   3478999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccC-------------------------------------
Q 007167          378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN-------------------------------------  420 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-------------------------------------  420 (615)
                      +|..+.+..       ...++...+..++.++++.|..||+..                                     
T Consensus       124 ~G~~l~~~~-------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (359)
T 3dxp_A          124 SGRVLWDQS-------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA  196 (359)
T ss_dssp             CCBCCCCTT-------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred             CCeecCCCc-------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence            987765422       124678888899999999999999731                                     


Q ss_pred             ------------------CCCceecCCCCCCEEeCCCCc--EEEeecccccc
Q 007167          421 ------------------GGKLVHGGIKASNIFLNSQGH--VCVSDIGLAAL  452 (615)
Q Consensus       421 ------------------~~~iiHrDik~~Nill~~~~~--~kl~DfG~a~~  452 (615)
                                        .+.++|+|+++.||+++.++.  +.|+||+.+..
T Consensus       197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                              245999999999999997753  68999998864

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=98.87  E-value=6.4e-11  Score=127.06  Aligned_cols=132  Identities=18%  Similarity=0.154  Sum_probs=93.5

Q ss_pred             CcEEEEEeCCCCcccc----cCCCcccCCCCccEEEcCCCCCCCc----CCCCccccccCcEEecccccccCCCCccccc
Q 007167           67 SRVVALRLPGMALRGE----IPPNTIGRLSALQNLSLRSNSLSGL----FPSDFSKLENLTSLHLQFNSFSGPLPLDFSV  138 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~----i~~~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~  138 (615)
                      .+++.|+|++|.+++.    +.+..+..+++|++|+|++|.+++.    ++..+.++++|++|+|++|.+++..+..+..
T Consensus       227 ~~L~~L~Ls~n~l~~~~~~~l~~~~~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~  306 (461)
T 1z7x_W          227 ASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCE  306 (461)
T ss_dssp             TTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHHHH
T ss_pred             CCccEEeccCCcCChHHHHHHHHHHhcCCCCceEEECcCCCCCHHHHHHHHHHHhhCCCcceEECCCCCCchHHHHHHHH
Confidence            5688888888887753    2232334678888888888888864    5677777888888888888887554444443


Q ss_pred             c-----cccceeecCCCcCCcc----CCCcccCCCCCCeeeccCccccCCCcccc--------ccCCcccccCCCCC
Q 007167          139 W-----NNLTVIDLSNNFFNAS----IPASISKLTHLSALNLANNSLTGTLPRSL--------QRFPSWAFAGNNLS  198 (615)
Q Consensus       139 l-----~~L~~l~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~g~~p~~~--------~~l~~l~~~~n~~~  198 (615)
                      .     ++|+.|+|++|.+++.    +|..+.++++|+.|+|++|.+++..+..+        .++..+.+++|.+.
T Consensus       307 ~l~~~~~~L~~L~L~~n~l~~~~~~~l~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~  383 (461)
T 1z7x_W          307 TLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVS  383 (461)
T ss_dssp             HHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCC
T ss_pred             HhccCCccceeeEcCCCCCchHHHHHHHHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCC
Confidence            2     5788888888888765    45666777888888888888876544322        26667777777664

>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I

Probab=98.86  E-value=1e-10  Score=125.53  Aligned_cols=133  Identities=20%  Similarity=0.208  Sum_probs=105.4

Q ss_pred             CCcEEEEEeCCCCcccc----cCCCcccCCCCccEEEcCCCCCCCcCCCCcccc-----ccCcEEecccccccCC----C
Q 007167           66 HSRVVALRLPGMALRGE----IPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKL-----ENLTSLHLQFNSFSGP----L  132 (615)
Q Consensus        66 ~~~v~~l~l~~~~l~g~----i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l-----~~L~~L~l~~N~l~g~----~  132 (615)
                      ..+++.|+|++|++++.    ++. .+..+++|++|+|++|.+++..+..+...     ++|++|+|++|.+++.    +
T Consensus       255 ~~~L~~L~L~~n~l~~~~~~~l~~-~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~l  333 (461)
T 1z7x_W          255 SSRLRTLWIWECGITAKGCGDLCR-VLRAKESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHF  333 (461)
T ss_dssp             TCCCCEEECTTSCCCHHHHHHHHH-HHHHCTTCCEEECTTCCCHHHHHHHHHHHHTSTTCCCCEEECTTSCCBGGGHHHH
T ss_pred             CCCceEEECcCCCCCHHHHHHHHH-HHhhCCCcceEECCCCCCchHHHHHHHHHhccCCccceeeEcCCCCCchHHHHHH
Confidence            35799999999999854    565 57789999999999999986655555443     6999999999999875    5


Q ss_pred             CcccccccccceeecCCCcCCccCCCcccC-----CCCCCeeeccCccccC----CCcccc---ccCCcccccCCCCCC
Q 007167          133 PLDFSVWNNLTVIDLSNNFFNASIPASISK-----LTHLSALNLANNSLTG----TLPRSL---QRFPSWAFAGNNLSS  199 (615)
Q Consensus       133 p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~-----l~~L~~l~l~~N~l~g----~~p~~~---~~l~~l~~~~n~~~~  199 (615)
                      |..+..+++|+.|+|++|.+++..+..+..     .++|+.|+|++|++++    .+|..+   .++..+.+++|++..
T Consensus       334 ~~~l~~~~~L~~L~Ls~n~i~~~~~~~l~~~l~~~~~~L~~L~L~~n~i~~~~~~~l~~~l~~~~~L~~L~l~~N~i~~  412 (461)
T 1z7x_W          334 SSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGD  412 (461)
T ss_dssp             HHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCCCCCEEECCSSSCCH
T ss_pred             HHHHhhCCCccEEEccCCccccccHHHHHHHHcCCCCceEEEECCCCCCChhhHHHHHHHHHhCCCccEEECCCCCCCH
Confidence            667778899999999999998765554443     6799999999999986    677664   556677888998754

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.77  E-value=1.7e-09  Score=109.24  Aligned_cols=181  Identities=16%  Similarity=0.195  Sum_probs=116.5

Q ss_pred             hcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCC-CCc--ccceeEEEEecC---eeeEEeecCCCC
Q 007167          307 VLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIR-HEN--VVALRAYYYSKD---EKLMVYDYFEPG  380 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~-h~n--iv~l~~~~~~~~---~~~lV~e~~~~g  380 (615)
                      .++.|....||+..    ..+++|+.... .....+.+|.++++.+. +..  +.+++.+....+   ..++|||+++|.
T Consensus        27 ~~~~G~~n~v~~v~----~~~vlR~~~~~-~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~  101 (304)
T 3sg8_A           27 ISGEGNDCIAYEIN----RDFIFKFPKHS-RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGV  101 (304)
T ss_dssp             EEEECSSEEEEEST----TSEEEEEESSH-HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCE
T ss_pred             ecCCCCcceEEEEC----CEEEEEecCCc-chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCe
Confidence            47889999999863    56888876432 22456889999988773 333  334444433332   347899999998


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc-----------------------------------------
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE-----------------------------------------  419 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-----------------------------------------  419 (615)
                      ++.....       ..++..++..++.++++.+..||+.                                         
T Consensus       102 ~l~~~~~-------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A          102 PLTPLLL-------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             ECCHHHH-------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             ECCcccc-------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            8765332       1356667777778888888777751                                         


Q ss_pred             --------------CCCCceecCCCCCCEEeCC--CCcEEEeecccccccCCCCC----CCC---CCC--------cc--
Q 007167          420 --------------NGGKLVHGGIKASNIFLNS--QGHVCVSDIGLAALMSPMPP----PAM---RAA--------GY--  466 (615)
Q Consensus       420 --------------~~~~iiHrDik~~Nill~~--~~~~kl~DfG~a~~~~~~~~----~~~---~~~--------~y--  466 (615)
                                    ..+.++|+|+++.||++++  ...+.|+||+.+..-.+...    ...   ...        +|  
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~  254 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKH  254 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTC
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCC
Confidence                          1235899999999999998  45678999998865432100    000   000        12  


Q ss_pred             cC-ccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 007167          467 RA-PEVTDTRKATQASDVFSFGVLLLELLTGKSPIH  501 (615)
Q Consensus       467 ~a-PE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~  501 (615)
                      .. |+....  .....+.|+++.++|.+.+|+.+|-
T Consensus       255 ~~~~~~~~r--~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          255 KDIPTVLEK--YRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             SCHHHHHHH--HHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             CCcHHHHHH--HHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            11 111110  1123589999999999999987763

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=98.77  E-value=2.2e-10  Score=119.11  Aligned_cols=132  Identities=20%  Similarity=0.182  Sum_probs=92.4

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCc-----cccccCcEEecccccccC----CCCcccc
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDF-----SKLENLTSLHLQFNSFSG----PLPLDFS  137 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~-----~~l~~L~~L~l~~N~l~g----~~p~~~~  137 (615)
                      ..++.|+|++|+++..-.......+++|+.|+|++|.|+..-...+     ...++|++|+|++|.|+.    .++..+.
T Consensus       101 ~~L~~L~Ls~n~l~~~~~~~l~~~L~~L~~L~Ls~n~l~~~~~~~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~  180 (372)
T 3un9_A          101 HALDEVNLASCQLDPAGLRTLLPVFLRARKLGLQLNSLGPEACKDLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLA  180 (372)
T ss_dssp             SCEEEEECTTCCCCHHHHHHTHHHHHTEEEEECCSSCCCHHHHHHHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHH
T ss_pred             CCceEEEecCCCCCHHHHHHHHHHHHhccHhhcCCCCCCHHHHHHHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHh
Confidence            4788888988888643332233346678889999988875544444     245778999999998864    2444456


Q ss_pred             cccccceeecCCCcCCcc----CCCcccCCCCCCeeeccCccccCC----Ccccc---ccCCcccccCCCCC
Q 007167          138 VWNNLTVIDLSNNFFNAS----IPASISKLTHLSALNLANNSLTGT----LPRSL---QRFPSWAFAGNNLS  198 (615)
Q Consensus       138 ~l~~L~~l~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~g~----~p~~~---~~l~~l~~~~n~~~  198 (615)
                      .+++|++|+|++|.|+..    ++..+...++|+.|+|++|.|++.    ++..+   ..+..|.+++|++.
T Consensus       181 ~~~~L~~L~Ls~N~l~~~g~~~L~~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~  252 (372)
T 3un9_A          181 GNTSVTHLSLLHTGLGDEGLELLAAQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELS  252 (372)
T ss_dssp             TCSSCCEEECTTSSCHHHHHHHHHHHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCC
T ss_pred             cCCCcCEEeCCCCCCCcHHHHHHHHHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCC
Confidence            778899999999988752    355667778899999999988753    22222   46777888888764

>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A

Probab=98.64  E-value=1.7e-08  Score=98.94  Aligned_cols=80  Identities=21%  Similarity=0.216  Sum_probs=68.1

Q ss_pred             cCCCCccEEEcCCCCCCC--cCCCCccccccCcEEecccccccCCCCccccccc--ccceeecCCCcCCccCCC------
Q 007167           89 GRLSALQNLSLRSNSLSG--LFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWN--NLTVIDLSNNFFNASIPA------  158 (615)
Q Consensus        89 ~~l~~L~~L~L~~N~l~g--~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~--~L~~l~l~~N~l~~~~p~------  158 (615)
                      .++++|+.|+|++|+|++  .+|..+..+++|+.|+|++|+|++.  ..+..+.  +|+.|+|++|.+++.+|.      
T Consensus       167 ~~l~~L~~L~Ls~N~l~~l~~l~~~~~~l~~L~~L~Ls~N~i~~~--~~l~~l~~l~L~~L~L~~Npl~~~~~~~~~y~~  244 (267)
T 3rw6_A          167 ENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSE--RELDKIKGLKLEELWLDGNSLCDTFRDQSTYIS  244 (267)
T ss_dssp             HHCTTCCEEECTTSCCCCCGGGTTHHHHSTTCCEEECTTSCCCSG--GGGGGGTTSCCSEEECTTSTTGGGCSSHHHHHH
T ss_pred             hhCCCCCEEECCCCCCCCCccchhHHhhCCCCCEEECCCCccCCc--hhhhhcccCCcceEEccCCcCccccCcchhHHH
Confidence            468899999999999998  5677888999999999999999975  4455565  999999999999987773      


Q ss_pred             -cccCCCCCCeee
Q 007167          159 -SISKLTHLSALN  170 (615)
Q Consensus       159 -~~~~l~~L~~l~  170 (615)
                       .+..+++|+.||
T Consensus       245 ~il~~~P~L~~LD  257 (267)
T 3rw6_A          245 AIRERFPKLLRLD  257 (267)
T ss_dssp             HHHHHCTTCCEES
T ss_pred             HHHHHCcccCeEC
Confidence             367888888775

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=98.59  E-value=6.4e-08  Score=98.84  Aligned_cols=100  Identities=18%  Similarity=0.122  Sum_probs=46.5

Q ss_pred             cEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCc-EEecccccccCCCCcccccccccceee
Q 007167           68 RVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLT-SLHLQFNSFSGPLPLDFSVWNNLTVID  146 (615)
Q Consensus        68 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~-~L~l~~N~l~g~~p~~~~~l~~L~~l~  146 (615)
                      +++.|+|++|+++ .|+...|.++++|+.|+|.+| ++.+-+..|.+|.+|+ .|+|++ +++..-+..|.+|++|+.|+
T Consensus       227 ~L~~l~L~~n~i~-~I~~~aF~~~~~L~~l~l~~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~  303 (329)
T 3sb4_A          227 NLVSLDISKTNAT-TIPDFTFAQKKYLLKIKLPHN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVL  303 (329)
T ss_dssp             TCCEEECTTBCCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEE
T ss_pred             CCeEEECCCCCcc-eecHhhhhCCCCCCEEECCcc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEE
Confidence            3444445444444 444444445555555555444 4433334444555554 455544 33333334444455555555


Q ss_pred             cCCCcCCccCCCcccCCCCCCeee
Q 007167          147 LSNNFFNASIPASISKLTHLSALN  170 (615)
Q Consensus       147 l~~N~l~~~~p~~~~~l~~L~~l~  170 (615)
                      |++|+++..-+..|.++++|+.++
T Consensus       304 l~~n~i~~I~~~aF~~~~~L~~ly  327 (329)
T 3sb4_A          304 ATGDKITTLGDELFGNGVPSKLIY  327 (329)
T ss_dssp             ECSSCCCEECTTTTCTTCCCCEEE
T ss_pred             eCCCccCccchhhhcCCcchhhhc
Confidence            544444443344444444444443

>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron}

Probab=98.58  E-value=8.6e-08  Score=97.86  Aligned_cols=128  Identities=17%  Similarity=0.213  Sum_probs=93.3

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCcc---------------------------------
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFS---------------------------------  113 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~---------------------------------  113 (615)
                      .+++.|+|++ +++ .|+...|.++++|+.|+|++|.+....+..|.                                 
T Consensus       101 ~~L~~l~L~~-~i~-~I~~~aF~~~~~L~~l~l~~n~i~~i~~~aF~~~~~l~~l~~~~~~~~~~~~~i~~~~f~~~~~L  178 (329)
T 3sb4_A          101 QTLEKVILSE-KIK-NIEDAAFKGCDNLKICQIRKKTAPNLLPEALADSVTAIFIPLGSSDAYRFKNRWEHFAFIEGEPL  178 (329)
T ss_dssp             TTCCC-CBCT-TCC-EECTTTTTTCTTCCEEEBCCSSCCEECTTSSCTTTCEEEECTTCTHHHHTSTTTTTSCEEESCCC
T ss_pred             CCCcEEECCc-ccc-chhHHHhhcCcccceEEcCCCCccccchhhhcCCCceEEecCcchhhhhcccccccccccccccc
Confidence            4677888888 777 78888888888888888888875322111110                                 


Q ss_pred             ---------------------------------------------ccccCcEEecccccccCCCCcccccccccceeecC
Q 007167          114 ---------------------------------------------KLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLS  148 (615)
Q Consensus       114 ---------------------------------------------~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~  148 (615)
                                                                   .+++|+.|+|++|+++..-+..|.++++|+.|+|+
T Consensus       179 ~~~i~~~~~~~l~~~~~~~~~~~~~~~~l~~~~~l~~~~~~~l~~~~~~L~~l~L~~n~i~~I~~~aF~~~~~L~~l~l~  258 (329)
T 3sb4_A          179 ETTIQVGAMGKLEDEIMKAGLQPRDINFLTIEGKLDNADFKLIRDYMPNLVSLDISKTNATTIPDFTFAQKKYLLKIKLP  258 (329)
T ss_dssp             EEEEEECTTCCHHHHHHHTTCCGGGCSEEEEEECCCHHHHHHHHHHCTTCCEEECTTBCCCEECTTTTTTCTTCCEEECC
T ss_pred             ceeEEecCCCcHHHHHhhcccCccccceEEEeeeecHHHHHHHHHhcCCCeEEECCCCCcceecHhhhhCCCCCCEEECC
Confidence                                                         26789999999999986555679999999999999


Q ss_pred             CCcCCccCCCcccCCCCCC-eeeccCccccCCCccccccCC---cccccCCCCC
Q 007167          149 NNFFNASIPASISKLTHLS-ALNLANNSLTGTLPRSLQRFP---SWAFAGNNLS  198 (615)
Q Consensus       149 ~N~l~~~~p~~~~~l~~L~-~l~l~~N~l~g~~p~~~~~l~---~l~~~~n~~~  198 (615)
                      +| ++..-+..|.++++|+ .|++.+ .++..-+..|.+++   .+.+.+|.+.
T Consensus       259 ~n-i~~I~~~aF~~~~~L~~~l~l~~-~l~~I~~~aF~~c~~L~~l~l~~n~i~  310 (329)
T 3sb4_A          259 HN-LKTIGQRVFSNCGRLAGTLELPA-SVTAIEFGAFMGCDNLRYVLATGDKIT  310 (329)
T ss_dssp             TT-CCEECTTTTTTCTTCCEEEEECT-TCCEECTTTTTTCTTEEEEEECSSCCC
T ss_pred             cc-cceehHHHhhCChhccEEEEEcc-cceEEchhhhhCCccCCEEEeCCCccC
Confidence            88 7766677889999999 999988 66644445666554   4456666653

>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens}

Probab=98.56  E-value=5.3e-09  Score=108.73  Aligned_cols=118  Identities=18%  Similarity=0.179  Sum_probs=91.2

Q ss_pred             CcEEEEEeCCCCcccccCCCcc-----cCCCCccEEEcCCCCCCCc----CCCCccccccCcEEecccccccCC----CC
Q 007167           67 SRVVALRLPGMALRGEIPPNTI-----GRLSALQNLSLRSNSLSGL----FPSDFSKLENLTSLHLQFNSFSGP----LP  133 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~-----~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----~p  133 (615)
                      .+++.|+|++|+|+..-.. .+     ...++|++|+|++|.|+..    ++..+..+++|++|+|++|.|+..    ++
T Consensus       126 ~~L~~L~Ls~n~l~~~~~~-~L~~~L~~~~~~L~~L~Ls~n~l~~~~~~~l~~~L~~~~~L~~L~Ls~N~l~~~g~~~L~  204 (372)
T 3un9_A          126 LRARKLGLQLNSLGPEACK-DLRDLLLHDQCQITTLRLSNNPLTAAGVAVLMEGLAGNTSVTHLSLLHTGLGDEGLELLA  204 (372)
T ss_dssp             HTEEEEECCSSCCCHHHHH-HHHHHHHSTTCCCCEEECCSSCCHHHHHHHHHHHHHTCSSCCEEECTTSSCHHHHHHHHH
T ss_pred             HhccHhhcCCCCCCHHHHH-HHHHHHHhcCCccceeeCCCCCCChHHHHHHHHHHhcCCCcCEEeCCCCCCCcHHHHHHH
Confidence            3689999999999743221 23     3568899999999999752    455567889999999999999852    35


Q ss_pred             cccccccccceeecCCCcCCcc----CCCcccCCCCCCeeeccCccccCCCccccc
Q 007167          134 LDFSVWNNLTVIDLSNNFFNAS----IPASISKLTHLSALNLANNSLTGTLPRSLQ  185 (615)
Q Consensus       134 ~~~~~l~~L~~l~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~  185 (615)
                      ..+...++|+.|+|++|.|+..    ++..+...++|+.|+|++|.|++.-...+.
T Consensus       205 ~~L~~~~~L~~L~Ls~N~i~~~g~~~l~~~L~~~~~L~~L~Ls~N~i~~~g~~~L~  260 (372)
T 3un9_A          205 AQLDRNRQLQELNVAYNGAGDTAALALARAAREHPSLELLHLYFNELSSEGRQVLR  260 (372)
T ss_dssp             HHGGGCSCCCEEECCSSCCCHHHHHHHHHHHHHCSSCCEEECTTSSCCHHHHHHHH
T ss_pred             HHHhcCCCcCeEECCCCCCCHHHHHHHHHHHHhCCCCCEEeccCCCCCHHHHHHHH
Confidence            5677888999999999999853    445566778999999999999865444343

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=98.35  E-value=1.5e-08  Score=112.12  Aligned_cols=132  Identities=12%  Similarity=0.067  Sum_probs=85.1

Q ss_pred             CcEEEEEeCCCCcccccCCCcccC-CCCccEEEcC----CCCCCCc-----CCCCccccccCcEEecccc--cccCCCCc
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGR-LSALQNLSLR----SNSLSGL-----FPSDFSKLENLTSLHLQFN--SFSGPLPL  134 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~-l~~L~~L~L~----~N~l~g~-----~p~~~~~l~~L~~L~l~~N--~l~g~~p~  134 (615)
                      .+++.|+|..+++++..+. .++. +++|+.|+|+    .|.+++.     ++..+.++++|+.|+|+++  .+++..+.
T Consensus       378 ~~L~~L~l~~~~l~~~~~~-~l~~~~~~L~~L~l~~~~~~n~l~~~p~~~~~~~~~~~~~~L~~L~L~~~~~~l~~~~~~  456 (592)
T 3ogk_B          378 QELEYMAVYVSDITNESLE-SIGTYLKNLCDFRLVLLDREERITDLPLDNGVRSLLIGCKKLRRFAFYLRQGGLTDLGLS  456 (592)
T ss_dssp             TTCSEEEEEESCCCHHHHH-HHHHHCCSCCEEEEEECSCCSCCSSCCCHHHHHHHHHHCTTCCEEEEECCGGGCCHHHHH
T ss_pred             ccCeEEEeecCCccHHHHH-HHHhhCCCCcEEEEeecCCCccccCchHHHHHHHHHHhCCCCCEEEEecCCCCccHHHHH
Confidence            3566666666666655444 3443 6777777774    5666653     3333566777777777632  35554444


Q ss_pred             cccc-ccccceeecCCCcCCc-cCCCcccCCCCCCeeeccCccccCC-Ccc---ccccCCcccccCCCCCC
Q 007167          135 DFSV-WNNLTVIDLSNNFFNA-SIPASISKLTHLSALNLANNSLTGT-LPR---SLQRFPSWAFAGNNLSS  199 (615)
Q Consensus       135 ~~~~-l~~L~~l~l~~N~l~~-~~p~~~~~l~~L~~l~l~~N~l~g~-~p~---~~~~l~~l~~~~n~~~~  199 (615)
                      .+.. +++|+.|+|++|++++ .++..+.++++|+.|+|++|.+++. ++.   .+.++..|.+++|++..
T Consensus       457 ~~~~~~~~L~~L~L~~n~l~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~~~~~l~~L~~L~ls~n~it~  527 (592)
T 3ogk_B          457 YIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRGCCFSERAIAAAVTKLPSLRYLWVQGYRASM  527 (592)
T ss_dssp             HHHHSCTTCCEEEECSCCSSHHHHHHHHTCCTTCCEEEEESCCCBHHHHHHHHHHCSSCCEEEEESCBCCT
T ss_pred             HHHHhCccceEeeccCCCCCHHHHHHHHhcCcccCeeeccCCCCcHHHHHHHHHhcCccCeeECcCCcCCH
Confidence            4443 7788888888888876 3455567788888888888888754 222   24567777788887643

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.34  E-value=1.7e-06  Score=85.31  Aligned_cols=134  Identities=14%  Similarity=0.198  Sum_probs=90.8

Q ss_pred             cCcCCcc-EEEEEEEC-CCCEEEEEEeccccCCHHHHHHHHHHHhCCC-CCcccceeEEEEecCeeeEEeecCCCCChhh
Q 007167          308 LGKGTFG-TAYKAALE-DASTVVVKRLKEVNVGKREFEQQMEIVGGIR-HENVVALRAYYYSKDEKLMVYDYFEPGSVSA  384 (615)
Q Consensus       308 lG~G~fg-~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  384 (615)
                      +..|..| .||+.... ++..+++|+-...  ...++.+|.++++.+. +--+-++++++.+.+..++|||++++.++.+
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~--~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~  109 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS--VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ  109 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH--HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC--CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence            4445554 69987754 5667889886533  2456788998888774 3346678899999999999999999987765


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc---------------------------------------------
Q 007167          385 MLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE---------------------------------------------  419 (615)
Q Consensus       385 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~---------------------------------------------  419 (615)
                      ......         .....+..+++..|..||..                                             
T Consensus       110 ~~~~~~---------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (272)
T 4gkh_A          110 VLEEYP---------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW  180 (272)
T ss_dssp             HHHHCG---------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred             cccCCH---------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence            442110         11223344444444444421                                             


Q ss_pred             ----------CCCCceecCCCCCCEEeCCCCcEEEeecccccc
Q 007167          420 ----------NGGKLVHGGIKASNIFLNSQGHVCVSDIGLAAL  452 (615)
Q Consensus       420 ----------~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~  452 (615)
                                ..+.++|+|+.+.||++++++.+-|+||+.+..
T Consensus       181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                      112379999999999999887778999998753

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.34  E-value=4.6e-08  Score=91.01  Aligned_cols=110  Identities=13%  Similarity=0.132  Sum_probs=72.3

Q ss_pred             CcEEEEEeCCC-Ccccc----cCCCcccCCCCccEEEcCCCCCCCc----CCCCccccccCcEEecccccccCC----CC
Q 007167           67 SRVVALRLPGM-ALRGE----IPPNTIGRLSALQNLSLRSNSLSGL----FPSDFSKLENLTSLHLQFNSFSGP----LP  133 (615)
Q Consensus        67 ~~v~~l~l~~~-~l~g~----i~~~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----~p  133 (615)
                      ..++.|+|++| ++...    +.. .+...++|++|+|++|.|+..    +...+...++|++|+|++|.++..    +.
T Consensus        36 ~~L~~L~L~~n~~i~~~g~~~l~~-~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~~~l~  114 (185)
T 1io0_A           36 PDLEEVNLNNIMNIPVPTLKACAE-ALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV  114 (185)
T ss_dssp             TTCCEEECTTCTTCCHHHHHHHHH-HHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred             CCCCEEEecCCCCCCHHHHHHHHH-HHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHHHHHH
Confidence            46777888877 66531    222 455667788888888887642    233455557788888888877642    34


Q ss_pred             cccccccccceeec--CCCcCCcc----CCCcccCCCCCCeeeccCcccc
Q 007167          134 LDFSVWNNLTVIDL--SNNFFNAS----IPASISKLTHLSALNLANNSLT  177 (615)
Q Consensus       134 ~~~~~l~~L~~l~l--~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~  177 (615)
                      ..+...+.|+.|+|  ++|.|+..    +...+...++|+.|+|++|.+.
T Consensus       115 ~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i~  164 (185)
T 1io0_A          115 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQG  164 (185)
T ss_dssp             HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSHH
T ss_pred             HHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCCC
Confidence            45666677888888  67777743    3344555577888888887765

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.33  E-value=1.9e-06  Score=86.90  Aligned_cols=134  Identities=19%  Similarity=0.187  Sum_probs=88.3

Q ss_pred             hcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCC---cccceeEEEE-ecCeeeEEeecCCCCCh
Q 007167          307 VLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHE---NVVALRAYYY-SKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~---niv~l~~~~~-~~~~~~lV~e~~~~gsL  382 (615)
                      .++.|....||+.    +..+++|+-.. ......+.+|.++++.+.+.   .+.+++.++. ..+..++||||++|..+
T Consensus        26 ~l~~G~~n~v~~v----g~~~VlR~~~~-~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l  100 (306)
T 3tdw_A           26 SLGEGFRNYAILV----NGDWVFRFPKS-QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQIL  100 (306)
T ss_dssp             EEEECSSEEEEEE----TTTEEEEEESS-HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEEC
T ss_pred             ecCCCcceeEEEE----CCEEEEEecCC-chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeEC
Confidence            4777888899987    56788887432 12245688999999988643   3456666664 34567899999999887


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc-------------------------------------------
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE-------------------------------------------  419 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-------------------------------------------  419 (615)
                      ......       .++...+..++.++++.|..||+.                                           
T Consensus       101 ~~~~~~-------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~  173 (306)
T 3tdw_A          101 GEDGMA-------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT  173 (306)
T ss_dssp             HHHHHT-------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred             chhhhh-------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence            653210       123333444444444444444432                                           


Q ss_pred             --------------CCCCceecCCCCCCEEeCC---CCc-EEEeecccccc
Q 007167          420 --------------NGGKLVHGGIKASNIFLNS---QGH-VCVSDIGLAAL  452 (615)
Q Consensus       420 --------------~~~~iiHrDik~~Nill~~---~~~-~kl~DfG~a~~  452 (615)
                                    ..+.++|+|+++.||+++.   ++. +.|+||+.+..
T Consensus       174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                          2234799999999999997   455 58999998754

>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B*

Probab=98.22  E-value=3.1e-07  Score=101.55  Aligned_cols=104  Identities=11%  Similarity=0.105  Sum_probs=67.1

Q ss_pred             cEEEEEeCCCC-ccc-ccCCCcccCCCCccEEEcCCCCCCCc----CCCCccccccCcEEecccccccC----CCCcccc
Q 007167           68 RVVALRLPGMA-LRG-EIPPNTIGRLSALQNLSLRSNSLSGL----FPSDFSKLENLTSLHLQFNSFSG----PLPLDFS  137 (615)
Q Consensus        68 ~v~~l~l~~~~-l~g-~i~~~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g----~~p~~~~  137 (615)
                      +++.|+|+++. ++. .++. .+.++++|++|+|++|.+++.    ++..+.++++|++|+|++|.+++    .++..+.
T Consensus       139 ~L~~L~L~~~~~~~~~~l~~-~~~~~~~L~~L~L~~~~~~~~~~~~l~~~~~~~~~L~~L~L~~n~~~~~~~~~l~~~~~  217 (592)
T 3ogk_B          139 DLETLKLDKCSGFTTDGLLS-IVTHCRKIKTLLMEESSFSEKDGKWLHELAQHNTSLEVLNFYMTEFAKISPKDLETIAR  217 (592)
T ss_dssp             GCCEEEEESCEEEEHHHHHH-HHHHCTTCSEEECTTCEEECCCSHHHHHHHHHCCCCCEEECTTCCCSSCCHHHHHHHHH
T ss_pred             cCcEEECcCCCCcCHHHHHH-HHhhCCCCCEEECccccccCcchhHHHHHHhcCCCccEEEeeccCCCccCHHHHHHHHh
Confidence            37778887765 221 1221 234677788888888877655    33345667778888888887762    3344456


Q ss_pred             cccccceeecCCCcCCccCCCcccCCCCCCeeeccC
Q 007167          138 VWNNLTVIDLSNNFFNASIPASISKLTHLSALNLAN  173 (615)
Q Consensus       138 ~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~  173 (615)
                      ++++|+.|+|++|.+.+ +|..+.++++|+.|++++
T Consensus       218 ~~~~L~~L~L~~~~~~~-l~~~~~~~~~L~~L~l~~  252 (592)
T 3ogk_B          218 NCRSLVSVKVGDFEILE-LVGFFKAAANLEEFCGGS  252 (592)
T ss_dssp             HCTTCCEEECSSCBGGG-GHHHHHHCTTCCEEEECB
T ss_pred             hCCCCcEEeccCccHHH-HHHHHhhhhHHHhhcccc
Confidence            67778888888777775 556666666666666664

>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1

Probab=98.19  E-value=7.1e-08  Score=89.73  Aligned_cols=111  Identities=14%  Similarity=0.196  Sum_probs=83.5

Q ss_pred             cccCCCCccEEEcCCC-CCCCc----CCCCccccccCcEEecccccccCC----CCcccccccccceeecCCCcCCcc--
Q 007167           87 TIGRLSALQNLSLRSN-SLSGL----FPSDFSKLENLTSLHLQFNSFSGP----LPLDFSVWNNLTVIDLSNNFFNAS--  155 (615)
Q Consensus        87 ~~~~l~~L~~L~L~~N-~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~~~--  155 (615)
                      .+...+.|++|+|++| .|+..    +...+...++|++|+|++|.+...    +...+...+.|+.|+|++|.|+..  
T Consensus        31 ~l~~~~~L~~L~L~~n~~i~~~g~~~l~~~L~~~~~L~~L~Ls~n~i~~~g~~~l~~~L~~n~~L~~L~L~~N~i~~~g~  110 (185)
T 1io0_A           31 IQNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGI  110 (185)
T ss_dssp             HHTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHH
T ss_pred             HHhcCCCCCEEEecCCCCCCHHHHHHHHHHHHhCCCcCEEECcCCCCChHHHHHHHHHHHhCCCcCEEECcCCcCCHHHH
Confidence            5778899999999999 88843    344566778999999999998742    334456668999999999999853  


Q ss_pred             --CCCcccCCCCCCeeec--cCccccCCCc----ccc---ccCCcccccCCCC
Q 007167          156 --IPASISKLTHLSALNL--ANNSLTGTLP----RSL---QRFPSWAFAGNNL  197 (615)
Q Consensus       156 --~p~~~~~l~~L~~l~l--~~N~l~g~~p----~~~---~~l~~l~~~~n~~  197 (615)
                        +...+...++|+.|+|  ++|.|+..-.    ..+   ..+..|.+++|.+
T Consensus       111 ~~l~~~L~~n~~L~~L~L~~~~N~i~~~g~~~l~~~L~~n~~L~~L~L~~n~i  163 (185)
T 1io0_A          111 LALVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ  163 (185)
T ss_dssp             HHHHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred             HHHHHHHHhCCCceEEEecCCCCCCCHHHHHHHHHHHHhCCCcCEEeccCCCC
Confidence              4567788889999999  8899985422    222   3455666666644

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.15  E-value=3.8e-06  Score=86.53  Aligned_cols=78  Identities=13%  Similarity=0.109  Sum_probs=54.0

Q ss_pred             hc-CcCCccEEEEEEEC-------CCCEEEEEEecccc---C-CHHHHHHHHHHHhCCC-C--CcccceeEEEEec---C
Q 007167          307 VL-GKGTFGTAYKAALE-------DASTVVVKRLKEVN---V-GKREFEQQMEIVGGIR-H--ENVVALRAYYYSK---D  368 (615)
Q Consensus       307 ~l-G~G~fg~Vy~~~~~-------~~~~vavK~l~~~~---~-~~~~~~~e~~~l~~l~-h--~niv~l~~~~~~~---~  368 (615)
                      .| +.|....+|+....       ++..+++|+-....   . ....+.+|+++++.+. +  -.+.++++++.+.   +
T Consensus        27 ~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g  106 (357)
T 3ats_A           27 GVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLG  106 (357)
T ss_dssp             EECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTS
T ss_pred             ECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccC
Confidence            46 78888999998754       25678888765432   1 2356788888888774 2  3466778777654   3


Q ss_pred             eeeEEeecCCCCChhh
Q 007167          369 EKLMVYDYFEPGSVSA  384 (615)
Q Consensus       369 ~~~lV~e~~~~gsL~~  384 (615)
                      ..++||||++|..+.+
T Consensus       107 ~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          107 TPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SCEEEEECCCCBCCCB
T ss_pred             CceEEEEecCCCChhh
Confidence            4689999998876653

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=98.06  E-value=8.4e-08  Score=106.07  Aligned_cols=106  Identities=9%  Similarity=0.062  Sum_probs=49.6

Q ss_pred             CCCccEEEcCCCCCCCcCCCCcc-ccccCcEEecc--c----ccccCC-----CCcccccccccceeecCCCcCCccCCC
Q 007167           91 LSALQNLSLRSNSLSGLFPSDFS-KLENLTSLHLQ--F----NSFSGP-----LPLDFSVWNNLTVIDLSNNFFNASIPA  158 (615)
Q Consensus        91 l~~L~~L~L~~N~l~g~~p~~~~-~l~~L~~L~l~--~----N~l~g~-----~p~~~~~l~~L~~l~l~~N~l~~~~p~  158 (615)
                      +++|++|+++.|++++..+..+. ++++|+.|+|+  +    |.+++.     ++..+..+++|+.|+|++ .+++..+.
T Consensus       371 ~~~L~~L~~~~~~l~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~~~l~~~~~~L~~L~L~~-~l~~~~~~  449 (594)
T 2p1m_B          371 CPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTLEPLDIGFGAIVEHCKDLRRLSLSG-LLTDKVFE  449 (594)
T ss_dssp             CTTCCEEEEEESCCCHHHHHHHHHHCTTCCEEEEEESSTTCCCTTTCCCTHHHHHHHHHHCTTCCEEECCS-SCCHHHHH
T ss_pred             chhHHHHHHhcCCcCHHHHHHHHhhCCCcceeEeecccCCCcccccCCchhhHHHHHHhhCCCccEEeecC-cccHHHHH
Confidence            55566665555665554444443 35566666665  2    334421     111134445555555544 44433333


Q ss_pred             cccC-CCCCCeeeccCccccCCCcc----ccccCCcccccCCCC
Q 007167          159 SISK-LTHLSALNLANNSLTGTLPR----SLQRFPSWAFAGNNL  197 (615)
Q Consensus       159 ~~~~-l~~L~~l~l~~N~l~g~~p~----~~~~l~~l~~~~n~~  197 (615)
                      .+.. +++|+.|+|++|.+++..+.    .+.++..|.+++|++
T Consensus       450 ~l~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~L~~L~L~~n~~  493 (594)
T 2p1m_B          450 YIGTYAKKMEMLSVAFAGDSDLGMHHVLSGCDSLRKLEIRDCPF  493 (594)
T ss_dssp             HHHHHCTTCCEEEEESCCSSHHHHHHHHHHCTTCCEEEEESCSC
T ss_pred             HHHHhchhccEeeccCCCCcHHHHHHHHhcCCCcCEEECcCCCC
Confidence            3333 45555555555555433221    123444455555544

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=98.03  E-value=8.6e-06  Score=85.26  Aligned_cols=125  Identities=12%  Similarity=0.169  Sum_probs=90.7

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEeccccccc-----CCCCcccccccc
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFS-----GPLPLDFSVWNN  141 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~-----g~~p~~~~~l~~  141 (615)
                      ..++.|+|+. +++ .|+...|.+ .+|+.++| .|+++.+-+..|.+|++|+.++|.+|.+.     ..-+..|.+|++
T Consensus       226 ~~L~~l~l~~-~l~-~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~~~~~~~~I~~~aF~~c~~  301 (401)
T 4fdw_A          226 SQLKTIEIPE-NVS-TIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTFNDDPEAMIHPYCLEGCPK  301 (401)
T ss_dssp             TTCCCEECCT-TCC-EECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCCCCCTTCEECTTTTTTCTT
T ss_pred             CCCCEEecCC-Ccc-Ccccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccccCCcccEECHHHhhCCcc
Confidence            4677888876 465 777778887 78999999 55677666778999999999999888775     334567888999


Q ss_pred             cceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccc--cCCcccccCCCC
Q 007167          142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQ--RFPSWAFAGNNL  197 (615)
Q Consensus       142 L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~--~l~~l~~~~n~~  197 (615)
                      |+.++|. |+++..-...|.+|++|+.+.|.+| ++..-+..|.  +|..+.+.+|..
T Consensus       302 L~~l~l~-~~i~~I~~~aF~~c~~L~~l~lp~~-l~~I~~~aF~~~~L~~l~l~~n~~  357 (401)
T 4fdw_A          302 LARFEIP-ESIRILGQGLLGGNRKVTQLTIPAN-VTQINFSAFNNTGIKEVKVEGTTP  357 (401)
T ss_dssp             CCEECCC-TTCCEECTTTTTTCCSCCEEEECTT-CCEECTTSSSSSCCCEEEECCSSC
T ss_pred             CCeEEeC-CceEEEhhhhhcCCCCccEEEECcc-ccEEcHHhCCCCCCCEEEEcCCCC
Confidence            9999998 4577555678888899999998655 5422233343  455566777654

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.96  E-value=2.3e-05  Score=79.93  Aligned_cols=140  Identities=14%  Similarity=0.193  Sum_probs=79.0

Q ss_pred             cCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCC-----CCCccccee-E--EEEecCeeeEEeecCCC
Q 007167          308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGI-----RHENVVALR-A--YYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       308 lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l-----~h~niv~l~-~--~~~~~~~~~lV~e~~~~  379 (615)
                      |+.|..+.||+....++ .+++|+...   ....+..|.+++..+     ..|.++... |  +....+..++||+|++|
T Consensus        40 l~gG~~n~~~~v~~~~~-~~vlk~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~G  115 (346)
T 2q83_A           40 IQGNQMALVWKVHTDSG-AVCLKRIHR---PEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIEG  115 (346)
T ss_dssp             CC----CEEEEEEETTE-EEEEEEECS---CHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCCC
T ss_pred             ccccccCcEEEEEeCCC-CEEEEecCC---CHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeecC
Confidence            55677899999987655 588888864   234444555554443     234444311 1  12346678999999998


Q ss_pred             CChh--------------hhhccCCCC---C------CCCCCHHHHH-------------------------------HH
Q 007167          380 GSVS--------------AMLHGRRGE---G------QSSLDWDTRV-------------------------------RI  405 (615)
Q Consensus       380 gsL~--------------~~l~~~~~~---~------~~~l~~~~~~-------------------------------~i  405 (615)
                      ..+.              ..+|.....   .      ...-.|....                               .+
T Consensus       116 ~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (346)
T 2q83_A          116 RPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDGF  195 (346)
T ss_dssp             BCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHHH
T ss_pred             ccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHHH
Confidence            6542              112211100   0      0112343211                               01


Q ss_pred             HHHHHHHHHHhhc----------cCCCCceecCCCCCCEEeCCCCcEEEeeccccc
Q 007167          406 AIGAARGIAHIHT----------ENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAA  451 (615)
Q Consensus       406 ~~~ia~~l~~LH~----------~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~  451 (615)
                      ...+..++++|+.          ...+.++|+|+++.||+++.++.+.|+||+.+.
T Consensus       196 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          196 IEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            1123345666653          123459999999999999888889999999764

>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B*

Probab=97.93  E-value=7.5e-07  Score=98.40  Aligned_cols=86  Identities=20%  Similarity=0.186  Sum_probs=48.6

Q ss_pred             CCCCccEEEcCCCCCCCcCCCCcc-ccccCcEEecccc-cccCC-CCcccccccccceeecCCCcCCccCCCccc----C
Q 007167           90 RLSALQNLSLRSNSLSGLFPSDFS-KLENLTSLHLQFN-SFSGP-LPLDFSVWNNLTVIDLSNNFFNASIPASIS----K  162 (615)
Q Consensus        90 ~l~~L~~L~L~~N~l~g~~p~~~~-~l~~L~~L~l~~N-~l~g~-~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~----~  162 (615)
                      .+++|++|+|++|.+++..+..+. ++++|++|+|++| .++.. ++..+.++++|+.|+|++|.+++..+..+.    .
T Consensus       103 ~~~~L~~L~L~~~~~~~~~~~~l~~~~~~L~~L~L~~~~~~~~~~l~~~~~~~~~L~~L~L~~~~i~~~~~~~l~~~~~~  182 (594)
T 2p1m_B          103 SYTWLEEIRLKRMVVTDDCLELIAKSFKNFKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDT  182 (594)
T ss_dssp             HCTTCCEEEEESCBCCHHHHHHHHHHCTTCCEEEEESCEEEEHHHHHHHHHHCTTCCEEECTTCEEECCCGGGGGGSCTT
T ss_pred             hCCCCCeEEeeCcEEcHHHHHHHHHhCCCCcEEeCCCcCCCCHHHHHHHHHhCCCCCEEeCcCCccCCcchHHHHHHhhc
Confidence            455666666666666655555554 4666666666666 33321 333344566666666666666554333332    4


Q ss_pred             CCCCCeeeccCcc
Q 007167          163 LTHLSALNLANNS  175 (615)
Q Consensus       163 l~~L~~l~l~~N~  175 (615)
                      +++|+.|+|++|.
T Consensus       183 ~~~L~~L~l~~~~  195 (594)
T 2p1m_B          183 YTSLVSLNISCLA  195 (594)
T ss_dssp             CCCCCEEECTTCC
T ss_pred             CCcCcEEEecccC
Confidence            4566666666665

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.83  E-value=5.6e-05  Score=78.97  Aligned_cols=72  Identities=7%  Similarity=0.070  Sum_probs=47.1

Q ss_pred             hcCcCCccEEEEEEEC-CCCEEEEEEecccc--------CCHHHHHHHHHHHhCCCC--Cccc-ceeEEEEecCeeeEEe
Q 007167          307 VLGKGTFGTAYKAALE-DASTVVVKRLKEVN--------VGKREFEQQMEIVGGIRH--ENVV-ALRAYYYSKDEKLMVY  374 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--------~~~~~~~~e~~~l~~l~h--~niv-~l~~~~~~~~~~~lV~  374 (615)
                      .||.|.++.||++... +++.++||......        .....+..|.++++.+..  +..+ +++.+  +.+..++||
T Consensus        37 ~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lvm  114 (397)
T 2olc_A           37 EIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTVM  114 (397)
T ss_dssp             ECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEEE
T ss_pred             ECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEEE
Confidence            5899999999999754 46789999764321        123456778888876632  3333 45443  455678999


Q ss_pred             ecCCCC
Q 007167          375 DYFEPG  380 (615)
Q Consensus       375 e~~~~g  380 (615)
                      ||+++.
T Consensus       115 E~l~g~  120 (397)
T 2olc_A          115 EDLSHL  120 (397)
T ss_dssp             CCCTTS
T ss_pred             EeCCCc
Confidence            999764

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=97.81  E-value=2.2e-06  Score=88.36  Aligned_cols=128  Identities=20%  Similarity=0.218  Sum_probs=87.9

Q ss_pred             CCcEEEEEeCCCC-cccccCCCcccCCCCccEEEcCCCCCCCcCCCCcc--ccccCcEEeccc--ccccCC-----CCcc
Q 007167           66 HSRVVALRLPGMA-LRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFS--KLENLTSLHLQF--NSFSGP-----LPLD  135 (615)
Q Consensus        66 ~~~v~~l~l~~~~-l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~--~l~~L~~L~l~~--N~l~g~-----~p~~  135 (615)
                      ..+++.|+|+++. +  .+++  +. +++|+.|+|..+.++...-..+.  .+++|+.|+|+.  |...|.     +...
T Consensus       171 ~P~L~~L~L~g~~~l--~l~~--~~-~~~L~~L~L~~~~l~~~~l~~l~~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~  245 (362)
T 2ra8_A          171 MPLLNNLKIKGTNNL--SIGK--KP-RPNLKSLEIISGGLPDSVVEDILGSDLPNLEKLVLYVGVEDYGFDGDMNVFRPL  245 (362)
T ss_dssp             CTTCCEEEEECCBTC--BCCS--CB-CTTCSEEEEECSBCCHHHHHHHHHSBCTTCCEEEEECBCGGGTCCSCGGGTGGG
T ss_pred             CCCCcEEEEeCCCCc--eecc--cc-CCCCcEEEEecCCCChHHHHHHHHccCCCCcEEEEeccccccccchhHHHHHHH
Confidence            4689999998873 3  3444  43 88999999998887754333444  789999999864  332221     1112


Q ss_pred             c--ccccccceeecCCCcCCccCCCccc---CCCCCCeeeccCccccCC----Cccc---cccCCcccccCCCCC
Q 007167          136 F--SVWNNLTVIDLSNNFFNASIPASIS---KLTHLSALNLANNSLTGT----LPRS---LQRFPSWAFAGNNLS  198 (615)
Q Consensus       136 ~--~~l~~L~~l~l~~N~l~~~~p~~~~---~l~~L~~l~l~~N~l~g~----~p~~---~~~l~~l~~~~n~~~  198 (615)
                      +  ..+++|+.|+|++|.++...+..+.   .+++|+.|+|+.|.|++.    ++..   +.+|..|.+.+|.+.
T Consensus       246 l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d~G~~~L~~~L~~l~~L~~L~L~~n~i~  320 (362)
T 2ra8_A          246 FSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLS  320 (362)
T ss_dssp             SCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBHHHHHHHHTTHHHHTTCSEEECCSBBCC
T ss_pred             HhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCChHHHHHHHhhcccCCcceEEECCCCcCC
Confidence            2  3478999999999998864443333   578999999999999863    3333   466777888888663

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.79  E-value=0.00011  Score=73.72  Aligned_cols=138  Identities=14%  Similarity=0.172  Sum_probs=90.6

Q ss_pred             hcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCC---CCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          307 VLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIR---HENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~---h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      .|+.|....+|+... ++..+++|+....  ....+..|.+.++.+.   ...+.++++++...+..++||||+++..+.
T Consensus        43 ~l~gG~~n~~y~v~~-~~~~~vlK~~~~~--~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~~  119 (312)
T 3jr1_A           43 KLYSGEMNEIWLIND-EVQTVFVKINERS--YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKNK  119 (312)
T ss_dssp             EECCSSSSEEEEEES-SSCEEEEEEEEGG--GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCCC
T ss_pred             EeCCccceeeeEEEE-CCCeEEEEeCCcc--cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCCC
Confidence            478899999999875 4678889887543  2566888988888773   356788898888888899999999987652


Q ss_pred             h-----------hhccCCC-CC----------------CCCCCHHHHH---HHHH----------------HHHHH-HHH
Q 007167          384 A-----------MLHGRRG-EG----------------QSSLDWDTRV---RIAI----------------GAARG-IAH  415 (615)
Q Consensus       384 ~-----------~l~~~~~-~~----------------~~~l~~~~~~---~i~~----------------~ia~~-l~~  415 (615)
                      .           .||.... ..                ...-+|....   ++..                .+... ...
T Consensus       120 ~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~~  199 (312)
T 3jr1_A          120 QSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVADT  199 (312)
T ss_dssp             TTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHHH
T ss_pred             chhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHHH
Confidence            1           2332211 00                0012565322   1111                11111 223


Q ss_pred             hhc-cCCCCceecCCCCCCEEeCCCCcEEEeecc
Q 007167          416 IHT-ENGGKLVHGGIKASNIFLNSQGHVCVSDIG  448 (615)
Q Consensus       416 LH~-~~~~~iiHrDik~~Nill~~~~~~kl~DfG  448 (615)
                      |.. ...+.++|+|+.+.|++++.++ +.|.|+.
T Consensus       200 L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          200 LSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             hccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            432 2246799999999999999887 8899974

>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis}

Probab=97.77  E-value=5.4e-06  Score=85.36  Aligned_cols=129  Identities=13%  Similarity=0.180  Sum_probs=82.9

Q ss_pred             CcEEEEEeCCCCc---------ccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccc
Q 007167           67 SRVVALRLPGMAL---------RGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFS  137 (615)
Q Consensus        67 ~~v~~l~l~~~~l---------~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~  137 (615)
                      .++..|.+..+..         .+.+.+ .+..+++|+.|+|++|.-. .++. + .+++|+.|+|..+.++......+.
T Consensus       139 ~~L~~L~l~~~~~e~~~is~~~~~~L~~-ll~~~P~L~~L~L~g~~~l-~l~~-~-~~~~L~~L~L~~~~l~~~~l~~l~  214 (362)
T 2ra8_A          139 AHFEGLFWGDIDFEEQEISWIEQVDLSP-VLDAMPLLNNLKIKGTNNL-SIGK-K-PRPNLKSLEIISGGLPDSVVEDIL  214 (362)
T ss_dssp             TTCSEEEECCCCTTTCCGGGCBCCBCHH-HHHTCTTCCEEEEECCBTC-BCCS-C-BCTTCSEEEEECSBCCHHHHHHHH
T ss_pred             chhhheeecCcchhhcccccccccCHHH-HHhcCCCCcEEEEeCCCCc-eecc-c-cCCCCcEEEEecCCCChHHHHHHH
Confidence            4677777765432         112333 5677899999999887311 2333 4 388999999998887643333343


Q ss_pred             --cccccceeecCC--CcCCcc-----CCCcc--cCCCCCCeeeccCccccCCCcc------ccccCCcccccCCCCCC
Q 007167          138 --VWNNLTVIDLSN--NFFNAS-----IPASI--SKLTHLSALNLANNSLTGTLPR------SLQRFPSWAFAGNNLSS  199 (615)
Q Consensus       138 --~l~~L~~l~l~~--N~l~~~-----~p~~~--~~l~~L~~l~l~~N~l~g~~p~------~~~~l~~l~~~~n~~~~  199 (615)
                        .+++|+.|+|+.  |...|.     +...+  ..+++|+.|+|++|.+.+..+.      .+.++..|.++.|.+..
T Consensus       215 ~~~lp~L~~L~L~~~~~~~~~~~~~~~l~~~l~~~~~p~Lr~L~L~~~~i~~~~~~~la~a~~~~~L~~LdLs~n~L~d  293 (362)
T 2ra8_A          215 GSDLPNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQLETMDISAGVLTD  293 (362)
T ss_dssp             HSBCTTCCEEEEECBCGGGTCCSCGGGTGGGSCTTTCTTCCEEEEESCTTHHHHHHHHHHCSSGGGCSEEECCSSCCBH
T ss_pred             HccCCCCcEEEEeccccccccchhHHHHHHHHhcCCCCCcCEEeCCCCCCchHHHHHHHhCccCCCCCEEECCCCCCCh
Confidence              688999999853  332221     11122  3578999999999998754322      35577788888887643

>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A

Probab=97.73  E-value=5.3e-05  Score=79.21  Aligned_cols=123  Identities=15%  Similarity=0.227  Sum_probs=82.4

Q ss_pred             cEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeec
Q 007167           68 RVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL  147 (615)
Q Consensus        68 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l  147 (615)
                      .++.+.|++ +++ .|+...|.++++|+.++|++|+++..-...|. +.+|+.+.|..| ++..-...|.++++|+.++|
T Consensus       158 ~L~~i~lp~-~l~-~I~~~aF~~c~~L~~l~l~~n~l~~I~~~aF~-~~~L~~l~lp~~-l~~I~~~aF~~~~~L~~l~l  233 (401)
T 4fdw_A          158 TVQEIVFPS-TLE-QLKEDIFYYCYNLKKADLSKTKITKLPASTFV-YAGIEEVLLPVT-LKEIGSQAFLKTSQLKTIEI  233 (401)
T ss_dssp             CCCEEECCT-TCC-EECSSTTTTCTTCCEEECTTSCCSEECTTTTT-TCCCSEEECCTT-CCEECTTTTTTCTTCCCEEC
T ss_pred             CceEEEeCC-Ccc-EehHHHhhCcccCCeeecCCCcceEechhhEe-ecccCEEEeCCc-hheehhhHhhCCCCCCEEec
Confidence            477888885 677 78888899999999999999988865555565 588888888854 66455567888888888888


Q ss_pred             CCCcCCccCCCcccCCCCCCeeeccCccccCCCcccccc---CCcccccCCCC
Q 007167          148 SNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQR---FPSWAFAGNNL  197 (615)
Q Consensus       148 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~---l~~l~~~~n~~  197 (615)
                      ..| ++..-...|.+ .+|+.+.| .|.++..-+..|.+   |..+.+.+|..
T Consensus       234 ~~~-l~~I~~~aF~~-~~L~~i~l-p~~i~~I~~~aF~~c~~L~~l~l~~~~~  283 (401)
T 4fdw_A          234 PEN-VSTIGQEAFRE-SGITTVKL-PNGVTNIASRAFYYCPELAEVTTYGSTF  283 (401)
T ss_dssp             CTT-CCEECTTTTTT-CCCSEEEE-ETTCCEECTTTTTTCTTCCEEEEESSCC
T ss_pred             CCC-ccCcccccccc-CCccEEEe-CCCccEEChhHhhCCCCCCEEEeCCccc
Confidence            765 44333445555 56777777 33444222334433   33344555443

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.50  E-value=0.00082  Score=67.89  Aligned_cols=142  Identities=14%  Similarity=0.096  Sum_probs=80.8

Q ss_pred             cCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCC--cccceeEE-----EEecCeeeEEeecCCCC
Q 007167          308 LGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHE--NVVALRAY-----YYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       308 lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~--niv~l~~~-----~~~~~~~~lV~e~~~~g  380 (615)
                      ++ |....||+....+|+.+++|...........+..|.+++..+...  .+.+++..     ....+..++||+|++|.
T Consensus        34 l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i~G~  112 (328)
T 1zyl_A           34 LN-SYENRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR  112 (328)
T ss_dssp             EC-CSSSEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred             ec-CcccceEEEEcCCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEecCCC
Confidence            55 777899998877777899999864434566777788877766321  23334332     22345668899999875


Q ss_pred             Chhh--------------hhccCC----CCCCCCCCHHHH----------------------HHHHHHHHHHHHHhhc-c
Q 007167          381 SVSA--------------MLHGRR----GEGQSSLDWDTR----------------------VRIAIGAARGIAHIHT-E  419 (615)
Q Consensus       381 sL~~--------------~l~~~~----~~~~~~l~~~~~----------------------~~i~~~ia~~l~~LH~-~  419 (615)
                      .+..              .+|...    .......++...                      ...+..+...++.+-. .
T Consensus       113 ~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  192 (328)
T 1zyl_A          113 QFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRED  192 (328)
T ss_dssp             ECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSC
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHhhhc
Confidence            4321              122110    000112232211                      0111111222221111 1


Q ss_pred             CCCCceecCCCCCCEEeCCCCcEEEeecccccc
Q 007167          420 NGGKLVHGGIKASNIFLNSQGHVCVSDIGLAAL  452 (615)
Q Consensus       420 ~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~  452 (615)
                      ....++|+|+++.||+++ + .+.|+||+.+..
T Consensus       193 ~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          193 FTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             SCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             CCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            233489999999999999 4 899999987643

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.47  E-value=0.00056  Score=67.87  Aligned_cols=72  Identities=13%  Similarity=0.191  Sum_probs=51.8

Q ss_pred             hcCcCCccEEEEEEECCCCEEEEEEecccc-CCHHHHHHHHHHHhCCCCC---cccceeEEEEecCeeeEEeecCCCCCh
Q 007167          307 VLGKGTFGTAYKAALEDASTVVVKRLKEVN-VGKREFEQQMEIVGGIRHE---NVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~---niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      .+|.|..+.||+.+..||+.|++|+-.... .....|+.|.+.|+.+.-.   -+.+++++  +  ..++||||++++..
T Consensus        22 ~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~l~~~~~   97 (288)
T 3f7w_A           22 ERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEWVDERPP   97 (288)
T ss_dssp             EEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEECCCCCCC
T ss_pred             ecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEeecccCC
Confidence            488999999999999999999999876442 2245688899888877421   23444443  2  34789999987653

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.44  E-value=0.00041  Score=72.94  Aligned_cols=74  Identities=11%  Similarity=0.077  Sum_probs=44.9

Q ss_pred             CCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCCC--C--CCCcccCccccCCCC---CCCccchhhHHHHHHHHH
Q 007167          422 GKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPA--M--RAAGYRAPEVTDTRK---ATQASDVFSFGVLLLELL  494 (615)
Q Consensus       422 ~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~~--~--~~~~y~aPE~~~~~~---~~~~~DvwS~Gvvl~ell  494 (615)
                      +.++|+|+++.||+++.++ ++|+||+.+..-.+...-.  .  -...|.+|+......   .....++......+|+.+
T Consensus       232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y  310 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNLF  310 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHHH
Confidence            4599999999999999876 9999999886533210000  0  012356665543211   112344557777777776


Q ss_pred             hC
Q 007167          495 TG  496 (615)
Q Consensus       495 tg  496 (615)
                      .+
T Consensus       311 ~~  312 (420)
T 2pyw_A          311 NK  312 (420)
T ss_dssp             HH
T ss_pred             HH
Confidence            65

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.29  E-value=0.00052  Score=68.56  Aligned_cols=138  Identities=10%  Similarity=0.035  Sum_probs=72.5

Q ss_pred             hcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCccc-ceeEEEEecCeeeEEeecC-CCCChhh
Q 007167          307 VLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVV-ALRAYYYSKDEKLMVYDYF-EPGSVSA  384 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lV~e~~-~~gsL~~  384 (615)
                      .|+.|....+|+.     ..+++|+.........+..+|.++++.+....+. +++++  +.+.-++|+||+ ++.++..
T Consensus        25 ~l~gG~tN~~~~~-----~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~l~~   97 (301)
T 3dxq_A           25 ERLGGLTNLVFRA-----GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQTMSP   97 (301)
T ss_dssp             EEESCSSEEEEEE-----TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEECCH
T ss_pred             EcCCcccccccee-----eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCccCCH
Confidence            4778888999998     5688887754311112335677776666433333 44443  444567899999 5544421


Q ss_pred             ------------------hhccCCCCCCCCCCHHH-HHHHHHH--------------HHHHH----HHhhc-cCCCCcee
Q 007167          385 ------------------MLHGRRGEGQSSLDWDT-RVRIAIG--------------AARGI----AHIHT-ENGGKLVH  426 (615)
Q Consensus       385 ------------------~l~~~~~~~~~~l~~~~-~~~i~~~--------------ia~~l----~~LH~-~~~~~iiH  426 (615)
                                        .+|..........+... ...+...              +...+    +.+.. ...+.++|
T Consensus        98 ~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~l~H  177 (301)
T 3dxq_A           98 EKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLAACH  177 (301)
T ss_dssp             HHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCEEEC
T ss_pred             hhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCceeec
Confidence                              12221110011111111 1111000              11111    11111 12335899


Q ss_pred             cCCCCCCEEeCCCCcEEEeecccccc
Q 007167          427 GGIKASNIFLNSQGHVCVSDIGLAAL  452 (615)
Q Consensus       427 rDik~~Nill~~~~~~kl~DfG~a~~  452 (615)
                      +|+.+.||+ ..++.+.++||..+..
T Consensus       178 gDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          178 CDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             SCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             cCCCcCCEE-ECCCCEEEEecccccC
Confidence            999999999 5566789999998754

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=97.21  E-value=6.6e-05  Score=68.24  Aligned_cols=83  Identities=8%  Similarity=0.070  Sum_probs=51.4

Q ss_pred             CccEEEcCCCCCCCcCCCCccccccCcEEeccccc-ccCCCCcccccc----cccceeecCCC-cCCccCCCcccCCCCC
Q 007167           93 ALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNS-FSGPLPLDFSVW----NNLTVIDLSNN-FFNASIPASISKLTHL  166 (615)
Q Consensus        93 ~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~-l~g~~p~~~~~l----~~L~~l~l~~N-~l~~~~p~~~~~l~~L  166 (615)
                      +|+.|||+++.++..--..+.++++|+.|+|+++. ++..-=..++.+    ++|+.|+|+++ ++|..-=..+.++++|
T Consensus        62 ~L~~LDLs~~~Itd~GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~~L  141 (176)
T 3e4g_A           62 KIQAIDATDSCIMSIGFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFRNL  141 (176)
T ss_dssp             CEEEEEEESCCCCGGGGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCTTC
T ss_pred             eEeEEeCcCCCccHHHHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCCCC
Confidence            57777777777664433456677777777777774 543211223332    36788888776 4664322346677888


Q ss_pred             CeeeccCcc
Q 007167          167 SALNLANNS  175 (615)
Q Consensus       167 ~~l~l~~N~  175 (615)
                      +.|+|++..
T Consensus       142 ~~L~L~~c~  150 (176)
T 3e4g_A          142 KYLFLSDLP  150 (176)
T ss_dssp             CEEEEESCT
T ss_pred             CEEECCCCC
Confidence            888887764

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.12  E-value=0.00067  Score=58.59  Aligned_cols=55  Identities=20%  Similarity=0.226  Sum_probs=24.6

Q ss_pred             EEEcCCCCCC-CcCCCCccccccCcEEecccccccCCCCcccccccccceeecCCCcC
Q 007167           96 NLSLRSNSLS-GLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFF  152 (615)
Q Consensus        96 ~L~L~~N~l~-g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l  152 (615)
                      .++.++++|+ ..+|..+.  .+|++|+|++|+|+..-+..|..+++|+.|+|++|.+
T Consensus        12 ~v~Cs~~~L~~~~vP~~lp--~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~   67 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTAFP--VDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPW   67 (130)
T ss_dssp             EEECCSSCCCTTTSCSCCC--TTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCC
T ss_pred             EEEeCCCCCccccCCCCCC--cCCCEEECCCCcCCccChhhhhhccccCEEEecCCCe
Confidence            4555555554 23343321  2345555555555433333344444444444444443

>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A*

Probab=97.12  E-value=0.00075  Score=58.27  Aligned_cols=56  Identities=23%  Similarity=0.314  Sum_probs=39.3

Q ss_pred             EEEeCCCCcc-cccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEeccccccc
Q 007167           71 ALRLPGMALR-GEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFS  129 (615)
Q Consensus        71 ~l~l~~~~l~-g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~  129 (615)
                      .++.++++|+ ..+|.. +  -++|+.|+|++|+|+..-+..|..+++|+.|+|++|.+.
T Consensus        12 ~v~Cs~~~L~~~~vP~~-l--p~~l~~L~Ls~N~l~~l~~~~f~~l~~L~~L~L~~NP~~   68 (130)
T 3rfe_A           12 LVDCGRRGLTWASLPTA-F--PVDTTELVLTGNNLTALPPGLLDALPALRTAHLGANPWR   68 (130)
T ss_dssp             EEECCSSCCCTTTSCSC-C--CTTCSEEECTTSCCSSCCTTTGGGCTTCCEEECCSSCCB
T ss_pred             EEEeCCCCCccccCCCC-C--CcCCCEEECCCCcCCccChhhhhhccccCEEEecCCCee
Confidence            5666777775 355542 1  235788888888888766667788888888888888765

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.05  E-value=0.0035  Score=63.03  Aligned_cols=143  Identities=10%  Similarity=0.103  Sum_probs=77.6

Q ss_pred             hcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCC-----CCccccee-E--EEEecCeeeEEeecCC
Q 007167          307 VLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIR-----HENVVALR-A--YYYSKDEKLMVYDYFE  378 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~-----h~niv~l~-~--~~~~~~~~~lV~e~~~  378 (615)
                      .|+.|....+|+....++ .+++|..... .....+..|++++..+.     -|.++... |  +....+..++|++|++
T Consensus        29 ~i~~G~~n~~~~v~~~~g-~~vlk~~~~~-~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~  106 (322)
T 2ppq_A           29 GIAEGVENSNFLLHTTKD-PLILTLYEKR-VEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLE  106 (322)
T ss_dssp             EECC---EEEEEEEESSC-CEEEEEECC----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCC
T ss_pred             ccCCCcccceEEEEeCCc-cEEEEEeCCC-CCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCC
Confidence            367788889999987665 6888887652 12345666777666553     23333210 1  1123456789999998


Q ss_pred             CCChhh--------------hhccCC-C--CCC----CCCCHHHHHHH------------HHHHHHHHHHhhcc----CC
Q 007167          379 PGSVSA--------------MLHGRR-G--EGQ----SSLDWDTRVRI------------AIGAARGIAHIHTE----NG  421 (615)
Q Consensus       379 ~gsL~~--------------~l~~~~-~--~~~----~~l~~~~~~~i------------~~~ia~~l~~LH~~----~~  421 (615)
                      |..+..              .+|... .  ...    ....|.....-            ...+...+++++..    ..
T Consensus       107 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~  186 (322)
T 2ppq_A          107 GMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLP  186 (322)
T ss_dssp             CBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSC
T ss_pred             CcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCC
Confidence            765321              122110 0  000    01124331110            01133444555432    23


Q ss_pred             CCceecCCCCCCEEeCCCCcEEEeeccccc
Q 007167          422 GKLVHGGIKASNIFLNSQGHVCVSDIGLAA  451 (615)
Q Consensus       422 ~~iiHrDik~~Nill~~~~~~kl~DfG~a~  451 (615)
                      ..++|+|+.+.||+++++..+.|+||+.+.
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            358999999999999987666899999764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.00  E-value=0.0028  Score=64.20  Aligned_cols=141  Identities=14%  Similarity=0.101  Sum_probs=70.6

Q ss_pred             cCcCCccE-EEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCC--CcccceeEEEEecCeeeEEeecCCCCChhh
Q 007167          308 LGKGTFGT-AYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRH--ENVVALRAYYYSKDEKLMVYDYFEPGSVSA  384 (615)
Q Consensus       308 lG~G~fg~-Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h--~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  384 (615)
                      |+.|+... +|+....++..+++|......  ...+..|++++..+..  -.+.+++.+..  +.-++|||++.+..+.+
T Consensus        26 l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~--~~~~~~e~~~l~~L~~~g~~vP~v~~~d~--~~g~ll~e~l~~~~l~~  101 (333)
T 3csv_A           26 LAGDASSRRYQRLRSPTGAKAVLMDWSPEE--GGDTQPFVDLAQYLRNLDISAPEIYAEEH--ARGLLLIEDLGDALFTE  101 (333)
T ss_dssp             --------CCEEEECTTCCEEEEEECCTTT--TCCSHHHHHHHHHHHHTTCBCCCEEEEET--TTTEEEECCCCSCBHHH
T ss_pred             CCCCCCCceEEEEEcCCCCeEEEEECCCCC--CccccHHHHHHHHHHhCCCCCCceeeecC--CCCEEEEeeCCCcchHH
Confidence            55554444 667765446778777654321  1344556666665532  23445666532  22378999997766654


Q ss_pred             hhccCC---------------------CCCCCCCCHHHHH--------------------HHHHHHHHHHHHhh---ccC
Q 007167          385 MLHGRR---------------------GEGQSSLDWDTRV--------------------RIAIGAARGIAHIH---TEN  420 (615)
Q Consensus       385 ~l~~~~---------------------~~~~~~l~~~~~~--------------------~i~~~ia~~l~~LH---~~~  420 (615)
                      ++....                     ......++.....                    .....+...++.+.   ...
T Consensus       102 ~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~~  181 (333)
T 3csv_A          102 VINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLEG  181 (333)
T ss_dssp             HHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCCS
T ss_pred             HhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhcccC
Confidence            432110                     0001112211100                    00001111222221   112


Q ss_pred             CCCceecCCCCCCEEeCCC----CcEEEeecccccc
Q 007167          421 GGKLVHGGIKASNIFLNSQ----GHVCVSDIGLAAL  452 (615)
Q Consensus       421 ~~~iiHrDik~~Nill~~~----~~~kl~DfG~a~~  452 (615)
                      .+.++|+|+.+.||+++.+    ..+.|+||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            3459999999999999875    6799999998764

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=96.98  E-value=0.0012  Score=68.77  Aligned_cols=86  Identities=17%  Similarity=0.217  Sum_probs=37.0

Q ss_pred             CcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeecCCCcCCccCCCcccCCCC
Q 007167           86 NTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTH  165 (615)
Q Consensus        86 ~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~  165 (615)
                      ..|.+++.|+.+.+. +.++.+-...|.++.+|+.++|..| ++..-...|.++.+|+.+.|..+ ++..-...|.++++
T Consensus       282 ~aF~~c~~L~~i~l~-~~i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~  358 (394)
T 4gt6_A          282 GAFMNCPALQDIEFS-SRITELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTA  358 (394)
T ss_dssp             TTTTTCTTCCEEECC-TTCCEECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTT
T ss_pred             cccccccccccccCC-CcccccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCC
Confidence            344444444444443 2333233334445555555555433 33222334445555555555332 33222334445555


Q ss_pred             CCeeeccCc
Q 007167          166 LSALNLANN  174 (615)
Q Consensus       166 L~~l~l~~N  174 (615)
                      |+.+++.+|
T Consensus       359 L~~i~~~~~  367 (394)
T 4gt6_A          359 LNNIEYSGS  367 (394)
T ss_dssp             CCEEEESSC
T ss_pred             CCEEEECCc
Confidence            555555444

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=96.91  E-value=0.0021  Score=66.29  Aligned_cols=90  Identities=17%  Similarity=0.170  Sum_probs=46.3

Q ss_pred             ccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeecCCCcCCccCCCccc
Q 007167           82 EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASIS  161 (615)
Q Consensus        82 ~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~  161 (615)
                      .|....+.+...|+.+.+..+ ++.+-...|.++.+|+.+.+..+ +...-...|.++++|+.+++.+|.++..-...|.
T Consensus       230 ~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~~i~l~~~~i~~I~~~aF~  307 (379)
T 4h09_A          230 TLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLTKVVMDNSAIETLEPRVFM  307 (379)
T ss_dssp             EECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCCEEEECCTTCCEECTTTTT
T ss_pred             EEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccccccccccccceehhhhhc
Confidence            344445555566666665543 44333445555555665555433 3322233455555666666655555543344555


Q ss_pred             CCCCCCeeeccC
Q 007167          162 KLTHLSALNLAN  173 (615)
Q Consensus       162 ~l~~L~~l~l~~  173 (615)
                      ++.+|+.+.|.+
T Consensus       308 ~c~~L~~i~lp~  319 (379)
T 4h09_A          308 DCVKLSSVTLPT  319 (379)
T ss_dssp             TCTTCCEEECCT
T ss_pred             CCCCCCEEEcCc
Confidence            555565555543

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.91  E-value=0.0021  Score=66.27  Aligned_cols=141  Identities=12%  Similarity=0.184  Sum_probs=79.8

Q ss_pred             cCcCCccEEEEEEEC--------CCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcc-cceeEEEEecCeeeEEeecCC
Q 007167          308 LGKGTFGTAYKAALE--------DASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENV-VALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       308 lG~G~fg~Vy~~~~~--------~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~~  378 (615)
                      +..|-...+|+....        ++..+++|+..........+.+|.++++.+.-..+ .++++++.+    .+||||++
T Consensus        58 lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~  133 (379)
T 3feg_A           58 VSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIP  133 (379)
T ss_dssp             C-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCS
T ss_pred             cCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEec
Confidence            556777889998764        24678888753322345667789888877743233 456655532    28999998


Q ss_pred             CCChhh-----------------hhccCCCCCCCCCC--HHHHHHHHHHHHH-------------------HHHH----h
Q 007167          379 PGSVSA-----------------MLHGRRGEGQSSLD--WDTRVRIAIGAAR-------------------GIAH----I  416 (615)
Q Consensus       379 ~gsL~~-----------------~l~~~~~~~~~~l~--~~~~~~i~~~ia~-------------------~l~~----L  416 (615)
                      |..|..                 .||...........  |.+..++..++..                   .+..    |
T Consensus       134 G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L  213 (379)
T 3feg_A          134 SRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLL  213 (379)
T ss_dssp             EEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHH
T ss_pred             CccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHH
Confidence            765531                 12221111111222  4444444433321                   1222    2


Q ss_pred             hcc-CCCCceecCCCCCCEEeCCC----CcEEEeecccccc
Q 007167          417 HTE-NGGKLVHGGIKASNIFLNSQ----GHVCVSDIGLAAL  452 (615)
Q Consensus       417 H~~-~~~~iiHrDik~~Nill~~~----~~~kl~DfG~a~~  452 (615)
                      ... ....++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       214 ~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          214 ESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             hhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            222 12358999999999999876    6899999998753

>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165}

Probab=96.74  E-value=0.0014  Score=68.17  Aligned_cols=103  Identities=17%  Similarity=0.247  Sum_probs=72.8

Q ss_pred             cEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeec
Q 007167           68 RVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL  147 (615)
Q Consensus        68 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l  147 (615)
                      .++.+.++ ++++ .|+...|.++++|+.++|.+| ++.+-..+|.+|.+|+.+.|..+ ++..-...|.++++|+.+++
T Consensus       289 ~L~~i~l~-~~i~-~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~C~~L~~i~ip~s-v~~I~~~aF~~C~~L~~i~~  364 (394)
T 4gt6_A          289 ALQDIEFS-SRIT-ELPESVFAGCISLKSIDIPEG-ITQILDDAFAGCEQLERIAIPSS-VTKIPESAFSNCTALNNIEY  364 (394)
T ss_dssp             TCCEEECC-TTCC-EECTTTTTTCTTCCEEECCTT-CCEECTTTTTTCTTCCEEEECTT-CCBCCGGGGTTCTTCCEEEE
T ss_pred             ccccccCC-Cccc-ccCceeecCCCCcCEEEeCCc-ccEehHhHhhCCCCCCEEEECcc-cCEEhHhHhhCCCCCCEEEE
Confidence            45556664 4565 788889999999999999865 66566788999999999999765 66444567999999999999


Q ss_pred             CCCcCCccCCCcccCCCCCCeeeccCcccc
Q 007167          148 SNNFFNASIPASISKLTHLSALNLANNSLT  177 (615)
Q Consensus       148 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~  177 (615)
                      .+|....   ..+..+.+|+.+.+..|.+.
T Consensus       365 ~~~~~~~---~~~~~~~~L~~i~i~~~~~~  391 (394)
T 4gt6_A          365 SGSRSQW---NAISTDSGLQNLPVAPGSID  391 (394)
T ss_dssp             SSCHHHH---HTCBCCCCC-----------
T ss_pred             CCceeeh---hhhhccCCCCEEEeCCCCEE
Confidence            9987553   46777889999988877664

>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A

Probab=96.71  E-value=0.00032  Score=63.74  Aligned_cols=86  Identities=10%  Similarity=0.107  Sum_probs=64.1

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCC-CCCcCCCCcccc----ccCcEEeccccc-ccCCCCccccccc
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNS-LSGLFPSDFSKL----ENLTSLHLQFNS-FSGPLPLDFSVWN  140 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~-l~g~~p~~~~~l----~~L~~L~l~~N~-l~g~~p~~~~~l~  140 (615)
                      .+++.|||+++.++-. --..+..+++|+.|+|+++. |+..-=..+..+    ++|++|+|+++. +|..-=..+..++
T Consensus        61 ~~L~~LDLs~~~Itd~-GL~~L~~~~~L~~L~L~~C~~ItD~gL~~L~~~~~~~~~L~~L~Ls~C~~ITD~Gl~~L~~~~  139 (176)
T 3e4g_A           61 YKIQAIDATDSCIMSI-GFDHMEGLQYVEKIRLCKCHYIEDGCLERLSQLENLQKSMLEMEIISCGNVTDKGIIALHHFR  139 (176)
T ss_dssp             CCEEEEEEESCCCCGG-GGGGGTTCSCCCEEEEESCTTCCHHHHHHHHTCHHHHHHCCEEEEESCTTCCHHHHHHGGGCT
T ss_pred             ceEeEEeCcCCCccHH-HHHHhcCCCCCCEEEeCCCCccCHHHHHHHHhcccccCCCCEEEcCCCCcCCHHHHHHHhcCC
Confidence            4799999999988732 22257899999999999984 774422345553    479999999975 7643223577899


Q ss_pred             ccceeecCCCc-CC
Q 007167          141 NLTVIDLSNNF-FN  153 (615)
Q Consensus       141 ~L~~l~l~~N~-l~  153 (615)
                      +|+.|+|++.. ++
T Consensus       140 ~L~~L~L~~c~~It  153 (176)
T 3e4g_A          140 NLKYLFLSDLPGVK  153 (176)
T ss_dssp             TCCEEEEESCTTCC
T ss_pred             CCCEEECCCCCCCC
Confidence            99999999874 55

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=96.66  E-value=0.0024  Score=65.74  Aligned_cols=72  Identities=7%  Similarity=0.091  Sum_probs=41.1

Q ss_pred             hcCcCCccEEEEEEECC---------CCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcc-cceeEEEEecCeeeEEeec
Q 007167          307 VLGKGTFGTAYKAALED---------ASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENV-VALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~~---------~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~  376 (615)
                      .++.|....+|+....+         +..+++|+.........+...|.++++.+...++ .++++..  .  -++||||
T Consensus        40 ~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~e~  115 (369)
T 3c5i_A           40 QILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIEEW  115 (369)
T ss_dssp             EC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEEC
T ss_pred             EeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEEEE
Confidence            36778888999988654         2678887764321111124567777776643333 3565543  2  3689999


Q ss_pred             CCCCCh
Q 007167          377 FEPGSV  382 (615)
Q Consensus       377 ~~~gsL  382 (615)
                      ++|..+
T Consensus       116 i~G~~l  121 (369)
T 3c5i_A          116 LYGDPL  121 (369)
T ss_dssp             CCSEEC
T ss_pred             ecCCcC
Confidence            987543

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=96.53  E-value=0.004  Score=65.46  Aligned_cols=71  Identities=8%  Similarity=0.121  Sum_probs=46.8

Q ss_pred             hcCcCCccEEEEEEECC--------CCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcc-cceeEEEEecCeeeEEeecC
Q 007167          307 VLGKGTFGTAYKAALED--------ASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENV-VALRAYYYSKDEKLMVYDYF  377 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~  377 (615)
                      .|+.|-...||+....+        +..+++|+.... .....+.+|..+++.+...++ .++++.+.  +  .+|+||+
T Consensus        80 ~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~-~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e~l  154 (429)
T 1nw1_A           80 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP-ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEEYI  154 (429)
T ss_dssp             EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC-CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEECCC
T ss_pred             EeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC-CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEEEe
Confidence            37778889999998653        477888877432 222556678888887743334 45666543  2  3899999


Q ss_pred             CCCCh
Q 007167          378 EPGSV  382 (615)
Q Consensus       378 ~~gsL  382 (615)
                      ++-++
T Consensus       155 ~G~~l  159 (429)
T 1nw1_A          155 PSRPL  159 (429)
T ss_dssp             CEEEC
T ss_pred             CCccc
Confidence            86443

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=96.40  E-value=0.0045  Score=64.30  Aligned_cols=84  Identities=15%  Similarity=0.150  Sum_probs=41.3

Q ss_pred             cccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCC
Q 007167           87 TIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHL  166 (615)
Q Consensus        87 ~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L  166 (615)
                      .|..+.+|+.+.+.+| ++.+-...|.++.+|+.++|..+ ++..-..+|.++++|+.++|..| ++..-...|.++++|
T Consensus       292 ~F~~~~~L~~i~l~~~-i~~I~~~aF~~c~~L~~i~lp~~-v~~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~C~~L  368 (394)
T 4fs7_A          292 TFYGCSSLTEVKLLDS-VKFIGEEAFESCTSLVSIDLPYL-VEEIGKRSFRGCTSLSNINFPLS-LRKIGANAFQGCINL  368 (394)
T ss_dssp             TTTTCTTCCEEEECTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCEECCCTT-CCEECTTTBTTCTTC
T ss_pred             cccccccccccccccc-cceechhhhcCCCCCCEEEeCCc-ccEEhHHhccCCCCCCEEEECcc-ccEehHHHhhCCCCC
Confidence            3444555555555433 33333444555555555555433 43222344555555555555544 443334455555555


Q ss_pred             CeeeccC
Q 007167          167 SALNLAN  173 (615)
Q Consensus       167 ~~l~l~~  173 (615)
                      +.+++..
T Consensus       369 ~~i~lp~  375 (394)
T 4fs7_A          369 KKVELPK  375 (394)
T ss_dssp             CEEEEEG
T ss_pred             CEEEECC
Confidence            5555543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.39  E-value=0.013  Score=59.37  Aligned_cols=31  Identities=23%  Similarity=0.352  Sum_probs=27.2

Q ss_pred             CCceecCCCCCCEEeCCCCcEEEeecccccc
Q 007167          422 GKLVHGGIKASNIFLNSQGHVCVSDIGLAAL  452 (615)
Q Consensus       422 ~~iiHrDik~~Nill~~~~~~kl~DfG~a~~  452 (615)
                      ..++|+|+.+.||++++++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4599999999999999888899999987654

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=96.36  E-value=0.00053  Score=63.48  Aligned_cols=86  Identities=13%  Similarity=0.161  Sum_probs=38.7

Q ss_pred             cCCCCccEEEcCCC-CCCCc----CCCCccccccCcEEecccccccCC----CCcccccccccceeecCCCcCCcc----
Q 007167           89 GRLSALQNLSLRSN-SLSGL----FPSDFSKLENLTSLHLQFNSFSGP----LPLDFSVWNNLTVIDLSNNFFNAS----  155 (615)
Q Consensus        89 ~~l~~L~~L~L~~N-~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~~~----  155 (615)
                      .+-+.|++|+|++| +|...    +-..+..-+.|+.|+|++|++...    |-..+..=+.|+.|+|++|.|+..    
T Consensus        38 ~~n~~L~~L~L~~nn~igd~ga~~la~aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~a  117 (197)
T 1pgv_A           38 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR  117 (197)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred             hcCCCccEEECCCCCCCCHHHHHHHHHHHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHH
Confidence            33445555555553 44321    222333344555555555555421    111222334555555655555531    


Q ss_pred             CCCcccCCCCCCeeeccCc
Q 007167          156 IPASISKLTHLSALNLANN  174 (615)
Q Consensus       156 ~p~~~~~l~~L~~l~l~~N  174 (615)
                      +-+.+..-+.|+.|+|++|
T Consensus       118 la~aL~~N~tL~~L~L~n~  136 (197)
T 1pgv_A          118 LLRSTLVTQSIVEFKADNQ  136 (197)
T ss_dssp             HHHHTTTTCCCSEEECCCC
T ss_pred             HHHHHhhCCceeEEECCCC
Confidence            1223333344566666543

>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus}

Probab=96.29  E-value=0.0077  Score=62.46  Aligned_cols=54  Identities=22%  Similarity=0.329  Sum_probs=26.1

Q ss_pred             cEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecc
Q 007167           68 RVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQ  124 (615)
Q Consensus        68 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~  124 (615)
                      .++.+.|+. +++ .|....|.++++|+.++|.+| ++-+-...|.++.+|+.+.+.
T Consensus        72 ~L~~i~lp~-~i~-~I~~~aF~~c~~L~~i~lp~~-l~~I~~~aF~~c~~L~~i~~p  125 (394)
T 4fs7_A           72 KVTEIKIPS-TVR-EIGEFAFENCSKLEIINIPDS-VKMIGRCTFSGCYALKSILLP  125 (394)
T ss_dssp             TEEEEECCT-TCC-EECTTTTTTCTTCCEECCCTT-CCEECTTTTTTCTTCCCCCCC
T ss_pred             CceEEEeCC-Ccc-CcchhHhhCCCCCcEEEeCCC-ceEccchhhcccccchhhccc
Confidence            455555542 244 455545555555555555433 332333445555555554443

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.24  E-value=0.016  Score=61.25  Aligned_cols=72  Identities=7%  Similarity=0.117  Sum_probs=44.5

Q ss_pred             hcCcCCccEEEEEEECC-CCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcc-cceeEEEEecCeeeEEeecCCCCCh
Q 007167          307 VLGKGTFGTAYKAALED-ASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENV-VALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      .|+.|-...+|+....+ +..+++|+........-+..+|.+++..+...++ .++++.+  .+  .+||||+++-+|
T Consensus       115 ~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          115 IINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYAL  188 (458)
T ss_dssp             EECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEEC
T ss_pred             EcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCccC
Confidence            47778889999998765 4678888764321111123578888887764445 4566665  22  359999987544

>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum}

Probab=96.08  E-value=0.014  Score=60.05  Aligned_cols=87  Identities=11%  Similarity=0.151  Sum_probs=37.3

Q ss_pred             ccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCC
Q 007167           88 IGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLS  167 (615)
Q Consensus        88 ~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~  167 (615)
                      +....+|+.+.+..+ +...-...|.++.+|+.+.+..+ ++..-...|.++.+|+.+.+..+ ++..-...|.++++|+
T Consensus       213 f~~~~~l~~i~~~~~-~~~i~~~~f~~~~~L~~i~lp~~-v~~I~~~aF~~~~~l~~i~l~~~-i~~i~~~aF~~c~~L~  289 (379)
T 4h09_A          213 FSYGKNLKKITITSG-VTTLGDGAFYGMKALDEIAIPKN-VTSIGSFLLQNCTALKTLNFYAK-VKTVPYLLCSGCSNLT  289 (379)
T ss_dssp             TTTCSSCSEEECCTT-CCEECTTTTTTCSSCCEEEECTT-CCEECTTTTTTCTTCCEEEECCC-CSEECTTTTTTCTTCC
T ss_pred             cccccccceeeeccc-eeEEccccccCCccceEEEcCCC-ccEeCccccceeehhcccccccc-ceeccccccccccccc
Confidence            444444555544332 22233334445555555555443 33222334444455555554332 2222233444455555


Q ss_pred             eeeccCcccc
Q 007167          168 ALNLANNSLT  177 (615)
Q Consensus       168 ~l~l~~N~l~  177 (615)
                      .+.+.+|.++
T Consensus       290 ~i~l~~~~i~  299 (379)
T 4h09_A          290 KVVMDNSAIE  299 (379)
T ss_dssp             EEEECCTTCC
T ss_pred             cccccccccc
Confidence            5555444444

>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1

Probab=95.96  E-value=0.0015  Score=60.50  Aligned_cols=110  Identities=12%  Similarity=0.147  Sum_probs=72.8

Q ss_pred             CCcEEEEEeCCC-Cccc----ccCCCcccCCCCccEEEcCCCCCCCc----CCCCccccccCcEEecccccccCC----C
Q 007167           66 HSRVVALRLPGM-ALRG----EIPPNTIGRLSALQNLSLRSNSLSGL----FPSDFSKLENLTSLHLQFNSFSGP----L  132 (615)
Q Consensus        66 ~~~v~~l~l~~~-~l~g----~i~~~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----~  132 (615)
                      ...++.|+|+++ ++..    .|-. .+..-+.|+.|+|++|+|...    +-..+..-+.|++|+|++|+|+..    +
T Consensus        40 n~~L~~L~L~~nn~igd~ga~~la~-aL~~N~~L~~L~L~~n~igd~ga~alA~aL~~N~tL~~L~L~~N~Ig~~Ga~al  118 (197)
T 1pgv_A           40 DTDLKEVNINNMKRVSKERIRSLIE-AACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARL  118 (197)
T ss_dssp             CSSCCEEECTTCCSSCHHHHHHHHH-HHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHH
T ss_pred             CCCccEEECCCCCCCCHHHHHHHHH-HHhhCCCcCEEEccCCCCChHHHHHHHHHHhcCCccCeEecCCCcCCHHHHHHH
Confidence            457889999885 6642    1222 456678899999999999843    233444567899999999998743    1


Q ss_pred             CcccccccccceeecCCC---cCCc----cCCCcccCCCCCCeeeccCccc
Q 007167          133 PLDFSVWNNLTVIDLSNN---FFNA----SIPASISKLTHLSALNLANNSL  176 (615)
Q Consensus       133 p~~~~~l~~L~~l~l~~N---~l~~----~~p~~~~~l~~L~~l~l~~N~l  176 (615)
                      -..+..=+.|+.|+|++|   .+..    .+-..+..-+.|+.|+++.|.+
T Consensus       119 a~aL~~N~tL~~L~L~n~~~~~ig~~g~~~ia~aL~~N~tL~~L~l~~~~~  169 (197)
T 1pgv_A          119 LRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFASM  169 (197)
T ss_dssp             HHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCCH
T ss_pred             HHHHhhCCceeEEECCCCcCcCcCHHHHHHHHHHHHhCCCcCeEeccCCCc
Confidence            223444467999999865   3332    1334455556788888876644

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=95.74  E-value=0.052  Score=50.51  Aligned_cols=102  Identities=11%  Similarity=0.070  Sum_probs=65.3

Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCC
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP  459 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~  459 (615)
                      -+|.++|...    ..++++.+++.++.|.+.+|.-+-....+  ..+=+.|..|++..+|.+...+ +.+.        
T Consensus        33 vSL~eIL~~~----~~PlsEEqaWALc~Qc~~~L~~~~~~~~~--~~~i~~~~~i~l~~dG~V~f~~-~~s~--------   97 (229)
T 2yle_A           33 LSLEEILRLY----NQPINEEQAWAVCYQCCGSLRAAARRRQP--RHRVRSAAQIRVWRDGAVTLAP-AADD--------   97 (229)
T ss_dssp             EEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTCC--CCCCCSGGGEEEETTSCEEECC-C-----------
T ss_pred             ccHHHHHHHc----CCCcCHHHHHHHHHHHHHHHHhhhhcccC--CceecCCcceEEecCCceeccc-cccc--------
Confidence            3788888754    35899999999999999988766211111  1222456889999999988754 1110        


Q ss_pred             CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCC
Q 007167          460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKS  498 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~  498 (615)
                       .....+.|||... ...+++.=|||+|+++|..+--..
T Consensus        98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL  134 (229)
T 2yle_A           98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL  134 (229)
T ss_dssp             ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC
T ss_pred             -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC
Confidence             1123466888764 345788899999999999887333

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=93.98  E-value=0.14  Score=53.36  Aligned_cols=71  Identities=4%  Similarity=0.101  Sum_probs=43.7

Q ss_pred             cCcCCccEEEEEEECC--------CCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcc-cceeEEEEecCeeeEEeecCC
Q 007167          308 LGKGTFGTAYKAALED--------ASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENV-VALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       308 lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~ni-v~l~~~~~~~~~~~lV~e~~~  378 (615)
                      +..|-...+|+....+        +..+++++........-+..+|.++++.+.-.++ .++++.+  .  -++||||++
T Consensus        78 lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~efI~  153 (424)
T 3mes_A           78 IFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEEFID  153 (424)
T ss_dssp             ECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEECCC
T ss_pred             cCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEEEeC
Confidence            5567778899988653        5778888754322111234577777776643333 3455433  2  378999999


Q ss_pred             CCCh
Q 007167          379 PGSV  382 (615)
Q Consensus       379 ~gsL  382 (615)
                      |..|
T Consensus       154 G~~l  157 (424)
T 3mes_A          154 GEPL  157 (424)
T ss_dssp             SEEC
T ss_pred             CccC
Confidence            8654

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=90.58  E-value=0.17  Score=32.74  Aligned_cols=29  Identities=17%  Similarity=0.288  Sum_probs=19.3

Q ss_pred             CCCCCCcchhhhhhhhhHHHHHHHHHhhh
Q 007167          221 STKLSEPALLGIALGGVALAFVICALLMI  249 (615)
Q Consensus       221 ~~~~~~~~iigi~~~~~~l~~l~~~~~~~  249 (615)
                      +..++..++.|++++.++.+.+++++.++
T Consensus         5 ~~~ls~GaIAGiVvG~v~gv~li~~l~~~   33 (38)
T 2k1k_A            5 SRGLTGGEIVAVIFGLLLGAALLLGILVF   33 (38)
T ss_dssp             STTCCHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCceeeeehHHHHHHHHHHHHHHH
Confidence            34567788899998887765554444443

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=90.38  E-value=1.2  Score=41.27  Aligned_cols=123  Identities=12%  Similarity=0.142  Sum_probs=83.3

Q ss_pred             HHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCc
Q 007167          345 QMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKL  424 (615)
Q Consensus       345 e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~i  424 (615)
                      |+.++.. .||+.+.. ..-.+.+...+.|+.-+.+.=+.-+.        ..+...+++++..++....++++.     
T Consensus        36 el~LL~~-~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik--------~~~~~eKlr~l~ni~~l~~~~~~r-----  100 (215)
T 4ann_A           36 LMYLLEQ-HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK--------SFTKNEKLRYLLNIKNLEEVNRTR-----  100 (215)
T ss_dssp             GGGGGGS-CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG--------GSCHHHHHHHHHHGGGGGGGGGSS-----
T ss_pred             HHHHHhc-cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH--------hcCHHHHHHHHHHHHHHHHHhcCc-----
Confidence            3444432 58888876 45566677666676654332223333        477889999999999988766643     


Q ss_pred             eecCCCCCCEEeCCCCcEEEeecccccccCCCCCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 007167          425 VHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIH  501 (615)
Q Consensus       425 iHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~  501 (615)
                      +|--+.|+|++++.++.+++.=.|+-..+.+              .     ..++..=.-.+=+++..+++++..|.
T Consensus       101 ~tf~L~P~NL~f~~~~~p~i~~RGik~~l~P--------------~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          101 YTFVLAPDELFFTRDGLPIAKTRGLQNVVDP--------------L-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             EECCCSGGGEEECTTSCEEESCCEETTTBSC--------------C-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             eEEEEecceEEEcCCCCEEEEEccCccCCCC--------------C-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            6888999999999999999988776544322              1     11222223456678888999998885

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=90.04  E-value=0.23  Score=33.11  Aligned_cols=30  Identities=13%  Similarity=0.213  Sum_probs=15.7

Q ss_pred             CcchhhhhhhhhHHHHHHHHHhhheeeccC
Q 007167          226 EPALLGIALGGVALAFVICALLMICRYNKQ  255 (615)
Q Consensus       226 ~~~iigi~~~~~~l~~l~~~~~~~~~~~~~  255 (615)
                      .+.+++.+++++++++++++.++++.+||+
T Consensus        10 ~~~IA~gVVgGv~~~~ii~~~~~~~~RRr~   39 (44)
T 2ks1_B           10 IPSIATGMVGALLLLLVVALGIGLFMRRRH   39 (44)
T ss_dssp             SSSSTHHHHHHHHHHHHHHHHHHHHHHTTT
T ss_pred             cceEEeehhHHHHHHHHHHHHHHHHhhhhH
Confidence            345666666666665554444444444433

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=89.85  E-value=0.23  Score=33.10  Aligned_cols=31  Identities=13%  Similarity=0.248  Sum_probs=16.7

Q ss_pred             CcchhhhhhhhhHHHHHHHHHhhheeeccCC
Q 007167          226 EPALLGIALGGVALAFVICALLMICRYNKQD  256 (615)
Q Consensus       226 ~~~iigi~~~~~~l~~l~~~~~~~~~~~~~~  256 (615)
                      .+.+++.+++++++++++++.++++.+||++
T Consensus         9 ~~aIA~gVVgGv~~v~ii~~~~~~~~RRRr~   39 (44)
T 2l2t_A            9 TPLIAAGVIGGLFILVIVGLTFAVYVRRKSI   39 (44)
T ss_dssp             SHHHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             cceEEEeehHHHHHHHHHHHHHHHHhhhhhh
Confidence            3456666666666655545444444444433

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=86.62  E-value=2.7  Score=39.09  Aligned_cols=115  Identities=16%  Similarity=0.109  Sum_probs=79.4

Q ss_pred             CCCcccceeEEEEecCeeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHH-HhhccCCCCceecCCCC
Q 007167          353 RHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIA-HIHTENGGKLVHGGIKA  431 (615)
Q Consensus       353 ~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~-~LH~~~~~~iiHrDik~  431 (615)
                      .||+.  -...-.+.+...+.|+.-+++.=+..++        .++...+++++..++.... ++++     -+|--+.|
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~--------~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P  112 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR--------KTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCP  112 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH--------TSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCG
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH--------hcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeC
Confidence            57777  3444466777777787765554444443        4778899999999998877 6654     46788999


Q ss_pred             CCEEeCCCCcEEEeecccccccCCCCCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCC
Q 007167          432 SNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIH  501 (615)
Q Consensus       432 ~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~  501 (615)
                      +|+++|.++.++|.=.|+-..+.              |.-     .++.-=.-.+=+++..++.++..|.
T Consensus       113 ~NL~f~~~~~p~i~hRGi~~~lp--------------P~e-----~~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          113 ENLMFNRALEPFFLHVGVKESLP--------------PDE-----WDDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             GGEEECTTCCEEESCCEETTTBS--------------SCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             ceEEEeCCCcEEEEEcCCcccCC--------------CCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            99999999999998888654432              211     1222223355677888888887774

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	615
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	8e-53
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	5e-52
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-51
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-50
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-50
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-48
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-47
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	8e-47
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	7e-46
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	7e-46
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-45
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-45
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-44
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-44
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-44
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	7e-44
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-43
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-43
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-43
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-43
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-42
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	2e-42
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-42
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-42
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	9e-42
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-41
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-41
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-40
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-40
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-40
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	5e-40
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	8e-38
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-37
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-36
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-36
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	6e-36
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-35
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-35
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	9e-35
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-34
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	1e-34
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-34
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	3e-34
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	6e-33
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	7e-33
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	9e-33
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	1e-32
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-32
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-31
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-31
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-30
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	8e-30
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-29
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-29
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	7e-29
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-27
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-27
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	6e-26
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-24
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-24
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-24
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	7e-21
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	5e-20
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-11
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	1e-10
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	2e-09
d1ogqa_	313	c.10.2.8 (A:) Polygalacturonase inhibiting protein	4e-08
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-12
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	7e-12
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	7e-12
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	1e-05
d2omza2	384	c.10.2.1 (A:33-416) Internalin A {Listeria monocyt	4e-04
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	2e-11
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	9e-07
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	1e-05
d1xkua_	305	c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99	0.001
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-10
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	2e-09
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	4e-06
d1ozna_	284	c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept	1e-05
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	1e-08
d1dcea3	124	c.10.2.2 (A:444-567) Rab geranylgeranyltransferase	0.003
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	3e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	4e-08
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	8e-07
d1jl5a_	353	c.10.2.6 (A:) Leucine rich effector protein YopM {	2e-05
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	4e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	5e-08
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	3e-07
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	1e-06
d1z7xw1	460	c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (	9e-05
d2astb2	284	c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1	2e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-06
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	1e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-05
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	2e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	3e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	4e-04
d1p9ag_	266	c.10.2.7 (G:) von Willebrand factor binding domain	0.004
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	3e-06
d1koha1	162	c.10.2.3 (A:201-362) mRNA export factor tap {Human	5e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	5e-06
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	1e-04
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.003
d1h6ua2	227	c.10.2.1 (A:36-262) Internalin H {Listeria monocyt	0.004
d2ifga3	156	c.10.2.7 (A:36-191) High affinity nerve growth fac	1e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	1e-05
d2ca6a1	344	c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom	0.001
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	1e-05
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	2e-04
d1xwdc1	242	c.10.2.7 (C:18-259) Follicle-stimulating hormone r	0.001
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	8e-05
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.003
d1h6ta2	210	c.10.2.1 (A:31-240) Internalin B {Listeria monocyt	0.004
d2omxa2	199	c.10.2.1 (A:37-235) Internalin B {Listeria monocyt	0.002

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 8e-53
 Identities = 69/273 (25%), Positives = 120/273 (43%), Gaps = 29/273 (10%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           E LG G FG  +       + V VK LK+ ++    F  +  ++  ++H+ +V L A   
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYA-VV 77

Query: 366 SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLV 425
           +++   ++ +Y E GS+   L    G     L  +  + +A   A G+A I   N    +
Sbjct: 78  TQEPIYIITEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEERN---YI 131

Query: 426 HGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAA----GYRAPEVTDTRKATQAS 481
           H  ++A+NI ++      ++D GLA L+      A   A     + APE  +    T  S
Sbjct: 132 HRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKS 191

Query: 482 DVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
           DV+SFG+LL E++T G+ P       EV+  +                   ++R  N  E
Sbjct: 192 DVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER--------------GYRMVRPDNCPE 237

Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
           E+ +++     C    PE+RP    +  ++ED 
Sbjct: 238 ELYQLM---RLCWKERPEDRPTFDYLRSVLEDF 267

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 5e-52
 Identities = 62/281 (22%), Positives = 118/281 (41%), Gaps = 33/281 (11%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRA 362
           + +G G+FGT YK        V VK L          + F+ ++ ++   RH N++    
Sbjct: 14  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 71

Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGG 422
           Y  +  +  +V  + E  S+   LH          +    + IA   A+G+ ++H ++  
Sbjct: 72  YS-TAPQLAIVTQWCEGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLHAKS-- 124

Query: 423 KLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAA-----GYRAPEVTDTRKA 477
            ++H  +K++NIFL+    V + D GLA + S                + APEV   +  
Sbjct: 125 -IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDK 183

Query: 478 ---TQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLR 534
              +  SDV++FG++L EL+TG+ P       + +  +                  +L +
Sbjct: 184 NPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFM----------VGRGYLSPDLSK 233

Query: 535 YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
             +   +   M ++   C+ +  +ERP    +L  +E + R
Sbjct: 234 VRSNCPK--AMKRLMAECLKKKRDERPLFPQILASIELLAR 272

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 2e-51
 Identities = 52/274 (18%), Positives = 108/274 (39%), Gaps = 29/274 (10%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           + +G G FG  +     +   V +K ++E  + + +F ++ E++  + H  +V L     
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL 70

Query: 366 SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLV 425
            +    +V+++ E G     L       +     +T + + +    G+A++       ++
Sbjct: 71  EQAPICLVFEFMEHGC----LSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VI 123

Query: 426 HGGIKASNIFLNSQGHVCVSDIGLAALMSP----MPPPAMRAAGYRAPEVTDTRKATQAS 481
           H  + A N  +     + VSD G+   +                + +PEV    + +  S
Sbjct: 124 HRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKS 183

Query: 482 DVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
           DV+SFGVL+ E+ + GK P       EVV  +     + +    +               
Sbjct: 184 DVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST-------------- 229

Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLKMVEDIR 574
               + Q+   C    PE+RP  + +L+ + +I 
Sbjct: 230 ---HVYQIMNHCWKERPEDRPAFSRLLRQLAEIA 260

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 1e-50
 Identities = 54/273 (19%), Positives = 104/273 (38%), Gaps = 29/273 (10%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           + LG G FG            V +K +KE ++ + EF ++ +++  + HE +V L     
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT 69

Query: 366 SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLV 425
            +    ++ +Y   G +   L   R            + +       + ++ ++     +
Sbjct: 70  KQRPIFIITEYMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLESKQ---FL 122

Query: 426 HGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRA----AGYRAPEVTDTRKATQAS 481
           H  + A N  +N QG V VSD GL+  +      +         +  PEV    K +  S
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182

Query: 482 DVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
           D+++FGVL+ E+ + GK P       E    +     + R    +E              
Sbjct: 183 DIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASE-------------- 228

Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
              ++  +  +C     +ERP    +L  + D+
Sbjct: 229 ---KVYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (438), Expect = 3e-50
 Identities = 61/272 (22%), Positives = 106/272 (38%), Gaps = 27/272 (9%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           + +GKG FG          + V VK +K  +   + F  +  ++  +RH N+V L     
Sbjct: 13  QTIGKGEFGDVMLGDYRG-NKVAVKCIKN-DATAQAFLAEASVMTQLRHSNLVQLLGVIV 70

Query: 366 SKDEKL-MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKL 424
            +   L +V +Y   GS+   L  R   G+S L  D  ++ ++     + ++   N    
Sbjct: 71  EEKGGLYIVTEYMAKGSLVDYLRSR---GRSVLGGDCLLKFSLDVCEAMEYLEGNN---F 124

Query: 425 VHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTRKATQASDVF 484
           VH  + A N+ ++      VSD GL    S           + APE    +K +  SDV+
Sbjct: 125 VHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTKSDVW 184

Query: 485 SFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEMV 543
           SFG+LL E+ + G+ P       +VV  V                  +  +    +    
Sbjct: 185 SFGILLWEIYSFGRVPYPRIPLKDVVPRVE-----------------KGYKMDAPDGCPP 227

Query: 544 EMLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
            + +V   C       RP    + + +E I+ 
Sbjct: 228 AVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (430), Expect = 1e-48
 Identities = 57/296 (19%), Positives = 108/296 (36%), Gaps = 33/296 (11%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           E +GKG FG  ++        V VK            E ++     +RHEN++   A   
Sbjct: 9   ESIGKGRFGEVWRGKWRG-EEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADN 67

Query: 366 SKDEKL----MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENG 421
             +       +V DY E GS+   L+         +  +  +++A+  A G+AH+H E  
Sbjct: 68  KDNGTWTQLWLVSDYHEHGSLFDYLNRYT------VTVEGMIKLALSTASGLAHLHMEIV 121

Query: 422 G-----KLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAA-------GYRAP 469
           G      + H  +K+ NI +   G  C++D+GLA            A         Y AP
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 470 EVTDTR------KATQASDVFSFGVLLLELLTGKSPIHATGGDEV----VHLVRWVNSVV 519
           EV D        ++ + +D+++ G++  E+    S        ++    +         +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

Query: 520 REEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
           R+    +     +       E +  M ++   C       R     + K +  + +
Sbjct: 242 RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 1e-47
 Identities = 77/286 (26%), Positives = 116/286 (40%), Gaps = 29/286 (10%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
             LG+G FG  +       + V +K LK   +    F Q+ +++  +RHE +V L A   
Sbjct: 23  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYA-VV 81

Query: 366 SKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLV 425
           S++   +V +Y   GS+   L G  G+          V +A   A G+A++   N    V
Sbjct: 82  SEEPIYIVTEYMSKGSLLDFLKGETGKYL---RLPQLVDMAAQIASGMAYVERMN---YV 135

Query: 426 HGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAA----GYRAPEVTDTRKATQAS 481
           H  ++A+NI +       V+D GLA L+      A + A     + APE     + T  S
Sbjct: 136 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 195

Query: 482 DVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
           DV+SFG+LL EL T G+ P       EV+  V                     R P   E
Sbjct: 196 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVE-----------------RGYRMPCPPE 238

Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTEN 586
               +  +   C  + PEERP    +   +ED            EN
Sbjct: 239 CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPGEN 284

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 8e-47
 Identities = 73/297 (24%), Positives = 127/297 (42%), Gaps = 40/297 (13%)

Query: 306 EVLGKGTFGTAYKAALEDAS-----TVVVKRLKE--VNVGKREFEQQMEIVGGIRHENVV 358
           +V+G G FG  YK  L+ +S      V +K LK       + +F  +  I+G   H N++
Sbjct: 13  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 72

Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT 418
            L          +++ +Y E G++   L  + GE          V +  G A G+ ++  
Sbjct: 73  RLEGVISKYKPMMIITEYMENGALDKFLREKDGE----FSVLQLVGMLRGIAAGMKYLAN 128

Query: 419 ENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG------YRAPEVT 472
            N    VH  + A NI +NS     VSD GL+ ++   P      +G      + APE  
Sbjct: 129 MN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185

Query: 473 DTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
             RK T ASDV+SFG+++ E++T     +         +++ +N              + 
Sbjct: 186 SYRKFTSASDVWSFGIVMWEVMTYGERPY--WELSNHEVMKAIN--------------DG 229

Query: 533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTENRSE 589
            R P   +    + Q+ M C  +    RPK AD++ +++ + R     P S +  ++
Sbjct: 230 FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR----APDSLKTLAD 282

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (412), Expect = 7e-46
 Identities = 46/293 (15%), Positives = 105/293 (35%), Gaps = 37/293 (12%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKRLK--EVNVGKREFEQQMEIVGGIRHENVVALRA 362
             LG G  G  +K +       +  K +        + +  ++++++       +V    
Sbjct: 12  SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYG 71

Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGG 422
            +YS  E  +  ++ + GS+  +L          +      +++I   +G+ ++  ++  
Sbjct: 72  AFYSDGEISICMEHMDGGSLDQVLKKAGR-----IPEQILGKVSIAVIKGLTYLREKHK- 125

Query: 423 KLVHGGIKASNIFLNSQGHVCVSDIGLA-ALMSPMPPPAMRAAGYRAPEVTDTRKATQAS 481
            ++H  +K SNI +NS+G + + D G++  L+  M    +    Y +PE       +  S
Sbjct: 126 -IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQS 184

Query: 482 DVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEE 541
           D++S G+ L+E+  G+ PI      E+  +          E                 + 
Sbjct: 185 DIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDS 244

Query: 542 MVEMLQVGMA--------------------------CVVRMPEERPKMADVLK 568
              M    +                           C+++ P ER  +  ++ 
Sbjct: 245 RPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 297

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  162 bits (410), Expect = 7e-46
 Identities = 67/293 (22%), Positives = 117/293 (39%), Gaps = 43/293 (14%)

Query: 306 EVLGKGTFGTAYKAAL----EDASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVA 359
           +V+G G FG      L    +    V +K LK       +R+F  +  I+G   H NV+ 
Sbjct: 32  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIH 91

Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE 419
           L          +++ ++ E GS+ + L    G+          V +  G A G+ ++   
Sbjct: 92  LEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQF----TVIQLVGMLRGIAAGMKYLADM 147

Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPA--------MRAAGYRAPEV 471
           N    VH  + A NI +NS     VSD GL+  +                    + APE 
Sbjct: 148 N---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 204

Query: 472 TDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDV 530
              RK T ASDV+S+G+++ E+++ G+ P       +V++ +                  
Sbjct: 205 IQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIE----------------- 247

Query: 531 ELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPS 583
           +  R P   +    + Q+ + C  +    RPK   ++  ++ + R    NP S
Sbjct: 248 QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIR----NPNS 296

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  160 bits (406), Expect = 2e-45
 Identities = 59/275 (21%), Positives = 111/275 (40%), Gaps = 27/275 (9%)

Query: 306 EVLGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYY 364
             LG G +G  Y+   +  S  V VK LKE  +   EF ++  ++  I+H N+V L    
Sbjct: 23  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC 82

Query: 365 YSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKL 424
             +    ++ ++   G++   L     +    +     + +A   +  + ++  +N    
Sbjct: 83  TREPPFYIITEFMTYGNLLDYLRECNRQ---EVSAVVLLYMATQISSAMEYLEKKN---F 136

Query: 425 VHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAA----GYRAPEVTDTRKATQA 480
           +H  + A N  +     V V+D GL+ LM+     A   A     + APE     K +  
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 196

Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
           SDV++FGVLL E+ T     +   G ++  +   +                  R    E 
Sbjct: 197 SDVWAFGVLLWEIATYGMSPY--PGIDLSQVYELLEKD--------------YRMERPEG 240

Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
              ++ ++  AC    P +RP  A++ +  E + +
Sbjct: 241 CPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 3e-45
 Identities = 66/297 (22%), Positives = 113/297 (38%), Gaps = 37/297 (12%)

Query: 292 NLVFDLEDLLRASAEVLGKGTFGTAYKAALEDAST----VVVKRLKEVN--VGKREFEQQ 345
           ++V     L+    EV+G+G FG  Y   L D         VK L  +       +F  +
Sbjct: 19  HVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTE 78

Query: 346 MEIVGGIRHENVVALRAYYYSKDEK-LMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVR 404
             I+    H NV++L       +   L+V  Y + G +   +                + 
Sbjct: 79  GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHN----PTVKDLIG 134

Query: 405 IAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMR-- 462
             +  A+G+  + ++   K VH  + A N  L+ +  V V+D GLA  M      ++   
Sbjct: 135 FGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNK 191

Query: 463 -----AAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNS 517
                   + A E   T+K T  SDV+SFGVLL EL+T  +P +       V+       
Sbjct: 192 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPD-----VNTFDITVY 246

Query: 518 VVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIR 574
           +++             R    E     + +V + C     E RP  ++++  +  I 
Sbjct: 247 LLQGR-----------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIF 292

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 2e-44
 Identities = 60/293 (20%), Positives = 113/293 (38%), Gaps = 38/293 (12%)

Query: 293 LVFDLEDLLRASAEVLGKGTFGTAYKAALEDAST---VVVKRLKEVN--VGKREFEQQME 347
           L    ++LL A  E LG G FG+  +           V +K LK+        E  ++ +
Sbjct: 3   LFLKRDNLLIADIE-LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQ 61

Query: 348 IVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAI 407
           I+  + +  +V L     + +  ++V +    G +   L G+R E    +       +  
Sbjct: 62  IMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREE----IPVSNVAELLH 116

Query: 408 GAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRA---- 463
             + G+ ++  +N    VH  + A N+ L ++ +  +SD GL+  +              
Sbjct: 117 QVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 173

Query: 464 --AGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVR 520
               + APE  + RK +  SDV+S+GV + E L+ G+ P     G EV+  +        
Sbjct: 174 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ------ 227

Query: 521 EEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
                      +   P    E+  ++     C +   E+RP    V + +   
Sbjct: 228 --------GKRMECPPECPPELYALM---SDCWIYKWEDRPDFLTVEQRMRAC 269

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  158 bits (401), Expect = 5e-44
 Identities = 55/269 (20%), Positives = 110/269 (40%), Gaps = 27/269 (10%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNVGKRE-FEQQMEIVGGIRHENVVALRAY 363
           E LG G FG  ++       +    K +   +   +E   ++++ +  +RH  +V L   
Sbjct: 32  EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91

Query: 364 YYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGK 423
           +   +E +M+Y++   G +   +          +  D  V       +G+ H+H  N   
Sbjct: 92  FEDDNEMVMIYEFMSGGELFEKVADEHN----KMSEDEAVEYMRQVCKGLCHMHENN--- 144

Query: 424 LVHGGIKASNIFLNSQ--GHVCVSDIGLAALMSPMPPPAM--RAAGYRAPEVTDTRKATQ 479
            VH  +K  NI   ++    + + D GL A + P     +    A + APEV + +    
Sbjct: 145 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGY 204

Query: 480 ASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE 539
            +D++S GVL   LL+G SP      DE +  V+  +           ++++   +  I 
Sbjct: 205 YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD-----------WNMDDSAFSGIS 253

Query: 540 EEMVEMLQVGMACVVRMPEERPKMADVLK 568
           E+  + ++     ++  P  R  +   L+
Sbjct: 254 EDGKDFIR---KLLLADPNTRMTIHQALE 279

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (394), Expect = 6e-44
 Identities = 56/275 (20%), Positives = 114/275 (41%), Gaps = 31/275 (11%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALR 361
             +G G++G   K     D   +V K L   ++    K+    ++ ++  ++H N+V   
Sbjct: 10  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 69

Query: 362 AYYYSKDEKL--MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE 419
                +      +V +Y E G +++++     E Q  LD +  +R+       +   H  
Sbjct: 70  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY-LDEEFVLRVMTQLTLALKECHRR 128

Query: 420 NGG--KLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPA---MRAAGYRAPEVTDT 474
           + G   ++H  +K +N+FL+ + +V + D GLA +++     A   +    Y +PE  + 
Sbjct: 129 SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR 188

Query: 475 RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLR 534
               + SD++S G LL EL     P  A    E+   +R               + +  R
Sbjct: 189 MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR---------------EGKFRR 233

Query: 535 YP-NIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
            P    +E+ E++      +      RP + ++L+
Sbjct: 234 IPYRYSDELNEII---TRMLNLKDYHRPSVEEILE 265

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  156 bits (396), Expect = 7e-44
 Identities = 58/301 (19%), Positives = 114/301 (37%), Gaps = 53/301 (17%)

Query: 306 EVLGKGTFGTAYKA------ALEDASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENV 357
             +G+G FG  ++A        E  + V VK LKE      + +F+++  ++    + N+
Sbjct: 19  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78

Query: 358 VALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGE-------------------GQSSLD 398
           V L           ++++Y   G ++  L                         G   L 
Sbjct: 79  VKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLS 138

Query: 399 WDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP 458
              ++ IA   A G+A++        VH  +   N  +     V ++D GL+  +     
Sbjct: 139 CAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY 195

Query: 459 PAMRA-----AGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLV 512
                       +  PE     + T  SDV+++GV+L E+ + G  P +    +EV++ V
Sbjct: 196 YKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYV 255

Query: 513 RWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVED 572
           R               D  +L  P  E   +E+  +   C  ++P +RP    + ++++ 
Sbjct: 256 R---------------DGNILACP--ENCPLELYNLMRLCWSKLPADRPSFCSIHRILQR 298

Query: 573 I 573
           +
Sbjct: 299 M 299

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 2e-43
 Identities = 65/284 (22%), Positives = 115/284 (40%), Gaps = 39/284 (13%)

Query: 306 EVLGKGTFGTAYKAALEDAS----TVVVKRLKEVNVGK----REFEQQMEIVGGIRHENV 357
           E LG G+FG   +   +  S    +V VK LK   + +     +F +++  +  + H N+
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73

Query: 358 VALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIH 417
           + L     +   K MV +    GS+   L   +G         T  R A+  A G+ ++ 
Sbjct: 74  IRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYLE 128

Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRA------AGYRAPEV 471
           ++     +H  + A N+ L ++  V + D GL   +       +          + APE 
Sbjct: 129 SKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185

Query: 472 TDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDV 530
             TR  + ASD + FGV L E+ T G+ P     G +++H +                D 
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI----------------DK 229

Query: 531 ELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIR 574
           E  R P  E+   ++  V + C    PE+RP    +   + + +
Sbjct: 230 EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (394), Expect = 2e-43
 Identities = 61/295 (20%), Positives = 110/295 (37%), Gaps = 45/295 (15%)

Query: 306 EVLGKGTFGTAYKAAL------EDASTVVVKRLK--EVNVGKREFEQQMEIVGGI-RHEN 356
           + LG G FG   +A        + A TV VK LK       +     +++++  +  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 357 VVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRG-------------EGQSSLDWDTRV 403
           +V L          L++ +Y   G +   L  +R              + + +LD +  +
Sbjct: 89  IVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLL 148

Query: 404 RIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMR- 462
             +   A+G+A + ++N    +H  + A NI L       + D GLA  +       ++ 
Sbjct: 149 SFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKG 205

Query: 463 ----AAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSV 518
                  + APE       T  SDV+S+G+ L EL +  S  +  G        + +   
Sbjct: 206 NARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP-GMPVDSKFYKMIK-- 262

Query: 519 VREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
                       E  R  + E    EM  +   C    P +RP    +++++E  
Sbjct: 263 ------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  155 bits (393), Expect = 2e-43
 Identities = 58/271 (21%), Positives = 114/271 (42%), Gaps = 33/271 (12%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRLKEVNVGKRE----FEQQMEIVGGIRHENVVAL 360
             +G G+FG  Y A  + ++  V +K++        E      +++  +  +RH N +  
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN 420
           R  Y  +    +V +Y    +   +   ++      L       +  GA +G+A++H+ N
Sbjct: 81  RGCYLREHTAWLVMEYCLGSASDLLEVHKKP-----LQEVEIAAVTHGALQGLAYLHSHN 135

Query: 421 GGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEV---TDTRKA 477
              ++H  +KA NI L+  G V + D G A++M+P     +    + APEV    D  + 
Sbjct: 136 ---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF-VGTPYWMAPEVILAMDEGQY 191

Query: 478 TQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN 537
               DV+S G+  +EL   K P+     + +  L     +           +   L+  +
Sbjct: 192 DGKVDVWSLGITCIELAERKPPLF--NMNAMSALYHIAQN-----------ESPALQSGH 238

Query: 538 IEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
             E     +    +C+ ++P++RP    +LK
Sbjct: 239 WSEYFRNFV---DSCLQKIPQDRPTSEVLLK 266

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (388), Expect = 7e-43
 Identities = 52/273 (19%), Positives = 105/273 (38%), Gaps = 32/273 (11%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRLKEVNVGKRE-FEQQMEIVGGIRHENVVALRAY 363
             LG G FG  YKA   E +     K +   +  + E +  +++I+    H N+V L   
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 364 YYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGK 423
           +Y ++   ++ ++   G+V A++          L       +       + ++H      
Sbjct: 78  FYYENNLWILIEFCAGGAVDAVMLELER----PLTESQIQVVCKQTLDALNYLHDNK--- 130

Query: 424 LVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEV-----TDTR 475
           ++H  +KA NI     G + ++D G++A  +          G   + APEV     +  R
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 190

Query: 476 KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY 535
                +DV+S G+ L+E+   + P H      V+        + + E         L + 
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK------IAKSEP------PTLAQP 238

Query: 536 PNIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
                   + L+    C+ +  + R   + +L+
Sbjct: 239 SRWSSNFKDFLK---KCLEKNVDARWTTSQLLQ 268

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 1e-42
 Identities = 62/269 (23%), Positives = 104/269 (38%), Gaps = 32/269 (11%)

Query: 306 EVLGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQM----EIVGGIRHENVVAL 360
             LGKG FG  Y A  + +  ++ +K L +  + K   E Q+    EI   +RH N++ L
Sbjct: 12  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN 420
             Y++      ++ +Y   G+V   L           D           A  +++ H++ 
Sbjct: 72  YGYFHDATRVYLILEYAPLGTVYRELQKLSK-----FDEQRTATYITELANALSYCHSKR 126

Query: 421 GGKLVHGGIKASNIFLNSQGHVCVSDIGLA-ALMSPMPPPAMRAAGYRAPEVTDTRKATQ 479
              ++H  IK  N+ L S G + ++D G +    S           Y  PE+ + R   +
Sbjct: 127 ---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDE 183

Query: 480 ASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE 539
             D++S GVL  E L GK P  A    E    +  V     +  T    D  L+      
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARD--LIS----- 236

Query: 540 EEMVEMLQVGMACVVRMPEERPKMADVLK 568
                        +   P +RP + +VL+
Sbjct: 237 -----------RLLKHNPSQRPMLREVLE 254

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 2e-42
 Identities = 59/280 (21%), Positives = 100/280 (35%), Gaps = 39/280 (13%)

Query: 307 VLGKGTFGTAYKAALEDAST---VVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVAL 360
            LG G FGT  K   +       V VK LK        K E   +  ++  + +  +V +
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN 420
                  +  ++V +  E G ++  L   R      +     + +    + G+ ++   N
Sbjct: 74  IGICE-AESWMLVMEMAELGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESN 127

Query: 421 GGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRA------AGYRAPEVTDT 474
               VH  + A N+ L +Q +  +SD GL+  +                  + APE  + 
Sbjct: 128 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY 184

Query: 475 RKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELL 533
            K +  SDV+SFGVL+ E  + G+ P     G EV  ++                  +  
Sbjct: 185 YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE-----------------KGE 227

Query: 534 RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
           R         EM  +   C     E RP  A V   + + 
Sbjct: 228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 3e-42
 Identities = 60/307 (19%), Positives = 109/307 (35%), Gaps = 38/307 (12%)

Query: 306 EVLGKGTFGTAYKAALEDAST---VVVKRLKEVNV--GKREFEQQMEIVGGI-RHENVVA 359
           +V+G+G FG   KA ++         +KR+KE       R+F  ++E++  +  H N++ 
Sbjct: 16  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 75

Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGR-----------RGEGQSSLDWDTRVRIAIG 408
           L      +    +  +Y   G++   L                   S+L     +  A  
Sbjct: 76  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 135

Query: 409 AARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRA--AGY 466
            ARG+ ++  +     +H  + A NI +       ++D GL+          M      +
Sbjct: 136 VARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRW 192

Query: 467 RAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAE 526
            A E  +    T  SDV+S+GVLL E+++     +   G     L   +    R E    
Sbjct: 193 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYC--GMTCAELYEKLPQGYRLEKPLN 250

Query: 527 VFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTEN 586
             D              E+  +   C    P ERP  A +L  +  +   +     +T  
Sbjct: 251 CDD--------------EVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLY 296

Query: 587 RSEISSS 593
                + 
Sbjct: 297 EKFTYAG 303

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (383), Expect = 5e-42
 Identities = 50/268 (18%), Positives = 105/268 (39%), Gaps = 29/268 (10%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRLKEVNVGKRE-FEQQMEIVGGIRHENVVALRAY 363
           E +G+G  GT Y A  +     V ++++      K+E    ++ ++   ++ N+V     
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 364 YYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGK 423
           Y   DE  +V +Y   GS++ ++           D      +     + +  +H+     
Sbjct: 86  YLVGDELWVVMEYLAGGSLTDVVTETCM------DEGQIAAVCRECLQALEFLHSNQ--- 136

Query: 424 LVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTDTRKATQA 480
           ++H  IK+ NI L   G V ++D G  A ++P         G   + APEV   +     
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196

Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
            D++S G++ +E++ G+ P         ++L+    +   +                +  
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP------------EKLSA 244

Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLK 568
              + L     C+    E+R    ++L+
Sbjct: 245 IFRDFLN---RCLDMDVEKRGSAKELLQ 269

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 9e-42
 Identities = 61/273 (22%), Positives = 116/273 (42%), Gaps = 32/273 (11%)

Query: 306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVGKRE---FEQQMEIVGGIRHENVVALR 361
             +G+G+F T YK    E    V    L++  + K E   F+++ E++ G++H N+V   
Sbjct: 15  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFY 74

Query: 362 AYYYS----KDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIH 417
             + S    K   ++V +    G++   L   +      +             +G+  +H
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLH 129

Query: 418 TENGGKLVHGGIKASNIFLNSQ-GHVCVSDIGLAALMSPMPPPAMRA-AGYRAPEVTDTR 475
                 ++H  +K  NIF+    G V + D+GLA L       A+     + APE+ +  
Sbjct: 130 -TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE-E 187

Query: 476 KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY 535
           K  ++ DV++FG+ +LE+ T + P           + R V S V+     +V        
Sbjct: 188 KYDESVDVYAFGMCMLEMATSEYPYS--ECQNAAQIYRRVTSGVKPASFDKVAI------ 239

Query: 536 PNIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
                E+ E+++    C+ +  +ER  + D+L 
Sbjct: 240 ----PEVKEIIE---GCIRQNKDERYSIKDLLN 265

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (380), Expect = 2e-41
 Identities = 60/323 (18%), Positives = 116/323 (35%), Gaps = 39/323 (12%)

Query: 306 EVLGKGTFGTAYKAAL-----EDASTVVVKRLKEVNVGK--REFEQQMEIVGGIRHENVV 358
           +VLG G FGT YK        +    V +K L+E    K  +E   +  ++  + + +V 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74

Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT 418
            L     +   +L +      G +   +   +            +   +  A+G+ ++  
Sbjct: 75  RLLGICLTSTVQL-ITQLMPFGCLLDYVREHKDNI----GSQYLLNWCVQIAKGMNYLED 129

Query: 419 ENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG-----YRAPEVTD 473
                LVH  + A N+ + +  HV ++D GLA L+           G     + A E   
Sbjct: 130 RR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186

Query: 474 TRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
            R  T  SDV+S+GV + EL+T G  P       E+  ++                  + 
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE-----------------KG 229

Query: 533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKAENPPSTENRSEISS 592
            R P      +++  + + C +   + RPK  +++     + R   +     +    +  
Sbjct: 230 ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR-DPQRYLVIQGDERMHL 288

Query: 593 SAATPKATETASSSTAHLDSFLS 615
            + T      A      +D  + 
Sbjct: 289 PSPTDSNFYRALMDEEDMDDVVD 311

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  150 bits (380), Expect = 4e-41
 Identities = 64/318 (20%), Positives = 123/318 (38%), Gaps = 32/318 (10%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKRL-KEVNVGKREFEQQMEIVGGIRHENVVALRAY 363
           E LG G FG  ++          V K +     + K   + ++ I+  + H  ++ L   
Sbjct: 35  EELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 94

Query: 364 YYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGK 423
           +  K E +++ ++   G +   +          +     +     A  G+ H+H  +   
Sbjct: 95  FEDKYEMVLILEFLSGGELFDRIAAEDY----KMSEAEVINYMRQACEGLKHMHEHS--- 147

Query: 424 LVHGGIKASNIFLNSQ--GHVCVSDIGLAALMSP--MPPPAMRAAGYRAPEVTDTRKATQ 479
           +VH  IK  NI   ++    V + D GLA  ++P  +       A + APE+ D      
Sbjct: 148 IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGF 207

Query: 480 ASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE 539
            +D+++ GVL   LL+G SP       E +  V+  +    E+            + ++ 
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED-----------AFSSVS 256

Query: 540 EEMVEMLQVGMACVVRMPEERPKMADVLK---MVEDIRRVKAENPPSTEN--RSEISSSA 594
            E  + ++     + + P +R  + D L+   +  D   + +  P S  N  R +I    
Sbjct: 257 PEAKDFIK---NLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKY 313

Query: 595 ATPKATETASSSTAHLDS 612
           A   A + A    A+  S
Sbjct: 314 ADWPAPQPAIGRIANFSS 331

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 1e-40
 Identities = 52/272 (19%), Positives = 96/272 (35%), Gaps = 32/272 (11%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKRL--KEVNVGKREFEQQMEIVGGIRHENVVALRA 362
           + LG+G +G    A        V VK +  K         ++++ I   + HENVV    
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 70

Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGG 422
           +    + + +  +Y   G +   +    G     +      R       G+ ++H     
Sbjct: 71  HRREGNIQYLFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLHGIG-- 123

Query: 423 KLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAA-----GYRAPEVTDTRK- 476
            + H  IK  N+ L+ + ++ +SD GLA +        +         Y APE+   R+ 
Sbjct: 124 -ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182

Query: 477 ATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP 536
             +  DV+S G++L  +L G+        D       W                    + 
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGE-LPWDQPSDSCQEYSDWKEKKTYLN-----------PWK 230

Query: 537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
            I+   + +L      +V  P  R  + D+ K
Sbjct: 231 KIDSAPLALLH---KILVENPSARITIPDIKK 259

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 1e-40
 Identities = 57/296 (19%), Positives = 108/296 (36%), Gaps = 50/296 (16%)

Query: 306 EVLGKGTFGTAYKAALEDAS------TVVVKRLKEV--NVGKREFEQQMEIVGGI-RHEN 356
           +VLG G FG    A     S       V VK LKE   +  +     +++++  +  HEN
Sbjct: 43  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102

Query: 357 VVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRG------------------EGQSSLD 398
           +V L           ++++Y   G +   L  +R                   E  + L 
Sbjct: 103 IVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 162

Query: 399 WDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP--- 455
           ++  +  A   A+G+  +  ++    VH  + A N+ +     V + D GLA  +     
Sbjct: 163 FEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN 219

Query: 456 --MPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVR 513
             +   A     + APE       T  SDV+S+G+LL E+ +     +  G     +  +
Sbjct: 220 YVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP-GIPVDANFYK 278

Query: 514 WVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM 569
            + +  + +                 EE+  ++Q   +C      +RP   ++   
Sbjct: 279 LIQNGFKMDQP-----------FYATEEIYIIMQ---SCWAFDSRKRPSFPNLTSF 320

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (374), Expect = 2e-40
 Identities = 57/318 (17%), Positives = 125/318 (39%), Gaps = 29/318 (9%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYY 364
           E LG+G FG  ++        T + K +K     +   ++++ I+   RH N++ L   +
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESF 70

Query: 365 YSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKL 424
            S +E +M++++     +   ++    E    L+    V         +  +H+ N   +
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSAFE----LNEREIVSYVHQVCEALQFLHSHN---I 123

Query: 425 VHGGIKASNIFLNSQ--GHVCVSDIGLAALMSPMPP--PAMRAAGYRAPEVTDTRKATQA 480
            H  I+  NI   ++    + + + G A  + P         A  Y APEV      + A
Sbjct: 124 GHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA 183

Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
           +D++S G L+  LL+G +P  A    +++  +        EE            +  I  
Sbjct: 184 TDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEE-----------AFKEISI 232

Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLK---MVEDIRRVKAENPPSTENRSEISSSAATP 597
           E ++ +      +V+  + R   ++ L+   + + I RV  +   + ++R    +     
Sbjct: 233 EAMDFVD---RLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKD 289

Query: 598 KATETASSSTAHLDSFLS 615
                +++  +   +  S
Sbjct: 290 LNMVVSAARISCGGAIRS 307

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 5e-40
 Identities = 57/281 (20%), Positives = 108/281 (38%), Gaps = 36/281 (12%)

Query: 306 EVLGKGTFGTAYKAAL----EDASTVVVKRLKEV--NVGKREFEQQMEIVGGIRHENVVA 359
             +G+G FG  ++         A  V +K  K    +  + +F Q+   +    H ++V 
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72

Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE 419
           L     +++   ++ +    G + + L  R+     SLD  + +  A   +  +A++ ++
Sbjct: 73  LIGVI-TENPVWIIMELCTLGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLESK 127

Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG----YRAPEVTDTR 475
                VH  I A N+ ++S   V + D GL+  M                + APE  + R
Sbjct: 128 R---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184

Query: 476 KATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLR 534
           + T ASDV+ FGV + E+L  G  P      ++V+  +                   L  
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN--------------GERLPM 230

Query: 535 YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
            PN    +  ++     C    P  RP+  ++   +  I  
Sbjct: 231 PPNCPPTLYSLM---TKCWAYDPSRRPRFTELKAQLSTILE 268

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 8e-38
 Identities = 65/296 (21%), Positives = 112/296 (37%), Gaps = 48/296 (16%)

Query: 306 EVLGKGTFGTAYKA--------ALEDASTVVVKRLKE--VNVGKREFEQQMEIVGGI-RH 354
           + LG+G FG    A             + V VK LK         +   +ME++  I +H
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78

Query: 355 ENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEG-----------QSSLDWDTRV 403
           +N++ L           ++ +Y   G++   L  RR  G           +  L     V
Sbjct: 79  KNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLV 138

Query: 404 RIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPA--- 460
             A   ARG+ ++ ++     +H  + A N+ +     + ++D GLA  +  +       
Sbjct: 139 SCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTT 195

Query: 461 --MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNS 517
                  + APE    R  T  SDV+SFGVLL E+ T G SP      +E+  L++    
Sbjct: 196 NGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK---- 251

Query: 518 VVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
                        E  R         E+  +   C   +P +RP    +++ ++ I
Sbjct: 252 -------------EGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 3e-37
 Identities = 51/286 (17%), Positives = 101/286 (35%), Gaps = 37/286 (12%)

Query: 306 EVLGKGTFGTAYKAAL------EDASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENV 357
             LG+G+FG  Y+         E  + V +K + E      + EF  +  ++      +V
Sbjct: 26  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85

Query: 358 VALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRG-----EGQSSLDWDTRVRIAIGAARG 412
           V L          L++ +    G + + L   R         +       +++A   A G
Sbjct: 86  VRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADG 145

Query: 413 IAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP-----PAMRAAGYR 467
           +A+++       VH  + A N  +     V + D G+   +            +    + 
Sbjct: 146 MAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 202

Query: 468 APEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEV 527
           +PE       T  SDV+SFGV+L E+ T     +   G     ++R+V      +     
Sbjct: 203 SPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQ--GLSNEQVLRFVMEGGLLDKPDNC 260

Query: 528 FDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
            D               + ++   C    P+ RP   +++  +++ 
Sbjct: 261 PD--------------MLFELMRMCWQYNPKMRPSFLEIISSIKEE 292

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 1e-36
 Identities = 48/276 (17%), Positives = 105/276 (38%), Gaps = 36/276 (13%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRLKEVNVGKRE----FEQQMEIVGGIRHENVVAL 360
           ++LG+G+F T   A  L  +    +K L++ ++ K        ++ +++  + H   V L
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN 420
              +   ++      Y + G +   +         S D              + ++H + 
Sbjct: 74  YFTFQDDEKLYFGLSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGKG 128

Query: 421 GGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMR-----AAGYRAPEVTDTR 475
              ++H  +K  NI LN   H+ ++D G A ++SP    A        A Y +PE+   +
Sbjct: 129 ---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185

Query: 476 KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY 535
            A ++SD+++ G ++ +L+ G  P  A     +   +  +     E++  +  D  L+  
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARD--LVE- 242

Query: 536 PNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVE 571
                            +V    +R    ++     
Sbjct: 243 ---------------KLLVLDATKRLGCEEMEGYGP 263

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (343), Expect = 1e-36
 Identities = 68/299 (22%), Positives = 119/299 (39%), Gaps = 44/299 (14%)

Query: 306 EVLGKGTFGTAYKA------ALEDASTVVVKRLKE--VNVGKREFEQQMEIVGGIRHE-N 356
           + LG+G FG   +A            TV VK LKE   +   R    +++I+  I H  N
Sbjct: 19  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78

Query: 357 VVALRAYYYSKDEKLM-VYDYFEPGSVSAMLHGRRGE-----------GQSSLDWDTRVR 404
           VV L          LM + ++ + G++S  L  +R E            +  L  +  + 
Sbjct: 79  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138

Query: 405 IAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAA 464
            +   A+G+  + +      +H  + A NI L+ +  V + D GLA  +   P    +  
Sbjct: 139 YSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 195

Query: 465 -----GYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVV 519
                 + APE    R  T  SDV+SFGVLL E+ +  +  +       V +       +
Sbjct: 196 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY-----PGVKIDEEFCRRL 250

Query: 520 REEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKA 578
           +E            R    +    EM Q  + C    P +RP  +++++ + ++ +  A
Sbjct: 251 KEG----------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQANA 299

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (341), Expect = 6e-36
 Identities = 47/273 (17%), Positives = 100/273 (36%), Gaps = 29/273 (10%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYY 364
           +VLG G  G   +           +K L++    +RE E         +  ++V +   Y
Sbjct: 18  QVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRA---SQCPHIVRIVDVY 74

Query: 365 YSKDEK----LMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN 420
            +        L+V +  + G + + +  R   G  +        I       I ++H+ N
Sbjct: 75  ENLYAGRKCLLIVMECLDGGELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSIN 131

Query: 421 GGKLVHGGIKASNIFLNSQ---GHVCVSDIGLAALMSP--MPPPAMRAAGYRAPEVTDTR 475
              + H  +K  N+   S+     + ++D G A   +             Y APEV    
Sbjct: 132 ---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE 188

Query: 476 KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY 535
           K  ++ D++S GV++  LL G  P ++  G  +          ++       ++     +
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG-------MKTRIRMGQYEFPNPEW 241

Query: 536 PNIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
             + EE+  +++     +   P +R  + + + 
Sbjct: 242 SEVSEEVKMLIR---NLLKTEPTQRMTITEFMN 271

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  134 bits (338), Expect = 2e-35
 Identities = 66/287 (22%), Positives = 110/287 (38%), Gaps = 34/287 (11%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYY 365
           +V+G G+FG  Y+A L D+  +V   +K+V   KR   ++++I+  + H N+V LR ++Y
Sbjct: 26  KVIGNGSFGVVYQAKLCDSGELVA--IKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFY 83

Query: 366 SKDEK------LMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE 419
           S  EK       +V DY          H  R +   +L             R +A+IH+ 
Sbjct: 84  SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ--TLPVIYVKLYMYQLFRSLAYIHSF 141

Query: 420 NGGKLVHGGIKASNIFLNSQGHVC-VSDIGLAALMSPMPPPA--MRAAGYRAP-EVTDTR 475
               + H  IK  N+ L+    V  + D G A  +    P    + +  YRAP  +    
Sbjct: 142 G---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGAT 198

Query: 476 KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEV-------- 527
             T + DV+S G +L ELL G+       G + +  +  V      E   E+        
Sbjct: 199 DYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 258

Query: 528 ------FDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
                      +  P    E + +       +   P  R    +   
Sbjct: 259 FPQIKAHPWTKVFRPRTPPEAIALCS---RLLEYTPTARLTPLEACA 302

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (333), Expect = 3e-35
 Identities = 54/297 (18%), Positives = 98/297 (32%), Gaps = 26/297 (8%)

Query: 306 EVLGKGTFGTAYKA--ALEDASTVVVKRLKEVNVGKREFEQQ------MEIVGGIRHENV 357
             +G+G +G  +KA         V +KR++     +            +  +    H NV
Sbjct: 13  AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNV 72

Query: 358 VALRAYYYSKDEKLMVYDYFEPGSVS-AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHI 416
           V L                     V   +        +  +  +T   +     RG+  +
Sbjct: 73  VRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFL 132

Query: 417 HTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRA--AGYRAPEVTDT 474
           H+     +VH  +K  NI + S G + ++D GLA + S             YRAPEV   
Sbjct: 133 HSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 189

Query: 475 RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLR 534
                  D++S G +  E+   K     +   + +  +  V  +  EE       +    
Sbjct: 190 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA 249

Query: 535 YPNIEEEMVEMLQVGMA---------CVVRMPEERPKMADVLKM--VEDIRRVKAEN 580
           + +   + +E     +          C+   P +R      L     +D+ R K EN
Sbjct: 250 FHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCK-EN 305

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  131 bits (331), Expect = 9e-35
 Identities = 47/268 (17%), Positives = 96/268 (35%), Gaps = 24/268 (8%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRLKEVNVGKRE--FEQQMEIVGGIRHENVVALRA 362
           +VLG G F     A        V +K + +  +  +E   E ++ ++  I+H N+VAL  
Sbjct: 15  DVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDD 74

Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGG 422
            Y S     ++      G +   +  +              R+       + ++H     
Sbjct: 75  IYESGGHLYLIMQLVSGGELFDRIVEKG-----FYTERDASRLIFQVLDAVKYLHDLGIV 129

Query: 423 KLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRA--AGYRAPEVTDTRKATQA 480
                        L+    + +SD GL+ +  P    +      GY APEV   +  ++A
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKA 189

Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
            D +S GV+   LL G  P +     ++   +               ++ +   + +I +
Sbjct: 190 VDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAE-----------YEFDSPYWDDISD 238

Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLK 568
              + ++     + + PE+R      L+
Sbjct: 239 SAKDFIR---HLMEKDPEKRFTCEQALQ 263

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  132 bits (333), Expect = 1e-34
 Identities = 57/280 (20%), Positives = 105/280 (37%), Gaps = 35/280 (12%)

Query: 306 EVLGKGTFGTAYKAALEDASTVV-VKRLKEVNVGKREFEQQ-------MEIVGGIRHENV 357
            ++G+G FG  Y     D   +  +K L +  +  ++ E         + +V       +
Sbjct: 10  RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 69

Query: 358 VALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIH 417
           V +   +++ D+   + D    G +   L                   A     G+ H+H
Sbjct: 70  VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVF-----SEADMRFYAAEIILGLEHMH 124

Query: 418 TENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP-MPPPAMRAAGYRAPEVTDTRK 476
                 +V+  +K +NI L+  GHV +SD+GLA   S   P  ++   GY APEV     
Sbjct: 125 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGV 181

Query: 477 A-TQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY 535
           A   ++D FS G +L +LL G SP       +   + R   ++  E              
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP------------ 229

Query: 536 PNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
            +   E+  +L+     + R    R       +  ++++ 
Sbjct: 230 DSFSPELRSLLE---GLLQRDVNRRLGCLG--RGAQEVKE 264

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (328), Expect = 1e-34
 Identities = 55/277 (19%), Positives = 104/277 (37%), Gaps = 36/277 (12%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRLK-------EVNVGKREFEQQMEIVGGIRHENV 357
           E LG G F    K            K +K          V + + E+++ I+  I+H NV
Sbjct: 16  EELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNV 75

Query: 358 VALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIH 417
           + L   Y +K + +++ +    G +   L  +       L  +           G+ ++H
Sbjct: 76  ITLHEVYENKTDVILILELVAGGELFDFLAEKES-----LTEEEATEFLKQILNGVYYLH 130

Query: 418 TENGGKLVHGGIKASNIFLNSQG----HVCVSDIGLAALMSPMPPPAMRAA--GYRAPEV 471
           +     + H  +K  NI L  +      + + D GLA  +              + APE+
Sbjct: 131 SLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 187

Query: 472 TDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE 531
            +       +D++S GV+   LL+G SP       E +  V  VN    +E+        
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY-------- 239

Query: 532 LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
              + N      + ++     +V+ P++R  + D L+
Sbjct: 240 ---FSNTSALAKDFIR---RLLVKDPKKRMTIQDSLQ 270

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  130 bits (327), Expect = 2e-34
 Identities = 55/286 (19%), Positives = 109/286 (38%), Gaps = 39/286 (13%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRLKEVNVGK----REFEQQMEIVGGIRHENVVAL 360
           E+LG G     + A  L     V VK L+            F ++ +    + H  +VA+
Sbjct: 13  EILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 72

Query: 361 RAYYYSKDEKL----MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHI 416
                ++        +V +Y +  ++  ++H         +     + +   A + +   
Sbjct: 73  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-----MTPKRAIEVIADACQALNFS 127

Query: 417 HTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRA------AGYRAPE 470
           H      ++H  +K +NI +++   V V D G+A  ++       +       A Y +PE
Sbjct: 128 HQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPE 184

Query: 471 VTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDV 530
                     SDV+S G +L E+LTG+ P        V +        VRE+        
Sbjct: 185 QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQ------HVREDPIP----- 233

Query: 531 ELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV 576
              R+  +  ++  ++   +  + + PE R + A  ++   D+ RV
Sbjct: 234 PSARHEGLSADLDAVV---LKALAKNPENRYQTAAEMR--ADLVRV 274

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  129 bits (324), Expect = 3e-34
 Identities = 45/283 (15%), Positives = 94/283 (33%), Gaps = 42/283 (14%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIR----------- 353
           E+LG+G      +           VK +     G    E+  E+                
Sbjct: 9   EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 68

Query: 354 HENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGI 413
           H N++ L+  Y +     +V+D  + G +   L  +       L      +I       I
Sbjct: 69  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVT-----LSEKETRKIMRALLEVI 123

Query: 414 AHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP--------MPPPAMRAAG 465
             +H  N   +VH  +K  NI L+   ++ ++D G +  + P          P  +    
Sbjct: 124 CALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180

Query: 466 YRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTA 525
                  +     +  D++S GV++  LL G  P        ++ ++   N         
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN--------- 231

Query: 526 EVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
             +      + +  + + +++      +V  P++R    + L 
Sbjct: 232 --YQFGSPEWDDYSDTVKDLVS---RFLVVQPQKRYTAEEALA 269

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  126 bits (318), Expect = 6e-33
 Identities = 51/275 (18%), Positives = 111/275 (40%), Gaps = 33/275 (12%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRLKEVNVGK----REFEQQMEIVGGIRHENVVAL 360
             LG G+FG  +   +  +     +K LK+  V +         +  ++  + H  ++ +
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN 420
              +    +  M+ DY E G + ++L   +               A      + ++H+++
Sbjct: 70  WGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF-----PNPVAKFYAAEVCLALEYLHSKD 124

Query: 421 GGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTRKATQA 480
              +++  +K  NI L+  GH+ ++D G A  +  +         Y APEV  T+   ++
Sbjct: 125 ---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKS 181

Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
            D +SFG+L+ E+L G +P + +   +    +                + EL   P   E
Sbjct: 182 IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL---------------NAELRFPPFFNE 226

Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
           ++ ++L      + R   +R    ++    ED++ 
Sbjct: 227 DVKDLLS---RLITRDLSQRL--GNLQNGTEDVKN 256

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 7e-33
 Identities = 61/272 (22%), Positives = 104/272 (38%), Gaps = 35/272 (12%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRLKEVNVGKREFEQQME-----IVGGIRHENVVA 359
           ++LGKG+FG  + A   +      +K LK+  V   +  +        +     H  +  
Sbjct: 8   KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67

Query: 360 LRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE 419
           +   + +K+    V +Y   G +   +           D       A     G+  +H++
Sbjct: 68  MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK-----FDLSRATFYAAEIILGLQFLHSK 122

Query: 420 NGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTDTRK 476
               +V+  +K  NI L+  GH+ ++D G+               G   Y APE+   +K
Sbjct: 123 G---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179

Query: 477 ATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP 536
              + D +SFGVLL E+L G+SP H    +E+ H +R  N         E  D  LL   
Sbjct: 180 YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKD--LLV-- 235

Query: 537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
                            VR PE+R  +   ++
Sbjct: 236 --------------KLFVREPEKRLGVRGDIR 253

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (318), Expect = 9e-33
 Identities = 50/293 (17%), Positives = 117/293 (39%), Gaps = 42/293 (14%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRLKEVN--VGKREFEQQMEIVGGIRHENVVALRA 362
             +G+G +G    A    +   V +K++         +   ++++I+   RHEN++ +  
Sbjct: 14  SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND 73

Query: 363 YYYSKD----EKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT 418
              +      + + +  +     +  +L  +       L  D          RG+ +IH+
Sbjct: 74  IIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH------LSNDHICYFLYQILRGLKYIHS 127

Query: 419 ENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP------MPPPAMRAAGYRAPEV- 471
            N   ++H  +K SN+ LN+   + + D GLA +  P           +    YRAPE+ 
Sbjct: 128 AN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIM 184

Query: 472 TDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE 531
            +++  T++ D++S G +L E+L+ +         + ++ +  +     +E    + +++
Sbjct: 185 LNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK 244

Query: 532 LLRY----------------PNIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
              Y                PN + + +++L      +   P +R ++   L 
Sbjct: 245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEVEQALA 294

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  124 bits (313), Expect = 1e-32
 Identities = 52/284 (18%), Positives = 111/284 (39%), Gaps = 32/284 (11%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRL---KEVNVGKREFEQQMEIVGGIRHENVVALRA 362
           E +G+GT+G  YKA      T  +K++   KE         +++ I+  ++H N+V L  
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 363 YYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGG 422
             ++K   ++V+++ +      +     G     L+  T     +    GIA+ H     
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEGG-----LESVTAKSFLLQLLNGIAYCHDRR-- 120

Query: 423 KLVHGGIKASNIFLNSQGHVCVSDIGLAALM---SPMPPPAMRAAGYRAPEV-TDTRKAT 478
            ++H  +K  N+ +N +G + ++D GLA             +    YRAP+V   ++K +
Sbjct: 121 -VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179

Query: 479 QASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLR---- 534
              D++S G +  E++ G          + +  +  +      +    V ++        
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239

Query: 535 ----------YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
                        ++E  +++L      +   P +R      L+
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLS---KMLKLDPNQRITAKQALE 280

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  124 bits (312), Expect = 2e-32
 Identities = 36/282 (12%), Positives = 84/282 (29%), Gaps = 32/282 (11%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYY 364
             +G G+FG  Y    +     V +K    V     +   + +I   ++    +    + 
Sbjct: 13  RKIGSGSFGDIYLGTDIAAGEEVAIKLEC-VKTKHPQLHIESKIYKMMQGGVGIPTIRWC 71

Query: 365 YSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKL 424
            ++ +  ++       S+  + +    +        T + +A      I +IH++N    
Sbjct: 72  GAEGDYNVMVMELLGPSLEDLFNFCSRK----FSLKTVLLLADQMISRIEYIHSKN---F 124

Query: 425 VHGGIKASNIFLNSQGH---VCVSDIGLAALMSPMPPPAMRA----------AGYRAPEV 471
           +H  +K  N  +        V + D GLA                       A Y +   
Sbjct: 125 IHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINT 184

Query: 472 TDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE 531
               + ++  D+ S G +L+    G  P               ++          +    
Sbjct: 185 HLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLC--- 241

Query: 532 LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI 573
                    E    L     C     +++P  + + ++  ++
Sbjct: 242 ----KGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFRNL 276

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 1e-31
 Identities = 51/287 (17%), Positives = 110/287 (38%), Gaps = 36/287 (12%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKRLK---EVNVGKREFEQQMEIVGGIRHENVVALR 361
           E +G+GT+G  YKA        V +K+++   E         +++ ++  + H N+V L 
Sbjct: 8   EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLL 67

Query: 362 AYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENG 421
              +++++  +V+++        M           +             +G+A  H+   
Sbjct: 68  DVIHTENKLYLVFEFLHQDLKKFMDASALTG----IPLPLIKSYLFQLLQGLAFCHSHR- 122

Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP---MPPPAMRAAGYRAPEV-TDTRKA 477
             ++H  +K  N+ +N++G + ++D GLA             +    YRAPE+    +  
Sbjct: 123 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180

Query: 478 TQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY-- 535
           + A D++S G +  E++T ++     G  E+  L R   ++   +         +  Y  
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFP--GDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 238

Query: 536 --------------PNIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
                         P ++E+   +L      +   P +R      L 
Sbjct: 239 SFPKWARQDFSKVVPPLDEDGRSLLS---QMLHYDPNKRISAKAALA 282

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 1e-31
 Identities = 51/288 (17%), Positives = 111/288 (38%), Gaps = 35/288 (12%)

Query: 306 EVLGKGTFGTAYKAALEDASTVV-VKRLKEVNVGK------REFEQQMEIVGGIRHENVV 358
           + LG+G F T YKA  ++ + +V +K++K  +  +      R   ++++++  + H N++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 359 ALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT 418
            L   +  K    +V+D+ E      +           L         +   +G+ ++H 
Sbjct: 64  GLLDAFGHKSNISLVFDFMETDLEVIIKDNSLV-----LTPSHIKAYMLMTLQGLEYLHQ 118

Query: 419 ENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEV-TDT 474
                ++H  +K +N+ L+  G + ++D GLA                  YRAPE+    
Sbjct: 119 HW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGA 175

Query: 475 RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELL- 533
           R      D+++ G +L ELL     +      + +  +        EE   ++  +    
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV 235

Query: 534 ------------RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM 569
                        +    +++++++Q      +  P  R      LKM
Sbjct: 236 TFKSFPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQALKM 280

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  119 bits (298), Expect = 2e-30
 Identities = 34/286 (11%), Positives = 75/286 (26%), Gaps = 34/286 (11%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYY 364
             +G+G+FG  ++   L +   V +K          +   +      +     +    Y+
Sbjct: 11  RRIGEGSFGVIFEGTNLLNNQQVAIKFEPR-RSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 365 YSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKL 424
             +    ++       S+  +L              T    A      +  IH ++   L
Sbjct: 70  GQEGLHNVLVIDLLGPSLEDLLDLCGR----KFSVKTVAMAAKQMLARVQSIHEKS---L 122

Query: 425 VHGGIKASNIFLNSQ-----GHVCVSDIGLAAL----------MSPMPPPAMRAAGYRAP 469
           V+  IK  N  +          + V D G+                        A Y + 
Sbjct: 123 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 182

Query: 470 EVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD 529
                R+ ++  D+ + G + +  L G  P               +    +     E+  
Sbjct: 183 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC- 241

Query: 530 VELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
                     EE  + +           +  P    +  +   +  
Sbjct: 242 ------AGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKVLE 278

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  118 bits (296), Expect = 8e-30
 Identities = 47/268 (17%), Positives = 98/268 (36%), Gaps = 26/268 (9%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRLKEVNVGKRE----FEQQMEIVGGIRHENVVAL 360
           + LG G+FG        E  +   +K L +  V K +       +  I+  +    +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN 420
              +       MV +Y   G + + L                   A        ++H+ +
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR-----FSEPHARFYAAQIVLTFEYLHSLD 161

Query: 421 GGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEVTDTRKATQA 480
              L++  +K  N+ ++ QG++ V+D G A  +              APE+  ++   +A
Sbjct: 162 ---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKA 218

Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE 540
            D ++ GVL+ E+  G  P  A    ++   +          +++++ D+          
Sbjct: 219 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDL---------- 268

Query: 541 EMVEMLQVGMACVVRMPEERPKMADVLK 568
            +  +LQV +    R    +  + D+  
Sbjct: 269 -LRNLLQVDLTK--RFGNLKNGVNDIKN 293

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (290), Expect = 1e-29
 Identities = 45/276 (16%), Positives = 97/276 (35%), Gaps = 44/276 (15%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRLKEVNVGK-------REFEQQMEIVGGIR--HE 355
            +LG G FG+ Y    + D   V +K +++  +              ++ ++  +     
Sbjct: 10  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69

Query: 356 NVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAH 415
            V+ L  ++   D  +++ +  EP          RG    +L  +            + H
Sbjct: 70  GVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRH 125

Query: 416 IHTENGGKLVHGGIKASNIFLN-SQGHVCVSDIGLAALMSPMPPPAMRA-AGYRAPEVTD 473
            H      ++H  IK  NI ++ ++G + + D G  AL+             Y  PE   
Sbjct: 126 CHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIR 182

Query: 474 TRKA-TQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL 532
             +   +++ V+S G+LL +++ G  P                          E+   ++
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFEH---------------------DEEIIRGQV 221

Query: 533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
                +  E   +++    C+   P +RP   ++  
Sbjct: 222 FFRQRVSSECQHLIR---WCLALRPSDRPTFEEIQN 254

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 2e-29
 Identities = 54/284 (19%), Positives = 107/284 (37%), Gaps = 28/284 (9%)

Query: 306 EVLGKGTFGTAYKAA-LEDASTVVVKRLKEVNVGK---REFEQQMEIVGGIRHENVVALR 361
           + +G G +G    A      + V +K+L      +   +   +++ ++  +RHENV+ L 
Sbjct: 24  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83

Query: 362 AYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENG 421
             +   +      D++          G+  + +  L  D    +     +G+ +IH    
Sbjct: 84  DVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK-LGEDRIQFLVYQMLKGLRYIHAAGI 142

Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEV-TDTRKATQA 480
              +H  +K  N+ +N    + + D GLA          +    YRAPEV  +  + TQ 
Sbjct: 143 ---IHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQT 199

Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY----- 535
            D++S G ++ E++TGK+    +   + +  +  V      E+   +   E   Y     
Sbjct: 200 VDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLP 259

Query: 536 -----------PNIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
                       N     V +L+     +V   E+R    + L 
Sbjct: 260 ELEKKDFASILTNASPLAVNLLE---KMLVLDAEQRVTAGEALA 300

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 7e-29
 Identities = 50/268 (18%), Positives = 100/268 (37%), Gaps = 36/268 (13%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRLKEVNVGKRE----FEQQMEIVGGIRHENVVAL 360
           ++LGKGTFG               +K L++  +  ++       +  ++   RH  + AL
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 361 RAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN 420
           +  + + D    V +Y   G +   L   R         +            + ++H+ +
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERV-----FTEERARFYGAEIVSALEYLHSRD 125

Query: 421 GGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAG---YRAPEVTDTRKA 477
              +V+  IK  N+ L+  GH+ ++D GL               G   Y APEV +    
Sbjct: 126 ---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDY 182

Query: 478 TQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP- 536
            +A D +  GV++ E++ G+ P +    + +  L+                    +R+P 
Sbjct: 183 GRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE----------------IRFPR 226

Query: 537 NIEEEMVEMLQVGMACVVRMPEERPKMA 564
            +  E   +L      + + P++R    
Sbjct: 227 TLSPEAKSLLA---GLLKKDPKQRLGGG 251

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 2e-27
 Identities = 45/286 (15%), Positives = 106/286 (37%), Gaps = 34/286 (11%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRLKEVNVGK---REFEQQMEIVGGIRHENVVALR 361
           E +G+GT+GT +KA   E    V +KR++  +  +       +++ ++  ++H+N+V L 
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 362 AYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENG 421
              +S  +  +V+++ +                   D +          +G+   H+ N 
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDL-----DPEIVKSFLFQLLKGLGFCHSRN- 121

Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS----PMPPPAMRAAGYRAPEVTDTRKA 477
             ++H  +K  N+ +N  G + +++ GLA              +         +   +  
Sbjct: 122 --VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179

Query: 478 TQASDVFSFGVLLLELLTGKSPI-HATGGDEVVHLVRWVNSVVREEWTAEVFDVELLR-- 534
           + + D++S G +  EL     P+      D+ +  +  +     EE    +  +   +  
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239

Query: 535 ------------YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
                        P +     ++LQ     +   P +R    + L+
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQ---NLLKCNPVQRISAEEALQ 282

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 2e-27
 Identities = 54/295 (18%), Positives = 102/295 (34%), Gaps = 38/295 (12%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRLKEVNVGK---REFEQQMEIVGGIRHENVVALR 361
             +G+GTFG  +KA   +    V +K++   N  +       ++++I+  ++HENVV L 
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 362 AYYYSKDEKLMVYD---YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT 418
               +K           Y         L G               R+      G+ +IH 
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 135

Query: 419 ENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRA-------AGYRAPEV 471
                ++H  +KA+N+ +   G + ++D GLA   S                  YR PE+
Sbjct: 136 NK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 192

Query: 472 -TDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDV 530
               R      D++  G ++ E+ T    +        + L+  +   +  E    V + 
Sbjct: 193 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 252

Query: 531 ELLRYPNI-----------------EEEMVEMLQVGMACVVRMPEERPKMADVLK 568
           EL     +                 +   ++++      +V  P +R    D L 
Sbjct: 253 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID---KLLVLDPAQRIDSDDALN 304

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  107 bits (267), Expect = 6e-26
 Identities = 54/284 (19%), Positives = 106/284 (37%), Gaps = 28/284 (9%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRLK---EVNVGKREFEQQMEIVGGIRHENVVALR 361
             +G G +G+   A   +    V VK+L    +  +  +   +++ ++  ++HENV+ L 
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83

Query: 362 AYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENG 421
             +          D +    +         + Q  L  D    +     RG+ +IH+ + 
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK-LTDDHVQFLIYQILRGLKYIHSADI 142

Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRAAGYRAPEVT-DTRKATQA 480
              +H  +K SN+ +N    + + D GLA          +    YRAPE+  +     Q 
Sbjct: 143 ---IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT 199

Query: 481 SDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY----- 535
            D++S G ++ ELLTG++    T   + + L+  +      E   ++       Y     
Sbjct: 200 VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLT 259

Query: 536 -----------PNIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
                             V++L+     +V   ++R   A  L 
Sbjct: 260 QMPKMNFANVFIGANPLAVDLLE---KMLVLDSDKRITAAQALA 300

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (254), Expect = 2e-24
 Identities = 53/286 (18%), Positives = 103/286 (36%), Gaps = 40/286 (13%)

Query: 306 EVLGKGTFGTAYKA----ALEDASTVVVKRLKEVNVGKRE-----FEQQMEIVGGIRHE- 355
           +VLG G +G  +        +      +K LK+  + ++         + +++  IR   
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 356 NVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAH 415
            +V L   + ++ +  ++ DY   G +   L  R                       + H
Sbjct: 90  FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-----FTEHEVQIYVGEIVLALEH 144

Query: 416 IHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMR----AAGYRAPEV 471
           +H      +++  IK  NI L+S GHV ++D GL+                   Y AP++
Sbjct: 145 LHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 201

Query: 472 --TDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD 529
                    +A D +S GVL+ ELLTG SP    G       +              +  
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS-----------RRILK 250

Query: 530 VELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR 575
            E      +     +++Q     +++ P++R       +  ++I+ 
Sbjct: 251 SEPPYPQEMSALAKDLIQ---RLLMKDPKKRLGCGP--RDADEIKE 291

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  102 bits (255), Expect = 2e-24
 Identities = 48/336 (14%), Positives = 109/336 (32%), Gaps = 52/336 (15%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRA-- 362
             LG G F T + A  + + + V +K ++   V     E +++++  +   +     +  
Sbjct: 19  RKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMG 78

Query: 363 ---------YYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGI 413
                    ++  K    +            +L   +      +      +I+     G+
Sbjct: 79  ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138

Query: 414 AHIHTENGGKLVHGGIKASNIFLNSQG------HVCVSDIGLAALMSPMPPPAMRAAGYR 467
            ++H   G  ++H  IK  N+ +           + ++D+G A         +++   YR
Sbjct: 139 DYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196

Query: 468 APEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGG-------DEVVHLVRWVNSVVR 520
           +PEV         +D++S   L+ EL+TG        G       D +  ++  +  +  
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS 256

Query: 521 EEWTAEVF-----------------------DVELLRYPNIEEEMVEMLQVGMACVVRMP 557
                  +                       DV   +Y   ++E  E+       +   P
Sbjct: 257 YLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDP 316

Query: 558 EERPKMADVLKM--VEDIRRVKAENPPSTENRSEIS 591
            +R     ++    ++D   ++    P  E     S
Sbjct: 317 RKRADAGGLVNHPWLKDTLGMEEIRVPDRELYGSGS 352

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  101 bits (252), Expect = 4e-24
 Identities = 46/292 (15%), Positives = 106/292 (36%), Gaps = 43/292 (14%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIR-HENVVALRAY 363
             LG+G +   ++A  + +   VVVK LK V   K++ +++++I+  +R   N++ L   
Sbjct: 41  RKLGRGKYSEVFEAINITNNEKVVVKILKPVK--KKKIKREIKILENLRGGPNIITLADI 98

Query: 364 YYSKDEKL--MVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENG 421
                 +   +V+++        +          +L             + + + H+   
Sbjct: 99  VKDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMG- 149

Query: 422 GKLVHGGIKASNIFLNSQG-HVCVSDIGLAALMSPMPPPAMRAAG--YRAPEVT-DTRKA 477
             ++H  +K  N+ ++ +   + + D GLA    P     +R A   ++ PE+  D +  
Sbjct: 150 --IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMY 207

Query: 478 TQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPN 537
             + D++S G +L  ++  K P    G D    LVR    +  E+    +    +   P 
Sbjct: 208 DYSLDMWSLGCMLASMIFRKEPFFH-GHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266

Query: 538 IEEEMVEMLQVGMA---------------------CVVRMPEERPKMADVLK 568
             + +    +                          +    + R    + ++
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 92.3 bits (228), Expect = 7e-21
 Identities = 48/296 (16%), Positives = 99/296 (33%), Gaps = 41/296 (13%)

Query: 306 EVLGKGTFGTAYKA-ALEDASTVVVKRLKEVNVGK---REFEQQMEIVGGIRHENVVALR 361
           + +G G  G    A        V +K+L      +   +   +++ ++  + H+N+++L 
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82

Query: 362 AYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENG 421
             +  +       D +    +  M        Q  LD +    +      GI H+H+   
Sbjct: 83  NVFTPQKTLEEFQDVYLVMEL--MDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAGI 140

Query: 422 GKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRA--AGYRAPEVTDTRKATQ 479
              +H  +K SNI + S   + + D GLA                 YRAPEV       +
Sbjct: 141 ---IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKE 197

Query: 480 ASDVFSFGVLLLELLTGKSPIHATGGDEVVHLV--------------------------- 512
             D++S G ++ E++  K         +  + V                           
Sbjct: 198 NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRP 257

Query: 513 RWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLK 568
           ++      + +   +F  +         +  ++L      +V  P +R  + D L+
Sbjct: 258 KYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLS---KMLVIDPAKRISVDDALQ 310

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 89.0 bits (219), Expect = 5e-20
 Identities = 54/181 (29%), Positives = 84/181 (46%), Gaps = 10/181 (5%)

Query: 27  EDKQALLDFIHNIHNSRSL-NWNESSSLC-KSWTGVTCSAD--HSRVVALRLPGMALRGE 82
           +DKQALL    ++ N  +L +W  ++  C ++W GV C  D    RV  L L G+ L   
Sbjct: 6   QDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65

Query: 83  IP-PNTIGRLSALQNLSLRSN-SLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWN 140
            P P+++  L  L  L +    +L G  P   +KL  L  L++   + SG +P   S   
Sbjct: 66  YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125

Query: 141 NLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPS----WAFAGNN 196
            L  +D S N  + ++P SIS L +L  +    N ++G +P S   F         + N 
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNR 185

Query: 197 L 197
           L
Sbjct: 186 L 186

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 63.6 bits (153), Expect = 1e-11
 Identities = 22/61 (36%), Positives = 35/61 (57%), Gaps = 2/61 (3%)

Query: 139 WNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRS--LQRFPSWAFAGNN 196
             NL  +DL NN    ++P  +++L  L +LN++ N+L G +P+   LQRF   A+A N 
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNK 302

Query: 197 L 197
            
Sbjct: 303 C 303

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 60.9 bits (146), Expect = 1e-10
 Identities = 17/59 (28%), Positives = 27/59 (45%), Gaps = 1/59 (1%)

Query: 99  LRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIP 157
           LR+N + G  P   ++L+ L SL++ FN+  G +P          V   +NN      P
Sbjct: 251 LRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 57.1 bits (136), Expect = 2e-09
 Identities = 18/65 (27%), Positives = 23/65 (35%), Gaps = 1/65 (1%)

Query: 117 NLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSL 176
           NL  L L+ N   G LP   +    L  +++S N     IP     L        ANN  
Sbjct: 245 NLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKC 303

Query: 177 TGTLP 181
               P
Sbjct: 304 LCGSP 308

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

 Score = 52.8 bits (125), Expect = 4e-08
 Identities = 15/62 (24%), Positives = 24/62 (38%), Gaps = 4/62 (6%)

Query: 74  LPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSF--SGP 131
           L    + G +P   + +L  L +L++  N+L G  P     L+         N      P
Sbjct: 251 LRNNRIYGTLPQ-GLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVSAYANNKCLCGSP 308

Query: 132 LP 133
           LP
Sbjct: 309 LP 310

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 67.3 bits (163), Expect = 1e-12
 Identities = 21/84 (25%), Positives = 35/84 (41%), Gaps = 6/84 (7%)

Query: 91  LSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNN 150
           L  L  L+L  N++S + P   S L  L  L    N  S    L  +   N+  +   +N
Sbjct: 306 LKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSDVSSL--ANLTNINWLSAGHN 361

Query: 151 FFNASIPASISKLTHLSALNLANN 174
             +   P  ++ LT ++ L L + 
Sbjct: 362 QISDLTP--LANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 65.0 bits (157), Expect = 7e-12
 Identities = 24/116 (20%), Positives = 41/116 (35%), Gaps = 8/116 (6%)

Query: 36  IHNIHNSRSLNWNESSSLCKSWTGVTCSADH-SRVVALRLPGMALRGEIPPNTIGRLSAL 94
           I NI     L    +  L ++         +   +  L L    +    P   +  L+ L
Sbjct: 275 ISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP---VSSLTKL 331

Query: 95  QNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNN 150
           Q L   +N +S    S  + L N+  L    N  S   PL  +    +T + L++ 
Sbjct: 332 QRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTPL--ANLTRITQLGLNDQ 383

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 65.0 bits (157), Expect = 7e-12
 Identities = 39/167 (23%), Positives = 64/167 (38%), Gaps = 28/167 (16%)

Query: 36  IHNIHNSRSLNWNESSSLCK-SWTGVTCSADHSRVVALRLPGMALRGEIPPNTIGRLSAL 94
           I +I     L   +  SL       +   A  + +  L L    +    P   +  L+ L
Sbjct: 209 ISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP---LSGLTKL 265

Query: 95  QNLSLRSNSLSGLFP--------------------SDFSKLENLTSLHLQFNSFSGPLPL 134
             L L +N +S + P                    S  S L+NLT L L FN+ S   P 
Sbjct: 266 TELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISP- 324

Query: 135 DFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLP 181
             S    L  +  +NN    S  +S++ LT+++ L+  +N ++   P
Sbjct: 325 -VSSLTKLQRLFFANNKV--SDVSSLANLTNINWLSAGHNQISDLTP 368

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.4 bits (106), Expect = 1e-05
 Identities = 14/75 (18%), Positives = 27/75 (36%), Gaps = 6/75 (8%)

Query: 107 LFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHL 166
           +F      L       L   + +  +    +  + +T +         SI   +  L +L
Sbjct: 15  IFTDT--ALAEKMKTVLGKTNVTDTVSQ--TDLDQVTTLQADRLGIK-SID-GVEYLNNL 68

Query: 167 SALNLANNSLTGTLP 181
           + +N +NN LT   P
Sbjct: 69  TQINFSNNQLTDITP 83

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

 Score = 40.8 bits (94), Expect = 4e-04
 Identities = 9/48 (18%), Positives = 16/48 (33%), Gaps = 2/48 (4%)

Query: 87  TIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPL 134
           +   L  +  L      +  +       L NLT ++   N  +   PL
Sbjct: 39  SQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITPL 84

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 63.1 bits (152), Expect = 2e-11
 Identities = 32/157 (20%), Positives = 49/157 (31%), Gaps = 17/157 (10%)

Query: 52  SLCK-SWTGVTCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPS 110
             C+     V CS      V           ++PP+          L L++N ++ +   
Sbjct: 6   FRCQCHLRVVQCSDLGLEKVP---------KDLPPD-------TALLDLQNNKITEIKDG 49

Query: 111 DFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALN 170
           DF  L+NL +L L  N  S   P  F+    L  + LS N            L  L    
Sbjct: 50  DFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHE 109

Query: 171 LANNSLTGTLPRSLQRFPSWAFAGNNLSSENARPPAL 207
                +  ++   L +        N L S      A 
Sbjct: 110 NEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAF 146

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 48.5 bits (114), Expect = 9e-07
 Identities = 32/170 (18%), Positives = 56/170 (32%), Gaps = 6/170 (3%)

Query: 32  LLDFIHNIHNSRSLNWNESSSLCKSWTGVTCSADHSRVVALRLPGMALRGEIPPNTIGRL 91
           L +    +  +        + + K    V    +   VV L    +   G         +
Sbjct: 91  LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIEN-GAFQGM 149

Query: 92  SALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNF 151
             L  + +   +++ +         +LT LHL  N  +          NNL  + LS N 
Sbjct: 150 KKLSYIRIADTNITTIPQGLPP---SLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206

Query: 152 FNASIPASISKLTHLSALNLANNSLTGTLP--RSLQRFPSWAFAGNNLSS 199
            +A    S++   HL  L+L NN L          +         NN+S+
Sbjct: 207 ISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISA 256

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 45.4 bits (106), Expect = 1e-05
 Identities = 26/125 (20%), Positives = 40/125 (32%), Gaps = 32/125 (25%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPL--------- 132
            IP        +L  L L  N ++ +  +    L NL  L L FNS S            
Sbjct: 164 TIPQGL---PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPH 220

Query: 133 --------------PLDFSVWNNLTVIDLSNNFFNA------SIPASISKLTHLSALNLA 172
                         P   +    + V+ L NN  +A        P   +K    S ++L 
Sbjct: 221 LRELHLNNNKLVKVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLF 280

Query: 173 NNSLT 177
           +N + 
Sbjct: 281 SNPVQ 285

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 38.9 bits (89), Expect = 0.001
 Identities = 13/90 (14%), Positives = 30/90 (33%), Gaps = 20/90 (22%)

Query: 84  PPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLT 143
            P  +     +Q + L +N++S +  +DF      T                     + +
Sbjct: 234 VPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKK------------------ASYS 275

Query: 144 VIDLSNNFFNAS--IPASISKLTHLSALNL 171
            + L +N        P++   +   +A+ L
Sbjct: 276 GVSLFSNPVQYWEIQPSTFRCVYVRAAVQL 305

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 58.3 bits (140), Expect = 2e-10
 Identities = 19/156 (12%), Positives = 47/156 (30%), Gaps = 23/156 (14%)

Query: 306 EVLGKGTFGTAYKAALEDASTVVVKRLK-----------EVNVGKREFEQQMEIVGGIRH 354
           +++G+G     +    E     VVK  K           + + G   F            
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 355 ENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIA 414
             +  L+     K      Y +     +  ++  +       +  +    +       +A
Sbjct: 66  RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKE---LYRVRVENPDEVLDMILEEVA 117

Query: 415 HIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLA 450
             +      +VHG +   N+ ++ +G + + D   +
Sbjct: 118 KFYHRG---IVHGDLSQYNVLVSEEG-IWIIDFPQS 149

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.7 bits (135), Expect = 2e-09
 Identities = 37/174 (21%), Positives = 56/174 (32%), Gaps = 7/174 (4%)

Query: 37  HNIHNSRSLNWNESSSLCKSWTGVTCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQN 96
              H    L+            G       + +  L L   AL+  +P +T   L  L +
Sbjct: 99  ATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQA-LPDDTFRDLGNLTH 157

Query: 97  LSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASI 156
           L L  N +S +    F  L +L  L L  N  +   P  F     L  + L  N  +A  
Sbjct: 158 LFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALP 217

Query: 157 PASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLSSENAR---PPAL 207
             +++ L  L  L L +N          +   +W       SS       P  L
Sbjct: 218 TEALAPLRALQYLRLNDNPWVCDCR--ARPLWAW-LQKFRGSSSEVPCSLPQRL 268

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 46.7 bits (109), Expect = 4e-06
 Identities = 27/156 (17%), Positives = 43/156 (27%), Gaps = 33/156 (21%)

Query: 61  TCSADHSRVVALRLPGM-ALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLT 119
            C  +     +    G+ A+   IP  +       Q + L  N +S +  + F    NLT
Sbjct: 7   VCYNEPKVTTSCPQQGLQAVPVGIPAAS-------QRIFLHGNRISHVPAASFRACRNLT 59

Query: 120 SLHLQFNSFSGPL-------------------------PLDFSVWNNLTVIDLSNNFFNA 154
            L L  N  +                            P  F     L  + L       
Sbjct: 60  ILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQE 119

Query: 155 SIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSW 190
             P     L  L  L L +N+L      + +   + 
Sbjct: 120 LGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNL 155

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.8 bits (104), Expect = 1e-05
 Identities = 25/97 (25%), Positives = 35/97 (36%), Gaps = 4/97 (4%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNN 141
            + P+    L  L  L L +N+LS L     + L  L  L L  N +         +W  
Sbjct: 191 HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAW 249

Query: 142 LTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTG 178
           L     S++    S+P     L       LA N L G
Sbjct: 250 LQKFRGSSSEVPCSLPQR---LAGRDLKRLAANDLQG 283

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 51.3 bits (122), Expect = 1e-08
 Identities = 26/106 (24%), Positives = 38/106 (35%), Gaps = 7/106 (6%)

Query: 88  IGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL 147
           + +L  + +L L  N L  L P+  + L  L  L    N+         +    L  + L
Sbjct: 16  LEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVDG--VANLPRLQELLL 72

Query: 148 SNNFFNA-SIPASISKLTHLSALNLANNSLT---GTLPRSLQRFPS 189
            NN     +    +     L  LNL  NSL    G   R  +  PS
Sbjct: 73  CNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 118

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 35.8 bits (82), Expect = 0.003
 Identities = 8/38 (21%), Positives = 21/38 (55%), Gaps = 2/38 (5%)

Query: 144 VIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLP 181
           V+ L++   + ++   + +L  ++ L+L++N L    P
Sbjct: 2   VLHLAHK--DLTVLCHLEQLLLVTHLDLSHNRLRALPP 37

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 53.7 bits (127), Expect = 3e-08
 Identities = 18/89 (20%), Positives = 31/89 (34%), Gaps = 10/89 (11%)

Query: 99  LRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPA 158
              N+ S    S      +L  L++  N     LP   ++   L  +  S N     +P 
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LP---ALPPRLERLIASFNHLA-EVPE 321

Query: 159 SISKLTHLSALNLANNSLTG--TLPRSLQ 185
               L     L++  N L     +P S++
Sbjct: 322 LPQNLKQ---LHVEYNPLREFPDIPESVE 347

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 52.9 bits (125), Expect = 4e-08
 Identities = 18/132 (13%), Positives = 35/132 (26%), Gaps = 9/132 (6%)

Query: 35  FIHNIHNSRSLNWNESSSLCKSWTGVTCSADHSRVVALRLPGMALRGEIPPNTIGRLSAL 94
              N+ ++   +  E                    +   L  +        +      +L
Sbjct: 227 EALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSNEIRSLCDLPPSL 286

Query: 95  QNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNA 154
           + L++ +N L  L          L  L   FN  +  +P       NL  + +  N    
Sbjct: 287 EELNVSNNKLIELPAL----PPRLERLIASFNHLAE-VPELPQ---NLKQLHVEYNPLR- 337

Query: 155 SIPASISKLTHL 166
             P     +  L
Sbjct: 338 EFPDIPESVEDL 349

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 49.1 bits (115), Expect = 8e-07
 Identities = 17/87 (19%), Positives = 30/87 (34%), Gaps = 5/87 (5%)

Query: 122 HLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLP 181
               N+ S  +     +  +L  +++SNN     +PA   +L     L  + N L   +P
Sbjct: 266 LYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLER---LIASFNHLA-EVP 320

Query: 182 RSLQRFPSWAFAGNNLSSENARPPALP 208
              Q         N L      P ++ 
Sbjct: 321 ELPQNLKQLHVEYNPLREFPDIPESVE 347

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

 Score = 45.2 bits (105), Expect = 2e-05
 Identities = 20/71 (28%), Positives = 28/71 (39%), Gaps = 5/71 (7%)

Query: 140 NNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNLSS 199
                ++L+N   + S+P     L     L  + NSLT  LP   Q   S     NNL +
Sbjct: 38  RQAHELELNNLGLS-SLPELPPHLES---LVASCNSLT-ELPELPQSLKSLLVDNNNLKA 92

Query: 200 ENARPPALPVQ 210
            +  PP L   
Sbjct: 93  LSDLPPLLEYL 103

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.8 bits (127), Expect = 4e-08
 Identities = 13/91 (14%), Positives = 29/91 (31%), Gaps = 10/91 (10%)

Query: 94  LQNLSLRSNSLSGL-FPSDFSKLENLTSLHLQFNSFSG----PLPLDFSVWNNLTVIDLS 148
           +Q+L ++   LS   +      L+    + L     +      +     V   L  ++L 
Sbjct: 4   IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63

Query: 149 NNFFNASIPASISKL-----THLSALNLANN 174
           +N         + +        +  L+L N 
Sbjct: 64  SNELGDVGVHCVLQGLQTPSCKIQKLSLQNC 94

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 53.4 bits (126), Expect = 5e-08
 Identities = 13/73 (17%), Positives = 25/73 (34%), Gaps = 5/73 (6%)

Query: 117 NLTSLHLQFNSFS-GPLPLDFSVWNNLTVIDLSNNFFN----ASIPASISKLTHLSALNL 171
           ++ SL +Q    S         +     V+ L +          I +++     L+ LNL
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 172 ANNSLTGTLPRSL 184
            +N L       +
Sbjct: 63  RSNELGDVGVHCV 75

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.7 bits (119), Expect = 3e-07
 Identities = 16/87 (18%), Positives = 25/87 (28%), Gaps = 9/87 (10%)

Query: 108 FPSDFSKLENLTSLHLQFNSFSG----PLPLDFSVWNNLTVIDLSNNFFNASIPASISK- 162
                     L  L L     S      L       ++L  +DLSNN    +    + + 
Sbjct: 361 CQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVES 420

Query: 163 ----LTHLSALNLANNSLTGTLPRSLQ 185
                  L  L L +   +  +   LQ
Sbjct: 421 VRQPGCLLEQLVLYDIYWSEEMEDRLQ 447

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.8 bits (114), Expect = 1e-06
 Identities = 21/95 (22%), Positives = 31/95 (32%), Gaps = 15/95 (15%)

Query: 92  SALQNLSLRSNSLSGL----FPSDFSKLENLTSLHLQFNSFS--GPLPLDFSVWNN---L 142
           S L+ L L    +S        +      +L  L L  N     G L L  SV      L
Sbjct: 369 SVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLL 428

Query: 143 TVIDLSNNFFNASIPASISKLTHLSALNLANNSLT 177
             + L + +++  +         L AL     SL 
Sbjct: 429 EQLVLYDIYWSEEMEDR------LQALEKDKPSLR 457

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 43.0 bits (99), Expect = 9e-05
 Identities = 10/71 (14%), Positives = 22/71 (30%), Gaps = 8/71 (11%)

Query: 141 NLTVIDLSNNFFN-ASIPASISKLTHLSALNLANNSLTG----TLPRSLQRFPS---WAF 192
           ++  +D+     + A     +  L     + L +  LT      +  +L+  P+      
Sbjct: 3   DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62

Query: 193 AGNNLSSENAR 203
             N L      
Sbjct: 63  RSNELGDVGVH 73

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.8 bits (112), Expect = 2e-06
 Identities = 16/90 (17%), Positives = 34/90 (37%), Gaps = 2/90 (2%)

Query: 83  IPPNTIGRLSALQNLSLR-SNSLSGLFPSDFSKLENLTSLHLQFNSFSG-PLPLDFSVWN 140
           + P+  GRL +   ++ R   S      ++      +  + L  +      L    S  +
Sbjct: 12  LHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCS 71

Query: 141 NLTVIDLSNNFFNASIPASISKLTHLSALN 170
            L  + L     +  I  +++K ++L  LN
Sbjct: 72  KLQNLSLEGLRLSDPIVNTLAKNSNLVRLN 101

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.0 bits (110), Expect = 2e-06
 Identities = 13/67 (19%), Positives = 26/67 (38%), Gaps = 3/67 (4%)

Query: 87  TIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID 146
            + ++++   ++    +L+ L P D  K  + T LHL  N            +  LT ++
Sbjct: 5   EVSKVASHLEVNCDKRNLTAL-PPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 147 LSNNFFN 153
           L      
Sbjct: 62  LDRAELT 68

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.7 bits (104), Expect = 1e-05
 Identities = 15/65 (23%), Positives = 28/65 (43%), Gaps = 3/65 (4%)

Query: 111 DFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALN 170
           + SK+ +   ++    + +  LP D     + T++ LS N       A++   T L+ LN
Sbjct: 5   EVSKVASHLEVNCDKRNLTA-LPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLN 61

Query: 171 LANNS 175
           L    
Sbjct: 62  LDRAE 66

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.3 bits (103), Expect = 2e-05
 Identities = 17/75 (22%), Positives = 23/75 (30%), Gaps = 1/75 (1%)

Query: 102 NSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASIS 161
           N L  L P   +    L  L L  N+ +       +   NL  + L  N    +IP    
Sbjct: 134 NELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSL-YTIPKGFF 192

Query: 162 KLTHLSALNLANNSL 176
               L    L  N  
Sbjct: 193 GSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 41.2 bits (95), Expect = 2e-04
 Identities = 17/52 (32%), Positives = 24/52 (46%), Gaps = 1/52 (1%)

Query: 102 NSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFN 153
           N+L+ L     + LENL +L LQ NS    +P  F   + L    L  N + 
Sbjct: 158 NNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWL 208

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.9 bits (94), Expect = 3e-04
 Identities = 10/47 (21%), Positives = 16/47 (34%), Gaps = 3/47 (6%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSF 128
            +PP+ + +      L L  N L     +       LT L+L     
Sbjct: 24  ALPPD-LPKD--TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAEL 67

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.5 bits (93), Expect = 4e-04
 Identities = 14/47 (29%), Positives = 19/47 (40%), Gaps = 1/47 (2%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSF 128
           E+P   +  L  L  L L+ NSL  + P  F     L    L  N +
Sbjct: 162 ELPAGLLNGLENLDTLLLQENSLYTI-PKGFFGSHLLPFAFLHGNPW 207

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.0 bits (84), Expect = 0.004
 Identities = 8/55 (14%), Positives = 20/55 (36%), Gaps = 3/55 (5%)

Query: 135 DFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPS 189
           + S   +   ++        ++P  + K    + L+L+ N L      +L  +  
Sbjct: 5   EVSKVASHLEVNCDKRNLT-ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTR 56

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 45.2 bits (106), Expect = 3e-06
 Identities = 22/93 (23%), Positives = 34/93 (36%), Gaps = 3/93 (3%)

Query: 91  LSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSG--PLPLDFSVWNNLTVIDLS 148
            +    L+ RS+  + L       +  L SL+L  N       +        NL +++LS
Sbjct: 41  QNIDVVLNRRSSMAATL-RIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLS 99

Query: 149 NNFFNASIPASISKLTHLSALNLANNSLTGTLP 181
            N   +       K   L  L L  NSL+ T  
Sbjct: 100 GNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.0 bits (90), Expect = 5e-04
 Identities = 20/98 (20%), Positives = 30/98 (30%), Gaps = 9/98 (9%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGL--FPSDFSKLENLTSLHLQFNSFSGPLPLDFSVW 139
                    +  L +L+L +N L  L    S   K  NL  L+L  N       LD    
Sbjct: 55  ATLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKG 114

Query: 140 NNLTVIDLSNNFFNASIPAS-------ISKLTHLSALN 170
             L  + L  N  + +             +   L  L+
Sbjct: 115 LKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 45.8 bits (107), Expect = 5e-06
 Identities = 20/62 (32%), Positives = 31/62 (50%), Gaps = 4/62 (6%)

Query: 88  IGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL 147
           +  LS L  L    N +S + P   + L NL  +HL+ N  S   PL  +  +NL ++ L
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSPL--ANTSNLFIVTL 224

Query: 148 SN 149
           +N
Sbjct: 225 TN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.9 bits (97), Expect = 1e-04
 Identities = 16/67 (23%), Positives = 27/67 (40%), Gaps = 4/67 (5%)

Query: 107 LFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHL 166
              +  + L  LT+L    N  S   P   +   NL  + L NN  +   P  ++  ++L
Sbjct: 164 SDLTPLANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNL 219

Query: 167 SALNLAN 173
             + L N
Sbjct: 220 FIVTLTN 226

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.003
 Identities = 10/46 (21%), Positives = 22/46 (47%), Gaps = 2/46 (4%)

Query: 136 FSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLP 181
            +  + LT +   +N  +   P  ++ L +L  ++L NN ++   P
Sbjct: 169 LANLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP 212

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

 Score = 36.9 bits (84), Expect = 0.004
 Identities = 9/63 (14%), Positives = 26/63 (41%), Gaps = 4/63 (6%)

Query: 91  LSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNN 150
           L+    ++   ++++       + L+ +T+L       +    + +   NNL  ++L +N
Sbjct: 18  LANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEGVQY--LNNLIGLELKDN 73

Query: 151 FFN 153
              
Sbjct: 74  QIT 76

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.0 bits (102), Expect = 1e-05
 Identities = 29/163 (17%), Positives = 48/163 (29%), Gaps = 22/163 (13%)

Query: 54  CKSWTGVTCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSN-SLSGLFPSDF 112
               +G+ C+ D +                  + +     L  L + +   L  L   D 
Sbjct: 7   PHGSSGLRCTRDGALDS--------------LHHLPGAENLTELYIENQQHLQHLELRDL 52

Query: 113 SKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLA 172
             L  L +L +  +      P  F     L+ ++LS N    S+     +   L  L L+
Sbjct: 53  RGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLS 111

Query: 173 NNSLTGTLPRSLQRFPSWAFAGNNLSSEN----ARPPALPVQP 211
            N L      +L+    W   G     E          L   P
Sbjct: 112 GNPL--HCSCALRWLQRWEEEGLGGVPEQKLQCHGQGPLAHMP 152

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 45.3 bits (105), Expect = 1e-05
 Identities = 15/117 (12%), Positives = 37/117 (31%), Gaps = 9/117 (7%)

Query: 89  GRLSALQNLSLRSNSLSG----LFPSDFSKLENLTSLHLQFNSFSGP----LPLDFSVWN 140
            R S ++  SL+ ++++        +   + +++  + L  N+        L  + +   
Sbjct: 1   ARFS-IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKK 59

Query: 141 NLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGNNL 197
           +L + + S+ F           L  L    L    L           P+      + 
Sbjct: 60  DLEIAEFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDF 116

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 38.7 bits (88), Expect = 0.001
 Identities = 10/67 (14%), Positives = 15/67 (22%), Gaps = 11/67 (16%)

Query: 122 HLQFNSFSG------PLPLDFSVWNNLTVIDLSNNFFNASIPASI-----SKLTHLSALN 170
            L     S                  L  + L  N        ++      K+  L  L 
Sbjct: 249 GLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLE 308

Query: 171 LANNSLT 177
           L  N  +
Sbjct: 309 LNGNRFS 315

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.5 bits (103), Expect = 1e-05
 Identities = 7/44 (15%), Positives = 13/44 (29%)

Query: 80  RGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHL 123
             E+P +     S    L +    +  L       L+ L +   
Sbjct: 189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.7 bits (93), Expect = 2e-04
 Identities = 10/50 (20%), Positives = 20/50 (40%), Gaps = 4/50 (8%)

Query: 136 FSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQ 185
           F   +   ++D+S    ++     +  L  L A +  N      LP +L+
Sbjct: 197 FHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNLK---KLP-TLE 242

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.7 bits (88), Expect = 0.001
 Identities = 13/104 (12%), Positives = 24/104 (23%), Gaps = 17/104 (16%)

Query: 51  SSLCK-SWTGVTCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFP 109
             +C  S     C          ++    +  ++P N          L      L  +  
Sbjct: 3   HRICHCSNRVFLCQE-------SKV--TEIPSDLPRN-------AIELRFVLTKLRVIQK 46

Query: 110 SDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFN 153
             FS   +L  + +  N     +  D                 N
Sbjct: 47  GAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 90

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 41.9 bits (97), Expect = 8e-05
 Identities = 14/72 (19%), Positives = 28/72 (38%), Gaps = 6/72 (8%)

Query: 107 LFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHL 166
           +F  D          +L+  S +  +  +    N++  I  +N+  +      I  L ++
Sbjct: 17  IFSDD--AFAETIKDNLKKKSVTDAVTQNE--LNSIDQIIANNS--DIKSVQGIQYLPNV 70

Query: 167 SALNLANNSLTG 178
           + L L  N LT 
Sbjct: 71  TKLFLNGNKLTD 82

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 36.9 bits (84), Expect = 0.003
 Identities = 16/42 (38%), Positives = 22/42 (52%), Gaps = 4/42 (9%)

Query: 82  EIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHL 123
           +I P  +  L+ LQNL L  N +S L     + L+NL  L L
Sbjct: 170 DIVP--LAGLTKLQNLYLSKNHISDL--RALAGLKNLDVLEL 207

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 36.9 bits (84), Expect = 0.004
 Identities = 11/76 (14%), Positives = 26/76 (34%), Gaps = 5/76 (6%)

Query: 67  SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFN 126
           +  +   L   ++   +   T   L+++  +   ++ +  +       L N+T L L  N
Sbjct: 24  AETIKDNLKKKSVTDAV---TQNELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGN 78

Query: 127 SFSGPLPLDFSVWNNL 142
             +   PL        
Sbjct: 79  KLTDIKPLANLKNLGW 94

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

 Score = 37.7 bits (86), Expect = 0.002
 Identities = 17/87 (19%), Positives = 32/87 (36%), Gaps = 5/87 (5%)

Query: 35  FIHNIHNSRSLNWNESSSLCKSWTGVTCSADHSRVVALRLPGMALRGEIPPNTIGRLSAL 94
                      N N       + + ++  +  + +  L      +    P   +  L+ L
Sbjct: 118 ITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTDLKP---LANLTTL 174

Query: 95  QNLSLRSNSLSGLFPSDFSKLENLTSL 121
           + L + SN +S +  S  +KL NL SL
Sbjct: 175 ERLDISSNKVSDI--SVLAKLTNLESL 199

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	615
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.94
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.88
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.77
d1w8aa_	192	Slit {Fruit fly (Drosophila melanogaster) [TaxId:	99.67
d1ogqa_	313	Polygalacturonase inhibiting protein PGIP {Kidney	99.61
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.53
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.53
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.52
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.44
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.44
d1ozna_	284	Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma	99.44
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.41
d1dcea3	124	Rab geranylgeranyltransferase alpha-subunit, C-ter	99.41
d1p9ag_	266	von Willebrand factor binding domain of glycoprote	99.38
d1xkua_	305	Decorin {Cow (Bos taurus) [TaxId: 9913]}	99.3
d1a9na_	162	Splicesomal U2A' protein {Human (Homo sapiens) [Ta	99.28
d2ifga3	156	High affinity nerve growth factor receptor, N-term	99.26
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.2
d2omxa2	199	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.15
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.14
d1h6ta2	210	Internalin B {Listeria monocytogenes [TaxId: 1639]	99.11
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.1
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	99.07
d1m9la_	198	Outer arm dynein light chain 1 {Green algae (Chlam	99.04
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	99.02
d2omza2	384	Internalin A {Listeria monocytogenes [TaxId: 1639]	98.98
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	98.98
d1h6ua2	227	Internalin H {Listeria monocytogenes [TaxId: 1639]	98.82
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.72
d1xwdc1	242	Follicle-stimulating hormone receptor {Human (Homo	98.63
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	98.31
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.3
d1koha1	162	mRNA export factor tap {Human (Homo sapiens) [TaxI	98.28
d1jl5a_	353	Leucine rich effector protein YopM {Yersinia pesti	98.28
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	98.28
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.11
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	98.04
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.01
d2astb2	284	Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa	98.0
d2ca6a1	344	Rna1p (RanGAP1), N-terminal domain {Fission yeast	97.9
d1z7xw1	460	Ribonuclease inhibitor {Human (Homo sapiens) [TaxI	97.78
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.46
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.24
d1pgva_	167	Tropomodulin C-terminal domain {nematode (Caenorha	97.16
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.14
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	96.36
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.82
d1io0a_	166	Tropomodulin C-terminal domain {Chicken (Gallus ga	95.22
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	93.7

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-51  Score=408.53  Aligned_cols=247  Identities=21%  Similarity=0.404  Sum_probs=197.9

Q ss_pred             hhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChhhh
Q 007167          306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSAM  385 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~  385 (615)
                      +.||+|+||+||+|.+.++..||||+++......++|.+|++++++++|||||+++|+|..++..++||||+++|+|.++
T Consensus        11 ~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~   90 (263)
T d1sm2a_          11 QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY   90 (263)
T ss_dssp             EEEECCSSCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHH
T ss_pred             EEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHH
Confidence            46999999999999999888999999987777788999999999999999999999999999999999999999999999


Q ss_pred             hccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC----CCCC
Q 007167          386 LHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP----PPAM  461 (615)
Q Consensus       386 l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~----~~~~  461 (615)
                      +...    ...++|..+..++.|+|.||+|||+++   |+||||||+|||+++++.+||+|||+++......    ....
T Consensus        91 l~~~----~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~  163 (263)
T d1sm2a_          91 LRTQ----RGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK  163 (263)
T ss_dssp             HHTT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-----------------
T ss_pred             hhcc----ccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCceeeccee
Confidence            8743    346899999999999999999999998   9999999999999999999999999998765432    2234


Q ss_pred             CCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHH
Q 007167          462 RAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE  540 (615)
Q Consensus       462 ~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  540 (615)
                      +|..|+|||++.+..++.++|||||||++|||+| |+.||......+....   +....           ........++
T Consensus       164 gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~---i~~~~-----------~~~~p~~~~~  229 (263)
T d1sm2a_         164 FPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED---ISTGF-----------RLYKPRLAST  229 (263)
T ss_dssp             -CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHH---HHHTC-----------CCCCCTTSCH
T ss_pred             cCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHH---HHhcC-----------CCCCccccCH
Confidence            6788999999999999999999999999999999 4555654333222221   11110           0111223345


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          541 EMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       541 ~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                      ++.+++   .+||+.||++||||+||+++|+++.+.
T Consensus       230 ~l~~li---~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         230 HVYQIM---NHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             HHHHHH---HHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHH---HHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence            555544   499999999999999999999999753

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-50  Score=403.33  Aligned_cols=246  Identities=26%  Similarity=0.417  Sum_probs=201.4

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChhh
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSA  384 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  384 (615)
                      .+.||+|+||+||+|.+++++.||||+++......+.|.+|++++++++|||||+++|++. ++..++||||+++|+|.+
T Consensus        18 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~~~~~iv~Ey~~~g~L~~   96 (272)
T d1qpca_          18 VERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVD   96 (272)
T ss_dssp             EEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHH
T ss_pred             eEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec-cCCeEEEEEeCCCCcHHH
Confidence            3569999999999999998889999999877777888999999999999999999999875 456799999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC----CCC
Q 007167          385 MLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP----PPA  460 (615)
Q Consensus       385 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~----~~~  460 (615)
                      ++....   ...++|..+++|+.|+++||+|||+++   |+||||||+|||+++++.+||+|||+|+.+....    ...
T Consensus        97 ~~~~~~---~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~  170 (272)
T d1qpca_          97 FLKTPS---GIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA  170 (272)
T ss_dssp             HTTSHH---HHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTC
T ss_pred             HHhhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCcccccccc
Confidence            886432   235999999999999999999999998   9999999999999999999999999998875432    234


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCC-CCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPI-HATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      .+|..|+|||++....++.++|||||||++|||+||..|+ ......+.   ...+..   .        ........++
T Consensus       171 ~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~---~~~i~~---~--------~~~~~p~~~~  236 (272)
T d1qpca_         171 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV---IQNLER---G--------YRMVRPDNCP  236 (272)
T ss_dssp             CCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHH---HHHHHT---T--------CCCCCCTTCC
T ss_pred             CCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHH---HHHHHh---c--------CCCCCcccCh
Confidence            5678899999998888999999999999999999965554 43332222   222211   0        0111123445


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhH
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIR  574 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~  574 (615)
                      +++.++++   +||+.||++||||+||++.|+++-
T Consensus       237 ~~l~~li~---~cl~~~P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         237 EELYQLMR---LCWKERPEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             HHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHH---HHcCCCHhHCcCHHHHHHHhhhhh
Confidence            55555555   999999999999999999999864

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-50  Score=401.77  Aligned_cols=249  Identities=26%  Similarity=0.436  Sum_probs=196.7

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccC---CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNV---GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~---~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      .+.||+|+||+||+|+.+  ..||||+++....   ..+.|.+|++++++++|||||++++++. .+..++||||+++|+
T Consensus        13 ~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~~~~~lv~Ey~~~g~   89 (276)
T d1uwha_          13 GQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSS   89 (276)
T ss_dssp             CSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEEECCCEEE
T ss_pred             EEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-ccEEEEEEecCCCCC
Confidence            357999999999999865  3699999975432   2467889999999999999999999875 456899999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC----
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP----  457 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~----  457 (615)
                      |.++++...    ..+++..+..|+.|+|+||+|||+++   |+||||||+|||++.++++||+|||+|+......    
T Consensus        90 L~~~l~~~~----~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~  162 (276)
T d1uwha_          90 LYHHLHIIE----TKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQ  162 (276)
T ss_dssp             HHHHHHTSC----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC---------
T ss_pred             HHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccCCccc
Confidence            999997532    36999999999999999999999998   9999999999999999999999999998765322    


Q ss_pred             -CCCCCCCcccCccccCC---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccccccc
Q 007167          458 -PPAMRAAGYRAPEVTDT---RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELL  533 (615)
Q Consensus       458 -~~~~~~~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  533 (615)
                       ....+|+.|+|||++.+   ..++.++|||||||++|||+||+.||.+....+..  ...+..    .    ...+.+.
T Consensus       163 ~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~--~~~~~~----~----~~~p~~~  232 (276)
T d1uwha_         163 FEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI--IFMVGR----G----YLSPDLS  232 (276)
T ss_dssp             ---CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH--HHHHHH----T----SCCCCGG
T ss_pred             ccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH--HHHHhc----C----CCCCcch
Confidence             23457889999999864   35789999999999999999999999875543321  111111    1    1111111


Q ss_pred             C-CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          534 R-YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       534 ~-~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                      . .+.+++++.+++.   +||+.||++|||++||+++|+.+++.
T Consensus       233 ~~~~~~~~~l~~li~---~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         233 KVRSNCPKAMKRLMA---ECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             GSCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             hccccchHHHHHHHH---HHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence            1 2344556655555   99999999999999999999998863

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-50  Score=396.94  Aligned_cols=245  Identities=22%  Similarity=0.375  Sum_probs=207.4

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChhh
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSA  384 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  384 (615)
                      .++||+|+||+||+|+.++++.||||+++.....+++|.+|++++++++|||||+++|+|.+++..++||||+++|+|..
T Consensus         9 ~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~   88 (258)
T d1k2pa_           9 LKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLN   88 (258)
T ss_dssp             CCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHH
T ss_pred             eEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHH
Confidence            35799999999999999988899999998877778899999999999999999999999999999999999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC----CC
Q 007167          385 MLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP----PA  460 (615)
Q Consensus       385 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~----~~  460 (615)
                      ++....    ..+++..+.+++.|+++||+|||+++   |+||||||+||++++++.+||+|||+++.......    ..
T Consensus        89 ~~~~~~----~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~  161 (258)
T d1k2pa_          89 YLREMR----HRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS  161 (258)
T ss_dssp             HHHSGG----GCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCS
T ss_pred             hhhccc----cCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCceeeccc
Confidence            987543    36899999999999999999999998   99999999999999999999999999987654322    23


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      .+|..|+|||.+....++.++|||||||++|||+| |+.||......+....+.   .    .       .........+
T Consensus       162 ~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~---~----~-------~~~~~p~~~~  227 (258)
T d1k2pa_         162 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA---Q----G-------LRLYRPHLAS  227 (258)
T ss_dssp             CCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH---T----T-------CCCCCCTTCC
T ss_pred             CCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHH---h----C-------CCCCCccccc
Confidence            46788999999998899999999999999999998 899998766544433221   1    0       0111122344


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI  573 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l  573 (615)
                      +++.++++   +||+.||++|||++|++++|.+|
T Consensus       228 ~~l~~li~---~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         228 EKVYTIMY---SCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             HHHHHHHH---HTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             HHHHHHHH---HHccCCHhHCcCHHHHHHHhhCC
Confidence            55555555   99999999999999999999764

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3e-50  Score=406.69  Aligned_cols=246  Identities=25%  Similarity=0.431  Sum_probs=192.9

Q ss_pred             hhcCcCCccEEEEEEECC-C---CEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          306 EVLGKGTFGTAYKAALED-A---STVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~-~---~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      ++||+|+||+||+|.++. +   ..||||++.....  ..+.|.+|++++++++|||||+++|++.+++..++||||+++
T Consensus        32 ~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~  111 (299)
T d1jpaa_          32 QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMEN  111 (299)
T ss_dssp             EEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTT
T ss_pred             eEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCC
Confidence            579999999999998753 2   2588898865422  245789999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC-
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP-  458 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~-  458 (615)
                      |+|.+++...    ...++|..+..++.|+|.||+|||+++   |+||||||+|||++.++++||+|||+++.+..... 
T Consensus       112 g~L~~~~~~~----~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~  184 (299)
T d1jpaa_         112 GSLDSFLRQN----DGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD  184 (299)
T ss_dssp             EEHHHHHHTT----TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred             Ccceeeeccc----cCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCCCCc
Confidence            9999988743    236999999999999999999999998   99999999999999999999999999987654221 


Q ss_pred             -------CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccc
Q 007167          459 -------PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDV  530 (615)
Q Consensus       459 -------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  530 (615)
                             ...+|..|+|||.+.+..++.++|||||||++|||+| |+.||......+....+   ..   .        .
T Consensus       185 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i---~~---~--------~  250 (299)
T d1jpaa_         185 PTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAI---EQ---D--------Y  250 (299)
T ss_dssp             -----------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH---HT---T--------C
T ss_pred             ceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHH---Hc---C--------C
Confidence                   1235778999999999999999999999999999998 89999876544332222   11   1        1


Q ss_pred             cccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          531 ELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       531 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                      .......+++++.++++   +||+.||++|||+.||++.|+++.+
T Consensus       251 ~~~~~~~~~~~l~~li~---~cl~~~P~~RPs~~ei~~~L~~~l~  292 (299)
T d1jpaa_         251 RLPPPMDCPSALHQLML---DCWQKDRNHRPKFGQIVNTLDKMIR  292 (299)
T ss_dssp             CCCCCTTCCHHHHHHHH---HHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCCCccchHHHHHHHH---HHcCCCHhHCcCHHHHHHHHHHHhc
Confidence            11122344555555554   9999999999999999999999865

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-50  Score=396.46  Aligned_cols=239  Identities=24%  Similarity=0.399  Sum_probs=201.2

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccc----cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEV----NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||+||+|..+ +++.||+|++...    ....+.+.+|+++++.++|||||++++++.+++..++||||+++
T Consensus        11 ~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~   90 (263)
T d2j4za1          11 GRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL   90 (263)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             EEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCC
Confidence            467999999999999975 6789999998643    23356789999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC-C
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP-P  458 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~-~  458 (615)
                      |+|.+++...     ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+...... .
T Consensus        91 g~L~~~l~~~-----~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~  162 (263)
T d2j4za1          91 GTVYRELQKL-----SKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT  162 (263)
T ss_dssp             CBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCE
T ss_pred             CcHHHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCCccc
Confidence            9999999743     36999999999999999999999998   9999999999999999999999999998765432 3


Q ss_pred             CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCc
Q 007167          459 PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI  538 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  538 (615)
                      ...||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+      .+.         .....+.+
T Consensus       163 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i------~~~---------~~~~p~~~  227 (263)
T d2j4za1         163 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI------SRV---------EFTFPDFV  227 (263)
T ss_dssp             ETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HTT---------CCCCCTTS
T ss_pred             ccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHH------HcC---------CCCCCccC
Confidence            446889999999999999999999999999999999999999765433322211      111         11112345


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          539 EEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       539 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ++++.+++.   +|++.||++|||++|++++
T Consensus       228 s~~~~~li~---~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         228 TEGARDLIS---RLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             CHHHHHHHH---HHTCSSGGGSCCHHHHHTC
T ss_pred             CHHHHHHHH---HHccCCHhHCcCHHHHHcC
Confidence            666766666   9999999999999999875

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.3e-50  Score=402.40  Aligned_cols=249  Identities=23%  Similarity=0.336  Sum_probs=204.6

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      .+.||+|+||+||+|.++ +++.||||+++......+.|.+|++++++++|||||+++++|.+.+..++||||+++|+|.
T Consensus        22 ~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~  101 (287)
T d1opja_          22 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLL  101 (287)
T ss_dssp             EEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHH
T ss_pred             eeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchH
Confidence            356999999999999976 4778999999877667788999999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC----C
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP----P  459 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~----~  459 (615)
                      +++....   ...++|..+..|+.|++.||+|||+++   |+||||||+|||+++++++||+|||+|+.......    .
T Consensus       102 ~~l~~~~---~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~  175 (287)
T d1opja_         102 DYLRECN---RQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG  175 (287)
T ss_dssp             HHHHHSC---TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETT
T ss_pred             HHhhhcc---ccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCCCceeecc
Confidence            9997532   347999999999999999999999998   99999999999999999999999999987754322    1


Q ss_pred             CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      ..++..|+|||++.+..++.++|||||||++|||++|..||......  ....+.+..    .       ......+.++
T Consensus       176 ~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~--~~~~~~i~~----~-------~~~~~~~~~~  242 (287)
T d1opja_         176 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL--SQVYELLEK----D-------YRMERPEGCP  242 (287)
T ss_dssp             EEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH--HHHHHHHHT----T-------CCCCCCTTCC
T ss_pred             ccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH--HHHHHHHhc----C-------CCCCCCccch
Confidence            23567899999999899999999999999999999977766443221  112221211    1       1111223455


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                      +++.++++   +||+.||++|||++||++.|+.+.+
T Consensus       243 ~~l~~li~---~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         243 EKVYELMR---ACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             HHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             HHHHHHHH---HHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            66655555   9999999999999999999988754

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-49  Score=397.32  Aligned_cols=240  Identities=20%  Similarity=0.366  Sum_probs=199.9

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEecccc-CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEVN-VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      +.||+|+||+||+|.. .+|+.||||+++... ...+.+.+|+++++.++|||||++++++.+++..++||||+++|+|.
T Consensus        26 ~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~  105 (293)
T d1yhwa1          26 EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT  105 (293)
T ss_dssp             EECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHH
T ss_pred             EEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHH
Confidence            5699999999999985 468999999987543 34677999999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC---CCCC
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM---PPPA  460 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~---~~~~  460 (615)
                      +++...      .+++..+..++.|++.||+|||+++   |+||||||+|||++.++++||+|||+|+.+...   ....
T Consensus       106 ~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~  176 (293)
T d1yhwa1         106 DVVTET------CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM  176 (293)
T ss_dssp             HHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred             HHhhcc------CCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccccccccc
Confidence            988642      5899999999999999999999998   999999999999999999999999999877543   2345


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE  540 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  540 (615)
                      .||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+...      .......      +.+...+.+++
T Consensus       177 ~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~------~~~~~~~------~~~~~~~~~s~  244 (293)
T d1yhwa1         177 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY------LIATNGT------PELQNPEKLSA  244 (293)
T ss_dssp             CSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHHCS------CCCSSGGGSCH
T ss_pred             ccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHH------HHHhCCC------CCCCCcccCCH
Confidence            68999999999999999999999999999999999999997654322211      1111110      11111233456


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          541 EMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       541 ~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      +++++++   +||+.||++|||+.|+++|
T Consensus       245 ~~~~li~---~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         245 IFRDFLN---RCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             HHHHHHH---HHTCSSTTTSCCHHHHTTC
T ss_pred             HHHHHHH---HHccCChhHCcCHHHHhcC
Confidence            6666666   9999999999999999875

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-49  Score=394.86  Aligned_cols=242  Identities=21%  Similarity=0.325  Sum_probs=195.3

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc--CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN--VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      .+.||+|+||+||+|..+ +++.||||++....  ...+.+.+|++++++++|||||++++++.+++..++||||+++|+
T Consensus        10 ~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~   89 (271)
T d1nvra_          10 VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE   89 (271)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEE
T ss_pred             EEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCc
Confidence            357999999999999974 68899999986542  234578999999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC-----
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM-----  456 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~-----  456 (615)
                      |.+++...     ..+++..+..++.|++.||+|||+++   |+||||||+|||+++++++||+|||+|+.....     
T Consensus        90 L~~~l~~~-----~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~  161 (271)
T d1nvra_          90 LFDRIEPD-----IGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  161 (271)
T ss_dssp             GGGGSBTT-----TBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             HHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence            99999642     36999999999999999999999998   999999999999999999999999999876422     


Q ss_pred             CCCCCCCCcccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCC
Q 007167          457 PPPAMRAAGYRAPEVTDTRKA-TQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY  535 (615)
Q Consensus       457 ~~~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  535 (615)
                      .....||+.|+|||++.+..+ +.++||||+||++|||++|+.||......... ...+...    .       ......
T Consensus       162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~~~~~----~-------~~~~~~  229 (271)
T d1nvra_         162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKEK----K-------TYLNPW  229 (271)
T ss_dssp             BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHHHHTT----C-------TTSTTG
T ss_pred             ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HHHHhcC----C-------CCCCcc
Confidence            234568999999999987765 67899999999999999999999765433211 1111100    0       001112


Q ss_pred             CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          536 PNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       536 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      +.+++++.++++   +||+.||++|||++|++++
T Consensus       230 ~~~s~~~~~li~---~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         230 KKIDSAPLALLH---KILVENPSARITIPDIKKD  260 (271)
T ss_dssp             GGSCHHHHHHHH---HHSCSSTTTSCCHHHHTTC
T ss_pred             ccCCHHHHHHHH---HHcCCChhHCcCHHHHhcC
Confidence            234566666665   9999999999999999764

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-49  Score=396.79  Aligned_cols=244  Identities=22%  Similarity=0.372  Sum_probs=200.0

Q ss_pred             hcCcCCccEEEEEEEC---CCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          307 VLGKGTFGTAYKAALE---DASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~---~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      +||+|+||+||+|.++   ++..||||+++....  ..+.|.+|++++++++|||||+++|++.+ +..++||||+++|+
T Consensus        16 ~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~   94 (285)
T d1u59a_          16 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGP   94 (285)
T ss_dssp             EEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEE
T ss_pred             EEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCc
Confidence            3999999999999764   345799999975422  24678999999999999999999999865 56899999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC----
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP----  457 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~----  457 (615)
                      |.+++...+    ..+++..+.+++.|+|.||+|||+++   |+||||||+|||++.++.+||+|||+++.+....    
T Consensus        95 L~~~l~~~~----~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~  167 (285)
T d1u59a_          95 LHKFLVGKR----EEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT  167 (285)
T ss_dssp             HHHHHTTCT----TTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEEC
T ss_pred             HHHHhhccc----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccccccccc
Confidence            999986432    36999999999999999999999998   9999999999999999999999999998775432    


Q ss_pred             --CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccC
Q 007167          458 --PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLR  534 (615)
Q Consensus       458 --~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  534 (615)
                        ....+|..|+|||++....++.++|||||||++|||+| |+.||......+....+.      ...        ....
T Consensus       168 ~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~------~~~--------~~~~  233 (285)
T d1u59a_         168 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE------QGK--------RMEC  233 (285)
T ss_dssp             CCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHH------TTC--------CCCC
T ss_pred             cccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHH------cCC--------CCCC
Confidence              23346788999999988899999999999999999998 999998766544333221      110        1112


Q ss_pred             CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          535 YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       535 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                      .+.+++++.++++   +||+.+|++|||+.+|++.|+.+-.
T Consensus       234 p~~~~~~l~~li~---~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         234 PPECPPELYALMS---DCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             CTTCCHHHHHHHH---HTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCcCCHHHHHHHH---HHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            2345566655555   9999999999999999999988754

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-49  Score=394.56  Aligned_cols=242  Identities=24%  Similarity=0.367  Sum_probs=195.1

Q ss_pred             hhcCcCCccEEEEEEECC---CCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          306 EVLGKGTFGTAYKAALED---ASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~---~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      ++||+|+||+||+|.+++   ++.||||+++.....   .+.|.+|++++++++|||||+++|+|.. +..++||||+++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~   91 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL   91 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCC
Confidence            359999999999998643   457999999754222   4578999999999999999999999865 567899999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      |+|.++++..     ..++|..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.+....  
T Consensus        92 g~L~~~l~~~-----~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~  163 (277)
T d1xbba_          92 GPLNKYLQQN-----RHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  163 (277)
T ss_dssp             EEHHHHHHHC-----TTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred             CcHHHHHhhc-----cCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccc
Confidence            9999999743     36999999999999999999999998   9999999999999999999999999998765432  


Q ss_pred             ----CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccc
Q 007167          458 ----PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVEL  532 (615)
Q Consensus       458 ----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~  532 (615)
                          ....+|+.|+|||.+.+..++.++|||||||++|||++ |+.||.+....+....+.      ...        ..
T Consensus       164 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~------~~~--------~~  229 (277)
T d1xbba_         164 YKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE------KGE--------RM  229 (277)
T ss_dssp             EEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHH------TTC--------CC
T ss_pred             cccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHH------cCC--------CC
Confidence                22356788999999988889999999999999999998 899998765443322221      110        11


Q ss_pred             cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 007167          533 LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI  573 (615)
Q Consensus       533 ~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l  573 (615)
                      .....+++++.++++   +||+.||++|||++||++.|+..
T Consensus       230 ~~p~~~~~~~~~li~---~cl~~dp~~RPs~~~i~~~L~~~  267 (277)
T d1xbba_         230 GCPAGCPREMYDLMN---LCWTYDVENRPGFAAVELRLRNY  267 (277)
T ss_dssp             CCCTTCCHHHHHHHH---HHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             CCCcccCHHHHHHHH---HHcCCCHhHCcCHHHHHHHhhCH
Confidence            122345566655555   99999999999999999988775

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-49  Score=394.50  Aligned_cols=246  Identities=20%  Similarity=0.343  Sum_probs=188.7

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEe--cCeeeEEeecCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYS--KDEKLMVYDYFEP  379 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~--~~~~~lV~e~~~~  379 (615)
                      +.||+|+||+||+|..+ +|+.||||.+......   .+.+.+|++++++++|||||++++++.+  .+..++||||+++
T Consensus        10 ~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~   89 (269)
T d2java1          10 YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEG   89 (269)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTT
T ss_pred             EEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCC
Confidence            57999999999999864 6889999999765433   3458899999999999999999999975  3568999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccC--CCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN--GGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~--~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~  457 (615)
                      |+|.+++..... ....+++..++.++.|++.||+|||+++  ..+|+||||||+|||++.++.+||+|||+++.+....
T Consensus        90 g~L~~~i~~~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  168 (269)
T d2java1          90 GDLASVITKGTK-ERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT  168 (269)
T ss_dssp             EEHHHHHHHHHH-HTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC----
T ss_pred             CcHHHHHHhccc-cCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCC
Confidence            999999864321 2347999999999999999999999865  2359999999999999999999999999998875432


Q ss_pred             ---CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccC
Q 007167          458 ---PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLR  534 (615)
Q Consensus       458 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  534 (615)
                         ....+|+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+      ..... .       ..
T Consensus       169 ~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i------~~~~~-~-------~~  234 (269)
T d2java1         169 SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI------REGKF-R-------RI  234 (269)
T ss_dssp             -------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH------HHTCC-C-------CC
T ss_pred             CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHH------HcCCC-C-------CC
Confidence               3456799999999999999999999999999999999999999865443322211      11110 0       01


Q ss_pred             CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          535 YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       535 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ...+++++.++++   +||+.||++|||++|++++
T Consensus       235 ~~~~s~~l~~li~---~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         235 PYRYSDELNEIIT---RMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             CTTSCHHHHHHHH---HHTCSSGGGSCCHHHHHTS
T ss_pred             CcccCHHHHHHHH---HHcCCChhHCcCHHHHHhC
Confidence            2245566666666   9999999999999999864

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-49  Score=393.83  Aligned_cols=247  Identities=27%  Similarity=0.429  Sum_probs=192.5

Q ss_pred             hhcCcCCccEEEEEEECCC-----CEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCC
Q 007167          306 EVLGKGTFGTAYKAALEDA-----STVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~-----~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      ++||+|+||+||+|.+++.     ..||||+++....  ....|.+|++++++++|||||+++|++.+.+..++||||+.
T Consensus        13 ~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~   92 (283)
T d1mqba_          13 KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYME   92 (283)
T ss_dssp             EEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred             eEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecc
Confidence            5799999999999986543     3699999865432  23568899999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC-
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP-  457 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~-  457 (615)
                      +|++.+.+...    ...++|..+.+++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.... 
T Consensus        93 ~~~l~~~~~~~----~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~  165 (283)
T d1mqba_          93 NGALDKFLREK----DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  165 (283)
T ss_dssp             TEEHHHHHHHT----TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred             cCcchhhhhcc----cccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence            99999988643    246999999999999999999999998   9999999999999999999999999998765422 


Q ss_pred             -----CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCC-CCCcchhhHHHHHHHhhhccccccccccc
Q 007167          458 -----PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHA-TGGDEVVHLVRWVNSVVREEWTAEVFDVE  531 (615)
Q Consensus       458 -----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  531 (615)
                           ....+|..|+|||++.+..++.++|||||||++|||++|..|+.. ....+.   ...+....           .
T Consensus       166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~---~~~i~~~~-----------~  231 (283)
T d1mqba_         166 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---MKAINDGF-----------R  231 (283)
T ss_dssp             --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHH---HHHHHTTC-----------C
T ss_pred             cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHH---HHHHhccC-----------C
Confidence                 123467889999999999999999999999999999996655543 322222   22221110           1


Q ss_pred             ccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          532 LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       532 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                      .......++++.+   ++.+||+.+|++||||.||+++|+++.+.
T Consensus       232 ~~~~~~~~~~l~~---li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         232 LPTPMDCPSAIYQ---LMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             CCCCTTCBHHHHH---HHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CCCchhhHHHHHH---HHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            1112234455555   45599999999999999999999998763

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-48  Score=391.94  Aligned_cols=248  Identities=27%  Similarity=0.381  Sum_probs=198.8

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChhh
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVSA  384 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~  384 (615)
                      .+.||+|+||+||+|.++++.+||||+++......+.|.+|++++++++|||||+++|++. .+..++||||+++|+|..
T Consensus        22 ~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~~g~l~~  100 (285)
T d1fmka3          22 EVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMSKGSLLD  100 (285)
T ss_dssp             EEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHH
T ss_pred             eeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecCCCchhh
Confidence            4579999999999999999889999999877777889999999999999999999999985 456899999999999999


Q ss_pred             hhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC----CCC
Q 007167          385 MLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP----PPA  460 (615)
Q Consensus       385 ~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~----~~~  460 (615)
                      ++....   ...++|..++.|+.|++.||+|||+.+   |+||||||+|||++.++++||+|||+++......    ...
T Consensus       101 ~~~~~~---~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  174 (285)
T d1fmka3         101 FLKGET---GKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA  174 (285)
T ss_dssp             HHSHHH---HTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred             hhhhcc---cccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCCceeeccc
Confidence            987532   236999999999999999999999998   9999999999999999999999999998764332    224


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE  540 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  540 (615)
                      .+|..|+|||++..+.++.++|||||||++|||++|..|+......  ......+....           .....+.+++
T Consensus       175 ~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~i~~~~-----------~~~~~~~~~~  241 (285)
T d1fmka3         175 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVERGY-----------RMPCPPECPE  241 (285)
T ss_dssp             -CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTTC-----------CCCCCTTSCH
T ss_pred             cccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHHhcC-----------CCCCCcccCH
Confidence            5688899999999999999999999999999999976665443221  12222221110           1112234555


Q ss_pred             HHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          541 EMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       541 ~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                      ++.+++.   +||+.||++||+++||+++|++...
T Consensus       242 ~l~~li~---~cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         242 SLHDLMC---QCWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             HHHHHHH---HHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             HHHHHHH---HHcccCHhHCcCHHHHHHHHhhhhc
Confidence            5555555   9999999999999999999988653

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-49  Score=394.15  Aligned_cols=243  Identities=20%  Similarity=0.348  Sum_probs=199.1

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc-CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN-VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      .+.||+|+||+||+|... ++..||||+++... ...+.+.+|++++++++|||||++++++.+++..++||||+++|+|
T Consensus        17 ~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L   96 (288)
T d2jfla1          17 IGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAV   96 (288)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEH
T ss_pred             eEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcH
Confidence            356999999999999965 68889999997543 3346789999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC---CCC
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM---PPP  459 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~---~~~  459 (615)
                      .+++...    ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+.....   ...
T Consensus        97 ~~~~~~~----~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~  169 (288)
T d2jfla1          97 DAVMLEL----ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS  169 (288)
T ss_dssp             HHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTC
T ss_pred             HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCcccccc
Confidence            9998643    236999999999999999999999998   999999999999999999999999999765421   234


Q ss_pred             CCCCCcccCccccC-----CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccC
Q 007167          460 AMRAAGYRAPEVTD-----TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLR  534 (615)
Q Consensus       460 ~~~~~~y~aPE~~~-----~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  534 (615)
                      ..||+.|+|||++.     ...|+.++|||||||++|||++|+.||...+..+....+      .....      +.+..
T Consensus       170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i------~~~~~------~~~~~  237 (288)
T d2jfla1         170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI------AKSEP------PTLAQ  237 (288)
T ss_dssp             CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHH------HHSCC------CCCSS
T ss_pred             cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHH------HcCCC------CCCCc
Confidence            57899999999983     456889999999999999999999999876554432211      11111      11111


Q ss_pred             CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          535 YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       535 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+.+++++.++++   +||+.||++|||++|+++|
T Consensus       238 ~~~~s~~~~~li~---~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         238 PSRWSSNFKDFLK---KCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             GGGSCHHHHHHHH---HHSCSSTTTSCCHHHHTTS
T ss_pred             cccCCHHHHHHHH---HHccCChhHCcCHHHHhcC
Confidence            2234566666666   9999999999999999875

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-49  Score=388.73  Aligned_cols=246  Identities=24%  Similarity=0.385  Sum_probs=195.2

Q ss_pred             hhhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEe-cCeeeEEeecCCCCChh
Q 007167          305 AEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYS-KDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~-~~~~~lV~e~~~~gsL~  383 (615)
                      .+.||+|+||+||+|.++ |++||||+++.. ...+.|.+|++++++++|||||+++|+|.+ ++..++||||+++|+|.
T Consensus        12 ~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~   89 (262)
T d1byga_          12 LQTIGKGEFGDVMLGDYR-GNKVAVKCIKND-ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV   89 (262)
T ss_dssp             EEEEEECSSCEEEEEEET-TEEEEEEECCCC-C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHH
T ss_pred             eEEEecCCCeEEEEEEEC-CeEEEEEEECcH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHH
Confidence            357999999999999985 678999999754 345779999999999999999999999865 45689999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCCCCCC
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPAMRA  463 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~  463 (615)
                      ++|+...   ...++|..+++|+.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++..........++
T Consensus        90 ~~l~~~~---~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~~~~  163 (262)
T d1byga_          90 DYLRSRG---RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP  163 (262)
T ss_dssp             HHHHHHH---HHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------------CC
T ss_pred             HHHHhcC---CCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCCCCcccccc
Confidence            9997432   235899999999999999999999997   9999999999999999999999999999877666666778


Q ss_pred             CcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHHHH
Q 007167          464 AGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEEEM  542 (615)
Q Consensus       464 ~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~  542 (615)
                      ..|+|||++.+..++.++|||||||++|||+| |+.||......+..   .++....           .....+..++++
T Consensus       164 ~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~---~~i~~~~-----------~~~~~~~~~~~~  229 (262)
T d1byga_         164 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV---PRVEKGY-----------KMDAPDGCPPAV  229 (262)
T ss_dssp             TTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH---HHHTTTC-----------CCCCCTTCCHHH
T ss_pred             ccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHH---HHHHcCC-----------CCCCCccCCHHH
Confidence            89999999998899999999999999999998 78888766544433   2221110           111123345666


Q ss_pred             HHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          543 VEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       543 ~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                      .++++   +||..||++|||+.|++++|++++.
T Consensus       230 ~~li~---~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         230 YEVMK---NCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             HHHHH---HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHH---HHcccCHhHCcCHHHHHHHHHHHHh
Confidence            66655   9999999999999999999999875

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.9e-48  Score=393.04  Aligned_cols=243  Identities=21%  Similarity=0.377  Sum_probs=186.3

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEecccc--CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVN--VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~--~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      .+.||+|+||+||+|..+ +++.||||++....  ...+.+.+|+++++.++|||||++++++.+++..++||||+++|+
T Consensus        14 ~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~   93 (307)
T d1a06a_          14 RDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGE   93 (307)
T ss_dssp             EEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCB
T ss_pred             EEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCc
Confidence            457999999999999975 67899999987542  234567899999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeC---CCCcEEEeecccccccCCCC-
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLN---SQGHVCVSDIGLAALMSPMP-  457 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~---~~~~~kl~DfG~a~~~~~~~-  457 (615)
                      |.+++...     ..+++..+..++.|++.||+|||+++   |+||||||+||++.   +++.+||+|||+++...... 
T Consensus        94 L~~~l~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~  165 (307)
T d1a06a_          94 LFDRIVEK-----GFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV  165 (307)
T ss_dssp             HHHHHHTC-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred             HHHhhhcc-----cCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCCCe
Confidence            99999743     36999999999999999999999998   99999999999994   57899999999998765432 


Q ss_pred             -CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          458 -PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       458 -~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                       ....||+.|+|||++.+..++.++||||+||++|||++|+.||.+....+....      +....     ........+
T Consensus       166 ~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~------i~~~~-----~~~~~~~~~  234 (307)
T d1a06a_         166 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ------ILKAE-----YEFDSPYWD  234 (307)
T ss_dssp             -------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH------HHTTC-----CCCCTTTTT
T ss_pred             eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHH------HhccC-----CCCCCcccc
Confidence             345689999999999999999999999999999999999999976543332211      11111     111111234


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+++++.++++   +|++.||++|||++|++++
T Consensus       235 ~~s~~~~~li~---~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         235 DISDSAKDFIR---HLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             TSCHHHHHHHH---HHSCSSGGGSCCHHHHHHS
T ss_pred             CCCHHHHHHHH---HHccCCHhHCcCHHHHhcC
Confidence            55667767666   9999999999999999885

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-48  Score=398.35  Aligned_cols=248  Identities=23%  Similarity=0.362  Sum_probs=198.2

Q ss_pred             hhhcCcCCccEEEEEEECCC------CEEEEEEeccc--cCCHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEee
Q 007167          305 AEVLGKGTFGTAYKAALEDA------STVVVKRLKEV--NVGKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYD  375 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~~------~~vavK~l~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e  375 (615)
                      .++||+|+||+||+|++...      ..||||++...  ......+.+|++++.++ +|||||++++++.+.+..++|||
T Consensus        42 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E  121 (325)
T d1rjba_          42 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFE  121 (325)
T ss_dssp             EEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             eeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEE
Confidence            56799999999999986432      25899998654  22346788999999988 89999999999999999999999


Q ss_pred             cCCCCChhhhhccCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeC
Q 007167          376 YFEPGSVSAMLHGRRGE------------------GQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLN  437 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~  437 (615)
                      |+++|+|.++|+..+..                  ....++|..++.|+.|++.||+|||+++   |+||||||+|||++
T Consensus       122 y~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~Nill~  198 (325)
T d1rjba_         122 YCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVT  198 (325)
T ss_dssp             CCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGGGEEEE
T ss_pred             cCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCchhccccc
Confidence            99999999999764321                  1235899999999999999999999998   99999999999999


Q ss_pred             CCCcEEEeecccccccCCCCC-----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhH
Q 007167          438 SQGHVCVSDIGLAALMSPMPP-----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHL  511 (615)
Q Consensus       438 ~~~~~kl~DfG~a~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~  511 (615)
                      .++++||+|||+|+.......     ...+|+.|+|||++.+..++.++|||||||++|||+| |+.||.+....+..  
T Consensus       199 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~--  276 (325)
T d1rjba_         199 HGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF--  276 (325)
T ss_dssp             TTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHH--
T ss_pred             cCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHH--
Confidence            999999999999987654332     2345788999999999999999999999999999998 89999875544322  


Q ss_pred             HHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHH
Q 007167          512 VRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVE  571 (615)
Q Consensus       512 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~  571 (615)
                      ...+.    ...       .+.....+++++.++++   +||+.||++|||++||+++|.
T Consensus       277 ~~~~~----~~~-------~~~~p~~~~~~l~~li~---~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         277 YKLIQ----NGF-------KMDQPFYATEEIYIIMQ---SCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             HHHHH----TTC-------CCCCCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHh----cCC-------CCCCCCcCCHHHHHHHH---HHcCCChhHCcCHHHHHHHHh
Confidence            11111    110       11122345566666655   999999999999999999985

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-48  Score=383.19  Aligned_cols=242  Identities=23%  Similarity=0.414  Sum_probs=192.3

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEe----cCeeeEEeecC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYS----KDEKLMVYDYF  377 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~----~~~~~lV~e~~  377 (615)
                      ++||+|+||+||+|... ++..||+|++......   .+.+.+|++++++++|||||++++++.+    +...++||||+
T Consensus        15 ~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~   94 (270)
T d1t4ha_          15 IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM   94 (270)
T ss_dssp             EEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECC
T ss_pred             eEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCC
Confidence            35999999999999965 5788999998765433   3568899999999999999999999875    34579999999


Q ss_pred             CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeC-CCCcEEEeecccccccCCC
Q 007167          378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLN-SQGHVCVSDIGLAALMSPM  456 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~-~~~~~kl~DfG~a~~~~~~  456 (615)
                      ++|+|.+++...     ..+++..+..++.|++.||+|||+++ ++|+||||||+|||++ +++.+||+|||+|+.....
T Consensus        95 ~~g~L~~~l~~~-----~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~  168 (270)
T d1t4ha_          95 TSGTLKTYLKRF-----KVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS  168 (270)
T ss_dssp             CSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT
T ss_pred             CCCcHHHHHhcc-----ccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC
Confidence            999999999743     36899999999999999999999875 3599999999999996 5789999999999876543


Q ss_pred             -CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCC
Q 007167          457 -PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY  535 (615)
Q Consensus       457 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  535 (615)
                       .....||+.|+|||++.+ .++.++|||||||++|||++|+.||......+  .+.+.+   .....     ....  .
T Consensus       169 ~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~--~~~~~i---~~~~~-----~~~~--~  235 (270)
T d1t4ha_         169 FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRV---TSGVK-----PASF--D  235 (270)
T ss_dssp             SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHH---TTTCC-----CGGG--G
T ss_pred             ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH--HHHHHH---HcCCC-----Cccc--C
Confidence             234568999999999865 69999999999999999999999997544322  111111   11100     0011  1


Q ss_pred             CCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          536 PNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       536 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ...++++.++++   +||+.||++|||++|+++|
T Consensus       236 ~~~~~~~~~li~---~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         236 KVAIPEVKEIIE---GCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             GCCCHHHHHHHH---HHSCSSGGGSCCHHHHHTS
T ss_pred             ccCCHHHHHHHH---HHccCCHhHCcCHHHHhCC
Confidence            123455556555   9999999999999999874

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-48  Score=399.23  Aligned_cols=193  Identities=20%  Similarity=0.377  Sum_probs=170.6

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      +.||+|+||+||+|... +|+.||+|+++....  ....+.+|+++++.++|||||+++++|.++++.++||||+++|+|
T Consensus        12 ~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L   91 (322)
T d1s9ja_          12 SELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL   91 (322)
T ss_dssp             EEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEH
T ss_pred             EEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcH
Confidence            56999999999999965 678899999875422  246788999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhcc-CCCCceecCCCCCCEEeCCCCcEEEeecccccccCC-CCCCC
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTE-NGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP-MPPPA  460 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~-~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~-~~~~~  460 (615)
                      .+++...     ..+++..+..++.|++.||+|||++ +   |+||||||+|||++.++++||+|||+|+.+.. .....
T Consensus        92 ~~~l~~~-----~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~  163 (322)
T d1s9ja_          92 DQVLKKA-----GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF  163 (322)
T ss_dssp             HHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC---
T ss_pred             HHHHhhc-----CCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCCccccc
Confidence            9999743     3699999999999999999999975 6   99999999999999999999999999987643 23455


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCc
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGD  506 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~  506 (615)
                      .||+.|+|||++.+..|+.++||||+||++|||++|+.||...+..
T Consensus       164 ~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~  209 (322)
T d1s9ja_         164 VGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK  209 (322)
T ss_dssp             CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTT
T ss_pred             cCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence            7899999999999999999999999999999999999999875543

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-48  Score=390.67  Aligned_cols=239  Identities=18%  Similarity=0.301  Sum_probs=198.9

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccc----cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEV----NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||+||+|... +++.||||+++..    ....+.+.+|++++++++|||||++++++.+++..++||||+++
T Consensus        13 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~g   92 (288)
T d1uu3a_          13 GKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKN   92 (288)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTT
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCC
Confidence            457999999999999974 6889999998643    23356789999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      |+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||+++++.+||+|||+|+.+....  
T Consensus        93 g~L~~~~~~~-----~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_          93 GELLKYIRKI-----GSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             EEHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             CCHHHhhhcc-----CCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence            9999998743     36999999999999999999999998   9999999999999999999999999998775322  


Q ss_pred             ---CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccC
Q 007167          458 ---PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLR  534 (615)
Q Consensus       458 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  534 (615)
                         ....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+...      .+....         ...
T Consensus       165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~------~i~~~~---------~~~  229 (288)
T d1uu3a_         165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ------KIIKLE---------YDF  229 (288)
T ss_dssp             -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH------HHHTTC---------CCC
T ss_pred             cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHH------HHHcCC---------CCC
Confidence               23468999999999999999999999999999999999999998654333222      111111         111


Q ss_pred             CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          535 YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       535 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ...++++++++++   +||+.||++|||++|++++
T Consensus       230 p~~~s~~~~~li~---~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         230 PEKFFPKARDLVE---KLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             CTTCCHHHHHHHH---TTSCSSGGGSTTSGGGTCH
T ss_pred             CccCCHHHHHHHH---HHccCCHhHCcCHHHHcCC
Confidence            2345666666666   9999999999999998765

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.8e-48  Score=392.33  Aligned_cols=240  Identities=23%  Similarity=0.413  Sum_probs=196.6

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC----HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG----KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||+||+|... +++.||||+++.....    .+.+.+|++++++++|||||++++++.+++..++||||+++
T Consensus        20 l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~   99 (309)
T d1u5ra_          20 LREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG   99 (309)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred             eEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCC
Confidence            457999999999999864 6788999999765332    24588999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCC
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP  459 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~  459 (615)
                      |+|..++...     ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++++||+|||+|+..... ..
T Consensus       100 g~l~~~~~~~-----~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-~~  170 (309)
T d1u5ra_         100 SASDLLEVHK-----KPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-NS  170 (309)
T ss_dssp             EHHHHHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-CC
T ss_pred             CchHHHHHhC-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCCC-Cc
Confidence            9998766532     36999999999999999999999998   999999999999999999999999999876543 34


Q ss_pred             CCCCCcccCccccCC---CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          460 AMRAAGYRAPEVTDT---RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~---~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                      ..||+.|+|||++.+   ..|+.++|||||||++|||++|+.||......+...      .......      +. ....
T Consensus       171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~------~i~~~~~------~~-~~~~  237 (309)
T d1u5ra_         171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALY------HIAQNES------PA-LQSG  237 (309)
T ss_dssp             CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH------HHHHSCC------CC-CSCT
T ss_pred             cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHH------HHHhCCC------CC-CCCC
Confidence            578999999999853   458999999999999999999999997654322211      1111110      00 1123


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+++++.++++   +||+.||++|||++|+++|
T Consensus       238 ~~s~~~~~li~---~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         238 HWSEYFRNFVD---SCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             TSCHHHHHHHH---HHTCSSGGGSCCHHHHTTC
T ss_pred             CCCHHHHHHHH---HHCcCChhHCcCHHHHHhC
Confidence            45566767666   9999999999999999874

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.6e-47  Score=387.66  Aligned_cols=239  Identities=21%  Similarity=0.351  Sum_probs=203.8

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccc----cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEV----NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||+||+|+. .+|+.||||+++..    ....+.+.+|+++++.++|||||++++++.+++..++||||+++
T Consensus         9 ~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~g   88 (316)
T d1fota_           9 LRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG   88 (316)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             EEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCC
Confidence            45799999999999996 46899999998643    23356789999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCC
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPP  459 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~  459 (615)
                      |+|..++...     ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++++||+|||+|+........
T Consensus        89 g~l~~~~~~~-----~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~~  160 (316)
T d1fota_          89 GELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT  160 (316)
T ss_dssp             CBHHHHHHHT-----SSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCC
T ss_pred             cccccccccc-----ccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEecccccc
Confidence            9999998753     36788999999999999999999998   999999999999999999999999999998877777


Q ss_pred             CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      ..||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+....+      ...         .....+.++
T Consensus       161 ~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i------~~~---------~~~~p~~~s  225 (316)
T d1fota_         161 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI------LNA---------ELRFPPFFN  225 (316)
T ss_dssp             CCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HHC---------CCCCCTTSC
T ss_pred             ccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHH------HcC---------CCCCCCCCC
Confidence            78999999999999999999999999999999999999999875443332211      111         111223456


Q ss_pred             HHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007167          540 EEMVEMLQVGMACVVRMPEERP-----KMADVLKM  569 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  569 (615)
                      +++.++++   +|+..||.+|+     |++|+++|
T Consensus       226 ~~~~~li~---~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         226 EDVKDLLS---RLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             HHHHHHHH---HHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHHHHHHH---HHhhhCHHhccccchhhHHHHHcC
Confidence            66766666   99999999996     89999875

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-47  Score=383.62  Aligned_cols=243  Identities=22%  Similarity=0.357  Sum_probs=199.9

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEecccc-------CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVN-------VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-------~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      .+.||+|+||+||+|.. .+|+.||||+++...       ...+.+.+|++++++++|||||++++++.+++..++||||
T Consensus        15 ~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~   94 (293)
T d1jksa_          15 GEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL   94 (293)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred             eEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEc
Confidence            46799999999999997 468899999986532       1256799999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCC----cEEEeecccccc
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG----HVCVSDIGLAAL  452 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~----~~kl~DfG~a~~  452 (615)
                      +++|+|.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++    .+||+|||+++.
T Consensus        95 ~~gg~L~~~i~~~-----~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~  166 (293)
T d1jksa_          95 VAGGELFDFLAEK-----ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  166 (293)
T ss_dssp             CCSCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             CCCccccchhccc-----cccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhhh
Confidence            9999999999743     36999999999999999999999998   99999999999998876    599999999987


Q ss_pred             cCCC--CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccc
Q 007167          453 MSPM--PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDV  530 (615)
Q Consensus       453 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  530 (615)
                      ....  .....+|+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+....+.      ....     ..
T Consensus       167 ~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~------~~~~-----~~  235 (293)
T d1jksa_         167 IDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS------AVNY-----EF  235 (293)
T ss_dssp             CTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------TTCC-----CC
T ss_pred             cCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHH------hcCC-----CC
Confidence            7543  234567889999999999899999999999999999999999998755443322211      1100     00


Q ss_pred             cccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          531 ELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       531 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .....+..++++.++++   +||..||++|||++|++++
T Consensus       236 ~~~~~~~~s~~~~~li~---~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         236 EDEYFSNTSALAKDFIR---RLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             CHHHHTTSCHHHHHHHH---TTSCSSGGGSCCHHHHHHS
T ss_pred             CchhcCCCCHHHHHHHH---HHccCChhHCcCHHHHhcC
Confidence            01112334556666666   9999999999999999875

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.5e-47  Score=394.54  Aligned_cols=244  Identities=23%  Similarity=0.428  Sum_probs=200.7

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccC-CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNV-GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~-~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      .+.||+|+||+||+|..+ +|+.||||++..... ..+.+.+|++++++++|||||++++++.+++..++||||+++|+|
T Consensus        31 ~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L  110 (350)
T d1koaa2          31 HEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL  110 (350)
T ss_dssp             EEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBH
T ss_pred             EEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCH
Confidence            457999999999999964 688999999975432 346688999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCC--CCcEEEeecccccccCCCCC--
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNS--QGHVCVSDIGLAALMSPMPP--  458 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~--~~~~kl~DfG~a~~~~~~~~--  458 (615)
                      .+++...    ...+++..+..|+.||+.||+|||+++   |+||||||+|||++.  ++.+||+|||+++.+.....  
T Consensus       111 ~~~l~~~----~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~  183 (350)
T d1koaa2         111 FEKVADE----HNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK  183 (350)
T ss_dssp             HHHHTCT----TSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEE
T ss_pred             HHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccccccc
Confidence            9998643    236999999999999999999999998   999999999999964  57899999999988765432  


Q ss_pred             CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCc
Q 007167          459 PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI  538 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  538 (615)
                      ...+|+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+....+      ....+.     ......+.+
T Consensus       184 ~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i------~~~~~~-----~~~~~~~~~  252 (350)
T d1koaa2         184 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNV------KSCDWN-----MDDSAFSGI  252 (350)
T ss_dssp             EECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHTCCC-----SCCGGGGGC
T ss_pred             eecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHH------HhCCCC-----CCcccccCC
Confidence            346799999999999999999999999999999999999999865443332221      111110     011112334


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          539 EEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       539 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      +++++++++   +||..||++|||++|+++|
T Consensus       253 s~~~~~li~---~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         253 SEDGKDFIR---KLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             CHHHHHHHH---HHCCSSGGGSCCHHHHHHS
T ss_pred             CHHHHHHHH---HHccCChhHCcCHHHHhcC
Confidence            566666666   9999999999999999886

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-47  Score=389.72  Aligned_cols=246  Identities=22%  Similarity=0.378  Sum_probs=198.6

Q ss_pred             hhhcCcCCccEEEEEEEC-CCC----EEEEEEeccc--cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecC
Q 007167          305 AEVLGKGTFGTAYKAALE-DAS----TVVVKRLKEV--NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYF  377 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~----~vavK~l~~~--~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~  377 (615)
                      .++||+|+||+||+|.+. +|+    +||+|+++..  ....+.|.+|++++++++|||||+++|+|.++ ..++++||+
T Consensus        14 ~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~   92 (317)
T d1xkka_          14 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLM   92 (317)
T ss_dssp             EEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECC
T ss_pred             eeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEec
Confidence            357999999999999864 333    5899988654  23467899999999999999999999999865 567889999


Q ss_pred             CCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC
Q 007167          378 EPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP  457 (615)
Q Consensus       378 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~  457 (615)
                      .+|+|.+.+...    ...+++..+++++.|+|.||+|||+++   |+||||||+|||++.++++||+|||+++......
T Consensus        93 ~~~~l~~~~~~~----~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~  165 (317)
T d1xkka_          93 PFGCLLDYVREH----KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  165 (317)
T ss_dssp             TTCBHHHHHHHT----SSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred             cCCccccccccc----ccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence            999999988753    346999999999999999999999998   9999999999999999999999999998775432


Q ss_pred             C-----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccccccccc
Q 007167          458 P-----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE  531 (615)
Q Consensus       458 ~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  531 (615)
                      .     ...+|..|+|||++.++.++.++|||||||++|||+| |+.||......+....+.   .   .        ..
T Consensus       166 ~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~---~---~--------~~  231 (317)
T d1xkka_         166 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE---K---G--------ER  231 (317)
T ss_dssp             C--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHH---H---T--------CC
T ss_pred             ccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHH---c---C--------CC
Confidence            2     2246889999999999999999999999999999998 899998766555433332   1   0        01


Q ss_pred             ccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          532 LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       532 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                      +...+.+++++.+++.   +||..||++|||+.||+++|+.+..
T Consensus       232 ~~~p~~~~~~~~~li~---~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         232 LPQPPICTIDVYMIMV---KCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             CCCCTTBCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCcccCHHHHHHHH---HhCCCChhhCcCHHHHHHHHHHHHh
Confidence            1222345555555555   9999999999999999999998865

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.8e-48  Score=389.22  Aligned_cols=250  Identities=21%  Similarity=0.366  Sum_probs=200.2

Q ss_pred             hhhcCcCCccEEEEEEEC------CCCEEEEEEeccccCC--HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAALE------DASTVVVKRLKEVNVG--KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      .+.||+|+||+||+|+.+      +++.||||+++.....  .+.|.+|+++++.++||||++++++|...+..++||||
T Consensus        18 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~   97 (301)
T d1lufa_          18 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEY   97 (301)
T ss_dssp             EEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             eEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEe
Confidence            356999999999999864      3568999999754322  45789999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeC
Q 007167          377 FEPGSVSAMLHGRRG-------------------EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLN  437 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~  437 (615)
                      +++|+|.++++....                   .....++|..++.|+.|++.||+|||+.+   |+||||||+|||+|
T Consensus        98 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlKp~NILld  174 (301)
T d1lufa_          98 MAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVG  174 (301)
T ss_dssp             CTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEC
T ss_pred             cCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEcccceEEC
Confidence            999999999964321                   12335899999999999999999999998   99999999999999


Q ss_pred             CCCcEEEeecccccccCCCC-----CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCC-CCCCCCCCcchhhH
Q 007167          438 SQGHVCVSDIGLAALMSPMP-----PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGK-SPIHATGGDEVVHL  511 (615)
Q Consensus       438 ~~~~~kl~DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~-~p~~~~~~~~~~~~  511 (615)
                      .++++||+|||+++.+....     ....++..|+|||.+.+..++.++|||||||++|||++|. .||......+....
T Consensus       175 ~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~  254 (301)
T d1lufa_         175 ENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYY  254 (301)
T ss_dssp             GGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred             CCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHH
Confidence            99999999999998664321     2335677899999999999999999999999999999985 57776554443322


Q ss_pred             HHHHHHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhH
Q 007167          512 VRWVNSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIR  574 (615)
Q Consensus       512 ~~~~~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~  574 (615)
                      +   .    ....       ......+++++.++   +.+||+.+|++||||.||+++|++|.
T Consensus       255 v---~----~~~~-------~~~p~~~~~~~~~l---i~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         255 V---R----DGNI-------LACPENCPLELYNL---MRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             H---H----TTCC-------CCCCTTCCHHHHHH---HHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             H---H----cCCC-------CCCCccchHHHHHH---HHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            2   1    1100       01122444555554   55999999999999999999999875

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=3.4e-47  Score=392.15  Aligned_cols=244  Identities=22%  Similarity=0.380  Sum_probs=201.8

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEecccc-CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVN-VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~-~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      .+.||+|+||+||+|.. .+|+.||||+++... ...+.+.+|++++++++|||||++++++.+++..++||||+++|+|
T Consensus        34 ~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L  113 (352)
T d1koba_          34 LEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL  113 (352)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBH
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChH
Confidence            45799999999999996 468999999987543 2345688999999999999999999999999999999999999999


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeC--CCCcEEEeecccccccCCCCC--
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLN--SQGHVCVSDIGLAALMSPMPP--  458 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~--~~~~~kl~DfG~a~~~~~~~~--  458 (615)
                      .+.+...    ...+++..+..|+.||+.||+|||+++   |+||||||+|||++  .++.+||+|||+|+.+.....  
T Consensus       114 ~~~~~~~----~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~  186 (352)
T d1koba_         114 FDRIAAE----DYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK  186 (352)
T ss_dssp             HHHTTCT----TCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred             HHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCCcee
Confidence            9887642    236999999999999999999999998   99999999999998  678999999999998765432  


Q ss_pred             CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCc
Q 007167          459 PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNI  538 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~  538 (615)
                      ...+|+.|+|||++.+..++.++||||+||++|||++|+.||.+....+....+      ....     ........+.+
T Consensus       187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i------~~~~-----~~~~~~~~~~~  255 (352)
T d1koba_         187 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNV------KRCD-----WEFDEDAFSSV  255 (352)
T ss_dssp             EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHH------HHCC-----CCCCSSTTTTS
T ss_pred             eccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCC-----CCCCcccccCC
Confidence            346789999999999999999999999999999999999999765443322211      1111     01111123456


Q ss_pred             HHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          539 EEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       539 ~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ++++.++++   +||+.||++|||++|+++|
T Consensus       256 s~~~~~li~---~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         256 SPEAKDFIK---NLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             CHHHHHHHH---TTSCSSGGGSCCHHHHHTS
T ss_pred             CHHHHHHHH---HHccCChhHCcCHHHHhcC
Confidence            677777766   9999999999999999875

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-47  Score=387.64  Aligned_cols=262  Identities=23%  Similarity=0.335  Sum_probs=195.0

Q ss_pred             hhcCcCCccEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecC----eeeEEeecCCCCC
Q 007167          306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKD----EKLMVYDYFEPGS  381 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lV~e~~~~gs  381 (615)
                      +.||+|+||+||+|++ +|+.||||+++........++.|+..+..++|||||++++++.+.+    ..++||||+++|+
T Consensus         9 ~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~   87 (303)
T d1vjya_           9 ESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGS   87 (303)
T ss_dssp             EEEECCSSSEEEEEEE-TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCB
T ss_pred             EEEeeCCCeEEEEEEE-CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCC
Confidence            5699999999999987 5789999999754322222344555556789999999999998764    5799999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccC-----CCCceecCCCCCCEEeCCCCcEEEeecccccccCCC
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTEN-----GGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM  456 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-----~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~  456 (615)
                      |.++|+..      .++|..+.+++.|+|.||+|||+..     .++|+||||||+|||++.++++||+|||+++.....
T Consensus        88 L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~  161 (303)
T d1vjya_          88 LFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA  161 (303)
T ss_dssp             HHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETT
T ss_pred             HHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCC
Confidence            99999742      5999999999999999999999741     234999999999999999999999999999876432


Q ss_pred             -------CCCCCCCCcccCccccCCCC------CCCccchhhHHHHHHHHHhCCCCCCCCCCcchh--------hHHHHH
Q 007167          457 -------PPPAMRAAGYRAPEVTDTRK------ATQASDVFSFGVLLLELLTGKSPIHATGGDEVV--------HLVRWV  515 (615)
Q Consensus       457 -------~~~~~~~~~y~aPE~~~~~~------~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~--------~~~~~~  515 (615)
                             .....+|++|+|||++....      ++.++|||||||++|||+||..||......+..        ......
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (303)
T d1vjya_         162 TDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM  241 (303)
T ss_dssp             TTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHH
T ss_pred             CcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHH
Confidence                   22346899999999986542      567899999999999999999887543322110        001111


Q ss_pred             HHhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhhc
Q 007167          516 NSVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVKA  578 (615)
Q Consensus       516 ~~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~~  578 (615)
                      ......    ...++.+.......+....+.+++.+||+.||++|||+.||+++|+++.+...
T Consensus       242 ~~~~~~----~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~~~  300 (303)
T d1vjya_         242 RKVVCE----QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEG  300 (303)
T ss_dssp             HHHHTT----SCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHHhc----cccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHhcC
Confidence            111111    11122221111122344556677779999999999999999999999987553

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-46  Score=383.56  Aligned_cols=239  Identities=21%  Similarity=0.319  Sum_probs=201.3

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccc----cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCC
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEV----NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEP  379 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~  379 (615)
                      .+.||+|+||+||+|+. .+++.||||+++..    ....+.+.+|+++++.++|||||++++++.+++..++||||+++
T Consensus        10 ~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~g   89 (337)
T d1o6la_          10 LKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANG   89 (337)
T ss_dssp             EEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTT
T ss_pred             EEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCC
Confidence            35799999999999996 47899999999753    23356788999999999999999999999999999999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC--
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~--  457 (615)
                      |+|.+++...     ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++++||+|||+|+......  
T Consensus        90 g~L~~~~~~~-----~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~  161 (337)
T d1o6la_          90 GELFFHLSRE-----RVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             CBHHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             Cchhhhhhcc-----cCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccCCcc
Confidence            9999999753     36899999999999999999999998   9999999999999999999999999998764322  


Q ss_pred             -CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCC
Q 007167          458 -PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYP  536 (615)
Q Consensus       458 -~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~  536 (615)
                       ...+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+..+....+      ...         ......
T Consensus       162 ~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i------~~~---------~~~~p~  226 (337)
T d1o6la_         162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI------LME---------EIRFPR  226 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH------HHC---------CCCCCT
T ss_pred             cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHH------hcC---------CCCCCc
Confidence             3456899999999999999999999999999999999999999876543332211      111         111223


Q ss_pred             CcHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 007167          537 NIEEEMVEMLQVGMACVVRMPEERPK-----MADVLKM  569 (615)
Q Consensus       537 ~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~  569 (615)
                      .++++++++++   +||+.||.+||+     ++|+++|
T Consensus       227 ~~s~~~~dli~---~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         227 TLSPEAKSLLA---GLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             TSCHHHHHHHH---HHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             cCCHHHHHHHH---hhccCCchhhcccccccHHHHHcC
Confidence            56677777776   999999999995     8888875

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-47  Score=379.64  Aligned_cols=247  Identities=23%  Similarity=0.390  Sum_probs=193.5

Q ss_pred             hhhcCcCCccEEEEEEECC----CCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALED----ASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~----~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      .+.||+|+||+||+|.+..    +..||||.++....  ..+.|.+|++++++++|||||++++++. ++..++||||++
T Consensus        12 ~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~   90 (273)
T d1mp8a_          12 GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCT   90 (273)
T ss_dssp             EEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCT
T ss_pred             EEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEecc
Confidence            4679999999999998643    34688998865432  2456899999999999999999999985 567899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC-
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP-  457 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~-  457 (615)
                      +|+|.+++...    ...+++..++.++.|++.||+|||+.+   |+||||||+||+++.++.+||+|||+++.+.... 
T Consensus        91 ~g~l~~~~~~~----~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~  163 (273)
T d1mp8a_          91 LGELRSFLQVR----KYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY  163 (273)
T ss_dssp             TEEHHHHHHHT----TTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC------------
T ss_pred             CCcHHhhhhcc----CCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence            99999987643    236899999999999999999999998   9999999999999999999999999998765332 


Q ss_pred             ---CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccccccccccc
Q 007167          458 ---PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELL  533 (615)
Q Consensus       458 ---~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~  533 (615)
                         ....+|+.|+|||.+....++.++|||||||++|||++ |+.||......+....+.      ...        ...
T Consensus       164 ~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~------~~~--------~~~  229 (273)
T d1mp8a_         164 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE------NGE--------RLP  229 (273)
T ss_dssp             -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH------TTC--------CCC
T ss_pred             eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHH------cCC--------CCC
Confidence               23346788999999999999999999999999999998 899998766555433221      110        111


Q ss_pred             CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          534 RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       534 ~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                      ..+.+++++.++++   +||..||++|||+.||+++|+.+.+.
T Consensus       230 ~~~~~~~~~~~li~---~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         230 MPPNCPPTLYSLMT---KCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             CCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHH---HHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence            23455666666665   99999999999999999999998654

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.5e-46  Score=384.57  Aligned_cols=238  Identities=18%  Similarity=0.243  Sum_probs=202.1

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccc----cCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEV----NVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPG  380 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~g  380 (615)
                      +.||+|+||+||+|..+ +|+.||||++...    ....+.+.+|+++++.++|||||++++++.+....++||||+.+|
T Consensus        47 ~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g  126 (350)
T d1rdqe_          47 KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG  126 (350)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred             EEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccccccccc
Confidence            56999999999999964 6899999998643    233467889999999999999999999999999999999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCCCC
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPPPA  460 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  460 (615)
                      +|.+++...     ..+++..+..++.|++.||.|||+++   ||||||||+|||++.++++||+|||+|+.+.......
T Consensus       127 ~l~~~l~~~-----~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~~~  198 (350)
T d1rdqe_         127 EMFSHLRRI-----GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL  198 (350)
T ss_dssp             BHHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCCC
T ss_pred             chhhhHhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccccccc
Confidence            999999743     26999999999999999999999998   9999999999999999999999999999887766677


Q ss_pred             CCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcHH
Q 007167          461 MRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIEE  540 (615)
Q Consensus       461 ~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~~  540 (615)
                      .||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....      +...         .....+.+++
T Consensus       199 ~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~------i~~~---------~~~~p~~~s~  263 (350)
T d1rdqe_         199 CGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK------IVSG---------KVRFPSHFSS  263 (350)
T ss_dssp             EECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHHC---------CCCCCTTCCH
T ss_pred             cCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHH------HhcC---------CCCCCccCCH
Confidence            899999999999999999999999999999999999999976543222211      1111         1112234566


Q ss_pred             HHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007167          541 EMVEMLQVGMACVVRMPEERP-----KMADVLKM  569 (615)
Q Consensus       541 ~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  569 (615)
                      ++.++++   +|+..||.+|+     |++|+++|
T Consensus       264 ~~~~li~---~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         264 DLKDLLR---NLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             HHHHHHH---HHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHHHHHH---HHhhhCHHhccccccccHHHHHcC
Confidence            7777766   99999999994     89999874

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=382.77  Aligned_cols=253  Identities=23%  Similarity=0.378  Sum_probs=202.1

Q ss_pred             hhhcCcCCccEEEEEEECC-CC--EEEEEEeccc--cCCHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALED-AS--TVVVKRLKEV--NVGKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~-~~--~vavK~l~~~--~~~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      .++||+|+||+||+|.+++ +.  .||||+++..  ....+.|.+|++++.++ +|||||+++++|.+++..++||||++
T Consensus        15 ~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~   94 (309)
T d1fvra_          15 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   94 (309)
T ss_dssp             EEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCT
T ss_pred             EEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecC
Confidence            4679999999999999754 33  4778887643  22356799999999998 79999999999999999999999999


Q ss_pred             CCChhhhhccCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeec
Q 007167          379 PGSVSAMLHGRR-----------GEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDI  447 (615)
Q Consensus       379 ~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~Df  447 (615)
                      +|+|.++|+...           ......++|..+.+++.|+|.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        95 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~kl~Df  171 (309)
T d1fvra_          95 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF  171 (309)
T ss_dssp             TCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCT
T ss_pred             CCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCceEEccc
Confidence            999999997542           122457999999999999999999999998   999999999999999999999999


Q ss_pred             ccccccCCCCC--CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCC-CCCCCCCCcchhhHHHHHHHhhhcccc
Q 007167          448 GLAALMSPMPP--PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGK-SPIHATGGDEVVHLVRWVNSVVREEWT  524 (615)
Q Consensus       448 G~a~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~  524 (615)
                      |+++.......  ...+|..|+|||.+....++.++|||||||++|||++|. .||...+..+..   ..+.   . .  
T Consensus       172 G~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~---~~i~---~-~--  242 (309)
T d1fvra_         172 GLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY---EKLP---Q-G--  242 (309)
T ss_dssp             TCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH---HHGG---G-T--
T ss_pred             cccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHH---HHHH---h-c--
Confidence            99987654322  334788999999999889999999999999999999965 567654433322   2111   1 1  


Q ss_pred             cccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhh
Q 007167          525 AEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVK  577 (615)
Q Consensus       525 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~  577 (615)
                           ........+++++.++++   +||+.||++||||+||+++|+++.+..
T Consensus       243 -----~~~~~~~~~~~~~~~li~---~cl~~dP~~RPs~~eil~~L~~i~~~~  287 (309)
T d1fvra_         243 -----YRLEKPLNCDDEVYDLMR---QCWREKPYERPSFAQILVSLNRMLEER  287 (309)
T ss_dssp             -----CCCCCCTTBCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             -----CCCCCCccCCHHHHHHHH---HHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence                 011123345667777666   999999999999999999999997643

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-46  Score=378.88  Aligned_cols=248  Identities=25%  Similarity=0.390  Sum_probs=196.5

Q ss_pred             hhcCcCCccEEEEEEECCC----CEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEec-CeeeEEeecCC
Q 007167          306 EVLGKGTFGTAYKAALEDA----STVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSK-DEKLMVYDYFE  378 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~----~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~-~~~~lV~e~~~  378 (615)
                      ++||+|+||+||+|.+.++    ..||||+++....  ..+.|.+|++++++++|||||+++|++... ...++||||++
T Consensus        33 ~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~  112 (311)
T d1r0pa_          33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMK  112 (311)
T ss_dssp             EEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCT
T ss_pred             eEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEee
Confidence            5699999999999997542    2589999975322  236799999999999999999999998764 58899999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC-
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP-  457 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~-  457 (615)
                      +|+|.++++..    ...+++..+++++.|++.||.|||+.+   |+||||||+|||+++++.+||+|||+++...... 
T Consensus       113 ~g~l~~~~~~~----~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~  185 (311)
T d1r0pa_         113 HGDLRNFIRNE----THNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  185 (311)
T ss_dssp             TCBHHHHHHCT----TCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTC
T ss_pred             cCchhhhhccc----cccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhcccccc
Confidence            99999998753    346789999999999999999999998   9999999999999999999999999998765322 


Q ss_pred             ------CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccccc
Q 007167          458 ------PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVE  531 (615)
Q Consensus       458 ------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~  531 (615)
                            ....+|..|+|||.+....++.++||||||+++|||++|+.||......  .+...++.   ...        +
T Consensus       186 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~i~---~g~--------~  252 (311)
T d1r0pa_         186 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLL---QGR--------R  252 (311)
T ss_dssp             CCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHH---TTC--------C
T ss_pred             ccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHHHH---cCC--------C
Confidence                  1234678899999999999999999999999999999988887643221  11111111   111        1


Q ss_pred             ccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          532 LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       532 ~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                      ....+.+++++.+++   .+||+.||++||+|.||+++|+.+...
T Consensus       253 ~~~p~~~~~~l~~li---~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         253 LLQPEYCPDPLYEVM---LKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             CCCCTTCCHHHHHHH---HHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCcccCcHHHHHHH---HHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            111233445555554   599999999999999999999999764

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-47  Score=377.07  Aligned_cols=245  Identities=24%  Similarity=0.407  Sum_probs=189.2

Q ss_pred             hhhcCcCCccEEEEEEECC--C--CEEEEEEeccccC----CHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAALED--A--STVVVKRLKEVNV----GKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~--~--~~vavK~l~~~~~----~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      .+.||+|+||+||+|..+.  +  ..||||+++....    ..+.|.+|++++++++|||||+++|++.+ +..++||||
T Consensus        13 ~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~   91 (273)
T d1u46a_          13 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTEL   91 (273)
T ss_dssp             EEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred             EEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeee
Confidence            3569999999999998532  2  3689999875422    13578999999999999999999999965 467899999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM  456 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~  456 (615)
                      +++|++.+.+....    ..+++..++.++.|+|.||+|||+++   |+||||||+||+++.++.+||+|||+++.....
T Consensus        92 ~~~~~l~~~~~~~~----~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~  164 (273)
T d1u46a_          92 APLGSLLDRLRKHQ----GHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN  164 (273)
T ss_dssp             CTTCBHHHHHHHHG----GGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred             ecCcchhhhhhccc----CCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhcccC
Confidence            99999999887532    36999999999999999999999998   999999999999999999999999999987543


Q ss_pred             CC------CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHHHhhhccccccccc
Q 007167          457 PP------PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD  529 (615)
Q Consensus       457 ~~------~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  529 (615)
                      ..      ...++..|+|||.+.+..++.++|||||||++|||+| |+.||.+.+..+....      +.+..       
T Consensus       165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~------i~~~~-------  231 (273)
T d1u46a_         165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHK------IDKEG-------  231 (273)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH------HHTSC-------
T ss_pred             CCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHH------HHhCC-------
Confidence            22      2345678999999999899999999999999999998 8999986554433221      11111       


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHh
Q 007167          530 VELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDI  573 (615)
Q Consensus       530 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l  573 (615)
                      ......+.+++++.++++   +||..||++|||+.||++.|++.
T Consensus       232 ~~~~~~~~~~~~l~~li~---~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         232 ERLPRPEDCPQDIYNVMV---QCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             CCCCCCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCCcccccHHHHHHHH---HHcCCChhHCcCHHHHHHHHHhc
Confidence            011122345566655555   99999999999999999999875

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.3e-45  Score=382.27  Aligned_cols=242  Identities=23%  Similarity=0.349  Sum_probs=196.8

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccc----cCCHHHHHH---HHHHHhCCCCCcccceeEEEEecCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEV----NVGKREFEQ---QMEIVGGIRHENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~---e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      .++||+|+||+||+|... +|+.||||++...    ......+.+   |+++++.++|||||++++++.+.+..++||||
T Consensus         9 ~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~   88 (364)
T d1omwa3           9 HRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL   88 (364)
T ss_dssp             EEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECC
T ss_pred             eeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEe
Confidence            357999999999999965 6899999998643    122333434   47778888999999999999999999999999


Q ss_pred             CCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC
Q 007167          377 FEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM  456 (615)
Q Consensus       377 ~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~  456 (615)
                      +++|+|.+++...     ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|+.+...
T Consensus        89 ~~gg~L~~~l~~~-----~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~  160 (364)
T d1omwa3          89 MNGGDLHYHLSQH-----GVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK  160 (364)
T ss_dssp             CCSCBHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred             cCCCcHHHHHHhc-----ccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence            9999999999743     36889999999999999999999998   999999999999999999999999999877543


Q ss_pred             -CCCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccC
Q 007167          457 -PPPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLR  534 (615)
Q Consensus       457 -~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  534 (615)
                       .....||+.|+|||++.. ..++.++|||||||++|||++|+.||......+......   ..         .......
T Consensus       161 ~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~---~~---------~~~~~~~  228 (364)
T d1omwa3         161 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR---MT---------LTMAVEL  228 (364)
T ss_dssp             CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHH---HS---------SSCCCCC
T ss_pred             cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hc---------ccCCCCC
Confidence             344568999999999864 568999999999999999999999998765544332221   11         1111112


Q ss_pred             CCCcHHHHHHHHHHHHHcccCCCCCCCC-----HHHHHHH
Q 007167          535 YPNIEEEMVEMLQVGMACVVRMPEERPK-----MADVLKM  569 (615)
Q Consensus       535 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs-----~~evl~~  569 (615)
                      ...+++++.++++   +||..||++|||     ++|+++|
T Consensus       229 ~~~~s~~~~~li~---~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         229 PDSFSPELRSLLE---GLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             CSSSCHHHHHHHH---HHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             CCCCCHHHHHHHH---HHcccCHHHhCCCcccCHHHHHcC
Confidence            2356677777776   999999999999     6888875

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-46  Score=377.79  Aligned_cols=254  Identities=27%  Similarity=0.387  Sum_probs=189.1

Q ss_pred             hhhcCcCCccEEEEEEECC------CCEEEEEEeccccC--CHHHHHHHHHHHhCC-CCCcccceeEEEEec-CeeeEEe
Q 007167          305 AEVLGKGTFGTAYKAALED------ASTVVVKRLKEVNV--GKREFEQQMEIVGGI-RHENVVALRAYYYSK-DEKLMVY  374 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~-~~~~lV~  374 (615)
                      .++||+|+||+||+|.+..      ++.||||+++....  ..+.+.+|.+++.++ +|+|||.+++++... ...++||
T Consensus        18 ~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~   97 (299)
T d1ywna1          18 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIV   97 (299)
T ss_dssp             EEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEE
T ss_pred             eeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEE
Confidence            4679999999999998532      35799999975422  245677777777766 689999999998765 4689999


Q ss_pred             ecCCCCChhhhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEE
Q 007167          375 DYFEPGSVSAMLHGRRGE-----------GQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVC  443 (615)
Q Consensus       375 e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~k  443 (615)
                      ||+++|+|.++++..+..           ....+++..+..++.|++.||+|||+++   |+||||||+|||+++++++|
T Consensus        98 E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~NILl~~~~~~K  174 (299)
T d1ywna1          98 EFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVK  174 (299)
T ss_dssp             ECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEE
T ss_pred             EecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCccceeECCCCcEE
Confidence            999999999999754321           1335899999999999999999999998   99999999999999999999


Q ss_pred             EeecccccccCCCC-----CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhC-CCCCCCCCCcchhhHHHHHHH
Q 007167          444 VSDIGLAALMSPMP-----PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTG-KSPIHATGGDEVVHLVRWVNS  517 (615)
Q Consensus       444 l~DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~  517 (615)
                      |+|||+|+......     ....+|+.|+|||++.+..++.++|||||||++|||++| +.||......+..  ...+. 
T Consensus       175 l~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~--~~~~~-  251 (299)
T d1ywna1         175 ICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRLK-  251 (299)
T ss_dssp             ECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH--HHHHH-
T ss_pred             EccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHH--HHHHh-
Confidence            99999998764332     233578899999999999999999999999999999996 5678665433221  11111 


Q ss_pred             hhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhh
Q 007167          518 VVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVK  577 (615)
Q Consensus       518 ~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~  577 (615)
                         ...       ........++++.+++   .+||+.||++|||++||+++|+++.+..
T Consensus       252 ---~~~-------~~~~~~~~~~~l~~li---~~cl~~dP~~Rpt~~eil~~L~~ilq~n  298 (299)
T d1ywna1         252 ---EGT-------RMRAPDYTTPEMYQTM---LDCWHGEPSQRPTFSELVEHLGNLLQAN  298 (299)
T ss_dssp             ---HTC-------CCCCCTTCCHHHHHHH---HHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ---cCC-------CCCCCccCCHHHHHHH---HHHcCCChhHCcCHHHHHHHHHHHHhCC
Confidence               111       0111223445555554   4999999999999999999999987654

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=5.5e-46  Score=370.65  Aligned_cols=243  Identities=19%  Similarity=0.362  Sum_probs=198.2

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccCC----------HHHHHHHHHHHhCCC-CCcccceeEEEEecCeeeE
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVG----------KREFEQQMEIVGGIR-HENVVALRAYYYSKDEKLM  372 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~----------~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~l  372 (615)
                      .+.||+|+||+||+|+. .+++.||||+++.....          .+.+.+|++++++++ |||||++++++.+++..+|
T Consensus         8 ~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~i   87 (277)
T d1phka_           8 KEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL   87 (277)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             ceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEE
Confidence            46799999999999996 47889999998754321          135788999999997 9999999999999999999


Q ss_pred             EeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccc
Q 007167          373 VYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAAL  452 (615)
Q Consensus       373 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~  452 (615)
                      ||||+++|+|.++++..     ..+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        88 vmE~~~~g~L~~~l~~~-----~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~  159 (277)
T d1phka_          88 VFDLMKKGELFDYLTEK-----VTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ  159 (277)
T ss_dssp             EEECCTTCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             EEEcCCCchHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeE
Confidence            99999999999999743     36999999999999999999999998   99999999999999999999999999988


Q ss_pred             cCCC--CCCCCCCCcccCccccC------CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccc
Q 007167          453 MSPM--PPPAMRAAGYRAPEVTD------TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWT  524 (615)
Q Consensus       453 ~~~~--~~~~~~~~~y~aPE~~~------~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  524 (615)
                      ....  .....+|..|+|||.+.      ...++.++||||+||++|||++|+.||.+.+..+....      +..... 
T Consensus       160 ~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~------i~~~~~-  232 (277)
T d1phka_         160 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRM------IMSGNY-  232 (277)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH------HHHTCC-
T ss_pred             ccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHH------HHhCCC-
Confidence            7643  23456789999999884      34578899999999999999999999987543332211      111111 


Q ss_pred             cccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          525 AEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       525 ~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                          .......+.++++++++++   +|++.||++|||++||+++
T Consensus       233 ----~~~~~~~~~~s~~~~~li~---~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         233 ----QFGSPEWDDYSDTVKDLVS---RFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             ----CCCTTTGGGSCHHHHHHHH---HHCCSSGGGSCCHHHHTTS
T ss_pred             ----CCCCcccccCCHHHHHHHH---HHccCChhHCcCHHHHHcC
Confidence                1111122345667777666   9999999999999999875

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-46  Score=375.62  Aligned_cols=252  Identities=25%  Similarity=0.405  Sum_probs=197.6

Q ss_pred             hhhcCcCCccEEEEEEECC--------CCEEEEEEeccccC--CHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEE
Q 007167          305 AEVLGKGTFGTAYKAALED--------ASTVVVKRLKEVNV--GKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMV  373 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~~--------~~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV  373 (615)
                      .+.||+|+||.||+|+...        +..||||+++....  ...++.+|...+.++ +|||||+++++|.+++..++|
T Consensus        18 ~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v   97 (299)
T d1fgka_          18 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVI   97 (299)
T ss_dssp             EEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             eeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEE
Confidence            4579999999999998532        24699999976432  236778888888888 899999999999999999999


Q ss_pred             eecCCCCChhhhhccCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcE
Q 007167          374 YDYFEPGSVSAMLHGRRGE-----------GQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHV  442 (615)
Q Consensus       374 ~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~  442 (615)
                      |||+++|+|.+++......           ....+++..+++++.|++.||+|||+.+   |+||||||+|||++.++.+
T Consensus        98 ~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl~~~~~~  174 (299)
T d1fgka_          98 VEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVTEDNVM  174 (299)
T ss_dssp             ECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCE
T ss_pred             EEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceeecCCCCe
Confidence            9999999999999754321           2346899999999999999999999998   9999999999999999999


Q ss_pred             EEeecccccccCCCC-----CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 007167          443 CVSDIGLAALMSPMP-----PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVN  516 (615)
Q Consensus       443 kl~DfG~a~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  516 (615)
                      ||+|||+++......     ....+++.|+|||.+.++.|+.++|||||||++|||++ |+.||......+..   ..+.
T Consensus       175 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~---~~i~  251 (299)
T d1fgka_         175 KIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF---KLLK  251 (299)
T ss_dssp             EECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH---HHHH
T ss_pred             EeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHH---HHHH
Confidence            999999998765432     23456788999999999999999999999999999998 78888765443322   2221


Q ss_pred             HhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhh
Q 007167          517 SVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRV  576 (615)
Q Consensus       517 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~  576 (615)
                      .    ..       .......+++++.+++.   +||+.||.+|||+.||++.|+++...
T Consensus       252 ~----~~-------~~~~p~~~~~~l~~li~---~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         252 E----GH-------RMDKPSNCTNELYMMMR---DCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             T----TC-------CCCCCSSCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             c----CC-------CCCCCccchHHHHHHHH---HHccCCHhHCcCHHHHHHHHHHHhhc
Confidence            1    10       11112344555555555   99999999999999999999998764

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=7.4e-46  Score=370.98  Aligned_cols=248  Identities=21%  Similarity=0.315  Sum_probs=197.0

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccCC----HHHHHHHHHHHhCCCCCcccceeEEEEecC----eeeEEee
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVG----KREFEQQMEIVGGIRHENVVALRAYYYSKD----EKLMVYD  375 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~----~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lV~e  375 (615)
                      .+.||+|+||+||+|.. .+++.||||+++.....    .+.+.+|+++++.++|||||++++++...+    ..++|||
T Consensus        12 ~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE   91 (277)
T d1o6ya_          12 GEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVME   91 (277)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEE
T ss_pred             eEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEE
Confidence            35799999999999996 46889999999754322    246889999999999999999999998754    3789999


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      |+++|+|.+++...     ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++..+|+|||.+.....
T Consensus        92 ~~~g~~L~~~~~~~-----~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~  163 (277)
T d1o6ya_          92 YVDGVTLRDIVHTE-----GPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIAD  163 (277)
T ss_dssp             CCCEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred             CCCCCEehhhhccc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhcc
Confidence            99999999988643     36999999999999999999999998   99999999999999999999999999876543


Q ss_pred             C------CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccc
Q 007167          456 M------PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD  529 (615)
Q Consensus       456 ~------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  529 (615)
                      .      .....||+.|+|||++.+..++.++||||+||++|||+||+.||...+..+..      ........     .
T Consensus       164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~------~~~~~~~~-----~  232 (277)
T d1o6ya_         164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA------YQHVREDP-----I  232 (277)
T ss_dssp             ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH------HHHHHCCC-----C
T ss_pred             ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHH------HHHHhcCC-----C
Confidence            2      22345789999999999989999999999999999999999999765433221      11121111     1


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHcccCCCCCCC-CHHHHHHHHHHhH
Q 007167          530 VELLRYPNIEEEMVEMLQVGMACVVRMPEERP-KMADVLKMVEDIR  574 (615)
Q Consensus       530 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-s~~evl~~L~~l~  574 (615)
                      +.....+.+++++.++++   +|++.||++|| |++|+.+.|.+++
T Consensus       233 ~~~~~~~~~s~~l~~li~---~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         233 PPSARHEGLSADLDAVVL---KALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             CGGGTSSSCCHHHHHHHH---HHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             CCchhccCCCHHHHHHHH---HHccCCHhHCHhHHHHHHHHHHHHh
Confidence            111223455667777666   99999999999 8999999988875

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-46  Score=380.23  Aligned_cols=244  Identities=21%  Similarity=0.363  Sum_probs=200.8

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      .+.||+|+||+||+|... +++.||||.++........+.+|+++++.++|||||++++++.+++..++||||+++|+|.
T Consensus        10 ~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~   89 (321)
T d1tkia_          10 AEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIF   89 (321)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHH
T ss_pred             EEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHH
Confidence            457999999999999975 5778999999866544567889999999999999999999999999999999999999999


Q ss_pred             hhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCC--CcEEEeecccccccCCCC--CC
Q 007167          384 AMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQ--GHVCVSDIGLAALMSPMP--PP  459 (615)
Q Consensus       384 ~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~--~~~kl~DfG~a~~~~~~~--~~  459 (615)
                      +++...    ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.+  ..+||+|||+++......  ..
T Consensus        90 ~~i~~~----~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~  162 (321)
T d1tkia_          90 ERINTS----AFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL  162 (321)
T ss_dssp             HHHTSS----SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEE
T ss_pred             HHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccCCcccc
Confidence            999743    236899999999999999999999998   9999999999999854  589999999998775433  23


Q ss_pred             CCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCCCCcH
Q 007167          460 AMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRYPNIE  539 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~~~~  539 (615)
                      ..+++.|+|||...+..++.++||||+||++|||++|+.||...+..+....+      .....     ......++.++
T Consensus       163 ~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i------~~~~~-----~~~~~~~~~~s  231 (321)
T d1tkia_         163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENI------MNAEY-----TFDEEAFKEIS  231 (321)
T ss_dssp             EESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH------HHTCC-----CCCHHHHTTSC
T ss_pred             cccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHH------HhCCC-----CCChhhccCCC
Confidence            35788999999999999999999999999999999999999875543332221      11111     00011123455


Q ss_pred             HHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          540 EEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       540 ~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ++++++++   +|+..||++|||+.|+++|
T Consensus       232 ~~~~~li~---~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         232 IEAMDFVD---RLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             HHHHHHHH---TTSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHH---HHccCChhHCcCHHHHhcC
Confidence            66666666   9999999999999999985

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-46  Score=381.40  Aligned_cols=244  Identities=18%  Similarity=0.323  Sum_probs=190.9

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEeccccCCHHHHHHHHHHHhC-CCCCcccceeEEEEe----cCeeeEEeecCCC
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVGKREFEQQMEIVGG-IRHENVVALRAYYYS----KDEKLMVYDYFEP  379 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~-l~h~niv~l~~~~~~----~~~~~lV~e~~~~  379 (615)
                      ++||+|+||+||+|.. .+++.||||+++.    .+.+.+|++++.+ .+|||||++++++.+    +...++|||||++
T Consensus        18 ~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~g   93 (335)
T d2ozaa1          18 QVLGLGINGKVLQIFNKRTQEKFALKMLQD----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDG   93 (335)
T ss_dssp             EEEEECSSCEEEEEEETTTCCEEEEEEEEC----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCS
T ss_pred             EEeeeccCeEEEEEEECCCCCEEEEEEECC----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCC
Confidence            4699999999999996 5688999999864    3567889988654 589999999999876    4568999999999


Q ss_pred             CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCC---CCcEEEeecccccccCCC
Q 007167          380 GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNS---QGHVCVSDIGLAALMSPM  456 (615)
Q Consensus       380 gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~---~~~~kl~DfG~a~~~~~~  456 (615)
                      |+|.+++...   +...+++..+..|+.|++.||+|||+.+   |+||||||+|||++.   ++.+||+|||+|+.....
T Consensus        94 g~L~~~i~~~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~  167 (335)
T d2ozaa1          94 GELFSRIQDR---GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH  167 (335)
T ss_dssp             EEHHHHHHSC---SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCC
T ss_pred             CcHHHHHHhc---CCCCcCHHHHHHHHHHHHHHHHHHHHcC---CccccccccccccccccccccccccccceeeeccCC
Confidence            9999999743   2346999999999999999999999998   999999999999985   567999999999876543


Q ss_pred             --CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccC
Q 007167          457 --PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLR  534 (615)
Q Consensus       457 --~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~  534 (615)
                        .....+|+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+..+....+.   ...    ....++.....
T Consensus       168 ~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~---~~i----~~~~~~~~~~~  240 (335)
T d2ozaa1         168 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---TRI----RMGQYEFPNPE  240 (335)
T ss_dssp             CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CC----CSCSSSCCTTH
T ss_pred             CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHH---HHH----hcCCCCCCCcc
Confidence              344568999999999999899999999999999999999999998755433222110   000    00000000000


Q ss_pred             CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          535 YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       535 ~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .+.+++++.++++   +|++.||++|||+.|++++
T Consensus       241 ~~~~s~~~~~li~---~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         241 WSEVSEEVKMLIR---NLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             HHHSCHHHHHHHH---HHSCSSTTTSCCHHHHHHS
T ss_pred             cccCCHHHHHHHH---HHccCChhHCcCHHHHHcC
Confidence            1123445555555   9999999999999999885

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-46  Score=375.73  Aligned_cols=253  Identities=20%  Similarity=0.329  Sum_probs=192.5

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC------HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG------KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~------~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      ++||+|+||+||+|..+ +|+.||||+++.....      .+.+.+|+++++.++|||||++++++.+++..++||||+.
T Consensus         4 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~   83 (299)
T d1ua2a_           4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFME   83 (299)
T ss_dssp             EEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCS
T ss_pred             eEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhc
Confidence            56999999999999964 6889999998654221      2468899999999999999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC-
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP-  457 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~-  457 (615)
                      ++++..+...     ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++...... 
T Consensus        84 ~~~~~~~~~~-----~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~  155 (299)
T d1ua2a_          84 TDLEVIIKDN-----SLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  155 (299)
T ss_dssp             EEHHHHHTTC-----CSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             chHHhhhhhc-----ccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCcc
Confidence            8877776643     236888899999999999999999998   9999999999999999999999999998765432 


Q ss_pred             --CCCCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHH-HHHHhhhcccccccc---cc
Q 007167          458 --PPAMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVR-WVNSVVREEWTAEVF---DV  530 (615)
Q Consensus       458 --~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~---d~  530 (615)
                        ....+|+.|+|||++... .++.++||||+||++|||++|+.||......+....+. .+.....+.+....-   ..
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~  235 (299)
T d1ua2a_         156 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYV  235 (299)
T ss_dssp             CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCC
T ss_pred             cccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhh
Confidence              334678999999998654 57999999999999999999999998755433322211 111111111110000   00


Q ss_pred             cccC---------CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          531 ELLR---------YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       531 ~~~~---------~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ....         .+..++++.++++   +|++.||++|||++|+++|
T Consensus       236 ~~~~~~~~~~~~~~~~~s~~~~dll~---~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         236 TFKSFPGIPLHHIFSAAGDDLLDLIQ---GLFLFNPCARITATQALKM  280 (299)
T ss_dssp             CCCCCCCCCHHHHCTTCCHHHHHHHH---HHHCSSTTTSCCHHHHHTS
T ss_pred             hhccCCCCChHHhcccCCHHHHHHHH---HHccCChhhCcCHHHHhCC
Confidence            0000         1233445555555   9999999999999999875

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-46  Score=376.68  Aligned_cols=238  Identities=24%  Similarity=0.407  Sum_probs=196.1

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccc----cCCHHHHHHHHHHHh-CCCCCcccceeEEEEecCeeeEEeecCC
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEV----NVGKREFEQQMEIVG-GIRHENVVALRAYYYSKDEKLMVYDYFE  378 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~----~~~~~~~~~e~~~l~-~l~h~niv~l~~~~~~~~~~~lV~e~~~  378 (615)
                      .+.||+|+||+||+|..+ +++.||||+++..    ....+.+..|..++. .++|||||++++++.+++..++||||++
T Consensus         7 ~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~   86 (320)
T d1xjda_           7 HKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLN   86 (320)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCT
T ss_pred             eeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecC
Confidence            357999999999999965 6888999999643    233455667777655 6899999999999999999999999999


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC--
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM--  456 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~--  456 (615)
                      +|+|.++++..     ..+++..+..++.|++.||+|||+++   |+||||||+|||+++++++||+|||+++.....  
T Consensus        87 ~g~L~~~i~~~-----~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          87 GGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA  158 (320)
T ss_dssp             TCBHHHHHHHH-----SSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             CCcHHHHhhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcccccc
Confidence            99999999753     36889999999999999999999998   999999999999999999999999999866432  


Q ss_pred             -CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccccccCC
Q 007167          457 -PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDVELLRY  535 (615)
Q Consensus       457 -~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~  535 (615)
                       .....||+.|+|||++.+..++.++||||+||++|||++|+.||.+.+..+....+.      ..         .....
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~------~~---------~~~~p  223 (320)
T d1xjda_         159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR------MD---------NPFYP  223 (320)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH------HC---------CCCCC
T ss_pred             cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH------cC---------CCCCC
Confidence             234568899999999999999999999999999999999999998755443322221      11         11112


Q ss_pred             CCcHHHHHHHHHHHHHcccCCCCCCCCHH-HHHH
Q 007167          536 PNIEEEMVEMLQVGMACVVRMPEERPKMA-DVLK  568 (615)
Q Consensus       536 ~~~~~~~~~l~~l~~~cl~~~P~~RPs~~-evl~  568 (615)
                      ..+++++.++++   +||..||++||++. |+++
T Consensus       224 ~~~s~~~~dli~---~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         224 RWLEKEAKDLLV---KLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             TTSCHHHHHHHH---HHSCSSGGGSBTTBSCGGG
T ss_pred             ccCCHHHHHHHH---HhcccCCCCCcCHHHHHHh
Confidence            345677777776   99999999999995 7765

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-46  Score=378.37  Aligned_cols=251  Identities=21%  Similarity=0.353  Sum_probs=201.1

Q ss_pred             hhhcCcCCccEEEEEEEC------CCCEEEEEEeccccCC--HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeec
Q 007167          305 AEVLGKGTFGTAYKAALE------DASTVVVKRLKEVNVG--KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDY  376 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~------~~~~vavK~l~~~~~~--~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~  376 (615)
                      .+.||+|+||+||+|.+.      +++.||||+++.....  ...|.+|++++++++|||||+++++|..++..++||||
T Consensus        25 ~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~  104 (308)
T d1p4oa_          25 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMEL  104 (308)
T ss_dssp             EEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             eeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEee
Confidence            467999999999999863      3568999999754322  34588999999999999999999999999999999999


Q ss_pred             CCCCChhhhhccCC-----CCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeeccccc
Q 007167          377 FEPGSVSAMLHGRR-----GEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAA  451 (615)
Q Consensus       377 ~~~gsL~~~l~~~~-----~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~  451 (615)
                      +++|+|.++++...     ......+++..+.+++.|+|+||.|||+++   |+||||||+|||+++++++||+|||+++
T Consensus       105 ~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~DFGla~  181 (308)
T d1p4oa_         105 MTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTR  181 (308)
T ss_dssp             CTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEECCTTCCC
T ss_pred             cCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEeecccce
Confidence            99999999986432     112345799999999999999999999997   9999999999999999999999999998


Q ss_pred             ccCCCC-----CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhC-CCCCCCCCCcchhhHHHHHHHhhhccccc
Q 007167          452 LMSPMP-----PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTG-KSPIHATGGDEVVHLVRWVNSVVREEWTA  525 (615)
Q Consensus       452 ~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (615)
                      .+....     ....+|+.|+|||.+.+..++.++|||||||++|||+|| +.||...+..+....+      ....   
T Consensus       182 ~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i------~~~~---  252 (308)
T d1p4oa_         182 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV------MEGG---  252 (308)
T ss_dssp             GGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH------HTTC---
T ss_pred             eccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHH------HhCC---
Confidence            765332     223467889999999999999999999999999999997 5777665444333222      1111   


Q ss_pred             ccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          526 EVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       526 ~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                           .....+.+++++.+++.   +||+.+|++||||+||+++|++..+
T Consensus       253 -----~~~~p~~~~~~l~~li~---~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         253 -----LLDKPDNCPDMLFELMR---MCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             -----CCCCCTTCCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             -----CCCCcccchHHHHHHHH---HHcCCChhHCcCHHHHHHHHHHhcC
Confidence                 11112334455555544   9999999999999999999987754

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-45  Score=373.13  Aligned_cols=252  Identities=25%  Similarity=0.389  Sum_probs=200.5

Q ss_pred             hhhcCcCCccEEEEEEE------CCCCEEEEEEeccccC--CHHHHHHHHHHHhCC-CCCcccceeEEEEecCeeeEEee
Q 007167          305 AEVLGKGTFGTAYKAAL------EDASTVVVKRLKEVNV--GKREFEQQMEIVGGI-RHENVVALRAYYYSKDEKLMVYD  375 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~------~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l-~h~niv~l~~~~~~~~~~~lV~e  375 (615)
                      .++||+|+||.||+|++      ..++.||||+++....  ....|.+|+++++.+ +|||||+++++|.+++..++|||
T Consensus        28 ~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE  107 (311)
T d1t46a_          28 GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITE  107 (311)
T ss_dssp             EEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred             eeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEE
Confidence            46799999999999985      2456799999975432  245688999999998 69999999999999999999999


Q ss_pred             cCCCCChhhhhccCCC-------------CCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcE
Q 007167          376 YFEPGSVSAMLHGRRG-------------EGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHV  442 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~-------------~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~  442 (615)
                      |+++|+|.++++....             .....+++..+..++.||+.||+|||+++   |+||||||+||+++.++.+
T Consensus       108 ~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~~~~~~~  184 (311)
T d1t46a_         108 YCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRIT  184 (311)
T ss_dssp             CCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEETTTEE
T ss_pred             cCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccccccCcc
Confidence            9999999999975432             12346899999999999999999999998   9999999999999999999


Q ss_pred             EEeecccccccCCCCC-----CCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHh-CCCCCCCCCCcchhhHHHHHH
Q 007167          443 CVSDIGLAALMSPMPP-----PAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLT-GKSPIHATGGDEVVHLVRWVN  516 (615)
Q Consensus       443 kl~DfG~a~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~ellt-g~~p~~~~~~~~~~~~~~~~~  516 (615)
                      |++|||.++.......     ...+|+.|+|||.+.+..++.++|||||||++|||+| |+.||......+...  ..+.
T Consensus       185 ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~--~~i~  262 (311)
T d1t46a_         185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY--KMIK  262 (311)
T ss_dssp             EECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH--HHHH
T ss_pred             cccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHH--HHHh
Confidence            9999999987754332     2346788999999998999999999999999999999 555565544433221  1111


Q ss_pred             HhhhcccccccccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          517 SVVREEWTAEVFDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       517 ~~~~~~~~~~~~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                      ...           ........++++.+++.   +||+.||++||||.||+++|+++..
T Consensus       263 ~~~-----------~~~~~~~~~~~l~~Li~---~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         263 EGF-----------RMLSPEHAPAEMYDIMK---TCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             HTC-----------CCCCCTTSCHHHHHHHH---HHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCC-----------CCCCcccccHHHHHHHH---HHcCCChhHCcCHHHHHHHHHHhhc
Confidence            111           11112234455555555   9999999999999999999998754

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-44  Score=365.01  Aligned_cols=252  Identities=19%  Similarity=0.317  Sum_probs=191.8

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEecccc---CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEVN---VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      +.||+|+||+||+|.. .+++.||||+++...   ...+.+.+|++++++++|||||++++++.+++..++||||+.++ 
T Consensus         8 ~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~-   86 (298)
T d1gz8a_           8 EKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD-   86 (298)
T ss_dssp             EEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEE-
T ss_pred             cEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCc-
Confidence            5699999999999996 568999999996542   22467889999999999999999999999999999999999765 


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---C
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---P  458 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~  458 (615)
                      +.+.+...   ....+++..+..++.|++.||+|||+++   ||||||||+|||++.++.+||+|||+|+......   .
T Consensus        87 ~~~~~~~~---~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~  160 (298)
T d1gz8a_          87 LKKFMDAS---ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT  160 (298)
T ss_dssp             HHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTT
T ss_pred             hhhhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCCcccce
Confidence            44444322   2346999999999999999999999998   9999999999999999999999999998775432   3


Q ss_pred             CCCCCCcccCccccCCCC-CCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhh--hcccccccc-----cc
Q 007167          459 PAMRAAGYRAPEVTDTRK-ATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVV--REEWTAEVF-----DV  530 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~-----d~  530 (615)
                      ...+|+.|+|||.+.... ++.++||||+||++|||++|+.||...+..+....+  .....  .+.......     ..
T Consensus       161 ~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i--~~~~~~~~~~~~~~~~~~~~~~~  238 (298)
T d1gz8a_         161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRI--FRTLGTPDEVVWPGVTSMPDYKP  238 (298)
T ss_dssp             CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH--HHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             eecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHH--HHhcCCCchhhcccccccccccc
Confidence            346789999999876655 588999999999999999999999865433322211  11110  000000000     00


Q ss_pred             ccc---------CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          531 ELL---------RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       531 ~~~---------~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ...         ..+..++++.++++   +|+..||++|||++|++++
T Consensus       239 ~~~~~~~~~~~~~~~~~s~~~~dll~---~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         239 SFPKWARQDFSKVVPPLDEDGRSLLS---QMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             TSCCCCCCCHHHHSTTCCHHHHHHHH---HHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccchhhhccCCCHHHHHHHH---HHccCChhHCcCHHHHhCC
Confidence            000         01233455555555   9999999999999999986

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.4e-44  Score=361.86  Aligned_cols=253  Identities=20%  Similarity=0.334  Sum_probs=195.5

Q ss_pred             hhcCcCCccEEEEEEECCCCEEEEEEecccc---CCHHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          306 EVLGKGTFGTAYKAALEDASTVVVKRLKEVN---VGKREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      ++||+|+||+||+|+.++|+.||||+++...   ...+.+.+|+.++++++|||||++++++.+.+..++++||+.++.+
T Consensus         8 ~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~   87 (286)
T d1ob3a_           8 EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLK   87 (286)
T ss_dssp             EEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHH
T ss_pred             cEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhH
Confidence            5699999999999999999999999996542   2246789999999999999999999999999999999999988777


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCC---CC
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMP---PP  459 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~---~~  459 (615)
                      ..+...     ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+|++|||.+.......   ..
T Consensus        88 ~~~~~~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  159 (286)
T d1ob3a_          88 KLLDVC-----EGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH  159 (286)
T ss_dssp             HHHHTS-----TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred             HHHHhh-----cCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCccccce
Confidence            766643     246999999999999999999999998   9999999999999999999999999998775432   23


Q ss_pred             CCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHh-hhccccc--cc--ccc---
Q 007167          460 AMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSV-VREEWTA--EV--FDV---  530 (615)
Q Consensus       460 ~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~--~~--~d~---  530 (615)
                      ..+++.|+|||.+... .++.++||||+||++|||++|+.||.+.+..+....+...... ....+..  ..  .+.   
T Consensus       160 ~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T d1ob3a_         160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT  239 (286)
T ss_dssp             --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred             ecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccc
Confidence            3577889999998654 5699999999999999999999999875543332222111110 0011100  00  000   


Q ss_pred             ------cccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          531 ------ELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       531 ------~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                            .....+..++++.++++   +|+..||++|||++|+++|
T Consensus       240 ~~~~~~~~~~~~~~s~~~~dli~---~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         240 VYEPLPWESFLKGLDESGIDLLS---KMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             CCCCCCGGGTCCSCCHHHHHHHH---HHTCSSTTTSCCHHHHHTS
T ss_pred             cccCcchhhhcccCCHHHHHHHH---HHccCChhHCcCHHHHhcC
Confidence                  00112344566666666   9999999999999999864

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-45  Score=363.30  Aligned_cols=233  Identities=19%  Similarity=0.385  Sum_probs=190.2

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC-------HHHHHHHHHHHhCCC--CCcccceeEEEEecCeeeEEe
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG-------KREFEQQMEIVGGIR--HENVVALRAYYYSKDEKLMVY  374 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~-------~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lV~  374 (615)
                      .++||+|+||+||+|... +++.||||+++.....       ...+.+|++++++++  |||||++++++.+++..++||
T Consensus         9 ~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~   88 (273)
T d1xwsa_           9 GPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL   88 (273)
T ss_dssp             EEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEE
T ss_pred             eEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEE
Confidence            457999999999999964 6899999998754211       234678999999886  899999999999999999999


Q ss_pred             ecCCC-CChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCC-CcEEEeecccccc
Q 007167          375 DYFEP-GSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQ-GHVCVSDIGLAAL  452 (615)
Q Consensus       375 e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~-~~~kl~DfG~a~~  452 (615)
                      ||+.+ +++.+++...     ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.+ +.+||+|||+|+.
T Consensus        89 e~~~~~~~l~~~~~~~-----~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~~  160 (273)
T d1xwsa_          89 ERPEPVQDLFDFITER-----GALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGAL  160 (273)
T ss_dssp             ECCSSEEEHHHHHHHH-----CSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EeccCcchHHHHHhcc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccccee
Confidence            99976 5777777643     36999999999999999999999998   9999999999999854 7999999999987


Q ss_pred             cCCCC-CCCCCCCcccCccccCCCCC-CCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccccc
Q 007167          453 MSPMP-PPAMRAAGYRAPEVTDTRKA-TQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFDV  530 (615)
Q Consensus       453 ~~~~~-~~~~~~~~y~aPE~~~~~~~-~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~  530 (615)
                      ..... ....||+.|+|||++.+..+ +.++||||+||++|||++|+.||....     ..       .+.         
T Consensus       161 ~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~-----~i-------~~~---------  219 (273)
T d1xwsa_         161 LKDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE-----EI-------IRG---------  219 (273)
T ss_dssp             CCSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH-----HH-------HHC---------
T ss_pred             cccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch-----HH-------hhc---------
Confidence            65433 44568999999999876665 678999999999999999999996421     11       111         


Q ss_pred             cccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          531 ELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       531 ~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .....+.+++++.++++   +|+..||++|||++|++++
T Consensus       220 ~~~~~~~~s~~~~~li~---~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         220 QVFFRQRVSSECQHLIR---WCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             CCCCSSCCCHHHHHHHH---HHTCSSGGGSCCHHHHHTS
T ss_pred             ccCCCCCCCHHHHHHHH---HHccCCHhHCcCHHHHhcC
Confidence            11112345667777766   9999999999999999875

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-43  Score=359.74  Aligned_cols=254  Identities=20%  Similarity=0.299  Sum_probs=192.1

Q ss_pred             hhcCcCCccEEEEEEEC-C-CCEEEEEEeccccC---CHHHHHHHHHHHhCC---CCCcccceeEEEEe-----cCeeeE
Q 007167          306 EVLGKGTFGTAYKAALE-D-ASTVVVKRLKEVNV---GKREFEQQMEIVGGI---RHENVVALRAYYYS-----KDEKLM  372 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~-~~~vavK~l~~~~~---~~~~~~~e~~~l~~l---~h~niv~l~~~~~~-----~~~~~l  372 (615)
                      +.||+|+||+||+|... + ++.||||+++....   ....+.+|+++++.+   +|||||+++++|..     ....++
T Consensus        13 ~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~   92 (305)
T d1blxa_          13 AEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL   92 (305)
T ss_dssp             EEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEE
T ss_pred             EEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEE
Confidence            56999999999999963 4 45689999865322   234566787776655   89999999999864     246799


Q ss_pred             EeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccc
Q 007167          373 VYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAAL  452 (615)
Q Consensus       373 V~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~  452 (615)
                      +|||+.++++......    ....+++.....++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~~e~~~~~~~~~~~~~----~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~dfg~~~~  165 (305)
T d1blxa_          93 VFEHVDQDLTTYLDKV----PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARI  165 (305)
T ss_dssp             EEECCSCBHHHHHHHS----CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred             EEEeccCCchhhhhhc----cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecchhhhhh
Confidence            9999988877655442    2346899999999999999999999998   99999999999999999999999999876


Q ss_pred             cCCC--CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHH-HHhhhcccccccc-
Q 007167          453 MSPM--PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWV-NSVVREEWTAEVF-  528 (615)
Q Consensus       453 ~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-  528 (615)
                      ....  .....+|+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+..+....+... .......+..... 
T Consensus       166 ~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  245 (305)
T d1blxa_         166 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL  245 (305)
T ss_dssp             CCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSS
T ss_pred             hcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccc
Confidence            5432  24557899999999999999999999999999999999999999876544433322211 1111111111110 


Q ss_pred             ----------cccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          529 ----------DVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       529 ----------d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                                .+.....+..++++.++++   +|++.||++|||++|+++|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~---~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         246 PRQAFHSKSAQPIEKFVTDIDELGKDLLL---KCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             CGGGSCCCCCCCGGGTCCSCCHHHHHHHH---HHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhccccccchhhccccCCHHHHHHHH---HHCcCChhHCcCHHHHhcC
Confidence                      0000112345566666666   9999999999999999886

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-43  Score=361.68  Aligned_cols=259  Identities=23%  Similarity=0.324  Sum_probs=191.5

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccceeEEEEec------CeeeEEeecCC
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVALRAYYYSK------DEKLMVYDYFE  378 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lV~e~~~  378 (615)
                      ++||+|+||+||+|+.. +++.||||+++...   ..+.+|++++++++|||||++++++...      .+.++||||++
T Consensus        26 k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~---~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~  102 (350)
T d1q5ka_          26 KVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK---RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVP  102 (350)
T ss_dssp             EEEEEETTEEEEEEEETTTCCEEEEEEEECCS---SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCS
T ss_pred             eEEeeCcCeEEEEEEECCCCCEEEEEEECccc---hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccC
Confidence            56999999999999975 68899999997543   2345799999999999999999998653      24789999998


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCC-cEEEeecccccccCCC-
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG-HVCVSDIGLAALMSPM-  456 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~-~~kl~DfG~a~~~~~~-  456 (615)
                      +|.+..+.+...  ....+++..+..++.|++.||+|||+++   |+||||||+|||++.++ .+||+|||+++..... 
T Consensus       103 ~~~~~~l~~~~~--~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~  177 (350)
T d1q5ka_         103 ETVYRVARHYSR--AKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE  177 (350)
T ss_dssp             EEHHHHHHHHHH--TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred             CccHHHHHhhhh--ccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence            765444433211  2347999999999999999999999998   99999999999999775 8999999999877543 


Q ss_pred             -CCCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHH-HHHhhhcccc---cccccc
Q 007167          457 -PPPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRW-VNSVVREEWT---AEVFDV  530 (615)
Q Consensus       457 -~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~-~~~~~~~~~~---~~~~d~  530 (615)
                       .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||......+....+.. ......+.+.   ....+.
T Consensus       178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~  257 (350)
T d1q5ka_         178 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF  257 (350)
T ss_dssp             CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CC
T ss_pred             ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhc
Confidence             334567889999998765 5689999999999999999999999987554332222111 1000000000   000000


Q ss_pred             cc----------cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhHh
Q 007167          531 EL----------LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM--VEDIRR  575 (615)
Q Consensus       531 ~~----------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~l~~  575 (615)
                      ..          ...+..++++.++++   +|+..||++|||++|+++|  ++++..
T Consensus       258 ~~~~~~~~~~~~~~~~~~s~~~~dLl~---~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         258 KFPQIKAHPWTKVFRPRTPPEAIALCS---RLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             CCCCCCCCCGGGTSCTTSCHHHHHHHH---HHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             cccccccCchhhhcccCCCHHHHHHHH---HHccCChhHCcCHHHHhcCHhhccccC
Confidence            00          012234556666665   9999999999999999985  555544

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-42  Score=358.34  Aligned_cols=256  Identities=21%  Similarity=0.332  Sum_probs=192.7

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecC------eeeEEee
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKD------EKLMVYD  375 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~------~~~lV~e  375 (615)
                      +.||+|+||+||+|... +|+.||||+++.....   .+.+.+|+++++.++|||||+++++|...+      +.++|||
T Consensus        24 ~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e  103 (346)
T d1cm8a_          24 QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMP  103 (346)
T ss_dssp             EEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEE
T ss_pred             EEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEe
Confidence            46999999999999964 6899999999754333   346789999999999999999999997654      5699999


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      |+ +++|..+.+.      ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+|++|||+++....
T Consensus       104 ~~-~~~l~~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~  173 (346)
T d1cm8a_         104 FM-GTDLGKLMKH------EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADS  173 (346)
T ss_dssp             CC-SEEHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             cc-cccHHHHHHh------ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceeccCC
Confidence            99 6678777753      25999999999999999999999998   99999999999999999999999999998887


Q ss_pred             CCCCCCCCCcccCccccCC-CCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccc----------
Q 007167          456 MPPPAMRAAGYRAPEVTDT-RKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWT----------  524 (615)
Q Consensus       456 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------  524 (615)
                      ......+|+.|+|||.+.+ ..++.++||||+||++|||++|+.||...+..+.................          
T Consensus       174 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (346)
T d1cm8a_         174 EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKN  253 (346)
T ss_dssp             SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHH
T ss_pred             ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhh
Confidence            7777788999999999865 45689999999999999999999999876543322221111110000000          


Q ss_pred             -----cccccccc-cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH--HHHhH
Q 007167          525 -----AEVFDVEL-LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM--VEDIR  574 (615)
Q Consensus       525 -----~~~~d~~~-~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~--L~~l~  574 (615)
                           .+...... ...+..++++.++++   +|+..||++|||++|+++|  ++++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~---~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         254 YMKGLPELEKKDFASILTNASPLAVNLLE---KMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             HHHHSCCCCCCCGGGTCTTCCHHHHHHHH---HHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             hhccCCcccccchHHhccCCCHHHHHHHH---HHCcCChhHCcCHHHHhcChhhCcCC
Confidence                 00000000 012344566666665   9999999999999999986  54443

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-42  Score=352.28  Aligned_cols=256  Identities=21%  Similarity=0.282  Sum_probs=189.3

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEecccc---CCHHHHHHHHHHHhCCCCCcccceeEEEEe--------cCeeeEE
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEVN---VGKREFEQQMEIVGGIRHENVVALRAYYYS--------KDEKLMV  373 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~---~~~~~~~~e~~~l~~l~h~niv~l~~~~~~--------~~~~~lV  373 (615)
                      +.||+|+||+||+|.. .+|+.||||++....   ...+.+.+|+++++.++||||+++++++..        ++..++|
T Consensus        16 ~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv   95 (318)
T d3blha1          16 AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLV   95 (318)
T ss_dssp             EEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEE
T ss_pred             EEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEE
Confidence            5699999999999996 578999999986442   234668899999999999999999999855        3467999


Q ss_pred             eecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeeccccccc
Q 007167          374 YDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALM  453 (615)
Q Consensus       374 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~  453 (615)
                      |||+.++.+......     ...++......++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++..
T Consensus        96 ~e~~~~~~~~~~~~~-----~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~~~  167 (318)
T d3blha1          96 FDFCEHDLAGLLSNV-----LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLARAF  167 (318)
T ss_dssp             EECCCEEHHHHHTCT-----TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EeccCCCccchhhhc-----ccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceeeec
Confidence            999988877655542     236888999999999999999999998   999999999999999999999999999766


Q ss_pred             CCC-------CCCCCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccc
Q 007167          454 SPM-------PPPAMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTA  525 (615)
Q Consensus       454 ~~~-------~~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  525 (615)
                      ...       .....+|+.|+|||.+.+. .++.++||||+||++|||++|+.||.+....+....+.............
T Consensus       168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  247 (318)
T d3blha1         168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP  247 (318)
T ss_dssp             CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence            532       1234578999999998765 68999999999999999999999998755444433333222111111111


Q ss_pred             ccccc----cc----cCCCCcHHHH------HHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          526 EVFDV----EL----LRYPNIEEEM------VEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       526 ~~~d~----~~----~~~~~~~~~~------~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .....    ..    .......+..      ..+.+++.+|+..||++|||++|+++|
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            10000    00    0001111111      233455669999999999999999976

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.8e-41  Score=341.49  Aligned_cols=254  Identities=14%  Similarity=0.175  Sum_probs=200.7

Q ss_pred             hhhcCcCCccEEEEEEEC-CCCEEEEEEeccccCCHHHHHHHHHHHhCCCC-CcccceeEEEEecCeeeEEeecCCCCCh
Q 007167          305 AEVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVGKREFEQQMEIVGGIRH-ENVVALRAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      .++||+|+||+||+|+.. +++.||||.+.... ....+.+|++.++.++| +|++.+++++..+...++||||+ +|+|
T Consensus        10 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l   87 (293)
T d1csna_          10 GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS-DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSL   87 (293)
T ss_dssp             EEEEEECSSCEEEEEEETTTTEEEEEEEEECCT-TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEEcccc-CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCH
Confidence            357999999999999965 67889999886532 34567889999999965 89999999999999999999999 6899


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCC-----CCcEEEeecccccccCCC-
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNS-----QGHVCVSDIGLAALMSPM-  456 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~-----~~~~kl~DfG~a~~~~~~-  456 (615)
                      .++++..    ...+++..+..++.|++.||+|||+.+   |+||||||+|||++.     ++.+||+|||+|+.+... 
T Consensus        88 ~~~~~~~----~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~  160 (293)
T d1csna_          88 EDLLDLC----GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV  160 (293)
T ss_dssp             HHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTT
T ss_pred             HHHHHhh----ccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEcccCc
Confidence            9988643    236899999999999999999999998   999999999999974     568999999999876432 


Q ss_pred             ---------CCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccc
Q 007167          457 ---------PPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEV  527 (615)
Q Consensus       457 ---------~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  527 (615)
                               .....||+.|+|||.+.+..++.++|||||||++|||++|+.||..............+..........  
T Consensus       161 ~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~--  238 (293)
T d1csna_         161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR--  238 (293)
T ss_dssp             TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHH--
T ss_pred             cccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChH--
Confidence                     123458999999999999999999999999999999999999998765544333322222111110000  


Q ss_pred             ccccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHhhh
Q 007167          528 FDVELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRRVK  577 (615)
Q Consensus       528 ~d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~~~  577 (615)
                         ++  .+.+++++.++++   .|+..+|++||+++.+.+.|+++.+..
T Consensus       239 ---~l--~~~~p~~l~~ii~---~~~~~~~~~rP~y~~l~~~l~~~~~~~  280 (293)
T d1csna_         239 ---EL--CAGFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKVLERL  280 (293)
T ss_dssp             ---HH--TTTSCHHHHHHHH---HHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             ---Hh--cCCCCHHHHHHHH---HHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence               11  1234455555555   999999999999999999999976533

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-42  Score=357.32  Aligned_cols=252  Identities=19%  Similarity=0.307  Sum_probs=187.0

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEeccccC--CHHHHHHHHHHHhCCCCCcccceeEEEEecC----eeeEEeecCC
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNV--GKREFEQQMEIVGGIRHENVVALRAYYYSKD----EKLMVYDYFE  378 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~--~~~~~~~e~~~l~~l~h~niv~l~~~~~~~~----~~~lV~e~~~  378 (615)
                      ++||+|+||+||+|.. .+|+.||||++.....  ..+.+.+|+++++.++||||+++++++....    ..+++++|+.
T Consensus        14 ~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~   93 (345)
T d1pmea_          14 SYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLM   93 (345)
T ss_dssp             EECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECC
T ss_pred             EEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeec
Confidence            5799999999999986 5789999999975432  2356889999999999999999999997653    2345566777


Q ss_pred             CCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCC--
Q 007167          379 PGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPM--  456 (615)
Q Consensus       379 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~--  456 (615)
                      +|+|.+++...      .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....  
T Consensus        94 ~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~  164 (345)
T d1pmea_          94 GADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD  164 (345)
T ss_dssp             CEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred             CCchhhhhhcC------CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCCCc
Confidence            99999999642      5899999999999999999999998   999999999999999999999999999866432  


Q ss_pred             ----CCCCCCCCcccCccccC-CCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccc-----
Q 007167          457 ----PPPAMRAAGYRAPEVTD-TRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAE-----  526 (615)
Q Consensus       457 ----~~~~~~~~~y~aPE~~~-~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  526 (615)
                          .....+|+.|+|||.+. ...++.++||||+||++|||++|+.||......+.......+...........     
T Consensus       165 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (345)
T d1pmea_         165 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLK  244 (345)
T ss_dssp             BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHH
T ss_pred             cceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhh
Confidence                23445788999999984 45678999999999999999999999977543332222211111000000000     


Q ss_pred             ----cc-cccc------cCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          527 ----VF-DVEL------LRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       527 ----~~-d~~~------~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                          .. .+..      ...+..+.++.+++.   +|++.||++|||++|++++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~---~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         245 ARNYLLSLPHKNKVPWNRLFPNADSKALDLLD---KMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHH---HHSCSSTTTSCCHHHHHTS
T ss_pred             hhcccccCCccCCCCHHHhCCCCCHHHHHHHH---HHccCChhHCcCHHHHhcC
Confidence                00 0000      012233445555554   9999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-41  Score=344.38  Aligned_cols=252  Identities=15%  Similarity=0.184  Sum_probs=190.7

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcccce-eEEEEecCeeeEEeecCCCCCh
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENVVAL-RAYYYSKDEKLMVYDYFEPGSV  382 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv~l-~~~~~~~~~~~lV~e~~~~gsL  382 (615)
                      .+.||+|+||+||+|.+ .+++.||||.+.... ..+.+.+|+++++.++|+|+|.. .+++.+.+..++||||+ +|++
T Consensus        12 ~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~-~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l   89 (299)
T d1ckia_          12 GRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT-KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSL   89 (299)
T ss_dssp             EEEEEECSSSEEEEEEETTTTEEEEEEEEESCT-TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBH
T ss_pred             eEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc-cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCch
Confidence            35799999999999986 467899999886542 34568899999999987776555 55556778899999999 5566


Q ss_pred             hhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCC---CCcEEEeecccccccCCCC--
Q 007167          383 SAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNS---QGHVCVSDIGLAALMSPMP--  457 (615)
Q Consensus       383 ~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~---~~~~kl~DfG~a~~~~~~~--  457 (615)
                      .+.+...    ...+++..+..++.|++.||+|||+++   |+||||||+|||++.   +..+||+|||+|+.+....  
T Consensus        90 ~~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~  162 (299)
T d1ckia_          90 EDLFNFC----SRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  162 (299)
T ss_dssp             HHHHHHT----TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTC
T ss_pred             hhhhhhc----cCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccccccc
Confidence            6665432    236999999999999999999999998   999999999999864   4579999999998775322  


Q ss_pred             --------CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhccccccccc
Q 007167          458 --------PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVFD  529 (615)
Q Consensus       458 --------~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d  529 (615)
                              ....+|+.|+|||.+.+..++.++|||||||++|||++|+.||......+....+..........       
T Consensus       163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~-------  235 (299)
T d1ckia_         163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST-------  235 (299)
T ss_dssp             CBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS-------
T ss_pred             cceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC-------
Confidence                    23357899999999999999999999999999999999999998765544332222111110000       


Q ss_pred             ccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHHHHHhHh
Q 007167          530 VELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKMVEDIRR  575 (615)
Q Consensus       530 ~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~L~~l~~  575 (615)
                      +.....+.+++++.++++   .|++.+|++||++.++.+.|+++..
T Consensus       236 ~~~~~~~~~p~~~~~li~---~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         236 PIEVLCKGYPSEFATYLN---FCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             CHHHHTTTSCHHHHHHHH---HHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             ChhHhccCCCHHHHHHHH---HHccCChhHCcCHHHHHHHHHHHHH
Confidence            000012344556666665   9999999999999999999998754

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-41  Score=341.11  Aligned_cols=253  Identities=20%  Similarity=0.345  Sum_probs=194.5

Q ss_pred             hhcCcCCccEEEEEEE-CCCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEecCeeeEEeecCCCCC
Q 007167          306 EVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSKDEKLMVYDYFEPGS  381 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~~~~~lV~e~~~~gs  381 (615)
                      +.||+|+||+||+|++ .+++.||||+++.....   ...+.+|+.+++.++|||||++++++.+....++|+||+.+++
T Consensus         8 ~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~   87 (292)
T d1unla_           8 EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDL   87 (292)
T ss_dssp             EEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEH
T ss_pred             eEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccc
Confidence            5699999999999996 46788999999754322   4678899999999999999999999999999999999999999


Q ss_pred             hhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCCCCC---
Q 007167          382 VSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSPMPP---  458 (615)
Q Consensus       382 L~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~~~~---  458 (615)
                      +..++...     ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.++.......   
T Consensus        88 l~~~~~~~-----~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~  159 (292)
T d1unla_          88 KKYFDSCN-----GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             HHHHHHTT-----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCC
T ss_pred             cccccccc-----cccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCCccce
Confidence            98888643     36889999999999999999999998   99999999999999999999999999988754332   


Q ss_pred             CCCCCCcccCccccCCCC-CCCccchhhHHHHHHHHHhCCCCCCCCCC-cchhhHHHHHHHhhh-ccccccc--------
Q 007167          459 PAMRAAGYRAPEVTDTRK-ATQASDVFSFGVLLLELLTGKSPIHATGG-DEVVHLVRWVNSVVR-EEWTAEV--------  527 (615)
Q Consensus       459 ~~~~~~~y~aPE~~~~~~-~~~~~DvwS~Gvvl~elltg~~p~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~--------  527 (615)
                      ...++..|+|||.+.... ++.++||||+||++|||++|+.||....+ .+....+........ ..+....        
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (292)
T d1unla_         160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY  239 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred             eeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccccc
Confidence            334567799999987655 68999999999999999999999754332 121111111111100 0110000        


Q ss_pred             --cc---ccccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          528 --FD---VELLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       528 --~d---~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                        ..   ......+..++++.++++   +|++.||.+|||++|+++|
T Consensus       240 ~~~~~~~~~~~~~~~~s~~~~dll~---~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         240 PMYPATTSLVNVVPKLNATGRDLLQ---NLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CCCCTTCCCTTTSTTCCHHHHHHHH---HHSCSSGGGSCCHHHHTTS
T ss_pred             ccccccchhhhccccCCHHHHHHHH---HHccCChhHCcCHHHHhcC
Confidence              00   000012234455666655   9999999999999999875

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-41  Score=346.19  Aligned_cols=243  Identities=21%  Similarity=0.346  Sum_probs=194.6

Q ss_pred             hhhcCcCCccEEEEEEE----CCCCEEEEEEeccc-----cCCHHHHHHHHHHHhCCCC-CcccceeEEEEecCeeeEEe
Q 007167          305 AEVLGKGTFGTAYKAAL----EDASTVVVKRLKEV-----NVGKREFEQQMEIVGGIRH-ENVVALRAYYYSKDEKLMVY  374 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~----~~~~~vavK~l~~~-----~~~~~~~~~e~~~l~~l~h-~niv~l~~~~~~~~~~~lV~  374 (615)
                      .+.||+|+||+||+|..    .+|+.||||.++..     ....+.+.+|++++++++| |||+++++++.+....++||
T Consensus        29 ~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~  108 (322)
T d1vzoa_          29 LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLIL  108 (322)
T ss_dssp             EEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEE
T ss_pred             EEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeee
Confidence            45799999999999985    24789999998643     2235678899999999976 89999999999999999999


Q ss_pred             ecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccC
Q 007167          375 DYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMS  454 (615)
Q Consensus       375 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~  454 (615)
                      ||+.+|+|.+++....     .+.......++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+++.+.
T Consensus       109 e~~~~~~L~~~i~~~~-----~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         109 DYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             CCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             ecccccHHHHHHHhcc-----cccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhc
Confidence            9999999999997543     5678888999999999999999998   9999999999999999999999999998764


Q ss_pred             CCC----CCCCCCCcccCccccCCC--CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccccc
Q 007167          455 PMP----PPAMRAAGYRAPEVTDTR--KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAEVF  528 (615)
Q Consensus       455 ~~~----~~~~~~~~y~aPE~~~~~--~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  528 (615)
                      ...    ....+++.|+|||.+.+.  .++.++||||+||++|||++|+.||......+....+.  .....        
T Consensus       181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~--~~~~~--------  250 (322)
T d1vzoa_         181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS--RRILK--------  250 (322)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH--HHHHH--------
T ss_pred             ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--Hhccc--------
Confidence            322    234578889999998654  46889999999999999999999998766554433221  11111        


Q ss_pred             cccccCCCCcHHHHHHHHHHHHHcccCCCCCCC-----CHHHHHHH
Q 007167          529 DVELLRYPNIEEEMVEMLQVGMACVVRMPEERP-----KMADVLKM  569 (615)
Q Consensus       529 d~~~~~~~~~~~~~~~l~~l~~~cl~~~P~~RP-----s~~evl~~  569 (615)
                       .........++++.++++   +|+..||++||     |++|+++|
T Consensus       251 -~~~~~~~~~s~~~~~li~---~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         251 -SEPPYPQEMSALAKDLIQ---RLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             -CCCCCCTTSCHHHHHHHH---HHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             -CCCCCcccCCHHHHHHHH---HHcccCHHHcCCCCcccHHHHHcC
Confidence             111112345667777766   99999999999     47888874

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=5.4e-41  Score=344.05  Aligned_cols=249  Identities=16%  Similarity=0.280  Sum_probs=188.6

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccCCHHHHHHHHHHHhCCC-CCcccceeEEEEec--CeeeEEeecCCCC
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVGKREFEQQMEIVGGIR-HENVVALRAYYYSK--DEKLMVYDYFEPG  380 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~--~~~~lV~e~~~~g  380 (615)
                      .++||+|+||+||+|+. .+++.||||+++..  ..+.+.+|+++++.++ ||||+++++++...  ...++||||+.+|
T Consensus        40 ~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~  117 (328)
T d3bqca1          40 VRKLGRGKYSEVFEAINITNNEKVVVKILKPV--KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT  117 (328)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECSS--CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSC
T ss_pred             EEEEecCcCeEEEEEEECCCCCEEEEEEECHH--HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCC
Confidence            45799999999999996 46888999998753  3567899999999995 99999999999854  4689999999999


Q ss_pred             ChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCC-cEEEeecccccccCCC--C
Q 007167          381 SVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQG-HVCVSDIGLAALMSPM--P  457 (615)
Q Consensus       381 sL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~-~~kl~DfG~a~~~~~~--~  457 (615)
                      +|....+        .+++..+..++.|++.||+|||+++   |+||||||+|||++.++ .+||+|||+|+.....  .
T Consensus       118 ~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~  186 (328)
T d3bqca1         118 DFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY  186 (328)
T ss_dssp             BGGGTTT--------SCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCC
T ss_pred             cHHHHhc--------CCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCCCcc
Confidence            9987643        5899999999999999999999998   99999999999998655 6999999999877543  3


Q ss_pred             CCCCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcch--hhHHHHHHHhhhccc-----------
Q 007167          458 PPAMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATGGDEV--VHLVRWVNSVVREEW-----------  523 (615)
Q Consensus       458 ~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~-----------  523 (615)
                      ....+|..|+|||.+.+. .++.++||||+||+++||++|+.||........  ......+.......+           
T Consensus       187 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~  266 (328)
T d3bqca1         187 NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR  266 (328)
T ss_dssp             CSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGG
T ss_pred             cccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcc
Confidence            344578899999998765 479999999999999999999999976443211  111111110000000           


Q ss_pred             cccccc-------ccccC---CCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          524 TAEVFD-------VELLR---YPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       524 ~~~~~d-------~~~~~---~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ......       .....   ...++++..++++   +|+..||++|||++|+++|
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~---~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLD---KLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             GGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHH---HHSCSSGGGSCCHHHHHTS
T ss_pred             cchhcccccccchhhcccccccccCCHHHHHHHH---HHccCChhHCcCHHHHhcC
Confidence            000000       00000   1123455555555   9999999999999999874

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-41  Score=351.35  Aligned_cols=253  Identities=21%  Similarity=0.295  Sum_probs=191.2

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEec-----CeeeEEee
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSK-----DEKLMVYD  375 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~-----~~~~lV~e  375 (615)
                      .++||+|+||+||+|.. .+|+.||||+++.....   .+.+.+|+++++.++|||||++++++...     ...++|++
T Consensus        23 ~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~  102 (348)
T d2gfsa1          23 LSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVT  102 (348)
T ss_dssp             EEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEE
T ss_pred             EEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEE
Confidence            35799999999999996 46899999999765333   34678999999999999999999998643     34577788


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      |+.+|+|.++++.      ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+|++|||++.....
T Consensus       103 ~~~gg~L~~~~~~------~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~  173 (348)
T d2gfsa1         103 HLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD  173 (348)
T ss_dssp             ECCSEEHHHHHTT------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCTG
T ss_pred             eecCCchhhhccc------ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccCc
Confidence            8889999999963      25999999999999999999999998   99999999999999999999999999987776


Q ss_pred             CCCCCCCCCcccCccccCCC-CCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHHHHHHhhhcccccc----c---
Q 007167          456 MPPPAMRAAGYRAPEVTDTR-KATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVRWVNSVVREEWTAE----V---  527 (615)
Q Consensus       456 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~----~---  527 (615)
                      ......++..|+|||...+. .++.++||||+||++|||++|+.||.+.+.......+..............    .   
T Consensus       174 ~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  253 (348)
T d2gfsa1         174 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARN  253 (348)
T ss_dssp             GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHH
T ss_pred             ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhh
Confidence            66666778889999987665 468999999999999999999999987554333222211110000000000    0   


Q ss_pred             cccccc---------CCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          528 FDVELL---------RYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       528 ~d~~~~---------~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      ......         .....++++.++++   +|+..||++|||++|+++|
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~s~~~~dli~---~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         254 YIQSLTQMPKMNFANVFIGANPLAVDLLE---KMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             HHTTSCCCCCCCHHHHSTTCCHHHHHHHH---HHSCSSGGGSCCHHHHHTS
T ss_pred             hhhhcccCCCcchhhhcCCCCHHHHHHHH---HHCcCChhhCcCHHHHhcC
Confidence            000000         01234455666655   9999999999999999985

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-40  Score=343.89  Aligned_cols=253  Identities=19%  Similarity=0.270  Sum_probs=180.7

Q ss_pred             hhcCcCCccEEEEEEEC-CCCEEEEEEeccccCC---HHHHHHHHHHHhCCCCCcccceeEEEEec------CeeeEEee
Q 007167          306 EVLGKGTFGTAYKAALE-DASTVVVKRLKEVNVG---KREFEQQMEIVGGIRHENVVALRAYYYSK------DEKLMVYD  375 (615)
Q Consensus       306 ~~lG~G~fg~Vy~~~~~-~~~~vavK~l~~~~~~---~~~~~~e~~~l~~l~h~niv~l~~~~~~~------~~~~lV~e  375 (615)
                      ++||+|+||+||+|.+. +|+.||||+++.....   .+.+.+|+++++.++|||||++++++...      .+.++|||
T Consensus        23 ~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~E  102 (355)
T d2b1pa1          23 KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVME  102 (355)
T ss_dssp             EECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEE
T ss_pred             EEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEe
Confidence            57999999999999965 6899999999765333   24578999999999999999999999643      67899999


Q ss_pred             cCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEEeecccccccCC
Q 007167          376 YFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCVSDIGLAALMSP  455 (615)
Q Consensus       376 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl~DfG~a~~~~~  455 (615)
                      |+.++ +.+.++       ..+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+|++|||+++....
T Consensus       103 y~~~~-l~~~~~-------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~  171 (355)
T d2b1pa1         103 LMDAN-LCQVIQ-------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_dssp             CCSEE-HHHHHT-------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             ccchH-HHHhhh-------cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhcccc
Confidence            99765 444443       25889999999999999999999998   99999999999999999999999999887654


Q ss_pred             CC--CCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhhHHH-HH---------------HH
Q 007167          456 MP--PPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVHLVR-WV---------------NS  517 (615)
Q Consensus       456 ~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~~~~-~~---------------~~  517 (615)
                      ..  ....+|+.|+|||++.+..++.++||||+||+++||++|+.||.+.+.......+. -.               ..
T Consensus       172 ~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  251 (355)
T d2b1pa1         172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRN  251 (355)
T ss_dssp             ---------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHH
T ss_pred             ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHH
Confidence            32  34457889999999999999999999999999999999999997654322211110 00               00


Q ss_pred             hhhcccc------cccccccccCCC--CcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          518 VVREEWT------AEVFDVELLRYP--NIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       518 ~~~~~~~------~~~~d~~~~~~~--~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                      .......      ...+........  .......++.+++.+|+..||++|||++|+++|
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         252 YVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            0000000      000000000000  011122345556669999999999999999876

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=3.8e-37  Score=319.77  Aligned_cols=260  Identities=17%  Similarity=0.256  Sum_probs=186.0

Q ss_pred             hhhcCcCCccEEEEEEE-CCCCEEEEEEeccccCCHHHHHHHHHHHhCCC-----------CCcccceeEEEEec--Cee
Q 007167          305 AEVLGKGTFGTAYKAAL-EDASTVVVKRLKEVNVGKREFEQQMEIVGGIR-----------HENVVALRAYYYSK--DEK  370 (615)
Q Consensus       305 ~~~lG~G~fg~Vy~~~~-~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~~~~~~~--~~~  370 (615)
                      .++||+|+||+||+|+. .+|+.||||+++......+.+.+|+++++.++           |+|||++++++...  ...
T Consensus        18 ~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~   97 (362)
T d1q8ya_          18 VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGV   97 (362)
T ss_dssp             EEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEE
T ss_pred             EEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccce
Confidence            45799999999999996 47899999999865444567788998887765           57899999888653  456


Q ss_pred             eEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhc-cCCCCceecCCCCCCEEeCCCC------cEE
Q 007167          371 LMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHT-ENGGKLVHGGIKASNIFLNSQG------HVC  443 (615)
Q Consensus       371 ~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~-~~~~~iiHrDik~~Nill~~~~------~~k  443 (615)
                      +++++++..+.........  .....+++..+..++.|++.||+|||+ .+   |+||||||+|||++.++      .++
T Consensus        98 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~~~k  172 (362)
T d1q8ya_          98 HVVMVFEVLGENLLALIKK--YEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLIQIK  172 (362)
T ss_dssp             EEEEEECCCCEEHHHHHHH--TTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred             eeeeeeccccccccccccc--ccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccceee
Confidence            6777766555433332211  234578899999999999999999998 65   99999999999998665      399


Q ss_pred             EeecccccccCCCCCCCCCCCcccCccccCCCCCCCccchhhHHHHHHHHHhCCCCCCCCCCcchhh----HHHHHHHhh
Q 007167          444 VSDIGLAALMSPMPPPAMRAAGYRAPEVTDTRKATQASDVFSFGVLLLELLTGKSPIHATGGDEVVH----LVRWVNSVV  519 (615)
Q Consensus       444 l~DfG~a~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwS~Gvvl~elltg~~p~~~~~~~~~~~----~~~~~~~~~  519 (615)
                      ++|||.+...........+|+.|+|||++....++.++||||+||+++||++|+.||..........    +...+....
T Consensus       173 l~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg  252 (362)
T d1q8ya_         173 IADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLG  252 (362)
T ss_dssp             ECCCTTCEETTBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHC
T ss_pred             EeecccccccccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhC
Confidence            9999999887776677788999999999998899999999999999999999999998654321111    111111000


Q ss_pred             ---h-----cccccccccc-----c-------------ccCCCCcHHHHHHHHHHHHHcccCCCCCCCCHHHHHHH
Q 007167          520 ---R-----EEWTAEVFDV-----E-------------LLRYPNIEEEMVEMLQVGMACVVRMPEERPKMADVLKM  569 (615)
Q Consensus       520 ---~-----~~~~~~~~d~-----~-------------~~~~~~~~~~~~~l~~l~~~cl~~~P~~RPs~~evl~~  569 (615)
                         .     .......++.     .             ............++.+++.+|+..||.+|||++|+++|
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~H  328 (362)
T d1q8ya_         253 ELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNH  328 (362)
T ss_dssp             SCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTC
T ss_pred             CCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence               0     0000000000     0             00112223445566667779999999999999999875

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.94  E-value=2.2e-27  Score=240.51  Aligned_cols=174  Identities=31%  Similarity=0.545  Sum_probs=156.0

Q ss_pred             CChhHHHHHHHHHHhcCCCC-CCCCCCCCCCCC-CCcceEecCCC--CcEEEEEeCCCCccc--ccCCCcccCCCCccEE
Q 007167           24 DPVEDKQALLDFIHNIHNSR-SLNWNESSSLCK-SWTGVTCSADH--SRVVALRLPGMALRG--EIPPNTIGRLSALQNL   97 (615)
Q Consensus        24 ~~~~d~~al~~~k~~~~~~~-~~~w~~~~~~c~-~w~gv~C~~~~--~~v~~l~l~~~~l~g--~i~~~~~~~l~~L~~L   97 (615)
                      |.++|++||++||+++.++. +.+|+.++|||. +|.||+|+...  .||+.|+|++++++|  .||+ .|++|++|++|
T Consensus         3 c~~~e~~aLl~~k~~~~~~~~l~sW~~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~~~lp~-~l~~L~~L~~L   81 (313)
T d1ogqa_           3 CNPQDKQALLQIKKDLGNPTTLSSWLPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPS-SLANLPYLNFL   81 (313)
T ss_dssp             SCHHHHHHHHHHHHHTTCCGGGTTCCTTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSCEECCG-GGGGCTTCSEE
T ss_pred             CCHHHHHHHHHHHHHCCCCCcCCCCCCCCCCCCCcCCCeEEeCCCCcEEEEEEECCCCCCCCCCCCCh-HHhcCcccccc
Confidence            78899999999999998765 458988888874 59999998643  489999999999998  5777 89999999999


Q ss_pred             EcCC-CCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccc
Q 007167           98 SLRS-NSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSL  176 (615)
Q Consensus        98 ~L~~-N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l  176 (615)
                      +|++ |+++|.+|..|++|++|++|+|++|++++..|..+..+..|+.+++++|++.+.+|..+.++++|+.+++++|.+
T Consensus        82 ~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l  161 (313)
T d1ogqa_          82 YIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI  161 (313)
T ss_dssp             EEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEESCCCGGGGGCTTCCEEECCSSCC
T ss_pred             ccccccccccccccccccccccchhhhccccccccccccccchhhhcccccccccccccCchhhccCcccceeecccccc
Confidence            9997 999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCccccccCCcc----cccCCCCC
Q 007167          177 TGTLPRSLQRFPSW----AFAGNNLS  198 (615)
Q Consensus       177 ~g~~p~~~~~l~~l----~~~~n~~~  198 (615)
                      +|.+|..+..+..+    .+.+|.+.
T Consensus       162 ~~~ip~~~~~l~~l~~~l~~~~n~l~  187 (313)
T d1ogqa_         162 SGAIPDSYGSFSKLFTSMTISRNRLT  187 (313)
T ss_dssp             EEECCGGGGCCCTTCCEEECCSSEEE
T ss_pred             cccccccccccccccccccccccccc
Confidence            99999988776543    34556553

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.88  E-value=1.8e-23  Score=195.45  Aligned_cols=161  Identities=12%  Similarity=0.121  Sum_probs=118.1

Q ss_pred             HhhhcCcCCccEEEEEEECCCCEEEEEEeccccCC-------------------HHHHHHHHHHHhCCCCCcccceeEEE
Q 007167          304 SAEVLGKGTFGTAYKAALEDASTVVVKRLKEVNVG-------------------KREFEQQMEIVGGIRHENVVALRAYY  364 (615)
Q Consensus       304 ~~~~lG~G~fg~Vy~~~~~~~~~vavK~l~~~~~~-------------------~~~~~~e~~~l~~l~h~niv~l~~~~  364 (615)
                      .+++||+|+||+||+|...+|+.||||+++.....                   .....+|...+.++.|.+++..+++.
T Consensus         4 vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~   83 (191)
T d1zara2           4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE   83 (191)
T ss_dssp             EEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE
T ss_pred             hCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec
Confidence            35689999999999999989999999987532110                   12345678889999999999887653


Q ss_pred             EecCeeeEEeecCCCCChhhhhccCCCCCCCCCCHHHHHHHHHHHHHHHHHhhccCCCCceecCCCCCCEEeCCCCcEEE
Q 007167          365 YSKDEKLMVYDYFEPGSVSAMLHGRRGEGQSSLDWDTRVRIAIGAARGIAHIHTENGGKLVHGGIKASNIFLNSQGHVCV  444 (615)
Q Consensus       365 ~~~~~~~lV~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~~~~iiHrDik~~Nill~~~~~~kl  444 (615)
                          ..++||||++++.+..            ++......++.|+++|++|||+.+   |+||||||+|||++++ .++|
T Consensus        84 ----~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~l  143 (191)
T d1zara2          84 ----GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWI  143 (191)
T ss_dssp             ----TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEE
T ss_pred             ----CCEEEEEeeccccccc------------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEE
Confidence                3479999998765433            222345678999999999999998   9999999999999965 4899


Q ss_pred             eecccccccCCCCCCCCCCCcccCc------cccCCCCCCCccchhhHHHHH
Q 007167          445 SDIGLAALMSPMPPPAMRAAGYRAP------EVTDTRKATQASDVFSFGVLL  490 (615)
Q Consensus       445 ~DfG~a~~~~~~~~~~~~~~~y~aP------E~~~~~~~~~~~DvwS~Gvvl  490 (615)
                      +|||.|+.......     ..|...      |. ..+.|+.++|+||..--+
T Consensus       144 iDFG~a~~~~~~~~-----~~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         144 IDFPQSVEVGEEGW-----REILERDVRNIITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CCCTTCEETTSTTH-----HHHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             EECCCcccCCCCCc-----HHHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence            99999987653221     111110      11 135678899999976443

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.77  E-value=1e-18  Score=162.91  Aligned_cols=130  Identities=26%  Similarity=0.363  Sum_probs=108.5

Q ss_pred             CCCCCCCcceEecCCC---------CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEE
Q 007167           51 SSLCKSWTGVTCSADH---------SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSL  121 (615)
Q Consensus        51 ~~~c~~w~gv~C~~~~---------~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L  121 (615)
                      .+.| +|..|.|++..         ..++.|+|++|.|++.++...|+.+++|+.|+|++|.+.+..+..|..+++|++|
T Consensus         5 ~C~C-~~~~v~Cs~~~L~~iP~~lp~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L   83 (192)
T d1w8aa_           5 MCHC-EGTTVDCTGRGLKEIPRDIPLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQEL   83 (192)
T ss_dssp             TSEE-ETTEEECTTSCCSSCCSCCCTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEE
T ss_pred             CCEE-cCCEEEEeCCCcCccCCCCCCCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccccccccccccee
Confidence            3445 78888887421         4678899999999877877788889999999999999998888888889999999


Q ss_pred             ecccccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCc
Q 007167          122 HLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLP  181 (615)
Q Consensus       122 ~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p  181 (615)
                      +|++|+|++..|..|.++++|+.|+|++|+|++..|..|.++++|++|+|++|.+.+..+
T Consensus        84 ~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~~~  143 (192)
T d1w8aa_          84 QLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCNCH  143 (192)
T ss_dssp             ECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCSGG
T ss_pred             eeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccccc
Confidence            999999987777788889999999999999998778888889999999999998886544

>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Slit
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.67  E-value=1.5e-16  Score=147.99  Aligned_cols=134  Identities=25%  Similarity=0.374  Sum_probs=116.8

Q ss_pred             cceEecCCCCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcC-CCCccccccCcEEecccccccCCCCccc
Q 007167           58 TGVTCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLF-PSDFSKLENLTSLHLQFNSFSGPLPLDF  136 (615)
Q Consensus        58 ~gv~C~~~~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~-p~~~~~l~~L~~L~l~~N~l~g~~p~~~  136 (615)
                      .|..|+.     +.++.++++|+ .||.+ +  .+++++|+|++|.|++.+ +..|.++++|+.|+|++|++++..+..|
T Consensus         4 ~~C~C~~-----~~v~Cs~~~L~-~iP~~-l--p~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~   74 (192)
T d1w8aa_           4 AMCHCEG-----TTVDCTGRGLK-EIPRD-I--PLHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAF   74 (192)
T ss_dssp             TTSEEET-----TEEECTTSCCS-SCCSC-C--CTTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTT
T ss_pred             CCCEEcC-----CEEEEeCCCcC-ccCCC-C--CCCCCEEEeCCCCCcccccccccCCCceEeeeecccccccccccccc
Confidence            5778863     26889999999 89984 4  278999999999998755 5678999999999999999999999999


Q ss_pred             ccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCcccccc---CCcccccCCCCCCC
Q 007167          137 SVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQR---FPSWAFAGNNLSSE  200 (615)
Q Consensus       137 ~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~---l~~l~~~~n~~~~~  200 (615)
                      ..+++|+.|+|++|+|++..|..|.++++|+.|+|++|+|++..|..|..   +..+.+++|++.|.
T Consensus        75 ~~~~~L~~L~Ls~N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~~  141 (192)
T d1w8aa_          75 EGASHIQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNCN  141 (192)
T ss_dssp             TTCTTCCEEECCSCCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCCS
T ss_pred             ccccccceeeeccccccccCHHHHhCCCcccccccCCccccccCHHHhcCCcccccccccccccccc
Confidence            99999999999999999988889999999999999999999877776655   45667889988664

>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Polygalacturonase inhibiting protein PGIP
domain: Polygalacturonase inhibiting protein PGIP
species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]

Probab=99.61  E-value=2e-16  Score=158.86  Aligned_cols=138  Identities=30%  Similarity=0.472  Sum_probs=107.1

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCc-cEEEcCCC-----------------------CCCCcCCCCccccccCcEEe
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSAL-QNLSLRSN-----------------------SLSGLFPSDFSKLENLTSLH  122 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L-~~L~L~~N-----------------------~l~g~~p~~~~~l~~L~~L~  122 (615)
                      ..++.+++++|.++|.+|. .+..+..| +.+++++|                       .+.|.+|..+..+++|+.|+
T Consensus       149 ~~L~~l~l~~n~l~~~ip~-~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~~l~l~~~~~~~~~~~~~~~~~~l~~l~  227 (313)
T d1ogqa_         149 PNLVGITFDGNRISGAIPD-SYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDLSRNMLEGDASVLFGSDKNTQKIH  227 (313)
T ss_dssp             TTCCEEECCSSCCEEECCG-GGGCCCTTCCEEECCSSEEEEECCGGGGGCCCSEEECCSSEEEECCGGGCCTTSCCSEEE
T ss_pred             cccceeecccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            3455666666666666665 34444443 44555554                       44455555566777889999


Q ss_pred             cccccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCccc--cccCCcccccCCCCCCC
Q 007167          123 LQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRS--LQRFPSWAFAGNNLSSE  200 (615)
Q Consensus       123 l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~--~~~l~~l~~~~n~~~~~  200 (615)
                      +++|.+++.+| .++.+++|+.|+|++|+|+|.+|..|+++++|++|+|++|+|+|.+|..  +.++..+.+.+|+..|+
T Consensus       228 ~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~~L~~L~~l~l~~N~~l~g  306 (313)
T d1ogqa_         228 LAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCG  306 (313)
T ss_dssp             CCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCSTTGGGSCGGGTCSSSEEES
T ss_pred             ccccccccccc-ccccccccccccCccCeecccCChHHhCCCCCCEEECcCCcccccCCCcccCCCCCHHHhCCCccccC
Confidence            99999998765 6888999999999999999999999999999999999999999999963  55677788999998898


Q ss_pred             CCCCCC
Q 007167          201 NARPPA  206 (615)
Q Consensus       201 ~~~~~~  206 (615)
                      .|.|.|
T Consensus       307 ~plp~c  312 (313)
T d1ogqa_         307 SPLPAC  312 (313)
T ss_dssp             TTSSCC
T ss_pred             CCCCCC
Confidence            887766

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.53  E-value=1e-14  Score=124.82  Aligned_cols=102  Identities=25%  Similarity=0.283  Sum_probs=90.0

Q ss_pred             EEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeecCCC
Q 007167           71 ALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNN  150 (615)
Q Consensus        71 ~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N  150 (615)
                      .|+|++|+++ .++.  ++.+++|++|+|++|.|+ .+|..|+.+++|+.|++++|+|++ +| .+..+++|+.|++++|
T Consensus         2 ~L~Ls~n~l~-~l~~--l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           2 VLHLAHKDLT-VLCH--LEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             EEECTTSCCS-SCCC--GGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred             EEEcCCCCCC-CCcc--cccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence            5899999998 7764  899999999999999998 568889999999999999999995 55 5899999999999999


Q ss_pred             cCCccC-CCcccCCCCCCeeeccCccccC
Q 007167          151 FFNASI-PASISKLTHLSALNLANNSLTG  178 (615)
Q Consensus       151 ~l~~~~-p~~~~~l~~L~~l~l~~N~l~g  178 (615)
                      +|+... ...+..+++|+.|++++|++++
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~  104 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQ  104 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGGG
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCCc
Confidence            999643 2568899999999999999984

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.53  E-value=2.1e-14  Score=140.35  Aligned_cols=130  Identities=26%  Similarity=0.299  Sum_probs=73.8

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCC-----------------------CcCCCCccccccCcEEec
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLS-----------------------GLFPSDFSKLENLTSLHL  123 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~-----------------------g~~p~~~~~l~~L~~L~l  123 (615)
                      .+++.|+|++|+|+ .++.  ++.+++|++|+|++|+++                       +..+..+..+.+|++|++
T Consensus        55 ~~L~~L~L~~N~l~-~l~~--~~~l~~L~~L~Ls~N~l~~~~~~~~~l~~L~~L~l~~~~~~~~~~~~~~~l~~l~~L~l  131 (266)
T d1p9ag_          55 TRLTQLNLDRAELT-KLQV--DGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYL  131 (266)
T ss_dssp             TTCCEEECTTSCCC-EEEC--CSCCTTCCEEECCSSCCSSCCCCTTTCTTCCEEECCSSCCCCCCSSTTTTCTTCCEEEC
T ss_pred             cccccccccccccc-cccc--ccccccccccccccccccccccccccccccccccccccccceeeccccccccccccccc
Confidence            34555555555555 4442  345555555555555555                       333334444444444555


Q ss_pred             ccccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCcccccc---CCcccccCCCCCCC
Q 007167          124 QFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQR---FPSWAFAGNNLSSE  200 (615)
Q Consensus       124 ~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~---l~~l~~~~n~~~~~  200 (615)
                      ++|.+++..+..+..+++|+.|++++|+|++..+..|..+++|++|+|++|+|+ .+|..+..   +..+.+.||+|.|.
T Consensus       132 ~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~~~~~~~~~~l~~L~~L~Ls~N~L~-~lp~~~~~~~~L~~L~L~~Np~~Cd  210 (266)
T d1p9ag_         132 KGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN  210 (266)
T ss_dssp             TTSCCCCCCTTTTTTCTTCCEEECTTSCCSCCCTTTTTTCTTCCEEECCSSCCC-CCCTTTTTTCCCSEEECCSCCBCCS
T ss_pred             cccccceeccccccccccchhcccccccccccCccccccccccceeecccCCCc-ccChhHCCCCCCCEEEecCCCCCCC
Confidence            555555444444556666666777777776665666666667777777777766 56655443   33455666766654

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.52  E-value=1e-14  Score=144.09  Aligned_cols=133  Identities=28%  Similarity=0.316  Sum_probs=100.7

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID  146 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~  146 (615)
                      .+++.|+|++|++. .++...+..+++|+.+++++|+|++..+..|.++++|+.|+|++|+|++..|..|.++++|+.++
T Consensus       105 ~~L~~L~l~~n~~~-~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~  183 (284)
T d1ozna_         105 GRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLL  183 (284)
T ss_dssp             TTCCEEECTTSCCC-CCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEE
T ss_pred             ccCCEEecCCcccc-cccccccchhcccchhhhccccccccChhHhccccchhhcccccCcccccchhhhccccccchhh
Confidence            46777888888776 45555677778888888888888876667777788888888888888876677778888888888


Q ss_pred             cCCCcCCccCCCcccCCCCCCeeeccCccccCCCcccccc---CCcccccCCCCCCC
Q 007167          147 LSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQR---FPSWAFAGNNLSSE  200 (615)
Q Consensus       147 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~---l~~l~~~~n~~~~~  200 (615)
                      +++|++++..|..|.++++|++|++++|.+++..|..|..   +..+.+++|++.|.
T Consensus       184 l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~  240 (284)
T d1ozna_         184 LHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCD  240 (284)
T ss_dssp             CCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECS
T ss_pred             hhhccccccChhHhhhhhhcccccccccccccccccccccccccCEEEecCCCCCCC
Confidence            8888888777888888888888888888888776665544   44566778877664

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.44  E-value=1.7e-13  Score=136.48  Aligned_cols=145  Identities=28%  Similarity=0.338  Sum_probs=106.5

Q ss_pred             CCCCCCCcceEecCC---------CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEE
Q 007167           51 SSLCKSWTGVTCSAD---------HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSL  121 (615)
Q Consensus        51 ~~~c~~w~gv~C~~~---------~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L  121 (615)
                      .+.| .|++|.|+..         ...++.|+|++|+|+ .||+..|.++++|++|++++|.+....|..|.++++|++|
T Consensus         7 ~c~c-~~~~~~C~~~~L~~lP~~l~~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L   84 (305)
T d1xkua_           7 RCQC-HLRVVQCSDLGLEKVPKDLPPDTALLDLQNNKIT-EIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERL   84 (305)
T ss_dssp             TCEE-ETTEEECTTSCCCSCCCSCCTTCCEEECCSSCCC-CBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEE
T ss_pred             CCEe-cCCEEEecCCCCCccCCCCCCCCCEEECcCCcCC-CcChhHhhccccccccccccccccccchhhhhCCCccCEe
Confidence            3445 8999999752         256889999999999 8988789999999999999999998888899999999999


Q ss_pred             ecccccccCCCC------------------------------------------------cccccc--------------
Q 007167          122 HLQFNSFSGPLP------------------------------------------------LDFSVW--------------  139 (615)
Q Consensus       122 ~l~~N~l~g~~p------------------------------------------------~~~~~l--------------  139 (615)
                      +|++|+++. +|                                                ..+..+              
T Consensus        85 ~l~~n~l~~-l~~~~~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L~~l~l~~n~l~  163 (305)
T d1xkua_          85 YLSKNQLKE-LPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT  163 (305)
T ss_dssp             ECCSSCCSB-CCSSCCTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTCCEEECCSSCCC
T ss_pred             cccCCccCc-CccchhhhhhhhhccccchhhhhhhhhhccccccccccccccccccCCCccccccccccCccccccCCcc
Confidence            999998763 32                                                012222              


Q ss_pred             -------cccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccc---cCCcccccCCCCC
Q 007167          140 -------NNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQ---RFPSWAFAGNNLS  198 (615)
Q Consensus       140 -------~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l~~~~n~~~  198 (615)
                             ++|+.|++++|.+++..+..+.+++.++.|++++|.+++..+..+.   ++..|.+++|.+.
T Consensus       164 ~l~~~~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N~L~  232 (305)
T d1xkua_         164 TIPQGLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLV  232 (305)
T ss_dssp             SCCSSCCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSSCCS
T ss_pred             ccCcccCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeeeccccccc
Confidence                   2344555555555555566667777777777777777766665554   3445566777664

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.44  E-value=5.7e-14  Score=126.09  Aligned_cols=119  Identities=20%  Similarity=0.215  Sum_probs=97.7

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID  146 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~  146 (615)
                      .++..|+|++|+|+ .|+. .+..+++|+.|||++|.|+.. + .|..+++|++|+|++|+++...+..+..+++|+.|+
T Consensus        18 ~~lr~L~L~~n~I~-~i~~-~~~~l~~L~~L~Ls~N~i~~l-~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L~   93 (162)
T d1a9na_          18 VRDRELDLRGYKIP-VIEN-LGATLDQFDAIDFSDNEIRKL-D-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELI   93 (162)
T ss_dssp             TSCEEEECTTSCCC-SCCC-GGGGTTCCSEEECCSSCCCEE-C-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEEE
T ss_pred             CcCcEEECCCCCCC-ccCc-cccccccCCEEECCCCCCCcc-C-CcccCcchhhhhcccccccCCCccccccccccccce
Confidence            46889999999998 7875 678899999999999999954 4 589999999999999999965555567899999999


Q ss_pred             cCCCcCCccCC--CcccCCCCCCeeeccCccccCCCcc----ccccCCccc
Q 007167          147 LSNNFFNASIP--ASISKLTHLSALNLANNSLTGTLPR----SLQRFPSWA  191 (615)
Q Consensus       147 l~~N~l~~~~p--~~~~~l~~L~~l~l~~N~l~g~~p~----~~~~l~~l~  191 (615)
                      |++|+|+. ++  ..+..+++|+.|++++|.++. .|.    .+..+++|.
T Consensus        94 L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~~-~~~~r~~~i~~lp~L~  142 (162)
T d1a9na_          94 LTNNSLVE-LGDLDPLASLKSLTYLCILRNPVTN-KKHYRLYVIYKVPQVR  142 (162)
T ss_dssp             CCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGGG-STTHHHHHHHHCTTCS
T ss_pred             eccccccc-cccccccccccccchhhcCCCcccc-ccchHHHHHHHCCCcC
Confidence            99999985 33  468889999999999999974 332    345556554

>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.44  E-value=7.8e-14  Score=137.59  Aligned_cols=115  Identities=25%  Similarity=0.283  Sum_probs=108.0

Q ss_pred             CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCccccccccccee
Q 007167           66 HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVI  145 (615)
Q Consensus        66 ~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l  145 (615)
                      ...+..+++++|+|+ .+|+..|..+++|+.|+|++|+|++..|..|.++++|++|++++|++++..|..|..+++|+.|
T Consensus       128 ~~~L~~l~l~~N~l~-~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L  206 (284)
T d1ozna_         128 LAALQYLYLQDNALQ-ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL  206 (284)
T ss_dssp             CTTCCEEECCSSCCC-CCCTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEE
T ss_pred             hcccchhhhcccccc-ccChhHhccccchhhcccccCcccccchhhhccccccchhhhhhccccccChhHhhhhhhcccc
Confidence            356889999999999 6777789999999999999999999989999999999999999999999999999999999999


Q ss_pred             ecCCCcCCccCCCcccCCCCCCeeeccCccccCCCc
Q 007167          146 DLSNNFFNASIPASISKLTHLSALNLANNSLTGTLP  181 (615)
Q Consensus       146 ~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p  181 (615)
                      ++++|++++..|..|.++++|++|+|++|.+.+..+
T Consensus       207 ~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C~C~  242 (284)
T d1ozna_         207 YLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCR  242 (284)
T ss_dssp             ECCSSCCSCCCHHHHTTCTTCCEEECCSSCEECSGG
T ss_pred             cccccccccccccccccccccCEEEecCCCCCCCcc
Confidence            999999999888999999999999999999998765

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.41  E-value=3.4e-13  Score=120.09  Aligned_cols=112  Identities=19%  Similarity=0.187  Sum_probs=90.5

Q ss_pred             CCCCCCcceEecCCCCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCC-CCCCcCCCCccccccCcEEecccccccC
Q 007167           52 SLCKSWTGVTCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSN-SLSGLFPSDFSKLENLTSLHLQFNSFSG  130 (615)
Q Consensus        52 ~~c~~w~gv~C~~~~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N-~l~g~~p~~~~~l~~L~~L~l~~N~l~g  130 (615)
                      ..|+.+.+++|.            +++++ .+|. .+..+++|++|+|++| .|+..-+..|.++++|+.|+|++|+|+.
T Consensus         5 C~c~~~~~l~c~------------~~~~~-~~p~-~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~   70 (156)
T d2ifga3           5 CCPHGSSGLRCT------------RDGAL-DSLH-HLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRF   70 (156)
T ss_dssp             SCCSSSSCEECC------------SSCCC-TTTT-TSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCE
T ss_pred             CCcCCCCeEEec------------CCCCc-cCcc-cccCccccCeeecCCCccccccCchhhccccccCcceeeccccCC
Confidence            344457777775            34444 5555 5888999999999876 5887777789999999999999999998


Q ss_pred             CCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccC
Q 007167          131 PLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTG  178 (615)
Q Consensus       131 ~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g  178 (615)
                      ..|..|..+++|++|+|++|+|+. +|.......+|+.|+|++|.+..
T Consensus        71 i~~~~f~~l~~L~~L~Ls~N~l~~-l~~~~~~~~~l~~L~L~~Np~~C  117 (156)
T d2ifga3          71 VAPDAFHFTPRLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLHC  117 (156)
T ss_dssp             ECTTGGGSCSCCCEEECCSSCCSC-CCSTTTCSCCCCEEECCSSCCCC
T ss_pred             cccccccccccccceeccCCCCcc-cChhhhccccccccccCCCcccC
Confidence            778889999999999999999995 55544444579999999999974

>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.41  E-value=3.6e-13  Score=114.96  Aligned_cols=101  Identities=27%  Similarity=0.407  Sum_probs=85.5

Q ss_pred             cEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCc
Q 007167           95 QNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANN  174 (615)
Q Consensus        95 ~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N  174 (615)
                      ++|||++|+|+ .+| .+.++++|++|+|++|+|+ .+|..++.+++|+.|++++|+|++ +| .+.++++|+.|++++|
T Consensus         1 R~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N   75 (124)
T d1dcea3           1 RVLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNN   75 (124)
T ss_dssp             SEEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSS
T ss_pred             CEEEcCCCCCC-CCc-ccccCCCCCEEECCCCccC-cchhhhhhhhcccccccccccccc-cC-ccccccccCeEECCCC
Confidence            58999999999 445 5999999999999999999 588899999999999999999996 55 5899999999999999


Q ss_pred             cccCCCc-cccc---cCCcccccCCCCCCC
Q 007167          175 SLTGTLP-RSLQ---RFPSWAFAGNNLSSE  200 (615)
Q Consensus       175 ~l~g~~p-~~~~---~l~~l~~~~n~~~~~  200 (615)
                      +|+.... ..+.   ++..+.+++|++...
T Consensus        76 ~i~~~~~~~~l~~~~~L~~L~l~~N~i~~~  105 (124)
T d1dcea3          76 RLQQSAAIQPLVSCPRLVLLNLQGNSLCQE  105 (124)
T ss_dssp             CCCSSSTTGGGGGCTTCCEEECTTSGGGGS
T ss_pred             ccCCCCCchhhcCCCCCCEEECCCCcCCcC
Confidence            9985432 3444   455677899988644

>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: von Willebrand factor binding domain of glycoprotein Ib alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.38  E-value=9e-13  Score=128.53  Aligned_cols=128  Identities=27%  Similarity=0.292  Sum_probs=97.1

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID  146 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~  146 (615)
                      ..++.|+|++|.|+ .+|+..|.++++|++|+|++|+|+. +| .++.+++|++|+|++|++++ +|..+.++++|+.|+
T Consensus        31 ~~l~~L~Ls~N~i~-~l~~~~f~~l~~L~~L~L~~N~l~~-l~-~~~~l~~L~~L~Ls~N~l~~-~~~~~~~l~~L~~L~  106 (266)
T d1p9ag_          31 KDTTILHLSENLLY-TFSLATLMPYTRLTQLNLDRAELTK-LQ-VDGTLPVLGTLDLSHNQLQS-LPLLGQTLPALTVLD  106 (266)
T ss_dssp             TTCCEEECTTSCCS-EEEGGGGTTCTTCCEEECTTSCCCE-EE-CCSCCTTCCEEECCSSCCSS-CCCCTTTCTTCCEEE
T ss_pred             cCCCEEECcCCcCC-CcCHHHhhccccccccccccccccc-cc-cccccccccccccccccccc-ccccccccccccccc
Confidence            46899999999999 6887789999999999999999994 45 46789999999999999985 677788888888888


Q ss_pred             cCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccc---cCCcccccCCCCC
Q 007167          147 LSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQ---RFPSWAFAGNNLS  198 (615)
Q Consensus       147 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l~~~~n~~~  198 (615)
                      +++|.+.+..+..+..+.+|..|++++|.++...+..+.   ++..+.+++|.+.
T Consensus       107 l~~~~~~~~~~~~~~~l~~l~~L~l~~n~l~~l~~~~~~~l~~l~~l~l~~N~l~  161 (266)
T d1p9ag_         107 VSFNRLTSLPLGALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLT  161 (266)
T ss_dssp             CCSSCCCCCCSSTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECTTSCCS
T ss_pred             ccccccceeeccccccccccccccccccccceeccccccccccchhccccccccc
Confidence            888887766666666666666666666666644333332   3334445555553

>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Decorin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=99.30  E-value=2.9e-12  Score=127.44  Aligned_cols=129  Identities=19%  Similarity=0.296  Sum_probs=109.2

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID  146 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~  146 (615)
                      ..++.+++++|+++ .+|..   .+++|+.|+|++|.+++..+..|.+++.+++|++++|.+++..|..+.++++|++|+
T Consensus       150 ~~L~~l~l~~n~l~-~l~~~---~~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~  225 (305)
T d1xkua_         150 KKLSYIRIADTNIT-TIPQG---LPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELH  225 (305)
T ss_dssp             TTCCEEECCSSCCC-SCCSS---CCTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEE
T ss_pred             cccCccccccCCcc-ccCcc---cCCccCEEECCCCcCCCCChhHhhccccccccccccccccccccccccccccceeee
Confidence            46788999999988 67653   368899999999999999999999999999999999999988888999999999999


Q ss_pred             cCCCcCCccCCCcccCCCCCCeeeccCccccCCCcccc---------ccCCcccccCCCCCCC
Q 007167          147 LSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSL---------QRFPSWAFAGNNLSSE  200 (615)
Q Consensus       147 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~---------~~l~~l~~~~n~~~~~  200 (615)
                      |++|+|+ .+|..+.++++|+.|+|++|+|+..-...|         ..+..+.+.+|++...
T Consensus       226 L~~N~L~-~lp~~l~~l~~L~~L~Ls~N~i~~i~~~~f~~~~~~~~~~~L~~L~L~~N~~~~~  287 (305)
T d1xkua_         226 LNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYW  287 (305)
T ss_dssp             CCSSCCS-SCCTTTTTCSSCCEEECCSSCCCCCCTTSSSCSSCCTTSCCCSEEECCSSSSCGG
T ss_pred             ccccccc-ccccccccccCCCEEECCCCccCccChhhccCcchhcccCCCCEEECCCCcCccC
Confidence            9999999 578899999999999999999994322222         3455677889988643

>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: U2A'-like
domain: Splicesomal U2A' protein
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.28  E-value=2.1e-12  Score=115.58  Aligned_cols=108  Identities=19%  Similarity=0.210  Sum_probs=90.0

Q ss_pred             cccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCC
Q 007167           87 TIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHL  166 (615)
Q Consensus        87 ~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L  166 (615)
                      .+.+...|++|||++|+|+.. |..+..+++|+.|||++|+++ .++ .|..+++|+.|+|++|+++...+..+..+++|
T Consensus        13 ~~~n~~~lr~L~L~~n~I~~i-~~~~~~l~~L~~L~Ls~N~i~-~l~-~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L   89 (162)
T d1a9na_          13 QYTNAVRDRELDLRGYKIPVI-ENLGATLDQFDAIDFSDNEIR-KLD-GFPLLRRLKTLLVNNNRICRIGEGLDQALPDL   89 (162)
T ss_dssp             EEECTTSCEEEECTTSCCCSC-CCGGGGTTCCSEEECCSSCCC-EEC-CCCCCSSCCEEECCSSCCCEECSCHHHHCTTC
T ss_pred             hccCcCcCcEEECCCCCCCcc-CccccccccCCEEECCCCCCC-ccC-CcccCcchhhhhcccccccCCCcccccccccc
Confidence            477888999999999999954 777788999999999999999 454 58999999999999999997656566789999


Q ss_pred             CeeeccCccccCCCc--ccc---ccCCcccccCCCCC
Q 007167          167 SALNLANNSLTGTLP--RSL---QRFPSWAFAGNNLS  198 (615)
Q Consensus       167 ~~l~l~~N~l~g~~p--~~~---~~l~~l~~~~n~~~  198 (615)
                      +.|+|++|+|+. ++  ..+   .++..+.+.+|++.
T Consensus        90 ~~L~L~~N~i~~-~~~l~~l~~l~~L~~L~l~~N~i~  125 (162)
T d1a9na_          90 TELILTNNSLVE-LGDLDPLASLKSLTYLCILRNPVT  125 (162)
T ss_dssp             CEEECCSCCCCC-GGGGGGGGGCTTCCEEECCSSGGG
T ss_pred             ccceeccccccc-cccccccccccccchhhcCCCccc
Confidence            999999999984 33  233   45666778888774

>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: High affinity nerve growth factor receptor, N-terminal domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.26  E-value=7.8e-12  Score=111.06  Aligned_cols=110  Identities=18%  Similarity=0.151  Sum_probs=92.1

Q ss_pred             CCCccEEEcCCCCCCCcCCCCccccccCcEEeccccc-ccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCee
Q 007167           91 LSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNS-FSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSAL  169 (615)
Q Consensus        91 l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~-l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l  169 (615)
                      ......++.+++++. .+|..+..+++|++|+|++|+ |+..-+..|.++++|+.|+|++|+|+...|..|..+++|++|
T Consensus         7 c~~~~~l~c~~~~~~-~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L   85 (156)
T d2ifga3           7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRL   85 (156)
T ss_dssp             CSSSSCEECCSSCCC-TTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEE
T ss_pred             cCCCCeEEecCCCCc-cCcccccCccccCeeecCCCccccccCchhhccccccCcceeeccccCCcccccccccccccce
Confidence            344567899999988 568889999999999998765 886556779999999999999999998888999999999999


Q ss_pred             eccCccccCCCccccc--cCCcccccCCCCCCCC
Q 007167          170 NLANNSLTGTLPRSLQ--RFPSWAFAGNNLSSEN  201 (615)
Q Consensus       170 ~l~~N~l~g~~p~~~~--~l~~l~~~~n~~~~~~  201 (615)
                      +|++|+|+...+..|.  ++..+.+++|++.|..
T Consensus        86 ~Ls~N~l~~l~~~~~~~~~l~~L~L~~Np~~C~C  119 (156)
T d2ifga3          86 NLSFNALESLSWKTVQGLSLQELVLSGNPLHCSC  119 (156)
T ss_dssp             ECCSSCCSCCCSTTTCSCCCCEEECCSSCCCCCG
T ss_pred             eccCCCCcccChhhhccccccccccCCCcccCCc
Confidence            9999999944444443  4567889999997753

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.20  E-value=2.8e-11  Score=112.19  Aligned_cols=122  Identities=25%  Similarity=0.412  Sum_probs=65.4

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID  146 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~  146 (615)
                      .+++.|+|++|.++ .+++  ++++++|++|++++|.+... | .+.++++|+.|++++|.+...  ..+..+++|+.|+
T Consensus        62 ~nL~~L~Ls~N~l~-~~~~--l~~l~~L~~L~l~~n~~~~~-~-~l~~l~~L~~L~l~~~~~~~~--~~~~~l~~L~~L~  134 (199)
T d2omxa2          62 NNLTQINFSNNQLT-DITP--LKNLTKLVDILMNNNQIADI-T-PLANLTNLTGLTLFNNQITDI--DPLKNLTNLNRLE  134 (199)
T ss_dssp             TTCCEEECCSSCCC-CCGG--GTTCTTCCEEECCSSCCCCC-G-GGTTCTTCSEEECCSSCCCCC--GGGTTCTTCSEEE
T ss_pred             CCcCcCcccccccc-Cccc--ccCCcccccccccccccccc-c-ccccccccccccccccccccc--cccchhhhhHHhh
Confidence            34556666666655 2332  55566666666666655532 2 255566666666666655532  2355566666666


Q ss_pred             cCCCcCCccCCCcccCCCCCCeeeccCccccCCCc-cccccCCcccccCCCC
Q 007167          147 LSNNFFNASIPASISKLTHLSALNLANNSLTGTLP-RSLQRFPSWAFAGNNL  197 (615)
Q Consensus       147 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p-~~~~~l~~l~~~~n~~  197 (615)
                      +++|++.. +| .+..+++|+.|++++|++++..+ ..+.++..|.+++|++
T Consensus       135 l~~n~l~~-~~-~l~~~~~L~~L~l~~n~l~~l~~l~~l~~L~~L~ls~N~i  184 (199)
T d2omxa2         135 LSSNTISD-IS-ALSGLTSLQQLNFSSNQVTDLKPLANLTTLERLDISSNKV  184 (199)
T ss_dssp             CCSSCCCC-CG-GGTTCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCC
T ss_pred             hhhhhhcc-cc-cccccccccccccccccccCCccccCCCCCCEEECCCCCC
Confidence            66666653 22 35556666666666666654322 2233444455555554

>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.15  E-value=6.3e-11  Score=109.78  Aligned_cols=124  Identities=21%  Similarity=0.405  Sum_probs=102.9

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID  146 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~  146 (615)
                      .+++.|++++++++ .++  .+..+++|++|+|++|++++..|  ++++++|++|++++|.+.. +| .+.+++.|+.|+
T Consensus        40 ~~l~~L~l~~~~i~-~l~--~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~~-~~-~l~~l~~L~~L~  112 (199)
T d2omxa2          40 DQVTTLQADRLGIK-SID--GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIAD-IT-PLANLTNLTGLT  112 (199)
T ss_dssp             TTCCEEECTTSCCC-CCT--TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCC-CG-GGTTCTTCSEEE
T ss_pred             cCCCEEECCCCCCC-Ccc--ccccCCCcCcCccccccccCccc--ccCCccccccccccccccc-cc-cccccccccccc
Confidence            46889999999998 675  48899999999999999997644  9999999999999999984 55 488999999999


Q ss_pred             cCCCcCCccCCCcccCCCCCCeeeccCccccCCCc--cccccCCcccccCCCCCCC
Q 007167          147 LSNNFFNASIPASISKLTHLSALNLANNSLTGTLP--RSLQRFPSWAFAGNNLSSE  200 (615)
Q Consensus       147 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p--~~~~~l~~l~~~~n~~~~~  200 (615)
                      +++|.+...  ..+.++++|+.|++++|+++. ++  ..+.++..+.+.+|.+..-
T Consensus       113 l~~~~~~~~--~~~~~l~~L~~L~l~~n~l~~-~~~l~~~~~L~~L~l~~n~l~~l  165 (199)
T d2omxa2         113 LFNNQITDI--DPLKNLTNLNRLELSSNTISD-ISALSGLTSLQQLNFSSNQVTDL  165 (199)
T ss_dssp             CCSSCCCCC--GGGTTCTTCSEEECCSSCCCC-CGGGTTCTTCSEEECCSSCCCCC
T ss_pred             ccccccccc--cccchhhhhHHhhhhhhhhcc-cccccccccccccccccccccCC
Confidence            999999864  358889999999999999984 44  2245566777888877543

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.14  E-value=8e-11  Score=110.06  Aligned_cols=123  Identities=28%  Similarity=0.424  Sum_probs=91.2

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID  146 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~  146 (615)
                      .+++.|+|++|.++ .+++  ++.+++|++|+|++|+|++ +| .+.++++|+.|++++|.+.. + ..+.+++.|+.++
T Consensus        68 ~~L~~L~L~~n~i~-~l~~--~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~l~~~~~~~-~-~~l~~l~~l~~l~  140 (210)
T d1h6ta2          68 PNVTKLFLNGNKLT-DIKP--LANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLSLEHNGISD-I-NGLVHLPQLESLY  140 (210)
T ss_dssp             TTCCEEECCSSCCC-CCGG--GTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEECTTSCCCC-C-GGGGGCTTCCEEE
T ss_pred             CCCCEEeCCCcccc-Cccc--cccCccccccccccccccc-cc-cccccccccccccccccccc-c-ccccccccccccc
Confidence            56888888888888 4553  6788888888888888885 34 57888888888888888763 3 3577788888888


Q ss_pred             cCCCcCCccCCCcccCCCCCCeeeccCccccCCCc-cccccCCcccccCCCCC
Q 007167          147 LSNNFFNASIPASISKLTHLSALNLANNSLTGTLP-RSLQRFPSWAFAGNNLS  198 (615)
Q Consensus       147 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p-~~~~~l~~l~~~~n~~~  198 (615)
                      +++|.+++  +..+.++++|+.+++++|++++..+ ..+.++..|.+++|.+.
T Consensus       141 ~~~n~l~~--~~~~~~l~~L~~l~l~~n~l~~i~~l~~l~~L~~L~Ls~N~i~  191 (210)
T d1h6ta2         141 LGNNKITD--ITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNHIS  191 (210)
T ss_dssp             CCSSCCCC--CGGGGGCTTCSEEECCSSCCCCCGGGTTCTTCCEEECCSSCCC
T ss_pred             cccccccc--cccccccccccccccccccccccccccCCCCCCEEECCCCCCC
Confidence            88888875  3456778888888888888886433 23455666777888764

>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin B
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.11  E-value=1.1e-10  Score=108.95  Aligned_cols=124  Identities=22%  Similarity=0.326  Sum_probs=103.8

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID  146 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~  146 (615)
                      ..++.|++++++++ .++.  +..+++|++|+|++|.|++..  .+++|++|++|+|++|++++ +| .+..+++|+.|+
T Consensus        46 ~~L~~L~l~~~~i~-~l~~--l~~l~~L~~L~L~~n~i~~l~--~~~~l~~L~~L~l~~n~i~~-l~-~l~~l~~L~~L~  118 (210)
T d1h6ta2          46 NSIDQIIANNSDIK-SVQG--IQYLPNVTKLFLNGNKLTDIK--PLANLKNLGWLFLDENKVKD-LS-SLKDLKKLKSLS  118 (210)
T ss_dssp             HTCCEEECTTSCCC-CCTT--GGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCC-GG-GGTTCTTCCEEE
T ss_pred             cCccEEECcCCCCC-Cchh--HhhCCCCCEEeCCCccccCcc--ccccCccccccccccccccc-cc-cccccccccccc
Confidence            36889999999998 5653  889999999999999999753  47899999999999999995 56 588999999999


Q ss_pred             cCCCcCCccCCCcccCCCCCCeeeccCccccCCCc-cccccCCcccccCCCCCC
Q 007167          147 LSNNFFNASIPASISKLTHLSALNLANNSLTGTLP-RSLQRFPSWAFAGNNLSS  199 (615)
Q Consensus       147 l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p-~~~~~l~~l~~~~n~~~~  199 (615)
                      +++|.+.. + ..+.++++|+.+++++|.+++..+ ..+.++..+.+++|.+..
T Consensus       119 l~~~~~~~-~-~~l~~l~~l~~l~~~~n~l~~~~~~~~l~~L~~l~l~~n~l~~  170 (210)
T d1h6ta2         119 LEHNGISD-I-NGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISD  170 (210)
T ss_dssp             CTTSCCCC-C-GGGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSSCCCC
T ss_pred             cccccccc-c-ccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999974 3 468899999999999999986432 235567777888888754

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.10  E-value=7.3e-13  Score=122.94  Aligned_cols=108  Identities=23%  Similarity=0.271  Sum_probs=75.2

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceee
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVID  146 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~  146 (615)
                      .+++.|+|++|+|+ .++  .|..+++|++|+|++|.|+ .+|..+..+++|++|++++|+++. ++ .+..+++|+.|+
T Consensus        48 ~~L~~L~Ls~n~I~-~i~--~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~  121 (198)
T d1m9la_          48 KACKHLALSTNNIE-KIS--SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNLRVLY  121 (198)
T ss_dssp             TTCCEEECSEEEES-CCC--CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHHSSEEE
T ss_pred             cccceeECcccCCC-Ccc--cccCCccccChhhcccccc-cccccccccccccccccccccccc-cc-cccccccccccc
Confidence            46777788877777 664  3777777888888888777 445555556677888888887774 33 467777788888


Q ss_pred             cCCCcCCccCC-CcccCCCCCCeeeccCccccCCC
Q 007167          147 LSNNFFNASIP-ASISKLTHLSALNLANNSLTGTL  180 (615)
Q Consensus       147 l~~N~l~~~~p-~~~~~l~~L~~l~l~~N~l~g~~  180 (615)
                      |++|+|+.... ..+.++++|+.|+|++|+++...
T Consensus       122 L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~~~  156 (198)
T d1m9la_         122 MSNNKITNWGEIDKLAALDKLEDLLLAGNPLYNDY  156 (198)
T ss_dssp             ESEEECCCHHHHHHHTTTTTCSEEEECSSHHHHHH
T ss_pred             cccchhccccccccccCCCccceeecCCCccccCc
Confidence            88887774221 35677777888888887776443

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.07  E-value=1.6e-10  Score=117.91  Aligned_cols=107  Identities=28%  Similarity=0.421  Sum_probs=60.6

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCC--------------------CCccccccCcEEecccc
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFP--------------------SDFSKLENLTSLHLQFN  126 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p--------------------~~~~~l~~L~~L~l~~N  126 (615)
                      ..++.+++++|.+++ +++  ++.+++|++|++++|.+++..|                    ..+..+++|+.|+|++|
T Consensus       241 ~~L~~L~l~~n~l~~-~~~--~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~~~n~l~~~~~~~~~~~l~~L~ls~n  317 (384)
T d2omza2         241 TNLTDLDLANNQISN-LAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYFN  317 (384)
T ss_dssp             TTCSEEECCSSCCCC-CGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEECCSSCCSCCGGGGGCTTCSEEECCSS
T ss_pred             cccchhccccCccCC-CCc--ccccccCCEeeccCcccCCCCccccccccccccccccccccccccchhcccCeEECCCC
Confidence            456777788777774 332  6677777777777777775432                    12344445555555555


Q ss_pred             cccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCC
Q 007167          127 SFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTL  180 (615)
Q Consensus       127 ~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~  180 (615)
                      ++++..  .+..+++|+.|+|++|+|++ +| .+.++++|++|+|++|+|++.+
T Consensus       318 ~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~  367 (384)
T d2omza2         318 NISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLT  367 (384)
T ss_dssp             CCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCG
T ss_pred             CCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCCCh
Confidence            555422  24555555555555555553 22 3555555555555555555443

>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: Outer arm dynein light chain 1
family: Outer arm dynein light chain 1
domain: Outer arm dynein light chain 1
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=99.04  E-value=2.9e-12  Score=118.78  Aligned_cols=108  Identities=28%  Similarity=0.342  Sum_probs=89.9

Q ss_pred             cccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCC
Q 007167           87 TIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHL  166 (615)
Q Consensus        87 ~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L  166 (615)
                      .++.|++|++|+|++|+|+. ++ .|.+|++|++|+|++|+++ .+|..+..+++|+.|++++|+++. ++ .+.++++|
T Consensus        43 sl~~L~~L~~L~Ls~n~I~~-i~-~l~~l~~L~~L~Ls~N~i~-~i~~~~~~~~~L~~L~l~~N~i~~-l~-~~~~l~~L  117 (198)
T d1m9la_          43 TLSTLKACKHLALSTNNIEK-IS-SLSGMENLRILSLGRNLIK-KIENLDAVADTLEELWISYNQIAS-LS-GIEKLVNL  117 (198)
T ss_dssp             HHHHTTTCCEEECSEEEESC-CC-CHHHHTTCCEEECCEEEEC-SCSSHHHHHHHCCEEECSEEECCC-HH-HHHHHHHS
T ss_pred             HHhcccccceeECcccCCCC-cc-cccCCccccChhhcccccc-cccccccccccccccccccccccc-cc-cccccccc
Confidence            68899999999999999995 45 6999999999999999998 578777777899999999999996 43 58889999


Q ss_pred             CeeeccCccccCCCc----cccccCCcccccCCCCCC
Q 007167          167 SALNLANNSLTGTLP----RSLQRFPSWAFAGNNLSS  199 (615)
Q Consensus       167 ~~l~l~~N~l~g~~p----~~~~~l~~l~~~~n~~~~  199 (615)
                      +.|+|++|+++....    ..+.++..+.+++|++..
T Consensus       118 ~~L~L~~N~i~~~~~~~~l~~l~~L~~L~L~~N~l~~  154 (198)
T d1m9la_         118 RVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLYN  154 (198)
T ss_dssp             SEEEESEEECCCHHHHHHHTTTTTCSEEEECSSHHHH
T ss_pred             cccccccchhccccccccccCCCccceeecCCCcccc
Confidence            999999999984321    234566677889997643

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=99.02  E-value=4.5e-10  Score=106.10  Aligned_cols=134  Identities=19%  Similarity=0.368  Sum_probs=96.0

Q ss_pred             CCcceEecCCCCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCC--
Q 007167           56 SWTGVTCSADHSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLP--  133 (615)
Q Consensus        56 ~w~gv~C~~~~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p--  133 (615)
                      ++.|+..   -.+++.|+|++|.++ .+++  +..+++|++|++++|.++. ++ .+.++++|++|++++|...+..+  
T Consensus        55 ~l~~l~~---l~~L~~L~ls~n~i~-~~~~--l~~l~~l~~l~~~~n~~~~-i~-~l~~l~~L~~l~l~~~~~~~~~~~~  126 (227)
T d1h6ua2          55 TIEGVQY---LNNLIGLELKDNQIT-DLAP--LKNLTKITELELSGNPLKN-VS-AIAGLQSIKTLDLTSTQITDVTPLA  126 (227)
T ss_dssp             CCTTGGG---CTTCCEEECCSSCCC-CCGG--GTTCCSCCEEECCSCCCSC-CG-GGTTCTTCCEEECTTSCCCCCGGGT
T ss_pred             cchhHhc---CCCCcEeecCCceee-cccc--ccccccccccccccccccc-cc-cccccccccccccccccccccchhc
Confidence            4555532   457888899988888 3443  7888889999999888874 33 57888888888888887665322  


Q ss_pred             ------------------cccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCc-cccccCCcccccC
Q 007167          134 ------------------LDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLP-RSLQRFPSWAFAG  194 (615)
Q Consensus       134 ------------------~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p-~~~~~l~~l~~~~  194 (615)
                                        ..+..+++|+.|++++|.+++..  .+.++++|+.|+|++|++++..+ ..+.++..|.+++
T Consensus       127 ~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n~~~~~~--~l~~l~~L~~L~Ls~n~l~~l~~l~~l~~L~~L~Ls~  204 (227)
T d1h6ua2         127 GLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLT--PLANLSKLTTLKADDNKISDISPLASLPNLIEVHLKN  204 (227)
T ss_dssp             TCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSSCCCCCG--GGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECTT
T ss_pred             cccchhhhhchhhhhchhhhhccccccccccccccccccch--hhcccccceecccCCCccCCChhhcCCCCCCEEECcC
Confidence                              12456677888888888887532  37888889999999998885322 2345666677888


Q ss_pred             CCCCC
Q 007167          195 NNLSS  199 (615)
Q Consensus       195 n~~~~  199 (615)
                      |++..
T Consensus       205 N~lt~  209 (227)
T d1h6ua2         205 NQISD  209 (227)
T ss_dssp             SCCCB
T ss_pred             CcCCC
Confidence            87654

>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.98  E-value=4.9e-10  Score=114.29  Aligned_cols=125  Identities=33%  Similarity=0.401  Sum_probs=89.8

Q ss_pred             CCcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCC------------
Q 007167           66 HSRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLP------------  133 (615)
Q Consensus        66 ~~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p------------  133 (615)
                      ..+++.|++++|.++ .++  .+..+++|+.|++++|.+++..|  +..+++|++|++++|++++..+            
T Consensus       218 ~~~L~~L~l~~n~l~-~~~--~l~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~~~~~~~~l~~l~~  292 (384)
T d2omza2         218 LTNLDELSLNGNQLK-DIG--TLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLEL  292 (384)
T ss_dssp             CTTCCEEECCSSCCC-CCG--GGGGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCGGGTTCTTCSEEEC
T ss_pred             cCCCCEEECCCCCCC-Ccc--hhhcccccchhccccCccCCCCc--ccccccCCEeeccCcccCCCCccccccccccccc
Confidence            356788899999888 454  57889999999999999997644  8888999999999998886432            


Q ss_pred             --------cccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccc---cCCcccccCCCCCC
Q 007167          134 --------LDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQ---RFPSWAFAGNNLSS  199 (615)
Q Consensus       134 --------~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~---~l~~l~~~~n~~~~  199 (615)
                              ..+..+++|+.|+|++|++++..  .+..+++|+.|+|++|+|++ +| .+.   +|..+++++|++..
T Consensus       293 ~~n~l~~~~~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~  365 (384)
T d2omza2         293 NENQLEDISPISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFANNKVSD-VS-SLANLTNINWLSAGHNQISD  365 (384)
T ss_dssp             CSSCCSCCGGGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCB
T ss_pred             cccccccccccchhcccCeEECCCCCCCCCc--ccccCCCCCEEECCCCCCCC-Ch-hHcCCCCCCEEECCCCcCCC
Confidence                    12445567777777777777643  26777777777777777774 33 344   34455667776654

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.98  E-value=4.8e-10  Score=106.86  Aligned_cols=103  Identities=18%  Similarity=0.215  Sum_probs=66.5

Q ss_pred             EEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCC-cccccccccceeecC-C
Q 007167           72 LRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLP-LDFSVWNNLTVIDLS-N  149 (615)
Q Consensus        72 l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p-~~~~~l~~L~~l~l~-~  149 (615)
                      ++.++.+++ .+|++ +  .+++++|+|++|.|+...+..|.++++|++|+|++|.+...+| ..|..++.++.|++. .
T Consensus        13 i~c~~~~l~-~iP~~-l--~~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~   88 (242)
T d1xwdc1          13 FLCQESKVT-EIPSD-L--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA   88 (242)
T ss_dssp             EEEESCSCS-SCCSC-S--CSCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECC
T ss_pred             EEEeCCCCC-CcCCC-C--CCCCCEEECcCCcCCccChhHhhccchhhhhhhccccccceeecccccccccccccccccc
Confidence            333445566 66653 2  2466777777777775545567777777777777777665443 346667777777664 3


Q ss_pred             CcCCccCCCcccCCCCCCeeeccCccccC
Q 007167          150 NFFNASIPASISKLTHLSALNLANNSLTG  178 (615)
Q Consensus       150 N~l~~~~p~~~~~l~~L~~l~l~~N~l~g  178 (615)
                      |++....+..|.++++|+.|++++|.++.
T Consensus        89 n~l~~~~~~~~~~l~~L~~l~l~~~~l~~  117 (242)
T d1xwdc1          89 NNLLYINPEAFQNLPNLQYLLISNTGIKH  117 (242)
T ss_dssp             TTCCEECTTSEECCTTCCEEEEESCCCCS
T ss_pred             ccccccccccccccccccccccchhhhcc
Confidence            56666666667777777777777777764

>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin H
species: Listeria monocytogenes [TaxId: 1639]

Probab=98.82  E-value=6.6e-09  Score=97.85  Aligned_cols=115  Identities=23%  Similarity=0.410  Sum_probs=81.2

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCC--------------------CCccccccCcEEecccc
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFP--------------------SDFSKLENLTSLHLQFN  126 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p--------------------~~~~~l~~L~~L~l~~N  126 (615)
                      .+++.+++++|.++ .++  .+..+++|+.|++++|...+..+                    ..+.++++|++|++++|
T Consensus        85 ~~l~~l~~~~n~~~-~i~--~l~~l~~L~~l~l~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~L~~L~l~~n  161 (227)
T d1h6ua2          85 TKITELELSGNPLK-NVS--AIAGLQSIKTLDLTSTQITDVTPLAGLSNLQVLYLDLNQITNISPLAGLTNLQYLSIGNA  161 (227)
T ss_dssp             CSCCEEECCSCCCS-CCG--GGTTCTTCCEEECTTSCCCCCGGGTTCTTCCEEECCSSCCCCCGGGGGCTTCCEEECCSS
T ss_pred             cccccccccccccc-ccc--cccccccccccccccccccccchhccccchhhhhchhhhhchhhhhcccccccccccccc
Confidence            35556666666555 443  25556666666666555443211                    23677888999999999


Q ss_pred             cccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccccCCcc
Q 007167          127 SFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSW  190 (615)
Q Consensus       127 ~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l  190 (615)
                      .+++..  .++++++|+.|+|++|++++ +| .+.++++|++|+|++|++++..|  +.+++.|
T Consensus       162 ~~~~~~--~l~~l~~L~~L~Ls~n~l~~-l~-~l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L  219 (227)
T d1h6ua2         162 QVSDLT--PLANLSKLTTLKADDNKISD-IS-PLASLPNLIEVHLKNNQISDVSP--LANTSNL  219 (227)
T ss_dssp             CCCCCG--GGTTCTTCCEEECCSSCCCC-CG-GGGGCTTCCEEECTTSCCCBCGG--GTTCTTC
T ss_pred             ccccch--hhcccccceecccCCCccCC-Ch-hhcCCCCCCEEECcCCcCCCCcc--cccCCCC
Confidence            998533  48899999999999999996 44 38999999999999999996443  4444443

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.72  E-value=3.4e-08  Score=98.70  Aligned_cols=112  Identities=26%  Similarity=0.322  Sum_probs=88.1

Q ss_pred             cEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeec
Q 007167           68 RVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDL  147 (615)
Q Consensus        68 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l  147 (615)
                      +++.|+|++++|+ .+|. .   +++|++|+|++|+|+ .+|..+   .+|+.|++++|+++ .++...   +.|++|+|
T Consensus        39 ~l~~LdLs~~~L~-~lp~-~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~-~l~~lp---~~L~~L~L  105 (353)
T d1jl5a_          39 QAHELELNNLGLS-SLPE-L---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLK-ALSDLP---PLLEYLGV  105 (353)
T ss_dssp             TCSEEECTTSCCS-CCCS-C---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCS-CCCSCC---TTCCEEEC
T ss_pred             CCCEEEeCCCCCC-CCCC-C---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccc-hhhhhc---cccccccc
Confidence            5778999999998 7885 2   578999999999999 668654   57899999999998 455321   46999999


Q ss_pred             CCCcCCccCCCcccCCCCCCeeeccCccccCCCccccccCCcccccCC
Q 007167          148 SNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAFAGN  195 (615)
Q Consensus       148 ~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~~~n  195 (615)
                      ++|.++. +|. ++++++|+.|++++|.++. .|.....+..+....+
T Consensus       106 ~~n~l~~-lp~-~~~l~~L~~L~l~~~~~~~-~~~~~~~l~~l~~~~~  150 (353)
T d1jl5a_         106 SNNQLEK-LPE-LQNSSFLKIIDVDNNSLKK-LPDLPPSLEFIAAGNN  150 (353)
T ss_dssp             CSSCCSS-CCC-CTTCTTCCEEECCSSCCSC-CCCCCTTCCEEECCSS
T ss_pred             ccccccc-ccc-hhhhccceeeccccccccc-cccccccccchhhccc
Confidence            9999994 674 6889999999999999984 4445555555554443

>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Ngr ectodomain-like
domain: Follicle-stimulating hormone receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.63  E-value=3.7e-08  Score=93.41  Aligned_cols=123  Identities=15%  Similarity=0.126  Sum_probs=66.9

Q ss_pred             cEEEEEeC-CCCcccccCCCcccCCCCccEEEcCCCCCCCc-------------------------CCCCccccc-cCcE
Q 007167           68 RVVALRLP-GMALRGEIPPNTIGRLSALQNLSLRSNSLSGL-------------------------FPSDFSKLE-NLTS  120 (615)
Q Consensus        68 ~v~~l~l~-~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~-------------------------~p~~~~~l~-~L~~  120 (615)
                      .+..+.+. .+++. .+++..|..+++|++|++++|.+...                         .+..|.+++ .++.
T Consensus        79 ~l~~l~~~~~n~l~-~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~  157 (242)
T d1xwdc1          79 KLHEIRIEKANNLL-YINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVI  157 (242)
T ss_dssp             TCCEEEEECCTTCC-EECTTSEECCTTCCEEEEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEE
T ss_pred             cccccccccccccc-ccccccccccccccccccchhhhccccccccccccccccccccccccccccccccccccccccee
Confidence            34444443 34555 44444566666666666666666533                         222333332 4556


Q ss_pred             EecccccccCCCCccccccccc-ceeecCCCcCCccCCCcccCCCCCCeeeccCccccCCCccccccCCcccc
Q 007167          121 LHLQFNSFSGPLPLDFSVWNNL-TVIDLSNNFFNASIPASISKLTHLSALNLANNSLTGTLPRSLQRFPSWAF  192 (615)
Q Consensus       121 L~l~~N~l~g~~p~~~~~l~~L-~~l~l~~N~l~~~~p~~~~~l~~L~~l~l~~N~l~g~~p~~~~~l~~l~~  192 (615)
                      |++++|+++. ++.......++ +.+++++|+++...+..|.++++|+.|+|++|+|+...+..|.+++.|..
T Consensus       158 L~l~~n~l~~-i~~~~~~~~~l~~~~~l~~n~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~  229 (242)
T d1xwdc1         158 LWLNKNGIQE-IHNCAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRA  229 (242)
T ss_dssp             EECCSSCCCE-ECTTTTTTCCEEEEECTTCTTCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEES
T ss_pred             eecccccccc-cccccccchhhhccccccccccccccHHHhcCCCCCCEEECCCCcCCccCHHHHcCCccccc
Confidence            6666666664 33333333333 33355666776433445677777777777777777443445666666543

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.31  E-value=4.9e-08  Score=95.08  Aligned_cols=127  Identities=24%  Similarity=0.253  Sum_probs=69.1

Q ss_pred             cEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccc-cccCC-CCccccccccccee
Q 007167           68 RVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFN-SFSGP-LPLDFSVWNNLTVI  145 (615)
Q Consensus        68 ~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N-~l~g~-~p~~~~~l~~L~~l  145 (615)
                      ++..|||+++.+++......+.++++|++|+|+++.+++..+..++.+++|++|+|+++ .++.. +..-+.++++|+.|
T Consensus        47 ~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L  126 (284)
T d2astb2          47 RVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDEL  126 (284)
T ss_dssp             CCCEEECTTCEECHHHHHHHHTTBCCCSEEECTTCBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEE
T ss_pred             CCCEEECCCCccCHHHHHHHHHhCCCcccccccccCCCcHHHHHHhcCCCCcCccccccccccccccchhhHHHHhcccc
Confidence            56666776666654332224556666666666666666655566666666666666663 34311 11112344555555


Q ss_pred             ecCCC-cCC----------------------------cc-CCCcccCCCCCCeeeccCc-cccCCCccccccCC---ccc
Q 007167          146 DLSNN-FFN----------------------------AS-IPASISKLTHLSALNLANN-SLTGTLPRSLQRFP---SWA  191 (615)
Q Consensus       146 ~l~~N-~l~----------------------------~~-~p~~~~~l~~L~~l~l~~N-~l~g~~p~~~~~l~---~l~  191 (615)
                      +|+++ +++                            .. +...+.++++|+.|+|++| .+++.....+.+++   .+.
T Consensus       127 ~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~  206 (284)
T d2astb2         127 NLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLS  206 (284)
T ss_dssp             ECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEE
T ss_pred             ccccccccccccchhhhcccccccchhhhcccccccccccccccccccccccccccccccCCCchhhhhhcccCcCCEEE
Confidence            55542 222                            10 1112245678888888875 56766665555444   445


Q ss_pred             ccC
Q 007167          192 FAG  194 (615)
Q Consensus       192 ~~~  194 (615)
                      +++
T Consensus       207 L~~  209 (284)
T d2astb2         207 LSR  209 (284)
T ss_dssp             CTT
T ss_pred             CCC
Confidence            555

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.30  E-value=7.5e-08  Score=85.28  Aligned_cols=65  Identities=28%  Similarity=0.231  Sum_probs=29.3

Q ss_pred             CCCCccEEEcCCCCCCCc--CCCCccccccCcEEecccccccCCCCcccccccccceeecCCCcCCc
Q 007167           90 RLSALQNLSLRSNSLSGL--FPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNA  154 (615)
Q Consensus        90 ~l~~L~~L~L~~N~l~g~--~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~  154 (615)
                      .+++|++|+|++|+|+..  ++..+..+++|+.|+|++|+++..-+-.+....+|+.|+|++|.++.
T Consensus        63 ~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~  129 (162)
T d1koha1          63 NIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSD  129 (162)
T ss_dssp             HCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSS
T ss_pred             hCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccccceeecCCCCcCc
Confidence            445555555555555532  12334445555555555555553211112222344555555555543

>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: mRNA export factor tap
domain: mRNA export factor tap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.28  E-value=1.2e-08  Score=90.68  Aligned_cols=93  Identities=23%  Similarity=0.136  Sum_probs=66.5

Q ss_pred             ccCCCCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCC--CCcccccccccceeecCCCcCCccCCCcccCCCC
Q 007167           88 IGRLSALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGP--LPLDFSVWNNLTVIDLSNNFFNASIPASISKLTH  165 (615)
Q Consensus        88 ~~~l~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~--~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~  165 (615)
                      +..+..+..|++.+|... .++..+.++++|++|+|++|+++..  ++..+..+++|+.|+|++|.|+...+-......+
T Consensus        38 l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L~Ls~N~i~~l~~l~~l~~~~  116 (162)
T d1koha1          38 LVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLK  116 (162)
T ss_dssp             TTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCCCCTTSCCCCGGGHHHHTTCC
T ss_pred             hhhccchhhcchhhhHhh-hhHHHHHhCCCCCEeeCCCccccCCchhHHHHhhCCcccccccccCccccchhhhhhhccc
Confidence            344444455555554433 4455566799999999999999853  2455778999999999999999643323334557


Q ss_pred             CCeeeccCccccCCCc
Q 007167          166 LSALNLANNSLTGTLP  181 (615)
Q Consensus       166 L~~l~l~~N~l~g~~p  181 (615)
                      |+.|+|++|.+++...
T Consensus       117 L~~L~L~~Npl~~~~~  132 (162)
T d1koha1         117 LEELWLDGNSLSDTFR  132 (162)
T ss_dssp             CSSCCCTTSTTSSSSS
T ss_pred             cceeecCCCCcCcCcc
Confidence            9999999999987655

>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Leucine rich effector protein YopM
domain: Leucine rich effector protein YopM
species: Yersinia pestis [TaxId: 632]

Probab=98.28  E-value=1.4e-06  Score=86.53  Aligned_cols=95  Identities=26%  Similarity=0.270  Sum_probs=73.0

Q ss_pred             CCccEEEcCCCCCCCcCCCCccccccCcEEecccccccCCCCcccccccccceeecCCCcCCccCCCcccCCCCCCeeec
Q 007167           92 SALQNLSLRSNSLSGLFPSDFSKLENLTSLHLQFNSFSGPLPLDFSVWNNLTVIDLSNNFFNASIPASISKLTHLSALNL  171 (615)
Q Consensus        92 ~~L~~L~L~~N~l~g~~p~~~~~l~~L~~L~l~~N~l~g~~p~~~~~l~~L~~l~l~~N~l~~~~p~~~~~l~~L~~l~l  171 (615)
                      .+|++|||++|+|+ .+|+.   +++|++|+|++|+|+ .+|..+   .+|+.|++++|+++. ++..   .+.|++|++
T Consensus        38 ~~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~-l~~l---p~~L~~L~L  105 (353)
T d1jl5a_          38 RQAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKA-LSDL---PPLLEYLGV  105 (353)
T ss_dssp             HTCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSC-CCSC---CTTCCEEEC
T ss_pred             cCCCEEEeCCCCCC-CCCCC---CCCCCEEECCCCCCc-ccccch---hhhhhhhhhhcccch-hhhh---ccccccccc
Confidence            46899999999998 57853   578999999999999 788764   578999999999984 5532   146999999


Q ss_pred             cCccccCCCccc--cccCCcccccCCCCCC
Q 007167          172 ANNSLTGTLPRS--LQRFPSWAFAGNNLSS  199 (615)
Q Consensus       172 ~~N~l~g~~p~~--~~~l~~l~~~~n~~~~  199 (615)
                      ++|.++ .+|..  +.++..+.+.+|.+..
T Consensus       106 ~~n~l~-~lp~~~~l~~L~~L~l~~~~~~~  134 (353)
T d1jl5a_         106 SNNQLE-KLPELQNSSFLKIIDVDNNSLKK  134 (353)
T ss_dssp             CSSCCS-SCCCCTTCTTCCEEECCSSCCSC
T ss_pred             cccccc-cccchhhhccceeeccccccccc
Confidence            999998 45642  3455566677776643

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.28  E-value=2e-08  Score=104.16  Aligned_cols=112  Identities=17%  Similarity=0.195  Sum_probs=86.5

Q ss_pred             CcEEEEEeCCCCcccccCCCcccCCCCccEEEcCCCCCCC----cCCCCccccccCcEEecccccccCC----CCcccc-
Q 007167           67 SRVVALRLPGMALRGEIPPNTIGRLSALQNLSLRSNSLSG----LFPSDFSKLENLTSLHLQFNSFSGP----LPLDFS-  137 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~i~~~~~~~l~~L~~L~L~~N~l~g----~~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~-  137 (615)
                      .+++.||++++++++.-=...+..+++|++|+|++|+|+-    .++..+..+++|++|||++|.++..    +...+. 
T Consensus         2 ~~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~   81 (460)
T d1z7xw1           2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQT   81 (460)
T ss_dssp             EEEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCS
T ss_pred             CCCCEEEeeCCcCChHHHHHHHHhCCCCCEEEeCCCCCCHHHHHHHHHHHhcCCCCCEEECcCCcCChHHHHHHHHHHhc
Confidence            3689999999999863212246678999999999999883    3455678899999999999998621    222232 


Q ss_pred             cccccceeecCCCcCCcc----CCCcccCCCCCCeeeccCccccC
Q 007167          138 VWNNLTVIDLSNNFFNAS----IPASISKLTHLSALNLANNSLTG  178 (615)
Q Consensus       138 ~l~~L~~l~l~~N~l~~~----~p~~~~~l~~L~~l~l~~N~l~g  178 (615)
                      ...+|+.|+|++|+++..    ++..+..+++|+.|+|++|.++.
T Consensus        82 ~~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~  126 (460)
T d1z7xw1          82 PSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD  126 (460)
T ss_dssp             TTCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHH
T ss_pred             CCCCCCEEECCCCCccccccccccchhhccccccccccccccchh
Confidence            235799999999999853    46678889999999999999874

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.11  E-value=7e-06  Score=78.10  Aligned_cols=129  Identities=14%  Similarity=0.099  Sum_probs=85.0

Q ss_pred             CccEEEEEEECCCCEEEEEEeccc-cCCHHHHHHHHHHHhCCC-CCcccceeEEEEecCeeeEEeecCCCCChhhhhccC
Q 007167          312 TFGTAYKAALEDASTVVVKRLKEV-NVGKREFEQQMEIVGGIR-HENVVALRAYYYSKDEKLMVYDYFEPGSVSAMLHGR  389 (615)
Q Consensus       312 ~fg~Vy~~~~~~~~~vavK~l~~~-~~~~~~~~~e~~~l~~l~-h~niv~l~~~~~~~~~~~lV~e~~~~gsL~~~l~~~  389 (615)
                      +.+.||+... ++..+++|+.... ......+.+|.+.+..+. +--+-+++.+..+++..++||+++++..+.+.....
T Consensus        26 s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~~  104 (263)
T d1j7la_          26 SPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYEDE  104 (263)
T ss_dssp             SSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTTC
T ss_pred             CCCcEEEEEe-CCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccccccc
Confidence            3468999864 5567888887644 223445778888776653 334567788888888999999999988776543211


Q ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHhhccC-------------------------------------------------
Q 007167          390 RGEGQSSLDWDTRVRIAIGAARGIAHIHTEN-------------------------------------------------  420 (615)
Q Consensus       390 ~~~~~~~l~~~~~~~i~~~ia~~l~~LH~~~-------------------------------------------------  420 (615)
                             .   ....++.++++.+..||+..                                                 
T Consensus       105 -------~---~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  174 (263)
T d1j7la_         105 -------Q---SPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFL  174 (263)
T ss_dssp             -------S---CHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHH
T ss_pred             -------c---cHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHH
Confidence                   0   11222333334444444211                                                 


Q ss_pred             -------CCCceecCCCCCCEEeCCCCcEEEeeccccc
Q 007167          421 -------GGKLVHGGIKASNIFLNSQGHVCVSDIGLAA  451 (615)
Q Consensus       421 -------~~~iiHrDik~~Nill~~~~~~kl~DfG~a~  451 (615)
                             .+.++|+|+.|.||++++++.+-|+||+.+.
T Consensus       175 ~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         175 KTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                   1237899999999999987777799999775

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=98.04  E-value=2.6e-07  Score=92.39  Aligned_cols=111  Identities=22%  Similarity=0.307  Sum_probs=59.6

Q ss_pred             ccCCCCccEEEcCCCCCCCc-----CCCCccccccCcEEecccccccCC----CCcccccccccceeecCCCcCCccCC-
Q 007167           88 IGRLSALQNLSLRSNSLSGL-----FPSDFSKLENLTSLHLQFNSFSGP----LPLDFSVWNNLTVIDLSNNFFNASIP-  157 (615)
Q Consensus        88 ~~~l~~L~~L~L~~N~l~g~-----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~~~~p-  157 (615)
                      +...+.|+.|+|++|+++..     +...+..+++|+.|+|++|.++..    +...+..+++|+.|+|++|.|++.-. 
T Consensus       182 l~~~~~L~~L~L~~n~i~~~g~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~  261 (344)
T d2ca6a1         182 FQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAA  261 (344)
T ss_dssp             HHHCTTCCEEECCSSCCCHHHHHHHHHTTGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHH
T ss_pred             hhhhhhhcccccccccccccccccchhhhhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhH
Confidence            34455666777776666531     233455666677777777666422    23345566667777777776664311 


Q ss_pred             ---CcccC--CCCCCeeeccCccccCC----Ccc----ccccCCcccccCCCCC
Q 007167          158 ---ASISK--LTHLSALNLANNSLTGT----LPR----SLQRFPSWAFAGNNLS  198 (615)
Q Consensus       158 ---~~~~~--l~~L~~l~l~~N~l~g~----~p~----~~~~l~~l~~~~n~~~  198 (615)
                         ..+..  .+.|+.|++++|+++..    +..    ....+..+.+++|.+.
T Consensus       262 ~l~~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~  315 (344)
T d2ca6a1         262 AVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS  315 (344)
T ss_dssp             HHHHHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSC
T ss_pred             HHHHHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCC
Confidence               11211  24566777777766532    111    1234555666666653

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.01  E-value=7.9e-06  Score=77.29  Aligned_cols=74  Identities=7%  Similarity=0.024  Sum_probs=52.9

Q ss_pred             cCcCCc-cEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCC--CCcccceeEEEEecCeeeEEeecCCCCChh
Q 007167          308 LGKGTF-GTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIR--HENVVALRAYYYSKDEKLMVYDYFEPGSVS  383 (615)
Q Consensus       308 lG~G~f-g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~--h~niv~l~~~~~~~~~~~lV~e~~~~gsL~  383 (615)
                      +..|.. +.||+....++..+++|.-....  ...+..|.+.++.+.  .-.+.+++++..+.+..++||+|+++-++.
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~--~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGA--LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCT--TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccC--HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence            444543 67999988888888889765442  335677777776653  233566788888888899999999876654

>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Cyclin A/CDK2-associated p19, Skp2
domain: Cyclin A/CDK2-associated p19, Skp2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.00  E-value=7.5e-07  Score=86.44  Aligned_cols=117  Identities=21%  Similarity=0.225  Sum_probs=56.3

Q ss_pred             CcEEEEEeCCC-Ccccc-cCCCcccCCCCccEEEcCCC-CCCCc-CCCCccc-cccCcEEecccc--cccCC-CCccccc
Q 007167           67 SRVVALRLPGM-ALRGE-IPPNTIGRLSALQNLSLRSN-SLSGL-FPSDFSK-LENLTSLHLQFN--SFSGP-LPLDFSV  138 (615)
Q Consensus        67 ~~v~~l~l~~~-~l~g~-i~~~~~~~l~~L~~L~L~~N-~l~g~-~p~~~~~-l~~L~~L~l~~N--~l~g~-~p~~~~~  138 (615)
                      .+++.|+|+++ +++.. +.. .+..+++|++|+|+++ .++.. ++..+.. .++|+.|+|++.  .++.. +...+.+
T Consensus        95 ~~L~~L~Ls~c~~itd~~l~~-l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~~i~~~~l~~l~~~  173 (284)
T d2astb2          95 SNLVRLNLSGCSGFSEFALQT-LLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRR  173 (284)
T ss_dssp             TTCSEEECTTCBSCCHHHHHH-HHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGGGSCHHHHHHHHHH
T ss_pred             CCCcCccccccccccccccch-hhHHHHhccccccccccccccccchhhhcccccccchhhhcccccccccccccccccc
Confidence            46777777764 44421 111 2345677777777763 34321 1122222 245666666542  22211 2222334


Q ss_pred             ccccceeecCCC-cCCccCCCcccCCCCCCeeeccC-ccccCCCcccc
Q 007167          139 WNNLTVIDLSNN-FFNASIPASISKLTHLSALNLAN-NSLTGTLPRSL  184 (615)
Q Consensus       139 l~~L~~l~l~~N-~l~~~~p~~~~~l~~L~~l~l~~-N~l~g~~p~~~  184 (615)
                      +++|+.|+|++| .+++.....+.++++|++|+|++ +.+++.....+
T Consensus       174 ~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L  221 (284)
T d2astb2         174 CPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLEL  221 (284)
T ss_dssp             CTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGG
T ss_pred             cccccccccccccCCCchhhhhhcccCcCCEEECCCCCCCChHHHHHH
Confidence            555666666553 35544455555556666666655 34554433333

>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: Rna1p (RanGAP1), N-terminal domain
domain: Rna1p (RanGAP1), N-terminal domain
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=97.90  E-value=6.2e-07  Score=89.56  Aligned_cols=112  Identities=21%  Similarity=0.240  Sum_probs=84.8

Q ss_pred             CcEEEEEeCCCCcccc-----cCCCcccCCCCccEEEcCCCCCCCc----CCCCccccccCcEEecccccccCCCCcc--
Q 007167           67 SRVVALRLPGMALRGE-----IPPNTIGRLSALQNLSLRSNSLSGL----FPSDFSKLENLTSLHLQFNSFSGPLPLD--  135 (615)
Q Consensus        67 ~~v~~l~l~~~~l~g~-----i~~~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~p~~--  135 (615)
                      ..++.|+|++|+++..     +.. .+..+++|+.|+|++|.++..    +...+..+++|++|+|++|.+++.-...  
T Consensus       186 ~~L~~L~L~~n~i~~~g~~~~l~~-~l~~~~~L~~L~Ls~N~i~~~g~~~L~~~l~~~~~L~~L~Ls~n~i~~~g~~~l~  264 (344)
T d2ca6a1         186 RLLHTVKMVQNGIRPEGIEHLLLE-GLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVV  264 (344)
T ss_dssp             TTCCEEECCSSCCCHHHHHHHHHT-TGGGCTTCCEEECCSSCCHHHHHHHHHHHGGGCTTCCEEECTTCCCCHHHHHHHH
T ss_pred             hhhcccccccccccccccccchhh-hhcchhhhcccccccccccccccccccccccccccchhhhhhcCccCchhhHHHH
Confidence            4688999999988632     223 577889999999999998743    4456788999999999999998542222  


Q ss_pred             --ccc--ccccceeecCCCcCCcc----CCCccc-CCCCCCeeeccCccccCC
Q 007167          136 --FSV--WNNLTVIDLSNNFFNAS----IPASIS-KLTHLSALNLANNSLTGT  179 (615)
Q Consensus       136 --~~~--l~~L~~l~l~~N~l~~~----~p~~~~-~l~~L~~l~l~~N~l~g~  179 (615)
                        +..  .+.|+.|+|++|+|+..    +...+. ++++|+.|+|++|++...
T Consensus       265 ~~l~~~~~~~L~~L~ls~N~i~~~~~~~l~~~l~~~~~~L~~L~l~~N~~~~~  317 (344)
T d2ca6a1         265 DAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEE  317 (344)
T ss_dssp             HHHHTCSSCCCCEEECCSSCCBHHHHHHHHHHHHHHCTTCCEEECTTSBSCTT
T ss_pred             HHhhhccCCCCCEEECCCCcCChHHHHHHHHHHHccCCCCCEEECCCCcCCCc
Confidence              222  35799999999999853    233442 578999999999999743

>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Ribonuclease inhibitor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.78  E-value=6e-07  Score=92.64  Aligned_cols=87  Identities=23%  Similarity=0.239  Sum_probs=44.0

Q ss_pred             CCccEEEcCCCCCCCcCCCC----ccccccCcEEecccccccCC----CCcccc-cccccceeecCCCcCCcc----CCC
Q 007167           92 SALQNLSLRSNSLSGLFPSD----FSKLENLTSLHLQFNSFSGP----LPLDFS-VWNNLTVIDLSNNFFNAS----IPA  158 (615)
Q Consensus        92 ~~L~~L~L~~N~l~g~~p~~----~~~l~~L~~L~l~~N~l~g~----~p~~~~-~l~~L~~l~l~~N~l~~~----~p~  158 (615)
                      ..|+.+++++|.++..-...    +....+|++|+|++|+++..    ++..+. ..+.|+.|+|++|+|+..    ++.
T Consensus       312 ~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~L~Ls~n~i~~~~~~~l~~  391 (460)
T d1z7xw1         312 CQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAA  391 (460)
T ss_dssp             CCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHH
T ss_pred             cccccccccccchhhhhhhhcccccccccchhhhheeeecccCcccchhhhhhhcccCCCCEEECCCCCCChHHHHHHHH
Confidence            34556666665555332222    22334566666666665431    222222 234566666666666531    333


Q ss_pred             cccCCCCCCeeeccCccccC
Q 007167          159 SISKLTHLSALNLANNSLTG  178 (615)
Q Consensus       159 ~~~~l~~L~~l~l~~N~l~g  178 (615)
                      .+..+++|++|+|++|+|+.
T Consensus       392 ~l~~~~~L~~L~Ls~N~i~~  411 (460)
T d1z7xw1         392 TLLANHSLRELDLSNNCLGD  411 (460)
T ss_dssp             HHHHCCCCCEEECCSSSCCH
T ss_pred             HHhcCCCCCEEECCCCcCCH
Confidence            44455666666666666653

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.46  E-value=0.00025  Score=71.37  Aligned_cols=73  Identities=8%  Similarity=0.078  Sum_probs=45.4

Q ss_pred             hcCcCCccEEEEEEECC-CCEEEEEEeccc--------cCCHHHHHHHHHHHhCC-CC--CcccceeEEEEecCeeeEEe
Q 007167          307 VLGKGTFGTAYKAALED-ASTVVVKRLKEV--------NVGKREFEQQMEIVGGI-RH--ENVVALRAYYYSKDEKLMVY  374 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~~-~~~vavK~l~~~--------~~~~~~~~~e~~~l~~l-~h--~niv~l~~~~~~~~~~~lV~  374 (615)
                      .||.|....||+....+ ++.|+||.-...        .........|.+.++.+ .+  ..+.+++.  .+.+..++||
T Consensus        33 eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~--~d~~~~~lvm  110 (392)
T d2pula1          33 EIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFY--SDTEMAVTVM  110 (392)
T ss_dssp             ECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEE--EETTTTEEEE
T ss_pred             EeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEE--EcCCCCEEEE
Confidence            48999999999998654 568888864321        11223345677777655 22  23444543  4566778999


Q ss_pred             ecCCCCC
Q 007167          375 DYFEPGS  381 (615)
Q Consensus       375 e~~~~gs  381 (615)
                      |++++..
T Consensus       111 E~L~~~~  117 (392)
T d2pula1         111 EDLSHLK  117 (392)
T ss_dssp             CCCTTSE
T ss_pred             eccCCcc
Confidence            9997654

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.24  E-value=2.8e-05  Score=68.46  Aligned_cols=65  Identities=14%  Similarity=0.059  Sum_probs=27.9

Q ss_pred             ccCCCCccEEEcCCCCCCCcC----CCCccccccCcEEecccccccCC----CCcccccccccceeecCCCcC
Q 007167           88 IGRLSALQNLSLRSNSLSGLF----PSDFSKLENLTSLHLQFNSFSGP----LPLDFSVWNNLTVIDLSNNFF  152 (615)
Q Consensus        88 ~~~l~~L~~L~L~~N~l~g~~----p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~l~l~~N~l  152 (615)
                      +...+.|++|+|++|.++..-    ...+...+.|++|+|++|.++..    +-..+...+.|+.|+|++|.+
T Consensus        40 L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~l~~aL~~n~sL~~L~l~~n~~  112 (167)
T d1pgva_          40 ACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLARLLRSTLVTQSIVEFKADNQRQ  112 (167)
T ss_dssp             HTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHHHHHHTTTTCCCSEEECCCCSS
T ss_pred             HhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHHHHHHHHhCCcCCEEECCCCcC
Confidence            334445555555555554211    12223344455555555554421    111233334455555555443

>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: nematode (Caenorhabditis elegans) [TaxId: 6239]

Probab=97.16  E-value=5.1e-05  Score=66.72  Aligned_cols=89  Identities=12%  Similarity=0.154  Sum_probs=66.2

Q ss_pred             cCCCCccEEEcCCC-CCCCc----CCCCccccccCcEEecccccccCC----CCcccccccccceeecCCCcCCcc----
Q 007167           89 GRLSALQNLSLRSN-SLSGL----FPSDFSKLENLTSLHLQFNSFSGP----LPLDFSVWNNLTVIDLSNNFFNAS----  155 (615)
Q Consensus        89 ~~l~~L~~L~L~~N-~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----~p~~~~~l~~L~~l~l~~N~l~~~----  155 (615)
                      .+.+.|++|+|+++ .++..    +-..+...++|++|+|++|.+...    +...+...+.|+.|+|++|.|+..    
T Consensus        12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~   91 (167)
T d1pgva_          12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR   91 (167)
T ss_dssp             TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred             hCCCCCcEEEeCCCCCCCHHHHHHHHHHHhhCCccceeeccccccchhHHHHHhhhhhhcccccceeeehhhcchHHHHH
Confidence            45688999999974 56532    223566778899999999998732    223455678899999999999853    


Q ss_pred             CCCcccCCCCCCeeeccCcccc
Q 007167          156 IPASISKLTHLSALNLANNSLT  177 (615)
Q Consensus       156 ~p~~~~~l~~L~~l~l~~N~l~  177 (615)
                      +-..+...++|+.|+|++|.+.
T Consensus        92 l~~aL~~n~sL~~L~l~~n~~~  113 (167)
T d1pgva_          92 LLRSTLVTQSIVEFKADNQRQS  113 (167)
T ss_dssp             HHHHTTTTCCCSEEECCCCSSC
T ss_pred             HHHHHHhCCcCCEEECCCCcCC
Confidence            2235667788999999999766

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.14  E-value=0.00093  Score=65.14  Aligned_cols=137  Identities=14%  Similarity=0.117  Sum_probs=79.3

Q ss_pred             cEEEEEEECCCCEEEEEEeccccCCHHHHHHHHHHHhCCCCCcc-----cce--eEEEEecCeeeEEeecCCCCChhh--
Q 007167          314 GTAYKAALEDASTVVVKRLKEVNVGKREFEQQMEIVGGIRHENV-----VAL--RAYYYSKDEKLMVYDYFEPGSVSA--  384 (615)
Q Consensus       314 g~Vy~~~~~~~~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~ni-----v~l--~~~~~~~~~~~lV~e~~~~gsL~~--  384 (615)
                      -.||++..++|..|++|.........+++..|.+.+..+....+     +..  -..+...+..+.++++++|..+..  
T Consensus        36 N~vy~v~~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~  115 (325)
T d1zyla1          36 NRVYQFQDEDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADN  115 (325)
T ss_dssp             SEEEEECCTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSC
T ss_pred             ceeEEEEcCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCC
Confidence            47999999999999999987666667888889888776632211     111  112244567888999987643321  


Q ss_pred             ------------hhc----cCCCCCCCCCCHHH----------------------HHHHHHHHHHHHHHh-hccCCCCce
Q 007167          385 ------------MLH----GRRGEGQSSLDWDT----------------------RVRIAIGAARGIAHI-HTENGGKLV  425 (615)
Q Consensus       385 ------------~l~----~~~~~~~~~l~~~~----------------------~~~i~~~ia~~l~~L-H~~~~~~ii  425 (615)
                                  .+|    .........+++..                      ....+..+...+.-. .+.....+|
T Consensus       116 ~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~li  195 (325)
T d1zyla1         116 IDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRL  195 (325)
T ss_dssp             HHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEEC
T ss_pred             HHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceee
Confidence                        111    11111111222211                      111222222222221 222234589


Q ss_pred             ecCCCCCCEEeCCCCcEEEeecccccc
Q 007167          426 HGGIKASNIFLNSQGHVCVSDIGLAAL  452 (615)
Q Consensus       426 HrDik~~Nill~~~~~~kl~DfG~a~~  452 (615)
                      |+|+.+.|||++++  ..++||+-+..
T Consensus       196 HgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         196 HGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             cCCCCcccEEEeCC--ceEEechhccc
Confidence            99999999999754  45899997753

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=96.36  E-value=0.0002  Score=62.55  Aligned_cols=109  Identities=14%  Similarity=0.140  Sum_probs=64.5

Q ss_pred             CcEEEEEeCC-CCcccc----cCCCcccCCCCccEEEcCCCCCCCc----CCCCccccccCcEEecccccccCC----CC
Q 007167           67 SRVVALRLPG-MALRGE----IPPNTIGRLSALQNLSLRSNSLSGL----FPSDFSKLENLTSLHLQFNSFSGP----LP  133 (615)
Q Consensus        67 ~~v~~l~l~~-~~l~g~----i~~~~~~~l~~L~~L~L~~N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~----~p  133 (615)
                      ..++.|+|++ +.++..    +-. .+...++|++|+|++|.++..    +-..+...++|+.|++++|.++..    +-
T Consensus        17 ~~L~~L~L~~~~~i~~~~~~~l~~-al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~l~   95 (166)
T d1io0a_          17 PDLEEVNLNNIMNIPVPTLKACAE-ALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILALV   95 (166)
T ss_dssp             TTCCEEECTTCTTCCHHHHHHHHH-HHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHHHH
T ss_pred             CCCcEEEcCCCCCCCHHHHHHHHH-HHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHHHHH
Confidence            4677777776 344321    111 345677788888888877643    223345567788888887776532    22


Q ss_pred             cccccccccceeec--CCCcCCc----cCCCcccCCCCCCeeeccCccc
Q 007167          134 LDFSVWNNLTVIDL--SNNFFNA----SIPASISKLTHLSALNLANNSL  176 (615)
Q Consensus       134 ~~~~~l~~L~~l~l--~~N~l~~----~~p~~~~~l~~L~~l~l~~N~l  176 (615)
                      ..+...+.|+.++|  ++|.+..    .+...+...++|+.|+++.|+.
T Consensus        96 ~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~~  144 (166)
T d1io0a_          96 EALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQQ  144 (166)
T ss_dssp             HGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSSH
T ss_pred             HHHHhCccccEEeeccCCCcCcHHHHHHHHHHHHhCCCcCEEeCcCCCC
Confidence            34556667765444  4566653    2344555667777777766544

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.82  E-value=0.0072  Score=60.26  Aligned_cols=71  Identities=8%  Similarity=0.104  Sum_probs=45.4

Q ss_pred             hcCcCCccEEEEEEECCC--------CEEEEEEeccccCCHHHHHHHHHHHhCCCCCccc-ceeEEEEecCeeeEEeecC
Q 007167          307 VLGKGTFGTAYKAALEDA--------STVVVKRLKEVNVGKREFEQQMEIVGGIRHENVV-ALRAYYYSKDEKLMVYDYF  377 (615)
Q Consensus       307 ~lG~G~fg~Vy~~~~~~~--------~~vavK~l~~~~~~~~~~~~e~~~l~~l~h~niv-~l~~~~~~~~~~~lV~e~~  377 (615)
                      .|+.|-.-.+|+....++        ..|++++.- .....-+..+|.++++.+.-.+++ ++++++.+    .+|+||+
T Consensus        49 ~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi  123 (395)
T d1nw1a_          49 RIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYI  123 (395)
T ss_dssp             EECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCC
T ss_pred             EcCCccccceEEEEeCCCCccccCCCCcEEEEecC-CcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEe
Confidence            477777889999886543        345554443 333345567888888877433444 67776632    5899999


Q ss_pred             CCCCh
Q 007167          378 EPGSV  382 (615)
Q Consensus       378 ~~gsL  382 (615)
                      ++-.+
T Consensus       124 ~g~~l  128 (395)
T d1nw1a_         124 PSRPL  128 (395)
T ss_dssp             CEEEC
T ss_pred             ccccC
Confidence            87544

>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: RNI-like
family: 28-residue LRR
domain: Tropomodulin C-terminal domain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=95.22  E-value=0.0017  Score=56.42  Aligned_cols=90  Identities=14%  Similarity=0.210  Sum_probs=64.4

Q ss_pred             ccCCCCccEEEcCC-CCCCCc----CCCCccccccCcEEecccccccCCC----CcccccccccceeecCCCcCCcc---
Q 007167           88 IGRLSALQNLSLRS-NSLSGL----FPSDFSKLENLTSLHLQFNSFSGPL----PLDFSVWNNLTVIDLSNNFFNAS---  155 (615)
Q Consensus        88 ~~~l~~L~~L~L~~-N~l~g~----~p~~~~~l~~L~~L~l~~N~l~g~~----p~~~~~l~~L~~l~l~~N~l~~~---  155 (615)
                      ..+.+.|++|+|++ |.++..    +-..+...++|++|+|++|.++..-    -..+...+.|+.+++++|.++..   
T Consensus        13 ~~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~   92 (166)
T d1io0a_          13 QNNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGIL   92 (166)
T ss_dssp             HTTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHH
T ss_pred             HhcCCCCcEEEcCCCCCCCHHHHHHHHHHHhcCCccCeeeccCCcccHHHHHHHHHHHhhcccchhhhhccccccchhHH
Confidence            45678999999998 567632    2234567889999999999887432    22456678999999999998743   


Q ss_pred             -CCCcccCCCCCCeeec--cCcccc
Q 007167          156 -IPASISKLTHLSALNL--ANNSLT  177 (615)
Q Consensus       156 -~p~~~~~l~~L~~l~l--~~N~l~  177 (615)
                       +-..+...++|+.++|  ++|.+.
T Consensus        93 ~l~~~l~~~~~L~~l~L~l~~n~i~  117 (166)
T d1io0a_          93 ALVEALQSNTSLIELRIDNQSQPLG  117 (166)
T ss_dssp             HHHHGGGGCSSCCEEECCCCSSCCC
T ss_pred             HHHHHHHhCccccEEeeccCCCcCc
Confidence             2356677788886555  567775

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=93.70  E-value=0.039  Score=52.60  Aligned_cols=30  Identities=17%  Similarity=0.288  Sum_probs=26.6

Q ss_pred             CCceecCCCCCCEEeCCCCcEEEeeccccc
Q 007167          422 GKLVHGGIKASNIFLNSQGHVCVSDIGLAA  451 (615)
Q Consensus       422 ~~iiHrDik~~Nill~~~~~~kl~DfG~a~  451 (615)
                      .++||+|+.+.||+++.+...-|.||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            359999999999999998877899999774